system_prompt,user_prompt,assistant_output
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: LEFT SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR (0/1). PART 2: LEFT SENTINEL LYMPH NODE #2, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR (0/1). PART 3: LEFT SENTINEL LYMPH NODE #3, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR (0/1). PART 4: SKIN OF LEFT BREAST, EXCISION -. SKIN WITH FIBROSIS. PART 5: LEFT BREAST, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCT CARCINOMA 1.0 X 1.0 X 0.9 CM ASSOCIATED WITH MICROCALCIFICATIONS. B. NOTTINGHAM SCORE 6 OUT OF 9 (TUBULES 3, NUCLEI 2, MITOSIS 1). C. NO LYMPHOVASCULAR INVASION IDENTIFIED. D. DUCTAL CARCINOMA IN-SITU, CRIBRIFORM TYPE, NUCLEAR GRADE 2 COMPRISING 1% OF INVASIVE. TUMOR. E. SURGICAL MARGINS NEGATIVE. F. CLOSEST MARGIN ANTERIOR-0.4 CM. G. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITES. H. TUMOR IS ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE AND HER-2/NEU. NEGATIVE AS PER CORE BIOPSY REPORT. I. FIBROCYSTIC CHANGES, FIBROADENOMATOID NODULES AND MICROCALCIFICATIONS ASSOCIATED. WITH BENIGN DUCTS. J. THERMAL EFFECT. PART 6: LEFT BREAST, NEW INFERIOR MARGIN, RESECTION -. NEGATIVE FOR TUMOR. PART 7: LEFT BREAST, EXCISION OF FIBROADENOMA- -. A. FIBROADENOMA. B. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 2. DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by in situ component: 1 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: Fibroadenoma, FCD. T STAGE, PATHOLOGIC: pT1b. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Patient ID: Gross Description: Renal tumor is located in a pole, moderately-margin, soft, solid, or yellow, gray. surface with 5x4x4cm in size. Microscopic Description: Tumor is high density and is composed of elongated tubules or papillary, back. to back, variability in shape and size, lined by moderrately straitified cylindrical or cuboidal cells. Nuclei. are irregular large, hyperchromatic with prominent nucleioli. Mitoses are present. Cytoplasm are. moderate, eosinophilic or clear. Diagnosis Details: Renal cell carcinoma, papillary type. Comments: Formatted Path Reports: KIDNEY TISSUE CHECKLIST. Specimen type: Radical nephrectomy. Tumor site: Kidney. Tumor size: 5x4x4cm. Focality: Single -. Histologic type: Papillary renal cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Limited to kidney. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Left.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: A. Left kidney: Papillary renal cell carcinoma, grade 1/4, 4 cm,. confined to the kidney. Procedure/laterality: Left robotic nephrectomy. Histologic type Papillary renal cell carcinoma, type I. Nuclear grade (Fuhrman, 1-4) : Grade 1/4. Tumor size: 4 X 3.7 X 3.7 cm. Tumor site: Upper pole left kidney. Tumor focality: A single circumscribed lesion in the cortex. Sarcomatoid features: Absent. Tumor necrosis: Absent. Microscopic tumor extension: No extension into perinephric tissue,. renal sinus, renal vein or collecting system. Surgical margins The external soft tissue and ureteral margins are. negative for carcinoma. Lymph-vascular invasion: Absent. Lymph nodes Absent. Pathologic findings in nonneoplastic kidney Adjacent to the. carcinoma there is a 2 cm unilocular renal cyst. Sections of cortex away from the carcinoma show less than 58. sclerotic glomeruli, minimal interstitial fibrosis, some dilated. atrophic tubules, and severe renal artery and intra-renal artery. atherosclerosis. Pathologic staging: pTla, pNX. Biorepository sample (if applicable) : Yes, non-malignant cortex and. carcinoma. Block (s) containing malignancy suitable for additional testing: A1,. A3, A4, A5. The frozen section diagnosis is confirmed by the permanent sections. CLINICAL INFORMATION: Left renal mass. SPECIMEN (S) : A:Left kidney. PRELIMINARY INTRAOPERATIVE DIAGNOSIS: A. Left kidney, frozen section diagnosis : Papillary renal cell. carcinoma. GROSS DESCRIPTION: and ""left kidney"". Procedure : Radical nephrectomy. Specimen laterality: Left. Tumor site: Upper pole. Tumor size: 4.0 x 3.7 x 3.7 cm. Tumor focality: Unifocal. Gross extent of tumor: Extension into perinephric tissue: : Absent. Extension beyond Gerota's fascia: Absent. Extension into renal sinus: : Absent. Extension into renal vein: Absent. Extension into collecting system: Absent. Adrenal gland: Absent. Gross notes: Gross tumor characteristics : Well-demarcated, tan and a rubbery. mass with somewhat obulated-appearing cut surfaces with a couple. foci of yellow-orange, moderately soft areas measuring up to 1.2 cm. in greatest dimension. Kidney weight : 564 g with fat; weight without fat 165 g. Kidney dimensions: 11.5 X 6.0 x 4.7 cm. Ureter dimensions: Length--8.5 cm and diameter--0.4 cm. Lymph nodes : None identified. Inking details: : The outer-most surface of the fat adjacent to. the mass is inked blue. Biorepository sample submitted: Yes, see block key. Other findings : Abutting the mass, there is a 2.0-cm in greatest. dimension unilocular cyst compartment containing tan, clear fluid. The inner cyst lining is smooth. Block key for specimen A: A1) representative section of mass submitted for frozen section. A2) ureter margin and vascular margins at hilum, shave. A3-A4) - mass in relation to inked outer surface of adjacent fat. A5) mass in relation to adjacent cystic structure. A6) mass in relation to adjacent parenchyma and superior calyx. A7) inferior pole, to include parenchyma and inferior calyx. A8) mirror image of tissue submitted for. (grossly. normal parenchyma and tumor).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Physician Portal. TEST: Surgical Pathology. Result Name. Reference Range. Frozen Section Diagnosis: Large cell carcinoma, margins free. Pre-Op Diagnosis. Left lung cancer. Post-Op Diagnosis. Same as above. Clinical History. Same as above. Gross Description: Received in a single container labeled. wedge. resection left upper lobe. The specimen consists of a wedge. resection of the lung measuring 9 x 6 x 1.5 cm. The pleural surface. is yellow to red tan and slightly anthracotic. On sectioning reveals. a circumscribed white tan firm nodule measuring 2 cm in greatest. dimension that is 0.1 cm from the pleural surface and extends 1 cm. from the resection margin. A representative section was examined at. the time of surgery. Received with the specimen are cassettes. labeled. Representative sections are submitted as. follows: A frozen section, B shaved resection margin, C through F. additional sections from nodule. Microscopic Description: The slides labeled are examined. See diagnosis. Final Diagnosis. Lung, left upper lobe (wedge biopsy) : Adenocarcinoma: moderately differentiated. measuring 2.0 cm in greatest diameter. extending up to but not through pleura. tumor identified within endothelial lined lymphovascular space. areas of fibrosis. lymph nodes: No lymph nodes resected (see comment). PAS 9. SPC-A. CPT: 88307, 88331. Comments. The frozen section diagnosis is confirmed. In some areas dense fibrosis is present associated with the tumor. Although the adenocarcinoma grows along alveolar spaces, the areas of. fibrosis remove this from the differential diagnosis of a. bronchoalveolar carcinoma. The tumor focally extends up to the. pleural surface but does not extend into the pleural surface. This test has been finalized at the. Campus.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
""inical Diagnosis & History: female with invasive ductal carcinoma right breast. Specimens Submitted: 1: SP: Sentinel node #1 level one right axilla (fs). 2: SP: Sentinel node #2 level one right axilla (fs). 3: SP: Right breast tissue. 4: SP: Medial margin, right breast. 5: SP: Superior margin, right breast. 6: SP: Inferior margin, right breast. 7: SP: Lateral margin, right breast. 8: SP: Posterior margin, right breast. DIAGNOSIS: Summary of findings in this case: Invasive lobular carcinoma spans 2.2 cm and does not involve the separately. submitted margins. Sentinel lymph nodes: 1/2. Non-sentinel lymph nodes: 0. Total lymph nodes: 1/2. Type of metastasis: ITC. 1. LYMPH NODE SENTINEL #1, LEVEL I, RIGHT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). -ADDITIONAL H/E STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS FOR. CYTOKERATINS (AE1:AE3) SHOW NO EVIDENCE OF METASTATIC TUMOR. 2. LYMPH NODE, SENTINEL #2 LEVEL I RIGHT AXILLA; EXCISION: - RARE CYTOKERATIN-POSITIVE CELLS (ABOUT 10 CELLS) ARE PRESENT IN 1 OF. 1 LYMPH NODE (s) THESE CELLS ARE NOT IDENTIFIED ON THE CORRESPONDING H/E. STAINED SECTIONS OR IN THE FROZEN SECTION SLIDE OR IN THE FROZEN SECTION. CONTROL SLIDE. BREAST, RIGHT; EXCISION: - INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE, MEASURING 2.2 CM IN. LARGEST DIMENSION MICROSCOPICALLY. A NEGATIVE E-CADHERIN STAINING SUPPORTS. THE MORPHOLOGIC IMPRESSION OF LOBULAR PHENOTYPE. - EXTENSIVE LOBULAR CARCINOMA IN SITU (LCIS) IS ALSO IDENTIFIED. - NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. NO VASCULAR INVASION IS NOTED. SURGICAL MARGINS (SEE PARTS 4-8). THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES. - RESUT me. STAINS (HER2-NEU) ARE AS FOLLOWS: HER2. Negative (1+). (1% of invasive tumor cells exhibit complete membranous staining;. Uniformity of staining: absent;. Homogeneous, dark circumferential. 3ent). Comment: Controls are satisfactory. PATHWAY anti-HER-2/neu is an. FDA-approved rabbit monoclonal primary antibody (clone 4B5) directed against. the internal domain of the c-erbB-2 oncoprotein (HER2) for. immunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation. The HER2 test. results are reported in accordance with the ASCO/CAP guideline. recommendations for HER2 testing in breast cancer (J Clin Oncol 2007;. 25 (1) ):118-145). 4. BREAST, RIGHT, MEDIAL MARGIN; EXCISION: - BREAST TISSUE WITH LOBULAR CARCINOMA IN SITU (LCIS). 5. BREAST, RIGHT, SUPERIOR MARGIN; EXCISION: - BREAST TISSUE WITH LOBULAR CARCINOMA IN SITU (LCIS) . BREAST, RIGHT, INFERIOR MARGIN; EXCISION: - BREAST TISSUE WITH LOBULAR CARCINOMA IN SITU (LCIS). 7. BREAST, RIGHT, LATERAL MARGIN; EXCISION: - BREAST TISSUE WITH LOBULAR CARCINOMA IN SITU (LCIS). 8. BREAST, RIGHT, POSTERIOR MARGIN; EXCISION: - BENIGN FIBROADIPOSE TISSUE AND SKELETAL MUSCLE. Some of the immunohistochemistry and ISH tests were develoned and. performance characteristics were determined by i. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of 1988 (CLIA , 88) as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh for frozen section consultation labeled. ""sentinel node #1, level 1, right axilla"" and consists of a single lymph. node measuring 0.4 cm in greatest dimension. The lymph node is bisected and. entirely submitted for frozen section consultation. Summary of sections: FSC-frozen section control. 2) The specimen is received fresh for frozen section consultation labeled. Sentinel node #2, level 1, right axilla"" and consists of a single lymph. node measuring 1.9 cm in greatest dimension, which is bisected and entirely. submitted for frozen section consultation. Summary of sections: FSC-frozen section control. 3) The specimen is received fresh, labeled ""Right breast tissue"" and. consists of an unoriented, 7.2 x 5.5 x 3.3 cm, piece of fibrofatty breast. tissue with a needle localization wire. The company specimen radiograph. displays the needle localization wire in place and a Bar-clip located. at. coordinates: F,G-5,6. The specimen is entirely inked black. Serial. sectioning reveals the Bar-clip situated within a 2.3 x 2.3 x 2.1 cm, poorly. defined, lobular bordered, fatty infiltrating, pink-white mass with fine. tan-yellow reticulations, located 0.1 cm from the closest inked resection. margin. Partially surrounding the mass is a 4.8 x 4.1 x 3.0 cm area of. moderately dense, focally nodular, tan-white fibrous tissue which is. separated by scant lobules of yellow-orange adipose. A representative. section of the tumor is submitted to TPS. Representative sections are. submitted for permanent. Summary of sections: MT - tumor and closest tissue edge. FFT -- full face of tumor. T - tumor. RS -- representative sections. 4) The specimen is received fresh, labeled ""Medial margin, right breast"" and. consists of a piece of fibrofatty breast tissue measuring 3.8 x 2.1 cm, and. 1.0 cm thick. A clip marks the new margin of excision, which is inked black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - sequential sections. 5) The specimen is received fresh, labeled ""Superior margin, right breast"". 'and consists of a piece of fibrofatty breast tissue measuring 3.0 x 2.5 cm,. and 1.0 cm thick. A clip marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - sequential sections. 6) The specimen is received fresh, labeled ""Inferior margin, right breast"". and consists of a piece of fibrofatty breast tissue measuring 2.8 x 1.7 cm,. and 0.8 cm thick. A clip marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - sequential sections. 7) The specimen is received fresh, labeled ""Lateral margin, right breast"". and consists of a piece of fibrofatty breast tissue measuring 5.1 x 2.1 cm,. and 1.3 cm thick. A clip marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - sequential sections. 8) The specimen is received fresh, labeled ""Posterior margin, right breast"". and consists of a piece of fibrofatty breast tissue measuring 2.3 x 1.7 cm,. and 0.5 cm thick. A clip marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - seguential sections. Summary of Sections: Part 1: SP: Sentinel node #1 level one right axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Sentinel node #2 level one right axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Right breast tissue. 'Blbck. Sect. Site. PCs. 1. FFT. 1. 1. MT. 1. 3. RS. 5. 4. 4. Part 4: SP: Medial margin, right breast. Block. Sect. Site. PCs. 5. SS. 8. Part 5: SP: Superior margin, right breast. Block. Sect. Site. PCs. 6. SS. 8. Part 6: SP: Inferior margin, right breast. Block. Sect. Site. PCs. 3. SS. 7. Part 7: SP: Lateral margin, right breast. Block. Sect. Site. PCs. 6. SS. 12. Part 8: SP: Posterior margin, right breast. Block. Sect. Site. PCs. 2. SS. 5. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTTON mrn ""NOSIS: SP: Sentinel node #1 level one right. axilla (fs) : Benign. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION ITRAGNOSIS: SP: Sentinel node #2 level one right. axilla (fs) : Benign. PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #1 level one right. axilla (fs) : Benign. PERMANENT DIAGNOSIS: SAME. '2). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #2 level one right. axilla (fs): Benign. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Gender: M. Histology Report. Status Final. Clinician: Document Id: Microscopic Diagnosis: A) Lymph nodes, superficial zone 2 of left neck, dissection: - Six lymph nodes and associated soft tissue, negative for carcinoma (0/6). B) Left mandible, mandibulectomy: - Invasive well differentiated keratinizing squamous cell carcinoma (4.2 cm). - Carcinoma invades into mandibular bone. - Perineural invasion is identified. - Microscopic focus of carcinoma is present on section of posterior bony margin; all other. sampled margins are negative for carcinoma. - See Comments and Macroscopic and Microscopic Summary. C) ""True posterior margin (RNT),"" excision: - Negative for carcinoma (benign squamous mucosa, fibroadipose tissue and skeletal muscle with. tal chronic inflammation). D) Left alveolar nerve, biopsy: - Negative for carcinoma (benign nerve tissue). E) True deep posterior margin, excision: Negative for carcinoma (benign fibroadipose tissue, skeletal muscle and nerve tissue). F) Lymph nodes, zone 1 of right neck, dissection: Six lymph nodes and associated soft tissue, negative for carcinoma (0/6). G) Lymph nodes, zones 2 and 3 of right neck, dissection: - Seven lymph nodes and associated soft tissue, negative for carcinoma (0/7). H) Lymph nodes, zone 1 of left neck, dissection: - Eleven lymph nodes and associated soft tissue, negative for carcinoma (0/11). I) Lymph nodes, zones 2 and 3 of left neck, dissection: - Twenty-three lymph nodes and associated soft tissue, negative for carcinoma (0/23). J) Teeth numbers 5, 6, 23, 10 and 26, extraction: - Teeth (gross diagnosis). Comments: The carcinoma cells are strongly (3+) and diffusely (almost 100%) positive for EGFR by immunohistochemistry. HPV studies have been ordered and will be reported separately. has reviewed key slides of this case and concurs with the diagnosis. Clinical History: An year-old male with squamous cell carcinoma of the left mandible. MACROSCOPIC AND MICROSCOPIC SUMMARY. Specimen: Mandible (partial). Procedure: Segmental mandibulectomy. Specimen Integrity: Intact. SpÃ©cimen Laterality: Left. nor Site: Mandible. Tumor Focality: Single focus. Tumor Size: Greatest dimension: 4.2 cm (additional dimensions: 2.6 x 1.5 cm). Histologic Type: Squamous cell carcinoma, conventional, keratinizing. Histologic Grade: G1: Well differentiated. Margins: Focally positive for carcinoma (Specify margin: microscopic focus involving posterior bony margin). Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Pathologic Staging (pTNM): Primary Tumor (pT). pT3: Tumor more than 4 cm in greatest dimension. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. (Specify: number examined: 53; number involved: 0). Distant Metastasis (pM). Not Applicable. Gross Description: Received are ten specimens, labeled with the patient's name and medical record number. A Fresh, labeled ""left superficial zone 2 lymph nodes,"" are two fragments of red-tan fatty tissue, measuring 1.8 x 1 x 0.4 cm and 1.4 x 0.7 >. cm. The larger fragment is bisected and entirely submitted for frozen sectioning, and the remnant is submitted for permanent in cassette. (FSA1). The smaller fragment is bisected and entirely submitted entirely for frozen sectioning, and the remnant is submitted for permanent i. cassette (FSA2). B) Fresh, labeled ""left composite resection,"" is a partial resection of mandible, measuring 6.7 cm in length and 2.5 x 1.3 cm in average cross. sectional area, with attached muscle and soft tissue. There is a single long stitch designated as ""anterior"", a double long stitch is designated : ""posterior,"" a single short stitch designated as ""lateral,"" and a double short stitch which is designated as ""medial"". At the anterior aspect of t. specimen there is single remaining tooth with a metal cap. The overlying muscle and soft tissue is yellow-white and fibrotic. On the medial. aspect of the specimen there is an ulcerated, friable, tan-pink tumor, measuring 4.2 x 2.6 x 1.5 cm. A rim of mucosal tissue surrounds the. lesion, and the soft tissue margins appear negative for tumor on gross examination. The bony margins are viable-appearing without evidence. of necrosis or tumor on gross examination. The specimen's surgical margins are inked as follows: Lateral = Green. Medial = Blue. Posterior = Red. Anterior = Orange. Representative sections are then submitted as follows: (B1-B2) Bone underlying tumor, following decalcification. (B3) Anterior lateral mucosal margin. (B4-B8) Full thickness sections of tumor, every other section. (B9) Tumor with posterolateral margin. (B10) Tumor with posteromedial margin. (B11) Tumor with anteromedial margin. (B12) Anterior soft tissue margin. (B13) Inferomedial soft tissue margin. (214) Inferolateral soft tissue margin. 5) Anterior bony margin, en face, following decalcification. (B16) Posterior bony margin, en face, following decalcification. Pt. Name: Print Date: C) Fresh, labeled ""true posterior margin (RNT),"" is a fragment of tissue, 2.5 x 0.5 x 0.3 cm. The specimen is submitted entirely for frozen. section and the remnant is submitted for permanent in cassette (FSC1). D). Fresh,. labeled. ""left. alveolar. nerve,"". is. a. fragment. of. soft. tissue,. 0.5. x. 0.3. x. 0.2. cm. The. specimen. is. submitted. entirely. for. frozen. section. the remnant is submitted for permanent in cassette (FSD1). E) Fresh, labeled ""true deep posterior margin,"" is a fragment of red soft tissue, 1 x 1 x 0.5 cm. The specimen is bisected and submitted. entirely for frozen section and the remnant is submitted for permanent in cassette (FSE1). F) Formalin, labeled ""right neck dissection zone 1,"" is a single fragment of yellow adipose tissue, 6.0 x 3.5 x 2.2 cm, which includes. multip. palpable lymph nodes. Representative sections are submitted as follows: (F1) Three candidate lymph nodes. (F2) One candidate lymph node, bisected. (F3) One candidate lymph node, bisected. (F4-F5) Representative adipose tissue. G) Formalin, labeled ""right neck dissection zone 2 and 3 (stitch on zone 2),"" is a single fragment of yellow-tan fibroadipose tissue, 6.8 x 3.8. 2.0. cm,. with a single black stitch designating the zone 2 location. There is a single palpable lymph node within zone 2 and multiple palpable. lymph nodes within zone 3. Representative sections are submitted as follows: (G1) One candidate lymph node, bisected, zone 2. (G2) Two candidate lymph nodes, zone 3. (G3) One candidate lymph node, bisected, zone 3. (G4-G5) Representative adipose tissue, zone 3. H) Formalin, labeled ""left neck dissection, zone 1,"" is a single fragment of yellow-brown fibroadipose tissue, 9.8 x 4.5 x 2.0 cm. There are. multiple palpable lymph nodes within the specimen. Representative sections are submitted as follows: (H1) Six candidate lymph nodes. One candidate lymph node, bisected. (n3) One candidate lymph node, bisected. (H4) One candidate lymph node, bisected. (H5) One candidate lymph node. (H6) One candidate lymph node, bisected. (H7) One candidate lymph node. (H8-H10) Representative adipose tissue. I) Formalin, labeled ""left neck dissection, zone 2 and 3 (stitch on zone 2),"" is a single fragment of yellow-brown fibroadipose tissue, 9.7 x 3. x 1.5 cm, with a single stitch designating zone 2. There are multiple palpable lymph nodes within zone 2 and zone 3. Representative sectior. are submitted as follows: (II) Three candidate lymph nodes, zone 2. (I2) One candidate lymph node, bisected, zone 2. (I3-I4) I3 and I4 together equal one candidate lymph node, bisected, zone 2. (I5) Five candidate lymph nodes, zone 3. (I6) Six candidate lymph nodes, zone 3. (I7) One candidate lymph node, bisected, zone 3. (18) Two candidate lymph nodes, zone 3. (I9-I10) Representative adipose tissue, zone 3. J) Formalin, labeled ""teeth #5, 6, 23, 10, 26,"" are five extracted teeth, 4.5 x 3 x 0.5 cm in aggregate. A digital photograph is taken. No tissu. is submitted for histology. Intraoperative Consultation: ten section consultation. (FSA1): Lymph node tissue, negative for carcinoma. Pt. Name. Print Date: /. (FSA2): Lymph node tissue, negative for carcinoma. Total time: 19 minutes. C): Negative for carcinoma. (rSD): Negative for carcinoma. (FSE): Negative for carcinoma. Total time: Interpreted bv: Interpreted by: Some tests used in this case were developed in and their performance characteristics determined by the. The procedures and reagents have been validated by evaluation of both negative and positiv. controls. This testing has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that suc. clearance or approval is not necessarv. Test results are used for clinical purposes. They should not be regarded as investigational or for. research. The. is accredited by the College of American Pathologists and is certified under. the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing. ertify that (1) all services on this form were rendered and are hereby approved for billing, (2) all specimens/slides have been. examined/reviewed, (3) the medical record has been documented for these services, and (4) the rendering of the services and the. documentation in the medical record are in accordance with. guidelines."". The following special evaluations were performed on this specimen. Please refer to the Microscopic Description or Comment section(s). Stain. Specimen. Block. Level. Tissue. EGFr. B. 6. 2. Bone. HPV. B. 6 3 Bone. CMOCO-ENT. B. 6. 4. Bone. Recut. B. 6. 5. Bone. EGFr. B. 6. 6. Bone. The following cases, on this patient, were collected on the same day as this case. Pt. Name. Print Date:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis/Diagnoses: 16-cm long large bowel resection specimen including a polypoid, moderately differentiated. adenocarcinoma of the colorectal type with infiltration of the pericolic fatty tissue and with three. regional lymph node metastases. Tumor-free large bowel resection margins. Tumor-free. mesenteric resection margin. An inflammatory portion of the urinary bladder fused with the large. bowel and a ductus deferens segment, adhering in the tumor area. Tumor stage: pT3 pN1 (3/43) pMX; G2, LO V0, local R0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
AP Surgical Pathology: Corrected. CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. ""Left axilla non-sentinel node (AF1) "". Received fresh for frozen section is. a 1.8 x 1 x 0.6 cm tan-yellow lymph node candidate which is bisected and. frozen as AF1, the frozen section remnant is submitted in block A1. B. ""Left sentinel node number one (BF1) "". Received fresh for frozen section. are three tan-yellow lymph node candidates. The larger lymph node candidate (2. x 1.2 x 1 cm) is bisected and frozen as BF1, and frozen section remnant is. submitted in block B1. The remaining two lymph node candidates (0.5 x 0.5 x. 0.3 cm and 1 x 0.7 x 0.4 cm lymph node candidate) are submitted in toto as. frozen section BF2, and the frozen remnant is submitted in block B2. C. ""Left sentinel node number two (CF1) Received fresh for frozen section is. a 3 x 2.5 x 0.8 cm fragment of tan-yellow fibrofatty tissue. One lymph node. candidate is identified (1.9 x 1 x 0.7 cm) which is bisected and frozen as. CF1. The frozen section remnant is submitted in block C1. D. ""Left breast cancer, 1:00"", received fresh and placed in formalin: Procedure: Wire guided partial mastectomy. Specimen orientation: Suture: long=lateral, short-superior. Clips: two clips. medial, one clip=inferior. Specimen dimensions: Medial to Lateral: 8.5 cm. Anterior to Posterior: 2.5 cm. Superior to Inferior: 9.5 cm. Skin dimensions: 4.3 x 1.3 cm with a 0.4 cm long scar. Margins inked: Superior: Red. Inferior: Yellow. Anterior: Blue. Posterior: Black. Sectioned: Medial to lateral. Gross findings: There is a tan-white indurated ill defined area with. peripheral hemorrhage and fat necrosis. Lateral and superior to this area is a. second focus of white-tan induration with adjacent thick white-tan fibrous. tissue. The remaining parenchyma is tan-yellow lobulated adipose tissue. Gross tumor size: 2.3 x 2.1 x 1.2 cm. Multifocal tumor: Additional lesion is 1.2 x 0.8 x 0.5 cm which directly abuts. the primary focus. Distance of tumor from gross surgical margin for the primary tumor: Superior: 2.1 cm. Inferior: 3.2 cm. Anterior: 0.6 cm. Posterior: 1.2 cm. Medial: 4.2 cm. Lateral: 1 cm. Additional lesion: Superior: 3.1 cm. Inferior: 2 cm. Anterior: 1 cm. Posterior: 1 cm. Medial: 6.9 cm. Lateral: 0.5 cm. Sectioned specimen radiographed? Yes. Radiograph findings: Mass: Yes. Microcalcifications: Yes. Biopsy site microclip: No. Specimen photograph? Yes. Block diagram? Yes. Sections submitted from medial to lateral in blocks D1 through D35. Specimen completely submitted? No. BLOCK SUMMARY: Medial margin-D1. Lateral margin-D34 and D35. Inferior margin: D13. Superior margin: D19. Anterior and posterior margins: D23. Primary tumor: D10, D11, D15, D16, D17, D18, D21, D22, D23, D24, D25, D27,. D28, D31, D33. Secondary lesion: D25, D27, D28, D31, D32, D33. Microcalcifications: D12, D15, D16, D17, D18, D20, D23, D25, D33. E. ""Left axillary mass, long stitch-lateral, short-superior"", received fresh. and placed in formalin: Procedure: Wire guided partial mastectomy. Specimen orientation: Long stitch lateral, short stitch superior. Specimen dimensions: Medial to Lateral: 5.6 cm. Anterior to Posterior: 1 cm. Superior to Inferior: 3.6 cm. Margins inked: Superior: Red. Inferior: Yellow. Anterior: Blue. Posterior: Black. Sectioned: Medial to lateral. Gross findings: A well circumscribed white-brown nodule with an embedded. microclip in the medial portion. Lateral to this first nodule is a second ill. defined firm nodule. The remaining parenchyma is yellow-tan lobulated adipose. tissue. Gross tumor size:1.6 x 0.6 x 0.5 cm. Multifocal tumor: Second lesion is 1.2 x 0.5 x 0.4 cm, and it is 0.7 cm from. the first. Distance of tumor from gross surgical margin: First nodule: Superior: 1.8 cm. Inferior:0. cm. Anterior: 0.2 cm. Posterior: 0.2 cm. Medial: 2 cm. Lateral: 3.6 cm. Second nodule: Superior: 1.7 cm. Inferior: 1 cm. Anterior: 0.2 cm. Posterior 0.3 cm. Medial: 5.9 cm. Lateral: 1.8 cm. Sectioned specimen radiographed?. Radiograph findings: Mass: Yes. Microcalcifications: Yes. Biopsy site microclip: Yes. Specimen photograph? Yes. Block diagram? Yes. Sections submitted from medial to lateral in blocks E1 through E21. Specimen completely submitted? Yes. BLOCK SUMMARY: Medial margin-E1. Lateral margin:E21. Anterior, posterior, inferior margins for first nodule=E8. Anterior, posterior, superior, inferior margin for second nodule-E13. First nodule-E6, E7, E8, E9, E10, E11. Second nodule:E13, E14, E15, E16. Microclip: E11. Microcalcifications: E8, E13, E19. F. ""Left axillary contents"". Received fresh and placed in formalin is a 6.5 x. 6.5 x 2 cm aggregate of multiple fragments of tan-yellow fibrofatty tissue. Fourteen lymph node candidates are identified ranging in size from 0.5 x 0.5 x. 0.4 cm to 3.5 x 1.5 x 1.3 cm. The smallest lymph node candidate is submitted. in blocks F1-F3, and the two largest lymph node candidates are inked blue and. black, bisected and submitted in blocks F4-F6. A. REPORT REVISED ON. INTRA OPERATIVE CONSULTATION: A. ""Non-sentinel node right axilla"": AF1- one lymph node candidate, bisected. (1.3 x 1 x 0.6 cm) - no tumor is seen (Dr. B. ""Sentinel node number one"": BF1 (one lymph node candidate, bisected, 2 x. 1.6 x 1 cm) positive for metastatic cancer (micrometastases) (Dr. BF2 (two lymph node candidates, intact (0.5 x 0.5 x 0.3 cm) and 1 x 0.6 x 0.4. cm, no tumor is seen (Dr. C. ""Sentinel node number two"": CF1- one lymph node candidate, bisected, 1.9 x. 2 x 0.7 cm, positive for metastatic cancer (micrometastases) (Dr. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: Partial mastectomy, sentinel lymph node biopsy with completion. axillary dissection. PATHOLOGIC STAGE (AJCC. Edition) : pT2 pN2a pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. REVISED DIAGNOSIS. A. ""LEFT AXILLA, NON-SENTINEL LYMPH NODE"" (BIOPSY) : ONE LYMPH NODE, NO EVIDENCE OF MALIGNANCY (0/1) . B. ""LEFT AXILLA, SENTINEL LYMPH NODE # 1"" (BIOPSY) : METASTATIC ADENOCARCINOMA IN THREE LYMPH NODES (3/3) . SIZE OF LARGEST METASTASIS: 6 MILLIMETERS. EXTRACAPSULAR INVASION: ABSENT. C. ""LEFT AXILLA, SENTINEL LYMPH NODE # 2"" (BIOPSY) : METASTATIC ADENOCARCINOMA IN ONE LYMPH NODE (1/1) . SIZE OF LARGEST METASTASIS: 4 MILLIMETERS. EXTRACAPSULAR INVASION: ABSENT. D. ""LEFT BREAST CANCER, 1:00"" (WIRE GUIDED PARTIAL MASTECTOMY) : INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 3. GROSS TUMOR SIZE: 2.3 x 2.1 x 1.2 CM. SIZE OF INVASIVE COMPONENT: 2.3 CM. LOCATION OF THE TUMOR: ADJACENT TO PREVIOUS BIOPSY SITE. LYMPHATIC/VASCULAR INVASION: PRESENT. MULTIFOCAL TUMOR: ABSENT (SECOND MASS LESION DESCRIBED GROSSLY IS FAT. NECROSIS) . IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: COMEDO. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. NECROSIS: PRESENT. DCIS EXTENDING OUTSIDE INVASIVE TUMOR MASS: ABSENT. SIZE OF IN-SITU CARCINOMA: NOT APPLICABLE. SKIN STATUS: FREE OF TUMOR. STATUS OF NON-NEOPLASTIC BREAST TISSUE: NEEDLE CORE BIOPSY SITE, AND FAT. NECROSIS. SURGICAL MARGIN STATUS: NEGATIVE (GREATER THAN 2 MM) . ESTROGEN/PROGESTERONE RECEPTOR, CELL CYCLE, EGFR AND HER2/NEU ANALYSIS: PENDING, PARAFFIN BLOCK NUMBER D11. RESULTS WILL BE ISSUED SEPARATELY FROM THE IMAGE CYTOMETRY LAB. E. ""LEFT AXILLARY MASS"" (EXCISION) : METASTATIC ADENOCARCINOMA IN ONE OF FOUR AXILLARY LYMPH NODES (1/4). SIZE OF METASTASIS: 1.6 CM. EXTRACAPSULAR INVASION: PRESENT. CHANGES CONSISTENT WITH A NEEDLE CORE BIOPSY SITE ARE PRESENT. MARGIN STATUS: NEGATIVE. F. ""LEFT AXILLARY CONTENTS"" (COMPLETION NODE DISSECTION) : METASTATIC ADENOCARCINOMA IN ONE OF TWENTY LYMPH NODES (1/20) . SIZE OF METASTASIS: 0.5 MILLIMETERS. EXTRACAPSULAR INVASION: ABSENT. COMMENT: This report revised. to correct the site for specimens A-C,. which were received labelled as ""right"" Per. the correct site is. left. is notified of this revision. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). DIAGNOSIS: SEE REVISED REPORT: REPORT REVISED ON. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . CI ADDENDUM 1: Please see. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Panel: Surgical Pathology Final Report. Abnormal Flags key: C Critical H Figh L Low R Review  Abnormal. Interpretation Codes: (S) Susceptible (R) Resistant (MS) Moderately Susceptible (I) Intermediate. Status Dates and times displayed below are colection dates; to see the observation date and time for a result, hold your course over the collection. codes: P-Preliminary F-Final c-Corrected I-In progress/incomplete X-Cancelled. time. Times are on a 24-hour clock. An. asterisk  in the Note column or next to a panel name indicates a note is present. To view it, rest your mouse cursor on the . Value. Range. Note. Panel. Obs d/t: !. Final Diagnosis. 1. Right testicle, 31.7 g, right zadical orchiectomy: A. Classical seminoma, 1.5 Cm, confined to the testis, The tumor invades. the tunica albugenia and the rete testis. No invoivement of the tunice. vaginalis seen. No lymphovascular invasion identified. B. The spermatic cord and spermatic cord margin are free of tumor. The case material was reviewed and che report verified by: (Electronic signature). Verification Date: Pathologist (s). Gross Description. Specimen "" designated ""right testicle"" is received fresin, labeled with the. patient's name and medical record number and consists of a testicle. weighing 31.7 g and measuring 5.5 x 3.8 x 1.4 cm. The spermatic cord is. identified and measures 9.5 x 0.3 The excernal surface is inked. entirely in blus. The testicle is bivalved to reveal a well-circuascribed,. ovoid mass with a white-tan rim and and pink red inner core altogether. measuring 1.5 x 1.2 x 1.0 cm. The mass is located at the most distal. aspect of the testicle and is far removed from the spermatic cord. Representative sections are submitted as follows: 1A, spermatic cord. margin; 18 through 1F, tumor submitted in toto; 1G and 1H, unrenarkable. testicle and rete testis,. of 2. SUMMARY OF SECTIONS: 8, multiple, representative. Clinical Information. ""year-old man with right testicular mass. Past medical history: Asthma, right inquinal hernia repair, orchiopexy in. vasectomy. Pre-Operative Diagnosis: Not specified. Post-Operative Diagnosis: Not specified. Operation: Right radical orchiectomy. specific questions to be answered: None. specimen: Right testicle. ! of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis. Left mastectomy preparation with a predominantly solid, moderately differentiated ductal. breast carcinoma showing invasive growth with a minimum dorsal margin of less than 0.1 cm,. with overlying carcinoma-free skin and the inclusion of eleven carcinoma-free lymph nodes. Tumor classification: M-8500/3, G 2 (seven points), pT2, pNO (0/11), MX, pL0, pV0. Assessment: Dorsal margin of carcinoma less than 0.1 cm, ventral margin 0.5 cm and the remaining. resection margins markedly greater than 1 cm.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical History/Diagnosis: Right Renal Mass. Source of Specimen(s): 1: Right kidney. 2: Portion of right adrenal. Gross Description: Received in two parts. Source of Tissue: 1. Labeled #1, ""right kidney"". Gross Description: Received fresh in a container labeled ""right kidney"". It consists of a. right kidney weighing 850. grams and measuring 15.0 x 11.0 X 10.5 cm. The kidney is markedly. distorted from numerous bulging areas and it is grossly enlarged. Superiorly at the hilum is some residual adrenal gland measuring 1.5 X 1.0. X 0.6 cm that is otherwise unremarkable. Also at the hilum are a few tan. to brown rubbery to firm nodes measuring from 0.7 up to 1.5 cm. The nodes. have tan to brown cut surfaces. A segment of ureter measures 6.0 X 0.3 cm. and is grossly unremarkable. Also at the hilum the vessels are. unremarkable however, there is multiple bulging areas from the kidney. Perinephric fat is only present in a few areas ranging from 0.1 up to 0.5. cm. Some of the fat that is overlying some of the nodules will be. submitted for histological impression. Elsewhere, the capsule overlying. the presumed tumor nodules are inked black and will be submitted in. relationship to the kidney lesion. The specimen is bivalved disclosing a. yellowish-orange soft tumor measuring 12.0 x 9.0 x 9.5 cm comprising. approximately 80% of the kidney. The tumor markedly distorts the calyceal. system and is pushing into the renal pelvis and capsule. No gross. invasion into the aforementioned areas is identified. Fresh tissue was. prepared for. in the mass there is. some white fibrous possible scar and an appreciable amount of hemorrhage. The adjacent uninvolved parenchyma has slight scarring and well-defined. cortical-medullary junctions. Representative sections are submitted in. 1A-P. Designation of Sections: 1A- ureter and vascular margins, 1B- tumor in. relationship to renal pelvis, 1C-1D- tumor in relationship to capsule, 1E-. center of tumor, 1F- tumor in relationship to adjacent uninvolved kidney. parenchyma, 1G- tumor overlying fat, 1H- residual adrenal gland, 1I-1J-. lymph nodes K-1P- additional section of tumor. Source of Tissue: 2. Labeled #2, ""portion of right adrenal"". Gross Description: Received fresh labeled,. portion of right adrenal"" is a 6 gram, 5.0 x 2.2 x 0.8 cm portion of. adrenal gland. It is sectioned to reveal golden-yellow-orange unremarkable. cut surfaces. Representative sections are submitted in two blocks. Designation of Sections: 2A-2B. Summary of Sections: multiple. Final Diagnosis: 1. Right kidney and adrenal gland, nephrectomy and partial adrenalectomy: - Renal oncocytic neoplasm, 12 cm, confined to renal parenchyma (see. note). - Vascular and ureteral margins, free of tumor. - Adrenal gland, no tumor seen. - Seven lymph nodes, no tumor seen (0/7). Note: Immunohistochemical stains show the tumor is positive for E-Cadherin. (membranous staining), many cells positive for CK7, and weakly positive. for Vimentin, whereas negative for CD10, CK903, and CD117 (only. cytoplasmic staining). Special stain colloidal iron shows many cells with. strong, granular cytoplasmic staining. Mucicarmine special stain is. negative. Differential diagnosis includes low grade chromophobe carcinoma. versus atypical Oncocytoma. Cytogenetic study is pending, and the result. may assist the differential diagnosis. 2. Portion of adrenal, completion of adrenalectomy: - Adrenal gland, no tumor seen. Procedures/Addenda. FC Cytogenetics Solid Tumor. Results-Comments. CYTOGENETIC ANALYSIS REPORTS. DIAGNOSIS: Right Renal Mass. KARYOTYPE: Normal male karyotype: 46,XY[20]. RESULTS: The renal mass was harvested after thirteen days in culture. The chromosomes from twenty metaphases were counted and analyzed, and. three of these metaphases were karyotyped by G-banding. The modal. chromosome number was 46, and the cells appeared to have a normal. karyotype. These normal results may reflect an overgrowth of normal. interstitial tissue rather than tumor. Procedures/Addenda. Addendum. Addendum Diagnosis. The cytogenetic analysis. reveals a normal. karyotype. The histomorphology is that of an atypical oncocytoma, however, foci of. the tumor are strongly positive for colloidal iron, and many cells are. positive for CK7. Thus, an oncocytic neoplasm with low malignant. potential is favored, which is a borderline neoplasm between oncocytoma. and chromophobe carcinoma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - left breast with axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Macroscopic description: Left breast sized 22.4 x 17.8 x 6.4 cm removed along with axillary tissues sized 12 x 5 x 3 cm and a skin flap of 24.2 x 11.3 cm. Weight 950 g. Tumour sized 2.7 x 1.4 x 2.8 cm found in the central part, removed 6.0 cm from the lower boundary, 0.3 cm from the base and 1.4. cm from the skin. Microscopic description: Carcinoma lobulare invasivum (classical type, partly solid) multifocale - NHG2 (3+2+1/0 mitoses/10 HPF - visual area. 0.55mm). Infiltratio carcinomatosa mamillae. In situ lesions of the type pagetoid spread and hyperplasia within the foci of adenosis sclerosans. Glandular tissue. showing lesions of the type fibrosa et cystica, adenosis sclerosans. AXILLARY LYMPH NODES: Metastases. carcinomatosae in lymphonodis (No IX/XI). Test result: Carcinoma lobulare mixtum invasivum mammae sinistrae. Metastases carcinomatosae in lymphonodis axillae (No IX/XI) (NHG2, pTIc, pN2a). Examination performed or. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTestâ¢M by DAKO. Score = 2+. FISH verification recommended. Compliance validated by: 1. Examination: Histopathological examination. page 2 / 2. Gender: F. Histopathological diagnosis: Carcinoma lobulare invasivum mammae sinistrae. Invasive lobular carcinoma of the left breast. Metastases in lymphonodis axillae (No IX/XI) (NHG2, pTIc, pN2a). Cancer metastases in axillary lymph nodes (No IX/XI) (NHG2, pTIc, pN2a). Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Colon, transverse, partial colectomy. Tumor Histologic Type: invasive adenocarcinoma. Histologic Grade: moderately differentiated (grade 2 of 4). Tumor Location: transverse colon. Depth of Invasion: -Through muscularis propria and into the subserosa and pericolic. soft tissue. Lymphovascular Invasion not identified Adenscareenoma NOS. Perineural Invasion: not identified. Margins. Proximal margin: negative. Distal margin: negative. Mesenteric margin: negative. Distance of carcinoma from closest margin (specify) : 6.6 cm to. the closest distal margin of resection. Regional Lymph Nodes: Total number with metastasis: 0. Total number examined: 25. Additional Pathologic Findings: Immunohistochemical stains for MLH-1, MSH-2, PSH-6 and PMS-2 are. performed on block A7. The tumor cells demonstrate appropriate. positive nuclear expression for all four markers. This is the. normal phenotype and does NOT support a diagnosis of. microsatellite instability/hereditar non-polyposis colorectal. cancer (HNPCC) Separate molecular testing for microsatellite. instability markers will be performed and reported separately. Appropriate controls are performed. AJCC Pathologic TNM Stage: pT3 pNO. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Clinical History: -year-old female with colon cancer. Gross Description: Received is one appropriately labeled container, additionally. labeled ""transverse colon and omentum. It consists of a 23.5 cm. long X 5.2 cm in circumference segment of large bowel with. attached omentum (30.4 X 15.6 X 0.8 cm), pericolonic adipose. tissue up to 4.3 cm thick and appendix is absent. There. is a 5.2 X 2.6 X 0.7 cm (protruding into lumen) firm, pink/tan,. centrally ulcerated circumferential mass with raised borders. that is 10.7 cm from the proximal margin and 6.6 cm from the. distal margin. The distal margin has an attached suture, which. is inked blue and the serosa overlying the mass is inked. black. The mass on cut section is firm, smooth, gray/white,. extends 1.1 cm through the wall and into the mesentery focally. retracting the serosa but not extending through it, and 3.5 cm. from the mesenteric margin. The uninvolved mucosa is tan with. normal folding pattern. The omentum has patchy areas of. hemorrhage but nodules are absent. The pericolonic adipose. tissue is dissected for lymph node candidates of which 29 are. identified ranging from 0.2 cm in greatest dimension up to 0.8 X. 0.8 X 0.8 cm in greatest dimension. Block summary: A1 - mesenteric margin, en face. A2-A3 - proximal mucosal margin, en face. A4-A5 - distal mucosal margin, en face. A6 - mass retracting the serosa. A7-A8 - each contains deepest extension of mass with positive. lymph node in A8. A9 - mass with distal mucosa. A10 - mass with proximal mucosa. A11 - omentum. A12-A14 - each contains six lymph node candidates. A15-A16 - each contains four lymph node candidates. A17 - two lymph node candidates, each bisected, one is inked. black. A18-A19 - one lymph node candidate, serially sectioned. Tumor and normal are given to.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
TINAL DIAGNOSIS: TERMINAL ILEUM AND RIGHT COLON, RIGHT HEMI-COLECTOMY -. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA (5,5 CM) OF CECUM. B. ADENOCARCINOMA INVADES THROUGH MUSCULARIS PROPRIA TO SUBSEROSAL ADIPOSE TISSUE. C. PROXIMAL, DISTAL, AND RADIAL MARGINS FREE OF CARCINOMA. D. NO ANGIOLYMPHATIC INVASION PRESENT. E. NO PERINEURAL INVASION PRESENT. F. TWENTY-FIVE BENIGN PERICOLONIC LYMPH NODES (0/25/. G. PATHOLOGIC TUMOR STAGE pT3a, NO, MX. H. TERMINAL ILEUM WITH NO SIGNIFICANT ABNORMALITY. APPENDIX WITH NO SIGNIFICANT ABNORMALITY. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY COLON, RECTAL, APPENDIX TUMORS. SPECIMEN TYPE: Right hemicolectomy. SPECIMEN LENGTH: 24cm. TUMOR SITE: Cecum. TUMOR CONFIGURATION: Exophytic (polypoid). TUMOR SIZE: Greatest dimension: 5.5 cm. Additional dimensions: 4.0 X 1.3 cm. INTACTNESS OF MESORECTUM: Not applicable. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Low-grade (well to moderately differentiated). PATHOLOGIC STAGING (pTNM): pT3a/b. pNO. Number of nodes examined: 25. Number of nodes involved: 0. pMX. MARGINS: Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (radial) margin - Not applicable. Mesenteric margin uninvolved by invasive carcinoma. ANGIOLYMPHATIC INVASION: Absent. PERINEURAL INVASION: Absent. TUMOR BORDER CONFIGURATION: Infiltrating. TUMORAL LYMPHOCYTIC RESPONSE: Mild to moderate.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A. Liver segment 4-5 and gallbladder. B. Portal tissue. Clinical Information. Gallbladder cancer. Infectious patient:No. Immunocompromised: No. History of neoplasm: No. Diagnosis. A. Liver (segment 4-5) and Gallbladder, Resection: Poorly differentiated adenocarcinoma (cholangiocarcinoma) arising. within mid and distal portion of the gallbladder, 3.8 cm in greatest. dimension (see Synoptic Report). Chronic cholecystitis and cholelethiasis with perforation (no tumor. at the perforation site). Resection margin (liver and peritoneal surfaces) free of tumor. B. Portal Tissue, Resection: Fibroadipose tissue with non-specific inflammation. No neoplasia. Verified: Responsible Resident: Synoptic Report. A: Gallbladder, Microscopic. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades muscle layer. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.3 mm. Specified margin: Liver parenchymal margin. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Not identified. PRIMARY TUMOR (pT) : pT1b: Tumor invades muscle layer. REGIONAL LYMPH NODES (pN) : Number examined: 1. Number involved: 0. ADDITIONAL PATHOLOGIC FINDINGS: Cholelithiasis. Chronic cholecystitis. Acute cholecystitis. Gross Description. Received are specimen containers A to B. All requisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers are. labelled with the Surgical Number. A. Specimen is received fresh. The container is designated ""A. Liver segment 4-5 and. gallbladder"". The specimen consists of a gallbladder with attached liver tissue. The. gallbladder measures 11.0 cm in length and 4.0 cm in diameter. There is a cholelithiasis. measuring 1.5 cm in greatest diameter perforating through the gallbladder at the cystic. duct end. This perforation site has been painted yellow. There is also an indurated. area on the anterior side of the gallbladder without evidence of perforation externally. and this area has been painted orange. The indurated area at the anterior surface of the. gallbladder appears to be fibrosed with some necrosis on sectioning without grossly. evident tumor. The external surface of the liver resection margin has been painted blue. and appears to be uninvolved by mass lesions. The attached adjacent adipose tissue. measures 9.7 x 6.0 x 1.7 cm in greatest dimension. Within the gallbladder is a. tan/white, friable, polypoid lesion measuring 3.8 x 2.4 x 2.5 cm in greatest dimension. roughly arising from the wall and occupying the whole lumen of the mid portion of the. gallbladder Adjacent to this and close to a cystic duct is the perforated. cholelithiasis that is dark brown and ovoid in shape measuring 3.9 x 2.2 x 2.2 cm in. dimension. The tumor is seen to be attached to the perihepatic wall of the gallbladder. and has a maximum depth of invasion .1cm through the gallbladder wall into the hepatic. parenchyma as measured from the gallbladder mucosa to the deepest portion within the. adjacent liver parenchyma. At this area, the maximum depth of invasion in the hepatic. parenchyma itself as measured from the outer surface of the perihepatic gallbladder wall. into the liver parenchyma is 0.3 cm. There is necrosis and hemorrhage in the central. part of the tumor. Sections are submitted as follows: A1 - shaved cystic duct margin. A2 - grossly uninvolved part of the liver and gallbladder. A3 - site of the cholelithiasie perforation at the end towards the cystic duct. A4 - maximum depth of tumor invasion, split in half. A5 - maximum depth of tumor invasion. A6 - area of gallbladder wall induration. B. Specimen is received fresh and fixed overnight in formalin. The container is. designated ""B. portal tissue"". Within it is a tan/brown fibrous tissue with hemorrhage. The tissue measures 1.2 x 0.4 x 0.2 cm in maximum dimension. The specimen is bisected. and submitted in toto in one cassette, Bl. Encounter Number. Patient Location.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN TAKEN: FINAL DIAGNOSIS. 1. THYROID (TOTAL THYROIDECTOMY): SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Left lobe. HISTOLOGIC TYPE: Papillary carcinoma. TUMOR SIzE: Greatest dimension 2.5 cm. FOCALITY: Unifocal. LYMPH NODES: None submitted. EXTENT OF INVASION. PRIMARY TUMOR: pT2: Tumor >2cm, but <4cm, limited to thyroid. REGIONAL LYMPH NODES: pNx: Cannot be assessed. DISTANT METASTASIS: pMx: Cannot be assessed. MARGINS: Margins are uninvolved. VENOUS/LYMPHATIC INVASION: Absent.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
HISTORY. (R) pneumonectomy for malignancy. MACROSCOPIC. Four specimens received: 1: The specimen is labelled 'right lung' and consists of a right pneumonectomy measuring 215 mm. superior to inferior, 180 mm anterior to posterior and 60 mm medial to lateral in the inflated state. On. the pleural surface of the medial aspect of the lower lobe there is an area of puckering abutting the hilar. resection margin measuring approximately 70 x 40 X 55 mm. On sectioning, a pale poorly-defined. firm mass is present in the lower lobe extending from the bronchus and hilar resection margin and. measuring 50 X 45 x 70 mm. The tumour is 4 mm to the closest bronchial resection margin and up to. 2. mm from the interlobar fissure, 25 mm from the lateral pleural surface and appears to involve the. pleura on the medial aspect of the lobe. No other lesions are noted in the upper or middle lobes, the. lung parenchyma appearing normal. Please note the lung has been sampled for research. [Bronchial. margin and pulmonary artery margin, 1A; hilar resection margin, 1B-C; bronchial resection margin,. 1D; tumour and medial pleural surface, 1E; tumour and bronchus, 1F; tumour to interlobar fissure, 1G;. tumour, 1H; tumour and lung parenchyma, 1I; normal lung tissue lower lobe, 1J; normal lung tissue. middle lobe, 1K; normal lung tissue upper lobe, 1L; peribronchial lymph nodes, 1M-O]. 2: The specimen is labelled ""hilar lymph node' and consists of a piece of dark brown tissue measuring. 11. X 4 x 5 mm. [Wrapped, BIT, 2A]. 3: The specimen is labelled 'subcarinal lymph node right' and consists of a piece of pale firm tissue. covered in fat measuring 38 X 32 X 24 mm. On sectioning, there are five lymph nodes within the tissue,. the largest measuring 26 X 12 X 10 mm. [Large lymph node, 3A-C; 1 lymph node bisected, 3D; 2. lymph nodes bisected, 3E]. 4: The specimen is labelled 'upper medial sternal node (right)' and consists of a piece of fatty tissue. containing a lymph node measuring 20 X 9 x 10 mm. [Bisected and BIT, 4A]. MICROSCOPIC. 1: Sections show a moderately differentiated adenocarcinoma. In areas, there is production of. abundant mucin by the tumour cells. A small micropapillary component is identified. Numerous. psammoma bodies are identified within the tumour. The lesion is arising in the region of the hilum and. is invading into soft tissue around bronchi and large pulmonary vessels. A separate deposit measuring. 1.4 mm is identified in the random sections from the lower lobe and there is a deposit measuring 0.7. mm in diameter in the random sections from the middle lobe. Carcinoma is identified in the random. sections from the upper lobe but this is in a lymphangitis carcinomatosa pattern. Pleural invasion is not. identified. There is no blood vessel invasion but there is prominent lymphatic permeation is seen. No. perineural permeation is identified. Lymphatic permeation by carcinoma is identified within the. lamina propria of the bronchial resection margin. Tumour approaches the hilar resection margin. In. most areas carcinoma is separated from hilar tissues that in visceral pleura but in some areas the lung. has been transected. In one area in particular, tumour is approximately 0.5 mm from the diathermied. margin. Peribronchial lymph node metastases are seen. All the lymph node Cross sections appear to. contain at least some tumour and there is lymphatic permeation within the surrounding soft tissue. The. lung shows evidence of mild centriacinar emphysema that is best seen within the upper lobe. 2-4: Sections show focal to extensive involvement of the lymph nodes by metastatic adenocarcinoma. SUMMARY. 1-4: Right lung and hilar, subcarinal and upper 'medial sternal' lymph nodes: A: Moderately differentiated adenocarcinoma; 70 mm in maximal dimension. B: Prominent lymphatic permeation but no blood vessel or perineural invasion present. C: Lymphatic permeation at the bronchial margin; tumour very close to hilar soft tissue margin; no. definite pleural invasion identified. D: Peribronchial, hilar, subcarinal and upper ""medial sternal' lymph node metastases. E: T4N2M1. F: Non-neoplastic lung: Lymphangitis carcinomatosa; mild emphysema. T-28000 M-81403 P1-03000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
'nternal Sample ID: Diagnosis: This is a moderately differentiated adenocarcinoma of the sigmoid colon with. histopathological grade G2 differentiation, with erosions of the inner tumor surface, with. peritumorous, chronic recurrent concomitant inflammation, with tumor infiltration of the. parietal layers of the sigmoid colon extending to the outer layers of the tunica muscularis,. with chronic lymphadenitis of the tumor-free lymph nodes (0/12) and tumor-free overview. sections from the resection margins and from the region of the vascular ligature. According to these section preparations, the tumor spread of the sigmoid colon carcinoma. corresponds to a tumor stage of pT2, pNo, MX, R0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. Examination: Histopathological examination. PESEL: Gender: F. Material: Multiple organ resection - left breast with tis-ies. Expected time of examination: up to. Clinical diagnosis: Cancer of the left breast. Results of immunohistochemical examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 10% of. neoplastic cell nuclei. HER2 protein stained with HercepTestâ¢ by DAKO. Positive reaction in invasive cancerous cells ( Score = 3+ ). Macroscopic description: Left breast, sized 22 x 17 x 5cm, removed along with axillary tissues sized 9 x 6 x 2 cm and a skin. flap of 23 x 11 cm. Tumour sized 3.1 x 1.5 x 1.7 cm in the upper outer quadrant, placed 6 cm. from the upper edge, 0.7 cm from the base and 1.2 cm from the skin. Microscopic description: Carcinoma ductale invasÃ­vum - NHG3 (2+3+3/21 mitoses/10 HPF - visual area: 0.55mm). Glandular tissue outside the tumour showing lesions of the type mastopathia fibrosa et cystica,. hyperplasia. ductalis simplex (UDH). Axillary lymph nodes: Metastases carcinomatosae in lymphonodo (No I/XV). Infiltratio capsulae lymphonodi. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. Metastases carcinomatosae in lymphonodo axillae (No I/XV). (NHG3; pT2; pN1a). Compliance validated.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FATIENI MISTURT: DATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT SEG MAST AND AXILLARY DISSECTION. CLINICAL HISTORY: MATERIAL SUBMITTED: A) LEFT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. B) LEFT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: CONSULT: 2) left breast tissue with usual markings; 7.5 by 7.0 by 2.0 cm breast mass with specimen. radiograph. Specimen is received inked and previously sectioned by Dr. There is a medial 1.8 by 1.5. by 1.1 cm firm to hard area which is 0.4 cm from theposterior margin and 0.3cmfrom the anterior. margin;. lateral to this mass is an area of calcification on radiograph. Section thru this area shows ill defined. fibrous tissue, approximately 1.2 by 1.0 by 0.8 cm with white punctate tissue, < 0.1 cm. ADDENDA: Addendum. MACROSCOPIC DESCRIPTION: BLOCKS B3 AND B8 SUBMITTED FOR ER/PR AND HER-2/NEU. FINAL DIAGNOSIS: My signature is attestation that I have personally reviewed the submitted material(s) and the final. diagnosis reflects that `evaluation. ER/PR. IMMUNOPEROXIDASE IDENTTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON BLOCKS B3 AND B8. DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (90%) AND FOR PROGESTERONE RECEPTOR. (60%) THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. HER-2/NEU. c-erbB2 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON BLOCKS B3 AND 88 (BREAST CANCER) USING A 1:300 DILUTION. OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN or c-erbB2) WITHOUT ANTIGEN. RETRIEVAL. DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED ONLY RARELY IN 5% OF TUMOR CELLS. THEREFORE, c-. erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 1+). FINAL DIAGNOSIS: FINAL DIAGNOSIS: PREVIOUS REPORTS. A) LEET AXILLARY CONTENTS: - ELEVEN (11) LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA. B) LEFT BREAST, SEGMENTAL MASTECTOMY: INFILTRATING MULTIFOCAL, POORLY DIFFERENTIATED. DUCT CARCINONA, 1.8 CM AND 1.2 CM (CR. 300-312,. SEE. NOTE). - NOTTINGHAM SCORE FOR BOTH TUMORS - 8/9 (TUBULES - 3, NUCLEAR ATYPIA - 3, MITOTIC INDEX. - DUCTAL CARCINOMA IN SITU, COMEDO AND NON-COMEDO TYPE, COMPRISES <5% OF EACH TUMOR. - MARGINS OF RESECTION ARE FREE OF INFILTRATING TUMOR; HOWEVER, DUCTAL CARCINOMA IN SITU EXTENDS TO INVOLVE. INKED ANTERIOR MARGIN AND INFILTRATING TUMOR EXTENDS TO WITHIN 0.3 CM OF THE ANTERIOR MARGIN. - LYMPHOVASCULAR PERMEATION IS IDENTIFIED. - TUMOR AND NON-TUMOR ASSOCIATED MICROCALCITICATIONS. - CHANGES CONSISTENT WITH PREVIOUS BIOPSY. - FIBROCYSTIC CHANGES. NOTE: Both tumor nodules have similar architectural and cytologic features NOTE: ER/PR immunoparoxidase. assay and Her-2/NEU testing will be performed on both tumors (blocks 93 and B8).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Procedure: Left adrenalectomy. Gross description: tumor is 96g; measuring 6.7 X 4.6cm. Diagnosis: Adrenal cortical carcinoma. Weiss score = 7.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Pathologic Diagnosis: A: Lymph node, 4R subcarinal, resection: Eight benign lymph nodes. B: LUNG, Resection: Specimen: Right Lung; Lower lobe of lung;. Procedure: lobectomy. Specimen laterality: Right. Tumor site: Right lower lobe. Specimen integrity: Intact. Tumor size (greatest dimension): 2.4x 2.4cm. Tumor focality: Unifocal. Tumor histologic type: Adenocarcinoma. Tumor grade: Moderately differentiated. Visceral pleura invasion: Present. Tumor Extension: Not identified. Margins: Bronchial: Uninvolved by invasive carcinoma. Vascular: Uninvolved by invasive carcinoma. Parenchymal: Uninvolved by invasive carcinoma. Parietal pleural: Not applicable. Chest wall: Not applicable. Other attached tissue margin: Not applicable. If all margins uninvolved by invasive carcinoma: Distance of invasive carcinoma from closest margin: less than 1mm. Specify margin: visceral pleura. Treatment effect: Not applicable. Lymph-vascular invasion: Not identified. Pathologic staging (pTNM): TNM Descriptors: none. Primary tumor: pT. Regional lymph nodes: pNO. Number examined: 14. Number involved: 0. Distant metastasis: pMX. Additional pathologic findings: Emphysematous changes in uninvolved. lung parachyma. C: Lymph nodes, #9 inferior pulmonary, excision: Two benign lymph nodes. D: Lymph nodes, lower paratracheal, excision: Four benign lymph nodes. The examination of this case material and the preparation of this report were. Signing Location: Gross Description: Received are three specimen containers, each labeled with the patient's name,. "". Part A is received in formalin additionally labeled ""subcarinal lymph node"" and. consists of multiple red-brown nodular portions of soft tissue, some of which. have a gray-black tinge, grossly consistent with probable anthracotic pigment. Sectioning of the tissue reveals at least eight probable lymph nodes, which. range from 0.6 to 1.5 cm in greatest dimension. These lymph node candidates are. submitted as follows: A1. four whole probable lymph nodes;. A2. three whole probable lymph nodes;. A3. remaining soft tissues with possible additional lymph node for. microscopic analysis. This specimen has been submitted in its entirety. Part B is additionally labeled ""right lower lobe"" and consists of a lobe of lung. with overall dimensions of 15 X 10.2 X 2.2 cm. The pleural surface is. purple-tan to pink-gray with focal gray-black pigmentation. The specimen is. received with a portion of black ink along one side. There are multiple staple. lines present without designation. Additional sectioning reveals a gray-tan to. red-brown, firm, well circumscribed, focally degenerative mass with overall. dimensions of 2.4 X 2.4 X 2.1 cm. This mass is approximately 3 cm from the. bronchial margin of resection. Also this mass corresponds to the overlying. inked pleural surface. The remaining lung parenchyma is red-brown to pink-tan. and spongy. Representative sections are submitted as follows: B1. vascular and bronchial margin;. B2. possible lymph node adjacent to bronchial margin;. B3-6. sections of mass;. B7,8. uninvolved lung parenchyma. Part C is received additionally labeled ""inferior pulmonary ligament"" and. consists of a single nodular portion of tan-yellow soft tissue, containing two. probable lymph nodes, having greatest dimensions of 0.5 and 0.8 cm. These. tissues are submitted entirely in cassette C. Part D is received additionally labeled ""4R lower paratracheal lymph node"" and. consists of a single nodular portion of red-brown nodular soft tissue, which is. 5 mm in greatest dimension. This tissue is submitted in toto in cassette D. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
HISTOPATHOLOGY. Lab No. Clinical Consultant & Location. Unit No. SPECIMEN. RESECTION OF EYE AND EYE APPENDAGES. ENUCLEATED RIGHT EYE. CLINICAL DETAILS. Right eye choroidal melanoma and exudative retinal. detachment. MACROSCOPIC DESCRIPTION. A fresh intact right globe. Dimensions: Axial 27.5mm Horizontal 25. . mm Vertical 25mm. Cornea Horizontal 11.25mm Vertical 11.5mm. Optic Nerve Fresh. On trans-illumination, a large shadow is seen measuring. approximately 20mm ?? on the lateral side. Plane of Section Horizontal. Intraocular description: On opening, a large solitary ? shape is seen. Query: Cilio choroidal mass seen. Tumour Size LBD 15mm Height 12mm. MICROSCOPY. Histologically, the enucleated eye demonstrates a normal. anterior segment with an unremarkable cornea, a deep. anterior chamber and open angles. The iris leaves are. unremarkable. The lens shows advanced cataractous changes. On one side of the eye, a large melanoma is arising from the. ciliary muscle and body. This is bilobed and extends. posteriorly into the adjacent choroid. In the central apical. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. part of the tumour, there is a small area of necrosis. The. tumour is associated with disruption of the ciliary body. processes and with a detachment of the retina. It is pigmented and consists of a mixture of cells, both. epithelioid and spindle cells, with a dominance of the. former cell type. The melanoma cells are immunoreactive for. MelanA, CD117 and HSP-27 (score 1) The number of mitoses is. approx. 21/40 high power fields. The microvasculature of the melanoma is prominent, and. closed loops are present in the tissue planes evaluated. The. lymphocytic infiltrate within tumour is minimal. Macrophages. are scattered throughout the tumour in a moderate. density. There is no evidence of scleral invasion or of. extraocular growth. The optic nerve is tumour free, and. demonstrates mild atrophic changes. The examined vortex. veins are free of tumour. FINAL DIAGNOSIS. Choroidal melanoma of epithelioid cell type. COMMENT. Molecular genetic examination of DNA extracted from the. tumour cells will be performed using multiplex-ligation. dependent probe amplification (MLPA), looking at chromosomes. 1, 3, 6 and 8. A supplementary report will follow as soon as. these investigations are complete. MOLECULAR GENETICS. In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) . These investigations were. performed in the. The kit P027 from. which examines for gains or. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. quality assessed using multiplex-PCR prior to the MLPA. reaction. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. In summary, sequence analysis. demonstrated: Normal chromosome 1,. monosomy 3,. normal chromosome 6. and gains in chromosome 8. Taken together, these molecular data would place the patient. in the high risk group with respect to the development of. metastatic melanoma. Consideration of clinical features of. the tumour is, however, also required.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
INFORMATION. RMATION. SPECIMEN INFORMATION. Acct / Reg #: PHOTOMICROGRAPHIS. DIAGNOSIS. DIAGNOSIS: A. Soft tissue (abdominal nodule), blopsy: Benign soft tissue with fat necrosis and fibrosis. B. Liver (left lobe), wedge resection: Hepatocellular carcinoma, moderately differentiated, with vascular Invasion. and extension to the inked surgical excision margin. C. Gallbladder, cholecystectomy: Benign gallbladder with mild chronic cholecystitis; cholelithiasis. D. Liver (additional left lobe), blopsies: Hepatocellular carcinoma with vascular Invasion; tumor appears to extend to the cauterized edges of the biopsy. here reviewed the liver sections and concurs with the diagnosis of hepatocellular carcinoma. The histomorphology and the immunostains support e diagnosis of hepatocellular carcinoma in spite of the negative Hepar stain. The reason for the. negative stain is not evident as both the internal and external controls stained appropriately. Melanoma and adrenal cortical carcinoma are the two other. diagnostic considerations. Melanoma is excluded by the negative Melan-A and S-100; adrenal cortical carcinoma is excluded by the constellation of. morphology and immunostaining results. CLINICAL INF FORMA TION. CLINICAL HISTORY: Preoperative Diagnosie: Hepatocellular carcinoma. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Abdominal nodule, rule out METS. B. Left liver lobe. C. Gallbladder. D. Additional left lobe liver. SPECIMEN DATA. GROSS DESCRIPTION: A. The first container A is labeled A and abdominal nodule rule out METS and consists of a yellow-tan nodule measuring 1.0% 1.0 x 0.5 cm. The specimen is bisected. One-half of the specimen was examined at the time of surgery. The specimen is subsequently entirely submitted in. cassettes. no as follows: frozen section-1; remainder of specimen-2. B. The second container B is labeled. and left lobe fiver and consists of a portion of liver measuring 15.0: x 11.0 x 7.0 cm and weighs 393. grams. The surface is gray to red-tan with areas of hemorrhagic adhesions. There are multiple gray-tan nodules measuring from 1.0x 1.0 x 0.7 cm to. 11.0 x 10.0 x 2.0 cm. The nodules appear to involve approximately 90% of the liver parenchyma. The surgical resected margin has been inked. There. are surgical clips present at the surgical margin surrounding are two possible ducts. One of the possible duct appears to have tumor protruding through. the lumen and is visible at the surgical margin. On sectioning the cut surface is paie tan fleshy multilobular with areas of hemormhage. There is also an. ares of fibrous bands surrounding yellow-tan firm tissue. The mass appears focally less than 0.1 cm from the resected margin in the previously. mentioned area of possible duct. There is a rim of normal liver parenchyma that is yellow to brown-tan. Attached to one edge of the liver is a portion of. Microscopie image and dingrass, if presect, are a symbolic representation of the key findiags of this case. The site(s) designated on the orgae diagrasm are based upou clinical informatios provided and do - necessarily. indicate the specific location from where the biopry was takea The image and diagrama are not icsended to replace & complete reading of the final report. REPORT CON TINUED ON NEXT PAGE. Pace: 1 of 2. PATIENT INFORMATION. SPECIMEN INFORMATION. fibroadipose tissue that is yellow-tan hemonhagic measuring 6.0 x 2.0. x 1.0 cm. On sectioning there is a vessel, 2.0 cm in length and 0.3 cm in. diameter that appears to show tumor within the lumen. Representative sections were taken for genomic studies and placed in orange cassettes labeled. A-D, Also recaived are two cassettes, one yellow and one green, labeled. Representative sections are submitted in cassettes 100807. Pas follows: perpendicular section from margin in relationship to mass from possible ducts-1 and 2; additional perpendicular sections from margin. in relationship to mass-. ; sections from vessel near the resected-8; submitted portion of vessel with tumor-10. C. The third container c is labeled n, C and galibladder and consists of an intact gallbladder measuring 7.0 x 3.0 x 2.0 cm. The surface is gray-. tan. to purpla-gray with adhesions. The gallbladder wall measures 0.2 cm. The fining is velvety and bile stained. There are calculi identified. Representative sections are submitted in a single cassette. D. The. fourth. container. o. is. D and additional left lobe liver and consista of three separate brown-tan fragments of tiver meesuring 1.0 x. 0.5. x. 0.5. cm. to. 2.0. x. 1.0. x. 0.5. cm. The surfaces shows marked cautery artifact. The two larger pieces have been bisected and the specimen is entirely. submitted in cassettes 11. follows: small fragment-1; second fragment bisected-2 third fragment bisected-3. INTRA-OPERATIVE CONSULTATION: FSA: 'Negative for malignancy. fibrous tissue, inflammation' per. MICROSCOPIC'EXAMINATION. Section A, labeled ""abdominal nodule"" shows an area of fat necrosis with fibrosis. No metastatic malignancy is identified. Sections of the wedge biopsy of the left lobe of the liver, specimen B, shows multiple expanse isle nodules consisting of cords, nests, and trabecular. structures of a large cell malignant neoplasm having the architectural and cytologic characteristics of hepatocellular carcinoma. The tumor celis have. large vesicular nuclei with prominent nucleoli, with scattered intranuclear cytoplasmic inclusions, and a moderate to large amount of pink, granular. cytoplasm. Scattered mitoses are easily identified and there are occasional bi and multinuclested tumor cells with bizzare giant nuclear forms. These. features are in sharp contrast to the adjacent normal liver. There is evidence of vascular invasion by the tumor. Tumor appears present at the inked. surgical margins. A battery of immunohistocherical stains shows the tumor cella staining with CAM5.2 and focally with cytokeratin 20. A CD10 is done. on blocks B3, 4, 7, and 8 and shows prominent staining of bile canalÃ­culi. A polycional CEA is uninterpretable as it is over stained. The tumor cella are. immuno negative with S100 pratein, Melan-A, cytokeratin 7, alpha-fetoprotein, and Hepar antigen. Control slides stained appropriately. Additionally,. a. reticulin stain performed on block 83 shows an absence of reticulin in the tumor, in contradistinction to its presence in the adjacent normal liver. Section c shows a gallbladder with mild chronic cholecystitis. There is no morphologic evidence of malignancy, either primary or metastatic. Sections from specimen D. labeled ""additional left lobe of liver"" disclosed nodules of hepatocellular carcinoma in a fibrous stroma. Iron stains show. stored iron. Trichrome stains highlight a number of thickened fibrous trabeculas coursing through the tumor. A reticulin stain shows a general lack of. reticulin within the tumor proper. Page: 2 of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. Yeast, left, wide local excision: Invasive ductal carcinoma, Nottingham grade III (of III), forming a 2.7 x 2.7 x 1.5 cm mass. (AJCC pT2). The margins, including the separately submitted superior margin, are negative for tumor. The closest margin. (superior) is free by 1.5 cm. Lymph nodes, left axillary sentinel, excision: Multiple (2) left axillary sentinel lymph nodes are negative for tumor [AJCCpNO (i-. sn)]. Blue dye is identified in both left axillary sentinel lymph nodes. Immunohistochemical cytokeratin stain was performed on. the paraffin embedded sentinel lymph node tissue and confirms the H&E impression.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Date or Procedure: Clinical Diagnosis & History: year old female with history of toxic goiter questionable UCO IB1, now with dominant right nodule; biopsy positive for papillary. carcinoma. Specimens Submitted: 1: SP: Lymph node, delphian, excision (fs). 2: SP: Lymph node, left paratrachea, excision (fs). 3: SP: Thyroid, total thyroidectomy. 4: SP: Pretracheal tissue, excision. 5: SP: Left supramediastinal tissue, excision. DIAGNOSIS: 1. SP: Lymph node, delphian, excision (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.6cm. Size of the largest metastatic focus : 0.4 cm. Extranodal extension is not identified. 2. SP: Lymph node, left paratrachea, excision (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 1cm. Size of the largest metastatic focus : 0.6 cm. Extranodal extension is not identified. 3. SP: Thyroid, total thyroidectomy: Tumor Type: Papillary carcinoma, tall cell variant. Mitotic Activity: Mild to moderate. Tumor Necrosis: Not identified. Other Tumor Features: Psammoma bodies. Tumor Location: Both lobes and isthmus. Tumor Size: The tumor spans the entire thyroid and is at least 7 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: There is extensive extension into peri-thyroidal fibroadipose tissue and skeletal muscle. Surgical Margins: Tumor is at the posterior margin. Non-Neoplastic Thyroid: shows changes consistent with previous radioactive iodine administration. Parathyroid Glands: One parathyroid gland involved by thyroid carcinoma. Lymph Nodes: Perinodal (extracapsular) extension identified. Metastatic carcinoma in 4 of 4 lymph nodes (4/4). 4. SP: Pretracheal tissue, excision: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 5. SP: Left supramediastinal tissue, excision: Benign thymus. One unremarkable parathyrold gland. |ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1. The specimen is received fresh for frozen section consultation, labeled ""Delphian node"" and consists of two lymph nodes. measuring in aggregate 0.9 x 0.8 x 0.4 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2. The specimen is received fresh for frozen section consultation, labeled ""left paratracheal lymph node"" and consists of a lymph. node measuring 1x 1 x 0.6 cm. The specimen is bisected and entirely submitted for frozen section. rsc - trÃ¶zen section contral. 3). The specimen is received fresh, labeled ""Total thyroidectomy stitch marks right lobe of thyroid"" and consists of a thyrold. weighing 50 g. The right lobe measures 4 x 4 x 4 cm, the left lobe measures 3 x 1.5 x 1.5 cm and the isthmus measures 0.3 x 0.3. x 0.2 cm. Both lobes appear to be matted by small amount of Isthmus. The external surface is covered by a thin fibrous capsule,. and attached pink tan soft tissue. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning. reveals a 4 x 4 x 4 white-tan nodule with attached matted 1 x 1 x 1 cystic nodule, located on the right lobe abutting the capsular. margin and abutting the left lobe which shows a 2.5 x 2 x 2cm nodule extended to all parenchyma. Sections through the. remaining tissue reveal predominantly white tan firm cut surface extended to the all specimen parenchyma. Representative. sections of the specimen are submitted for. and a photograph has been taken. The remaining tissue is serially sectioned and. entirely submitted. Summary of sections: RL right lobe. LL left lobe. IS isthmus. 4). The specimen is received in formalin, labeled ""Pretracheal tissue"" and consists of a 0.3 x 0.3 x 0.2 cm pink-tan irregular. portion of soft tissue. The specimen is entirely submitted. Summary of sections: U-- undesignated. 5). The specimen is received in formalin, labeled ""Left supramedlastinal tissue"" and consists of a 2.0 x 1.0 x 0.3 cm portion. of. yellow lobulated tissue. No lymph nodes are grossly identified. The entire specimen submitted. Summary of sections: U-- undesignated. Summary of Sections: Part 1: SP: Lymph node, delphian, excision (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: SP: Lymph node, left paratrachea, excision (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Thyrold, total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 6. LL. 6. 19. RL. 19. Part 4: SP: Pretracheal tissue, excision. Block. Sect. Site. PCs. U. 1. Part 5: SP: Left supramediastinal tissue, excision. Block. Sect. Site. PCs. 1. U. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. FROZEN SECTION DIAGNOSIS: SP: DELPHIAN NODE (FS): METASTATIC PAPILLARY CARCINOMA IN TWO OF. TWO LYMPH NODES (2/2). PERMANENT DIAGNOSIS: SAME. 2. FROZEN SECTION DIAGNOSIS: SP: LEFT PARATRACHEAL NODE (FS): METASTATIC PAPILLARY CARCINOMA. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
LABORATORY SERVICES. Patient ID: PHN: ALT ID: UTD:FADAEF13-D4B0-4C12-9617-04878D3FC98D. Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: ORIGINAL REPORT. SPECIMEN: A. Gallbladder. B. Right liver and diaphragm. CLINICAL HISTORY: Hypervascular lesion in right liver in segment 7. DIAGNOSIS: A. GALLBLADDER, CHOLECYSTECTOMY: CHRONIC CHOLECYSTITIS AND CHOLELITHIASIS. B. RIGHT LIVER AND DIAPHRAGM, RESECTION: HEPATOCELLULAR CARCINOMA, MODERATELY DIFFERENTIATED (GRADE II/III). TUMOR SIZE: 12 X 9. X 2.- CM. INVADING INTO PERI-HEPATIC ADIPOSE TISSUE. PERITUMORAL INTRAVASCULAR INVASION PRESENT. TWO SATELLITE NODULES IDENTIFIED. RESECTION MARGIN IS 1 MM FROM THE SATELLITE NODULE, HOWEVER SMALL. CLUSTERS OF TUMOR CELLS PRESENT AT RESECTION MARGIN. BACKGROUND HEPATIC TISSUE SHOWING CIRRHOSIS AND PERIPORTAL. INFLAMMATION CONSISTING OF SIGNIFICANT NUMBERS OF PLASMA CELLS AND. EOSINOPHILS. (Electronic Signature). GROSS DESCRIPTION: A. The specimen is received fresh and is subsequently placed into formalin,. and consists of a dark tan intact gallbladder which measures 8.0 x 3.0 x 3.0. cm. The serosal surface is smooth and glistening. Opening the gallbladder. reveals it to be filled with a thick green bile and contains round. multifaceted calculi ranging in size from 0. cm up to 0.6 cm in greatest. dimension. The mucosa surface is dark green, velvety and the gallbladder wall. measures 0.2 cm in thickness. Found within the cystic duct are two brown. Page 1  CONTINUED. LABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: GROSS DESCRIPTION: multifaceted calculi measuring 0.2 cm in greatest dimension. Grossly the. cystic duct lymph node is not identified. Three representative sections are. submitted in one cassette. B. The specimen is received fresh and is subsequently placed into formalin,. and consists of a portion of liver weighing 859 g and measuring 15.0 x 12.0 x. 8.0 cm. The resection margin of the specimen has been inked blue. Sectioning. of the specimen reveals a lobulated necrotic mass occupying approximately 80%. of the liver measuring 12 x 9.6 x 2.4 cm. The border of this mass has an. ill-defined appearance and two small tan nodules are identified within the. liver parenchyma adjacent to this large mass. Both these nodules measures 0.2. cm in greatest dimension. A prominent blood vessel is noted within the liver. parenchyma that contains thrombus material. Grossly the liver capsule has a. lobulated appearance due to invasion of the mass. Grossly the main mass comes. to within approximately 1.5 cm of the blue painted margin. The liver capsule. overlying the normal liver parenchyma has a slightly bumpy appearance. ?cirrhosis. Sections of the specimen is as follows: B1. section of vessel with thrombus at blue painted margin. B2-3. two random sections of blue painted margin. B4-6. section of nodules on liver capsule. B7. section of nodule on liver capsule and small nodule close to. overlying blue painted margin, 0.2 cm. B8-10. three sections from the large mass. B11-12. two random sections from adjacent liver parenchyma. B13. section of small nodule ?satellite lesion in liver parenchyma. MICROSCOPIC DESCRIPTION: The hepatocellular carcinoma is composed of mainly trabecular and. pseudoglandular pattern. The tumor cells are hyperchromatic with easily. identifiable mitoses. Focal tumor necrosis is also present. There are. peritumoral intravascular invasion. The tumor is focally infiltrating into. the perihepatic adipose tissue (? diaphragm) The immunohistochemical stains. demonstrate the nature of the hepatocellular origin. The tumor cells show. canalicular stain for CEA and are strongly positive for Hep-par-1. They are. negative for CK7, CK20, synaptophysin and AFP. The background hepatic tissue. is cirrhotic. The etiology of cirrhosis cannot be determined. However, there. are significant numbers of lymphoplasmacytes and eosinophils in the periportal. area. The hepatocytes show no ground glass change or Mallory bodies. Procedure:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/POST-OP DIAGNOSIS: Invasive ductal carcinÃ³ma in the left breast at 10 o'clock. Calcifications. and atypia at 12 o'clock. LMP DATE: Not listed. PROCEDURE: Left segmental mastectomy, sentinel lymph node biopsy, excisional biopsy. SPECIFIC CLINICAL QUESTION: Not listed. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: LEFT BREAST, 40 O'CLOCK, SEGMENTAL MASTECTOMY -. A. TWO FOCI OF INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE. B. NOTTINGHAM GRADE 2 (TUBULE FORMATION: 2, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: TOTAL SCORE: 7/9). 2;. C. THE DOMINANT MASS OF INVASIVE CARCINOMA MEASURES 1.9 CM IN LARGEST DIMENSION. D. THE SATELLITE FOCUS MEASURES 0.6 CM AND IS PRESENT 0.5 CM AWAY FROM THE MAIN MASS. E. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM TYPE. F. THE DCIS CONSTITUTES 10% OF THE TOTAL TUMOR VOLUME AND IS ADMIXED WITH INVASIVE. COMPONENT. G. NO LYMPHOVASCULAR SPACE INVASION IS NOTED. H. THE INVASIVE CARCINOMA (DOMINANT MASS) FOCALLY EXTENDS TO THE SUPERIOR MARGIN AND IS. <0.1 CM TO THE POSTERO-INFERIOR MARGIN. I. THE SATELLITE FOCUS OF INVASIVE CARCINOMA IS 0.15 CM FROM THE POSTERIOR MARGIN. J. FLAT EPITHELIAL ATYPIA. K. CALCIFICATIONS ARE ASSOCIATED WITH INVASIVE CARCINOMA AND BENIGN BREAST PARENCHYMA. L. THE NON-NEOPLASTIC BREAST SHOWS FLORID DUCTAL HYPERPLASIA, COLUMNAR CELL CHANGE AND. FIBROCYSTIC CHANGES. M. PREVIOUS BIOPSY SITE CHANGES. N. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR (H- score 240) AND POSITIVE. FOR PROGESTERONE RECEPTOR (H-score 240) AND NEGATIVE FOR HER-2, AS PER PREVIOUS. PART 2: LEFT BREAST, 12 O'CLOCK, BIOPSY -. A. FLORID DUCTAL HYPERPLASIA. B. COLUMNAR CELL CHANGES AND HYPERPLASIA. C. RADIAL SCAR. D. FIBROADENOMATOID AND FIBROCYSTIC CHANGES. E. NO RESIDUAL ATYPIA SEEN. F. PREVIOUS BIOPSY SITE. PART 3: LEFT SENTINEL LYMPH NODE #1, BIOPSY -. A. ONE LYMPH NODE, POSITIVE FOR METASTATIC TUMOR (1/1). B. THE METASTATIC FOCUS MEASURES 0.6 CM IN LARGEST DIMENSION. C. FOCAL EXTRACAPSULAR EXTENSION (<0.1 CM) IS IDENTIFIED. PART 4: LEFT SENTINEL LYMPH NODE #2, BIOPSY -. TWO LYMPH NODES, NEGATIVE FOR METASTATIC TUMOR (0/2). COMMENT: The invasive tumor nuclear grade is variable and ranges-from nuclear grade 2 to nuclear grade 3. The highest grade is. taken into account for Nottingham scoring and grading. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. Antibody/Antigen. E-cadherin. Membranous reactivity in invasive tumor cells. P120. Membranous reactivity in invasive tumor cells. Utilizing formalin-fixed (8-96 hour range), paraffin embedded tissue, immunohistology is. performed with the following selected antibodies and designated antibody clone (s) directed. against the following antigenic target (s) with adequate positive and negative internal and. external controls. Antibodies are optimized appropriate for fixation times. ANTIBODY. CLONE. TARGET ANTIGEN. VENDOR. E-cadherin. 36. Ductal Carcinoma. P120. 98. Lobular carcinoma. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position: 10.00. SIZE OF TUMOR: Maximum dimension invasive component: 19 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.5 mm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 2. Mitotic activity score: 2. Total Nottingham score: 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 10 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Yes, focal. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 6 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Yes, Maximum size is:0.75mm. NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNX. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 240. PROGESTERONE RECEPTORS: positive, H-score: 240. HER2/NEU: 1+. Comment: The tumor pN stage is at least pN1. Since the sentinel node is positive, a final N. stage will be assigned after complete lymph node dissection.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor. Account Number: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT BREAST LUMPECTOMY, LEFT AXILLARY SENTINEL MAPPING, F.S. TISSUES. A. BREAST EXCISION, NEEDLE LOC, SIMPLE, MARGINS, ETC. - LEFT BREAST LUMP. B. MARGINS - ADDITIONAL ANTERIOR MARGIN. C. MARGINS - ADDITIONAL SUPERIOR MARGIN. D. LYMPH NODE (S) - SENTINEL LYMPH NODE #1 FS. E. LYMPH NODE (S) - SENTINEL LYMPH NODE #2 FS. F. LYMPH NODE (S) - SENTINEL LYMPH NODE #3 FS. G. LYMPH NODE (S) - SENTINEL LYMPH NODE #4 FS. H. LYMPH NODE (S) - ADDITIONAL NON-SENTINEL NODE FS. FS DIAGNOSIS. A. LEFT BREAST LUMP ""GROSS MARGINS"". BREAST TISSUE WITH TUMOR (2.4 X 2.2 2.2 CM.) EXTENDING WITHIN 0.2 CM. OF NEAREST SUPERIOR SURGICAL MARGIN AND 0.3 CM. OF ANTERIOR SURGICAL. MARGIN. ALL DESIGNATED SURGICAL MARGINS ARE FREE OF TUMOR (GROSS). D. SENTINEL LYMPH NODE #1, F.S.-. LYMPH NODE, NEGATIVE FOR MALIGNANCY,. E. SENTINEL LYMPH NODE #2, F.S. -. LYMPH NODE, NEGATIVE FOR MALIGNANCY. F. SENTINEL LYMPH NODE #3, F.S.-. LYMPH NODE, NEGATIVE FOR MALIGNANCY. G. SENTINEL LYMPH NODE #4, F.S. LYMPH NODE, NEGATIVE FOR MALIGNANCY. H. SENTINEL LYMPH NODE #5, F.S. -. LYMPH NODE, NEGATIVE FOR MALIGNANCY. (Reported to surgeon: SURGICAL REPORT. Pathology Numb. Diagnosed by: FINAL DIAGNOSIS. A. LEFT BREAST LUMP -. INFILTRATIVE DUCT CARCINOMA (2.4 CM.). BLOOM-RICHARDSON GRADING: GRADE III OF III (MINIMAL TUBULE FORMATIONS, HIGH NUCLEAR GRADE. AND HIGH MITOTIC INDEX). DCIS: NONE IDENTIFIED. TUMORAL NECROSIS/CALCIFICATION: NECROSIS ONLY. LOBULAR CANCERIZATION: PRESENT, FOCAL. SURGICAL MARGINS: UNINVOLVED, SUPERIOR MARGIN IS THE CLOSEST AND IS 0.2 CM. FROM. THE TUMOR. B. ADDITIONAL ANTERIOR MARGIN -. BENIGN BREAST TISSUE, THE NEW REVISED ANTERIOR MARGIN IS 0.9 CM. (0.3. 0.6 CM.). C. ADDITIONAL SUPERIOR MARGIN -. BENIGN BREAST TISSUE, THE NEW REVISED SUPERIOR MARGIN IS 0.8 CM. (0.2 + 0.6 CM.). D. SENTINEL LYMPH NODE #1 -. ONE BENIGN REACTIVE LYMPH NODE (0/1). E. SENTINEL LYMPH NODE #2-. ONE BENIGN REACTIVE LYMPH NODE (0/1). F. SENTINEL LYMPH NODE #3. ONE BENIGN REACTIVE LYMPH NODE (0/1). G. SENTINEL LYMPH NODE #4. ONE BENIGN REACTIVE LYMPH NODE (0/1). H. ADDITIONAL NON-SENTINEL LYMPH NODE-. ONE BENION REACTIVE LYMPH NODE. PTNM CLASSIFICATION: T2, NO, MX, STAGE IIA. Diagnosedby: COMMENT. The ER, PR, and Her-2/neu have been performed on previous surgical. This case is. discussed with Dr. by Dr. COMMENT2. SURGICAL REPORT. Patmology Number: Lymph nodes in parts D, E, F, G and H are negative for malignancy by Cytokeratin (AE1/AE3). staining. GROSS DESCRIPTION. The specimen is received in eight separate containers labeled. hated A. through H. A. The container is received fresh unfixed labeled ""left breast lump for gross margin"". The specimen. consists of a 20 gm. ovoid mass of apparent fatty and fibrous encased tissue which is 4.1 X 3.3 x. 2.5 cm. in greatest overall dimension. There is a single short suture indicating anterior margin. inked with yellow dye, posterior/deep margin is inked black. There are two short sutures. Indicating superior margin Inked with orange dye, inferlor is Inked red. There is a single long. suture indicating lateral margin inked with blue dye, medial is inked green. Sectioning reveals. a. well-circumcised tumor mass which is 2.4x 2.2x 2.2 cm. in greatest overall dimension and. consists of a pink-tan firm with scattered cystic spaces filled with amber-colored fluld. The tumor. mass grossly appears to be 0.3 cm. from the anterior, 0.5 cm. from the posterior/deep, 0.2 cm. from the superior, o 4 cm. from the inferior, 0.6 cm. from the lateral, 0.6 cm. from the medial. The. specimen is submitted In ten blocks. Key Note Block Summary: 1-anterior, 2-posterlor/deep, 3-superior, 1-inferior, 5-. medial, 6-lateral, 7 through 10-remaining. B. The container is received fresh unfixed labeled ""additional anterior margin - suture on new. anterior margin"". The specimen consists of a 2 gm. ovoid mass of apparent fatty tissue which is. 3.5 x 2) 0.6 cm. In greatest overall dimension. There is an attached suture indicating new. anterior margin Inked orange. Serial sectioning reveals fatty tissue and a scant amount of pink-. tan firm tissue. The entire specimen is submitted in two blocks. C. The container is received fresh unfixed labeled ""additional superior margin - suture on new. superior margin"". The specimen consists of a 3 gm. ovoid mass of apparent fatty tissue which. is. 2.5 x 2.5 x 0.6 cm. in greatest overall dimension. The attached suture indicates new superior. margin inked with yellow dye. Serial sectioning reveals fatty tissue. The entire specimen is. submitted in two blocks. The container is received fresh unfixed labeled ""sentinel lymph node #1 for frozen section"". The. specimen consists of an ovoid nodule of tan-gray firm rubbery tissue with attached fatty material. measuring 0.6 x 0.6x 0.4 cm. Touch prep and frozen section are obtained by Dr. The entire specimen Including frozen section is submitted In two blocks. E. The container is received fresh unfixed labeled ""sentinel lymph node #2 for frozen section"". The. specimen consists of an ovoid nodule of tan-gray firm rubbery tissue with attached fatty material. 0.3 x 0.3 x 0.2 cm. Touch prep and frozen section are obtained by Dr. The. specimen is bisected and the entire specimen including frozen section is submitted in two blocks. F. The container is received fresh unfixed labeled ""sentinel lymph node #3"". The specimen consists. of an ovold nodule of tan-gray firm rubbery tissue with attached fatty material 0.3 x 0.3 x 0,3 cm. Frozen section and touch prep are obtained by Dr. The specimen is bisected and. the entire specimen including frozen section is submitted in two blocks. G. The container is received fresh unfixed labeled ""sentinel lymph node #4 for frozen section"". The. specimen consists of an ovold nodule of tan-gray firm rubbery tissue with fatty material 0.6x 0.3 x. 0.3 cm. Frozen section and touch prep are obtained by Dr. (. The specimen is. bisected. The entire specimen including frozen section is submitted in two blocks. SURGICAL REPORT. Number: H. The container is received fresh unfixed labeled ""additional non-sentinel node for frozen section"". The specimen consists of an ovoid nodule of tan-gray firm rubbery tissue with attached fatty. material 0.3 x 0.2 x 0.2 cm. Frozen section and touch prep are obtained by Dr. The. specimen is bisected. The entire specimen including frozen section is submitted in two blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: Cytokeratin (AE1/AE3) (specimens D, E, F, a, H). SURGICAL REPORT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. LYMPH NODE, DESIGNATED ""N8R"", BIOPSY: - FRAGMENTS OF ANTHRACOTIC LYMPH NODE. - NEGATIVE FOR MALIGNANCY. B. LUNG, RIGHT LOWER LOBE, LOBECTOMY: - INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA OF. THE LUNG, WITH VISCERAL PLEURAL INVASION. - THE TUMOR MEASURES 62 MM IN DIAMETER. - SATELLITE TUMOR NODULES PRESENT ADJACENT TO MAIN MASS. - THE BRONCHIAL MARGIN IS FREE OF TUMOR. THE TUMOR IS PRESENT 50 MM FROM THE BRONCHIAL MARGIN. - LUNG TISSUE WITH EMPHYSEMATOUS CHANGES AND RESPIRATORY. BRONCHIOLITIS. - METASTATIC CARCINOMA IN ONE OF THREE PERIBRONCHIAL LYMPH. NODES (1/3). - BENIGN GLANDULAR EPITHELIAL INCLUSION WITHIN. PERIBRONCHIAL LYMPH NODE. FOCAL NONCASEATING, HYALINIZED GRANULOMATOUS. INFLAMMATION WITHIN PERIBRONCHIAL LYMPH NODE. C. LYMPH NODE, DESIGNATED ""N9R"", BIOPSY: - ANTHRACOTIC LYMPH NODE. - NEGATIVE FOR MALIGNANCY. - SEE SYNOPTIC CANCER STAGING CHECKLIST. COMMENT: Dr. has co-reviewed representative slides from this. case, and concurs with the diagnosis of adenocarcinoma. This report continues. FINAL SURGICAL PATHOLOGY REPORT. Lung Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Procedure: Right lower lobectomy, with mediastinal lymph node. biopsies. TUMOR FEATURES: Tumor site: Right lower lobe. Tumor size: 62 mm. Tumor focality: Main tumor mass with at least 3 smaller satellite tumor. nodules. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Lymphovascular invasion: Present. Visceral pleural invasion: Present. LYMPH NODES: Two mediastinal lymph nodes submitted separately,. without evidence of metastatic carcinoma. At least three. peribronchial lymph nodes, one of which is involved by a. small focus of metastatic carcinoma in the subcapsular. sinus. MARGINS: Bronchial margin: Negative (tumor present 50 mm from bronchial. margins). Vascular margin: Negative. PATHOLOGIC TUMOR STAGING: Primary tumor: pT3 (based on presence of separate satellite tumor. nodules in the same lobe of lung). Regional lymph nodes: pN1 (metastasis in ipsilateral peribronchial lymph. nodes). Distant metastasis: pMX (not applicable). Pathologic stage: IIIA. This report continues. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Lung bx. B. Lung. C. Lung bx. Clinical History/Operative Dx: Malignant neoplasm, right lower lobe. Intraoperative Diagnosis: B. Right lower lobe frozen section diagnosis: ""Bronchial margin free of tumor"". The. intraoperative interpretation(s) was/were performed and rendered at. Gross Description: A. The specimen is labeled N8R and is received in formalin. It consists of two 0.7 cm fragments of red-. brown to anthracotic tissue. The specimens are inked with contrasting colors and each specimen is. bisected. The tissue is entirely submitted in cassette A1. B. The specimen is labeled right lower lobe and is received without fixative. It consists of a lobe of lung. which measures 16.0 X 9.5 X 3.8 cm and weighs 269.0 grams. The pleural surface of the superior portion. of the lobe has a mottled red to dark violet appearance and appears smooth. There is a prominent area. of puckering and distortion of the lateral basilar portion of the lung. Adjacent to this pleural puckering and. distortion are three subpleural firm prominent nodules which vary from 0.7 to 1.2 cm. There is another. subpleural nodule in the lateral apical portion of the lung. At the hilum of the lung a staple line is. dissected from the specimen and the bronchial margin is removed as a thin shave. There are three small. up to 0.6 cm peribronchial lymph nodes. The bronchi are opened and there is no gross evidence of. intraluminal tumor. Sections of the lateral basilar portion of the lung reveal a dull yellow relatively well. circumscribed neoplasm which measures 6.2 X 5.0 X 2.9 cm. This neoplasm is 5,0 cm from the bronchial. resection margin. It abuts and distorts the pleural surface. Representative sections are submitted. Sections summary: B1) bronchial margin from frozen section, B2) vascular margins, B3) peribronchial. nodes, B4-B5) lateral basilar tumor and pleural surface, B6-B7) additional sections of tumor, B8) three. subpleural nodules just adjacent to tumor, B9) subpleural node anterior apical lung, B10) uninvolved. lung. C. The specimen is labeled N9R and is received in formalin. It consists of a single 1.1 X 0.7 X 0.5 cm. fragment of red-brown tissue. It is serially sectioned and entirely submitted in cassette C1. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. This report continues (FINAL). FINAL SURGICAL PATHOLOGY REPORT. B. Special stain: Elastin stain, performed on blocks B5, B6, and B7, demonstrating visceral pleural. invasion. Immunohistochemical stain: cytokeratin OSCAR, TTF-1, performed on block B3, demonstrating. 1 mm metastatic focus within subcapsular sinus of peribronchial lymph node. The metastatic tumor and. the epithelial inclusion stain positive for cytokeratin OSCAR, where as only the metastatic tumor stains. positive for TTF-1. Appropriate positive and negative controls reviewed. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. REPRINT: Orig. printing on.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Printed. Ref. by. Sex: M. CLINICAL HISTORY: Fi. Pleural effusion and blood ? meso. MACROSCOPIC: Lung biopsy: Six tan fragments ranging from 2-5mm (1x6ae,. Pati. Noti. Patier. MICROSCOPIC: C: Sections show a fragment of an infiltrating epithelioid neoplasm. The. tumour cells do not produce mucin but some tissue mucin is present. Ma. A panel of antibodies shows the following profile;. Appoir. Keratin broad spectrum (AE1/3), i Calretinin and WT-1 all positive. Coll. TTF-1 and CEA (polyclonal) : both negative. Presar. CONCLUSION: Lung biopsy; MALIGNANT MESOTHELIOMA, epithelioid. o. Treati. Chi. Wi. Doc. Confidentiality: This document is confidential. If you are not the Intended recipient you must not read, copy, distribute or act in. reliance on it. If you have recieved this document in error please notify us immediately and destroy the original message.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
RUN DATE: RUN TIME. RUN USER: ACCT # : LOC: AGE/SX: /M. ROOM: REG DR: BED: SPEC # : RECD. PERFORMED AT. COLL. TIME IN FORMALIN: 5:18. hrs. COLD ISCHEMA TIME 0:00. mins. Addendum # 1. The case is discussed with Dr. by telephone. The gross specimen is. reviewed in an attempt to find additional lymph nodes. Dissection reveals in the. periserosal adipose tissue one area, possibly suspicious for metastatic tumor measuring. 4. mm. No additional obvious gross lymph nodes are identified. The following additional. sections are submitted. A10. additional periserosal adipose tissue with suspicious nodule. A11-15- additional periserosal adipose tissue. In the sections. four additional small lymph nodes are found, and these are negative for. malignancy. Addendum Signed. (signature on file). intestinal type 8/44/3. RUN DATE : RUN TIME. Specimen Inquiry. RUN USER: Lab Database: SPEC #: CLINICAL INFORMATION: Pre-Op Diagnosis: Gastric CA. Remarks: Specimen (s) : A. Subtotal gastrectomy for gross evaluation. B. Posterior vagus. C. Anterior vagus. MICROSCOPIC DIAGNOSIS. Ã. PORTION DISTAL STOMACH. SUBTOTAL GASTRECTOMY: MODERATELY DIFFERENTIATED ADENOCARCINOMA. TUMOR MEASURES 3 CM AND INFILTRATES MUSCULARIS. SURGICAL MARGINS FREE OF TUMOR. NO TUMOR SEEN IN ANY OF 3 REGIONAL LYMPH NODES. SEE COMMENT FOR SYNOPTIC REPORT. B. PORTION POSTERIOR VAGUS NERVE, VAGOTOMY: SEGMENT OF NERVE PRESENT. C. PORTION ANTERIOR VAGUS NERVE, VAGOTOMY: SEGMENT OF NERVE PRESENT. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY - CAP APPROVED. Specimen: Portion of stomach. Procedure: Partial gastrectomy, distal. Tumor Site: Antrum. Tumor Size: 3 cm in greatest dimension. Histologic Type: Adenocarcinoma intestinal type. Histologic Grade: G2: Moderately differentiated. Microscopic Extent of Tumor. Tumor invades muscularis propria. Margins: Distance of carcinoma from closest margin: 6 cm: proximal. Treatment Effect: No prior treatment. Lymph-Vascular Invasion: Not identified. Pathologic Staging: Primary Tumor pT2. Regional Lymph Nodes: pNO. Number examined : 3. Number involved : 0. Distant Metastasis: Not applicable. RUN DATE. RUN TIME. Specimen Inquiry. RUN USER. Lab Database: SPEC #. GROSS DESCRIPTION: The specimen is received in the fresh state from the operating room in three parts. A. This is a subtotal gastrectomy specimen with adjacent tissues also resected The. stomach measures 15 x 7 x 3 cm. The proximal and distal margins are stapled closed. Present centrally is a red tumor which measures 3 x 2.5 x 1 cm. The tumor involves the. wall but does not penetrate through the all and is located 6 cm from the proximal margin. and 8 cm from the distal margin. Omentum attached to the specimen measures 18 x 18 x 4 cm. There is no gross evidence of metastatic tumor in the omentum. The surgeon has tagged. subpyloric lymph node. No enlarged lymph nodes are found. Representative portions of the. tumor are removed by aseptic technique and are submitted for tumor banking. The following. sections are submitted. A1. distal margin. A2. proximal margin. A3,4 - whole prepyloric lymph node candidate. A5. red nodules in omentum. A6-9 -. gastric tumor. B. This is a 1 cm fragment of soft tissue, totally examined by frozen section as block B1. C. This is a 1 cm fragment of soft tissue, totally examined by frozen section as block C1. INTRAOPERATIVE CONSULTATION: A. IMMEDIATE GROSS EVALUATION, SUBTOTAL GASTRECTOMY: TUMOR PRESENT IN CENTRAL PORTION OF SPECIMEN. SURGICAL MARGINS FREE OF TUMOR. TUMOR PROCESSED FOR TUMOR BANKING. B. FROZEN SECTION DIAGNOSIS. POSTERIOR VAGUE: PORTION OF NERVE PRESENT. C. FROZEN SECTION DIAGNOSIS, ANTERIOR VAGUS: PORTION OF NERVE PRESENT. PHOTO LOCUMENTATION. Image. : Picture Copy Error. (signature on file).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: Male. Race: Report Date: FINAL PATHOLOGIC DIAGNOSIS. A. Right pelvic lymph nodes; biopsy: - Eight benign lymph nodes (0/8). B. Left pelvic lymph nodes; biopsy: - One lymph node with metastatic urothelial carcinoma (1/1). - No extranodal extension. C. Left pelvic lymph nodes; biopsy: - Three of sixteen lymph nodes with metastatic urothelial carcinoma (3/16). - No extranodal extension. D. Bladder and prostate; radical cystectomy: - Invasive urothelial carcinoma, see parameters. E. Right distal ureter, resection: - Fragment of ureter, no tumor. Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Papillary urothelial carcinoma. 2. Grade of tumor: High grade. 3. Depth of invasion: Extravesicular soft tissue. 4. Tumor distribution: Solitary, 9 x 6.5 X 3 cm. Dome. Right lateral wall. Left lateral wall. Anterior wall. Posterior wall. 5. Ureteral margins: Negative. 6. Distal urethral margin: Negative. 7. Soft tissue margin or serosa: Negative (< 1 mm from cauterized and inked. margin). 8. Lymph nodes: Positive left pelvic lymph nodes (4/17), negative right pelvic. lymph nodes (0/8). 9. pTNM: pT3a, N2. Effective. this Checklist utilizes the edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). , M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow,  MD. Clinical History: The patient is a. -year-old male with malignant neoplasm of bladder undergoing. a radical cystectomy with Neo-bladder. Specimens Received: A: Right pelvic lymph nodes. B: Left pelvic lymph node. C: Left pelvic lymph nodes. D: Bladder, prostate. E: Right distal ureter, stitch on non-margin side. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. Right pelvic lymph. nodes"". Received fresh and placed in formalin is a 7 x 6 x 2 cm aggregate of. yellow-tan fibrofatty tissue. 10 lymph node candidates are identified ranging. from 0.3 x 0.2 x 0.2 cm to 2 x 1 x 1 cm. The lymph node candidates are submitted. as follows: A1-A2: 3 lymph node candidate in each cassette. A3: 2 lymph node candidates. A4: 1 serially sectioned lymph node candidate. A5-A6: 1 serially sectioned lymph node candidate. B. The second container is additionally identified as, ""2. Left pelvic lymph. node"". Received fresh and placed in formalin is a 12 gm, 5.0 x 3.5 x 2.5 cm. pink-tan nodule consistent with lymph node. The lymph node candidate is serially. sectioned to reveal white-tan and firm focal with cystic and necrotic tissue. The specimen is representatively submitted for frozen section diagnosis and read. as ""one lymph node frozen, positive for carcinoma, approximately 2 cm"" per Dr. The frozen section remnant is submitted in blocks B1FS-B2FS. Representative sections are submitted as follows: B1FS-B2FS: Frozen remnant. B3: Section of lymph node. C. The third container is additionally identified as, ""3. Left pelvic lymph. nodes"". Received fresh and placed in formalin is a 7 x 5 x 2 cm aggregate of. yellow-tan fibrofatty tissue. 18 lymph node candidates are identified ranging. from 0.4 x 0.3 x 0.2 cm to 2 x 1.5 x 1 cm. The lymph node candidates are. submitted as follows: C1-C2: 4 lymph node candidates in each cassette. C3-C4: 3 lymph node candidate in each cassette. C5: 1 serially sectioned lymph node candidate. C6: 1 serially sectioned lymph node candidate. C7-C8: 1 serially sectioned lymph node candidate. C9-C10: 1 serially sectioned lymph node candidate. D. The fourth container is additionally identified as, ""4. Bladder, prostate"". Received fresh and placed in formalin is a 525.1 g, 16.5 x 11.5 x 5.5 cm. cystoprostatectomy specimen consisting of a 9.0 x 8.5 x 4.0 cm bladder with. attached pericystic adipose tissue and a 5.5 x 4.5 x 3.5 cm prostate. The right. seminal vesicles measure 5.5 x 2.0 x 0.8 cm and right vas deferens measures 15.5. cm in length by 0.2-0.5 cm in diameter. The left seminal vesicles measures 4.5 x. 1.8 x 0.8 cm and left vas deferens measures 13.5 cm in length by 0.2-0.7 cm in. diameter. The right ureteral stump measures 1.4 x 0.5 cm, the left measures 1.1. x 0.5 cm, and the urethral stump measures 1.4 x 0.7 cm, which demonstrate. intact, patent lumens. The right half of the prostate is inked blue, the left half is inked black, and. the reminder of outer surface of the specimen is inked black. The bladder and. prostate are opened along the posterior aspect due to the location of the. bladder tumor. The prostate is surrounded by thin, shaggy membranous tissue and. sectioning demonstrates rubbery, pink-tan, and spongy with no discrete masses. and indurations. The opened bladder reveals a 9.0 x 6.5 x 3.0 cm fungating, shaggy, gray-tan firm. to friable mass occupying the entire anterior and lateral walls of the right and. left sides. Approximately 30% of the posterior wall is also involved. On cut. section, the mass is diffusely solid and white-tan with focal yellow-tan areas. consistent with necrosis. The mass extends through the muscularis propria and. focally abuts the deep margin with a maximal wall thickness of 3.0 cm, and. located 3.5 cm from the urethral margin. The remaining surrounding bladder mucosa is wrinkled, white-tan with a uniform. 1.1 cm wall thickness. Bilateral ureteral orifices, adjacent to the trigone, are. identified and probe patent. The pericystic adipose tissue is dissected for lymph node candidates. No lymph. nodes are identified. Also received is a detached vessel 5.0 cm in length by 0.2-0.3 cm in diameter. Gross photographs are taken. Representative sections are submitted as follows: D1: Right ureter resection margin. D2: Left ureter resection margin. D3: Distal urethral margin. D4-D5: Apical prostatic margin, perpendicularly sectioned. D6-D7: Bladder mass, including deep margin (tandem sections). D8: Bladder mass and uninvolved mucosa, anterior wall. D9: Bladder mass and uninvolved mucosa, dome. D10-D11:Additional bladder mass. D12: Uninvolved bladder mucosa, dome. D13: Uninvolved bladder mucosa, posterior wall. D14: Uninvolved trigone. D15: Representative prostate through verumontanum. D16: Representative prostate above verumontanum. D17: Bilateral seminal vesicles and vasa deferentia. E. The fifth container is additionally identified as, ""5. Right distal ureter,. stitch on non-margin site"". Received fresh and placed in formalin is a 1.5 cm in. length and 0.6 cm in diameter tubal structure consistent with ureter. A stitch. is designating non-margin side, and opposite side is inked blue. The specimen is. sectioned to reveal a 0.3 cm lumen and a wall thickness 0.2 cm. The outer. surface of the specimen is pink-tan to yellow-tan, and shaggy. The inner surface. is gray-tan and smooth. The marginal side is submitted en face as E1. Intraoperative Consult Diagnosis: B1FS-B2FS: ""one lymph node frozen, positive for carcinoma, approximately 2 cm"" "". per Dr.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Pre-Operative/Clinical History. Left renal mass. Specimen(s) Received. A: MARGIN - BASE OF TUMOR, LEFT KIDNEY MASS. B: LEFT RENAL MASS. Gross Description. Specimen A, received fresh for frozen section labeled margin (base) of tumor, left kidney mass, consists of three friable,. tan soft tissue fragments that measure 0.2 to 0.5 cm in greatest dimension. The fragments are entirely submitted for. frozen section in (A1 FS. Specimen B, received in formalin labeled left renal mass, consists of a 12 gm, 4.0 x 4.0 x 2.5 cm aggregate of multiple. pink, friable to papillary soft tissue fragments admixed with a small amount of adipose tissue. Representative sections are. submitted in (B1-6). Intraoperative Consultation. Specimen A, frozen section diagnosis of ""neoplasm present in one of three fragments"" is rendered by. Microscopic Description. Sections of the first specimen reveal a fragment of adipose tissue, a fragment of benign renal parenchyma, and a single. small fragment of papillary renal cell carcinoma, as described below. Summary of Pathologic Findings. Renal Carcinoma. Specimen B: Operative procedure: Enucleation; robotically-assisted laparoscopic left partial nephrectomy. Tumor size: The specimen was received morcellated and measured 4.0 x 4.0 x 2.5. cm in aggregate. Clinically, the tumor measured approximately 2.7 cm in. maximum dimension. Laterality and focality: Left, unifocal. Histologic type: Papillary carcinoma, type I. (The tumor demonstrates a papillary. architecture with delicate fibrovascular cores lined by small cells with low. grade nuclear features. Clusters of foamy histiocytes are present within. HISTOLOGY REPORT. some of the cores. There is no evidence of necrosis or vascular invasion. The specimen contains small fragments of adjacent renal parenchyma.). Sarcomatoid features: Absent. Histologic grade: Grade I. Extent of invasion: Cannot be determined. Lymph/vascular invasion: Cannot be determined. Margins: Cannot be assessed. Adrenal gland: Not submitted. Regional lymph nodes: Not submitted. Special studies: The following immunostains are performed with the tumor cells staining as follows: Pax-8. Positive. P504S. Positive. CK7. Positive. CK20. Negative. Vimentin. Negative. CD10. Negative. TTF-1. Negative. These immunohistochemical features are compatible with a diagnosis of papillary renal cell carcinoma. pTNM stage: The specimen was received morsellated, precluding an accurate pTNM stage. Staging in this. case relies on the clinical imaging. Pathologic findings in nonneoplastic kidney: Insufficient tissue. Diagnosis. LEFT RENAL MASS, ROBOTICALLY-ASSISTED LAPAROSCOPIC LEFT PARTIAL NEPHRECTOMY: LOW GRADE PAPILLARY RENAL CELL CARCINOMA. Intradepartmental Consult. Comment. Positive and negative controls react satisfactorily. HISTOLOGY REPORT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. LEFT BREAST WLE NEEDLE LOC. B. SLN #1. C. SLN #2. D. RIGHT BREAST. E. SLN #3. F. ADDITIONAL SENTINEL LYMPH NODE RIGHT AXILLA. G. RIGHT AXILLARY CONTENTS LEVELS 1 &2. SPECIMEN(S): A. LEFT BREAST WLE NEEDLE LOC. B. SLN #1. C. SLN #2. D. RIGHT BREAST. E. SLN #3. F. ADDITIONAL SENTINEL LYMPH NODE RIGHT AXILLA. G. RIGHT AXILLARY CONTENTS LEVELS 1 & 2. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-left breast: No definitive mass seen, tissue with fibrosis by Dr. to Dr. at. TPB-SLN #1: Lymph node negative for carcinoma. TPC/TPE-SLN #2 & #3: Lymph nodes positive for carcinoma. Called by Dr. to Dr at. GROSS DESCRIPTION: A. LEFT BREAST WLE NEEDLE LOC. Received fresh labeled with the patient's identification and ""left breast WLE needle localization"" is an. oriented (single-anterior, double-lateral, triple-superior) needle localized lumpectomy with out. radiograph. Ink code: anterior-yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-. orange. The specimen is serially sectioned into 5 sections revealing dense fibrous tissue without a. distinct mass. No tissue is procured. Entirely submitted: A1-A3: slice 1, lateral margin, perpendicular sections. A4: slice 2, anterior. A5: slice 2, posterior. A6: slice 3, anterior. A7: slice 3, posterior. A8: slice 4, anterior. A9: slice 4, posterior. A10-A11: slice 5, medial margin, perpendicular sections. B. SLN #1. Received fresh is a 3 x 0.8 X 0.5 cm lymph node, A touch prep is performed and the lymph node is. submitted entirely in cassette B1. C. SLN #2. Received fresh is a lymph node measuring 1.4 x 1.2 X 0.5 cm. One touch prep is performed and the. lymph node is submitted entirely in cassette C1. D. RIGHT BREAST. Received fresh labeled with the patient's identification and ""right breast"" is an oriented 678 g, 24 X 21 x. 5 cm mastectomy with 11.5 x 7 the skin ellipse and 1.7 cm everted nipple. Ink code: anterior/superior-. blue, anterior/inferior-orange, posterior-black. The specimen is serially sectioned into 12 slices from. medial to lateral with nipple and slice 5 revealing an area of dense nodular firm fibrous tissue, 10 x 8 X 4. cm, extending from the upper inner quadrant to the mid outer quadrant at is closest to the. posterior/deep margin at 1.5 cm. Representatively submitted. D1: slice 2, lower-superior anterior. D2: slice 2, upper-inferior anterior. D3-D8: slice 3, mid section submitted from superior to inferior. D9: slice 4, lower-superior anterior. D10: slice 4, lower-superior posterior. D11: slice 5, lower-superior anterior. D12: slice 5, lower-superior posterior. D13: slice 5, made anterior. D14: slice 5, mid posterior. D15: slice 5, upper-inferior anterior. D16: slice 5, upper-inferior posterior. D17: slice 6, mid superior. D18: slice 6, lower-superior posterior. D19: slice 6, upper-inferior anterior. D20: slice 6, mid inferior. D21: slice 7, mid superior. D22: slice 7, mid inferior. D23: slice 8, mid lower-superior. D24: slice 8, mid upper-inferior. D25: slice 9, mid upper-inferior. D26: slice 9, mid inferior. D27: slice 10, mid upper-inferior. D28: slice 10, mid inferior. D29: slice 11, upper-inferior posterior. D30: slice 1, mid. D31-D32: nipple, perpendicular sections. D33: skin. D34: 1 axillary lymph node. E. SLN #3. Received fresh is a lymph node, 2 x 1 X 0.5 cm. A touch prep is performed and the lymph node is. submitted entirely in cassette E1. F. ADDITIONAL SENTINEL LYMPH NODE RIGHT AXILLA. Received fresh is a piece of yellow-tan tissue 2.5 x 2.1 x 1 cm. Two lymph nodes are identified. measuring 1.4 and 1.8 cm. Lymph nodes are submitted separately in cassettes F1-F2. G. RIGHT AXILLARY CONTENTS LEVELS 1 AND 2. Received fresh is an aggregate of adipose tissue, 7 x 5 x 1.5 cm. Multiple lymph nodes are identified. ranging from 0.1 to 2.1 cm; they have a variegated pink-tan cut surface. Lymph nodes submitted as. follows: G1-G2: 4 lymph nodes each. G3: 6 lymph nodes. G4: 2 lymph nodes. G5-G8: 1 lymph node each. DIAGNOSIS: A. BREAST/LEFT, WIDE LOCAL EXCISION: USUAL DUCTAL HYPERPLASIA WITHOUT ATYPIA, MICROCALCIFICATIONS IN BENIGN DUCTS. AND FIBROCYSTIC CHANGES WITH FIBROSIS. - FOCAL FAT NECROSIS AND MILD ACUTE INFLAMMATION, NO TUMOR SEEN. B. LYMPH NODE, SENTINEL #1, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, SENTINEL #2, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 0.8-CM WITH NO EXTRANODAL EXTENSION. D. BREAST, RIGHT, SIMPLE MASTECTOMY: 1 - MULTIFOCAL, INVASIVE, LOBULAR CARCINOMA, SBR GRADE 2, MEASURING 10-CM. - INVASIVE TUMOR PRESENT 2-MM FROM DEEP SURGICAL RESECTION MARGIN. - METASTATIC CARCINOMA TO ONE OF TWO AXILLARY LYMPH NODES (1/2). - SEE SYNOPTIC REPORT AND SEE NOTE. E. LYMPH NODE, SENTINEL #3, EXCISION : - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 0.7-CM WITH FOCAL EXTRANODAL EXTENSION. F. LYMPH NODE, ADDITIONAL SENTINEL, RIGHT AXILLA, BIOPSY: - METASTATIC CARCINOMA TO ONE OF TWO LYMPH NODES (1/2). G. LYMPH NODES, RIGHT AXILLARY CONTENTS, LEVELS 1 AND 2, DISSECTION: TWENTY LYMPH NODES, NEGATIVE FOR METASTASES (0/20). NOTE: Extensive and multifocal invasive lobular carcinoma is identified. The tumor grossly measures. 10-cm. Microscopic examination reveals that the tumor extends from slice #1 to slice #8 (predominantly. in the inner half, central and subareolar region, with extension to outer quadrants. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 10cm. Tumor Site: Upper outer quadrant. Lower outer quadrant. Upper inner quadrant. Lower inner quadrant. Central. Margins: Negative. Distance from closest margin: 0.2cm. deep. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 4 / 27 Extranodal extension. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Negative. HER2: Negative by FISH. Performed on Case: HER2 by FISH performed in outside facility. Pathological staging (pTN): pT 3N2a. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: D1. ER: Positive. Allred Score: 8 = Proportion Score 5 + Intensity Score 3. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer S instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Right breast cancer, left abnormal imaging. Microscopic/Diagnostic Dictation:. Pathologist,. Final Review: Pathologist,. Final Review: Pathologist. Final Review: Pathologist,. Final: Pathologist,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Kidney, right, laparoscopic right radical nephrectomy. Procedure: laparoscopic radical nephrectomy. Laterality: right. Histologic tumor type/subtype: Renal cell carcinoma, chromophobe. type, eosinophilic variant. Immunostains/special stains show the following results: - BER EP4: positive. - CD117: negative. - CD15: negative. - RCC: negative. - CK7: strongly positive. - E-Cadherin: strongly positive. - Colloidal iron: positive. Sarcomatoid features: not identified. Histologic grade (if applicable) : 3. Tumor size (greatest dimension) : 8.7 cm. Tumor focality: unifocal. Extent of tumor invasion (if present specify if macroscopic or. microscopic) : Capsular invasion/perirenal adipose tissue: not identified. Gerota' S fascia: uninvolved with tumor. Renal sinus: tumor invades into renal sinus adipose tissue. Major veins (renal vein or segmental branches, IVC) : free of. tumor. Ureter: free of tumor. Venous (large vessel) : not identified. Lymphatic (small vessel) : not identified. Histologic assessment of surgical margins: Gerota' S fascia (nephrectomy) : margins uninvolved with tumor. Renal vein (nephrectomy) : margins uninvolved with tumor. Ureter (nephrectomy) : margins uninvolved with tumor. Adrenal gland: not present in specimen. Lymph nodes : none present in specimen. Pathologic findings in non-neoplastic kidney: none. AJCC Staging: pT3a. pNx. This staging information is based on information available at. the time of this report, and is subject to change pending. clinical review and additional information. Comment: We note that the core biopsy of this tumor was interpreted as. renal oncocytoma. This excision specimen has much more tissue to. examine, and shows the eosinophilic variant of chromophobe. carcinoma. This variant of chromophobe carcinoma has granular,. eosinophilic tumor cells without the punched out nuclear. halos of usual chromophobe carcinoma. Eosinophilic variant of. chromophobe carcinoma may look very similar to oncocytoma in a. small sample. The immunostains and the colloidal iron results on. this excision specimen are very typical of chromophobe. carcinoma, with the exception of the negative CD117. The. entire immunostain/colloidal iron profile along with the. morphology strongly supports the interpretation of chromophobe. carcinoma. The tumor involves the renal sinus adipose tissue. Grossly, the tumor extended into the perinephric fat, but. microscopically the bulge into the perinephric tissues is. covered by renal capsule, so capsular invasion is not. identified. Clinical History. -year-old male with NKDA, right renal mass. Gross Description: Received is one appropriately labeled container, additionally. labeled ""right kidney"". Specimen fixation: Formalin. Type of specimen: Radical right nephrectomy. Side of specimen: Right. Size and weight of specimen: Nephrectomy is 955 grams (24.0. x. 10.7 X 6.7 cm) ; kidney 11.7 x 6.7 x 4.0 cm). Orientation: Inking: perinephric fat/blue. Presence/absence of adrenal gland: Absent. Tumor site: Renal cortex/medulla at the lower pole and extends. to the mid portion of the kidney and into the hilum. Tumor description: Tumor is a solid soft mahogany brown,. circumscribed with focal lobulated borders. Approximately 30% of. the mass is necrotic. Hemorrhage is absent. Tumor size: 8.7 x 6.6 x 5.2 cm. Presence/absence of multicentricity: Absent. Confinement/non-confinement to the kidney : Mass is not confined,. extends into the hilum, through the capsule and into the. perinephric fat. Extent of invasion: Perirenal adipose tissue: Tumor grossly involves. Gerota' S fascia: Does not involve. Renal vein: Does not involve. Ureter: Does not involve. Renal Sinus: Grossly involves. Pelvicaliceal: Does not involve. Adrenal: N/A. Other organs: N/A. Surgical margins: Perirenal adipose tissue: Negative, is 0.2 cm from the perirenal. adipose tissue margin. Renal vein: Negative. Renal artery: Negative. Ureter: Negative. Description of kidney away from tumor: The parenchyma is. red/brown with a well-demarcated cortex medulla. The tumor. compresses and displaces the renal pelvis. The renal pelvis. lining is pink/tan and smooth. Hilar lymph nodes: No. Other significant findings : At the superior pole is a 0.7 x 0.5. cm ovoid area of smooth gray cortical discoloration. This. discoloration is 3.3 cm from the mass. Tissue submitted for. Tumor and normal. are given to. Digital picture: No. Block Summary: : A1 - Renal vein, renal artery and ureter margins, en face. A2 - Mass with renal sinus. A3-A5 - Perpendicular of mass at the hilum. A6-A7 - Mass closest to the perirenal adipose tissue margin. A8 - Mass with renal pelvis. A9-10 - Additional sections of mass. A11 - Superior pole cortical discoloration.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Thyroid, total thyroidectomy. Tumor histologic type: Papillary thyroid carcinoma, usual. variant. Tumor size: 2.4 cm (gross measurement). Tumor focality & laterality: Unifocal, right. Tumor capsule: Not applicable. Extent of invasion: Capsular Invasion: Not applicable. Lymphovascular invasion: Not identified. Blood vascular invasion: Present. Extra thyroidal extension: Not identified. Surgical margins: Positive, transected over a distance of 9. mm at the black inked posterior margin (A4) . Isthmus and. anterior margins are negative. Status of thyroid gland away from tumor: Severe lymphocytic. thyroiditis, with follicle formation. Lymph nodes: Three negative lymph nodes are identified. in this specimen (0/3). Size of largest metastasis (greatest dimension) : Not applicable. Extracapsular (perinodal) extension: Not applicable. AJCC Pathologic TNM Stage: pT2 pNO. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. B: Lymph node, right level 6, regional dissection. - No metastatic carcinoma in 5 lymph nodes (0/5). - Benign parathyroid tissue also present. Clinical History : +year-old female with FNA positive for malignancy, favor. papillary thyroid carcinoma. Gross Description: Specimen A is received in a formalin-filled container labeled. with the patient's name and total thyroid and is a 36.2 gram,. thyroid. The specimen arrives with one suture in place. designated right. The right lobe measures 7.1 cm superior. to inferior X 3.4 cm medial to lateral X 2.5 cm anterior to. posterior and the left lobe measures 4.9 cm superior to inferior. X 2.3 cm medial to lateral X 2.3 cm anterior to posterior and. the isthmus measures 2.9 X 0.8 X 0.3 cm. The specimen is inked. as follows: anterior/blue, posterior/black, and. isthmus/yellow. Tumor is given to tissue procurement. The. thyroid gland is sectioned from superior to inferior. The cut. surface reveals a 2.4 X 2.4 X 1.6 cm well-circumscribed. white/tan mass centered in the right lobe. The center of. the mass is significant for soft hemorrhagic material. The. uninvolved thyroid gland is red/brown and firm. There are no. other focal nodules or lesions. The mass grossly abuts the blue. and black inked margins, but does not appear to extend beyond. the capsule. Block Summary. A1-A4 - - Representative sections of mass (A1 shows closest. approach to blue and black inked margins). A5 - Uninvolved thyroid, left lobe. A6 - Uninvolved thyroid, right lobe. Specimen B is received in a formalin filled container labeled. with the patient's name and ""level 6 nodes right"" and is a 2.1 X. 1.2 X 0.6 cm aggregate of yellow lobulated fat. The specimen is. palpated and two lymph node candidates are identified measuring. 0.6 X 0.5 X 0.5 cm and 0.5 X 0.3 X 0.3 cm. Block Summary : B1 - Two lymph node candidates. B2 - Remainder of fat, submitted entirely,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: A mass is located in left heel skin and ulcerated, with 4x4x1.0cm, firm, brown, black-. gray surface. Microscopic Description: Epidermis is necrotic ulcerated and hyperplastic. Tumor is composed of. spindle or oval tumor cells with quitely abundant cytoplasm. Sometime the cytoplasm contains finely. divided melanin pigment granulaes. Tumor cells have a quite low nucleo-cytoplasmic ratio. Nucleus. varies in shape and size with large esinophilic nucleoli. Mitotic figures are present. Tumor cells invade. into dermis or fat tissue. Diagnosis Details: Malignant melanoma. Comments: Formatted Path Reports: SKIN TISSUE CHECKLIST. Specimen type: Surgical resection. Tumor site: Skin, foot. Tumor size: 4x4x1cm. Tumor features: Ulcerated, Pigmented, Necrotic. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Poorly differentiated. Lymph nodes: 1/2 positive for metastasis (Left inguinal lymph node 1/2). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Breslow tumor thickness at diagnosis = 8 mm.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Ih right renal mass/ranal vein thrombus. Specimens Submitted: 1: Right kidney and paracaval lymph nodes Nephrectomy. 2: Falciform ligament Excision. DIAGNOSIS: 1. Right kidney and paracaval lymph nodes , Nephrectomy: Tumor Type: Ranal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 9 cm. Local Invasion (for renal cortical types): Involves renal sinus fat. Renal Vein Invasion: Identified. Surgical Margins: Free of tumor. Non-Naoplastic Kidnay: Chronic interstitial inflammation. Adrenal Gland: Not involved. Lymph Nodes: Not identifiad. Staging for ranal cell carcinoma/oncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava balow the diaphragm. 2. Falciform ligament Excision: Benign fibro-adipose tissue, no tumor seen. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT ) HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen Is received fresh for frozen section consultation labeled ""right kidney and paracaval lymph nodes"" and consists of. a kidney with attached ureter, renal vessels and perinephric fat weighing 514 g in total. Tha kidney measures 24 x 10.6 X 4.5 cm. The atteched uretar measures 12 cm in langth and 0.3 cm in diameter. The attached renal vein measures 0.8 cm In length and. 1.4 cm in diameter. The renal vessels and ureter margins are grossly unremarkable. An adrenal gland is identified measuring 6 x. 1.5 x 1 cm. The kidney is inked black and bivalved to reveal a yellow - orange labulated mass with focal areas of hemorrhage. measuring g x 8.6 x 4 cm, located in upper pole. Tha tumor appears to invalve the renal capsule hawaver does not reach the. inked margins of resection. It grassly invalves the renal vain. Sections through the remainder of the kidney reveal a pink brown. parenchyma, with a well-defined cortico-medullary junction. The cartex measures 1.2 cm and the calyces appear normal. The. specimen is photographed. Representative sections are submitted for TPS and for permanent sections. Summary of sections: FSC - frozen section control. UVM -- ureteral and vessel margins. RVT-tumor with renal vein. T-- tumor. TC-- tumar with capsule. HF- hilar fet. TSF -- tumor with sinus fat. RP -- renal pelvis representative sections. N -- representative sections kidney. A -- adrenal gland. 2). The specimen is received in formalin labeled ""falciform ligament"". It cansists of a fatty soft tissue piece measuring 10 x 6.5. x. 3 cm. It Is serially sectioned to reveal unremarkable cut surfaces. Representative sections are submitted,. Summary of sections: U-undesignated. Summary of Sections: Part 1: Right kidney and paracaval lymph nodes, Nephrectomy. Block. Sect. Site. PCs. 1. a. 1. 1. fsc. 1. hf. 1. n. 1. 1. 1. rvt. 2. 4. t. 4. 2. to. 2. 2. itsf. 2. 1. uvm. 3. Part 2: Falciform ligament, Excision. Black. Sect. Site. PCs. 2. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS RENAL CELL CARCINOMA, CLEAR CELL TYPE. PERMANENT DIAGNOSIS: Same.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PHN: ACB: Telephone: Encounter: Surgical Patholoav Report. Collected Date: Received Date/Time: Specimen Description. A. Gallbladder. B. Liver. Clinical Information. Hepatocellular carcinoma, hepatitis B. Diagnosis. A. Gallbladder: No pathologic diagnosis. B. Liver: Chronic hepatitis B of mild activity (Grade 2). Fibrosis, severe, (Stage 3). Hepatocellular carcinoma, moderately differentiated, 3.0 cm in the. greatest dimension (progressed type), completely excised. No. Chart Request ID: Pathology: Provider - Permanent. Print Date/Time: www. PHN: ACB: Collected Date: Received Date/Time: evidence of endothellum-tined space invasion. Gross Description. Received are specimens A to B. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. A. The specimen is received fresh and is subsequently placed into formalin and consists of an intact gallbladder. measuring 7.5 x 4.0 X 3.0 cm. The serosal surface is tan and smooth. The lumen contains bile. Calculi are not grossly. identified. The mucosal surface is bile stained and velvety. The wall averages 0.2 cm in thickness. The cystic duct is. patent. The cystic duct lymph node is identified. Representative sections are submitted in one cassette. B. The specimen is received fresh and is subsequently placed into formalin and consists of a portion of liver weighing. 101.8. g. and. measuring 10 x 6 x 5.4 cm. The resection margin is dyed blue. Upon sectioning a firm tan mass is identified. measuring 3.0 X 2.0 x 1.7 cm. This mass is located 0.5 cm from the capsular surface and comes within 1.0 cm of the blue. painted resection margin. The remainder of the liver parenchyma is grossly unremarkable. Representative sections are. submitted as follows: B1 - section of the mass in relation to the capsular surface. B2 - section of the mass in relation to the closest blue painted margin. B3 - further section of the mass. B4 - section of grossly unremarkable liver parenchyma. One section was also submitted for the. study. Chart Request ID: Pathology: Provider - Permanent. Print Date/Time: www.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Addandad Report. Resident: Pathologis. PATHOLOGIC DIAGNOSIS: SPECIMEN LABELED ""RIGHT HEMICOLECTOMY"": MUCINOUS ADENOCARCINOMA (~508 mucinous component), MODERATELY. DIFFERENTIATED (3.0 cm in greatest dimension). Tumor is located in the cecum/ascending colon, forms a polypoid mass, is. ulcerative and has an infiltrating border. Tumor invades through muscularis propria and into pericolonic adipose. tissue. Proximal, distal and radial resection margins are negative for tumor. Invasive tumor is 9.9 cm from proximal resection margin, 9.5 cm from. distal resection margin, and 7.2 cm from radial resection margin. Lymphovascular invasion is not identified. Venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response (including Crohn's-like infiltrate) is. mild. Residual adenoma is absent. REGIONAL LYMPH NODE (POSITIVE/TOTAL) : Zero (0) / thirty (30). One (1) separate adenoma. Mural pigment consistent with tattoo site. Associated diseases include diverticulosis. Appendix and terminal ileum with no significant pathologic change. AJCC Classification. T3 NO MX. NOTE: Levels examined on block A5. CLINICAL DATA: History: None given. Operation: None given. Operative Findings: None given. Clinical Diagnosis: Colon cancer. TISSUE SUBMITTED: A/1. Hemicolectomy. GROSS DESCRIPTION: The specimen is received in formalin, labeled with the patient's name, unit. number, and ""#1. Right hemicolectomy"", and consists of a portion of terminal. ileum (2.2 x 2.8 cm), and attached cecum and ascending colon (20.3 cm in length. x. 4.5 cm in diameter), and attached appendix (5. x 0.8 cm), a 3.2 cm proximal. resection margin, and a 2.8 cm distal staple resection margin. An ulcerated. mass (3.0 x 2.2 x 0.5 cm) is present in the cecum/ascending colon, 6.5 cm. distal to the ileocecal valve, 9.9 cm from the proximal stapled resection. margin, and 9.5 cm from the distal staple resection margin. Approximately 15. other mucosal ridges (polyps) are present in the ascending colon, measuring 0.2. to 0.5 cm in greatest dimension, and they may actually represent hyperplastic. folds of mucosa. Representative sections of normal mucosa and tumor are. submitted for tissue bank. Radial margin is 7.2 cm from the mass. Occasional. diverticula are present, with impact of fecaliths. An area of submucosal. tattoo pigment is identified 1.8 cm proximal to the mass. Micro A1: Proximal resection margin (en face), 1 frag,. Micro A2: Distal resection margin with diverticulum (en race), 2 frags,. Page: 1 of 2. Micro A3: Appendix tip, 2 frags,. Micro A4: Appendix cross sections, 2 frags,. Micro A5-A7: Mass, 1 frag each,. Micro A8: Tattoo site with mucosal polyps, 3 frags. Micro A9-A10: Mucosal fold/polyps, 3 frags each,. Micro A11: 1 lymph node, 2 frags,. Micro A12-A19: 4 possible lymph nodes each, 4 frags each,. Micro A20: 3 possible lymph nodes, 3 frags,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Addendum: Upon re-review of this case, there is a focus of possible invasion into a. venule outside of muscularis propria. In that focus, a tumor cell nest is. surrounded by discontinuous smooth muscle cells, which probably represent. residual venular wall. Addendum #1 by. Addendum #2: This primary tumor is still classified as T3. The focus mentioned in the. previous addendum is suspicious for extramural venous invasion. Addendum #2 by. Page: 2 of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Service: Otolaryngology. Resulted: Facility: SPECIMEN (S) RECEIVED. 1. bral-Cavity Posterior Margin of Tongue. 2. Oral Cavity Right lateral tongue floor of mouth. 3. Oral Cavity i left lateral tongue floor of mouth. 4. Oral Cavity Deep posterior tongue margin. 5. Oral Cavity : Dorsum of Tongue Right floor of mouth 1single stitch. anterior 2 double long posterior 1 single short lateral. 6. Neck :Right neck contents. 7. Neck left neck contents. 8. Soft Tissue Right external jugular tissue. DIAGNOSIS. 1. Posterior margin of tongue. Squamous mucosa with chronic inflammation and reactive changes . Negative for high-grade dysplasia or carcinoma. 2. Right lateral tongue floor of mouth. Squamous mucosa negative for tumor. 3. Left lateral tongue floor of mouth. Squamous mucosa negative for tumor. 4. Deep posterior tongue margin. Skeletal muscle negative for tumor. 5. Oral cavity; dorsum of tongue and right floor of mouth. Keratinizing squamous cell carcinoma, moderately differentiated. (Please. see comment). a. Maximum tumor diameter 3.4 cm. b. Tumor thickness 1.6 cm. C. Positive for perineural invasion. d. Negative for lymphovascular invasion. e. The posterior and deep margins are positive for tumor. The. remaining margins are negative. Service: Otolaryngology. Resulted: Facility: 6. Right neck contents. Twenty-seven lymph nodes negative for tumor (0/27). Submandibular gland with no pathologic changes. 7. Left neck contents. Ten lymph nodes negative for tumor (0/10) -. Submandibular gland with no pathologic changes. 8. Right external jugular tissue. Soft tissues with no pathologic changes. Negative for tumor. COMMENT. Two of the specimen margins (specimen 5) are positive for tumor; however,. the separately submitted patient's margins were negative (see specimens. 1-4). SYNOPTIC DATA. Clinical History: No neoadjuvant therapy. Specimen: Dorsal surface of tongue, NOS. Fresh. Procedure: Glossectomy: dorsum of tongue right. floor of mouth. Neck (lymph node) dissection: right. and left neck. Specimen Integrity: Intact. Specimen Size: Greatest dimension: 4.2 cm. Additional dimension: 3 cm. Additional dimension: 1.8 cm. Specimen Laterality: Right. Tumor Site: Dorsal surface of tongue, NOS. Tumor Focality : Single focus. Tumor Size: Greatest dimension: 3.4 cm. Tumor Thickness (pT1 and pT2 tumors) : Tumor thickness: 16 mm. Tumor Description: Exophytic, Endophytic. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G2: Moderately differentiated. Margins. Margins uninvolved by invasive. Page: 2 of 5. Service : Otolaryngology. Resulted: Facility: carcinoma. Distance from closest margin: 0.1 cm. Margin (s) : SEE COMMENT. Margin status for carcinoma in situ. is not applicable. Treatment Effect: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Lymph Nodes, Extranodal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT) : pT2 : Tumor more than 2 cm but not. more than 4 cm in greatest dimension. Regional Lymph Nodes (pN) : pNO No regional lymph node. metastasis. Number of regional lymph nodes. examined: 37. Number of regional lymph nodes. involved: 0. Distant Metastasis (pM) : Not applicable. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. CLINICAL HISTORY. Tongue CA. GROSS DESCRIPTION. 1. The specimen is labeled with the patient's name and as ""posterior. margin of tongue"". It consists of a fragment of tissue measuring 1. 7 x. 0.2 x 0.2 cm. The specimen is submitted in toto for frozen section. 1A. frozen section control. 2. The specimen is labeled with the patient's name and as ""right lateral. tongue floor of mouth"" It consists of a fragment of tissue measuring 1. Page : 3 of 5. Service: Otolaryngology. Resulted: 3. Facility: x 0.5 x 0.2 cm. The specimen is submitted in toto for frozen section. 2A. frozen section control. 3. The specimen is labeled with the patient's name and as ""left lateral. tongue floor of mouth"". It consists of a fragment of tissue measuring. 0. 6 x 0.4 x 0.3 cm. The specimen is submitted in toto for frozen. section. 3A. frozen section control. 4. The specimen is labeled with the patient's name and as ""deep posterior. tongue margin"". It consists of 2 fragments of tissue measuring 1 x 0.6 x. 0.3 and 0.4x 0.3x0.2 cm. The specimen is submitted in toto for frozen. section. 4A. frozen section control. 5. The specimen is labeled the patient's name and as ""dorsum of tongue. right floor of mouth 1 single stitch anterior 2 double long posterior 1. single short lateral"". It consists of an oriented portion of tongue. measuring 1. 8 SI x 3 ML x 4.2 AP cm. There is a raised tumor involving. the dorsal surface of the tongue. The tumor measures 1.6 SI x 2.8 ML x. 3.4 AP cm. The tumor is homogeneous and partly friable. It is located. at 0.3 cm from the lateral margin (double short suture), 0.7 cm from the. medial margin (opposite to double short), less than 0.1 cm from the deep. margin, 0.2 cm from the anterior margin, and close to the posterior. margin. Representative sections are submitted. 5A. anterior margin. 5B. posterior margin. 5C. double short suture margin. 5D. opposite margin of double short. 5E. tumor and deep margin. 5F. tumor. 6. The specimen labeled with the patient's name and as ""right neck. contents"". It consists of an oriented left neck dissection with overall. dimensions of 18 x 3 x 1 cm. There is a diagram indicating levels I-IV. The submandibular gland measures 2.5 x 3 x 1 cm and is unremarkable. Multiple lymph nodes ranging from 0.2 to 1.2 cm are identified in. multiple levels. Representative sections are submitted. 6A. submandibular gland. 6B. level I, multiple lymph nodes. 6C. level II, one lymph node. Service: Otolaryngology. Resulted: Facility: 6D-6E. level III, multiple lymph nodes. 6F. level IV, multiple lymph nodes. 6G. level IV, four lymph nodes. 6H. level IV, multiple lymph nodes. 7. The specimen is labeled with the patient's name and as ""left neck. contents"". It consists of an oriented left neck dissection with overall. dimensions of 11 x 6 x 1.2 cm. There is a diagram indicating levels. I-IV. The submandibular gland measures 2.5 x 3 x 1cm and is. unremarkable. Multiple lymph nodes ranging from 0.3 to 1.3 cm are. identified in multiple levels. Representative sections are submitted. 7A. submandibular gland. 7B. level I, multiple lymph nodes. 7C. level II, one lymph node bisected. 7D. level III, 2 lymph nodes. 7E. level IV multiple lymph nodes. 8. The specimen is labeled with the patient's name and as ""right. external jugular tissue"" It consists of one piece of soft tissue. measuring 1.8 x 1.5 x 0.2 cm. The specimen is submitted in toto. 8A. vessel. 8B. remaining tissue. QUICK SECTION. 1-4. - Margins (posterior tongue, right lateral tongue/floor of mouth, left. lateral tongue/floor of mouth and deep posterior tongue) . - Negative for malignancy. Called at. Page : 5 of 5.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Gender: F. Examination result. Clinical diagnosis (suspicion) Cancer of the cardia. Date of admission: Material: 1) Material: stomach, Method of collection: Total organ resection. Final reult: Stomach adenocarcinoma (G3, pT2, pNO). (8140/3 T-63000). codes according to ICD-O-3 or SNOMED. Macroscopic description: Specimen consisting of the stomach, having been incised along the greater curvature, sized 28.6 x 27.9 cm, with. omentum sized 52 X 18 cm and spleen sized 12.2 x 5.8 x 3.9 cm. In the omentum, spleen with additional diameter of 1 cm and pieces of pancreas sized: 4x 1, 5x2 cm. Tumour sized 12.8 X 11.7 x 2.9 cm in the cardia region on the back wall. Distance from the proximal end: 0.4 cm, from distal end: 23 cm. Microscopic description: Gastric adenocarcinoma (papillary, partially solid type with some mucous cells (mixed type acc. to Lauren class). Cancer infiltrated the whole thickness of the stomach wall and fat tissue of the omentum. Excision lines, omentum and lymph nodes (17) - free of neoplastic lesions. Spleen and pancreas free of neoplastic lesions.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
HISTORY. Large right upper lobe tumour. MACROSCOPIC. Six specimens received: 1: The specimen is labelled ""middle and upper right lobe"" and comprises right upper and middle lobe,. received fresh, and measuring 160 X 60 X 60 mm. There is a marked degree of pleural puckering and. indrawing over the postero-lateral surface of the upper lobe. The pleura overlying the middle lobe. appears normal. A stapled margin, 65 mm in length, is present above the hilum. The bronchial. resection margins and vascular resection margins show no evidence of tumour. Peribronchial lymph. nodes are black and soft. Transverse slicing reveals a somewhat ill-defined tumour mass, 47 mm. in. diameter, within the postero-lateral aspect of the upper lobe extending almost to the pleural surface and. extending to within 10 mm of the bronchial resection margin. The surrounding lung parenchyma. appears consolidated and yellowish in colour. The main tumour mass is pale grey to cream in colour. with focal carbon pigmentation. The remainder of the lung parenchyma shows no pathological. features. Towards the apex of the upper lobe there is a second contiguous lobulated tumour mass, 30. mm in diameter, which also appears clear of the pleura. This has a more tan cut surface. [1A, upper. lobe bronchial resection margin and peribronchial lymph nodes; 1B, middle lobe bronchial resection. margin and peribronchial lymph nodes; 1C-E, tumour with overlying pleura; 1F, central tumour; 1G, 2. representative TS of additional tumour mass towards apex; 1H, uninvolved lung parenchyma from. middle lobe; 11, tissue adjacent to bronchus]. 2: The specimen is labelled ""pulmonary vein lymph node"" and comprises an irregular portion of fatty. and anthracotic soft tissue, 25 X 10 X 5 mm. [BIT, 2A]. 3: The specimen is labelled ""pulmonary vein lymph node No. 2"" and comprises fragments of. anthracotic soft tissue, 20 X 10 X 5 mm in aggregate. [BIT, 3A]. 4: The specimen is labelled ""No. 10 lymph node"" and comprises two fragments of soft anthracotic. tissue, the first 5 mm in greatest diameter, and the second 15 X 15 X 7 mm. [BIT, the larger fragment. after bisection, 4A]. 5: The specimen is labelled ""right middle lobe lymph node"" and comprises an irregular fragment of. soft anthracotic tissue, 20 X 8 X 5 mm. [BIT, 5A]. 6: The specimen is labelled ""No. 4 lymph node"" and comprises a lymph node with surrounding fat,. overall size 20 X 15 X 8 mm. The lymph node is 12 X 8 X 5 mm. [BIT after bisection, 6A]. MICROSCOPY. 1: Sections show a moderately differentiated adenocarcinoma. The carcinoma has areas of mucinous. and papillary differentiation. The contiguous nodule has a similar appearance and it is considered that. these represent part of the same tumour. The main lesion is invading into an area of subpleural. elastotic scarring. Although no convincing pleural invasion is identified within the sections, special. stains will be performed. The other component also abuts the pleura but there is no pleural invasion. Blood vessel invasion is present but no lymphatic or perineural permeation is seen. The mass is well. clear of the bronchial resection margin but there is squamous metaplasia with severe dysplasia at the. middle lobe bronchial resection margin. No lymph node metastases are seen. The uninvolved lung. shows no specific abnormality. 2: Sections of the lymph nodes show reactive changes only. There is no evidence of malignancy. 3: Sections of the lymph node fragments show reactive changes only. There is no evidence of. malignancy. 4: Sections of the lymph node show reactive changes only. There is no evidence of malignancy. 5: Sections of the lymph node show reactive changes only. There is no evidence of malignancy. 6: Sections of the lymph node show reactive changes only. There is no evidence of malignancy. SUMMARY. Right upper and middle lobes and lymph nodes: 1: Moderately differentiated adenocarcinoma of right upper lobe; approximately 47 mm in maximal. dimension. 2: Blood vessel permeation identified but no lymphatic or perineural invasion present. 3: No convincing pleural invasion identified but special stains being performed; clear of bronchial. margin. 4: No lymph node metastases. 5: T2N0MX. 6: Squamous metaplasia with severe dysplasia at right middle lobe bronchial resection margin. SUPPLEMENTARY REPORT. Some of the tumour cell nuclei stain strongly with TTF 1 in keeping with a pulmonary primary. SUPPLEMENTARY REPORT. No pleural invasion is identified with special stains. T-28000 M-81403 P1-03000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Surgery Date: SPECIMENS: A. PRE TRACHEAL LYMPH NODE. B. THYROID WITH PARATRACHEAL NODES. C. RIGHT PARATRACHEAL NODE. DIAGNOSIS: A. LYMPH NODE, PRETRACHEAL BIOPSY: - ONE BENIGN LYMPH NODE (0/1). B. THYROID AND PARATRACHEAL LYMPH NODE, THYROIDECTOMY: - PAPILLARY CARCINOMA OF THYROID, FOLLICULAR VARIANT (1.0CM). - TWO OF EIGHT PARATRACHEAL LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. (2/8). - BENIGN, PARATHYROID. - NEGATIVE RESECTION MARGIN. - CHRONIC LYMPHOCYTIC THYROIDITIS. C. LYMPH NODE, RIGHT PARATRACHEAL, BIOPSY: - ONE BENIGN LYMH NODE (0/1). THYROID TEMPLATE. Specimen Type: Total thyroidectomy. Tumor Site: Right lobe. Tumor Focality: Multifocal. Tumor Size (Largest nodule): 1.0cm. Additional Dimensions: 1.0x0.7cm. Histologic Type: Papillary carcinoma. - Follicular variant. Margins: Margins uninvolved by carcinoma. - Distance of carcinoma to closest margins: <1mm. Venous/Lymphatic Invasion: Absent. Additional Findings: Thyroiditis. Lymph Nodes: Pathologic Stage: pT 1, N 1a, Mx. Primary Tumor (pT): pT1: Tumor size 2cm or less, limited to thyroid. Regional Lymph Nodes (pN): PN1a: Nodal metastasis to Level VI (pretracheal and prelaryngeal/Delphian) lymph nodes. Distant Metastases(pM). PMX: Cannot be assessed. SPECIMEN(S): A. PRE TRACHEAL LYMPH NODE B. THYROID WITH PARATRACHEAL NODES C. RIGHT. PARATRACHEAL NODE. CLINICAL HISTORY: None given. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSC: Lymph node: Negative for tumor. By Dr., called to Dr. at. GROSS DESCRIPTION: A. PRE TRACHEAL LYMPH NODE. Received in formalin and labeled as ""pre tracheal lymph node"" is a pink-tan lymph node measuring. 0.8x0.5x0.3cm. Submitted in toto in block A1. B. THYROID WITH PARATRACHEAL NODES. Received fresh for tissue procurement and labeled ""total thyroid with paratracheal node"" is a 15gm. thyroid gland with the right lobe measuring 5.0x2.5x0.9cm, isthmus is 1.5x1.2x0.3cm and the left lobe is. 4.0x2.5x0.7cm. The serosa is unremarkable. The specimen is inked as follows: posterior-red, anterior. left lobe-blue, anterior isthmus-orange, anterior right lobe-black. Specimen is serially sectioned from. superior left lobe to inferior and the isthmus from left to right and no abnormalities are seen. The right. lobe is sectioned from superior to inferior and there is a well circumscribed, firm, white-tan nodule. present measuring 1.0x1.0x0.7cm which is located in the mid portion of the medial side. The remainder. of the parenchyma has a meaty red appearance. Specimen is submitted in toto as follows: B1-B4: left lobe, serially submitted from superior to inferior. B5: isthmus. B6-B12: right lobe, submitted from superior to inferior, mass is submitted in toto in block B10. Representative section is submitted for tissue procurement. C. RIGHT PARATRACHEAL NODE. Received fresh and labeled as ""right paratracheal node"" is a 0.7x0.4x0.3cm lymph node. It is submitted. in toto for frozen section in block labeled FSC1. Microscopic/Diagnosuc Ductation: , M.D., PATHOLOGIST. Final Review: . M.D., PATHOLOGIST,. Final Review: M.D., PATHOLOGIST. Final: , M.D., PATHOLOGIST, (.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Patient with h/o right renal mass (right sided); renal cell cancer. Specimens Submitted: 1: SP: Right kidney, ureter and part of adrenal. 2: SP: Portion of right 11th rib. 3: SP: Right hilar lymph nodes. 4: SP: Fat at lower pole of kidney. DIAGNOSIS: 1). KIDNEY, RIGHT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE II/IV. -THE PATTERN OF GROWTH IS PAPILLARY AND TUBULAR. - THE TUMOR GREATEST DIAMETER IS 6.5 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. - THE ADRENAL GLAND IS NOT IDENTIFIED. 2). BONE, PORTION OF RIGHT 11TH; BIOPSY;. GROSSLY UNREMARKABLE. SECTIONS NOT YET READY BECAUSE OF NEED TO DECAI.CIFY. IF. SIGNIFICANT MICROSCOPIC ABNORMALITIES ARE FOUND, AN ADDENDUM REPORT WILL BE ISSUED. 3). LYMPH NODES, RIGHT HILUM; BIOPSY: - BENIGN LYMPH NODE. 4). SOFT TISSUE, LOWER POLE OF KIDNEY; BIOPSY: - BENIGN ADIPOSE TISSUE. The specimen is received labeled ""Right kidney, ureter and part of adrenal"". It consists of a kidney with attached. perirenal fat and a portion of Gerota's fascia. The entire specimen welghs 250 grams. The entire specimen measures 12 x 7.5 X. 4 cm. The kidney itself measures 10.5 x 7 x 3.5 cm. Present in the inferior pole of the kidney, is a friable variegated yellow. focally hemorrhagic mass extending from the cortex up to the pelvis measuring 6.5 x 2 x 1.6 cm in greatest dimension. This mass. extends up to the renal capsule, pushing the renal capsule, but not protruding through it. The tumor abuts the calyces and the. renal pelvis but does not appear to invade them. The portion of ureter attached to the kidney measures 5 cm in length and 0.3 cm. In diameter. The urothalial lining of tha urater is tan and grassly unremarkable. The vascular structuras ara grassly. unremarkable withaut involvement by tumor. The remaindar of tha ranal paranchyma is grassly unremarkable. Na adrenal gland. is identified and this information is canvayed to the Surgeon. A portion of the tumor is submitted far. A photograph of tha. speciman is takan. Representative sactions are submittad. Summary of sections: UM - ureteral resaction margin. VM -- vascular margin. TC - tumor in relations to capsule. TP - tumor in reletions to renal pelvis. TN - tumar in relations to normal renal parenchyma. NK - narmal kidnay. F  periranal fat with Garata's fascia. 2). The specimen is received in formalin, labaled ""Portion of right 11th rlb"". Il cansists of a partion of rib measuring 7.6 cm in. length and 1.2 cm In width and 0.3 cm in thicknass. Portions of soft lissue and skalatal muscle are adherent to the rib. Rapresentativa sactians ara submittad. Tha spacimen is decalcified prior to submission. Summary of sactions: B - bona tissua. 3). The specimen is received in formalin, labaled ""Right hilar lymph nodas"". It cansists of a singla tan lymph node maasuring. 0.6x0,4x 0.3 cm, Tha spaciman Is entiraly submitted. Summary of sections: LN - lymph nodas. 4). The spaciman Is raceivad in formalin, labalad ""Fat at lowar pola of kidnay"". It cansists of a 3.2 X 1.5 X 0.5 cm aggregata. of adipose tissua, Tha spacimen Is entiraly submitted. Summary of sactions: F fat. Summary of Sections: Part 1: SP: Right kidney, ureter and part of adrenal. Black. Sact. Site. PCs. 1. F. 2. 1. NK. 1. 2. TC. 2. 2. TN. 2. 2. TP. 2. UM. 1. VM. 2. Part 2: SP: Partion of right 11th rib. Block. Sect. Sita. PCs. 1. B. 3. Part 3: SP: Right hilar lymph nodas. Black. Sect. Site. PCs. 1. LN. Part 4: SP: Fat at lowar pola of kidney. Block. Sect. Site. PCs. 2. F. 3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
ORIGINAL REPORT. SPECIMEN: A: Distal pancreas and spleen. B: Gallbladder. CLINICAL HISTORY: Pancreatic cancer. DIAGNOSIS: A: PANCREAS, DISTAL: - INVASIVE POORLY DIFFERENTTATED DUCTAL ADENOCARCINOMA (2.8 CM). - RESECTION MARGINS NEGATIVE FOR MALIGNANCY. - LYMPHVASCULAR (VENOUS) INVASION BY TUMOR,. - 11/11 LYMPH NODES, NEGATIVE FOR MALIGNANCY. - POSITIVE FOR PERINEURAL INVASION. SPLEEN: - WITHIN NORMAL LIMITS. OMENTUM: - ACCESSORY SPLENULE IDENTIFIED,. B: GALLBLADDER, CHOLECYSTECTOMY: - CHOLELITHIASIS. - INTESTINAL METAPLASIA WITHOUT DYSPLASTA. GROSS DESCRIPTION: A: The specimen consists of pancreatic tail (5.0 cm in length x 4.5 x 2.2. cm), spleen (9.9 x 8.8 x 5.5 cm) , and attached portion of fatty tissue (19.5. x. 10.5 x 3.8 cm) The entire specimen is painted with silver nitrate. The. proximal pancreatic resection margin is painted blue. On cut section of the pancreas, there is white, firm, fibrotic tumor measuring. 2.8 x 2.5 x 1.5 cm in width. The tumor is located 1.3 cm from the surgical. HISTOPATHOLOGY REPORT. Division Head. GROSS DESCRIPTION: pancreatic resection margin, 1.1 Cm from the superior resection margin, 1.1 an. from the inferior soft tissue resection margin, and 0.6 cm from the the. posterior soft tissue resection margin. The tumor is abutting but not. involving the splenic vein. The tumor does not extend into the splenic hilum. soft tissue. The splenic tissue is unremarkable. Upon the attached omental. fat, there is a 0.6 6 cm attached splenule. The remaining fatty tissue is. grossly unremarkable. The specimen is submitted as follows: Al and A2 - painted blue resection margin. A3 - vascular margins,. A4 - tumor and closest superior margin. A5 - tumor and closest posterior margin. A6 - tumor and closest inferior margin. A7 through A9 - representative sections of tumor. A10 - representative section of spleen. A11 .. splenule bisected,. A12 - thrombosed vessel in splenic hilum. A13 - normal appearing pancreas. A14 - potential Jymph node (hilar spleen) . A15 - four putative lymph nodes. A16-19, additional lymph nodes. B: The specimen consists of a cholecystectomy specimen (9.1 cm in length and. up to 4.5 cm in diameter) The entire specimen is painted with silver. nitrate. The outer surface of the gallbladder is smooth and unremarkable. The. lumen contains enumerable numbers of yellow cholesterol stones with. hemorrhagic centers ranging in size between 1.0 cm and 0.: cm. The. gallbladder wall is thin (measuring 0.1 em in greatest thickness) and. attenuated. Representative sections of the gallbladder wall and resection margin are. submitted in cassette B. MICROSCOPIC DESCRIPTION: Sections of pancreas demonstrate a pancreatic intraductal neoplasia of low. grade dysplasia (panIN 1) that extends to resection margin. HISTOPATHOLOGY REPORT. Division Head. RESIDENT:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Chief of Pathology. Specimen: !tatus: SOUT. Spec Type: SURGICAL P. GROSS DESCRIPTION. C RECEIVED LABELED. RIGHT NONSENTINEL NODE #1 IS A 3.4. x 2 x 1.5 CM PORTION OF YELLOW FATTY TISSUE WHICH IS A GROSSLY FAT. REPLACED LYMPH NODE SUBMITTED ENTIRELY LABELED C1 THROUGH C3. D RECEIVED LABELED. RIGHT BREAST SIMPLE MASTECTOMY. STITCH AT 12 O' CLOCK IS A 1,250 GRAM SIMPLE MASTECTOMY WHICH INCLUDES. 4. IRREGULAR ADDITIONAL FRAGMENTS OF YELLOW-RED FATTY TISSUE IN AGGREGATE. MEASURING 9 x 7 x 1 CM. THIS TISSUE IS NOT ORIENTED. THE MASTECTOMY. ITSELF MEASURES 28.5 x 21 x 5 CM. THE NIPPLE IS FLATTENED AND SITS. WITHIN A 26 x 13 CM SKIN ELLIPSE. THERE IS PALPABLE FIRMNESS IN THE. LOWER OUTER QUADRANT. THE SUPERFICIAL ASPECT OF THE MASTECTOMY IS. MARKED WITH BLUE INK, THE DEEP WITH BLACK. SECTIONING REVEALS 2. DISTINCT FIRM MASSES, ONE IN THE 12 O'CLOCK AREA AND THE 2ND. CORRESPONDING TO THE PALPABLE FIRMNESS IN THE LOWER OUTER QUADRANT. THIS HAS A RIBBON CLIP AND THE 12 O' CLOCK LESION HAS A WING CLIP. THE. DEEP MARGIN ASSOCIATED WITH THE LOWER OUTER QUADRANT LESION IS FIRM AND. PINK-TAN FIBROUS TISSUE DOES EXTEND TOWARDS THE MARGIN BUT THE ACTUAL. FIRM MASS IS GROSSLY WITHIN THE CONFINES. THE LOWER OUTER MASS MEASURES. 2.5 x 2.5 x 2.5 CM. THE 12 O'CLOCK MASS IS SEPARATED BY 3 CM OF TISSUE. AND MEASURES 3.5 X 2.5 x 2.5 CM IN GREATEST DIMENSION. ADDITIONAL. PINK-TAN FIBROUS TISSUE IS FOUND IN THE MIDPORTION OF THE SPECIMEN WHICH. IS THEN SURROUNDED BY YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: D1--NIPPLE, D2 AND --DEEP MARGIN OVER LOWER OUTER QUADRANT. LESION, D4--DEEP MARGIN TO 12 O' CLOCK LESION, D5 AND 6--12 O' CLOCK. LESION, D7 THROUGH --LONGITUDINAL SECTION OF 12 0'CLOCK LESION,. D10--TISSUE BETWEEN THE 2 LESIONS, D11 AND 12 -LOWER OUTER QUADRANT. LESION LONGITUDINAL SECTION, D13--TUMOR LOWER OUTER QUADRANT. THE. TISSUE TO THE 6 O'CLOCK MARGIN OF THE LOWER OUTER QUADRANT LESION IS. NODULAR AND FOCALLY THERE IS BROWN DISCOLORATION. A SECTION IS. SUBMITTED IN D14. THIS IS 1 CM FROM THE LOWER OUTER QUADRANT LESION AND. 5 CM FROM THE 12 0'CLOCK LESION. OTHER NODULES DEMONSTRATE CYSTS AS A. SECTION IN D15 DEMONSTRATES. D16--UPPER INNER QUADRANT (3 CM FROM 12. O' CLOCK LESION), 17--UPPER OUTER QUADRANT (5 CM FROM 12 O' CLOCK. LESION), D18--LOWER OUTER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) , 019--LOWER INNER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) THE SEPARATELY SUBMITTED PORTIONS OF FATTY TISSUE ARE GROSSLY. UNREMARKABLE AND REPRESENTATIVE TISSUE IS SUBMITTED IN D20 AND 21. E RECEIVED LABELED. RIGHT AXILLARY NODE CONTENTS IS. YELLOW-RED FATTY TISSUE MEASURING 12 x 9.5 x 2.5 CM. THE TISSUE IS. EXAMINED FOR LYMPH NODES. LYMPH NODES ARE IDENTIFIED AND SUBMITTED AS. FOLLOWS: E1--ONE-HALF OF A FIRM NODE WITH MIRROR IMAGE SUBMITTED PER. PROTOCOL, E2--1 NODE BISECTED, E3--1 NODE BISECTED (MAY ACTUALLY. REPRESENT 2 IMMEDIATELY ADJACENT NODES), E4--1 NODE TRISECTED, E5--1. NODE BISECTED, E6--1 NODE BISECTED, E7--1 NODE TRISECTED, E8--3 NODES (1. BISECTED), E9--6 NODES, E10-- NODE BISECTED. /F. Specimen. Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: SENTINEL NODE Bx/LYMPHADENECTOMY/STMPLE MASTECTOMXY/AXILLARY. PROCEDURE (CONT) : NODE DISSECTION. TISSUE REMOVED. A. RT SENTINEL NODE #1 - FS. B. RT SENTINEL NODE #2 - FS. C. RT AXILLARY NON SENTINEL NODE. D. RT BREAST SIMPLE MASTECTOMY. E. RT AXILLARY NODE CONTENTS. FROZEN SECTION DIAGNOSIS. A. NEGATIVE FOR TUMOR. B. METASTATIC CARCINOMA. GROSS DESCRIPTION. THE SPECIMEN IS RECEIVED IN 5 PARTS. PART A IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 1 GAMMA. HOT AT. IT IS RECEIVED IN THE FRESH STATE FOR. FROZEN SECTION AND CONSISTS OF A 3.5 X 2.3 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH 2 PALPABLE NODULES MEASURING 2 x. 1.2 x 0.6 CM AND 0.8 x 0.8 x 0.5 CM. EACH NODULE IS PINKISH-RED AND. SECTIONING SHOWS REDDISH-PINE CROSS SECTION. ONE-HALF OF EACH IS. SUBMITTED FOR FROZEN SECTION LABELED FSA. SUBSEQUENT TO THE FROZEN. SECTION, THE FROZEN TISSUE IS SUBMITTED FOR PERMANENTS LABELED FSA. THE. REMAINING UNFROZEN NODULES ARE SUBMITTED FOR PERMANENTS LABELED A. PART B IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 2 GAMMA. HOT/BLUE AT. IT IS RECEIVED IN THE FRESH STATE. FOR FROZEN SECTION AND CONSISTS OF A 2.7 x 2.1 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH PALPABLE NODULE. THE NODULE IS. ISOLATED AND FOUND TO MEASURE 1.7 x 1.4 X 0.5 CM. THE NODULE IS. BISECTED SHOWING A REDDISH-PINK RIM SURROUNDING YELLOW ADIPOSE TISSUE. WITH A GLISTENING WHITISH-TAN NODULE AT ONE MARGIN MEASURING 0.4 CM IN. DIAMETER. SUBSEQUENT TO THE FROZEN SECTION, THE FROZEN TISSUE IS. SUBMITTED FOR PERMANENTS LABELED FSB. THE REMAINDER OF THE NODULE IS. SUBMITTED FOR PERMANENTS LABELED B. Specimen: Req# : spec Type: SURGICAL P. GROSS DESCRIPTION. PATH PROCEDURES. PROCEDURES: 88305, 88307/2, 88309, PATH FS /2, A BLK, B BLK, C BLK, D BLK/21, E BLK/10,. FS-A, FROZ.SEC.-B. FINAL DIAGNOSIS. PART A RIGHT AXILLARY NO EVIDENCE OF %/ISN. SENTINEL LYMPH NODE #1, BIOPSY: MALIGNANCY. PART B RIGHT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY: METASTATIC. BREAST CARCINOMA HAVING A MAXIMUM MICROSCOPIC DIMENSION OF 0.6 CM IS. IDENTIFIED IN 1 LYMPH NODE EXAMINED. THERE IS NO EVIDENCE OF EXTRANODAL. EXTENSION OF TUMOR. PART C RIGHT AXILLARY NONSENTINEL LYMPH NODE, BIOPSY: NO EVIDENCE OF. MALIGNANCY IN 1 LYMPH NODE EXAMINED. PART D RIGHT BREAST, SIMPLE MASTECTOMY: MULTICENTRIC INTRALOBULAR, AND INFILTRATING LOBULAR CARCINOMA OF THE. 1. PLEOMORPHIC TYPE. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2/3,. LOW MITOTIC INDEX, AND TUBULE FORMATION 3 WITH TOTAL NOTTINGHAM SCORE. OF 6. LCIS OF THE PLEOMORPHIC TYPE, NUCLEAR GRADE 2/3, AND LOW 50% LCIS 8 2. MITOTIC INDEX COMPRISES APPROXIMATELY 50% OF THE TUMOR. 2. THE LARGEST FOCUS OF INVASIVE TUMOR MEASURES 3.5 CM IN GREATEST. DIMENSION AND IS LOCATED IN THE 12 O'CLOCK PORTION OF THE BREAST. THE SECOND LARGEST MEASURES 2.5 CM AND IS SEEN IN THE LOWER OUTER. QUADRANT. ADDITIONAL SMALLER FOCI OF INVASION MEASURING FROM 1 MM TO. 5 MM IN GREATEST DIMENSION ARE PRESENT. LCIS IS SEEN ON 14 OF 21. BLOCKS EXAMINED HAVING A MAXIMUM CALCULATED DIMENSION OF 5.6 CM. 3. THE MARGINS OF RESECTION AND NIPPLE SKIN ARE FREE OF TUMOR. 4. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. 5. PROLIFERATVE FIBROCYSTIC CHANGES INCLUDING INTRADUCTAL PAPILLOMAS,. INTRADUCTAL PAPILLOMATOSIS, MICROSCOPIC COMPLEX SCLEROSING LESIONS,. ADENOSIS, APOCRINE METAPLASIA, MICROCYST FORMATION, PATCHY DENSE. STROMA AND RARE LUMINAL CALCIFICATIONS. Specimen: Received: (. spec Type: SURGICAL P. FINAL DIAGNOSIS. 6. THE BIOPSY SITES (. ARE PRESENT. PART E RIGHT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST. CARCINOMA IS IDENTIFIED IN 1 OF 16 LYMPH NODES EXAMINED. NO EVIDENCE OF. EXTRANODAL EXTENSION BY TUMOR. CODE. 1. (prelim.).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL PATHOLOGIC DIAGNOSIS. A. Left pelvic lymph nodes; dissection: - Fifteen lymph nodes, no tumor present (0/15). B. Right pelvic lymph nodes; dissection: - Ten Tymph nodes, no tumor present (0/10). c. Bladder, bilateral vas deferens; radical cystoprostatectomy : Urothelial carcinoma of the urinary bladder, high grade, with squamous. differentiation,. invasive into outer half of the muscularis propria. - Margins of resection (soft tissue, prostatic urethra, right and left ureter). no tumor present. - See pathologic parameters and comment. - Prostate, seminal vesicles and vasa deferentia, no tumor present. Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Urothelial carcinoma with squamous differentiation. 2. Grade of tumor: High grade. 3. Depth of invasion: Muscularis propria, outer half. 4. Tumor distribution: Solitary, right lateral/anterior wall. Size: 3.2 x 2.3 x 1.3 cm. 5. Ureteral margins: Negative. 6. Distal urethral margin: Negative. 7. Soft tissue margin: Negative. 8. Lymph nodes: Twenty five lymph nodes, no tumor present (0/25). 9. pTNM: pT2b, NO, Mx. Effective. this Checklist utilizes the 7th edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). Comment. Parts B5 and C1: Deeper levels are examined. , M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow,  M.D., Ph.D. M.D. clinical History: The patient is a. radical cystectomy. -year-old male with malignant neoplasm of bladder undergoing. Specimens Received: A: Left pelvic lymph node. B: Right pelvic Tymph node. C: Bladder, bilateral vas deferens. Gross Description: The specimens are received in three containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""left pelvic lymph node"". Received fresh and placed in formalin is a 5.3 x 3.2 x 2.2 cm aggregate of. lobulated yellow fibrofatty tissue. The specimen is dissected for Tymph nodes. to reveal 9 apparent lymph nodes ranging from 0.4-2.1 cm in greatest dimension. All apparent Tymph nodes are submitted as follows: A1-A3: One lymph node candidate, bisected in each casette. A4-A5: Three lymph node candidates in each casette. B. The second container is additionally identified as, ""right pelvic lymph. node"". Received fresh and placed in formalin is a 3.5 x 2.3 x 1.3 cm aggregate. of lobulated yellow fibrofatty tissue. The specimen is dissected for Tymph. nodes to reveal 10 apparent lymph nodes ranging from 0.3-3.3 cm in greatest. dimension. All apparent lymph nodes are submitted as follows: B1, B2: One lymph node candidate, bisected in each casette. 83, B4: Three lymph node candidates in each casette. B5: Two lymph node candidates in each casette. C. The third container is additionally identified as, ""bladder, bilateral vas. deferens"". Received fresh and placed in formalin is a 38 x 21 x 12.2 cm. cystoprostatectomy specimen with attached mesenteric fat. The bladder measures. 8.5. x. 6.1 x 5.8 cm. The right ureteral stump measures 3 cm and the left 3 cm,. and both demonstrate patent lumina. The prostate gland measures 6.8 x 4.5 x 3.4. cm. The right seminal vesicle measures 7.2 x 1.5 x 1.5 cm and the right vas. deferens measures 7.0 cm in length and 0.6 cm in diameter. The left seminal. vesicle measures 7.5 x 1.3 x 1.3 cm and the left vas deferens measures 7.2 cm in. length and 0.6 cm in diameter. The right half of the prostate is inked blue and. the left half is inked black. The bladder is inked black. The prostate is opened. anteriorly along the urethra and continued superiorly through the bladder in. a. Y-shaped incision. The prostate is serially sectioned from apex to base to. reveal a 1.1 x 1.0 cm area of rubbery, white, firm nodule along the right side. of the prostate which is 1.0 cm from the inked surface. The bladder demonstrates. a 3.2 x 2.3 cm ulceration involving right lateral wall extending to the anterior. wall. Serial sectioning of the ulcer area reveals 3.2 x 2.3 x 1.3 cm rubbery. white mass invasion into the muscularis propria to a depth of 1.3 cm, extending. to 0.4 cm of the inked surface. The remainder of the mucosa is tan-brown,. edematous, and glistening with 1.1-1.8 cm wall thickness. The bilateral ureteral. orifices are identified and probe patent. Representative sections are submitted. as follows: C1: Right ureteral margin. C2: Left ureteral margin. C3: Distal urethral margin. C4, C5 : Prostatic apex. C6: Representative prostate through verumontanum. C7, C8: Representative sections of prostate nodule on the right side. c9, C10: Representative sections of normal prostate tissue on the left side. C11: Seminal vesicles and vasa deferentia. C12-C14: Multiple tumor sections, closest to the inked margin. C15 : Uninvolved left wall. C16: Uninvolved posterior wall. C17: Uninvolved dome. MB, PhD.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Material examined: Mediastinal squamous epithelium. Clinical diagnosis and question. Bronchial carcinoma left upper lobe, attempted angioplasty upper lobe, discontinuation with central tumor in. REPORT ON FINDINGS. Macroscopy. 1.) Mediastinal squamous epithelium: 0.6 cm hard pale brownish specimen. Inflated, fixed left lung measuring. 17 x 12 cm at the base and up to 27 cm high, central bronchus resection plane located 3 cm proximal to the. bifurcation of the upper lobe bronchus. A staple suture line runs from the hilus in a ventrocaudal direction over. the upper and lower lobes for 7.5 cm in each case and dorsal over S2 and 6 for 6.5 cm in each case, evidently. corresponding staple suture lines. Main bronchus largely skeletonized. At the hilus four partly lesioned, mobile. blackish nodes between 0.4 and 0.8 cm. Resection margin of pulmonary artery shows high-grade lesion. Apical. and lateral region over S1, 2 and 3 shows a 16 x 14.5 cm area of parietal pleura that shows predominantly. extensive adhesion and marginally loose attachment in parts. Ostium of upper lobe bronchus constricted by a. central moderately firm, pale brown to whitish tumor, max. 4.9 cm in size, in the upper lobe, with a. predominantly relatively clear and arcuate demarcation and patchy grayish-black pigmentation in parts. Extension of tumor right up to hilar resection surface, where 1.5 cm is questionably part of the pericardial sac,. which is not macroscopically infiltrated. Involvement of some grayish-black nodes up to 1.5 cm in size by the. tumor. Narrowing of numerous blood vessels and questionable wall infiltration of an already patent pulmonary. artery branch of the upper lobe, with not tumor tissue discernible in the lumen. In S3 at the junction with S3. laterally below the section of parietal pleura is a 3.5 cm hemorrhagic zone, partly with a clear demarcation,. extending to the pleura. Peripheral bronchi of the upper lobe in parts slightly dilated and filled with thick. mucus, rest of parenchyma of the upper and lower lobes inconspicuous. From the bifurcation of the bronchus. into the basal lower lobe bronchi, three blackish nodes between 0.4 and 0.7 cm. In the subpleural region in S6 at. the junction with S8 a 0.3 cm flat blackish node. 3.) Repeat resection material from pulmonary artery: irregular portion of pulmonary artery measuring 3.7 x max. 1.3 cm. 4.) Interlobar LN (station 11): 0.7 cm lesioned node. 5.) Pulmonary ligament LN (station 9): 0.6 cm node with surrounding tissue. 6.) Paraesophageal LN (station 8): 0.6 cm node with surrounding tissue. 7.) Paraaortic LN (station 6): two lesioned grayish-black nodes or node parts, 0.8 and 0.4 cm. 8.) Low paratracheal LN (station 4) left: 1 cm node with surrounding tissue. 9.) Low paratracheal LN (station 4) right: 0.4 cm node. Examined: Re 1.) Rapid section remains,. Re 2.) a: Tumor with rest of parenchyma, b: tumor with ostium of upper lobe bronchus and involved nodes as. well as central blood vessels, c: tumor with pulmonary artery upper lobe branch, d: tumor with hilar resection. surface (color-marked), e: tumor with questionable portion of pericardial sac (resection margin color-marked),. f: hemorrhagic zone, g: pleural adhesion zone in S1, h: central bronchus resection plane and resection margin. pulmonary artery, i: mobile hilar nodes and resection margin pulmonary veins, j: node subpleural and at the. bronchus bifurcation of the lower lobe,. Re 3.)-9.) All material (in 3. preparation lamellated),. 16 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Re 1.) Immediate intraoperative evaluation. ): squamous cell carcinoma. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Locally advanced, central, bronchopulmonary, histologically poorly differentiated, large-cell and. polymorphocellular, nonkeratinizing squamous cell carcinoma of the left upper lobe of the lung (G3). Tumor. classification according to this picture pT4 pN1 V1 RX(R1?), stage III. C34.M8070/3. Secondary diagnosis/diagnoses: Tumor necroses. Active resorptive alveolar and lymphofollicular interstitial inflammation in the lung. parenchyma adjacent to the tumor. Lung tissue necrosis with marginal organizing and fibrous remodeling. process under the pleural adhesion area in S1. Fresh hemorrhagic pulmonary infarction in the boundary region. of S1/S3. Fibrinous pleuritis and pleural adhesions. Moderate anthracotic pigment deposits in the lung. parenchyma and varying degrees of partly mixed dust pigment deposits in the lymph nodes with reactive. accumulation of macrophages. Remark/addendum: The carcinoma shows partially endobronchial growth as far as the ostium of the upper lobe, continuously. metastasized to local bronchopulmonary lymph nodes with invasion via the mediastinal pleura into the. mediastinum, where it reaches the resection plane in places. This finding explains the pT4 classification,. although the evidently co-resected layer of parietal pericardium is not reached or infiltrated by the tumor. The. precondition is thus also met for the R1 category. If this area is directly followed by the preparation registered. under 1.), which is likewise marginally occupied by tumor, a category of R0 may also be diagnosed. Large. pulmonary vessels are only surrounded, but not invaded by tumor. The resection margins of the main bronchus,. the large pulmonary vessels, the lower lobe of the lung and all other lymph nodes are tumor-free.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
MRN : OV. MD. Laboratory Patient Report. Print Date/Time: Histopathological Examination. 4. - Received: ; Complete. Pre-op Diagnosis : Left Breast Car. MD. Specimens. Breast, left. Frozen Diagnosis. : GROSS EXAMINATION: The specimen is received in a container labeled with the. name of the patient and labeled as breast, left. The. specimen consists of a mastectomy designated left which. measures en bloc 31 x 20 x 5.5 cm and weighs 1515 g. Anteriorly located is an ellipse of brown skin which. measures 22 x 17 cm. Centrally located is a 4.5 cm diameter. areolar complex with slightly retracted nipple which is. sampled in block 1. The deep margin is inked and the. specimen is serially sectioned and shows a gray-tan firm. mass in the upper outer quadrant. This mass measures 2.8. x. 2.5 x 2.3 cm and grossly extends to within 1 cm of the inked. deep margin. A section of skin overlying the mass is. submitted in block 2. A section of the Inked deep margin is. submitted in block 3. Sections of the mass are submitted in. block 4-7. The remaining breast is composed of yellow. lobulated adipose tissue admixed with islands of gray-white. rubbery tissue. The breast is divided into four quadrants;. upper inner, lower inner, upper outer and lower outer and. sampled in blocks 8-11. The attached axillary tissue is. dissected for lymph nodes with the lower part sampled in. blocks 12-14 in the upper part sampled in blocks 15-16. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION: SPECIMEN TYPE: Modified radical mastectomy. LYMPH NODE SAMPLING: Axillary dissection. LATERALITY Left. TUMOR SITE: Upper outer quadrant. SIZE OF INVASIVE COMPONENT: Greatest dimension. 2.8 cm. ADDITIONAL DIMENSIONS: 2.5 x 2.3 cm. HISTOLOGIC TYPE: Invasive ductal carcinuna. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. Path # : 4. Visit # : HISTOLOGIC GRADE: Nottingham histologic score 3/3. DUCT IN SITU COMPONENT: Not identified. MICROCALCIFICATIONS Not identified. EXTENT OF INVASION. PRIMARY TUMOR (PT) : pT2: Tumor more than 2.0 cm but not more. than 5.0 cm in greatest dimension. REGIONAL LYMPH NODES (PN) : pN2a: Metastases in 4 to 9. axillary lymph nodes. NUMBER EXAMINED: 23. NUMBER INVOLVED: 6. DISTANT METASTASIS (PM) : PMX. MARGINS : Uninvolved by invasive carcinoma. DISTANCE TO NEAREST MARGIN: 1.0 cm to deep margin. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L) : Present. Summary of pathologic staging: pT2N2aMXG3 . Intradepartmental consultation obtained. COMMENT: Immunohistochemical stains for estrogen and. progesterone receptors and HER2 are pending and will be. supplementally reported when complete. M.D. ., MD. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. Path # : of 2. Visit # :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 2. copy No. 5. Examination: Histopathological examination. Cost of diagnostic procedure. Material: Multiple organ resection - left breast. Material received or. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTestâ¢M by. Score = 2+, verification by the FISH method recommended. Macroscopic description: Left breast sized 26 x 20 x 5.5 cm removed along with axillary tissues sized 10 x 8 x 2.5 cm and a 25 x 14 cm skin. flap. Tumour sized 2.6 x 2 x 1.8 cm found in the outer lower quadrant, 5.3 cm from the lower boundary, 1.2 cm. from the base and 1.4 cm from the skin. Microscopic description: Carcinoma ductale partim papillare - NHG1 (2 + 2 +3/22 mitoses/ 10 HPF, visual area diameter: 0.55 m). Glandular tissue showing lesions of the type fibrosa et cystica, hyperplasia ductalis simplex. Invasive lesions reaching the base. Axillary lymph nodes: Lymphonodulitis chronica et lymphonodorum No XV. Examination: Histopathological examination 1. page 2 / 2. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by. HER2 DNA Probe Kit. HER-2 gene AMPLIFICATION NOT FOUND. Histopathological diagnosis: Mixed ductal and papillary invasive carcinoma of the left breast. Usual ductal hyperplasia (. 1. Fibrocystic. changes. Lymph nodes negative for cancer.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: BREAST. RIGHT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA,NOS TYPE, POORLY DIFFERENTIATED. B. THE INVASIVE TUMOR MEASURES 2.0 CM IN GREATEST DIMENSION.NOTTINGHAM GRADE 3 (TUBULE. FORMATION 3, NUCLEAR PLEOMORPHISM 3, MITOTIC ACTIVITY 3; TOTAL SCORE 9/9). C. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 3, MICROPAPILLARY AND PAPILLARY TYPES. WITH COMEDONECROSIS; CONSTITUTES 60% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED. WITH AND AWAY FROM THE INVASIVE COMPONENT. D. LYMPH VASCULAR SPACE INVASION IS IDENTIFIED. E. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA, HOWEVER THE INVASIVE CARCINOMA EXTENDS. TO 0.5 CM FROM THE ANTERIOR MARGIN.DUCTAL CARCINOMA IN-SITU EXTENDS TO <0.1 CM FROM THE. LATERAL MARGIN AND 0.2 CM FROM THE ANTERIOR MARGIN. F. SKIN IS NEGATIVE FOR TUMOR. G. FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA, PREVIOUS BIOPSY SITE CHANGES. H. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. NEGATIVE FOR HER-2 (1+), AS PER PREVIOUS PATHOLOGY REPORT. PART 2: BREAST, RIGHT, NEW DEEP MARGIN, SEGMENTAL MASTECTOMY -. A. NO CARCINOMA IDENTIFIED. B. FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA,COLUMNAR CELL CHANGE. PART 3: LYMPH NODE, RIGHT AXILLA, SENTINEL #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). CASE SYNOPSIS: SYNOPTIC LATERALITY: - PRIMARY INVASIVE CARCINOMA OF BREAST. PROCEDURE: Right. Segmental. SIZE OF TUMOR: Not specified. MULTICENTRICITY/MULTIFOCALITY OF Maximum dimension invasive component: 2 cm. INVASIVE FOCI: TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 3. DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Yes, malignant zones. Papillary. Micropapillary. Percent DCIS admixed and outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE of COMPONENT: tumor occupied by in situ component: 60 %. SURG MARGINS INVOLVED BY IN SITU Distance COMPONENT: of invasive tumor to closest margin: 5 mm. LYMPH NODES POSITIVE: 0 Distance of in situ disease to closest margin: 1 mm. LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: SENTINEL NODE METASTASIS: H/E stain. ONLY KERATIN POSITIVE CELLS ARE PRESENT: SKIN INVOLVED (ULCERATION): T NON-NEOPLASTIC BREAST TISSUE: FCD, Other: columnar cell change. STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pT1c. pNO. M STAGE, PATHOLOGIC: ESTROGEN RECEPTORS: pMX. PROGESTERONE RECEPTORS: positive. HER2/NEU: positive. zero or 1+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: 1) TONGUE MUSCLE, DEEP, EXCISION: NEGATIVE FOR MALIGNANCY. 2) TONGUE BASE, MUCOSAL MARGIN, EXCISION: NEGATIVE FOR MALIGNANCY. 3) TONGUE, ORAL MUCOSAL MARGIN, EXCISION: NEGATIVE FOR MALIGNANCY. 4) PHARYNGEAL WALL, SUPERIOR MARGIN, EXCISION: NEGATIVE FOR MALIGNANCY. 5) FLOOR OF MOUTH, MUCOSAL MARGIN, EXCISION: NEGATIVE FOR MALIGNANCY;. FRAGMENT OF BENIGN LYMPHOID TISSUE. 6) LYMPH NODE, LEFT LEVEL 1, EXCISION: 1 OF 3 LYMPH NODES INVOLVED BY. CARCINOMA (NODE ENTIRELY REPLACED BY CARCINOMA); ADDITIONAL SOFT TISSUE. DEPOSIT OF CARCINOMA PRESENT; BENIGN SALIVARY TISSUE. 7) LYMPH NODE, LEFT LEVEL 2, EXCISION: 1 OF 1 LYMPH NODES INVOLVED BY. CARCINOMA, 4.0 CM IN GREATEST DIMENSION (GROSS MEASURMENT) WITH EXTRANODAL. EXTENSION PRESENT. 8) LYMPH NODE, LEFT LEVEL 3, EXCISION: 5 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 9) LYMPH NODE, LEFT LEVEL 4, EXCISION: 4 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 10) SALIVARY GLAND, RIGHT LEVEL 1, EXCISION: SALIVARY TISSUE, NEGATIVE FOR. MALIGNANCY; NO LYMPHOID TISSUE IDENTIFIED. 11) LYMPH NODE, RIGHT LEVEL 2, EXCISION: 1 OF 12 LYMPH NODES INVOLVED BY. CARCINOMA. 12) LYMPH NODE, RIGHT LEVEL 3, EXCISION: 4 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 13) TONGUE, TONSILLAR PILLAR/FLOOR OF MOUTH, EXCISION: MODERATE TO POORLY. DIFFERENTIATED SQUAMOUS CELL CARCINOMA, (SIMILAR TO PREVIOUS. 4.0 CM IN GREATEST DIMENSION, INVOLVING MULTIPLE INKED UNORIENTED MARGINS;. EXTENSIVE PERINEURAL INVASION IDENTIFIED; LYMPHOVASCULAR INVASION. IDENTIFIED (SEE COMMENT). COMMENT: These findings correspond to AJCC Pathologic Stage IVA (pT4a,. pN2c, pM n/a). CLINICAL DATA. Clinical Features: Unspecified. Operator: Dr. Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) deep tongue muscle; 2)tongue base. mucosal margin; 3)oral tongue mucosal. margin; 4)pharyngeal wall superior. margin; 5) floor of mouth mucosal margin;. 6) )lymph node left level 1; 7) lymph node,. left level 2; 8) lymph node, left level. 3;9) lymph node, left level 4; 10) lymph. node, right level 1; 11) lymph node,. right level 2; 12)lymph node, right level. 3; 13) )tongue, tonsil pilar floor of mouth. GROSS DESCRIPTION: 1) SOURCE: Tongue - Deep, Muscle. The specimen labeled ""deep tongue mucosal margin"" is received fresh for. intraoperative consultation and consists of a 1.0 X 0.4 X 0.3 cm of. yellow-tan glistening tissue. The sample is submitted entirely for frozen. section analysis. Summary of sections: 1AFSC, 1/1. 2) SOURCE: Tongue - Base, Mucosal Margin. The specimen labeled ""base of tongue, mucosal margin"" is received fresh for. intraoperative consultation and consists of a 5.0 X 0.8 X 0.3 cm piece of. tan-yellow, glistening tissue with the anterior surface marked in blue ink. The sample is submitted entirely submitted for frozen section analysis. Summary of sections: 2AFSC, 1/1. 3) SOURCE: Tongue - Oral, Mucosal Margin. The specimen labeled ""oral tongue mucosal margin"" is received fresh for. intraoperative consultation and consists of a 2.1 X 0.7 X 0.3 cm piece of. tan-yellow, smooth glistening tissue with the anterior surface marked with. blue ink. The sample is entirely submitted for frozen section analysis. Summary of sections: 3AFSC, 1/1. 4) SOURCE: Pharyngeal Wall Superior Margin. The specimen labeled ""pharyngeal wall margin"" is received fresh for. intraoperative consultation and consists of a 0.3 X 0.3 X 0.2 cm piece of. tan, smooth glistening tissue with the superior margin inked in blue. The. sample is entirely submitted for frozen section analysis. Summary of sections: 4AFSC, 1/1. 5) SOURCE: Floor of Mouth Mucosal Margin. The specimen labeled ""floor of mouth mucosal margin"" is received fresh for. intraoperative consultation and consists of a 4.0 X 0.3 X 0.2 cm piece of. tan, smooth glistening tissue with the anterior surface marked with blue. ink. The sample is submitted entirely for frozen section analysis. Summary of sections: 5AFSC, 1/1. 6) SOURCE: Lymph node, Left Level 1. The specimen labeled ""left neck level 1"" is received fresh and consists of. a 6.5 X 5.0 X 2.3 cm piece of tissue that is red-tan and contains lobulated. fibroadipose tissue. There are several staples and one suture mark present. The sample is received unoriented. There are two firm nodules present. The. first measures 3.0 X 1.0 X 1.2 cm and the second measures 0.9 X 0.7 X 0.7. cm. Serially sectioning of the nodule reveals a white, fibrous interior. Representative sections are submitted. Summary of sections: 6A, section of largest nodule, 2/1; 6B, representative. sections of candidate lymph node #2, 3/1; 6C, representative sections of. candidate lymph nodes, 4/1. 7) SOURCE: Lymph node, Left Level 2. The specimen labeled ""level 2"" is received fresh and consists of a 5.5 X. 4.0 X 2.0 cm piece of red-tan glistening tissue with attached lobulated. fibroadipose tissue. There are multiple staples present. There is a firm. nodule measuring 4.0 X 1.5 X 1.5 cm. Serial sectioning of the nodule. reveals a white-tan fibrous interior. Representative sections are. submitted. Summary of sections: 7A, representative section of nodule, 1/1; 7B,. representative section of fibroadipose tissue with lymph node candidate,. 1/1. 8) SOURCE: Lymph node, Left Level 3. The specimen labeled ""left level 3"" is received fresh and consists of a. 14.5 X 1.0 X 0.8 cm piece of tissue with two distinct areas. The first is. consistent with muscle measuring 5.5 cm in length and the second is 9.5 cm. in length. No discrete nodules are palpated. The sample is smooth,. glistening and tan-yellow in appearance. Summary of sections: 8A, candidate lymph nodes, 4/1. 9) SOURCE: Lymph node, Left Level 4. The specimen labeled, ""left level 4,"" is received fresh and consists of a. 5.5 X 5.0 X 0.6 cm piece of tissue that is yellow-tan, smooth, and. glistening, consistent with lobulated, fibroadipose tissue. No discrete. nodules or lesions are palpated. The specimen is serially sectioned and. representative sections are submitted. Summary of sections: 9A, candidate lymph nodes, 4/1. 10) SOURCE: Lymph node, Right Level 1. ""The specimen labeled, ""right level 1,"" is received fresh and consists of a. 5.5 X 3.3 X 1.8 cm fragment of smooth, and glistening, pink and tan,. lobulated, fibroadipose tissue and several adherent staples. The specimen. is serially sectioned and representative sections are submitted. Summary of sections: 10A-B, candidate lymph nodes, 3/1 each. 11) SOURCE: Lymph node, Right Level 2. The specimen labeled, ""right level 2,"" is received fresh and consists of a. 4.0 X 3.5 X 0.5 cm piece of tissue that is yellow-pink, smooth, and. glistening with no discrete nodules palpated. Representative sections are. submitted. Summary of sections: 11A-B, candidate lymph nodes, 4/1 each. 12) SOURCE: Lymph node, Right Level 3. The specimen labeled, ""right level 3,"" is received fresh and consists of a. 4.0 X 2.0 X 0.5 cm segment of tan-yellow tissue, consistent with yellow,. lobulated, fibroadipose tissue. There are no discrete nodules or lesions. Representative sections are submitted. Summary of sections: 12A, four candidate lymph nodes, 4/1. 13) SOURCE: Tongue, Tonsillar Pillar, Floor of Mouth. The specimen labeled, ""tongue, tonsillar pillar, floor of mouth,"" is. received fresh and consists of a segment of tongue with surrounding. connective tissue. The sample measures 6.5 cm in the anterior to posterior. dimension, 3.5 cm medial to lateral, and 6.0 cm superior to inferior. There. is. a suture in the anterior tongue. The sample is not oriented per. requisition only. There are two areas of induration in the tongue. The. first measures 2.2 cm and is a triangular-shaped wedge; the specimen was. received in this manner. The second is a 3.5 X 0.6 X 0.4 cm area where. tissue is submitted for research. The surface of the tongue is tan to pink. with multiple papillae. There is an ill-defined nodule on the posterior. surface, measuring 4.0 X 3.5 X 1.0 cm. The specimen is inked as follows: deep inferior margin-black (this contains the hyoid bone), posterior. margin-green, medial margin-red, lateral margin-blue. Buccal mucosa. inferior to the tongue and is smooth, tan, and glistening. The specimen is. sectioned anterior to posterior, perpendicular to the long axis of the. tongue. The superior surface is not inked. The specimen is submitted for. research, in glutaraldehyde, in -80 degree freezer and in RPMI. Summary of sections: 13A, section of nodule on posterior tongue with. surface of tongue, 1/1; 13B, representative section of lateral margin, 2/1;. 13C, inferior and lateral margins, 1/1; 13D, representative section of. medial and posterior margin, 1/1; 13E, section of tongue with posterior. margin, 1/1; 13F, section of tongue with medial margin, 1/; 13G, /1. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Tongue - Deep, Muscle. FROZEN SECTION DIAGNOSIS: BENIGN. 2) SOURCE: Tongue - Base, Mucosal Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 3) SOURCE: Tongue - Oral, Mucosal Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 4) SOURCE: Pharngeal Wall Superior Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 5) SOURCE: Floor of Mouth Mucosal Margin. FROZEN SECTION DIAGNOSIS: BENIGN. R.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: Clinical history is not given. PRE-OP DIAGNOSIS: Right upper lobe mass. POST-OP DIAGNOSIS: Not given. PROCEDURE: Not given. ADDENDA: Addendum. Fluorescence in-situ hybridization studies performed on the adenocarcinoma show a ratio of Her2/Neu to the centromere of. chromosome 17 of 1.40, indicating low-level amplification in the targeted region. The ratio of cyclin-D1 gene to the centromere of. 85.7% chromosome 11 is 2.16, indicating cyclin-D1 amplification in the targeted region where this is associated with a monosomy rate of. targeted region and corresponding to hyperploidy rate of 87.3% of analyzed cells. of analyzed cells. The ratio of EGFR gene to the centromere of chromosome 7 is 9.33, indicating amplification in the. together with other major risk factors. Her2/neu and Cyclin D1 amplification may help in identifying those patients likely to experience shorter survival when considered. FINAL DIAGNOSIS: Summary Statement. The right upper lobe demonstrates a 1.6 cm invasive moderately differentiated adenocarcinoma. There is no. angiolymphatic invasion or visceral pleural invasion. Surgical resection margins are free of tumor. All sampled lymph. nodes are benign. Pathologic stage: T1 NO MX. PART 1: LYMPH NODE, ""SUBCARINAL"", BIOPSY -. FIVE (5) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 2: LYMPH NODE, ""RIGHT TRACHEOBRONCHIAL ANGLE"", BIOPSY -. SIX (6) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 3: LYMPH NODE, ""RIGHT PARATRACHEAL"", BIOPSY -. SIX (6) FRAGMENTS OF FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 4: LYMPH NODE, ""SUBINNOMINATE"", BIOPSY -. TWO (2) FRAGMENTS OF REACTIVE LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 5: PLEURA, RIGHT, BIOPSY -. FRAGMENTS OF FIBRIN WITH REACTIVE MESOTHELIAL CELLS, MACROPHAGES AND BONE MARROW. PART 6: LUNG, RIGHT UPPER LOBE, WEDGE RESECTION-. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA (1.6 CM IN DIAMETER). NO EVIDENCE OF. VISCERAL PLEURAL OR ANGIOLYMPHATIC INVASION. MILD LYMPHOCYTIC HOST RESPONSE. PATHOLOGIC STAGE: T1 NO MX,. B. SURGICAL RESECTION MARGINS ARE FREE OF TUMOR. C. BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGE AND RESPIRATORY BRONCHIOLITIS. PART 7: LYMPH NODE, ""ANTERIOR HILAR"", BIOPSY -. THREE (3) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Anatomic site: perihilar. Histology diagnosis: moderately differentiated perihilar cholangiocarcinoma (extrahepatic). Histological examination. - Right Hepatic lobe containing gallbladder and cystic duct: hepatic resection of 20x20x11.5 cm, characterized. by the presence of a whitish nodule of 12x12x12 cm arising from the right hepatic duct. Multiple satellite. lesions are also presents. Histologically, the lesions are consistent with a moderately differentiated. cholangiocarcinoma arising from the right hepatic duct, presenting inavion of lymphatic vessels and of the. gallbladder (G2, pT3 UICC 2009).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) RIGHT LOWER POLE TUMOR, PARTIAL NEPHRECTOMY: RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL TYPE), FUHRMAN'S. NUCLEAR GRADE 2. TUMOR MEASURES 4.7 CM IN MAXIMUM DIMENSION. TUMOR PRESENT IN A VASCULAR SPACE AT THE MARGIN OF RESECTION. (SEE. COMMENT). (B) 11TH RIB: Segment of rib for gross inspection only. (C) PERINEPHRIC FAT: Adipose tissue, no tumor present. COMMENT. The tumor is present as a bulging nodule in a large caliber vascular. space at the parenchymal margin of resection extending to the inked. surface indicated by the surgeon. The immunohistochemical stain for. CD31 (vascular marker) highlights the endothelial surface of the. vascular structure. This histologic finding is not diagnostic of renal. vein involvement. Additional sections prepared from the frozen section. block (A1FS) demonstrate a minute amount of adipose tissue adjacent to. the vascular structure consistent with renal sinus adipose tissue. The. tumor does not invade this adipose tissue or the perinephric adipose. tissue. GROSS DESCRIPTION. (A) RIGHT LOWER POLE TUMOR, INK AT MARGIN - A partial nephrectomy. specimen (7.7 X 5.3 X 4.2 cm) including a portion of kidney and. surrounding adipose. At the margin of resection is a protruding area of. orange-yellow tumor (0.7 X 0.5 X 0.4 cm) marked with blue surgical ink. This area is re-inked blue. The remaining resection margin is tan-gray. A 4.7 X 4.3 X 3.6 cm orange-yellow, partially cystic and. hemorrhagic tumor is present. Focally within the tumor are small areas. of gray mucoid material. The tumor is encapsulated by a rim of tan. fibrous tissue. The tumor bulges into the adjacent perinephric adipose. without gross infiltration. The surrounding uninvolved renal parenchyma is unremarkable. Representative sections of tumor and normal are submitted for tumor. bank. A portion of the tumor is sequestered for potential electron. microscopy. INK CODE: Blue - reinked surgical ink, yellow - surgical. parenchymal margin, and black - Gerota's fascia. SECTION CODE: A1, frozen section of protruding tumor nodule; A2,. additional close margin, frozen; A3, nodule protruding at margin (mirror. image to A1); A4, tumor and nearest fascia; A5-A6, tumor and surrounding. normal kidney; A7, gray mucoid area of tumor; A8, cystic area of tumor;. A9-A10, representative sections of tumor. FS/DX: CARCINOMA PRESENT AT INKED MARGIN OF RESECTION. NO. APPARENT CAPSULE AT SITE OF POSITIVE MARGIN. PT:SM/msm. (B) 11TH RIB, GROSS ONLY - An irregular fragment of rib (3.5 X 1.0 X. 0.5 cm). The specimen is entirely submitted for gross only. (C) PERINEPHRIC FAT - An irregular fragment of adipose tissue (7.5 x. 1. 6.0 X 1.0 cm). The specimen is serially sectioned and grossly. unremarkable. Representative sections in C1 and C2. CLINICAL HISTORY. Right renal mass. SNOMED CODES. T-71000, M-83123.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, left axilla, biopsy: Two negative lymph. nodes (0/2) . B. Breast, left, excisional biopsy: Invasive ductal carcinoma, grade. 3, size 3.0 cm in greatest dimension, close to the medial and. inferior margins. Microscopic Description: Invasive carcinoma: Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT2) : Size 3.0 cm in greatest dimension. Specimen margins: Carcinoma is well-demarcated, and forms a. discrete mass lesion that is less than 1 mm from the medial. margin and 0.5 mm from the inferior margin. Vessel invasion: Not identified. Ductal carcinoma in situ: Not identified. Comment: Prior biopsy site identified. Distant metastasis (pM) : Unknown. Lymph nodes: Two negative sentinel lymph nodes, 0/2. Prognostic markers: See previous core biopsy. Specimen. A. Left axillary sentinel node. B. Left breast biopsy. Clinical Information. Left breast cancer,. yo BF with grade 3 IDC. Gross Description. A. Received unfixed, labeled left axillary sentinel node, are two. lymph nodes, the larger of which is 1.4 x 1.2 x 1.0 cm, bisected. and submitted in blocks 1-2, and an additional node, 1.0 x 0.5. x. 0.5 cm, bisected and submitted in block 3. B. Received unfixed in a. container, lapeled left breast, is. a portion of fibrofatty tissue that is oriented and 6.0 cm anterior. to posterior, 4.5 cm medial to lateral, and 2.3 cm superior to. inferior. Margins are inked: inferior blue, superior black,. medial yellow, lateral green. The specimen is serially sectioned. from anterior to posterior. There is a 3.0 x 2.0 x 1.9 cm tumor. present, adjacent to the medial and inferior margins. Representative sections, including the anterior and posterior shave. margins, sequentially submitted in 8 blocks.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
specimen consists of a single piece of tan and brown soft tissue. which measures 3.4 x 1.1 X 0.7 cm. The specimen appears to have a. brown, rough surface which appears to be a cut surgical margin and a. tan-brown, smooth mucosal margin. The specimen is received. unoriented and the entire surgical margin is inked black. The. specimen is serially sectioned to reveal unremarkable tan-pink,. homogeneous parenchyma. The specimen is submitted in its entirety. SUMMARY OF SECTIONS. 2 - A,B - 5 EACH. 2 - TOTAL - 10. Other Surgical Pathology Specimens known to the computer: Note: This note provides information pertaining only to a specific event. A more detailed medical history is available in the Medical Record. FINAL DOCUMENT. INTERPRETATION AND DIAGNOSIS: 1) HYPOGLOSSAL NERVE (BIOPSY) : PORTION OF NERVE, NEGATIVE FOR TUMOR. 2) RIGHT SOFT TISSUE ON VAGUS (BIOPSY) : INFILTRATING SQUAMOUS CELL. CARCINOMA. 3) RIGHT TONSIL (BIOPSY) : SQUAMOUS MUCOSA WITH SALIVARY GLAND. TISSUE AND SKELETAL MUSCLE, NEGATIVE FOR TUMOR. 4) RIGHT DEEP BASE ON TONGUE (BIOPSY) : FIBROADIPOSE TISSUE AND. SALIVARY GLAND TISSUE, NEGATIVE FOR TUMOR. 5) RIGHT BASE OF TONGUE MUCOSA (BIOPSY) : TONSILLAR TISSUE, NEGATIVE. FOR TUMOR. 6) LEFT BASE OF TONGUE MUCOSA (BIOPSY) : INFILTRATING SQUAMOUS CELLS. CARCINOMA. 7) DEEP BASE OF TONGUE MIDLINE (BIOPSY) : FIBROMUSCULAR TISSUE,. NEGATIVE FOR TUMOR. 8) LEFT BASE OF TONGUE (BIOPSY) : SQUAMOUS MUCOSA WITH SALIVARY. GLAND TISSUE AND SKELETAL MUSCLE, NEGATIVE FOR TUMOR. 9) RIGHT NECK LEVEL 1B (EXCISION) : SEROMUCINOUS SALIVARY GLAND,. NEGATIVE FOR TUMOR. 10). RIGHT NECK (DISSECTION) : METASTATIC SQUAMOUS CELL CARCINOMA. INVOLVING SEVENTEEN (17) OF FORTY-ONE (41) LYMPH NODES (7/10 IN LEVEL. II, 2/6 IN LEVEL III, 8/18 IN LEVEL IV, AND 0/7 IN LEVEL V) . LARGEST. FOCUS: 4.0 CM (LEVEL II). EXTRANODAL EXTENSION IDENTIFIED. 11) LEFT NECK LEVEL 1B (EXCISION) : SEROMUCINOUS SALIVARY GLAND,. NEGATIVE FOR TUMOR. 12) LEFT NECK LEVEL 2B (DISSECTION) : METASTATIC SQUAMOUS CELL. CARCINOMA INVOLVING EIGHT (8) OF FOURTEEN (14) LYMPH NODES. LARGEST. FOCUS: 0.8 CM. EXTRANODAL EXTENSION IS IDENTIFIED. 13) LEFT NECK (DISSECTION) : METASTATIC SQUAMOUS CELL CARCINOMA. INVOLVING NINETEEN (19) OF THIRTY-FIVE (35) LYMPH NODES (4/4 IN LEVEL. II, 8/9 IN LEVEL III, 6/13 IN LEVEL IV, 1/9 IN LEVEL V). . LARGEST. FOCUS: 2.7 CM. EXTRANODAL EXTENSION IDENTIFIED. 14) LARYNX AND BASE OF TONGUE (TOTAL LARYNGECTOMY) : SPECIMEN: Laryngectomy, bilateral neck dissections. FINAL DOCUMENT. TUMOR SITE: Tumor centered in base of tongue with involvement of supraglottis,. glottis and subglottis. HISTOLOGIC TYPE: Squamous cell carcinoma. TUMOR SIZE: Greatest dimension: 3.5 cm. HISTOLOGIC GRADE: G2: Moderately differentiated. LYMPH NODES: Metastatic carcinoma in 45 of 91 lymph nodes. Specify largest node: 4.0 cm. EXTRANODAL EXTENSION: Present (extensive). EXTENT OF INVASION. PRIMARY TUMOR: Tumor of Oropharynx (Base of tongue). pT4a: Tumor invades larynx. See note. REGIONAL LYMPH NODES: pN2: Metastasis in single or multiple lymph nodes, none larger. than 6 cm. MARGINS: Carcinoma involves base of tongue/superior specimen. margin. Other specimen margins uninvolved. (Please see specimens 1-8. and 16 for additional margins). VENOUS/LYMPHATIC INVASION: Present, including large vessel invasion. PERINEURAL INVASION: Present. NOTE: Sections through the thyroid cartilage show no definite tumor. invasion. 15) RIGHT SKULL BASE RETROPHARYNGEAL NODE (EXCISION) : METASTATIC. SQUAMOUS CELL CARCINOMA INVOLVING ONE (1) LYMPH NODE. LARGEST FOCUS: 1.6 CM. EXTRANODAL EXTENSION IS IDENTIFIED. 16) BASE OF TONGUE (EXCISION) : INVASIVE SQUAMOUS CELL CARCINOMA. TUMOR EXTENDS TO <1 MM OF THE UNDESIGNATED CAUTERIZED MARGIN. based upon my personal examination of the slides (and / or other. material indicated in the diagnosis), and that I have reviewed and. approved this report. Clinical History: TOTAL LARYNGECTOMY. FINAL DOCUMENT. GROSS DESCRIPTION. PART #1: FS: HYPOGLOSSAL NERVE. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Other Pathologists. FS: Hypoglossal nerve: Nerve margin (designated with clip) : Negative for tumor. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated , hypoglossal nerve -. look at side with staple. The specimen consists of a red-pink. portion of soft tissue measuring 1.5 x 0.7 X 0.3 cm. A staple is. present at one end. This area is inked black and submitted for. frozen section diagnosis. The specimen is submitted in its entirety. SUMMARY OF SECTIONS. 1 - FSC - 1. (TISSUE FOR FROZEN SECTION). 1 - A - 4. (REMAINDER OF SPECIMEN). 2 - TOTAL - 5. PART #2: FS: RIGHT SOFT TISSUE ON VAGUS. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Other Pathologists. FS: Right soft tissue on vagus: Positive for tumor; infiltrating. squamous cell carcinoma. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated 'right soft tissue on. vagus nerve. , The specimen consists of a 1.4 x 0.2 x 0.2 cm portion. of pink-tan soft tissue. The specimen is submitted in its entirety. for frozen section diagnosis. SUMMARY OF SECTIONS. 1 - FSC - 1. 1 - TOTAL - 1. PART #3: FS: RIGHT TONSIL. Resident Pathologist: FROZEN SECTION DIAGNOSIS: FINAL DOCUMENT. FS: Right tonsil: Negative for tumor. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated 'right tonsil. ' The. specimen consists of a single piece of red-tan soft tissue measuring. 0.7 x 0.5 X 0.3 cm. The specimen is submitted in its entirety for. frozen section diagnosis. SUMMARY OF SECTIONS. 1 - FSC - 1. 1 - TOTAL - 1. PART #4: FS: RIGHT DEEP BASE OF TONGUE. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Other Pathologists. FS: Right deep base of tongue : Negative for tumor. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated 'right deep base of. tongue. The specimen consists of a single piece of pink-tan soft. tissue measuring 1.0 x 0.4 X 0.3 cm. 100% of the specimen is. submitted for frozen section diagnosis. SUMMARY OF SECTIONS. 1 - FSC - 1. 1 - TOTAL - 1. PART #5: FS: RIGHT BASE OF TONGUE MUCOSA. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Other Pathologists. FS: Right base of tongue mucosa: Negative for tumor. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated 'right base of tongue. mucosa. The specimen consists of a single piece of pink-tan soft. tissue measuring 1.5 x 0.5 x 0.5 cm. 100% of the specimen is. submitted for frozen section diagnosis. SUMMARY OF SECTIONS. 1 - FSC - 1. 1 - TOTAL - 1. FINAL DOCUMENT. PART #6: FS: LEFT BASE OF TONGUE MUCOSA. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Other Pathologists. FS: Left base of tongue mucosa: Positive for tumor. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated 'Left base of tongue. mucosa. The specimen consists of a single piece of pink-tan soft. tissue measuring 1.7 x 0.5 x 0.2 cm. 100% of the specimen is. submitted for frozen section diagnosis. SUMMARY OF SECTIONS. 1 - FSC - 1. 1 - TOTAL - 1. PART #7: FS: DEEP BASE OF TONGUE MIDLINE. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Other Pathologists. FS: Deep base of tongue midline: Negative for tumor. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated 'Deep base of tongue. midline. The specimen consists of a single piece of pink-tan soft. tissue measuring 0.8 x 0.6 x 0.5 cm. 100% of the specimen is. submitted for frozen section diagnosis. SUMMARY OF SECTIONS. 1 - FSC - 1. 1 - TOTAL - 1. PART #8: FS: LEFT BASE OF TONGUE. Resident Pathologist: FROZEN SECTION DIAGNOSIS: Other Pathologists. FS: Left base of tongue: Negative for tumor. The specimen is received fresh for frozen section, labeled with the. patient's name,. and designated 'Left base of tongue. â¹. The specimen consists of one fragment of pink-tan soft tissue. measuring 1.8 x 1.0 x 0.5 cm. The specimen is submitted for frozen. FINAL DOCUMENT. section diagnosis. SUMMARY OF SECTIONS. 1 - FSC - 1. (LEFT BASE OF TONGUE). 1 - TOTAL - 1. PART #9: RIGHT NECK LEVEL 1B. Resident Pathologist: The specimen is received fresh labeled with the patient's name,. and designated 'Right neck level 1B. The specimen consists. of a single piece of brown to yellow fibroadipose tissue measuring. 5.0 x 3.0 x 1.0 cm. Grossly, the specimen resembles a submandibular. salivary gland with a small amount of fibroadipose tissue attached. The submandibular gland is serially sectioned to reveal unremarkable,. lobulated, tan-brown parenchyma with no nodules or other lesions. grossly identified. Representative sections of the submandibular. gland in addition to all of the attached fibroadipose tissue are. submitted. Approximately 30% of the specimen is submitted. SUMMARY OF SECTIONS. 1 - A - 1. (SOFT TISSUE). 1 - B - 2. (SUBMANDIBULAR GLAND). 2 - TOTAL - 3. PART #10: RIGHT RADICAL NECK DISSECTION LEVELS 2-5. Resident Pathologist: The specimen is received labeled with the patient's name,. and designated 'right radical neck dissection level 2-5. The specimen consists of a single piece of tan to yellow fibroadipose. tissue measuring 15.0 x 5.0 X 3.0 cm. Along the length of the. specimen are several sets of staple marks with a number of staples. corresponding to the level in the neck. Conjoining the level 2 and. level 3 segments is a large ill-defined nodular mass that measures. approximately 4.0 X 3.5 x 2.5 cm. Sectioning into this nodule. reveals an infiltrating white nodular mass that appears to meld into. the surrounding fibroadipose tissue and muscle. Also within the. level 2 section, five potential lymph nodes are found ranging in size. from 1.5 to 0.5 cm in greatest dimension. The largest lymph node is. trisected to reveal a pale tan parenchyma with a white hard nodule. within it. Within the level 3 segment aside from the large nodule,. five potential lymph nodes are dissected out ranging in size from 1.8. to 0.3 cm in greatest dimension. The largest lymph node is trisected. to reveal a dark red and tan mottled parenchyma. Within the level. 4. segment, 11 potential lymph nodes are found ranging in size from 2.6. to 0.4 cm in greatest dimension. The largest lymph node is trisected. to reveal a variegated tan and yellow hard nodular parenchyma. The. second largest lymph node which measures 1. 6 cm is also bisected to. reveal a variegated surface that is tan and white. Within the level. 5. segment, no potential lymph nodes are found. Representative sections. of the nodules in levels 2 and 3 are submitted. All potential lymph. nodes are submitted. All associated fibroadipose tissue is. FINAL DOCUMENT. submitted. Approximately 80% of the specimen is submitted. SUMMARY OF SECTIONS. 1 - A - 3. (1 LN TRISECTED LEVEL 2). 1 - B - 3. (3 LNS LEVEL 2). 4 - C-F - 1 EACH. (NODULE LEVEL 2-3). 2 - G-H - 1 EACH. (SOFT TISSUE, LEVEL 2). 1 - I - 3. (1 LN TRISECTED, LEVEL 3). 1 - J - 4. (4 LNS LEVEL 3). 1 - K - 1. (SOFT TISSUE, LEVEL 3). 1 - 1 - 1. (1 LN, LEVEL 4). 1 - M - 2. (2ND HALF OF LN IN L). 1 - N - 2. (1 LN, BISECTED). 1 - o - 4. (4 LNS, LEVEL 4). 1 - P - 5. (5 LNS, LEVEL 4). 4 - Q-T - MULTIPLE EACH (SOFT TISSUE LEVEL 4). 5 - U-Y - MULTIPLE EACH (SOFT TISSUE LEVEL 5). 25 - TOTAL - M. SUMMARY OF SECTIONS. 1 - FSC - 1. 1 - TOTAL - 1. PART #11: LEFT NECK LEVEL 1B. Resident Pathologist: The specimen is received fresh labeled with the patient's name,. and designated 'left neck level 1B. The specimen consists. of one roughly ovoid shaped portion of dark yellow soft tissue. consistent with submandibular gland weighing 8.9 gm and measuring 4.6. x 3.0 x 1.0 cm. No orientation is provided. The specimen is inked. black and serially sectioned to reveal dark yellow, lobulated,. unremarkable parenchyma. Representative sections are submitted. SUMMARY OF SECTIONS. 3 - A-C - 1 EACH. (SUBMANDIBULAR GLAND). 3 - TOTAL - 3. PART #12: LEFT NECK LEVEL 2B. Resident Pathologist: The. specimen is received fresh labeled with the patient's name,. and designated 'left neck level 2B. The specimen consists. of a single piece of fibroadipose tissue which measures 5.5 X 2.5 x. 1.0 cm. Dissection of the soft tissue reveals eight potential lymph. nodes ranging in size from 1.3 to 0.5 cm in greatest dimension. The. largest lymph node is bisected to reveal a mottled tan and white. nodular mass. All lymph nodes and the remaining fibroadipose tissue. are entirely submitted. SUMMARY OF SECTIONS. FINAL DOCUMENT. 1 - A - 2. (1 LN BISECTED). 1 - B - 3. (3 LNS). 1 - C - 4. (4 LNS). 2 - D, E - MULT EA. (FAT). 5 - TOTAL - M. PART #13: LEFT MODIFIED RADICAL NECK DISSECTION LEVELS 2-5. Resident Pathologist: The specimen is received fresh labeled with the patient's name,. and designated 'left radical neck levels 2-5.' The specimen. consists of one large, irregular portion of red-tan to yellow-tan. soft tissue measuring 10.0 x 7.5 x 2.0 cm. Two staples are. identified designating level 2. Three staples are identified. designating level 3. Four staples are identified designating level. 4, and five staples are identified designated level 5. Level 2. contains four possible lymph nodes ranging from 0.8 to 2.6 cm in. greatest dimension. The largest lymph node displays a tan-white,. firm and gritty cut surface. A segment of vessel is also identified. measuring 1.0 cm in length by 0. cm in average diameter. The. remainder of level 2 consists of unremarkable skeletal muscle and. fibroadipose tissue. The lymph nodes are entirely submitted. Level. 3. contains nine possible lymph nodes ranging from 0.7 to 1.8 cm in. greatest dimension. The remainder of level 3 consists of. unremarkable fibroadipose tissue and skeletal muscle. The lymph. nodes are entirely submitted. Level 4 contains thirteen possible. lymph nodes ranging from 0.4 to 1.6 cm in greatest dimension. The. remainder of level 4 consists of unremarkable fibroadipose tissue. The lymph nodes are entirely submitted. Level 5 contains ten. possible lymph nodes ranging from 0.2 to 1.0 cm in greatest. dimension. The remainder of level 5 consists of unremarkable. fibroadipose tissue and skeletal muscle. The lymph nodes are entirely. submitted. SUMMARY OF SECTIONS. 1 - A - 1. (REP. CROSS SECTION OF VESSEL IN LEVEL 2). 1 - B - 2. (2 POSS. LNS LEVEL 2). 1 - C - 2. (1 BISECTED LN, LEVEL 2). 1 - D - 1. (CROSS SECTION OF LARGEST LN, LEVEL 2). 1 - E - 3. (3 POSS. LNS, LEVEL 3). 6 - F-K - 2 EACH. (1 BISECTED LN EACH, LEVEL 3). 2 - L-M - 4 EACH. (4 POSS. LNS EACH, LEVEL 4). 1 - N - 2. (2 POSS. LNS, LEVEL 4). 3 - O-Q - 2 EACH. (1 BISECTED LN EACH LEVEL 4). 2 - R, S - 4 EACH. (4 POSS. LNS EACH LEVEL 5). 1 - T - 2. (2 POSS. LNS LEVEL 5). 20 - TOTAL - M. PART #14: TOTAL LARYNGECTOMY PHARYNGECTOMY BASE OR TONGUE. Resident Pathologist: The specimen is received fresh labeled with the patient's name,. and designated 'total laryngectomy and base of tongue. The. specimen consists of a laryngectomy specimen that includes the base. FINAL DOCUMENT. of the tongue which measures 8.0 x 7.5 x 5.5 cm. The larynx itself. measures 4.5 x 4.5 x 4.0 cm and the distal tracheal margin is 1.7 x. 1.8 cm. The specimen is inked black on the outside and is opened. along the posterior aspect of the larynx to reveal a large ulcerating. mass at the superior aspect of the larynx and at the posterior aspect. at the base of the tongue which measures 3.5 X 3.5 cm. This. ulceration appear to have eroded away the epiglottis and has grossly. involved the false vocal cords, but does not grossly appear to. involve the true vocal cords. This ulceration also appears to. encroach upon the base of the tongue. The ulceration is 1.0 cm from. the proximal base of the tongue margin and is 3.1 cm from the distal. tracheal margin. The mass also appears to approach within 1.0 mm of. the anterior inked margin at the superior aspect of the specimen near. the base of the tongue. The mass does not appear to invade into the. thyroid cartilage. Representative sections are submitted as. indicated on the photograph. SUMMARY OF SECTIONS. 1 - A - 1. (DISTAL TRACHEAL MARGIN/DECAL). 1 - B - 1. (LEFT BASE OF TONGUE MARGIN). 1 - C - 1. (SUPERIOR BASE OF TONGUE MARGIN). 1 - D - 1. (RIGHT SUPERIOR BASE OF TONGUE MARGIN). 1 - E - 1. (LEFT VOCAL CORDS). 1 - F - 1. (ANTERIOR COMMISSURE). 1 - G - 1. (RIGHT VOCAL CORDS). 1 - H - 1. (LEFT ARYEPIGLOTTIC FOLD AND PYRIFORM SINUS). 1 - I - 1. (RIGHT ARYEPIGLOTTIC FOLD AND PYRIFORM SINUS). 2 - J, K - 1 EACH. (ANTERIOR/SUPERIOR SOFT TISSUE MARGIN). 1 - L - 1. (RIGHT VOCAL CORDS AND THYROID CARTILAGE). 1 - M - 1. (LEFT VOCAL CORDS AND THYROID CARTILAGE). 2 - N, o - 1 EACH. (TUMOR). 15 - TOTAL - 15. PART #15: RIGHT SKULL BASE RETROPHARYNGEAL. NODE. Resident Pathologist: The specimen is received fresh labeled with the patient's name,. and designated 'right skull base retroperitoneal node. The. specimen consists of a single piece of tan and yellow soft tissue. which measures 2.0 x 1.6 x 0.8 cm. The specimen appears to be a. nodular lymph node. The specimen is bisected to reveal mottled tan. and white interior which grossly appears to be involved by metastatic. tumor. The specimen is submitted in its entirety. SUMMARY OF SECTIONS. 1 - A - 2. 1 - TOTAL - 2. PART #16: RE RESECTION BASE OF TONGUE. Resident Pathologist: The specimen is received fresh labeled with the patient' name,. and designated 'Left re-excision base of tongue. - The. FINAL DOCUMENT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
A total of 50 cells were scored. FINDINGS: FISH was performed on paraffin embedded tissue sections using the. Vysis ALK Break Apart Probe for the ALK gene at 2p23 (. FDA approved). When a rearrangement involving ALK is. present, either inversion or translocation, one of the two fusion. signals separates as one red and one green signal. In this. specimen, separated signals were present in 0% of the nuclei scored. This result is within the normal limits. COMMENTS: Three to four copies of ALK were observed in 26.0% of. cells. This gain of intact ALK fusion hybridization signals. represents an aneuploid population with extra copies of chromosome. 2/2p ALK region. Additional copies of ALK are not uncommon in. NSCLCs, although the significance of extra copies of the ALK gene in. lung carcinoma is unclear at this time (Salido M. et al. J Thorac. Oncol. 2011;6:21-27). References: (1). Soda M, et al. Identification of the transforming. EML4-ALK fusion gene in non-small cell lung cancer. Nature. 2007:448:561-566; (2). Rodrig S, et al. Unique clinicopathologic. features characterize ALK-rearranged lung adenocarcinoma in the. western population. Clin Cancer Res. 2009:15:5216-5223; (3). Shaw. A, et al. Clinical features and outcome of patients with non-small. cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009:27:4247-4253; (4). Koivunen J, et al. EML4-ALK fusion gene and. efficacy of an ALK kinase Inhibitor in lung cancer. Clin Cancer. Res. 2008:14:4275-4283; (5). Kwak EL. et al. Anaplastic lymphoma. kinase inhibition in non-small cell lung cancer. N Engl J Med. 2010:363(18):1693-1703 (6). The FDA approved Vysis ALK Break Apart. FISH Probe Kit. ISCN RESULTS: nuc ish(ALKx3 4)[59/100]. The Vysis ALK Break Apart Probe FISH test (. 1 is FDA. approved for use in the detection of rearrangements involving the. ALK gene via fluorescence in situ hybridization (FISH) in. formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer. (NSCLC) tissue specimens. Addendum #4 performed by. The electronic signature attests that the. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S RIGHT MIDDLE LOBE NODULE. 2. STATION 9 LYMPH NODE, RIGHT CHEST. 3. STATION 10 LYMPH NODE, RIGHT CHEST. 4. COMPLETION OF RIGHT MIDDLE LOBECTOMY. 5. STATION 4 LYMPH NODE. 6. STATION 7 LYMPH NODE. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. Reason For Addendum #4: Biomarker Report. DIAGNOSIS: 1. LUNG, RIGHT MIDDLE LOBE: WEDGE RESECTION. - ADENOCARCINOMA, PAPILLARY PREDOMINANT (1.1 CM), SEE NOTE. - THE STAPLE LINE MARGIN IS FREE OF TUMOR. Note: The tumor consists of papillary (70%) and micropapillary. (30%) components. Results of molecular studies will be reported in. addenda. 2. LYMPH NODE, RIGHT LEVEL 9: BIOPSY. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 3. LYMPH NODE, RIGHT LEVEL 10: BIOPSY. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). 4. LUNG, RIGHT MIDDLE LOBE: COMPLETION LOBECTOMY. - NO RESIDUAL TUMOR IS SEEN. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. - ONE INTRAPARENCHYMAL LYMPH NODE, NEGATIVE FOR CARCINOMA. (0/1). 5. LYMPH NODE, LEVEL 4: BIOPSY. - THREE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/3). 6. LYMPH NODE, LEVEL 7: BIOPSY. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). Specimens: 1: F/S RIGHT MIDDLE LOBE NODULE. 2: STATION 9 LYMPH NODE, RIGHT CHEST. 3: STATION 10 LYMPH NODE, RIGHT CHEST. 4: COMPLETION OF RIGHT MIDDLE LOBECTOMY. 5: STATION 4 LYMPH NODE. 6: STATION 7 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). right middle. Procedure: Lobectomy. Specimen Laterality: Right. Tumor Site: Middle lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G2: Moderately differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 1.1cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. STAGE (pTNM). Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung. or visceral pleura, without bronchoscopic evidence of invasion more. proximal than the lobar bronchus (i.e., not in the main bronchus);. or Superficial spreading tumor of any size with its invasive. component limited to the bronchial wall, which may extend proximally. to the main bronchus. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Distant Metastases (pM): Not applicable. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Emphysema. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: M smoker (100 pack-years) with hx of prostate cancer (. ) and. COPD, now with a 1.5 cm RML mixed solid and ground-glass nodule and. multiple additional bilateral lung nodules. MACROSCOPIC DESCRIPTION: The specimen is received fresh, in six parts, each labeled with the. patient's name. 1. Part one is labeled 'right middle lobe nodule'. It consists of a. wedge shaped portion of lung measuring 11 x 5 x 2 cm. There is a. staple line identified on the specimen, measuring 10 cm in length. There is a cut identified on the specimen measuring 1.5 cm in. length. On further sectioning there is a gray white ill defined area. measuring 1.1 x 1 cm is identified. This area is 0.3 cm from the. staple line and 0.4 cm from the pleural surface. The staple line is. inked blue. Further sectioning of the lung reveals spongy tan maroon. parenchyma. One portion from the ill defined area is submitted for. frozen section analysis. Representative sections are submitted. 2. Part two is labeled 'station #9 lymph node'. It consists of a. single lymph node measuring 2.4 x 1.5 x 1 cm. The cut surface is. grey-black. Entirely submitted in one cassette. 3. Part three is labeled 'station #10 lymph node'. It consists of. multiple irregular fragments of grey-black lymph nodes measuring 1.5. x 0.8 x 0.5 cm in aggregate. Entirely submitted in one cassette. 4. Part four is labeled 'completion of right middle lobectomy'. It. consists of a lobe of lung measuring 10.5 x 5.5 x 2 cm and weighing. 38 grams. Two staple lines, measuring 8 cm and 6 cm in length are. noted. The bronchial and vascular margins are identified. The. serosal surface is grey-purple and shows a subpleural grey-black. nodule measuring 0.9 x 0.8 cm. Sectioning reveals an unremarkable. red beefy lung parenchyma. The subpleural nodule likely represents. the lymph node. No discrete mass lesions are noted. Representative. sections are submitted. 5. Part five is labeled 'station #4 lymph node'. It consists of. three irregular segments of grey-black lymph nodes ranging from 0.2. to 0.5 cm in greatest dimension. Entirely submitted in one. cassette. 6. Part six is labeled 'station #7 lymph node'. It consists of a. single grey-black lymph node measuring 0.8 x 0.5 x 0.3 cm. Entirely. submitted in one cassette. SUMMARY OF SECTIONS: 1A frozen section control, ill defined area. 1B area adjacent to ill defined area. 1C area adjacent to ill defined area. 1D area adjacent to ill defined area. 1E unremarkable lung parenchyma. 1F stapled line. 2A in toto. 3A in toto. 4A bronchial and vascular margins. 4B entire subpleural nodule. 4C-4E lung, representative. 5A in toto. 6A in toto. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Lung, right middle lobe: wedge resection (FS). - Invasive adenocarcinoma. Intra-Operative Consultation #1 performed by. Final Diagnosis performed by. ADDENDUM #1 FOR MOLECULAR TESTS: KRAS, EGFR and ALK FISH were sent on. The test is to be performed on tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 1A appropriate to. the specifications of the ordered molecular analysis. x1 H&E and x9. unstained slides were prepared and forwarded to. where the subject molecular test will be performed. An. addendum report will be issued when the results of this molecular. test are available. Addendum #1 performed by. ADDENDUM #2: MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Body Site: Right middle lobe of lung. Specimen Type: Slides. Clinical Data: Adenocarcinoma. RESULTS: Wild-type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated. for use in identifying KRAS codon 12 and codon 13 mutations in. fresh, frozen, or formalin-fixed paraffin embedded tissue. In. particular the test performance has been established in samples of. colorectal cancer and non-small cell lung carcinoma which harbor. these mutations, although several other tissues are also known to. harbor KRAS mutations (e.g. tumors of pancreas, bile duct, ovary,. appendix, etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: NSCLC. Mascaux C, Iannino N, et al. British Journal of Cancer, 2005;. 92:11-139. Pao W, Wang TY, et al. PLoS Medicine, 205; 2(1):57-61. Eberhard DA, Johnson BE, et al. J Clin Oncol, 2005; 23:5900-5909. Han SW, Kim TY, et al. Clin Cancer Res. 2006; 12(8):253888888-2544. CRC. DiFiore C, Blanchard F, et al. Br J Cancer, 20007; 96:1166-1169. Lievre A, Bachet J-B, et al. Cancer Res, 2006; 66:3992-3995,. This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand along test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #2 performed by. ADDENDUM #3: EGFR Mutation Analysis. Body Site: Right middle lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 70% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361>GA (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine kinase domain of the epidermal growth. factor receptor (EGFR) gene are reported to be associated with. differential responsiveness or resistance to EGFR tyrosine kinase. inhibitor (TKI) therapies. The objective response rate among. patients with a sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: 1. Azzoli CG, et al. J Clin Oncol. 20095; 27:6251-6266. 2. Jackman DM et al. Clin Carcinoma Res. 2009; 15:5267-5273. 3. Mok TS, et al. N Engl J Med. 1009; 361;947-957. 4. Sharma SV, et al. Nat Rev Carcinoma, 2007; 7:169-181. DISCLAIMER: This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand alone test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #3 performed by. ADDENDUM 4: INTEGRATED ONCOLOGY. Fluorescence In-Situ Hybridization (FISH). Body Site: Right middle lobe of lung. Clinical Data: Adenocarcinoma. INTERPRETATION: Negative for a rearrangement involving the ALK gene. Probe #Nuclei Examined % Positive Nuclei %. Control values. 2p23(ALK) 50 0.0 <15.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. Breast, left, total mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of III), [tubules 2/3, nuclei 2/3, mitoses. 3/3;. Nottingham. score 7/9], forming a 4.2 x 4.0 x 3.0 cm mass located in the upper outer quadrant of the breast [AJCC pT2]. Focal. ductal carcinoma in situ, intermediate nuclear grade, comprising approximately 5% of tumor volume. The non-neoplastic breast. parenchyma shows nonproliferative fibrocystic changes. Biopsy site changes present. The tumor does not involve. the. nipple,. overlying. skin,. or underlying chest wall. All surgical resection margins, including deep margin, are negative for tumor (minimum. tumor free margin, 1.5 cm, anterior margin). Lymph nodes, left axillary sentinel, excision: Multiple (8) left axillary sentinel lymph nodes are negative for tumor (AJCCpN0(i-. )(sn)). Blue dye was identified in lymph node Nos. 2A, 2B, and 2C. No blue dye was identified in lymph node Nos. 1,. 3,. 4,. 5,. and. 6. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and confirms. the H&E impression. Estrogen and progesterone receptor analysis and HER2/neu have been ordered on paraffin embedded tissues.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SUPPLEMENTAL REPORT. COMMENT: Sections of the mandibular condyle which has been decalcified show. squamous carcinoma destroying the mandibular ramus and infiltrating through. the aricul ar surface of the condyle into the temporal mandibular joint. DIAGNOSIS. (A). LEFT MAXILLECTOMY, MANDIBULECTOMY, BILATERAL NECK DISSECTION, TOTAL. LARYNGECTOMY, PARTIAL PHARYNGECTOMY AND INFRATEMPORAL RESECTION: INVASIVE SQUAMOUS CARCINOMA, MODERATELY DIFFERENTIATED,. 19.0 X 12.0 X 6.0 CM. (SEE COMMENT). (B) TEETH: Five molar teeth. COMMENT. Squamous carcinoma infiltrates the temporomandibular joint,. mandibular ramus, palate, oropharynx, tongue, laryngeal cartilage and soft. tissue of the neck bilaterally. The mandibular condyle is to be processed. following decalcification for which a supplemental report will be issued. Tumor is not present in the representative margins examined. SPECIMEN. (A) LEFT MAXILLECTOMY, MANDIBULECTOMY, BILATERAL NECK DISSECTION, TOTAL. (B) TEETH: SNOMED CODES. T-51004,M-80703.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Microscopic Description. Diagnosis Details. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 9.5 X 8 X 1.2 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma, intestinal type. Histologic grade: Poorly differentiated. Tumor extent: Adjacent structures (specify) -. lesser omentum. Lymph nodes: 6/7 positive for metastasis. (Intraabdominal 6/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None. Case ID.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: Right lobe liver (1045 grams, 20 x 17 x 7.5 cm) and gallbladder (10 X 4 x 3 cm). A1, B1, B2, B3, B4, B5, B6, B7, B8, B9, B10, B11. DIAGNOSIS: Liver, right lobe, resection: Grade 3 (of 4) hepatocellular carcinoma, usual type. forming a dominant 4.6 x 4.3 x 3.2 cm mass with a single satellite nodule measuring. 0.4 cm in greatest dimension. The tumor is located in the right lobe. The hepatic. capsule is free of tumor. The surgical margins are free of tumor. Extramural. vascular invasion is not identified. The tumor is not encapsulated, infiltration of. parenchyma being of the pushing type. The non-neoplastic liver will be reported in. an addendum. Gallbladder, cholecystectomy: Mild chronic cholecystitis. ADDENDUM: The non-neoplastic liver shows mild tumor effect. No evidence of chronic or. primary liver disease.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Surgery Date. carcinoms, papillary and fullicular 8340/3. SPECIMENS: A. PRETRACHEAL LYMPH NODE. B. LEFT PARATRACHEAL LYMPH NODE. C. RIGHT PARATRACHEAL LYMPH NODE. D. THYROID. DIAGNOSIS: A. PRETRACHEAL LYMPH NODE, EXCISION: ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). B. LEFT PARATRACHEAL LYMPH NODE, EXCISION: - METASTATIC PAPILLARY THYROID CARCINOMA PRESENT IN ONE OF TWO LYMPH NODES. (1/2). C. RIGHT PARATRACHEAL LYMPH NODE, EXCISION: - METASTATIC PAPILLARY THRYOID CARCINOMA PRESENT IN TWO OF TWO LYMPH NODES. (2/2). D. THYROID, TOTAL THYROIDECTOMY: - MULTIFOCAL PAPILLARY THYROID CARCINOMA IN RIGHT AND LEFT THYROID, LARGEST. TUMOR FOCUS MEASURING 1.7 x 1.1 CM. - CARCINOMA FOCALLY EXTENDING TO RIGHT PERI-THYROID SOFT TISSUE. ONE LYMPH NODE ATTACHED TO RIGHT THYROID, POSITIVE FOR METASTATIC CARCINOMA. (1/1). - SURGICAL RESECTION MARGINS, NEGATIVE FOR TUMOR. - CHRONIC LYMPHOCYTIC THYROIDITIS. - SEE TEMPLATE. THYROID TEMPLATE. Specimen Type: Total thyroidectomy. Tumor Site: Right and left lobes. Tumor Focality: Multifocal. Tumor Size (Largest nodule): 1.7 cm in greatest dimension, 1.1 x 0.9 cm in additional dimension. (right); 1.0 x 1.0 cm (left); and 1 mm (right). Histologic Type: Papillary carcinoma: mixed papillary and follicular variant. Margins: Uninvolved; distance to closest margin: <1 mm. in both right. and left thyroid. Venous/Lymphatic Invasion: Present. Additional Findings: Chronic lymphocytic thyroiditis. Lymph Nodes: Right and Left. Procedure: Lymph nodes biopsy. Metastatic papillary thyroid carcinoma present in 1/2 left paratracheal lymph nodes, 2/2 right. paratracheal lymph nodes, and 1/1 right peri-thyroid lymph node. One pretracheal lymph node, negative for tumor. Pathologic Stage: pT3 N1a Mx. SPECIMEN(S): A. PRETRACHEAL LYMPH NODE B. LEFT PARATRACHEAL LYMPH NODE C. RIGHT. PARATRACHEAL LYMPH NODE D. THYROID. CLINICAL HISTORY: None given. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSB: Left paratracheal lymph node: Positive for metastatic thyroid carcinoma. By Dr., called to Dr. at. GROSS DESCRIPTION: A. PRETRACHEAL LYMPH NODE. Received in formalin and labeled as ""pretracheal lymph node"" is a piece of yellow-tan adipose tissue. measuring 2.8x0.9x0.2cm containing 2 possible lymph nodes measuring 0.3 and 0.5cm. Submitted in. toto in block A1. B. LEFT PARATRACHEAL LYMPH NODE. Received fresh for frozen section and labeled ""left paratracheal lymph node"" are 2 lymph nodes in. aggregate measuring 1.5x0.8x0.2cm. Touch preps are performed and the specimen is submitted in toto. block FSB1. C. RIGHT PARATRACHEAL LYMPH NODE. Received in formalin and labeled ""right paratracheal lymph node"" are 2 pink-tan lymph nodes. measuring 0.2 and 0.3cm. Submitted in toto in block C1. D. THYROID. Received fresh for possible tissue procurement and labeled ""thyroid"" is a 1.5gm thyroid gland. The. right lobe is 5.0x2.3x0.5cm and the left lobe is 2.5x2.3x0.3cm. Right lobe is inked blue and the left lobe. is inked yellow and the specimen is serially sectioned. Within the right lobe is a firm, tan mass,. 1.7x1.1x0.9cn In the left lobe is an area of diffuse white-tan discoloration measuring up to 0.9cm in. greatest dimension. The remainder of the thyroid tissue has a meaty red-brown coloration. Sections. are submitted for tissue procurement. Specimen is submitted in toto as follows: D1-D2: mass from the right thyroid lobe. D3-D7: remainder of the tissue from the right lobe of thyroid. D8: isthmus. D9-D10: normal appearing left thyroid lobe. D11-D13: area of discoloration from left lobe. Microscopic/Diagnostic Dictation: M.D., Pathologist. Final Review: , M.D., Pathologist. Final: , M.D., Pathologist.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
LEFT LUNG AND LYMPH NODES. Clinical Notes: L pneumonectomy, number 7 LN, number 5 LN. Three specimens are received: 1: L LUNG. Macroscopy: Specimen consists of a left pneumonectomy specimen measuring 300 x 290 x 58 mm in the. inflated state. There is an area of adhesion between the upper and lower lobes across the. oblique fissure. The pleura otherwise appears normal. Located in the upper lobe 25 mm from. the resection margin is a large well circumscribed firm grey mass measuring 62 mm in. maximal dimension. It appears to extend across the oblique fissure into the lower lobe. It. comes close to the external pleural margin but it appears to be clear of it. The tumour shows. central necrosis and cavitation. Near its most medial aspect of the specimen, several lymph. nodes show some pale discolouration suggestive of direct invasion by tumour. Adjacent lung. tissue shows evidence of mild centri-acinar emphysema. The lung tissue distal to the tumour. in the lower lobe shows yellow discolouration suggestive of lipoid pneumonia. [Bronchial. resection margin with hilar lymph nodes, 1A; further hilar lymph nodes, 1B; tumour where it. appears to cross the oblique fissure, 1C and 1D; tumour with no pleura or margins, 1E; tumour. with pleura, 1F; ? lymph node invasion, 1G; emphysema, 1H; ? lipoid pneumonia, 1I]. Microscopy: Sections show a poorly differentiated carcinoma in which there are some squamous features. The tumour has central necrosis. It invades across the oblique fissure to involve both lobes. Blood vessel invasion is present and there is tumour within an intrapulmonary peribronchial. lymph node. The tumour is clear of the bronchial margin. Centriacinar emphysema is noted. Lung distal to the tumour shows patchy organising pneumonia and endogenous lipid. pneumonia with collections of intra-alveolar foamy macrophages. 2: NUMBER 5 LYMPH NODE. Macroscopy: Specimen consists of two grey pieces of tissue which measure 20 x 10 x 3 mm in aggregate. [BIT, 2A]. Microscopy: The lymph nodes show no evidence of malignancy. The adjacent connective tissue contains. nodules of concentric fibrotic tissue consistent with silicotic nodules. These are probably. within an obliterated node. 3: NUMBER 7 LYMPH NODE. Macroscopy: Specimen consists of three tan coloured pieces of tissue measuring 12 x 12 x 3 mm in. aggregate. [BIT, 3A]. Microscopy: The lymph nodes show no evidence of malignancy. Summary-Specimens 1-3: Left pneumonectomy and mediastinal lymph nodes: 1: Poorly differentiated squamous cell carcinoma of the upper lobe with extension. through the oblique fissure into the lower lobe, 62 mm in maximal dimension. 2: Peribronchial lymph node involvement. 3: Blood vessel and pleural invasion. 4: Clear of bronchial resection margin. 5: Pathological stage T2N1MX. T-28000 M-80703 P1-03000. Copies:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PROCEDURE. Robotic assisted liver resection. HISTORY. Hepatocellular carcinoma. GROSS. Received in formalin, labeled ""liver resection, "" is a 4 x 3.5 x. 2 cm, 10-gram irregular-shaped portion of liver. It has previously. been incised. The surface is partly smooth and mostly roughened. The surgeon has marked the superficial with yellow ink, the deep. with red ink, the medial with orange ink, and the lateral with black. ink. Ink has spilled into the area where it has been previously. incised. Cut section shows a 2.4 x 2.2 x 2 cm tan circumscribed. mass. The mass is 0.1 cm to the yellow margin, 0.1 cm or less to. the red inked deep margin, 0.2 cm to the orange inked medial margin,. and 0.1 cm or less to the black inked lateral margin. The unvinolved. liver is tan. Submitted entirely in 10 cassettes. Tissue is submitted for the TCGA research study per protocol. Total time in 10% neutral buffered formalin from collection through. processing: 21 hours. Total cold ischemia time: DIAGNOSIS. HEPATOCELLULAR CARCINOMA PROFILE. SPECIMEN TYPE: WEDGE RESECTION. CLINICAL/WORKING STAGE: N/A. TISSUE COLD ISCHEMIA TIME: TISSUE DURATION IN 10 PERCENT NEUTRAL BUFFERED FORMALIN: 21. HOURS. TUMOR FOCALITY: SOLITARY. TUMOR SIZE: 2.4 x 2.2 x 2 CM. HISTOLOGIC TYPE AND GRADE: HEPATOCELLULAR CARCINOMA, TRABECULAR. PATTERN,. GRADE II. TUMOR EXTENSION: TUMOR IS CONFINED TO THE LIVER. LYMPH-VASCULAR INVASION: NOT IDENTIFIED. PERINEURAL INVASION: NOT IDENTIFIED. MARGINS: THIS IS A LARGELY ENCAPSULATED TUMOR WITH THE TUMOR MARGIN. DEFINED. BY NARROW BAND OF DESMOPLASTIC FIBROUS STROMA. ALL MARGINS ARE. NEGATIVE WITH. THE EXCEPTION THAT THE POSTERIOR MARGIN IS INDETERMINATE DUE TO. ENCROACHMENT. OF THIS MARGIN AFTER EXCISION OF THE TUMOR. ADDITIONAL PATHOLOGIC FINDINGS: TUMOR IS PRESENT ON A BACKGROUND OF. MICRONODULAR CIRRHOSIS. DISTANT METASTASIS: NOT APPLICABLE. CANCER STAGE: pT1, pNX. 88307. (Electronic Signature). Completed Action I ist. on. Type: Sura Path Final Report. Title: Contributor system:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical. Index. Diagnosis. Lung. 1. Cancer. Lung. Cancer. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. on. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. n/a. Squamous cell carcinoma. 2. 2. 0. 1. none. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. 74. n/a. n/a.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. Left kidney. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left renal mass. GROSS DESCRIPTION. The specimen is received unfixed labeled ""left kidney"" and. consists of a radical nephrectomy specimen measuring 24 x. 14 x 6.5 cm. The kidney itself measures 12 x 11 cm in greatest. cross sectional dimension. On cut section there is a central. yellow. and tan tumor in the kidney. The tumor measures 9.5 x 7.5 by. approximately 4.5 cm. The adrenal gland is present. A portion of. the tumor is taken for research purposes. Sections after fixation. Block summary: 1 - adrenal gland; 2 - margins of resection 3-9 -. tumor and adjacent normal kidney. MICROSCOPIC DESCRIPTION. Tumor type : Clear cell type renal cell carcinoma. Tumor grade. 3 (out of 4; Fuhrman et al. AJSP 6:655,. The tumor is mostly Fuhrman grades 1 and 2,. but grade 3 change is seen in block #6. Tumor size : 9.5 cm. Renal capsule Negative for malignancy. Renal sinus Negative for malignancy. Vascular invasion: Absent. Hilar margins : Negative for malignancy. Kidney away from tumor : Focal chronic interstitial. inflammation. pTNM Stage : T2a. MICROSCOPIC DESCRIPTION. Adrenal gland: Normal. 4. DIAGNOSIS. Kidney and adrenal gland, left, resection: Clear cell type renal cell carcinoma, Fuhrman grade 3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
HISTORY. Frozen section. Right lower and middle lobectomy. (L) nodes hilar. Lung Ca. MACROSCOPIC. Three specimens received: 1: The specimen is received fresh for frozen section and is labelled 'arterial margin' and consists of a. piece of muscular artery wall measuring 15 X 4 X 1 mm. No abnormalities are apparent. [BIT for. frozen section, 1A]. FROZEN SECTION DIAGNOSIS. No evidence of malignancy. Result phoned to. on the. 2: The specimen is labelled 'right lung lower and middle' and consists of the right middle and lower. lobes as stated. The lower lobe measures 155 x 100 x 40 mm and the middle lobe 135 x 90 x 30 mm. There is a stapled resection margin along the middle lobe, 150 mm in length. A rounded endobronchial. tumour plug extends to the bronchial resection margin, however there is no attachment to the bronchial. wall in this region. The pleural surface appears indurated and tethered on the anterior apical part of the. lower lobe over an area approximately 25 x 30 mm. Sectioning reveals a tumour within the apical. segment of the lower lobe measuring 50 x 45 x 45mm with endobronchial extension up to a distance of. 40mm. The entire lesion measuring approximately 75mm in maximal dimension. The endobronchial. plug of tumour extends to involve the proximal portion of the middle lobe bronchus and is focally. tethered to the wall at this point. The alveolated parenchyma of the middle lobe appears clear of. tumour and no tumour is present at the stapled resection margin. The endobronchial plug of tumour. also extends up the bronchus to the bronchial resection margin. However, as mentioned previously the. tumour is not attached to the bronchial wall in this region. A peribronchial lymph node appears to be. involved by tumour, possibly by direct extension. The bronchial and peribronchial resection margins. appear macroscopically clear of the tumour. Localised bronchiectasis is present distal to the. endobronchial tumour plug. [2A, 5 hilar lymph nodes; 2B, bronchial resection margin en face; 2C-D,. LS to inked peribronchial resection margin; 2E, tumour plug; 2F, RS tumour plus at branch of. bronchus intermedius; 2G, RS of attachment of tumour plug; 2H, RS tumour extending into bronchus;. 2I, RS tumour and attachment of tumour plug; 2J, branching of bronchus intermedius with. peribronchial tumour and involved peribronchial lymph nodes; 2K, RS tumour and pleural surface; 2L,. RS lower lobe uninvolved; 2M, RS middle lobe uninvolved]. 3: The specimen is labelled ""No. 7 node' and consists of two pieces of fibrofatty tissue, 35 x 23 x 13. mm and 25 X 24 x 6 mm. Within both pieces of tissue there appears to be a lymph node, 24 mm and 34. mm in maximum extent. [3A-B, first lymph node bisected; 3C-D, second lymph node bisected]. MICROSCOPIC. 1: Paraffin sections confirm the frozen section diagnosis of an elastic walled artery with no evidence of. tumour. 2: Sections reveal a poorly differentiated squamous cell carcinoma involving the apical segment of the. right lower lobe with extensive endobronchial extension. The tumour does not invade the visceral. pleura. The bronchial resection margin is clear of tumour. Tumour extends into peribronchial. connective tissue adjacent to the resection margin but is 0.3mm clear of the peribronchial resection. margin. Within peribronchial connective tissue in this region perineural permeation by tumour is. identified. The involved nerve measures 350um in diameter and in the section examined is 1.3mm. clear of the peribronchial resection margin. Lymphatic invasion is identified. Some small blood. vessels show evidence of recanalisation, however no unequivocal vascular invasion is seen. A. peribronchial lymph node is involved by tumour, possibly by direct extension. Peribronchial lymph. nodes also show evidence of sinus histiocytosis, carbon pigment deposition, fibrosis and scattered. flecks of birefringent material consistent with silicate. Within adjacent lung parenchyma there is. bronchiectasis with mucoid plugging and focal endogenous lipoid pneumonia consistent with. obstructive pneumonitis. The section of right middle lobe alveolated lung parenchyma shows. bronchiectasis with mucoid plugging, however no tumour is identified. Rare mixed duct macules are. present within the remaining alveolated lung parenchyma which is otherwise unremarkable. 3: Sections of the lymph node show reactive changes with sinus histiocytosis, follicular hyperplasia,. carbon pigment deposition, fibrosis and scattered flecks of birefringent material consistent with silicate. No tumour is identified. SUMMARY. 1-3: Right lower and middle lobes, separately submitted No. 7 lymph node: Poorly differentiated squamous cell carcinoma involving the apical segment of the right lower lobe. Tumour size 75mm in maximal dimension. Extensive endobronchial extension by tumour, endobronchial tumour attached at origin of right middle. lobe bronchus (macroscopic finding). Visceral pleura not involved. Resection margins clear of tumour. Perineural permeation by tumour within peribronchial tissue adjacent to margin (see microscopic. description). Lymphatic invasion present. No vascular invasion seen. Peribronchial lymph node involved by tumour, no tumour in separately submitted No. 7 lymph node. Pathological stage: T2 N1. Bronchiectasis and focal endogenous lipoid pneumonia in adjacent lung parenchyma. T-28000 M-80703 P1-03000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
I 22. TISSUES: A. LYMPH NODE. B. LYMPH NODE. C. LUNG-RIGHT UPPER LOBE. D. LYMPH NODE. CODES: P88305 - 88305. p88309 - 88309. P88331 - 88331. D50175 - RESECTION. D50177 - REGIONAL LYMPH. 88305TC - LEVEL IV - GROS. 88309TC - LEVEL VI - GROS. 88331TC - PATHOLOGY CONSU. 88342TC - IMMUNOPEROXIDAS. 1 - SURGICAL SPECIM. T08000 - LYMPH NODE. T28200 - RT UP LOBE LUNG. T282001M81403 - RT UP LOBE LUNG ADENOCARCINOMA,. ICD CODES: 162.9 - MAL NEO BRONCH/LUNG NOS. MARKERS: 88305, 88305TC, 88309, 88309TC, 88331, PATH CONSULT FS, IMMUNOPEROXIDASE, RES, RLN,. CHICATON SDRCIMEN. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY: RT LUNG CA. FINAL DIAGNOSIS. A. RIGHT DIAPHRAGMATIC NODULE, BIOPSY: FIBROADIPOSE TISSUE WITH MESOTHELIAL PROLIFERATION AND CHRONIC. INFLAMMATION. NO MALIGNANCY IS IDENTIFIED. B. LYMPH NODE, RIGHT SUPERIOR HILAR 10R: THREE LYMPH NODES, NEGATIVE FOR TUMOR. C. LUNG, RIGHT UPPER LOBE, LOBECTOMY: MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH FOCAL PAPILLARY. FEATURES, SEE SYNOPTIC REPORT. D. LUNG, RIGHT UPPER NODE: MATTED LYMPH NODE, NEGATIVE FOR TUMOR. E. LYMPH NODE, RIGHT POSTERIOR SUPERIOR HILAR: LYMPH NODE, NEGATIVE FOR TUMOR. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""right. diaphramatic nodule"" and consists of five tan tissue fragments ranging. from 0.2 to 0.3 cm in dimension; submitted 5 (1) labeled ""FSP"" for frozen. section. FROZEN SECTION DIAGNOSIS: Focal cluster of atypical cells of uncertain. nature; ? mesothelial cells, dissimilar to. primary lung adenoca in recent aspiration. B. The specimen is submitted fresh for frozen section as ""right superior. hilar node 10R"" and consists of three red black nodes ranging from 0. to. 1.1 cm in dimension. Each is sectioned and the specimen submitted in. toto, 5 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Negative for tumor. C. The specimen is submitted fresh as ""right upper lobe"" and consists of. a 131 gram (416), 16 x 7 x 3 cm lung lobe. The pleural surface shows a. 2.2 x 2 cm firm puckered indurated area. The pleural surface overlying. this area is inked blue. The pleural surface also shows four ill-defined. tan white firm subpleural nodules measuring 0. to 0.4 cm with the closest. located 6.5 cm from the puckered area. The specimen is received with. multiple stapled margins measuring 3.5 to 7 cm in length along with a. stapled bronchial margin measuring 2.5 cm in diameter and several adjacent. stapled vascular margins measuring 0.2 cm in length x 0.5 cm in diameter. to 0.5 cm in length x 1 cm in diameter. The stapled margins are removed. and the underlying parenchyma inked black. Sectioning reveals a 4.3 x 3 x. 2.2 cm well circumscribed tan yellow to white firm, focally hemorrhagic. mass corresponding to the previous described puckered and indurated area. on the pleural surface grossly appearing to abut the pleural surface. measuring 0. cm from the closest black inked parenchyma underlying the. stapled resection margin and 3 cm from the bronchial margin. The. remaining parenchyma is red to maroon, spongy, homogenous and grossly. unremarkable. No other discrete masses or nodularities are grossly. evident. Also identified at the hilum is a 1 cm in greatest dimension. gray black possible hilar lymph node which is trisected and submitted. entirely. Representative sections are submitted, multiple (7) as follows: Cassette 1: Vasculature and bronchial margins submitted en face. Cassette 2: Subpleural nodules submitted entirely. Cassette 3: Mass with closest pleural surface. Cassette 4: Perpendicular section of mass to the closest stapled. resection margin. GROSS DESCRIPTION. Cassette 5: Additional section of mass with adjacent uninvolved. parenchyma. Cassette 6: Uninvolved parenchyma. Cassette 7: One possible hilar lymph node, trisected. D. The specimen is submitted fresh as ""right upper node"" and consists of. a cluster of multiple gray black to deep red nodules ranging from 0.3 to. 0.7 cm in dimension, the individual nodes separated and the specimen. submitted in toto, multiple (1) -. E. The specimen is submitted fresh as ""right posterior superior hilar. node"" and consists of a single deep red 1. 1 cm nodule, bisected and. submitted in toto, 2 (1). PRIORITY. PRIORITY: FROZEN SEC. SURGICAL PROCEDURES: RESECTION, REGIONAL LYMPH. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. LATERALITY: RIGHT. TUMOR SITE: RIGHT UPPER LOBE. TUMOR SIZE: 4.3 CM. HISTOLOGIC TYPE: ADENOCARCINOMA WITH FOCAL PAPILLARY FEATURES. HISTOLOGIC GRADE: 2 (MODERATELY DIFFERENTIATED). EXTENT OF INVASION: TUMOR INVADES VISCERAL PLEURA. EXTENTION TO PLEURA/OTHER STRUCTURES: NONE IDENTIFIED. MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. SYNOPTIC REPORT. DISTANCE TO PERTINENT MARGIN: 3 CM FROM THE BRONCHIAL MARGIN. VENOUS INVASION: ABSENT. ARTERIAL (LARGE VESSEL) INVASION: ABSENT. LYMPH NODE: N1 - # INVOLVED/# EXAMINED: 0/6. N2 - # INVOLVED/#EXAMINED: 0/8. N3 - # INVOLVED/# EXAMINED: 0/0. OTHER PERTINENT FINDINGS: INCIDENTAL PULMONARY MENINOGOTHELIAL-LIKI NODULES/CHEMODECTOMAS (0.3-. 0.4 CM) THESE ARE PR+, CD56+ AND CHROMOGRANIN-. pTNM STAGE: pT2 NO (AJCC 6TH ADDITION). Unless otherwise specified, the performance characteristics of the. immunoperoxidase stains performed here have been confirmed by the St. These tests have not been cleared or. approved by the U.S. Food and Drug Administration, although such approval. is not necessary. Preli. IMMUNOPEROXIDAS. CLINICAL HISTORY. HISTORY: RUL CAVITARY MASS (2 CM) PICKED UP AS AN INCIDENTAL FINDING ON CT SCAN. RENAL MASS - CRYO ABLATION. X-RAY FINDINGS: 2 CM RUL LUNG MASS. GROSS DESCRIPTION. Slide 40 CC Fluid. X Fresh. Fixed. Type Fix. Volume may reflect total of specimen, fixative, and/or collection fluid. APPEARANCE: X Clear. Cloudy. Foamy. Bloody. Clotted. Tissue. Color COLORLESS. PREP : 6 Smear (s). Diff Quick (s). Filter(s). 1 Cell Block (s). Cytospin (s) - 2 Singles (s). Double (s). H&E. Unstained. Comment: FINAL DIAGNOSIS. LUNG, RIGHT UPPER LOBE, NEEDLE ASPIRATION BIOPSY: POSITIVE FOR MALIGNANT CELLS. - ADENOCARCINOMA CONSISTENT WITH LUNG PRIMARY. COMMENT: THE TUMOR SHOWS GLAND FORMATION AND APPEARS MODERATELY. DIFFERENTIATED. A TTF-1 STAIN IS POSITIVE. THE TUMOR MORPHOLOGY IS DISSIMILAR TO THE TUMOR IN THE KIDNEY. SURGICAL PROCEDURES : REGIONAL LYMPH. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY: NON-SMALL CELL LUNG CA, RIGHT. GROSS DESCRIPTION. A. The specimen is submitted fresh as ""4L left lower paratracheal"" and. consists of three pink to red lymph nodes ranging 0.2 cm to 0.8 cm in. dimension. The largest lymph node is bisected. The specimen is submitted. in toto, 4 (1) The largest lymph node is inked with blue dye. B. The specimen is submitted fresh as ""10L left tracheobronchial angle"". and consists of a 0.6 cm grey black lymph node; bisected and submitted,. 2 (1). C. The specimen is submitted fresh as ""2R right upper paratracheal' and. consists of multiple segments of adipose tissue intermixed with pink to. red possible lymph nodes with aggregate dimension 2 x 1.5 x 0.4 cm with. the lymph nodes measuring up to approximately 0. cm. The specimen is. submitted in toto, multiple (1) . D. The specimen is submitted fresh as ""4R right lower paratracheal"" and. consists of multiple segments of yellow adipose tissue intermixed with. pink to purple tan lymph nodes with aggregate dimension 2.3 x 1.6 X 0.4 cm. with the lymph nodes measuring up to 0.5 cm; submitted, multiple (1). E. The specimen is submitted fresh as ""3A lower pretracheal"" and consists. of multiple segments of yellow adipose tissue intermixed with pink lymph. nodes with aggregate dimension 2 x 1.5 x 0.4 cm with the lymph nodes. measuring up to approximately 0.5 cm; submitted, multiple (1). F. The specimen is submitted fresh as ""7 subcarinal"" and consists of. multiple segments of yellow adipose tissue intermixed with pink to red. lymph nodes with aggregate dimension 2 x 2 x 0.3 cm with the lymph nodes. measuring up to approximately 0. cm; submitted, multiple (1) . GROSS DESCRIPTION. G. The specimen is submitted fresh as ""2L left upper paratracheal"" and. consists of a segment of adipose tissue measuring 1.5 X 1 x 0.2 cm with a. single red to pink elongate lymph node measuring 0.8 cm. The lymph node. is bisected and submitted, 2 (1). FINAL DIAGNOSIS. A. 4L LEFT LOWER PARATRACHEAL: THREE LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR TUMOR. (0/3). B. 10L LEFT TRACHEOBRONCHIAL ANGLE: SINGLE LYMPH NODE SHOWING ANTHRACOSIS; NEGATIVE FOR TUMOR (0/1) . C. 2R RIGHT UPPER PARATRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. D. 4R RIGHT LOWER PARATRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. E. 3A LOWER PRETRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. F. 7 SUBCARINAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. G. 2L LEFT UPPER PARATRACHEAL: SINGLE LYMPH NODE AND ADJACENT ADIPOSE TISSUE, NEGATIVE FOR. TUMOR (0/1) .

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. 5. Examination: Histopathological examination. Material: 1. Total organ resection - rectum and sigmoid colon. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the rectosigmoid junction. Macroscopic description: A 21.3 cm length of the large intestine with mesorectum tissue of 2 cm in thickness. Ulcerous tumour sized 3.3 X 3.4 X. 0.7 cm found in the mucosa, sized 2.6 X 1.8 X 0.6 cm. The lesion surrounds 100% of the intestine circumference. narrowing its lumen, is located 12.7 cm from the proximal incision line and 3.6 cm from the distal incision line. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa telae adiposae mesorecti. Incision lines clear free of neoplastic lesions. Metastases carcinomatosae in lymphonodis (No III / VIII). Histopathological diagnosis: Adenocarcinoma tubulare recti. Tubular adenocarcinoma of the rectum. Metastases carcinomatosae in lymphonodis regionalis. Cancer metastases in regional lymph nodes. (No III/VIII). (G2, Dukes C, Astler-Coller C2, pT3, pNI, RO).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. DIAGNOSIS: Lymph node, level 9, biopsy: Anthracosis. Negative for malignancy (two small lymph nodes). Lymph nodes, level 7, excisional biopsy: Anthracosis and reactive change, two lymph nodes. Both are negative for malignancy. Lung, right lower lobe, wedge resection: Adenocarcinoma, poorly differentiated, with extensive necrosis. Stapled surgical margin is free of malignancy. Malignancy extends to within 0.1 mm of free pleural surface. Malignancy is 1.6 cm in greatest dimension. Definite lymphovascular space invasion is not identified. COMMENTS: The malignancy is poorly differentiated, present in sheets in some areas. Focally, however, definite gland formation is present. The small cell compone. is not identified. The frozen section diagnosis is confirmed. Staging sheet # 22. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: with right lung masses, rule out malignancy. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Level 9 lymph node. B. Level 7 lymph node. C. Right lower lobe lung nodule. SPECIMEN DATA. GROSS DESCRIPTION: is a 0.5 cm soft yellow slightly lobular fragment. It is submitted whole in one cassette. is a 1.1 x 0.6 x 0.2 cm rubbery brown lymph node. It is bisected and entirely submitted in one cassette. and RLL nodule is a 6.3 gram wedge of lung tissue, 4.5 X 1.5 X 0.7 cm. The specimen has been partially sampled for frozen section. The. margin is inked stapled. The pleura is gray and remarkable for an area of firm yellow discoloration and nodularity. The staple is removed, the margin is inked and shaved. Further sectioning reveals a yellow chalky firm nodule, 1.6 x 1.5 x 1.4 cm. The. nodule. is. 0.2. from the shave staple margin and less than 0.1 cm from the inked pleura. The uninvolved tissue is brown and spongy. Representative sections are submitted as follows: 1--frozen section residue; 2 and 3--shave staple margin; 4 to 6--perpendicular sections through lesic. 7--uninvolved tissue. Cassette A research tissue labeled. INTRA-OPERATIVE CONSULTATION:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Right hemicolectomy preparation with a colon and cecal carcinoma characterized. histologically as a moderately differentiated, colorectal adenocarcinoma, measuring. 3 cm. in diameter at the widest point. Invasive spread of the tumor within all intestinal. wall layers. up to the bordering mesocolic fatty tissue. Aborally to Bauhin's valve, ascending colon with a tubular adenoma measuring 2.3 cm. with moderate epithelial dysplasia (synonym: low-grade intraepithelial neoplasia). An isolated section of the appendix displays enduring, slightly florid, chronic. appendicitis. and distinctive, enduring periappendicitis with resorptive xanthous tissue reaction,. clearly. as a result of a tumor-related relocation of the appendix ostium. The subserosa of. the. cecum and the oral section of the ascending colon have evidently progressive and. extensive. macrophage-rich inflammation in the context of perityphlitis. The stage of tumor is therefore: pT3, pNO, (0/40) LO vo; G2 RO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Print Date/Time: Histopathological Examination. Complete: Pre-Op Diagnosis : Right Renal- Mass. Specimens. Kidney, Right. Frozen Diagnosis. : GROSS EXAMINATION. The specimen is received in a container labeled with the. name of the patient and labeled as kidney, right and. adrenal. The specimen consists of a kidney and attached. perinephric fat. The kidney stripped of fat measures 13 X 8. X 5.5 cm and weighs 282 g. The ureter and vascular margins. of resection are submitted in block one. The capsule strips. with ease. The kidney is bivalved and shows an oval golden. yellow mass measuring 5.5 x 4.0 X 4.0 cm. This mass is in. the lower pole of the kidney. The mass does not grossly. involve the capsule. Sections of the capsule are submitted. in block two. Sections of the mass are submitted in blocks. 3-6. The pelvis and calyces are not grossly dilated. The. cortex averages 0.7 cm. There is a cortical cyst measuring. 4 cm. Sections of the cyst are submitted in block 7. A. random section of kidney is submitted in block 8. Sectioning into the attached fat shows an adrenal gland. measuring 7.0 X 2.3 x 0.8 cm. Sections of the adrenal are. submitted in blocks nine and 10. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION: SPECIMEN TYPE: Radical nephrectomy, right kidney. TUMOR SITE: Lower pole. FOCALITY Unifocal. TUMOR SIZE (LARGEST TUMOR IF MULTIPLE) Greatest dimension: 5.5 cm. ADDITIONAL DIMENSIONS: 4.0 X 4.0 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. HISTOLOGIC GRADE (FUHRMAN NUCLEAR GRADE) : Predominant grade. II with a focal area of grade IV (the grade IV component. occupies approximately 5% of the tumor examined.) . THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2. EXTENT OF INVASION. PRIMARY TUMOR (PT) : pT1b: Tumor more than 4 cm, but not more. than 7 cm in greatest dimension, limited to the kidney. REGIONAL LYMPH NODES (PN) : pNX: Cannot be assessed. DISTANT METASTASIS (PM) : pMX: Cannot be assessed. MARGINS : Margins uninvolved by invasive carcinoma. ADRENAL GLAND: Present and uninvolved by tumor. VENOUS (LARGE VESSEL) INVASION (V) : Absent. LYMPHATIC (SMALL VESSEL) INVASION (L) : Absent. ADDITIONAL PATHOLOGIC FINDINGS : Renal cortical cyst. Focal mild chronic interstitial inflammation. [T-71000 M-83103 189.0 P3-44070]. Intradepartmental consultation was obtained. Ptnm: pT1bNXMX. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. Path # : of 2. Visit # :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. Yeast, left, wide local excision No. 1: Infiltrating ductal carcinoma, Nottingham grade II (of III) [tubules 3/3, nuclei 2/3, mitoses. 1/3; Nottingham score 6/9], forming a mass (1.5 x 1.2 x 1.0 cm) [AJCC pTlc]. Ductal carcinoma in situ, intermediate nuclear. grade, solid type comprises approximately 5-25% of the tumor volume. Angiolymphatic invasion is absent. The non-neoplastic. breast parenchyma shows proliferative fibrocystic changes. Biopsy site changes are present. The nipple is unremarkable. All. surgical resection margins, after a single re-excision of the anterior margin and a single re-excision of the inferior margin, are. negative for tumor (minimum tumor free margin, 0.5 cm, anterior inferior margin). Sentinel lymph nodes; left axillary Nos. 1, 2, and 3; sentinel biopsy: Multiple (4) left axillary sentinel lymph nodes are negative. for metastatic carcinoma [AJCC pNO (i-) (sn)]. Immunohistochemical cytokeratin stain was performed on the paraffin embedded. sentinel lymph node tissue and confirms the H&E impression. Blue dye is identified in lymph nodes Nos. 1 and 3. Blue dye is. not present in lymph node No. 2. Lymph node, left axillary, biopsy: A single left axillary lymph node is negative for tumor. Breast, left, excisional biopsy: Fibroadenoma and previous biopsy site changes. Fibrocystic changes are present. Lateral. biopsy. margins are negative for tumor. Seen in consultation with Dr.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) RIGHT EXTENDED MODIFIED RADICAL NECK DISSECTION: METASTATIC MODERATELY DIFFERENTIATED SQUAMOUS CARCINOMA INVOLVING. MATTED MASS OF SUBDIGASTRIC AND UPPER POSTERIOR CERVICAL. LYMPH NODES (5 X 3 X 1.! CM) WITH EXTRACAPSULAR EXTENSION. Thirty-nine cervical lymph nodes; no tumor present (0/4 submental;. 0/7 subdigastric; 0/2 midjugular; 0/9 lower jugular; 0/10 upper. posterior cervical and 0/7 midposterior cervical). (B). LATERAL NASOPHARYNGEAL MARGIN: Squamous and respiratory mucosa, no tumor present. (c). BUCCAL MUCOSA AND RETROMOLAR TRIGONE: Squamous mucosa, no tumor present. LINGUAL, TONGUE, FLOOR OF MOUTH MARGIN: Squamous mucosa, no tumor present. VALLECULA MARGIN: Squamous mucosa, no tumor present. (F). BASE OF TONGUE: Squamous mucosa, lymphoid tissue and salivary gland, no tumor present. LEFT SOFT PALATE: Squamous mucosa, no tumor present. NASOPHARYNGEAL ROOF MARGIN: Squamous mucosa, no tumor present. RIGHT HARD PALATE MARGIN: Squamous mucosa, no tumor present. PARTIAL GLOSSECTOMY, PARTIAL MAXILLECTOMY, PARTIAL PHARYNGECTOMY, TOTAL. PALECTECTOMY - NASOPHARYNGECTOMY: INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CARCINOMA INVOLVING TONGUE,. RIGHT RETROMOLAR TRIGONE, HYPOPHARYNX, UVULA AND SOFT PALATE;. MAXIMUM DEPTH OF INVASION 1.4 CM, FOCAL PERINEURAL INVASION. PRESENT; DEEP MARGIN OF RESECTION FREE OF TUMOR. (SEE COMMENT). (K) TEETH: Fifteen teeth (gross only). COMMENT. The tumor measures 7.0 X 3.5 X 1.4 cm. The matted mass of. subdigastric and upper posterior cervical lymph nodes (5.0 X 3.0 X 0.5 cm). shows 95% replacement by squamous carcinoma with focal extranodal extension. (3-4 mm). SPECIMEN. RIGHT EXTENDED MODIFIED RADICAL NECK DISSECTION. LATERAL NASOPHARYNGEAL MARGIN: BUCCAL MUCOSA AND RETROMOLAR TRIGONE: LINGUAL, TONGUE, FLOOR OF MOUTH MARGIN: VALLECULA MARGIN: BASE OF TONGUE: LEFT SOFT PALATE: NASOPHARYNGEAL ROOF MARGIN: RIGHT HARD PALATE MARGIN: (J) PARTIAL GLOSSECTOMY, PARTIAL MAXILLECTOMY, PARTIAL PHARYNGECTOMY, TOTAL. (K) TEETH:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
INTERPRETATION AND DIAGNOSIS: 1. LUNG, RIGHT UPPER LOBE (LOBECTOMY) : INFILTRATING MODERATELY. DIFFERENTIATED ADENOCARCINOMA (1.7 CM) . THE TUMOR DOES NOT INVADE. THE PLEURA. BRONCHIAL AND VASCULAR MARGINS, NEGATIVE FOR TUMOR. TWO. (2) HILAR LYMPH NODES, NEGATIVE FOR TUMOR. TWO (2) HYALINIZED. PLEURAL PLAQUES IN THE NON-NEOPLASTIC LUNG. SEE NOTE. 2. LYMPH NODE, R4 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 3. LYMPH NODE, R7 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. NOTE: The pathologic stage is T1NoMx. This case was shown at the. Clinical History: LUNG MASS. GROSS DESCRIPTION. PART #1: FS: RIGHT UPPER LOBE. Resident Pathologist: FS: RIGHT UPPER LOBE: INFILTRATING POORLY DIFFERENTIATED CARCINOMA,. FAVOR NON-SMALL CELL. Attending: Pa: The specimen is received fresh labeled. and designated. right upper lobe. It consists of a grossly recognizable lobectomy. specimen weighing 180 gms, and measuring 17.7 x 9 x 2.4 cm. There is. a firm nodule palpable in the medial portion of the lower lobe. The. pleura superficial to the area is inked black. On cut section, there. is a firm tan gray nodule measuring 1.5 x 1.3 x 1.7 cm. The tumor. approaches the inked pleural margin. The nodule measures 3.2 cm from. the hilar structures, and 6.5 cm from the stapled margin. A portion. of this nodule is submitted for frozen section diagnosis. There is a. row of staples in the superior portion of the lung at the hilum. This. row of staples measures 3.5 cm in length. The staples are removed,. and the underlying pulmonary parenchyma is inked blue. There is. a. white circular nodule on the lateral pleural surface measuring 0.4 cm. in maximum dimension. This nodule is located 6 cm from the apex and. approximately 4 cm from the hilar structures. On cut section, the. nodule is firm and gray-white in color. There is a second nodule on. the lateral pleural surface approximately 4 cm from the inferior. portion of the specimen. This nodule measures 0.7 cm in maximum. dimension. It measures approximately 7 cm from the hilar structures. On cut section, the remainder of the non-neoplastic lung is tan red. brown and spongy with focal anthracotic pigmentation. No other. lesions are identified. A portion of the tumor is harvested for. tissue banking purposes. Representative sections of the tumor and. non-neoplastic lung are submitted. SUMMARY OF SECTION: 1. - FSC. -1. (TUMOR). 1. - A. M. (VASCULAR AND BRONCHIAL MARGINS). 1. - B. - 2 (HILAR LYMPH NODE). 1. - C. - 2. (HILAR LYMPH NODES). 3. -D-F. - 1 EA. (TUMOR). 1. -G. - 2. (SUPERIOR PLEURAL NODULE). 1. -H. - 1. (INFERIOR PLEURAL NODULE). 3. - I-K. - 1 EA. (REPRESENTATIVE NON-NEOPLASTIC LUNG). 12. - TOTAL. - M. PART #2: : R-4. Resident Pathologist: The specimen is received in formalin labeled. and. designated R-4 lymph node. It consists of one piece of tan pink. fibroadipose tissue measuring 1.2 x 0.5 x 0.5 cm. On cut section, the. specimen is consistent with an anthracotic lymph node. The specimen. is submitted in its entirety. SUMMARY OF SECTIONS. 1. A. - 2. - TOTAL - 2. PART #3 R-7. Resident Pathologist : The specimen is received in formalin labeled. and. designated R-7 lymph node. It consists of one piece of tan pink. tissue with anthracotic pigmentation measuring 1 x 0.5 x 0.5 cm. On cut section, the specimen is consistent with an anthracotic lymph. node. The specimen is submitted in its entirety. SUMMARY OF SECTIONS : 1. - A. 2. - TOTAL- 2. printed. INTTERPRETATION AND DIAGNOSIS: 1). #1 (PROSTATE BX,. 2) MINUTE FOCUS OF ADENOCARCINOMA OF THE PROSTATE, GLEASON GRADE. 3+3=6. SEE NOTE. NOTE: The diagnosis of carcinoma is supported by the failure of. immunoperoxidase staining for high molecular weight cytokeratin to. demonstrate basal cells in the atypical glands. Signed copy on file. GROSS DESCRIPTION. PART #1: PROSTATE. Resident Pathologist: Received 4 slides. printed.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL DIAGNOSIS: HCC. Specimen : HCC. Gross Photo : GROSS: Specimen: Liver: 7.6 x 7.0 X 3.2 cm, unfixed. Gallbladder: 5.8 cm in length and 3.6 cm in diameter, stone (3.2 cm in diameter). Tumor location: Center of the specimen. Tumor number: One. Tumor size: 2.8 X 2.5 X 2.3 cm. Satellite nodule: No. Gross type. HCC: Expanding nodular. Tumor necrosis: Yes (20 %). Hemorrhage/peliosis: No. Portal vein invasion: Unknown. Bile duct invasion: Unknown. Peritumoral cirrhosis, micronodular. Gross photo present. Blocks. T1-4 and TB, mass and surrounding tissue X 5. RM, mass and resection margin X 1. A and NB, remaining liver x 2. GB, gallbladder X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma, trabecular and solid. Differentiation, II-III. Fibrous capsule formation: Yes. Surgical resection margin invasion: Free of tumor. Non-tumor liver pathology. Chronic hepatitis: Yes. Etiology: HBV. Grade, lobular: Minimal (grade 1). Grade, portoperiportal: Minimal (grade 1). Stage (fibrosis): Septal fibrosis (stage 3). Dysplastic nodule: No. Ductal epithelial dysplasia: No. Other liver diseases: Steatosis, moderate. NOT reported. Gross: Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. Gallbladder, ectomy, chronic inflammation, cholelithiasis. T57000, P10, M43000, M30011. DIAGNOSIS: Liver, segment 8, subsegmentectomy: Hepatocellular carcinoma, moderately differentiated. Gallbladder, cholecystectomy: Inflammation, chronic. Cholelithiasis. Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
M. (174.0cm . 74.8kg BSA: 1.9mÂ². MODIFIED REPORT REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) LEFT NECK DISSECTION, LEVEL 2A: Twelve lymph nodes, negative for tumor (0/12). (B) LEFT NECK DISSECTION, LEVEL 2B: Fibroadipose tissue without lymphoid tissue, negative for tumor. (C) LEFT NECK DISSECTION. LEVEL 3: Seven lymph nodes. negative for tumor(0/7). (D) LEFT NECK DISSECTION, LEVEL 4: Eight lymph nodes, negative for tumor(0/8). (E) LATERAL DEEP MARGIN: Fibroadipose tissue and skeletal muscle, negative for tumor. (F) MASSETER MARGIN: Skeletal muscle. negative for tumor. (G) ANTERIOR SUBLINGUAL MARGIN: Fibroadipose tissue and minor salivary gland, negative for tumor,. (H) ANTERIOR ALVEOLAR NERVE: Nerve, negative for tumor. (I) RETROMOLAR TRIGONE, DEEP MARGIN: Squamous mucosa with lymphoid stroma, negative for tumor. (J) POSTERIOR BUCCAL MARGIN: Ulcerated mucosa with fordyce granules negative for tumor. (K) POSTERIOR FLOOR OF MOUTH. MARGIN: Squamous mucosa, negative for tumor. (L) COMPOSITE RESECTION LEFT MANDIBLE. BUCCAL. FOM: INVASIVE SQUAMOUS CARCINOMA -- Well differentiated. Tumor Features: Gross: Exophytic. Size: 5.0 cm in largest dimension. Invasion: Present, depth at least 1.5 cm. Tumor Border: Infiltrative with thick cords > 4 cells. Perineural Invasion: final evaluation pending decalcification sections. Vascular Invasion: Absent. Bone / Cartilage Invasion: Pending Decalcification (see addendum). Three lymph nodes. negative for tumor (0/3). (M) TEETH: Teeth, gross only. Page: L. 74.8kg BSA: 1.9m. Specimen Date/Tice: GROSS DESCRIPTION. (A) LEFT NECK DISSECTION, LEVEL 2A - Received is a 4.0 X 2.2 x 1.0 cm fragment of fibroadipose tissue from which 14. possible lymph nodes are identified. ranging in size from 0.3 to 1.2 cm. SECTION CODE: A1, five possible lymph nodes; A2, five possible lymph nodes; A3, four lymph nodes. (B) LEFT NECK DISSECTION, LEVEL 28 - Received is a 3.0 x 1.5 x 0.3 cm fragment of fibroadipose tissue from in which no. definite lymph nodes are identified. SECTION CODE: B1, B2, tissue, entirely submitted. (C) LEFT NECK DISSECTION, LEVEL 3 - Received is a 3.3 X 3.3 x 1.0 cm fragment of adipose tissue from which seven possible. lymph nodes are identified ranging in size from 0.5 to 1.3 cm. SECTION CODE: C1, one lymph node; C2, five possible lymph nodes; C3, one lymph node. (D) LEFT NECK DISSECTION, LEVEL 4 - Received is a 4.0 x 2.8 X 0.8 cm fragment of adipose tissue from which eight possible. lymph nodes are identified, ranging in size from 0.3 to 2.0 cm. SECTION CODE: D1, one lymph node, bisected; D2, four possible lymph nodes; D3, three lymph nodes. (E) LATERAL DEEP MARGIN, TRUE MARGIN INKED, STITCH ANTERIOR - Received is a 2.9 x 1.2 X 0.3 cm fragment. of. fibroadipose tissue with ink on one side and a stitch marking anterior aspect. The true margin is inked black and the anterior. aspect is inked yellow, posterior aspect is inked green and the specimen is serially sectioned and entirely submitted in E1 and E2. for frozen section evaluation. INK CODE: True margin - blue, anterior - yellow, posterior - green. FS/DX: MARGIN NEGATIVE FOR CARCINOMA. (F) MASSETER MARGIN - Received is a fragment of muscle tissue measuring 1.3 X 1.1 x 0,5 cm, with cattery on one side. SECTION CODE: F1, entirely submitted for frozen section evaluation. FS/DX: NEGATIVE FOR CARCINOMA. (G) ANTERIOR SUBLINGUAL MARGIN - Received is a fragment of fibroadipose tissue measuring (0.9 x 0.6 X 0.3 cm). Submitted entirely for frozen section in G1. FS/DX: NEGATIVE FOR CARCINOMA. (H) ANTERIOR ALVEOLAR NERVE - Received are two fragments of pate-pink glistening firm tissue measuring 1.0 x 0.5 x 0.3. cm in aggregate. Entirely submitted for frozen section evaluation in H1. FS/DX: NEGATIVE FOR CARCINOMA. (I) RETROMOLAR TRIGONE, DEEP MARGIN. TRUE MARGIN INKED - A fragment of mucosa (1.4 X 0.6 x 0.6 cm) One surface. shows smooth glistening mucosa with a faint surgeon's ink. The mucosa is reinked black and the specimen is submitted entirely. for frozen section examination in block 11. FS/DX: NEGATIVE FOR CARCINOMA. (J) POSTERIOR BUCCAL MARGIN, INK AT TRUE MARGIN - A segment of mucosa (1.2 x 0,3 X 0.3 cm). One surface of the. mucosa shows stained surgeon's ink. The specimen is submitted entirely for frozen section examination in block J1. FS/DX: NEGATIVE FOR CARCINOMA. (K) POSTERIOR FLOOR OF MOUTH MARGIN, TRUE MARGIN INKED - A fragment of mucosa (1.6 X 0.3 x 0.3 cm). One. surface of the mucosa bears faint surgeon's ink that is reinked black and submitted entirely for frozen in K1. FS/DX: NEGATIVE FOR CARCINOMA. (L) COMPOSITE RESECTION LEFT MANDIBLE. BUCCAL, FOM - A composite resection consists of a segment of mandible,. portion of buccal mucosa and portion of the floor of mouth, overall 9.5 X 4 x 4 cm. An ulcerated lesion (2.8 X 2.5x 1 5 cm) is in the. floor of mouth however corresponds to a larger lesion extending to involve the gingival and buccal surface (~5.0 cm maximum. dimension. The surface of the mandible appears eroded. The lesion is about 0.5 cm to the closest soft tissue margin. Multiple. lymph nodes are identified. Soft tissue is entirely submitted in L1 - L10. The mandible is submitted to bone lab for further. processing. Both tumor and normal tissue were submitted to tissue bank. (M) TEETH, GROSS ONLY - Multiple pale-gray teeth (7.0 X 1.5 X 1.2 cm in aggregate) Gross ID only. CLINICAL HISTORY. SNOMED CODES. T-51200, M-80703. Gome rests reported here may have been developed and performance characteristica determined by. These tests have nct been. Page: 3. (174.00m 74.3kg BSA: 1.9m. Spectmen Date/Tire: specifically cleared or approved by the U.S. Food and Drug Administration 24. Entire report and diagnosis completed by: Start of ADDENDUM. Page: 1. (1.74.00m 71.8kg BSA: Specimen Dace/Time: ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (L) COMPOSITE RESECTION LEFT MANDIBLE, BUCCAL AND FOM. SQUAMOUS CARCINOMA.involving bone. Anterior mandible margin, en face: Negative for tumor. GROSS DESCRIPTION. (L) COMPOSITE RESECTION LEFT MANDIBLE, BUCCAL AND FOM - The bone is serially sectioned and lesion extends to a. depth of 0.7 cm and grossly abutts the nerve. The mandible margin is grossly uninvolved. SECTION CODE: L11, anterior mandible margin, bisected and en face; L12, L13, representatives of lesion involving bone. and nerve. L11-L13 submitted after decalcification. Entire report and diagnosis completed by: END OF REPORT-.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure: Diagnosis. A. Lung, right upper lobe with adjacent chest wall, en bloc resection: Invasive poorly differentiated adenocarcinoma extending into the soft. tissues of the chest wall. The radial, vascular and bronchial margins of resection are free of. tumor. Apical emphysematous changes. Benign pleural plaque. 4 hilar lymph nodes negative for metastatic carcinoma (0/4) . Nonnecrotizing granulomatous lymphadenitis; special stains for. acid-fast and fungal organisms. are both negative. B. Rib, third, medial margin: Negative for malignancy. C. Lymph nodes, part of 4R, resection: Nonnecrotizing granulomatous lymphadenitis; negative for malignancy. D. Lymph node, level X, resection: Nonnecrotizing granulomatous lymphadenitis; negative for malignancy. E. Lymph node, level XI, resection: Nonnecrotizing granulomatous lymphadenitis; negative for malignancy. F. Rib, fourth, medial margin: Negative for malignancy. G. Lymph node, 2R, resection: Nonnecrotizing granulomatous lymphadenitis; negative for malignancy. H. Lymph node, level IX, resection: Nonnecrotizing granulomatous lymphadenitis; negative for malignancy. I. Lymph node, level VII, resection: Nonnecrotizing granulomatous lymphadenitis; negative for malignancy. Microscopic Description: Sections of the lung tumor reveals a poorly differentiated. non-small cell carcinoma. The tumor does not have any well formed. glands or areas of keratinization. Immunohistochemistry reveals. positive staining for both CEA and TTF-1 with a negative result for CK. 5/6 and P63. This pattern of staining is indicative of a. adenocarcinoma. Results of the resection as summarized in the. following template -. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : Tumor has extended from the lung through the chest. wall into the soft tissue adjacent to ribs (pT3) . Margins of resection: Negative. Direct extension of tumor: Direct extension into the chest wall is. present. Venous (large vessel) invasion: Positive. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : All of the hilar lymph nodes and sampled. mediastinal lymph nodes are negative for metastatic carcinoma (pNO). Distant metastasis (pM) : pMx. Other findings: All the lymph nodes containing non-necrotizing. granulomatous lymphadenitis. Special stains for acid-fast and fungal. organisms are both negative. Specimen. A. Right upper lobe with chest wall. B. 3rd rib margin medial. C. Part of 4R. D. level X nodes. E. Level XI. F. 4th rib medial margin. G. 2R. H. Level 9. I. Level 7. Clinical Information. Lung mass. Intraoperative Consultation. lobe - Poorly differentiated non-small carcinoma. Gross Description. A. Received fresh labeled ""right upper lobe with chest wall"" is a 308. g, 18.0 X 11.0 X 4.5 cm lobectomy specimen with attached 1.5 cm in. length, 1.5 X 1.5 cm in diameter bronchial stump. Several soft. gray-black perihilar lymph nodes measuring up to 2.4 cm are recovered. A 19 cm staple line traverses the pleura (subsequently removed) . Three. ribs spanning an area of 9.8 X 5.8 cm are present along one aspect. The pleura is smooth to scaberous tan red with a subjacent induration. adjacent to the adherent ribs. The pleura overlying the induration is. inked orange. The external surface of the ribs is inked blue. On. sectioning, there is a 5.5 X 4.7 X 3.5 cm rubbery tan-white to. gray-black tumor mass subjacent to the adherent ribs. The tumor. appears to extend into the intercostal muscles and to within 0.1 cm of. the inked pleural surface. A portion of tumor and a portion of normal. parenchyma are submitted for tissue procurement as requested. The. remaining parenchyma is spongy form tan-red without additional mass. lesion. Diffuse crepitance is present in the vicinity of the tumor. mass. In addition, a rubbery 1.4 cm greatest imension tan-white. nodule is noted within the adherent pleura. Summary: 1 - bronchial margin, 2 - vascular gins, 3 and 4 - tumor. to. inked pleural surface, 5 and 6 - tumor to intercostal muscle, 7 and 8 -. random tumor, 9 - random parenchyma, 10 - bisected pleural nodule,. early 11 - 4 hilar lymph nodes, 12 and 13 - bisected largest hilar. lymph node, 14 through 18 - tumor to rib following fixation and. alcification. B. Received fresh labeled ""3rd rib margin medial"" is an irregular, 1.9. X 1.4 X 1.0 cm portion of focally fragmented hard tan-white bone with a. scant amount of associated soft tissue. The specimen is inked,. sectioned, and entirely submitted in one block following fixation and. decalcification. C. Received fresh labeled ""part of 4R"" is slightly fragmented 0.6 cm. greatest dimension soft tan-gray tissue. D. Received fresh labeled ""level X nodes"" are 4 ft tan-gray tissues. ranging from 0.4-0.8 cm in greatest dimension. E. Received fresh labeled ""level XI"" is a 0.7 X 0.5 X 0.4 cm soft. tan-gray tissue which is bisected and entirely submitted in one block. F. Received fresh labeled ""4th rib medial margin"" is an irregular,. slightly fragmented, 1.5 X 1.3 X 0.5 cm hard tan-white portion of bone. The specimen is inked, sectioned, and entirely submitted in one block. following fixation and decalcification. G. Received fresh labeled ""2R"" are 3 so an-gray tissues ranging. from 0.3-1.2 cm in greatest dimension. Summary: 1 - 2 tissues, 2 - bisected lary. tissue. H. Received fresh labeled ""level IX"" is an irregular 1.3 X 0.3 X 0.2. cm soft tan-gray tissue which is submitted in toto in one block. I. Received fresh labeled ""level VII"" are 2 soft tan-gray tissues. averaging 1. cm in greatest dimension. The specimens are bisected and. irely submitted independently in 2 blocks.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN TAKEN: FINAL DIAGNOSIS. 2. THYROID: SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Right lobe. HISTOLOGIC TYPE: Papillary carcinoma, follicular variant. TUMOR SIZE: Greatest dimension: 1.0 cm. FOCALITY: Multifocal (1 additional 0.3 cm focus, also in the right lobe). LYMPH NODES: Both (2) lymph nodes negative for tumor. EXTENT OF INVASION. PRIMARY TUMOR: pT1: tumor size <2 cm, limited to thyroid. REGIONAL LYMPH NODES: pNO: No regional lymph node metastasis. DISTANT METASTASIS: pMX: Cannot be assessed. MARGINS: Margins are uninvolved. VENOUS/LYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Nodular hyperplasia and chronic lymphocytic thyroiditis consistent with nodular. Hashimoto's thyroiditis. NOTE: This case was reviewed at the. Dr. ,. was present and he concurs with the above diagnosis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical History/Diagnosis: Left renal mass. Source of Specimen(s): 1: Para aortic Lymph Node. 2: Kidney resection with Adrenal gland. Gross Description: Received in two parts. Source of tissue: 1. Labeled #1, ""para-aortic lymph nodes"". Gross Description: Received fresh labeled. para-aortic lymph nodes"" consists of multiple soft yellow-tan irregular. fibrofatty tissue fragments measuring 5.5 x 4.5 x 2 cm in aggregate. The. specimen is sectioned to reveal multiple soft to firm lymph nodes. measuring from 0.3 up to 2.2 cm in greatest dimension. The lymph nodes. are entirely submitted in 1A-1D. Designation of Sections: 1A one bisected lymph nodes. 1B-1D multiple. additional lymph nodes. Source of tissue: 2. Labeled #2, ""left kidney"". Gross Description: Received fresh labeled,. left kidney"" consists of a kidney with surrounding perinephric fat. weighing 1,080 grams and measuring 22 x 18 x 9.5 cm. The attached ureter. measures 11.5 cm in length and 0.3 cm in diameter. The ureter is. sectioned to show a homogeneous, soft tan-pink smooth mucosal lining with. no ulcerations or polyps present. The specimen is bisected to show a 12.5. X 8.5 x 6 cm kidney. A 7.5 x 6.5: x 5 cm ill-defined variegated midpole. mass is identified at approximately 0.5 cm from the closest superior pole. capsule. The mass also obliterates approximately 90% of the renal pelvis. Representative sections are submitted in 2A-2I. Designation of Sections: 2A ureteral and vascular margins. 2B-2D tumor. closest to capsule. 2E-2F tumor with adjacent uninvolved parenchyma. 2G-2I tumor with surrounding fat margin inked black. Final Diagnosis: 1. Paraaortic lymph nodes, excision: - Thirty-three lymph nodes with no tumor seen, (0/33). 2. Left kidney, nephrectomy: - Papillary renal cell carcinoma, type 2, (7.5 cm); definitive extrarenal. extension not seen. - Vascular and ureteral margins with no tumor seen. (pT2NOMx). Procedures/Addenda. FC Cytogenetics Solid Tumor. Results-Comments. CYTOGENETIC ANALYSIS REPORTS. DIAGNOSIS: Left Renal Mass. KARYOTYPE: Abnormal mosaic. karyotype: 45,X,-Y[3]/45. 9,XY,+7[cp5]/46,XY[15]. RESULTS: The renal mass was harvested after eight and ten days in. culture. The chromosomes from 23 metaphases were counted and analyzed,. and four of these metaphases were karyotyped by G-banding. Three cells. had a modal chromosome number of 45 and were missing the Y chromosome. Five cells had a modal chromosome number of 47 and contained an extra copy. of chromosome 7. Fifteen cells had a modal chromosome number of 46 and. appeared to have a normal karyotype. Procedures/Addenda. Addendum Date Ordered: Addendum Diagnosis. The nuclear grade of the tumor is equivalent to Fuhrman grade 3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
printed. Clinical Consultant & Location. Forenan. Unit No. SPECIMEN. Enucleated left eye. CLINICAL DETAILS. Suspected choroidal melanoma. MACROSCOPIC DESCRIPTION. A left eye. Dimensions: Axial 24mm, Horizontal 23mm, Vertical 23mm. Cornea: Horizontal 12mm, Vertical 12mm. Description: clear. Optic nerve. Length 12mm, Diameter 4mm. Anterior chamber: normal depth. On rans-illumination, a shadow located superiorly measuring. 19 x 18mm. Plane of section: vertical. Intraocular description: On opening he eye a large pigmented choroidal melanoma. measuring 16mm LBD x 12mm in height. Tumour size. BD 16mm, Height 12mm. MICROSCOPY. Histologically, the enucleated eye demonstrates a normal. anterior segment with an unremarkable cornea, a deep. anterior chamber and open angles. The iris leaves are. unremarkable. The ciliary muscles are moderately atrophic. and there is moderate hyalinisation of the ciliary. processes. The lens shows advanced cataractous changes. In the posterior third of the posterior segment, a choroidal. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. melanoma can be seen. This is dome-shaped with a large. accompanying exudative retinal detachment. The retina. overlying the tumour is atrophic with degenerative changes. The tumour is pigmented and consists of a mixture of cells,. both epithelioid and spindle cells, with a dominance of the. latter. The epithelioid cell component represents 15% of the. tumour cell population. The melanoma cells are immunoreactive. for MelanA and HSP-27 (score 2). The number of mitoses is high approx. 12/40 high power. fields. The microvasculature of the melanoma is prominent, and. closed loops are focally present. Occasional ""vascular. lakes"" can be observed; in these tumour cells can be see. located within the lumen. The lymphocytic infiltrate within tumour is minimal. Macrophages are scattered throughout the tumour in a. moderately density There is no evidence of scleral invasion. or of extraocular growth. The optic nerve is tumour free,. and demonstrates mild atrophic changes. The examined vortex. veins are free of tumour. DIAGNOSI9. Choroid melanoma of mixed cell type. COMMENT. SPECIMEN. 2= Eye. TUMOUR PRESENT. TUMOUR TYPE. 1= Melanoma. CELL TYPE. 3= Mixed. CT LOOPS. 2= Closed loops. NECROSIS. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. PIGMENTATION. LYMPHOCYTIC INFILTRATION. MITOTIC FREQUENCY. 12 /40 HPF. DIFFUSE MELANOMA. SPREAD. 1= No. CLEARANCE. 2= Adequate. HSP-27 POSITIVITY. 2= 21 -70%. LARGE DIAMETER. 16 mm. THICKNESS. 12 mm. COMMENTS: Molecular genetic examination of DNA extracted from the. tumour cells will be performed using multiplex-ligation. dependent probe amplification (MLPA), looking at chromosomes. 1, 3, 6 and 8. A supplementary report will follow as soon as. these investigations are complete. SUPPLEMENTARY REPORT. In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) These investigations were. performed in the. The kit P027 from. which examines for gains or. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. In summary, sequence analysis demonstrated: normal. chromosome 1, monosomy 3, normal chromosome 6 and gains in. chromosome 8. These molecular data require correlation with the clinical. and morphological data for metastatic risk assessment.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
REVIOUS DIAGNOSIS INQUIRY. 2. SEX: F. - adenocarinoma, NOS 8140/3. PROCEDURE: SPHS. Poorty-differentiated adenocarcinoma with extensive necrosis. Clinical. Diagnosis: Esophageal cancer. Operative Procedure: PROCEDURE: SPGD. 1. ""Proximal stomach distal esophagus"". Received in formalin in a large. container is a 6.5 cm long distal esophagus with a 6.5 x 4.2 x 1.3 cm attached. proximal stomach. The adventitia is ragged. The mucosa of the esophagus is. gray-white and prominently folded. The mucosa of the stomach is tan and. rugated. The esophageal mucosa is remarkable for a 4.2 x 3.3 x 1.3 cm gray-tan. necrotic Lesion that is located at the esophageal gastric junction however the. mid point of the tumor is 1.5 cm above the esophageal gastric junction. The. tumor is 4.1 cm away the proximal margin of resection and 2.2 cm away from the. gastric margin of resection. The tumor has a maximum depth of 0.3 cm and. extends to the muscularis, The tumor is friable and mostly necrotic. Multiple. possible lymph nodes are identified ranging up to 1.2 cm. The cut surface of. the largest is gray-white. No other abnormalities are noted. 1A. Tumor to adjacent proximal normal. 1B. Tumor to adjacent distal. 16 Tumer to deepr. 1E and F. Additional esophageal gastric junction. 1G. Multiple possible Lymph nodes. 1H and 1. One bisected lymph node. each). 2. ""Lesser curvature"". Received in format in in a small container is a 3.7 x. 3.2 x 1.1 cm irregular portion of yellow fibroadipose tissue. Two possible. lymph nodes are identified, 0.7 and 1.1 cm. 2A and B. One bisected tymph node each. Fat retained. 3. ""Lesser curvature gastric node"". Received in formalin in a small container. is a 1.3 cm possible lymph node. Bisected. 4. ""Celiac node"". Received in formalin in a small container is a 1.1 cm. PREVIOUS DIAGNOSIS INQUIRY. 3. SEX: F. possible lymph node. Bisected. 5. ""Cervical esophago-gastric margin"". Received in formalir in a small. container is a 1.1 cm long segment of esophagus that is 2.2 cm in diameter. Staple line is present on one aspect with the other being left open. Tissue is. removed from the staple line. Staple line retained. PROCEDURE: SPM!. GASTROESOPHAGEAL JUNCTION. Gastroesophageal junction. SIZE: 4.2 cm. TYPE OF CARCINOMA: Adenocarcinoma not arising in Barrett's mucosa. DEPTH OF INVASION: Muscutaris propria. NUMBER OF POSITIVE LYMPH NOOES / TOTAL NUMBER OF NODES EXAMINED: 1/13. DISTANT METASTASIS: Unknown. RESECTION MARGIN INVOLVED: No. T2 N1. PROCEDURE: SPDX. 1&5. Distal esophagus and proximal stomach, resection: Invasive,. peen. the. gestroesephegee+. junction. and invading into the muscularis propria (4.2 cm). No intestinal metaplasia. No vascular invasion. Margins negative. Metastatic carcinoma in one of nine. Lymph nodes (1/9). 2. Lymph nodes, lesser curvature of stomach, excision: Two lymph nodes. negative for neoplasm (0/2). 3. Lymph node, lesser curvature of stomach, excision: One lymph node negative. for neoplasm (0/1). PREVIOUS DIAGNOSIS INQUIRY. 4. SEX: F. 4. Lymph node, celiac, excision: One tymph node negative for neoplasm (0/1). the signing staff pathologist, have personally. examined and interpreted the slides from this case. ENO OF PREVIOUS DIAGNOSIS INQUIRY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. A. LYMPH NODE, HEPATIC ARTERY, EXCISION: One lymph node, negative for metastatic carcinoma (0/1). B. PANCREAS AND SPLEEN, SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic endocrine neoplasm, grade 2. Tumor size: 3 x 2.5: cm. Surgical margins: Free of tumor. Necrosis: present. Mitotic rate: 7/10 HPFs. Fifteen regional lymph nodes with no evidence of metastasis. Unremarkable spleen. See Key Pathological Findings. C. ACCESSORY SPLEEN, ""SPLENULE"", EXCISION: Unremarkable splenic parenchyma. D. GALLBLADDER, CHOLECYSTECTOMY: Chronic cholecystitis and cholesterolosis. No evidence of dysplasia or malignancy. I,. the attending pathologiat, personally reviewed all. aliues and / or materials and rendered the final diagnosis. Electronically. Key Pathological Findings. B: Pancreas Endocrine. SPECIMEN: Tail of pancreas. Spleen. SPECIMEN: Splenectomy. TUMOR SITE: Pancreatic fail. TUMOR SIZE: Greatest dimension: 3.0 cm. Additional dimensions: 2.5x2.0 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Well-differentiated neuroendocrine tumor. WORLD HEALTH ORGANIZATION CLASSIFICATION: Well-differentiated endocrine tumor, uncertain behavior. FUNCTIONAL TYPE: Cannot be assessed. MITOTIC ACTIVITY: Greater than or equal to 2 mitoses/10 HPF to 10 mitoses/10 HPF; number of mitoses per 10. HPF: 7 mitoses / 10 high power fields. Ki67 LABELING INDEX: 3%-20% Ki67-positive cells. TUMOR NECROSIS: Present. MICROSCOPIC TUMOR EXTENSION: Tumor is confined to pancreas. MARGINS: Margina uninvolved by tumor. Distance of tumor from closest margin: 0.2 mm. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT): pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional fymph node metastasis. Number examined: 16. Number involved: 0. DISTANT METASTASIS. ADDITIONAL PATHOLOGIC FINDINGS: PANIN lla. ANCILLARY STUDIES: The neoplastic cells are positive for synaptophysin, focally positive for chromogranin by. immunohistochemistry. The Ki-67 immunostain is positive in approximately 15% of the. neoplastic cells. COMMENT(S). B2-7 adequate for molecular studies. Specimen(s) Received. A. HEPATIC ARTERY LYMPH NODE. B. SUBTOTAL PANCREATECTOMY AND SPLENECTOMY FS. C. SPLENULE. D. GALLBLADDER GROSSLY CHECK FOR POLYP. Clinical History. Y/O FEMALE MORBID OBESITY, HM-ASTHMA. Preoperative Diagnosis. PANCREATIC NEUROENDOCRINE TUMOR. Intraoperative Consultation. FSB1 SUBTOTAL PANCREATECTOMY AND SPLENECTOMY: Pancreatic margin, no evidence of malignancy. GROSS EXAMINATION. D. GALLBLADDER GROSSLY CHECK FOR POLYP: Partially calcified mucosal polyps, measuring 3 mm to 5 mm. FSD1 GALLBLADDER GROSSLY CHECK FOR POLYP: Largest polyp no evidence of malignancy. Intradepartmental Consultation: The case was also reviewed by. MD, who concurs. with the above interpretation (FSD1). Comment: These frozen section diagnoses/results were communicated to and acknowledged by Dr. I.D., have performed the intraoperative consultations and issued the above. diagnosis. Gross Description. A. Specimen A is received fresh labeled ""hepatic artery lymph node."" The specimen consists of. a 2.0 x 1.5 x 1.0, moderately firm gray tan irregular lymph node which is serially sectioned and entirely. submitted as A1-A2. B. Specimen B is received fresh for frozen section analysis labeled ""subtotal pancreatectomy and. spienectomy."" The specimen consists of a subtotal pancreatectomy (8.0 x 4.0 x 2.5 cm) attached to a. grossly unremarkable spleen (14.0 x 8.0 x 6.0 cm). Both specimens are adherent to a moderate. amount of fat. The pancreatic margin of resection is stapled. The staples are removed and the. underlying tissue is removed tangentially and entirely submitted on frozen section as FSB1. The. pancreatic duct is markedly dilated but is probe-patent for approximately 2 cm where it is filled with. a. soft brown tan protruding tissue (possible tumor). The end of the pancreas which attaches to the. spleen is markedly indurated and exhibits a gray white smooth ill-defined mass (3.0 x 2.5 x 2.0 cm). abutting the soft tissue margin of resection and is approximately 4 cm from the pancreatic margin of. resection. The mass at this point totally occludes the pancreatic duct. The mass occupies. approximately 75% of the pancreas. The random pancreatic parenchyma is lobulated gray tan grossly. unremarkable. The capsule of the spleen is brown tan and intact. The cut surface exhibits a soft red brown tissue. with grossly unremarkable parenchyma. Sectioning of the adipose tissue isolates no definitive fymph. nodes. A representative section of the tumor is submitted to Tissue Procurement Laboratory. Representative sections are submitted as: B2: Mirror image of tumor submitted to Tissue Bank. B3-B6: Sections of tumor showing relationship to soft tissue margin of resection. B7-B8: Sections of tumor showing relationship to pancreatic duct. B9: Grossly unremarkable pancreatic parenchyma. B10: Grossly unremarkable spleen. B11-B26: Representative sections of adipose tissue. c. Specimen C is received fresh labeled ""splenule."" The specimen consists of what grossly. appears to be a lobule of spienic tissue partially covered by adipose tissue (2.5 x 2.0 x 2.0 cm). The. overlying adipose tissue is marked with black ink. The specimen is serially sectioned and reveals a. red brown grossly unremarkable splenic parenchyma. Representative sections submitted as C1. D. Specimen D is received fresh for frozen section analysis labeled ""gallbladder grossly check for. polyps. The specimen consists of a club-shaped gallbladder (8.0 x 3.0 x 1.5 cm). Te external surface. is green yellow, wrinkled with a small amount of attached fibroadipose tissue. The lumen is filled with. a. green vicile bile. No calculi grossly appreciated. There are several adherent soft lesions (possible. polyps) ranging from 0.2 cm to 0.5 cm in greatest dimension. A representative section of these. lesions is submitted for frozen section as FSD1. The remainder of the mucosal surface is. green-yellow, velvet-like and grossly unremarkable. Permanent representative sections are submitted. as D2-D3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) RIGHT RADICAL NEPHRECTOMY AND EN BLOCK LYMPH NODES: RENAL CELL CARCINOMA, CONVENTIONAL (90% CLEAR CELLS, 10% EOSINOPHILIC. CELLS), FUHRMAN'S NUCLEAR GRADE 4. (SEE COMMENT). TUMOR MEASURES 4.5 CM IN MAXIMUM DIMENSION. NO EXTENSION INTO THE PERINEPHRIC ADIPOSE TISSUE. (SEE COMMENT). Vascular and ureteral margins free of tumor. One lymph node with lipid granulomas, no tumor present (0/1). COMMENT. The tumor measures 4.0 x 3.0 x 3.0 cm and contains areas with marked. anaplasia; however, these areas are not diagnostic of sarcomatoid. dedifferentiation. The tumor focally bulges into the renal sinus adipose tissue without. infiltrative borders. GROSS DESCRIPTION. (A) RIGHT RADICAL NEPHRECTOMY AND EN BLOCK LYMPH NODES - A radical. nephrectomy specimen including the kidney (12.0 x 5.0 x 5.0 cm) with. attached Gerota's fascia (18.0 x 11.0 x 7.0 cm overall). No adrenal. gland is identified. Located in the middle portion of the kidney is well-circumscribed. brown-yellow tumor with focal hemorrhage (4.5 x 3.0 x 3.0 cm). No. necrosis is identified. The tumor is confined to the kidney and. approaches the renal capsule but the renal capsule still intact. No. invasion of the renal sinus or renal vein is identified. The Gerota's. fascia is free of tumor. One unremarkable lymph node is identified (2.0 x 1.5 x 1.0 cm). SECTION CODE: C1, vascular and ureteral resection margin; A2-A10,. tumor with adjacent kidney and renal capsule; A11, A12, tumor with renal. sinus; A13-A15, one lymph node; A16, Gerota's fascia, en face. CLINICAL HISTORY. None given. SNOMED CODES. T-71000, M-83123.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. Examination: Histopathological examination. Gender: F. Material: 1. Multiple organ resection - left breast""with axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Macroscopic description: Left breast sized 16.8 x 15.3 x 5.2 cm removed along with axillary tissues sized 10 x 6 x 5 cm and a 16.2 x 9.8 cm skin flap and a. fragment of the muscle sized 4 x 3 cm. Weight 620 g. Tumour sized 3.5 x 3 x 3 cm found in the inner upper quadrant, 1 cm from the inner boundary, 0.2 cm from the base and 0.8 cm. from the skin. Microscopic description: Carcinoma ductale invasivum - NHG3 (3+3+3/36 mitoses/10 HPF - visual area: 0.55mm'. Mamilla sine laesionibus. Glandular tissue with lesions of the type mastopathia fibrosa and cystica. Invasive lesions 0.1 cm away from the base. Axillary lymph nodes: Metastases carcinomatosae in lymphonodis (No III/XVIII). Histopathological diagnosis: Carcinoma invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast. Metastases carcinomatosae in lymphonodis axillae (NHG3, pT2, pN1a). Cancer metastases in axillary lymph nodes. Compliance validated b. Results of immunohistochemical examination: No estrogen receptors found in neoplastic cell nuclei. No progesterone receptors found in neoplastic cell nuclei. HER2 protein stained with HercepTestâ¢M by DAKO. Negative reaction in invasive carcinoma cells ( Score = 0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Pathology. bort. atholo. Confecteo. Case type: Surgical Case. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A-C) RIGHT NECK DISSECTION, LEVEL II, LEVEL III, LEVEL IV: LEVEL II: Two lymph nodes, no tumor present (0/2). LEVEL III: METASTATIC PAPILLARY CARCINOMA IN FOUR OF NINE LYMPH NODES (B). 1.3 CM IN GREATEST DIMENSION. LEVEL IV: METASTATIC PAPILLARY CARCINOMA IN FOUR OF NINE LYMPH NODES (4/9). METASTATIC CARCINOMA IN SOFT TISSUE. (D) RIGHT PARATRACHEAL NECK DISSECTION: METASTATIC PAPILLARY CARCINOMA IN SIX OF EIGHT LYMPH NODES (6/8). (E) LEFT SUPERIOR PARATHYROID: Parathyroid tissue, no tumor present. (F) TOTAL THYROID: PAPILLARY THYROID CARCINOMA, PRIMARILY FOLLICULAR PATTERN (2.2 CM). TUMOR EXTENDS INTO ADJACENT PARATHYROID (F6). TUMOR PRESENT AT MARGIN. METASTATIC PAPILLARY CARCINOMA IN ONE OF ONE LYMPH NODE (1/1). Entire report and diagnosis completed b,. GROSS DESCRIPTION. (A) CONTENTS, RIGHT LATERAL NECK DISSECTION, LEVEL II - An irregular fragment of fibroadipose tissue (8.0 x 3.0 x 0.8. cm). The specimen is serially sectioned and two lymph nodes are identified (1.5 x 0.6 x 0.4 and 2.0 x 0.8 x 0.8 cm). SECTION CODE: A1, one lymph node bisected; A2, one lymph node. cm). The specimen is serially sectioned and nine lymph nodes are identified ranging from 0.4 x 0.3 x 0.3 to 2.0 x 0.8 x 0.5. (B) RIGHT LEFT NECK DISSECTION, LEVEL III - An irregular fragment of fibroadipose tissue, skeletal muscle (6.0 x 3.0 x cm. 0.8. SECTION CODE: B1, representative sections of skeletal muscle; B2, three lymph nodes; B3, four lymph nodes; B4, two. (C) RIGHT CONTENTS, LEVEL IV - An irregular fragment of fibroadipose tissue (6.0 x 3.5 x 1.5 cm). The specimen is serially. lymph nodes. sectioned and 10 lymph nodes are identified ranging from 0.2 x 0.2 x 0.2 to 3.0 x 1.5 x 1.0 cm. SECTION CODE: C1, three lymph nodes; C2, C3, one lymph node bisected; C4, C5, one lymph node bisected; C6, five. lymph nodes. (D) CONTENTS, RIGHT PARATRACHEAL NECK DISSECTION - An irregular fragment of fibroadipose tissue (5.0 x 3.0 1.0 x 1.5. cm). The specimen is serially sectioned and eight lymph nodes are identified ranging from 0.4 x 0.4 x 0.3 to 2.5 x 2.0 x cm. Case type: Surgical Case. The cut surface of the largest lymph node is. filled with yellow clear liquid. SECTION CODE: D1, three lymph nodes; D2, two lymph nodes; D3, one fymph node bisected; D4, one lymph node. bisected; D5, D6, one lymph node bisected. (E) RULE OUT LEFT SUPERIOR PARATHYROID - a 0.2 x 0.2 x cm red, tan soft tissue fragment entirely submitted for frozen. section as E after touch preparation. FS/DX: PARATHYROID TISSUE. (F) TOTAL THYROID- Total thyroidectomy consists of right lobe (3.5 cm from lateral to medial, 2.5 cm from superior to inferior;. white-tan, homogeneous, and grossly does not invade the capsule. It is 1.8 cm from the isthmus, 0.5 cm from the inferior,. In the superior part of the right lobe is a firm tumor nodule which measures 2.2 x 1.4 x 1.3 cm. The cut surface of the tumor and is. 1.4 cm anterior to posterior), isthmus (1.4 x 0.8 x 0.3 cm) and left lobe (1.5 x 2.0x 1.2 cm). within less than 0.1 cm from the superior part. Tumor and uninvolved thyroid are sampled for tumor bank. SECTION CODE: F1-F6. tumor nodule in toto; from superior pole to inferior pole; F7, isthmus; F8-F10, left thyroid -. representative sections. CLINICAL HISTORY. Thyroid cancer. SNOMED CODES. T-B6000, M-80503, T-C4200, M-80506. These tests have not been specifically cleared or approved. ""Some tests reported here may have been developed and performance characteristics determined by. by the U.S. Food and Drug Administration. Released by: Case type: Surgical Case. ADDENDUM. Addendum completed by. COMMENT. One lymph node in level II showed a psammoma body surrounded by giant cells without epithelial cells identified. A cytokeratin. stain is negative for metastatic carcinoma. The above diagnosis remains unchanged. Released by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Histopathology Report. HISTORY. Left lower lobe; L/N 10; Bronchial Ca left lower lobe; patient has mild. pulmonary fibrosis. MACROSCOPIC. Two specimens submitted. 1. The first specimen is labelled `left lower lobe' and consists of a lobe of. lung measuring 125 x 80 x 65 mm. No parietal pleura is included. The visceral. pleural surface shows focal puckering of the lateral surface. The area of. puckering measures 25 mm in diameter. Several enlarged hilar nodes are. identified. They measure between 15 mm and 30 mm in diameter. Serial slicing. shows a solitary, ill-defined subpleural tumour measuring 24 x 10 x 22 mm. It. is located immediately beneath the area of pleural puckering, and is 33 mm from. the bronchial resection margin. The non-neoplastic lung shows extensive. dilatation of the subpleural airspaces toward the apex. Some of the dilated. airspaces measure up to 35 mm in maximum diameter. Toward the base, there is. diffuse firmness of the lung parenchyma, which is associated with grey. discolouration. [1A, shave bronchial resection margin; 1B, shave vascular. resection margin; 1C-1D, composite section of tumour and associated puckered. pleura; 1E-1F, composite section of full face of tumour and its relation to the. pleura; 1G, rep TS of tumour; 1H-1I, 2 rep TS of apical lung showing. extensively dilated airspaces; 1J, rep TS of basal lung showing the firm grey. area; 1K-1N, hilar lymph nodes (1 node per block).]. 2. The second specimen is labelled `left no 10 lymph node' and consists of two. fragments of brown to black tissue measuring 16 x 8 x 7 mm and 9 X 6 x 6 mm. Each of the fragments is bisected. [BIT, 2A.]. MICROSCOPIC. 1: Sections show a poorly differentiated squamous cell carcinoma. The tumour. is subpleural and measures 27mm in maximum dimension [1G]. Pleural invasion is. identified [1G]. There is no vascular invasion or lymphatic permeation is. seen. No perineural invasion is identified. The lesion is well clear of the. bronchial resection margin. There is metastatic carcinoma within all the. identified hilar lymph nodes, with some of the lymph nodes showing transected. tumour deposits at the margins. The adjacent lung shows evidence of emphysema. and fibrosis with a usual interstitial pneumonia (UIP)-like pattern. Fibrosis. is most pronounced in the base of the lobe, where there is honeycomb change. with fibroblastic foct. 2: The No. 10 lymph node does not show evidence of metastases and contains. carbon pigment and birefringent material consistent with silica. SUMMARY. 1&2. Lung, left lower lobe and lymph nodes: - Poorly differentiated squamous cell carcinoma; 27mm in maximal dimension. - No lymphatic invasion, blood vessel and perineural invasion. - Pleural invasion identified; clear of bronchial margin. - Metastatic carcinoma in hilar lymph nodes. - No evidence of malignancy in No 10 lymph node (Specimen 2). - T2a N1 [AJCC 7th ed]. - Non-neoplastic lung: Emphysema, fibrosis with UIP-like pattern. T-28000 M-80703 M-78000 P1-03000. ANATOMICAL PATHOLOGY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Patient ID: Gross Description: There is an esophagus fragment up to 9 x 5 cm in its size, with a grey-white tumor up. to 6.5 cm in its size, with superficial ulceration. Microscopic Description: Squamous cell carcinoma of the esophagus, keratinizing sub-type, G-1 (pT2),. with ulceration. Two paraesophageal lymph nodes were examined. One of them demonstrated. metastasis. Another one demonstrated lipomatosis. Eight lymph nodes along the a. gastrica sinistrae. were examined. One of them demonstrated metastasis. All other lymph nodes demonstrated. anthracosis, follicular hyperplasia. Diagnosis Details: Tumor Features: Ulcerated, Tumor Extent: Muscularis Propria, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: ESOPHAGUS TISSUE CHECKLIST. Specimen type: Esophagectomy. Tumor site: Esophagus. Tumor size: 0 x 0x 6.5 cm. Histologic type: Squamous cell carcinoma, keratinizing. Histologic grade: Well differentiated. Tumor extent: Muscularis propria. Lymph nodes: 2/10 positive for metastasis (Paraesophageal (2), along the a. gastrica sisnistr 2/10). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: tumor location; lower third of esophagus. tumor features: ulcerated. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial hepatectomy. Organ: Liver (17.0 X 8.0 X 5.5 cm, 397.0 gm). Gallbladder (9.5 cm in length, 3.5 cm in diameter, 0.6 cm in wall thickness). [Liver]. Lesion: A hepatic mass. Size: 5.5 X 5.0 X 7.0 cm. Cut surface: Well demarcated, mahogany and nodular. Gross type: Multinodular confluent. Extent: Confined to the hepatic parenchyma. Serosal surface: Bulging but smooth. Resection margin: Not involved, grossly (safety margin: 0.1 cm). Remaining parenchyme: Cirrhosis. [Gallbladder]. Serosal surface: Yellowish pink and smooth. Mucosal surface: Dark green and velvety. Stone: No stone. Representative sections submitted. Gross photo: Present. Blocks. T1-6, TB, mass of liver X 7. L, nontumorous liver parenchyme x 1. GB, gallbladder x 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Edmondson-steiner grade. The worst differentiation II. The major differentiation III. Histologic type: Trabecular. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis. Parotid gland, aspiration, inflammation, atypical cells. NOT reported. Gross: er,ectomy,hepatocellular carcinoma. T56000, P10, M81703. gallbladder,ectomy,chronic cholecystitis,autolysis. T57000, P10, M43005, M54001. lymph node,biopsy,no tumor. T08000, P50, M09450. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma, well differentiated. Gallbladder, cholecystectomy: Chronic cholecystitis. Autolysis. Lymph node, pericystic, biopsy: No tumor present (0/1). Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Case type: Surgical Case. DIAGNOSIS. 8340/3. (A) LEFT THYROID LOBE AND ISTHMUS: PAPILLARY THYROID CARCINOMA, FOLLICULAR VARIANT CQCF: carcinoma, papillary, theroid. Location: Left lobe. Multi-focal: No. Size = 2.2 cm. Extrathyroidal extension: Absent. Lymphovascular invasion: Present. Resection Margins: Negative. Lymph nodes: No lymph nodes present. GROSS DESCRIPTION. (A) LEFT THYROID LOBE AND ISTHMUS - A hemithyroidectomy specimen (4.0 : x 1.5 x 1.5 cm) contains a well-. circumscribed pink-tan nodule within the superior aspect of the left lobe (2.2 x 1.5 x 1.5 cm). The nodule appears confined to. the thyroid with a smooth overlying thyroid surface. The isthmus is unremarkable. The specimen is serially sectioned and. submitted from superior to inferior in A1-A6 with A7 isthmus. CLINICAL HISTORY. Follicular neoplasm, left thyroid. CONSULTANT(S). SNOMED CODES. T-B6000, M-83403,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
LABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: ORIGINAL REPORT. SPECIMEN: A. Gallbladder. B. Segment 5 & 6 liver. CLINICAL HISTORY: Chronic Hep B. Portal vein embolization. Segment 5 and 6 hepatoma. DIAGNOSIS: A. GALLBLADDER, CHOLECYSTECTOMY: - CHRONIC CHOLECYSTITIS. B. LIVER, SEGMENTAL RESECTION: - CHRONIC HEPATITIS CONSISTENT WITH HEPATITIS B GRADE 2, STAGE 2. HEPATOCELLULAR CARCINOMA, POORLY DIFFERENTIATED, RESECTION MARGIN. UNINVOLVED. IRON OVERLOAD (3+). (Electronic Signature). GROSS DESCRIPTION: A. The specimen consists of a 7.3 x 2.7 x 2.1 cm gallbladder that has a. tan-grey outer serosa that appears complete apart from the area of attachment. to the liver bed. It contains a viscous dark green fluid without calculi. Around the proximal end of the gallbladder and extending down to the. midportion is a cord-like portion of fibrofatty tissue without nodularity. The. inner mucosa is bile stained and velvety and speckled with pinpoint yellow. lesions. Cassettes submitted as follows: representative sections of. gallbladder in block A. B. The specimen consists of a 12.5 x 10.5 x 6 cm portion of liver weighing 301. g. It has previously been inked with silver nitrate and the surgical margin. has been inked black. Within the liver there is a 6.5 x 5.3 x 5.1 cm. irregularly circumscribed tan-yellow multiply lobulated smooth heterogeneous. Printed: Page 1  CONTINUED. ABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. nivicion Wead. GROSS DESCRIPTION: lesion. It abuts the serosa and is creating nodules on the serosal surface. It comes to within 1.3 cm of the surgical margin. As well there is a similar. appearing lesion that is 1.0 cm in diameter that is 0.7 cm away from the major. lesion, 0.9 cm away from the serosal surface, and 1.0 cm away from the. surgical margin. The remainder of the parenchyma has an orange-brown. heterogeneous slightly nodular appearance. Cassettes submitted as follows: B1,B2. - liver parenchyma uninvolved by tumor. B3. - portion of tumor abutting serosal surface. B4. tumor with serosal nodule. B5. - section of parenchyma between nodules. B6. - smaller tumor with serosal and surgical margin. B7. - largest tumor with surgical margin. B8. - representative section of tumor. B9. - representative section of tumor with serosa. MICROSCOPIC DESCRIPTION: B. Sections of liver away from the tumor show a preserved lobular. architecture. The portal areas are expanded due to inflammatory cell. infiltration and fibrosis. Piecemeal necrosis and portal to portal fibrous. strands are present. The lobular parenchyma shows spotty necrosis and. sinusoidal permeation by lymphocytes. Mild macrovesicular steatosis is also. present. Special stain for iron shows iron overload in hepatocytes (3+) and. special stain for alpha 1 antitrypsin globules is negative. Procedure: Printed: Name. :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
IP <DIS IN C. Specimen: spec Type: SURGICAL P. PREOPERATIVE DIAGNOSES. LEFT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: MASTECTOMY MODIFIED RADICAL. TISSUE REMOVED. A. LT BREAST AND AXILLARY TISSUE. B. ADDITIONAL LYMPH NODES LT AXILLA. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT BREAST AND AXILLARY. CONTENTS SUTURE AT 12 O'CLOCK, AND CONSISTS OF A MODIFIED RADICAL. MASTECTOMY SPECIMEN WITH OVERALL DIMENSIONS OF 31 x 20.5 x 5.8 CM. THE. NIPPLE IS UNREMARKABLE AND SITS WITHIN A SKIN ELLIPSE MEASURING 21 x 12.3. CM. THERE IS A 3.5 CM IN LENGTH WELL-HEALED PERIAREOLAR SCAR EXTENDING. FROM 12 TO 2 O' CLOCK. THERE IS A PALPABLE MASS IN THE UPPER OUTER. QUADRANT. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP. ASPECT WITH BLACK INK. THE AXILLARY TAIL IS REMOVED AND EXAMINED FOR. LYMPH NODES, OF WHICH MULTIPLE ARE IDENTIFIED. SECTIONS ARE SUBMITTED AS. FOLLOWS: A1 --NIPPLE - SKIN AND SCAR; A2 -FIVE NODES; A3 - -FIVE NODES;. A4--THREE - NODES, EACH BISECTED; A5--THREE NODES, EACH BISECTED;. A6--SECTION OF ONE NODE; A7--SECTION OF ONE NODE; A8--SECTION OF ONE. NODE; A9--SECTION OF ONE NODE; A10--SECTION OF ONE NODE. NOTE THAT A6. THROUGH A10 ARE MIRROR IMAGES OF PROTOCOL SECTIONS. All--TWO NODES, EACH. BISECTED; A12--ONE NODE BISECTED; A13--ONE - NODE BISECTED; A14--ONE NODE. BISECTED. SECTIONING THE BREAST REVEALS THE UPPER OUTER QUADRANT TO-BE A. ROUNDED PINK-TAN SOFT MASS WHICH IS CENTRALLY CYSTIC. IT MEASURES 4 x. 3.7 x 2.8 CM. GROSSLY, THIS ABUTS THE DEEP MARGIN. IMMEDIATELY. SUPERFICIAL TO THIS MASS IS A SECOND NODULE WITH A COIL CLIP MEASURING. 1.5 x 1.2 x 1.0 CM. MEDIAL AND CENTRAL TO THE BREAST, THE SPECIMEN HAS A. TAN FIBROUS BAND WHICH EXTENDS 9 CM FROM SUPERIOR TO INFERIOR AND THERE. IS TAN FIBROUS TISSUE CENTRAL WITHIN THE BREAST. THIS IS SURROUNDED BY A. PERIMETER OF BLAND YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: A15 AND 16-MASS IN DEEP MARGIN; A17--SECTION OF THE MASS AND. THE ADJACENT MORE SUPERFICIAL NODULE; A18, 19 AND 20 --SECTIONS OF MASS. CORRESPONDING TO SECTIONS FROM THE SUBMITTED PER PROTOCOL, WITH A20. REPRESENTING THE ADJACENT FIBROUS TISSUE; A21--AN ADDITIONAL SECTION OF. THE SUPERFICIAL LESION (MIRROR IMAGE TO PROTOCOL) ; A22--UPPER OUTER. QUADRANT; A23--PUPPER INNER QUADRANT; A24 --LOWER - INNER QUADRANT;. A25 - -LOWER - OUTER QUADRANT (A22 THROUGH A25 ARE MIRROR IMAGE SECTIONS TO. PROTOCOL) ; A26--TISSUE FROM SUPERIOR PORTION OF BREAST. THE AXILLARY TAIL IS REEXAMINED FOR LYMPH NODES AFTER FIXATION TIME IN. ACETIC FORMALIN. ADDITIONAL NODES ARE THEN SUBMITTED AS FOLLOWS: Specimen: Spec Type: SURGICAL P. GROSS DASCRIPTION. A27--FIVE - NODES; A28--TWO - NODES, EACH BISECTED. PART B RECEIVED FRESH LABELED. ADDITIONAL LYMPH NODES. LEFT AXILLA (LEVEL 2), IS YELLOW-PINK FATTY TISSUE MEASURING 2.4 x 1.6 x. 0.8 CM. THIS IS BISECTED REVEALING NO DISTINCT NODAL TISSUE AND. SURMTTTRN RNTIRELY LABELED B1 AND 2. PATH PROCEDURES. PROCEDURES: 88309, A BLK/26, B BLK/2. FINAL DIAGNOSIS. PART A LEFT MODIFIED RADICAL MASTECTOMY: 1. POORLY DIFFERENTIATED INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE. III/III WITH A HIGH MITOTIC INDEX, 4.0 CM IN MAXIMUM GROSS DIMENSION. 2. THE IDENTIFIED IN 1 INTRAMAMMARY LYMPH NODE (MARKED 1/1 Intramann. TUMOR IS LOCATED 1 MM FROM THE DEEP MARGIN OF THE SPECIMEN. METASTATIC CARCINOMA. WITH A COIL CLIP CONFIRMING A PREVIOUS BIOPSY SITE) . 3. NO EVIDENCE OF METASTATIC DISEASE IN 37. AXILLARY LYMPH NODES. %/37 ALN. 4. PERIDUCTAL CHRONIC MASTITIS IN SECTIONS OF BREAST TISSUE AWAY FROM. THE PRIMARY TUMOR SITE. PART B LEFT AXILLARY BIOPSY: ADIPOSE TISSUE CONTAINING SECTIONS OF 1 % Level 2. SMALL LYMPH NODE WITH NO EVIDENCE OF METASTATIC DISEASE. CX IMMENT. THE. LIDITION OF THE AJCC STAGING MANUAL DOES SPECIFICALLY NOT ADDRESS. FOR POSITIVE INTRAMAMMARY NODES IN THE ABSENCE OF AXILLARY. METASTATIC DISEASE, HOWEVER THE PATIENT WILL BE STAGED AS HAVING N1. DISEASE. CODE. 1. (prelim.). (signature on file). S IN. Specimen: Spec Type: CA SUMMARY. CANCER SUMMARY. Breast Pathology Summary: Macroscopic: Breast procedure: mastectomy, modified radical. Lymph node procedure: Sentinel (yes/no) : no. Axillary (yes/no) : yes. Specimen size (greatest dimension) (xy,n/a) cm: 31. Neoadjuvant therapy (yes/no) : no. Laterality: left. Tumor site: upper outer quadrant. Multifocal (yes/no) : no. Multicentric (yes/no) : no. Microscopic: Size of invasive component (xy,n/a) mm: 40. Size of DCIS (xy,n/a) mm: n/a. Histologic type: Atypical: n/a. In situ: n/a. Invasive: infiltrating duct. Histologic grade : Tubule formation (0-3,n/a) : 3. Nuclear pleomorphism (0-3,n/a) : 3. Mitotic count (0-3,n/a) : 3. Nottingham Score: 9. Nottingham Grades based on total score: Grade I 3-5 points. Grade II 6-7 points. Grade III 8-9 points. Venous/lymphatic invasion (yes/no) : no. Closest margin size (xy,n/a) mm: 1. If less than 2 mm then: Single focus of invasive tumor (yes/no) : yes. Single focus of DCIS (yes/no) : no. Multifocal invasive tumor (yes/no) : no. Multifocal DCIS (yes/no) : no. Nodes: Sentinel- number examined (xy,n/a) : 0. Sentinel- number involved (xy,n/a) : n/a. Regional- number examined (xy,n/a) : 39. Regional - number involved (xy,n/a) : 1. Markers: ER (xy%,n/a) : 95. Specimen: :atus: Reg# : Spec Type: CA SUMMARY. CANCER SUMMARY. PR (xy%,n/a) : o. Her-2/neu (0-3+,n/a) : 1. Ki-67 (xyt,n/a) : 95. Summary TNM: T: pT2. pN: pN1. Summary stage: 2B. ) (prelim.). (signature on file).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of the last page of. the report YOU DO NOT HAVE THE ENTIRE REPORT. Please try printing it again. CONFIDENTIAL. Relevant. Information. Demographics. (for verification. Date of Birtr. purposes). Sex: M. urgical Pathology Report. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder. B. Segment 7- liver. wt 62 g. Clinical Information. Infectious patient:Yes, Hep C+ ve. Immunocompromised: NK. History of neoplasm: NK. Hepatitis C related cirrhosis; hypervascular lesion in segment 8. Diagnosis. A. Gallbladder;. No pathologic diagnosis. B. Segment 7, Liver: Well differentiated hepatocellular carcinoma, solid variant, involving. deep margin. Chronic hepatitis C of mild activity. Cirrhosis. Verified: Gross Description. Received are specimens A rn a. All remisitions and specimen containers are labelled. with the patient's name,. The cassettes and AP identifiers are. labelled with the Surgical Number. A. The specimen is received fresh and is subsequently placed into formalin and consists. of an intact gallbladder measuring 9.5 x 4.5 x 3.0 cm. The serosal surface is slightly. hemorrhagic, smooth, congested and glistening. The adventitial surface is congested and. roughened. The cystic duct resection margin is identified and is patent. The cystic duct. lymph node is not identified. The lumen is filled with thick green mucinous bile. (measuring about 20 ml) Also thick partially solidified bile flakes are identified. attached to the mucosal surface of the fundus. The mucosal surface is green and slightly. velvety. The wall thickness of the gallbladder measures 0.1 cm. Specimen is serially. sectioned and representative sections are submitted in Al including cyst duct resection. margin and sections from neck, body and fundus. B. The specimen is received fresh and is subsequently placed into formalin and consists. of a portion of liver weighing 62 g and measuring 7.5 x 6.8 cm with a maximum thickness. of 2.9 cm. The serosal surface of a liver has a grey purple and dark brown slightly. roughened appearance. Serosal surface also appears slightly nodular. Resection margin of. the liver is marked with blue dye. Specimen is serially sectioned. A light tan opaque. nodule is identified on the cut surface of the specimen measuring 3.0 x 3.0 x 2.4 cm. This nodule grossly coming to within less than 0.1 cm of the blue inked resection margin. as well as serosal surface. The remaining cut surface of the liver has a light tan nodular appearance. Sections are submitted as follows: B1-5. - Sections from the opaque nodule also including blue inked resection margin. and the. serosal surface. B6, 7. - Sections from the remaining liver parenchyma. Number. Encounter. Number. Patient Location. - END OF PRINTED REPORT -.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: :LYMPH NODE, LEVEL 11, BASILAR SEGMENT, BIOPSY -. ONE (1) BENIGN LYMPH NODE WITH ANTHRACOTIC PIGMENT DEPOSITS, FREE OF TUMOR (0/1). PART 2: LYMPH NODE, LEVEL 11, MIDDLE LOBE, BIOPSY -. ONE (1) BENIGN LYMPH NODE WITH ANTHRACOTIC PIGMENT DEPOSITS, FREE OF TUMOR (0/1). PART 3: LUNG, RIGHT UPPER LOBE POSTERIOR SEGMENTECTOMY -. A. INVASIVE PAPILLARY ADENOCARCINOMA WITH A FEW PSAMMOMA BODIES AND FOCAL LEPIDIC. GROWTH, MODERATELY DIFFERENTIATED, PERIPHERAL SUBPLEURAL (2.0 X 2.0 X 1.8 CM.). B. NEGATIVE FOR VISCERAL PLEURA INVASION (PLO). C: NEGATIVE FOR LYMPHOVASCULAR INVASION. D. SURGICAL PARENCHYMAL MARGIN OF RESECTION NEGATIVE FOR TUMOR (TUMOR AT 2.0 CM.). E. EMPHYSEMATOUS CHANGES. F. AJCC TNM STAGE: pT1a NO. PART 4: LYMPH NODE, LEVEL 4, BIOPSY -. ONE (1) LYMPH NODE WITH ANTHRACOTIC PIGMENT DEPOSITS, FREE OF TUMOR (0/1). PART 5: LYMPH NODE LEVEL 10, BIOPSY -. ONE (1) BENIGN LYMPH NODE, FREE OF TUMOR (0/1). PART 6:LYMPH NODE, LEVEL 7, BIOPSY -. ONE (1) BENIGN LYMPH NODE, FREE OF TUMOR (0/1). COMMENT: Special elastic stains performed on slides 3A and 3B with adequate controls are negative for tumor invasion of visceral. pleura. Molecular studies were performed on the previous right upper lobe FNA biopsy. they are EGFR,. KRAS and BRAF negative. ALK FISH studies positive. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Upper Lobe. LUNG SEGMENT(S) INVOLVED: Posterior. PROCEDURE: Segmental. TUMOR SIZE: Maximum dimension: 2.0 cm. Minor dimension: 2.0 cm. TUMOR TYPE: Invasive adenocarcinoma,. Dominant Pattern: Papillary. HISTOLOGIC GRADE: G2, Moderately differentiated. EXTRAPULMONARY EXTENSION/INVASION OF TUMOR: None identified (PLO). ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 20 mm, Parenchymal margin. IFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 0. Number of N1 lymph nodes examined: 3. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 2. UNDERLYING DISEASE(S): Emphysema. T STAGE, PATHOLOGIC: pT1a. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: Not applicable. ANCILLARY STUDIES: Histochemical stains, FISH studies, Molecular studies.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: KIDNEY, RIGHT, RADICAL NEPHRECTOMY -. A. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE. B. FUHRMAN NUCLEAR GRADE IS 3 of 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 10.6 cm. D. THE NEOPLASM EXTENDS OUTSIDE THE RENAL CAPSULE INTO THE PERINEPHRIC FAT. E. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. F. UPPER POLE SOFT TISSUE RESECTION MARGIN IS INVOLVED BY NEOPLASM (ALSO SEE PART 2). G. NON-NEOPLASTIC KIDNEY ADJACENT TO TUMOR SHOWS MILD INTERSTITIAL CHRONIC INFLAMMATION,. MODERATE ARTERIAL AND ARTERIOLAR SCLEROSIS. H. TNM STAGE: pT3a NX MX. PART 2: SOFT TISSUE, RIGHT UPPER POLE MARGIN, RESECTION -. A. RENAL CELL CARCINOMA WITH FAT INVASION. B. MARGIN IS INVOLVED BY CARCINOMA (SEE COMMENT). PART 3: ADRENAL GLAND, LEFT, ADRENALECTOMY (31.5 GRAMS) -. A. ADRENOCORTICAL ADENOMA (2.0 CM). B. NO INVOLVEMENT BY RENAL CELL CARCINOMA. COMMENT: Grossly and microscopically, the tumor shows extracapsular extension at upper pole with positive margin at disrupted. edge in part 1. Upper pole margin received separately in Part 2 shows the margin involved by cauterized tumor. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Radical nephrectomy. LATERALITY: Right. TUMOR SITE: Upper pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 10.6 cm. Additional dimensions: 8.0 x 7.5 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor extension into perinephric tissues. Tumor extension beyond Gerota's fascia. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G3. PATHOLOGIC STAGING (pTNM): pT3a. pNX. Number of regional lymph nodes examined: 0. Number of regional lymph nodes involved: 0. pMX. MARGINS: Margin(s) involved by invasive carcinoma. ADRENAL GLAND: Uninvolved by tumor. VENOUS (LARGE VESSEL) INVASION (V): Absent. LYMPHATIC (SMALL VESSEL) INVASION (L): Absent. ADDITIONAL PATHOLOGIC FINDINGS: Inflammation (type): chronic. Other: moderate arterial and arteriolar sclerosis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: A. Gallbladder, cholecystectomy Chronic cholecystitis. A single. cystic duct lymph node is benign. B. Liver, right, partial hepatectomy : 11-to-moderately. differentiated grade 2 (of 4) hepatocellular carcinoma is identified. forming a dominant mass (6. 8 x 5.9 x 4.1 cm) with one satellite mass. (0.2 2 x 0.2 x 0.2 cm) The tumor is confined to the liver. The liver. parenchyma resection margin is negative for tumor (minimum tumor. free margin, 0.9 cm). Macroscopic large vessel invasion is absent. Microscopic large vessel invasion is present. No regional lymph. nodes are identified.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. A. GALLBLADDER, CHOLECYSTECTOMY: Chronic cholecystitis. No evidence of malignancy. B. LIVER NODULE NO. 1, LEFT LOBE, CORE NEEDLE BIOPSY: Liver parenchyma with focal scar. No evidence of malignancy. C. LIVER NODULE NO. 2, LEFT LOBE, NEEDLE BIOPSY: Liver parenchyma with focal scar. No evidence of malignancy. D. PORTAL LYMPH NODE: One lymph node (0/1), free of malignancy. E. RIGHT LOBE LIVER, PARTIAL RESECTION: Hepatocellular carcinoma. See Key Pathologic Findings. KEY PATHOLOGICAL FINDINGS: Tumor type: Hepatocellular carcinoma, moderately differentiated. Tumor configuration: Circumscribed. Tumor size: 3.3 x 2.5 x 1.5 cm. Tumor necrosis: Not identified. Extent of invasion: Carcinoma is confined to within hepatic parenchyma. Vascular invasion: Not identified. Perineural invasion: Not identified. Parenchymal and surgical margins: Free of malignancy. Additional findings: Focal steatosis and portal triad chronic inflammation. Pathologic stage: pT1 NO MX. the attending pathologist, personally reviewed all. slides and / or materials and rendered the final diagnosis. Electronically. Specimen(s) Received. A. GALLBLADDER. B. LIVER NODULE #1 LEFT LOBE FS. C. LIVER NODULE #2 LEFT LOBE FS. D. PORTAL LYMPH NODES. E. RIGHT LOBE LIVER. Clinical History. HCC. Preoperative Diagnosis. HCC. Intraoperative Consultation. FSB1. LIVER NODULE, NO. 1, LEFT LOBE: Benign liver with focal scar. FSC1. LIVER NODULE, NO 2, LEFT LOBE: Benign liver with focal scar. Comment: This frozen section diagnosis/result was communicated to and acknowledged by. in person at. I,. have performed the intraoperative consultation (s) and issued the above. diagnosis. Gross Description. A. The specimen is received fresh labeled ""gallbladder"" and consists of a 7.7 x 2.8 x 2.5-cm. intact gallbladder. The serosa is smooth and glistening. The wall averages 0.2 cm in thickness. The. mucosa is velvety. No mass or other lesions are identified. The lumen contains a dark green viscous. bile. No stones are identified. Representative sections are submitted as follows: A1: Cross section of cystic duct margin. A2: Random sections of gallbladder. B. The specimen is received fresh for frozen section consultation labeled ""liver nodule No. 1, left. lobe,"" and consists of a 0.1-cm in diameter elongated portion of tan tissue which is 1.2 cm in length. The tissue is entirely frozen and submitted in FSB1. C. The specimen is received fresh for intraoperative consultation labeled ""liver nodule No. 2, left. lobe,"" and consists of a 0.1-cm in diameter elongated portion of tan tissue which is 1.5 cm in length. The tissue is entirely frozen and submitted in FSC1. D. The specimen is received fresh labeled ""portal lymph nodes"" and consists of a 1.9 X 1.4 x. 0.9-cm firm tan lymph node with surrounding adipose tissue. The tissue is sectioned and entirely. submitted in D1. E. The specimen is received fresh labeled ""right lobe liver"" and consists of a 761.9-g, 17.5 x 16.0. x 7.0-cm lobe of liver. The surgical margin is inked black. The capsule is smooth and without. adhesions. 3.8-cm from the closest surgical margin is a 3.3 x 2.5 X 1.5-cm well-circumscribed soft tan. lobulated mass. The mass is 1.5 cm from the capsule. There is an additional soft discolored pale. area adjacent to the mass. The remaining parenchyma is homogeneous tan without additional. lesions. No frozen section is performed as per. A portion of the tissue is submitted to. Tissue Procurement Laboratory. Representative sections are submitted as follows: E1: Tissue adjacent to tissue submitted for tumor bank. E2: Margin closest to mass, perpendicular. E3-E4: Sections of mass. E5: Mass with surrounding normal parenchyma. E6: Separate pale lesion. E7: Normal parenchyma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
F. Encounter. Number. COPY ONLY DO NOT FILE. carcinoma, wrothelial, Nos 8120/3 Final. Source of Specimen. A. LEFT PELVIC LYMPH NODES - FS-. B. LEFT PELVIC LYMPH NODES-NFS-. C. RIGHT PELVIC LYMPH NODES-FS-. D. RIGHT PELVIC LYMPH NODES-NFS-. E. APPENDIX-. F. LEFT URETER MARGIN-FS-. G. RIGHT URETER MARGIN-FS-. H. BLADDER, UTERUS, BILATERAL FALLOPIAN TUBES SEE WORKSHEET-. FINAL DIAGNOSIS: A. LEFT PELVIC LYMPH NODES- FS-. THREE FATTY LYMPH NODES, NO MALIGNANCY SEEN. B. LEFT PELVIC LYMPH NODES-NFS-. SEE PART ""A"". C. RIGHT PELVIC LYMPH NODES-FS-. TWO FATTY LYMPH NODES, NO MALIGNANCY SEEN. D. RIGHT PELVIC LYMPH NODES-NFS-. SEE PART ""C"". 3. APPENDIX-. VERMIFORM APPENDIX WITH NO DIACNOSTIC ABNORMALITY SEEN. F. LEFT URETER MARCIN-F3-. NO CARCINOMA SEEN. G. RIGHT URETFR MARGIN-FS-. NO CARCINOMA SEEN. II. BLADDER, UTERUS, BILATERAL FALLOPIAN TUBES SEE WORKSHEET-. INVASIVE CARCINOMA, HIGH GRADE. Prepare. TUMOR SITE: POSTERIOR, URINARY BLADDER. HISTOLOGIC TYPE: UROTHELIAL. SQUAMOUS DIFFERENTLATION: NOT PRESENT. GLANDULAR DIFFERENTIATION: TS PRESENT, EXTENSIVE. TUMOR SIZE: 3.0 CM. HISTOLOGIC GRADE: 3/3. TUMOR INVADES PERIVESICAL SOFT TISSUE, MICROSCOPICALLY. SPECIMEN TYPE: ANTERIOR EXENTERATION: RADICAL CYSTECTOMY, TOTAL. HYSTERECTOMY AND BILATERAL SALPINGOOPHORECTOMY, ANTERIOR. VAGINECTOMY. TNM STAGE: pT3a, pNO, pMX. LYMPH NODE (S) INCLUDED IN ALL PARTS NUMBER INVOLVED: 0. NUMBER EXAMINED: 5. LYMPHATIC (SMALL VESSEL) INVASION: IS PRESENT. PERINEURAL INVASION: PRESENT, EXTENSIVE. ASSOCIATED EPITHELIAL LESIONS: EXTENSIVE SURFACE ULCERATION. MODERATE UROTHELIAL DYSPLASIA FOCALLY SEEN. NO TUMOR SEEN AT URETERAL AND URETHRAL MARGINS. PERIVESICAL SOFT TISSUE MARGIN: NEGATIVE FOR TUMOR. VAGINA, UTERUS AND CERVIX: NEGATIVE FOR MALIGNANCY. OTHER BENIGN FINDINGS: ATROPHIC ENDOMETRIUM. INTRAMURAL LEIOMYOMATA. ATROPHIC OVARIES WITH FOCAL ENDOSALPINGIOSIS. PARATUBAL CYSTS. Prepar. Signed Others. Frozen Section. A. RIGHT URETER MARGIN: NO CARCINOMA. LEFT URETER MARGIN: NO CARCINOMA. RIGHT AND LEFT PELVIC LYMPH NODES: FATTY LYMPH NODES ON BOTH. SIDES, REPRESENTATIVE SECTIONS TAKEN FOR FS. RIGHT PELVIC LYMPH NODES: 2 FATTY LYMPH NODES. NO TUMOR SEEN. LEFT PELVIC LYMPH NODES: 3 FATTY LYMPH NODES. NO TUMOR SEEN. (0/3). Frozen section performed by. Case Clinical Information. BLADDER CANCER. Gross Description. A. Received in formalin labeled with the patient's name and. ""left pelvic lymph nodes FS"" are three fatty, yellow-tan tissue. fragments measuring up to 2 x 1.2 x 0.2 cm thick. The entire. specimen is submitted in A1. B. Received in formalin labeled with the patient's name and. ""left pelvic lymph nodes NFS"" are multiple fragments of finely. divided fat, measuring 3 x 3 x 3 cm in compact aggregate. Residual induration is submitted in B1-B3. C. Received in formalin labeled with the patient's name and. ""right pelvic lymph nodes FS"" are two elongated, fatty, pink-tan. Lissues measuring 2 x 1.1 x 0.2 cm thick. The entire specimen. is submitted in C1. D. Received in formalin labeled with the patient's name and. ""right pelvic lymph nodes NFS"" are multiple fragments of finely. divided fat, measuring 3 x 3 x 3 cm in compact aggregate. Residual induration is submitted in D1-D3. F. Received in formalin labeled with the patient's name and. ""appendix"" is a grossly unremarkable vermiform appendix with. attached periappendiceal fat measuring 7 x 0.4 cm thick, with. the surgical margin revealing a staple closure. The appendiceal. lumen is pinpoint. A shave of the resection margin adjacent to. Prepared. the staple closure and entire appendiceal tip is submitted in. El. F. Received in formalin labeled with the patient's name and. ""left ureter FS"" is yellow tan, sott tissue measuring 1 x 1 x. 0.2 cm. Totally submitted in F1. G. Received in formalin labeled with the patient's name and. ""right ureter FS"" is yellow-tan, soft tissue measuring 9 x 6. x. 1. mm thick. The specimen is submitted totally in G1. H. Received in formalin labeled with the patient's name and. ""uterus, bilateral tubes and ovaries, bladder, anterior vaginal. wall"" is a specimen so designated, measuring overall 13 cm. superior to inferior, 10 cm right to left, 8 cm anterior to. posterior. The uterus and cervix measure 7 cm superior to. inferior, 4.5 cm right to left, 2.2 cm anterior to posterior. Unremarkable right and left fallopian tubes, measuring 6.5 x 0.6. and 6 x 0.5 cm with unremarkable, atrophic appearing right. and. left ovaries measuring 2 x 1.5 x 0.6 and 2 x 1.5 x 0.6 cm in. greatest dimensions. The included portion of anterior vaginal. wall is continuous with the perineal and distal urethral mucosa,. it measures up to 5 cm in width superiorly and appears. unremarkable. The cervix is 3 cm in diameter with a 1.2 cm. linear os. The specimen previously has been inked blue on the. left, black on the right, and the bladder cavity is exposed. The bladder wall appears indurated with a diminished bladder. cavity measuring 2.5 cm right to left, superior to inferior, 2. cm. anterior to posterior. The posterior superior aspect of the. bladder is replaced by an area of ulceration and induration,. measuring 3 X 3 cm. Section code: H1=distal urethra; H2=shaved. entire left vaginal resection margin; H3=shaved entire right. vaginal resection margin; H4=left cross sections mid urethra;. H5=right mid urethral cross sections; H6=half left ovary;. H7=left fallopian tube; H8=half of right ovary; H9=right. fallopian tube; H10=posterior cervix; H11=anterior cervix;. 312-H13=anterior posterior uterine wall, including thin. endometrium and two fibroid-like nodules with uterine cavity. measuring 1.2 em in width, 2 cm in length; H14-H18=extensivo. sampling of bladder tumor, which measures up to 2 cm thick,. deeply penetrating posterior bladder fat. H19-820=tumor to. inked left posterior soft tissue margin. The included stubs of. ureter are deeply retracted and are not sampled at this time due. to their presence in parts F1 and G1. Procedure. A. AA ROUTINE H&E X1 BLOCK. H&E X1. B. AA ROUTINE HSE X1 BLOCK. 1. Prepared. H&E X1. B. AA ROUTINE H&E X1 BLOCK. 2. H&E X1. B. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. C. AA H&E X1 BLOCK. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 2. H&F X1. D. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. E. AA ROUTINE H&E X1 BLOCK. H&E X1. F. AA ROUTINE H&E X1 BLOCK. H&E x1. G. AA ROUTINE H&E X1 BLOCK. H&E X1. H. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. H. AA ROUTINE H&E X1 BLOCK.2. H&E X1 A RECUTS. H. AA ROUTINE H&E X1 BLOCK. 3. H&E X1 A RECUTS. H. AA ROUTINE H&E X1 BLOCK. 4. II&E X1. H. AA ROUTINE H&E X1 BLOCK. 5. H&E X1. H. AA ROUTINE H&E X1 BLOCK. 6. II&E X1. H. AA ROUTINE H&E X1 BLOCK. 7. H&E X1. H. AA ROUTINE H&E X1 BLOCK.: 8. H&E X1. a. AA ROUTINE H&E X1 BLOCK. 9. H&E X1. H. AA ROUTINE H&E X1 BLOCK. 10. R&E X1 A RECUTS. H. AA ROUTINE H&E X1 BLOCK. 11. P&E X1. n. AA ROUTINE H&E X1 BLOCK.12. H&E X1. H. AA ROUTINE H&E X1 BLOCK.13. H&E X1. H. AA ROUTINE li&E X1 BLOCK. 14. H&E X1. H. AA ROUTINE H&E X1 BLOCK. 15. Prepared 1. H&E x1. H. AA ROUTINE H&E X1 BLOCK. 16. H&E x1. II. AA ROUTINE H&E X1 BLOCK. 17. H&E X1. H. AA ROUTINE II&E X1 BLOCK. 18. H&E X1. II. AA ROUTINE H&E X1 BLOCK. 19. H&E X1. H. AA ROUTINE H&E X1 BLOCK.20. H&E X1. Prepared.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Colect date: PRIMARY SITE: Larynx. 1 - ""Left neck dissection specimen levels 2, 3 and 4"": - Twelve lymph nodes with no evidence of metastatic carcinoma (0/12). 2 - ""Right neck dissection specimen levels 2, 3 and 4"": - Thirty lymph nodes with no evidence of metastatic carcinoma (0/30). 3 - ""Total laryngectomy and total thyroidectomy specimen"": Larynx. - Moderately differentiated squamous cell carcinoma involving bilateral vocal cords,. preepiglottic space, thyroid cartilage and perithyroidal soft tissue. - Tumor size: 3.5 cm. - Lymphovascular invasion: absent. - Perineural invasion: absent. - Margins univolved by invasive tumor. Thyroid: Papillary microcarcinoma (3 focuses; the major focus measures 0.4 cm). Absence of vascular invasion and extrathyroidal invasion. Adenomatous goiter with hyperplastic nodule.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Kidney, left, laparoscopic nephrectomy. - Renal cell carcinoma, papillary type, grade 2 (of 4,. Furhman classification), 5.8 cm diameter, extending into. but not through capsule, without angiolymphatic invasion,. surgical margins not involved. - Medullary fibromata, multiple. B: Testicle, right, orchiectomy. - Benign testicular parenchyma, mild decreased. spermatogenesis, no neoplasm identified. C: Testicle, left, orchiectomy. - Benign testicular parenchyma, mild decreased. spermatogenesis, no neoplasm identified. Comment: None. Clinical History: Patient is with a clinical diagnosis of prostate carcinoma. and a renal mass, in for left laparoscopic nephrectomy and. bilateral orchiectomy. Gross Description : Received are three appropriately labeled containers. Container A is additionally labeled ""left kidney. "". Specimen fixation: formalin. Type of specimen: laparoscopic nephrectomy. Size and weight of specimen: 650 grams, approximately 19 X. 11 X 5.2 cm nephrectomy specimen. Presence/absence of adrenal gland: absent. Tumor description: there is a well circumscribed soft. yellow lower pole mass; the majority of the inner portion. of the mass is markedly hemorrhagic; there are no cysts or. areas of calcification noted; the mass is in the medulla. but is compressing the pelvis. Tumor size: approximately 5.8 X 4.0 X 2.9 cm. Presence/absence of multicentricity: absent. Confinement/Non-confinement to kidney: confined. Extent of invasion: Perirenal adipose tissue: tumor does not grossly involve. Renal vein: tumor does not grossly involve. Ureter: tumor does not grossly involve. Other organs: n/a. Surgical margins: Perirenal adipose tissue: grossly negative. Renal vein: grossly negative. Renal artery: grossly negative. Ureter:grossly negative. Description of kidney away from tumor: The remainder of the. kidney is pink/tan with a relatively distinct. corticomedullary junction with a cortex measuring. approximately 0.6 cm, the medulla measuring approximately. 1.3 cm; additionally, there are three firm, white nodules. noted in the cortex up to 0.5 X 0.3 X 0.3 cm; these nodules. do not grossly resemble the main tumor mass. Lymph nodes (hilar) : No hilar lymph node candidates are. palpated. Tissue submitted for special investigations: A small. section of tumor and normal tissue were given to Tissue. Block Summary: Al - ureter and hilar vascular margins. A2 - tumor and adjacent kidney. A3 - tumor and capsule, tumor and adjacent kidney. A4, A5 - additional tumor. A6 - representative from three firm white cortical nodules. A7, A8 - representative normal kidney. A9 - representative hilar fat. A10 - additional possible ureter margin. A11 - lymph node candidates. Container B is additionally labeled ""right testicle. It. holds a 37.1 gram, 5.5 X 3.0 X 2.5 cm testicle with. approximately 3.5 X 1.2 x 1.0 cm attached epididymis. The. external surface of the testicle and the epididymis is tan,. smooth and glistening. The external surface is inked blue. to exhibit grossly unremarkable orange/pink, soft. testicular parenchyma. The tunica vaginalis is. approximately 0. cm thick, intact and grossly. unremarkable. The testicular parenchyma is grossly. unremarkable. No masses or lesions are identified in either. testicular or epididymal cut surfaces. Representative. sections are submitted per block summary. B1 - spermatic cord margin. B2 - testicle. B3 - testicle and epididymis. Container C is additionally labeled ""left testicle. It. holds a 40.3 gram, 5 X 3.3 X 3.0 cm testicle with attached. approximately 5.5 X 2.0 cm epididymis. The external. surface of both the testicle and epididymis is tan, smooth. and glistening. The external surface is inked blue and the. testicle is bivalved to exhibit orange/browr soft. testicular parenchyma with no gross lesions or masses. identified. The tunica vaginalis is intact and on average. 0. 1 cm thick. Sections are submitted as per block summary. C1 - spermatic cord margin. C2 - testicle. C3 - testicle and epididymis. Light Microscopy: Light microscopic examination is performed. Histologic tumor type/subtype: renal cell. carcinoma/papillary subtype. Histologic grade (if applicable) : grade 2 (of 4, Furhman. classification). Tumor size (greatest dimension) : grossly 5.8 cm diameter. Extent of tumor invasion: Capsular invasion/perirenal adipose tissue: extension into. but not through capsule in block A3. Renal vein: not involved. Ureter: not involved. Blood vascular: not identified. Lymphovascular: not identified. Depth of invasion: Adjacent organs: no adrenal received. Histologic assessment of surgical margins: negative. Adrenal gland: not included. Lymph nodes: none sampled. Other significant findings non-neoplastic kidney shows. scattered medullary fibromata.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
RUN DATE: RUN TIME. RUN USER. LOC: AGE/SX: ROOM. REG DR: BED: SPEC #. RECD : COLL: TIME IN FORMALIN: hrs. COLD ISCHEMA TIME: mins. CLINICAL INFORMATION: Pre-Op Diagnosis: Squamous cell CA left upper lobe lung. Remarks : Specimen (s) : A. Biopsy for 4R lymph node for frozen section. B. Biopsy level 7 lymph node for frozen section. C. Level 7 lymph node for permanent. D. Left upper lobe with bronchial margin. E. Level 5 lymph node. F. Level 10 lymph node. MICROSCOPIC DIAGNOSIS. A. R4 LYMPH NODE (BIOPSY) : - NEGATIVE FOR METASTASIS. B. LEVEL 7 LYMPH NODE (BIOPSY) : - NEGATIVE FOR METASTASIS. C. LEVEL 7 LYMPH NODE (BIOPSY) : - NEGATIVE FOR METASTASIS. D. LUNG, LEFT UPPER LOBE (LOBECTOMY) : ADENOCARCINOMA. 4.5 CM GREATEST DIMENSION. METASTATIC CARCINOMA IN 3 OF 5 PERIBRONCHIAL LYMPH NODES WITH EXTRANODAL. EXTENSION. VASCULAR INVASION PRESENT. VISCERAL PLEURAL INVASION PRESENT. SURGICAL MARGINS UNINVOLVED. SEE COMMENT FOR SYNOPTIC REPORT. E. LEVEL 5 LYMPH NODE (BIOPSY) : - NEGATIVE FOR METASTASIS. F. LEVEL 10 LYMPH NODE (BIOPSY) : - METASTATIC CARCINOMA. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY - CAP APPROVED. Specimen. Left upper lobe. Procedure: Lobectomy. Specimen Integrity: Intact. RUN DATE. RUN TIME : RUN USER : SPEC #. COMMENT (s). Specimen Laterality: Left. Tumor Site: Upper lobe. Tumor Size. 4.5 cm in greatest dimension. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma. Histologic Grade: G3: poorly differentiated. Visceral Pleural Invasion. Present. Tumor Extension : Not applicable. Margins: Distance of invasive carcinoma from closest margin: 15. mm; parenchymal margin. Bronchial Uninvolved by invasive carcinoma and. carcinoma in situ. Vascular: Uninvolved by invasive carcinoma. Parenchymal: Uninvolved by invasive carcinoma. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. Lymph Nodes Extranodal Extension : Present. Pathologic Staging: Primary Tumor: pT2a. Regional Lymph Nodes: pN1. Number examined : 10. Number involved : 4. Distant Metastasis: Not applicable. GROSS DESCRIPTION: The specimen is received in the fresh state in two parts for frozen section evaluation. Ã. This is fragments of soft, tan and black lymph node measuring 8 mm in aggregate. totally examined by frozen section as block A1. B. This is fragments of soft, black lymph node measuring 8 mm in aggregate, totally. examined by frozen section as block B1. C. This specimen is received in the fresh state from the operating room for permanent. section evaluation and consists of fragments of soft. black lymph node measuring 1 cm. in. aggregate. totally submitted as block C1. D. This specimen is received in the fresh state from the operating room for evaluation. of. surgical margins and for tumor banking. requests evaluation of the specimen for. bronchial margin and for a parenchymal margin staple line present on the specimen. The. specimen consists of a left upper lobectomy specimen which measures 18 x 10 x 6 cm. Present centrally is an area of distorted visceral pleura with underlying palpable tumor. Blue ink is applied to the visceral pleural surface. Sections reveal a firm, partly. necrotic tan tumor which measures 4.5 x 3.5 x 2.5 cm, located 1.5 cm from the parenchymal. margin of concern to. and 3 cm from the bronchial margin. Representative sections. of the tumor are removed by aseptic technique and submitted for tumor banking. Three soft. black peribronchial lymph nodes are present measuring up to 1.5 cm in greatest dimension. The following sections are submitted. RUN DATE : RUN TIME : RUN USER: SPEC # is. GROSS DESCRIPTION: (Continued). D1. one peribronchial lymph node sectioned and totally submitted. D2. two peribronchial lymph nodes sectioned and totally submitted. D3. bronchial margins. D4. vascular margins. D5. two peribronchial lymph nodes bisected and totally submitted. D6-9 -. representative tumor with blue ink on visceral pleura. D10 -. representative lung. Two additional specimens are received in formalin. E. This is multiple fragments of soft, black lymph node which in aggregate measure 2 x 2 x. 0.4 cm. totally submitted as block E1. F. This is fragments of soft, black lymph node measuring 1 x 1 x 0.3 cm, totally submitted. as block F1. INTRAOPERATIVE CONSULTATION: Ã. FROZEN SECTION DIAGNOSIS: NO TUMOR SEEN. B. FROZEN SECTION DIAGNOSIS: NO TUMOR SEEN. D. IMMEDIATE GROSS EVALUATION LEFT UPPER LOBE : 4.5 CM TUMOR PRESENT 1.5 CM FROM PARENCHYMAL MARGIN AND 3.0 CM FROM BRONCHIAL. MARGIN. PHOTO DOCUMENTATION. image. (signature on file).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Invasive ductal breast carcinoma (maximum diameter 5.5 cm, malignancy grade. III) with angioinvasion and a mediocranial safety margin at least 3 mm wide. Tumor classification: G3 (L0, V0), pT3, Nx, Mx. Diagnosis: Tumor-free lymph nodes (total N = 11, pN0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Lab No.: Sex: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Account No: CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: LEFT BREAST CA. POSTOPERATIVE DIAGNOSIS: LEFT BREAST CA. OPERATION: LEFT SIMPLE MASTECTOMY, SENTINEL LYMPH. NODE BIOPSY, F.S. SPECIMENS: A. LEFT SENTINEL LYMPH NODE #1, F.S. B. LEFT SENTINEL LYMPH NODE #2, F.S. C. SENTINEL LYMPH NODE #3, F.S. D. LEFT BREAST SIMPLE MASTECTOMY. FROZEN SECTION DIAGNOSIS: A. LEFT SENTINEL LYMPH NODE #1 -. NUMEROUS HISTIOCYTES WITH ATYPICAL CELLS. DEFER FOR PERMANENT SECTION. B. LEFT SENTINEL LYMPH NODE #2 -. ONE NEGATIVE LYMPH NODE (0/1). C. SENTINEL LYMPH NODE #3 -. ONE NEGATIVE LYMPH NODE (0/1). FINAL DIAGNOSIS: A. LEFT SENTINEL LYMPH NODE #1 -. POSITIVE FOR METASTATIC CARCINOMA (1/1); THE TUMOR. INVOLVES THREE-FOURTHS OF THE NODE WHICH MEASURES .6. CM. IN DIAMETER, NO PERICAPSULAR SOFT TISSUE EXTENSION. B. LEFT SENTINEL LYMPH NODE #2 -. ONE REACTIVE LYMPH NODE (0/1). Lab No.: C. SENTINEL LYMPH NODE #3 -. ONE REACTIVE LYMPH NODE (0/1). D. LEFT BREAST MASTECTOMY -. INVASIVE LOBULAR CARCINOMA (7 CM.). TUMORAL CALCIFICATION/NECROSIS: NONE IDENTIFIED. DCIS/LCIS: NONE IDENTIFIED. SURGICAL MARGINS/NIPPLE, SKIN AND AREOLA: UNINVOLVED. NON-NEOPLASTIC BREAST: FIBROCYSTIC CHANGES TO INCLUDE DUCTAL EPITHELIAL. HYPERPLASIA. PTNM CLASSIFICATION: T3 N1 MX; STAGE IIIA. COMMENT: The multiple sections from the tumor reveal patchy areas of tumor infiltration. extending up to lactiferous ducts. In addition, the tumor cells also display unfavorable. nuclear features in many areas. The ER, PR and Her-2/neu have been performed on the. previous biopsy. The PanKeratin Immunostain is performed on specimens A, B. and C. GROSS: A. The container is received fresh unfixed labele. eft sentinel lymph node #1. for frozen section"". The specimen consists of an ovoid mass of pink-tan soft rubbery. tissue mixed with fatty tissue measuring 0.6 cm. in greatest dimension. Frozen section is. obtained by. The entire specimen including frozen section in one block. B. The container is received fresh unfixed labele. left sentinel lymph node #2. for frozen section"". The specimen consists of an ovoid mass of tan-gray soft rubbery. tissue with attached fat. Frozen section is obtained by. The entire specimen. including frozen section in one block. Lab No.: C. The container is received fresh unfixed labele. sentinel lymph node #3 for. frozen section"". The specimen consist of an ovoid mass of pink-tan soft rubbery tissue. measuring 1.3 cm. in diameter in the aggregate. Frozen section is obtained by. The entire specimen including frozen section in one block. D. The container is received fresh unfixed labeled. ""left breast"". The specimen. consists of an 809 gm. apparent left breast which is 23 x 15 x 4 cm. in greatest overall. dimension. There is an inverted nipple. The attached skin ellipse is 21 x 9.5 cm. Sectioning through the breast stroma reveals dense gray-white fibrous tissue varying up. to 7.5 cm. in greatest dimension. This area has been previously marked with blue dye. There are scattered cystic spaces varying up to 0.1 cm. in greatest dimension filled with. an amber-colored fluid. Sectioning also reveals a firm tan-gray striated tumor mass. which is 7 x approximately 5.5 cm. in greatest overall dimension and is approximately. 0.7 cm. from the deep/underlying resection margin. The specimen is submitted in ten. blocks. Key Note Block Summary: 1-nipple, 2 through 4-cystic spaces, 5-random,. 6. through 10-tumor mass. MICROSCOPIC EXAMINATION: MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: PanKeratin (specimens A,B,C).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Asterand Case ID. Open Clinica. Gross. Microsc. Diagnos. Subject ID. Descript. opic. is. ion. Descript. Details. ion. BR-7717. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: 5 X 4.5 X 1 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Adjacent. structures (specify) - lesser. omentum. Lymph nodes: 2/8 positive for. metastasis (Intraabdominal. 2/8). Lymphatic invasion: Not. specified. Venous invasion: Not specified. Perineural invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SURGICAL PROCEDURES: RESECTION, REGIONAL LYMPH. CLINICAL HISTORY. PRE-OPERATIVE DIAGNOSIS: RIGHT LOWER LOBE CA. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""level 10"" and. consists of a pink red cauterized segment of tissue measuring 1 x 0.7 X. 0.5 cm, sectioned and submitted in toto, 3 (1) labeled ""FSP"" used for. frozen section. FROZEN SECTION DIAGNOSIS: Adeno CA. B. The specimen is submitted fresh as ""inferior pulmonary ligament lymph. nodes level 9"" and consists of two deep red 0.3 and 0.9 cm nodules. submitted intact and in toto; 2 (1). C. The specimen is submitted fresh as ""level 8R"" and consists of a deep. red to black 1 cm nodular bisected and submitted in toto; 2 (1). D. The specimen is submitted fresh as ""level liR"" and consists of two. deep red to black semi nodular segments of tissue measuring 0. and 0.8 cin. in dimension. Submitted intact and in toto, 2 (1) -. E. The specimen is submitted fresh as ""level 7"" and consists of two deep. red nodules measuring 0. cm and 0.6 cm in dimension; submitted, 2 (1). F. The specimen is submitted fresh as ""subcarinal level 7"" and consists. of two deep red to black 0.1 and 1. semi nodular segments of tissue. The. largest marked with black dye for identification purposed. The largest is. bisected and submitted in toto, 3 (1). G. The specimen is submitted fresh as ""right lower lobe - stitch on 11R. node"" and consists of a 133 gram (formalin fixed), 14 x 9 x 3.4 cm lung. lobectomy received with a stitch designating the 11R node. The outer. GROSS DESCRIPTION. pleural surface shows a 3 x 2 cm firm puckered indurated area. The. pleural surface overlying this area is inked blue. The remaining pleural. surface is pink to purple tan, smooth and glistening with focal areas of. anthracotic pigmentation. The specimen is received with a stapled. bronchial margin measuring 1.5 cm in diameter with adjacent stapled. vasculature margin measuring 0.5 cm in length and 1 cm in diameter and 0.2. cm in length and 1.2 cm in diameter. The stapled margin measures 5 cm in. length. The stapled margin is removed and the underlying parenchyma inked. black. Sectioning reveals a 3.8 x 2.8 X 2.5 cm tan gray to white firm. focally hemorrhagic mass corresponding to the previously described. puckered area on the pleural surface grossly appearing to abut the blue. inked pleura, measuring 3.5 cm from the bronchial margin and 4.5 cm from. the parenchyma underlying the stapled resection margin. The remaining. parenchyma is inked red, spongy, homogenous and grossly unremarkable. No. other discrete masses or nodularities are grossly identified. At the. hilum are two gray black lymph nodes including the one previously. designated with a stitch at the 11R node measuring 0.8 and 1 cm in. greatest dimension, each of which are submitted entirely intact. Representative sections are submitted, multiple (8) as follows: 1: Vasculature and bronchial margin. 2: Mass with closest blue inked pleural surface. 3: Additional sections of mass. 4: Perpendicular section of the stapled resection closest to. mass. 5: Mass with adjacent uninvolved parenchyma. 6: Uninvolved parenchyma and pleura. One intact hilar lymph node. 8: Intact 11R node designated by stitch. X1-2: Additional sections of the tumor. FINAL DIAGNOSIS. A. LYMPH NODE, LEVEL 10, BIOPSY: METASTATIC ADENOCARCINOMA INVOLVING MULTIPLE LYMPH NODE. FRAGMENTS. B. LYMPH NODE, INFERIOR PULMONARY LIGAMENT LEVEL 9, BIOPSY: TWO LYMPH NODES, NEGATIVE FOR TUMOR. C. LYMPH NODE, LEVEL 8R, BIOPSY: LYMPH NODE, NEGATIVE FOR TUMOR. FINAL DIAGNOSIS. D. LYMPH NODE, LEVEL llR, BIOPSY: LYMPH NODE, NEGATIVE FOR TUMOR. E. LYMPH NODE, LEVEL 7, BIOPSY: LYMPH NODE, NEGATIVE FOR TUMOR. F. LYMPH NODE, SUBCARINAL LEVEL 7, BIOPSY: LYMPH NODE, NEGATIVE FOR TUMOR. G. LUNG, RIGHT LOWER LOBE, LOBECTOMY: MODERATELY DIFFERENTIATED ADENOCARCINOMA. SEE SYNOPTIC REPORT. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. LATERALITY: RIGHT. TUMOR SITE: RIGHT LOWER LOBE. TUMOR SIZE: 3.8 CM. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: 2 (MODERATELY DIFFERENTIATED). EXTENT OF INVASION: CONFINED TO LUNG. EXTENTION TO PLEURA/OTHER STRUCTURES (SPECIFY) : NONE. MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. DISTANCE TO PERTINENT MARGIN (S) : 3.5 CM FROM THE BRONCHIAL MARGIN. VENOUS INVASION: ABSENT. ARTERIAL (LARGE VESSEL) INVASION: ABSENT. LYMPH NODE : N1 - # INVOLVED/# EXAMINED: 2/3 (INVOLVEMENT OF LEVEL 10 NODE. AND A PERIHILAR LYMPH NODE ON THE LOBECTOMY SPECIMEN). f, N2 - # INVOLVED/#EXAMINED: 0/8+. f, N3 - # INVOLVED/# EXAMINED: 0/0. SYNOPTIC REPORT. OTHER PERTINENT FINDINGS: - ON GROSS AND MICROSCOPIC EXAMINATION, A SEPARATE TUMOR NODULE IS NOT. IDENTIFIED. - NO PLEURAL INVASION IS IDENTIFIED. ON THE LOBECTOMY SPECIMEN, METASTATIC CARCINOMA IS PRESENT IN ONE OF. TWO PERIHILAR LYMPH NODES. UNINVOLVED LUNG IS UNREMARKABLE. pTNM STAGE: pT2 N1 MX.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SURG PATH REPORT. 1st Specimen collected on. FINAL DIAGNOSIS. 1. R4 LYMPH NODE (EXCISION) : METASTATIC CARCINOMA INVOLVING I OF. LYMPH NODE (4 MM FOCUS). 2. HIGH R4 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 3. R10 LYMPH NODE (EXCISION) : METASTATIC CARCINOMA INVOLVING 1 OF 1. LYMPH NODE (4 MM FOCUS). 4. RIGHT LUNG UPPER LOBE (LOBECTOMY) : SPECIMEN TYPE: Lobectomy. TUMOR SITE: Right, upper lobe. HISTOLOGIC TYPE: Adenosquamous carcinoma. TUMOR SIZE: Greatest dimension: 7.5 cm. LOCATION, SIZE, AND HISTOLOGIC TYPE OR ADDITIONAL SEPARATE TUMOR. NODULES, IF ANY: None identified. HISTOLOGIC GRADE: G3: Poorly differentiated. LYMPH NODES: Metastatic carcinoma in 3 of 9 lymph nodes. (see part 1-6). EXTENT OF INVASION (STAGING). PRIMARY TUMOR: pT2 Tumor which is >3 cm. REGIONAL LYMPH NODES: pN2: Metastasis in ipsilateral mediastinal or subcarinal lymph nodes. DISTANT METASTASIS;. pMx: Cannot be assessed. MARGINS: Margins uninvolved by invasive carcinoma. VENOUS/ARTERIAL (LARGE VESSEL) INVASION: Indeterminate. LYMPHATIC (SMALL VESSEL) INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. 5. P3 LYMPH NODE (DISSECTION) : TWO (2) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 6. STATION 7 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. ADDENDUM. EGFR MUTATION ANALYSIS: RESULTS: No mutation detected. K-RAS MUTATION ANALYSIS: RESULTS: No mutations were identified at codons 12 and 13. of the KRAS gene. NOTE: A copy of the complete report is available in. and is on. file in the molecular pathology laboratory. End of Diagnosis. Clinical History: ? LUNG CANCER.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Sample ID #. Diagnosis: Section of resected colon (rectosigmoid) with a rectal carcinoma of the histological type of. a moderately differentiated colorectal adenocarcinoma, extending a max of 4 cm to the. aboral resection margin and measuring 3.3 cm in diameter at the widest point. Invasive. spread of the tumor. Invasive spread of the tumor to the inner layers of the muscularis. propria. Oral and aboral resection border is tumor-free. 34 local lymph nodes are tumor-free with uncharacteristically reactive changes. Stage of tumor: pT2 pN0 (0/34) G2 R0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: 4. Resected material from'l left breast segment with a 1.4 cm poorly differentiated (G3). invasive ductal breast carcinoma. Carcinoma-free resection margins, carcinoma-free skin. Fibrous mastopathy of surrounding tissue. Tumor stage: pTlc pN1mi (intranodal micrometastasis), MX, R0; G3 (L0, V0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
V3.00 110614. Instructions: The TCGA Missing Pathology Report Form should be completed for cases for which a pathology report is not. available. General Pathology Report Information. #. Data Element. Entry Alternatives. Working Instructions. Provide the tumor type of the case. 1. Tumor type: Indicate to which BCR location the case was originally sent. 2. BCR specimen originally sent. NCH. to: IGC. Biospecimen Core Resource (BCR). Date specimen received at. 3. BCR: ICD-0-3 Histology Code: Provide the histology code for the sample from the Case. Quality Control Form (CQCF) and the overall case (patient. For Specimen: (CQCF). diagnosis, if different). 4. For Case: (patient. diagnosis, if available. elsewhere). ICD-0-3 Site Code: Provide the site code for the sample from the Case Quality. Control Form (CQCF) and the overall case (patient diagnosis, if. different). For Specimen: (CQCF). 5. For Case: (patient. diagnosis, if available. elsewhere).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Tumor entity. This concerns a moderately differentiated, invasive colic adenocarcinoma, partly of the. type of an extracellular mucus-forming carcinoma with penetration of all wall layers (pT3,. L0, V0), with free resection margins and concomitant chronic recurrent appendicitis. There. are also free lymph nodes. pNO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Numbe. PRE-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. POST-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. PROCEDURE. MODIFIED RADICAL MASTECTOMY RIGHT BREAST, INSERTION MEDIPORT. TISSUES. BREAST MASTECTOMY (WMV) NODES - RIGHT BREAST AND AXILLARY CONTENTS. FINAL DIAGNOSIS. RIGHT BREAST AND AXILLARY CONTENTS -. POORLY DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA, SCARFF-. BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 10.5 CM. IN MAXIMUM. DIMENSION. LYMPHOVASCULAR INVASION IDENTIFIED INSIDE THE TUMOR. ALL SURGICAL MARGINS ARE FREE OF THE LESION. THE CLOSEST SURCICAL. MARGIN IS THE DEEP SURGICAL MARGIN WHICH IS 1.2 MM. FROM THE TUMOR (JUST. ABOVE THE MUSCLE). BENIGN SKIN AND NIPPLE. TEN OF FOURTEEN LYMPH NODES ARE POSITIVE FOR METASTATIC. CARCINOMA (10/14). TUMOR STAGE: STAGE IIIC, T3, N3, MX. PQRI CATEGORY II: 3260F. Diagnosed by: COMMENT. This case is discussed with. GROSS DESCRIPTION. The container is received fresh unfixed labele. ight breast and axillary contents"" and. consists of a 788 gm. apparent right breast which is 24x 17 x 5 cm. in greatest overall dimension. The. attached skin ellipse is 11.5 x 8.5 cm. There is an eccentrically attached nipple. There is also an. SURGICAL REPORT. of 2. attached suture indicating superior lateral/upper outer aspect inked with an orange dye. The lower outer. is inked green, the upper inner is inked black, the lower inner is inked red. The deep surgical margin is. inked yellow. Sectioning reveals a dense gray-white slightly swirled tumor mass which is 10.5 x 5.5 x 4. cm. in greatest overall dimension and grossly appears to be 3 cm. from the superior lateral/upper outer, 3. cm. from the upper inner and appears to be 3.5 cm. from the lower outer and 4 cm. from the lower inner. It grossly appears to be 0.8 cm. from the deep surgical margin. The tumor mass has scattered yellow-tan. chalky areas varying up to 0.2 cm. and hemorrhagic areas varying up to 0.1 cm. Sectioning through the. axillary fat reveals tan-gray nodules varying up to 2.5 cm. in greatest dimension, each are bisected, one-. half submitted. Twenty blocks. Key Note Block Summary: 1-nipple, 2-deep surgical margin, 3-superior lateral/upper. outer, 4--lower outer, 5-upper inner, 6-lower inner, 7 through 10-tumor, 11 through 13-random, 14. through 20-apparent nodes. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Pancreas Cancer. <Slide key: A: pancreatic resection margin, B. #13, C: LN #14, D: omentum,. E: LN #5, F: LN #8, G: LN #12, H: LN 13#, 1: LN 16#, 1: 2-5: duodenum. (2: ampulla of vater, 3. 6: duodenum. 7-8: CBD. 9: CBI. 0-11: GB. (10: CBD opening. , 12: 13: ampulla of vater. MICRO (25HE). DIAGNOSIS: Head of pancreas, duodenum, common bile duct and gallbladder,. pylorus-preserving pancreat ticoduodenectomy: Ductal adenocarcinoma, well differentiated, pancreas. with 1) tumor size: 3.5x2.3cm. 2) extension to per ipancreatic soft tissue. 3) invasion to duodenum, common bile duct and ampulla of Vater. 4) perineural invasion, multifocal. 5) venous invasion: not identified. 6) clear pancreatic, common bile duct and duodenal resection margins. 7) metastasis to two out of 22 regional Tymph nodes. (LN #13: 0/4, LN #14: 0/1, LN #5: 0/0, LN #8: 0/2, LN #12: 0/11,. LN #16: 0/13, per ipancreatic LN: 1/1). 8) pathologic staging: pT3 N1b.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
y Case. IV Report. Case type: Surgical History. Case imported from. computer system. The format of this report does not match the original case. For cases prior to. section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) LEVEL IIA AND IIIA LYMPH NODES: Four lymph nodes, no tumor present. (8) LEVEL IIB, IIIB, IVB AND VB LYMPH NODES: NO tumor present in five of level IIB lymph nodes. METASTATIC PAPILLARY CARCINOMA OF THYROID IN 3/10 OF LEVEL IIIB. LYMPH NODES. METASTATIC PAPILLARY CARCINOMA OF THYROID IN 1/5 LEVEL IVB LYMPH. NODES. No tumor present in six of level V lymph nodes. (c). INFERIOR RIGHT PRETRACHEAL MASS: METASTATIC PAPILLARY CARCINOMA OF THYROID IN 2/2 LYMPH NODES. (D) THYROID, TOTAL THYROIDECTOMY: PAPILLARY CARCINOMA OF THYROID WITH COMBINED PAPILLARY AND FOLLICULAR. COMPONENTS, EXTENDING INTO ADJACENT SOFT TISSUE. METASTASIS INTO 1/1 PARATHYROID LYMPH NODE. (E) RIGHT UPPER PARATRACHEAL MASS: METASTATIC PAPILLARY CARCINOMA OF THYROID IN 3/3 LYMPH NODES. Entire report and diagnosis completed bv: Report released by: GROSS DESCRIPTION. (A) LEVEL II AND III A LYMPH NODES - A single piece of fibrofatty tissue (3.5. x 2.0 x 0.8 cm). Four separate lymph nodes are identified within this tissue. They range in maximum dimension from 0.5 to 1.8 cm. SECTION CODE: A1, largest lymph node hicerted; A2, two possible lymph. nodes; A3, one possible Tymph node. (B) LEVEL IIB, IIIB, IVB, AND VB LYMPH NODES - A right neck dissection. including fibrofatty tissue, muscle folds, lymph nodes, and vascular tissue. which is 9.5 x 5.0 x 3.0 cm. The largest 1ymph node recovered is 3.5 x 3.0. x. 2.7 cm, and is grossly positive for tumor. It is located in level 3. Other. lymph nodes in level 3 and level 4 are also grossly positive for tumor. SECTION CODE: Lymph nodes submitted as follows: Level 2B - B1, three possible lymph nodes; B2, four possible lymph nodes. Level 38 - representative sections B3, 84, representative sections of. largest, grossly positive lymph node; B5, representative sections of. additional grossly positive lymph node; B6, B7, four possible lymph nodes,. each cassette; B8, three possible lymph nodes. Lymph nodes from level 4B - B9, one lymph node, bisected; 810, four. possible lymph nodes; B11, five possible Tymph nodes. I evel 5 Tymph nodes: B12, B13, four possible lymph nodes, each cassette. (c) INFERIOR RIGHT PRETRACHEAL MASS - Two tan ovoid firm nodules measuring. History Case. Dathology Report. Pathologis. Case type: Surgical History. 1.3 and 0.5 cm, respectively. They are entirely submitted as follows: SECTION CODE: C1, C2, larger nodule; C3, smaller nodule. (D) THYROID - A thyroidectomy specimen (7.0 x 4.5 x 2.3 cm). The right lobe. contains a tan firm nodule measuring 2.0 cm in greatest dimension. A second. nodule is present in the left lobe (0.8 cm). INK CODE: Black - capsule. SECTION CODE: D1-D5, right lobe nodule; D6, right lobe, representative. section of uninvolved parenchyma; D7-D8, left lobe nodule; 09, left lobe. representative resection. RIGHT UPPER PARATRACHEAL MASS - Three tan ovoid nodules measuring 3.0,. 1.1 and 1.0 cm, respectively in greatest dimension. The cut surfaces are tan. and lobulated. All the nodules are submitted in toto as follows: SECTION CODE: E1-E4, largest nodule; E5, mid size nodule; E6, smallest. nodule. SNOMED CODES. M-80503 M-80506 T-B6000 T-C4100.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. A. Left axillary sentinel lymph node. B. Left breast biopsy. CLINICAL NOTES. CLINICAL HISTORY. A. -year-old - white female with left breast. cancer. FROZEN SECTION DIAGNOSIS. AFS: Left axillary sentinel node, excision - One lymph node with no. metastasis identified. GROSS DESCRIPTION. A. Container A is labeled with the patient's name, medical. record number and ""left axillary sentinel node"". The. specimen consists of a single partially fatty replaced lymph node. measuring 1.3 x 1 x 0.6 cm. AFS, bisected. B. Container B is labeled with the patient's name, medical. record number and ""left breast biopsy, long anterior,. short. superior. The specimen consists of a single piece of fibrous. adipose tissue oriented by two sutures and measuring 6.5 cm in. medial to lateral, 3.5 cm from superior to inferior and 3 cm from. anterior to posterior. The specimen margins are inked as follows: Blue -- anterior; black -- posterior; yellow -- lateral; orange --. medial; red -- superior; green -- inferior. The specimen is. serially sectioned. On cut section, there is a firm tan. fibrotic-appearing tumor mass measuring 2.2 x 1.5 x 1.8 cm. The. mass appears to extend to the posterior margin of resection. A. portion is submitted for tissue procurement. The remainder of the. tissue is submitted in blocks 1-15. MICROSCOPIC DESCRIPTION. A. Sections of the left axillary sentinel lymph node. demonstrate 1 lymph node with no evidence of metastasis. The lymph node was examined and multilevel sectioning with H&E. stain. as well as immunohistochemistry for pankeratin. B. The following template applies to the left breast. biopsy : Invasive Carcinoma: Present. Histologic type: Infiltrating ductal carcinoma. Histologic grade. Overall grade : 3. Architectural score: 3. Nuclear score: 3. Mitotic score: 2. Greatest dimension (pT) : 2.2 cm. (pT2). Specimen margins : Positive. Invasive carcinoma extended to the green ink involving the. inferior margin. Vessel invasion : Not identified. Calcification: : Present. Ductal carcinoma in situ: Present. Histologic pattern: Solid and cribriform. Nuclear grade: 2-3. Central necrosis: Focally present. %DCIS of total tumor: 25%. Extensive intraductal component (present/absent) : Present. Specimen margins : Close. In situ carcinoma is less than 1 mm. from the anterior, posterior, medial and inferior margins. Calcification: Present. Description of non-tumorous breast : Proliferative changes. Comments: None. MICROSCOPIC DESCRIPTION. Prognostic markers: Previously performed. 4x2, 20. DIAGNOSIS. A. Left axillary sentinel lymph node, resection: No evidence of metastasis in one lymph node (0/1). B. Left breast, excisional biopsy: Infiltrating ductal carcinoma, grade 3, 2.2 cm. extending to. the inferior margin. Extensive ductal carcinoma in situ, solid and cribriforming. subtypes, nuclear grade 2-3, less than 1 mm from multiple. margins. M.D, (Electronic Signature). --- End Of Report.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. 1. F. ADM DATE: OPER DATE: PROCEDURE: SPHS. ear-old with history of adrenal mass and Cushing's syndrome per CT. No. mets. Operative Procedure: Right adrenalectomy, right nephrectomy, wedge. resection of liver. PROCEDURE: SPGD. 1. ""R. radical adrenalectomy."" Received fresh is a 253 gram trimmed portion of. ovoid possible adrenal tissue, 9.3 x 8.2 x 6.7 cm. The cut surface reveals. a. 9.8 x 7.3 x 6.0 cm hemorrhagic possibly necrotic tan tumor that abuts the. margin. A scant amount of bright orange-yellow tissue is identified measuring. 3.7 x 1.3 x 0.8 cm. Attached to the periadrenal adipose is a 4.3 x 2.2 x 0.3. cm possible portion of liver. The cut surface is red-brown. Also attached to. the periadrenal adipose is a 193 gram kidney, 11 x 6 x 4.2 cm. The cut surface. of the kidney is a tan-brown with a well-defined corticomedullary junction. Lesions are noted. The adrenal gland is somewhat embedded within the kidney. cortex. No other lesions are noted. 1A-I. Adrenal mass. 1J. Adrenal mass to possible liver. 1K. Kidney margins. 1L. Adrenal gland to kidney. 1M. Normal kidney. PROCEDURE: SPDX. 1. Right adrenal and kidney, excision: Adrenal cortical carcinoma (9.8.cm),. high-grade, adherent to, but not directly invading, the kidney and liver. Margins negative. Histologically unremarkable kidney. Case reviewed by. the signing staff pathologist, have personally. examined and interpreted the Slides from this case. END OF PREVIOUS DIAGNOSIS INQUIRY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: Left lobe liver (2195 grams, 26 x 16 x 9 cm), separately submitted tissue from. Segment V liver (30 grams, 5 x 4 x 3 cm), needle biopsy from Segment V liver No. 1. (2 mm) and No.2 (7 mm), left periportal lymph node (2.1 x 1.3 x 0.8 cm) and. gallbladder (8 x 3.5 x 2 cm). A1, B1, C1, C2, C3, C4, C5, C6, C7, D1, D2, E1. DIAGNOSIS: Liver, left lobe, excision: Grade 3 (of 4), hepatocellular carcinoma, usual type,. forming a 25 x 16 x 9 cm multinodular mass. The tumor is located in left lobe. The. hepatic capsule is free of tumor. The surgical margins are free of tumor, the. clearance being 1.2 cm microscopically. Extramural vascular invasion is not. identified. The tumor is encapsulated by a 0.5 cm thick fibrous capsule. The. approximate percent of necrosis is 10%. The non-neoplastic liver will be assessed. on permanent sections and an addendum will be issued. Liver, Segment V, excision: Grade 3 (of 4) hepatocellular carcinoma, forming a mass. (3 x 2 x 1.8 cm). The margins are negative for tumor. Liver, Segment V, needle biopsy #1: Hemangioma. Liver, Segment V, needle biopsy #2: Negative for tumor. Lymph node, periportal, excision: A single benign lymph node is identified. Gallbladder, cholecystectomy: No diagnostic abnormalities. ADDENDUM: Permanent sections of the adjacent non-neoplastic liver tissue show no diagnostic. abnormalities. An iron stain and PAS-D are negative. Seen with Dr.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Stomach (Antrum). 1 - ""Body and antrum of the stomach"": -Poorly differentiated adenocarcinoma (intestinal pattern of LaurÃ©n) ulcerated,. infiltrating the subserosal adipose tissue;. -Greatest dimension of tumor: 7.5 cm;. -Angiolymphatic invasion: present;. -Perineural invasion: not detected;. -Adjacent mucosa: low-grade epithelial dysplasia and intestinal metaplasia;. -Surgical margins: uninvolved by neoplasia. -Omentum: absence of neoplasia. Lymph nodes of lesser curvature: absence of neoplasia (0/10). Lymph nodes of greater curvature: absence of neoplasia (0/6). 2 - ""Number 6 lymph node"": Fibrous connective tissue and adipose tissue uninvolved by neoplasia. 3 - ""Peripancreatic lymph node"": Fibrous connective tissue and adipose tissue uninvolved by neoplasia. 4 - Anterior layer of the transverse mesocolon"": Absence of neoplasia. 5 - ""8P lymph node : Uninvolved by neoplasia (0/4). 6 - ""11P lymph node"": Fibrous connective tissue and adipose tissue uninvolved by neoplasia. 7 - ""Gallbladder"": Uninvolved by neoplasia.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with right colon mass and. Specimens Submitted: I: SP: Colon, right; hemicolectomy. DIAGNOSIS: 1. SP: Colon, right; hemicolectomy: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Ascending colon. Tumor Size: Length is 5.5 cm. width is 6.5 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Tubular adenoma; number: 2. Hyperplastic polyp; number: 1. Non-Neoplastic Bowel: Unremarkable. Appendix: Fibrous obliteration of the lumen. Lymph Nodes: Number with metastasis: 1. Total number examined: 24. Tumor deposits in pericolorectal soft tissue: Identified. Tumor Staging (AJCC 7th Edition). pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : N1 (Metastasis in 1-3 regional lymph nodes). PENDING K-RAS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. KRAS. Gross Description: 1) The specimen is received fresh, labeled ""Right hemicolectomy colon"" and. consists of a segment of terminal ileum, cecum with attached appendix and. ascending colon, The terminal ileum measures 7.5 cm in length and 3.5 cm. in. circumference at the proximal resected margin. The remaining colon measures. 19 in length with a circumference of 8 cm at the distal resected margin. The attached appendix measures 6.5 cm in length and averages 0.7 cm in. diameter. The appendiceal and intestinal serosa is pink tan and smooth. Focally hemorrhagic lobulated yellow tan adipose tissue spans the length of. the specimen measuring up to 5 cm in thickness. The specimen is opened to. reveal a circumferential, centrally ulcerative, fungating, brown tan tumor. measuring 5.5 cm in length, 6.5 cm in width, and 2.0 cm in height. On cut. section of the tumor, it measures 2.5 cm in maximum depth and abuts the. black inked radial margin. The tumor is located 6.3 cm from the ileocecal. valve and 6 cm from the distal resected margin. Also identified, 4.0 cm from. the ileocecal valve and 4.2 cm from the main tumor mass, there is a. brown-tan polypoid structure measuring 1.8 x 0.8 x 0.7 cm. The remaining. mucosa shows brown-tan folded appearance and several polypoid areas. measuring up to 0.4 x 0.3 cm in greatest dimensions, which are entirely. submitted. The specimen is submitted for lymph node dissection. The. attached adipose tissue is thoroughly examined and all identified lymph. nodes are submitted. Representative sections of the specimen are submitted. for permanent sections and for TPS. Summary of sections: PM - proximal margin shave. DM - distal margin shave. T - tumor (box 11 and 12, 13 and 14 are full-thickness section of tumor with. underlying cause of lymph node, bisected). APP - appendix representative sections. RS -representative sections. LN - lymph nodes. LPOL-largest polypoid area. POL-polypoid areas. Summary of Sections: Part 1: SP: Colon, right; hemicolectomy. Block. Sect. Site. PCs. 2. app. 2. 1. dm. 1. 7. LN. 18. 2. 1pol. 2. 1. pm. 1. 1. pol. 1. 1. rs. 1. 6. 6. Specimens Submitted: 1: DM SUBMITTED 10 UNSTAINED SLIDES AND 1 H&E, RIGHT COLON. Test Performed: KRAS Gene Exon 2 mutation analysis (codons 12 and 13). DNA quality: good. Methodology: PCR was performed to amplify exon 2 of the KRAS gene from genomic DNA. prepared from the submitted tissue. The PCR product was analyzed on an ABI. 3730 DNA sequencer and the sequences were compared to control sequences. DIAGNOSTIC INTERPRETATION: Negative for KRAS exon 2 mutation. Technical sensitivity: This assay cannot detect a KRAS exon 2 mutation if. the proportion of tumor cells in the sample studied is less than 25%. 1. This result cannot be used as sole evidence for or against cancer and has. to be interpreted. in the context of all available clinical and pathological information. 2. This test was developed and its performance characteristics determined by. the Laboratory of. Diagnostic Molecular Pathology. It has not been cleared or approved by the. U.S. Food and Drug. Administration (FDA). The FDA has determined that such clearance is not. necessary. This test. is used for clinical purposes. Pursuant to the requirements of CLIA - 88,. our laboratory has. established the accuracy and precision of this test. This test has been. approved by. as a laboratory specific assay. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. NONE OF THESE MUTATIONS WERE DETECTED IN THE TUMOR. CLINICAL PANEL. Gene Codon. BRAF V600. EGFR L858. INVESTTIGATIONAL PANEL. Gene Codon. Gene Codon. Gene Codon. AKT1 E17. EGFR L861. NRAS G12. BRAF G469. ERBB2 L755. NRAS G13. BRAF D594. ERBB2 D769. NRAS Q61. EGFR E709. ERBB2 V777. PIK3CA R88. EGFR G719. KRAS Q61. PIK3CA N345. EGFR D761. KRAS K117. PIK3CA C420. EGFR S768. KRAS A146. PIK3CA E542. EGFR R776. MEK1 Q56. PIK3CK E545. EGFR T790. MEK1 K57. PIK3CA M1043. EGFR T854. MEK1. D67. PIK3CA H1047. Diagnostic sensitivity: This finding does not exclude the possibility of. other mutations. Technical sensitivity: This test may not detect certain mutations if the. proportion of tumor cells in the sample studied is less than 10%. Test Performed: Sequenom masa-spectrometry genotyping for specific mutations in 8 genes: AKT1, BRAF, EGFR, ERBB2, KRAS, MEK1 (MAP2K1), NRAS, and PIK3CA. Methodology. The specific mutations are detected by amplification of the corresponding. exons by polymerase chain reaction (PCR), followed by a single base. extension at the site of the point mutation. The single base extension. product is detected by tandem mass-spectrometry on a Sequenom MassArray. Spectrometer. Addendum Comment. PLATE# P10-42. This result cannot be used as sole evidence for or against cancer and has to. be interpreted in the context of all available clinical and pathological. information. This test was developed, and its performance characteristics determined, by. the. It has not been cleared or. approved by the U.S. Food and Drug Administration (FDA) . The FDA has. determined that such clearance is not necessary. This test is used for. clinical purposes. Pursuant to the requirements of CLIA ,. bur laboratory. has established the accuracy and precision of this test. The results of the investigational panel are for investigational use only.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: This involves an invasive, poorly differentiated colon adenocarcinoma (G 3; partially mucinous. carcinoma) with penetration of all parietal layers (p T 3), as well as free lymph nodes and free. resection margins.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Pathology Report-Summary: Material: lung, right, lower lobe: 17.0 X 15.0 X 9.0 cm with middle lobe: 12.0 X 9.0 x 4.0. tumor in lower lobe: 10.0 X 8.0 X 7.0 cm. Diagnosis: Adenocarcinoma, mixed subtype (partially: acinar, papillary, BAC, solid). Partially neuroendocrine. Infiltration of pleura visceralis. pT2, pN2 (10/35), pMx, G3. Supplementary examinations: IHC: Tumor cells positive for: CK7, CK18, CEA, partially positive for TTF1, NSE,. Chromogranin A. Tumor cells not positive for synaptophysin, CD56.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Left lower lobe. Tumour Size (cm). 9.5. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2,NOS. Pathological N. N2. Clinical M. M0. VALCSG Stage. Histology Comments. Metastatic carcinoma in 4/9 segmental and lobar lymph. nodes. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Report Status: Amend/Addenda. Type: Surgical Pathology. Specimen Type: Kidney. partial or total resection. Procedure Date: PATHOLOGIC DIAGNOSTS: SPECIMEN DESIGNATED ""LEFT KIDNEY"". our. UL. 5463. RENAL CELL CARCINOMA (12.8 cm) Clear cell type,. Fuhrman nuclear grade II/IV. The tumor abuts but does not invade the renal capsule. The tumor invades the renal sinus and abuts the endothelium. of large veins (tumor is not present in the renal vein). The tumor shows extensive hyalinization. The ureter, renal artery, and renal vein resection margins are. negative for tumor. AJCC Classification: T3a Nx MX. The non-neoplastic kidney will be evaluated by the Renal Pathology. Division, and the findings will be reported in an addendum. CLINICAL DATA: History: None given. Operation: Left radical nephrectomy. Operative Findings: None given. Clinical Diagnosis: Left renal mass. ORGANS/TISSUE SUBMITTED: A/1. Left kidney. GROSS DESCRIPTION: The specimen is received fresh, in one part, labeled with the patient' name,. medical record number and ""Left kidney"", and consists of a 1642-gram. nephrectomy specimen (24.5 x 13.0 x 9.8 cm) with ureter (11.5 in length x 0.4. cm in diameter). renal vein (1.3 cm in length x 0.5 cm in diameter), and renal. artery (2.3 cm in length x 0.5 cm in diameter) No adrenal glands are. identified. There is a tan/red to tan/yellow, loculated, partially. encapsulated mass (12.8 x 10.3 x 8.5 cm) in the lower pole, replacing the. majority of the lower pole parenchyma. It is less than 0.1 cm to the black. inked resection margin, 6.0 cm to the ureteral margin, 2.0 cm to the renal vein. margin, and 2.2 cm to the renal artery resection margin. The tumor extends to. the surface of the adhesed ureter. Representative sections of the tumor are. submitted for cytogenetics, EM, quick fix, and tissue bank. Representative. sections of the normal renal parenchyma are submitted for tissue banking, IF,. and EM. Gross photographs are taken. Micro A1: Resection margin for the renal vein, the renal artery, and. the ureter, 3 frags,. Micro A2-A4 : Representative sections of the tumor, 3 frags in A2, 1 frag. in. A3 and 2 frags in A4, 6 frags total,. Micro A5: The tumor in relation to the closest resection margin, which. was inked black, 1 frag,. Micro A6-A. Tumor in relation to the adhesed ureter, 2 frags, 1 frag in. each block,. Micro A8: The tumor in relation to the renal pelvis, 1 frag,. Micro A9: The tumor in relation to perirenal adipose tissue, 1 frag,. Micro A10: The tumor in relation to surrounding normal renal. parenchyma,. 1 frag,. Micro All: The normal renal parenchyma, 1 frag,. Page: 1. Report Status Final. Type: Cytogenetics. KARYOTYPE: T1:42,X,-Y,-3,-8,-14[5) T3 :42,-Y,-3,-8,-14[5) -. METAPHASES COUNTED: 10. ANALYZED: 10. SCORED : 0. BANDING: GTG. INTERPRETATION: Three different specimens from this tumor were received. All metaphases from specimens labeled T1 and T3 contained clonal aberrations. including monosomy for chromosome 3, which is a typical finding in renal cell. carcinoma, clear cell type. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. No metaphases were available from specimen T2, therefore the cytogenetic. analysis could not be performed. INDICATION FOR TEST: ? RCC; Kidney Tumor #1-#3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS. LEFT KIDNEY, RADICAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, FUHRMAN'S NUCLEAR GRADE 3 OF 4. B. THE TUMOR IS 7.5 cm IN GREATEST DIMENSION. C. A 3.5 cm SATELLITE FOCUS OF RENAL CELL CARCINOMA IS IDENTIFIED, THIS FOCUS IS OF CONVENTIONAL. TYPE, FUHRMAN'S NUCLEAR GRADE 3 OF 4. D. THE TWO FOCI OF RENAL CELL CARCINOMA ARE CONFINED TO THE KIDNEY, WITH NO INVASION INTO THE. PERINEPHRIC OR HILAR ADIPOSE TISSUE. E. ALL SURGICAL MARGINS ARE FREE OF NEOPLASIA. F. ADRENAL GLAND WITH RECENT HEMATOMA AND NO SIGNIFICANT PATHOLOGIC FINDINGS (see comment). G. PATHOLOGIC TNM STAGING: pT2 Nx Mx.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with. colonoscopy on. showed 3cm semi-circumferential - mass 10cm from ileocecal valve, cecal. adenocarcinoma. Specimens Submitted: 1: SP:Right colon; hemicolectomy. DIAGNOSIS: 1. SP:Right colon; hemicolectomy : Tumor Type: Adenocarcinoma with mucinous features (<50% mucinous component). Histologic Grade: Moderately differentiated. Tumor Location: Ascending colon. Tumor Size: Length is 2.1 cm. Width is 2.8 cm. Maximal thickness is 0.4 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubular adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic - Bowel: Unremarkable. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 31. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1). The specimen is received fresh, labeled ""Right colon"" and consists of a. segment of terminal ileum, cecum with attached appendix and ascending colon. The terminal ileum measures 12.0 cm in length and 3.6 cm in circumference. at the proximal resected margin. The remaining colon measures 14.0 in. length with a circumference of 5.4 cm at the distal resected margin. The. attached appendix measures 5.8 cm in length and averages 0.7 cm in diameter. The appendiceal and intestinal serosa is pink tan and smooth. Focally. hemorrhagic lobulated yellow tan adipose tissue spans the length of the. specimen measuring up to the 3.8 cm in thickness. The specimen is opened to. reveal a mass lesion measuring 2.1 cm in length and 2.8 cm in width. The. mass is located in the right colon, 3.8 cm distal to the ileocecal valve,. 17.0 cm from the proximal margin and 6.5 cm from the distal margin. Sectioning shows that the tumor invades the underlying muscularis. The depth. of invasion is 0.5 cm grossly. The remaining mucosa is remarkable for a 0.7. x 0.1 to 0.4 cm sessile polyp 1.0 cm distal to the tumor. The attached. adipose tissue is thoroughly examined and all identified lymph nodes are. submitted. Representative sections of the specimen are submitted for. permanent sections and for TPS. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. A - appendix representative sections. PL polyp. RS -representative sections. LN - lymph nodes. BLN - bisected lymph nodes. Summary of Sections: Part 1: SP:Right colon; hemicolectomy. Block. Sect. Site. PCs. 1. A. 1. 2. D. 2. 1. DV. 1. 8. LN. 36. 1. P. 1. 1. PL. 1. 1. RS. 1. 3. T. 3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Pre-Op Diagnosis. Lung cancer. Post-Op Diagnosis. Same. Clinical History. Nothing indicated on requisition. Gross Description: Five parts. Container labeled. 1 - level 6 lymph node"" is a 1.4 x. 1.0 x 0.6 cm of gray yellow to black fleshy and fatty tissue. fragments entirely submitted in a single cassette. Container labeled. 2 - level 7 lymph node"" are 0.7 x. 0.5 x 0.4 cm of gray black fleshy tissue fragments entirely. submitted in a single cassette. Container labeled. 3 - upper lobe of left lung"" is a. 193 gram previously partially sectioned lobular portion of. recognizable pulmonary parenchyma grossly consistent with left up. lobe. This is received after tissue harvest for genomic study. Within the specimen container are three tissue cassettes each. "". labeled. The specimen on reconstruction. is 16.8 x 10.0 x 4.8 cm. The margin of resection includes the. bifurcated tertiary bronchi with an adjacent 1.0 cm fragmented gray. black fleshy nodule. The pleura is slightly wrinkled mottled tan. brown with moderate anthracotic streaking. Noted on the posterior. aspect in the mid region of the specimen there is an area of. indurated umbilication which is previously sectioned over an area of. 4.0 x 4.0 cm. On sectioning within this region there is a fairly. well defined 3.7 x 3.5 x 3.3 cm gritty gray tan fibrotic lesion with. a gritty necrotic gray tan fibrotic cut surface. This is seen at. its nearest point 3.2 cm from the bronchial margin. An apparent. bronchial connection is identified. This grossly extends to within. 0.1 cm of the medial pleura and within 0.2 cm of the lateral pleura. The remaining parenchyma is spongy and pink red with focal. anthracotic streaking. No additional gross lesions are identified. Representative sections are submitted labeled as follows: A -. bronchial margin in adjacent nodule, B through F - representative. lesion and surrounding tissue, G - random uninvolved parenchyma. Container labeled. 4 - level 9 lymph node"" is a 1.1 x. 0.8 x 0.7 cm partially fragmented nodular portion of fleshy gray tan. to brown black tissue which is bisected and entirely submitted in a. single cassette. Container labeled. 5 - level 5 lymph node"" is a 0.6 x. 0.4 x 0.3 cm of gray black fleshy tissue fragments entirely. submitted in a single cassette. Microscopic Description: Reviewed are slides labeled. Final Diagnosis. Lymph node, level 6, excisional biopsy: One lymph node negative for metastatic carcinoma (0/1). Lymph node, level 7, excisional biopsy: One lymph node negative for metastatic carcinoma (0/1). Lung, left upper lobe, lobectomy: Tumor characteristics: Specimen integrity: Intact. Specimen laterality: Left upper lobe. Histologic type: Poorly differentiated carcinoma with features of. adenosquamous carcinoma. (see comment). Histologic grade: III (poorly differentiated). Tumor site: Left upper lobe, posterior mid region. Tumor focality: Unifocal. Tumor size: 3.7 x 3.5 x 3.3 cm. Visceral pleural invasion: Not identified. Lymphovascular space invasion: No unequivocal lymphovascular space. invasion identified. Tumor extension: Tumor confined to lung parenchyma. Treatment effect: Not identified/not applicable. Surgical margin status: Tumor distance from bronchial margin: 3.2 cm. Tumor distance from parenchymal margin: Not applicable. Tumor distance from pleural surface: 1 mm. Lymph node status: One peribronchial lymph node negative for metastatic carcinoma. (0/1). See also parts 1, 2, 4 and 5. Other: Emphysematous change. pTN stage: pT2a NO. Lymph node, level 9, excisional biopsy: One lymph node negative for metastatic carcinoma (0/1). Lymph node, level 5, excisional biopsy: One lymph node negative for metastatic carcinoma (0/1). PAS. 9. SPC-A. Comments. The histologic sections of the neoplasm demonstrate a poorly. differentiated non-small cell carcinoma composed of large. pleomorphic cells with large nuclei demonstrating irregular nuclear. contours. In areas, the cells demonstrate smooth chromatin; in other. areas, the nuclei appear more vesicular. The cells are arranged in. groups and clusters including large sheet-like growth patterns. Rare. pseudoglandular-like structures are noted. Occasional cells appear. vacuolated. To better characterize this neoplasm, a limited panel of. immunohistochemical stains is performed (with working controls). The. cells are strongly positive for CK5/6 and positive for CK7. The. majority of the nuclei are positive for p63 (greater than 75%). Occasional nuclei (approximately 10%) appear positive for TTF1. The histologic and immunohistochemical features of this neoplasm. have overlap between both adenocarcinoma as well as squamous cell. carcinoma. In areas, features histologically compatible with. squamous cell carcinoma are seen. In other areas, however, features. of adenocarcinoma are present. Clinical correlation is recommended. At the request of the undersigned pathologist, these slides have. been additionally reviewed by. who concurs with the. diagnosis. This test was developed and its performance characteristics. determined by. It has not been. cleared or approved by the U.S. Food and Drug Administration. The. FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded. as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. as qualified to perform high complexity clinical. laboratory testing.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: F. Examination result No. Unit in charge: (. Clinical diagnosis (suspicion) Stomach cancer. Date of admission: (urgency: Standard). Material: 1) Material: stomach, stomach with the tumour. Method of collection: Total organ resection. Histopathological diagnosis: Stomach adenocarcinoma mucinous with metastases to lymph nodes (G3, pT2, pNI). (8140/3 T-63000). Macroscopic description: The specimen containing the stomach, incised along the lesser curvature sized 1 9 x 13 cm. Tumour with. ulceration sized 7x5x2 cm in the pyloric region. Distance from the proximal end: 12 cm, from distal end: 0.5 cm. Microscopic description: Gastric adenocarcinoma mucocellulare (G3, diffuse type acc. to Lauren class.). The lesion invades the. submucosa and the muscular layer of the stomach wall. Incision lines free of neoplastic lesions. Metastases to 3/10 lymph nodes.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Surgical Pathology: Final. OUID:CA834E5F-30DC-46CF-AF33-AD11226FC09E. CLINICAL HISTORY: Bilateral carcinoma of the breast. GROSS EXAMINATION: A. ""Medial margin right breast biopsy"", fresh. The specimen consists of 3.7 x. 2.2 x 0.6 cm disc of firm white, unremarkable breast tissue; four sutures. denote the true margin, which is inked black. Serial radial sections are. submitted as follows: BLOCK SUMMARY: A1 frozen section remnant Af1. A2 frozen section remnant AF2. A3 frozen section remnant AF3. A4 additional tissue. B. ""Right breast biopsy sample"". Contains an irregular 10 x 0.5 x 1.7 cm disc. tan-brown coarsely papillary tissue. Portions are submitted for ER/PR and for. tissue. bank and for frozen section. Frozen section remnant submitted in Block. B1. C. ""Left breast tumor, wide reexcision, long suture lateral, short suture. superior"", fresh. The specimen consists of a 4.5 x 4.3 x 2.2 cm wide. reexcision of the breast. The long suture denotes the lateral aspect of the. specimen and a short suture the superior. The superior pole of the tissue is. inked black, and the inferior blue. On cut section, there is a 1.3 x 1.3 x 1 cm round, white, firm, gritty,. sharply-circumscribed tumor in the superior portion of the resection. The. tumor extends to within 2 mm of the superior margin, and does not approach. closely to any other margin. The remainder of the breast consists of firm,. white and tan admixed breast parenchyma. Tissue is divided into deep (towards. chest wall) and superficial (towards skin) halves and submitted from medial to. lateral as follows: BLOCK SUMMARY: C1 frozen section remnant Cfl. C2-C8 superficial half from medial to lateral. C9-C15 deep half from medial to lateral. D. ""Right axillary dissection and wide reexcision"", fresh. The specimen. consists of an excisional breast biopsy and attached axillary dissection. The. biopsy is incised, to obtain tissue for frozen section, ER/PR, and tissue. bank, prior to receipt by pathology. The biopsy measures 6.7 x 6.5 x 3.2 cm. The axillary tail measures 10 x 2.3 x 0.9 cm. The medial surface (not a true. margin) is inked in red, the inferior margin black and the superior margin in. blue. On cut section, there is a 4.5 x 2.3 x 2.5 cm white firm tumor, composed of. tan-yellow loose aggregates of tumor. The tumor approaches to within 3 mm of. the inked superior margin of resection and to within 1 cm of the superior and. 5 mm of the inferior margin. Tumor approaches to within 4 mm of the deep. margin of resection. The remainder of the breast is unremarkable. The axillary dissection is divided into low, mid and distal level. There are. numerous lymph nodes, ranging from 0.3 to 1.4 cm, none grossly involved by. tumor. BLOCK SUMMARY: 1 of 2. D1-D5 Anterior (superficial) tumor from lateral to medial. D6-D10 Posterior (deep) tumor from lateral to medial. D11 - Lower lymph node candidate. D12 - One mid-level lymph node, bisected. D13 - Five mid-level lymph node candidates. D14 - Four distal lymph node candidates. D15 - Highest lymph node. E. ""Left axillary dissection, silk on apex"", fresh. The specimen consists of. a 6 x 9 x 1.7 cm lymph node dissection, with a black suture at one pole. The. lymph node dissection is divided into three sections, lower, middle and. distal. Numerous lymph nodes are identified ranging from 0.3 to 1.7 cm in. greatest dimension. None grossly contains tumor. BLOCK SUMMARY: E1 Lower nodes, 3 lymph node candidates. E2 Three lymph node candidates, lower node. E3 Middle nodes, 2 lymph node candidates. E4 Middle nodes, 2 lymph node candidates. E5 Three lymph node candidates, upper lobe. E6 Upper nodes, 1 lymph node candidate. E7 Upper node, 1 lymph node candidates, bisected. E8 Highest apical node. INTRA OPERATIVE CONSULTATION: AF1-Af3: ""Medial margin right breast biopsy"": Inked margin free of carcinoma. (KR). Bf1: ""Right breast biopsy sample"": Carcinoma. Cf1: ""Left breast biopsy"": Carcinoma. DIAGNOSIS: A. ""MEDIAL MARGIN RIGHT BREAST BIOPSY"": BENIGN BREAST TISSUE. B. ""RIGHT BREAST BIOPSY"": POORLY-DIFFERENTIATED ADENOCARCINOMA. C. ""LEFT BREAST TUMOR, WIDE RE-EXCISION"": INVASIVE AND INTRADUCTAL ADENOCARCINOMA. 1.3 x 1.3 x 1.3 CM. NSABP HISTOLOGIC GRADE 3, NUCLEAR GRADE 3. NON-COMEDO TYPE INTRADUCTAL COMPONENT COMPRISES 5% OF TUMOR. VASCULAR SPACE INVASION IDENTIFIED (C13) . INKED MARGINS OF RESECTION FREE OF TUMOR. EXTENDING TO WITHIN 1 MM OF INKED SUPERIOR MARGIN OF RESECTION (C14) . ASSOCIATED WITH MICROCALCIFICATION. REMAINDER OF BREAST WITH APOCRINE METAPLASIA AND MICROCYST FORMATION. D. ""RIGHT AXILLARY RESECTION OF BREAST AND WIDE RE-EXCISION"": INVASIVE AND INTRADUCTAL CARCINOMA. 4.5 x 2.3 x 2.5 CM. NSABP HISTOLOGIC GRADE 3, NUCLEAR GRADE 2. NON-COMEDO TYPE INTRADUCTAL CARCINOMA COMPRISES 5% OF TUMOR. INTRADUCTAL CARCINOMA EXTENDS BEYOND TUMOR MASS. VASCULAR SPACE INVASION NOT IDENTIFIED. TUMOR APPROACHES TO WITHIN 100 MICRONS OF INKED MARGIN OF RESECTION. (D7, D8, D9, D10, D6), SEE NOTE. REMAINDER OF BREAST WITH MICROCYST FORMATION AND FIBROADENOMATOUS CHANGE. 10 REGIONAL LYMPH NODES WITH NO TUMOR SEEN (0/10) . E. ""LEFT AXILLARY DISSECTION"": 8 LYMPH NODES WITH NO TUMOR SEEN (0/8) . NOTE: FOCALLY, CAUTERY ARTIFACT EXTENDS TO TUMOR inal. 2 of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Biopsy proven left breast ILC, approximately 3-4 cm in si-e. Presents for. left TM, SLN Biopsy, as well as right TM. Protocol. History of right. breast MRI guided core biopsy. Specimens Submitted: 1: SP: Sentinel node #1 level one left axilla (fs). 2: SP: Sentinel node #2 level one left axilla (fs). 3: SP: Sentinel node #3 level one left axilla (Es). 4: SP: Right breast. 5: SP: Left breast. 6 : SP: Additional lympn node, left axilla. DIAGNOSIS: SENTINEL LYMPH NODE #1, LEVEL I LEFT AXILLA, EXCISION: - ONE BENIGN LYMPH NODE (0/1). - ADDITIONAL H/E STAINED SECTIONS AND IMMMUNOPEROXIDASE STAINS FOR. CITOKERATINS (AE1:AE3) SHOW NO EVIDENCE OF METASTATIC CARCINOMA. SENTINEL LYMPH NODE #2, LEVEL I LEFT AXILLA, EXCISION: ONE BENIGN LYMPH NODE (0/1). - ADDITIONAL H/E STAINED SECTIONS AND IMMUNOPEROXIDASE STAINS FOR. CITOKERATINS (AE1:AE3) SHOW NO EVIDENCE OF METASTATIC CARCINOMA. 3). SENTINEL LYMPH NODE #3, LEVEL I LEFT AXILLA, EXCISION: - METASTATIC CARCINOMA IN THE FORM OF MICROSCOPIC CLUSTERS AND SINGLE. CELLS IS IDENTIFIED IN ONE OF ONE LYMPH NODE ON ADDITIONAL CYTOKERATINS. IMMUNOHISTOCHEMICAL STAINS (AE1:AE3) EACH CLUSTER OF CARCINOMA MEASURES. LESS THAN 0.2 MM, BUT SEVERAL CLUSTERS ARE PRESENT DISPERSED THROUGHOUT THE. LYMPH NODE, ADDING UP TO ABOUT 300-400 CELLS IN TOTAL. RARE TUMOR CLUSTERS ARE ALSO IDENTIFIED ON ADDITIONAL H/E STAINED SECTIONS. 4). BREAST, RIGHT TOTAL NASTECTONY: - BENIGN BREAST TISSUE WITH FOCAL ATYPICAL DUCTAL HYPERPLASIA (ADH),. COLUMNAR CELLS,. FIBROADENOMATOID CHANGES AND BIOPSY SITE. - CALCIFICATIONS ARE ASSOCIATED WITH ADH AND BENIGN EPITHELIUM. - BENIGN SKIN AND NIPPLE. 5). BREAST, LEFT, TOTAL MASTECTOMY: :riteria. - INVASIVE LOBULAR CARCINOMA. CLASSICAL TYPE, PRESENT AS MULTIPLE FOCI. DISTRIBUTED OVER AN AREA SPANNING ABOUT 6 CM GROSSLY. - EXTENSIVE LOBULAR CARCINOMA IN SITU (LCIS) IS ALSO IDENTIFIED,. CLASSICAL TYPE (TYPE A). - THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER OUTER QUADRANT AND. LOWER OUTER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINONA. IS IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN THE IN SITU AND INVASIVE CARCINOMA, AND. IN BENIGN BREAST. PARENCHYMA. - NO VASCULAR INVASION IS NOTED. - NO PERINEURAL INVASION IS IDENTIFIED IN A SECTION IMMUNOSTAINED FOR. CYTOKERATIN AE1:AE3. - INVASIVE CARCINOMA IS 0.6 CM FROM THE NEAREST (DEEP) MARGIN. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. THE SKIN SHONS SCAR. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE, FIBROADENOMATOID. CHANGES AND APOCRINE METAPLASIA. IMMUNOHISTOCHEMICAL STAINS WERE PERFORMED ON FORMALIN-FIKED TISSUE WITH. THE FOLLOWING RESULTS FOR INVASIVE CARCINOMA (BLOCK 5-5) : ESTROGEN RECEPTOR (6F11, VENTANA) : 95% NUCLEAR STAINING WITH STRONG. INTENSITY. PROGESTERONE RECEPTOR (1E2; VENTANA) : 90% NUCLEAR STAINING WITH STRONG. INTENSITY. HER2 (HERCEPTEST: DAKO) : NEGATIVE (0). CONTROLS ARE SATISFACTORY. Comment: HercepTestTM (Dako) is an YDA-approved method for assessment of. HER2 protein overexpression in breast cancer tissue routinely processed for. histological evaluation. The HER2 test results are reported in accordance. with the ASCO/CAP guideline recommandations for HER2 testing in breast. cancer (J Clin Oncol 2007; 25 (1):118-145) Some of the immmunohistochemimtry. and ISH tests were developad and their performance characteristics were. determined by the Department of Pathology. They have not been cleared or. approved by the us Food and Drug Administration. The FDA has determined that. such clearance or approval is not necessary. These tests are used for. clinical purposes. They should not be regarded as investigational or for. research. This laboratory is certified under the Clinical Laboratory. Improvement Amendments of 1988 (CLIA - 88) as qualified to perform high. complexity clinical laboratory testing. 6). LYMPH NODE, LEFT AXILLA, EXCISION: - ONE BENIGN LYMPH NODE (0/1). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1). The specimen is received fresh for frozen section consultation, labeled. ""sentinel node #1, level 1, left axilla"" and consists of a pink tan firm. lymph node measuring 1.8 x 0.6 x 0.4 cm. The specimen is bisected and. entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 2) The specimen is received fresh for frozen section consultation, labeled. ""sentinel node #2, level 1, left axilla"" and consists of a pink tan firm. lymph node measuring 2.8 x 1.5 x 0.4 cm. The specimen is bisected and. entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 3). The specimen is received fresh for frozen section consultation, labeled. ""sentinel node #3, level 1, left axilla"" and consists of two pink tan firm. lymph nodes measuring 1.2 x 1.2 x 0.6 cm and 0.8 x 0.8 x 0.4 cm. The. specimen is bisected and entirely submitted for frozen section. Summary of sections: FSC frozen section control. 4). The specimen is received fresh labeled, ""Right breast stitch marks. axillary tail"" and consists of a breast measuring 19 x 18 x 3.5 cm with. overlying skin ellipse measuring 9.5 x 3.5 cm. Situated centrally on the. skin surface is an everted nipple measuring 1.7 x 1.5 x 0.3 cm and areola. measuring 3.7 x 3.4 cm. No visible scar is identified on the skin surface. A suture demarcates the axillary aspect. The posterior surface of the. breast is inked black, the anterior surface in inked blue and the specimen. is serially sectioned to reveal a dark red well circumscribed biopsy cavity. filled with red hemorrhagic material measuring 2.5 x 2 x 2 cm, and located. in the midline of the lower quadrants and 0.6 cm from the deep margin. A. clip is not identified in the specimen. Sectioning of the axillary aspect. reveals no grossly identifiable lymph nodes. Representative sections are. submitted. Sample of all quadrants were given to TPS protocol. Summary of sections: N nipple. NB - nipple base. S - skin scar. D - deep margin. BX - biopsy site. 3. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. 5). The specimen is received fresh labeled, ""left breast and consists of. a. breast measuring 23 x 19 x 2 cm with overlying skin ellipse measuring 9 x 4. cm. Situated center on the skin surface is a nipple measuring 1.5 x 1.2. cm. and areola measuring 3.2 x 3.2 cm. The skin shows a linear scar measuring. 3. cm, situated lateral to the nipple. A suture demarcates the axillary. aspect. The posterior surface of the breast is inked black, the anterior. blue and the axillary aspect is inked yellow. The specimen is serially. sectioned to reveal a tan white firm stellate tumor mass measuring 6 x 3.5. x. 2.0 cm, located in LOQ 0.5 cm from the deep margin, extending to the. overlying skin. A clip is not identified. Sectioning of the axillary. aspect reveals no grossly identifiable lymph nodes. Representative sections. are submitted. Summary of sections: N - nipple. NB - nipple base. S - skin scar. D - deep margin. BX - biopsy site. T tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. 6) The specimen is received in formalin, labeled 'additional lymph nodes. left axilla' and consists of irregular yellow tan lobulated tissue measuring. 0.8 x 0.3 x 0.3 cm. The specimen is entirely submitted. Summary of sections: LN- lymph nodes. Summary of Sections: Part 1: SP: Sentinel node #1 level one left axilla (fa). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: SP: Sentinel node #2 level one left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 3: SP: Sentinel node #3 level one left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 4: SP: Right breast. Block. Sect. Site. PCs. 4. BX. 4. 1. D. 1. 2. LIQ. 2. 2. LOQ. 2. 1. N. 1. NB. 1. 1. S. 1. 2. UIQ. 2. 2. vog. 2. Part S: SP: Left breast. Block. Sect. Site. PCs. 2. 2. 1. BX. 1. 2. D. 2. 2. LIQ. 2. 2. LOQ. 2. 1. N. 1. NB. 1. 1. S. 1. 5. T. 5. 2. vog. 2. Part 6: SP: Additional lymph node, left axilla ,. Block. Sect. Site. PCs. 1. LN. 1. Procedures/Addenda: Addendunn. wace. Addendum Diagnosia. ADDENDUM. PART #5. LEFT BREAST: INVASIVE LOBULAR CARCINOMA IS PRESENT IN TEN OUT OF NINETEEN SLIDES, and. involves upper outer and lower outer quadrants. A microscopic focus of. invasive lobular carcinoma is also presaent in a section from the lower. inner quadrant (<lmm) THE SIZE OF THE INVASIVE TUMOR IS DIFFICULT TO. ASSESS IN THIS CASE, AS INVASIVE CARCINOMA IS PRESENT AS MULTIPLE NODULES,. MANY OF WHICH MERGE INTO ONE ANOTHER. THE LARGEST CONTIGUOUS SPAN OF. INVASIVE CARCINOMA MEASURES AT LEAST 2.0 CM MICROSCOPICALLY IN SLIDE 5-10. IN THIS SLIDE THE TUMOR IS PERIPHERALLY TRANSECTED ALONG A BROAD FRONT. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #1 level one left axilla. (fa) (. : Benign. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION TAGNOSIS: SP: Sentinel node #2 level one left axilla. : Benign. PERNANIENT DIAGNOSIS: SANE. 3). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #3 level one left axilla. (fs). Benign. PERMANENT DIAGNOSIS: SEE FINAL. Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #1 level one left axilla. : Benign. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #2 level one left axilla. Benign. PERMANENT DIAGI. SAME. 3). FROZEN SECTIOM PYAGNCSIS: SP: Sentinel node #3 level one left axilla. (fs). Benign. MANENT DIAGNOSIS: SEE FINAL.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS. PART 1: LEFT PERIHILAR TISSUE, EXCISION -. HIGH GRADE CARCINOMA WITH EXTENSIVE NECROSIS, INVADING SKELETAL MUSCLE, CARCINOMATOUS. ANGIOLYMPHATIC EMBOLI IDENTIFIED (SLIDE 1B). PART 2: LEFT RENAL VEIN CUFF, EXCISION -. A. SEGMENT OF LARGE VEIN OCCLUDED BY HIGH GRADE, FOCALLY SARCOMATOID CARCINOMA. B. CARCINOMA INVADES THROUGH VEIN WALL INTO PERIVENULAR ADVENTITIA. PART 3: TUMOR THROMBUS, EXCISION -. SARCOMATOID CARCINOMA WITH NECROSIS,. PART 4: LEFT KIDNEY, SPLEEN, TAIL OF PANCREAS AND ASSOCIATED SOFT TISSUE, RESECTION -. A. HIGH-GRADE, PARTIALLY CYSTIC, PARTIALLY SARCOMATOID CARCINOMA, FAVOR DEDIFFERENTIATED. RENAL CELL CARCINOMA,10.5 CM. PROBÃBLE SMALL â¬LEAR CELL CARCINOMATOUS COMPONENT. PRESENT (SLIDE 4E) (see comment). B. CARCINOMA INVOLVES THE UPPER POLE OF THE KIDNEY, PERIRENAL ADIPOST TISSUE, GEROTA'S. FASCIA, TAIL OF PANCREAS AND RETROPERITONEAL SOFT TISSUE. C. LARGE OCCLUSIVE TUMOR THROMBUS IS PRESENT IN THE MAIN RENAL VEIN, EXTENDING TO THE. RENAL VEIN SURGICAL RESECTION MARGIN (SLIDE 4D). SMALL VESSEL ANGIOLYMPHATIC INVASION IS. ALSO IDENTIFIED (SLIDE 4L). D. BRISK HOST LYMPHOCYTICREACTION. E. BENIGN URETER, SPLEEN, ACCESSORY SPLEEN AND SIX (6) RENAL AND PERISPLENIC LYMPH NODES. F. CARCINOMA IS PRESENT AT THE MAIN RENAL VEIN SURGICAL RESECTION MARGIN AND GEROTA'S. FASCIA RESECTION MARGIN. ALL OTHER SURGICAL RESECTION MARGINS ARE BENIGN. G. PATHOLOGIC STAGE (ASSUMING PRIMARY RENAL CELL CARCINOMA): pT4 Nx Mx; G4 (see comment). PART 5: LEFT PSOAS MUSCLE, EXCISION -. SARCOMATOID CARCINOMA INFILTRATING SKELETAL MUSCLE.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
INTERPRETATION AND DIAGNOSIS: 1). STATION R-4 (EXCISION) : FOUR (4) LYMPH NODES NEGATIVE FOR TUMOR. 2). STATION 7 (EXCISION) : THREE (3) LYMPH NODES NEGATIVE FOR TUMOR. 3). LOWER R-4 (EXCISION) : ONE (1) LYMPH NODE NEGATIVE FOR TUMOR. 4). STATION R-11 (EXCISION) : ONE (1) LYMPH NODE NEGATIVE FOR TUMOR. 5). STATION R-10 (EXCISION) : METASTATIC CARCINOMA PRESENT IN ONE OF. ONE (1/1) LYMPH NODE. 6). LUNG, RIGHT UPPER LOBE (LOBECTOMY): SPECIMEN TYPE: Lobectomy. TUMOR SITE: Right upper lobe. HISTOLOGIC TYPE: Adenocarcinoma, NOS. SEE NOTE. NOTE: Immunostains show that the neoplastic cells are positive for. TTF-1 and CK7, negative for CK20, S-100, and calretinin, supporting. the diagnosis of adenocarcinoma, while against the diagnosis of. malignant mesothelioma or melanoma. This case was shown at the. TUMOR SIZE: 3.0 cm greatest dimension. HISTOLOGIC GRADE: G3: Poorly differentiated. LYMPH NODES: Metastatic carcinoma in 1 of 13 lymph nodes. (see part 5). EXTENT OF INVASION. PRIMARY TUMOR: pT2: Tumor which is > or = 3 cm. REGIONAL LYMPH NODES : pN1: Metastasis in ipsilateral peribronchial, hilar,. or intrapulmonary nodes, including those involved. by direct extension. DISTANT METASTASIS : pMx: Cannot be assessed. MARGINS: Margins uninvolved by invasive carcinoma. VENOUS/ARTERIAL (LARGE VESSEL) INVASION: Venous invasion present. LYMPHATIC (SMALL VESSEL) INVASION: Present. 7) STATION 7 (EXCISION) : THREE (3) LYMPH NODES NEGATIVE FOR TUMOR. 8) PLEURAL PLAQUE (EXCISION) : DENSE FIBROUS TISSUE, NEGATIVE FOR. TUMOR. Some stains/tests used in arriving at the diagnosis were performed. here using reagents that have not been cleared or approved by the. US Food and Drug Administration. These were developed and their. performance characteristics determined by the. Their use does not require FDA approval. Clinical History: LUNG CANCER. GROSS DESCRIPTION. PART #1: FS: R-4. Resident Pathologist: FROZEN SECTION DIAGNOSIS: FS: R-4: Four (4) lymph node, negative for tumor. The specimen is received fresh labeled. and designated. ""R-4"". It consists of four (4) red to black nodules, measuring in. aggregate 1.5 x 0.8 x 0.3 cm. The specimen is submitted in its. entirety for FSC. SUMMARY OF SECTIONS : 1. - FSC. - 4. 1. - TOTAL - 4. PART #2: STATION 7. Resident Pathologist : FROZEN SECTION DIAGNOSIS: FS: Station 7: Three (3) lymph nodes, negative for tumor. The specimen is received fresh labeled. and. designated ""station 7"". It consists of three (3) red to black nodules. measuring in aggregate 1.0 x 1.0 x 0.4 cm. The specimen is submitted. in its entirety for FSC. SUMMARY OF SECTIONS: : 1. - FSC - 3. 1. -TOTAL - 3. PART #3: LOWER R-4. Resident Pathologist : (Parts 3-8) . The specimen for Part 3 is received fresh, labeled with the patient's. and designated ""Lower R4. "" The specimen. consists of one 11 prece of red-tan-brown soft tissue measuring 1.8 x. 1.0 x 1.0 cm. Fifty percent (50%) of the specimen is submitted to be. saved for possible future studies. The remaining fifty percent (50%). of the specimen is submitted for permanent sections. SUMMARY OF SECTIONS : 1 - A. - 1. 1 - TOTAL - 1. PART #4: R-11. Resident Pathologist: The specimen for Part 4 is received fresh, labeled with the patient's. and designated ""R11. "" The specimen consists. of one (1) piece of red to tan to brown soft tissue measuring 1.5 x. 0.9 x 0.7 cm. Fifty percent (50%) of the specimen is preserved for. possible future studies and the remaining fifty percent (50%) is. submitted in its entirety. SUMMARY OF SECTIONS : 1 - A. - 1. 1 - TOTAL - 1. PART #5: R-10. Resident Pathologist: The specimen for Part 5 is received fresh, labeled with the patient's. and designated ""R10."" The specimen consists. of one (1) piece of red to tan to brown soft tissue measuring 2.0 x. 1.5 x 1.1 cm. Fifty percent (50%) of the specimen is preserved for. possible future studies. The remaining fifty percent (50%) is. submitted in its entirety. SUMMARY OF SECTIONS : 1 - A. - 1. 1 - TOTAL - 1. PART #6: RIGHT UPPER LOBE. Resident Pathologist: The specimen for Part 6 is received fresh, labeled with the patient's. and designated ""Right Upper Lobe. "" The. specimen consists of a 186.0 gram right lobectomy measuring 16.2 x. 10.0 x 2.7 cm. The lung is diffusely noncrepitant. The pleura is. hemorrhagic and mottled with anthracotic pigmentation. Located in the. outer aspect of the lobe is a tan, white, firm 3.0 x 2.5 cm ill. defined mass. The mass does not appear to ulcerate the pleura;. however, it does closely approximate the pleura to within 0.1 cm. The. area around the tumor is inked orange. Tissue from the tumor is. harvested for future studies. The tumor mass is over 3.0 cm away from. the bronchial margin, but does closely approximate a bronchiole, and. this is submitted in representative sections. The remaining airways. are unremarkable, with tan, glistening mucosa. The vascular margins. and bronchial margins are removed as shaved margins; the staple line. is removed, and the underlying parenchyma is inked black. The lung is. serially sectioned, and the remaining lung tissue is congested, red. to brown, with focal emphysematous changes and generalized. anthracotic pigmentation. Hilar vessels are unremarkable. No hilar. nodes are identified. Representative sections are submitted of the. tumor as well as normal lung. SUMMARY OF SECTIONS : 1 - A. - 4. (BRONCHIAL AND VASCULAR MARGINS). 1 - B. 1. (PLEURAL MARGIN). 1 - C. - 1. (PLEURAL MARGIN). 1 - D. - 1. (TUMOR TO BRONCHIAL). 1 - E. - 1. (TUMOR TO NORMAL). 2 - F,G. 1. EA. (NORMAL LUNG). 1 - H. - 1. (PARENCHYMAL MARGIN). 8 - TOTAL - 11. PART #7: STATION 7. Resident Pathologist: The specimen for Part 7 is received fresh, labeled with the patient's. , and designated ""Station 7. "" The specimen. consists of three (3) pieces of red to tan to black soft tissue. measuring 2.0 x 2.0 X 0.7 cm. Twenty-five percent (25%) of the tissue. is harvested for possible future studies. The remaining seventy-five. percent (75%) of the specimen is submitted. SUMMARY OF SECTIONS : 2 - A, B. - 1 EA. 2 - TOTAL - 2. PART #8 : PLEURA PLAQUE. Resident Pathologist: The specimen for Part 8 is received fresh, labeled with the patient's. and designated ""Pleural Plaque. "" The. specimen consists of two (2) pieces of white, firm tissue measuring. 1.3 x 0.5 x 0.4 cm in aggregate. The specimen is submitted in its. entirety for light decalcification. SUMMARY OF SECTIONS : 1 - A. - 2. 1 - TOTAL - 2. printed.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Laboratory Patient Report. Print Date/Time : Surgical Pathol. Histopathological Examination. Complete : Pre-Op - Diagnosis : Left Renal Mass. Specimens. : Kidney, Left. Frozen Diagnosis. GROSS EXAMINATION. The specimen is received in a container labeled with the. name of the patient and labeled as kidney, left. The. specimen consists of a kidney and attached perinephric fat. which measures en bloc 24 X 14 X 10 cm and weighs 1709 g. The ureter and vascular margins of resection are submitted. in block 1. The lower pole and midportion of the kidney. shows a large golden yellow mass measuring 12. 0 X 9.0 X 7.0. cm. The mass grossly bulges against the capsule and is. focally adherent to the capsule. Sections of the capsule. adjacent to the mass are submitted in block 2. The kidney. stripped of capsule and fat measures 13.5 X 11.0 X 7.0 cm. and weighs 542 g. Sections of the mass are submitted in. block 3-8. Sections of the renal sinus are submitted in. blocks 9-10. The pelvis and calices are not grossly. dilated. The cortex averages 0. cm. A random section of. kidney is submitted in block 11. Sectioning through the. attached fat shows an adrenal gland measuring 8.0 x 2.5 X. F. Representative sections are submitted in block 12. MICROSCOPIC EXAMINATION: Multiple sections of kidney shows a renal cell carcinoma. with clear cell features, moderately rell-differentiated. consistent with a Fuhrman grade 2 forming a tumor mass that. by description measures up to 12 cm greatest diameter. Sections of the capsule show no apparent adherence of the. tumor to the capsule or in the surrounding pericapsular. adipose tissue. Both the ureter and vascular margins are. free of tumor. No definite blood vessel invasion by the. tumor could be seen. Section of the area of the renal sinus. is negative for tumor and the pelvis of the kidney and. bordering ureter is also negative. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION : Left kidney, radical nephrectomy, left: Renal cell. carcinoma, clear cell type, Fuhrman grade 2, 12 cm greatest. diameter. No invasion of capsule, no blood vessel invasion identified. with ureter and vascular margin of resection free of tumor. Renal sinus free of tumor. Adrenal gland, benign. Pathologic stage pT2, NX, MX provisional stage II. [T-71000 4-83103 189.0 P3-44070]. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
RUN DATE. RUN TIME. RUN USER. ACCT # : LOC: AGE/SX: ROOM: REG DR: BED: SPEC #: RECD: PERFORMED AT. COLL: TIME IN FORMALIN. hrs. CLINICAL INFORMATION: Pre-Op Diagnosis: Colon polyps. Remarks: Specimen (s) : Right hemicolon. MICROSCOPIC DIAGNOSIS. COLON, RIGHT, RIGHT HEMICOLECTOMY: INVASIVE LOW-GRADE ADENOCARCINOMA OF CECUM/ILEOCECAL VALVE MEASURING 9 CM IN. GREATEST DIMENSION. TUMOR INVADES THROUGH MUSCLE WALL INTO SUBSEROSAL ADIPOSE TISSUE (pT3). NO ANGIOLYMPHATIC INVASION IDENTIFIED. FOUR (4) OF 35 REGIONAL LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA WITH. EXTRANODAL CAPSULAR EXTENSION PRESENT. MARGINS NEGATIVE WITH CLOSEST MARGIN MESENTERIC (4.5 CM). APPENDIX WITH NO PATHOLOGIC DIAGNOSIS. FEW SHALLOW DIVERTICULA. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY - APPROVED BY COLLEGE OF AMERICAN PATHOLOGISTS. SPECIMEN: Terminal ileum, cecum, appendix. ascending colon. PROCEDURE. Right hemicolectomy. TUMOR SITE: Cecum. ileocecal valve. TUMOR SIZE: Greatest dimension 9 cm. MACROSCOPIC TUMOR PERFORATION: Not identified. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Low-grade. MICROSCOPIC TUMOR EXTENSION: Tumor invades through the muscularis propria into the. subserosal adipose tissue. MARGINS : If all margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin : 4.5 cm, mesenteric/radial. Proximal margin : uninvolved by invasive carcinoma. Distal margin: uninvolved by invasive carcinoma. Circumferential margin: uninvolved by invasive carcinoma. TREATMENT EFFECT. No prior treatment. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Not identified. RUN DATE. RUN TIME. Specimen Inquiry. RUN USER. SPEC # : COMMENT (S). TUMOR DEPOSITS: Not identified. PATHOLOGIC STAGING: Primary tumor pT3. Regional lymph nodes: pN2a. Number of lymph nodes examined 35. Number of lymph nodes involved. 4. Distant metastasis: not applicable. GROSS DESCRIPTION: Received fresh for tissue banking is a 25 cm segment of large bowel. The bowel is received. with. cecum and a 6.0 cm appendix. The colon is consistent with a right colectomy specimen. and includes a 5.5 cm segment of small bowel The cecum is indurated. and the serosa is. focally puckered. The serosa is inked blue. The bowel is opened to have a linear 9.0 x. 4.0. x at least 1.0 cm tumor mass. The mass fills and involves the cecum and extends to the. ileocecal valve to be circumferential involving the ileocecal valve. The tumor diffusely. extends to involve and focally extend through the bowel wall. There is an area of tattoo. dye in the ascending colon. This area of tattoo dye is approximately 2.5 x 2.5 cm and is. 6.0 cm from the ileocecal valve and at least 10 cm from the distal margin. The tumor is at. least 15 cm from the distal margin. The mesenteric/fal margin is 4.5 cm. The remainder of. the mucosa of the large bowel and small bowel are unremarkable with normal tan folds. There is a diverticular area of puckering in the distal segment of colon which is at least. 2. cm from the distal margin. The surrounding adipose is sectioned to have multiple. nodular lymph nodes. Both tumor and normal are sampled for tissue banking. The specimen. is sampled as labeled. 1. proximal margin. 2. distal margin. 3. mesenteric fat margin nearest tumor. 4. representative sections of appendix. 5. ileocecal valve. 6-9. sections of tumor with representative sections showing tumor to normal. mucosa. associated underlying fat, inked serosa. 10. representative sections of normal bowel and bowel with submucosal tattoo dye. 11. sections of diverticular puckering and distal ascending colon. 12. whole lymph nodes. 13. one lymph node bisected. 14. whole lymph nodes. 15. whole lymph nodes. 16. whole lymph nodes. 17. whole lymph nodes and ? tumor implant. 18. two lymph nodes. each bisected. INTRAOPERATIVE CONSULTATION. RIGHT HEMICOLON: GROSS SPECIMEN REVIEWED WITH. IN OPERATING ROOM. ONLY ONE LESION IS. PRESENT AT THE ILEOCECAL VALVE. TATTOO PIGMENT IS PRESENT WITHIN THE MID. ASCENDING COLON, 6 CM DISTAL TO THE ILEOCECAL VALVE TUMOR. NO SEPARATE LESION IS. RUMILITE : RUN. RUN USER : SPEC # : PATIENT: . Continued). INTRAOPERATIVE CONSULTATION: (Continued). IDENTIFIED THE TATTOO PIGMENT LIES 15 CM FROM THE DISTAL MARGIN. THE SPECIMEN. IS PROCESSED FOR TISSUE BANKING. PHOTO DOCUMENTATION. Image. Picture Copy Error. Image. Picture Copy Error. (signature on file).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis/diagnoses: Rectal resection material shows a moderately differentiated adenocarcinoma (G2) located. in the distal rectum, with superficial infiltration of the perirectal fatty tissue (pT3) and. tumor-free oral, aboral and perirectal resection margins. Follow-up report: Following acetone clarification, 34 lymph nodes in the pericolic fatty tissue bordering the. tumor were prepared, measuring up to 1.2 cm. Amongst these, three metastatic infiltrations of the previously diagnosed adenocarcinoma. and colon carcinoma were identified. In conclusion and in summary a stage of pT3 pN1 (3/34) is established.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
A description for each data field can be found in the 'Data description' worksheet (yellow tab). Sample Collection Details. Histology and staging. Site of Tissue. Year of. Age at Sample. Days to. Days to. Type of. Site of. Tumour. Histology. Number. Type. Preparation. Comments. Procedure. Diagnosis. Procedure. Primary. Size (cm). (Histology). TUMOUR. FF. 0. 17. RESECT. RUL. 6.00. 07. BUFFY. FF. 11. 28. RESECT. RUL. 6.00. 07. Grade/. Pathological T Pathological N Clinical M VALCSG Stage Histology Comments. Slide URL. Differentiation. III. T2,NOS. MO. III. T2,NOS. MO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN (s) RECEIVED. 1. Lung Station 11L. 2. Lymph node: Lobar ST12. 3. Lungs Left lower lobe - bronchial resection margin. 4. Lungs Completion left pneumonectomy - bronchial resection margin. 5. Lymph node: Aorto-pulmonary ST5. DIAGNOSIS. 1., 2. Interlobar ST11, lobar ST12: - Negative for malignancy, lymph node. 3. Left lower lobe lung lobectomy : - Squamous cell carcinoma, moderately differentiated, central. Tumor greatest diameter 4.7 cm. At the hilum, tumor has invaded into peribronchial fatty tissue. 2 lobar peribronchial lymph nodes negative for tumor. Bronchial resection margin positive for tumor involvement. 4. Left completion pneumonectomy : Microscopic residual squamous cell carcinoma noted in hilar area. All 4 lobar and 3 segmental peribronchial lymph nodes negative for. tumor. One focus of effete granuloma involving pleural lymph node. Focal pleural and parenchymal fibrosis. - Remaining lung parenchyma unremarkable. Bronchial resection margin negative for tumor. 5. Aorto-pulmonary ST5: Negative for malignancy, lymph node. COMMENT. conjunction with the negative mediastinal lymph node biopsy results. this tumor is staged as a pT2NO cancer. Page: 1 of 4. CLINICAL HISTORY. CANCER OF LEFT LUNG. GROSS DESCRIPTION. 1. The specimen container labeled with the patient' s name and as. interlobar ST11"", contains two pieces of gray-black nodal tissue. asuring 1.0 x 0.4 x 0.2 cm and 1.8 x 0.8 x 0.4 cm. received in 10%. buffered formalin. The larger piece is bisected. 1A - submitted in toto. 2. The specimen container labeled with the patient S name and as ""lobar. ST12"", contains a large black lymph node measuring 1.0 x 0.8 x 0.4 cm. received in 10% buffered formalin. 2A - bisected and submitted in toto. 3. The specimen container labeled with the patient S name and as ""left. lower lobe - bronchial resection margin"", contains a lobe of lung that. measures 15.5 x 14. x 5.7 cm in formalin-inflated state. The pleura is. intact, mostly smooth and partly hemorrhagic. On the medial aspect. adjacent to the bronchus there is ragged soft tissue adhered. On the. medial anterior aspect extending from the apex to the inferior aspect. there is a staple line margin measuring 14.0 cm long. The bronchial. resection margin is examined at intraoperative consultation by frozen. section. On sectioning the lung, there is a central tumor mass present. measuring 4.7 cm in maximum diameter. The mass is solid tan-white with. some gray-black query segmental lymph nodes admixed. Grossly the tumor. appears to extend beyond the pleura and into the overlying ragged area of. soft tissue which is adjacent to the bronchus. In this area the soft. tissue is painted with silver nitrate. The tumor invades into the lobar. bronchus and into the segmental bronchi. The tumor is also 2.0 cm away. from the staple line resection margin. The rest of the lung parenchyma. ranges from unremarkable to mildly emphysematous with more prominence at. the apex. Four pieces of tumor and four pieces of grossly normal lung. prenchyma are taken for tissue banking. A. - bronchial resection margin, frozen section resubmitted. 3B-3D - tumor with overlying ragged soft tissue. Page: 2 of 4. 3E, 3F - tumor with invasion into lumen of bronchus and ?segmental lymph. nodes admixed. 3G, 3H - grossly normal lung parenchyma away from tumor. 3I - shaved staple line resection margin closest to tumor. - one possible lobar lymph node measuring 0.7 cm. 4. The specimen container labeled with the patient s name and as. ""completion left pneumonectomy bronchial resection margin"", contains a. lobe of lung received in 10% buffered formalin. It measures 17.5 x 13. 0. x. 4.5 cm in its formalin-inflated state. The pleura is intact, smooth and. shiny. The main stem bronchus is cut long measuring N 3.0 cm and is. tent and unremarkable. Along the medial aspect adjacent to the bronchus. there is a staple line which measures 16.0 cm long from the apex to. inferior aspect. Several black lobar and interlobar lymph nodes are. identified, the largest 0.8 cm in diameter. On sectioning the lung, no. lesions are identified. The parenchyma is mostly normal appearing with. very mild emphysematous changes present at the periphery. Several black. segmental lymph nodes are identified. The bronchial resection margin is. examined at intraoperative consultation by frozen section. 4A - bronchial resection margin, frozen section resubmitted. 4B - three lobar lymph nodes. 4C - one lobar lymph node bisected. 4D - ?one interlobar lymph node. 4E - three segmental lymph nodes. 4F - ?one bisected subsegmental lymph node or peripheral nodule measuring. 0.8 cm in diameter. 4G - thickened firm area of vessel. 4H-4J - lung parenchyma. 4K left lower lobe bronchial resection margin at main stem bronchus. 4L, 4M main stem bronchus serially sectioned transversely. 4N vascular resection margin. 5. The specimen container labeled with the patient' S name and as. aorto-pulmonary ST5"", contains two pieces of gray-black nodal tissue. measuring 0.3 x 0.3 x 0.3 cm and 0.9 x 0.8 x 0.4 cm. received in 10%. buffered formalin. The larger is bisected. 5A - submitted in toto. 1A ""POSSIBLE FOR SQUAMOUS CELL CA"". Page: 3 of 4. Page : 4 of 4.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: nnDATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT MOD. RADICAL MASTECTOMY, TRAM. CLINICAL HISTORY. MATERIAL SUBMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. & axillary contents. INTRAOPERATIVE CONSULTATION: Skin: 6.0 by 4.5 cm. Overall breast: 17.0 by 24.0 by 5.0 cm. Tumor mass: 2.5 by 2.0 by 3.5 cm. Close to. anterior margin. Possible tumor approximately 1.0 cm close to inferior margin. ADDENDA: Addendum. HER-2/neu AMPLIFICATION ANALYSIS (FISH). AS PER THE REQUEST OF FLUORESCENCE IN SITU HYBRIDIZATION (FISH) WAS PERFORMED ON SURGICAL. CANCER) USING THE VYSIS DNA PROBE FOR THE HER-2/neu GENE. - (BREAST. CHROMOSOME 17 CENTROMERE SIGNALS WAS DETERMINED TO BE 2.05. A RATIO OF 2.0 OR GREATER IS CONSIDERED. THE RATIO OF HER-2/neu SIGNALS TO. AMPLIFIED; THEREFORE, THIS SPECIMEN IS AMPLIFIED,. Addendum. MATERIAL SUBMITTED: BLOCK ""A2"" FOR ER/PR AND HER-2/NEU (BREAST CANCER). FINAL DIAGNOSIS: ESTROGEN/PROGESTERONE RECEPTORS AND HER-2/NEU PERFORMED ON LEFT BREAST TISSUE. ESTROGEN RECEPTOR 20%; 1+ 30%; 2+ 30%; 3+ 20%) HSCORE OF 150. ESTROGEN RECEPTOR IS INTERPRETED AS. POSITIVE. PROGESTERONIE RECEPTOR (0- 10%; 1+ 10%; 2+ 20%; 3+ 60%) HSCORE OF 230. PROGESTERONE RECEPTOR IS INTERPRETED. AS POSITIVE. HSCORE: <= 15 NEGATIVE. > 15 <= 30 BORDERLINIS. > 30 POSITIVE. HER-2/NEU - DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF. THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE (SCORE 2+). NOTE: Hor-2/Neu FISH was ordered. The Her-2/NEU and estrogen assays were performed with FDA approved. methods. The progesterone receptor. immunoperoxidase test used in this case has been devaloned and the performance characteristics determined by. the Department of Pathology at. They have not been cleared. or. approved by the U.S Food and Drug Adinistration. HSCORE is modified from: Estrogen Receptor Analysis, Arch. Pathol Lab Med 1985; 109:716-721. My signature is attestation that I have personally reviewed the submitted material(s) and the final. diagnosis reflects that evaluation. FINAL DIAGNOSIS: FINAT. DIAGNOSIS: LEFT BREAST AND AXILLARY CONTENTS. - INFILTRATING MULTIFOCAL AND MULTICENTRIE-DUCTAL CARCINONA WITH FOCAL LOBULAR FEATURES, 2.5 BY 2.0 BY 3.5. CM, NOTTINGHAM SCORE 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1) WITH DUCTAL CARCINOMA IN-SITU, NON-COMEDO WITH. CENTRAL NECROSIS AND CRIBRIFORM TYPE. - DUCTAL CARCINOMA IN-SITU REPRESENT APPROXIMATELY 20% OF THE TUMOR VOLUME. - FIBROCYSTIC CHANGES. TWO (2) SEPARATE NODULE OF INFILTRATING DUCTAL CARCINOMA ARE PRESENT IN THE LOWER INNER QUADRANT, 0.8 CM,. AND UPPER INNER QUADRANT, 0.5 CM. - TUMOR IN THE LOWER INNER QUADRANT IS WITHIN 1.0 MM FROM THE MARGIN OF RESECTION. - ALL MARGINS OF RESECTION ARE FREE OF TUMOR. - FOUR OF SIX (4/6) LYMPH NODES ARE POSITIVE FOR METASTATIC TUMOR. - TWO (2) LYMPH NODES SHOW EXTRACAPSULAR SPREAD. - THREE (3) SMALL FIRM NODULES SIMULATING LYMPH NODES IN THE AXILLARY CONTENTS SHOW INFILTRATING DUCTAL. CARCINOMA. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""A2"".

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. RIGHT COLON. DIAGNOSIS: A. RIGHT COLON, RIGHT HEMICOLECTOMY: - EXOPHYTIC CIRCUMFERENTIAL ULCERATED INVASIVE MODERATE TO. POORLY DIFFERENTIATED ADENOCARCINOMA OF CECUM, PROXIMAL. ASCENDING COLON WITH EXTENSION TO ILEOCECAL VALVE, WITH. FULL MUSCLE WALL THICKNESS INVASION, EXTENSION TO SUB-. SEROSAL FAT., METASTASIS TO SIX OF THIRTY-SIX (6/36) PERICOLIC. LYMPH NODES (WITH PERINODAL FAT EXTENSION). - SIZE OF TUMOR- 8X4X1CM. - TUBULOVILLOUS ADENOMA (1.2 X 1.1 CM). - VERMIFORM APPENDIX - NEGATIVE FOR TUMOR. PROXIMAL, DISTAL AND RADIAL MARGINS OF RESECTION - NEGATIVE. FOR TUMOR. COLORECTAL CANCER TEMPLATE. Specimen Type: Right hemicolectomy. Tumor Site: Cecum,proximal ascending coln. Tumor Configuration: Exophytic (polypoid), Infiltrative, Ulcerating. Tumor Size: 8.0 X 4.0 X 1.0 cm. Histologic Type: Adenocarcinoma. Histologic Grade: G3. Extent of Invasion: Subserosa. Margins: Margins uninvolved by invasive carcinoma. Venous/Lymphatic Invasion: Present. Perineural Invasion: Present. Additional Pathologic Findings: Adenoma. Extent of Resection: R0. Lymph Nodes: Positive (6/36). Implants: Absent. EGFR Expression: Pending. Pathologic Stage: pT3 N2 MX. ADDENDUM: Additional report: Results of immunostain: EGFR ( section with tumor,#A5) - negative immunoreactivity. SPECIMEN(S): A. RIGHT COLON. GROSS DESCRIPTION: A. RIGHT COLON TERMINAL ILEUM: Received fresh labeled with the patient's name, unit number and ""right colon terminal ileum"" is a. 28.5x8.5x4 cm. right hemicolectomy specimen. The ileum is 8 cm. long and 7 cm. in circumference,. the. colon is 20.5 cm. long, 8.5 cm. in circumference and the attached appendix is 5.8 cm. long and 0.9 cm. in diameter. The serosal surface of the specimen is tan, smooth and multiple firm lymph nodes are. palpated throughout the adherent pericolonic fat at the cecum. The specimen when opened shows a. circumferential exophytic centrally ulcerated tumor with raised indurated peripheral borders occupying. proximal ascending olon,cecum, and extending to involved the iliocecal valve,measuring 8x4x1.0 cm. Tumor 14.5 cm from distal, and 5.5cm from proximal margin. Cut sections show tan white granular. surface.and tumor seen infiltrating muscle wall and grossly appears to extend to subjacent subserosal. fat. The rest of colonic mucosa shows a flattened appearance .with a small polyp along hepatic flexure. measuring 1.2x1.1 cm. Dissection of the adherent pericolonic fat shows multiple lymph nodes, the. largest measuring 2x1.1x0.9 cm. Appendix is grossly free of tumor. Multiple sections submitted as. follows in 30 cassettes labeled A1-A17. Block summary: A1: margin. A2: apex. A3,A4,A5,A6: tumor and tandom section from ileum to colon. A7,A8: tumor. A9-A11: tumor deep section. A12: polyp. A13: three lymph nodes ileum. A14: three lymph nodes ileum. A15 lymph nodes cecum colon. A16: lymph nodes cecum colon. A17: two lymph nodes distal colon. A19-21: lymph nodes distal colon. A22-25: lymph nodes cecum. A26-30: sections of tumor, A29 and A30 are random sections.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Requesting Doctor's Information: Site: Adrenal Gland,corter C74.0 P. SPECIMEN TYPE: Adrenal. T. CLINICAL NOTES: H. Left adrenal cancer. o. L. MACROSCOPIC: 'Tumour left adrenal and left kidney'. The specimen consists of the left. O. kidney, the left adrenal gland and the perinephric fat, 160 x 125 x 70mm,. G. weighing 653g together. The ureter is 35mm in length and 5mm in maximum. external diameter. The external surface of the kidney has a nodular appearance. Y. with multiple tumour nodules/lymph nodes present in the hilum. There is an. area of capsular defect in the posterosuperior aspect of the specimen, 15 x. 10mm (? site of tumour sampling for ancillary studies). The cut surface of the. specimen shows an enlarged adrenal gland replaced almost entirely by a tan. tumour with a heterogenous cut surface showing areas of haemorrhage and large. areas of necrosis. This tumour measures 95 x 95 x 70mm and has a. multilobulated appearance. Tumour deposits are also identified in the renal. vein, as well as six tumour deposits/involved lymph nodes present in the hilum,. ranging from 7-40mm in maximum dimension. The kidney, ureter and renal sinuses. are not involved by the tumour. The remainder of the kidney is unremarkable. A. Block 1: transverse section of ureteric margin and hilar vessels. Blocks 2 and 3: tumour deposits in renal vein. N. Blocks 4 to 11: tumour and overlying capsule, including area of capsular defect. noted superior posteriorly in blocks 7 to 10. A. Block 12: tumour and necrosis. T. Block 13: tumour and area of haemorrhage. Block 14: tumour interface with kidney. O. Block 15: kidney away from tumour. M. Blocks 16 to 20: representative from involved hilar lymph node/tumour deposits;. one node in each block, except for block 20, which has two nodes. I. C. MICROSCOPIC: The 95mm tumour with an estimated weight of 450mg is a poorly differentiated. A. adrenal cortical carcinoma. It shows all 9 of 9 Weiss criteria of malignancy. The mitotic count is 10 mitoses per 10 high power field. There is widespread. L. vascular and sinusoidal invasion. There is extensive coagulative necrosis. The carcinoma is separated from the soft tissue resection margin by an intact,. but thin, soft tissue plane 0.2mm. The tumour does not extend into the. P. adjacent kidney, and the adjacent kidney is normal. Carcinoma does invade the. A. renal vein. Metastatic adrenal cortical carcinoma replaces 6 of 6 perirenal. lymph nodes. The venous resection margin and ureteric resection margins are. free of tumour. H. O. O. Requesting Doctor's Information: Ã. SPECIMEN TYPE: Adrenal. T. H. Immunohistochernistry is as follows: o. IGF2: Positive (dot-like perinuclear pattern). L. Glucocorticoid Receptor: 2+ positive. ACADVL: Positive. o. Ki-67 Proliferative index: 40%. G. Calretinnin, Inhibin: Focally positive. Y. Melan A: Very focally positive. S-100: Negative. SUMMARY: Left kidney and adrenal: High grade adrenal cortical carcinoma 95mm. Metastatic carcinoma is present in 6 of 6 lymph nodes. ADDITIONAL REPORTL. At the request of. A. immunohistochemistry for microsatellite instability associated markers was. performed. The results are as follows: N. A. MLH1: Positive. MSH2: Positive. T. PMS2: Positive. O. MSH6: Positive. M. Although we have no experience in using this test in adrenal carcinoma, this is. the normal pattern of staining which makes Lynch syndrome unlikely. I. C. A. L. REPORTING PATHOLOGIST: (Electronic Signature). P. A. T. H. o. L. O. G. Where 'Collected' indicates Rec: No collection:detalls given: Received detalls.entered ascollection.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures o. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Document Date: SUPPLEMENTAL REPORT. SUPPLEMENTAL DIAGNOSIS: The diagnosis remains unchanged. COMMENT: Stains for acid fast bacilli and fungus have been performed on a sclerotic. granuloma, and both of these stains are negative. DIAGNOSIS: 1. LUNG, POSTERIOR RIGHT UPPER LOBE AND SUPERIOR SEGMENT RIGHT LOWER LOBE,. RESECTION, FS1A, TP1A: SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED (6.5 X 4.6 X 3.7 CM). - LYMPHOVASCULAR AND PERINEURAL INVASION ARE NOT IDENTIFIED. - SEE SYNOPTIC REPORT. - SEE COMMENT. 2. #8 LYMPH NODE, EXCISION: - REMOTE GRANULOMAS WITH CALCIFICATION. - NO RESIDUAL LYMPH NODE TISSUE IDENTIFIED. - NO NEOPLASTIC TISSUE IDENTIFIED. 3. #9 LYMPH NODE: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1) . 4. 10R LYMPH NODE, EXCISION: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1) . - REMOTE GRANULOMAS WITH CALCIFICATION. 5. 11R LYMPH NODE, EXCISION: - FRAGMENTED LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). - REMOTE GRANULOMAS. 6. 4R LYMPH NODE, EXCISION: - FRAGMENTED LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1) . - REMOTE GRANULOMAS WITH CALCIFICATION. 7. #7 LYMPH NODE, EXCISION: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). REMOTE GRANULOMAS WITH CALCIFICATION AND OSsIFICATION. 8. LUNG, RIGHT UPPER LOBE AND SUPERIOR SEGMENT, RIGHT LOWER LOBE, COMPLETION. LOBECTOMY: - RESIDUAL CARCINOMA WITHIN PERIBRONCHIAL FAT. - BRONCHOVASCULAR MARGINS ARE NEGATIVE FOR CARCINOMA. - BULLOUS EMPHYSEMATOUS CHANGES OF PERIPHERAL LUNG PARENCHYMA. - REMOTE GRANULOMAS. - EIGHT LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/8). Histologic type : Squamous cell carcinoma. -- AJCC TNM Staging, 7th Edition,. 1 (Continued.. DIAGNOSIS: Primary tumor (pT) extent : pT2b Tumor more than 5 cm, but 7 cm or less in. greatest dimension. Tumor size : Maximum tumor diameter : 6.5 cm. Histologic grade : G2 Moderately differentiated. Surgical margins : Bronchial margin: negative. Pulmonary artery margin: negative. Pulmonary vein margin: negative. Vascular invasion : Absent. Lymphatic invasion : Absent. Perineural invasion : Absent. Pleural involvement : The visceral pleura are free of involvement;. tumor is less than 0.1 cm from the visceral. pleura. Extra-pulmonary invasion : Lymph Node Summary (pN). Number examined 13. Number involved 0. pNO No regional lymph node metastasis. Distant Metastasis (pM). pMX. Cannot be assessed. Non-neoplastic lung : The non-neoplastic lung shows bullous. emphysematous changes and calcified granulomas. COMMENT : Immunohistochemical stains performed on block 1F are positive in tumor cells. for cytokeratin-7 and are negative in tumor cells for both cytokeratin-20 and. uroplakin; this supports the likelihood of the primary origin of the squamous. carcinoma within the lung. A bladder tumor metastatic to the lung would likely. be positive for CK20 and uroplakin. Stains for AFB and GMS on the granulomas are in preparation. SPECIMEN: 1. Posterior RUL and superior segment RLL. 2. #8 lymph node. 3. #9 lymph node. 4. 10R lymph node. 5. 11R L node. 6. 4R L node. 7. #7 L node. 8. Completion RUL and superior segment RLL. CLINICAL HISTORY/OPERATIVE FINDINGS: Right VATS with wedge excision. History of bladder cancer. Lung mass (RUL) . GROSS DESCRIPTION: Parts 2-4 are received fresh for frozen section, each labeled with the. patient's name and medical record number. Specimen #1 is received fresh for intraoperative diagnosis, labeled with the. patient's name, medical record number and as ""posterior RUL and superior. segment RLL."" The specimen consists of part of right upper lobe and attached. Page 2 (Continued. GROSS DESCRIPTION: right lower lobe measuring 17.5 X 7.5 X 3.8 cm. A poorly circumscribed firm. subpleural tumor is identified in the specimen measuring 6.5 X 4. X 3.7 cm. Dark pigmentation and necrosis are present in the tumor. The tumor abuts the. resection margin. The uninvolved right upper lobe is unremarkable. The right. lower lobe is emphysematous, and no lesions are identified. A representative. section of the tumor in relation to pleura is submitted for frozen section. diagnosis in cassette ""FS1A.' The pleura is inked black and the resection. margin is inked blue. In addition a scrape (touch prep) of the tumor is. submitted for intraoperative diagnosis Additional sections are submitted as. stated below. Part #2 is labeled ""#8 lymph node"" and consists of a fatty and calcified,. possible lymph node measuring 1.3 X 0.8 X 0. cm. Specimen cannot be cut and. therefore no frozen section is done. Specimen is bisected and submitted. entirely in cassette ""2A"" after decalcification. Specimen #3 is labeled ""#9 lymph node"" and consists of a fatty, possible lymph. node measuring 0.6 X 0.4 X 0.2 cm. The specimen is entirely submitted for. Medical Laboratory is certified under the Clinical Laboratory Improvement. Amendments (CLIA) as qualified to perform high complexity clinical laboratory. testing. The pathologist has reviewed and interpreted the case with the. resident/fellow. SPECIAL STAINS: AFB. DONE. GMS. DONE. CYTO7. DONE. CYTO20. DONE. UROPLAKIN. DONE. Medical Records. 4 (End of Report).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Procedure: adrenalectomy. Gross description: 7 X 5 X 4.5cm, 127g. Diagnosis: adrenocortical carcinoma, KI67 5%. Reference Pathology only: Weiss score: 4. Hough score: 2.29. Van Slooten score: 9.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Page : 9/13. Prnt this Page. Specimen Description. Accession # : Clinical History. Papillary carcinoma of thyroid. Final Pathologic Diagnosis. A. Adipose tissue, excision: Mature adipose tissue; no parathyroid tissue seen. B. Thyroid, total thyroidectomy: Papillary thyroid carcinoma with secondary cystic changes, left. lobe (see synoptic report). Microscopic focus of papillary carcinoma, 2 mm. in greatest. diameter, right lobe. Small parathyroid gland. Small perithyroidal lymph nodes (4/4) involved with microscopic. subcapsular foci of metastatic papillary carcinoma. Parathyroid, excision: Lymph node (1/1) with cystic metastasis of papillary carcinoma. lectronically Signed By. Synoptic Report. SYNOPTIC REPORT FOR THYROID CANCER : Specimen type: Total thyroidectomy. Tumor location: Left- lobe. Tumor size: 3.5 x 3.0 x 2.5 cm. Histologic type: Papillary carcinoma. Tumor grade: Low-grade. Lymphatic/vascular invasion: No. Capsular invasion: No. Tumor extent: Confined to the thyroid: Yes. Specimen Description. Clinical History. Papillary carcinoma of thyroid. Final Pathologic Diagnosis. A. Adipose tissue, excision: Mature adipose tissue; no parathyroid tissue seen. B. Thyroid, total thyroidectomy: Papillary thyroid carcÃ­noma with secondary cystic changes, left. lobe (see synoptic report). Microscopic focus of papillary carcinoma, 2 mm. in greatest. diameter, right lobe. Small parathyroid gland. Small perithyroidal lymph nodes (4/4) involved with microscopic. subcapsular foci of metastatic papillary carcinoma. C. Parathyroid, excision: Lymph node (1/1) with cystic metastasis of papillary carcinoma. Synoptic Report. SYNOPTIC REPORT FOR THYROID CANCER: Specimen type : Total thyroidectomy. Tumor location : Left lobe. Tumor size: 3.5 x 3.0 x 2.5 cm. Histologic type: Papillary carcinoma. Tumor grade Low-grade. Lymphatic/vascular invasion: No. Capsular invasion: No. Tumor extent: Confined to the thyroid: Yes. Multifocal: Yes; one microscopic focus (2 mm diameter) is present in the. contralateral lobe. Invasion of thyroid cartilage or hyoid bone: No. Infiltration of adjacent structures: No. Lymph nodes: Total number examined: 5. Sites/laterality: Bilateral. Number positive: 5. Number negative: 0. Extranodal extension: No. pTNM: pT2N1Mx. The above synoptic report complies, in slightly modified form, with the. guidelines of the College of American Pathologists and the Association of. Directors of Anatomic and Surgical Pathology for the reporting of cancer. specimens. INTRAOPERATIVE CONSULTATION DIAGNOSIS. AF1. Rule out parathyroid: (FROZEN SECTION PERFORMED). Adipose tissue, no parathyroid. Examining pathologist. SPECIMEN(S) RECEIVED. A: Parathyroid, REG. B: Thyroid, REG. C: Parathyroid, REG. GROSS DESCRIPTION: The specimens are received in three properly labeled containers with the. patient' s name and accession number. A. The specimen is designated as ""rule out parathyroid"" and. consists of one fragment of tissue that measures 0.3 x 0.3 x 0.1 cm. The. specimen was previously submitted for frozen section and was totally. submitted for microscopic evaluation. TE 1. Summary of Cassettes: AF1, adipose tissue. B. The specimen is designated as ""total thyroid and left central. neck contents"" and consists of a 31.9 grams of total thyroid that measures. 8.0 x 5.0 x 2.5 cm. The specimen was previously inked as follows: the. left lobe was inked black, the right lobe was inked blue, and the isthmus. was inked green. The external surface of the thyroid is smooth and shows. an irregular area of induration along the anterior surface of the left. lobe. The specimen was previously sectioned and reveals an irregular,. ill-defined area of grayish, firm, rubbery tissue with areas of hemorrhage. and cystic degeneration located in the left lobe that measures 3.5 x 3.0 x. 2.5 cm. The lesion shows infiltrative borders and grossly does not seem to. invade the thyroid capsule. The lesions do not extend up to the isthmus or. the contralateral lobe. The uninvolved surrounding thyroid parenchyma is. beefy red-brown and unremarkable. Attached to the right lobe, there is one. fragment of adipose tissue that measures 4.0 x 1.5 x 1.0 cm. RS 10. Summary of Cassettes: B1-5, tumor with capsule and with adjacent. thyroid parenchyma; B6-7, right lobe; B8, isthmus; B9-10, totally submitted. additional fragment of adipose tissue. C. The specimen is designated ""possible parathyroid from left. central neck dissection"" and consists of one small fragment of fibroadipose. tissue that measures 1.2 x 1.0 x 0.5 cm. The specimen is totally submitted. for microscopic evaluation. TE. 1. Summary of Cassettes: C1, totally embedded fibroadipose tissue. Gross description by: Top of Page.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Anonymous number: Accession Date: FINAL DIAGNOSIS: PART 10: SOFT TISSUE, LEFT GASTRIC, EXCISION -. TWO (2) ANTHRACOTIC LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA. PART 2: LYMPH NODE, INFERIOR PULMONARY LIGAMENT, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 3: LYMPH NODE, LEVEL 7 NEAR BRONCHUS INTERMEDIUS, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 4: LYMPH NODE, NEAR PERICARDIUM, EXCISION -. ONE (1) MINUTE ANTHRACOTIC LYMPH NODE FRAGMENT, NEGATIVE FOR METASTATIC CARCINOMA. PART 5: LYMPH NODE, NEAR LEFT MAINSTEM, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 6: LYMPH NODE, PARAESOPHAGEAL NEAR LUNG, EXCISION -. A. ONE (1) LYMPH NODE FRAGMENT WITH MINUTE HYALINIZED NODULE, NEGATIVE FOR METASTATIC. CARCINOMA. B. AFB AND GMS ARE NEGATIVE FOR FUNGAL ORGANISMS. PART 7: LYMPH NODE, LEVEL 7 NEAR AORTA, EXCISION -. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR METASTATIC CARCINOMA. PART 8: LYMPH NODE, LEVEL 7 NEAR LEFT DISTAL MAINSTEM, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 9: LYMPH NODE, SUBCARINAL, EXCISION -. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR METASTATIC CARCINOMA. PART 10: LYMPH NODE, SUBCARINAL ON ESOPHAGUS, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 11: LYMPH NODE, SUBCARINAL NEAR AZYGOUS, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 12: ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY -. A. INVASIVE POORLY DIFFERENTIATED ADENO CARCINOMA WITH SQUAMOUS DIFFERENTIATION,. INVOLVING GASTROESOPHAGEAL JUNCTION, 2.2 CM. B. CARCINOMA INVADES FOCALLY THROUGH MUSCULARIS PROPRIA INTO SUBADVENTITIAL TISSUE. C. NEGATIVE FOR LYMPHVASCULAR SPACE INVASION. Anonymous No.: Gender: F. Race: White. CLINICAL HISTORY. PRE-OP DIAGNOSIS: Esophageal cancer. POST-OP DIAGNOSIS: Same/ pending. PROCEDURE: Esophagogastroduodenoscopy bronchoscopy, laparoscopic. staging, MIV IVOR, laparoscopic Lewis esophagectomy. FINAL DIAGNOSIS. PART 10: SOFT TISSUE, LEFT GASTRIC, EXCISION. TWO (2) ANTHRACOTIC LYMPH NODES, NEGATIVE FOR METASTATIC. CARCINOMA. PART 2: LYMPH NODE, INFERIOR PULMONARY LIGAMENT, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 3: LYMPH NODE, LEVEL 7 NEAR BRONCHUS INTERMEDIUS, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 4: LYMPH NODE, NEAR PERICARDIUM, EXCISION. ONE (1) MINUTE ANTHRACOTIC LYMPH NODE FRAGMENT, NEGATIVE FOR. METASTATIC CARCINOMA. PART 5: LYMPH NODE, NEAR LEFT MAINSTEM, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 6: LYMPH NODE, PARAESOPHAGEAL NEAR LUNG, EXCISION. A. ONE (1) LYMPH NODE FRAGMENT WITH MINUTE HYALINIZED NODULE,. NEGATIVE FOR METASTATIC. CARCINOMA. B. AFB AND GMS ARE NEGATIVE FOR FUNGAL ORGANISMS. PART 7: LYMPH NODE, LEVEL 7 NEAR AORTA, EXCISION. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR. METASTATIC CARCINOMA. PART 8: LYMPH NODE, LEVEL 7 NEAR LEFT DISTAL MAINSTEM, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 9: LYMPH NODE, SUBCARINAL, EXCISION. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR. METASTATIC CARCINOMA. PART 10: LYMPH NODE, SUBCARINAL ON ESOPHAGUS, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 11: LYMPH NODE, SUBCARINAL NEAR AZYGOUS, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 12: ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY. A. INVASIVE. POORLY DIFFERENTIATED ADENO CARCINOMA WITH SQUAMOUS per TSS, squamous = 5%. DIFFERENTIATION,. INVOLVING GASTROESOPHAGEAL JUNCTION, 2.2 CM. B. CARCINOMA INVADES FOCALLY THROUGH MUSCULARIS PROPRIA INTO. SUBADVENTITIAL TISSUE. C. NEGATIVE FOR LYMPHVASCULAR SPACE INVASION. D. TWENTY FIVE LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA. (0/25). E. MARGINS NEGATIVE FOR CARCINOMA. F. AJCC 7TH EDITION PATHOLOGIC TUMOR STAGE IS: pT3 NO. PART 13: LYMPH NODE, PROXIMAL PARAESOPHAGEAL, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 14: LYMPH NODE, MID PARAESOPHAGEAL, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 15: LYMPH NODE, PARAESOPHAGEAL NEAR DIAPHRAGM, EXCISION. SCANT FRAGMENT OF ANTHRACOTIC LYMPH NODE, NEGATIVE FOR. METASTATIC CARCINOMA. PART 16: ANASTOMOTIC RING, ESOPHAGOGASTRECTOMY. BENIGN SQUAMOUS AND GASTRIC MARGINS. PART 17: FINAL GASTRIC MARGIN, ESOPHAGOGASTRECTOMY. BENIGN GASTRIC MARGIN. PART 18: OMENTUM, OMENTECTOMY. BENIGN FIBROADIPOSE TISSUE, NEGATIVE FOR METASTATIC CARCINOMA. COMMENT. reviewed select slides from part 12 and agrees with the above. interpretaiton. GRGSS DESCRIPTIONved in 18 parts. Part 1 is received in formalin labeled with the patient name, initiais and ""left gastric. tissue"". The specimen consists of two portions of yellow fatty tissue, the larger is 2.5 x 1.4. x. 0.3 cm. No lesions are seen or palpated. The smaller portion of tissue is 0.7 x 0.5 x 0.3. cm. No lesions are seen or palpated. The specimen is entirely submitted in a cassette. labeled 1A. 1A x 2, entirely submitted. Part 2 is received in formalin labeled with the patient name, initiais. and ""inferior. pulmonary ligament node"". The specimen consists of a black nodule, 0.7 x 0.7 x 0.6 cm. The specimen is bisected and the cut surface has a homogenous black appearance. The. specimen is entirely submitted in a cassette labeled 2A. 2A x 2, entirely submitted. Part 3 is received in formalin labeled with the patient name, initials. and ""level 7 LN near. bronchus intermedius"". The specimen consists of an irregular portion of black soft tissue,. 1.0 x 0.5 x 0.3 cm. The specimen is entirely submitted in a cassette labeled 3A. 3A x 1, entirely submitted. Part 4 is received in formalin labeled with the patient name, initiais and ""lymph node. near pericardium"". The specimen consists of a tiny black fragment of soft tissue, 0.1 cm in. greatest dimension. The specimen is entirely submitted in a cassette labeled 4A. 4A x 1, entirely submitted. Part 5 is received in formalin labeled with the patient name, initials. and ""lymph node. near left mainstem"". The specimen consists of a fragment of gray-tan soft tissue, 0.3 x 0.2. x 0.1 cm. The specimen is entirely submitted in a cassette labeled 5A. 5A x 1, entirely submitted. Part 6 is received in formalin labeled with the patient name, initials. and. ""paraesophageal lymph node near lung"". The specimen consists of a black nodule, 0.6 x. 0.5 x 0.1 cm. The specimen consists of a black nodule, 0.6 x 0.5 x 0.1 cm. The specimen. is entirely submitted in a cassette labeled 6A. 6A x 1, entirely submitted. Part 7 is received in formalin labeled with the patient name, initiais and ""level 7 LN near. aorta"". The specimen consists of two black portions of soft tissue, the larger is 0.7 x 0.5 x. 0.4 cm, the smaller is 0.4 x 0.2 x 0.2 cm. The specimen is entirely submitted in a cassette. labeled 7A. 7A x 2, entirely submitted. Part 8 is received in formalin labeled with the patient name, initials and ""level 7 near. distal left mainstem"". The specimen consists of a black nodule, 0.6 x 0.6 x 0.3 cm. The. specimen is entirely submitted in a cassette labeled 8A. 8A x 1, entirely submitted. Part 9 is received in formalin labeled with the patient name, initials. and ""subcarinal. lymph node'. The specimen consists of four yellow-black portions of soft tissue, the. largest is 0.7 x 0.7 x 0.3 cm, the smallest is 0.5 x 0.3 x 0.2 cm. The specimen is entirely. submitted in a cassette labeled 9A. 9A x 4, entirely submitted. Part 10 is received in formalin labeled with the patient name, initials and ""subcarinal. lymph node on esophagus"". The specimen consists of a black nodule, 1.0 x 0.9 x 0.4 cm. The cut surface has a homogenous black appearance. The specimen is entirely submitted. in a cassette labeled 10A. 10A x 1, entirely submitted. Part 11 is received in formalin labeled with the patient name, initials and ""subcarinal. lymph node near azygous"". The specimen consists of a black nodule, 1.4 x 1.0 x 0.5 cm. The cut surface reveals a homogenous black appearance. The specimen is bisected and. entirely submitted in a cassette labeled 11A. 11A x 2, entirely submitted. Part 12 is received fresh labeled with the patient name, initials. and. ""esophagogastrectomy"". The specimen consists of a portion of esophagus and stomach. The esophagus is 8.0 cm in length. The esophageal margin 6.5 cm in circumference. The. stomach is up to 6.8 cm in length. The gastric margin is 11.0 cm in circumference. Located in the esophagus, 6.0 cm from the esophageal resection edge is an ulcerated. gray-white lesion, 2.2 x 2.0 x 0.7 cm. This grossly involves the gastroesophageal junction. It is also 5.5 cm away from the closest gastric margin. The esophageal margin and the. gastric margin were used for frozen section. On sectioning the lesion extends into the. muscularis but not through the entire thickness of the muscularis. Remaining esophageal. mucosa has a gray-white appearance. The gastric mucosa is red-tan. The attached fat is. 5.5 x 4.0 x 2.5 cm. Serial sectioning reveais multiple pink-tan and red-tan nodules within. the fat, the largest is 0.9 x 0.4 x 0.3 cm, the smallest is 0.3 x 0.4 x 0.2 cm. Representative. sections are submitted labeled: 12AFS x 1, esophageal margin used for frozen section. 12BFS x 1, gastric margin used for frozen section. 12C-12D x 1 each, remainder of the gastric margin taken as a shavÃ©. 12E-12K x 1 each, lesion, entirely submitted. 12L-12M x 1 each, esophagus proximal to the lesion. 12N-120 x 1 each, stomach distal to the lesion. 12P-12R x multiple each, lymph nodes. 12S-12Al x multiple each, fat entirely submitted. The soft tissues beneath the lesion are painted with blue ink. Part 13 is received in formalin labeled with the patient name, initiais and ""proximal. paraesophageal lymph node"". The specimen consists of a black nodule, 0.8 x 0.7 x 0.6. cm. The cut surface reveals a gray-black tissue. The specimen is entirely submitted in a. cassette labeled 13A. 13A x 2, entirely submitted. Part 14 is received in formalin labeled with the patient name, initials and ""mid. paraesophageal lymph node"". The specimen consists of a pink-tan nodule, 1.3 x 1.0 x 0.3. cm. The specimen is entirely submitted in a cassette labeled 14A. 14A x 1, entirely submitted. Part 15 is received in formalin labeled with the patient name, initials. and. ""paraesophageal lymph node near diaphragm"". The specimen consists of an irregular. portion of gray-black soft tissue, 1.2 x 0.5 x 0.2 cm. The specimen is entirely submitted in. a cassette labeled 15A. 15A x 1, entirely submitted. Part 16 is received in formalin labeled with the patient name, initials. and ""anastomotic. ring"". The specimen consists of two ring-shaped portions of mucosal tissue attached to a. metal anvil, each is approximately 1.5 cm in diameter, 1.3 cm in length. On sectioning. tissue contains metal staples and sutures. Representative section of Ã¨ach is submitted in. a cassette labeled: 16A x 2, soft tissue. Part 17 is received in formalin labeled with the patient name, initials. and ""final gastric. margin"". The specimen consists of a previously opened portion of stomach, 4.0 cm in. length, 3.8 cm in diameter. One edge of the specimen is closed with metal staples. The. end opposite this is left open and it contains green sutures and metal staples. The. mucosal surface has a pink-tan to red-tan appearance. No lesions are seen. Representative sections are submitted labeled: 17A x 2, shave of each margin. 17B x 2, random section. The stapled margin is painted with blue ink, the open margin is painted with black ink. Part 18 is received in formalin labeled with the patient name, initials and ""omentum"". The specimen consists of lobulated portion of fatty tissue, 7.0 X 3.0x0.3 cm. The cut. surface reveals a pale yellow tissue. No masses are seen or palpated. The specimen is. entirely submitted labeled: 18A-18E x 2 each, entirely submitted. MICROSCOPIC DESCRIPTION. AFB and GMS control slides reacted appropriately. Microscopic examination substantiates. the above diagnosis. INTRAOPERATIVE DIAGNOSIS. ESOF HAGOGASTRECTOMY (FROZEN SECTION). A. SUFFICIENT FOR ANCILLARY STUDIES. B. DEFER. C. GASTRIC AND ESOPHAGEAL MARGINS NEGATIVE. Reported to. on.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. RIGHT COLON, TERMINAL ILEUM. DIAGNOSIS: A. RIGHT COLON, TERMINAL ILEUM, RIGHT HEMICOLECTOMY: - INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA OF THE. COLON, WITH INVASION INTO SUBSEROSAL ADIPOSE TISSUE (4.2X3X0.7. CM). - ALL SURGICAL MARGINS OF EXCISION, NEGATIVE FOR NEOPLASM. - SEPARATE TUBULOVILLOUS ADENOMA, ADJACENT TO THE APPENDICEAL. ORIFICE. - APPENDIX WITH FIBROUS OBLITERATION OF THE DISTAL PORTION. - PORTION OF TERMINAL ILEUM WITH NO SIGNIFICANT PATHOLOGIC. CHANGES. - SIXTEEN MESENTERIC LYMPH NODES, NEGATIVE FOR MALIGNANCY. (0/16). - SEE TEMPLATE. COLORECTAL CANCER TEMPLATE. Specimen Type: Right hemicolectomy. Tumor Site: Right (ascending) colon. Tumor Configuration: Ulceration. Tumor Size: 4.2x3x0.6cm. Histologic Type: Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Extent of Invasion: Subserosa. Margins: Margins uninvolved by invasive carcinoma (proximal. distal, radial). Venous/Lymphatic Invasion: Absent. Perineural Invasion: Absent. Additional Pathologic Findings: Adenoma. Extent of Resection: R0: Complete resection with grossly and. microscopically negative margins. Lymph Nodes: Negative (0/16). Implants: Absent. Pathologic Stage: pT3a NO Mx. SPECIMEN(S): A. RIGHT COLON, TERMINAL ILEUM. CLINICAL HISTORY: Not given. GROSS DESCRIPTION: A. RIGHT COLON, TERMINAL ILEUM. Received fresh for tissue procurement is a segment of terminal ileum with attached right colon. The. terminal ileum is 4 cm in length and 4 cm in circumference and is grossly unremarkable. A segment of. the right colon is 25 cm in length and 9.5 cm in maximum circumference. The serosal surface is tan-. pink, smooth and grossly unremarkable. The attached appendix is 7 cm in length and 0.4 cm in. diameter and shows unremarkable external and cut surfaces. The specimen is opened and shows a. 4.2. X 3 X 0.6 cm tumor mass with central ulceration located at the mid portion of the right colon at 8 cm. from the closest (distal margin) and 12.5 cm from the ileo-cecal valve. This lesion involves the portion. of the colon which is not covered with serosa. It invades through the muscularis into the subserosa. A. second polypoid lesion is identified in the area corresponding to the base of the appendix. This lesion. measures 2.5 X 2.3 X 0.7 cm. Sectioning shows the lesion to be confined to the mucosa without definite. evidence of invasion. The remainder of the colon shows an unremarkable tan pink mucosa. Throughout the pericolic adipose tissue, multiple presumptive lymph nodes are identified ranging. between 0.3 and 0.6 cm in greatest dimension. All the lymph nodes and representative sections of the. specimen are submitted as follows: A1: appendix. A2: proximal margin. A3: distal margin. A4-7: sections of tumor. A8-12: sections of cecal polypoid mass in the area of the appendiceal orifice. A13: uninvolved colon proximal to the tumor. A14: uninvolved colon distal to the tumor. A15-16: lymph node underlying the tumor. A17-18: lymph node from the ileocecal artery region. Tissue procurement was performed on the specimen. Gross photographs are taken of the specimen.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Specimen # : (Age: Race: Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 B: LEFT AXILLARY TISSUE. C: LEFT MASTECTOMY D: NEW INFERIOR MARGIN. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE #1, BIOPSY: - ONE OF TWO LYMPH NODES WITH ISOLATED TUMOR CELLS (ITC) DETECTED BY. CYTOKERATIN IMMUNOHISTOCHEMICAL STAINING, refer to part C. B. SOFT TISSUE, LEFT AXILLA, EXCISION: BENIGN FIBROADIPOSE AND VASCULAR CONNECTIVE TISSUE WITH NERVE. - NO EVIDENCE OF LYMPH NODES. - NEGATIVE FOR MALIGNANCY. C. /. I, MASTECTOMY: i TYPE: INVASIVE LOBULAR CARCINOMA. AISTOLOGIC GRADE: GRADE 2, MODERATELY DIFFERENTIATED. - NOTTINGHAM SCORE: 6 (Tubules= 3, Nuclei 2, Mitoses= 1). TI"". IZE (GREATEST DIMENSION) : GREATER THAN 5.0 CM, see comment. ITE (QUADRANT) : OUTER UPPER AND MID. ""YPE: INVASIVE LOBULAR CARCINOMA. OLC IC GRADE: GRADE 1, WELL DIFFERENTIATED. NOTTINGHAM SCORE: 5 (Tubules= 3, Nuclei 1, Mitoses= 1). - TUMOR SIZE (GREATEST DIMENSION) : 0.3 CM, measured microscopically. - TUMOR SITE (QUADRANT) : INNER UPPER. - TUMOR FOCALITY: MULTIFOCAL. - TUMOR NECROSIS: NOT IDENTIFIED. - MICROCALCIFICATIONS: PRESENT; ASSOCIATED WITH INVASIVE AND IN SITU. TUMOR AND ALSO NON-NEOPLASTIC TISSUE. - LYMPH-VASCULAR INVASION: PRESENT, slide C6. - MARGINS: NEGATIVE FOR MALIGNANCY. - DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN = 0.5 CM, DEEP. - IN SITU COMPONENT: LOBULAR CARCINOMA IN SITU (LCIS). - DISTANCE OF LCIS FROM NEAREST MARGIN = LESS THAN 0.1 CM, DEEP. - LYMPH NODES: ONE OF TWO NODES WITH ISOLATED TUMOR CELLS. - NUMBER OF SENTINEL LYMPH NODES EXAMINED: 2. - NUMBER OF LYMPH NODES WITH MACROMETASTASES: o. - NUMBER OF LYMPH NODES WITH MICROMETASTASES: o. - NUMBER OF LYMPH NODES WITH ISOLATED TUMOR CELLS: 1. - EXTRANODAL EXTENSION: NOT IDENTIFIED. Specimen #: FINAL DIAGNOSIS (continued) : - NIPPLE/ SKIN INVOLVEMENT: NOT IDENTIFIED. ANCILLARY STUDIES (performed on core biopsy. - ESTROGEN RECEPTORS: POSITIVE. - PROGESTERONE RECEPTORS: POSITIVE. - HER 2 NEU by IHC: NEGATIVE. - ADDITIONAL PATHOLOGIC CHANGES: - PRIOR BIOPSY SITE CAVITY/ CHANGES. PATHOLOGIC STAGE: pT3 (m) NO (i+) (sn), (AJCC 7th Edition). D. SOFT TISSUE, NEW INFERIOR MARGIN, EXCISION: - FIBROADIPOSE CONNECTIVE TISSUE AND SCATTERED ATROPHIC BREAST. PARENCHYMA; NEGATIVE FOR MALIGNANCY. Comments: Macroscopically, two masses were noted within the outer upper and outer. mid regions, separated by approximately 1.5 cm. However, sampling of the. intervening tissue confirms the presence of invasive lobular carcinoma. The masses have a similar histologic appearance of invasive lobular. carcinoma, grade 2. Therefore, the upper outer/mid tumors are best. classified as a single mass and staged as pT3. A smaller separate tumor. is noted within the inner upper quadrant. The prior core biopsy. ) and ancillary studies are reviewed. This case received prospective peer review. CLINICAL DIAGNOSIS AND HISTORY: ear-old female with left breast cancer. PRE-OPERATIVE DIAGNOSIS: Breast cancer. POST-OPERATIVE DIAGNOSIS: None provided. Specimen #: GROSS DESCRIPTION: A: Received fresh, labelled with the patient's name. and designated, ""Sentinel Node #1"" consists of 2.0 x 2.0 x 0.6 cm. irregular portion of red-yellow soft tissue. Sectioning reveals a single. 1.3 x 0.5 x 0.4 cm pink-tan lymph node. The lymph node is bisected and. entirely submitted in 2 cassettes. B: Received in formalin, labeled with the patient's name. and designated, ""Left Axillary Tissue"" consists of two irregular. shaped fragments of yellow lobular adipose tissue measuring 2.3 and 1.3 cm. in greatest dimension. Sectioning reveals six possible lymph nodes. measuring up to 0.2 cm in greatest dimension each. The specimen is. entirely submitted in three cassettes as follows: B1- -. five. possible. lymph. nodes; B2- one possible lymph node, bisected; B3- remaining adipose. tissue. C: Receivo fresh, labelled with the patient's name. and de. lated, ""Left Mastectomy (Long-Lateral; Short-Superior)"" consists. of. so gram mastectomy specimen oriented with a short stitch superior. and ung st. lateral. The specimen measures 25.0 cm medial to lateral;. 21.0 cm r. to inferior; and 4.0 cm anterior to posterior. The. lightÂ¹. ed superficial skin ellipse measures 24.0 x 14.2 cm and. cm centrally located, everted nipple. No discharge is. The deep margin is inked black. Serial sections reveal a 4.0. x 4. x 3.0 cr poorly defined mass in the mid-outer breast (mass #1) . On. section. t. cut surface is firm, pink-white and shows a 0.3 cm. bloc. opsy cavity. The mass comes to within 0.5 cm of the deep. per/outer quadrant and lower/outer quadrant fibrous tissue. mass is markedly dense and nodular. Located in the. u. =1,. quan ant, adjacent to the superior-medial portion of mass #1,. is a secu fairly well defined mass measuring 0.9 x 0.8 x 0.5 cm. This. mass is located 2.0 cm from the deep margin. The second mass is located. approximately 1.5 cm from the first mass. The remainder of the specimen. is. composed of lobulated, yellow-tan adipose tissue admixed with a moderate. amount of otherwise unremarkable fibrous tissue. Located along the. lateral edge of the specimen (at the junction of the deep and superficial. margins) there is a single 0.4 cm ill-defined induration. This lateral. margin is inked blue. No lymph nodes are identified. Representative. sections are submitted as follows: C1 - skin; C2- upper/outer quadrant. mass; C3- upper/outer quadrant deep margin (to C2) ; C4- outer mid (OM). mass with cavity and deep margin; C5- deep margin, OM; C6- outer mid mass. C7-C9- additional outer mid mass; C10-C11- - induration along margin; C12-. upper/inner quadrant; C13- lower/inner quadrant; C14-lower/outer quadrant;. C15-upper/outer quadrant; C16- nipple; C17- sections of firm areas between. first and second mass. Matched sections of C1,C2,C4,C6-C9 and C12-C15 are submitted in OCT and. Specimen #: GROSS DESCRIPTION (continued) : Paraffin per CBCP protocol. D: Received in formalin, labeled with the patient's name. d designated, ""New Inferior Margin"" consists of an unoriented. The specimen is inked. Serial sectioning reveals a yellow lobular cut. fragment. of yellow lobular adipose tissue measuring 14.0 x 6.5 x 3.0 cm. surface with no well defined lesions or nodules grossly identified and. scattered areas of dense fibrous tissue. Representative sections are. submitted in seguential order in six cassettes representing various. fibrous areas. Time in formalin: >80 hours.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
TEST: Surgical Pathology. Collected Date & Time: Result Name. Reference Range. Pre-Op Diagnosis. Left renal mass. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Received in formalin labeled. - left kidney and adrenal"". is a 342 gram nephrectomy specimen consisting of a 12.2 x 6.4 x 2.7. cm kidney and a moderate amount of attached perinephric fat. There is. a 5.2 x 1.7 x 1.1 cm adrenal gland in the upper portion of the. attached fat. At the hilum is a 2.7 x 0.2 cm segment of ureter, a 0.8. x. 0.4 cm segment of renal artery, and a 0.5 x 0.3 cn segment of renal. vein. The capsule is smooth and tan-red. There is a 10.7 x 7.6 x 1.7. cm shaggy tan-yellow to red mass in the upper pole, which appears to. abut the capsule and is 0.5 cm from the inked perinephric fat margin. The cut surfaces of the mass consist of focally cystic friable. tan-red to yellow tissue. The mass does not involve the renal vein. margin. The remainder of the kidney consists of red-brown parenchyma. The corticomedullary junction is ill-defined. No additional lesions. are identified. The cut surface of the adrenal is hemorrhagic. The. specimen is inked, serially sectioned, and representative sections. submitted as follows: A - ureterovascular margin; B - mass to. uninvolved parenchyma; c - mass to perinephric fat; D-E - mass to. inked margin; F-G - uninvolved parenchyma; H-I - adrenal. Also. received in the same container is a blue, green and yellow cassette. labeled. for genomic research study. Microscopic Description: Slides are reviewed labeled. Final Diagnosis. Left kidney and left adrenal: Renal cell carcÃ­noma, clear cell type. Site: Neoplasm is identified in the upper pole of the kidney. Tumor size: 10.7 x 7.6 x 1.7 cm. Extent of the tumor: Neoplasm is confined to the kidney and does not. extend into major vessels. Nuclear grade: Fuhrman grade: 2/4. Lymphovascular space invasion: No. Transcapsular invasion: No. Renal vein invasion: No. Venal caval invasion: Not resected. Adrenal gland: The adrenal gland is not involved by neoplasm. Surgical margin status: Soft tissue margin: Negative. Oreteral margin: Negative. Vascular margin: Negative. Lymph node status: No lymph nodes removed for examination. Other: Chronic pyelonephritis. Nephrocalcinosis. Vascular wall thickening consistent with arteriolonephrosclerosis. Stage: pT2NXMX. PAS 9 SPC-A. CPT: 88307 x 2. Comments. At the request of the undersigned pathologist, these slides have been. additionally reviewed by Dr. who concurs with the. diagnosis. This test has been finalized at the.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis(es): Total gastrectomy specimen including an extensively ulcerated, weakly to largely. dedifferentiated gastric adenocarcinoma of maximum diameter 6.5 cm in the area of the. cardia directly beneath the Z line with infiltration of the perimuscular fatty tissue and. evidence of carcinomatous lymphangitis. Tumor-free regional lymph nodes. Free-free oral. resection margin lined with typical squamous epithelium and aboral resection margin lined. with typical duodenal mucosa. Free-free omental fatty tissue. Free stage: pT2b pNO (0/60) pMX;.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Report Status. Type: Surgical Pathology. Specimen Type: Kidney, partial or total resection. Procedure Date: Resident : Pathologi. PATHOLOGIC DIAGNOSIS: LEFT KIDNEY, NEPHRECTOMY (210.5g) : RENAL CELL CARCINOMA,/ clear cell type, 4.2 cm, involving lower pole, Fuhrman. nuclear grade II (of IV). Tumor is confined to the kidney. Soft tissue margin of resection is negative for tumor. Renal vein, renal artery, and ureteral margins are negative for tumor. No lymphovascular invasion present. AJCC Stage (6th edition) : Tlb NO MX. REGIONAL LYMPH NODES, BIOPSY: Four lymph nodes with no tumor present. EVALUATION OF NON-NEOPLASTIC KIDNEY (NEPHRECTOMY SPECIMEN) : KIDNEY WITH MINOR, NON-SPECIFIC ABNORMALITIES, INCLUDING MILD FOCAL GLOBAL. GLOMERULOSCLEROSIS (4% OF TOTAL GLOMERULI). ARTERIAL AND ARTERIOLAR SCLEROSIS, MILD TO MODERATE. MICROSCOPIC DESCRIPTION. The sample consists of kidney cortex and medulla. There are up to one. hundred ninety six (196) glomeruli present in the sample submitted for light. microscopy. Eight (8) glomeruli are globally obsolescent (sclerosed). The. preserved glomeruli show normal cellularity and reveal no significant. pathological changes. Very mild mesangial expansion and occasional reabsorption. granules are recognized. On PAS and. silver methenamine stain, the. glomerular basement membranes appear of normal thickness. Tubules are well. preserved; occasional tubules are mildly distended and show few hyaline casts. The interstitium shows minimal fibrosis and mononuclear inflammation. Less than. 5% of the sample shows tubular atrophy and interstitial fibrosis, as evidenced. on the trichrome stains (AFOG) Arteries and arterioles reveal mils to. moderate sclerosis of the wall, with focal hyalinosis and mild signs of. vasoconstriction in the arteriolar walls. The non-neoplastic kidney was evaluated by. Renal Pathology. CLINICAL DATA: History: with incidental finding of (L) renal mass. Operation: Not specified. Operative Findings: None given. Clinical Diagnosis: Not provided. TISSUE SUBMITTED. A/1. (L) kidney - FS. B/2. Regional nodes. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patient?s. name and unit number. Part A, received fresh in the frozen section lab, labeled ""#1. (L) kidney -. FS"", consists of a left `nephrectomy specimen (210.5 gm; 11.7 x 6.5 x 4.8 cm). to. include ureter (6.8 cm in length x 0.3 cm in diameter). renal veins (1.4 cm in. length x 0.5 cm in diameter each) renal artery (2.3 cm in length x 0.4 cm in. diameter), and scant loosely attached perinephric fat (7.2 x 5:2 ""Cm. predominately at the lower pole) - The specimen is inked black and bivalved,. revealing a golden yellow, focally hemorrhagic, predominately solid. encapsulated mass (4. 2 x 3.5 x 3.9 cm) within the lower pole, 4.5 cm from the. ureter, 1.6 cm from the nearest renal vein margin, and 2.6 cm from the renal. artery margin. The mass grossly abuts the renal capsule but does not appear to. invade through the capsule into the perinephric fat. Representative sections. of the mass are submitted to the tissue bank, cytogenetics; and electron. microscopy for special studies. Representative normal cortex is held for. future electron microscopy, immunofluorescence, and tissue banking studies. The renal pelvis displays unremarkable tan/white glistening urothelium. The. cortical medullary junction is well-demarcated with no other gross lesions. identified. No lymph nodes are identified within the scant perihilar or. perinephric fat. The adrenal gland is not identified. Photographs are taken. Micro A1: Ureteral, renal vein, and renal artery margins, (en face), 4. frags total,. Micro A2: ""Tl"" (tumor quick-fix), 1 frag,. Micro. A3-A4: Deepest extension of mass in relationship to perinephric fat and. capsule, 2 frags,. Micro A5: Focally cystic component of mass to include areas of hemorrhage,. 1 frag,. Micro A6: Mass in relationship to pelvis, 1 frag,. Micro A7: Mass in relationship to adjacent uninvolved parenchyma, 1 frag,. Micro A8: Cortical medullary junction, 1 frag,. Part B, labeled ""#2. Regional nodes"", consists of a 3.6 x 2.2 x 0.6 cm. aggregate of yellow/tar lobulated fat, within which four tan rubbery lymph node. candidates (ranging from 0.2 cm up to 1.1 cm in greatest dimension) are. identified. Micro B1: 2 single whole lymph node candidates, 2 frags,. Micro B2: 2 single whole lymph node candidates, 2 frags,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Resident Review by. Final Diagnosis by. Type: Cytogenetics. Cytogeneticist. KARYOTYPE: 45,XX,der (3) t (3 ;14) (p1?4;q2?1), ins (4;5) (q?31;q2?3q3?2), -14. METAPHASES COUNTED: 15. ANALYZED: 8. SCORED: 7. BANDING: GTG. INTERPRETATION: All metaphases contained clonal aberrations that included 3p deletion, which is. a characteristic finding in renal cell carcinoma, clear cell type. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: ?RCC. REPORT by. Final Diadnosis wy. tectronically signed on.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: female with large right renal mass, radical nephrectomy. specimen. Specimens Submitted: 1: SP: Rt. kidney & adrenal. 2: SP: Rt. gonadal vein. DIAGNOSIS: 1). KIDNEY, RIGHT; NEPHRECTOMY: - CHROMOPHOBE RENAL CELL CARCINOMA (9.7 CM) . THE TUMOR IS. CONFINED WITHIN THE RENAL CAPSULE AND ALL SURGICAL MARGINS. ARE FREE OF TUMOR. 2). VEIN, RIGHT GONADAL; EXCISION: - UNREMARKABLE VEIN, NEGATIVE FOR TUMOR. NOTE: CASE REVIEWED AT INTRADEPARTMENTAL CONFERENCE. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON THE PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL) BY THE. PATHOLOGIST WHOSE NAME APPEARS ABOVE MINE, AND THAT I HAVE REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Right Kidney and. Adrenal"" It consists of a nephrectomy specimen with attached. perirenal fat. The ureter is 7.5 cm in length and 0.5 cm in. diameter. The renal artery and vein are 1.5 and 1 cm in length and. 0. 6 and 0. 8 cm in diameter. The specimen weighs 530 grams all. together and measures 15 X 10 X 8 cm. There is a tumor mass in the. middle portion of the specimen measuring 9 X 7.5 X 7.5 cm and it is. bulging under the capsule to the lateral side of the specimen. This area is inked. After the perirenal fat is removed, the. specimen weighs 430 grams. The specimen is bisected and in the. middle portion of the kidney, which measures 14, 8 X 7.5 cm, a 9.7. X 9 x 7.5 cm tumor occupying the entire middle portion of the. kidney, occluding the hilar area is seen with a tan-yellow, light. brown color and areas of cystic degeneration. The tumor grossly. involves the capsule, only three calices can be identified in the. hilar area. The renal parenchyma measures 3 cm in greatest. dimension in the areas which is not involved by the tumor. The. tumor shows some multinodularity. Some of these nodules are. lighter in color than the surrounding tumor tissue. No definite. adrenal gland is identified in the specimen. Summary of Sections: SM - surgical margin of artery, vein and ureter. T - tumor. C. - capsule overlying the tumor. TK - tumor with normal looking kidney tissue. H - hilar area. K. - normal looking kidney. 2). The specimen is received in formalin, labeled ""Right Gonadal. Vein"". It consists of a portion of a vein measuring 1.3 cm in. length and 0.5 cm in diameter. Entirely submitted in one cassette. Summary of Sections: U - undesignated. Histo Stain Results/Comments: Stain/Procedure Name. Comment. RECUT ADDITIONAL H&E. RECUT ADDITIONAL H&E. Summary of Sections: Part. Sect. SiteBlocks Pieces. All. AG. M. N. C. 3. M. H. 2. M. K. 1. M. SM. 1. M. T. 1. 1. TK. 1. 1. 2. U. 1. M.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Report Type. PATIENT HISTORY : CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Malignant neoplasm of. larynx. PROCEDURE: Laryngectomy. SPECIFIC CLINICAL QUESTION Not given. OUTSIDE TISSUE DIAGNOSIS: Not given. PRIOR MALIGNANCY: Not given. CHEMORADIATION THERAPY : Not given. ORGAN TRANSPLANT: Not given. IMMUNOSUPPRESSION Not given. DISEASES: Not given. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT, LEVEL 2, 3 AND 4, NECK DISSECTION. SIXTY-ONE BENIGN LYMPH NODES. PART 2: LYMPH NODES, LEFT, LEVEL 2, 3 AND 4, NECK DISSECTION. THIRTY-SIX BENIGN LYMPH NODES. PART 3: LARYNX AND THYROID GLAND, TOTAL LARYNGECTOMY AND RIGHT THYROID. LOBECTOMY. A. INVASIVE, MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. OF THE. SUPRAGLOTTIC REGION PREDOMINANTLY ON THE RIGHT SIDE AND WITH INVASION. OF THE. PRE-EPIGLOTTIC SPACE, 4.5 CM. B. TUMOR ASSOCIATED ACUTE ABCESS FORMATION. C. MARGINS FREE OF TUMOR. D. NO PERINEURAL INVASION SEEN. E. PRESENCE OF A TRACHEOSTOMY. F. RIGHT THYROID LOBE WITH FOCAL FIBROSIS. G. pT3 NO MX. PART 4: LARYNX, RIGHT LATERAL MARGIN. NO TUMOR SEEN. PART 5: LARYNX, LEFT LATERAL MARGIN. NO TUMOR SEEN. PART 6: LARYNX, INFERIOR MARGIN. NO TUMOR SEEN. PART 7: LARYNX, RIGHT SUPERIOR MARGIN. NO TUMOR SEEN. PART 8: LARYNX, LEFT SUPERIOR MARGIN. O TUMOR SEEN. My si. station that I have personally reviewed the. submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received fresh in eight parts. Part 1 is labeled with the patient's name, initials, xx, and ""right. neck. levels 2, 3, and 4"". The specimen is received unoriented and measures. 14.0 X. 5.5 X 3.0 cm. It contains nodules ranging from 0.4 to 3.2 cm. All the. nodules are submitted. Cassette code. 1A 1J nodules from the first third. 1A one lymph node, 3.2 cm. 1B one lymph node, 2.2 cm. 1C one lymph node, 2.0 cm. 1D 1E one lymph node, 2.8 cm. 1F 1J multiple lymph nodes. 1K. 1N lymph nodes from second third. 1K one lymph node, 2.0 cm. 1L 1N multiple lymph nodes. 10. 1T multiple lymph nodes from last third. 10 one lymph node, 2.8 cm. 1P 1T multiple lymph nodes. Part 2 is labeled with the patient's name, initials, xx, and ""left neck. levels. 2, 3, and 4"". The specimen is received unoriented and measures 13.0 X. 5.4 X. 2.5 cm. It contains nodules ranging from 0.4 to 2.0 cm. All the nodules. found. are submitted. Cassette code: 2A 2B one lymph node, 2.0 cm, from first third. 2C 2D multiple lymph nodes from first third. 2E 2H multiple lymph nodes from second third. 2I. 2L multiple lymph nodes from last third. Part 3 is received labeled with the patient's name, initials, xx, and. ""larynx"". It measures 10.0 cm (SI) X 9.0 (L) X 6.5 (AP) Skin is. present on. the anterior side with a central opening that is communicating with the. trachea. The right and left supraglottic region and almost the entire. epiglottis are involved by a white-gray, firm lesion of 4.5 (SI) X 2.5. (L) X. 2.2 (AP) This lesion is at 0.2 cm from the right anterior margin, at. 0.3 cm. from the right lateral margin, at 5.0 cm from the trachea, 0.8 cm from. the. left lateral margin and at 0.9 cm from the left anterior margin. A 4.5. X 2.5. X 1.5 cm right thyroid lobe is also present. Its parenchyma is red,. homogeneous and does not contain any lesions. Digital images are taken. Cassette code: 3A shave trachea margin. 3B shave left anterior margin. 3C shave then perpendicular right anterior margin. 3D 3H right larynx, full section (D epiglottis upper, 3E epiglottis. lower,. 3F vocal cords, 3G soft tissue anterior to vocal cords, 3H inferior). 3I 3J lateral right margin. 3K right thyroid lobe, representative section. 3L 30 left larynx full section (3L epiglottis superior, 3M. epiglottis. lower, 3N vocal cords, 30 inferior section). 3P left lateral margin,. 3Q lymph node? left anterior soft tissue. Part 4 is labeled with the patient's name, initials, xx, and ""right. lateral. margin, stitch superior"". It consists of a tan-pink fragment of 6.0. X. 0.5 X. 0.2 cm. The side identified by a stitch is inked blue. The specimen is. submitted totally in cassette labeled 4AFS. Part 5 is labeled with the patient's name, initials, XX and ""left. lateral. margin"". It consists of a tan-pink fragment, 4.3 X 0.2 X 0.3 cm. A. clip. identifies the superior side and this region is inked blue. The. specimen is. totally submitted in cassette labeled 5AFS. Part 6 is labeled with the patient's name, initials, XX and ""inferior. margin"". The tan-pink fragment is 2.5 X 0.5 X 0.2 cm. The right side is. identified by. a clip and this region is inked blue. The specimen is totally submitted. in. cassette labeled 6AFS. Part 7 is labeled with the patient's name, initials, XX and ""right. superior. margin"". It consists of two fragments of tan-pink tissue measuring 1.1. X 0.5. X 0.3 and 1.7 X 0.3 X 0.3 cm. The right side is identified by double. clips. and one clip identifies external margin. These regions are inked blue. The. specimen is totally submitted in a cassette labeled 7AFS. Part 8 is labeled with the patient's name, initials, XX and ""left. superior"". It consists of pink to tan fragment, 3.5 X 0.4 X 0.2 cm. A clip. identifies the. left side and this region is inked blue. The specimen is totally. submitted in. RAOPERATIVE CONSULTATION: 4AFS : RIGHT LATERAL MARGIN (frozen section). A. BENIGN. B. NO TUMOR SEEN. 5AFS: LEFT LATERAL. n section). A. BENIGN. B. NO TUMOR SEEN. 6AFS. INFERIOR MAR. tion). A. BENIGN. B. NO TUMOR SEEN. 7AFS: RIGHT SUPERI. en section). A. BENIGN. B. NO TUMOR SEEN. 8AFS : LEFT SUPERIO. section). A. BENIGN. NO TUMOR SEEN. COPIC: Microscopic examination substantiates the above diagnosis. One H&E. recut. was performed on 3F. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics. dete. the. Department of Pathology, as required by. regulations. The testing has not been cleared or approved for the. S. cific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue. fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laborator. certified under the Clinical Laboratory Improvement. Amendments of. (""CLIA"") as qualified to perform high-complexity. clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this. laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - LARYNX RESECTIONS. TYPE OF LARYNGECTOMY : Total. TUMOR LATERALITY: Bilateral. ATTACHED STRUCTURES: Tracheotomy, Thyroid, Skin. TUMOR LOCATION/SEGMENT: Supraglottic. TUMOR SIZE: Maximum dimension: 4.5 cm. HISTOLOGIC TYPE OF TUMOR: Squamous cell carcinoma. HISTOLOGIC GRADE: Moderately differentiated. STRUCTURES INVOLVED BY TUMOR: False cord, Epiglottis, Pre-. epiglottic. space. LYMPH NODES: Lymph nodes positive, Right: 0. Total number of right sided lymph nodes examined: 61. Lymph nodes positive, Left: 0. Total number of left sided lymph nodes examined: 36. EXTRACAPSULAR SPREAD OF LYMPH NODE METASTASES. INTRA-PERINEURAL INVASION: Absent. VASCULAR INVASION: SURGICAL MARGIN INVOLVEMENT: Free (2 mm or more). T STAGE, PATHOLOGIC: Supraglottis, pT3. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: ck Level 2,3, and 4. 00:00. 07:49. Stain/c. ock. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. L. H&E X 1. M. H&E X 1. N. H&E X 1. O. H&E X 1. P. H&E X 1. Q. H&E X 1. R. H&E X 1. S. H&E X 1. Part 2 : ls 2,3, and 4. Taken: : Stain/ C11. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. L. H&E X 1. M. H&E X 1. N. H&E X 1. O. Part 3 : 00:00. Stain/ CTTC. ock. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. H&E X 1. M. H&E X 1. O. H&E X 1. P. H&E X 1. Q. H&E X 1. R. H&E X 1. S. H&E Recut X. 1. FDC. H&E X 1. FDC. H&E X 1. NDC. Margi. H&E X 1. AFS. argin. H&E X 1. AFS. n Cli. H&E X 1. AFS. Marg. p Far Right. H&E X 1. AFS. Margi. H&E X 1. AFS. TC1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
INTERPRETATION AND DIAGNOSIS: 1. PARATHYROID (BIOPSY) : LYMPHOID AND FIBROADIPOSE TISSUE. PARATHYROID IDENTIFIED. 2. TOTAL THYROID AND CENTRAL NECK DISSECTION LEVEL 6 (THYROIDECTOMY. AND CENTRAL NECK DISSECTION) : SPECIMEN TYPE: Total thyroidectomy. TUMOR SITE: Isthmus, left lobe. HISTOLOGIC TYPE: Papillary carcinoma with focal solid areas. TUMOR SIZE: Greatest dimension: 2.8cm. FOCALITY: Unifocal. LYMPH NODES: Small foci of metastatic carcinoma in 3 of 15 lymph nodes. See note. EXTENT OF INVASION. Edition AJCC) : PRIMARY TUMOR: pT2: Tumor >2cm, but <=4cm, limited to thyroid. REGIONAL LYMPH NODES: pN1A: regional lymph node metastasis, See note. MARGINS: Margins are uninvolved. Distance of invasive carcinoma from nearest. margin: <1mm. Specify margin: anterior and deep. VENOUS/LYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis (lymphocytic). NOTE: Psammomatous calcifications are present in 3 of 15 lymph. nodes, and levels and immunostains for cytokeratin highlight. individual metastatic carcinoma cells in association with these. cells. Thyroglobulin is noncontributory (high background) while TTF-1. labels a few of these cells.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL PATHOLOGIC DIAGNOSIS: A. Level 10 lymph node: Benign, hyperplasia. B. Level 11 lymph node: Benign, hyperplasia. C. Right upper lobe of lung lobectomy: Carcinoma. Tumor characteristics: Histologic type: Adenocarcinoma with mucinous and. bronchoalveolar features. Histologic grade: Low-grade (1/3). Tumor site: Peripheral. Tumor focality: Unifocal. Tumor size: 3.0 x 2.0 X 2.0 cm. Visceral pleural invasion: No. Lymphovascular space invasion: Not identified. Tumor extension: Tumor confined to lung. Treatment effect: Not identified. Surgical margin status: Tumor distance from bronchial margin: 2.5 cm. Tumor distance from parenchymal margin: 2.5 cm. Tumor distance from pleural surface: less than 0.1 cm. Lymph node status (utilizing all specimens submitted): Total number of lymph nodes received: Seven. Total number of lymph nodes containing metastatic carcinoma: None. Other: Other significant findings: the frozen section diagnosis is. confirmed. pTN stage: pT1,NO. D. Level 4 lymph node: Benign hyperplasia. COMMENTS: CLINICAL HISTORY: Preoperative Diagnosis: left upper lobe. mass, positive smoker, question malignancy. Please call. results to. Postoperative Diagnosis: Symptoms/Radiologia Findings: SPECIMENS: A. Level 10 lymph node. B. Level 11 lymph node. C. Right upper lobe with frozen section. D. Level 4 lymph node. CODES: 88305. 88305. 88309. 88331. 88342. 88342. 88342. 88342. 88305. GROSS DESCRIPTION: The specimen is received in four containers labeled with the. Container A is additionally labeled nevel 10 lymph node"". and contains a 2.0 x 1.0 X 0.5 cm, yellow-tan, firm, fatty. nodule consistent with possible lymph node. The specimen is. bisected to reveal a black, anthracotic cut surface. The. specimen is entirely submitted in cassette A labeled &. Container B is additionally labeled ""level 11 lymph nodes"". and contains a 1.5 X 1.5 X 1.0 cm, tan-brown, rubbery nodule. bisected to reveal a gray-black anthracotic cut surface. The specimen is entirely submitted in cassette B labeled. Container C is additionally labeled ""right upper lobe"" and. contains a 13.0 X 10.5 x 4.0 cm, purple-pink, moderately. anthracotic lung lobe featuring an 8,5 cm in length stapled. parenchymal margin as well as an additional stapled vascular. margin and stapled bronchial margin, each measuring 0.5 cm. in length by 1.5 cm in diameter. The bronchus is opened to. reveal a yellow-tan striated endothelium. No discrete. masses are identified. The stapled line is removed and the. underlying parenchyma is inked black. The specimen is. serially sectioned to reveal a 3.0 X 2.0 X 2.0 cm,. yellow-tan, glistening, mucoid mass that abuts the inked. pleura and approaches to within 2.5 cm of the vascular,. bronchial and inked parenchymal margins. The remainder of. the cut surface is beefy red and congested with no. additional lesions. Five possible anthracÃ³tic parabronchial. lymph nodes are identified ranging from 0.3 to 0.5 cm in. greatest dimension. A representative section of the mass is. submitted for frozen section with ule residual entirely. resubmitted for permanent section in cassette C1 labeled. Additional representative sections are. submitted in cassettes C2-10 designated as follows: C2. bronchial and vascular margin, en face; C3 inked parenchymal. margin, perpendicular; C4 through 8 entire mass to inked. pleura, perpendicular; C9 uninvolved parenchyma; C10 five. whole possible lymph nodes. Additionally, a yellow and green. cassette are submitted for genomic research, each labeled. Container D is additionally labeled ""level 4 lymph node"". and contains a 2.8 X 1.7 X 1.2 cm, yellow-tan fibrofatty. soft tissue. On section and palpation, ill defined areas of. black discoloration are identified, however no discrete. lymph nodes are palpated. The specimen is entirely. submitted in cassettes D1-2 labeled. INTRA-PROCEDURE CONSULTATION: Frozen section diagnosis part C: Consistent with. adenocarcinoma with mucinous features. Per. MICROSCOPIC DESCRIPTION: The frozen section diagnosis is confirmed. The neoplastic. cells are CK7 and TTF positive as well as CK 20 and CDX2. negative.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Encounter. info: REVISED REPORT. Clinic Number: DIAGNOSIS: AMENDMENT REPORT. This amendment is being performed to. correct the AJCC pathologic stage grouping. The stage grouping will. be changed to pT1b,NO. Procedure/laterality: Kidney, left, partial nephrectomy. Histologic type: Papillary renal cell carcinoma, type 1. Nuclear grade (Fuhrman, 1-4) : 2 of 4. Tumor size: 5.5 cm in greatest dimension. Tumor site: Midportion left kidney. Tumor focality: Unifocal. Sarcomatoid features: Absent. Tumor necrosis: Absent. Microscopic tumor extension: Extension into perinephric tissue: Not applicable. Extension beyond Gerota's fascia: Not applicable. Extension into renal sinus: Not applicable. Extension into renal vein: Not applicable. Extension into collecting system: Not applicable. Extension into adrenal gland (if applicable) : Not applicable. Surgical margins : Negative. Lymph-vascular invasion: Absent. Lymph nodes: Not applicable. Pathologic findings in nonneoplastic kidney: There is insufficient. non-neoplastic kidney available for evaluation. Pathologic staging: pT1b, NO. Biorepository sample (if applicable) : Positive for malignancy. Block (s) containing malignancy suitable for additional testing: A1-A6. DIAGNOSIS COMMENT: Frozen section diagnosis confirmed on permanent sections. Representative sections shared with. who concurs. AMENDMENTS: (Previous Signout Date: Revision Description: See final report for amendment reason. Original Diagnosis. Procedure/laterality: Kidney, left, partial nephrectomy. Histologic type: Papillary renal cell carcinoma, type 1. Nuclear grade (Fuhrman, 1-4) : 2 of 4. Tumor size: 5.5 cm in greatest dimension. Tumor site: Midportion left kidney. Tumor focality: Unifocal. Sarcomatoid features: Absent. Tumor necrosis: Absent. Microscopic tumor extension: Extension into perinephric tissue: Not applicable. Extension beyond Gerota's fascia: Not applicable. Extension into renal sinus: Not applicable. Extension into renal vein: Not applicable. Extension into collecting system: Not applicable. Extension into adrenal gland (if applicable) : Not applicable. Surgical margins: Negative. Lymph-vascular invasion: Absent. Lymph nodes: Not applicable. Pathologic findings in nonneoplastic kidney: There is insufficient. non-neoplastic kidney available for evaluation. Pathologic staging: pT2, NX. Biorepository sample (if applicable) : Positive for malignancy. Block (s) containing malignancy suitable for additional testing: A1-A6. CLINICAL INFORMATION: Left kidney mass. SPECIMEN (S) : A:Left renal mass. PRELIMINARY INTRAOPERATIVE DIAGNOSIS: Intraoperative Pathologist (s) : A. Left renal mass, frozen section diagnosis: A1) Papillary renal cell carcinoma. GROSS DESCRIPTION: A. Received fresh labeled and ""left renal mass"". Procedure : Partial nephrectomy. Specimen laterality: Left. Tumor site: Midportion of left kidney, as indicated in the. radiologic imaging. Tumor size: 5.5 x 4.5 x 3.5 cm. Tumor focality: Unifocal. Gross extent of tumor: Extension into perinephric tissue: Absent. Extension beyond Gerota's fascia: Absent. Extension into renal sinus: Not grossly apparent. Extension into renal vein: Not grossly apparent. Extension into collecting system: Not grossly apparent. Adrenal gland: Absent. Gross notes: Gross tumor characteristics: Tan-yellow, centrally hemorrhagic,. well-demarcated, solid mass with diffusely soft cut surfaces. Kidney weight: 43 g. Kidney dimensions: 5.5 x 4.5 x 3.5 cm. Distance to margin: The tumor grossly appears to abut the inked. parenchymal margin. Lymph nodes: Absent. Inking details: The parenchymal resection margin is inked black. and the margin is designated by the surgeon. Biorepository sample submitted: Yes, see block key. Other: Representative sections from the cut surface of the tumor. are submitted for frozen section in one block. Block key for specimen A: A1) Representative sections from cut surface of tumor, submitted for. frozen section. A2-A4) Additional sections of tumor in relation to inked parenchymal. margin. A5) Mirror image of tissue submitted for IRB study. A6) Section of tumor in relation to outermost surface (renal. capsule) . Support for the diagnosis in this case may have included the. use of mmunohistochemistry tests that were developed and whose. performance characteristics were determined by. They have not been cleared. or approved by the U.S. Food and Drug Administration (FDA) . The FDA has determined that such clearance or approval is not. necessary. These tests should not be regarded as investigational. or for research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of 1988 ('CLIA') as qualified. to perform high complexity clinical laboratory testing.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
(Age: Urology. Clinical Diagnosis & History: T2 UCB. Specimens Submitted: 1: Bladder, prostate, seminal vesicles, peri-vesicle lymph nodes, radical cystoprostatectomy. 2: Right distal pelvic lymph nodes, resection. 3: Left distal pelvic lymph nodes, resection. 4: Right distal ureter, excision. 5: Left distal ureter, excision. DIAGNOSIS: 1. Bladder, prostate, seminal vesicles, peri-vesicle lymph nodes, radical cystoprostatectomy: Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Flat (in situ carcinoma). Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Identified. Bladder Local Invasion: Perivesical soft tissues. Extravesical Tumor Extension: Right ureter involved. Left ureter involved. Urethra involved. Periurethral prostatic ducts involved. Prostatic stroma involved. Vascular Invasion: Identified. extensive. Perineural Invasion: Identified. Surgical Margins: Tumor present at right ureteral margin. Tumor present at left ureteral margin. Tumor present at urethral margin. For actual ureteral margins, please see parts 4 and 5. Non-Neoplastic Mucosa: Exhibiting ulceration. Prostate: Other Extensively involved by urothelial carcinoma. Seminal Vesicles: Other Involved by invasive urothelial carcinoma, bilateral. Perivesical Lymph Nodes: Not identified. The Pathologic Stage is (AJCC 2002): pT3 (Invasion of perivesicle soft tissue). PR2 (Periprostatic or periseminal vesicle soft tissue invasion). 2. Right distal pelvic lymph nodes, resection: Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 1.8cm. Size of the largest metastatic focus : 0.9 cm. extension is identified. 3. Left distal pelvic lymph nodes, resection: Lymph Node Dissection: Benign fibroadipose tissue. 4. Right distal ureter: - Urothelial carcinoma in situ. - Resection margin involved by carcinoma in situ. 5. Left distal ureter: - Urothelial carcinoma in situ. - Resection margin involved by carcinoma in situ. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh labeled, ""Bladder, prostate, seminal vesicles, peri-vesicle lymph node"". It consists of a bladder. with attached prostate and adnexa measuring 19.0 cm from superior to inferior, 11.0 cm laterally and 5.0 cm from anterior to. posterior. The anterior aspect of the bladder is inked blue and the posterior black. The prostatic urethral margin is shaved and. submitted. The bladder is opened along the anterior midline to reveal hemorrhagic, ulcerated, indurated, necrotic tumor measuring. 5.0 x 4.8 x 1.8 cm which is grossly situated within the left and right posterior walls. The tumor grossly involves both the left and. right ureteral orifices. Both ureters are probed patent measuring up to 0.2 cm in maximum diameter. The lesion is sectioned. to. reveal white-pink cut surface with invades the underlying fat. Possible extension to the inked fat is grossly identified. The remaining. bladder mucosa is pink-tan with the normal folds. Two ovoid lesions measuring 0.6 x 0.4 cm are identified at the dome and right. posterior wall. Discrete perivesical lymph nodes are grossly not identified. The prostate is serially sectioned to reveal white-tan. prostatic parenchyma with multiple yellow foci and white fluid filled cysts identified. A gold thread-like material is identified within. the prostate. Representative sections are submitted sections from each prostatic quadrant and transition zone. TPS is submitted,. gross photograph taken. Summary of sections: UTHM - urethral margin. RUM - right ureter margin. LUM - left ureter margin. T tumor. DL-dome lesion. WL--wall lesion. RUO - right ureter orifice. LUO - left ureter orifice. LP - left posterior wall. LA - left anterior wall. RP - right posterior wall. RA - right anterior wall. TRI -- trigone. DOM dome. F perivesical fat. RSV - right seminal vesicle. LSV - left seminal vesicle. RAP - right apex prostate. LAP - left apex prostate. RAM - right anterior mid prostate. RPM - right posterior mid prostate. LAM - left anterior mid prostate. LPM - left posterior mid prostate. RAB - right anterior base prostate. RPB - right posterior base prostate. LAB - left anterior base prostate. LPB - left posterior base prostate. 2). The specimen is received in formalin, labeled ""Right distal pelvic lymph nodes"" and consists of three pink tan firm, fatty lymph. nodes ranging from 1.5 to 3.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph node. BL1 - bisected lymph node #1. BL2 - bisected lymph node #2. 3). The specimen is received in formalin, labeled ""Left distal pelvic lymph nodes"" and consists of a portion of yellow tan adipose. tissue measuring 4 x 1 x 1 cm. No palpable lymph node is identified. Entirely submitted. Summary of sections: U - undesignated. 4) The specimen is received in formalin, labeled ""right distal ureter- unclipped end is margin"" and consists of a gray-tan segment of. ureter measuring 0.7 cm in length and 0.4 cm in diameter. A clip is present at one end which is inked black. The opposite end,. identified as the margin, is inked blue. The specimen is serially sectioned and totally submitted. Summary of sections: M - margin (blue ink). SS - serial sections. 5) The specimen is received in formalin, labeled ""left distal ureter- unclipped end is margin"" and consists of a gray-tan segment of. ureter measuring 2.3 cm in length and 0.4 cm in diameter. A clip is present at one end which is inked black. The opposite end,. identified as the margin, is inked blue. The specimen is serially sectioned and totally submitted. Summary of sections: M - margin (blue ink). SS - serial sections. Summary of Sections: Part 1: Bladder, prostate, seminal vesicles, peri-vesicle lymph nodes, radical cystoprostatectomy. Block. Sect. Site. PCs. 1. DL. 2. 1. DOM. 2. 1. F. 1. 1. LA. 2. 1. LAB. 1. 1. LAM. 1. 1. LAP. 1. 1. LP. 2. 1. LPB. 1. 1. LPM. 1. 1. LSV. 1. 1. LUM. 1. 1. LUO. 1. 1. RA. 2. 1. RAB. 1. 1. RAM. 1. 1. RAP. 1. 1. RP. 2. 1. RPB. 1. 1. RPM. 1. 1. RSV. 1. 1. RUM. 1. 1. RUO. 1. 7. T. 7. 1. TRI. 2. 1. UTHM. 1. 1. WL. 2. Part 2: Right distal pelvic lymph nodes, resection. Block. Sect. Site. PCs. 2. BL1. 2. 2. BL2. 2. 1. LN. 1. Part 3: Left distal pelvic lymph nodes, resection. Block. Sect. Site. PCs. 3. U. 3. Part 4: Right distal ureter, excision. Block. Sect. Site. PCs. 1. M. 1. 1. SS. 2. Part 5: Left distal ureter, excision. Block. Sect. Site. PCs. 1. M. 1. 2. SS. 4.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical History/Diagnosis: Not entered. Source of Specimen(s): A: L4 LN. B: R4 LN. C: LEVEL 7 LN. D: CYTO. E: L LEVEL 8 LN. F: LEVEL 7 LN. G: L LEVEL 10 LN. H:L LUNG. Gross Description: GROSS DESCRIPTION: Received fresh for frozen section evaluation is a 1031. gram, 22.0 x 12.5 X 6.0cm left pneumonectomy. It is covered by a red-purple focally. anthracotic stained pleura having a 7.5 x 7.5 X 0.8cm fragment of yellow-tan attached parietal. pleura in the superior segment of the lower lobe. There is up to 1.5cm of attached bronchus. and the bronchial margin is submitted for frozen section evaluation and the frozen section. residue is submitted in one block. On sectioning the lung at the junction of the upper and. lower lobes, there is a 9.5 X 7.5 X 6.5cm firm mass. This lies beneath the previously described. parietal pleura. The cut surfaces of the mass are tan to gray-tan, variegated, firm and nodular. with focal anthracotic stain. The margins are irregular. The remaining cut surfaces of the upper. lobe are red-purple, glistening and soft. On sectioning the lower lobe the cut surfaces range. from pink-red to golden yellow having focal areas of a yellow-tan exudate. There are several. palpable hilar lymph nodes, 1.0 to 2.0cm in greatest dimension. The cut surface of each is tan. to gray-black and focally anthracotic stained. A representative section of each lymph node is. submitted. Representative sections are submitted in thirteen blocks. DESIGNATION OF SECTIONS: 8FS - frozen section, bronchial margin, 8A to 8B - vascular. margin, 8C thru 8F - tumor with inked pleura, 8G thru 8H - random tumor sections, 8I -. random sections upper lobe, 8J thru 8K -random section lower lobe, 8L thru 8M - hilar lymph. nodes. SUMMARY OF SECTIONS: 8FS-1, 8A-3, 8B-1, 8C-1, 8D-1, 8E-1, 8F-1, 8G-1, 8H-1, 8I-2,. 8J-1, 8K-1, 8L-2, 8M-3. Final Diagnosis: DIAGNOSIS: 1. L4 LYMPH NODES: - TWO NEGATIVE LYMPH NODES (0/2). 2. R4 LYMPH NODE: - TWO NEGATIVE LYMPH NODES (0/2). 3. LEVEL 7 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 4. CYTOLOGY. 5. LEFT LEVEL 8 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 6. LEVEL L7 LYMPH NODES: - FIVE NEGATIVE LYMPH NODES (0/5). 7. LEFT LEVEL 10 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 8. LEFT LUNG: SYNOPTIC REPORT FOR LUNG CANCER. - A NEOPLASM IS PRESENT. - LOCATION OF TUMOR IS LEFT LUNG. - THE HISTOLOGIC CLASSIFICATION OF THE TUMOR IS SQUAMOUS CELL. (EPIDERMOID). CARCINOMA, KERATINIZING TYPE. - POORLY DIFFERENTIATED. - THE MAXIMUM DIMENSION OF THE TUMOR IS 9.5 CM. - LYMPHATIC INVASION BY TUMOR IS ABSENT. - VENOUS INVASION BY TUMOR IS ABSENT. - ARTERIAL INVASION BY TUMOR IS ABSENT. - INVASION INTO BUT NOT THROUGH THE PLEURA BY TUMOR IS ABSENT. - INVASION THROUGH THE PLEURA BY TUMOR IS ABSENT. - TUMOR NECROSIS IS MODERATE. - THE SURGICAL MARGINS ARE UNINVOLVED BY TUMOR. - THE NON-NEOPLASTIC LUNG TISSUE SHOWS PNEUMONIA WITH ABSCESS. - THE TOTAL NUMBER OF NODES EXAMINED IS: 5. - THE TOTAL NUMBER OF POSITIVE NODES IS: 0. STAGING DATA. T2. N-0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: A1 A2 A3 A4 A5 A6. Tissue from liver segment VI with portion of liver segment V (255.0. grams, 11.9 x 8.5 x 8.0 cm). DIAGNOSIS: Liver, segment VI with portion of segment V, resection: Well. differentiated hepatocellular carcinoma forming a mass (3.6 x 2.1 x. 2.1 cm) . The surgical resection margins are uninvolved. See. comment. Seen in consultation wit. Comment: Reticulin stain shows loss of reticulin framework in the. carcinoma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: 5. Invasive breast carcinoma of mixed differentiation with partly ductal and partly lobular. components (max. diameter 1.5 cm, malignancy grade II). No angioinvasion, no coarse. calcification. Minimum width of ventral safety margin 0.5 cm. Distant fibrolipomatous. parenchyma of the breast and adjacent skin spindle free of atypia. Tumor classification: pTlc (1.5 cm), pN0 sn (n=4), MX, R0; G2 (LO, V0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Female. Admission Date: Discharge Date: Collected Date/Time: Received Date/Time: Final Diagnosis. A. L YMPH NODES, RIGHT SENTINEL, EXCISION: - THREE OUT OF FOUR YMPH NODES SHOW ONE TO TWO POSITIVE TUMOR CELLSBY CYTOKERATIN. STAIN, pNO (i+). - SEE SPECIAL STAINS SECTION BELOW. B. REAST, RIGHT, EXCISION WITH NEEDLE WIRE LOCALIZATION: - INVASIVE DUCTAL CARCINOMA, GRADE 3, NOTTINGHAM HISTOLOGIC SCORE 8 (TUBULE FORMATION 3,. NUCLEAR PLEOMORPHISM 3, MITOTIC RATE 2). DUCTAL CARCINOMA IN SITU, GRADE II-III, SOLID AND CRIBRIFORM TYPES WITH SMALL AREAS OF. NECROSIS. - LOBULAR CARCINOMA IN SITU, PLEOMORPHIC AND CLASSICAL TYPES. -LYMPHOVASCULAR INVASION PRESENT. SEE NOTE. - SEE SPECIAL STAINS SECTION BELOW. - SEE ALSO SYNOPTIC REPORT. NOTE: B. There is a focus of lymphovascular invasion that is 0.2mm from the anterior margin. (Electronic signature). Verified: Synoptic Report. SPECIMEN: Partial breast. PROCEDURE: Excision with wire-guided localization. LYMPH NODE SAMPLING: Sentinel lymph node(s). SPECIMEN INTEGRITY: Print Date/Time: Distribute to: Patient Locations: Female. Collected Date/Time: Received Date/Time: Single intact specimen (margins can be evaluated). SPECIMEN SIZE: Greatest dimension: 5.0 cm. Additional dimensions: 4.0 x 3.5 cm. SPECIMEN LATERALITY: Right. TUMOR SITE: INVASIVE CARCINOMA: Not specified. TUMOR SIZE: SIZE OF LARGEST INVASIVE CARCINOMA: Greatest dimension of largest focus of invasion over 0.1 cm: 2.0 cm (Based on gross evaluation). Additional dimensions: 2.0 x 1.8 cm. TUMOR FOCALITY: Single focus of invasive carcinoma. MACROSCOPIC AND MICROSCOPIC EXTENT OF TUMOR: Skin: Skin is not present. Skeletal Muscle: No skeletal muscle present. DUCTAL CARCINOMA IN SITU (DCIS): DCIS is present. Extensive intraductal component (EIC) negative. SIZE (EXTENT) OF DCIS: Number of blocks with DCIS: 19. Number of blocks examined: 29. ARCHITECTURAL PATTERNS: Cribriform. Solid. NUCLEAR GRADE: Grade III (high) (DCIS is mostly Grade II). NECROSIS: Present, focal (small foci or single cell necrosis). LOBULAR CARCINOMA IN SITU (LCIS): Present (Pleomorphic and classical types). HISTOLOGIC TYPE OF INVASIVE CARCINOMA: Invasive ductal carcinoma (no special type or not otherwise specified) (With a minor component of apocrine differentiation). GLANDULAR (ACINAR)/TUBULAR DIFFERENTIATION: Score 3: <10% of tumor area forming glandular/tubular structures. NUCLEAR PLEOMORPHISM: Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very. large and bizarre forms. MITOTIC COUNT: Score 2. OVERALL GRADE: Grade 3: scores of 8 or 9. MARGINS: Margins uninvolved by invasive carcinoma. Distance from closest margin: 1.6 mm (Anterior margin). Print Date/Time: Collected Date/Time: Received Date/Time: Margins uninvolved by DCIS (if present). Distance from closest margin: 1.2 mm (Anterior margin). TREATMENT EFFECT: RESPONSE TO PRESURGICAL THERAPY: IN THE BREAST: No known presurgical therapy. TREATMENT EFFECT: RESPONSE TO PRESURGICAL THERAPY: IN THE LYMPH NODES: No known presurgical therapy. LYMPH-VASCULAR INVASION: Present. DERMAL LYMPH-VASCULAR INVASION: Not identified. LYMPH NODES: Number of sentinel lymph nodes examined: 4. Total number of lymph nodes examined (sentinel and nonsentinel): 4. Number of lymph nodes with macrometastases (>0.2 cm): 0. Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells): 0. Number of lymph nodes with isolated tumor cells (less than or equal to 0.2 mm and less than or equal to 200 cells): 3. EXTRANODAL EXTENSION: Not identified. METHOD OF EVALUATION OF SENTINAL LYMPH NODES: H&E, multiple levels. Immunohistochemistry. PRIMARY TUMOR (INVASIVE CARCINOMA (pT): pTlc: Tumor >10 mm but less than or equal to 20 mm in greatest dimension. REGIONAL LYMPH NODES (pN): pNO (i+): Malignant cells in regional lymph node(s) no greater than 0.2 mm and no more than 200 cells (detected by H&E or. IHC including ITC) (pNO (i+). DISTANT METASTASIS (M): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Intraductal papilloma (3.5 mm), fibrocystic changes, usual ductal hyperplasia, reactive changes at prior biopsy site. ESTROGEN RECEPTOR: Performed on another specimen. Specimen (accession number): Immunoreactive tumor cells present (greater than or equal to 1%). Quantitation: 75%, positive. PROGESTERONE RECEPTOR: Performed on another specimen. Specimen (accession number): Immunoreactive tumor cells present (greater than or equal to 1%). Quantitation: 75%, positive. HER2/NEU IMMUNOPEROXIDASE STUDIES: Performed on another specimen. Specimen (accession number): Positive (Score 3+). MICROCALCIFICATIONS: Present in both carcinoma and non-neoplastic tissue. Print Date/Time: Female. Collected Date/Time: Received Date/Time: Source of Specimen. A. Lymph Nodes, Sentinel Right Axillary. B. RT. BREAST TISSUE. Clinical Information. markings: double long-12:00, single long-6:00, double short-deep. PRE-OP DIAGNOSIS: Right breast cancer. POST-OP DIAGNOSIS: Same. TYPE OF PROCEDURE: Right breast needle localization biopsy and right Sentinel node biopsy. Gross Description. Specimen is received in 2 parts: A. The specimen is labeled ""RIGHT SENTINEL NODE"" and is received unfixed. It consists of 4 x 4x 1 cm fragment of fatty tissue. which reveals 6 lymph nodes ranging from 0.5 x 0.5 x 0.3-2 x 1 x 1 cm. All lymph nodes are entirely submitted as follows: A1 = possible two lymph nodes. A2 = bisection of a single lymph node. A3-A4 = entire sections of single lymph node. Specimen is in formalin more than 6 hours and less than 48 hours. Time specimen was removed from the patient: Time specimen was placed in formalin : Ischemic time: 16 minutes. B. The specimen labeled ""RIGHT BREAST TISSUE"" is received in formalin. (Specimen is in formalin more than 6 hours and less. then. 48. hours). It consists of an ovoid piece of yellow-tan fatty tissue with 3 sutures designating double long - 12 o'clock, single long -. 6 o'clock and double short - deep margin. A needle guide wire is inserted within the specimen. The specimen measures 5 x 4 x 3.5. cm, is oriented and inked as follows: Anterior-yellow, posterior-black, superior-orange, inferior-red, medial-blue, and lateral. margin. with green color. On sectioning, the cut surface shows centrally, a 2 x 2x 1.8 cm in ill-defined mass with 0.5 x 0.5 x 0.5 cm. calcification. Entirely submitted in cassettes B1-B29. Time specimen was removed from the patient: Time specimen was placed in formalin : Ischemic time: One hour 4 minutes. Special Stains / Slides. Immunohistochemical studies were performed on formalin fixed, paraffin-embedded tissue (Block S A1, A2, A3 & A4) with adequate. positive and negative control sections. Al and A2 each shows a single positive cells, A3 reveals 2 positive cells and A4 is entirely. negative. Immunohistochemical stains were also performed on B18 with appropriate positive and negative controls. The results are as. follows: B18-. E-cadherin : Pleomorphic LCIS shows speckled pattern. Print Date/Time: Female. Collected Date/Time: Received Date/Time: p63: Present in the pleomorphic and classical LCIS; negative in DCIS-like areas and invasive ductal carcinoma, the former mostly. representing lymphovascular invasion. Calponin: Present in the pleomorphic and classical LCIS; negative among neoplastic cells within the lymphovascular space. Podoplanin: Highlights lymphovascular invasion. The performance characteristics of these antibodies were determined by the. They have not been cleared or approved by the U.S. Food and Drug Administration The FDA has determined that such. clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high-complexity clinical laboratory testing. 37 H&E, 8 IHC. Tissue Code. Print Date/Time:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: FSA: Kidney mass, right, biopsy. - Positive for renal cell carcinoma, conventional clear cell type. B: Kidney, right, nephrectomy. Histologic tumor type/subtype: renal cell carcinoma, conventional clear cell type. Sarcomatoid features: absent. Histologic grade (if applicable): Fuhrman nuclear grade 3 (of 4). Tumor size (greatest dimension): 10.1 cm. Tumor focality: focal. Extent of invasion: Capsular invasion/perirenal adipose tissue: not involved. Gerota's fascia: not involved. Renal sinus: not involved. Renal vein: involved. Ureter: not involved. Lymphatic (small vessel): not involved. Surgical margins: Peri-nephric soft tissue: not involved. Renal vein (nephrectomy): involved. Ureter (nephrectomy): not involved. Adrenal gland: absent. Lymph nodes: separately submitted, spec C: no metastatic carcinoma identified (0/3). Other significant findings: benign, mild nephrosclerosis. AJCC Stage: T3a pNO pMx. This staging information is based on information available at the time of this report, and is subject to change pending clinical review and. additional information. C: Right hilar lymph nodes, removal. - No metastatic carcinoma identified (0/3). Intraoperative Consult Diagnosis: An intraoperative consultation is requested by. FSA1: Right kidney mass, biopsy. - Renal cell carcinoma. Frozen Section Pathologist: Clinical History: a right renal mass. Gross Description: Received are three appropriately labeled containers. Container A: Received fresh for frozen section is a 2 x 0.9 x 0.6 cm red/tan soft tissue fragment which is totally submitted as FSA1, NTR. Container B: Specimen fixation: formalin. Type of specimen: radical nephrectomy. Side of specimen: right. Size and weight of specimen: 850 grams; total specimen measures 18 x 10 X 10 cm; The kidney measures 12.5 X 8.0x5.1. cm. Orientation: The external surface of the specimen has been inked blue after the specimen was bivalved in the OR. Presence/absence of adrenal gland: absent. Tumor description/site: The tumor has a rounded, yet infiltrative and lobular appearance. The tumor has a yellow/tan color with. scattered areas of necrosis and hemorrhage. Sections of the tumor demonstrate prominent fibrosis. The tumor has a firm, fibrous texture. Tumor size: 10.1 x 8.1 x 5.1 cm; The tumor involves the superior and inferior halves of the kidney. Presence/absence of multicentricity: absent, the tumor is unifocal. Confinement/non-confinement to the kidney: confined. Extent of invasion: Perirenal adipose tissue: tumor grossly does not involve. Gerota' fascia: grossly does not involve. Renal vein: tumor grossly involves renal vein. Ureter: tumor grossly does not involve ureter. Other organs: tumor appears to invade the renal pelvis. Surgical margins: Perirenal adipose tissue: negative. Renal vein: negative. Renal artery: negative. Ureter: negative. Description of kidney away from tumor: unremarkable. Lymph nodes (hilar): see Specimen C. Other significant findings: none. Tissue submitted for special investigations: tumor is submitted to Tissue Procurement. Digital photograph taken: no. Block summary: B1 - vascular and ureteral margins. B2 - tumor involving urothelium, tumor adjacent to normal parenchyma. B3 - tumor expanding capsule, ?fat involvement. B4 - tumor closest to inked margin. B5 - additional representative tumor. B6 - kidney away from tumor. B7 - tumor adjacent to hilar fat. B8,B9 - ?vascular and ureteral involvement by tumor. B10- Additional ureteral margin. B11 ureter and kidney. B12 tumor at renal pelvis. Container C is additionally labeled ""right hilar lymph node."" The specimen consists of an aggregate of fibrofatty tissue fragments measuring. 4.1 X 2.5 X 1.2 cm. Three lymph node candidates are isolated from the tissue fragments. The lymph node candidates range in size from 5 mm. to 1.2 cm in greatest dimension. Block summary: C1 - two lymph node candidates, one inked blue and bisected. C2 - one lymph node candidate, fat remains. Grossing Pathologist. Light Microscopy: Light microscopic examination is performed by. The FS diagnosis is confirmed.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Patient Identifier: TISSUE DESCRIPTION: Portion right kidney (13.3 grams, 3.8 X 2.9 X 2.7 cm) . DIAGNOSIS: Kidney, right, partial nephrectomy Grade 2 (of 4) renal cell. carcinoma, clear cell type, forms a 2.5 X 2.2 X 2.1 cm mass. The. tumor is confined to the kidney. Coagulative tumor necrosis is. absent. Sarcomatoid lifferentiation is absent. The surgical. margins are negative by 0.1 cm.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: RIB, FIFTH, EXCISION -. A. UNREMARKABLE BONE AND BONE MARROW WITH TRILINEAGE HEMATOPOIESIS. B. NO EVIDENCE OF MALIGNANCY. PART 2: LYMPH NODE, INTRALOBAR, EXCISION -. ONE OF TWO IDENTIFIED LYMPH NODAL FRAGMENTS POSITIVE FOR METASTATIC ADENOCARCINOMA (1/2). PART 3: LYMPH NODE, RIGHT MIDDLE LOBE, EXCISION -. THREE OF FOUR IDENTIFIED LYMPH NODAL FRAGMENTS POSITIVE FOR METASTATIC CARCINOMA (3/4). PART 4: LUNG, RIGHT LOWER LOBE, LOBECTOMY AND INTRAOPERATIVE CONSULTATION. A. MUCINOUS ADENOCARCINOMA WITH ACINAR BRONCHIOLAR ALVEOLAR MICROPAPILLARY FEATURES. (MEASURING 6.0 CM IN MAXIMUM DIMENSION). B. THE TUMOR INVOLVES THE OVERLYING VISCERAL PLEURA. C. THE TUMOR EXTENSIVELY INVOLVES THE ANGIOLYMPHATIC CHANNELS. D. SMALL PULMONARY VASCULATURE SHOWS THROMBOEMBOLIC PHENOMENON WITH SECONDARY. PULMONARY INFARCTION. E. BRONCHIAL AND VASCULAR MARGINS SHOW NO EVIDENCE OF MALIGNANCY. F. FOUR OF SIX IDENTIFIED HILAR LYMPH NODES ARE POSITIVE FOR METASTATIC ADENOCARCINOMA (4/6). WITH PROMINENT EXTRACAPSULAR EXTENSION. G. TNM STAGE: T2. N2, MX. PART 5: LYMPH NODE, LEVEL 7 (SUBCARINAL), EXCISION -. FIVE OF SIX SUBMITTED LYMPHOIDAL FRAGMENTS POSITIVE FOR METASTATIC ADENOCARCINOMA WITH. EXTRACAPSULAR EXTENSION (5/6). PART 6: LYMPH NODE, RIGHT PERITRACHEAL, EXCISION -. SINGLE IDENTIFIED LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1). ADDENDA: Addendum. Molecular Anatomic Pathology testing: A. KRAS Exon 1 mutation IS IDENTIFIED (Gly12Cys). B. EGFR Exon 19 mutation NOT identified. C. EGFR Exon 21 mutation NOT identified. Note: KRAS codon 12/13 mutations are found in approximately 10-30% lung adenocarcinomas and associated with history of. smoking (1). EGFR exon 19 and 21 mutations are present in about 10% of non-Asians and up to 40% in the Asian. population, common in non-smokers and associated with the tumor response to treatment with EGFR inhibitors (2). These mutations are mutually exclusive and their presence may have prognostic and/or therapeutic implications (3,4). Sample Preparation and Gene Sequencing Analysis. For cytology samples, extraction of DNA was performed from the fluid or sample provided. For surgical specimens, tumor microdissection was. performed. DNA was isolated using standard laboratory procedure. Optical density readings were obtained. For the detection of mutation, DNA. was amplified with primers flanking exon 1 in the KRAS gene and exons 19 and 21 of the EGFR gene. Then, forward and reverse sequencing. was. performed using the BigDye Terminator Kit on AB/3130 (Applied Biosystems). The known hotspots were analyzed for the presence of mutations. with Mutation Surveyor V3.01 (SoftGenetics). Addendum. TM. PROBE: Vysis LSI EGFR SpectrumOrange/ CEP 7 SpectrumGreen Probe. Fluorescence in-situ hybridization studies performed on the adenocarcinoma shows a ratio of EGFR gene to the centromere of. chromosome 7 of 1.2 indicating no EGFR amplification in the targeted region. The rate of hyperploidy for the centromere of. chromosome 7 was 26% of the analyzed cells. The signal to nucleus ratio (SNR) for the EGFR gene was 2.5. Interpretation guidelines for EGFR Gene Copy Number by FISH: Ratio of EGFR to the centromere of chromosome 7: Less than 2.0: No EGFR amplification. Greater than 2.0: EGFR amplification. Hyperploidy: Greater than two centromere copies/cell. SNR: The average number of EGFR signals per analyzed cell within the targeted region. Clinical studies show high EGFR gene copy number by FISH analysis to be associated with favorable clinical benefit (clinical. response, stable disease, time to progression, and survival) in patients with advanced non-small cell lung cancer treated with. EGFR tyrosine kinase inhibitors. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Lower Lobe. PROCEDURE: Lobectomy. TUMOR SIZE: Maximum dimension: 6.0 cm. Minor dimension: 5.0 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G2, Moderately differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: Visceral pleura. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 10 mm, Bronchial margin. INFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 8. Number of N1 lymph nodes examined: 12. EXTRACAPSULAR SPREAD OF N1 METASTASES: N2 LYMPH NODE GROUPS INVOLVED: Level 4R, Level 12R, Level 7. N2 LYMPH NODES: Number of N2 lymph nodes positive: 6. Number of N2 lymph nodes examined: 7. EXTRACAPSULAR SPREAD OF N2 METASTASES: UNDERLYING DISEASE(S): Emphysema. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains, FISH studies.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Pa. Me. Da. En. Phy. SPECIMEN(S). A. 4L LEFT DISTAL PARATRACHEAL. B. 4R RIGHT DISTAL PARATRACHEAL. C. ADDITIONAL 4R LYMPH NODE. D. LEVEL 7 SUBCARINAL LYMPH NODE. E. 2R RIGHT PROXIMAL PARATRACHEAL. F. LEFT UPPER LOBE. G. PORTION OF LUNG ATTACHED TO MEDIASTINUM. H. LEVEL5 LYMPH NODES. I. LEVEL 9 LYMPH NODES. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left upper lobe lung mass. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA, FSB, FSC-lymph nodes 4L, 4R, 4R additional: Negative for tumor. FSD-7 subcarinal: Fibroadipose tissue negative for tumor; no lymphoid tissue identified. FSE-2R: Negative for tumor. FSF-left lung, upper lobe, lobectomy: Bronchial margin is negative for carcinoma, tumor is. adenocarcinoma diagnosis called by. m.(17). GROSS DESCRIPTION: A. 4L LEFT DISTAL PARATRACHEAL. Page of. Received fresh, labeled with matching patient identifiers, are 4 pieces of soft tissue ranging in. size from 0.5 x 0.4 x 0.1 cm to 0.2 X 0.2 X 0.1 cm; submitted entirely for frozen section diagnosis. in cassette FSA. B. 4R RIGHT DISTAL PARATRACHEAL. Received fresh, labeled with matching patient identifiers, are 5 pieces of soft tissue ranging from. 1 x 0.6 x 0.3 cm to 0.3 x 0.1 x 0.1 cm; submitted entirely for frozen section diagnosis in cassette. FSB. C. 4R RIGHT DISTAL PARATRACHEAL (ADDITIONAL). Received fresh, labeled with matching patient identifiers, is a piece of soft tissue measuring 0.4. x. 0.3 X 0.1 cm; submitted entirely for frozen section diagnosis in cassette FSC. D. LEVEL 7 LYMPH NODE. Received fresh, labeled with matching patient identifiers, are 3 pieces of soft tissue ranging in. size from 0.6 X 0.2 x 0.1 cm to 0.4 x 0.1 x 0.1 cm; submitted entirely for frozen section diagnosis. in cassette FSD. E. 2R RIGHT PROXIMAL PARATRACHEAL. Received fresh, labeled with matching patient identifiers, are 3 pieces of soft tissue each. measuring 0.4 X 0.3 x 0.2 cm; submitted entirely for frozen section diagnosis in cassette FSE. F. LEFT UPPER LOBE. Received fresh, labeled with matching patient identifiers, is a 315-g lobectomy measuring 20 X 9. x 5 cm including entire upper lobe and a 6.7 x 5.6 x 1.9-cm segment of lower lobe (which is. adhered to the upper lobe by adhesions). A blue stripe marks the margin to the superior. mediastinal pericardial border. A shave is taken of the bronchial margin and submitted for frozen. section diagnosis; the bronchi are opened and are smooth and tan in coloration. The pleural. surface is focally puckered; it is inked. On sectioning, there is a firm well circumscribed mass,. 4.2 x 3.5 x 3 cm. A section is submitted for frozen section diagnosis. The remainder of the. parenchyma is unremarkable; tissue is procured. Representative sections are submitted as. follows: FSF1-FSF2: frozen sections. F3: area indicated with a blue stripe. F4: mass and relationship to lower lobe. F5: mass and relationship to pleura/pleural adhesions. F6: mass and bronchi. F7: 1 lymph node. F8: 8 lymph nodes. F9: normal-appearing parenchyma. G. PORTION OF LUNG ATTACHED TO MEDIASTINUM. Received fresh, labeled with matching patient identifiers, is a wedge of lung, 8 x 3.5 x 1.8 cm. and weighing 22 g. The surgical margin is 9 cm in length; pleural surface has adhesions and a. defect, 3.5 cm. On sectioning, no abnormalities are identified. Representative sections of area of. adhesions and defect are submitted in cassettes GI-G2. H. LEVEL 5 LYMPH NODES. Received fresh, labeled with matching patient identifiers, a piece of tan soft tissue admixed with. black lymphoid tissue measuring 2.4 x 1.3 x 0.5 cm. Submitted entirely in cassette H1. I. LEVEL 9 LYMPH NODE. Received fresh, labeled with matching patient identifiers, is an anthracotic lymph node admixed. with fat, 1.4 x 1.1 X 0.6 cm. Submitted in cassette II. DIAGNOSIS: A. LYMPH NODE, LEFT DISTAL PARATRACHEAL - 4L, RESECTION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). B. LYMPH NODE, RIGHT DISTAL PARATRACHEAL - 4R, RESECTION: NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). C. LYMPH NODE, RIGHT DISTAL PARATRACHEAL - 4R, RESECTION: NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). D. SOFT TISSUE, SUBMITTED AS, ""LEVEL 7 LYMPH NODE"", RESECTION: - NO MALIGNANCY IDENTIFIED. E. LYMPH NODE, RIGHT PROXIMAL PARATRACHEAL - 2R, RESECTION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). F. LUNG, LEFT UPPER LOBE, LOBECTOMY: - ADENOCARCINOMA WITH MICROPAPILLARY FEATURES, MODERATELY. DIFFERENTIATED. - 4.2 CM IN GREATEST DIMENSION. - 3.5 X 3.0 CM IN ADDITIONAL DIMENSIONS. - NO PLEURAL INVASION IDENTIFIED. - THE BRONCHIAL MARGINS NEGATIVE FOR TUMOR. NO ANGIOLYMPHATIC INVASION IDENTIFIED. - EMPHYSEMATOUS CHANGES. - METASTATIC CARCINOMA TO ONE OF ELEVEN PERIBRONCHIAL LYMPH. NODES (1/11), WITH EXTRANODAL EXTENSION. G. LUNG, ATTACHED TO MEDIASTINUM, RESECTION: - EMPHYSEMATOUS CHANGES,. - NO MALIGNANCY IDENTIFIED IN ONE INTRAPULMONARY LYMPH NODE. (0/1). Page ..! : H. LYMPH NODE, LEVEL 5, RESECTION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). I. LYMPH NODE, LEVEL 9, RESECTION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). SYNOPTIC REPORT - LUNG. Specimens Involved. Specimens: F: LEFT UPPER LOBE. Surgical Procedure: Lobectomy. Laterality: Left. Tumor Site: Upper lobe. Tumor Location: Peripheral. Tumor Size: Greatest diameter: 4.2cm. Additional dimensions: 3.5cm x 3cm. WHO CLASSIFICATION. Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Visceral Pleural Involvement: Absent. Satellite Tumor(s): Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Positive 1 / 12. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0/3. N3: Contralateral Mediastinal/Hilar, Scalene or Supraclavicular. Negative 0/3. Non-Neoplastic Lung: Emphysematous changes. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 2. N 1. M X.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN(S): A. 4R LYMPH NODE. B. LEVEL 7. C. 4L LYMPH NODE. D. RIGHT LEVEL 4 LNODE. E. RIGHT UPPER LOBE. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: RUL small cell lung ca. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-FSD: Lymph nodes - negative for tumor. FSE: Bronchial margin - negative for tumor. GROSS DESCRIPTION: A. 4R LYMPH NODE. Received fresh for frozen section is a tan-pink lymph node 0.4 x 0.2 x 0.1 cm. The specimen is. submitted entirely for frozen section in FSA1. B. LEVEL 7. Is a tan-pink aggregate of lymphoid tissue 0.7 x 0,4 x 0.2 cm. The entire specimen is submitted. for frozen section in FSB1. C. 4L LYMPH NODE. Is an aggregate of lymphoid tissue 0,5 X 0.3 x 0.2 cm. The specimen is submitted entirely for. frozen section in FSC1. D. RIGHT LEVEL 4 LYMPH NODE. Is a tan-pink aggregate of lymphoid tissue 0.8 x 0.8 x 0.3 cm. The specimen is submitted entirely. for frozen section in FSD1. E.LUNG, RIGHT UPPER LOBE,LOBECTOMY;. Received fresh and labeled with the patient name. right upper lobe"", is a. 121-gram lobectomy specimen measuring 14.5 x 10.7 x 2.3 cm. There is a defect on the pleural. surface exposing a mass measuring 3.0 x 2.5x1.5 cm. The mass is hemorrhagic and necrotic. It. extends to within 0.3 cm of the pleural margin and 1.2 cm from the bronchial margin. A shave. section is taken of the bronchial margin for frozen section. The bronchi are opened and they. have a smooth tan appearance. The lung is sectioned and the parenchyma has a variegated pink. and anthracotic appearance as well as areas of congestion. Possible anthracotic lymph nodes are. identified. Portions of mass were submitted for tissue procurement. Representative sections are. submitted as follows: FSE1: Shave section of bronchial margin. E2-E5: Sections of mass including relationship to normal appearing parenchyma and. pleural margin. E6: Additional portions of uninvolved parenchyma. E7: Possible lymph nodes. DIAGNOSIS: A. 4R RIGHT LYMPH NODE. - ANTHRACOSIS OF ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). B. LEVEL 7 LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). C. 4L LEFT LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). D. RIGHT LEVEL 4 LYMPH NODE: ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). E. LUNG, RIGHT UPPER LOBE, LOBECTOMY SPECIMEN: - NON SMALL CELL CARCINOMA (CONSISTENT WITH MODERATE TO. POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA) WITH AREAS OF. NECROSIS OF UPPER LOBE OF RIGHT LUNG. - SIZE OF TUMOR 3.0 X 2.5 X 1.5 CM. - CONGESTION AND FOCAL ATELECTATIC CHANGE. - SIX PERIBRONCHIAL LYMPH NODES - (0/6) NEGATIVE FOR TUMOR. - MARGINS OF RESECTION - NEGATIVE FOR TUMOR. SYNOPTIC REPORT - LUNG. Specimens Involved. Specimens: E: RIGHT UPPER LOBE. Surgical Procedure: Lobectomy. Laterality: Right. Tumor Site: Upper lobe. Tumor Location: Central. Tumor Size: Greatest diameter: 3cm. Additional dimensions: 2.5cm x 1.5cm. WHO CLASSIFICATION. Squamous cell carcinoma. Comment(s): Non small cell carcinoma. Histologic Grade: poorly to moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Tumor Distance from margin: 1.2cm. Visceral Pleural Involvement: Absent. Satellite Tumor(s): Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Negative 016. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0/3. N3: Contralateral Mediastinal/Hilar, Scalene or Supraclavicular. Negative 0/1. Non-Neoplastic Lung: Emphysematous changes. congestion and focal atelectatic change. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 1. M x.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Subject. LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Resection of. rectum. Specimen size: Not specified. Tumor site: Rectum. Tumor size: 15 X 7.5 X 10 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
8/4413. Gender: M. Examination result No. Clinical diagnosis (suspicion) Gastric cancer. Date of admission: Material: 1) Material: stomach, Method of collection: Total organ resection. Histopathological diagnosis. Invasive stomach adenocarcinoma (G3), pT3, pN2. Cancer metastases to lymph nodes No III/XVII. (8140/3 T-63000). codes according to ICD-O-3 or SNOMED. Macroscopic description: Specimen consisting of the stomach, having been cut out along the greater curvature, sized. 25 x 22 cm with the omentum sized 59 x 28 cm. Medallion shaped tumour sized 5.5 X 6 x 1.3 cm on the back wall. The infiltration visibly crosses the stomach wall. Distance from the proximal end 5.2 cm, from distal end, 4.7 cm. Microscopic description: Adenocarcinoma invasivum ventriculi (G3). (Intestinal type acc. to Lauren) Tumour penetrates the full thickness of the stomach wall, without invading the. peritoneum. Surgical excision lines are within the area of healthy tissue. Vessels invaded. Fat tissue uninvolved. Lymph nodes: 1.2- (cardia) - Lymphonodulitis reactiva No I. 3 (lesser curvature): Metastases carcinomatosae in lymphonodis No II/VIII. 4 (greater curvature) - Lymphonodulitis reactiva No VII.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. A. Lymph node level 10. B. Right lower lobe. C. Lymph node level 7. D. Lymph node level 3. E. Lymph node R4. CLINICAL NOTES. GROSS DESCRIPTION. A. Received in formalin, labeled ""lymph node level 10"". and. consists of multiple pieces of black soft tissue measuring 2 cm in. greatest aggregate dimension. AS-1. B. The specimen is received unfixed labeled ""right lower. lobe"" and consists of a lobe weighing 266 grams and. measuring 16 X 12 X 7 cm. There is a subtotal probable mass. measuring 2.5 X 1.5 X 2 cm. There is a puckered appearance over the. mass. Portions of the specimen are taken for research purposes. Additional sections after fixation. There is a stapled margin on. one. side of the specimen measuring 5 cm in length and there is a. stapled. bronchial margin as well. C. Received in formalin, labeled ""lymph node level 7"" and. consists of multiple pieces of black soft tissue. measuring. 2 cm in greatest aggregate dimension. AS-1. D. Received in formalin, labeled ""lymph node level 3"" and. consists of a piece of white and black and yellow soft. tissue measuring 2.5 x 1.5 X 0.3 cm. AS-1. E. Received in formalin, labeled ""lymph node - R4"" and. consists of multiple pieces of yellow and black soft. tissue. measuring 3 x 3 x 0.5 cm in aggregate. AS-2. MICROSCOPIC DESCRIPTION. A. There is no evidence of malignancy in any of ten lymph node. pieces. B. Tumor type : Non-small cell carcinoma. Tumor grade 3 out of 3. Mitotic Index: 1 mitoses/10 HPF's (1 HPF = 0.19 sq mm). Tumor size: 2.5 cm. Bronchial resection margin: Negative for malignancy. Pulmonary margin of resection Negative for malignancy. Pleura: Negative for malignancy. Vascular invasion: Absent. Attached lymph nodes There is no evidence of malignancy. in. any of 3 lymph nodes. pTNM Stage T1b NO. Non-tumorous lung: Mild to moderate emphysema. C. There's no evidence of malignancy in any of multiple lymph node. pieces. Approximately 12 pieces are present. D. A single lymph node is negative for malignancy. E. There is no evidence of malignancy in any of 16 lymph node. pieces. DIAGNOSIS. A. Lymph node, level 10, biopsy: There is no evidence of. malignancy in any of ten lymph node pieces. B. Lung, right lower lobe, resection: Poorly differentiated. non-small cell carcinoma. DIAGNOSIS. C. Lymph node, level 7, biopsy: There is no evidence of malignancy. in. any of 12 lymph nodes pieces. D. Lymph node, level 3, biopsy: A single lymph node is negative for. malignancy. E. Lymph node, R4, biopsy: There's no evidence of malignancy in any. of 16 lymph nodes pieces.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Main diagnosis/diagnoses: Large peripheral bronchopulmonary, histologically mixed adenocarcinoma of the left lower. lobe of the lung with an acinar and solid component, partially bronchioloalveolar pattern of. spread and localization in S9 and S10, as well as a small, non-mucinous bronchioloalveolar. carcinoma peripherally in S6. TNM classification on the basis of this material pT2(2) pNO pMX R0, stage IB. C34.3 M8255/3 and M8252/3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: No clinical history is given. PRE-OP DIAGNOSIS: Left leg melanoma. POST-OP DIAGNOSIS: Same. PROCEDURE: Wide local excision of skin and SLNB and skin graft. FINAL DIAGNOSIS: PART ISKIN, FOOT. LEFT, WIDE LOCAL EXCISION -. A. ULCERATED NODULAR MELANOMA, ACRAL LENTIGINOUS TYPE. B. CLARK LEVEL IV; 22 MM IN MAXIMUM THICKNESS. C. NO TUMOR INFILTRATING LYMPHOCYTES. D. MARGIN FREE OF TUMOR. E. NO ANGIOLYMPHATIC INVASION IDENTIFIED. F. POSSIBLE PERINEURAL INVASION SEEN. PART 2: SENTINEL LYMPH NODE #1, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS.(see comment). PART 3: SENTINAL LYMPH NODE #2, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. (see comment). PART 4: SENTINEL LYMPH NODE #3, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. PART 5: SENTINEL LYMPH NODE #4, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. PART 6: SENTINEL LYMPH NODE #1, POPLITEAL, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. .(see comment). COMMENT: No tumor cells found on immunostains with HMB 45, S100, melan A, CD58, tyrosinase in groin sentinel lymph nodes in. parts #1 and #2 and popliteal sentinel lymph node in part #6. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY CUTANEOUS MELANOMA. Family history of melanoma is unknown. Family history of dysplastic nevi is unknown. TUMOR LOCATION: Lower extremities. TYPE OF PROCEDURE: Wide excision. SIZE OF TUMOR: Maximum surface diameter of neoplasm: 66 mm. GROSS ULCERATION: GROSS SATELLITES: HISTOLOGIC TYPE: Acral lentiginous. SURFACE ULCERATION: < 50%. CLARK'S LEVEL: IV. BRESLOW'S THICKNESS: 22 mm. ANGIOLYMPHATIC INVASION: None. PERINEURAL INVASION: EVIDENCE OF REGRESSION: MICROSCOPIC SATELLITES: PREEXISTING NEVUS: No preexisting nevus. TUMOR INFILTRATING LYMPHOID INFILTRATE: None (absent). MITOTIC RATE: 10/10 HPF. VASCULARITY: Not increased to focally increased. SURGICAL MARGIN INVOLVEMENT: Deep margin is free of tumor, Lateral margin is free of tumor. SENTINEL LYMPH NODE MAPPING: Yes. SENTINEL LYMPH NODE INVOLVEMENT: Number of sentinel lymph nodes positive: 0. LYMPH NODES EXAMINED: Total number of lymph nodes examined: 5. COMPLETION DISSECTION: EXTRACAPSULAR SPREAD: None. T STAGE, PATHOLOGIC: pT4b. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
HISTOPATHOLOGY REPORT. Sex: M. Date Collected: Date Received: Date Printed: SPECIMEN DETAILS. Specimen A. Parietal pleura. Specimen B. Parietal pleura tumour. CLINICAL INFORMATION. Epithelioid mesothelioma T2 HO MO. MACROSCOPIC DESCRIPTION. Specimen A Parietal pleura. An irregular piece of cream coloured tumour measuring 8 x 3.5 x 2 cm. 4 in 4 + reserve. Specimen B Parietal pleura tumour. Several pieces of white, firm tumour tissue with attached adipose tissue and adherent clot, in aggregate. measuring 18 x 16 x up to 3 cm. Some of the pieces include overlying pleura. 4 x representative sections + reserve. MICROSCOPIC REPORT. Specimens A & B Parietal pleura tumour. Samples from both specimens reveal thickened pleura, extensively infiltrated by epithelioid tumour with a. predominantly papillary architecture. The epithelioid tumour cells exhibit a moderate degree of pleomorphism. and possess vesicular nuclei with small nucleoli and a moderate amount of eosinophilic cytoplasm. Focal. areas of tumour necrosis are present. Some of the sections include a small amount of adherent lung. parenchyma, which in areas shows reactive changes with organising pneumonia. Focally there is evidence of. infiltration of the visceral pleura. Immunohistochemistry - The tumour is positive for MNF116 and calretinin (cytoplasmic and variable nuclear. staining), shows patchy staining for WT1, focal weak staining for CK5/6 and diffuse membranous positivity for. EMA. Very focal staining for BerEP4 is noted, but most of the tumour is negative for this marker, as well as. TTF1. The appearances are those of epithelioid malignant mesothelioma. Reporting Pathologist: Authorising Pathologist: Lab No: Reports are authorised electronically.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: ""Right submandibular mass"", removal. -Lymph node with reactive follicular hyperplasia, negative for. malignancy (0/1). B: Parathyroid, left inferior, removal. -Normocellular parathyroid with no evidence of malignancy. C: Lymph node, prelaryngeal, removal. -Fibrovascular tissue, adipose tissue, and skeletal muscle. -Rare detached lymphocytes, no definite lymph node identified. -No malignancy identified. D: Lymph node, pretracheal, removal. -Fibrovascular tissue, adipose tissue, and skeletal muscle. -No lymph node identified. -No malignancy identified. E: Thyroid gland, total thyroidectomy. Tumor histologic type: Papillary thyroid carcinoma, usual type,. with focal oncocytic cytoplasmic features. Tumor size: 4.2 cm, located in the left lobe (gross dimension). Tumor growth pattern: invasive. Tumor focality: Unifocal. Extent of invasion: Capsular Invasion: Present, multifocal. Lymphovascular: Present, extensive. Blood vascular: Present. Extra thyroidal extension: Focus suspicious for extra thyroidal. involvement of adipose tissue (see comment) (E12). Surgical margins: Negative but close to black inked posterior (<. 1 mm) (E12). Status of thyroid gland away from tumor: Right thyroid and. isthmus negative. Lymph nodes: -7 of 8 left peritracheal lymph nodes positive (see. part F below). Size of largest metastasis (greatest dimension) : 0.5 cm. Extracapsular (perinodal) extension: Present (F2, F3) (see. comment). Other significant findings: Right thyroid and isthmus negative. AJCC PATHOLOGIC TNM STAGE: pT3 pN 1a pMX. NOTE: This pathologic stage assessment is based on information. available at the. time of this report, and is subject to change pending clinical. review and. additional information. F: Lymph node, left peritracheal, removal. -Seven of eight lymph nodes positive for metastatic papillary. thyroid carcinoma, 4 mm in greatest dimension, with involvement. of extracapsular adipose tissue (7/8) (See comment). Comment: In the thyroidectomy specimen, there is an area of adipose. tissue with psammoma bodies identified; however, no malignant. epithelial cells are identified in the adipose tissue in this. area (E12). Multiple recut sections are examined; however, no. definite malignant epithelial cells are identified in the focus. In specimen F (left peritracheal lymph nodes), papillary. carcinoma involves adipose tissue. This may be by direct. extension (extrathyroidal extension) or extracapsular extension. from lymph nodes. Intraoperative Consult Diagnosis: An intraoperative consultation was requested in. TPA1/FSA1: Right submandibular lymph node,. - Reactive follicular hyperplasia, no metastatic carcinoma. identified. FSB1: ""? Left inferior parathyroid"". - Parathyroid tissue present. Clinical History: The patient is a. -year-old female with likely papillary. thyroid carcinoma by FNA and an enlarges submandibular lymph. node (benign on FNA). Gross Description: Received are six appropriately labeled containers. Container A is additionally labeled ""R submandibular mass"" and. holds of a 2.9 X 1.4 X 1.6 cm lymph node, sectioned to reveal a. tan homogeneous lymphoid parenchyma. Touch prep and. representative section submitted as FSA1. Remaining tissue is. serially sectioned and submitted as A1-A3. Container B is additionally labeled ""? Left inferior. parathyroid"" and holds a 0.3 X 0.3 x 0.2 cm red/tan soft tissue. fragment totally submitted as FSB,. Container C is additionally labeled ""prelaryngeal lymph nodes"". and holds a 1.1 X 1 X 1 cm brown/tan fibromuscular soft tissue. fragment, trisected and submitted in block C1,. Container D is additionally labeled ""pretracheal lymph nodes"". and holds a 1.4 X 1.2 X 0.5 cm brown/tan soft tissue fragment,. bisected and submitted in D1,. Container E is additionally labeled ""thyroid gland, suture on. left lobe"". Specimen fixation: Formalin. Type of specimen: Total. Size and weight of specimen: 22.0 grams, overall 6 X 4.! 5 X 2.5. cm, left lobe 4.5 X 3 X 2.2 cm, right lobe 2.4 X 2.2 X 1. 4 cm. Orientation: Anterior/blue, posterior/black, isthmus/yellow. Tumor location: Left lobe. Focality: Unifocal. Dominant tumor: Left, solitary tumor. Tumor description: Solitary solid well-circumscribed mass with. fibrous septae coursing throughout, papillary tan to white. Tumor size: 4.2 x 3 X 2.2 cm. Confinement/non-confinement Confined. Distance of tumor to surgical margins: Abuts anterior and. posterior margins and is 0.2 cm from the yellow isthmus, 0.3 cm. from the inferior -pole and abuts the superior pole. Appearance of thyroid gland away from tumor: brown/tan and. homogeneous. Parathyroids: Not present. Tissue submitted for special investigations: Tumor to tissue. Lymph nodes: Submitted separately. Digital photograph taken: Not taken. Block Summary: E1-E7 - Entire right lobe, serially sectioned and sequentially. submitted from superior to inferior. E8-E9 - Entire isthmus. E10-E21 - Entire left lobe,. Container F is additionally labeled ""left peritracheal lymph. node"" and holds a yellow/tan soft tissue fragment measuring 6.5. X 1.5 X 0.6 cm. One lymph node candidate is identified measuring. 0.5 X 0.6 x 0.6 cm. Block Summary : F1 - Soft tissue fragment, bisected. F2 - Soft tissue fragment. F3 - One lymph node candidate, bisected,. Cri-a. Discrepancy. Tumar Sie Discrepancy. degnancy History. hronous Primary Noted. incle): ODALIFIED. DISQUIAUFICO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Report Status : Type: Surgical Pathology. Specimen Type : Rib marrow squeeze. Procedure Date: PATHOLOGIC DIAGNOSIS: A. SPECIMEN DESIGNATED ""RIB"": Bone and bone marrow with maturing trilineage hematopoiesis. No tumor present. B. SPECIMEN DESIGNATED ""RIGHT KIDNEY"": RENAL CELL CARCINOMA (7.5 cm) clear cell type, Fuhrman. nuclear grade IV (of IV), with extensive necrosis. Tumor involves perinephric fat but is confined within Gerota's fascia. The tumor invades into the renal vein. Lymphovascular invasion is present. AJCC Classification (6th Edition) : T3b NX M1 (by prior. pathology; BS06-635782). The non-neoplastic kidney will be evaluated by Renal Pathology, and the. findings will be reported in an addendum. Adrenal gland with no significant pathologic change. CLINICAL DATA: History: Not given. Operation: R radical nephrectomy. Operative Findings : Not given. Clinical Diagnosis: Not given. TISSUE SUBMITTED: A/1. Rib. B/2. R kidney-FS for tissue bank. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patient' 8. name and unit number. Part A, ""#1. Rib"", consists of two irregular indurated tan/yellow portions of. bone with a scant amount of hemorrhagic attached soft tissue (3.0 x 1.5 x 1.0. cm and 4.6 x 1.0 x 0.5 cm) No lesions are grossly identified. The specimen. is squeezed and a moderate amount of hemorrhagic red/brown material is obtained. (? bone marrow; measuring 1.5 x 1.0 x 0.3 cm in aggregate) . Representative. sections are submitted. Micro A1: ? bone marrow, multi frags,. Part B, ""#2. R kidney"", consists of a 566-gram right radical nephrectomy. specimen including kidney (18.0 x 9.5 x 6.8 cm), lymph node irregular tan/white. to tan/yellow thrombus (4.5 x 2.2 x 2.1 cm) extending out of the renal veins. (2.8 cm in length x 1.7 cm in diameter), portion of renal artery (1.2 cm in. length x 0.4 cm in diameter), segment of ureter. (4.2 cm in length x 0.5 cm in. diameter) and a portion of markedly fragmented adrenal (2.5 x 1.5 x 0.5 cm). There is a moderate amount of attached perirenal fat (measuring 15.5 cm in. length x 3.5 cm in thickness) There is a capsular area of dilatation (7.5 x. 7.0 cm). The renal vein resection margin is inked blue and the capsule is. inked black. The specimen is bivalved to reveal a tan/yellow to tan/white. hemorrhagic cystic multilobulated mass extending to the venous resection. margin, abutting and grossly involving the kidney capsule, abutting the pelvic. mucosa, 7.2 cm from the ureter, 1.6 cm from. the renal artery resection margin,. and located within the mid upper pole aspect of the kidnev. The. does. Report Status: Final. Type: Cytogenetics : Cytogenei. KARYOTYPE: K2:43,X,-Y, - der (3;14) (q10;910), -13,-14, [cp6). METAPHASES COUNTED: 6. ANALYZED: 6. SCORED: 0. BANDING: GTG. INTERPRETATION: All metaphases from one of the two specimens submitted had 3p deletion, which. is a characteristio finding in renal cell carcinoma, clear cell type. Metphases were not obtained from the other specimen. COMMENTS. Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: ? RCC.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Carcinoma, papillary renal cell. Diagnosis. A: Kidney, right, anterior renal mass, partial nephrectomy. Procedure: partial nephrectomy. Laterality: right. Histologic tumor type/subtype: papillary renal cell carcinoma. Sarcomatoid features: absent. Histologic grade (if applicable) : 3. Tumor size (greatest dimension) : 1.5 cm. Tumor focality: multifocal (see parts B and C). Extent of tumor invasion (if present specify if macroscopic or. microscopic) : Capsular invasion/perirenal adipose tissue: absent. Histologic assessment of surgical margins : Renal parenchymal margin (partial nephrectomy only) : positive. B: Kidney, right, posterior medial renal mass, partial. nephrectomy. Procedure: partial nephrectomy. Laterality: right. Histologic tumor type/subtype: papillary. Sarcomatoid features: absent. Histologic grade (if applicable) : grade 3. Tumor size (greatest dimension) : 3.8 cm. Tumor focality: multifocal. Extent of tumor invasion (if present specify if macroscopic or. microscopic) : Capsular invasion/perirenal adipose tissue: negative. Histologic assessment of surgical margins: Renal parenchymal margin (partial nephrectomy only) : negative. C: Kidney, right, posterior lateral renal mass, partial. nephrectomy. Procedure: partial nephrectomy. Laterality: right. Histologic tumor type/subtype: papillary. Sarcomatoid features: absent. Histologic grade (if applicable) : 3. Tumor size (greatest dimension) : 2.5 cm. Tumor focality: multifocal. Extent of tumor invasion (if present specify if macroscopic or. microscopic) : Capsular invasion/perirenal adipose tissue: negative. Histologic assessment of surgical margins: Renal parenchymal margin (partial nephrectomy only) : negative. AJCC Staging: prTla. pNx. This staging information is based on information available at. the time of this report, and is subject to change pending. clinical review and additional information. Clinical History : Fyear-olo male with right renal mass. Per , the patient has a. history of renal cell carcinoma. Gross Description: Received are three appropriately labeled containers. Container A is additionally labeled ""kidney, right, anterior. renal mass, partial nephrectomy' and consists of a 10.6 gram,. 3.5 X 3.0 X 2.1 cm brown/tan fragment of kidney. The surgical. margin is inked black. The renal capsule is inked yellow. A. defect, 1.2 X 0.8 cm is identified and the external surface. around the defect is inked yellow. The specimen is serially. sectioned perpendicular to the blue and black inked tube margin. Sectioning reveals a pale tan, at least 1.5 X 1.2 X 1.0 cm well-. circumscribed mass. The yellow inked defect goes right. through this mass. The mass abuts the yellow-inked margin,. black-inked margin and is less than 1 mm from the blue inked. margin. The adjacent renal parenchyma is yellow to brown/tan,. homogeneous. Block Summary: A1 - Perpendicular sections of the first slice with blue inked. margin, including closest approach of the mass. A2-A3 - Representative sections of the mass with adjacent. uninvolved renal parenchyma. A4 - Additional representative section of the mass. Container B is additionally labeled ""kidney, right, posterior. medial renal mass, partial nephrectomy"" and consists of a 28.0. gram, 4.0 X 3.7 X 3.0 cm fragment of kidney, that was received. with a prior cut for tissue procurement. The capsule is inked. blue and the surgical margin is inked black. Sectioning reveals. a pale tan, friable, vell-circumscribed mass, 3.8 X 3.6 X 2.9. cm. Focal gray to red/tan areas consistent with necrosis and. hemorrhage respectively, are identified. Normal renal parenchyma. is not identified in the specimen. The mass is 0.1 cm from the. blue and black inked margins. Representative sections,. including closest approach to the margin are submitted in blocks. B1-B2. Representative sections from the grossly necrotic and. hemorrhagic area is submitted in block B3. Container C is additionally labeled ""kidney, right, posterior. lateral renal mass"" and consists of a 13.5 gram 3.4 X 2.7 X 2.2. cm fragment of kidney, with a 3.5 X 1.7 X 0.6 cm fibroadipose. tissue attached. The capsule is inked blue and the resection. margin is inked black. The capsule is yellow to brown/tan,. smooth, and unremarkable. Sectioning reveals a pale tan friable. mass, 2.5 X 2.5 X 2.1 cm. The mass is hemorrhagic in the center,. abuts the blue inked capsule and is 0.2 cm from the black inked. resection margin. Block Summary : C1-C2 - - Representative sections of the mass, depicting closest. approach to the margins. C3 - Representative section of the mass with the attached. fibroadipose tissue fragment. with surgery only wf 5-yr disease-free survival.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: Tumor occupies bladder wall. It is invasive and protruded, ill - margins with. 2x1.5x1.2cm in size, soft and gray surface. Microscopic Description: Tumor cells are hyperplastic to arrange to form sheets or nest or groups or. cords one by one. Tumor cells have moderate and eosinophilic. Nuclei are very enlarged and varriability. in shape and size, irregular nuclear membranes, nucleoli and abnormal chromatin patterns. Mitoses are. common. Tumor invades in musculari propria and vessel. Diagnosis Details: Infiltrating urothelial carcinoma, high-grade, infiltrating in one half of muscularis. propria. Comments: Reports: BLADDER TISSUE CHECKLIST Carcenoma urothelial NOS 8120/3. Specimen type: Cystectomy. Tumor site: Bladder. Tumor size: 2 X 1.5x1.2 cm. Tumor features: None specified. Histologic type: Transitional cell carcinoma. qut 0/5/14. Histologic grade: Poorly differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/2 positive for metastasis (Inguinal lymph node 0/2). Lymphatic invasion: Not specified. Venous invasion: Present. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Focal extracapsular extension (bladder wall, vessel). Comments: None. lw 10/24/13 Yes.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
F. Pathologic Interpretation: A. Wedge resection right upper lobe,. - Moderately differentiated adenocarcinoma of lung, 1.5 cm in greatest dimension. - Multiple microscopic foci of bronchioalveolar carcinoma are present, including in the stapled resection margin. B. Hilar lymph node, 10: - One lymph node, no tissue seen. C. Right lower paratracheal, 4R: - One lymph node, no tissue seen. D. Subcourial lymph node, 7: - One lymph node, no tissue seen. E. Inferior pulmonary ligament lymph node, 9: - One lymph node, no tissue seen. F. Parabronchial lymph node, 11: - One lymph node, no tissue seen. G. Right upper lobe: - Multiple microscopic foci of bronchioalveolar carcinoma. - Atypical pneumocyte hyperplasia. H. Right upper lobe bronchial margin: - Segment of bronchus, no tumor seen. Tumor Summary: Specimen Type. - Lobectomy. Laterality. - Right. Tumor Site. - Upper lobe. Tumor Size. - Greatest dimension: 1.5 cm. Histologic Type. - Adenocarcinoma, not otherwise characterized. - Bronchioloalveolar carcinoma. Histologic Grade. - G2: Moderately differentiated. Margins. - Cannot be assessed. Direct extension of tumor: The visceral pleura is not involved by tumor. Venous (Large Vessel) Invasion (V). - Absent. Arterial (Large Vessel) Invasion. Absent. Lymphatic (Small Vessel) Invasion (L): - Absent. Regional Lymph nodes (pN): Number examined: 5. Number involved: 0. Pathologic Staging (pTNM). PT1 N pNO pMX. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Intraoperative Consultation. Wedge resection right upper lobe,. Adenocarcinoma. Multiple foci of bronchoalveolar carcinoma in margins. Clinical History: None Provided. Operation Performed. Right thoracotomy. Pre Operative Diagnosis: Right upper lobe lesion. Specimen(s) Received: A: Wedge resection right upper lobe, FS. B: Hilcu lymph node, 10. C: Right lower paratracheal, 4R. D: Subcourial lymph node, 7. E: Inferior pulmonary ligament lymph node, 9. F: Parabronchial lymph node, 11. G: Right upper lobe. H: Right upper lobe bronchial margin. Gross Description: A. Received fresh for frozen section is a 50 gram wedge resection specimen. There is a 1.5 x 1.3 X 1.3 cm lobulated tan,. firm lesion. The specimen measures 7.0 X 5.0 X 4.0 cm and has extensive metal staples throughout the perimeter. Sections are submitted as follows: 1. Section through lesion for frozen section. 2&3. Margins for frozen sections. 4-7. Mass lesions, submitted in toto. 8. Satellite nodules immediately adjacent to mass lesion. 9&10. Lung parenchyma distant to mass. B. Received in formalin is a tan-white soft tissue specimen that measures 1.3 x 0.6 x 0.6 cm. Bisected and submitted in toto. in one cassette. C. Received in formalin is a 1.5 x 1.0 x 0.5 cm fibrofatty specimen that has been bisected and submitted in toto in one. cassette. D. Received in formalin is a 1.0 x 1.0 x 1.0 cm fibrofatty specimen that has potential lymph tissue, submitted and bisected in. toto in one cassette. E. Received in formalin is a 1.0 x 0.5 X 0.5 cm fibrofatty specimen that has been bisected and submitted in toto in one. cassette. F. Received in formalin is a 0.5 x 0.5 X 0.3 cm soft tissue specimen that has been submitted in toto in one cassette. G. Received in formalin is a 114 grams partial lobectomy specimen, measuring 12.0 x 5.0 x 3.0 cm. The specimen has been. serially sectioned to reveal a soft, hyperemic spongy mucosa with no masses present. Sections submitted as follows: 1. Bronchial and vascular margins. 2-6. Non adjacent section throughout parenchyma. 7-11. Additional sections of consolidated areas. H. Received in formalin is a 1.5 x 1.0 x 0.5 cm soft tissue specimen that has been submitted in one cassette.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description. Microscopic Description. Diagnosis Details. Comme. nts. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 5 X 5 X 5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/4 positive for metastasis. (Regional 0/4). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: Right-lower. Lateralit. y. Right-. lower.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Pancreas, bile duct margin, biopsy. - No tumor seen. B: Pancreas pancreatic duct margin, biopsy. - No tumor seen. C: Superior pancreatic lymph node, biopsy. - One lymph node with no malignancy identified (0/1). D: Aortocaval lymph node, biopsy. - One lymph node with no malignancy identified (0/1). E: Pancreas, duodenum, pancreaticoduodenectomy. Tumor Histologic Type: adenocarcinoma. Histologic grade: moderately differentiated. Tumor size: 3.5 cm. Extent of invasion: Peripancreatic soft tissues : present. Duodenum: identified. Ampulla: identified. Lymphatic Invasion: not identified. Venous Invasion: not identified. Perineural Invasion: present. Margins: Pancreatic neck: negative. Bile duct: negative. Posterior pancreatic surface (deep radial margin) : negative (<1. mm). Peripancreatic soft tissues: negative (<1 mm). Proximal (gastric) : negative. Distal (duodenal) : negative. Regional lymph nodes: Total number with metastasis: 0. Total number examined: 8 (including specimens A and B). AJCC PATHOLOGIC TNM STAGE: pT3 pNO pMx. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Intraoperative Consult Diagnosis: An intraoperative consultation is requested by. FSA1: Pancreas, bile duct margin, biopsy. - No tumor seen. FSB1: Pancreas, pancreatic duct margin, biopsy. - No tumor seen. Frozen Section Pathologist: Clinical History: The patient is a. .year-old. with pancreatic head cancer. Gross Description: Specimen A is received fresh in the frozen section room. appropriated labeled ""bile duct margin for frozen section"" and. consists of a 2.2 X 0.6 X 0.6 cm red/tan soft tissue fragment. with no lumen. The specimen is entirely submitted for frozen. section and resubmitted in block FSA1,. Specimen B is received fresh in the frozen section room. appropriately labeled ""pancreatic duct margin for frozen. section"" and consists of a 1.0 X 0.8 X 0.3 cm red/tan soft. tissue fragment. The specimen is entirely submitted for frozen. section and resubmitted in block FSB1,. Specimen C is labeled as ""superior pancreatic lymph node,. biopsy"". Received is a single pink/tan soft tissue fragment with. focal erythematous areas and cautery, 1.2 X 0.8 X 0.5 cm. The. specimen is serially sectioned and the entire specimen is. submitted in block C1,. Specimen D is labeled as ""aortocaval lymph node, biopsy"" and. consists of a white to pink/tan soft tissue fragment 2.2 X 0.9 X. 0.7 cm, with focal erythematous areas and cautery. The specimen. is serially sectioned and submitted in block D1,. Specimen E is labeled ""Whipple specimen."". Specimen fixation: formalin. Specimen type: Whipple. Organs received (Whipple Specimen) : stomach (3.5 cm long X up to. 6.5 cm in circumference), head of pancreas (4 X 3 X 1.5 cm),. duodenum (15 cm long X up to 6.7 cm in circumference) , common. bile duct (3.6 cm long X 1.7 cm in circumference proximally). Orientation: common bile duct=yellow, pancreatic body. margin=blue, uncinate=black, peripancreatic soft tissue=green. Tumor location: head. Tumor dimensions: 3.5 X 3.0 X 2.5 cm. Gross appearance of tumor: solid, firm, variegated, tan/white;. There is minimal amount of normal pancreas present. Extent of invasion: Confined / non-confined to the pancreas: : confined. Involvement of the ampulla: absent. Involvement of the duodenum: absent. Involvement of the bile duct: possibly into wall. Involvement of adjacent vessels: n/a. Spleen (if applicable) : n/a. Gallbladder (if applicable) : n/a. Stomach (if applicable) : uninvolved. Surgical margins: Pancreatic body: negative (0.2 cm). Uncinate (Retroperitoneal) : negative (<0.1 cm). Common Bile duct: negative (0.2 cm). Proximal margin (stomach) : negative (3.5 cm). Distal margin (duodenum) : negative (9.3 cm). Peripancreatic soft tissues: positive. Lymph nodes: multiple lymph node candidates are identified. ranging in size from 0.5 up to 2.0 cm. Other remarkable findings none. Digital photograph taken: no. Tissue submitted for special investigation: no. Block summary: E1, E2 - proximal (stomach) margin, en face. E3 - distal (duodenum) margin, en face. E4 - pancreatic body margin, en face. E5 - uncinate margin with closest approach of tumor,. perpendicular. E6 - closest approach to common bile duct margin, perpendicular,. full thickness, bisected. E7 - remaining common bile duct margin, en face. E8-E9 - - mass with relationship to common bile duct and duodenum,. one section, bisected. E10 - tumor with pancreatic duct. E11-E12 - tumor with relationship to ampulla. E13 - two lymph node candidates, one inked black and both. bisected. E14-E15 - largest lymph node candidate, serially sectioned. E16 - two lymph node candidates. E17 - one lymph node candidate, bisected.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Report Type. Date of Event. Authored by. Hosp/Group. PATIENT HISTORY: Carcinoma of tongue. PRE-OP DIAGNOSIS: None given. POST-OP DIAGNOSIS: None given. PROCEDURE: Hemiglossectomy, mandibulectomy and bilateral neck. tion. FINAL DIAGNOSIS: PARTS 1. AND 2: LYMPH NODES OF RIGHT NECK, LEVELS II-IV, DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA INVOLVING TWO OF TWENTY-SIX -. LYMPH NODES (2/26). 1. POSITIVE LYMPH NODES IN LEVEL II. 2. LARGEST LYMPH NODE WITH METASTATIC CARCINOMA IS 1.0 CM. (0.4 CM TUMOR. FOCUS) , WITH EXTRACAPSULAR SPREAD. B. SUBMANDIBULAR GLAND WITH MILD CHRONIC SIALADENITIS. PARTS 3. TO 5: LYMPH NODES, LEFT NECK, LEVELS 1-IV, SELECTIVE DISSECTION. A. SEVENTEEN LYMPH NODES; NO TUMOR PRESENT (0/17). B. SUBMANDIBULAR GLAND WITH MILD CHRONIC SIALADENITIS. PART 6: RIGHT TONGUE, FLOOR OF MOUTH AND MANDIBLE, COMPOSITE RESECTION. A. INVASIVE SQUAMOUS CELL CARCINOMA (5.0 CM.), WELL TO MODERATELY. DIFFERENTIATED, INVOLVING DEEP TONGUE AND FLOOR OF MOUTH MUSCLES, MARROW. SPACE. OF MANDIBLE AND EXTENDING TO ATTACHED SUBMENTAL SKIN ( SUBCUTANEOUS TISSUE). B. PERINEURAL INVASION AND ANGIOLYMPHATIC INVASION PRESENT. C. MARGINS FREE OF CARCINOMA. D. THREE LYMPH NODES; NO TUMOR PRESENT (0/3) . PATHOLOGIC STAGE: pT4a, N2b, MX. My si. station that I have personally reviewed the submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION. The specimen is received in six parts. Part 1 is received in formalin and labeled with the patient' S name, initials. XX and ""right neck dissection, 2, 3, 4"". The specimen is a 12.0 X 4.0 X 5.0. cm selective neck dissection with 4.5 X 3.0 X 1.5 cm submandibular gland. Multiple lymph nodes up to 1.8 cm are identified. Specimen is submitted as. follows: 1A. - level 2 node A. 1B. level 2 node B. 1C. level 3 node A. 1D. level 4 node A. 1E. - level 4 node B. 1F. - level 4 node C. 1G. level 4 node D. 1H. submandibular gland. 1I. one level 1 lymph node, bisected. 1J. one level 2 lymph node. 1K. - seven possible level 2 lymph nodes. 1L. - one level 3 lymph node. 1M. - nine possible level 3 lymph nodes. 1N. - seven possible level 4 lymph nodes. Part 2 is received in formalin labeled with the patient' S name, initials XX. and ""right neck dissection 2B"". The specimen is a 3.0 X 2.5 X 1.5 cm. excision. of fibroadipose tissue with five lymph nodes up to 0.6 cm. Specimen. submitted. as follows: 2A - lymph nodes. Part 3 is received in formalin labeled with the patient' S name, initials XX. and ""left neck level 1"". The specimen is a 7.0 X 4.0 X 2.0 cm selective neck. dissection with a 6.0 X 3.5 X 1.8 cm submandibular gland and four lymph nodes. ranging from 0.7 to 1. cm. Specimen is submitted as follows: 3A. - submandibular gland. 3B-3C - two lymph nodes each (one inked black in each cassette) . Part 4 is received in formalin labeled with the patient' S name, initials XX. and ""left neck level 2"". The specimen is a 3.0 cm excision of fibroadipose. tissue with nine possible lymph nodes up to 2.2 cm (largest grossly. positive). Sections are submitted as follows: 4A - largest lymph node. 4B-4C - four lymph nodes each. Part 5 is received in formalin labeled with the patient' S name, initials XX. and ""left neck level 3, 4"". The specimen consists of two pieces of. fibroadipose tissue, 3.5 X 3.0 X 3.0 cm and 3.0 X 2.0 X 1.0 cm with nine. lymph. nodes up to 3.1 cm. Sections are submitted as follows: 5A. - largest lymph node bisected. 5B. - four lymph nodes. Part 6 is received in formalin labeled with the patient' S name, initials XX. and ""tongue and mandible"". The specimen is a right hemiglossectomy and. anterior/right lateral segmental mandibulectomy specimen, 8.0 cm anterior to. posterior, 7.5 cm dorsal to ventral and 6.5 cm right to left. It consists. of. an 11.0 cm segment of mandible with an average diameter of 1.5 cm, 7.0 X 3. 0. X. 3.0 cm righ tongue with portion of floor of mouth and alveolar ridge mucosa. attached. In addition, is a 6.0 X 5.0 cm piece of skin in the submental. region with a central puckered area. Centered in the floor of mouth right lateral tongue junction is a 5.0 X 3.5. X. 4.0 cm centrally ulcerated tumor extending deep within the muscles of the. base. of tongue and floor of mouth. The tumor nearly encases the adjacent mandible. and appears to grossly invade through the cortex into the marrow space. The. closest extent of tumor to margin is 0.1 cm from the base of tongue soft. tissue. The tumor extends focally into the attached skin segment. A 0. 3 cm lymph node is identified in the base of tongue adipose tissue. Inking code: green medial, black base of tongue, blue anterior-lateral. alveolar ridge. Sections are submitted as follows: 6A. - base of tongue mucosa (shave) frozen section control. 6B. - lateral soft tissue (shave) frozen section control. 6C. lateral floor of mouth (shave) frozen section control. 6D. - anterior floor of mouth (shave) frozen section control. 6E. deep base of tongue (perpendicular) frozen section control. 6F. - deep base of tongue (perpendicular) frozen section control. 6G. - anterior medial shave, frozen section control. 6H. posterior medial shave, frozen section control. 6I. - posterior bony margin, decalcification. 6J. - anterior bony margin, decalcification. 6K. - tumor to bone, decalcification. 6L. - anterior skin shave. 6M. - left skin shave. 6N. - posterior skin shave. 60. - right skin shave. 6P. - tumor to skin and lymph node at base of tongue. 6Q-6R - tumor to deep tongue and floor of mouth muscle, respectively. 6S. - tumor to tongue mucosa. 6T-6U - cross section of tumor from tongue mucosa to alveolar mucosa,. bisected. tumor to alveolar ridge. RATIVE CONSULTATION: 6A-6H: RIGHT TONGUE AND MANDIBLE, COMPOSITE RESECTION (frozen sections). A. MALIGNANT. B. SQUAMOUS CELL CARCINOMA. ISSUE MARGINS FREE OF CARCINOMA. COPIC: PROCEDURAL NOTES. LYMPH NODE: FS. Permanent. Level II node A. negative. negative. Level II node B. positive. positive. Level III node A. negative. negative. Level IV node A. negative. negative. Level IV node B. negative. negative. Level IV node C. negative. negative. Level IV node D. negative. negative. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH) , Molecular Anatomic Pathology, and. Immunofluorescent Testing: The. d its performance characteristics determined by. the. Department of Pathology, as required by the. C. A. regulations. The testing has not been cleared or approved for the. sp cific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND MINOR SALIVARY. GLAND TUMORS. SPECIMEN TYPE: Resection: Right hemiglossectomy and mandible composite. resection. TUMOR SITE: Other: Right lateral tongue and floor of mouth. TUMOR SIZE : Greatest dimension: 5.0 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM) : pT4a. pN2b. Number of nasopharynx regional lymph nodes examined: 2. Number of nasopharynx regional lymph nodes involved: 46. Extra-capsular extension of nodal tumor: Present. pMX. MARGINS. Margins uninvolved by tumor. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L) : Present. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS : None identified. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: ght neck dissec. Stain/cil. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. H&E X 1. M. H&E X 1. N. Part 2 : dissection righ. Stain/c. H&E X 1. A. Part 3 : t neck level 1. Stain/cil. H&E X 1. A. H&E X 1. B. H&E X 1. C. Part 4 : 1 2. Stain/cil. H&E X 1. A. H&E X 1. B. H&E X 1. C. Part 5 : 1 3,4. Stain/cnt. Block. H&E X 1. A. H&E X 1. B. Part 6: le. Stain/cil. Decal X 1. H&E X 1. Decal X 1. H&E X 1. Decal X 1. K. H&E X 1. K. H&E X 1. L. H&E X 1. M. H&E X 1. N. H&E X 1. O. H&E X 1. P. H&E X 1. Q. H&E X 1. R. H&E X 1. S. H&E X 1. H&E X 1. H&E X 1. V. FRZ Single X. H&E X 1. FRZ Addit X. H&E X 1. FRZ Addit X. H&E X 1. FRZ Addit X. H&E X 1. FRZ Addit X. H&E X 1. FRZ Addit X. H&E X 1. FRZ Addit X. H&E X 1. FRZ Addit X. X 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Report Status: Final. Procedure Date: PATHOLOGIC DIAGNOSIS: A. RIGHT RIB: Bone marrow with maturing trilineage hematopoiesis,. negative for tumor. B. LEVEL 9 LYMPH NODE BIOPSY: Lymph node fragments with calcified nodules, negative. for tumor, see Note. Gram, fungal (MSS), and acid-fast stains are negative. for organisms. C. LEVEL 8 LYMPH NODE BIOPSY: Lymph node fragments with calcified nodules, negative. for tumor, see Note. Gram, fungal (MSS). and acid-fast stains are negative. for organisms. D. LEVEL 7 LYMPH NODE BIOPSY: Lymph node fragments negative for tumor. E. LEVEL 10R LYMPH NODE BIOPSY: Lymph node fragments negative for tumor. F. DIAPHRAGM: MALIGNANT MESOTHELIOMA epithelioid type invasive in. fibroadipose tissue. Skeletal muscle and tendon are present and uninvolved. G. VISCERAL AND PARIETAL PLEURA: MALIGNANT MESOTHELIOMA mixed epithelioid (90%) and. sarcomatoid (10%) types, invasive in fibroadipose. tissue (multiple nodules up to 6.8 cm), see Note. Tumor extends to inked pleural surface. NOTE: Select slides reviewed with. H. PHRENIC NERVE (INCLUDING FSA) : MALIGNANT MESOTHELIOMA epithelioid type invasive in. fibroadipose tissue. I OLD PORT SITE 1: Skin and subcutis with chronic inflammation and scar,. negative for tumor. NOTE: The calcified nodules noted in lymph nodes likely. represent a remote infection. Select slides reviewed. with. Page: 1 of 3. TISSUE SUBMITTED: A/1. Right rib. B/2. Level 9. C/3. Level 8. D/4. Level 7. E/5. Level 10R. F/6. Diaphragm. G/7. Visceral and parietal pleura. H/8. Phrenic nerve (FS). I/9. Old port site #1. O.R. CONSULTATION: SPECIMEN LABELED ""#8 PHRENIC NODULE"" (FSA) : Epithelioid mesothelioma, invasive in fibrous tissue. OR Consultation by: The senior physician certifies that he/she personally conducted a gross and/or. microscopic examination of the described specimen (s) and rendered or confirmed. the rapid diagnos (es) related thereto. GROSS DESCRIPTION: The specimen is received fresh, in nine parts, each labeled with the patient's. name and medical record number. Part A, ""#1. Right rib"", consists of four segments of rib (12.0, 5.8, 1.2, and. 2.5 cm in length x an average diameter of 2.2 cm). Scant attached tan/red. skeletal muscle and tan/red fibrous tissue is present. There is no gross. evidence of involvement by tumor. A bone marrow squeeze is performed. Micro A1: Bone marrow squeeze, multi frags, RSS. Part B, ""#2. Level 9"", consists of four fragments of tan/red fibrous tissue,. tan/yellow adipose tissue and focally anthracotic tan/red lymph node candidates. (3.6 x 1.5 x 1.2 cm in aggregate) One fragment exhibits a firm tan/yellow cut. surface. The specimen is entirely submitted for microscopic examination. Micro B1-B3: Soft tissue fragments, multi frags, ESS. Part C, ""#3. Level 8"" , consists of a single tan/white to tan/red focally. anthracotic soft tissue fragment consistent with lymph node (1.2 x 0.8 x 0.5. cm). The specimen is bisected and entirely submitted for microscopic. examination. Micro C1: Soft tissue fragment, 2 frags, ESS. Part D, ""#4. Level 7"" , consists of six fragments of tan/white to tan/red soft. tissue with focal anthracosis, consistent with lymph node candidates (3.9 x 2.1. x 0.6 cm). The specimen is entirely submitted for microscopic examination. Micro D1 through D2: Soft tissue fragments, multi frags, ESS. Part E, ""#5. Level 10R"", consists of a single tan/red to tan/white focally. anthracotic soft tissue fragment (0.6 x 0.3 x 0.2 cm). The specimen is. entirely submitted for microscopic examination. Page: 2 of 3. Micro E1: Soft tissue fragment, 1 frag, ESS. Part F, ""#6. Diaphragm"", consists of three fragments of tan/red skeletal muscle. and tan/red soft tissue focally lined by a smooth and glistening surface (5.6 x. 3.5 x 1.4 cm in aggregate) . Multiple (at least 10) tan/white firm nodules (up. to 0.2 cm in maximum dimension) are present on the soft tissue overlying the. skeletal muscle. No definitive involvement of skeletal muscle by tumor is. identified. Representative sections are submitted. Micro F1 through F2: Representative sections of soft tissue and skeletal. muscle, 3 frags each, RSS. Part G, ""#7. Visceral and parietal pleura"", consists of a 388.0 gram aggregate. of tan/pink fibromembranous soft tissue (29.0 x 24.0 x 3.8 cm in aggregate). with multiple (at least 100) tan/pink nodules (ranging from 0.2 to 6.8 cm) and. admixed tan/yellow lobulated adipose tissue. Representative sections of the. nodules are submitted to the. The surface overlying the nodules is focally inked black. and Representative sections are submitted for permanent microscopic. examination. Micro G1 through G4: Sections of largest nodules, 1-3 frags each, RSS. Part H, ""#8. Phrenic nerve"", consists of a single irregular yellow/pink soft. tissue fragment (1.2 x 1.0 x 0.5 cm). The specimen is inked black, bisected. and entirely submitted for frozen section examination as FSA. Micro H1: Frozen section remnant (FSA), 2 frags, ESS. Part I, ""#9. Old port site #1"", consists of a single fragment of tan/white skin. and subcutis (2.1 x 0.5 cm, extending to a depth of 2.2 cm). The subcutis is. firm with abundant tan/white fibrous scar tissue, but no focal mass lesions are. identified. The specimen is entirely submitted for microscopic examination. Micro Il through I2: Skin and subcutis, 1-2 frags each, ESS. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Specimen(s) Received. 1. Lymph-Node: Left Neck External Jugular Node. 2. Lymph node: Left neck level 4. 3. Tonsil: Left tonsil pillar/QS. 4. Oral-Cavity: Left retromolar trigone/QS. 5. Oral Cavity: Medial tongue margin/QS. 6. Oral Cavity: Tongue resection long stitch-anterior; short stitch-medial. 7. Neck: Left neck level IA & IB. 8. Neck: Left neck level II. 9. Neck: Left neck level III & IV. 10. Surgical Waste. Diagnosis. 1. Left neck external jugular node. One lymph node negative for tumor (0/1). 2. Left neck level IV. One lymph node negative for tumor (0/1). 3. Left tonsil pillar. Negative for tumor. 4. Left retromolar trigone. Negative for tumor. 5. Medial tongue margin. Negative for tumor. 6. Oral cavity; tongue; resection. Spindle cell (sarcomatoid) squamous cell carcinoma, poorly differentiated. a. Tumor maximum diameter 3.2 cm,. b. Tumor thickness 1.0 cm. C. No lymphatic/vascular invasion. d. No perineural invasion. e. Margins negative for tumor. 7. Left neck level IA and IB. Seven lymph nodes negative for tumor (0/7). Submandibular aland with no pathologic changes. 8. Left neck level II. Eight lymph nodes negative for tumor (0/8). 9. Left neck level III and IV. Four lymph nodes negative for tumor (0/4). 10. Surgical waste. Skin and soft tissues with no pathologic changes. (Gross examination only). Synoptic Data. Specimen Type: Resection:tongue; resection. Tumor Site: Tongue. Histologic Type: Spindle cell carcinoma. Tumor Size: Greatest dimension: 3.2 cm. Tumor thickness: 1.0 cm. Histologic Grade: G3: Poorly differentiated. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Perineural Invasion: Absent. Margins: Margins uninvolved by tumor. Pathologic Staging (pTNM): pT2: Tumor of lip or oral cavity more than 2 cm but not more than 4 cm in. greatest dimension. pNO: No regional lymph node metastasis for aerodigestive sites. Number of regional lymph nodes examined: 21. Number of regional lymph nodes involved: 0. pMX: Distant metastasis cannot be assessed. Clinical History. Oral CA. Gross Description. 1. The specimen is labeled with the patient's name and ""left external jugular node"". It consists of one lymph node. measuring 0.8 X 0.5 X 0.4 cm. 1A. one lymph node. 2. The specimen is labeled with the patient's name and ""left neck level IV"". It consists of one lymph node measuring 2.6 X. 1.5 X 0.9 cm. 2A. one lymph node. 3. The specimen is labeled with the patient's name and ""left tonsil pillar qs"". It consists of a fragment of tissue measuring. 2.4 x 0.4 X 0.3 cm. The specimen is submitted in toto for frozen section. 3A. frozen section control. 4. The specimen is labeled with the patient's name and ""left retromolar trigone"". It consists of a fragment of tissue. measuring 1.8 X 0.4 x 0.2 cm. The specimen is submitted in toto for frozen section. 4A. frozen section control. 5. The specimen is labeled with the patient's name and ""medial tongue margin"". It consists of a fragment of tissue. measuring 4.0 x 1.1 x 0.9 cm. The specimen is bisected and submitted in toto for frozen section. 5A 5B frozen section control. 6. The specimen is labeled the patient's name and ""tongue resection long stitch anterior short medial"". It consists of an. oriented portion of left lateral tongue measuring 4.4 SI x 3.3 ML X 7.7 AP cm. There is a well-circumscribed tumor. involving the lateral surface of the tongue. The tumor measures 2.7 SI X 1.0 ML x 3.2 AP cm. The tumor is ulcerated, tan,. solid and firm. It is located at 2.2 cm from the lateral/inferior floor of mouth margin, 1.5 cm from the medial/dÃ©ep soft. tissue margin, 2.2 cm from the anterior margin, 1.3 cm away from the superior tongue margin and 3.1 from the posterior. margin. The remaining tongue mucosa is grossly unremarkable. Representative sections are submitted. 6A. anterior tongue resection margin. 6B. posterior tongue resection margin. 6C. superior tongue margin. 6D. inferior/lateral floor of mouth margin. 6E. medial/deep soft tissue margin. 6F-6H. tumor. 7. The specimen is labeled with the patient's name and ""left neck level IA and level IB"". It consists of portion of. fibroadipose tissue measuring 8.3 X 4.8 X 2.2 cm. The submandibular gland is unremarkable and measures 4.3 X 3.8 x. 1.7 cm. Multiple lymph nodes ranging from 0.6 x 0.4 X 0.4 to 1.3 X 1.0 x 1.0 cm are identified. Representative sections. are submitted. 7A. submandibular gland. 7B. multiple lymph nodes. 7C. one lymph node. 7D. one lymph node. 8. The specimen is labeled with the patient's name and ""left neck level II"". It consists of portion of fibroadipose tissue. measuring 5.3 X 2.2 x 1.4 cm. Multiple lymph nodes ranging from 0.5 X 0.3 x 0.3 to 1.3 x 1.0 X 0.8 cm are identified. Representative sections are submitted. 8A. one lymph node. 8B. two lymph nodes. 8C. one lymph node. 8D. multiple lymph nodes. 9. The specimen is labeled with the patient's name and ""left level III and level IV"". It consists of portion of fibroadipose. tissue measuring 3.8 x 1.9 X 1.0 cm. Multiple lymph nodes ranging from 0.4 x 0,2 x 0.3 to 2.1 X 0.6 x 0.6 cm are identified. Representative sections are submitted. 9A. one lymph node. 9B. multiple lymph nodes. 9C. one lymph node bisected. 10. The specimen is labeled with the patient's name and ""surgical waste"". It contains three unremarkable and unoriented. pieces of tan skin with fibroadipose ranging from 4.5 x 0.9 X 0.5 cm to 9.5 x 4.3 x 0.7 cm. No samples are submitted for. histologic examination. 3A: Left tonsillar pillar: Negative for malignancy. 4A: Left retromolar trigone: Negative for malignancy. P.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Acct/Res. DIAGNOSIS. DIAGNOSIS. A. Right axiliary sentinel lymph nodes, excision: Metastatic adenocarcinoma involving da ; frozen section diagnosis confirmed. B. Right breast, mastectomy: Bloom Richardson up to 2.0 cm in maximal diameter as measured on glass slide, ruppecinger quadrent. Areas of anglolymphatic invasion suggested. No in situ component identified. Histologically unremarkable nipple and negative inked deep surgical margin of resection. Background of proliferative fibrocystic changes including moderate usual ductal hyperplasia and a single microscopic focus of atypical ductal. hyperplasia. Anciliary studies previously obtained. C. Right axillary contents, regional resection: Metastatic. The largest lymph node shows a multifocal microgranulomatous reaction associated with refractile foreign material. Staging sheet #25. Stage: T1cN1MX, stage lla. CÃINICA INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Right breast cancel-. Postoperative Diagnosis: Symptoms/Radlologic Findings: SPECIMENS: A. Right axiliary sentinel nodes. 8. Right breast. C. Right axillary contents. SPECIMEN DATA. GROSS DESCRIPTION: A. The first container A is labeled and consists of two lymph nodes measuring 1.2 x 1.0x0.5 cm and 1.5 x 1.2 x 0.5 cm. The lymph nodes. were examined at the time of surgery and are subsequently entirely submitted In cassettes. is follows: FSA1--1; FSA2--2,. B. The' second container 8 Is labeled. nd right breast and consists of a portion of fibroadipose breast tissue that has been received previously. inked and sectioned with attached skin measuring 25.0 x 15.0 x 6.0 cm and weighs 830 grams. The skin surface measures 20.0 x 9.0 cm and is light. tan wrinkled. There is an area discolored by blue contrast dye surrounding the nipple measuring 6.0 cm. The nipple is centrally placed and appears. grossly normal. The specimen has oriented with a suture at superior. On sectioning there is a firm gray-tan fibrous mass measuring 1.2 x 1.0 x 0.7 cm. that is 1.0 cm from the deep margin of resection and is located predominantly within the upper inner quadrant. The surrounding breast tissue reveais. fatty fibroadipose breast tissue with fibmus Neque. There are no other lesions grossly Identified. Received with the specimen are two casseltes, one. representative sections are submitted in cassettes. as follows: nipple-1; sections from mass-2. to. 5, doep wargin overiying mass=6; sections from upper Inner quadrant--7; lower Inner quadrant--8; lower outer quadrant-9; upper outer quadrant--10. C. The third container C is labeled. ad right axillary contents and consists of a portion of fibroadipose tissue measuring 8.0 x 5.5x2.5. Sectioning reveals twelve probable lymph nodes measuring from 0.2 to 1.5 cm. The lymph nodes are entirely submitted in cassette: as. follows: five probable nodes-13 six probable nodes-2; one lymph node trisected--3 and 4. INTRA-OPERATIVE CONSULTATION: FSA: 'Metastatic neoplasm in at least one of the two lymph nodes' DE. Addendum: Pathology of positive for invasive lobular carcinoma. Patient needs. to be referred to a breast surgeon; Patient was called with results and will followup with. oni. for the. necessary surgioal referral. END OF ADDENBUM. ### VOICE TO TEXT SYNOPSIS ADDENDUM. Invasive lobular carcinoma Patient needs to be refeured to a surgeon. ADS: (6) Known blopsy - proven malignancy. END on ADDENDUM. FULL RESULT: Indication: Right breast mass. Vacuum-assisted ultrasound-guided core blopsy: Scana through the right breast at 1:00 again confirm a solld Irregular. mass. It has shadowing posterlorly. Following local anesthesia, a 10-gauge Cassi device was Introduced into the mass. under ultrasound guidance. using vacuum assistance, multiple core samples were obtained. Procedure was well tolerated. Clip placement: Under ultrasound guidance, a blopsy cllp was Inserted percutaneously into the area of the mass. This was. successfully deployed under vitrasound guidance. Right mammogram, post procedure: A postblopsy mammogram was obtained. This confirms placement of the biopsy. marker clip. It is well within the spiculated mass in the upper inner quadrant. IMPRESSION: Irregular solid mass right breast at. Ultrasound-gulded vacuum-assisted core blopsy performed. Cllp. deployed auccessfully into the blopsy site. Pathology pending. PATIENT INFORMATION. PHYSICIAN INFORMATION. SPECIMEN INFORMATION. Acct/Reg#: (. ADDENDUM REPORT. ADDENDUM REPORT NUMBER TWO. BREAST PROGNOSTIC PANEL: Block 2. TEST. REFERENCE RANGES. DNA Analysis by Image: DNA Index: SEE COMMENT. 0.9-1.1 is Diploid. < 0.9 or > 1.1 le Aneuploid. COMMENT: Insufficient tumor volume is present for quantitation of DNA by Image analysie. Her2 Gene Amplification By FISH: NEGATIVE. Average copies per cell: Her-2/neu: 1.82. Chromosome 17: 1.67. Ratio: 1.09. 20 Her2/neu. Case interpreted by. Notes: Quantitative analysis performed using Chromavision ACIS. The Her2 /neu and CEP17 probes are manufactured by Vysis Inc. The Her2/neu gene detection by Fluorescence in Situ Hybridization (FISH) was performed using the LSI Her2/neu DNA probe, specific. for the Her2/neu gene locus 17q11.2-q12 and the CEP1 DNA probe specific for the alpha antellite DNA sequence at the centromerio. region of chromosome 17 (17p11.1-q11.1). These tests were developed and performance characteristics determined by the. They have not. been cleared or approved by the US Food and Drug Administration. The FDA has determined that such approval or clearance le not. necessary. These tests are used for clinical purposes. They should not be regarded as Investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement Act (CLIA) of 1988 as qualified to perform high complexity clinical. laboratory testing. Place of Service: Center for Advanced Diagnostics. ADDENDUM REPORT NUMBER ONE. BREAST PROGNOSTIC PANEL: (Preliminary test results on block A2). TEST. REFERENCE RANGES. Estrogen Receptor: POSITIVE (94%). > 4% is Positive. 2-4% is Borderline. < 2% is Negative. Progesterone Receptor: POSITIVE (89%). > 4% is Positive. 2-4% is Borderline. < 2% le Negative. KI-67 (MIB1) Proliferation Marker: BORDERINE (18%). 20% is High. 10-20% is Borderline. < 10% is Low. REPORT CONTINULE ON NE XT PAGE. Page: lof2. PATIENT INFORMATION. SPECIMEN INFORMATION. $. These results were interpreted by Dr. An additional addendum report will follow when DNA and Her-2-neu tests. are completed. These tests were developed and performance characteristics determined by. hey have not been cleared or approved by. the. US Food and Drug Administration. The FDA has determined that auch approval or clearance ls not necessary, These teats are used for. clinical purposes. They should not be regarded as Investigational or for research. This laboratory is certified under the Clinical Laboratory. improvement Act (CLIA) of 1988 as qualified to perform high complexity clinical laboratory testing. DIAGNOSIS. DIAGNOSIS: 10 gauge true cut ultrasound guided needle core biopsies of an Irregular 1 x 2 cm mass near the 0100 position within the right breast: Invasive lobular carcinoma. Size: Two cores partially Involved with largest linear dimension 6 mm as measured from siide A2. Eiston modification of Bloom-Richardson Grade: Architectural score: 3/3. Nuclear score: 2/3. Mitotic score: 1/3. Total score: No in situ carcinoma component present. No lymphovascular space invasion evident. No microcaleificatione seen. No other significant profiferative breast disease pattern present. Paraffin Block A2 submitted for breast cancer prognostic panel with results reported as an addendum (paraffin block A5 suitable If. additional material necessary). CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Core needie biopsy, true cut, uttrasound core blopay anciliary test If malignant: Estrogen/Progesterone receptora, Her2-neu. Postoperative Diagnosis: Symptome/Radiologic Findings: Mammogram, ultresound, size irregular mass 1 x 2 cm. SPECIMENS: Right breast. SPECIMEN DATA. GROSS DESCRIPTION: Received in one container labaled right breast are multiple (15 to 20) soft paie veligw wispy fragments and come massuring up to 1.2 cm in. greetest dimension. The specimen is entirely submitted in five cassettes labeled. Case color blue.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
LABORATORY MEDICINE PROGRAM. Specimen(s) Received. 1. Parathyroid: Right Upper/QS. 2. Lymph node: Right paratracheal node. 3. Thyroid: Total thyroid (stitch marks upper pole right lobe). Diagnosis. 1. No pathological diagnosis: Parathyroid (right upper) biopsy. 2. No pathological diagnosis: Lymph node (right paratracheal) excisional biopsy. 3. Multifocal papillary carcinoma, dominant widely invasive mixed classical and Warthin-like variant with focal tall cell. (<10%) and hobnail cell change (<20%), 2.6 cm, right lobe; underlying chronic lymphocytic thyroiditis: Thyroid. No pathological diagnosis: Parathyroid, left intrathyroidal. No pathological diagnosis: Lymph nodes, 2, isthmic. No pathological diagnosis: Lymph node, 1, left perithyroidal. - Total thyroidectomy specimen. Synoptic Data. Procedure: Total thyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 4.4 cm. 2.8 cm. 2.1 cm. Left lobe: 5.0 cm. 2.3 cm. 1.3 cm. Isthmus +/- pyramidal lobe: 4.0 cm. 1.0 cm. 0.7 cm. Specimen Weight: 24.1 g. Tumor Focality: Multifocal, bilateral. DOMINANT TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 2.6cm. Additional dimension: 1.6 cm. Additional dimension: 1.6 cm. Histologic Type: Papillary carcinoma, classical (usual). Papillary carcinoma, Warthin-like variant. Papillary carcinoma, other variant: with focal tall cell (<10%) and hobnail cell change. (<20%). Classical (papillary) architecture. Classical cytomorphology. Tall cell cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 0. 1mm. Tumor Capsule: Partially encapsulated. Tumor Capsular Invasion: Present, extent widely invasive. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. SECOND TUMOR. Tumor Laterality: Left lobe. Tumor Size: Greatest dimension: 0.2cm. Histologic Type: Papillary carcinoma, follicular variant. Papillary carcinoma, microcarcinoma (occult, small or microscopic) variant. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of regional lymph nodes examined: 4. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Thyroiditis, other: chronic lymphocytic thyroiditis. Parathyroid gland(s), within normal limits. Other: additional 0.1 cm follicular variant papillary microcarcinoma, left lobe. Pathologic Staging is based on AJCC/UICC TNM, Edition. Gross Description. 1. The specimen labeled with the patient's name and as ""right upper parathyroid"" consists of a tiny piece of tissue that. measures 0.3 x 0.3 x 0.2 cm. It is frozen for intraoperative consultation. 1A. frozen tissue resubmitted. 2. The. specimen labeled with the patient's name and as ""right paratracheal node"" consists of one lymph node that. measures 0.4 x 0.4 x 0.3 cm. 2A. bisected and. submitted in toto. 3. The specimen labeled with the patient's name and as ""total thyroid stitch marks upper pole right lobe"" consists of a. thyroid. gland that is oriented with a stitch marking the right upper pole and weighs 24.1 g. The right lobe measures 4.4 cm. SI x 2.8 cm ML x 2.1 cm AP, the left lobe measures 5.0 cm SI x 2.3 cm ML x 1.3 cm AP and the isthmus measures 4.0 cm. SI x 1.0 cm ML x 0.7 cm AP. The external surfaces have fibrous adhesions and are painted with blue dye. No parathyroid. glands or no lymph nodes are identified grossly. The superior mid right lobe contains one well delineated nodule that. measures 2.6 cm SI x 1.6 cm ML x 1.6 cm AP. A second tiny nodule is identified on the mid pole of the left lobe. measuring 0.5 SI x 0.4 ML x 0.5 cm AP. The cut surface of both nodules is red-tan in color and has a soft and flabby. consistency. The remainder of the thyroid tissue is grossly unremarkable. Sections of right nodule and normal tissue are. stored frozen. The remainder of the specimen is submitted as follows: 3A-1. right lobe, superior to inferior. 3J. isthmus. 3K-Q. left lobe, superior to inferior. Quick Section Diagnosis. 1. Parathyroid, right upper. Parathyroid tissue.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Examination report. Macroscopic findings: 1. Parietal pleura: excised material, one with a diameter of max. 5 and one with. a diameter of 4 mm. 2. (a-i) Left inferior pulmonary lobe: resected lobe weighing 277 g and. measuring 180 X 120 x 70 mm with moderate mesh-like anthracosis of the pleura, hilar staple sutures and an. exposed bronchial stump measuring just under 10 mm. Next to this, individual, swollen lymph nodes with. anthracotic pigment but no suspicion of a tumor. In S 6 there is grayish-white tumor infiltration, well-. demarcated around the edge, measuring a good 40 mm, extending up to the outer pleura, with central, post-. necrotic-pseudocystic resorption featuring small lesions, and grayish-yellow, fragile, infiltrated, inflammatory. pulmonary tissue. In B6, no discernible tumor infiltration or destruction in the central branches examined. Immediately next to the tumor there is an inflammatory, adherent section of lung (from the middle pulmonary. lobe?), closed in by the base clip, measuring 15 mm, and without any discernible tumor infiltration. Other than. the tumorous and pneumonic infiltration on laminated sections, no further focal findings. 3. L 12: bipartite, pale lymph node tissue with anthracotic pigment, measuring. just under 10 mm together. 4. (a-b) L 11: segmented lymph adipose tissue with anthracotic pigment,. measuring 25 mm together, also displaying blood coagulation in between (complete embedment). 5. (a-b) L 9: bipartite lymph adipose tissue, measuring just under 20 mm. together. Nodes with anthracotic pigment and unremarkably imposing (complete embedment). 6. L7: bipartite lymph adipose tissue, measuring 10 mm together. 7. L 4: node with anthracotic pigment and adipose tissue, measuring 10 mm. 8. L 3: adipose tissue measuring 10 mm, with an unremarkable node measuring. 5 mm and with anthracotic pigment. Microscopic findings: 1. (HE) In the instantaneous section and the subsequent paraffin embedment,. pleura biopsy with knotty sclerohyalinosis with slit-shaped dehiscences between the thickened, collagen fiber. bundles. Base lymphoid infiltration and slight subpleural adipose connective tissue. 2. (HE, f: PAS, e to h: EvG) The central bronchial amputation border has a. bronchial wall with a regular structure, as does the peribronchial soft tissue. Next to this and further towards the. central and hilar section there are lymph nodes with anthracotic pigment build-up and moderate histiocytosis as. well as slightly lymphatic hyperplasia and small scarred areas. The tumor described comprises mesh-like. infiltrative, growing structures of a pluriform, partly keratinizing, partly severe pleomorphic cell and squamous. cell carcinoma with a clearly misaligned nucleoplasmic ratio, coarsening of the chromatin and prominent. nucleoli and frequent mitosis. Extensive necrosis in the center of the tumor, with pseudocystic transformation,. with concomitant stromadesmoplasia and lymphoid and lymphofollicular infiltrates in the tumor periphery. Extension to the perifocal, reactive, fibrosed pleura with fibrinous exudate which is no longer fresh; the base. membrane of the pleura, with fragmented, elastic membrane here, is, however, not infiltrated. Hemangioinvasion in the tumor center with a formation of obliterative tumor thrombi. Next to the tumor there. are several confluent alveolar cavities with a build-up of granulocytes and foam cell macrophages, fibrinous. exudate and finally confluent, sprouting mesenchyme buds as well as expanded bronchia with mucus permeated. by a large quantity of leucocytes. 3. (HE) Tumor-free lymph node tissue with lymphofollicular hyperplasia, with. activated germinal centers, sinus histiocytosis and marked anthracosis. 4. Similar to 3. 5. Similar to 3. 6. Similar to 3. 7. Similar to 3. 8. Similar to 3. Diagnosis: Resected left inferior lobe 1. to 8. with a centrally postnecrotically-pseudocystically transformed, poorly. differentiated and focal, keratinizing, maturing squamous cell carcinoma, measuring a maximum of 40 mm, and. located in the periphery of S 6. It extends to the still tumor-free, reactive, thickened pleura. The lobe also. displays hemoangioinvasion, and, in the peritumorous section, partly purulent, partly xanthomatous retention. pneumonia, and a tumor-free bronchial resection margin, as well as adjacent and hilar tumor-free lymph nodes. with anthracotic pigment. In samples 3 to 8 there are further tumor-free lymph nodes with anthracotic pigment. and parietal pleura with a small build-up of hyaline plaque. Tumor classification: M-8071/3, G3, pT2, pV 1, pN 0, pMX, stage IB. R 0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis. A: Sentinel lymph node, right axillary #1, removal. - No evidence of metastatic carcinoma in one lymph node (0/1). - See comment. B: Breast, right, total mastectomy. Tumor type: Infiltrating ductal carcinoma. Nottingham combined histologic grade 3. Tubule formation score: : 3. Nuclear Pleomorphism Score: 2. Mitotic count score: 3. Focality of tumor: unifocal. Tumor size (greatest dimension) : 35 mm. Lymphovascular invasion: not identified. In Situ Component: Minor component of ductal carcinoma in situ,. cribriform and solid types, nuclear grade 2 with necrosis, 2mm. in linear extent. Extensive intraductal component absent. Nipple/skin involvement: not identified. Margin status: Invasive component: negative, widely clear; 1.5 cm to closest. posterior. margin. In Situ component : negative; widely clear of all margins. Axillary lymph nodes: Total number with metastasis: 0. Total number examined: 14 ( see parts A & C). Microcalcifications not identified. Other findings: gynecomastia, biopsy site changes. See report of prior biopsy (. ') for results of ER, PR and. HER2 immunohistochemical studies. AJCC PATHOLOGIC TNM STAGE: pT2 pNO. Note: This pathologic stage assessment is based on information. available at the. time of this report, and is subject to change pending clinical. review and. additional information. C: Lymph nodes, right axillary, removal. - No evidence of metastatic carcinoma in 13 lymph nodes (0/13). - See comment. Comment: The axillary lymph nodes reveal lymphoid paracortical expansion,. which is. favored to be reactive in nature by H & E stains. Scattered. pigmented. histocytes are present suggestive of dermatopathic. lymphadenitis. Additional. immunohistochemical stains are pending to further evaluate this. process, results. of which will follow in an addendum report. Intraoperative Consult Diagnosis: Frozen section consultation was requested at. on. by in OR. FSA1,A2: Lymph node, right axillary SLN #1, biopsy. - No tumor seen. Drs. at. Frozen Section Pathologist: MD. Clinical History: with right poorly differentiated invasive. ductal carcinoma, Grade 3. Gross Description: Received are three appropriately labeled containers. Container A is additionally labeled ""right axillary SLN #1, hot. + blue. "" The. specimen is a 6 X 4.5 x 1.5 cm fatty soft tissue fragment. Examination of the. fat reveals a 2.0 X 2.0 x 1.0 cm blue lymph node candidate. This. candidate is. serially sectioned and submitted entirely in blocks FSA1 and. FSA2. Container B: Specimen fixation: formalin. Time in fixative: 28.5 hours. Type of mastectomy: simple mastectomy. Weight of specimen: 950 grams. Size of specimen: 26.0 cm medial to lateral, 26.7 cm superior to. inferior,. 4.0 cm anterior to posterior. Orientation of specimen: Sutures: Short=superior, long=lateral. Inking: anterior=blue, posterior=black, lateral=yellow. Skin ellipse dimensions: 18.6 x 9.3 cm. Nipple/areola Nipple, 1.0 cm; areola, 3.1 cm. Axillary tail: submitted separately. Biopsy site: present; Location is central breast/lower outer. quadrant;. Size: 0.8 X 0.5 X 0.5 cm. Appearance: Biopsy site (clip identified) is in the center of a. white/tan, firm area. Hemorrhage and fat necrosis. are noted in this area. Additional residual tumor is present. Discrete Mass (es) : present. Number of discrete masses: one. Size of mass (es)/biopsy site: 2.5 x 2.0 x 3.5 cm. Location of mass (es) : subareola/lowe outer quadrant. Distance of mass/biopsy site from surgical margin: The mass. measures 1.9 cm to. posterior margin, 8.5 cm to inferior margin, 10.5. cm to superior margin, 2.8 cm to anterior margin and is widely. clear. of medial/lateral margins. Gross involvement of skin or fascia/muscle by tumor: absent. Descript. remaining breast: consistent with yellow/tan. fibroad. issue. with increased fibrous areas noted in the subareolar. area; no other masses are identified. Other remarkable features: none. Tissue submi+ ed for special investigations: yes; Tumor to. Tissue Pr ment. Block Summary: (Inking: blue=anterior, black=posterior, yellow=lateral. B1 - nipple. B2 - areola. B3 - biopsy site. B4 - medial aspect of mass. B5-B8 - - central portion of mass. B9 - lateral aspect of mass. B10 - mass to posterior margin. B11 - representative dense fibrous tissue posterior to nipple. and anterior to mass. B12 - closest skin margin (inferior areola). B13 - upper inner quadrant. B14 - lower inner quadrant. B15 - lower outer quadrant. B16 - upper outer quadrant. B17 - mass to normal breast, superior. B18 - mass to normal breast, inferior. Container C is additionally labeled ""right axillary contents. "". The specimen. consists of two fragments of yellow/tan fibroadipose tissue that. measures 9.5 X. 6.5 x 3.0 cm in aggregate. Within the fibroadipose tissue,. fifteen lymph node. candidates are identified. These range in size from 0.4 up to. 1.5 cm in greatest. dimension. The largest lymph node candidate measures 2.3 X 1.5 x. 1.0 cm. Block summary: C1 - six lymph node candidates. C2 - five lymph node candidates (bisected node inked black). C3 - three lymph node candidates (bisected nodes inked black,. blue and. yellow). C4 - one lymph node candidate, sectioned. C5 - one lymph node candidate, sectioned. C6 - one lymph node candidate, sectioned. C7,C8 - largest lymph node candidate, sectioned. Procedures/Addenda: Addendum. Addendum. Immunohistochemical studies were performed on representative. blocks of axillary. lymph nodes (C6 and C7) and the results are as follows: CD20: Highlights many small lymphocytes in a generally nodular. distribution. CD3: Highlights majority of lymphocytes with focal expansion of. the paracortex. Interpretation: The immunohistochemical studies highlight an. essentially normal. pattern of distribution of B cells and T cells in the lymph. nodes, with primary. follicles composed predominantly of small B lymphocytes and. a. paracortex. populated by predominantly small T lymphocytes. Morphologic and. immunohistochemical findings are compatible with reactive lymph. nodes and do not. support a diagnosis of a lymphoproliferative disorder. The mild. paracortical. expansion can be seen as a feature of dermatopathic. lymphadenopathy.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN(S): A. 4R RIGHT DISTAL PARATRACHEAL. B. 4L LEFT DISTAL PARATRACHEAL. C. LEVEL 7 SUBCARINAL. D. 2R RIGHT PROXIMAL PARATRACHEAL. E. RIGHT MIDDLE AND LOWER LOBE BI LOBECTOMY. F. LEVEL 7 LYMPH NODE PACKET. G. LEVEL 11R RIGHT UPPER LOBE. H. MEDIAL MARGIN. I. LATERAL MARGIN. J. 9R LYMPH NODE. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Right lower lobe lung mass. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, TPD: Lymph nodes, 4R, 4L, level 7, 2R, excision: No malignancy identified. FSA-FSD: Lymph nodes, 4R, 4L, level 7, 2R, excision: No malignancy identified. FSE. Right middle lobe: Bronchial margin is negative for carcinoma but carcinoma is close to. the bronchial margin, less than 3 mm from the bronchial margin and protrudes into the bronchial. lumen. GROSS DESCRIPTION: A. 4R RIGHT DISTAL PARATRACHEAL. Received fresh and labeled with the patient name. signated ""A - 4R right. distal paratracheal"" are 3 pieces of soft tan tissue ranging from 0.3 x 0.1 x 0.1 cm to 0.5 x 0.5 x. 0.2 cm. The entire specimen is submitted for frozen section in cassette FSA. B. 4L LEFT DISTAL PARATRACHEAL. Received fresh and labeled with the patient name. designated ""B - 4L left distal. paratracheal"" are 3 fragments of pink-tan soft tissue ranging from 0.4 x 0.3 X 0.1 cm to 1.0 x 0.4. x 0.4 cm. The entire specimen is submitted for frozen section in cassette FSB. C. LEVEL 7 SUBCARINAL. Received fresh and labeled with the patient name. designated ""C - level 7. subcarinal"" are 5 fragments of pink-tan soft tissue ranging from 0.3 X 0.2 x 0.1 cm to 0.4 x 0.3 x. 0.1 cm. The entire specimen is submitted for frozen section in cassette FSC. D. 2R RIGHT PROXIMAL PARATRACHEAL. Received fresh and labeled with the patient name. designated ""D - 2R right. proximal paratracheal"" are 3 fragments of pink-tan soft tissue ranging from 0.5 x 0.3 x 0.1 cm to. 0.6 x 0.4 x 0.1 cm. The entire specimen is submitted for frozen section in cassette FSD. E. RIGHT MIDDLE AND LOWER LOBE BI LOBECTOMY. Received fresh and labeled right middle and lower lobe, bi-lobectomy is a 391 gm bi-lobectomy. specimen. The middle lobe is 14 x 9 x 3 cm and the lower lobe is 15 x 9 x 5.5 cm. The pleural. surface is smooth and the lower lobe is inked black. Shaved section is taken of the bronchial. margin and submitted for frozen section. In the central area of the lower lobe is a 4.5 x 4.0 X 3.0. cm white-tan necrotic mass. It surrounds the central bronchi and infiltrates the main bronchial. tree. The mass extends to the pleura. The remainder of the parenchyma has a red-tan and. speckled anthracotic appearance. No additional masses or lesions are observed. A section of. mass is submitted for tissue procurement. Representative sections are submitted as follows: FSE1: frozen section of bronchial margin. E2-E9: sections of mass in association with bronchi, lymph nodes, pleura and. parenchyma. E11: normal appearing parenchyma from middle lobe. E10 and E12: possible lymph nodes. F. LEVEL 7 LYMPH NODE PACKET. Received in formalin and labeled. 'level 7 lymph node packet"" is a piece of. pink-brown soft tissue measuring 2.9 x 1.5 x 0.5 cm. Specimen is bisected and the cut surface. has a variegated pink and black appearance. Specimen is submitted in toto in block F1-F2. G. LEVEL 11R RIGHT UPPER LOBE. Received in formalin and labeledt. flevel 11R right upper lobe"" are pieces of. pink and black soft tissue in aggregate measuring 1.8 x 1.4 x 0.3 cm. Submitted in toto in block. G1. H. MEDIAL MARGIN. Received in formalin and labeled. medial margin"" is an unoriented piece of. pink-tan soft tissue 1.0 x 0.5 x 0.3 cm. Submitted in block H1. I. LATERAL MARGIN. Received in formalin and labeled. ateral margin"" is a piece of pink-tan soft. tissue, 0.3 x 0.3 x 0.2 cm. Submitted in block I1. J. 9R LYMPH NODE. Received in formalin and labeled. ""9R lymph node"" is a piece of mottled black-. tan soft tissue measuring 3.3 x 0,4 x 0.3 cm. Submitted in toto in block J1. DIAGNOSIS: A. LYMPH NODE, 4R RIGHT DISTAL PARATRACHEAL, EXCISION: ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). B. LYMPH NODE, 4L LEFT DISTAL PARATRACHEAL, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). C. LYMPH NODE, LEVEL 7 SUBCARINAL, EXCISION: ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). D. LYMPH NODE, 2R RIGHT PROXIMAL PARATRACHEAL, EXCISION: ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). E. LUNG, RIGHT MIDDLE AND LOWER LOBE, BI-LOBECTOMY: - SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED, WITH. EXTENSIVE NECROSIS. - TUMOR MEASURES 4.5 x 4 x 3 CM AND IS PRESENT IN LOWER LOBE. - TUMOR IS PRESENT IN BRONCHUS (SEENOTE). - PLEURAL MARGINS, NEGATIVE FOR CARCINOMA. - NINE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/9). F. LYMPH NODE PACKET, LEVEL 7, DISSECTION: - FIVE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/5). G. LYMPH NODE, LEVEL 11R RIGHT UPPER LOBE, EXCISION: ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). H. LUNG, MEDIAL MARGIN, EXCISION: - BRONCHIAL TISSUE WITH SQUAMOUS METAPLASIA AND DETACHED. FRAGMENT OF DYSPLASTIC SQUAMOUS EPITHELIUM, NEGATIVE FOR. CARCINOMA (SEE NOTE). I. LUNG, LATERAL MARGIN, EXCISION: - BRONCHIAL TISSUE, NEGATIVE FOR CARCINOMA. J. LYMPH NODE, 9R, EXCISION: ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). NOTE: Tumor is present in the bronchial margin of the bi-lobectomy specimen on permanent. sections. No tumor is seen in specimens H and I that were submitted as medial and lateral. margins. The detached fragment of squamous epithelium seen in specimen H shows at least. moderate dysplasia. Multiple levels of specimen H were examined and. reviewed. selected slides of specimen H. A CD34 immunostain was performed with appropriate controls. on slide E6 and shows no evidence of lymphovascular invasion. SYNOPTIC REPORT - LUNG. Surgical Procedure: Lobectomy. Laterality: Right. Tumor Site: Lower lobe. Tumor Location: Central. Tumor Size: Greatest diameter: 4.5cm. Additional dimensions: 4cm x 3cm. WHO CLASSIFICATION. Squamous cell carcinoma. Conventional type 8070/3. Histologic Grade: G2: Moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Comment: see specimens E, H, and I. Visceral Pleural Involvement: Absent. Satellite Tumor(s): Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Negative 01 10. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0 / 10. Additional Pathologic Findings: Metaplasia. Type: squamous. Inflammation. Type: chronic. Pathological Staging (pTNM): pT 2. MX.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Curgical Pathology: Final. CLINICAL HISTORY: Large left breast CA with microcalcification diffusely around invasive tumor. Suggests diffuse intraductal carcinoma. GROSS EXAMINATION: A. ""Left breast mass (Af1)' "". Received is a breast biopsy specimen and frozen. section remnant. The breast tissue measures 5.0 x 4.0 x 3.5 cm. The surgeon. states that the margin is not important, thus the specimen is not inked. Sectioning of the specimen reveals a red-brown nodule measuring 3.0 x 2.5 x. 1.5 cm. Tissue from the nodule has been sent for ER/PR study. A remnant of. frozen section of the red-brown tissue measuring 1.7 x 1.3 x 0.3 cm is. submitted in toto in Block A1, with representative sections of the nodule. submitted in Blocks A2-A4. B. ""Left breast"", fresh. An 18 x 25 x 6 cm breast mastectomy specimen with a. 23 x 14 cm skin ellipse and a 12 x 9.5 cm axillary tail. The skin ellipse is notable for a grossly unremarkable nipple and areola and a. 5.5 cm recently dehised biopsy scar located in the lower medial portion of the. ellipse. The deep surface of the breast specimen is inked in black. Cut sectioning. through the breast reveals a 5 x 4 x 4 cm hollow biopsy cavity in the lower. medial quadrant which is lined by smooth white tissue in its cavity. The. cavity comes to within 0.5 cm of the inked distal surface, 0.8 cm from the. inked posterior surface, and 12 cm from the inked proximal surface. There is. a focal 1.5 x 1.5 x 1 cm firm, finely granular, grey-pink lesion located. adjacent to the lateral tip of the biopsy cavity. This lesion is, at its. closest points, 1.5 cm from the distal inked surface, 4 cm from the posterior. inked surface, 4 cm from the posterior inked surface, 11 cm from the proximal. inked surface, and 2 cm beneath the anterior skin surface. The remainder of. breast specimen is comprised of yellow-white fibrofatty tissue with an. especially prominent white fibrous focus in the upper midportion of breast. parenchyma. BLOCK SUMMARY: B1 representative section of nipple. B2-B5 tissue around biopsy cavity site which includes firm lesion described. above. B6-B7 representative sections from focal white fibrous area in upper. mid-portion of breast. B8-B9 representative sections of upper medial portion of breast. B10-B11 representative sections of lower medial portion of breast. B12-B13 representative sections of upper lateral portion of breast. B14-B15 representative sections of lower lateral portion of breast. B16 three lymph node candidates from intermediate portion of axillary tail. B17 four lymph node candidates from intermediate portion of axillary tail. B18 five lymph node candidates from most lateral portion of axillary tail. B19 four lymph node candidates from most lateral portion of axillary tail. B20 three lymph node candidates from most lateral portion of axillary tail. Dr. INTRA OPERATIVE CONSULTATION: Af1: ""Left breast mass"": Infiltrating carcinoma present. DIAGNOSIS: A. ""LEFT BREAST MASS"": 1 of 2. BREAST WITH INFILTRATING DUCTAL CARCINOMA (3 X 2.5 X 1.5 CM), NUCLEAR. GRADE WELL-DIFFERENTIATED, N.S.A.B.P. HISTOLOGY GRADE 1 OF 3, WITH. CANCERIZATION OF LOBULES AND CRIBRIFORM CARCINOMA IN SITU. B. ""LEFT BREAST"": BREAST WITH RESIDUAL INFILTRATING onconal DUCTAL CARCINOMA (1.5 x 1.5 x 1. CM),. WITH NUCLEAR GRADE WELL-DIFFERENTIATEB AND N.S.A.B.P. HISTOLOGIC GRADE 1. OF 3. THERE IS A COMPONENT OF COLLOID CARCINOMA REPRESENTING LESS THAN. 25% OF THE TOTAL TUMOR VOLUME. THREE OF FOURTEEN (3/14) AXILLARY LYMPH NODES CONTAINING METASTATIC. CARCINOMA. LARGEST METASTATIC FOCUS MEASURES 1.8 x 1.1 CM; NO EXTRANODAL. EXTENSION IDENTIFIED. ALL SURGICAL MARGINS FREE OF TUMOR. SKIN, NIPPLE AND LACTIFEROUS DUCT: NO TUMOR PRESENT. 2 of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Date or Procedure: Clinical Diagnosis & History: History of SCC of tongue. New finding bilateral thyroid nodules FNA positive papillary carcinoma left thyroid nodule. Specimens Submitted: 1: Thyroid; total thyroidectomy. DIAGNOSIS: 1. Thyroid; total thyroidectomy: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not Identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 1.2 cm. Tumor Encapsulation: Partially surrounded. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Two foci of papillary microcarcinoma are identified in the isthmus and right lobe, measuring 0.6 cm and 0.3 cm in. greatest dimension. The largest microcarcinoma has tall cell features. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis. Parathyroid Glands: Not identified. Lymph Nodes: Four benign lymph nodes (0/4). LATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. 1. Gross Description: 1). The specimen is received fresh, labeled ""Total thyroid in"" and consists of a thyroid weighing 28 grams. The right lobe. measures 6.2 x 3.1 x 2.2 cm, the left lobe measures 4.3 x 2.0 x 1.2 cm and the isthmus measures 3.2 x 1.2 x 0.5 cm. A pyramidal. lobe is present. It measures 3 x 0.8 x 0.5 cm. there are two lymph nodes identified at the superior aspect of the specimen, each. measuring 0.6 x 0.5 cm in greatest dimensions, which are entirely submitted. The external surface is covered by a thin fibrous. capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals a 1.2 x 0.7 x 0.5. cm. ill. defined firm white-tan nodule in the left lobe, which abuts the capsular surface but does not grossly involve it. A sample of. this nodule is given to. Sections through the remaining tissue reveal a multi-nodular appearance. The nodules range from. soft, brown-tan, and well circumscribed to firm, white-tan, and ill-defined. The largest nodule is located in the right lobe and. measures 2.5 x 1.8 x 1.7 cm. The remaining thyroid parenchyma is red tan and meaty. The specimen is completely sectioned at 3. mm intervals and submitted. Summary of sections: LN-lymph nodes. RL right lobe. LL left lobe. I - isthmus and pyramidal lobe. Summary of Sections: Part 1: Thyroid; total thyroidectomy. Block. Sect. Site. PCs. 5. i. 5. 10. Il. 10. 1. In. 1. 15. 15.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. 1. SEX: M. ADM DATE: OPER DATE: PROCEDURE: APMI. ADDITIONAL REPORT FOLLOWING ADDITIONAL SECTIONS: Please see diagnosis below. PROCEDURE: APDX. 1. Left adrenal, adrenalectomy: Adrenocortical carcinoma, low-grade, with. capsular invasion. No vascular invasion identified. I,. signing staff pathologist, have personally. examined and interpreted the slides from this case. OPER DATE: PROCEDURE: SPHS. Left adrenalectomy. PROCEDURE: SPGD. 1. ""Left adrenal mass"" A 8 x 7 x 4 cm specimen of adrenal gland with large tan. mass and adjacent adipose. Specimen received previously incised. Photographed. and inked blue. Trimmed weight is 60 grams. Trimmed adrenal is 6.5 long and 2. cm wide x 0.1 cm thick with a 4.5 x 5 x 3.5 cm homogenous smooth round tan. tumor protruding from it's midsection sections of the gland and tumor reveal. the tumor to be tan and homogenous throughout. Appearing to arise in the. cortex of he adrenal gland. The other cortex and medulla are unremarkable. A 2. cm area near the edge of the tumor is slightly more orange than the rest of. the tumor. 1A. Representative section of adrenal gland adjacent to tumor. 1B. Representative section of adrenal gland with tumor. 1C. Representative section of tumor. 10. Representative section of tumor. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 2. SEX: M. BIKTHUAIE: OPER DATE: 1E. Representative section of orange portion of tumor. PROCEDURE: SPDX. 1. Left adrenal, adrenalectomy: Adrenocortical carcinoma, low-grade, with. capsular invasion. Pending additional segments to identify vascular invasion. signing staff pathologist, have personally. examired and interpreted the stides from this case. END OF PREVIOUS DIAGNOSIS INQUIRY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Laterality:Left-UOC. Path Report: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3.5 X 3.5 x 3.5 cm. Grossly evident lesion: Yes. Histologic type: Lobular carcinoma. Histologic grade: Not specified. Tumor extent: Not specified. Lymph nodes: 4/8 positive for metastasis (Axillary 4/8). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: ER,PR-8 points, HER2NEU-O.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Gender: F. Clinical. diagnosis (suspicion) Cancer of the right breast. Date of admission: Material: 1) Material: right breast and axillary tissue. Method of collection: Mastectomy and axillary lymph nodes. Histopathological diagnosis: Invasive mucinous carcinoma of the right breast. Cancer metastases to the lymph node (1/13). (NHG2, pT3, pN1a). (8480/3 T-04915). codes according to ICD-O-3 or SNOMED. Macroscopic description: Right breast, sized 21 x 16 X 6 cm, removed along with armpit tissues sized 10 x 9 x 3 cm and a skin flap of 21 x 12 cm. Weight 1092 g. Tumour sized 5.5 x 4 x 4 cm found on the boundary of upper quadrants, placed 1 cm from the upper edge, 0.1 cm from. the base and 1 cm from the skin. Status after core needle biopsy (test No. Lymph nodes of 5.2 cm, fatty. Microscopic description: Invasive mucinous carcinoma - NHG2 (2 + 2 + 3/20 mitoses/ 10 HPF - visual area 0.55 mm). The nipple without pathological lesions. Glandular tissue showing parenchyma atrophy. Invasive lesions removed 0.1 cm from the base. Axillary lymph nodes: Cancer metastases to the lymph node (1/13). (metastasis of 0.5 transgressing the nodular capsule).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. 2. REPORT DATE. PATIENT NBR: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: PROCEDURE: rear-old male with long history of reflux. Recent onset dysphagia/weight. loss. Evaluation indicates adenocarcinoma. No chemo or x-ray therapy. PROCEDURE: 1. ""Esophagus. "" A 13.0 x 7.0 x 2.5 cm specimen comprised of 7 cm of distal. esophagus and 6 cm of proximal stomach. Received opened longitudinally. At the. GE junction there is a somewhat nodular thickening of the mucosa, 1.5 x 1.5. cm. Maximum depth of lesion 1.3 cm. Remainder of the GE junction shows slight. irregularity and possible ulceration. Distal and proximal staple lines. removed. Deep inked black. 1A-B. Distal stomach resection margin. 1C. Proximal uninvolved esophagus, proximal end inked black. 1D-G. Sections through major portion of Lesion. 1H-J. Lymph node dissection. 2. ""Cervical esophageal margin."" A 3.2 x 2.0 x 2.0 cm length of esophagus. closed at one end with staple line. 2A. Stapled end. 28. Non-stapled end. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. If adenocarcinoma, is it arising in: GE junction. Depth of invasion: Omental surface. Number of positive lymph nodes, the total number sampled is irrelevant: 0. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: Yes. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 3. PATIENT NBR: SEX: M. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: TNM classification: T2NOMx. PROCEDURE: 1. Esophagus, resection: Moderately to poorly differentiated adenocarcinoma. arising from the gastroesophageal junction (1.5 cm). Tumor penetrates. muscularis propria and reaches the omentum surface. Distal gastric margin. negative for neoplasm. Four lymph nodes negative for neoplasm. See template. 2. Cervical esophageal margin, resection: Negative for neoplasm. 1,. he signing staff pathologist, have personally examined and. interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Female. DIAGNOSIS: c. Liver, left lobe and segment VI, resection: Combined hepatocellular and. cholangiocarcinoma, grade 4 (of 4) is identified forming a mass (5.8 x 5.3 x 4.0 cm). Microvascular invasion is absent (no vein invasion identified microscopically). A. single regional lymph node is negative for tumor. All surgical resection margins. are negative for tumor (minimum tumor free margin, 0.1 cm). [AJCC pT1NWOMX]. The. background non-neoplastic hepatic parenchyma. is unremarkable. A. Lymph node, paracaval, biopsy: One paracaval lymph node is negative for tumor. B. Lymph node, hepatic artery, biopsy: one hepatic artery lymph node is negative. for tumor.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: Lung of 15x13x14 cm in size. The tumor is located near the bronchus up to 4 ?m in. size, grey-whitish coloured, dense. Microscopic Description: Squamous carcinoma of the lung, G1, keratinizing type. Two subcarinal lymph. nodes demonstrated anthracosis. Diagnosis Details: Tumor Features: Indeterminate, Tumor Extent: Localized, NOS, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 0 x0x4cm. Histologic type: Squamous cell carcinoma. Histologic grade: Well differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/2 positive for metastasis (Subcarinal lymph nodes 0/2). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right-lower.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
HX SURGICAL PATHOLOGY REPORT. Date - Date of Service: Contributor System: MICROSCOPIC DESCRIPTION: A-C: See final microscopic-diagnosis. D: Sections of the bladder show invasive transitional cell carcinoma, grade 4/4 penetrating the muscularis propria. extending into the perivesical fat to involve the soft tissue around the posterior prostate and the seminal vesicles. The tumor is composed of sheets of highly malignant cells with high nuclear cytoplasmic ratio. Vascular space. invasion is identified. Multiple soft tissue deposits are also identified. No urothelial carcinoma in situ (flat lesion). identified. The prostate parenchyma is free of urothelial carcinoma. Sections show focal prostatic adenocarcinoma, Gleason' S score 6 (3+3) identified in the left apical region,. confined to the gland. The prostatic urethra and stroma are free of urothelial dysplasia and carcinoma. E-U: See final microscopic-diagnosis. Signature Line. GROSS DESCRIPTION: A: The specimen is received fresh from the O.R. and labeled ""Right ureter distal."" It consists of a 1 x 1 x 0.5 cm. section of ureter. Entirely submitted for frozen section. B: The specimen is received fresh from the O.R. and labeled ""Left distal ureter."" It consists of a 1 X 1 x 0.5 cm. segment of ureter. Entirely submitted in one cassette for frozen section. C: The specimen is received fresh from the O.R. and labeled ""Paracaval LN proximal limits of dissection."" It. consists of a 2.5 x 2 x 0,5 cm portion of greasy yellow tissue containing a few tiny tan lymph nodes. The lymph. nodes are submitted for frozen section section in one cassette. HX SURGICAL PATHOLOGY REPORT. D: The specimen is received fresh from the O.R. and labeled ""Bladder & Prostate."" It consists of a 26 x 13.5 x 6. cm bladder and prostatectomy. The peritoneum measures 6 x 5 cm and shows tumor studding over a 2.2 cm. area. The tumor studs are each less than 0.2 cm in greatest dimension and bear a reddish discoloration. The. bladder measures 7 x 7 x 4 cm. The prostate measures 6 X 5 x 4 cm. The right distal ureter measures 3 cm in. length and 0.5 cm in diameter distally with a circumference of 4 cm proximally. The left distal ureter measures 4. cm in length and 1.9 cm in circumference. The ureteral mucosa is unremarkable. An ulcerated mass measuring. 3.5 cm in greatest dimension is located in the posterior bladder wall. The mass is firm and surmounted by. necrotic debris. The borders of the ulcerated mass are heaped and erythematous. Serial sectioning reveals a. maximal depth of invasion 0.9 cm. The mass is firm and white with geographic areas of necrosis and grossly. penetrates the fat. The uninvolved bladder wall is somewhat pliable but appears to be hypertrophy. The. non-neoplastic mucosa is unremarkable and there are no polypoid projections. Serial sectioning reveals diffuse. nodularity of the lateral lobe of the prostate. The prostatic urethra measures 3.8 cm in length and 4.8 cm in. circumference. The verumontanum measures 0.8 X 0.5 x 0.3 cm. The mucosa of the prostatic urethra is. unremarkable. Representative sections are submitted in 20 cassettes. E: The specimen is received in formalin and labeled ""Para aortic lymph nodes."" It consists of 5 x 3 x 1.5 cm of. greasy yellow tissue entirely submitted in two cassettes. F: The specimen is received in formalin and labeled ""Para caval lymph nodes."" It consists of 5 x 2.5 x 1 cm of. greasy yellow tissue fragment. Entirely submitted in one cassette. G: The specimen is received in formalin and labeled ""Right common iliac lymph nodes."". It. consists. of. 4. x. 2. x. 0.5. cm of greasy yellow tissue fragment. Entirely submitted in one cassette. H: The specimen is received in formalin and labeled ""Left common iliac lymph nodes."" it consists of 7.5 X 4.5 x 2. cm of greasy yellow tissue fragment. Entirely submitted in three cassettes. I: The specimen is received in formalin and labeled ""Right LN of cloquet."" It consists of 1.5 x 0.8 x 0.4 cm. of. greasy yellow tissue fragment. Entirely submitted in one cassette. J: The specimen is received in formalin and labeled ""Right external iliac lymph nodes."" It consists of 6.5 x 5.5 X 2. cm of greasy yellow tissue. Entirely submitted in four cassettes. K: The specimen is received in formalin and labeled ""Right obturator / hypogastric lymph nodes."" It consists of 8. X 5 x 3 cm of greasy yellow tissue fragment. Entirely submitted in five cassettes,. L: The specimen is received in formalin and labeled ""Left external iliac lymph nodes."" It consists of 7 x 5 x 2 cm. of greasy yellow tissue. Two palpable lymph nodes are identified. Entirely submitted in five cassettes. M: The specimen is received in formalin and labeled ""Left LN of cloquet."" It consists of 2 x 2 x 0.7 cm of adipose. HX SURGICAL PATHOLOGY REPORT. tissue fragment. Representative section in one cassette. N: The specimen is received in formalin and labeled ""Left hypogastric / obturator lymph nodes."" It consists of a 9. x 7 x 2.5 cm of greasy yellow tissue fragment. Representative sections are submitted in five cassettes. O: The specimen is received in formalin and labeled ""Right peri rectal soft tissue."" It consists of 3.5 x 1.5 x 0.3. cm of greasy yellow tissue. Entirely submitted in one cassette. P: The specimen is received in formalin and labeled ""Left peri rectal soft tissue."" It consists of 5.5 x 2.5 x 1 cm of. greasy yellow tissue fragment. No lymphadenopathy. Representative sections submitted in one cassette. Q: The specimen is received in formalin and labeled ""Right pre sciatic lymph nodes."" It consists of 3.2 x 2.7 x 0.5. cm of greasy yellow tissue and a 3 x 1 x 0.5 cm blood clot. The greasy yellow tissue is submitted in its entirety in. one cassette, and blood clot is submitted in cassette Q2. R: The specimen is received in formalin and labeled ""Pre sacral lymph node"". It consists of greasy yellow tissue. measuring 5.0 x 5.0 x 1.0 cm. The specimen is entirety submitted in four cassettes. S: The specimen is received in formalin and labeled ""Left presciatic LN."" It consists of 5 x 2.5 x 0.7 cm of greasy. yellow tissue. Entirely submitted in two cassettes. T: The specimen is received in formalin and labeled ""Left proximal ureter."" It consists of a 2.5 x 1 x 0.7 cm. greasy yellow tissue fragment. Entirely submitted in one cassette. U: The specimen is received in formalin and labeled ""Right proximal ureter."" It consists of a 1.2 x 1 x 0.7 cm. greasy yellow tissue fragment. Serially sectioned and entirely submitted in one cassette. SECTIONS: AFS: frozen section, right distal ureter. BFS: frozen section, left distal ureter. CFS: frozen section, paracaval lymph node proximal limits of dissection. D1,2: maximum depth of invasion. D3: peritoneal studding. D4-6: non-neoplastic mucosa. D7: right ureteral margin. D8: left ureteral margin. D9: right prostatic apex. D10: left prostatic apex. D11: right mid prostate. D12: left mid prostate. D13: right proximal prostate. HX SURGICAL PATHOLOGY REPORT. D14: left proximal prostate. D15-19: perivesical fat pad. D20: true peritoneal margin. E1,2: para-aortic lymph nodes. F: paracaval lymph nodes. G: right common iliac lymph nodes. H1-3: left common iliac lymph nodes. right lymph node of Cloquet. J1: single lymph node, bisected. J2: single lymph node, bisected. J3,4: remaining tissue. K1: lymph node. K2-5: remaining tissue. L1: first lymph node. L2: second lymph node. L3-5: remaining tissue. M: left lymph node of Cloquet. N1,2: lymph nodes. N3: possible lymph node. N4: lymph nodes. N5: sample of remaining tissue. O: right perirectal soft tissue. P: left perirectal soft tissue. Q1: right presciatic lymph nodes. Q2: blood clot. R1-4: presacral lymph node. S1: lymph node, bisected. S2: remaining tissue. T: left proximal ureter. U: right proximal ureter. INTRAOPERATIVE DIAGNOSIS: FROZEN SECTION DIAGNOSIS: AFS: Right ureter distal: - no high grade urothelial atypia or carcinoma identified. BFS: Left distal ureter: - no high grade urothelial atypia or carcinoma identified. HX SURGICAL PATHOLOGY REPORT. CFS: Paracaval lymph node proximal limits of dissection: - negative. DIAGNOSIS COMMENT: Section of the tumor (D2) is submitted for p53 analysis and the results will be issued in an addendum to follow. FINAL DIAGNOSIS: RIGHT DISTAL URETER (A): FROZEN SECTION DIAGNOSIS: NO HIGH GRADE UROTHELIAL ATYPIA OR CARCINOMA IDENTIFIED. FINAL DIAGNOSIS: - BENIGN URETER. - NO HIGH GRADE UROTHELIAL ATYPIA OR CARCINOMA IDENTIFIED. LEFT DISTAL URETER (B): FROZEN SECTION DIAGNOSIS: NO HIGH GRADE UROTHELIAL ATYPIA OR CARCINOMA IDENTIFIED. FINAL DIAGNOSIS: - BENIGN URETER. - NO HIGH GRADE UROTHELIAL ATYPIA OR CARCINOMA IDENTIFIED. PARA-AORTIC LYMPH NODES (C): FROZEN SECTION DIAGNOSIS: - NEGATIVE. FINAL DIAGNOSIS: - NO TUMOR IDENTIFIED IN ONE LYMPH NODE (0/1). URINARY BLADDER AND PROSTATE (D): BLADDER: - TRANSITIONAL CELL CARCINOMA, GRADE 4/4, PENETRATING THE MUSCULARIS. PROPRIA AND EXTENDING INTO PERIVESICAL FAT TO INVOLVE THE PERIVESICAL FAT. AND SOFT TISSUE AROUND THE POSTERIOR PROSTATE AND THE SEMINAL VESICLES. TUMOR GROSSLY MEASURES 3.5 CM AND IS LOCATED ON POSTERIOR WALL. - VASCULAR SPACE INVASION IDENTIFIED. - SOFT TISSUE TUMOR DEPOSITS ARE IDENTIFIED. NO UROTHELIAL IN SITU CARCINOMA IDENTIFIED (FLAT LESION). - THE PROSTATE PARENCHYMA IS FREE OF UROTHELIAL CARCINOMA. HX SURGICAL PATHOLOGY REPORT. PROSTATE: - FOCAL PROSTATIC ADENOCARCINOMA, GLEASON' S SCORE 6 (3+3) IDENTIFIED. IN THE LEFT APICAL REGION, CONFINED TO THE GLAND. - NO CAPSULAR INVASION IDENTIFIED. - PROSTATIC URETHRA AND STROMA, FREE OF UROTHELIAL DYSPLASIA OR. CARCINOMA. PARA-AORTIC LYMPH NODES (E): NO EVIDENCE OF MALIGNANCY IN THREE LYMPH NODES (0/3). PARACAVAL LYMPH NODES (F): NO EVIDENCE OF MALIGNANCY IN FIVE LYMPH NODES (0/5). RIGHT COMMON ILIAC LYMPH NODES (G): - NO EVIDENCE OF MALIGNANCY IN FOUR LYMPH NODES (0/4). LEFT COMMON ILIAC LYMPH NODES (H): - NO EVIDENCE OF MALIGNANCY IN TEN LYMPH NODES (0/10). RIGHT LYMPH NODE OF CLOQUET (1): - NO LYMPHOID TISSUE IDENTIFIED. - NO EVIDENCE OF MALIGNANCY. RIGHT EXTERNAL ILIAC LYMPH NODES (J): - NO EVIDENCE OF MALIGNANCY IN THREE LYMPH NODES (0/3). RIGHT OBTURATOR / HYPOGASTRIC LYMPH NODES (K): METASTATIC TRANSITIONAL CELL CARCINOMA IDENTIFIED IN TWO OF 21. LYMPH NODES (2/21). LEFT EXTERNAL ILIAC LYMPH NODES (L): - NO EVIDENCE OF MALIGNANCY IN TEN LYMPH NODES (0/10). LEFT LYMPH NODE OF CLOQUET (M): - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). LEFT HYPOGASTRIC / OBTURATOR LYMPH NODES (N): - TRANSITIONAL CELL CARCINOMA PRESENT IN SOFT TISSUE WITHOUT. ASSOCIATED NODAL TISSUE. - NO EVIDENCE OF MALIGNANCY IN SEVEN LYMPH NODES EXAMINED (0/7). HX SURGICAL PATHOLOGY REPORT. RIGHT PERIRECTAL SOFT TISSUE (O): - NO LYMPHOID TISSUE IDENTIFIED. - NO EVIDENCE OF MALIGNANCY. LEFT PERIRECTAL SOFT TISSUE (P): - NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES (0/2). RIGHT PRESCIATIC LYMPH NODES (Q): METASTATIC TRANSITIONAL CELL CARCINOMA IDENTIFIED IN THREE OF. FIVE LYMPH NODES (3/5). LEFT PRESACRAL LYMPH NODES (R): - NO EVIDENCE OF MALIGNANCY IN SIX LYMPH NODES (0/6). LEFT PRESCIATIC LYMPH NODES (S): - NO EVIDENCE OF MALIGNANCY IN FIVE LYMPH NODES (0/5). LEFT PROXIMAL URETER (T): - BENIGN URETER. - NO HIGH GRADE UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). RIGHT PROXIMAL URETER (U): - BENIGN URETER. - NO HIGH GRADE UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. PERIURETERAL SOFT TISSUE SHOWS A FOCUS OF TRANSITIONAL.CELL CARCINOMA. LYMPH NODE SUMMARY: METASTATIC TRANSITIONAL CELL CARCINOMA IDENTIFIED IN FIVE OUT OF. TOTAL OF 83 LYMPH NODES (5/83). Completed Action List:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. 5. Examination: Histopathological examination. Gender: F. Material: Multiple organ right breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Macroscopic description: Right breast sized 17.2 x 13.2 x 4.4 cm removed without axillary tissues and with a skin flap of 14.4 x 7.2 cm. Weight. 345 g. Tumour sized 1.2 x 1.4 x 0.9 cm found on the boundary of upper quadrants, located 4.3 cm from the upper. boundary, 0.8 cm from the base and 1.6 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG1 (1 + 2 + 1 : 0 mitoses/10 HPF - visual area: 0.55mm). Numerous foci of carcinoma ductale in situ DCIS found within the tumour (micropapillary type with medium nuclear. atypia and comedo necrosis, 70% of the tumour volume). Mamilla sine laesionibus. Glandular tissue showing parenchymal atrophy. Examination result: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the right breast. (NHG1, pTic, pNO (SN)). Examination performed G. Results of immunohistochemical examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 10% of neoplastic cell nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) Rabbit Monoclonal Antibody. Negative reaction in invasive cancerous cells (Score=1+).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
NAL DIAGNOSIS. LEFT LUNG, LOWER LOBE (LOBECTOMY) : MODERATELY WELL. >ENOCARCINOMA OF THE LUNG. THE CARCINOMA MEASURES 3 CM IN GREATEST. MENSIONS HAS FOCAL BRONCHIOLOALVEOLAR FEATURES, AND CLOSELY. 'PROACHES BUT DOES NOT INVOLVE THE PLEURA. SIXTEEN (16) LYMPH NODES. JD ALL MARGINS OF RESECTION ARE NEGATIVE FOR TUMOR. LYMPH NODE (LEVEL 5, EXCISION) : ONE (1) LYMPH NODE NEGATIVE FOR. JMOR. LYMPH NODE (LEVEL 7, EXCISION) : ONE (1) LYMPH NODE NEGATIVE FOR. JMOR. LYMPH NODE (LEVEL 9, EXCISION) : ONE (1) LYMPH NODE NEGATIVE FOR. JMOR.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Date Coll: SPECIMEN. Extended right hemicolectomy. CLINICAL NOTES. PRE-OP DIAGNOSIS: Hepatic flexure carcinoma. GROSS DESCRIPTION. Received fresh labeled ""extended right nemicolectomy"" is a. previously unopened 26 cm. segment of proximal right colon. with attached 8 cm. of distal ileum surfaced by smooth to slightly. scabrous tan pink serosa with a moderate amount of mesocolon,. mesentery, and unremarkable omentum. An unremarkable 3.5 cm. appendix averaging 0.8 cm. in diameter is present. A focus of. serosal retraction including a portion of omentum is noted at the. distal end of the specimen. The overlying surface is inked blue. On opening, there is a circumferential, 4.8 X 3.2 cm. tan white. tumor located 8 cm. from the distal margin. The tumor has a maximal. thickness of 1.5 cm., grossly extending through the muscularis to. within 0.1 cm. of the inked free radial serosal surface. The tumor. appears to extend into the retracted and adherent omentum (see. blocks 2 and 3) A portion of tumor and a portion of normal mucosa. are submitted for tissue procurement as requested. The proximal and. distal margins of the specimen measure 3.7 and 6.6 cm. in. circumference respectively. The ileal and remaining colonic mucosa. is glistening tan pink with regular folds and the walls average 0.5. cm. in thickness. No additional mass lesion or abnormality is. identified. A few soft to slightly rubbery pale tan white to tan. pink tissues in keeping with lymph nodes measuring up to 1.0 cm. in. greatest dimension are recovered from the attached mesocolon and. mesentery. Representative sections are submitted in 12 blocks as. labeled. BLOCK SUMMARY: 1 - Proximal and distal margins; 2 and 3 - tumor. extending into associated omentum; 4 - tumor to closest inked free. radial serosal surface; 5 - tumor to normal mucosa; 6 - ICB; 7 and. 8. - random from remainder of colon; 9 - appendix; 10 and 11 - eig. whole lymph nodes per cassette; 12 - seven whole lymph nodes. MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma. Histologic grade: High-grade (poorly differentiated). Primary tumor (pT) : The tumor extends through the full thickness of. the wall and through the pericolonic adipose tissue to the serosal. surface, pT4a. Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Tumor extends to within less than. 1 mm of the radial margin. Distance of tumor from closest margin: 8 cm from the distal margin. Vascular invasion: Areas highly suspicious for vascular invasion. identified. Regional lymph nodes (pN) : pNO (0/25). Non-lymph node pericolonic tumor: Perineural invasion is. identified. Distant metastasis (pM) : pMx. Other findings: Ileocecal valve lipoma. Appendix with fibrous. obliteration of the tip. DIAGNOSIS. Colon, right, hemicolectomy -. Invasive poorly differentiated adenocarcinoma (see tumor. characteristics in. the microscopic description). mber of lymph nodes. to microscopic template. End Of Report ---.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
HISTORY. ? Bronchiolo-alveolar carcinoma. MACROSCOPIC. Five specimens received: 1: The first specimen which is a frozen section is labelled ""Lung Bx, frozen section' and consists of a. wedge of lung tissue with overlying visceral pleura measuring 20 X 12 x 4 mm. Serial sections taken. through specimen. No discrete lesion identified. [BIT for FS.]. FROZEN SECTION DIAGNOSIS: Adenocarcinoma (abuts diathermy margin). Result phoned to. [Frozen section remnants, 1A.]. 2: The second specimen is labelled with the patient's details only and consists of a left. pneumonectomy specimen. The left upper lobe measures 250 (SI) X 150 (AP) x 70 mm (ML). The left. lower lobe measures 230 (SI) x 140 (AP) x 70 mm (ML). There is an incomplete fissure on the lateral. surface of the left lower lobe. Over the lateral aspect of the pleura of the left upper lobe there is a. broad area of pallor under which the lung parenchyma is firm. This area measures approximately 140. X 110 mm. Similar subpleural firm pale areas are present throughout the lingula and are present on. both. the lateral and medial aspects of the pleura and varying in size from 3 mm up to 30 mm. At the. hilar aspect of the lung the bronchial resection margin measures 20 mm in diameter and is raised 30. mm from the surrounding tissue. A single area of pale subpleural thickening is noted in the left lower. lobe measuring 11 mm in maximum dimension. This area occurs on the anterior aspect of the left. lower lobe in the interlobar fissure. There are three areas of pleural deficiency on the left upper lobe;. one anterior and lateral measuring 30 mm in diameter and one overlying the pale area posteriorly and. superiorly measuring 30 mm in diameter where the pleura appears pulled back and is able to be laid. over the deficit. A third sutured area of pleural deficit and an underlying parenchymal defect is noted. at the postero-inferior edge of the left upper lobe laterally. This area measures 30 mm in diameter. On sectioning the lung, the majority of the left upper lobe is replaced by confluent pale tumour. measuring 165 (SI) X 120 (AP) x up to 60 mm (ML). There are numerous other deposits in the lingula. and in the most inferior aspect of the left upper lobe varying in size from 1 mm up to 20 mm. There is. extensive subpleural tumour with the large majority of the lateral aspect of the pleura appearing to be. involved by tumour. Further sectioning reveals tumour to abut the pleura on the medial aspect of the. left upper lobe adjacent to the hilum. Tumour approaches but does not appear to reach the hilar. resection margin. There is no definite tumour on the visceral pleural surface. Sectioning the left lower lobe also reveals multiple deposits of pale tumour both in superior and. inferior aspects of the lobe. These tumour deposits vary in size from 5 up to 30 mm in maximum. extent. [Bronchial resection margin, 2A; hilar lymph nodes, 2B; vascular resection margins, 2C; hilar and. peribronchial lymph nodes, 2D-2E; tumour underlying pleura and adjacent inked hilar resection. margin, 2F; tumour underlying pleura of left upper lobe adjacent to hilar resection margin, 2G; solid. area of tumour medial left upper lobe no pleura, 2H; inferior left upper lobe tumour and overlying. pleura, 2I; superior, 2J; lateral area of inferior left upper lobe in region of sutured pleural defect (?. Frozen site), 2K; lateral left upper lobe, 2L; left lower lobe inferior, two separate tumour deposits, 2M;. left lower lobe superiorly, 2N-20; uninvolved lung left lower lobe, 2P.]. 3: The third specimen is labelled ""hilar lymph node' and consists of three lymph nodes which measure. 18. X. 20 X 15 mm in maximum extent. wo bisected, 3A; third bisected, 3B.]. 4: The fourth specimen is labelled ""mediastinal lymph node' and consists of five fragments of lymph. node varying in size from 5 up to 12 mm in maximum extent and one piece of fat measuring 5 mm. [Lymph nodes bisected in toto, 4A.]. 5: The fifth specimen is labelled ""hilar lymph node' and consists of a single lymph node measuring 12. mm in maximum extent. [Bisected in toto, 5A.]. MIICROSCOPIC. 1: Paraffin sections confirm the frozen section diagnosis of adenocarcinoma. Lepidic extension of. tumour is also noted. The overlying visceral pleura is not infiltrated by tumour, Tumour involves the. diathermied margin. 2: Within the upper and lower lobes there are multiple deposits of well differentiated adenocarcinoma. which in areas show relatively extensive lepidic extension. The invasive tumour shows a predominant. papillary architecture and is composed of mucinous and non-mucinous cells. Tumour deposits abut the. visceral pleura in number of areas and there is focal visceral pleural invasion. No pleural surface. involvement is seen. There is distension of some lymphatic channels. No unequivocal lymphatic. invasion is seen. No vascular invasion or perineural permeation is identified. The bronchial resection. margin is clear of tumour. Tumour approaches to within 30um of the peri-hilar margin in an area. devoid of pleura. Although this margin is closely approached, tumour is not transected in this region. Tumour abuts the area of diathermy artefact within the upper lobe corresponding to the biopsy site for. frozen section. In a separate area, tumour abuts visceral pleura which shows diathermy artefact. precluding further assessment. Tumour infiltrates one of the lymph nodes within the hilar region. direct extension. The remaining lymph nodes are not involved. Lung parenchyma away from the. tumours shows emphysema together with foci of atypical adenomatous hyperplasia. 3-5: The lymph nodes show reactive changes with sinus histiocytosis, carbon pigment deposition and. mild follicular hyperplasia. There is no evidence of malignancy. SUMMARY. Left lung and lymph nodes (hilar and mediastinal): Well differentiated adenocarcinoma. Multiple separate lesions involving the upper and lower lobes. Largest tumour deposit 165 mm in diameter. Visceral pleura focally involved, no surface involvement identified. No unequivocal lymphatic invasion seen. No vascular invasion or perineural permeation identified. Bronchial resection margin clear, peri-hilar margin closely approached. Perihilar lymph node involved by direct extension of tumour. Remaining hilar lymph nodes and mediastinal nodes not involved by tumour. Non-neoplastic lung: Emphysema and foci of atypical adenomatous hyperplasia. Pathological stage: T4 N1 M1. T-28000 M-81403 P1-03000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Operative Procedure: Right partial nephrectomy. Right renal mass. Final Pathologic Diagnosis: Kidney, right, partial nephrectomy: Tumor histologic type: Papillary renal cell carcinoma, type 2. Sarcomatoid features (%): Tumor size: greatest dimension. 4.8 cm. Other dimensions: 4.2 x 3.8 cm. Macroscopic extent of tumor: Tumor is confined to the kidney. Focality: Unifocal. If multifocal, number of tumors: Not applicable. Fuhrman grade: 3 of 4. Perinephric fat invasion: Renal sinus invasion: Not examined. Renal vein involvement: Not examined. Adrenal gland present: If yes, involved by tumor: Not applicable. If yes, direct invasion or metastasis: Not applicable. Cancer at resection margin: No, See Note. If yes, location(s). Not applicable. Pathologic findings in nonneoplastic kidney: None. Hilar lymph nodes present: If yes, number involved/number present: Not applicable. Pathologic stage (2010): pT1b__pNX pM-Not applicable. The examination of this case material and the preparation of this report were. Gross Description: The specimen is received in formalin labeled with the patient name and ""right renal mass"" and consists of. a 4.8 x 4.2 X 3.8 cm partial. nephrectomy specimen. The specimen appears to be entirely made up by the mass. The mass has a soft heterogeneous multiloculated yellow-tan and hemorrhagic cut. surface. A portion of thismass has been previously collected by the Tissue Bank. A gross photograph. has also been taken of the specimen. There does not appear to be any attached uninvolved renal parenchyma. Representative sections are submitted in cassettes 1-5. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Gender: M.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
De-Identified Specimen Code. /. SPECIMEN SUBMITTED: Part A: BLADDER AND PROSTATE. Part B: PELVIC LYMPH NODES #1. Part C: PELVIC LYMPH NODES #2. Part D: RIGHT DISTAL URETER. Final Diagnosis. 1. Bladder and prostate, radical cystoprostatectomy (A) - Invasive high grade urothelial carcinoma. is identified involving the previous biopsy site. The tumor focally invades into the muscularis propria. Associated urothelial carcinoma in situ is present. Right ureter margin is positive for urothelial carcinoma in-situ. The urethra margin and soft tissue. margins are negative for tumor. - The prostatic urethra shows involvement by urothelial carcinoma in situ. The prostate parenchyma. shows benign prostatic hyperplasia. - One lymph node negative for neoplasm (0/1). - See comment. 2. Pelvic lymph nodes #1, excision (B) - Fifteen lymph nodes negative for neoplasm (0/15). 3. Pelvic lymph nodes #2, excision (C) - Three lymph nodes negative for neoplasm (0/3). 4. Right distal ureter, excision (D) Urothelial carcinoma in situ is present at the margin. Diagnosis Comment: BLADDER TEMPLATE. Procedure: Radical cystoprostatectomy. Tumor Size (greatest dimension): 5 cm (including previous blopsy site changes). Histologic Type: Urothelial carcinoma. Associated Epithelial Lesions: None identified. Histologic grade: Urothelial Carcinoma (WHO. ): High-grade. Adenocarcinoma and Squamous Carcinoma: GX: Cannot be assessed. Margins: Margin(s) involved by carcinoma in situ. Specify margin(s): right distal ureter. Venous lymphatic invasion: Absent. Direct extension of invasive tumor:None identified. Pathologic Stage (TNM): pT1 pNO pMX. Number lymph nodes examined: 19. Number lymph nodes involved (any size): 0. Primary Tumor (pT). pT2a: Tumor invades superficial muscularis propria (inner half). Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Distant Metastasis (pM): pMX: Cannot be assessed. Seen in consultation with Dr. Frozen section slides were reviewed on the re-excision of the right. ureter. The cytologic atypia borders on dysplasia and urothelial carcinoma in situ, but review of the permanents. favors urothelial carcinoma in situ. Clinical Diagnosis: BLADDER CANCER. STITCH MARKS MARGIN. Gross Description: A. Received already fixed, inked, and opened labeled ""bladder and prostate"" is a specimen that. consists of urinary bladder, right ureter, prostate, attached seminal vesicles and vas deferens. The right. ureter is probed but there is no probe identifying the left ureter and the left ureter orifice in the trigone. area could not be seen or probed and after dissection a possible 3cm segment of left ureter is seen. The bladder measures 19 x 11 x 5 cm. The adhered surface of the bladder is covered by a smooth. serosal lining at the dome and fibroadipose tissue at the remaining portion. After the bladder is opened,. a. mass measuring 5 x 4 X 1 cm is identified and is located on the anterior wall, right lateral wall, left. lateral wall, posterior wall and the trigone area. The mass is 4 cm from the right ureter margin, 3.5 cm. from the urethral margin, and 3.5 cm from the possible left ureter margin, and appears to invade 1 cm. deep. The mass is principally papillary. On sectioning, the mass extends to roughly 1 cm grossly into. the wall but does not grossly appear to go through the muscularis propria. It does not appear to involve. the perivesicular adipose tissue. The bladder mucosa is erythematous near the urethra. A 4 cm. segment of right ureter and is patent, and the mucosa appears unremarkable. The left ureter was very. difficult to locate as there is no probe within it for fixation and the orfice in the trigone area could not be. identified. A possible 3 cm segment of left ureter is identified after dissection. Its mucosa appears. unremarkable. The prostate measures 4 x 4 x 4 cm craniocaudally, anteroposteriorly, and transversely. The apex of the gland is conical. The capsular surface is smooth. On palpation, an area of firmness is. not identified. The gland is inked blue on the right, and yellow on the left. After fixation, the gland is. serially sectioned at 3 mm intervals and the cross sections do not reveal a mass lesion. Rubbery. nodularity is present. The seminal vesicles appear unremarkable. Representative sections are. submitted as follows: FSA1 urethra, FSA2 suture, FSA3 left vas deferens, FSA4 right vas deferens,. FSA5 right ureter, FSA6 left ureter, A8 anterior wall with mass, A9 right trigone area and right ureter. with mass, A10 right lateral with mass, A11 dome, A12 left lateral wall with mass, A13 possible left. ureter distal margin, A14 left trigone area with mass, A15 mass in relation to right seminal vesicle, A16. bladder mucosa near urethra, A17 posterior wall with mass, A18 possible mid left ureter, A19 right mid. ureter, A20-A21 possible lymph nodes, A22 right apex, A23 left apex, A24 3 mm right, A25 3 mm left,. A26 mid prostate right anterior, A27 mid prostate left anterior, A28 mid posterior right posterior, A29. mid prostate left posterior, A30 base of prostate right anterior, A31 base of prostate left anterior, A32. base of prostate right posterior, A33 base of prostate left posterior, A34 right seminal vesicle, A35 left. seminal vesicle. B. Received fresh labeled ""pelvic lymph nodes #1"" are multiple segments of yellow fibrofatty tissue. aggregating to 10 x 5 x 1.5 cm. Palpation reveals 17 yellow firm nodules ranging in size from 0.5 to 4.0. cm in greatest dimension. The nodules are totally submitted as follows: B1 four nodules, B2 four. nodules, B3 four nodules, B4 two nodules, B5 one nodule, B6 nodule, B7 one nodule bisected. C. Received fresh labeled ""pelvic lymph nodes #2"" is a segment of yellow fibrofatty tissue measuring 7. x 4 x 1 cm. Palpation reveals 3 yellow firm nodules ranging in size from 3.0 to 5.0 cm in greatest. dimension. The nodules are totally submitted as follows: C1 one nodule, C2-C3 one nodule bisected,. C4-C5 one nodule bisected. D. Received fresh for intraoperative consultation is a specimen labeled ""right distal ureter"" consisting of. a segment of unoriented ureter, measuring 1.2 cm in length with a clip in place 0.4 cm from one end of. Gross Description: the ureter. The end of the ureter closest to the clip is inked black. The opposing ureter is dilated. Shaves of both ends of the ureter are submitted for frozen section in cassette FSD1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Findings and diagnosis relating to the problem: This is an invasive, mucinous adenocarcinoma of the colon, G3, with penetration of all parietal. layers (pT3) and vascular infiltrates (L1, V1) with free resection margins in the mucosa region. with a regular mucosa, submucosa and muscularis, as well as mature connective tissue in the. deep resection margin area and free lymph nodes, in addition there are tubulovillous adenomas. with focally severe dysplasia (high-risk intraepithelial neoplasia) and omental tissue with. reactive lesions. Tumor classification: ICDO-DA-M 8140/3. G3. pT3, L1, V1, pNO (0 of 13).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
1. M. Specimen # : Race: WHITE. Locatio. SPECIMEN: A: LEFT BREAST LUMPECTOMY B: SENTINEL LYMPH NODE #1. C: SENTINEL LYMPH NODE #2 D: SENTINEL LYMPH NODE #3. E: NON-SENTINEL NODE TISSUE. FINAL DIAGNOSIS: A. BREAST, LEFT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: 2 OF 3 (MODERATELY DIFFERENTIATED). - NOTTINGHAM SCORE: 7 OF 9. (Tubules=3 , Nuclei= 2, Mitoses= 2; mitotic count 8 per 10 HPF at. 40x power). - TUMOR SIZE (GREATEST DIMENSION) : 1.3 CM (MEASURED GROSSLY). - TUMOR NECROSIS: ABSENT. - MICROCALCIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: ABSENT. - MARGINS : -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.2 CM, FROM ANTERIOR. MARGIN (MEASURED GROSSLY). - INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, INTERMEDIATE. NUCLEAR GRADE (G2) WITH CENTRAL NECROSIS. ESTROGEN RECEPTORS POSITIVE (NEARLY 100% NUCLEAR STAINING, FROM. PREVIOUS BIOPSY. PROGESTERONE RECEPTORS: POSITIVE (95% NUCLEAR STAINING, FROM. PREVIOUS BIOPSY. - HER 2 NEU by IHC: NEGATIVE (1+, FROM PREVIOUS BIOPSY. - LYMPH NODES: SEE PARTS B, C, D, AND E. - PATHOLOGIC STAGE: pT1c NO (i-) MX. - ADDITIONAL PATHOLOGIC CHANGES : - FIBROCYSTIC CHANGES, INCLUDING CYSTS AND FIBROSIS. - CHANGES OF PRIOR BIOPSY. B. LYMPH NODE, SENTINEL #1, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. C. LYMPH NODE, SENTINEL #2, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. Specimen #: FINAL DIAGNOSIS (continued) : AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. D. LYMPH NODE, SENTINEL #3, RESECTION: - TWO LYMPH NODES NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. E. SOFT TISSUE, NON-SENTINEL NODE TISSUE, RESECTION: - TWO LYMPH NODES NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN. COMMENT: Part A: Immunohistochemical stains for e-cadherin (positive in. invasive carcinoma) cytokeratin 903 (positive in invasive carcinoma), ,. and. p63 (positive in myoepithelial cells), are reviewed with appropriate. controls. Parts B-D: Immunohistochemical stains for cytokeratin are reviewed with. controls. This case received prospective quality control review. R. CLINICAL DIAGNOSIS AND HISTORY. female with lump above left nipple. MMG showing. speculaced mass at twelve o' clock position with overlying skin retraction. US guided biopsy confirmed intraductal carcinoma. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated ""LEFT BREAST LUMPECTOMY"" is an ovoid portion of soft tissue. oriented with a short stitch superior, long stitch lateral. The specimen. measures 8.0 cm medial to lateral, 6.5 cm superior to inferior, and 3. 0 cm. anterior to posterior. Located on the anterior surface is a 4.5 x 2.0 cm. lightly pigmented, superficial skin ellipse. No scar is identified. The. specimen is inked as follows: superior = blue, inferior = green, medial. =. Specimen #: GROSS DESCRIPTION (continued) : red, lateral = yellow, anterior = orange, and posterior = black. Serial. sections reveal a fairly well defined, firm, gritty, pink-white mass. measuring 1.3 x 1.2 x 0.8 cm. The mass shows focal congestion with an. embedded clip on sectioning. The mass is located subadjacent to the skin. ellipse coming to within 0.2 cm of the anterior inked margin, and 0.4 cm. of the superior margin. The remainder of the specimen is composed of. lobulated, yellow-tan, adipose tissue admixed with a moderate amount of. fibrous tissue. No additional lesions are identified. Cassette Summary : A1: Mass with skin. A2: Adjacent normal with superior margin. A3: Mass with adjacent normal. A4-A5: - Superior and posterior margins. A6: Skin with anterior margin. A7: Medial margin. A8: Medial margin. A9: Lateral and inferior margin. A10: Lateral and anterior margin. A11: Inferior margin. Matched sections of A1 and A3 are submitted in. for CBCP protocol. B. Received fresh, labeled with the patient's name. designated ""SENTINEL LYMPH NODE #1"" is a 2.0 x 2.0 x 1.0 cm portion of. soft tissue. The specimen is bisected to reveal a predominantly fatty cut. surface with a partial thin, rim of pink-tan, lymphoid tissue. The. specimen is submitted in cassettes B1 and B2. C. Received fresh, labeled with the patient's name,. designated ""SENTINEL LYMPH NODE #2"" is a 2.5 x 2.5 x 1.0 cm portion UL. soft tissue. The specimen is bisected to reveal a predominantly fatty,. cut surface with minimal lymphoid tissue identified. The specimen is. entirely submitted in cassettes C1 and C2. D. Received fresh, labeled with the patient's name,. designated ""SENTINEL LYMPH NODE #3' is a 1.5 x 1.0 x 0.5 cm portion or. soft tissue. The specimen is bisected to reveal a predominantly fatty,. cut surface with minimal lymphoid tissue identified. The specimen is. entirely submitted in cassette D1. E. Received in formalin, labeled with the patient's name,. Specimen #: GROSS DESCRIPTION (continued). designated 'NON-SENTINEL NODE TISSUE"" are two portions of. yellow-brown, lobulated, soft tissue measuring 2.0 x 1.5 x 0.7 cm, and 1. 1. x 0.4 x 0.4 cm. Both fragments are bisected to reveal a predominantly,. fatty, cut surface admixed with lymphoid tissue. The larger fragment is. submitted in cassette E1. The smaller is submitted in cassette E2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Case type: Surgical Case. DIAGNOSIS. (A) RULE OUT LEFT INFERIOR PARATHYROID: Fibrous tissue, no parathyroid identified. (B) LEFT THYROID LOBE: PAPILLARY THYROID CARCINOMA, FOLLICULAR VARIANT (6.0 CM) CONFINED TO THYROID. Margins grossly free. (C) RULE OUT RIGHT PARATHYROID: Thyroid tissue present, no parathyroid identified. (D) RIGHT THYROID LOBE: Thyroid, no tumor present. (E) RULE OUT RIGHT PARATHYROID #2: Lymph node, no tumor present, no parathyroid identified. (F) LEFT PARATRACHEAL DISSECTION: Fibroadipose tissue, no tumor present, no lymph nodes identified. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) RULE OUT LEFT INFERIOR PARATHYROID - A portion of 0.2 x 0.1 x 0.1 cm tan-pink soft tissue. One touch preparation is. performed. Specimen is entirely submitted for frozen section as A. FS/DX: FIBROUS TISSUE, NO PARATHYROID IDENTIFIED. (B) LEFT THYROID LOBE - A lobe of thyroid (8.0 x 4.2 x 3.2 cm). There is a well-circumscribed nodule at the lower pole (6.0 x. 4.0 x 3.2). The entire nodule is well-encapsulated. The nodule is tan-white with focal areas of hemorrhage. Representative. section submitted to the tumor bank. SECTION CODE: B1, non-neoplastic thyroid; B2-B8, representative sections from tumor. (C). RULE OUT RIGHT PARATHYROID - A0.3 cm red-tan tissue fragment. One touch preparation is made and the entire tissue. is submitted for frozen section evaluation in C. FS/DX: THYROID TISSUE, NO PARATHYROID IDENTIFIED. (D) RIGHT THYROID LOBE STITCH AT SUPERIOR POLE - A lobe of thyroid (4.2 x 2.5 x 1.7 cm). No definitive focal lesion. identified. Entire specimen submitted in D1-D5. (E). RULE. OUT RIGHT PARATHYROID #2 - A0.3 cm red-tan tissue fragment. A touch prep is made and the specimen is entirely. submitted for frozen section evaluation in E. FS/DX: LYMPH NODE, NO PARATHYROID IDENTIFIED. (F) LEFT PARATRACHEAL DISSECTION - A nonoriented irregular fragment of fibroadipose tissue (1.0 x 0.8 x 0.2 cm). The. specimen is serially sectioned and no lesions or lymph nodes grossly identified. Entirely submitted in F. Case type: Surgical Case. CLINICAL HISTORY. Papillary thyroid carcinoma. SNOMED CODES. T-B6000, M-83403. ""Some tests reported here may have been developed and performance characteristics determined by. hese tests have not been specifically cleared or approved. by the U.S. Food and Drug Administration."". Released by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Date of Original Rep. Date of Amendment. Clinical Diagnosis & History: [CGA-BP-5190 -. Right renal mass,. Specimens Submitted: 1: SP: Kidney, right; partial nephrectomy. 2: SP: Soft tissue, right peritumoral fat; excision. 3: SP: Kidney, right lower pole cortex of renal mass; biopsy. 4: SP: Proximal right distal ureter; excision. AMENDED DIAGNOSIS: 1. SP: Kidney, right; partial nephrectomy: Tumor Type: Renal cell carcinoma = Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 4.0 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Shows focal glomerulosclerosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. Comment: Immunostains show diffuse cytoplasmic membranous pattern of CA IX expression in the tumor cells, which are. negative for CK7, c-KIT and racemase. This immunoprofile supports the diagnosis. 2. SP: Soft tissue, right peritumoral fat; excision: Benign fibroadipose tissue. 3. SP: Kidney, right lower pole cortex of renal mass; biopsy: Benign renal cortical parenchyma with focal glomerulosclerosis. 4. SP: Proximal right ureter; excision: Benign partially denuded urothelium and urethral wall. Note: This document represents an amended version of the surgical pathology report originally issued on. That report is. superseded by the present document. The amendment consists of the following change: ORIGINAL REPORT: Specimens Submitted: 4: SP: Proximal right distal urethra; excision. Gross Description: 4). The specimen is received in formalin labeled ""Proximal right distal urethra"". AMENDED REPORT: Specimens Submitted: 4: SP: Proximal right ureter; excision. Gross Description: 4). The specimen is received in formalin labeled ""Proximal right ureter"". The responsible clinician has been notified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CA-1X. CK7. NEG CONT. IMM RECUT. RACEMASE. CD117. Gross Description: 1). The specimen is received fresh for frozen section consultation, labeled ""right renal tumor/stitch marks surgical deep margin"". It. consists of a 6.5 x 5.0 x 4.0 cm wedge shaped portion of kidney with a suture marking the deep margin. The margin is inked black. and the specimen is serially sectioned to reveal a 4.0 x 3.3 x 2.0 cm, soft, yellow-tan mass. The clearance from the resection. SURGICAL PATHULUGI REPURI. margin is 0.1 cm. A representative section of the nearest margin is submitted for frozen section diagnosis. Representatively. submitted. Portions of the tumor are submitted for. Summary of sections: FSC - frozen section control. T tumor. TM - tumor with margin. TK -tumor with uninvolved kidney. 2). The specimen is received fresh, labeled ""Right peritumoral fat/kidney"". It consists of multiple pieces of lobulated yellow-tan. fatty tissue measuring 15 x 11 x 3 cm in aggregate. Cut section through the specimen does not reveal any discrete abnormalities. Representative sections are submitted. Summary of sections: U-undesignated. 3). The specimen is received in formalin, labeled ""Right lower pole cortex of renal mass"". It consists of a partially cauterized. piece of brown-tan renal parenchyma measuring 1.5 x 0.9x0.4 cm. The cauterized surface is inked black. The specimen. is. sectioned and submitted entirely. Summary of sections: U-undesignated. 4). The specimen is received in formalin labeled ""Proximal right distal ureter"". It consists of two pieces of yellow-tan soft tissue. measuring 0.8 x 0.8 x 0.4 cm in aggregate. The specimen is entirely submitted. Summary of sections: U-undesignated. Summary of Sections: Part 1: SP: Kidney, right; partial nephrectomy. Block. Sect. Site. PCs. 5. ADD. 7. 1. fsc. 1. 2. t. 2. 1. tk. 1. 2. tm. 2. Part 2: SP: Soft tissue, right peritumoral fat; excision. Block. Sect. Site. PCs. 1. U. 1. Part 3: SP: Kidney, right lower pole cortex of renal mass; biopsy. Block. Sect. Site. PCs. 1. u. 1. Part 4: SP: Proximal right distal ureter; excision. Block. Sect. Site. PCs. 1. U. 1. Amendments. Amend Date: Amended By: Original Diagnosis: 1. SP: Kidney, right; partial nephrectomy: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade HIIVI. Tumor Size: Greatest diameter is 4.0 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Shows focal glomerulosclerosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. Comment: Immunostains show diffuse cytoplasmic membranous pattern of CA !X expression in the tumor cells, which are. negative for CK7, c-KIT and racemase. This immunoprofile supports the diagnosis. 2. SP: Soft tissue, right peritumoral fat; excision: Benign fibroadipose tissue. 3. SP: Kidney, right lower pole cortex of renal mass; biopsy;. Benign renal cortical parenchyma with focal glomerulosclerosis. 4. SP: Proximal right distal urethra; excision: Benign partially denuded urothelium and urethral wall. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Papillary thyroid carcinoma. Specimens Submitted: 1: SP: Thyroid, Total thyroidectomy. 2: SP: Left paratracheal cyst. DIAGNOSIS: 1. SP: Thyroid, Total thyroidectomy: Tumor Type: with tall cell features. Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammoma type. Psammoma bodies. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 1.1 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyrold Extension: Not identified. Surgical Margins: Free of tumor. Clinical Diagnosis & History: Papillary thyroid carcinoma. I. Specimens Submitted: 1: SP: Thyroid, Total thyraidectomy. 2: SP: Left paratracheal cyst. DIAGNOSIS: 1. SP: Thyroid, Total thyroidectomy: Tumar Type: Papillary carcinoma, classical type. with tall call features. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammama type. Psammoma bodias. Tumor Location: Right lobe. Tumor Siza: Greatast diamater is 1.1 cm. Tumor Encapsulation: Complately surraunded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extansian: Not identifiad. Surgical Margins: Fraa of tumor. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. - Two benign lymph nodes (0/2). 2. SP: Soft tissue, Left paratracheal cyst; Excision: - Four benign lymph nodes. - Benign cyst lined by cuboidal epithelium most probably of branchial pouch derivation. - Benign portion of thymus. ATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT i HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen Is received fresh, labeled ""total thyroidectomy stitch is right superior pole"" and consists of a thyroid weighing 27. g. The right lobe measures 5 x 2.5 x2.2cm ,the left lobe measures 4.5 x2.5 x 2.2cmand the isthmus measures 1.5x1.1 x0 .5. cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the. anterior is inked blue. Sectioning reveals a 1.1 x 0.8 x 0.7 cm solid encapsulated calcified nodule in the right upper pole. Sections. through the remaining tissue reveal no other lesions. The remaining thyroid parenchyma is red tan and beefy. Representative. sections of the specimen is submitted for TPS. The remaining tissue Is serially sectioned and 60% submitted. Summary of sections: N nodule. RL right lobe. LL left lobe. IS - isthmus. 2). Specimen is received fresh labeled ""left paratracheal cyst"" and consists of an unoriented tan, soft tissue with dimensions of 2 x. 2 by 1 cm. The external surface is inked black. Sectioning reveals a smooth walled cyst filled with clear watery fluid with a. diameter of 1.5 cm. The specimen is entirely submitted. Summary of sections: U-undesignated. Summary of Sections: Part 1: SP: Thyroid, Total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 4. LL. 4. 2. N. 2. 4. RL. 4. Part 2: SP: Left paratracheal cyst. Block. Sect. Site. PCs. 2. U. 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
'Referring Physician: Patient Location: Date of Service: Date Received: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: KIDNEY, RIGHT, NEPHRECTOMY: - Chromophobe renal cell carcinoma. - Tumor size: 9.5 cm. - Surgical margins free of tumor. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade: Chromophobe renal cell carcinoma, Grade 2. Primary tumor: pT2a. Regional lymph nodes: pNX. Distant metastasis: pMX. Pathologic stage: II. Lymphovascular invasion: Not identified. Margin status: R0, negative. This report continues (FINAL). FINAL SURGICAL PATHOLOGY REPORT. Kidney Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Procedure: Radical nephrectomy. Specimen type: Right kidney. Specimen laterality: Right. Tumor Features: Tumor size: 9.5 cm. Tumor focality: Single focus. Histologic type: Chromophobe renal cell carcinoma. Histologic grade (Fuhrman nuclear grade): Grade 2. Sarcomatoid features: Not identifled. Macroscopic extent of tumor: Limited to kidney. Microscopic tumor extension: Limited to kidney. Lymph Nodes: N/A. Margin Evaluation: Distance to closest margin: Greater than 1 cm from all margins. Other margins: N/A. Pathologic tumor staging descriptors: Primary tumor (pT): pT2a. Regional Lymph nodes (pN): pNX. Distant metastasis (pM): pMX. Margin status (R): R0, negative. Pathologic stage: II. Pathologic findings in non-neoplastic kidney: Unremarkable. Additional pathologic findings: N/A. Comment: N/A. This report continues. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: Right Kidney nephrectomy. Clinical History/Operative Dx: Renal mass. Gross Description: The specimen is labeled right kidney and is received in formalin. It consists of a nephrectomy specimen. which together with perinephric fat weighs 478 grams, The specimen measures 14 cm from superior to. inferior, 9 cm from medial to lateral, and 7 cm from anterior to posterior. There is no adrenal gland. The. adipose tissue at the upper pole of the kidney has been stripped and disrupted. Along the anterior surface. of the kidney Is a filmy portion of pale tan tissue suggestive of Gerota's fascia measuring 8 x 4.5 cm. The. kidney is prominent bulging along the posterior and lateral surface. At the hilum, the renal artery and. renal vein are identified. The vessels are opened and there is no grossly obvious intraluminal tumor. Extending from the hilum Is a 6 cm segment of ureter which is 0.4 cm in diameter. The ureter is opened. and the urothelium is tan and smooth. There are some slight granularities in the renal pelvis. The renal. pelvis is pushed anteriorly due to the bulging tumor. The kidney is bivalved to reveal a somewhat friable,. yellow to focally brown tumor which is thinly encapsulated and does not appear to invade the perinephric. fat. It measures 9.5 X 7.5 x 6.5 cm. It abuts the renal pelvis but does not appear to invade the calyces or. renal pelvis. Representative sections of the tumor are submitted for research purposes. Away from the. tumor, the corticomedullary junction of the kldney appears distinct and cortical thickness is 0.6 cm. No. other masses are Identified. There are no lymph nodes identified in the peripelvic fat. Representative. sections are submitted. Section summary: A1) surgical margin, renal artery, renal vein and ureter, A2). additional sections of ureter and ureteropelvic Junction, A3) Gerota's fascia, A4-A7) representative tumor,. A8) section of tumor at renal pelvis, A9) uninvolved kidney. Microscopic Description: Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Immunohistochemistry was performed with adequate control for Vimentin, pancytokeratin, CK7,. E-Cadherin, PAX-8, and CD10. Sections show a tumor composed of solid proliferation of cells with. thickwalled blood vessels and enlarged perivascular cells. The cells are polygonal with transparent to. slightly eosinophilic cytoplasm and prominent cell membranes. The nuclei are irregular and focally. wrinkled with small nucleoli. Perinuclear halos are seen. The tumor cells are positive for CK7, E-. cadherin, PAX-8 and pancytokeratin (patchy, focal) and are negative for vimentin and CD10. Taken. together, the histomorphology and immunohlstochemistry staining pattern are consistent with. chromophobe renal cell carcinoma. An intradepartmental consultation with. was obtained. REPRINT: Orig. printing on.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. 10. REPORT DATE: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: PROCEDURE: SPHS. Liver cancer. Operative Procedure/Tissue Submitted: Laparoscopic assisted. liver resection. PROCEDURE: SPGD. 1. ""Gallbladder."" Received in formalin in a medium container is a previously. disrupted 11.8 x 4.6 x 1.6 cm gallbladder with focally adhesed serosa. The. Lumen is devoid of content. The mucosa is red-tan, velvety with a 0.2 cm. average wall thickness. The cystic duct is patent and there are no separate. stones in the container. 1A. Gallbladder. 2. ""Segment 5-6 liver resection, gross margins."" A 5.5 x 5.0 x 4.8 cm, 65 gm. resection of liver with nodular capsular surface. The margin is inked black. A. 2.1 cm nodule is 1.9 cm from the margin. The nodular mass comes to within 0.1. cm of the capsule. The remaining parenchyma has multiple nodules that average. 0.4 cm in greatest dimension. The diffuse nodular parenchyma is focally. fibrous. 2A-D. Mass with nodular parenchyma and surgical margin. INTRAOPERATIVE GROSS: PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 11. SEX: M. BIRTHDATE: ADM DATE: OPER DATE: 2. A 2.1 cm nodule is 1.9 cm from margin. PROCEDURE: SPMI. LIVER: HEPATOCELLULAR CARCINOMA. WAS THE TUMOR PREVIOUSLY TREATED?: No. TUMOR TYPE: Ordinary. SINGLE OR MULTIPLE MASSES: Single. MAXIMUM DIAMETER OF LARGEST MASS: 2.1 cm. ARE THE MARGINS OF RESECTION FREE OF TUMOR?: Yes. VASCULAR INVASION?: No. INVASION THROUGH THE CAPSULE TO THE SEROSAL SURFACE?: No. LYMPH NODE METASTASES?: Unknown. DISTANT METASTASES?: Unknown. IS THE LIVER CIRRHOTIC?: Yes, cryptogenic. pT1 NX. PROCEDURE: SPDX. 1. Gallbladder, resection: No significant abnormality. 2. Liver, segments 5 and 6, resection: Well-differentiated hepatocellular. carcinoma (2.1cm). Margins negative. Cryptogenic cirrhosis. Please see. TEMPLATE for details.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Larynx. 1 - ""Lymph Nodes - Level 2, 3, 4 and 5 - Right"": Lymph node previously designated as ""negative"": uninvolved by metastatic carcinoma. (0/1). - Lymph node previously designated as ""positive"": metastatic squamous cell carcinoma. with capsular involvement (1/1). - Three of sixteen lymph nodes involved by metastatic carcinoma (3/16), with capsular. involvement. - Muscular tissue uninvolved by carcinoma. 2 - ""Right recorrential lymph node"": - One of teen lymph nodes involved by metastatic carcinoma (1/10), with capsular. involvement. 3 - ""Lymph Nodes - Level 2, 3 and 4 - Left"": - Sixteen lymph nodes uninvolved by metastatic carcinoma (0/16). 4 - ""Left recorrential lymph node"": - One of teen lymph nodes involved by metastatic carcinoma (1/10), without capsular. involvement. 5 - ""Larynx"": - Keratinizing squamous cell carcinoma: - Histological grade 2. - Tumor size 5.5 cm. - Involving right vocal cord, cartilage tissue (thyroid, cricoid and arytenoid cartilages),. skeletal muscle tissue, soft tissue and thyroid gland. - Lymphatic invasion: present. - Vascular invasion: not identified. - Perineural invasion: not identified. - Preepiglottic space uninvolved by neoplasia. - Surgical margin uninvolved by neoplasia. 6 - ""Tracheal margin extension"": - Uninvolved by neoplasia.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Right hemicolectomy preparation with tumor-free resection margins and an ulcerated,. moderately differentiated adenocarcinoma of the ascending colon, with infiltration of the. perimuscular fatty tissue and without local lymph node metastases (G2, pT3 LO V0 R0 pN0. 0/34).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 2. copy No. Examination: Histopathological examination. PESEL: Gender: F. Material: Multiple organ resection - left breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Results of immunohistochemical examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 10% of neoplastic. cell nuclei. HER2 protein stained with HercepTestâ¢ by DAKO. Score = 2+, verification by the FISH method recommended. Macroscopic description: Left breast sized 17.8 x 11.3 x 4.8 cm removed with axillary tissues sized 9 x 5 x 3 cm. Weight 400 g. Skin flap. 21.7 x 9.2 cm in size. Tumour sized 3.9 x 6.6 x 2.8 cm found in the central part, placed 1.4 cm from the upper. edge, 0.9 cm from the base and 0.0 cm from the skin. Status after blopsy (test No. Microscopic description: Carcinoma lobulare invasivum (G2 acc. to Elston: 3+2+1; 0 mitoses /10 HPF diam. 0.55 mm) Infiltratio. carcinomatosa cutis et mammillae. Glandular tissue showing parenchyma atrophy. Invasive lesions are placed 0.1 cm from the base of the surgical specimen. Axillary lymph nodes: Metastases. carcinomatosae in lymphonodo (No XI/XIII). Histopathological diagnosis: (including test No. Ca rei nom alobulare invasivum mammae sinistrae. Invasive lobular carcinoma of the left breast. Metastases carcinomatosae in lymphonodis axillae (XI/XIII) Cancer metastases in axillary lymph nodes (XI/XIII). (NHG2, pT3, pN3a). Examination: Histopathological examination page 2 / 2. PESEL: Gender: F. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Patient ID: Gross Description: Dissected part of the stomach with greater and lesser omentum;. along the lesser curvature - 13cm, along the greater curvature - 20cm;. in the antral part there is a circular tumour 9 cm long; (while opened 9 X 9 X 1.5 cm), wall is diffusely. densed, thickened up to 1.5 cm; greater and lesser omentum lymph nodes are 0.2-1.5 cm in their. diameter (fifteen). Microscopic Description: Poorly differentiated adenocarcinoma of the stomach with all wall layers and. omentum tissues invasion; distal part of the surgical margins and lymphatic vessels contain tumor. elements; fifteen lymph nodes were examined, eleven demonstrated metastases. Diagnosis Details: Tumor Features: Diffusely infiltrating (linitus plastic), Tumor Extent: Perigastric fat ,. Venous Invasion: Absent, Margins: Present, Treatment Effect: Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Antrum. Tumor size: 9. Tumor features: Diffusely infiltrating (linitus plastica). Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 11/15 positive for metastasis (Greater and lesser curvature 11/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Involved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis. 1. Cystectomy preparation with infiltration of a small-cell urothelial carcinoma (90% of the. tumor shows small-cell morphology), measuring a maximum of 4.5 cm, with microscopic. infiltration of the perivesical fatty tissue and tumor infiltration of the lymph vessels (L1). Remaining urothelium with multifocal carcinoma in situ. Tumor-free surgical resection lines. A lymph node metastasis (measuring 0.9 cm) in the perivesical fatty tissue. 2. Carcinoma-free fatty tissue with fibrosis (peritoneum). 3. Carcinoma-free right ureter resection material. 4. Carcinoma-free left ureter resection material. Comment: Summary tumor classification (in light of the frozen section material sent in under. pT3a, pN1 (1/16), L1, V0; G3. Follow-up report: Diagnosis communicated to date: on 3. (bladder tumor): extensive, poorly differentiated, in part small-cell urothelial carcinoma. Foci of urothelial lining with carcinoma in situ. Small parts of tumor-free bladder wall. As announced, the material has in the meantime undergone immunohistochemical analysis for. more detailed characterization of the urothelial carcinoma (P53, CK20, S-100, synaptophysin,. EMA, AE1/AE3, chromatogranin, NSE). The tumor infiltrates are diffusely positive for pan-cytokeratin AE1/AE3. Parts of the tumor. are highly positive for synaptophysin and NSE and negative for chromatogranin, S-100 and. CK20. Parts of the tumor are highly positive for P53. The immunohistochemical marker constellation also confirms the diagnosis of small-cell. urothelial carcinoma already communicated.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Case type: Surgical Case. DIAGNOSIS. (A). LEFT THYROID LOBE AND ISTHMUS: PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Left lobe. Multi-focal: No. Size = 2.5 cm. Extrathyroidal extension: Present, extending into fibroadipose tissue. Lymphovascular invasion: Present. Resection Margins: Negative. Background Thyroid: Multinodular adenomatous goiter. Lymph nodes: No lymph nodes present. (B) COMPLETION, RIGHT THYROID LOBE: Multinodular adenomatous goiter, no tumor present. GROSS DESCRIPTION. (A). LEFT THYROID LOBE AND ISTHMUS - A thyroid lobectomy of left lobe (3.5 x 2.0 x 2.0 cm) is nearly entirely replaced by. a soft pink papillary tumor with hyalinized fibrosis surrounding the nodule (2.5 x 1.5 x 0.9 cm) shows an irregular border. outside of the area of fibrosis, but is confined to the thyroid. A portion of skeletal muscle is also present with the specimen. SECTION CODE: A1, representative section for frozen assessment with touch prep; A2-A8, serial sections of the left. lobe and full examination of the interface of nodule with surrounding soft tissue. FS/DX: PAPILLARY THYROID CARCINOMA. (B). COMPLETION, RIGHT THYROID LOBE - A right thyroid lobe measuring 4.4 x 3.0 x 1.0 cm. Serial sectioning revealed. beefy red spongy parenchyma with no grossly identifiable lesion. Representative sections from superior to inferior submitted. in B1-B4. CLINICAL HISTORY. Nodule, left thyroid. SNOMED CODES. T-B6000, M-Y3420, T-B6000, M-80503, M-Y3420,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Case type: Surgical Case. Entire report and diagnosis completed by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
AP Surgical Pathology: Additional Info. CLINICAL HISTORY: Spiculated mass with pleomorphic calcifications. If invasive carcinoma,. please obtain ER, PR, EGFR, HER2/Neu by immunohistochemistry; for all 2+ IHC. results please do FISH analysis. GROSS EXAMINATION: A. ""Left breast, seven cores, with calcifications, 1-2:00 region"", in. formalin. A 1.5 x 1.0 x 0.3 cm aggregate of multiple core biopsies of. pink-tan tissue is entirely submitted in a mesh bag in A1. MICROSCOPIC EXAMINATION: Microscopic examination is performed. DIAGNOSIS: A. ""LEFT BREAST, SEVEN CORES, WITH CALCIFICATIONS, 1-2:00 REGION"". (STEREOTACTIC NEEDLE CORE BIOPSY) : INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: LOBULAR. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 2 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 2. MITOTIC RATE SCORE: 2. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: LOBULAR (FOCAL DUCTAL FEATURES NOTED) . NUCLEAR GRADE OF IN-SITU CARCINOMA: 1. MICROCALCIFICATIONS: PRESENT IN ASSOCIATION WITH INVASIVE CARCINOMA. ESTROGEN/PROGESTERONE RECEPTOR, HER2/NEU, AND EGFR ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: A1. RESULTS WILL BE ISSUED IN A SEPARATE REPORT FROM THE IMAGE CYTOMETRY. LAB. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). : ADDENDUM 1: Please see -. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) .

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Right renal tumor. Specimens Submitted: 1: SP: Right kidney. 2: SP: Paracaval lymph nodes. DIAGNOSIS: 1). KIDNEY, RIGHT; NEPHRECTOMY. - RENAL CELL CARCINOMA, CLEAR CELL TYPE WITH FOCAL SPINDLE. CELL FEATURES, NUCLEAR GRADE III/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR'S GREATEST DIAMETER IS 8.0 CM. - FOCALLY, THE TUMOR EXTENDS THROUGH THE RENAL CAPSULE BUT. IS CONFINED WITHIN GEROTA'S FASCIA. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - ANGIOMYOLIPOMA, SMOOTH MUSCLE PREDOMINANT (0.6 CM;. SEE NOTE). - THE ADRENAL GLAND IS NOT SUBMITTED. NOTE: IMMUNOHISTOCHEMICAL STUDIES OF THE ANGIOMYOLIPOMA. ARE POSITIVE FOR SMA, FOCALLY POSITIVE FOR HMB-45. AND NEGATIVE FOR S-100 PROTEIN. PARACAVAL LYMPH NODE; RESECTION: - NINE BENIGN LYMPH NODES (0/9). Gross Description: 1). The specimen is received fresh for frozen section,. labeled, ""Right kidney"". It consists of product of right radical. nephrectomy which weighs 490 grams and measures 14.0 from. superior to inferior, 8.5 cm from medial to lateral and 5.5 cm. from anterior to posterior. The soft tissue margins are inked. blue. The specimen is bivalved revealing a fleshy mass in the. superior pole which measures 8.0 x 6.5 x 3. â¬ cm. Portions of the. tumor are yellow-orange and lobulated. In other regions, the. tumor is homogenous, tan and firm. Approximately 25% of the. tumor is composed of yellow-orange tumor and approximately 75%. of the tumor has a homogenous tan appearance. Soft tissue. margins are freely movable over the mass. The remaining renal. parenchyma is tan-brown and unremarkable. The cortical thickness. measure between 0.4 and 0.6 cm in thickness. The capsule strips. with ease over the unremarkable parenchyma but is focally. adherent in the region of the tumor. There is a 7.0 cm segment. of ureter attached. The tumor does not involve the medullary. cavity. The renal vein and artery are free of tumor, On serial. sectioning, in the anterior aspect in the inferior pole, is a. small, firm white nodule which measure 0. 6 cm in greatest. dimension. This distinct nodule is located about 1.5 cm from the. main tumor. Serial sectioning of the remaining of the large. tumor mass reveals areas of hemorrhage and variable areas of. necrosis. Examination of the hilar adipose tissue reveals no. lymph nodes. Summary of Sections: FSC - frozen section control. T - tumor. RP - renal parenchyma. N -nodule. VM - vascular margin. UM - ureteral margin. 2) The specimen is received in formalin, labeled, ""Paracaval. Lymph Nodes"". It consists of a fragment of adipose tissue,. measuring 4.0 X 2.2 x 1.5 Cm. Cut-section shows a few lymph. nodes, the largest measuring 2.5 cm in diameter. The larger. lymph node is bisected. The specimen is submitted in three. cassettes. Summary of Sections: BLN - bisected lymph nodes. LN - lymph nodes. Histo Stain Results/Comments: Stain/Procedure Name. Comment. SMOOTH MUSCLE ACTIN. MELANOMA-E (HMB-45). S100 PROTEIN. IMMUNO RECUT. NEGATIVE CONTROL. MELANOMA-E (HMB-45). NEGATIVE CONTROL. Summary of Sections: Part. Sect. SiteBlocks PÃ­eces All. 1. FSC. 1. 1. N. N. 1. 1. RP. 1. 1. 6. M. UM. 1. 1. VM. 1. 1. 2. BLN. 1. 1. LN. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the. intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. A. Level 1. B. Level 7. C. Level 4. D. Level 2L. E. Level 4L. F. Level 8. G. Level 12. H. Level 7. I. Right lower lobe. J. Level 9. K. Level 11. L. 2R fat pad. M. Middle lobe. N. Bronchus intermedius proximal margin. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung carcinoma. FROZEN SECTION DIAGNOSIS. B - Frozen section and touch prep. e 1 ymph nodal tissue. negative for metastatic disease. 0. h nodal tissue negative. isease. h nodal tissue negative for metastatic disease. h nodal tissue negative for metastatic disease. h nodal tissue negative for me. based on. frozen section and touch preparation. I - Squamous. Mucosa a. in negative. for tumor. GROSS DESCRIPTION. A. Received fresh labeled ""level 1"" are two soft pale tan. white to tan gold tissues averaging 1.0 cm. in greatest. dimension which are submitted in toto. AS-1. B. Part B is received fresh for frozen section, labeled. ""level 7"" and consists of two irregular portions of soft. tan black tissue, the larger of which measures 1.2 X 0.6 X 0.2 cm. The smaller measures 1 X 0.7 X 0.2 cm. A touch preparation is made. and the entire specimen is submitted in one block for frozen. section. C. Specimen received fresh for frozen section labeled. ""level 4"" consists of multiple fragments of soft pink-black. tissue measuring 1.5 X 1 X 0.4 cm in aggregate. All submitted for. frozen section in one block. D. Specimen received fresh for frozen section labeled. ""level 2L.' It consists of fragments of soft tan tissue. measuring 0.5 X 0.4 X 0.2 cm. All submitted for frozen section in. one block. E. Specimen is received fresh for frozen section labeled. ""4L."" It consists of two irregular fragments of soft black. tissue, one of which measures 5 X 4 X 2 mm. The other measures 4 X. 3 X. It is all submitted in one block for frozen section. F. Received fresh labeled ""level 8"" is a 0.7 cm. in. greatest dimension slightly rubbery tan pink-gray tissue. which is bisected and entirely submitted in one block. AS-1. G. Received fresh labeled ""level 12"" are five fragmented. soft pink-gray tissues ranging from 0.2 to 0.7 cm. in. greatest dimension which are submitted in toto. AS-1. H. Part H is received fresh for frozen section labeled. ""level 7"". It consist of multiple fragments of soft tan and. black tissue measuring 2.3 X 1.7 X 0.3 cm. in aggregate. Some of. the tissue is focally firm. A touch preparation is made and the. entire specimen is submitted in one block for frozen section. I. Received fresh labeled ""right lower lobe"" is a 318. gram, 16.8 X 8.5 X 5.0 cm. lobectomy specimen with a. stapled, 1 cm. in length, 1.4 X 1.1 cm. in diameter bronchial stump. A few soft tan gray tissues in keeping with lymph nodes measuring up. to 0.9 cm. in greatest dimension are recovered from the hilar. region. The pleura is smooth tan-pink-gray. There is a palpable,. centrally cavitary, moderately well circumscribed, 6.0 X 5.0 X 5.0. cm. rubbery tan white tumor mass occupying the superior aspect of. the specimen. The tumor appears to approach the pleura to within. 0.1 cm. The tumor also approaches the hilum but the bronchial stump. is without gross evidence of tumor at the margin. The hilar pleural. is torn and disrupted in the vicinity of tumor, see block 15. A. portion of tumor and a portion of normal are submitted for tissue. procurement as requested. Frozen sections are also performed (see. frozen section diagnosis - FSA tumor, FSB mucosa at bronchial. margin) . The wall of the bronchial stump is markedly calcified and. a complete cross section could not be frozen. Instead, the mucosa. is trimmed away from the margin and submitted for frozen section as. FS2. The parenchyma superior to the lesion is markedly edematous. (see block 9) The parenchyma throughout the remainder of the. specimen is spongiform tan pink-red and no additional mass lesion or. abnormality is identified. Representative sections are submitted in. 12 blocks as labeled. RS-12. BLOCK SUMMARY: 1 - Bronchial stump margin following light. decalcification; 2 - vascular margins; 3-5 - tumor to inked intact. and disrupted (block 5) pleura; 6, 7 - tumor to hilar structures (6. - bronchial stump, 7 - vascular structure) ; 8 - tumor to normal;. 9-11 ran. mainder of specimen; 12 - two whole hilar lymph. nodes. J. Received fresh labeled ""level 9"" are two soft pink-gray. tissues averaging 0.3 cm. in greatest dimension which are. submitted in toto. AS-1. K. Received fresh labeled ""level 11"" are six intact to. fragmented soft pink-gray tissues ranging from 0.3 to 0.6. cm. in greatest dimension which are submitted in toto. AS-1. L. Received fresh labeled ""2R fat pad"" are three. fragmented soft gray pink-gold tissues aggregating 1.7 X. 1.3 X 0.3 cm. which are submitted in toto. AS-1. M. Received fresh labeled ""middle lobe"" is a 7.8 X 7.5 X. 2.9 cm. portion of lung tissue with a stapled 1 cm. length. of apparent bronchus. A staple line is present along one aspect. The staple line is removed and the underlying surface is inked blue. Two soft tan-red tissues in keeping with lymph nodes measuring up to. 1. cm. in greatest dimension are recovered from the vicinity of the. bronchus. The pleura is smooth tan-pink. On sectioning, no. discrete mass lesion is identified. The parenchyma is uniformly. spongiform tan pink-red. Representative sections are submitted in. eight blocks as labeled. RS-8. BLOCK SUMMARY: 1 - Bronchial stump margin; 2-7 - random parenchyma;. 8 - two whole lymph nodes. N. Received fresh labeled ""bronchus intermedius proximal. margin"" is a 1.5 X 1.3 X 1.0 cm. rubbery tan white tissue. with multiple associated staples. The staples are rem. e. specimen is entirely submitted in one block. AS-1. MICROSCOPIC DESCRIPTION. A-H. Microscopic examination performed. I. Histologic type: Squamous cell carcinoma. Histologic. grade: Moderately differentiated. Primary tumor (pT) : The tumor measures 6 cm. in greatest dimension,. pT2b. Central cavitation is present. Margins of resection: The pleura and vascular margins are negative. for tumor. The mucosa trimmed away from the bronchial margin and. submitted for frozen section is negative for tumor. However,. following decalcification, the complete cross section of the. bronchus (which might be slightly distal to the actual resection. margin) contains squamous cell carcinoma infiltrating the full. thickness of the bronchus. It is difficult, therefore, to. ascertain status of the actual surgical margin but carcinoma is at. least quite close. Direct extension of tumor: None identified. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Arterial invasion present,. supported by stain for elastic on block #3. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : In addition to the lymphoid tissue found. in parts B-H and in J-M, this right lower lobe specimen contains. five lymph nodes, one of which contains carcinoma by direct. extension. (pN1). Distant metastasis (pM) : Cannot be assessed. Other findings: There is a rare minute focus of acute. bronchopneumonia. Also, between the tumor and the pleura there are. foci of obstructive type pneumonia. J-N. Microscopic examination performed. 14x5, 15, 64x2, 16, 5x2, 4x3, 3x9, 18. DIAGNOSIS. A. Level 1, excision - Fibrofatty tissue negative for tumor. B. Level 7, excision - Lymphoid tissue with anthricosis, negative. for tumor. C. Level 4, excision - Lymphoid tissue with anthricosis, negative. for tumor. D. Level 2L, excision - Lymphoid tissue, negative for tumor. E. Level 4L, excision - Lymphoid tissue, negative for tumor. F. Level 8, excision - Reactive lymph node with anthricosis,. negative for tumor. G. Level 12, excision - Portions of lymphoid tissue with. anthricosis, negative for tumor. H. Level 7, excision - Portions of lymphoid tissue with. anthricosis, negative for tumor. I. Right lower lobe of lung, lobectomy - Right lower lobe of lung. with 6 cm., cavitating moderately differentiated squamous cell. carcinoma, with arterial invasion. Bronchial margin at least suspicious for tumor. Five peribronchial lymph nodes, one of which is positive for. tumor by direct extension, 1/5. Obstructive pneumonia and small foci of acute bronchopneumonia. J. Level 9, excision - Two lymph nodes negative for metastatic. disease, 0/2. K. Level 11, excision - Six lymph nodes all negative. for metastatic disease, 0/6. L. 2R fat pad, excision - Three lymph nodes all negative for. metastatic disease, 0/3. M. Middle lobe, lobectomy - Right middle lobe, no significant. pathology. Bronchial margin negative for tumor. Two peribronchial. lymph nodes negative for metastatic disease, 0/2. N. Bronchus intermedius proximal margin, excision - Bronchus with. marked calcification, negative for tumor. End Of Report ---.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
From. To. P.8/33. RIGHT AXILLA, SENTINEL #1, SENTINEL NODG BIOPSY -. AVILLARY LYMPH NODE. NEGATIVE FOR METASTATIC TUMOR (0/1). FART 2: LYMPH NODE. LEFT AXILLA, SENTINEL #1, SENTINEL NODE BIOPSY -. ONE AXILLARY LYMPH NODE, NEGATIVE FOR METASTATIC TUMOR (0/1). PART 3: LYMPH NODE, LEFT AXILLA, SENTINEL #2, SENTINEL NODE BIOPSY -. ONE AXILLARY LYMPH NODE. NEGATIVE FOR METASTATIC TUMOR (0/1). PART 4: BREAST, LEET, SIMPLE MASTECTOMY. A. INVASIVE DUCTAL CARCINOMA NO SPECIAL TYPE. B. NOTTINGHAM GRADE 3 (TUBULETORMATION: 3, NUCLEAR PLEOMORPHI8M: 3, MITOTIC ACTIVITY: 2; TOTAL. SCORE - a/9). c. THE INVASIVE TUMOR MEASURES APPROXIMATELY 2.0 CM IN LARGEST DIMENSION (FIVE CONTIGUOUS. SECTIONS). D. THE INVASIVE CARCINOMA 18 LOCATED AT THE JUNCTION OF UPPER INNER AND LOWER INNFR. QUADRANTS. E. LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. F. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. G. THE NIPPLE 18 NEGATIVE FOR TUMOR. H. THE SKIN IS NEGATIVE FOR TUMOR. I. CALCIFICATIONS ARE ASSOCIATED WITH INVASIVE CARCINOMA AND BENIGN BREAST PARENCHYMA. J. ATYPICAL DUCTAL HYPERPLASIA. K INTRADUCTAL PAPILLOMA. L. THE NON-NEOPLASTIC BREAST SMOWS DUCTAL EFITHELIAL HYPERPLASIA, ADENOSIS AND FIBROCYSTIC. CHANGES. M. PREVIOUS BIOPSY SITE CHANGES. N. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT "". PART 5; BREAST, RIGHL SIMPLI MASTECTOMY -. A. INVASIVE DUCTAL CARCINONA NO SPECIAL TYPE. B. NOT TINGRAM GRADE 2 (TUBULE FORMATION: 2. NUCLEAR PLEOMORPHISM: 2. MITOTIC ACTIVITY: 2; TOTAL. SCORE - 8/9). C. THE INVASIVE TUMOR MFASUBEE. D. E. THE DCIS CONSTITUTES -10% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED WITH THE INVASIVE. DUCTAL CARCINOMA IN SITU (DCIS). CRIBRIFORM AND SOLID TYPES WITH MINIMAL NECROSIS. COMPONENT. F. LYMPHOVASCULAR SPACE INVASIÃN IS IDENTIFIED. G. RESECTION MARGINA ARE NEGATIVE FOR CARCINOMA. H. THE INVASIVE CARCINOMA IS LOCATED AT THE UPPER OUTER QUADRANT. I. THE NIPPLE IS NEGATIVE FOR TUMOR. J. THE SKIN IS NEGATIVE FOR TUMOR. K. ATYPICAL. DUCTAL HYPERPLASIA. L. THE NON-NEOPLASTIC BREAST SHOWS FIBROCYSTIC CHANGES WITH ASSOCIATED. MICROCALCIFICATIONS. M. PREVIOUS BIOPSY SITE CHANGES. N. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT. CASE SYNOPSIS: SYNOPTIC -PRIMARY INVASIVE CARCINOMA OF BREAST. LATERAI.ITY: I on. PROCEDURE. Simple mastectoniy. Upper inner quadrant. Lower inner quadrent. SIZE OF TUMOR: Maximum dimension invasive component: 2.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal sdenocarcinonia, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation 3. Mitolic activity score. 2. Total Nottingham scure: 8. Nultingham grade (1. 2. 3). 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Ycs. benign zonas. Yes. malignant zones. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: LYMPM NODES POSITIVE: o. I. YMPH NODES EXAMINED: 2. METHOD(S) OF LYMPN NODE EXAMINATION: HIVE stoin. SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH, Papilloma, rco. 1 STAGE, PATHOLOGIC: pTic. N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zoro or 1+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Pathologic Diagnosis: A. Lymph node, level 9R, excision: One lymph node, negative for metastatic tumor. Frozen section diagnosis confirmed. B. Lung, right upper lobe, lobectomy: Adenocarcinoma. Specimen: Right upper lobe of lung. Procedure: Lobectomy. Specimen laterality: Right. Tumor site: Upper lobe. Specimen integrity: Intact. Tumor size (greatest dimension): 2.7 cm. Tumor focality: Unifocal. Tumor histologic type: Adenocarcinoma. Tumor grade: Moderately differentiated. Visceral pleura invasion: Not identified. Tumor Extension: N/A. Margins: Bronchial: Negative for tumor (final margin negative for tumor). Vascular: Negative for tumor. Parenchymal: Negative for tumor. If all margins uninvolved by invasive carcinoma: Distance of invasive carcinoma from closest margin: At least 4 mm. Specify margin: Bronchial. Treatment effect: Not applicable. Lymph-vascular invasion: Not identified. Pathologic staging (pTNM): TNM Descriptors: None. Primary tumor: pT1b. Regional lymph nodes: pNo. Distant metastasis: pMX. Additional pathologic findings: Calcified nodule (0.5 cm). consistent with old granuloma. Focal calcification and foreign body giant cell. reaction. Emphysematous changes. C. Lymph node, level 7, excision: Three lymph nodes, all negative for. metastatic tumor but one with calcified granuloma. D. Lymph node, 10R, excision: Two lymph nodes, both negative for metastatic. tumor, but with calcified/fibrotic granulomas. No acid fast organisms identified on AFB stain. Rare yeast forms identified on GMS stain consistent with Histoplasma. capsulatum. E. Lymph node, 4R, excision: One lymph node, negative for metastatic tumor. F. True proximal bronchial margin, excision: No malignancy identified. Frozen section diagnosis confirmed. The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSA: Level 9: One lymph node, negative for malignancy. Tissue fragmented from truck,. only one section obtained. F/S TAT: 16 mins. FSB1: Right upper lobe, bronchial margin: Tumor present within bronchus. FSB2: Right upper lobe, mass: Non small cell carcinoma, favor adenocarcinoma. F/S TAT: 37 mins. FSF: Free edge true proximal margin: Negative for malignancy. F/S TAT: 20 mins. Gross Description: A. Received fresh, labeled ""level 9R"" is a 1.0 X 0.5 X 0.2. cm tan, irregular soft tissue, entirely exhausted for frozen section diagnosis. A permanent tissue block is not submitted. B. Received fresh, labeled ""right upper lobe"" is a 13.7 X. 10.8 X 3.8 cm lobe of lung with 0.4 cm of exposed bronchus. The pleura is. purple-pink, smooth, glistening with a single staple line extending from the. hilum. Sectioning reveals a 2.7 X 2.5 X 1.7 cm tan, soft, heterogeneous well. delineated mass that abuts the pleura, coming to within 1.5 cm from the. bronchial margin and 1.8 cm from the nearest staple margin. Located 7 cm from. the mass, at the periphery is a 0.5 X 0.4 X 0.3 cm tan, firm markedly calcified,. well delineated nodule that comes to within 0.3 cm from the pleura. The. uninvolved parenchyma is tan-pink, soft, heterogeneous with markedly distended. air spaces. There are three tan to black anthracotic hilar lymph nodes. identified up to 0.7 cm. The bronchial margin is taken en face and submitted. for frozen section microscopy, now in cassette B1. A portion of the mass. is. submitted for frozen section microscopy as FSB2, now in cassette B2. Representative sections of the remaining tissue are submitted as follows: B3. vascular margins taken en face;. B4. nearest inked stapled margin taken perpendicular;. B5-6. mass to pleura;. B7. random mass;. B8. smaller nodule in its entirety, submitted following decalcification;. B9. uninvolved parenchyma;. B10. one whole lymph node bisected;. B11. two whole possible lymph nodes. C. Received in formalin, labeled 'level 7 lymph nodes"" are. three tan to black, irregular soft tissues ranging from 0.5 X 0.4 X 0.2 cm to. 1.4 X 1.0 X 0.2 cm, submitted in toto in one cassette. D. Received in formalin, labeled ""10R lymph nodes"" are two. tan to black, irregular soft tissues, 0.7 X 0.6 X 0.2 cm and 1.5 X 0.9 X 0.3 cm. The specimens are entirely submitted as follows: D1. smaller specimen bisected;. D2. larger specimen trisected. E. Received in formalin, labeled ""4R lymph nodes"" is a 1.1. X 0.7 X 0.3 cm tan, irregular soft tissue, trisected and entirely submitted in. one cassette. F. Received fresh, labeled. ""free edge true proximal. margin"" is a 2.3 X 0.4 X 0.4 cm irregular portion of apparent bronchus. containing multiple staples and sutures. A portion is submitted for frozen. section microscopy, now in cassette F. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Takert.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
ORIGINAL REPORT. SPECIMEN: A. Mass head of pancreas,. B. Body of pancreas. c. Gallbladder. p. Bile duot margin. E. Hepatio artery node. F. Pancreas margin. G. Whipple's specimen. CLINICAL EISTORY: Fancreatic mass. DIAGNOSIS: A: PANCIREAS, (HEAD), . BIOPSY: INVASIVE DOCTAG ADENOCARCINGMA. B: PANCIRIZAS, (BODY), BIOPSY: CHRCONIC PANCREATITIS. C1 GALLBLADDER, CHOLICYSTECTONY: CERONIC CEOLECYSTITIS. ONE BENZGN LYMPH NODE (0/1). D: (BILE DUCT KARGIN), BIOPEX. CONSISTENT WITH LOW GRADE DYSPLASIA. E: LYMPH NODK, (HEPATIC ARTERY), EXCTSION: METASTATIC ADEROCARCINCHA IS PRESENT (1/1). NO EXTRANODAL SOFT ZISSUN EXTENSTON IS SEEN. (RANCHEAS MARQIN), BIOPSY: CONSISTENT NITH CHRONIC PANCREATITIS. @;. WITH PARTIAL GASTRECTOWY: KODERATELY DIFTERENTIATED INVASIVE PANREATOBILIARY DUCTAL. ADENOCARCINCHA. TOMOR SIZE - 6.1 X 4.5 x 2.0 CM. TUMOR EKTENDS zarro THE SOFT TISSUE, AND EXTENDS TO. LATERAL RESECTION MARGINS. THE DUODENAL MUCOSA IS INVOLVED. THE COMNON EIZE DUCT MARGIN BHOWS LOW GRADE DYSPLASIA. THE PROKIMAL (GASTRIC) AND DISTAL (DUODENAL) MARGING ARK FRKE OF. TUNOR. TRE PANCREATIC RESECTION MARGIN DEMONSTRATES ETRA-PANCREATI. CARCINOMA INVOLVING SMALE NERVES. LYMPRVASCULAR AND PRRINEURAL INVASTOR ann. DIAGNOSIS: LYMPH NODES: METASTATIC CARCINONA IS PRESENT IN ane OF TWO COMNON BILE DUCT LYMPH. NODES (1/2). METASTATIC CARCINONA (NITH EXTRNODAL SOFT TISSUE EXTERSICN) IS. PRESKNT IN FOUR OF NINE PERIDUODENAL LYNPH NODIS (4/9). METASTATIC CARCINOMA (WITH EXTRANODAL sort TISSUE EXTENSION) IS. PRESHNT IN NINE OF NINE LYMPE NODES (9/9). zus PANCREAS HAS PRATURES OF CERONIC PANCREATITIS. THE STOMACH BEOWS A HILD REACTIVE CASTRITIS. TEK HAS ACUTE ISCERNIC CHANGES DISTALLY. GROSS DESCRIPTION: A. The specimen connists of one of tan tissue measuring 0.3 cm. Embedded in toto as QS. B. The specimen consiets of one core measuring 1.5 am in length and 0.1 em in. diameter. Embedded in toto as Q8. c. The specimen consists of an intact cholecystection specimen measuring 7.0. x 2.8 x 2,5 am. There de a 0.4 am possible cyetio node identified submitted. in C1. The cystic duct is 0.3 en in diameter. There are no gallstones and. the bile ig thick and green. The nucosa is unremarkable and the wall. thickness is 0.1 cm. There is a thickening near the cyatic duct and a fold is. present within the mucosa. Representative sections of duct and wall are. submitted in C2, section of thickened fold is submitted in C3. D. The specimen consists of a white duct with two lumens, the diameter of the. firmt in 0.6 and the dismeter of the other is 0.7 cm. The specimen ie. submitted in toto in cassette D. E. The specimen consista of a tan-brown node, 1.5 x 1.5 x 0.3 cm. Submitted. in toto in cassette E3. HUSTOPATHOLOGY REPORT. Division Hend+. GROSS DESCRIPTION: F. The specimen connists of one piece of tan rissue measuring 0.9 x 0.4 x 0.1. cm, Embedded in toto as QS. G. The specimen consista of pancreaticoduodenectomy with partial. gastrectony. The entire specimen from proximal to distal measures 22.5 x 6.0. cm. and is painted with silver nitrate. The gastric segment measures 2.5 x 6,5. cm, and the duodenal segment is 20.0 x 6-0 on. The pancreatic head measures. 6. x:4,5-x-2.0 am. The pancreatic resection margin is painted blue,. The gastric segment is unremarkable, The serosal surface of the duodenum han. mild adhesions: The distal portion of the duodenal mucosa has & duaky. appearance. Just by the ampulla of vater, there is a 1.3 x 0.7 cm ulcerated. lesion. Deep to this, there is a frim grey area that lies in continuity with. the pancreatic head. The acamon bile duct ie opened, and is patent. At the. more proximal aspact, towards the cyattic duct, it is hemorrhagio. The. pancreatic duct, however, is not probe patent, Two lymph nodes are identified. near the common bile duct, measuring 2.0 om and 1.7 am, respectively, on. sectioning the pancreatic head, the out gurface ie a tan-grey and firm with a. central brown-red focus around the duct. The firm area is in continuity with. the duodenal, wall, and this abnormal area of pancreas measures approximately. 3. o x 2.2 x 1.1 cm. specimen 18 also submitted for the ampulla study, where a 3.0 x 3.0 cm block. of duodenum with ampulla of vater is taken and gerially sectioned. Specimen is eubmitted as follows: G1. enface common bile duct. G2. larger common bile duct node. G3. second common bile duot node bisected. G4. proximal perpendicular resection margin. 35,. distal perpendicular resection margin. 06. transition of possible normal duodenal mucosa to ischemic. G7,. representative section of normal duodenum. GB. perpendicular section of the common bile duct with painted black. margin. G9. enface shave of pancreatic resection margin. G10-11. transected first section furthest from the ampulla. G12-13. following serinl section. G14-16. following serial section trisected.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Larynx. I-) ""Biopsy of the left vocal fold"": - Invasive moderately differentiated squamous cells carcinoma. II-) "" Right neck dissection specimen level IV"": - Absence of neoplasia (0/5). III) ""Right neck dissection specimen level III"": - Absence of neoplasia (0/18). IV-) ""Right neck dissection specimen level II"": - Absence of neoplasia (0/8). V-) ""Left neck dissection specimen level II"": - Absence of neoplasia (0/17). VI-) ""Left neck dissection specimen level III"": - Metastatic squamous cell carcinoma in one lymph node (1/7), without capsular. involvement. VII) ""Left neck dissection specimen level IV"": - Absence of neoplasia (0/11). VIII) Product of thyroid and larynx ressection. - Moderately differentiated squamous cell carcinoma, measuring 5.0 x 3.0 cm on the. greatest dimensions, affecting the following structures: Glottic, supraglottic and infraglottic regions on the left. Infraglottic on the right. Piriform sinus on the left. Cricoid, arytenoid and thyroid cartilages. Thyroid isthmus. Soft tissues adjacent to the larynx. Trachea. - Angiolymphatic and perineural invasion not observed. - Left soft tissue margins involved by neoplasia. - Other surgical margins uninvolved by neoplasia. - Right thyroid lobe with no particularities. - Small follicular adenoma on the left thyroid lobe. SUMMARY OF HISTOLOGICAL FINDINGS: - Grade 2 squamous cell carcinoma of the larynx, transglottic on the left and infraglottic. on the right with involvement of the adjacent soft tissues, thyroid and hypopharynx on. the left. - Right lymph nodes: 0/31. - Left lymph nodes: 1/35 without capsular involvement.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Sex: F. Physic. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. COMMENT: Decalcification of mandibular bone revealed involvement of cortical bone by. squamous carcinoma. Entire report and diagnosis completed by: Report released by: ENTIRE. DIAGNOSIS. (A) RIGHT HEMIMANDIBULECTOMY: INVASIVE WELL DIFFERENTIATED SQUAMOUS CARCINOMA, MARGINS FREE OF. TUMOR. Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) RIGHT HEMIMANDIBULECTOMY - Overall measurement of 15.0 x 2.5 x 1.5 cm. Attached to the anterior bony segment is a soft tissue fragment with overall. measurements of 4.5 x 3.0 x 2.0 cm. within the soft tissue an ulcerated and. necrotic lesion 2.5 x 1.0 x 1.0 cm is noted. The anterior surgical margin. appears uninvolved and the deep soft tissue margin is free of gross tumor. Representative sections are submitted from anterior to posterior as A1-A8. SNOMED CODES. M-01100 M-09400 M-54000 T-1A000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Sigmoid cancer,. Spedimens Submitted: 1: SP: Sigmoid colon. 2: SP: Proximal donut. 3 SP: Distal donut. DIAGNOSIS: 1. LARGE BOWEL, SIGMOID, RESECTION;. - TUMOR TYPE; ADENOCARCINOMA, MODERATELY DIFFERENTIATED,. TUMOR LOCATION: SIGMOID. - TUMOR SIZE; LENGTH IS 4.4 CM, WIDTH IS 3.7 CM. GROSS CONFIGURATXON FONGATING. - PREEXISTING POLYP (AT THE SITE OF THE CARCINOMA) : IDENTIFIED, OF. TUBOLOVILLOUS TYPE,. - TUMOR INVASION: INVASION INTO MUSCULARIS PROPRIA,. GROSS TUMOR PERFORATION: NOT IDENTIFIED,. SBROSAL INVOLVRMENT; NOT IDENTIFIED. - VASCULAR INVASION: NOT IDENTIFIED. - PERINEURAL INVASION: NOT IDENTIFIED,. - SURGICAL MARGINS (FOR COLONIC TUMORS) : FREE OF TUMOR. - POLYPS (AWAY FROM THE CARCINOMA) : NUMBER IDENTIFIED: MUL/TIPLE, TYPE. IDENTIFIED: HYPERPLASTIC POLYP. TATTOO PIGEMNT IS NOTED INVOLVING MUSCULARIS PROPRIA IN THE AREA ADJACENT. TO THE TUMOR, CONSISTENT WITH PRIOR BIOPSY SITE. THE PATHOLOGIC STAGE IS. pT2. TUMOR INVADES. MUSCOLARIS PROPRIA. LYMPH NODES: NUMBER WITH METASTASES: 0, NUMBER EXAMINED: 17. - THE PATHOLOGIC STAGE IS. pNO. NO REGIONAL LYMPH NODE. METASTASES ARE IDENTIFIED. 2. COLON, PROXIMAL DONUT, EXCISION: . UNREMARKABLE COLONIC TISSUE,. COLON, DISTAL DONUT; EXCISION: - UNKEMARKABLE COLONIC TISSUE. x ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1.) The apecimen is received freah and is labeled ""sigmoid colon"", rt. consiets of a segment of colon that measurea 13.8 Cm in length by 6. cm in. circumference at proximal resection margin (inked yellow) and 8.0 cm in. circumference at distal resection margin (inked blue). The serosal purface. is smooth. The specimen is opened to reveal a pink fungating tumor that is. located 4.0 cm from the distal margin and 4.2 Cm from proximal margin. The. tumor measures 4.4 cm in length and 3.7 cm in width, Serial sectioning. reveals tumor invasion to a depth of 0.1 Cm, which is 0.5 cm from the. Berosa. The remaining mucosa shows at least 16 polyps measuring from 0.2 to. 0.4 cm in greatest dimension. Pericolic and peri-rectal adipose tissue is. thoroughly examined for lymph nodes, and all possible nodes are submitted. Representative sections are submitted The tumor is entirely submitted. TPS. is submitted. Summary of sections: PM -- proximal margin. DM -- distal margin. T -- tumor. 1 .. uninvolved muÃ§osa. P polyps. LN -- lymph nodes. 2) The specimen is received in formalin, labeled ""proximal donut"" and. consiste of a ring of pink tan soft tipsue measuring 2 x 2 x 1.5 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic, The sutures and staples are removed and the soft. tissue in entirely submitted. Summary of sections: J--undesignated. 3). The specimen is received in formalin, labeled ""Distal donut"" and. consists of a ring of pink tan soft tissue measuring 2.5 x 2.2 x 1.3 cm. the mucosa is removed and entirely submitted. Summary of nections: U-+undesignated. Summary of Sections: Part 11 SP: sigmoid colon. Block. Sect. Site. PCa. dm. 1. In. 18. 6. 5. 5. 1. 1. pm. 3. 3. Part 2: SP: Proximal donut. sect. site. PCs. Block. Part 3: SP: Distal donut. Block. Sect. Site. PCB. 1. u. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Laboratory Patient Renort. Print Date/Time: Histopathological Examination. Complete. Pre-Op Diagnosis : Hematuria/Renal Mass. Specimens. Kidney, Right. Frozen Diagnosis. : GROSS EXAMINATION: The specimen is received in a container labeled with the. name of the patient and labeled as kidney, right. The. specimen consists of a kidney and attached perinephric fat. which measures en bloc 22 X 13 X 8 cm and weighs 1154 g. The ureter and vascular margins of resection are submitted. in block 1. Sectioning into the kidney shows a central. oval, golden-yellow, focally hemorrhagic mass which measures. 6.3 X 5 X 4 cm. The mass bulges against the capsule but. does not grossly appear to extend through the capsule. Sections of the capsule are submitted in blocks 2-3. Sections of the mass are submitted in blocks 4-8. The. cortex averages 0.7 cm. The pelvis and calyces are not. grossly dilated. A random section of kidney is submitted in. block nine. The attached fat is dissected and no lymph nodes. or adrenal tissue is identified. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION. SPECIMEN TYPE: Radical nephrectomy. LATERALITY Right kidney. TUMOR SITE: Middle. FOCALITY Unifocal. TUMOR SIZE (LARGEST TUMOR IF MULTIPLE) : 6.3 x 5 X 4 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. HISTOLOGIC GRADE (FUHRMAN NUCLEAR GRADE) : G3. EXTENT OF INVASION. PRIMARY TUMOR (PT) : pT1b (tumor 4-7 cm, limited to kidney). REGIONAL LYMPH NODES (PN): pNX (cannot be assessed). DISTANT METASTASIS (PM) : pMX (cannot be assessed) . MARGINS Uninvolved by invasive carcinoma. ADRENAL GLAND: Not present. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of. 2. VENOUS (LARGE VESSEL) INVASION (v) : Absent. LYMPHATIC (SMALL VESSEL) INVASION (L) : Absent. [T-71000 M-83103 189.0 P3-44070]. pTNM summary: pT1bNXMX. Intradepartmental consultation was obtained. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. 1. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - stomach. Expected time of examination: Clinical diagnosis: Gastric cancer. Macroscopic description: The tested material consisting of the stomach, having been cut out along the greater curvature sized 18 x 13 cm with. the omentum sized 23 X 7 x 2 cm. Tumour sized 5.3 X 3.9 X 1.8 cm found on the front wall. Distance from the proximal boundary: 5.4 cm, from distal boundary: 9.2 cm. Microscopic description: Adenocarcinoma tubulare necroticans venticuli (G2, intestinal type) - in tilt ratio parietis totae ventriculi. The incision lines and omentum free neoplastic lesions. Nodes of lesser curvature: metastases in lymphonodis (II/X). Nodes of greater curvature: metastases in lymphonodis (III/IX). Histopathological diagnosis: Adenocarcinoma tubulare ventriculi. Tubular adenocarcinoma of the stomach. Metastases in lymphonodis. Cancer Metastases in. lymph nodes (V/XIX). (G2, pT2, pN2).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. SLN #1. B. LEFT BREAST EXCISION. C. ADDITIONAL MARGIN MEDIAL, ANTERIOR, POSTERIOR. SPECIMEN(S): A. SLN #1. B. LEFT BREAST EXCISION. C. ADDITIONAL MARGIN MEDIAL, ANTERIOR, POSTERIOR. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA-SLN #1: Negative for tumor called by Dr to Dr at. B: Gross only, tumor 0.1 cm from medial margin called by Dr. to Dr. at. GROSS DESCRIPTION: A. SLN #1. Received fresh is a 3.5 x 1.1 x 0.4 cm piece of soft tissue containing a lymph node. A touch prep is performed;. lymph node is submitted in cassette A1. B. LEFT BREAST. Received fresh labeled with the patient's identification and ""left breast"" is an oriented (single-anterior, double-lateral). 43 g, 4.1 x 3.2 x 3 cm lumpectomy without radiograph. The specimen has been inked in OR per protocol: Anterior-. yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-orange. Specimen is serially sectioned from. lateral to medial into 6 slices revealing a 1.9 x 1.4 x 1.3 cm firm tan circumscribed mass that is closest to the medial. margin at less than 0.2 cm. Tissue is procured. Representatively submitted. B1: lateral margin, perpendicular sections. B2: slice 3, mid posterior, mass. B3: slice 3, posterior inferior, mass. B4: slice 4, lower anterior, mass. B5: slice 5, superior anterior. B6: slice 5, superior posterior. B7: slice 5, mid anterior. B8: slice 5, mid posterior, mass. B9: slice 5, inferior anterior. B10: slice 5, inferior posterior. B11-B12: medial margin, perpendicular sections. C. ADDITIONAL MEDIAL, ANTERIOR-POSTERIOR MARGIN. Received fresh labeled with the patient's identification and ""additional medial, anterior-posterior margin"" is an. oriented (suture at final margin) 7 g, 0.7 x 3.2 x 0.9 cm fibrofatty tissue. Final margin is inked black. Serial. sectioning reveals no discrete lesions. Entirely submitted in cassettes C1-C5. DIAGNOSIS: A. LYMPH NODES, SENTINEL #1 left axilla, excision: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). B. BREAST, LEFT, WIDE LOCAL EXCISION: - INVASIVE ductal CARCINOMA, SBR GRADE 3, MEASURING 1.6-CM. - Tumor present 2-mm from inferior surgical margin (closest margin). -biopsy site changes with fibrosis. - SEE SYNOPTIC REPORT. C. BREAST, ADDITIONAL MEDIAL ANTERIOR POSTERIOR MARGIN, EXCISION: - BREAST TISSUE, NO TUMOR SEEN. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.6cm. Tumor Site: Upper outer quadrant. Margins: Negative. Distance from closest margin: 0.2cm. inferior. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/1. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: Left breast infiltrating cancer upper outer quadrant. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. Microscopic/Diagnostic Dictation: Final Review: Pathologist,. Final: Pathologist,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) BLADDER TUMOR: UROTHELIAL CARCINOMA, HIGH-GRADE, INVASIVE INTO MUSCULARIS. PROPRIA. LYMPHOVASCULAR INVASION PRESENT. Fragments of bladder wall including muscularis propria show chronic. inflammation and granulation tissue consistent with previous biopsy site. GROSS DESCRIPTION. (A) BLADDER TUMOR - Received are multiple fragments of tan-pink to. gray-white soft tissue aggregating to 2.2 X 1.1 X 0.5 cm. The specimen is. submitted entirely in A. CLINICAL HISTORY. Bladder CA.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Sex: F. Source of Specimen(s): 1: Para caval Lymph Node. 2: Right Kidney, resection. 3: Para caval Lymph Node. 4: Peri renal fat. Gross Description: Received in four parts. Source of tissue: 1. Labeled #1, ""paracaval lymph node"". Intraoperative Consultation: NO TUMOR SEEN PER. VERIFIED). Gross Description: Received fresh for frozen section diagnosis labeled. "", paracaval lymph node"" is a 1.8 x 1.1 x 0.6. cm brownish-tan firm rounded lymph node. Submitted entirely for frozen. section as IFSA. Source of tissue: 2. Labeled #2, ""right kidney"". Gross Description: Received fresh labeled. right kidney"" is a 273 gram/13 X 7 x 5 cm kidney partially covered by. retracted perinephric fat. Upon sectioning, obliterating approximately. two-thirds of the kidney by volume located within the mid/inferior pole is. a 8.5 x 5.5 x 5.0 cm hemorrhagic golden orangish-tan partially necrotic,. encapsulated rounded tumor mass. Along the outer surface vantage point. this mass appears very unevenly lobulated, and some points appear to. extend through the capsule to the inked outer surface. Also, this. impinging mass significant reduces the volume of the pelvocaliceal. collecting system, and the remaining viewable pelvic mucosa appears. pale-tan and glistening. The outer superior pole kidney surface is. lobulated, and this somewhat normal appearing renal parenchyma has. somewhat demarcated corticomedullary borders with a cortex thickness of. 0.9 cm. Upon opening, the 13.5 x 0.5 cm uninvolved ureter has an. unremarkable mucosal surface, and a very short vein segment is probed. closely along, but uninvolved by a tumor edge. Within the hilar fat are three pale grayish white hard rounded metastatic. appearing lymph nodes ranging in size 0.4-0.9 cm, and within the superior. pole fat is a 0.9 cm hemorrhagic firmness for probable lymph node, and no. obvious adrenal gland. Representative sections9. Designation of Sections: 2A vascular and ureteral margins. 2B/2C. capsule invasion?, and tumor in relation to normal kidney. 2D additional. tumor along outer surface. 2E/2F tumor in relation to pelvic mucosa. 2G. tumor in relation to vein. 2H superior pole. 2I lymph nodes. Source of tissue: 3. Labeled #3, ""paracaval lymph node"". Gross Description: Received fresh labeled'. paracaval lymph node"" is an 8 x 1.5 x 0.5 cm portion of soft lobulated fat. containing four potential lymph nodes ranging in size 0.2-1.9 cm. The. largest lymph node is color-coded by the application of black ink prior to. sectioning. Entirely submitted in 3A. Source of tissue: 4. Labeled #4, ""fat around kidney"". Gross Description: Received fresh labeled'. fat around kidney"" is a 6.5 x 5.5 X 0.4 cm portion of partially. hemorrhagic soft lobulated fat. Upon palpation, the 0.3 x 0.2 cm firm. focus is designated by the application of black ink. Otherwise, there are. no other obvious findings. Representative sections) 1. Final Diagnosis: 1. Paracaval lymph node, excision: - No tumor seen in one lymph node, (0/1). 2. Right kidney, nephrectomy: - Papillary renal cell carcinoma type 2, 8.5 cm, involving renal sinus and. perinephric fat. - Surgical resection margins are free of carcinoma. - Metastatic papillary renal cell carcinoma involving four of five hilar. lymph nodes, (4/5). - Extracapsular extension is identified. 3. Paracaval lymph nodes, excision: - No tumor seen in eight lymph nodes, (0/8). 4. Fat around kidney, excision: - Benign adipose tissue. pTNM: T3 N2 Mx.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
locally R0, additionally a villous adenoma with focally severe dysplasia (intraepithelial neoplasia. of the hisk-risk type) and a serrated adneoma and free lymph nodes (pN0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. RIGHT COLON RESECTION. B. LIVER BX. DIAGNOSIS: RIGHT COLON, RIGHT HEMICOLECTOMY: - EXOPHYTIC ULCERATED INVASIVE MODERATELY DIFFERENTIATED. ADENOCARCINOMA OF CECUM ARISING IN TUBULOVILLOUS ADENOMA. WITH FULL MUSCLE WALL THICKNESS INVASION AND EXTENSION TO. SUBSEROSAL FAT, METASTASIS TO TWO OUT OF TEN PERICOLIC LYMPH. NODES (2/10). - PROXIMAL AND DISTAL MARGINS OF RESECTION, NEGATIVE FOR TUMOR. - SIZE OF TUMOR -4 X 3.7 X 3.5 CM. LIVER, BIOPSY: - METASTATIC ADENOCARCINOMA CONSISTENT WITH METASTASIS FROM. THE ABOVE CECAL ADENOCARCINOMA. COLORECTAL CANCER TEMPLATE. Tumor Size (cm): 4 X 3.7 X 3.5 cm. Histologic Type: Adenocarcinoma. Grade/Differentiation: G2, Moderate. Invasion Depth: Subserosa. Invasion Vasc/Lymphatic: Invasion Perineural: Absent. Extension to Adj. Areas: Margins: Free. Lymph Nodes: N1, Positive (2/10). Stage Pathology: pT3N1. Implants: Absent. Precursor: Present - tubulovillous adenoma. Non-neoplastic areas: Staging: Tis: CIS. T1: Submucosa, Intraepithelial or invasion of lamina propria. T2: Into muscularis propria. T3: Thru muscularis propria. T4: Thru peritoneum or to other areas. Includes invasion of other segments of the colorectum by way of the serosa. Regional Lymph Nodes (N). NO: No lymph node metastasis. N1: 1-3 Lymph nodes positive. N2: ? 4 Lymph nodes positive. 7-14 Lymph nodes should be examined. SPECIMEN(S): A. RIGHT COLON RESECTION B. LIVER BX. CLINICAL HISTORY: with ca. colon. GROSS DESCRIPTION: RIGHT COLON RESECTION. Specimen consists of resected short segment of right colon measuring 15 cm in length. with attached. adherent indurated adipose tissue. Large firm palpable mass occupies mid portion of the specimen. which when the specimen is opened, shows an obstructing circumferential exophytic tumor measuring. 4 X 3.7 X 3.5 cm, involving cecum and extending to ileocecal valve and seen 3 cm from ileal margin and. 6 cm from distal colonic margin of resection. The tumor on sections shows a tan-cream-white surface. and infiltrates entire colonic wall with apparent extension to subjacent adipose tissue. Tumor occludes. cecal lumen. Attached adipose tissue measures 11 X 5 X 2.5 cm. Appendix is not identified. Multiple. sections submitted and labelled as follows. A1-A4: one transverse section of tumor divided into four sections. A5-A7: additional tumor representative. A8: colonic margin. A9: representative of colon. A10: representatives of ileum. A11: distal ileal margin. A12: three lymph nodes, one bisected and inked. A13: three lymph nodes, one inked and bisected. A14: three lymph nodes. A15: one bisected lymph node. LIVER BIOPSY. Received in formalin is a portion of tan brown soft tissue measuring 1.2x0.7x0.5cm. which is previously. partially bisected. The specimen is further sectioned and submitted completely in cassette B.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
RIGHT UPPER LOBECTOMY. Clinical Details: Right upper lobectomy for carcinoma of lung. Patient has been exposed to asbestos. Four specimens submitted: 1: RIGHT UPPER LOBE. Macroscopy: The specimen consists of a lobectomy specimen measuring 170 x 70 mm with a depth of up to 80 mm. Some puckering is present over the lateral pleural surface. The tumour measures 75 x 55 x 75 mm and. abuts, does not clearly penetrate, the pleural surface. The tumour appears at least 20 mm clear of the. hilar resection margin. There is no obvious endophytic bronchial component to the tumour, although it. clearly is associated with bronchial structures. A separate small pleural nodule is identified, 45 mm. from the nearest tumour. [Bronchial resection margin, 1A; vascular resection margin, 1B; hilar lymph. nodes, 1C-1G; block 1E includes inked resection margin; pleural surface with tumour, 1H-1I; tumour. towards hilar aspect, 1J-1L; separate pleural nodule, 1M; macroscopically unremarkable lung, 1N]. Microscopy: Sections show a poorly differentiated squamous cell carcinoma with extensive central necrosis and. cavitation. A definite bronchial origin is not identified. There is no evidence of pleural invasion, and. the separate pleural nodule is shown to represent a silicotic nodule within a pleural lymph node. No. lymphatic invasion is seen, however metastatic carcinoma is present in one of the peribronchial lymph. nodes. Vascular invasion is identified. The bronchial resection margin is clear of malignancy but. shows a benign mucous gland adenoma. Lung parenchyma adjacent to the tumour shows organising. pneumonia while distant lung parenchyma shows emphysema. 2: HILAR LYMPH NODE. Macroscopy: The specimen consists of a piece of dark brown tissue, 4 x 4 x 3 mm. [BIT, 2A]. Microscopy: Sections show fragments of lymph nodes containing large numbers of pigmented macrophages but. showing no evidence of metastatic carcinoma. 3: PARTIAL BRONCHUS RIGHT SIDE. Macroscopy: The specimen consists of a portion of bronchial wall measuring 25 x 15 x 5 mm. No obvious mucosal. abnormality is identified. [Serially sectioned and all pieces blocked, 3A]. Microscopy: Sections show full thickness bronchial wall in which there is no evidence of the mucous gland. adenoma seen in the resection margin of specimen 1. However there is squamous metaplasia with. severe dysplasia which falls short of carcinoma in situ. There is no evidence of invasive malignancy. Conclusion: Partial bronchus right side: squamous metaplasia with severe dysplasia. 4: MEDIASTINAL LYMPH NODE. Macroscopy: The specimen consists of a lymph node measuring 8 x 6 x 3 mm with attached fatty tissue. [All tissue. blocked, 4A]. Microscopy: Sections show a lymph node containing numerous pigmented macrophages but showing no evidence of. metastatic carcinoma. Conclusion (Specimens 1,2 and 4): Right upper lobectomy and lymph node sampling: Poorly differentiated squamous cell carcinoma, 75 mm in diameter. Vascular invasion is present. Metastatic carcinoma in peribronchial lymph node. No pleural invasion. Mucous gland adenoma at bronchial resection margin. Pathological stage T2 N1. T-28000 M-80703 P1-03000. T-26000 M-74000 P1-03000. T-26000 M-81400 P1-03000. Pathology Registrar/Anatomical Pathologist.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 2. SEX: M. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: APMI. ADDITIONAL REPORT FOLLOWING ADDITIONAL SECTIONS AND IMMUNOHISTOCHEMISTRY: Please see diagnosis below. PROCEDURE: APDX. 1. Adrenal gland, left, resection: Adenocortical carcinoma, low-grade by. mitotic activity, with capsular and vascular invasion. Ki-67 proliferation. marker shows a proliferation rate above that typically found in benign tumors. See COMMENT. COMMENT: This adrenocortical neoplasm has a very low mitotic activity as assessed by. counting of mitotic figures. The Ki-67 proliferation marker shows a. proliferation rate that is consistent with the diagnosis of low grade. adrenocortical carcinoma. In addition, research immunostains show a similar. proliferation rate using topoisomerase 2-alpha. Furthermore, the tumor shows. diffuse nuclear immunoreactivity for cyclin E which is also consistent with a. diagnosis of carcinoma. (These research stains are not performed by a. certified Tab and therefore are not billed to the patient. signing staff pathologist, have personally. examined and interpreted the stroes from this case. ""This test was developed and its performance characteristics determined by the. linical Immunoperoxidase Laboratory. It has not been. cleared or approved by the U.S. Food and Drug Administration. (The FDA has. determined that such clearance is not necessary. This test is used for. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 3. SEX: M. BIRTHDATE: PAT TYP_. ADM DATE: OPER DATE: clinical purposes. It should not be regarded as investigational or for. research. This laboratory is certified under the Clinical Laboratory. Improvement Amendments of 1988 [""CLIA""] as qualified to perform high. complexity testing)."". OPER DATE: PROCEDURE: SPHS. year-old male with left adrenal mas. PROCEDURE: SPGD. 1. ""Left adrenal"" Received fresh in a medium container is a 110 gram adrenal. with a scant amount of attached yellow adipose, 7.9 x 6.2 x 5.7 cm. The cut. surface is remarkable for a 6.2 x 5.3 x 6.0 cm, tan-brown, faintly-nodular,. soft, well-circumscribed tumor. The tumor has focal areas of bright-yellow. necrosis occupying approximately 15% of the cut surface. Tumor abuts the. margin. A 1.1 x 2.3 x 0.5 cm segments of normal adrenal gland is present. NO. other abnormalities are noted. Photographs have been taken. 1A&B. Tumor to normal. 1C-G. Tumor to capsule. 1H. Normal adrenal. PROCEDURE: SPDX. 1. Adrenal gland, left, resection: Adrenocortical carcinoma, low-grade by. mitotic activity, with capsular invasion. Additional report pending additional. sections and immunohistochemistry. , the signing staff pathologist, have personally. examined and interpreted the slides from this case. Criteria In 12/22/12.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL NOTES. 1. Gastrectomy total. 2. Donuts. 3. R gastroepiploic. MACROSCOPY. a. Specimen is labelled stomach. Total gastrectomy specimen, 120mm. along the lesser curve, approximately 195mm along the greater curve. The large portion of the body of the stomach, the wall is thickened. and indurated, and the mucosa granular and congested with loss of. the normal rugal folds. No proliferative mucosal lesion is seen. There is a relatively sharp contrast with normal antral mucosa. The. fat around both lesser and greater curves, is indurated. Omentum is. included showing obvious abnormality. On slicing the thickened wall. shows some pallor. Composite longitudinal section taken from mid. portion of stomach to distal margin in blocks A1-A4. A5 & A6 also. composite blocks also representing sections to proximal margin along. lesser curve. Random section of omentum block A7. Blocks A8&A9. greater curve lymph nodes A10 lesser curve lymph nodes. X in 10 TP. b. Specimen is labelled donuts proximal oesophageal and distal small. bowel. 2 pieces of ragged tissue received in the same container, the. largest with an external diameter of approximately 17mm. Most NX in. 1P. c. Specimen is labelled right gastroepiploic nodes. Ragged piece of. fatty tissue, up to 23mm. No definite node identified. AX in 1. MICROSCOPY. a. Sections taken from the abnormal thickened area described. macroscopically showed diffuse pattern poorly differentiated. adenocarcinoma, which infiltrates through the full thickness of the. gastric wall, into perigastric fat. The cells are poorly cohesive. The minor component have a signet-ring pattern, but generally the. cells are pleomorphic, with variable quantitive cytoplasm. Tumour. extends to the gastro-oesophageal junction, where there is a small. nodule of gland forming tumour, beneath squamous epithelium. Intramucosal tumour is identified in this region, unlikely the. remainder of the stomach, where the tumour is predominantly. submucosal and intramural. Tumour extends close to the proximal. margin but does not involve it. Two (2) greater curve lymph nodes. were identified, both showing metastatic carcinoma. There is. extensive infiltration of surrounding fat by tumour. Five lesser. curve nodes were retrieved, all showing metastatic adenocarcinoma. Again there is extensive infiltration of the surrounding fat. Sections of omentum show no significant abnormality. b. Sections of proximal and distal resection rings representing. portions of oesophagus and duodenum, show no evidence of involvement. by tumour. c. Sections show fat with a single lymph node. The latter shows. extensive sinusoidal infiltration by metastatic adenocarcinoma. DIAGNOSIS. 1 & 2. Total gastrectomy specimen extensively infiltrated by. diffuse type poorly differentiated adenocarcinoma (linitis plastica. pattern), with full thickness wall infiltration and metastases in 7. of 7 lesser and greater curve lymph nodes. Surgical margins are. clear. pT3N2Mx. 3. Right gastroepiploic lymph node showing metastatic adenocarcinoma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Colon, right, resection. Tumor Histologic Type: Invasive colonic adenocarcinoma (see. comment). Histologic Grade: Low grade, grade 2 of 4 (moderately. differentiated). Tumor Size: 3.4 cm in diameter. Tumor Location: Right colon. Depth of Invasion: To junction between muscularis propria and. subserosal soft tissues; no definite extension beyond muscularis. propria. identified (SMA immunostain performed). Lymphovascular Invasion: Not identified. Perineural Invasion: Not identified. Margins: Proximal margin: Negative, 16 cm away. Distal margin: Negative, 8.1 cm away. Mesenteric margin: Negative, 5.4 cm away. Regional Lymph Nodes: Total number with metastases : 0. Total number examined: 24. IHC for Mismatch Repair Protein Expression : MLH1: Normal expression. PMS2: Normal expression. MSH2: Normal expression. MSH6: Normal expression. Additional Pathologic Findings : Submucosal lipoma;. Fibrous obliteration of distal appendiceal lumen;. Separately submitted omentum with no involvement by carcinoma. identified. AJCC Pathologic TNM Stage: pT2 pNO. Note: This pathologic stage assessment is based on information. available at the. time of this report and is subject to change pending clinical. review and. additional information. Comment. Materials will be submitted to the. for. microsatellite. instability testing. These results will be issued in a separate. Clinical History: with colon cancer. Gross Description: Received is one appropriately labeled container, additionally. labeled ""right. colon and omentum.' It consists of a 2.9 cm long X 1.6 cm in. circumference. terminal ileum contiguous with a 26.8 cm long X 6.0 cm in. circumference large. bowel with attached vermiform appendix (4.7 cm long x 0.5 cm in. diameter) ,. omentum (13.9 X 4.7 X 1.3 cm), and pericolonic fat extending the. length of the. specimen up to 3.6 cm thick. There is a 3.4 X 2.7 X 0.7 cm firm gray/tan mass with raised. borders that is. 16.7 cm from the proximal margin and 8.1 cm from the distal. margin. The mass. extends 0.3 cm into the muscularis propria but not through it,. 0.6 cm from the. serosa (inked black) and 5.4 cm from the mesenteric margin. (inked red) . Proximal to the mass by 7.7 cm is a 1.0 X 0.7 X 0.4 cm. submucosal fatty nodule. that is 7.3 cm from the ileocecal valve. The appendix is. unremarkable. Also received in the same container is a 31.4 X 11.5 X 2.2 cm. focally red/brown. segment of lobulated adipose tissue consistent with omental. tissue. The. pericolonic adipose tissue is dissected for lymph node. candidates of which 21. are identified, ranging from 0.2 cm in greatest dimension up to. 0.8 X 0.8 X 0.7. cm. The lymph nodes are firm and white. Tumor and normal are given to. Block Summary: A1 - proximal margin, en face. A2 - distal margin, en face. A3 - mesenteric margin, en face. A4-A7 - mass, deepest extension. A8 - submucosal fatty nodule. A9 - appendix. A10 - separate segment of omentum. A11-A13 - each contains five lymph node candidates. A14-A16 - each contains two lymph node candidates, bisected, one. is inked. black.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Laterality: Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of skin lesion. Tumor site: Skin, hip. Tumor size: 2x 0 X 2.5 cm. Tumor features: Ulcerated, Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Breslow's depth is 5 mm.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: female with left renal mass, h/o ocular melanoma. Specimens Submitted: 1: SP: Kidney, left, partial nephreotomy. DIAGNOSIS: 1. SP: Kidney, left, partial nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade;. Nuclear grade II/IV. Tumor Size: Greatest diameter is 3.5 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: N/A. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. IATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT,. Gross Description: 1). The specimen is received for frozen section consultation labeled ""left renal tumor"". It consists of a 6.2 X 6.0 X 5.0 cm wedge. shaped portion of kidney with a suture marking the deep mergin. The margin is inked black and the specimen is serially sectioned. to reveal a cystic mass with a small yellow solid component, measuring overall 0.5 X 3.5 X 3.0 cm. The clearance from the. resection margin is 0.2 cm, A representative section of the nearest margin is submitted for frozen section diagnosis. Representatively submitted. Portions of the tumor are submitted for. Summary of sections: FSC - frozen section control. T tumor. M margin. RS - representative sections. Summary of Sections: Part 1: SP: Kidney, left, partial nephrectomy. Block. Sect. Site. PCs. fsc. 1. m. 1. 1. rs. 1. 4. t. Intraoperative Consultation;. Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. FROZEN SECTION DIAGNOSIS: RENAL CORTICAL EPITHELIAL TUMOR. MARGIN IS CLOSE BUT CLEAR. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with large right ranal mass - 9250 (+). Specimens Submitted: 1: SP: Kidnay, right, total naphractomy. 2: SP: Lymph node, precaval, paracaval and retrocaval, excision. 3: SP: Adrenal gland, right, adranalactomy. DIAGNOSIS: 1. SP: Kidney, right, total nephractamy. Tumor Typa: Ranal call carcinoma - Convantional (clear call) typa. Fuhrman Nuclear Grade: Nuclear grada III/IV. Tumor Siza: Greatest diameter is 8.1 cm. Local Invasion (for renal cortical types): Invalves renal sinus fat. Ranal Vein Invasion: Vassals wih muscular wall are involved by tumor. Surgical Margins: Frae of tumar. Non-Neoplastic Kidnay: Focal granulomatous raaction and glomerulosclerosis. Adranal Gland: Not identified. Lymph Nodes: Not identified. Staging for ranal call carcinoma/oncocytama: p T3a Tumor Invades the adranal gland or parinaphric tissues but not bayond Gerota's fascia. 2. SP: Lymph nade, precaval, paracaval and retrocaval, excisiari. Lymph Nodes: Not invalvad. Number of nades examinad:5. Benign segment of vessel is also identified. 3. SP: Adrenal gland, right, adrenalectomy. Benign adrenal gland. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. AE1:AE3. NEG CONT. IMM RECUT. AE1:AE3. NEG CONT. IMM RECUT. AE1:AE3. Gross Description: 1). The specimen is received fresh, previously incised and placed in formelin, labeled ""Right kIdney"" and consists of a total. nephrectomy specimen with an attached ureter, renal vessels and perinephric fat, weighing 642 g post fixation, The external. surface has been inked black. The kidney measures 12.5 x 8.3 x 4.6 cm. The atteched ureter measures 3.3 cm in length and. 0.4 cm in diameter in greatest dimension. The ureteral margin is identified and appears grossly uninvolved by tumor. On. opening,. the ureter is lined by a pink-ten soft faintly corrugated tissue. The attached renal vessels are identified, with a slight area. of firmness identified at the distal aspect of the smaller vessel, and the margins appear grossly uninvolved by tumor. The capsular. surface. is. smooth and pink-ten. The kidney is bivalved to reveal e pseudo encapsulated yellow-red tumor mass measuring 8.1 x. 7.5. X. 4.3. cm,. occupying the superior and mid poles of the kidney, which eppears to be partially surrounded by a rim of dense white. fibrous tissue. The mass appears to focally protrude Into the sinus fat with possible focal invesion, but does not grossly involve. the renal pelvis. At the center of the mass, an ill-defined firm white-ten focally hemorrhagic scarred area is identified measuring. 2.8. X. 2.3 cm in greatest dimension. Focal areas of necrosis are also identified. The mass abuts the renal celyces and serial. sectioning. reveals possible invasion by soft friable red-tan tumor tissue. The attached perinephric fat has been inked black and on. cut section reveals a focal area of possible extracapsular extension into the fat. The inked margins do not appear to be grossly. involved by tumor. Sectioning through the remainder of the kidney reveals a pink brown perenchyma, which appears grossly. unremarkable. The corticomedullary junction is well delineated, with the cortex measuring 0.6 cm in width. Sectioning through. the perinephric fat reveals no grossly identifiable lymph nodes. Representative sections of the specimen are submitted to TPS for. permanent section and photographs have been taken. Summary of sections: VM - vessel margin shave. UM - ureter margin sheve. TWP - tumor with pelvis. TWS - tumor with sinus. TWN - tumor with normal. RST - representative sections tumor. RS - representative sections normal kidney. TWC - tumor with possible extension into celyces. TWF - tumor with fat. 2). The specimen is received In formalin, labeled ""Precaval, paracaval lymph nodes and retrocaval lymph nodes"" and consists. of. multiple hemorrhagic lymph nodes ranging in size from 0.8 to 1.7 cm. A smooth pink-tan tubuler piece of vasculer tissue is also. identified measuring 3.0 X 0,5 cm, with each end stapled. Cut section reveals a patent lumen. Representative sections of the. vein are submitted in the lymph nodes, completely sectioned at 3 mm intervals and submitted. Summary of sections: V - representative sections blood vessel. BN1 - bisected lymph node number one. BN2 - bisected lymph node number two. BN3 - bisected lymph node number three. TLN - trisected lymph node. RSN -- lymph node at 3 mm intervals. 3). The specimen is received in formalin, labeled ""Right adrenal gland"" and consists of a total adrenalectomy specimen, with. attached adipose tissue measuring 51 x 2,9 x 1.0 cm and weighing 10.5 g post fixation. The external surface is inked black, and. serial sections reveal a rim of bright yellow soft tissue, with central areas of tan and dark red soft tissue noted. Representative. sections are submitted. Summary of sections: RS --- representative sections. Summary of Sections: Part 1: SP: Kidney, right, total nephrectomy. Block. Sect. Site. PCs. 1. rs. 1. 5. rst. 5. 2. twc. 2. 1. twf. 1. 1. twn. 1. twp. 1. 2. tws. 2. 1. um. 1. 1. vm. 1. Part 2: SP: Lymph node, precaval, paracaval and retrocaval, excision. Block. Sect. Site. PCs. 1. bn1. 1. bn2. 1. 1. bn3. rsn. 1. tIn. 1. V. 1. Part 3: SP: Adrenal gland, right, adrenalectomy. Block. Sect. Site. PCs. 4. rs. 4.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Colectomy. Specimen size: Not specified. Tumor site: Sigmoid colon. Tumor size: 5.2 X 2.2 cm. Tumor features: Infiltrative,. Ulcerated. Histologic type: Mucinous. adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Subserosa. Lymph nodes: 13/18 positive for. metastasis (Pericolonic 13/18). Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
; Final Diagnosis. Breast, right, simple mastectomy: Multiple (2) nodules of invasive mammary carcinoma are. identified. Infiltrating lobular carcinoma, Nottingham grade I (of III) [tubules 3/3, nuclei 1/3,. mitoses 1/3; Nottingham score 5/9] is identified forming a mass (1.1 x 0.9 x 0.8 cm) located in. the upper outer quadrant of the breast [AJCC pTlc]. This cancer shows HER2/neu protein. overexpression (scored as 2+; see comment below) and has metastasized to right axillary sentinel. lymph node No. 1D as a roughly 1.1 mm keratin positive collection of tumor cells barely visible. by routine H&E morphology (see comment regarding right axillary sentinel lymph node excision. below). Infiltrating ductal carcinoma, Nottingham grade I (of III) [tubules /3, nuclei /3, mitoses /3;. Nottingham score /9] is identified forming a second lesion (1.7 x 1.5 x 0.9 cm) in the upper outer. quadrant located 0.6 cm inferior and medial to the first lobular carcinoma mass [AJCC pT1c]. This tumor also shows HER2/neu protein overexpression (scored as 2+; see comment below). However, there is no morphologic evidence of metastasis by this second lesion into any of the. sentinel lymph nodes. Extensive ductal carcinoma in situ, intermediate nuclear grade, is present within and outside the. invasive component with a separate nodule in the central/deep breast, 1.2 x 1.2 x 0.6 cm, located. 1.4 cm medial to the infiltrating ductal carcinoma. Angiolymphatic invasion is not seen. The. non-neoplastic breast parenchyma shows proliferative fibrocystic changes. Biopsy site changes. are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All. surgical resection margins, including the deep margin, are negative for tumor (minimum tumor. free margin, 0.4 cm, anterior/superior margin). Lymph nodes, right axillary sentinel, excision: A single (of 12) right axillary sentinel lymph. node is positive for metastatic carcinoma [AJCC pN1 mi (sn)]. This positive sentinel node is. designated No. 1D (tissue block A4) and is characterized by a roughly 1.1 mm collection of. keratin positive tumor cells without much in the way of H&E morphologic correlation. As noted. above, this microscopic focus of cancer has lobular features. The remaining 11 right axillary. sentinel lymph nodes are negative for metastatic cancer (verified by keratin immunostaining). Blue dye is identified in right axillary sentinel lymph nodes No. 1A, No. 2A, No. 3A, No. 3B, and. No. 4. Blue dye is not identified in right axillary sentinel lymph nodes No. 1B, No. 1C, No. 1D,. No. 2B, No. 2C, No. 2D, or No. 3C. HER2/neu protein overexpression is weakly positive, score of 2+, according to the interpretation. guidelines in the FDA-approved HercepTest This degree of overexpression is seen in both tumor. nodules (using tissue blocks B2 and B4). Fluorescence in situ hybridization (FISH) for. HER2/neu amplification will be performed and reported in an addendum. HER2 protein immunohistochemical (IHC) test results are only valid for non-decalcified paraffin. embedded specimens fixed in neutral buffered formalin or Bouin's fixatives. Testing is. performed using commercially available kit/reagents employing a polyclonal antibody and a. polymer-based detection system. ADDENDA: No amplification for HER2/neu is demonstrated by fluorescence in situ hybridization (FISH,. performed in Laboratory Genetics) (blocks B2 and B4) according to the interpretation guidelines. in the FDA approved PathVysion Her2 DNA Probe Kit.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis. 1. Cystoprostatectomy preparation with a moderately differentiated, solid urothelial. carcinoma of squamous epithelial differentiation mainly in the right trigone, with penetration. of all parietal layers and macroscopic infiltration of the perivesical fatty tissue. Three tumor-. free lymph nodes. Deep resection margins, including urethra, ureters and vas deferens, are. tumor-free (compare frozen section, admission no.---). Foci of moderate dysplasia of the. remaining bladder urothelium. Comment: Tumor classification of the bladder carcinoma: pT3b, pNO (0/9), L0, V0, R0, G2; maximum. tumor size 2.5 cm.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
History Case. Sex: F. Tel: i. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) LEFT THYROID LOBE, EXCISION: MICROSCOPIC FOCUS OF PAPILLARY THYROID CARCINOMA. (SEE COMMENT). (B) THYROID, COMPLETION THYROIDECTOMY AND RIGHT NECK DISSECTION WITH RIGHT. PARATRACHEAL AND SUPERIOR MEDIASTINAL CONTENTS: PAPILLARY THYROID CARCINOMA, 5.0 CM. PAPILLARY THYROID CARCINOMA EXTENDS INTO EXTRATHYROIDAL SOFT. TISSUES. METASTATIC PAPILLARY THYROID CARCINOMA IN 10 OF 23 LYMPH NODES. WITH EXTRACAPSULAR EXTENSION (10/23). Entire report and diagnosis completed by: Report released by: COMMENT. In specimen A (left thyroid lobe) a single focus of papillary thyroid. carcinoma is identified adjacent to vessels and adipose tissue. This may be. continuous with the main tumor mass. GROSS DESCRIPTION. (A) LEFT THYROID LOBE - A segment of thvroid tissue 2.0 x 1.5 x 1.0 cm. Submitted entirely under A1 and A2. (B) TOTAL THYROIDECTOMY, RIGHT NECK DISSECTION AND RIGHT PARATRACHEAL. SUPERIOR MEDIASTINAL CONTENTS - An oblong hard mass and attached skeletal. muscle and fibrovascular tissue with overall measurement of 8.0 x 6.0 x 1.5. cm. The mass measures 5.0 x 3.5 x 2.5 cm. There is no gross involvement of the. surrounding fibrous and soft tissue and the mass is light-tan and firm. Representative sections are submitted under B1-B12. The neck contents. containing numerous lymph nodes ranging in size from 2.0 cm to 0.4 cm. Multiple grossly positive lymph nodes were noted. The lymph nodes were. submitted as B13,. ; B14, 2 lymph nodes; B15, probable four lymph. nodes; 816, 3 lymph nodes; B17, 2 lymph nodes; B18, 2 lymph nodes; 819,. 3. lymph nodes; B20, two lymph nodes; B21, B22, representative section of the. large lymph node. SNOMED CODES. M-80503 T-B6000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Right breast cancer. LMP DATE: PROCEDURE: Right needle localized segmental mastectomy and right axilla sentinel node biopsy. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: RIGHT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR NEOPLASM (0/1). PART 2: RIGHT BREAST AT 8 O'CLOCK, NEEDLE LOCALIZED SEGMENTAL MASTECTOMY -. A. INVASIVE DUCIAL CARCINOMA, NOTTINGHAM GRADE 3 (NUCLEAR GRADE 3, TUBULE SCORE 3, MITOTIC. ACTIVITY SCORE 2; TOTAL SCORE: 8/9). B. TUMOR MEASURES 2.7 CM (GROSS MEASUREMENT). C. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. D. MARGINS ARE NEGATIVE FOR NEOPLASM; TUMOR APPROACHES MOST CLOSELY TO THE SUPERIOR. MARGIN (0/9) CM. E. ATYPICAL DUCTAL HYPERPLASIA, AND RADIAL SCAR. F. SCLEROSING ADENOSIS AND FIBROCYSTIC CHANGES. G. FIBROSIS, SUGGESTIVE OF PREVIOUS BIOPSY. H. SKIN, NEGATIVE FOR TUMOR. TUMOR PREVIOUSLY REPORTED TO BE POSITIVE FOR ER AND PR AND NEGATIVE FOR HER-2/neu. J. PATHOLÃGIC STAGE: PT2 pNO pMX. PART 3: RIGHT BREAST, EXCISION (102 GRAMS) -. A. FAT NECROSIS AND FIBROSIS. B. FIBROCYSTIC CHANGES AND COLUMNAR CELL CHANGE. C. SKIN WITH NO SIGNIFICANT PATHOLOGIC DIAGNOSIS. PART 4: LEFT BREAST TISSUE, EXCISION (254 GRAMS) -. A. SCLEROSING ADENOSIS, COLUMNAR CELL CHANGE, AND FIBROCYSTIC CHANGES. 8. SKIN WITH NO SIGNIFICANT PATHOLOGIC DIAGNOSIS. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 27 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 8. Nottingham grade (1, 2. 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 9 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T STAGE, PATHOLOGIC: pT2. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 1+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL PATHOLOGIC DIAGNOSIS. A. Left axillary sentinel lymph node #1; biopsy: - Two lymph nodes, no tumor (0/2). B. Left axillary sentinel lymph node #2; biopsy: - One lymph node, no tumor (0/1). C. Left breast; simple mastectomy: Invasive ductal carcinoma, SBR grade III arising in a background of. ductal carcinoma in situ, high nuclear grade, solid type, with central necrosis. See parameters. - Uninvolved breast parenchyma with rare microcalcifications associated. with benign acini and focal apocrine metaplasia. Breast Pathologic Parameters. 1. Invasive carcinoma: A. Microscopic measurement: 7mm. B. Composite histologic (modified SBR) grade: III. - Architecture: 3. - Nuclear grade: 3. - Mitotic count: 2. C. Associated intraductal carcinoma in situ (DCIS): present. - Intermediate and high nuclear grades, solid type with central necrosis. - Extent of DCIS microscopically is consistent with the 10.2 X 5.4 X 3.5 cm. of non-mass like enhancement seen radiographically. 2. Excisional biopsy margins: Free of tumor. - Invasive carcinoma >1cm from closest margin. - DCIS 8mm from anterior margin, superior aspect. 3. Blood vessel and lymphatic invasion: Absent. 4. Nipple and skin: Unremarkable. 5. Skeletal muscle: Absent. 6. Axillary lymph nodes: Negative (0/3). 7 Special studies (invasive component, current specimen). - ER: weak expression in 30% of cells. - PR: no expression. - Ki-67: 10-20%. - HER2 (FISH): pending. 8. pTNM (AJCC, 7th edition, 2010): pT1b, NO(sn), MX. Clinical History: The patient is a. -year-old female who presented with an abnormal screening. mammogram on. that revealed a large area of pleomorphic calcifications. biopsied as ductal carcinoma in situ, high grade, solid type with central. necrosis. Left breast MRI on. evealed segmental clumped non-mass. enhancement with mixed kinetics measuring 10.2 X 5.4 x 2.5 cm associated with a. lateral biopsy clip. A 0.7 x 1.0 X 1.0 cm mass with washout kinetics, suspicious. for invasive component was seen just posterior to the biopsy clip. The patient. undergoes simple mastectomy, sentinel lymph node biopsy and breast. reconstruction. Specimens Received: A: Left sentinel lymph node #1. B: Sentinel node #2 left axilla. C: Left breast. Gross Description: The specimens are received in three containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, 'left sentinel node #1'. Received fresh for intraoperative diagnosis is a 4.0 X 2.0 x 1.0 cm segment of. tan-pink fibrofatty tissue that is dissected for lymph node candidates. Frozen. section diagnosis is 'lymph node, no tumor' per. . The frozen section. remnants are entirely submitted in cassettes A1 FS and A2 FS. The remaining. tissue is entirely submitted in cassettes A3 and A4. B. The second container is additionally identified as, 'sentinel node #2, left. axilla'. Received fresh for intraoperative diagnosis is a 3 X 2.0 X 2.0 cm. segment of tan-brown rubbery tissue grossly consistent with a lymph node. The. cut section reveals an unremarkable surface. The entire lymph node is frozen. Post section diagnosis is 'lymph node, no tumor' for. : The frozen. section remnant is entirely submitted in cassette B1FS. C. The third container is additionally identified as, 'left breast'. Received. fresh and placed in formalin is a 2640 gm mastectomy specimen measuring 32.5 cm. from medial to lateral, 32.5 cm from superior to inferior and 5.3 cm from. anterior to posterior. There is 80 cm long by 0.7-6.5 cm wide tan-brown,. wrinkled skin ellipse on the anterior surface, with ashort suture designating. the superior pole and a long suture designating the lateral pole. The areola. measures 5.5 X 3.5 cm areola and the nipple 1.5 cm in diameter. The nipple. areolar complex displays no evidence of ulceration or retraction. No axillary. tail is present with the specimen. The deep surface is inked black, the. anterior-superior surface blue and the anterior-inferior surface green and the. breast is serially sectioned from medial to lateral into 11 slices. There is a. 1.1 x 0.9 X 0.8 cm, gray-tan mass in slices 7 and 8, 5.5 cm from black ink and. 2.0 cm from blue ink. A metallic clip is identified in slice 7. A 1.5 cm. (greatest dimension) biopsy site is identified, adjacent to the lesion, with a. probable metallic clip (vs. staple) within the node. Additional masses or. nodules are not noted. Representative sections are submitted as follows: C1-8: Representative sections of lesion, slice 7 and 8 (clip in C1, C3. closest approach to blue ink). C9: Intramammary lymph node, adjacent to mass, bisected. C10: Representative slice 6, medial to mass. C11: Representative slice 9, lateral to mass. C12: UOQ, slice # 10. C13: UIQ, slice # 3. C14: LOQ, slice # 9. C15: LIQ, slice # 2. C16: Representative skin. C17-18: Nipple. Tissue fixed for at least 6 hours in 10% NBF and no more than 72 hours.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH FULL AXILLARY NODE DISSECTION. TISSUES. A. BREAST EXCISION, NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST. LUMPECTOMY. B. AXILLARY - CONTENTS. C. MARGINS - RIGHT BREAST. FS DIAGNOSIS. A. RIGHT BREAST LUMP (GROSS MARGINS) -. TUMOR EXTENDS TO SUPERIOR MARGIN, NEAR SKIN. (Reported to surgeon: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT BREAST LUMP NEEDLE LOC -. POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA, 7.5 CM. IN GREATEST. DIMENSION, EXTENDING TO SUPERIOR INKED SURGICAL MARGIN. SCARFF-BLOOM-RICHARDSON BREAST CANCER HISTOLOGIC SCORE, 9. (3+3+3). HIGH NUCLEAR GRADE DUCTAL CARCINOMA IN-SITU (DCIS) COMPONENT WITH. CENTRAL NECROSIS AND CALCIFICATION EXTENDS WITHIN LESS THAN 0.1 CM. OF THE SUPERIOR SURGICAL MARGIN. REMAINING DESIGNATED SURGICAL MARGINS ARE FREE OF TUMOR. PATHOLOGIC TNM STAGE: T3 N3 MX, STAGE IIIC, G3, INVASIVE DUCTAL CARCINOMA. PQRI CATEGORY II: 3260F. B. AXILLARY CONTENTS -. TEN (10) REGIONAL LYMPH NODES POSITIVE FOR METASTATIC INVASIVE. SURGICAL REPORT. DUCTAL CARCINOMA. C. RIGHT BREAST MARGINS -. SKIN AND ATTACHED FIBROFATTY BREAST TISSUE, NEGATIVE FOR. MALIGNANCY. Diagnosed by: (. Revlawed and alecimnicallu signed out by: GROSS DESCRIPTION. The specimen is received in three separate containers labele. unated A, B,. C. A. The container is received fresh unfixed labeled ""right breast lump"" and consists of a 67 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 7.5 : 7.5 x 3 cm. in greatest overall. dimension. The attached skin ellipse is 4 x 1 cm. There is a single short suture indicating. superior margin inked with black dye, inferior is inked orange. There is a single long suture. indicating lateral margin inked with blue dye, medial is inked green. The skin represents the. anterior margin, posterior is inked with red dye. Sectioning reveals an irregular bordered tan-gray. firm slightly whorled nodule with scattered hemorrhagic areas varying up to 3.5 cm. in greatest. overall dimension and grossly appears to be less than 0.1 cm. from the superior margin and. directly beneath the ellipse of skin. Gross margins are observed by Dr. The tumor. mass grossly appears to be approximately 1.5 cm. from the inferior, 1 cm, from the lateral, 1 cm. from the medial directly beneath the anterior, and 1 cm. from the posterior. The specimen is. submitted in tweive blocks. Key Note Block Summary: 1-superior, 2-inferior, 3-lateral, 4-medial, 5-anterior, 6-. posterior, 7 through 12-random. B. The container is received fresh unfixed labeled ""axillary contents"" and consists of an irregular. mass of apparent fat which is 13 x 12 x 4 cm. in greatest overall dimension. Sectioning reveals. firm tan-gray nodules varying up to 7 cm. in greatest dimension. The largest has scattered green-. black areas and scattered yellow-tan chalky material. The specimen is submitted in seven. blocks. C. The container is received fresh unfixed labeled ""additional right breast margin -skin represents. the anterior margin, suture on new superior margin"" and consists of an ellipse of skin with. attached underlying soft tissue which is 7 x 2.5 x 0.4 cm. in greatest overall dimension. There is. an attached suture indicating new superior margin inked with black dye. The entire specimen is. submitted in five blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Pathology #: Med. Record. No. Date of Birth: F. Date Received: Submitted by: Report also to. DIAGNOSIS: A. Right axillary sentinel node: Lymph node with metastatic.mammary carcinoma (5 mm focus), with extranodal. extension (less than 2 mm). B. Right axillary sentinel nodes: Metastatic mammary carcinoma (5 mm focus), without extracapsular extension involving. 1 of 2 lymph nodes. C. Left breast tissue. Benign breast tissue with fibrocystic changes. D. SPECIMEN. Laterality: Right breast. Specimen(s). Modified radical mastectomy. TUMOR. Histologic type: Invasive lobular carcinoma (two separate lesions). Histologic grade: Grade 1. Tumor grade (Nottingham combined) based on the following: Tubule formation score: 3. Nuclear pleomorphism score: 1. Mitotic count score: 1. Total score (range of 3-9): 5. Tumor size (greatest dimension): 7cm. Tumor site (quadrant): Upper. outer. Tumor site (add'l descriptors): O'clock orientation. Larger lesion - upper outer (9:00 - 11:00) 5-6 cm. from nipple; and smaller lesion - upper inner (2:00). 7-8 cm from nipple. Peritumoral intralymphatic tumor emboli: Absent. Dermal lymphatic involvement: Absent. Status of skin/nipple: Not involved. Coexistent DCIS: Absent. Microcalcifications: Absent. Additional findings: None. MARGINS. Regarding invasive carcinoma: Margin(s) positive: Posterior margin - 2mm linear extent. Margin(s) negative: Superior: > 1 cm. Medial: > 1cm. Inferior: > 1 cm. Lateral: > 1 cm. ANCILLARY STUDIES. IHC for ER and PR: Performed on a prior sample. See report: HER2 amplification by FISH: Performed on a prior sample. See report: REGIONAL LYMPH NODES. Positive for metastatic carcinoma (at least one focus > 0.2mm in size). Number of nodes positive: 2. Total number of nodes evaluated: 26. Size of largest metastatic focus: 5mm. Extranodal extension: Present. (tumor extends 2 mm or less beyond node capsule). Comment: The two positive lymph nodes are the sentinel lymph nodes from Part A (one sentinel. node) and Part B (1 of 2 sentinel nodes). STAGING (AJCC). Primary Tumor: pT3. Lymph Nodes: pN1a. Distant Metastasis: Not applicable. CLINICAL INFORMATION: Right breast multicentric cancer, ER/PR done previous biopsy. SPECIMEN(S) RECEIVED: A. Right axillary sentinel node. B. Right axiliary sentinel nodes. C. Left breast tissue. D. Right modified radial mastectomy with multicentric cancer. GROSS DESCRIPTION: A. Received fresh is a 2.3 x 2 x 1.5 cm fragment of golden yellow fibroadipose tissue containing one rubbery. partially fat-replaced 1.1 x 1 x 0.4 cm lymph node. The node is bisected and submitted for frozen section in A1. FROZEN SECTION DIAGNOSIS: Lymph node, positive for metastatic breast carcinoma. B. Received fresh is a3x2x15 cm fragment of golden yellow fibroadipose tissue. Dissection reveals two. rubbery, partially fat-replaced nodes, 0.6 x 0.6 x 0.4 cm and 1.1 x 0.9 x 0.5 cm. Both nodes are bisected and. submitted for permanent section in B1 and B2. C. Received fresh are two fragments of lobular golden yellow fibroadipose tissue along with attached and. unattached smooth, unremarkable tan-red skin weighing 256 grams in aggregate and measuring from 5 x 3.4 x 2.2. cm to 16 x 11 x 3.5 cm. Sectioning reveals a cut surface consistent of lobular yellow adipose tissue interspersed. with fibrous pink-white breast parenchyma. Representative tissue is submitted in C1 - C2. D. Fixed in formalin for approximately 33 hours is a 1,215 gram modified radical mastectomy with the breast. proper measuring 20 cm from medial to lateral x 19.5 cm from superior to inferior x 7 cm from anterior to posterior. Dissection of the 11 x 6 x 4 cm axillary tail reveals several rubbery tan-red lymph nodes, 0,3 to 2.3 x 1.5 x 1.1 cm. There is an 18 x 9 cm ellipse of tan-red skin on the anterior surface with a superomedial placed nipple. The. superior margin is inked black, inferior blue. medial green, lateral yellow and posterior red. The specimen is. serially sectioned from medial to lateral into 17 slices measuring from 1 to 1.3 cm. In the upper outer quadrant. of. the breast is a large firm, multinodular, ill-defined 7 x 5 x 3.8 cm pink-gray mass which extends from the 9 to 11. o'clock position, 5-6 cm away from the nipple. This large, multinodular lesion appears grossly to come within 0.5. cm of the posterior margin, 1.5 cm of the superior margin and greater than 2 cm away from all remaining margins. in the upper inner quadrant of the breast at approximately the 2 o'clock position, 7-8 cm away from the nipple is a. smaller, firm, ill-defined 0.9 x 0.9 x 0.8 cm pink-gray mass located 1 cm away from the superior margin and greater. than 2 cm from all remaining margins. This mass appears grossly to be located 3.5 cm away from the larger lesion. The rest of the specimen consists of lobular yellow adipose tissue interspersed with fibrous pink-white breast. parenchyma. A photograph of slices 4 through 14 is taken to illustrate both lesions and their relationship to the. inked margins. Sections submitted are indicated on the photograph and are sublabeled D10-D25. Sections to. include the mass at 2 o'clock are in D10 and D11, and the mass at the 1 to 3 o'clock position is in D14, D15, 017,. D20, D21, D22, D23, D24 and D25. The nipple is in D13, and an additional section of medial breast is in D8 and. lateral breast in D9. The lymph nodes are submitted as follows: D1-D2 - one node trisected: D3 - one node. bisected; D4-D7 - intact lymph nodes; D8 - medial breast tissue; D9 - lateral breast tissue. Slides were microscopically examined by the pathologist. Immunohistochemistry Results. Formalin-fixed paraffin-embedded tissue is utilized. Tissue sections are incubated with the following antibodies. Positive and. negative controls stain appropriately. Complete procedural methodology is available upon request. Results indicated below: Material: Block D22. Marker For: Comment. e-Cadherin. Negative. The immunohistochemical findings support the diagnosis of invasive lobular carcinoma. Note. charactentics of all immunohistochemical stains cited in this report were determined by the Department of Pathology at. as part of an ongoing quality assurance program and in compliance with federally mandated regulations. drawn from the Cilinical Laboratory Amendments of 1988 (CLIA '88) Some of these tests may rely on the use of tanalyte specific. reagents and have not been cleared or approved by the U.S Food and Drug Administration The FDA has determined that such clearance. or. approval is not necessary. Nevertheless, federal rules concerning the medical use of analyte specific reagents require that the following. disclaimer be attached to this report. These tests are used for clinical numpses and should not be regarded as investigational or for research. The immunohistochemistry laboratory at. lepartment of Pathology is certified by the Centers for Medicare. and Medicaid Services (formerly HCFA) as a high complexity laboratory under CLIA 88. Evaluation performed bu. diectronically signed.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Specimen #: )F Race: WHITE. SPECIMEN: A: SENTINEL LYMPH NODE#1 B: SENTINEL LYMPH NODE #2. C: RIGHT BREAST. FINAL DIAGNOSIS: A. RIGHT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY: ONE LYMPH NODE NEGATIVE FOR TUMRO BY H&E AND IMMUNOHISTOCHEMISTRY. B. RIGHT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY: ONE LYMPH NODE NEGATIVE FOR TUMRO BY H&E AND IMMUNOHISTOCHEMISTRY. C. RIGHT BREAST, MASTECTOMY: INFILTRATING DUCTAL CARCINOMA, WELL DIFFERENTIATED BY COMBINED. HISTOLOGIC CRITERIA (TUBULES- - 2; NUCLEAR GRADE- 2; MITOTIC RATE- 1). -MAXIMUM TUMOR SIZE: 2.4 CM, MEASURED GROSSLY. -DUCTAL CARCINOMA IN SITU, SOLID, CRIBRIFORM, AND MICROPAPILLARY. TYPES, NUCLEAR GRADE 2, WITH FOCAL NECROSIS, COMPRISING 10% OF. TUMOR. - -NO LYMPH VASCULAR OR PERINEURAL INVASION. -MARGINS NEGATIVE FOR TUMOR. -AJCC STAGE pT2NOMX. CLINICAL DIAGNOSIS AND HISTORY: new pleo calcifications. PRE-OPERATIVE DIAGNOSIS: r/o dcis. POST-OPERATIVE DIAGNOSIS: Operative Findings same. Post-operative Diagnosis: same. Specimen #: GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated ""SENTINEL LYMPH NODE #1"" and consists of a 0.7 x 0.7 x 0.4 cm. lymph node. One half of the node is submitted for the CBCP protocol. The. remainder is submitted in cassette A1. B. Received in formalin, labeled with the patient's name,. designated ""SENTINEL LYMPH NODE #2"" and consists of a 2.0 x 1.3 x 0.4 cm. fragment of fatty tissue containing a 0.2 cm lymph node. The specimen is. bisected and submitted in its entirety for paraffin section in one. cassette. C. Received fresh, labeled with the patient's name,. designated. ""RIGHT BREAST ONE TAG MEDIAL, TWO TAGS SUPERIOR"" and consists of a 505.0. gram simple mastectomy specimen, measuring 19.7 cm superior to inferior,. 19.8 cm medial to lateral, and 2.2 cm anterior to posterior. The overlying. ellipse of nipple bearing skin measures 10.5 x 5.2 cm, which is tagged for. its abnormalities Ink code: Superior superficial=blue, inferior. superficial=orange, deep=black. Sectioning reveals a 2.4 x 2.4 x 1.7 cm. ell-circumscribed, tan tumor in the central portion of the upper outer. quadrant, 0.6 cm from the deep margin. The tumor is surrounded by dense. fibrous tissue, which extends medially to the inner portions of the. breast. Within this fibrous tissue in the central portion of the breast. (1.0 to 2.0 cm from the tumor and 1.5 cm from the deep margin) is a 0.7. cm. Mammomark site without associated mass. Representative sections are. submitted in 13 cassettes as follows. C1: Skin, lateral tip. C2: Tumor, upper outer quadrant. C3: Tumor with deep margin upper outer quadrant . C4: Tumor with deep margin upper outer quadrant. C5: Fibrous tissue immedial medial to tumor. C6: Mammomark biopsy site. C7: Mammomark biopsy site. C8: Deep margin underlying Mammomark site. C9: Random fibrous tissue lower inner quadrant . C10: Random fibrous tissue upper inner quadrant. C11: Random fibrofatty tissue upper outer quadrant peripheral. C12: Random fibrofatty tissue lower outer quadrant. C13: Cross section of nipple. Specimen #: GROSS DESCRIPTION (continued) : Mirror images of the following sections are submitted for the CBCP. protocol: C1, C2, C3, C5, C6, C7, C9, C10, C11, and C12.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) LEFT NECK #1: Mandibular gland with fibrosis and inflammation, no tumor. TWO lymph nodes, no tumor. (B. COMPOSITE RESECTION LEFT MANDIBLE AND BASE OF TONGUE. POORLY DIFFERENTIATED KERATINIZING SQUAMOUS CARCINOMA OF TONGUE,. THICKNESS 1.5 CM WITH LYMPHATIC AND VASCULAR INVASION. Margins of lesion free of tumor. BASE OF TONGUE MARGIN: squamous mucosa, no tumor present. ANTERIOR MARGIN: MICROSCOPIC FOCUS OF ATYPICAL EPITHELIAL CELLS SUGGESTIVE OF SQUAMOUS. CARCINOMA. MEDIAL PHARYNGEAL WALL: Squamous mucosa, no tumor. SUPERIOR MARGIN: Fibroconnective tissue and skeletal muscle, no tumor present. NEW ANTERIOR MARGIN: Squamous mucosa, no tumor present. GROSS DESCRIPTION. (A) LEFT NECK #1 - Salivary gland with attached adipose tissue, 4.0 x 2.8 x. 1.0 cm. within the surrounding adipose tissue, two possible lymph nodes are. identified that are 0.3 and 0.6 cm in greatest dimension. SECTION CODE: A1, cross-section of salivary gland; A2, two possible. lymph nodes. (B) COMPOSITE RESECTION LEFT MANDIBLE AND BASE OF TONGUE - Consists of a. portion of left mandible, 7.0 x 5.5 x 1.6 cm, and a separate portion of base. of tongue (3.5 x 2.8 x 3.3 cm). An ulcerated tumor, 1.5 x 1.0 X 0.5 cm, is present in the posterior. portion of the base of tongue corresponding to the left tonsillar area. The. tumor is present within 0.2 cm from the posterior lateral margin of the. specimen (not the true margin), 0.7 cm from the anterior/inferior margin, 0.8. cm from the lateral margin and 1.2 cm from the medial margin. The tumor comes. within approximately 1.0 mm of the deep margin which appears to be free. INKING CODE: Black-deep margin; red-medial margin; yellow-lateral margin;. blue-superior margin; green-inferior margin. SECTION CODE: B1, tumor-superior margin, perpendicular section; B2,. tumor-lateral margin; B3, tumor-inferior margin; B4, medial margin, en face;. Case type: Surgicar Tistory. B5-B9, (C) BOT MARGIN - A single portion of tan-pink soft tissue (1.1 x 0.5 x 0.3. full thickness section of tumor including deep margin. cm), entirely submitted in C. (D) ANTERIOR MARGIN - A sliver of tan-pink tissue (2.0 x 0.2 x 0.2 cm),. FS/DX: NO TUMOR PRESENT. entirely submitted in D. FS/DX: FOCUS OF ATYPICAL CELLS CONSISTENT WITH SQUAMOUS CELL. CARCINOMA. (E) MEDIAL PHARYNGEAL WALL - A single sliver of tan-pink mucosa (1.5 X 0.2 X. 0.2 cm) Entirely submitted in E. SUPERIOR MARGIN - A single portion of tan-pink soft tissue (1.0 in X 0.3 X. FS/DX: NO TUMOR PRESENT. 0.3 (F) cm) Inked at one edge. Entirely submitted for frozen section F. margin (G) of the specimen is inked blue indicating the true margin. The entire. NEW ANTERIOR MARGIN INKED TRUE MARGIN - A strip of mucosa, 2.5 cm. one. FS/DX: NO TUMOR PRESENT. specimen is submitted in G. FS/DX: NO TUMOR PRESENT. SNOMED CODES. M-80703 T-53000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
ovurce. Clinical Diagnosis & History: ith a 3.8 right lower pole renal mass. Specimens Submitted: 1: SP:Kidney, right, total nephrectyomy. 2: SP:Perihilar lymph node, right, excision. DIAGNOSIS: 1. SP:Kidney, right, total nephrectyomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. the tumor Is partialy cystic. Fuhrmen Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 3,5 cm. Local Invasion (for renal cortical types): Not Identified. the tumor abuts the renal sinus. Renal Vein Invesion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: A small (0.5 cm) renal medullary fibroma is present. Adrenal Gland: Not identified. Lymph Nodes: Free of tumor. Number of metastatic nodes:2. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. 2. SP:Peribilar lymph node, right, excision. Lymph Nodes: Not identified. Benign fibroadipose tissue. IATTEST THAT THE ABOVE DIAGNOSIS is BASEO UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh labeled ""right kidney"" and consists of a kidney with attached ureter, renal vessels and. parinaphric fat welghing 253 g in total. The kidney measuras 12.5 x 8.0 x 4.0 cm. The atteched uretar measures 1.5 cm in length. and 0.4 cm in diameter. The attached renal vein measures 1.0 cm in length and 0.3 cm in diametar. The ranal vessals and ureter. margins are grossly unremarkable, An adrenal gland is not identifed. The kidney is inked black and bivalved to reveal 3.5 x 3.0 x. 2.2 cm wall circumscribed mass in the lower pole adjacent to the renal sinus. The cut surface of the mess is solid and cystic, tan. yellow and hemorrhagic. A second 0.5 x 0.4 X 0.3 cm tan nodule distal to the first mass is identified with a firm cut surface. Sections through the remainder of the kidney raveal a pink brown parenchyma, with a well-defined cortico-medullary junction. The. cortex measures 0.7 cm and the calyces appear normal. Representativa sactions are submitted for TPS and for permanent. sections. Summary of sections: UVM -- ureteral and vessel margins. T-- tumor. T2 - second nodule. THF- tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidnay. RP - representative of kidney. 2). The specimen is received in formalin, labeled ""right parihilar lympn hode and consists 013 portion of adipose tissua. No. lymph node identified. Entirely submitted. Summary of sactions: U- possible lymph node. Summary of Sections: Part 1: SP:Kidney, right, total nephrectyomy. Block. Sect. Site. PCs. 2. rp. 2. 3. t. 3. (2. 1. 2. thf. 2. 2. tk. 2. 2. tsf. 2. 1. uvm. 1. Part 2: SP:Peribilar lymph node, right, excision. Block. Sect. Site. PCs. 2. u. 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Right hemicolectomy preparation with a poorly differentiated adenosquamous carcinoma. in the ascending colon of histopathological differentiation grade G3, with ulceration of the. inner surface of the tumor, peritumorous chronic recurrent concomitant inflammation, with. carcinomatous lymphangitis, tumor infiltration in the parietal layers of the colon as far as. the pericolic fatty connective tissue, with moderately chronic lymphadenitis of the tumor-. free lymph nodes (0/12), chronic appendicitis and with tumor-free overview slices from the. resection margins, from the region of the vessel ligature and from the adjoining omental. fatty tissue. According to the sections examined, the tumor spreading from the colon carcinoma. corresponds a tumor stage of pT3, pNO, MX, L1, R0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: The patient is a -year-oid female with no clinical history or LMP given. PRE-OP DIAGNOSIS: Right breast CA. POST-OP DIAGNOSIS: Same. PROCEDURE: Right segmental mastÃ©ctomy, sentinel node. ADDENDA: Addendum. ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT. Using appropriate positive and negative controis, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method. and reported according to the. consensus statement on adjuvant. therapy for breast cancer, of,. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER negative. Percent cells staining as: (0 100%). PR negative. Percent cells staining as: (0 100%). HER-2/NEU DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE. THAN 10% OF THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE (SCORE 2+). NOTE: Her-2/Neu FISH was ordered and will be subsequently reported. The Her-2/neu and estrogeniprogesterone receptor assays were performed with FDA approved. methods. FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, 3.1 CM, POORLY DIFFERENTIATED, NOTTINGHAM SCORE - 9/9. (TUBULES = 3, NUCLEAR GRADE = 3, MITOSES = 3). B. LYMPHOVASCULAR INVASION IS IDENTIFIED. C. SEPARATE FOCI OF DUCTAL CARCINOMA IN SITU, SOLID TYPE, HIGH NUCLEAR GRADE. D. THE DUCTAL CARCINOMA IN SITU EXTENDS CLOSE (<0.1CM) TO THE POSTERIOR SURGICAL MARGIN. OF RECECTION. E. ALL SURGICAL MARGINS OF RESECTION ARE FREE OF TUMOR. F. NON-NEOPLASTIC BREAST WITH FIBROCYTIC CHANGES. PART 2: SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR TUMOR (0/1), (see comment). PART 3: SENTINEL LYMPH NODE #2, RIGHT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR, (0/1), (see comment). PART 4: NON-SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR, (0/1). COMMENT: Cytokeratin (AE1/3) stains have been performed and confirm the negative status of the sentinal lymph nodes.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
HISTORY. RLL. ? Soft tissue bronchial margin. MACROSCOPIC. Three specimens received. 1: The specimen is labelled ""right lower lobe"" and consists of a lobectomy specimen which measures. 135 mm from superior to inferior, 150 mm at the base from anterior to posterior and up to 55 mm from. lateral to medial. The pleural surface is smooth. There is a stapled resection margin superior to the. hilum. A firm nodule is palpable inferior to the hilum. Adjacent to the bronchial resection margin. there is a firm nodule which is relatively circumscribed. It measures approximately 18 mm in diameter. and on sectioning appears to represent an involved lymph node with an adjacent compressed bronchial. branch. Sectioning of the lung parenchyma reveals a large tumour mass which extends from the hilum. towards the periphery. The nodule is irregular in shape. It has a cream and grey cut surface. It. measures 55 x 50 X 35 mm and lies approximately 15 mm from the overlying diaphragmatic pleural. surface, but extends to within 3mm of the lateral pleura. Towards the hilum there is a second. circumscribed nodule which lies immediately adjacent to the main tumour mass. This nodule measures. 15 mm in diameter and may possibly represent an involved lymph node. A further suspicious lymph. node is identified within the lung parenchyma superior to the main bronchus and this measures 10 mm. in maximum dimension. There are no other focal lesions. [1A-bronchial and vascular resection. margins; 1B-peribronchial lymph nodes; 1C-large peribronchial nodule close to margin; 1D-suspicious. nodule on superior aspect of main bronchus; 1E-RS of tumour; 1F-1G tumour with overlying nearest. pleural margins; 1H-nodule adjacent to main tumour; 1I-uninvolved lung.]. 2: The specimen is labelled ""middle lobe lymphatic tissue"" and consists of a single fragment of cream. tissue which is elongated. It measures 15 x 2 x 2 mm. [BIT-2A.]. 3: The specimen is labelled ""No. 7 lymph node"" and consists of multiple fragments of black and grey. fibrofatty tissue having an aggregate measurement of 40 x 25 x up to 8 mm. Sectioning reveals. blackened lymph nodes. [The largest fragment is bisected and one half is blocked with all remaining. fragments in 3A-3B.1. MICROSCOPIC. 1: Sections show a poorly differentiated squamous cell carcinoma. The lesion is in the region of the. central bronchi and extends out towards the pleura. Pleural invasion is not identified. There is no. blood vessel invasion but lymphatic permeation is seen. No perineural permeation is identified. The. lesion is clear of the bronchial resection margin but there is a nodule of tumour within the adjacent soft. tissue. This is partly related to a lymph node and extends close to/if not at the inked resection margin. Further levels are being examined. Several peribronchial lymph node metastases are seen. There is. organising pneumonia surrounding the tumour and the adjacent lung shows evidence of emphysema. The bronchial resection margin shows squamous metaplasia with mild dysplasia. 2: Sections show an artery with surrounding fibroadipose tissue and nerves. There is no involvement. by tumour. 3: Sections of the lymph nodes show reactive changes only. There is no evidence of malignancy. SUMMARY. Right lower lobe lung and lymph nodes: 1: Poorly differentiated squamous cell carcinoma; 55 mm in maximal dimension. 2: Lymphatic permeation identified but no blood vessel or perineural invasion present. 3: No pleural invasion identified and clear of bronchial margin; soft tissue extension partly related to. a. lymph node that extends close to/if not at the hilar resection margin. 4: Peribronchial lymph node metastases. 5: T3N1MX. SUPPLEMENTARY REPORT. Deeper sections of the large peribronchial nodule close to the mediastinal margin have been examined. Carcinoma extends extremely closely to this margin. Convincing involvement is not seen but. involvement adjacent to the sections is not entirely excluded. T-28000 M-80703 P1-03000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: This is an invasive, moderately differentiated, rectal carcinoma (adenocarcinoma of. G2) with penetration - of all parietal layers (pT3, L1, v1). the colon.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Floor of mouth. 1 ""Left - Level IIA lymph node"": 5 lymph nodes were dissected, all uninvolved by neoplasia (0/5). 2-"" Right - Level IIB lymph node"": 1 of 10 lymph nodes involved by metastatic squamous cell carcinoma (1/10), without. capsular involvement. 3-"" Left - Level IB lymph node"": 2 lymph nodes were dissected, all uninvolved by carcinoma (0/2). Salivary gland uninvolved by neoplasia. 4-""Left - Level III lymph node"": 6 lymph nodes were dissected, all uninvolved by neoplasia (0/6). 5-"" Right - Level III lymph node"": 2 lymph nodes were dissected, all uninvolved by neoplasia (0/2). 6-"" Right - Level IIA lymph node"": . 2 of 10 lymph nodes involved by metastatic squamous cell carcinoma (2/10), with. capsular involvement, without formation of conglomerates. Salivary gland uninvolved by neoplasia. 7-""Level IA lymph node"": 2 lymph nodes were dissected, all uninvolved by neoplasia (0/2). 8- ""Right - Level IB lymph node"": 2 lymph nodes were dissected, all uninvolved by neoplasia (0/2). . Salivary gland uninvolved by neoplasia. 9-"" Pelvi-Glosso-Mandibulectomy"": Invasive well differentiated squamous cell carcinoma. Tumor size: 6.0 cm (greatest dimension) and 4.0 cm deep. Lymphatic invasion: present. Perineural invasion: not detected. Anterior mucous margin involved by neoplasia. Other mucous margins uninvolved by neoplasia. 10-""Marginal central mandibulectomy"": Osseous tissue uninvolved by neoplasia.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. A. Right pelvic lymph nodes grossly suspicious only. B. Left pelvic lymph nodes grossly suspicious only. C. Prostate. D. spleinc flexure colon. E. Recto-sigmoid colon. F. Appendix. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancer of the rectum and prostate. FROZEN SECTION DIAGNOSIS. FSA) No frozen section done. FSB) No frozen section done. GROSS DESCRIPTION. A. Is submitted fresh for possible frozen, labeled ""right. pelvic lymph nodes"" It consists of a 6 x 4 X 2 cm. portion of lymph node-bearing fat, which contains numerous steel. clips. The section of the fat reveals the presence of five. suspected lymph nodes. The smallest of these is 5 mm. in size, the. largest 3 cm. Bisecting all of the lymph nodes shows them to be. made up of soft fleshy reddish-brown tissue without grossly. suspicious areas of metastasis, therefore no frozen sections are. performed as per request of Dr. BLOCK SUMMARY: Block [09-30] - Quadrisected lymph node, [09-. 30) in each. cassette; blocks 5,6 - bisected lymph node, half in each cassette;. block 7 - two additional lymph nodes. RS-7. B. Is submitted fresh, labeled ""left pelvic nodes"" and. consists of a 3 X 3 x 2 cm. mass of lymph node-bearing. fat. The section of fat reveals a large single lymph node present,. measuring 4 X 2 x 1 cm. Bisecting the node shows it to be soft,. without evidence of any firm or suspicious areas. Therefore, no. GROSS DESCRIPTION. frozen section is done per request of Dr. 1). The single node is. bisected, half submitted in each cassette. RS-2. C. Received fresh, subsequently fixed in formalin,. labeled. ""prostate"" is a 28 gm prostate. This has an inserted catheter and. the prostate, itself, is 4.5 x 3.5 x 3.2 cm. This has attached. bilateral adnexa. The seminal vesicles average 2.2 x 1 x 0.7 cm. and. the vasa deferentia average 2.2 x 0.5 cm. The right side is inked. blue and the left side is inked black. The adnexa is amputated. from. the specimen and the apical and bladder margins are coned from the. specimen. The remainder of the specimen is sectioned from apex to. base to show a pink-tan rubbery and nodular cut surface with no. other discrete gross lesions identified. Representative sections. of. the specimen which include the entire prostate are submitted as. follows Block 1 - apical margin; block 2 - bladder margin; blocks. 3, 4 - slice 1 full thickness composite; blocks 5, 6 - slice 2 full. thickness composite; blocks 7, 8 - slice 3 full thickness. composite;. blocks 9, 10 - slice 4 full thickness composite; blocks 11, 12 -. slice 5 full thickness composite; blocks 13, 14 - slice 6 full. thickness composite; block 15 - last slice, slice 7, bisected full. thickness composite; block 16 - base of adnexa and possible vas. deferential margin. RS-16 (entire prostate submitted). D. Received fresh, subsequently fixed in formalin,. labeled. ""splenic flexure colon. The specimen consists of a 7 cm. long portion of colon which is stapled at both ends. The ends of. the specimen are arbitrarily inked blue and black. The serosa is. pink-tan smooth glistening and the specimen is partially covered. with fat. The specimen is previously opened to show a pink-tan. smooth glistening mucosa, having a circumference of 8.5 cm. There. is a large exophytic mass measuring 4 X 3.2 x 2.2 cm. This is. located equidistant in the specimen. There are two additional. small. polyps grossly identified in the mucosa which are 0.2 cm and 0.3 cm. in greatest dimension. The smaller is located 2 cm from the. nearest. luminal margin (inked black) and the larger is located 1.5 cm from. GROSS DESCRIPTION. the tumor located equidistant between both luminal margins. Lymph. nodes are grossly identified in fat. The cut surface of the tumor. shows minimal invasion into the muscularis propria, not through the. muscularis propria, and comes within 1.5 cm of the deep more radial. margin. Representative sections of the specimen are as follows : BLOCK SUMMARY: Block 1 - Representative luminal margins; block 2 -. small polyp; blocks [11-30] - representative sections of tumor. to normal. and radial margin; block 6 - has two possible lymph nodes. RS-6. E. Received fresh, subsequently fixed in formalin,. labeled. ""rectum and sigmoid. "" The specimen consists of a. rectosigmoid colon which is 13 cm long. The specimen is opened at. one end (inked blue) and at the opposite end is stapled. The. stapled end is inked black. The specimen is partially covered with. pink-tan, smooth glistening serosa and yellow lobular fat. The. retroperitoneal reflection is located 5 cm from the black inked end. The specimen is opened to show a pink-tar smooth glistening mucosa. with an average circumference of 7 cm. There is a large exophytic. mass which is 5.5 x 3.5 X 1.2 cm located 2.5 cm from the distal. margin. There are additional small polyps which range from 0.5 cm. to 1 cm. These are located within 0.5 cm of the blue-inked end to. 5. cm of the black inked end. The cut surface of the small polyps. shows no discrete invasions of muscularis propria. The cut surface. has a large mass and shows invasion through the muscularis propria. and comes within 2.5 cm of the radial margin. Lymph nodes are. grossly identified in the fat. Representative sections of the. specimen are as follows : BLOCK SUMMARY : Block 1 - representative luminal margins which. include small polyp at proximal end; blocks 2, 3 - additional. polyps; blocks [01-01] - tumor to normal and deep; block 7. representative radial margin; blocks 8, 9 - have nine possible. lymph. nodes each; block 10 - has five possible lymph nodes; block 11 -. has. four possible lymph nodes; block 12 - has one possible lymph node. GROSS DESCRIPTION. bisected. RS-12. -. F. Received in formalin labeled ""appendix"" is a grossly. unremarkable appendix, partially covered with yellow. lobular fat and pink-tan smooth glistening serosa. The specimen. is. 6.5 X 0.5 cm. The specimen is sectioned to show an intact wall. with. an average thickness of 0.4 cm. The lumen ranges from pinpoint to. 0.3 cm. No other discrete gross lesions are identified. Representative sections of the specimen are submitted in one. cassette with the proximal end inked. RS-1. MICROSCOPIC DESCRIPTION. A-C: Prostate, seminal vesicles, and bilateral pelvic nodes -. Histologic type: Adenocarcinoma, NOS. Histologic (Gleason) grade 7 (3+4). Primary tumor (pT) : Tumor involves the left lobe of the prostate. gland and exhibits extraprostatic extension (pT3a). Extraprostatic extension: Present. Seminal vesicle invasion: Negative. Margins of resection: Negative. Regional lymph nodes (pN) : Right and left pelvic nodes are. negative. for metastatic carcinoma (pNo). Distant metastasis (pM) : Cannot be assessed (pMx) . Vascular invasion: Negative. Other findings : Perineural invasion by tumor is present. D. Splenic flexure colon -. Histologic type: Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT) : Tumor has invaded into, but not through, the. MICROSCOPIC DESCRIPTION. muscularis propria (pT2). Proximal margin: Negative. Distal margin Negative. Circumferential (radial) margin: Negative. Vascular invasion: Negative. Regional lymph nodes (pN) : Two mesenteric lymph nodes are negative. for metastatic carcinoma (pNo). Non-lymph node pericolonic tumor: Absent. Distant metastasis (pM) : Cannot be assessed (pMx) . Other findings : The tumor has arisen in a tubulovillous adenoma. Hyperplastic polyp. E. Rectosigmoid colon -. Histologic type Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT) : The tumor has extended through the muscularis. propria into the pericolonic fat (pT3) . Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion : Negative. Regional lymph nodes (pN) : One of 26 mesenteric lymph nodes. contains metastatic adenocarcinoma (pN1a) . Non-lymph node pericolonic tumor Absent. Distant metastasis (pM) : Cannot be assessed (pMx). Other findings : 6 hyperplastic polyps. 5x3, 4, 3, 1, 13x2. DIAGNOSIS. A. Lymph nodes, right pelvic resection: Four lymph nodes negative for metastatic carcinoma (0/4). DIAGNOSIS. B. Lymph node, left pelvic, resection: Single lymph node negative for metastatic carcinoma (0/1) . C. Prostate and seminal vesicles, resection: Invasive moderate to poorly-differentiated prostatic. adenocarcinoma, Gleason's grade 7 (3+4) involving the left. lobe of the prostate gland. Extraprostatic extension is. present. The apex, bladder neck, and capsular margin of resection are. free of involvement by tumor. Seminal vesicles negative for involvement by tumor. Perineural invasion by tumor is present. D. Colon, splenic flexure, segmental resection. Invasive moderately-differentiated adenocarcinoma arising in. a. tubulovillous adenoma. Carcinoma has extended into, but not through, the muscularis. propria. Proximal, distal and radial margins of resection. free of tumor. Two mesenteric lymph nodes negative for metastatic carcinoma. (0/2) Hyperplastic polyp. E. Colon, rectosigmoid, segmental resection. Invasive moderately-differentiated colonic adenocarcinoma. extending through the wall of the colon into the serosal fat. Proximal, distal and radial margins of resection are free of. tumor. One of 26 mesenteric lymph nodes contains metastatic. adenocarcinoma. Six hyperplastic polyps. DIAGNOSIS. F. Appendix, incidental appendectomy : No significant histopathologic findings. 3. --- End Of Report.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: FSA: Urethra, margin, biopsy. Scant urothelium, without urothelial dysplasia or invasive carcinoma. - Small acinar proliferation, without prostatic invasive adenocarcinoma (see Light Microscopy). B: Bladder and prostate, radical cystoprostatectomy. - Bladder: Invasive urothelial carcinoma, high grade (WHO/ISUP classification), at least 3.5 cm diameter, involving. anterior wall, dome, and posterior wall, with extension through muscularis propria into posterior perivesical. fat, inked surgical margins not involved. - Ureter, right - no dysplasia or carcinoma identified. - Ureter, left - not identified. - Prostate:Â¹. - Adenocarcinoma, Gleason score 3+3, involving left apex and right mid, involving 10% of gland, without. angiolymphatic or extracapsular invasion, inked surgical margins not involved. - Seminal vesicles, bilateral - No carcinoma identified. - Vas deferens, bilateral - No carcinoma identified. C: Lymph nodes, right pelvic, excision. - No metastatic carcinoma identified (0/3). D: Lymph nodes, left pelvic, excision. - No metastatic carcinoma identified (0/8). E: Foreign object, abdominal cavity, removal. - Fat necrosis and peripheral fibrosis. Intraoperative Consult Diagnosis: An intraoperative frozen section was requested. FSA1: Urethra margin, biopsy. - Benign urothelium, no tumor seen. Clinical History: bladder cancer with a clinical diagnosis of bladder cancer undergoes cystoprostatectomy with ileal conduit. and bilateral pelvic lymph node dissection. Gross Description: Received are five appropriately labeled containers. Container A is received fresh for frozen section diagnosis, additionally labeled ""urethral margin"" rule out. cancer and holds a 1.5 x 1.0 x 0.4 cm aggregate of tan/red irregular soft tissue fragments with cautery. artifact. The specimen is totally submitted as FSA1. Container B is additionally labeled ""bladder and prostate"". The specimen was received in the fresh state for. acquisition by tumor procurement services, who obtained portions of tumor and uninvolved urinary bladder. Specimen fixation. Formalin. Type of specimen(s) received: Cystoprostatectomy. Size of urinary bladder: Approximately 8 x 9 x 4.2 cm; size of specimen 10.8 x 9.1 x 4.2 cm. Tumor size: 3.5 x 3 x 2.5 cm. Tumor location: Anterior wall, posterior wall, and dome. The deepest extent of tumor invasion is in the. posterior wall and these areas are preferentially sampled and represented in blocks involved by tumor. The. tumor mass appears unifocal with a papillary appearance and has a yellow/tan appearance with possible. areas of hemorrhage and necrosis. Other mucosal lesions: The uninvolved portions of bladder wall, predominantly the posterior wall show. edema. Otherwise, the mucosa is tan and coarsely folded. The trigone has some focal hyperemia. Gross description of other organs or structures: There is an attached prostate (4.7 x 3 x 2.5 cm). The. seminal vesicles are not identified. The urethral margin has been previously sampled and submitted for. frozen section. The specimen is inked such that the apex of the prostate is inked yellow. The posterior wall. of the bladder is inked black and the anterior wall is inked blue. Digital photograph taken: Block Summary: B1 - Right ureter at stapled margin. B2 - Right lateral wall including right ureter orifice. B3 - Possible left ureter margin (? ejaculatory duct margin) both have staples. B4 - Not dictated. B5 - Representative section of uninvolved posterior wall. B6 - Uninvolved representative section of anterior bladder wall. B7 - Representative section of trigone. B8 - Additional tumor, anterior, left lateral wall. B9 - Representative full thickness section of the posterior wall including bladder lumen and area of possible. neuro hemorrhage and necrosis/tumor involvement. B10 - Not dictated. B11 - Portion of neuro necrosis with tumor involvement. B12-B13 - Additional representative sections of tumor. B14 - Left prostate apical margin, radial sections. B15 - Right prostate apex margin, radial sections. B16 - Left lobe of prostate, mid prostate. B17 - Right lobe of prostate, mid prostate. B18-B27 - Additional unoriented blocks from prostate. B31 - Right ureter candidate. B32 - Left ureter candidate. Container C is additionally labeled ""right pelvic lymph node"" and holds a 3.5 x 1.5 x 1 cm portion of fibrofatty. tissue within which at least 1 lymph node is palpated. The specimen is bivalved and submitted as blocks C1. and C2, NTR. Container D is additionally labeled ""left pelvic lymph node"" and holds a 3.5 x 2 x 0.7 cm portion of fibrofatty. tissue within which lymph nodes are palpated. The specimen is divided into two pieces. Piece one is. bivalved and submitted as block D1 and piece two is bivalved and submitted as block D2, NTR. Container E is additionally labeled ""foreign object abdominal cavity"" and holds a firm white ovoid portion of. tissue (2.3 x 2 x 2.5 cm). The cut surface is firm and smooth with a central sphere of encapsulated hard. yellow/brown material. A portion is submitted for decalcification and submitted as block E1. The frozen section diagnosis is confirmed. Permanent sections of FSA (urethral margin) ow focal small. caliber prostatic glands. High molecular weight cytokeratin shows no basal cell loss, lending no support for. prostatic adenocarcinoma. Specimen B: Bladder primary: Tumor histologic type: urothelial. Tumor histology grade (WHO classification): high. Microscopic tumor size (greatest dimension): 3.5 cm diameter grossly. Microscopic extent of invasion: through muscularis propria into perivesical fat (block B9). Focality of tumor: unifocal. Angiolymphatic space invasion: not identified. Presence/absence of intraepithelial abnormality: high grade papillary carcinoma present. Ureters: R negative L not identified on repeated attempts. Histologic assessment of surgical margins: Negative (Scant ink in block B9 is interpreted as contamination rather than surface inking.). Ureter, left: not identified on repeated attempts. Ureter, right: negative. Urethra: negative (including negative HMW CK immunostain to exclude prostate adenocarcinoma). Paravesicular soft tissue: negative. Other significant findings: none. Lymph nodes: 0/11. Diagnoses of other organs or structures: Prostate adenocarcinoma, Gleason 3+3 (see below). AJCC Staging (Bladder): pT3a. pNO. pMx. This staging information is based on this pathologic specimen and may be incomplete. A comprehensive. review of all available information is recommended to determine final staging. Prostate primary: Tumor histologic type: adenocarcinoma. Tumor grade (Gleason system): 3+3. Approximate percentage of prostate involved by tumor: 10%. Extent of tumor: Location of tumor involvement in prostate: L apex (B14) and R mid (B19-21). Confinement/non-confinement of tumor within the prostatic capsule: confined. Location of extracapsular tumor involvement: Type of extracapsular tissue involved within tumor: Angiolymphatic space invasion: not identified. Seminal vesicles: not involved. Vas deferens: not involved. Histologic assessment of surgical margins: negative. Other significant findings: bladder carcinoma (see above). Lymph nodes: (0/11 pelvic nodes total). AJCC Staging: pT2c. pNO. pMx. This staging information is based on this pathologic specimen and may be incomplete. A comprehensive. review of all available information is recommended to determine final staging. I have personally conducted the evaluation of the above specimens and have. rendered the above diagnosis(es).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL DIAGNOSIS: HCC. Specimen : Liver. Gross Photo : GROSS: 1. Specimen: Liver: 10.0 x 9.5 x 5.5 cm, 169.5gm, unfixed. 8.0 X 6.0 X 5.2 cm, 66.0 gm, unfixed. 2. Tumor location: right. Tumor number: One. Tumor size: 5.3 x 4.9 X 5.5 cm. 3. Satellite nodule: no. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: no. 6. Hemorrhage/peliosis: yes (5-10%). 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks. TB, T1-5, tumor mass X 6. NB, A, non-tumorous tissue X 2. RM, resection margin X 1. MICROSCOPIC: 1. Hepatocellular carcinoma: 1-1. Differentiation. The worst differentiation II. The major differentiation II. 1-2. Histologic type: trabecular. 1-3. Cell type: clear. 1-4. Fatty change: no. 2. Fibrous capsule formation: complete capsule. 3. Capsular infiltration: no. 4. Septum formation: yes. 5. Surgical resection margin invasion: no, margin of the clearence (3.0 mm). 6. Serosal invasion: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. 9. Hepatic vein invasion: no. 10. Hepatic artery invasion: no. 11. Microvessel invasion: yes. 12. Intrahepatic metastasis: no. 13. Multicentric occurrence: no. NOT reported. Gross: Urine, smear, negative. Urine, smear, negative. Urine, smear, negative. Liver, ectomy, hepatocellular carcinoma, cirrhosis. T56000, P10, M81703, M49500. DIAGNOSIS: Liver, right lobe, lobectomy: Hepatocellular carcinoma, well differentiated. Cirrhosis. Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) BLADDER TUMOR: UROTHELIAL CARCINOMA, HIGH GRADE WITH EXTENSIVE SQUAMOUS. DIFFERENTIATION (GREATER. THAN 50%). TUMOR INVADES THE MUSCULARIS PROPRIA. POSITIVE FOR LYMPHOVASCULAR INVASION. (B) PROSTATIC URETHRA: Benign prostatic urethra with chronic inflammation and reactive changes. Benign prostatic glands and fibromuscular stroma also noted. GROSS DESCRIPTION. (A) BLADDER TUMOR - Multiple irregular fragments of white-tan soft tissue (2.0 x 2.0 x 1.0. cm in aggregate). Entirely submitted in A1-A3. (B) PROSTATIC URETHRA - Two irregular fragments of white-tan soft tissue (0.5 x 0.4 x 0.3. cm each). Entirely submitted in B. CLINICAL HISTORY. Bladder cancer.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure: Diagnosis. A. Lung, right upper lobe, resection: Adenocarcinoma, poorly differentiated, 3.9 cm. Surgical margins uninvolved. 2 lymph nodes with no evidence of metastatic disease (0/2). B. Lung, ""portion of lower lobe"", resection: No evidence of malignancy. C. Level 10 lymph nodes, resection: No evidence of metastasis in 4 lymph nodes (0/4) . D. R4 lymph nodes, resection: No evidence of metastasis in two lymph nodes (0/2). B. Level 7 lymph nodes, resection: No evidence of metastasis in 4 lymph nodes (0/4). Microscopic Description: Microscopic examination performed. A. Histologic type: adenocarcinoma. Histologic grade: poorly differentiated. Primary tumor (pT) : 3.9 cm, pT2. Margins of resection: negative. Direct extension of tumor: not identified. Venous (large vessel) invasion: not identified. Arterial (large vessel) invasion: not identified. Lymphatic (small vessel) invasion: not identified. Regional lymph nodes (pN) : negative, pNO. Distant metastasis (pM) : cannot be evaluated by this specimen, pMX. Other findings: none. B. Sections of the lower lobe demonstrate atelectasis and focal. hemorrhage but no evidence of malignancy. C. The level 10 lymph node demonstrates no evidence of metastasis in 4. lymph nodes. D. The R4 lymph node demonstrates no evidence of metastasis in 2 lymph. nodes. E. The level 7 lymph node demonstrates no evidence of metastasis. 4. lymph nodes. Specimen. A. Right upper lobe. B. Portion of lower lobe. C. Level 10 lymph node. D. R4 lymph node. E. Level 7 lymph node. Clinical Information. Lung cancer. Gross Description. A. Received fresh for tissue procurement labeled ""right upper lobe"" is. a 14.5 x 11.5 x 4.5 cm lobectomy specimen with attached 1 cm in length,. 1.2 x 0.9 cm in diameter bronchial stump. The pleura is smooth to. scaberous tan red-gray with an indurated focus along the medial aspect. The pleura is inked black and the specimen is sectioned. On. sectioning, there is a 3.9 x 3.5 x 3.2 cm rubbery tan-white tumor mass. which extends to within 0.3 cm of the inked pleural surface. A portion. of tumor and a portion of normal parenchyma are submitted for tissue. procurement as requested. The remaining parenchyma is spongiform. tan-pink-red without additional mass lesion or abnormality. Two soft. gray-black tissues in keeping with lymph nodes measuring up to 0.8 cm. are recovered from the hilum. RS 12. Summary: 1 - bronchial stump margin, 2 - vascular margins, 3 - hilar. lymph nodes, 4 through 6 - tumor to inked pleural surface, 7 through. 9. - tumor to adjacent parenchyma, 10 through 12 - random. B. Received fresh labeled ""portion of lower lobe"" is a wedge-shaped,. 5.4 x 2.7 x 1.3 cm soft portion of lung tissue with a single staple. line along one aspect. The staple line is removed and the underlying. surface is inked blue. The pleura is slightly scaberous tan-pink. On. sectioning, the parenchyma is spongiform tan red without apparent mass. lesion or abnormality. AS6. C. Received in formalin labeled ""level X lymph node"" is a 2.1 x 1.7 x. 0.7 cm rubbery tan-gray-pink tissue which is bisected and entirely. submitted in one block. D. Received in formalin labeled ""R. 4 lymph node"" are 2 slightly. fragmented rubbery tan-gray-pink tissues averaging 1 cm in greatest. dimension. AS1. E. Received in formalin labeled ""level VII lymph node"" are 4 slightly. rubbery tan-pink to gray-black tissues ranging from 0.4-0.9 cm in. greatest dimension. AS1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Specimen Information. SURGICAL PANEL. DIAGNOSIS. A) RIGHT PARATRACHEAL LYMPH NODE, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. B) RIGHT PARATRACHEAL LYMPH NODES, STATION 4R LYMPH NODE, EXCISION: 1. Four benign lymph nodes. 2. No evidence of metastatic carcinoma. C) STATION 10R LYMPH NODE, RIGHT CHEST, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. D) THORACIC LYMPH NODE, STATION 11R, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. E) TRACHEOBRONCHIAL ANGLE LYMPH NODE, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. F) LUNG, RIGHT UPPER LOBE, LOBECTOMY: 1. Moderately to poorly differentiated invasive squamous cell. carcinoma forming a mass measuring 6.5 X 4.3 X 3 cm. 2. Tumor infiltrates up to but not within visceral pleura. 3. Focal in-situ and superficially invasive squamous cell carcinoma is. present in the en face section of the proximal bronchial resection. margin. 4. Patchy hemorrhage and post-obstructive pneumonia present in. non-involved pulmonary parenchyma. 5. Ten (10) benign right hilar lymph nodes. Final TNM: pT2bN0M0. stage: IIA. MACROSCOPIC. SPECIMEN TYPE. Lobectomy. TUMOR SITE. Right Lung-Upper Lobe. TUMOR SIZE. 6.5 X 4.3 X 3.0 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Squamous cell carcinoma. HISTOLOGICAL GRADE. (moderately differentiated). VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. TUMOR EXTENSION. Not applicable. MARGINS. Margins involved by tumor (Bronchial). PATHOLOGIC STAGING. EXTENT OF INVASION. pT2b. (Tumor greater than 5 cm, but 7 cm or less in greatest. dimension). REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 18. Total positive nodes: 0. N1 nodes: 12. N1 positive nodes: 0. N2 nodes: 6. N2 positive nodes: 0. N2 sites sampled: Station 4: Lower paratracheal nodes. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT2bN0M0. stage: IIA. The pathologic stage presumes no distant metastasis. CLINICAL INFORMATION. History of lung cancer. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Right paratracheal lymph node. The specimen is received fresh from the OR labeled ""right paratracheal. lymph node"" and consists of a 0.3-0.4 cm diameter adipose tissue with a. possible 0.2-0.3 cm lymph node frozen in toto on one block. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Negative for. tumor"" is rendered by. B) SOURCE: Right paratracheal lymph nodes #2 4R lymph node. Received fresh labeled ""right paratracheal lymph node #2 4R lymph nodes"". consists of multiple anthracotic lymph node fragments and fat aggregating. to 3 cm in greatest dimension. The tissue is entirely submitted on two. chucks for frozen section diagnosis. INTRAOPFRATIVE PATHOLOG CONSULTATION WITH FROZEN SECTION: ""Negative"" is. C) SOURCE: Right chest 10 R lymph node. Labeled ""10 R node right chest"" is a 0.6 cm anthracotic apparent lymph. node. The specimen is entirely submitted in one cassette. D) SOURCE: Thoracic 11 R lymph node. Received fresh labeled ""11 R lymph node thoracic"" is a 1.5 cm aggregate of. black anthracotic apparent lymph node fragments in fat. It is entirely. submitted on one chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Negative"" is. E) SOURCE: Tracheal lymph node bronchial angle. The specimen is received fresh from the OR labeled ""tracheal bronchial. angle lymph node."" It consists of a 1.3 cm in diameter black-red lymph node. sectioned into four pieces and entirely frozen on one block. INTRAOPERATIVE DATHOL nay CONSULTATION WITH FROZEN SECTION: ""Negative"" is. rendered. F) SOURCE: Right upper lobe lung. The specimen is received fresh labeled ""right upper lobe."" It consists of a. tan-pink, 19 x 15 X 5.5 cm portion of right upper lobe. The bronchial. margin is patent and a tan-pink tumor is seen 0.7 cm distal to the margin. There is an intact, 12-cm staple line. The pleural surface is tan-pink and. mottled with a palpable mass seen just superior to the bronchus. This area. is inked blue. The staple line is removed, the specimen is sectioned. Cut. section of the specimen reveals a white lobulated tumor mass corresponding. to that seen at the mainstem bronchus and palpated. There are dilated. airways throughout the specimen that are filled with thick yellow-tan. mucoid material surrounded by tan-pink spongy mildly anthracotic. parenchyma. The tumor measures 6.5 x 4.3 x 3 cm. The tumor is 1.5 cm from. the nearest orange-inked staple line. No additional satellite lesions are. seen. A photograph is taken. Tissue is banked for possible ancillary. studies. The tumor extends to the inked pleural surface but does not. grossly extend through it. The hilum displays a 3-cm aggregate of lymph. nodes. Representative sections are submitted in 14 cassettes as follows: 1. Mainstem bronchus margin. 2. Vascular margin. 3. Closest staple line, no tumor. 4-5. Mainstem bronchus and tumor. 6. Tumor to inked pleura. 7-8. Random tumor. 9-11. Random parenchyma with no tumor. 12-14. Hilar lymph nodes. This case is accessioned in. MICROSCOPIC. A-E) The microscopic appearance substantiates the diagnosis. F) Sections through the right upper lobe tumor mass confirm the presence of. a moderately to poorly differentiated infiltrating squamous cell carcinoma. forming a mass measuring 6.5 cm in greatest dimension. Tumor infiltrates up. to but not within contiguous visceral pleura. An en face section from the. proximal bronchial resection margin demonstrates focal in-situ and. superficially invasive squamous cell carcinoma within bronchial mucosa. The. non-involved pulmonary parenchyma demonstrates areas of post-obstructive. pneumonia and patchy hemorrhage. Ten benign hilar lymph nodes are included. Interpreted at. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. - Order Result History. Result Date and Time. Provider Status. Lab. Parent Order ID. Child Order ID. Specimen Information. Specimen Source. Other. Audit Trail.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Research Gross Description. -year-old male with right liver lobe lesion. Research Dx. Right partial hepatectomy: Cholangiocarcinoma, sarcomatous. CASE SUMMARY FOR CARCINOMA OF INTRAHEPATIC BILE DUCTS: Specimen: right liver lobe. Procedure: right hepatic lobectomy. Tumor size: 8 x 5.5 x 6 cm. Tumor focality: single focus. Histologic type: cholangiocarcinoma, sarcomatous (pleomorphic). Histologic grade: poorly differentiated. Tumor growth pattern: mass-forming. Microscopic tumor extension: tumor confined to hepatic parenchyma . Margins: Hepatic parenchymal/bile duct margin: negative. Distance of invasive carcinoma from closest margin: 3 cm. Lymphovascular invasion: not definitively identified. Perineural invasion: present. Pathologic staging (pTNM). Primary tumor (pT): pT1 - solitary tumor without vascular invasion. Regional lymph nodes (pN): pNX - cannot be assessed. Distant metastasis (pM): not applicable. Additional findings: extensive tumor necrosis. AJCC Staging (7th edition): pT1 pNx pM not applicable. Research QC. Tumor I1. 85% tumor nuclei (not sarcomatoid/pleomorphic). 10% necrosis. 5% normal. Tumor T2: 20% tumor nuclei (approx. 1/2 sarcomatoid). 80% necrosis. 0% normal. Tumor T3: 33% tumor nuclei (not sarcomatoid). 67% necrosis. 0% normal. Normal: 100% liver. Research Specimen. Specimen Process Time. Blood draw time: Plasma frozen time: 1. Serum frozen time: Buffy coat frozen time: Cold ischemia start time: Formalin fixation start time: Total cold ischemia time: 34 minutes. Formalin fixation stopped time: Total formalin fixation time: Approximately 6 hours. Specimen Weight. T1-101 mg, T2-81mg, T3-100 mg, T4-125 mg. N1-274 mg. Specimen Size. Plasma x 4. Serum x 3. Buffy coat x 1. Cryovials x 8. Normal x 4. Tumor x 4. FFPE x 8. Normal x 4. Tumor x 4. Study. Patient Consent.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Female. Surgery Date: DIAGNOSIS: Liver, segment IVB, and gallbladder, resection: Invasive grade 3 (of 4). cholangiocarcinoma forming a hilar mass (10.0 x 9.4 x 7.0 cm) . The tumor invades. into the wall of the gallbladder. The gallbladder mucosa shows cholesterolosis. The. surgical margins are negative. Omentum, biopsy: Metastatic cholangiocarcinoma. Soft tissue, peri duodenal region, excision: Metastatic cholangiocarcinoma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) RIGHT KIDNEY: RENAL CELL CARCINOMA (7.0 CM MAXIMUM DIMENSION), CONVENTIONAL TYPE (60% CLEAR CELLS, 40%. EOSINOPHILIC CELLS), FUHRMAN NUCLEAR GRADE 3, INVASIVE INTO RENAL SINUS ADIPOSE. TISSUE AND RENAL PELVICALYCEAL SYSTEM. (SEE COMMENT). Margins of resection free of tumor. Adrenal gland, no tumor present. (B) PARACAVAL, INTERAORTIC CAVAL LYMPH NODES: Four lymph nodes, no tumor present. COMMENT. Renal cell carcinoma in the right kidney invades into the renal sinus adipose tissue and the renal pelvicalyceal system. There is no. invasion into the perinephric adipose tissue or the renal vein. Multifocal necrosis is present. The kidney parenchyma shows. hemorrhage in the renal tubules. GROSS DESCRIPTION. (A) RIGHT KIDNEY - A radical nephrectomy specimen (21.0 x 12.0 x 7.0 cm), including the right kidney (12.5 X 9.0 x 6.5 cm), a. regment of renal artery, the renal vein, ureter (5.0 cm in length and 0.5 cm in average diameter) and the adrenal gland (6.5 x 3.0 x 0.9. In). There is a 7.0 x 5.5 x 5.0 cm well circumscribed tumor in the mid pole of the kidney. The tumor is golden yellow, with extensive. areas of hemorrhage and necrosis, which are present predominantly in the center of the tumor. The tumor extends into the renal sinus. and renal pelvis. The tumor does not invade into the perinephric adipose tissue or renal. vein. The adjacent kidney parenchyma has multifocal black striated foci of discoloration in the renal cortex. Otherwise, the kidney. parenchyma is unremarkable. The pelvicalyceal system is smooth and devoid of other lesions. No lymph nodes are identified in the. hilum or the kidney. Serial cross sections of the right adrenal gland show unremarkable cortex and medulla. Portions of the tumor have been submitted for possible electron microscopy as well as for vaccine protocol. SECTION CODE: A1, ureter and vascular margins, A2-A4, tumor with renal sinus and pelvis; A5, tumor in renal pelvis; A6, tumor. and renal pelvis; A7, A8, tumor and perinephric fat; A9, tumor and adjacent kidney; A10, A11, uninvolved renal parenchyma; A12,. adrenal gland, representative section. (B) PARACAVAL INTER AORTIC LYMPH NODE - A segment of adipose tissue (6.2 x 4.5 x 1.0 cm) with four possible unremarkable. lymph nodes (from 0.8 to 4.0 cm in greatest dimension). SECTION CODE: B1-B4, one possible lymph node; B5-B8, one possible lymph node; B9, two possible lymph nodes. CLINICAL HISTORY. Renal mass,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Collected date and time: Clinical Information. Unspecified disease of pancreas. Surg Path Addendum. This addendum is to correct the tumor location from pancreatic neck to distal pancreas in Pathology. Synoptic Report as follows: Tumor location: distal pancreas by history. Per conversation with. the metastatic pancreatic carcinoma infiltrates the posterior cervix. rather than the anterior cervix. Therefore, the diagnosis of specimen C is amended as follows: C. UTERUS, TUBES, OVARIES, HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMY: - Metastatic pancreatic adenocarcinoma diffusely infiltrating posterior cervical wall. - Atrophic endometrium with a benign endometrial polyp. - Uterine leiomyoma with hyalinizing degeneration. - Benign serous cyst of right ovary. - Paratubal cyst of left fallopian tube. - Left ovary and right fallopian tube, no specific pathologic changes. There are no changes to the remainder of the diagnosis and pathology synoptic. Original report verified. end of addendum. Diagnosis. A. PANCREAS, NEAR TOTAL PANCREATECTOMY: - Ductal adenocarcinoma of pancreas, moderately to poorly differentiated, approximate tumor size 3.2 X. 2.4 cm. - Tumor focally extending to peripancreatic fat. - Extensive perineural invasion by carcinoma identified. - Focally suspicious for lymphatic space invasion. - Stabled pancreatic margin containing pancreatic duct, negative for invasive carcinoma (see comment). - Carcinoma focally extending to less than 1 mm of inked peripancreatic soft tissue margin. - Metastatic adenocarcinoma involving one out of twelve peripancreatic lymph nodes (1/12). - Marked dilatation of pancreatic duct with focal Pancreatic Intraepithelial Neoplasia 2 (PanIN-2). B. SPLEEN, SPLENECTOMY: - Congestion of splenic red pulp, negative for tumor. C. UTERUS, TUBES, OVARIES, HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMY: - Metastatic pancreatic adenocarcinoma involving anterior cervical wall. - Atrophic endometrium with a benign endometrial polyp. - Uterine leiomyoma with hyalinizing degeneration. - Benign serous cyst of right ovary. - Paratubal cyst of left fallopian tube. Left ovary and right fallopian tube, no specific pathologic changes. Comment: The stapled pancreatic parenchymal margin containing pancreatic duct is free of invasive. carcinoma; there is Pancreatic Intraepithelial Neoplasia 1B (PanIN-1B) involving the pancreatic ductal. margin. This case was reviewed at the. Pathology Synoptic. Specimen type: Near total pancreatectomy, splenectomy, hysterectomy and bilateral salpingo-. oophorectomy. Tumor location: Pancreatic neck per history. Histologic type: Ductal adenocarcinoma. Histologic grade: Moderately to poorly differentiated. Tumor size: 3.2 x 2.4 cm. Invasion of: Tumor extends beyond the pancreas, but without involvement of celiac axis or SMA. Lymphatic invasion: Suspicious. Large vessel invasion: Not identified. Margins: Common bile duct: NA. Proximal duodenal or gastric margin: N/A. Distal duodenal margin: N/A. Proximal pancreatic margin: Negative for invasive carcinoma; the pancreatic duct margin shows. PanIN-1B. Peripancreatic soft tissue margin: Negative; carcinoma focally extends to less than 1 mm of. peripancreatic soft tissue margin (cytokeratin stain highlights cancer glands). Total regional lymph nodes: 12 Number positive: 1. AJCC Pathologic Stage: pT3, N1, M1. Dictated and authenticated by: Performing Location: Gross Description. A. PANCREAS. Received fresh labeled with the patient name. Description: Unoriented 46 g, 9.2 x 3.5 x 2.8 cm segment of pancreas with the tenuously attached 12 X. 10 X 1.5 cm portion of omental apron. Duodenum and bile ducts are not present. Prior to sectioning the. stapled margin of the pancreas is stained with green dye. As the pancreas is received without. orientation, all remaining surfaces are stained black. A poorly defined 3.2 X 2.4 X 1.7 cm tumor is found. approximately 2 cm from the stapled margin. The tumor is grossly free of all margins. Much of the. pancreas demonstrates dilated pancreatic ducts, fat necrosis and fibrosis. There is no gross appearance. of tumor involving the omentum. The specimen is dissected for lymph nodes. SECTIONS: A1. Stapled margin en face. A2-5. All of the tumor. A6-11 sequential sections of the adjacent fibrosed pancreas. A12-14. 9 representative sections of the omentum. A15. 4 lymph nodes. A16. One lymph node trisected and all submitted. B. SPLEEN: Received in formalin labeled with the patient name. Description: 98 g, 6.2 X 5.2 x 4.9 cm partially disrupted spleen. Hilar fat reveals no gross lymph nodes or. accessory spleen. The cut surfaces are homogeneous, white pulp is well delineated, no gross. appearance of tumor. SECTIONS: B1-2. Representative sections. C. UTERUS, TUBES, OVARIES. Received in formalin labeled with the patient name. Specimen received: Uterus with attached right fallopian tube and ovary, left fallopian tube and. separately submitted left ovary. Integrity: Received disrupted. Weight and size of uterus with cervix: 45 g, 6.8 X 5.7 X 4.9 cm. Serosa: Posterior serosa is roughened. Endometrial cavity: 4.3 X 1.4 cm, endometrium averages 0.1 cm in thickness, 1.5 X 1.0 x 0.4 cm posterior. fundic endometrial polyp. Myometrium: Myometrial wall averages 1 cm in thickness, 0.6 cm anterior intramural myoma. Cervix: 1.8 cm in diameter, exocervix congested and roughened. Right ovary: 1.1 X 1.0 X 0.8 cm containing a 0.9 cm serous cyst. Right fallopian tube: 4.2 x 0.6 cm, no gross abnormality. Left ovary: 1.1 x 1.1 X 0.6 cm, roughened serosa. Left fallopian tube: 4.3 x 0.6 cm, no gross abnormality. SECTIONS: C1. Posterior cervix. C2. AnteriorPosterior cervix. C3. 2 full-thickness sections of the anterior uterine wall with all of the myoma. C4-5. 2 full-thickness sections of the posterior uterine wall to include all of the endometrial polyp. C6. All of the right ovary. C7. 2 cross sections of right fallopian tube and all of the right fimbriated end in longitudinal section. C8. All of the left ovary in 2 sections. C9. 2 cross sections of left fallopian tube and all of the fimbriated end in longitudinal section. Surg Path Non-Chartable Comment.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) LEFT ADRENAL-SPARING RADICAL NEPHRECTOMY: RENAL CELL CARCINOMA INVOLVING KIDNEY: Type: conventional/clear cells. Fuhrman grade: 2. Size: 4.5 x 3.0 x 3.0 cm. Location: mid-pole. Soft tissue invasion: through renal capsule into peri-renal connective tissue into renal sinus. Renal artery: no tumor present. Renal vein: no tumor present. Ureter: no tumor present. Resection margins: free of tumor. (B) GALLBLADDER: Chronic cholecystitis; no tumor present. Cholelithiasis. GROSS DESCRIPTION. (A). LEFT. ADRENAL-SPARING RADICAL NEPHRECTOMY - A radical nephrectomy specimen (19.0 x 11.0 x 4.0 cm) including the left. kidney. (11.5 x 5.0 x 4.0 cm), a segment of renal artery, renal vein, and a segment of ureter (4.5 cm in length and 0.3 cm average diameter). No adrenal gland is present. There is a well-circumscribed tumor (4.5 x 3.0 x 3.0 cm) in the mid pole of the kidney. The tumor is bright-yellow, without areas of. hemorrhage and necrosis. The tumor is confined to the kidney, approximates the kidney capsule, and does not grossly invade into the. perinephric adipose tissue. The tumor is situated in the proximity (0.1 cm) of the renal sinus and renal vein. The tumor does not extent. to the Gerota's fascia. The adjacent kidney parenchyma is unremarkable. The. pelvicalyceal system is smooth and devoid of any lesions. No lymph nodes are identified in the hilum of the kidney. Representative sections of the tumor are submitted for possible electron microscopy as well as other research protocol. INK CODE: Black: perinephric adipose tissue in the proximity of the tumor. SECTION CODE: A1,. ureter,. renal vein, artery vein resection margins (en face); A2-A4, tumor with closest renal capsule and inked perinephric adipose. tissue; A5, tumor in the proximity of the renal vein; A6, A7, tumor in the proximity of the renal sinus; A8, tumor with surrounding normal. renal parenchyma; A9, representative section of normal renal parenchyma. (B). GALLBLADDER - An intact gallbladder (9.0 cm in length and 5.0 cm in maximum circumference). The bile is dark green. The mucosa. is pink-green. The wall of the gallbladder is 0.2 cm in thickness. A black irregular stone is identified measuring 0.6 x 0.5 x 0.3 cm. SECTION CODE: B1, cyst duct; B2, representative sections of the gallbladder. CLINICAL HISTORY. None given. SNOMED CODES. T-71000, M-83123. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
RUN DATE: "". RUN TIME: RUN USER: T. LOC: U #: AGE/SX: ROOM: REG DR: BED: DIS: TLOC: SPEC #: RECD: PERFORMED AT. COLL: TIME IN FORMALIN: CLINICAL INFORMATION: Pre-op Diagnosis: Remarks: Tag = axillary / tail specimen #3. Specimen (s) : A. Sentinel node #1 left breast. B. Sentinel node #2. C. Left simple mastectomy. MICHOSCOPIC DIAGNOSIS. A. ONE LYMPH NODE, SENTINEL NODE #1 LEFT BREAST, LYMPHADENECTOMY: NO TUMOR SEEN IN MULTIPLE STEP SECTIONS STAINED WITH ROUTINE AND PAN KERATIN. IMMUNOCHEMICAL STAINS. B. THREE LYMPH NODES, SENTINEL NODE #2, LYMPHADENECTOMY: NO TUMOR SEEN IN MULTIPLE STEP SECTIONS STAINED WITH ROUTINE AND PAN KERATIN. IMMUNOCHEMICAL STAINS. c. LEFT BREAST, TOTAL MASTECTOMY: TWO AREAS OF INFILTRATING DUCTAL CARCINOMA (IDENTICAL MORPHOLOGY). MODIFIED NOTTINGHAM HISTOLOGIC GRADE 2 OF 3: NUCLEAR SCORE 2 OF 3, TUBULAR. FORMATION SCORE 3 OF 3, MITOTIC SCORE 1 OF 3 (TWO MITOTIC FIGURES PER SQUARE. MILLIMETER). LARGER TUMOR MEASURES 2.7 CM (pT2). EXTENSIVE DUCTAL CARCINOMA IN SITU, LOW GRADE WITH SOLID PATTERN. SURGICAL MARGINS FREE OF TUMOR WITH NEAREST MARGIN TO INVASIVE TUMOR 0.5 CM, THE. DEEP MARGIN (RO). SEE COMMENT FOR SYNOPTIC REPORT. COMMENT (s). SURGICAL PATHOLOGY CANCER CASE SUMMARY - APPROVED BY COLLEGE OF AMERICAN PATHOLOGISTS. PROCEDURE: Total mastectomy. LYMPH NODE SAMPLING: Sentinel lymph nodes. SPECIMEN LATERALITY: Left. HISTOLOGIC TYPE OF INVASIVE CARCINOMA: Invasive ductal carcinoma. TUMOR SIZE: Greatest dimension: 27 mm. HISTOLOGIC GRADE: Glandular/tubular differentiation: score 3. Nuclear pleomorphism: score 2. Mitotic rate: score 1. RUN DATE: RUN TIME: RUN USER: SPEC #: COMMENT (s). Overall grade: grade 2. TUMOR FOCALITY: Multiple foci of invasive carcinoma. DUCTAL CARCINOMA IN SITU: DCIS is present, positive for EIC. MARGINS: Invasive carcinoma: Margins uninvolved by invasive carcinoma. Distance from closest margin: 5 mm. DCIS: Margins uninvolved by DCIS. LYMPH NODES: Number of sentinel lymph nodes examined: 4. Total number of lymph nodes examined: 4. Number of lymph nodes with macrometastases: 0. Number of lymph nodes with micrometastases: o. Number of lymph nodes with isolated tumor cells: 0. PATHOLOGIC STAGING: Primary tumor: pT2. Regional lymph nodes: Modifier: (sn). Category: pNo (i-). Distant metastasis: not applicable. ANCILLARY STUDIES: Estrogen receptor: Results: positive (100% of tumor cells with. nuclear positivity). Progesterone receptor: Results: positive (1008 of tumor cells with. nuclear positivity). Immunoperoxidase studies: Results: equivocal (score 2+). In situ hybridization (FISH) : Results: not amplified. GROSS DESCRIPTION: A. Received in formalin labeled with the patient's name and ""sentinel node #1, left. breast"" is a 2.0 x 1.3 x 0.9 cm nodular fatty tissue biopsy. The fat is trimmed, and there. is a previously bisected, disrupted 1.5 x 0.8 x 0. cm lymph node present. The node is. sectioned perpendicular to the long axis to be entirely submitted for sentinel lymph node. protocol in cassette A1. B. Received in formalin labeled with the patient's name and ""sentinel node #2, left. breast"" is a 2.3 x 1.5 x 1.2 cm nodular fatty lymph node. The fat is trimmed, and there. are three small lymph nodes present which range up to 0.8 cm. The nodes are sectioned to. be entirely submitted per sentinel lymph node protocol as labeled: B1. two lymph nodes with one lymph node bisected. B2. largest lymph node serially sectioned perpendicular to the long axis. Received fresh for tissue banking labeled with the patient's name and ""left simple. mastectomy"" is a 481 gram, 17.0 x 16.0 x 4.5 cm fibrofatty breast. The breast is received. with an overlying 9.5 x 3.0 cm black-brown skin ellipse. The ellipse has a central,. circular 3.0 cm areola which extends to the skin margin and a 1.0 cm central nipple. The. RUN DATE: RUN TIME: RUN USER: SPEC #: GROSS DESCRIPTION: breast is absent of an axillary tail and consistent with a simple mastectomy specimen. The. deep fascial margin is smooth and will be inked blue. The breast is serially sectioned. from medial to lateral to have an inferior, 2.7 x 2.5 x 2.0 cm circumscribed red-brown. mass. The mass is more closely associated with the lower outer quadrant. This larger mass. comes to within 0.5 cm of the nearest inked deep margin. This mass is inferior and comes. to within 5.0 cm of the inferior margin, is 13 cm from the superior aspect, is at. least. 6.5. cm. from lateral and 7.5 cm from medial. There is a clip identified and a separate tumor. site which is centrally located between the upper and lower inner quadrant. This smaller. tumor is 2.3 cm from the nearest deep margin and is 1.3 x 0.8 x 0.8 cm. The smaller tumor. has a localization clip and is 11.0 Cm from superior, is 6.5 cm from inferior, is. approximately 4 cm from medial and at least 10 cm from lateral. The breast has diffuse. dense white fibrous tissue with fibrocystic changes. The white fibrous tissue makes. up. between. 60-75%. of the parenchyma. Sections of tumor are sampled for tissue banking. The. specimen is sampled as labeled: C1. sections of nipple. C2. areola at base of nipple. C3-C5. sections of large described brown septated mass sampled for tissue. banking in lower outer quadrant with cassette C3 being section of mass. nearest deep margin. C6. deep margin overlying smaller mass with localization clip. C7,C8. smaller tumor entirely submitted. C9. upper outer quadrant. C10. lower outer quadrant (quadrant closest to large tumor mass). C11. upper inner quadrant (quadrant associated with smaller tumor with. localization clip). C12. lower inner quadrant sampled. INTRAOPERATIVE CONSULTATION: IMMEDIATE GROSS EVALUATION C, LEFT BREAST: TUMOR PROCESSED FOR TUMOR BANKING. PHOTO. Image. Image. Image. (signature on file).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Page:11/13. Print this Page. Specimen Description. Accession # : Med. Rec # : Clinical History. Patient History and Preoperative Diagnosis: Right thyroid nodule. Final Pathologic Diagnosis. A. Lymph node, Delphian, biopsy. Lymph node (0/1), no tumor seen. B. Thyroid, total thyroidectomy: Papillary thyroid carcinoma, multifocal (see synoptic report). Synoptic Report. SYNOPTIC REPORT FOR THYROID CANCER: Specimen type: Total thyroidectomy. Tumor location: Main (largest) tumor is located in the right thyroid lobe. Tumor size: 3.9 x 2.7 x 2.0 cm (Targest mass) ; plus two additional foci of. papillary microcarcinoma one in the right lobe measuring 0.5 cm. in. greatest diameter, and a second one in the left lobe measuring 0.2 cm. in. greatest diameter. Histologic type: Papillary carcinoma. Tumor grade: Well-differentiated. Lymphatic/vascular invasion Yes. Capsular invasion: Yes, extensive. Tumor extent: Confined to the thyroid: No; tumor infiltrates perithyroidal soft tissue. and reaches up to the inked outer surface of the specimen. Multifocal Yes. Invasion of thyroid cartilage or hyoid bone: No. Lymph nodes N/A. Additional pathologic findings ; None. pTNM: pT3NxMx. Comments: In some areas, the tumor shows focally features of ""tall cell"". Specimen Description. Clinical History. Patient History and Preoperative Diagnosis: Right thyroid nodule. Final Pathologic Diagnosis. A. Lymph node, Delphian, biopsy: Lymph node (0/1), no tumor seen. B. Thyroid, total thyroidectomy: Papillary thyroid carcinoma, multifocal (see synoptic report) . Synoptic Report. SYNOPTIC REPORT FOR THYROID CANCER: Specimen type: Total thyroidectomy. Tumor location: Main (largest) tumor is located in the right thyroid lobe. Tumor size: 3. 9 x 2.7 x 2.0 cm (largest mass) i plus two additional foci of. papillary microcarcinoma: one in the right lobe measuring 0.5 cm. in. greatest diameter, and a second one in the left lobe measuring 0.2 cm. in. greatest diameter. Histologic type: Papillary carcinoma. Tumor grade: Well-differentiated. Lymphatic/vascular invasion: Yes. Capsular invasion: Yes, extensive. Tumor extent: Confined to the thyroid: No; tumor infiltrates perithyroidal soft tissue. and reaches up to the inked outer surface of the specimen. Multifocal: Yes. Invasion of thyroid cartilage or hyoid bone: No. Lymph nodes: N/A. Additional pathologic findings: None. pTNM: pT3NxMx. Comments: In some areas, the tumor shows focally features of ""tall cell"". I. variant of papillary carcinoma. The above synoptic report complies, in slightly modified form, with the. guidelines of the College of American Pathologists and the Association of. Directors of Anatomic and Surgical Pathology for the reporting of cancer. specimens. INTRAOPERATIVE CONSULTATION DIAGNOSIS: AF1. Delphian lymph node: (FROZEN SECTION PERFORMED). - No tumor identified. BF1. Thyroid: (FROZEN SECTION PERFORMED). Papillary carcinoma. Examining pathologist. SPECIMEN (S) RECEIVED: A: Lymph node, ENT, REG. B: Thyroid, REG. GROSS DESCRIPTION: The specimens are received in two properly labeled containers, which are. frozen sections, with the patient' s name and accession number. A. The specimen is designated ""Delphian lymph node"" and consists. of a 0.6 x 0.4 x 0.3 cm tan-pink lymph node. The entire specimen is. submitted for frozen section and frozen section in cassette AF1 is. resubmitted as received. TE 1. B. The specimen is designated ""thyroid"" and consists of a 5.0 x. 3.5 x 3.5 cm thyroid gland that weighs 17 grams. The outer surface is. tan-purple smooth and glistening. The entire specimen is inked black and. the specimen is serially sectioned to reveal a 3.9 x 2.7 x 2.0 cm. well-circumscribed tan firm nodule present in the right thyroid lobe that. grossly abuts the black inked capsular surface. The nodule is hemorrhagic. over approximately 40%. The right lobe also displays a separate 0.5 x 0.3. x 0.3 cm tan-white well-circumscribed nodule which is located 1.0 cm from. the largest nodule. The left lobe of the thyroid contains a 0.2 x 0.2 x 0.2. cm tan-white well circumscribed nodule that grossly abuts the black inked. capsular surface. This nodule is located 2.4 cm from the largest nodules. The remaining thyroid parenchyma is dark red and rubbery with no other. discrete lesions identified. A representative section of the largest nodule. is submitted for frozen section and frozen section cassette BF1 is. resubmitted as received. (P) RS 17. Summary of Cassettes: BF1, representative section, frozen section;. B1-11, entire largest nodule; B12, entire smaller nodule, right lobe; B13,. entire smaller nodule, left lobe; B14, uninvolved left lobe; B15,. uninvolved isthmus; B16, uninvolved right lobe. Lab Use Only : Gross description by: Top of.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. Examination: Histopathological examination. Cost of diagnostic procedure. Material: 1. Partial organ resection - sigmoid colon. Material received. Expected time of examination: Clinical diagnosis: Macroscopic description: A 17 cm length of the large intestine with a fragment of the mesentery sized 19 X 6 X 1.5 cm. A cauliflower-shaped. tumour sized 4.3 x 0.6 found in the mucosa. The lesion surrounds 100% of the intestine circumference and narrows its. lumen, is located 7 cm 7 cm away from the other one. The lesion macroscopically infiltrates the intestinal wall. Minimum side margin is 2.3 cm. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa tunicae muscularis priopriae. Excision lines clear of neoplastic infiltration. Lymphonodulitis reactiva lymphonodorum (NO VIII). Histopathology diagnosis: Adenocarcinoma tubulare coli. Tubular adenocarcinoma of the colon. (GI, Dukes A, Astler - Coller Bl, pT2, pNO).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Moderately differentiated invasive lobular carcinoma (tumor diameter 2.2 cm) with. several further satellite foci measuring up to 0.1 cm and also focal in situ spread. In conjunction with the preliminary finding, this gives rise to the following concluding. tumor classification: lobular carcinoma, G II, pT2N0(0/3;sn)LOVORO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. DIAGNOSIS: (B). HARD PALATE: Bone and mucosa, no tumor present. Entire report and diagnosis completed bv: DIAGNOSIS. BUCCAL FAT BIOPSY: Adipose tissue, no tumor present. BONE FROM POSTERIOR WALL OF MAXILLA: Tissue submitted for decalcification. Supplemental report will. follow. PARTIAL MAXILLECTOMY AND HEMIPALATECTOMY: INVASIVE SQUAMOUS CELL CARCINOMA, GRADE 2, PRESENCE OF PERINEURAL. INVASION, THICKNESS AREA OF TUMOR 2.5 CM. Tissue submitted for decalcification. Supplemental report will. follow. Bone margins of resection submitted for decal. Supplemental report. will follow. (D) HARD PALATE: Pending decalcification. MARGIN MEDIAL LINE: Salivary gland, no tumor present. (F). MUCOSA FROM MAXILLARY SINUS: Respiratory mucosa, no tumor present. INFERIOR TURBINATE: Respiratory mucosa, no tumor present. (H). TISSUE ALONG NASAL CAVITY: Mucuos glands, no tumor present. TEETH: Teeth (gross diagnosis only). . Entire report and diagnosis completed by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Pathohistological diagnosis. Seminoma testis (pT2 NXMX). Description: Testicle with cut tumor, size 8:6:5 cm, and 8 cm long funiculus was received. The tumor has. irregular edges, is white to brown in color, of medium consistency and is 8:5:4 cm in size. Histologically, the tumor is made of solid seats and tumor cell traces with round and oval. bright nuclei in which we see small nuclei and scarce, bright and pink cytoplasm. Inside the. tumor, at microscope's large visual field, we see 3-4 mitosis. Around tumor seats we find. connecting tissue containing moderately abundant lymphocyte infiltrates. Several channels. adjacent to tumor are coated with unclassified intratubular germ cell neoplasia (IGCNU). Performed imunohistochemical dying (positive PLAP in all tumor cells and in unclassified. intratubular germ cell neoplasia) with morphological examination indicates that this is a. malign testicular tumor of germ origin, seminoma. The tumor infiltrates tunica albuginea and is present in lumens of several blood vessels inside. tunica albuginea. The tumor was not detected in funiculus.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: Gallbladder (10.3 x 5.2 x 2 cm), cm), pericholedochal lymph node (3.2 x 2.3 x 0.7. cm), spleen 165 grams, 11.2 x 6.5 x 4.2 cm) and right lobe liver (1110 grams, 17.5 x. 14.5 X 8 cm). A1, B1, C1, D1, D2, D3, D4. DIAGNOSIS: Liver, right lobe, resection: Grade 2 (of 4) hepatocellular carcinoma, usual type,. forming a multinodular 7.5 x 5.8 x 5 cm mass. The tumor is located in the right lobe. The hepatic capsule is free of tumor. The surgical margins are free of tumor, the. clearance being 0.1 cm microscopically. Extratumoral vascular invasion is not. identified. The tumor is entirely encapsulated without capsular tumor extension. Spleen, excision: Without diagnostic abnormality. Lymph node, pericholedochal, excision: A single benign lymph node. Gallbladder, cholecystectomy: Chronic cholecystitis. No stones are present. (Seen with. ADDENDUM: Immunohistochemical studies performed on paraffin-embedded sections of the. liver show the. neoplastic cells are negative for insulin.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: 1. Tumor #1, right kidney (resection): Renal cell carcinoma, clear cell type, Fuhrman nuclear grade II. 2. Tumor #2, right kidney (resection): Renal cell carcinoma, clear cell type, Fuhrman nuclear grade II. 3. Tumor #3, right kidney (resection): Renal cyst. 4. Tumor #4, right kidney (resection): Renal cell carcinoma, clear cell type, Fuhrman nuclear grade II. 5. Tumor #5, right kidney (resection): Renal cell carcinoma, clear cell type, Fuhrman nuclear grade Il. 6. Tumor #6, right kidney (resection): Renal cell carcinoma, clear cell type, Fuhrman nuclear grade Il. 7. Rib, 11th, right (resection): Gross examination only. NOTE: CLINICAL INFORMATION: Allocate Order to Protocol: Brief Clinical History: VHL with. multiple tumors in right kidney. Specimen Taken For Protocol: PROCEDURE: Pre-Operative Diagnosis: multiple tumors in right kidney. Post-Operative Diagnosis: same Operative Findings: 6 tumors removed. from right kidney. SPECIMENS SUBMITTED: 1. TUMOR, # 1. 2. TUMOR, # 2. 3. TUMOR, # 3. 4. TUMOR, # 4. 5. TUMOR, # 5. 6. TUMOR, # 5. 7. RIB. 11th rib. GROSS DESCRIPTION: Received are 7 formalin-filled containers labeled with the patient's name, medical. record number. and further described as follows: 1. ""Tumor #1"" are two yellow/brown tissue fragments, each measuring 0.5 x 0.5 X 0.5 cm. Both specimens are. wrapped in lens paper and entirely submitted in a white cassette labeled. for permanent processing. 2. ""Tumor #2"" is a yellow/brown piece of tissue measuring 0.8 X 0.8 X 0.8 cm. 50% is procured for Research. In. Surgical Pathology, the remainder of the specimen is received and is consistent with the above description. The. specimen is placed in a filter bag and placed in a white cassette labeled. #2 for permanent processing. 3. ""Tumor #3"" is a white/tan/red piece of tissue measuring 1 cm in diameter consistent with a cyst wall"". The. specimen is serially sectioned and entirely submitted in a white cassette labeled. #3 for permanent. processing. 4. ""Tumor #4"" is a brown and yellow piece of tissue measuring 2 X 1.5 X 1.2 cm. 50% is procured for Research. The specimen is received in Surgical Pathology and is consistent with the above description. The specimen is. serially sectioned and entirely submitted in a white cassette labeled. #4 for permanent processing. 5. ""Tumor #5"" is a tan/brown/yellow piece of tissue 3.2 X 3.0 x 3.0 cm. 85% is procured for Research. The. specimen is received in Surgical Pathology and is consistent with the above description. The specimen is serially. sectioned and entirely submitted in a white cassette. -B for permanent processing. 6. ""Tumor #6"" is a tan/brown piece of tissue measuring 2.8 X 2.2 X 2.1 cm. The specimen is sectioned revealing a. mostly homogeneous surface with slightly hemorrhagic areas. 85% of the specimen is procured for Research. The specimen is received Surgical Pathology and is consistent with the above description. The specimen is. serially sectioned and entirely submitted in a white cassettes labeled. ^-B for permanent processing. 7. ""Rib, 11th is a white/tan 3.0 x 2.0 x0.8 cm piece of rib with some adherent tan soft tissue. No mass lesions are. identified. The specimen is kept for gross examination only. No consultants.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: SKIN TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Skin. Tumor size: 1.7 x1.5x0.7cm. Tumor features: Ulcerated, Pigmented. Satellite nodules: Not specified. Histologic type: Nodular melanoma. Histologic grade: Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: : 7.0 mm deep, IV level by Clarc.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
surgical Pathology Report. (Age: F. Pathologic Interpretation: A. Left thyroid lobe with nodule: -Papillary thyroid carcinoma, 1.7 cm. -Margins are free of tumor. -Chronic lymphocytic thyroiditis. B. Portion of midline nodule; parathyroid versus lymph node: -No carcinoma seen in one lymph node (0/1). C. Thyroid isthmus: -No carcinoma seen in thyroid parenchyma. -Chronic lymphocytic thyroiditis. D. Right tobe of thyroid: -No carcinoma seen in thyroid parenchyma. -Chronic lymphocytic thyroiditis. E. Right paratracheal node: -No carcinoma seen in five lymph nodes (0/5). F. Left upper paratracheal node: -No carcinoma seen in three lymph nodes (0/3). TUMOR SUMMARY. Specimen type: Total thyroidectomy. Tumor site: Left lobe. Tumor focality: Unifocal. Tumor size. Greatest dimension: 1.7 cm. Additional dimensions: 1.5 x 0.7 cm. Histologic type: Papillary carcinoma. Pathologic staging. Primary tumor: pT1. Regional lymph nodes: pNO. Number examined: 9. Number involved: 0. Distant metastasis: pMX. Margins: Uninvolved by carcinoma. Venous/Lymphatlc (Large/Small Vessel) Invasion: Absent. Additional Pathologic Findings: Thyroiditis. AJCC: pT1 NO MX. As the attending patho/ogist, / attest that I: (i) Examined the relevant. preparation(s) for the specimen(s). and (i) Rendered the dugrosis(es). Intraoperative Consultation. BFS: Lymph node, no malignancy seen. Clinical History: Patient is a -year old white female with history of thyroid nodule. Pre Operative Diagnosis: Thyroid nodule. Specimen(s) Received: A: Left thyroid lobe with nodule. B: Portion of midline nodule; parathyroid versus lymph node. C: Thyroid isthmus. D: Right lobe of thyroid. E: Right paratracheal node. F: Left upper paratracheal and mediastinal nodes. Gross Description: A. Received in formalin and labeled ""left thyroid lobe with nodule"" is an unoriented, partial thyroidectomy specimen, which. weighs 4.8 grams and measures 3.0 x 2.7 x 0.5 cm. There is a tan, granular, well-circumscribed nodule that extends to. the capsule and measures 1.7 x 1.5 x 0.7 cm. The nodule has been submitted in toto in cassettes 1-5. B. Received fresh and labeled ""portion of midline nodule; parathyroid versus lymph node"" is a tan, soft tissue specimen. measuring 0.4 x 0.3 x 0.2 cm. Submitted in toto in one cassette for frozen section. C. Received in formalin and labeled ""thyroid isthmus"" is a soft tissue measuring 1.8 x 1.0 x 0.4 cm. Specimen bisected and. submitted in toto in one cassette. D. Received in formalin and labeled ""right tobe of thyroid"" is an unoriented partial thyroidectomy specimen inked in black,. which measures 2.5 x 1.5 x 1.0 cm. The specimen has been serially sectioned to reveal an unremarkable parenchyma. Representative sections submitted in two cassettes. E. Received in formalin and labeled ""right paratracheal node"" is a fibroadipose tissue specimen measuring 1.2 x 0.6 x 0.4. cm, which contains lymph nodes. The specimen is bisected and submitted in cassette one along with the remainder of the. tissue submitted in toto. F. Received in formalin and labeled ""left upper paratracheal node"" is a fibroadipose specimen measuring 3.2 x 1.8 x 1.0 cm. No lymph nodes were identified grossly. Stromal sections submitted in cassettes 1-3. ICD-9(s): 193245.2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Specimen: Spec Type: SURGICAL P. BREAST CANCER. DOCTOR (s) : A. LEFT BREAST SUPERFICIAL MARGIN RE-EXCISION. B. RIGHT BREAST. C. LEFT BREAST. PART A RECEIVED LABELED. LEFT BREAST UPPER OUTER QUADRANT. SUPERFICIAL MARGIN REEXCISION STITCH NEW MARGIN, IS AN IRREGULAR PORTION. OF YELLOW-PINK FATTY TISSUE MEASURING 12.5 x 7.5 x 1.0 CM IN GREATEST. DIMENSIONS. A SUTURE DENOTES THE NEW MARGIN. THIS SIDE IS MARKED WITH. BLUE INK WITH A PERIMETER OF BLACK INK. REPRESENTATIVE SECTIONS TO. INCLUDE APPROXIMATELY 40% OF THE SPECIMEN ARE SUBMITTED LABELED A1. THROUGH 10. PART B RECEIVED LABELED. RIGHT BREAST STITCH AT 12. O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 24 x 18.5 x 5.5 CM. THE NIPPLE IS GROSSLY UNREMARKABLE WITHIN A 7 x 3.5-CM SKIN ELLIPSE. A. SUTURE DENOTES 12 O' CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE. INK, THE DEEP WITH BLACK. SECTIONING REVEALS DENSE GRAY-TAN FIBROUS. TISSUE INTERMIXED WITH YELLOW FATTY TISSUE. THE FIBROUS TISSUE IS. PRIMARILY IN THE MID TO LOWER OUTER QUADRANT AREAS. THIS IS SURROUNDED. BY BLAND YELLOW FATTY TISSUE. THE FIBROUS TISSUE COMPRISES UP TO 40% OF. THE SPECIMEN. SECTIONS ARE SUBMITTED AS FOLLOWS: 31--NIPPLE,. B2 --CENTRAL DEEP MARGIN, B3 AND 4--UPPER INNER QUADRANT, B5 AND --UPPER. OUTER QUADRANT, B7 AND 8 -LOWER OUTER QUADRANT, B9 AND 10--LOWER INNER. QUADRANT. PART C RECEIVED FRESH LABELED. LEFT BREAST STITCH AT 12. O'CLOCK, IS A 26 x 18 x 6-CM SIMPLE MASTECTOMY SPECIMEN. THE NIPPLE IS. UNREMARKABLE WITHIN AN 8 x 4.2-CM SKIN ELLIPSE. A SUTURE DENOTES 12. O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP WITH. BLACK. SECTIONING REVEALS A PINK-TAN FIRM GRITTY MASS AT, 30 O'CLOCK. LATERAL BREAST. THIS AREA MEASURES 4.5 x 2.4 x 4.0 CM IN GREATEST. DIMENSIONS. THE TISSUE BETWEEN THIS LESION AND THE DEEP MARGIN CONSISTS. OF YELLOW FATTY TISSUE AND PINK-TAN FIBROUS TISSUE. THE MARGIN GROSSLY. A. SECOND PALPABLE AREA OF FIRMNESS IN THE UPPER OUTER QUADRANT AT THE. IS 0.8 CM AWAY. THIS IS 0.8 CM FROM THE PROXIMAL MARGIN. THERE IS. LATERAL EDGE OF THE SPECIMEN WHICH WHEN SECTIONED REVEALS NO GROSS. LESION. BY PALPATION, THIS AREA IS 2 CM IN GREATEST DIMENSION. THIS. AREA DOES DEMONSTRATE YELLOW-WHITE COLORATION SUGGESTIVE OF GROSS FAT. specimen. Spec Type: SURGICAL P. NECROSIS. THIS AREA IS 5 CM FROM THE LESION. CENTRALLY, THE BREAST DOES. DEMONSTRATE GRAY-TAN FIBROUS TISSUE. THE PERIMETER OF THE SPECIMEN IS. BLAND YELLOW FATTY TISSUE. THE FIBROUS TISSUE COMPRISES NO MORE THAN 25%. OF THE SPECIMEN. SECTIONS ARE SUBMITTED AS FOLLOWS: C1--NIPPLE AND SKIN. (MIRROR IMAGE TO PROTOCOL), C2 AND 3--FULL CROSS-SECTION OF LESION. (MIRROR IMAGE TO TISSUE TAKEN PER PROTOCOL), C4--LESION AND DEEP MARGIN,. C5 AND 6--LESION AND SUPERFICIAL MARGIN, C7 AND 8--FULL CROSS-SECTION OF. LESION (MIRROR IMAGE TO TISSUE TAKEN PER PROTOCOL), C9 AND 10--TISSUE. EXTREME UPPER OUTER QUADRANT WITH INDURATION, 11--CENTRAL BREAST TISSUE. WITH FIBROSIS, C12--UPPER OUTER QUADRANT, 11--UPPER INNER QUADRANT,. C14 - -LOWER INNER QUADRANT, C15--LOWER OUTER QUADRANT. PROCEDURES: 88307/3, A BLK/10, B BLK/10, C BLK/15. PART A LEFT BREAST UPPER OUTER QUADRANT SUPERFICIAL MARGIN REEXCISION: FIBROADIPOSE TISSUE WITH NO EVIDENCE OF NEOPLASM. THE NEW INKED MARGIN. IS FREE OF NEOPLASM. FOCUS OF PREVIOUS BIOPSY SITE CHANGE WITH. ORGANIZING FAT NECROSIS WITH REACTIVE FIBROSIS. PART B RIGHT BREAST, SIMPLE MASTECTOMY: FIBROCYSTIC DISEASE WITH PATCHY. FIBROSIS, APOCRINE METAPLASIA, CYST FORMATION AND A SMALL FIBROADENOMA. NO EVIDENCE OF ATYPIA OR MALIGNANCY. UNREMARKABLE NIPPLE SKIN. PART C LEFT BREAST, SIMPLE MASTECTOMY: 1. MODERATELY DIFFERENTIATED INTRADUCTAL AND INFILTRATING DUCT. CARCINOMA, NUCLEAR GRADE II WITH LOW MITOTIC INDEX, WITH AN IN SITU. COMPONENT OF APPROXIMATELY 10% OF SOLID AND CRIBRIFORM TYPE WITH FOCI. OF INTRADUCTAL NECROSIS. 2. THE TUMOR GROSSLY MEASURES 4.5 CM IN GREATEST DIMENSION. THE NIPPLE,. DEEP AND SUPERFICIAL MARGINS ARE FREE OF NEOPLASM. 3. FOCI SUSPICIOUS FOR LYMPHATIC INVASION ARE PRESENT. 4. BIOPSY SITE CHANGE WITH REACTIVE FIBROSIS AND ORGANIZING FAT NECROSIS. INCLUDING AN AREA FROM THE UPPER OUTER QUADRANT WHICH MAY REPRESENT A. PREVIOUS SENTINEL NODE BIOPSY SITE. 5. FIBROCYSTIC CHANGE WITH PATCHY DENSE FIBROSIS AND CYST FORMATION. Specimen: Spec Type: SURGICAL p. 1. (prelim.). (signature on file).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. DIAGNOSIS: RIGHT MAXILLARY SINUS. Bone, no tumor. DIAGNOSIS. RIGHT MAXILLARY SINUS: Tissue submitted for decalcification, supplemental report will. follow. RIGHT [NFRA-STRUCTURE MAXILLARY: POORLY DIFFERENTIATED SQUAMOUS CARCINOMA, 6.0 MM IN DEPTH, PRESENCE. OF LYMPHATIC INVASION IS NEGATIVE. (C) RIGHT INFERIOR TURBINATE: Respiratory mucosa, no tumor present. RIGHT CHEEK MARGIN: Squamous mucosa, no tumor present. (E). RIGHT SOFT PALATE MARGIN: Squamous mucosa, no tumor. (F). HARD PALATE MARGIN: Squamous mucosa, no tumor. ANTERIOR GUM MARGIN: Squamous mucosa, no tumor present. GROSS DESCRIPTION. RIGHT MAXILLARY SINUS - Fragments of thin, bony tissue submitted for. decalcification under A. (B) RIGHT INFRA-STRUCTURE MAXILLARY - A portion of bone and soft tissue with. overall measurements of 5.0 x 2.5 x 2.0 cm. An ulcerated and friable mass. measuring 2.5 x 1.5 x 0.6 cm is noted. The ascending mucosal margin is seen. surrounding the ulcerated lesion. No visible or felt bony erosion is. identified. The specimen is submitted sequentially from one side to the other. under B1 to B10. (C) RIGHT INFERIOR TURBINATE - A small mucosal and soft tissue fragment, 2.0. x 0.5 x 1.0 cm. No identifiable lesion is noted. The specimen is submitted. under C1 and C2. (D) RIGHT CHEEK MARGIN - A strip of tan-pink, glistening mucosa (1.0 x 0.3 x. 0.2 cm). Submitted entirely for frozen section in D. FS/DX: SQUAMOUS MUCOSA, NO TUMOR PRESENT. T. RIGHT SOFT PALATE MARGIN - Two fragments of tan-pmik portions of mucosal. tissue (0.5 X 0.2 X 0.2 cm and 0.3 x 0.3 x 0.3 cm). Submitted entirely for. frozen section in E. FS/DX: SQUAMOUS MUCOSA, NO TUMOR PRESENT. (F) HARD PALATE MARGIN - A strip of tan-pink glistening mucosa (0.7 X 0.3 X. 0.2 cm). Submitted for frozen section in F. FS/DX: SQUAMOUS MUCOSA, NO TUMOR PRESENT. (G) ANTERIOR GUM MARGIN - A strip of tan-pink alistening mucosa (0.7 X 0.3 x. 0.2 cm) Submitted for frozen section in G. FS/DX: SQUAMOUS MUCOSA, NO TUMOR PRESENT. SNOMED CODES. M-80703 T-51800.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
AL DIAGNOSIS. IT 1: ADIPOSE, PERI-TUMOR, EXCISION - -. UNREMARKABLE MATURE, LOBULATED ADIPOSE TISSUE. PART A. 2: RENAL KIDNEY, CELL LEFT, CARCINOMA, PARTIAL NEPHRECTOMY CONVENTIONAL - (CLEAR CELL) TYPE. B. FUHRMAN NUCLEAR GRADE IS 2 OF 4. C. THE GREATEST DIAMETER OF THE NEOPL SM. IS. 3.8. CM. RENAL. CAPSULE. D. THE NEOPLASM IS CONFINED WITHIN THE IS IDENTIFIED. E. NO EVIDENCE OF ANGIOLYMPHATIC INVASION NEOPLASM. F. ALL SURGICAL MARGINS ARE FREE OF THE NO SIGNIFICANT PATHOLOGIC ABNORMALITY. G. THE NON-NEOPLASTIC KIDNEY SHOWS SYNOPTIC). H. TNM PATHOLOGIC STAGE: pT1a NX MX (SEE. PART. 3: UNREMARKABLE KIDNEY, ""DEEP MARGIN RENAL PARENCHYMA #1"", BIOPSY - AND FIBROCONNECTIVE TISSUE, NEGATIVE FOR TUMOR. PART 4: KIDNEY, ""DEEP MARGIN #2"", BIOPSY -. UNREMARKABLE RENAL PARENCHYMA, NEGATIVE FOR. TUMOR. PART 5: UNREMARKABLE KIDNEY, ""DEEP MARGIN MATURE, #3"", LOBULATED BIOPSY - ADIPOSE TISSUE, NEGATIVE FOR TUMOR.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Result Date: Encounter. info: DIAGNOSIS: A. Gallbladder, cholecystectomy : Mild chronic cholecystitis. No calculi identified. B. Left renal mass, partial nephrectomy: Procedure/laterality: Left partial nephrectomy. Histologic type: Papillary renal cell carcinoma. Nuclear grade (Fuhrman, 1-4) : 2/4. Tumor size: 4.2 x 3.8 x 3 cm. Tumor site: Clinically lower pole. Tumor focality: Unifocal. Sarcomatoid features: Not identified. Tumor necrosis: Not identified. Microscopic tumor extension: Extension into perinephric tissue: Not identified. Extension beyond Gerota's fascia: Not identified. Extension into renal sinus: Not included with the specimen. Extension into renal vein: Not applicable. Extension into collecting systefi: Not identified. Extension into adrenal gland (if applicable) : Not applicable. Surgical margins: Negative for carcinoma. Lymph-vascular invasion: Not identified. Lymph nodes: Not applicable. Pathologic findings in nonneoplastic kidney: Only minute benign. kidney tissue present with no significant pathologic changes. Pathologic staging: pT1b. Biorepository sample (if applicable) : Block B7 contains more than. 90% tumor cell nuclei. Block (s) containing malignancy suitable for additional testing: B1-7. C. Umbilical hernia sac, excision: Membranous fragment of fibroadipose tissue with mild chronic. inflammation with scarring, compatible with hernia sac. CLINICAL INFORMATION: Left renal mass. SPECIMEN (S) : A:Gallbladder. B:Left renal mass. C:Umbilical hernia sac. GROSS DESCRIPTION: A. Received fresh labeled and ""gallbladder, "" is a. previously opened gallbladder, 9 x 3 cm. The serosa is glistening. and smooth. The wall is uniformly 0.3 cm in thickness and the. mucosa velvety soft and pale green. No calculi are received. Sampled in one cassette labeled. B. Received fresh labeled and ""left renal mass"". Procedure: Partial nephrectomy. Specimen laterality: Left. Tumor site: Low pole clinically. Tumor size: 4.2 x 3.8 x 3 cm. Tumor focality: Unifocal. Gross extent of tumor: Extension into perinephric tissue: Not identified. Extension beyond Gerota's fascia: Not identified. Extension into renal sinus: Renal sinus tissue not included with. specimen. Extension into renal vein: Cannot evaluate with the specimen. Extension into collecting system: Not identified. Adrenal gland: Not present. Gross notes: Gross tumor characteristics: Mottled red-tan and gray, soft,. friable. Kidney weight: 40 g. Kidney dimensions: The specimen has overall dimensions of 5 x. 3.5 x 3.5 cm including attached fat. Distance to margin: 0.1 cm or less in multiple areas, grossly. Lymph nodes: None identified. Inking details: Parenchymal margin inked black, overlying fatty. soft tissue margin inked blue. Biorepository sample submitted: Yes. Block key for specimen B: B1) Tumor and overlying inked fatty. margin; B2-B4) tumor and parenchymal margin; B5-B6) additional tumor. samples; B7) mirror image of biorepository sample, IRE'. C. Received fresh labeled and ""umbilical hernia. sac,"" is a rubbery pink and tan-gray portion of fibrofatty tissue,. 2.7 x 1.2 x 0.8 cm. Sampled in one cassette labeled. Support for the diagnosis in this case may have included the. use of immunohistochemistry tests that were developed and whose. performance characteristics were determined by. They have not been cleared. or approved by the U.S. Food and Drug Administration (FDA) . The FDA has determined that such clearance or approval is not. necessary. . These tests should not be regarded as investigational. or for research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of 1988 ('CLIA') as qualified. to perform high complexity clinical laboratory testing.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: 1. Moderately differentiated invasive ductal carcinoma with discrete intraductal. spread (tumor diameter 1.9 cm). In conjunction with the preliminary finding, this gives rise to the following tumor. classification: NOS, G II, pT1cN1aLOVORO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. LEFT BREAST. E. RIGHT BREAST SKIN. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. LEFT BREAST. E. RIGHT BREAST SKIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TP A-C: Negative for tumor. By Dr., called to Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with patient name designated ""A - sentinel lymph node #1 left axilla"" is a. fragment of beige-tan possible lymphoid tissue measuring 1.1 X 0.9 x 0.3 cm. The specimen is serially. sectioned. Touch preps were performed. The entire specimen is submitted in cassette A1. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with patient name designated ""B - sentinel lymph node #2"" is a fragment of. yellow-red fibroadipose tissue measuring 3.2 x 1.5 x 0.7 cm. One possible lymph node is identified. measuring 1.2 X 0.6 X 0.5 cm. The specimen is bisected. Touch preps were performed. The entire. lymph node is submitted in cassette B1. C. SENTINEL LYMPH NODE#3 LEFT AXILLA. Received fresh labeled with patient name designated ""C - sentinel lymph node #3 left axilla"" is a. fragment of beige-tan possible lymphoid tissue measuring 1.2 x 0.6 X 0.4 cm. The specimen is serially. sectioned, touch preps were performed. The entire specimen is submitted in cassettes C1. D./EET BREAST. Received fresh labeled with patient name designated ""D - left breast"" is a resected mastectomy. specimen weighing 676 grams and measuring 22.5 X 19 X 3 cm. The specimen is received with. orientation. A suture designates the axillary end of breast. The deep margin is inked black. The. overlying beige-tan ellipse of skin measures 14.5 X 4.2 cm. The light brown areola measures 3.5 cm. in. diameter. The everted nipple measures 1.1 cm in diameter. The specimen is serially sectioned from. medial to lateral. Cut section shows a firm beige-tan mass in the upper outer quadrant approaching. the. deep surgical margin at closest distance 1.3 cm and is located 5 cm from the axillary tail. The lesion. measures 3.6 X 3 x 2.2 cm. This lesion extends to the lower outer quadrant for about 2.5 X 1.5 cm. A. second possible lesion is noted in the upper outer quadrant superior to the first main mass approaching. the deep surgical margin at a distance of 2.5 cm. This area is located 5.2 cm from the first lesion and. measures 0.5 x 0.5 x 0.4 cm. A third possible subareolar is noted located 4.5 cm from the first main. mass in the upper outer quadrant. This third lesion measures 0.6 X 0.5 x 0.5 cm. A fourth possible. mass is located approximately 2.5 cm from the main mass in the upper outer quadrant and approaches. the deep margin at a distance of 2.2 cm. The fourth lesion measures 0.5 x 0.3 x 0.3 cm. The. remainder of the breast parenchyma shows multiple patchy fibrous firm tissue. A portion of the. specimen is submitted for tissue procurement. Representative sections are submitted as follows: D1-D3: the main mass in the upper outer quadrant with overlying deep margin. D4-D5: remainder of the main mass in the upper outer quadrant. D6: lesion #2 upper outer quadrant. D7: lesion #3 subareolar. D8: lesion #4 upper outer quadrant. D9-D10: additional firm fibrous tissue adjacent to main mass of lower outer quadrant. D11-D14: additional section lower outer quadrant. D15-D16: fibrous tissue central subareolar. D17-D18: representative sections upper inner quadrant. D19-D21: representative sections lower inner quadrant. D22: section of nipple. D23: representative sections of skin. D24-D28: multiple possible axillary lymph nodes. E. RIGHT BREAST TISSUE SKIN. Received in formalin in a container labeled with the patient name designated ""e. right breast skin"" is an. irregular fragment of beige-tan skin measuring 11.4 X 4.5 X 0.3 cm. The surface of the specimen is. unremarkable. A section shows unremarkable skin tissue. Representative sections are submitted in. cassettes E1-E3. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). B. SENTINEL LYMPH NODE #2, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). C. SENTINEL LYMPH NODE #3, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). D. LEFT)BREAST, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, MULTIFOCI, SBR GRADE II. - SIZE OF LARGEST TUMOR FOCUS MEASURING 6.1 X 4.5 CM. - DUCTAL CARCINOMA IN-SITU, CRIBRIFORM AND MICROPAPILLARY TYPES. - ATTACHED SKIN AND NIPPLE, NEGATIVE FOR TUMOR. - SURGICAL RESECTION MARGINS, NEGATIVE FOR TUMOR. - SEE TEMPLATE. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: D: LEFT BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Specimen size: Size of Invasive focus 6.1cm. Additional dimensions: 4.5cm x 2.2cm. Tumor Site: Upper outer quadrant. Lower outer quadrant. Margins: Negative. Distance from closest margin: 1.3cm. Margin: deep. Tubular score: 2 (10-75% tubule). Nuclear grade: 2. Mitotic score (Olympus 40x): 2 (7-13/10. Modified Scarff Bloom Richardson Grade: Il (6-7 points). Necrosis: Present. Vascular/Lymphatic Invasion: Indeterminate. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/3. Non-neoplastic areas: Fibrocystic disease, pseudoangiomatous stromal hyperplasia. DCIS present. DCIS Quantity: Estimate % 10. DCIS type: Cribriform. Micropapillary. DCIS location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Absent. Location of CA++: Benign epithelium. Pathological staging (pTN): pT 3 N 0. Comment(s): See breast biomarker template. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimens Involved. Specimens: D: LEFT BREAST. SPECIMEN: Other. mastectomy. Block Number: D4. ER: Positive - Allred Score: 7 = Proportion score: 4 + Intensity Score 3. PR: Positive - Allred Score: 8 = Proportion Score 5 + Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30%. of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of. less than or equal to 2. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. ) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Mouse anti-human ER and PR,. Comment: This assay can be used to select invasive breast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5,. 1:100) and PR (PGR 136, 1:100) antibody provided by. following the manufacturer's instructions. listed in the package insert. This assay was not modified, and adherence to all instruction and. guidelines were strictly followed. Interpretation of the ER/PR immunohistochemical staining. characteristics is guided by published results in the medical literature (1), information provided by the. reagent manufacturer and by internal review of staining performance within the Pathology Department. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding. assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474-. 1481, 1999. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left breast ca. ADDENDUM: E. RIGHT BREAST SKIN, EXCISION: - FRAGMENT OF UNREMARKABLE SKIN, NEGATIVE FOR TUMOR. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. I. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used D4. Source of case: RPCI. Tissue fixation. formalin-fixed tissue. Outside Case No:NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.21. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapy is being considered. These tests were performed in the. under the direction. of The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation:., Pathologist,. Microscopia/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist, I. Addendum: Pathologist,. Addendum Review: Pathologist,. Addendum Final:., Pathologist, A. Addendum: Pathologist,. Addendum Final:., Patholugist,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Sex: F. Tel. -. Case type: Surgical Case. DIAGNOSIS. (A) LYMPH NODE, LEFT PARATRACHEAL, BIOPSY: One benign lymph node (0/1). (B) PARATHYROID TISSUE, BIOPSY: Parathyroid tissue identified. (C) THYROID, TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA (5.0 CM IN GREATEST DIMENSION). TUMOR CONFINED TO THYROID. One parathyroid lymph node, negative for tumor (0/1). Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) LEFT PARATRACHEAL LYMPH NODE - A 0.6 cm in diameter lymph node bisected and entirely submitted for frozen section. diagnosis in A. FS/DX: BENIGN LYMPH NODE. (B) PARATHYROID TISSUE - A tiny soft tan-pink tissue measuring < 0.1 x 0.1 x 0.1 cm. Entirely submitted for frozen diagnosis. in B. FS/DX: PARATHYROID PRESENT. TOTAL THYROIDECTOMY - A total thyroidectomy (6.0 x 5.5 x 4.0 cm). The right thyroid lobe is unremarkable. The left. thyroid (C) lobe is entirely replaced by a fleshy tan tumor. Within the central portion of the tumor there is an area that is more solid. and also contains calcifications. The tumor is surrounded by a thin capsule. The tumor measures 5.0 x 4.1 x 4.0 cm. A portion of abnormal thyroid and tumor submitted to the tissue bank. SECTION CODE: C1-C3, representative sections of the right thyroid; C4, isthmus; C5-C20, representative sections of. the left thyroid tumor to include capsule. CLINICAL HISTORY. History of thyroid cancer. SNOMED CODES. T-B6000, M-80503. Department of Patholog. Sex: F. Te. Physician: : Case type: Surgical Case. These tests have not been specifically cleared or approved. ""Some tests reported here may have been developed and performance characteristics determined by. by the U.S. Food and Drug Administration. Released by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
chief of Pathology. Specimen: Reg# 2. Spec Type: SURGICAL P. BREAST CANCER INVASIVE. DOCTOR (Â§) : PROCEDURE: A. RT BREAST DEEP MARGIN. B. LT BREAST. c. RT PREAST AND AXILLARY NODES. RECRIVED. RTS. LABELED. RIGHT DEEP MARGIN INK MARKS NEW. .RREGULAR PORTION OF YELLOW FATTY AND BRONN MUSCULAR TISSUE. ME. LNG 4.8 x 2.2 x 0.6 CM IN GREATEST DIMENSIONS. ONE SIDE OF THE. SPECIMEN IS RECEIVED MARKED WITH BLUE INK. THIS SIDE IS FURTHER MARKED. NTTU PITE INV. TH A PERIMETER OF RED INK. THE SPECIMEN IS SECTIONED AND. 3D LABELED A1 THROUGH A3. PA. ABELED. LEFT BREAST IS A SIMPLE. MAS1. EN MEASURING 24.5 x 21 x 3.8 CM. A SUTURE DENOTES 12. O'CLO. THE NI PLE IS FLAT WITHIN A 23.7 x 15.3 CM SKIN ELLIPSE. IN. THE 9 O'CLOCK AREA OF THE BREAST THERE IS A 0.5 CM IN DIAMETER. FLONER-SHAPED RED-BROWN SKIN LESION. THE SUPERFICIAL ASPECT IS MARKED. NITH BLUE INK, THE DEEP WITH BLACK INK. SECTIONING REVEALS THE SPECIMEN. TO CONSIST OF BLAND YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THERE. ARE NODULAR FIRM AREAS NOTED CENTRALLY THAT DO NOT FORM DISCRETE MASSES. SECTIONS ARE SUBMITTED AS FOLLOWS: 31--NIPPLE AND DESCRIBED SKIN LESION,. B2 - CENTRAL DEEP MARGIN, B3 AND B4 --UPPER OUTER QUADRANT, B5 AND. 86--UPPER INNER QUADRANT, B7 AND B8--LOWER INNER QUADRANT, B9 AND. B10--LOWER - OUTER QUADRANT, B11--TISSUE CENTRAL. NOTE THAT B1, B3, B5,. B7, B9, AND B11 ARE MIRROR IMAGE TISSUE TAKEN PER PROTOCOL. ADDITIONAL SECTIONS FROM THE LOWER INNER QUADRANT ARE SUBMITTED LABELED. B12 THROUGH B14, A SECTION FROM THE SUBAREOLAR AREA IN B15, AND. ADDITIONAL TISSUE FROM THE UPPER OUTER QUADRANT B16 AND 17. PART c RECEIVED LABELED. RIGHT BREAST AND AXILLARY LYMPH. NODE IS A RIGHT MODIFIED RADICAL MASTECTOMY SPECIMEN WITH FRAGMENTS OF. LOOSE TISSUE WHICH ALSO DEMONSTRATE PALPABLE LYMPH NODES. THE OVERALL. DIMENSIONS ARE 30 x 22 x 4.3 CM. THE NIPPLE IS FLATTENED. IMMEDIATELY. Chief of Pathology. Tax. Specimen: spec Type: SURGICAL P. LATERAL TO THE NIPPLE IS A PALPABLE MASS. THE SKIN ELLIPSE MEASURES 22.6. x 14. 0 CM. A SMALL RAISED PIGMENTED LESION IS FOUND IN THE LOWER OUTER. QUADRANT ADJACENT TO THE SKIN RESECTION MARGIN MEASURING 0.4 CM IN. DIAMETER. THE SUPERFICIAL ASPECT IS MARKED IN BLUE INK, THE DEEP. ASPECT WITH BLACK INK. WHERE THE AXILLARY TAIL IS REMOVED, IT IS MARKED. IN RED AND DOES NOT REPRESENT TRUE MARGIN. THE AXILLARY TAIL IS EXAMINED. FOR LYMPH NODES. IN THE LOW AXILLARY TAIL, THERE IS A 2.8 CM CENTRALLY. 7AT-REPLACED LYMPH NODE WITH A COIL CLIP. ONE HALF IS SUBMITTED PER. PROTOCOL. THE REMAINDER IS SUBMITTED AS C1. A SECOND LOW NODE IS. GROSSLY POSITIVE 1.6 CM IN GREATEST DIMENSION. ONE HALF IS SUBMITTED AS. C2 WITH THE REMAINDER SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE THEN. SUBMITTED AS FOLLOWS: C3--ONE HALF GROSSLY UNREMARKABLE LYMPH NODE. (MIRROR IMAGE TO PROTOCOL), C4--TWO NODES EACH BISECTED, C5--ONE NODE. BISECTED, C6--ONE NODE BISECTED, C7--ONE NODE BISECTED, C8--TWO NODES. EACH BISECTED, C9--FOUR NODES, C10--TWO NODES EACH BISECTED, C11 AND. C12--ONE NODE TOTAL. SECTIONING REVEALED THE BREAST TO CONSIST OF BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THE PALPABLE MASS IS. ILL-DEFINED WITH PINK-TAN TISSUE INTERSPERSED IN THE YELLOW-FATTY TISSUE. THIS EXTENDS FROM THE SUBAREOLAR AREA IN THE LONER OUTER QUADRANT. MEASURING 6 CM FROM MEDIAL TO LATERAL BY PALPATION 6.5 CM FROM SUPERIOR. TO INFERIOR AND 4 CM FROM SUPERFICIAL TO DEEP IN AN ILL-DEFINED MANNER. GROSSLY THIS EXTENDS TO WITHIN 0.5 CM OF THE DEEP MARGIN. SECTIONS ARE. SUBMITTED AS FOLLOWS: C13--NIPPLE (MIRROR IMAGE TO PROTOCOL), C14 AND. C15--LESION AND CLOSEST GROSS DEEP MARGIN, C16--THE MOST LATERAL ASPECT. OF THE LESION (MIRROR IMAGE TO PROTOCOL), C17--THE MOST CENTRAL AND. MEDIAL PORTION OF THE LESION (MIRROR IMAGE TO PROTOCOL) NOTE THAT C16. AND C17 ARE 6 CM APART, C18--TUMOR (MIRROR IMAGE TO PROTOCOL), C19--THE. MOST INFERIOR ASPECT OF THE LESION WITH INFERIOR SUPERFICIAL MARGIN,. C20--THE SUPERIOR PORTION OF THE LESION OR ADJACENT TO MARGIN CENTRAL. SPECIMEN, C21--UPPER OUTER QUADRANT, C22--LOWER INNER QUADRANT,. C23--UPPER INNER QUADRANT, C24 AND C25--ADDITIONAL SECTIONS OF CENTRAL. TUMOR (MIRROR IMAGE TO PROTOCOL) . PROCEDURES: 88307/2, 88309, A BLK/3, B BLK/17, C BLK/25, ER PR KI67 HER2. PART A RIGHT BREAST DEEP MARGIN REEXCISION: FIBROADIPOSE TISSUE AND. SKELETAL MOSCLE WITH NO EVIDENCE OF MALIGNANCY. THE NEW INKED MARGIN IS. FREE OF NEOPLASM. PART B LEFT BREAST, SIMPLE MASTECTOMY: 1. INFILTRATING LOBULAR CARCINOMA, NUCLEAR GRADE I WITH LOW MITOTIC. INDEX, IDENTIFIED IN THE LOWER INNER QUADRANT WITH AN ESTIMATED TUMOR. DIMENSION OF 21 MM (SLIDES B7, B8, B12-14). Chief of yathology. Speciment. status: Spec Type: SURGICAL P. 2. THE NIPPLE AND DEEP MARGIN ARE FREE OF NEOPLASM. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. PROLIFERATIVE FIBROCYSTIC DISEASE WITH A FOCUS OF LOBULAR CARCINOMA. IN SITU IDENTIFIED IN THE UPPER OUTER QUADRANT ALONG WITH SCLEROSING. ADENOSIS, DUCT HYPERPLASIA OF THE OSUAL TYPE, APOCRINE METAPLASIA AND. CYST FORMATION. PART C RIGHT BREAST, MODIFIED RADICAL MASTECTOMY: 1. LARGE MODERATELY DIFFERENTIATED INTRADUCTAL AND INFIL/TRATING DUCT. CARCINOMA, NUCLEAR GRADE II WITH LOW MITOTIC INDEX NITH FOCI OF. MUCINOUS DIFFERENTIATION SPANNING A DISTANCE OF 65 MM. 2. THE DEEP MARGIN IS FREE OF NEOPLASM. DUCTAL CARCINOMA IN SITU. INVOLVES THE NIPPLE. 3. LYMPHATIC INVASION IS PRESENT. 4. METASTATIC CARCINOMA TO 1 OF 15 AXILLARY LYMPH MODES. ONE LYMPH NODE. DEMONSTRATES PREVIOUS BIOPSY SITE CHANGE BUT NO RESIDUAL NEOPLASM. 5. HEMANGIOMA, SKIN OF BREAST. RECEPTOR AND PROGNOSTIC FACTOR DETERMINATION WILL BE PERFORMED ON BLOCK. B7. -. ESTROGEN RECEPTOR: POSITIVE. Nuclei Stained: 100%. Intensity: 3. Reference Range Negative <1%. Positive >= 1t. PROGESTERONE RECEPTOR: NEGATIVE. Nuclei stained: o. Intensity: 1. Reference Range: Negative <1%. Positive >= 1%. Her-2/neu: NEGATIVE. Score: 1+. Reference Range: Negative 0 - 1+. Equivocal 2+. Chief of Fatholegy. specimen: Spec Type: SURGICAL P. Positive 3+. Ki-67: LOW. Nuclei Stained: 3. Intensity: Reference Range: Low <10%. Borderline 10-20%. High >20%. See full scanned report for details. 1. 1. SENT TO: 2. REQUESTED BYs. 3. DATE SEST: 4. KETHOD or. 5. NO. or BLOCKS: 7. KATERIAL (#) TO BE RETURNED: 14. SPECINEE SENT (x/m) $ 1. (prelim.). (signature on file). 0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Stomach (Antrum). 1 _"" Product of gastrectomy according to standardization"". Adenocarcinoma of intestinal type, tubular, moderately differentiated, ulcerated. - Lesion size: 7.5 cm. - Level of infiltration: serosa and adjacent adipose tissue. - Lymphatic and perineural invasions: present. Lymph nodes from the lesser curvature affected by metastasis, with extracapsular. extension (4/4). - Presence of multiple neoplastic nodules in the lesser curvature, without lymphoid. remnant tissue (see note). - Distal surgical margin of resection affected by the neoplasia. 2 - ""Greater omentum"": - Lymph nodes affected by metastasis, with extracapsular extension (2/2). - Presence of two neoplastic nodules, without lymphoid tissue remnant (see note). 3 - ""Biopsy of mesentery"": - Implant of adenocarcinoma. 4 - ""Esophageal margin"". - Uninvolved by neoplasia. Note: We can not determine whether the neoplastic nodules are lymph nodes totally replaced. by metastasis or implants in adipose tissue. PATHOLOGIC STAGING. Topography. Morphology. Stage. Stomach, NOS. Tubular adenocarcinoma. pT4a. givewer thit.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Result Date: I. Final Diagnosis (Verified). Lateral floor of mouth, resection including partial mandibulectomy and. glossectomy, with multiple frozen sections: Moderately-differentiated keratinizing invasive squamous cell carcinoma. of right lateral floor of mouth. Tumor size: 5.3 cm in greatest dimension. The tumor invades through the anterior mandible and into. the subcutaneous soft tissue. Margins: All margins are negative for tumor. Soft tissue overlying anterior mandible: The tumor is 0.5 cm away from. this margin. Posterior soft tissue: The tumor is 0.5 cm away from this margin. Inferior soft tissue: The tumor is 0.8 cm away from this margin. Right soft tissue: The mucosal and deep soft tissue margins are free of. tumor. Right mandible: No tumor identified. Left soft tissue: No tumor identified. Left mandible: No tumor identified. AJCC pathologic stage: pT4a pNO. Right level 1A, 1B lymph nodes: Five (5) lymph nodes are identified, and all are negative for tumor. Right level 2A, 3 lymph nodes: Fourteen (14) lymph nodes are identified, and all are negative for tumor. Left level 1B lymph nodes: Six (6) lymph nodes are identified, and all are negative for tumor. Left level 2A lymph nodes: Five (5) lymph nodes are identified, and all are negative for tumor. Left level 3 lymph nodes: Five (5) lymph nodes are identified, and all are negative for tumor. Signature Line. |. I. Gross Description (Verified). ""FSA1."" All frozen section control tissue is submitted in ""FSA1"". ""FSA2."" All frozen section control tissue is submitted in ""FSA2"". ""NFSA."" The specimen consists of a 10.5 x 9 x 5.7 cm resection to include anterior aspect of mandible, tongue, inferior oral cavity and. attached soft tissue. The specimen has been partially inked by the pathologist as follows: posterior/deep margin = blue; inferior margin. =. black. The remaining specimen will be inked as follows: left soft tissue and bone margin = orange; tumor = yellow; anterior soft tissue margin. = green. A special section of the right soft tissue/mucosal margin is submitted with the margin inked black, and labeled A12. Representative. sections of the posterior/deep margin and inferior margin have previously been submitted for frozen section. On sectioning, there is a 3.7 cm. (anterior to posterior) x 3.4 cm (superior to inferior) x 5.3 cm (left to right) soft tan-white mass which comes to within 0.5 cm of the. posterior/deep margin, 0.3 cm of the inferior margin, and 1.5 cm of the left soft tissue margin. The mass grossly appears to erode. completely through the anterior mandible and into subcutaneous tissue. The mass does not grossly appear to involve the anterior aspect of. the tongue. No additional masses or areas of interest are grossly identified. ""A1,"" mass with adjacent posterior/deep soft tissue margin;. ""A2,"" mass with adjacent inferior soft tissue margin; ""A3,"" left soft tissue margin; A4,"" right soft tissue/tumor; ""A5,"" anterior mucosal margin;. ""A6,"" left mandible margin; ""A7,"" right mandible margin; ""A8,"" mass eroding into mandible; ""A9,"" mass with adjacent tongue; ""A10-A11,"". mass; ""A12,"" true right soft tissue margin. ""Right level 1A, 1B."" The specimen consists of a 5.2 x 5 x 3 cm portion of soft yellow-gray tissue. On sectioning, a 3.2 x 2.3 x 1.5 cm salivary. gland is identified. This has a yellow lobulated cut surface. On further examination, five possible lymph nodes are identified. These range in. size from 0.6 - 1.9 cm. ""B1-B2,"" lymph nodes; ""B3,"" salivary gland, representative. ""Right level 2A and 3."" The specimen consists of a 5 x 4.8 x 2.5 cm aggregate of soft yellow-gray tissue. On sectioning, fourteen possible. lymph nodes are identified. These range in size from 0.3 - 1.6 cm. ""C1-C3,"" fragments, representative. ""Left level 1B."" The specimen consists of a 6 x 4.2 x 2.5 cm portion of soft yellow-gray tissue. On sectioning, a 3.5 x 2.7 x 1.5 cm salivary. gland. is. identified. This has a yellow-tan lobulated cut surface. On further examination, six possible lymph nodes are identified. These range. in size from 0,3 - 1.1 cm. ""D1-D2,"" lymph nodes; ""D3,"" salivary gland, representative. ""Left level 2A."" The specimen consists of a 6.7 x 4.4 x 1.8 cm aggregate of soft yellow-gray tissue. On sectioning, five possible lymph nodes. are identified. These range in size from 0.3 - 1.6 cm. ""E1-E2,"" fragments, representative. ""Left level 3."" The specimen consists of a 3.1 x 2.8 x 1.5 cm aggregate of soft yellow-gray tissue. On sectioning, five possible lymph nodes. are identified. These range in size from 0.4 - 1 cm. ""F,"" 5p, representative. Received for research purposes is one yellow cassette labelec. ADDITIONAL TISSUE REQUESTED. SEND ADD SLIDE TO. Additional section of right margin submitted in cassette ""A12."". Signature Line. Frozen Section Diagnosis (Verified). History: Oral cancer. Mandible, mandibulectomy: Gross: Posterior surface inked blue, inferior black. Representative sections taken from these surfaces. FSA1: Negative for tumor (posterior margin. FSA2: Negative for tumor (inferior margin). NOTE: Small portion of tumor submitted to tissue bank. Clinical Information (Verified). Floor of mouth squamous cell carcinoma. Completed Action List: i. I. !. I. I.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: Male. Race: White. Report Date: Tissue Procurement Date: FINAL PATHOLOGIC DIAGNOSIS. A. #7 lymph node; biopsy: - One anthracotic lymph node, no tumor (0/1). B. #8 lymph node; biopsy: - Six anthracotic lymph nodes, no tumor (0/6). C. #9 lymph node; biopsy: - Three anthracotic lymph nodes, no tumor (0/3). D. 4R lymph node; biopsy: One of eight lymph nodes positive for metastatic tumor (1/8). E. Right pleura, diaphragm, pericardium; resection: - Malignant mesothelioma, epithelial type. See parameters and comment. - Four of twenty-four lymph nodes positive for metastastic mesothelioma. Thoracic Mesothelioma Pathologic Parameters. Pleura/Pericardium, Resection. MACROSCOPIC. Specimen Type: Pleural and pericardial resection. Tumor Site: Right pleura. Tumor Configuration and Size: Diffuse, Maximum thickness: 1.7 cm. MICROSCOPIC. Histologic Type: Epithelioid (epithelial) mesothelioma (60% tubular, 20%. trabecular, 10% micropapillary, 10% solid). Tumor Extension: Confluent visceral pleural tumor (including fissure). Into but not through diaphragm. Lung parenchyma (E10-11). Into mediastinal fat (E1-E2). Into but not through the pericardium (E1-E2). Venous/Lymphatic (Large/Small Vessel) Invasion: Present. Margins: Cannot be assessed. Pathologic Staging (pTNM): pT3, N2. pT3: Tumor (locally advanced but potentially resectable) involves any of. the ipsilateral. pleural surfaces, with at least 1of the following: invasion of the. endothoracic. fascia, invasion into mediastinal fat, solitary completely resectable focus of. tumor. invading the soft tissues of the chest wall, non-transmural involvement of the. pericardium. Regional Lymph Nodes (pN). pN2: Metastases in the subcarinal lymph node(s) and/or the ipsilateral. internal mammary or mediastinal lymph node(s). Specify: Number examined: 24. Number involved: 4. Effective January 1, 2010 this Checklist utilizes the 7th edition TNM staging. system for pleural mesothelioma of the American Joint Committee on Cancer (AJCC). and the International Union Against Cancer (UICC). Comment. Immunohistochemistry for WT-1 (+ve), Calretinin (+ve), MOC31 (-ve) and BG8 (-ve). confirms the diagnosis of malignant mesothelioma (block E7, controls. appropriate). M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow, M.D. Clinical History: The patient is a. male with no a malignant pleural mesothelioma of. the right pleural space who undergoes a right thoracotomy parietal pleurectomy. and decortication. Specimens Received: A: #7 lymph node. B: ## lymph node. C:#9 lymph node. D: 4R lymph node. E: Pleura, diaphragm, pericardiuim. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""#7 lymph node"". Received. fresh and placed in formalin is an unoriented 2.8 x 1.5 X 0.8 cm portion of. gray-brown rubbery tissue with a small amount of attached lobulated yellow. adipose. The specimen is bisected and entirely submitted as A1-A2. B. The second container is additionally identified as, ""#8 lymph node"". Received fresh and placed in formalin is a 4.3 X 2.5 x 0.5 cm portion of. lobulated yellow fibrofatty tissue. The specimen is dissected for lymph nodes to. reveal 6 gray-black apparent lymph nodes ranging from 0.2-1.2 cm in greatest. dimension. All apparent lymph nodes are submitted as follows: B1: : 3 lymph nodes. B2: 2 lymph nodes. B3: largest lymph node, bisected. C. The third container is additionally identified as, ""#9 lymph node"". Received. fresh and placed in formalin is a 2 x 1.2 x 0.5 cm unoriented portion of. lobulated yellow fibrofatty tissue. The specimen is sectioned revealing 2. gray-black rubbery apparent lymph nodes measuring 0.6 and 0.8 cm in greatest. dimension. The specimen is entirely submitted as C1. D. The fourth container is additionally identified as, ""4R"". Received fresh and. placed in formalin is a 3 x 2.3 x 0.8 cm portion of lobulated yellow fibrofatty. tissue. The specimen is dissected for lymph nodes to reveal 8 apparent tan to. gray-black rubbery lymph nodes ranging from 0.2-1 cm in greatest dimension. All. apparent lymph nodes are submitted as follows: D1-D2: 3 lymph nodes in each cassette. D3: 2 lymph nodes. E. The fifth container is additionally identified as, ""5. Pleura, diaphragm and. pericardium"". Received fresh and placed in formalin is a 629.5 g, 34.5 x 25 x 3. cm portion of visceral pleura with attached 7 X 6.5 cm glistening pink-gray. membranous tissue designated pericardium (marked by a black suture) and attached. 22.8 X 15 cm portion of diaphragm (marked by white suture). The specimen has an. overall volume of approximately 700 cc. The pericardium is smooth, glistening. and is inked blue. Adjacent to the pericardium is 8.5 x 6.5 X 2.5 cm area of. abundant yellow fibrofatty tissue in which multiple apparent tan to gray-black. rubbery lymph nodes ranging from 0.3-1.5 cm in greatest dimension are. identified. Sectioning through the pericardium reveals patchy ill-defined. gray-tan nodules ranging from 0.5-1.7 cm in greatest dimension which focally. abut the inked surface. The inner aspect of the specimen displays patchy areas. of visceral pleura measuring up to 7 x 6.7 cm. The superior inner aspect of the. specimen is covered by patchy gray-tan firm nodules ranging from 0.2-1.5 cm in. greatest dimension. The diaphragm is inked green. The diaphragm is diffusely. covered by a grey-tan firm plaque ranges from 0.5-1.7 cm in thickness. Upon. sectioning, the plaque focally invades into the diaphragm muscle extending to. within 0.3 cm of the inked surface. Gross photographs are taken. Representative. sections are submitted as follows: E1-E2: pericardium. E3-E4: sections of plaque and diaphragm, deepest invasion. E5-E7: additional sections of plaque and diaphragm. E8-E17: sections from remainder of specimen. E18-E19: 4 lymph nodes in each cassette. E20: one apparent lymph node, bisected.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Procedure: Right adrenalectomy and Right nephrectomy. Gross Description: Adrenal tumor is 172g; measuring 9 x 7 x 5cm. There is a 0.7cm. nodule in the right kidney with granulomatous cells and gigantic cells; possibility of. tuberculosis is raised. Diagnosis: Adrenal cortical carcinoma. Weiss score = 7. No LN mets (+0/10). No. invasion of renal artery. s/p cholecystectomy chronic inflammatory changes.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Omentum, mass, excision. - Metastatic adenocarcinoma, consistent with colonic primary. B: Terminal ileum, appendix and right colon, right hemicolectomy. Tumor Histologic Type: Invasive moderately differentiated colorectal adenocarcinoma. Histologic Grade: 2. Tumor Location: Right colon. Depth of Invasion: Through muscularis propria into the subserosa, pericolic soft tissue. Lymphovascular Invasion: Not identified. Perineural Invasion: Not identified. Margins: Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative but close, <1.0 mm. Distance of carcinoma from closest margin (specify): <1.0 mm from serosal surface; 8.5 cm from proximal mucosal margin. Regional Lymph Nodes: Total number with metastasis: 1. Total number examined: 24. Additional pathologic findings: Appendix with follicular lymphoid hyperplasia and no tumor seen; tumor satellite nodule identified. AJCC PATHOLOGIC TNM STAGE: pT3 pN1a. Note: This pathologic stage assessment is based on information available at the time of this report, and is subject to change pending clinical. review and additional information. C: Liver mass, Segment 5, removal. - No evidence of metastatic disease. - Benign liver with minimal steatosis and mild portal triaditis. D: Hernia sac, removal. - Benign fibrovascular and fibroadipose soft tissue, consistent with hernia sac, with focal foreign body giant cell reaction with associated. polarizable foreign material; no evidence of metastatic disease. Clinical History: large mass in the ascending colon. Biopsy demonstrates invasive moderately differentiated adenocarcinoma. CT imaging confirms mass and. evidence of metastatic disease. Gross Description: Received are four formalin-filled containers. Container A: SITE: ""omentum"". METHOD: excision. MEASURE: 6.5 x 3.6 X 1.5 cm. COMMENT: yellow/tan fibroadipose tissue with a central firm hard mass; cut section demonstrates a white/yellow firm surface. BLOCK: A1, omental mass. Container B: Specimen fixation: formalin. Parts of bowel received: terminal ileum, cecum and proximal ascending colon. Specimen length: 27.3 cm. Orientation: The specimen was received with a stitched end which appears to be the right ascending colon, inked blue. The distal. ileum is inked black. Tumor location: tumor is located just distal, but apparently involving the ileocecal valve. Gross appearance of tumor: distal to the ileocecal valve is a ulcerated mass with whorled edges, this mass is firm; proximal to this. is the ileocecal valve and this also appears to be at least superficially studded with tumor. Tumor dimensions: 3.5 x 2.4 x 1.2 cm. Circumferential growth: 70%. Gross depth of invasion: the mass appears to grossly invade the subserosal soft tissues. Gross evidence of perforation through visceral peritoneum: no. Luminal obstruction: no. Bowel circumference at tumor site: 6.0 cm, 1.5 cm diameter at tumor site. Gross distance of tumor from margins: 9 cm from blue inked distal margin, 8.5 cm from black inked proximal margin. Lymph nodes: per block summary. Other remarkable findings: The rest of the colon and ileum are grossly unremarkable. Appendix is present with the specimen and is. not grossly involved. Tissue submitted for special investigation: tissue submitted to Tissue Procurement. Digital photograph taken: no. Block Summary: (Inking: proximal ileal margin=black, distal right colonic margin with stitch=blue). B1 - appendix, longitudinal section of tip, cross section of base. B2 - proximal (black inked) margin, en face. B3,B4 - distal (blue inked) margin, en face. B5 - section of mass. B6,B7 - additional section of mass, bisected. B8 - mass in relation to pericolic fat. B9 - section of ileocecal valve. B10 - additional section of ileocecal valve. B11 - five lymph node candidates. B12 - five lymph node candidates. B13 - five lymph node candidates. B14,B15 - one grossly positive node, bisected. B16 four lymph node candidates. B17 - two lymph node candidates. Container C: SITE: ""liver, Segment 5"". METHOD: biopsy. MEASURE: 1.0 X 0.8 X 0.4 cm. COMMENT: tan/brown soft tissue mass. BLOCK: C1,. Container D is additionally labeled ""hernia sac."" It holds three pink/tan soft tissue fragments measuring 2.5 X 1.9 x 0.8 cm in aggregate. Block Summary: D1 hernia sac. Fibroadipose tissue remains. Grossing Pathologist: Light Microscopy: Light microscopic examination is performed by.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: 1) TONSIL, RIGHT, EXCISION: INVASIVE, MODERATELY-DIFFERENTIATEL - SQUAMOUS. CELL CARCINOMA, 2.2 CM IN GREATEST DIMENSION, ALL RESECTION MARGINS. NEGATIVE FOR TUMOR (SEE COMMENT). 2) SOFT TISSUE, RIGHT NECK, EXCISION: DENSE FIBROUS TISSUE AND FOREIGN. BODY GIANT CELL REACTION, NEGATIVE FOR TUMOR. 3) ""SOFT TISSUE,"" RIGHT NECK, LEVEL 1B, EXCISION: SALIVARY GLAND WITH NO. SIGNIFICANT HISTOPATHOLOGIC CHANGE, NEGATIVE FOR TUMOR. 4) LYMPH NODE, RIGHT NECK, LEVEL 2-3, EXCISION: BENIGN FIBROADIPOSE. TISSUE AND SKELETAL MUSCLE WITH SUTURE GRANULOMA; 11 LYMPH NODES,. NEGATIVE FOR TUMOR. 5) SKIN, RIGHT NECK, EXCISION: SCAR AND SUTURE GRANULOMA, NEGATIVE FOR. TUMOR. 6) LYMPH NODE, LEFT NECK, LEVEL 2-3, EXCISION: 13 LYMPH NODES, NEGATIVE. FOR TUMOR. 7) TONSIL, LEFT, EXCISION: NEGATIVE FOR TUMOR. 8) TOOTH, 1, 31, 32, REMOVAL: MOLAR TEETH WITH NO SIGNIFICANT. HISTOPATHOLOGIC CHANGE. COMMENT: This corresponds to AJCC stage II (pT2, pNO). CLINICAL DATA. Clinical Features/Dx: unspecified. Operator: Operation: unspecified. Operative Findings: unspecified. Operative Diagnosis: unspecified. Tissue Submitted: unspecified. GROSS DESCRIPTION: 1) SOURCE: Tonsil, Right. Received fresh is a specimen labeled, ""right tonsil,"" consisting of a. 2.8 X 2.0 X 1.1 cm tonsillectomy specimen. A 2.2 X 1.8 X 0.9 cm mass is. identified on the mucosal surface of the specimen. The specimen is inked. black. The specimen is serially sectioned and a portion of the specimen. is obtained for future research studies. A portion of the specimen is. submitted for frozen section analysis. The remainder of the specimen is. submitted for permanent section. Summary of sections: 1AFSC, 1/1; 1B-C, mass, 1B, 2/1, 1C, 3/1. 2) SOURCE: Right Neck adjacent to jugular vein. Received fresh is a specimen labeled, ""soft tissue right neck adjacent. to jugular vein,"" consisting of a 0.5 X 0.4 X 0.3 cm portion of soft. tissue, which is entirely submitted for frozen section analysis. Summary of sections: 2AFSC, 1/1. 3) SOURCE: Right neck level 1 B. Received fresh is a specimen labeled, ""right neck level 1B,"" consisting. of a 4.0 X 3.0 X 1.0 cm portion of yellow, soft, and lobulated adipose. tissue. A search for lymph nodes is performed. No lymph nodes are. identified through palpation. The specimen is serially sectioned to. reveal tissue consistent with a salivary gland. The specimen is entirely. submitted. Summary of sections: 3A, 2/1; 3B, 1/1; 3C, 2/1; 3D, 1/1; 3E, 1/1. 4) SOURCE: Right neck level 2 + 3. Received fresh is a specimen labeled, ""right neck level 2-3,"" consisting. of two fragments of fibroconnective and adipose tissue, measuring 5.0 X. 4.5 X 1.0 cm in aggregate. A search for lymph nodes is performed. The. specimen is serially sectioned and entirely submitted. Summary of sections: 4A, fragment of fibroconnective tissue, bisected,. 1/1; 4B, three lymph nodes, 3/1; 4C, one lymph node, bisected, 2/1;4D,. three lymph nodes, 3/1; 4E-G, fragment of fibroconnective tissue,. serially sectioned, 1/1 each. 5) SOURCE: Right neck scar. Received fresh is a specimen labeled, ""right neck scar,"" consisting of a. 7.0 X 0.7 X 0.4 cm portion of skin and subcutaneous tissue. A 6.0 cm. scar is identified on the cutaneous surface of the specimen. The. specimen is not oriented. The subcutaneous tissue is inked black. The. specimen is serially sectioned and entirely submitted. Summary of sections: 5A, tips, 2/1; 5B-C, scar, 5B, 8/1, 5C, 6/1. 6) SOURCE: Left neck level 2,3. Received fresh is a specimen labeled, ""left neck level 2-3,"" consisting. of a 7.0 X 3.0 X 1.0 cm portion of fibroadipose tissue. A search for. lymph nodes is performed. A representative portion of the specimen. containing lymph nodes is submitted. Summary of sections: 6A, four lymph nodes, 4/1; 6B, three lymph nodes,. 3/1; 6C, portion of fibroconnective tissue, 1/1. 7) SOURCE: Tonsil, Left. Received fresh is a specimen labeled, ""left tonsil,"" consisting of a. tonsillectomy specimen, measuring 2.5 X 1.5 X 1.0 cm. The specimen. reveals extensive cautery artifact. The specimen is inked black,. serially sectioned and entirely submitted. Summary of sections: 7A-B, tonsil, 2/1 each. 8) SOURCE: Teeth; 1,31,32. Received fresh is a specimen labeled, 'teeth, 1, 31, 32,"" consisting of. molar teeth with attached minimal amount of soft tissue, showing no. significant histopathologic changes. The specimen is filed in the. medicolegal file. No tissue is retained for permanent section. This is a. gross diagnosis only. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Tonsil , Right. FROZEN SECTION DIAGNOSIS: SQUAMOUS CELL CARCINOMA. 2) SOURCE: Right Neck adjacent to jugular vein. FROZEN SECTION DIAGNOSIS: FIBROSIS AND FOREIGN BODY GIANT CELL REACTION;. BENIGN. SNOMED: T-C5100,M-80103,. Release of Information.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: Tumor is located in Abdominal Esophagus, nearby of Zlines. It is ulcerated and. invasive, with 3.5x3x3cm in size, soft and white-gray surface. Microscopic Description: Mucosa is ulcerated. Tumor tissue arranges in the form of group or sheets or. trabecular of tumor cells. The malignant cells have moderate, light eosinophilic keratinized cytoplasm. The nuclei are enlarged, variability in size and shape, containing coarse clumped chromatin with. prominent nucleoli. Mitotic figures are present. Tumor invades in fat tissue. Stroma is fibrous and. invasion of lymphocytes. Diagnosis Details: Squamous cell carcinoma, Grade III, infiltrating adventitia. Comments: Formatted Path Reports: ESOPHAGUS TISSUE CHECKLIST. Specimen type: Esophagectomy. Tumor site: Abdominal esophagus. Tumor size: 3.5x3x3cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Adventitia. Lymph nodes: 6/20 positive for metastasis (Regional 6/20). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : 1. GROSS: 1. Specimen: Liver: 21.0 X 16.5 X 10.0 cm, unfixed. Gallbladder: 9.0 cm in length, 3.2 cm in diameter, and 2.0 mm in. wall thickness, unfixed. 2. Tumor location: right. Tumor number: one. Tumor size: 12.0 x 15.0 x 12.0 cm. 3. Satellite nodule: yes. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: yes (20 %). 6. Hemorrhage/peliosis: yes (20%). 7. Portal vein invasion: yes. 8. Bile duct invasion: no. Gross photo present. Blocks. T1-7, liver mass X 7. A, non-tumorous lesion X 1. RM, resection margin x 1. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. 1-1. Differentiation. The worst differentiation IV/IV. The major differentiation III. 1-2. Histologic type: trabecular. 1-3. Cell type: hepatic. 1-4. Fatty change: no. 2. Fibrous capsule formation: no. 3. Septum formation: no. 4. Surgical resection margin invasion: no, margin of the clearence (0.7 cm). 5. Serosal invasion: no. 6. Portal vein invasion: yes. 7. Bile duct invasion: no. 8. Hepatic vein invasion: no. 9. Hepatic artery invasion: no. 10. Microvessel invasion: yes. 11. Intrahepatic metastasis: yes. 12. Multicentric occurrence: no. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: minimal. 1-4. Stage (fibrosis): periportal. 1-5. Cirrhosis: no. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. NOT reported. Gross: NOT reported. Gross: Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. Lymph node, regional, biopsy, reactive hyperplasia. T08000, regional, P50, M72200. DIAGNOSIS: Liver, right, hemihepatectomy: Hepatocellular carcinoma, moderately differentiated. Gallbladder, cholecystectomy: Chronic cholecystitis. Lymph node, regional, biopsy: Reactive hyperplasia (0/1). NOTE: Recommend to order the IHC stains (Hepatocyte, CK7 and CK19) for block T2. Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
8340/ 3. F. Facility: Specimen(s) Received. 1. Thyroid: right subtotal hemithyroid stitch upper pole. Diagnosis. Multifocal papillary carcinoma, dominant follicular variant, 2.2 cm: Thyroid. No pathological diagnosis: Lymph node, isthmic. - Right hemithyroidectomy specimen. Synoptic Data. Procedure: Right hemithyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 3.9 cm. 2.3 cm. 1.6 cm. Isthmus +/- pyramidal lobe: 1.7 cm. 1.6 cm. 0.7 cm. Specimen Weight: 8.7 g. Tumor Focality: Multifocal, ipsilateral. DOMINANT TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 2.2cm. Additional dimension: 2.1 cm. Additional dimension: 1.5 cm. Histologic Type: Papillary carcinoma, follicular variant pn TSS, follocular varient = 100%. Papillary carcinoma, macrofollicular variant. Follicular architecture. Macrofollicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins uninvolved by carcinoma. Margins: Tumor Capsule: Partially encapsulated. Tumor Capsular Invasion: Present, extent minimal. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. SECOND TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 0.1cm. Histologic Type: Papillary carcinoma, follicular variant. Papillary carcinoma, microcarcinoma (occult, small or microscopic). variant. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT2: Tumor more than 2 cm, but not more than 4 cm, limited to. thyroid. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of regional lymph nodes examined: 1. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None Identified. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Comment. The dominant nodule exhibits multifocal transformation to papillary carcinoma and the extent of. malignancy warrants classification of the entire nodule as papillary carcinoma. There is also a 0.1cm. follicular variant papillary microcarcinoma in the right lobe. The overall morphological features are those. of a low risk papillary carcinoma. Gross Description. The specimen labeled with the patient's name and as ""right subtotal thyroid stitch upper pole"", consists of. a right hemithyroidectomy specimen that weighs 8.7 g. The lobe measures 3.9 cm SI x2.3 cm ML x 1.6. cm AP and the isthmus measures 1.7 SI x 1.6cm ML x 0.7cm AP. No parathyroid gland or lymph nodes. are identified grossly. The mid superior lobe contains one well delineated nodule that measures 2.1 cm SI. X 2.2cm ML x 1.5 cm AP. The cut surface of the nodule has a variegated red-tan color, and has a soft and. flabby consistency. Sections of nodule and normal tissue are stored frozen. The remainder of the. specimen is submitted as follows: 1A-F. lobe, superior to inferior. 1G. isthmus.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) LEFT NECK DISSECTION LEVEL 11: Ten lymph nodes, negative for tumor (0/10). (B) LEFT NECK DISSECTION LEVEL III: Ten lymph nodes, negative for tumor (0/10). (C) LEFT NECK DISSECTION, LEVEL IV: METASTATIC SQUAMOUS CARCINOMA IN ONE OF TWENTY LYMPH NODES (1/20). Extracapsular extension is not identified. (D) RIGHT RADICAL NECK DISSECTION: METASTATIC SQUAMOUS CARCINOMA IN THREE OF NINE LYMPH NODES. IN LEVELS I AND Il (3/9). EXTRANODAL EXTENSIÃN PRESENT. SQUAMOUS CARCINOMA IN SUBCUTANEOUS TISSUE INVOLVING LEVELS Il AND III. SKIN ULCERATION. Perineural invasion is not identified. (E) RIGHT NECK DISSECTION, LEVEL Il ""B"": METASTATIC SQUAMOUS CARCINOMA TWO OUT OF FIVE LYMPH NODES INVOLVED BY (2/5). SOFT TISSUE TUMOR DEPOSIT WITH DENSE FIBROSIS. Perineural invasion is not identified. (F) NO TISSUE SUBMITTED. (G) LEFT LATERAL PHARYNX: Squamous mucosa, negative for carcinoma. (H) POSTERIOR CRICOID. Squamous mucosa, negative for carcinoma. (I) RIGHT LATERAL PHARYNX: Squamous mucosa, negative for carcinoma. (J) BASE OF TONGUE: Benign squamous mucosa, negative for dysplasia or carcinoma; one benign lymph node (0/1). (K) TOTAL LARYNGECTOMY AND RIGHT THYROIDECTOMY. INVASIVE SQUAMOUS CARCINOMA - Moderately differentiated. Tumor Features: Gross: Exophytic. Size: 4,5 cm in largest dimension. Invasion: Present, depth 2.5 cm. Tumor Border: Infiltrative with thick cords > 4 cells. (K) TOTAL LARYNGECTOMY AND RIGHT THYROIDECTOMY (CONTINUED): Perineural Invasion: Absent. Vascular Invasion: Absent. Bone / Cartilage Invasion: Cartilage invasion Present. Thyroid, negative for tumor. GROSS DESCRIPTION. (A) LEFT NECK DISSECTION LEVEL II - Fibroadipose tissue (2.0 x 2.0 x 1.0 cm). Multiple lymph nodes are identified ranging. from 0.1 X 0.1 X 0.1 cm to 1,5 : X 1,0 x 0.7 cm. SECTION CODE: A1-A3, each subcutaneous three lymph nodes: A4, one lymph node, serially sectioned. (B) LEFT NECK DISSECTION LEVEL III - Fibroadipose tissue (2.0 X 2.0 X 1.3 cm). Eleven lymph nodes are identified ranging. from 0.1 x 0.1 X 0.1 cm to 1.8 X 0,8 x 0.6 cm. SECTION CODE: B1. four possible lymph nodes: B2, five lymph nodes; B3, one ymph node, bisected: B4. one lymph. node, serially sectioned. (C) LEFT NECK DISSECTION LEVEL IV - Fibroadipose tissue (4,0 x 4.0 x 1,8 cm). Multiple lymph nodes are identified. ranging from 0.1 x 0.1 x 0.1 to 1.2 x 0.8 x 0.6 cm. SECTION CODE: C1-C4, each containing four possible lymph nodes; C5, three lymph nodes; C6, three lymph rodes. (D) RIGHT RADICAL NECK DISSECTION LONG STITCH SUPERIOR ANTERIOR LEVEL II, SHORT STITCH POSTERIOR. LEVEL V - A 9.0 x 8.0x3.1 cm portion of fibroadipose and muscular tissue that is partly surfaced by a 4.2 X 4.0 cm irregular. portion of dark brown wrinkled skin. Located on the surface of the skin are two defects that 1.5 x 0.6 cm and 2.4 X 2.3 cm The. specimen is oriented by the surgeon with a long stitch designating superior anterior level II and a short stitch designating. posterior level V. The specimen is divided into levels and dissected. Level I - three possible lymph nodes ranging from 1.0 X 0.8 x 0,5 cm - 1.8 X 0.9 x 0.4 cm. Level II - three possible lymph nodes ranging from 0.7 X 0.6 x 0.4 cm - 4. 0 x 1 5 x 1.3 cm. The largest two possible. lymph nodes are grossly positive with firm white and yellow cut surfaces. Level HI - three grossly positive lymph nodes ranging from 2.3 x 1.5 x 0,6 cm - 3.0 X 1.7 X 1.5 GMT. The second largest is. possibly a matted lymph node. Level IV - three possible lymph nodes ranging from 0.7 x 0.5 x 0.3 cm - 1.5 X 1 1 X 0- 6 cm. Level V - one possible lymph node that measures 0.6 X 0.5 X 0.3 cm,. SECTION CODE: D1-D4, level I: D1, one possible lymph node serially sectioned; D2, one possible lymph node. serially sectioned; D3, D4, one possible lymph node serially sectioned; D5-D10, level II: D5, one possible lymph node bisected;. D6, D7. representative sections of one grossly positive lymph node serially sectioned; D8-D10, representative sections of one. grossly positive lymph node serially sectioned, including skin; D11-D16, level III: D11, representative sections of smallest. grossly positive lymph node serially sectioned; D12-D14, representative sections of matted grossly positive lymph node serially. sectioned; D15, D16. representative sections of largest grossly positive lymph node serially sectioned; D17-D19. level IV: D17,. one possible lymph node bisected; D18, one possible lymph node bisected: D19, one possible lymph node serially sectioned;. D20, level V D2C. one possible lymph node serially sectioned. (E) RIGHT NECK DISSECTION LEVEL II B - A piece of tan-brown soft tissue (4.5 x 2.0 x 1.5 cm) containing five possible. lymph nodes ranging in size from 0.5 cm in greatest dimension to 1.4 X 0.7 X 0.5 cm The largest lymph node is grossly. suspicious for tumor involvement. There is a portion of dense, fibrous tissue (2.5 x 8 X 0.5 cm). SECTION CODE: E1. largest lymph node (four pieces): E2, four possible lymph nodes; E3-E5, dense fibrous tissue. (F) NO TISSUE SUBMITTED. (G) LEFT LATERAL PHARYNX, INK AT TRUE MARGIN - A fragment of tan-pink soft tissue measuring 1.1 x 1.0 x 0.5 cm. Submitted for frozen section in toto. SECTION CODE: G1 the entire specimen for frozen section. FS/DX: NEGATIVE. (H) POSTERIOR CRICOID, INK AT TRUE MARGIN - A strip of tan-pink soft tissue measuring 1.8 X 0.8 X 0.8 cm. Submitted. for frozen section in toto. SECTIÃN CODE: H, the entire snecimen for frozen section. FS/DX: NEGATIVE. RIGHT LATERAL PHARYNX, INK AT TRUE MARGIN -tan-pink soft tissue. 1.5 x 0.5 x 0.5 cm submitted for frozen in I. FS/DX: NEGATIVE. (J) BASE OF TONGUE, INK AT TRUE MARGIN -tan-pink soft tissue. cm Submitted for frozen in. FS/DX: MILD DYSPLASIA, CARCINOMA NOT IDENTIFIED. (K) TOTAL LARYNGECTOMY AND RIGHT THYROIDECTOMY - A larynx including surrounding soft tissue and right thyroid. lobe (8.5 cm in length X 6.5 cm in width X 4.5 cm anteroposterior, overall). The right thyroid lobe measures 4.5 X 2.0 cm,. A transglottic, ill-defined, raised tumor (4.5 X 2.0 cm with a depth of 2.5 cm) involving the right and left true vocal cords. and extending to the supraglottic area, to vallecula. The tumor involves the thyroid cartilage and cricoid. but does not extend. into the right thyroid lobe. Below the vocal cords the mucosa is nodular, with no evidence of invasion. These papulations. extend near the tracheostomy site. The tracheostomy site and the tracheal resection margin are grossly uninvolved by tumor. SECTION CODE: K1, thyroid; K2-K18, contains sequential sections of the tumor from right to left and superior to. inferior as follows: K2-K4. tumor sections; K5, supraglottic; K6, infragiottic; K7, supraglottic; K8, glottic to infraglottic; K9,. supraglottic, full thickness: K10, transglottic; K11, infraglottic; K12, supraglottic; K13. transglottic; K14, infraglottic; K15,. supraglottic; K16, transglottic; K17, infraglottic; K18, additional section of tumor. CLINICAL HISTORY. Squamous carcinoma of the larynx. SNOMED CODES. T-24100, M-80703. M-80703, ""Some tests reportert here may have been developed and performance charactenstics delemned by. Palhology and Laboralory Medicina. These tests have not been specifically. cleares or approved bv the US. Food and Drng Administration. Entire report and diagnosis completed by;.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Pre-Op Diagnosis. Right lower lobe squamous cell cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Four parts. Received in formalin labeled "". 1 - level 9 lymph. node right lung"" is a 1.1 x 0.8 x 0.3 cm irregular black soft tissue. consistent with probable lymph node, which is bisected and submitted. in its entirety in one cassette. Received in formalin labeled. 2 - level 10 lymph. node right lung"" are three irregular granular black soft tissues. consistent with probable lymph node ranging from 0.5 x 0.4 x 0.2 cm. to 1.1 x 0.7 x 0.3 cm, which are submitted in toto in one cassette. Received labeled. 3 - right lower lung lobe"" is a. 185 gram, 19.4 x 10.5 x 3.2 cm lower lung lobe with an attached 0.8. cm segment of bronchus. The pleura is smooth to wrinkled and. tan-pink to gray-purple with black anthracotic areas. There is a 3.1. cm linear staple line adjacent to the hilum. No additional. parenchymal staple lines are identified. There is a 1.4 x 1.1 cm. slightly ill-defined umbilicated area of pleura 2.2 cm from the. hilum. The cut surface of this area consists of a 1.8 x 1.5 x 1.2 cm. well circumscribed tan nodule, 3.4 cm from the bronchial margin and. 3.8 cm from the staple line. The remainder of the cut surface. consists of spongy tan-red parenchyma. There are two tan-white. nodules measuring 0.1 cm and 0.2 cm in greatest dimension which abut. the pleura near the periphery of the specimen. The nodules are 3.6. cm from each other. No additional parenchymal lesions are. identified. No obvious intraparenchymal or hilar lymph nodes are. identified. The specimen is inked, serially sectioned and. representative sections are submitted as labeled: A - bronchial and. vascular margins (en face) ; B - pleural margin (perpendicular) i C-F. - lesion, entirely submitted; G - larger nodule, entirely submitted;. H - smaller nodule, in toto. Also received in the same container is. a blue, yellow and green cassette labeled. genomic. research study. Received in formalin labeled. 4 - level 4 lymph. node right lung"" is a 2.8 x 1.7 x 0.5 cm irregular fibroadipose. tissue bearing three irregular black firm tissues consistent with. probable lymph node ranging from 1.1 x 0.5 x 0.3 cm to 1.2 x 0.8 x. 0.5 cm. The specimen is sectioned and representative sections are. submitted, to include the lymph nodes in their entirety, as labeled: A-C - one lymph node, bisected in each. Microscopic Description: See diagnosis. Final Diagnosis. Lymph node, right lung, level 9, excision: Reactive hyperplasia, negative for malignancy, one node. Lymph node, right lung, level 10, excision: Reactive hyperplasia, negative for malignancy, three nodes. Lung, right lower lobe, lobectomy: Tumor characteristics: Specimen integrity: Intact, margins can be evaluated. Specimen laterality: Right side. Histologic type: Squamous cell carcinoma, non-keratinizing. Histologic grade: 2 (moderately differentiated). Tumor site: Right lower lobe. Tumor focality: Unifocal. Tumor size: 1.8 x 1.5 x 1.2 cm. Visceral pleural invasion: Not identified. Lymphovascular space invasion: Not identified. Tumor extension: Not identified. Treatment effect: Not identified (no specific history provided). Surgical margin status: Tumor distance from bronchial margin: 3.4 cm. Tumor distance from stapled margin: 3.8 cm. Tumor distance from pleural surface: 0.1 cm. Lymph node status: Total number of lymph nodes received (includes all four parts of. this case) : 10. Total number of lymph nodes containing metastatic carcinoma: 0. Other significant findings: Two small subpleural fibrous nodules are present consistent with. areas of scarring. pTN stage: pTla, NO PAS 9 SPC-NP. Comments. The history of ""back lower lobe squamous cell carcinoma"" is noted. There is however no prior material identified in our files for. review and comparison. The two small subpleural nodules identified grossly, separate from. the malignancy, are both areas of fibrosis containing some. histiocytes and reactive alveolar lining cells, possibly. representing areas of resold pneumonia. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Sex: Female. Date of Tumour Procurement: 1. GROSS ASSESSMENT: Cut section showed a variegated tumour. 5x3x2cm,. No lymph nodes. 2. MICROSCOPIC ASSESSMENT. Microscopic description: Section shows a necrotic and invasive tumour growing in. trabecular, cords, syncytium, solid nests and trabecular patterns. It is composed of large. cells having pleomorphic hyperchromatic nuclei and amphophilic cytoplasm. The stroma. is desmoplastic containing similar tumour cells and aggregates of lymphocytes. 3. Tumour Type: Malignant. 4. Tumour Site: Right Breast. 5. Distance of invasive carcinoma to closest margin: 3mm. Which margin? Deep resection. 6. HISTOLOGICAL DIAGNOSIS: Medullary Adenocarcinoma. 7. COMMENTS: Nuclear score:3, Pathological TNM stage: pT2. Dr. Reporting Pathologist Name.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Pathology Report-Summary: Material: lung, left, upper lobe: 22.0 X 15.0 X 7.0 cm. tumor: 8.0 X 7.0 X 4.0 cm. Diagnosis: Adenocarcinoma, papillary. Infiltration of pleura visceralis. Site : lung. upper 1. be C34.1. pT2, pNo (0/37), pMx, G2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Breast, left, wide local excision: Infiltrating ductal carcinoma, Nottingham grade II (of III), forming a 1.5 x 1.4 x 1.2 cm. mass. (AJCC pTlc). Associated ductal carcinoma in situ, intermediate nuclear grade, compromises approximately 20% of the tumor. Resection margins are free of tumor. Separately submitted lateral, deep, inferior and superior margins are free of tumor. Lymph nodes, left axillary sentinel Nos. 1, 2, and 3, excision: Multiple (3) left axillary sentinel lymph nodes without blue dye are. negative for tumor. [AJCCpNO(i-)] Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel. lymph node tissue and confirms the H&E impression.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
LABORATORY SERVICES. Accession # : Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: ORIGINAL REPORT. SPECIMEN: A: Gallbladder. B: Portal lymph node. C: Right liver - 423 gm. CLINICAL HISTORY: Hepatocellular cancer. DIAGNOSIS: A: GALLBLADDER, CHOLECYSTECTOMY: NEGATIVE FOR MALIGNANCY. B: PORTAL LYMPH NODE, BIOPSY: ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY. C: RIGHT LIVER, PARTIAL RESECTION: HEPATOCELLULAR CARCINOMA, 7.3 X 6.0 X 5.8 CM. TUMOR IS ABOUT 0.9 CM FROM THE LIVER RESECTION MARGIN. FOREIGN BODY TYPE REACTIONS PRESENT IN NUMEROUS INTRAHEPATIC VESSELS,. LIKELY DUE TO REACTIONS TO THE EMBOLIC PROCEDURE. BACKGROUND LIVER SHOW FOCAL MICROSTEATOSIS, PORTAL LYMPHOCYTIC. AGGREGATION AND INFLAMMATION. THE INFLAMMATION MAY BE THE RESULT OF. EMBOLIC PROCEDURE. CLINICAL CORRELATION REQUIRED. (Electronic Signature,. GROSS DESCRIPTION: A: The specimen consists of a collapsed gallbladder measuring 6.4 x 2.9 x 0.7. cm. The serosa is tan and smooth apart from where it attaches to the liver. bed, where it appears roughened and light green. There is a focal area of. puckering the distal end of the gallbladder. It contains a minimal amount of. viscous green bile. No calculi are identified. The mucosa is dark green and. velvety without signs of cholesterolosis. The wall thickness measures up to. 0.4 cm. Representative sections of the gallbladder, including the puckered. area of the wall. Page 1  CONTINUED. ABORATORY SERVICES. Patient ID: PHN: ALT ID: Telephone: Requesting Physician: Encounter: Chart ID: HISTOPATHOLOGY REPORT. Division Head: GROSS DESCRIPTION: B: The specimen consists of a portion of fibrofatty tissue measuring 1.4 x 1.1. x 0.2 cm. Within it is a lymph node with a maximal dimension of 0.9 cm. Entirely submitted in cassette B. C: The specimen consists of a portion of liver weighing 423 gm and measuring. 16.8 x 8.9 x 7.4 cm. The outer capsule is smooth with a slightly micronodular. appearance. The specimen has previously been treated with silver nitrate and. the surgical margin has been inked black. The surgical mÃ¤rgin measures 11. 3 x. 7.1 cm. Within the liver is a well circumscribed tan yellow nodule measuring. 6.0 x 5.8 x 7.3 cm. It has a soft rubbery consistency with a central area of. irregular hemorrhage. Within uninvolved parenchyma there are small areas. suspicious for tumor within the vascular space. The uninvolved parenchyma is. smooth, tan and has a subtle micronodular appearance. The closest tumor to the. surgical margin is 0.9 cm and is within 1 mm of the capsule. Cassette submitted as follows: C1 through C11 - shaved margin of the surgical margin closest and farthest. away. C12 through C14 - sections of tumor with capsule. C15 and C16 - suspicious for tumor emboli. C17 through C19 - background liver. Procedure:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
RUN DATE: RUN TIME. RUN USER: LOC: AGE/SX: ROOM: REG DR: BED: SPEC # : RECD: COLL: TIME IN FORMALIN: hrs. COLD ISCHEMA TIME: mins. CLINICAL INFORMATION: Pre-Op Diagnosis: Remarks: Specimen (s) : Left breast, stitch left axillary apex. MICROSCOPIC DIAGNOSIS. LEFT BREAST, SKIN-SPARING RADICAL MASTECTOMY: INVASIVE DUCTAL CARCINOMA, HIGH GRADE. NOTTINGHAM HISTOLOGIC SCORE. - GLANDULAR/TUBULAR DIFFERENTIATION SCORE 3. - NUCLEAR PLEOMORPHISM SCORE 3. - MITOTIC RATE SCORE 2. - OVERALL GRADE 3 (8 OF 9). MARGINS UNINVOLVED BY INVASIVE CARCINOMA. CARCINOMA IS 5.5 MM FROM THE CLOSEST MARGIN (POSTERIOR MARGIN). MINUTE FOCUS OF HIGH-GRADE DCIS PRESENT WITHIN AREA OF CARCINOMA (1 MM IN SIZE). LYMPH-VASCULAR INVASION IDENTIFIED. METASTATIC CARCINOMA INVOLVING TWO (2) OF ELEVEN (11) LYMPH NODES (2/11). LARGEST TUMOR DEPOSIT IS 14.5 MM. EXTRACAPSULAR EXTENSION IDENTIFIED. SEE SYNOPTIC REPORT. COMMENT(S). SURGICAL PATHOLOGY CANCER CASE SUMMARY - APPROVED BY. PROCEDURE: Total mastectomy, skin sparing. LYMPH NODE SAMPLING: Axillary dissection. SPECIMEN LATERALITY. Left. TUMOR SITE: Upper outer quadrant. HISTOLOGIC TYPE OF INVASIVE. CARCINOMA: Invasive ductal carcinoma. TUMOR SIZE: Greatest dimension of largest focus of invasion. 25 mm. Additional dimensions: 22 x 20 mm. HISTOLOGIC GRADE (NOTTINGHAM. HISTOLOGIC SCORE) : Glandular/tubular differentiation : score 3. Nuclear pleomorphism: score 3. RUN DATE: RUN TIME. RUN USER: SPEC #: COMMENT (S). Mitotic rate: score 2. Overall grade: grade 3. TUMOR FOCALITY: Single focus of invasive carcinoma. DUCTAL CARCINOMA IN SITU: DCIS is present. Estimated size of DCIS 1 mm. Architectural pattern: comedo. Nuclear grade: grade III. Necrosis: present, central. LOBULAR CARCINOMA IN SITU: Not identified. MARGINS. Invasive carcinoma : Margins uninvolved by invasive carcinoma. Distance from closest margin: 5.5 mm. posterior. DCIS: Margins uninvolved by DCIS. LYMPH NODES: Number of sentinel lymph nodes examined : 0. Total number of lymph nodes examined: 11. Number of lymph nodes with macrometastases: 2. Number of lymph nodes with ITC: 0. Size of largest metastatic deposit: 14.5 mm. Extranodal extension : present. Method of evaluation of sentinel lymph nodes. H&E. multiple levels. LYMPH-VASCULAR INVASION: Present. DERMAL LYMPH-VASCULAR INVASION: Not identified. PATHOLOGIC STAGING: Primary tumor pT2. Regional lymph nodes: pN1a. Distant metastasis: not applicable. ANCILLARY STUDIES: (RESULTS FROM CASE -. Estrogen Receptor positive (99% of tumor cells. with nuclear positivity). Progesterone Receptor: positive (99% of tumor. cells with nuclear positivity. Her2/neu: Immunoperoxidase studies negative (1+). GROSS DESCRIPTION: Received fresh is a skin-sparing left radical mastectomy weighing 756 grams and measuring. 27 cm from medial to the axillary tail. 18 cm from superior to inferior. and 2.5 cm. anterior to posterior. There is a linear portion of skin including nipple measuring 9 x. 2.1 cm. A mass is palpated in the lower portion of the upper outer quadrant . The deep. margin underlying this tumor is inked black. and the anterior margin is inked blue. A cut. is made from the posterior side. and a portion of tumor is given to the Tumor Bank. The. tumor measures 2.5 x 2.2 x 2.0 cm. It is firm with focal areas of hemorrhage. There is an. adjacent vell-circumscribed tan-white soft. freely mobile area measuring up to 4.5 cm in. greatest dimension. The carcinoma measures 0.8 cm from the posterior black-inked margin. and 0.9 cm from the anterior blue-inked margin. The other margins are greater than 3 cm. RUN DATE. RUN TIME: RUN USER: SPEC #. GROSS DESCRIPTION: (Continued). from the tumor including the nipple. The remainder of the breast is serially sectioned to. reveal no additional masses, cysts or other gross abnormalities There is a fat to fibrous. ratio. of up to 50:50. The most fibrotic areas are closest to the lateral quadrants,. particularly the upper outer quadrant . The detached axillary tail itself measures 13.2 x. 5.5 x 2.6 cm. Serial section reveals multiple lymph nodes, the largest of which measures. 2.2 x 1.5 x 1 cm. Sections are as follows: tumor as it most closely approximates the anterior margin. 2. tumor as it most closely approximates the posterior margin. 3. additional representative section of tumor. 4. representative section of fibrotic area adjacent to tumor. 5. representative section of nipple. 6-7. additional representative sections of very fibrotic areas in the. lateral quadrant. 8. representative sections of the medial quadrants. 9-10. multiple lymph nodes. 11-12. one lymph node each, bisected. PHOTO IXICUMENTATION. (signature on file).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Stomach (Gastroesophageal junction). 1 - ""Esophagus + Stomach"": Adenocarcinoma characterized as follows: Histological pattern(s) observed: tubular. Histological grade: II - moderately differentiated. Measure of the longest axis of the tumor: 12.70. Lauren's classification: Ulceration: present. Compromise of: Mucosa. Muscularis mucosae. Submucosa. Muscularis propria. Adjacent adipose tissue. Type of tumor invasion. Spiculated. Inflammatory reaction: Mild. Tumor implantation in peri-visceral adipose tissue: Not detected. Proximal margin: Free of neoplastic involvement. Distal margin: Free of neoplastic involvement. Radial margin: Free of neoplastic involvement. Neural infiltration: Present. Lymphatic vascular invasion: Not detected. Sanguineous vascular invasion: Present. Lymph nodes: Compromised: Compromised/dissected lymph nodes ratio: 1/23. Lymph node conglomerates: Not detected. - Discrimination of lymph nodes: Periesophageal: 0/3. Perigastric: 0/18. Note: the neoplasm is from esophagogastric transition. Intestinal pattern of. Lauren. 2 - ""Distal splenic artery (lymph node) : Absence of neoplasia in the examined materials (0/0). 3 - ""Inferior paraesophageal lymph node"": Absence of neoplasia in the analyzed materials (0/0). 4 - Recurrent lymph node : Adenocarcinoma metastatic to lymph node (1/1). 5 - ""Esophageal margin"": Free of neoplastic involvement. 6 - ""Epiploon"": Free of neoplastic involvement. PATHOLOGICAL STAGING. Topography. Morphology. Stage. Stomach, NOS. Adenocarcinoma. NOS. pT3 pN1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: Female. Color: White. Origin: Nature of material: Breast. Biopsy number: Gross description: Specimens are received in three containers. Container 01: Right breast (mastectomy) weighing 863 g. It measures 22.5 x 17.5 x 4.0 cm. Superficially, a skin ellipse is seen, and measures 18.0 X 7.0 cm. There is no superficial lesion. On. slicing in the breast parenchyma is a white spiculated nodule with central necrosis measuring 3.5. x 2.5 x 0.8 cm. Macroscopically, all the margins are clear. Container 02: Axillary lymph node: One white, soft and nodular tissue measuring 1.1 x 0.8 x 0.3. cm containing no gross lesion. Container 03: 10 Axillary lymph nodes. A gross nodular fibrofatty tissue measuring 3.0 x 2.2 x. 0.6 cm in aggregate. Contained within the tissue are 4 soft nodular structures with diameters. ranging from 0.2 to 0.4 cm in the largest diameters. Microscopy. Dispensable description. Conclusions: Right breast: Invasive lobular carcinoma, grade 1, measuring 1.1 cm in the largest diameter;. Clear surgical margins. Lymph nodes: There is no lymph nodes metastasis. PARTICIPANTS OF APPRAISAL REPORT. - Issuer. - Reviewer.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
LINICAL DIAGNOSIS: R/O HCC. Specimen : liver. Gross Photo : GROSS: The gross specimen consists of three cores of pale tan fragmented needle-biopsied liver tissue,. 1.6 x 0.2 X 0.1 cm in aggregates. Entirely submitted. Block X 1. SPECIAL STAIN: Mucicarmine and trichrome stains reveal no significant change. Reticulin stain reveals disruption of reticulin frame work. NOT reported. Gross: NOT reported. Gross: Stomach, antrum, scopic, atypical glands. Stomach, antrum, scopic, chronic gastritis. ver,needle, ,hepatocellular carcinoma. T56000, P28, M81703. DIAGNOSIS: Liver, CT guided needle biopsy: Hepatocellular carcinoma, well differentiated (see NOTE). (Edmondson-steiner grade (1/4). NOTE: This case was consulted to Dr. Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Case ID Gross Description. Microscopic Description. Diagnosis Details. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 8 X 7 X 1.5 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Adjacent structures. (specify) - Lesser and greater omentum. Lymph nodes: 5/7 positive for metastasis. (Intraabdominal 5/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Gender: M. Patient Location: Date of Service: Date Received: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: KIDNEY, RIGHT, PARTIAL NEPHRECTOMY: - CLEAR CELL RENAL CELL CARCINOMA. - 1.8 cm in maximum dimension. - Fuhrman nuclear grade 2. - MARGIN STATUS: POSITIVE. - Tumor focally extends to renal parenchymal margin. - LYMPHOVASCULAR INVASION: NOT IDENTIFIED. PATHOLOGIC STAGING SUMMARY: Primary tumor: pT1 (1.8 cm in greatest dimension, limited to the kidney). Regional lymph nodes: pNX. Distant metastasis: pMX. Pathologic stage: I. Margin status: R1 (tumor focally extends to parenchymal margin). Printed: This report continues (FINAL). FINAL SURGICAL PATHOLOGY REPORT. Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol, February 2011). Procedure: Partial nephrectomy. Specimen laterality: Right. Tumor site: Not specified. Tumor size: 1.8 cm in greatest dimension. Tumor focality: Unifocal. Macroscopic extent of tumor: Tumor limited to kidney. Histologic type: Clear cell renal cell carcinoma. Sarcomatoid features: Not identified. Tumor necrosis: Not identified. Histologic grade: Fuhrman nuclear grade 2 (of 4). Microscopic tumor extension: Tumor limited to kidney. Margin status: POSITIVE (R1); tumor focally extends to renal. parenchymal margin. Lymph-vascular invasion: Not identified. PATHOLOGIC STAGING SUMMARY: Primary tumor: pT1 (1.8 cm in greatest dimension, limited to the. kidney). Regional lymph nodes: pNX. Distant metastasis: pMX. Pathologic stage: I. Margin status: R1 (tumor focallly extends to renal capsular margin). Source of Specimen: Mass;Right Renal Mass. Clinical History/Operative Dx: Right renal mass. Printed: This report continues. FINAL SURGICAL PATHOLOGY REPORT. Gross Description: The specimen is labeled right renal mass and is received without fixative. It consists of a 3.5 x 3.5 x 2 cm. portion of renal cortical tissue. There is a small amount of adherent perirenal fat. The cortical surface is. inked blue and the resection margin is inked black. The specimen is serially sectioned to reveal a well. circumscribed golden yellow lobulated tumor mass which measures 1.8 cm in maximum dimension. The. tumor mass is grossly 0.2 cm from the renal parenchymal margin. Representative sections are submitted. Section summary: A1) cortical margin with closest approach of tumor, A2-A7) remainder of tumor. submitted as cross sections. Microscopic Description: Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Printed:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Resulted: SPECIMEN (S) RECEIVED. 1. Lymph-Node ST2R UP Paratracheal. 2. Lymph node: right low paratracheal ST4R. 3. Lymph node: subcarinal ST7. 4. Lymph node: left low paratracheal ST4L. 5. Lymph node: INF pulm ligament ST9. LUNG: LUL bronchial resection margin. DIAGNOSIS. 1-5. ST2R upper paratracheal, right low paratracheal 4R, ST7 subcarinal,. left low paratracheal 4L. and inferior pulmonary ligament ST9 lymph nodes - Negative for. malignancy. 6. Left upper lobe. a) Invasive moderately-differentiated squamous cell carcinoma,. peripheral but with. no invasion into overlying visceral pleura, 4.0 cm maximum. dimension. b) Bronchial margin of resection - Negative for malignancy. c) Lobar lymph nodes (2 examined) - Negative for malignancy. d) Focal area of nonspecific pleuropulmonary fibrosis. e) Pulmonary emphysema. COMMENT. Examination of this material indicates apparent complete resection of. a. T2NO squamous cell carcinoma. LINICAL HISTORY. Page: 1 of 3. Copath # : Resulted: GROSS DESCRIPTION. The specimen container labelled with the patient's name and as. ""lymph node: ST2R upper paratracheal"" consists of multiple pieces of dark. nodal tissue the largest measuring 1. x 0.7 x 0.5 cm received fresh. This is examined at intraoperative consultation by frozen section. perfomred on the entire specimen. 1A - frozen section embedded in toto (resubmitted). 2. The specimen container labelled with the patient's name and as. ymph node: right low paratracheal ST4R-QS"" consists of multiple. cagments of dark nodal tissue measuring in total 0.5 x 0.3 x 0.3 cm. received fresh. This is examined in intraoperative consultation by. frozen section performed on the entire specimen. 2A - frozen section embedded in toto (resubmitted). The specimen container labelled with the patient's name and as. lymph node: subcarinal ST7"" consists of multiple fragments of dark nodal. tissue measuring in total 0.5 x 0.5 x 0.3 cm received fresh. This is. examined at intraoperative consultation by frozen section performed on. the entire specimen. 3A - frozen section embeded in toto (resubmitted). 4. The specimen container labelled with the patient's name and as. ""lymph node: left low paratracheal ST4L-QS"" consists of fragments of dark. nodal tissue in total measuring 0.5 x 0.2 x 0.2 cm received fresh. This. is examined at intraoperative consultation by frozen section performed on. the entire specimen. 4A - frozen section embedded in toto (resubmitted). 5. The specimen container labelled with the patient's name and as. "" lymph node: inferior pulmonary ligament ST9"" consists of a piece of grey. yellow nodal tissue measuring 1.0 x 0.8 x 0.5 cm received in 10% buffered. formalin. 5A - submitted in toto. The specimen container labelled with the patient's name and as. lung: left upper lobe bronchial resection margin-QS"" consists of a left. per lobe of lung measuring 10.8 x 9.5 x 9.0 cm received fresh. This is. examined at intraoperative consultation by frozen section performed on. copath # : Resulted: part of the specimen. On sectioning there is an anthracotic yellow to. grey tan peripheral tumour noted measuring 4.0 cm in maximum dimension. There is also an area of fibrosis with pleural fibrosis noted also. measuring 1.3 X 0.4 cm. The remainder of the specimen appears to be. emphysematous and no other gross lesions are noted. Multiple lobar nodes. were identified measuring from 0.5 up to 1.2 cm. Sections are submitted as follows: 6A - frozen section, resection margin taken en face (resubmitted). 6B - two lobar nodes. 6C - one lobar node. to 6F - representative sections of tumour in relation to normal lung. arenchyma. 6G and 6H - representative sections of tumour in relation to pleura. 6I - one representative section of the area of fibrosis. 6J and 6K - representative sections from apparently emphysematous lung. 6L and 6M - representative sections from apparently normal lung parenchyma. Two pieces of tumour tissue and a piece of. tissue are taken for. tissue frozen. QUICK SECTION. Frozen section diagnosis by. on frozen section blocks. 1A to 4A - ""Negative for malignancy"". Frozen section diagnosis by. on frozen section block. 6A: ""Negative for malignancy"". Page: 3 of 3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Material: 1) Material: stomach, Method of collection: Lesion resection. Histopathological diagnosis: (including test No. G-3155/12): Adenocarcinoma tubulÃ¤re ventriculi. G3, pT3, pNO. Tubular adenocarcinoma of the. stomach. Typus intestinalis sec Lauren. Intestinal type Lauren. Macroscopic description: Adenocarcinoma tubulÃ¤re G3. Cancerous proliferation reaches the periteneal surface of the stomach. Surgical incision lines free of. neoplastic lesions. Mucosa outside the tumour showing features of chronic inflammation with focal intestinal metaplasia. Adjacent part of the omentum free of cancerous lesions. 3 - (lesser curvature): Lymphonodulitis reactivaNo VIII. 4 - (greater curvature) :Lymphonodulitis reactiva No VII. 5 - (peripyloric): Lymphonodulitis reactivaNo IV. Microscopic description: The specimen containing the stomach, after being incised along the greater curvature sized 18.5 X 16cm with the. omentum sized 30 X 16cm. Cauliflower-shaped tumour on the greater curvature sized 5.5 X 4.5 X 2.4 cm. Distance from. the proximal end: 8.0cm, from distal end: 5.0cm.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
(A) LEFT KIDNEY: CHROMOPHOBE RENAL CELL CARCINOMA, FUHRMAN'S NUCLEAR GRADE 3. (SEE COMMENT). TUMOR CONFINED TO KIDNEY. TUMOR MEASURES 3.9 CM IN MAXIMUM DIMENSION. Vascular, ureteral and soft tissue margins of resection, free of tumor. COMMENT. The tumor is friable and distorted clusters of tumor cells are present in artifactual clefts and spaces between the renal parenchyma. and renal sinus adipose tissue. These areas are interpreted as representing artifactual displacement of tumor cells rather than true. extension into the adipose tissue. Multiple additional deeper sections were examined. GROSS DESCRIPTION. (A) LEFT KIDNEY - A nephrectomy specimen (12.0 X 6.5 X 5.0 cm) including the left kidney (10.5 X 5.5 X 4.0 cm), a segment of. the renal artery and the renal vein (1.5 cm in length and 0.5 cm in average diameter) and ureter (13.0 cm in length and 0.2 cm in. average diameter). There is a 3.9 X 3.4 X 1.5 cm well-circumscribed tumor in the upper pole of the kidney. The tumor is yellow-brown, abutting the. renal sinus and appears to be confined to the kidney. The adjacent kidney parenchyma is unremarkable. The pelvicalyceal. system is smooth and devoid of any lesions. No lymph nodes are identified in the hilum of the kidney. Portions of the tumor have been submitted for possible EM. Tumor is also submitted to the tumor bank. SECTION CODE: A1, renal artery and vein margin; A2, ureter margin; A3, tumor with adjacent uninvolved kidney; A4-A7,. tumor with adjacent renal sinus and uninvolved kidney; A8, A9, tumor with adjacent uninvolved kidney; A10, tumor with adjacent. uninvolved kidney and perinephric fat; A11, uninvolved kidney, representative section. CLINICAL HISTORY. Left renal mass. SNOMED CODES. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Large left renal mass please correlate with FNA of cervical lymph node. Specimens Submitted: 1: SP: Left kidney, radical nephrectomy. 2: SP: Hilar lymph nodes, excision. 3: SP: Inferior mesentery artery lymph nodes, excision. 4: SP: Para aortic lymph nodes #1, excision. 5: SP: Para aortic lymph nodes #2, excision. 6: SP: Left hilar lymph nodes, excision. 7: SP: Left adrenal gland, adrenalectomy. 8: SP: Mesentary lymph nodes, excision. DIAGNOSIS: 1. SP: Left kidney, radical nephrectomy: Tumor Type: Renal cell carcinoma - Unclassified type. favor collecting duct type (see note). Tumor Size: Two masses identified (15 and 3 cm, respectively). Local Invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Extends into renal pelvis. Involves renal sinus fat. Involves renal hilar fat. Renal Vein Invasion: Not identified. Extensive small vessel and lymphtic invasion identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: see parts 6 and 7. Lymph Nodes: Number of metastatic nodes:1. Number of nodes examined:1. Staging for renal cell carcinoma/oncocytoma: pT3a Tumor invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia. NOTE: IMMUNOHISTOCHEMICAL STAINS WERE PERFORMED BUT ARE NON-CONTRIBUTORY. BASED ON THE. MORPHOLOGIC FEATURES, WE FAVOR THIS TUMOR TO BE OF COLLECTING DUCT ORIGIN (COLLECTING DUCT. CARCINOMA). CASE REVIEWED AT THE GENITOURINARY CONSENSUS CONFERENCE. 2. SP: Hilar lymph nodes, excision: Lymph Nodes: Metastatic carcinoma involving adipose tissue, measuring 5.8 cm. No lymphoid tissue identified. 3. SP: Inferior mesentery artery lymph nodes, excision: Lymph Nodes: Number of nodes examined:2. Number of metastatic nodes:2. The largest metastatic node is 1.5cm. Perinodal (extracapsular) extension not identified. 4. SP: Para aortic lymph nodes #1, excision: Lymph Nodes: Number of nodes examined:1. Number of metastatic nodes:1. The largest metastatic node is 4.5cm. Perinodal (extracapsular) extension not identified. 5. SP: Para aortic lymph nodes #2, excision: Lymph Nodes: Number of nodes examined:11. Number of metastatic nodes:11. The largest metastatic node is 6.0cm. Perinodal (extracapsular) extension not identified. 6. SP: Left hilar lymph nodes, excision: Lymph Nodes: Number of nodes examined:14. Number of metastatic nodes: 14. The largest metastatic node is 6.2cm. Perinodal (extracapsular) extension not identified. Portion of adrenal gland involved by metastatic carcinoma. 7. Left adrenal gland, adrenalectomy: -Metastatic carcinoma involving adrenal gland. 8. SP: Mesentary lymph nodes, excision: Lymph Nodes: Number of nodes examined:2. Number of metastatic nodes:2. The largest metastatic node is 2.0cm. Perinodal (extracapsular) extension not identified. NOTE: THIS TUMOR IS COMPATIBLE AS THE PRIMARY SITE OF ORIGIN FOR MATERIAL RECEIVED FROM THE PRIOR. CYTOLOGY SPECIMEN FROM THE LEFT NECK LYMPH NODE. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CK7. CK20. 34BE12. CD10. CA-1X. TTF-1. CD117. MUCIN. IMM RECUT. NEG CONT. RACEMASE. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. Gross Description: 1) The specimen is received fresh labeled ""left kidney"" and consists of a kidney with attached ureter, renal vessels and perinephric. fat weighing 1478 g in total. The kidney measures 19.5 x 14.0 x 9.0 cm. The attached ureter measures 12cm in length and 0.5. cm in diameter. The attached renal vein measures 2 cm in length and 1.2 cm in diameter. The renal vessels and ureter margins. are grossly unremarkable. An adrenal gland is not identified. The kidney is inked black and bivalved to reveal 2 tumors. The. first measures 15 x 13 x 12 cm. The second measures 3.0 X 2.2 X 1.9 cm and is located in the opposite pole. Both have. yellow-white cystic and focally hemorrhagic cut surfaces. Sections through the remainder of the kidney reveal a pink brown. parenchyma, with a well-defined cortico-medullary junction. The cortex measures 0.6 cm and the calyces appear normal. A 0.5. cm polyp is noted in the renal pelvis. One possible lymph node is identified in the perinephric fat. The specimen is photographed. Representative sections are submitted for TPS and for permanent sections. Summary of sections: UVM -- ureteral and vessel margins. T-- tumor. THF -- tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidney. RP -- renal pelvis representative sections (including polyp). T2--smaller tumor. K -- representative sections kidney. LN- possible lymph nodes. 2). The specimen is received fresh, labeled ""Hilar lymph node"" and consists of an enlarged firm lymph node with scant attached. adipose tissue measuring 5.8 x 3.5 x 3.2 cm. on cut section the specimen, it shows soft, necrotic, white-tan tumor. Representatives sections are submitted. Summary of sections: LN- lymph node. 3). The specimen is received fresh labeled ""Inferior mesenteric artery lymph node."" It consists of two firm brown-tan lymph. nodes measuring 1.0 X 0.8 x 0.4 cm and 1.5 x 1.2 x 0.8 cm. Larger lymph node is inked black and bisected. Lymph. nodes are entirely submitted. Summary of sections: LN-lymph nodes. 4). The specimen is received fresh, labeled ""Para-aortic lymph node number one"" and consists of a single firm brown-tan lymph. node measuring 4.0 x 2.7 x 1.7 cm. Representative sections are submitted. Summary of sections: LN- lymph node. 5). The specimen is received in formalin labeled ""Paraaortic lymph nodes #2"" and consists of multiple pink tan firm lymph nodes. with attached fatty fibrous tissue ranging from 0.4 cm up to 6.0 cm in greatest dimension. Lymph node have a white firm. papillary cut surface, the remaining lymph nodes are entirely submitted. TPS of the largest positive lymph node is submitted. All. identified lymph nodes are submitted. Summary of sections: LN1 - grossly positive lymph node. LN2 - grossly positive lymph node. LN3 - grossly positive lymph node. LN4 - grossly positive lymph node. LN5 - grossly positive lymph node. LN6 - grossly positive lymph node. LN7 - grossly positive lymph node. LN8 - grossly positive lymph node. BLN-bisected lymph nodes. LN-- lymph nodes. 6). The specimen is received in formalin labeled ""Left hilar lymph nodes"" and consists of multiple pink tan firm lymph nodes with. attached fatty fibrous tissue ranging from 0.3 cm up to 6.2 cm in greatest dimension. Lymph node have a white firm papillary cut. surface, the remaining lymph nodes are entirely submitted. TPS of the largest positive lymph node is submitted. All identified. lymph nodes are submitted. Summary of sections: LN1 - grossly positive lymph node. LN2 - grossly positive lymph node. LN3 - grossly positive lymph node. LN4 - grossly positive lymph node. LN5 - grossly positive lymph node. LN6 - grossly positive lymph node. LN7 - grossly positive lymph node. LN8 - grossly positive lymph node. LN9 - grossly positive lymph node. LN10 - grossly positive lymph node. LN11 - grossly positive lymph node. BLN-bisected lymph nodes. LN--lymph nodes. 7). The specimen is received in formalin, labeled ""Left adrenal gland "" and consists of a 8 X 5x 3 cm portion of tan fibrofatty tissue,. which weighs 47grams. The specimen is inked black. On cut section a 3.7 x 3 x 2.5cm orange adrenal bland is identified There is. a markedly, indurated, fleshy, hemorrhagic area, measuring 1.4 x 0.6 x 1cm located on the peripheral of the gland The remaining. parenchyma reveal firm, orange glandular cut surface. No lymph nodes are identified on the peri-adrenal fat. Representatively. submitted. Summary of sections: RS - representative sections. 8). The specimen is received in formalin, labeled ""Mesenteric lymph node"" and consists of a single white tan firm positive lymph. node measuring 2 x 1.2 x 0.8 cm. The lymph node is bisected and entirely submitted. Summary of sections: BLN- bisected a lymph node. Summary of Sections: Part 1: SP: Left kidney, radical nephrectomy. Block. Sect. Site. PCs. 1. k. 1. 1. In. 1. 1. rp. 1. 10. t. 10. 3. t2. 3. 1. thf. 1. 1. tk. 1. 1. tsf. 1. 1. um. 1. 1. vm. 1. Part 2: SP: Hilar lymph nodes, excision. Block. Sect. Site. PCs. 1. LN. 1. Part 3: SP: Inferior mesentery artery lymph nodes, excision. Block. Sect. Site. PCs. 1. LN. 1. Part 4: SP: Para aortic lymph nodes #1, excision. Block. Sect. Site. PCs. 1. In. 1. Part 5: SP: Para aortic lymph nodes #2, excision. Block. Sect. Site. PCs. 3. bIn. 3. 1. In. 1. 1. In1. 1. 1. In2. 1. 1. In3. 1. 1. In4. 1. 1. In5. 1. 1. In6. 1. 1. In7. 1. 1. In8. 1. Part 6: SP: Left hilar lymph nodes, excision. Block. Sect. Site. PCs. 3. bIn. 3. 2. In. 2. 1. In1. 1. 1. In10. 1. 1. In11. 1. 1. In2. 1. 1. In3. 1. 1. In4. 1. 1. In5. 1. 1. In6. 1. 1. In7. 1. 1. In8. 1. 1. In9. 1. Part 7: SP: Left adrenal gland, adrenalectomy. Block. Sect. Site. PCs. 5. RS. 5. Part 8: SP: Mesentary lymph nodes, excision. Block. Sect. Site. PCs. 2. BLN. 3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure. Diagnosis. Distal pancreas and spleen, excision -. Poorly differentiated pancreatic adenocarcinoma, extending into. peripancreatic soft tissues (see microscopic description) . Carcinoma extends at least near to outer resection margin, but not. definitively identified at outer margin. Proximal margin negative for. high-grade dysplasia and carcinoma (see microscopic description). Spleen without specific diagnostic abnormalities. Metastatic adenocarcinoma in one of twelve (1/12) lymph nodes. Microscopic Description: The following template summarizes the findings in this case: Histologic type: Adenocarcinoma. The specimen also has dilated ducts. lined by mucinous epithelium, including in the grossly separate cyst. submitted in blocks A3 & A4, compatible with (branch duct-type). intraductal papillary mucinous neoplasm (IPMN) See note below. Histologic grade: Poorly differentiated. Primary tumor: pT3. Carcinoma extends into peripancreatic soft. tissues. Margins of resection: Carcinoma extends at least near to the inked. outer margin, but is not definitively identified at this margin. There. is IPMN at the proximal margin, but it appears low grade at the margin,. without high grade dysplasia or carcinoma identified at the proximal. margin. Regional lymph nodes: pN1. There is metastatic adenocarcinoma in one. of twelve (1/12) lymph nodes, with the positive lymph node in block. #14. Distant metastasis: Not applicable. Vascular invasion: Not definitively identified. Other findings: There is perineural invasion by carcinoma, including. in. areas that grossly appeared normal (block #5) The spleen is without. specific diagnostic abnormalities. Note: It is uncertain if the poorly differentiated adenocarcinoma has. arisen from the IPMN, or if the IPMN is an incidental finding in the. background. This case has been reviewed in Intradepartmental. Consultation, with essential concurrence with the interpretation, with. most reviewers favoring the IPMN is incidental. Specimen. Distal pancreas, spleen. Clinical Information. PRE-OP DIAGNOSIS: Pancreatic cancer. Gross Description. Received fresh in a container labeled ""distal pancreas, spleen"" is a. 9. x 5.5 x 3.5 cm portion of distal pancreas, which attached 110 g, 10 x. 7.8 x 3.5 cm, spleen. The surface of the spleen is gray-tan and. wrinkled, and on cut surface it is dark red, smooth, and glistening,. with diffuse white stippling, without gross abnormality. There are. a. few areas on the hilar surface of the spleen, approximately 2 cm in. greatest dimension, where the capsule is absent. The pancreas has a. stapled margin proximally. The staples are removed and this surface. is. inked black. The remainder of the surface of the pancreas is inked. blue. A firm mass can be palpated from the outer aspect of the. specimen. The specimen is sectioned, and there is a white-tan ill. circumscribed mass 4.5 x 3.7 x 2.7 cm. The mass is 3 cm from the. proximal resection margin, and 3.5 cm from the spleen. The pancreatic. duct can be traced on cut surface to the tumor, but cannot be probed. The pancreatic duct appears to be markedly stenotic and possibly. obliterated through the area of the tumor. The pancreatic duct lining. is inked green for identification purposes. There is some residual. normal appearing tan pancreatic tissue grossly identified outside of. the mass. There is an apparent cystic structure near, but not clearly. at, the proximal margin of the specimen, 0.7 cm in greatest dimension. This cyst is 0.2 cm from the pancreatic duct. There are a few tan. lymph nodes identified in the surrounding adipose tissue. RS-15,. following fixation. BLOCK SUMMARY: 1 - vascular margin; 2 - spleen; 3,4 - entire pancreatic. cyst, with block 3 including adjacent pancreatic duct margin; 5 -. grossly normal pancreatic tissue; 6-11 - tumor, including relation to. the pancreatic duct and outer margin; 12-14 - lymph nodes; 15 -. additional tissue from proximal pancreatic margin.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
surgical Pathology. TISSUE DESCRIPTION: A1 B1 B2 C1 D1 E1. Tissue from left lower lobe lung (12.57 grams; 5 x 1.7 x 1.5 cm) ,. superior (right lower paratracheal) and inferior (subcarinal). mediastinal Tymph nodes. DIAGNOSIS: Lung, left lower lobe, wedge excision: Invasive grade 3 (of 4). adenocarcinoma forming a peripheral 2.1 x 2 x 1 cm mass. The. visceral pleura is not involved. The surgical margin of resection. is negative for tumor. Lymph nodes, superior (right lower paratracheal) and inferior. (subcarinal) mediastinal, excision: Multiple superior (8 right. lower paratracheal) and inferior (4 subcarinal) mediastinal Tymph. nodes are negative for tumor.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 6.2000000000000002. Histology. Squamous carcinoma. rade/Differentiation. II. Pathological T. T2,NOS. Pathological N. N1. Clinical M. M0. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. - Anatomic Site: Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 1 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Resectate of the colon (sigmoid colon) with tumor-free oral and aboral resection margins. and under inclusion of an ulcerated, moderately differentiated adenocarcinoma with. infiltration of the perimuscular fatty tissue and without regional lymph node metastases. (G2, pT3 L0 V0 R0 pNO 0/55). NÂ°. criteria. Primary Hip Print A Malis Tumor site Primiary.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
A-ZF-A9RN-01A-PR -. SPECIMEN. 1 Bladder, uterus, ovaries and cervix. 2 Left ureteric resection margin. 3 Right ureteric resection margin. CLINICAL DETAILS. Cystectomy for bladder cancer. MACROSCOPY. 1 - Radical cystectomy specimen with attached uterus, ovaries and anterior. vaginal wall. The bladder is approximately 90 mm diameter and has associated adipose tissue. around it. On the attached peritoneal surface there is an irregular. haemorrhagic mass approximately 15 mm diameter, suggesting extension of tumour. Opening the bladder reveals a fungating mass arising from the posterior wall and. with extensive surface necrosis. The tumour is approximately 70 mm diameter and. is attached by a broad base. In addition, the background mucosa has a 20 mm. separate mass and also two further 4 mm flattish nodules. Section through the. mass shows extension through the bladder wall to come close to the peritoneal. surface. Overall tumour thickness is approximately 40 mm. Away from the main. and smaller tumour nodules the bladder mucosa appears normal, though there is. marked trabeculation of the bladder. The urethra measures 25 mm and has normal. surface mucosa, but there is 5 mm nodule between the midpoint of the urethra and. the anterior vaginal wall. The uterus measures 60 mm supero-inferiorly, and there is no apparent. abnormality of cervix, endometrium or myometrium. The left ovary measures 20. mm, the right 18 mm, and both show senile atrophy with no further abnormality of. them or of the fallopian tubes. 2 - This is 5 mm of ureter. 3 - This is 9 mm of ureter. Block designation: Specimen 1. A = tumour peritoneum. J = background mucosa anterior. B = haemorrhagic area on peritoneum K = background mucosa. C = tumour and adjacent normal. L = urethra midpoint. D-E = composite full depth of tumour. M = urethra margin. F = tumour & background mucosa. N = cervix. G = tumour left lateral with invasion of fat O = endometrium. H = 20 mm separate nodule tumour. P = left ovary and tube. I = 5 mm nodules of tumour. Q = right ovary and tube. MICROSCOPY. 1 - The tumour is composed of extensive sheets of undifferentiated carcinoma. cells with small areas of necrosis. In addition, some areas show squamous. differentiation with keratinisation. These features would be consistent with. transitional cell carcinoma, grade 3, with squamous differentiation. Similar. tumour is seen in the main mass and in the separate nodules. The tumour invades right through the bladder wall to reach adipose tissue, and. there is also extravesical lymphovascular invasion. The haemorrhagic tissue on. the peritoneal surface is further tumour. In general the tumour seems 2 or 3 mm. clear of the peritoneal surface, but this peritoneal deposit of tumour suggests. there may be a focus with invasion, or local lymphatic spread to the surface. In addition, there is a nodule of tumour in the septum between midpoint urethra. and anterior vaginal wall. Two tiny lymph nodes in perivesical adipose tissue show reactive changes without. tumour. The usual regional lymph nodes have not been supplied. Away from the tumour, the bladder epithelium is either normal, or shows a minor. degree of glandular differentiation. The urethra mucosa and resection margin is. normal. The uterus shows no histological abnormality apart from atrophy, and the same. applies to the ovaries. 2 & 3 - These samples show normal ureters. SUMMARY. Radical cystectomy with hysterectomy; transitional cell carcinoma of bladder,. WHO 1973 Grade 3, pT3b, pNx with positive peritoneal surface. Pathologists -.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
DATE OBTAINED: DATE RECEIVED: DIAGNOSIS. #1- RESECTION, LIVER (SEGMENT 3): HEPATOCELLULAR CARCINOMA-. Tumor type: Hepatocellular carcinoma. Histologic grade: Moderately differentiated; nuclear grade (II). Tumor size: 8.5cm. Tumor multifocality: Unifocal. Vascular invasion: Microvascular invasion (focal). Hepatic capsule: Negative (1.8 cm); subcapsular hemorrhage. Local extension: Confined to the liver. Margins: Hepatic parenchymal transsection margin-negative (tumor-1.5 cm from staple line. margin). Lymph nodes: Not present. Other findings: Micronodular cirrhosis. pT2 NX. AJCC stage: Stage II. COMMENT. 88309, 88331x2. Clinical Diagnosis and History: Liver tumor. Tissue(s) Submitted: SEGMENT 3 LIVER LESION. Gross Description: The specimen is received fresh for intraoperative consultation labeled with patient name designated segment 3 liver lesion and. consists of a 292 gram, 11.5 x 8.0 X 6.5 cm intact segment of liver with a single stapled margin. The capsular surface is red brown,. intact and shaggy. The resection margin is inked and the specimen is serially sectioned to reveal an 8.5 x 7,0 x 5.5 cm soft tan. brown well defined mass measuring 1.5 cm from the stapled margin with surrounding dark red subcapsular hemorrhage. The. uninvolved liver parenchyma is tan brown and granular. No other discrete lesions are identified. Representative sections are. submitted as follows: 1AFS: soft tissue frozen section remnant. 1BFS: mass frozen section remnant. 1C-1E: mass to margin. 1F-1H: mass to subcapsular hemorrhage. 11-1J: mass. Intraoperative Consult Diagnosis. 1A/FSDX: GROSS RESECTION MARGIN NEGATIVE (1.8 CM TUMOR TO MARGIN): HEPATOCELLULAR CARCINOMA.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
AP Surgical Pathology: Additional Infc. Acca. Image Cytometry. TISSUB TYPE: LEFT LOWER LOBE BASILAR SEGMENTECTOMY CONTAINING WELL-DIFFERENTIATED. ADENOCARCINOMA WITH CLARA CELL FEATORES. EPIDERMAL GROWTH FACTOR: EPIDERMAL GROWTH FACTOR RECEPTOR (EGFr) IMMUNOHISTOCHEMISTRY BY. Approximately 100% of the cumor cells exhibie markedly intense, mostly. complete staining of their call membrane (score 3+), indicating that they. strongly express spidermal growch factor receptor. Benign basal bronchiolar. epithelial, cells scain positively and serve as an incernal control. HER2/neu Immunchistochemistry: HER2/NEU IMMUNOHISTOCHEMICAL ANALYSIS BY DAKO HERCEPTEST. Noze of the invasive tumor cells exhibit any staining of their cell membrane. (score 0). indicating that they do not overexpress HER2/neu oncoprocein. INTERPRETATIONS. TISSUE TYPE: LEFT LOWER LOBK BASILAR SEGMENTECTOMY CONTAINING. WELL-DIFFERENTIATED ADENOCARCINOMA WITK CLARA CELL FEATURES. IMMUNOHISTOCHEMISTRY STRONGLY POSITIVE (3+) FOR EXPRESSION. OF EPIDERMAL GROWTH FACTOR RECEPTOR. HER2/NEU IMMUNOHISTOCHEMISTRY: NEGATIVE (0) FOR OVEREXPRESSION OF HER2/NEU. ONCOPROTEIN. EGFR FISK RESULTS WILL BE ISSUED IN AN ADDENDUM TO THIS REPORT. I certify that I personally conducted the diagnostic evaluation of the above. specimen(a) and have randered the above diagnosis(es). CI ADDENDUM 2: EGFR FISK. Fluorescence in situ hybridization (FISH) with probes for the EGFR region of. chromosome 7 (7p11.1-q11.2) and the centromere of chromosome 7 (D7Z1) was. pexformed on. block DS. The EGFR and centromere 7 signals were. enumerated in 60 nuclei from an area of the tumor located by comparison wich. the hematoxylin and eosin and/or immunostained adjacent sections. Interphase, FISH 13 nuc ish 7cen (D17Z1x2-10) (60). The EGFR to. centromers 7 ratio was 1.11 +%- 0.35 (mean +/- 1 S.D.) in a total of 60 tumor. calla selected for analysis. An EGFR to D7Z1 ratio greater than 2.00 usually. indicates EGFr gene amplification. The percentage of calls with a ratio of. 2.00 or greater was 74. 1 of 6. The average copy number of EGFR was 5.4. The parcentage of cells with an EGFR copy number of greater than 2.0 was 95%. The average copy number of centromers 7 was 9.2. Tha percentage of cells with a centromere 7 copy number of greater than 2.0. was 35%. An increased number of chromosome 7 centromeres indicates aneusomy of. chromosome 7 or generalized aneuploidy. INTERPRETATION. TISSUE TYPE: LEFT LOWER LOBE BASILAR SEGMENTECTONY CONTAINING. WELL-DIFFERENTIATED ADENOCARCINOMA WITH CLARA CELL FEATURES. BLOCK DS). EGPR FISA INTERPRETATION: AVERAGE EGFR COPY NUMBER IN so TUMOR CELLS WAS 3.4. 95% OF THE TUMOR CELLS HAVE AN INCREASED COPY NUMBER OF THE ZGFR GENE. AVERAGE CHROMOSONE 7 COPY NUMBER IN 60 TUMOR CELLS WAS 5.2. 95% OF THE TUMOR CELLS HAVE AN INCREASED COPY NUMBER OF CHROMOSOME 7. RATIO OF 7 IN 60 TUMOR CELLS WAS 1.11+/-0.35. 74 OF THE TUMOR CELLS HAVE AN INCREASED EGFR/CHROMOSOME 7 RATIO. METHODOLOGY. EGFR PIEN: The epidezmal growch factor recepror DNA probe from. was. used to obtain thase results. The DNA probe is designed to decect. amplification of the EGFR gene via fluorescence in situ hyhridization (FISH). in formalin-fixed paraffin-embedded human cancer tissue specimens. I certify: that I personally conducted the diagnostic avaluation of the above. specimen(s) and have rendered the above diagnosis (es). CLINICAL HISTORY: Lung. cancer, left lower lobe lesion. GROSS EXAMINATION: 2 of 6. A. ""4R lymph node (AF1). Received fresh for frozen section is a 0.5 x 0.3 x. 0.2 cm aggregate of pink-black tissue frozen entirely as representative AF1. and the frozen section remnant submitted in block A1. B. ""4L lymph node (BF1)' "". Received fresh for frozen section is a 0.6 x 0.2 x. 0.1 em aggregate of pink-black tissua frozen entirely as representative BP1. and the frozen section remnant submitced in block 31. c. ""Level 7 lymph node (CF1)"" Recaived frash for frozen saction is a 1 x 0.8. x 0.2 cn aggregace of gink-black tissue frozen entirely as representative CF1. and the frozen section remnant submicted in block C1. D. ""Left lower lobe basilar segmentectomy (DF1) Received fresh for frozen. section is a 133 gram (20.1 x 11.2 x 3.2 cm) lobe of lung that has a 2.6 x 2 x. 1.2 cm firm gray-tan parenchymal circumscribed mass that is 1.9 em from the. overlying pleura and 0.8 cm from the bronchial and vascular margins which are. grossly free of mase. The mass is located approximately in the mid portion of. the lobe and a portion of the mass was frozen aa representative DF1. The. remainder of the parenchyma is spongy red-tan and without additional lesions. The pleura is pink-tan smooth and glistening and intact. Two lobar lymph nodes. are identified ranging from 0.3 up to 0.7 cm in greates: dimension. BLOCK SUMMARY: D1- frozen section remnant from DF1. D2- bronchial and vascular margins en face. D3-6- representative of mass with D3-4 with overlying pleura. D7- uninvolved parenchyma away from the mass. D8- one lobar lymph node. Dg- largest lobar lymph node. E. ""Level 10 lymph noder. Received unfixed and placad in formalin is a 0.6 x. 0.3 x 0.4 cm pink-tan lymph node, bisected and submicted entirely in block. E1. INTRA OPERATIVE CONSULTATION: A. ""4R lymph negative for malignancy. 3. ""4L lymph node"" BF1- negative for malignancy. C. ""Level 7. 'lymph node"":CFl- negative for malignancy. D. ""Left lower lobe basilar segmentectomy: DF1 (representative mass) -. carcinoma consistent with. bronchial alvenlar carcinoma. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: PATHOLOGIC STAGE (AJCC 6th Edition) pT1 pNo pMx. NOTE: Information on pathology stage and the operative procedure ia. transmitted to this Institution's Cancer Registry as required for. accreditation by che Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any apecimens aubmitted separately to our Cycology section,. past pathology information, imaging studies, or clinical or operative. findings. Fathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substicuted for. The exact ogerative procedure is available in the surgaon's operative report. DIAGNOSIS: A. ""4R LYMPH NODE (AF1) "" - NO PATHOLOGIC DIAGNOSIS (NO TUMOR SEEN, 0/1). 3 of 5. B. ""4L LYMPH NODE (3F1) "" - NO PATHOLOGIC DIAGNOSIS (NO TUMOR SEEN, 0/1). C. ""LEVEL 7 LYMPH NODE (CF1) - NO PATHOLOGIC DIAGNOSIS (NO TUMOR SEEN, 0/2). D. ""LEFT LOWER LOBE BASILAR SZGMENTECTOMY (DF1)'. CARCINOMA OF LUNG: Histologic type: ADENOCARCINOMA WITE CLARA CELL FEATURES. Histologic grade: NEL-DIFFERENTIATED. Extent of invasion. - Max. tumor diamerer: 2.6 CM. Mainstem bronchus: NEGATIVE. - Visceral pleura: NEGATIVE. - Chest wall: - Mediastinum: N/A. - >1 tumor nodules?. NEGATIVE. - Panlobar atelectasis?. NEGATIVE. Margins. - Bronchial: NEGATIVE. - Vascular: NEGATIVE. - Parenchymal: NEGATIVE. - Pleural: NEGATIVE. Other prognostic features. - Vascular invasione. NEGATIVE. Regional lymph nodes: NEGATIVE (0/2). Addicional findings: CENTRILOBULAR EMPHYSEMA, MILD. ION-NECROTIZING GRANULOMA, SMALL, FOCAL. E. ""LEVEL 10 LYMPH NODE (EXCISION) - NO PATHCLOGIC DIAGNOSIS (NO TUMOR SEEN,. I certify that I personally conducted the diagnostic evaluation of the above. specimen( (s) and have rendered the above diagnosis(es). CI ADDENDUM 1: Please sea. for results of supplementary. testa. I certify that I personally conducted the diagnostic evaluation of the above. specimen(s) and have rendered the above diagnosis(es).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Date or Proceuure: leck. Neck. Clinical Diagnosis & History: year old. with Non-Hodgkins lymphoma status post R chop with bilateral thyroid nodules and papillary thyroid cancer. Specimens Submitted: 1: Total thyroidectomy. DIAGNOSIS: 1. Total thyroidectomy: Tumor Type: Papillary carcinoma, tall cell variant. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 1.8 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:perithyroid fibroadipose tissue. Surgical Margins: Free of tumor. Tumor Multicentricity: Numerous foci of papillary microcarcinoma are present in the right lobe (0.1 to 0.8cm) and left lobe (0.1 to. 0.8cm). Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""total thyroidectomy"" and consists of a thyroid weighing 21 g. The right lobe measures. 5.5 x 2.5 x 1 cm, the left lobe measures 5 x 3x1 cm and the isthmus measures 1.5 x 1 x 1 cm. The external surface is covered by. a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveais an. ill-defined, tan, firm nodule in the left lobe measuring 1.8 x 1.2 x 1 cm and a well-circumscribed, tan nodule in the right lobe. measuring 0.8 x 0.7 x 0.7 cm. The remaining thyrold parenchyma is red tan and beefy. Representative sections of the specimen. are submitted for. The remaining tissue is serially sectioned and entirely submitted. Summary of sections: NL- nodule left lobe. NR- nodule right lobe. RL right lobe. "". LL left lobe. IS isthmus. Summary of Sections: Part 1: Total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 6. LL. 6. 4. NL. 4. 1. NR. 1. 11. RL. 11.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Male. Surgery Date: DIAGNOSIS: Liver, right lobe, resection: Grade 2 (of 4) cholangiocarcinoma forming a 2.4 x 2.3. x 2.0 cm mass around the right extrahepatic common hepatic bile duct in the hilar. region. The tumor extends into the liver and periductal soft tissues including the. serosa of the gallbladder. The surgical margins are negative. Multiple (9). hepatoduodenal lymph nodes are benign. Soft tissue, distal bile duct margin, excision: Bile duct; negative for malignancy.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
specimen #: Race: WHITE. SPECIMEN: A: RIGHT BREAST B: RIGHT SENTINEL LYMPH NODE #1. C: LEFT BREAST D: LEFT SENTINEL LYMPH NODE. FINAL DIAGNOSIS: A&B. RIGHT BREAST, SIMPLE MASTECTOMY AND SENTINEL NODE BIOPSY. - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). - NOTTINGHAM SCORE: 8/9. (Tubules = 3, Nuclei = 3, Mitoses = 2). - TUMOR SIZE (GREATEST DIMENSION) : 2.5 CM, MEASURED GROSSLY. - TUMOR NECROSIS: ABSENT. - MICROCALCIFICATIONS: PRESENT, IN BENIGN LESION. - VENOUS / LYMPHATIC INVASION: PRESENT. - MARGINS : NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.3 CM, FROM. SUPERFICIAL / SKIN MARGIN; 5.0 CM FROM DEEP MARGIN. - INTRADUCTAL COMPONENT: ABSENT. - LYMPH NODE: 1 OF 1 POSITIVE FOR MICROSCOPIC FOCUS OF TUMOR. (0.47 MM) ; PRESENT WITHIN SUBCAPSULAR SINUS. - NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. - MULTICENTRICITY: ABSENT. - HORMONE RECEPTORS. - ESTROGEN RECEPTOR: POSITIVE (90%). - PROGESTERONE RECEPTOR: POSITIVE (10%). - HER2: NEGATIVE (BY IMMUNOSTAINS AND FISH) . - ADDITIONAL PATHOLOGIC CHANGES FIBROADENOMA, WITH CALCIFICATION. C&D. LEFT BREAST, SIMPLE MASTECTOMY AND SENTINEL NODE BIOPSY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). - NOTTINGHAM SCORE: 9/9. (Tubules =3, Nuclei = 3, Mitoses = 3). - TUMOR SIZE (GREATEST DIMENSION) : 5.0 CM, MEASURED GROSSLY. - TUMOR NECROSIS: ABSENT. - MICROCALCIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: ABSENT. Specimen #: FINAL DIAGNOSIS (continued) : - MARGINS: NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.3 CM FROM SUPERFICIAL /. SKIN MARGIN; 1.0 CM FROM THE DEEP MARGIN. - INTRADUCTAL COMPONENT: ABSENT. - LYMPH NODES: ONE LYMPH NODE, NEGATIVE BY ROUTINE AND IMMUNO STAINS. - NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. - MULTICENTRICITY ABSENT. - HORMONE RECEPTORS (PREPARED ON. - ESTROGEN RECEPTOR: POSITIVE (NEARLY 100%). - PROGESTERONE RECEPTOR: POSITIVE (40%). HER2 : POSITIVE (3+ ON IHC, POSITIVE BY FISH) . - ADDITIONAL PATHOLOGIC CHANGES: : FIBROADENOMA. COMMENT: The lesion from the right side would be stage pT2 N1mi MX;. the lesion from the left side would be stage pT2 NO (i-) MX. CLINICAL DIAGNOSIS AND HISTORY: Bilateral breast cancer. GROSS DESCRIPTION: A. Received fresh labeled with the patient's name. designated ""RIGHT BREAST"" consists of a 1134 gram mastectomy specimen. oriented with a short stitch superior and a long stitch lateral. The. specimen measures 27 cm medial to lateral, 21 cm superior to inferior and. 4.5 cm superficial to deep. The lightly pigmented superficial skin ellipse. measure $6.0 x 3.5 cm and displays a 1.0 cm centrally located, everted. nipple free of discharge. The deep margin is inked black and a portion of. superficial margin is inked blue. Serial sections reveal a 2.5 x 1.5 x 1.0. cm well circumscribed pink white mass located in the upper mid breast. The. mass comes to within 0.3 cm of the inked superficial margin and is located. 5 cm from the deep margin. Located in the lower outer quadrant is a 1.0 x. 0. x 0.7 cm well circumscribed markedly calcified nodule (consistent with. a calcified fibroadenoma) The remainder of the breast is predominantly. composed of lobulated yellow tan adipose tissue admixed with unremarkable. ibrous tissue. No additional lesions are identified. No lymph nodes are. Specimen # : GROSS DESCRIPTION (continued) : identified. Sections are submitted as follows : A1: skin. A2: mass. A3-A4: mass with superficial margin. A5: upper outer quadrant. A6: lower outer quadrant. A7: central. A8: lower inner quadrant. A9: upper inner quadrant. A10: nipple. All: upper outer quadrant. A12: lower outer quadrant with calcified nodule. A13: lower inner quadrant. A14 upper inner quadrant. Matched section of A1, A2 and A6-A9 are preserved in OCT for CBCP. protocol. B. Received fresh labeled with the patient's name. designated ""SENTINEL NODE #1 RIGHT SIDE"" consists or a 2.4 x 2.0 x 0.8 cm. irregular portion of soft tissue. Sectioning reveals 2.0 x 1.0 x 0.5 cm. pink tan lymph node. The lymph node is unevenly bisected. The specimen is. entirely submitted as follows: B1: lymph node. B2: adipose tissue. A matched section of B1 is submitted in OCT for CBCP protocol. C. Received fresh labeled with the patient's name. designated ""LEFT BREAST"" consists of a 1321 gram mastectomy specimen. oriented with a short stitch superior and long lateral. The specimen. measures 28.0 cm superior to inferior, 23 cm medial to lateral, and 4.0 cm. anterior to posterior. The lightly pigmented superficial skin ellipse. measures 7.0 x 4.0 cm and displays a 1.0 cm centrally located everted. nipple. Scattered irregular portions of red brown muscle are noted on deep. resection margin. The deep margin is inkd black and a portion of. superficial margin is inked blue. Serial sections reveal a well. circumscribed gritty pink tan mass involving the upper mid and upper inner. quadrant of the breast. The mass measures 5.0 x 4.2 x 2.7 cm and is. located 3.0 cm from deep margin and 0.2 cm from superficial surface. Located 1.0 cm from the mass, within the central portion of the breast, is. a. 1.0 cm tan white rubbery nodule consistent with a fibroadenoma. The. remainder of the breast is composed of lobulated yellow tan adipose tissue. Specimen #: GROSS DESCRIPTION (continued) : admixed with a small amount of tan white fibrous tissue. No additional. lesions are identified. No lymph nodes are identified. Sections are. submitted as follows. C1: skin. C2: mass. C3: mass with superficial margin. C4: mass. C5: upper inner quadrant. C6: lower inner quadrant. C7: central nodule. C8: lower outer quadrant. C9: upper outer quadrant. C10: nipple. C11: upper inner quadrant. C12: lower inner quadrant. C13: lower outer quadrant. C14: upper outer quadrant . Matched sections of C1-C2 and C4-C9 are submitted in OCT for CBCP. protocol. D. Received fresh labeled with the patient's name. designated ""LEFT SIDE SENTINEL NODE #1"" consists of a 2.5 x 2.0 x 0.5 cm. irregular portion of soft tissue. The specimen is bisected to reveal a 1.7. x 1.0 x 0.5 cm pink tan lymph node. The specimen is entirely submitted in. D1. A matched section of D1 is submitted in OCT for CBCP protocol.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: In bladder, it is invasive and protruded masse, ill - margins with 3.5x2.5x1cm in size,. soft and gray surface. Microscopic Description: Tumor is density. Tumor cells are hyperplastic to form papillary or trabeculae. Tumor cells have moderate and eosinophilic or clear cytoplasm. Nuclei are enlarged and varriability in. shape and size, irregular nuclear membranes, nucleoli and abnormal chromatin patterns. Mitoses are. present. Tumor invades in muscularis propria. Diagnosis Details: Infiltrating urothelial carcinoma, high-grade, infiltrating muscularis propria. Comments: Formatted Path Reports: BLADDER TISSUE CHECKLIST. Specimen type: Cystectomy. Tumor site: Bladder. Tumor size: 3.5 x2.5x1cm. Tumor features: None specified. Histologic type: Transitional cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Muscularis propria. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
A and C. Liver, left. lobectony : HEPATOCELLULAR CARCINOMA. Tumor number : one. Satellite nodule: no. Gross type: nodular with perinodular extension. Size(cm): : 4x3.5x3. Differentiation: The worst differentiation: Edmondson grade IV. Differentiation: The major differentiation: Edmondson grade 111. Histologic type : microtrabecular. Cell type : hepatic. Tumor necrosis : yes (10%). Hemorrhage : no. Fatty change : no. Fibrous capsule : partial. Infiltration of capsule : yes. Septum formation : yes. Surgical margin invasion : no(margin of the clearance : 0.3 cm). Serosa invasion: no. Portal vein invasion : no. Bile duct invasion : no. Hepatic vein invasion : no. Hepatic artery invasion : no. Microvesse invasion : yes. Intrahepati netastasis : no. Multicenteric occurrence : no. r stage : pll. N stage: No metastasis in all 1 Tymph node(pNO). Non-tumor liver. Chronic hepatitis : yes. Etilogy : HCV. Grade. Icbular : minimal. Grade. portoperiportal mild. Stage(fibrosis) : periportal. Cirrhosis : no. Dysplastic nodule : no. Ouctal epithelial dysplasia : no. Other liver disease : no. Fatty change, macrovesicular (10%). B. Garibladder, cholecystectomy : Chronic cholecystitis. <Result of special stain>. fron(Block #A9) : Negative. <Results of immunohistochemical stain>. Cytokeratir 7(Block #A9) : Positive in bile duct. Cytokeratin 7. Cytokeratin 19, Hepatocyte(Bloci #A8) : Negative. A. The specimen received in formalin is a product of lobectomy of liver. measuring. 12x8x4cm and weighing 175gn. The external surface shows a protruding. subcapsular mass, The parenchyma resection margin is clear. On section, there. are nodular with per inodular extension Type mass. measuring 4x3.5x3cm. The mass is 0.3cm apart from parenchymal resection margin. On serial section. the remaining parenchyina is unremarkable, Representative sections are embedded. in 9 cassettes. (A1104-one plane. A5to8-one plane. A9-background / iver). B. The specimen received in formalin consists of a gallbladder. ineasur ing 9cm In length and 1.5cm in diameter. The capsular surface is. unremarkable. The wall measures 0.2cm in maximal thickness. The mucosa is. greenish velvety. There is no stone or polyp. Representative sections are. embedded in one cassette. C. The specimen received in formalin is a Tump of adipose issue labeled. ""Tymph node"" Entirely embedded in one cassette. H&E(11), MT(1). RTC(1). D-PAS(1) fron(i). Cytokeratin 7(1). Cytokeratin 19(1). Hepatocyte(1).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 3.0 cm). Concluding tumor classification: NOS, G III, pT2LOVORO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
n. Date Coll: SPECIMEN. A. R4 lymph node. B. L4 lymph node. C. Level 10 lymph node. D. Level 5 lymph node. E. Subcarinal lymph node. F. Level 6 lymph node. G. Left lung. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung cancer. FROZEN SECTION DIAGNOSIS. FSA) R4 lymph node - Negative for malignancy. FSB) L4 lymph node - Negative for malignancy. GROSS DESCRIPTION. A. Part A is submitted fresh for frozen labeled ""R4 lymph. node"" consists of multiple fragments of tan-white and. yellow tissue admixed with anthracotic pigment. The aggregate. measurement is 4 X 2 X 0.5 cm. Submitted entirely for frozen. section. B. Part B is submitted fresh for frozen labeled ""L4 lymph. node"" consists of multiple fragments of gray-red and yellow. tissue with an aggregate dime. f 2 X 2 X 0.5 cm. Submitted. entirely for frozen section. C. Received fresh,. 'level 10 lymph node"", are two. slightly rubbery gray-black-red tissues, in keeping with. lymph nodes, measuring 0.35 cm. in greatest dimension and 0.7 X 0.5. X. 0.5 cm. The larger tissue is bisected and the specimens are. entirely submitted in two blocks, as labeled. AS-2. BLOCK SUMMARY: 1 - Smaller node in toto; 2 - bisected larger node. D. Received fresh, labeled ""level 5 lymph node"", are two. slightly rubbery gray-black-red tissues, in keeping with. lymph nodes, averaging 1.1 X 0.6 X 0.6 cm. The specimens are. bisected and entirely submitted independently in two blocks (one. bisected node per cassette) . AS-2. E. Received fresh, labeled ""subcarinal lymph node"", are. four slightly rubbery tan-gray-red tissues, in keeping with. lymph nodes, measuring up to 0.6 cm. in greatest dimension. The. specimens are submitted in toto in one block. AS-1. F. Received fresh, labeled ""level 6 lymph node"", are two. soft tan-red to gray-black tissues, in keeping with lymph. nodes, measuring 0.5 and 2.4 cm. in greatest dimension, with a scant. amount of associated adipose tissue. The larger node is bisected. and the specimens are entirely submitted in two blocks, as labeled. AS-2. RY: 1 - Smaller node in toto; 2 - bisected larger node. G. Left lung submitted fresh for tissue procurement. labelled ""left lung"" is an intact lung with two lobes. weighing 442 grams. There is a suture line present at the. amputation point of the main left bronchus, the left main pulmonary. artery and main left pulmonary vein. The pleural surface of the. lung is intact with a finely stippled anthracotic pigment present. No obvious areas of puckering of the pleura or umbilication are. evident. Several small possible peribronchial lymph nodes are. present adjacent to the bronchial stump. There is a mass that is. palpable in the interlobar fissure. This appears to be below the. surface of the lung. Sections are placed through the mass and this. reveals a large tumor mass which is immediately inferior to the main. bronchus. The tumor mass measures maximally 6 X 5 X 4 cm. It. arises approximately 1 cm below the bronchial cuff margin that. grossly does not appear to be involved by tumor. There does appear. to be at least one lymph node which is partially involved by tumor. adjacent the bronchus. Portions of the t. ormal lung are. submitted for procurement per request of. Further. sectioning of the lung reveals a second t present deep to. the pleural surface of the lower lobe. This pleural mass as central. necrosis and measures maximally 3 X 2 X 1.5 cm. It has the same. fleshy tan-white gritty cut surface as does the main tumor mass. The upper lobe does not appear to have any discrete nodules. It. is. crepitant gray-tan tissue without focal nodularity. Sections after. fixation. BLOCK SUMMARY: 1 - bronchial margin; 2 - vascular margin; 3 -. pleural margin of the main dominant tumor mass; 4-7 - dominant tumor. mass; 8-10 - secondary smaller tumor including pleural surface; 11. random left upper lobe; 12 - random left lower lobe; 13-14 -. bronchial lymph nodes. MICROSCOPIC DESCRIPTION. Microscopic sections of both lesions present in the left. lung have a similar histologic appearance. Both are. moderate to poorly differentiated adenocarcinomas with cells. exhibiting prominent eosinophilic cytoplasm. It is not clear from. the histology if this represents two separate primary tumors or an. intrapulmonary metastasis from the main lung tumor. Results of. the. evaluation of the lung are summarized in the following template: Histologic type: Adenocarcinoma. Histologic grade: Moderate to poorly differentiated. Primary tumor (pT) : Two lesions are present. The larger lesion. measures 6 X 5 X 4 cm., the smaller lesion 3 X 2 X 1.5 cm. (pT2). Margins of resection: Bronchial and vascular margins of resection. are free of tumor. Visceral pleural surface free of tumor. Direct extension of tumor: Absent. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : Two of six bronchial lymph nodes contain. metastatic adenocarcinoma (2/6) . All mediastinal lymph nodes are. negative (pN1) . Distant metastasis (pM) : Cannot be assessed (pMX). DIAGNOSIS. A. Lymph node, R4, resection: Negative for malignancy. B. Lymph node, L4, resection: Negative for malignancy. C. Lymph node, level 10, resection: Negative for malignancy. D. Lymph node, level 5, resection: Negative for malignancy. E. Lymph node, subcarinal, resection: Negative for malignancy. F. Lymph node, level 6, resection: Negative for malignancy. G. Lung, left pneumonectomy : Multicentric, moderate to poorly differentiated. adenocarcinoma. Bronchial, vascular and visceral pleural. surfaces are free of involvement by tumor. Two of six peribronchial lymph nodes contain metastatic. adenocarcinoma (2/6) .

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: BREAST, LEFT, SEGMENTAL MASTECTOMY AT 2 O'CLOCK -. A. INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE. B. NOTTINGHAM GRADE 2 (TUBULE FORMATION 3, NUCLEAR ATYPIA 2, MITOTIC ACTIVITY 1; TOTAL SCORE. 6/9). C. INVASIVE TUMOR MEASURES 1.6 CM IN LARGEST DIMENSION (GROSS MEASUREMENT). D. NO LYMPHOVASCULAR IDENTIFIED. E. INVASIVE TUMOR IS 1 MM TO THE CLOSEST ANTERIOR MARGIN. F. LOBULAR CARCINOMA IN-SITU AND ATYPICAL LOBULAR HYPERPLASIA. G. NON-NEOPLASTIC BREAST TISSUE SHOWING FIBROCYSTIC CHANGE, SCLEROSING ADENOSIS,. AND. MICROCALCIFICATIONS. H. BIOPSY SITE CHANGE. I. INVASIVE TUMOR POSITIVE FOR ER, PR AND EQUIVOCAL FOR HER-2/NEU. PART 2: AXILLARY SENTINEL LYMPH NODE #1, LEFT, BIOPSY -. FIVE LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/5). PART 3: AXILLARY SENTINEL LYMPH NODE #2, LEFT, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: AXILLARY NON-SENTINEL LYMPH NODE TISSUE, LEFT, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position:2. SIZE OF TUMOR: Maximum dimension invasive component: 16 mm. MULTICENTRICITY/MULTIFOCALTY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Infiltrating lobular carcinoma. Classical. HISTOLOGIC TYPE: NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 7. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. NON-NEOPLASTIC BREAST TISSUE: ALH, FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 180. PROGESTERONE RECEPTORS: positive, H-score: 75. HER2/NEU: 2+. Addendum. Part #1: HER-2/NEU IMMUNOHISTOCHEMISTRY [NEGATIVE:0,1+ EQUIVOCAL: 2+; POSITIVE: 3+]. SCORE. HER-2/NEU. Equivocal. 2+. NOTE: HER2 FISH is being performed and the results will be subsequently reported. HER2 IMMUNOHISTOCHEMISTRY TEST DETAILS: Using appropriate formalin fixed (8 - 96 hours). controls and tissue test. block, 4B5 antibody clone is used as part of FDA approved. and. interpreted as follows: Score 0 (negative) = No staining is observed or membrane staining is observed in less than 10% of the. tumor cells. Score 1+ (negative) = A faint/barely perceptible membrane staining is detected in more than 10% of the tumor cells. The cells are only stained in part of their membrane. Score 2+ (equivocal) = A weak to moderate complete membrane staining is. observed in more than 10% of the tumor cells. This score requires reflex testing by FISH. Score 3+ (positive) = A strong complete. membrane staining is observed in more than 30% of the tumor cells. SPECIAL PROCEDURES: FISH. Interpretation. nucish(D17Z1x2-5,ERBB2x2-8)[40]. No amplification of the HER-2/NEU gene was seen by interphase FISH analysis. Fluorescence in situ hybridization (FISH) analysis was performed on a formalin-fixed Block 1H (left segmental mastectomy @ 2:00). using the DNA probe for the HER-2/NEU gene. An adequate number of invasive tumor cells were. present and evaluated by two independent observers. The ratio of HER-2/NEU signals (ERBB2) to chromosome 17 centromere. signals (D17Z1) was determined to be 1.34. A ratio of greater than 2.2 is considered to be amplified; therefore, this specimen is. not amplified. Although amplification was not seen, many of the cells exhibited 3 or more signals for both the HER-2/NEU gene. and for the chromosome 17 centromere. This may be indicative of either polyploidy or aneuploidy for chromosome 17. The. average number of HER-2/NEU signals per cell was 3.26. The average number of signals for the chromosome 17 centromere was. 2.44. Concurrent positive and negative control specimens showed the expected results. This FISH test is performed using a modification of the. FDA approved. HER-2 DNA Probe Kit (1:2 LSI HER-2/neu. / CEP17 probe : T-denhyb-2 buffer). This FISH test was developed and its performance determined by the. Pursuant to the requirements of CLIA '88, this laboratory has established and verified the test's. accuracy and precision.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Male. Specimen No. HISTOPATHOLOGY. Lab No: CLINICAL NOTES: Subtotal gastrectomy and extended right hemicolectomy for. adenocarcinoma of distal gastric region. ?spread to transverse colon. Peritoneal nodule. MACROSCOPIC DESCRIPTION: 1. A stomach and extended right hemicolectomy connected by attached. gastrocolic omentum. The proximal gastric margin measures 60mm in. diameter and the distal margin measures 35mm in diameter. The lesser. curvature measures 120mm and the greater curvature measures 165mm. The. lesser omentum measures 35mm in width. The greater omentum measures. 170mm in width. The right hemicolectomy specimen consists of terminal ileum, 100mm in. length x 25mm in diameter, appendix 80x5mm and right colon 550mm in. length x 25mm in diameter. There is a fungating ulcerated tumour plaque in the lesser curve of the. stomach. 75x82mm, approximately 20mm from the proximal resection. margin and 40mm from the distal resection margin. Tumour is up to 18mm. thick and has penetrated the full thickness of the stomach wall to. infiltrate up to approximately 10mm into lesser omentum. There is no. macroscopic direct extension of tumour into the greater/gastrocolic. omentum, however, numerous nodules suspicious of tumour metastases are. evident within both greater and lesser omenta in the vicinity of the. stomach. The right hemicolectomy specimen is macroscopically unremarkable. A sample of fresh gastric tumour was given to. for research purposes. Block 1A-1C - Proximal margin (posterior aurface). 1D - Anterior surface distal margin. 814413. 1E - Tumour and lesser omentum. 1F-1H - Tumour and posterior surface of stomach. 1I - Tumour and anterior surface of stomach. 1J-1M - Lesser omental nodes. 1N - Nodular surace posterior stomach. 10 - Nodes greater curvature. 1P - Nodes greater curvature. 1Q-1R - Nodules gastrocolic mesentery. 1S - Greater omentum. 1T - Gastrocolic nodules. Please contact the authorising Pathologist if you wish to discuss this casc. For enquiries on this test report please contact. This is a COPY. AUTHORISED BY. Printed: FINAL - File Permanently. Male. Specimen No. 1U - Margins of bowel. 1V - Appendix. 1W - Large bowel apical nodes. P23. 2. ""Peritoneal"". A peritoneum 40x30mm. The central portion is. thickened. There is an area of skeletal muscle. P1. MICROSCOPIC DESCRIPTION: 1. Sections show a large poorly differentiated gastric adenocarcinoma. of intestinal type which extends with an infiltrating margin through. the full thickness of stomach wall into subserosal tissues and omenta. Although tumour lies immediately beneath the peritoneal surface, no. actual breach of the peritoneum by tumour is identified in the sections. examined. Tumour consists of solid cohesive masses of cells, focally punctuated. by infrequent small granular lumina. Small quantities of desmoplastic. stroma are focally associated with tumour, however, in many areas,. there is no appreciable stromal response. Individual tumour cells are large round to polygonal cells with. moderate quantities of amphophilic cytoplasm, large moderately. pleomorphic rounded nuclei, granular to irregularly clumped chromatin. and conspicuous large amphophilic nucleoli. Mitoses are abundant. There ie extensive tumour invasion of lymphatic vessels, both within. the gastric wall and within omenta. There is, additionally, apparent. focal invasion of ectatic veins within omenta. There are numerous. deposits of metastatic tumour within omenta, both within lymph nodes. and as separate nodules growing directly out of lymphatic vessels. Exact counting of these ie very difficult, however, at least 55. apparently distinct metastases are present amongst 56 lymph nodes and. omental tumour nodules (present in both lesser and greater omenta). Tumour within mural lymphatic vessels appears to have approached to. within 1. Smm of the proximal longitudinal resection margin of the. stomach, but is nevertheless completely excised in the planes of. section. Tumour appears to be well clear of the distal resection. margin. No tumour is identified within the right hemicolectomy specimen,. including 5 ileocolic lymph nodes. 2. Sections show skeletal muscle and peritoneum. No tumour is. identified in this specimen. DIAGNOSIS: Please contact the authorising Pathologist if you wish to discuss this case. For enquiries on this test report please contact. This is a COPY. AUTHORISED BY. Printed: FINAL - File Fermaneruly. Male. Specimen No. 1. DISTAL SUBTOTAL GASTRECTOMY AND EXTENDED RIGHT HEMICOLECTOMY: POORLY DIFFERENTIATED GASTRIC ADENOCARCINOMA, INFILTRATING SUBSEROSA,. WITH EXTENSIVE LYMPHOVASCULAR INVASION, NARROWLY EXCISED 1.5MM) AT THE. PROXIMAL LONGITUDINAL RESECTION MARGIN; TUMOUR METASTASES TO AT LEAST. 55 OF 56 REGIONAL LYMPH NODES; RIGHT HEMICOLECTOMY WITHIN NORMAL. LIMITS. 2. PERITONEAL BIOPSY: NO TUMOUR IDENTIFIED. AJCC STAGE IV (T2,N3,MX) . Please contact the authorising Pathologist if you wish to discuss this case. For enquiries on this test report please contact. This is a COPY. AUTHORISED BY. Printed: FINAL . File Permanently.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
LABORATORY MEDICINE PROGRAM. Facility: Specimen(s) Received. 2. Thyroid: Lymph-Node: Thyroid left paratracheal node stitch left superior pole CPUF. carcinona, papillary. thypoid 826013. 1. RIGHT PARATRACHEAL LYMPH NODE AT THYMUS. 3. Lymph node: Left level 2 lymph node. 4. Lymph node: Left level 3 lymph node. 5. Lymph node: Right level 2B lymph node. 6. Lymph node: Right level 2,3,4 lymph nodes. Diagnosis. 1. No pathological diagnosis: Lymph node, 1 (right paratracheal at thymus) excisional biopsy. 2. Multifocal bilateral papiliary carcinoma, dominant widely invasive mixed classical and follicular variant with focal tall cell. change (<5%), 1.9 cm, isthmus; and follicular nodular disease with degeneration and oncocytic change: Thyroid. Metastatic papillary thyroid carcinoma: Lymph node, 3 of 3, isthmic. Metastatic papillary thyroid carcinoma: Lymph nodes, 4 of 8, central compartment. No pathological diagnosis: Parathyroid, right perithyroidal. Simple epithelial cysts: Parathyroid, central compartment. Ectopic serous and mucinous glands: Soft tissue, central compartment. - Total thyroidectomy specimen with central neck dissection. 3. No pathological diagnosis: Lymph nodes, 5 (left neck level II) excisional biopsy. 4. No pathological diagnosis: Lymph nodes, 6 (left neck level III) excisional biopsy. 5. No pathological diagnosis: Lymph nodes, 2 (right neck level IIB) excisional biopsy. 6. Micrometastatic papillary thyroid carcinoma: Lymph node, 1 of 9 (right neck level II, III and IV) excisional biopsy. Synoptic Data. Procedure: Other: Total thyroidectomy with central and bilateral neck dissection specimen. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 3.8 cm. 2.3 cm. 1.2 cm. Left lobe: 3.4 cm. 2.3 cm. 1.0 cm. Isthmus +/- pyramidal lobe: 3.2 cm. 2.1 cm. 1.4 cm. Central compartment: 4.3 cm. 3.8 cm. 1.1 cm. Rightmeskunssection: 6.8 cm. 1.5 cm. 1.5 cm. Left neck dissection: 2.8 cm. 1.5 cm. 1.4 cm. Specimen Weight: 17.2 g. Tumor Focality: Multifocal, bilateral. Multifocal, midline (isthmus). DOMINANT TUMOR. Tumor Laterality: Isthmus. Tumor Size: Greatest dimension: 1.9cm. Additional dimension: 1.7 cm. Additional dimension: 1.6 cm. Histologic Type: Papillary carcinoma, classical (usual). Papillary carcinoma, follicular variant. Papillary carcinoma, other variant: with focal tall cell change (<5%). Classical (papillary) architecture. Follicular architecture. Classical cytomorphology. Tall cell cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 0.2mm. Tumor Capsule: Partially encapsulated. Tumor Capsular Invasion: Present, extent widely invasive. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. SECOND TUMOR. Tumor Laterality: Right lobe. Tumor Size: Greatest dimension: 0.5cm. Histologic Type: Papillary carcinoma, classical (usual). Papillary carcinoma, microcarcinoma (occult, small or microscopic) variant. Classical (papillary) architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: Partially encapsulated. Tumor Capsular Invasion: Present, extent minimal. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to. the thyroid. Regional Lymph Nodes (pN): pN1b: Metastases to unilateral, bilateral or contralateral cervial or superior. medastinal lymph nodes. Number of regional lymph nodes examined: 32. Number of regional lymph nodes involved: 8. Lymph Node, Extranodal Extension Not identified. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Adenomatoid nodule(s) or Nodular follicular disease. Parathyroid gland(s) within normal limits. Parathyroid gland(s), other: simple epithelial cysts. Other: additional multiple papillary microcarcinomas: 0.1 cm, right lobe and 0.05 cm,. left lobe. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Gross Description. 1. The specimen labeled with the patient's name and as ""right paratracheal lymph node at thymus"" consists of a piece of. fibroadipose tissue that measures 2.2 x 1.6 x 0.5 cm. It contains two query lymph nodes measuring 0.5 x 0.5 x 0.4 and 0.6. x 0.5 x 0.4 cm, respectively. 1A. two lymph nodes. 2. The specimen labeled with the patient's name and as ""thyroid left paratracheal node stitch left superior pole"" consists of. an oriented thyroid gland with attached fibroadipose tissue on the inferior aspect that weighs 17.2 g. The right lobe. measures 3.8 cm SI x 2.3 cm ML x 1.2 cm AP, the left lobe measures 3.4 cm SI x 2.3 cm ML x 1.0 cm AP and the isthmus. measures 3.2 cm SI x 2.1 cm ML x 1.4 cm AP. The fibroadipose tissue measures 4.3 SI x 3.8 ML x 1.1 cm AP. The. external surfaces have fibrous adhesions and are painted with silver nitrate. No parathyroid glands are identified grossly. The isthmus contains one well delineated nodule that measures 1.7 cm SI x 1.6 cm ML x 1.9 cm AP. A second well. delineated nodule is identified in the inferior left lobe and measures 0.8 SI x 0.7 ML x 0.6 cm AP. Both nodules are tan. and firm. Multiple lymph nodes are identified on the inferior soft tissue ranging in size from 0.2 x 0.2 x 0.2 cm to 1.7 x 0,9 x. 0.8 cm. The remainder of the thyroid tissue is grossly unremarkable. Tissue is stored frozen. The remainder of the. specimen is submitted as follows: 2A-E. right lobe, superior to inferior. 2F-H. isthmus. 2I-L. left lobe, superior to inferior. 2M. one cystic lymph node bisected. 2N. multiple lymph nodes. 3. The specimen labeled with the patient's name and as ""left level Il lymph node"" consists of a piece of fibroadipose tissue. that measures 2.8 x 1.5 x 1.4 cm. It contains multiple lymph nodes that range from 0.6 x 0.7 x 0.6 to 1.0 x 0,8 x 0.6 cm. Representative sections are submitted. 3A. multiple lymph nodes. 4. The specimen labeled with the patient's name and as ""left level III lymph node"" consists of two pieces of fibroadipose. tissue that measures 1.3 x 1.5 x 0.8 and 2.4 x 1.5 x 1.3 cm. They contain multiple lymph nodes that range from 0.2 x 0.2 x. 0.2 to 1.0 x 0.8 x 0.6 cm. Representative sections are submitted. 4A. two lymph nodes. 4B. multiple lymph nodes. 5. The specimen labeled with the patient's name and as ""right level IIB lymph nodes"" consists of a piece of fibroadipose. tissue that measures 1.3 x 0.8 x 0.5 cm. It contains two lymph nodes that measures 0.3 x 0.4 x 0.4 and 0.4 X 0.4 x 0.4 cm. Representative sections are submitted. 5A. two lymph nodes. 6. The specimen labeled with the patient's name and as ""right level II, III and IV"" consists of a piece of unoriented. fibroadipose tissue that measures 6.8 x 1.5 x 1.5 cm. It contains multiple lymph nodes that range from 0.2 x 0.3 x 0.2 to. 1.2 x 0.9 x 0.9 cm. The lymph nodes are sequentially submitted after the specimen is trisected with the lymph nodes. submitted in. as follows: 6A. one lymph node bisected. 6B. multiple lymph nodes. 6C. one lymph node bisected. 6D. one lymph node bisected. 6E. multiple lymph nodes.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. Left upper lobe. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung mass. GROSS DESCRIPTION. Received fresh in a container labeled ""left upper lobe"" is. a wedge of lung tissue, spanning an area 10.5 x 4.3 X 3.2. cm. There is a stapled margin. The pleural surface is tan-pink,. smooth, and glistening, with some anthracotic pigment deposition. The specimen is sectioned, revealing a 2.2 X 2.2 X 1.2 cm firm. rubbery nodule, with minimal umbilication of the overlying pleura. The pleural surface is inked black, The lesion comes to within. approximately 0.7 cm from the stapled margin, which is inked blue. The specimen outside the nodule is spongy and tan-pink, without. focal lesion. RS-6. Please note that per the clinical request. tissue is taken for tissue procurement. MICROSCOPIC DESCRIPTION. The following template summarizes the findings in this case : Histologic type Adenocarcinoma, not otherwise characterized. Histologic grade: Moderately differentiated. Primary tumor (pT) : pT2. There is focal visceral pleural invasion. (block #2). Margins of resection: Negative. Direct extension of tumor: Visceral pleural invasion. Vascular invasion: Not definitively identified. Regional lymph nodes (pN) : pNX. Distant metastasis (pM) : pMX. Other findings : Focal fibrosis. MICROSCOPIC DESCRIPTION. 4. DIAGNOSIS. Lung, left upper lobe, wedge resection. - Moderately differentiated adenocarcinoma, with focal visceral. pleural invasion, margins negative for malignancy (see. microscopic. description).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure: Diagnosis. A. Submitted as lymph node, biopsy: Benign soft tissue; lymph node. not identified. B. Gallbladder, cholecystectomy: Chronic cholecystitis. C. Liver, partial resection: Hepatocellular carcinoma,. oderately-differentiated, 2.5 cm in greatest dimension without. vascular invasion; negative margins of excision. Microscopic Description: Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately-differentiated. Tumor size: Solitary tumor mass, 2.5 cm in greatest dimension. Primary tumor: pT1. Margins of resection: Negative (carcinoma is 5 mm from closest. resection margin). Vascular invasion: Negative. Regional lymph nodes (pN) : None submitted. Distant metastasis (pM) : Unknown. Comment: The presence of hepatocellular carcinoma (HCC) is confirmed. by reticulin staining, which shows loss of the normal hepatic. architecture with the nodular tumor, and by positive immunostaining by. HepParl. Stains for CK7, CK20, and CDX-2 are negative. 4, 3, 2, 18, 20x4. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.]. Specimen. A. Lymph node. B. Gallbladder. C. Liver mass. Clinical Information. Liver cancer. Gross Description. A. Received unfixed, labeled lymph node, is a 0.7 x 0.7 x 0.5 cm tan. soft tissue fragment without discrete lymph node identified, entirely. submitted in one block. AS1. B. Received in formalin labeled ""gallbladder"" is a 5.5 x 2.0 X 1.2 cm. intact gallbladder. The serosa is pink-tan, smooth and glistening. The. cystic duct is patent. The specimen is opened and partially filled with. green-brown viscid bile. The mucosa is pink-tan and velvety. No. choleliths are identified in the specimen or the specimen container. The average wall thickness is 0.3 cm. Greater than 50% of the specimen. is submitted in 2 cassettes including cystic duct which is inked. RS 2. C. Received unfixed for tissue procurement, labeled liver mass, is a 5. x 5 x 4 cm wedge-shaped partial liver resection specimen, with. cauterized surface. There is a nodular, firm tan mass lesion, 2.5 cm. in greatest dimension and 0.5 cm from the resection margin. A portion. of tumor and uninvolved liver tissue is submitted for tissue. procurement. Representative sections in 4 blocks.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Report Status: Amend/Addenda. Type: Surgical Pathology. Specimen Type: Kidney, partial or total resection. Procedure Date: PATIEN: Addended Report. PATHOLOGIC DIAGNOSIS: SPECIMEN LABELED ""RIGHT KIDNEY"": RENAL CELL CARCINOMA, clear-cell type, (2.4 cm), Fuhrman Grade II/IV. (focally III/IV), involving the mid and inferior pole. Tumor embolus is present at the renal vein margin. Tumor is confined to kidney (except for tumor emboli). Extensive tumor emboli are present in vasculature. Ureteral and arterial margins are negative for tumor. Gerota's fascial and oft-tissue margins are negative for tumor. AJCC Classification (6th Edition) : pT3b Nx Mx. The non-neoplastic kidney will be evaluated by Renal Pathology, and the. findings will be reported in an addendum. CLINICAL DATA: History: None given. Operation: Right radical nephrectomy. Operative, Findings None given. Clinical Diagnosis: Renal cell carcinoma. TISSUE SUBMITTED: A/1. Right kidney. GROSS DESCRIPTION: The specimen, Part A, is received fresh, labeled with the patient's name, unit. number, and ""#1. Right kidney"", consists of a 483-gram radical nephrectomy. specimen (overall dimensions 17.0 x 7.2 x 5.0 cm) consisting of kidney (10.2 x. 6.3 x 4.8 cm) and attached yellow/tan lobulated perinephric adipose tissue (up. to 3.5 cm in thickness) Extending from the renal hilum is a segment of ureter. 16. cm length x 0.3 cm in diameter), a segment of renal artery (1.6 cm length. x 0. cm in diameter), and a segment of renal vein (0.5 cm length x 1.0 Cm in. diameter). In the mid pole, there is a well-circumscribed golden yellow focally. hemorrhagic mass (2.4 x 2.4 x 1. cm), which grossly appears to arise from the. renal parenchyma and focally distorts but does not appear to invade into the. renal sinus. Upon, sectioning, the mass is confined to the renal parenchyma,. does not grossly appear to involve the renal capsule, and comes within 2.4 cm. of the perinephric soft tissue resection margin. Within the renal vein, there is a loosely adherent friable hemorrhagic. red/brown to yellow/brown necrotic tissue (probable tumor thrombus) contiguous. with the aforementioned mass, which grossly appears to come within 0.2 cm of. the renal vein margin (previously sampled en face in the frozen section room). The aforementioned comes within 2.4 cm of the renal artery margin and 5.5 cm of. the ureteral margin. A 0.9 cm inferior to the aforementioned mass, in the inferior pole of the. kidney, there is a well-circumscribed yellow/tan friable nodule (? satellite. lesion, 0.8 x 0.6 x 0.6 cm). The pelvic calyceal system exhibits smooth, glistening tan mucosa. The. corticomedullary junction is distinct. No lymph nodes are identified within. the perinephric adipose tissue. A representative section of. the specimen was photographed. which 7 (3.5 %) are globally. sclerosed. The remaining glomeruli show mild. diffuse mesangial expansion; overt nodular glomerulosclerosis is not noted at. this time. There are no discernible craters or double contours of the. glomerular basement membranes. Rare distal tubules contain PAS-positive. hyaline casts. Less than 5% of the cortical parenchyma shows tubular atrophy. and interstitial fibrosis. Arteries and arterioles exhibit a mild to focally. moderate degree of sclerosis; some small arteries reveal significant narrowing. of the lumen by accumulation of connective tissue in the subintima. Arterioles. show early focal hyaline degeneration. Report Status: Type: Cytogenetics. Cytogen-. KARYOTYPE: 45, XY, del (3) (p11) del (6) (q12q25) , der (9) t (7;9) (q171;q374), -21 [cp4] / 80, idem. x2 (6). METAPHASES COUNTED: 10. ANALYZED: 6. SCORED: 4. BANDING: GTG. INTERPRETATION: All metaphases contained clonal aberrations including loss of the short arm of. chromosome 3, which is a characteristic finding in renal cell carcinoma, clear. cell type. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: RCC.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: 1. and 2.: Right-sided hemicolectomy preparation with tumor-free oral and aboral resection. margins which also includes an ulcerated, moderately differentiated adenocarcinoma of the. cecum with invasion of all parietal layers, penetration of the peritoneum, multiple regional. lymph node metastases and peritoneal seeding. (G2, pT4 pN2 L1, V0, pN2 12/35 pM1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Esophagus (Mid third). 1. Specimen: Esophagus and proximal stomach. Procedure: Esophagogastrectomy. Tumor site: esophagus. Tumor size (greatest dimension): 4,2 cm. Histologic type: Squamous cell carcinoma. Histologic grade: G2 moderately differentiated. Microscopic tumor extension: tumor invades through submucosa. Lymph-vascular invasion: not identified. Perineural invasion: not identified. Peritumoral desmoplasia scarce. Moderate peritumoral lymphocitary infiltrate. Gastric mucosa congested. Margins: uninvolved by carcinoma. Regional lymph nodes: Number examined: 13 (right paracardics 0/1; left paracardics 1/2; lesser. curvature of stomach 0/6; celiac trunk 1/4). Number positive for neoplasia: 02. 2. ""Periesophageal lymph nodes"": Number examined: 01. Number positive for neoplasia: 00. 3. ""Esophageal margin"": Uninvolved by carcinoma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Report for. TEST: Surgical Pathology. Collected Date & Time: Result Name. Reference Range. SURGICAL P. Location: Discharge Location. (Age : Service: Surgery. Physician (s) : Specimen (s) Received. A: Total thyroid. B: Tip of possible left inferior parathyroid. C: Level six lymph nodes. D: Left level two lymph nodes. E: Left modified radical neck dissection. Pathologic Diagnosis. Total thyroid (A) : Multifocal papillary carcinoma involving the left. thyroid lobe and left portion of thyroid isthmus (largest focus. 2.2 cm) with numerous (<10) microscopic foci and remaining. thyroid lobe all measuring <1 mm in greatest dimension. Tumor confined to the thyroid, negative for extrathyroidal. extension. Margins of surgical resection negative for tumor. involvement. Negative for lymphovascular and perineural invasion. Background of lymphocytic thyroiditis. Tip of possible left inferior parathyroid (B) : Normocellar parathyroid tissue. Level 6 lymph nodes (C) : Metastatic papillary carcinoma involving two of three. lymph nodes (largest metastatic focus 2.0 cm, negative for. extranodal extension). Level 2 lymph nodes (D) : Metastatic papillary carcinoma involving one of four. lymph nodes (0.5 cm metastatic focus, negative for extranodal. extension). Left modified radical neck dissection (E) : Metastatic papillary thyroid carcinoma involving two. of 23 lymph nodes (2.5 cm and 2.0 cm metastatic foci with. extranodal extension present in both nodes). SURGICAL PATHOLOGY CANCER CASE SUMMARY CHECKLIST: THYROID GLAND. RESECTION: Procedure: Total thyroidectomy. Received: In formalin. Specimen Integrity: Intact. Specimen Size: Right lobe: 4.5 x 2.0 x 1.4 cm. Left lobe: 4.0 x 1.8 x 1.8 cm. Isthmus: 1.0 x 0.2 x 0.2 cm. Left neck dissection: 9.0 x 5.5 x 1.3 cm. Specimen Weight: 14 grams. Tumor Focality Multifocal, ipsilateral. Dominant Tumor: Tumor Laterality: Left lobe. Tumor Size: 2.2 cm. Histologic. Variant: Type: Papillary follicular and per TSS, Follicular. carcinoma,. classical. Architecture: Classical and follicular. Cytomorphology: Classical. Histologic Grade: Grade 1, well-differentiated. margins, uninvolved by carcinoma. Tumor Capsule: Not present. Tumor Capsular Invasion: Not applicable. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. Second Tumor: Tumor Laterality: Left lobe. Tumor Size: >10 foci of microscopic tumor surrounding. larger nodule, all measuring <1 mm in greatest dimension. Histologic Type: Variant: Follicular variant, papillary carcinoma. Architecture: Follicular. Histologic Grade: Well-differentiated. Grade 1. Margins: Uninvolved by carcinoma. Tumor Capsule: Not present. Tumor Capsular Invasion: Not applicable. Lymph-Vascular Invasion: Not present. Perineural Invasion: Not present. Extrathyroidal Extension: Not present. Additional Pathologic Findings: Lymphocytic thyroiditis,. benign Hurthle cell nodules and numerous microscopic foci of. tumor (>10) present in the left thyroid lobe and focally in the. left side of the thyroid isthmus (all measuring <1 mm in greatest. dimension). Ancillary Studies: Not performed. Clinical History: Defer to clinical correlation as to. whether this patient has a history of radiation exposure or. family history of thyroid neoplasia. PATHOLOGIC STAGE: pT2(m), pN1b (number of lymph nodes. examined 30, total number of positive lymph nodes 5), pMX. NOTE: Information on pathology stage and the operative procedure. is transmitted to this Institution' S Cancer Registry as required. for accreditation by the Commission on Cancer. Pathology stage. is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is. only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon'. S. operative report. Primary Pathologist: Clinical History. Papillary thyroid cancer. Intraoperative Consultation. B. Tip of possible left inferior parathyroid: Parathyroid. tissue (microscopic evaluation). Gross Description. A. The specimen is received fresh labeled ""total thyroidectomy"". and consists of a 14 g total thyroid resection. There is a. suture designating the pole of the left lobe of the thyroid. The. surface is shaggy and gray-purple. The right lobe which is inked. blue is 4.5 x 2.0 x 1.4 cm. The left lobe which is inked black. is 4.0 x 1.8 x 1.8 cm. The isthmus which is inked yellow is 1.0. x 0.2 x 0.2 cm. The specimen is serially sectioned to reveal a. multinodular ill-defined firm tan-brown lesion that encompasses. the majority of the left lobe of the thyroid and approximates 2.2. x 1.5 x 1.3 cm. There are additional nonsuspicious. well-circumscribed soft tan-brown nodules identified in the. isthmus and the right lobe that measure up to 0.4 cm. The. majority of the right lobe has a firm red-brown cut surface. Representative sections are submitted as A1-A6 entire left lobe. lesion; A7 isthmus and right lobe with nodules; A8 and A9 right. lobe with remaining nodules. This specimen is reviewed with. A portion of the lesion is submitted for. studies. B. The specimen is received fresh for frozen section labeled. ""possible tip of left inferior parathyroid"" and consists of two. irregular tan-pink soft tissue fragments that are 10 mg and. average 0.2 cm. The are frozen and submitted in their entirety. in cassette B1FS. C. The specimen is received in formalin labeled ""level 6 lymph. nodes"" and consists of two firm tan-gray grossly positive lymph. nodes that are 1.5 and 2.0 cm. Two representative sections. from. each lymph node are submitted as C1 one lymph node, and C2. other lymph node. D. The specimen is received in formalin labeled ""left level 2. lymph nodes"" and consists of four firm tan-gray lymph nodes that. range from 0.5 to 2.5 cm. Their cut surfaces are firm tan-gray. and grossly positive. They are submitted entirely as D1 one. bisected lymph node, D2 two whole lymph nodes; D3 one bisected. lymph node. E. The specimen is received in formalin labeled ""left modified. radical neck dissection"" and consists of a 9.0 x 5.! x 1.3 cm. irregular indurated tan-yellow portion of fibroadipose tissue. There is a double suture designating the lowest level 4 and a. single suture designating the lateral level 5. The specimen is. divided into a superior half (with level 4) and an inferior half. (with level 5). There is no attached salivary gland identified. Identified within the inferior half of the specimen is a. prominent vessel that is 1.5 cm in length and 0.4 cm in diameter. There is no gross evidence of tumor involvement. There are two. enlarged, grossly positive lymph nodes identified within level 4. There are a few additional firm tan-gray lymph nodes identified. that range from 0.2 to 0.6 cm. Also noted separate from the. oriented tissue are two irregular, indurated tan-yellow portions. of fibroadipose tissue that measure 4 cm in aggregate. Within. the tissue there are several firm tan-gray lymph nodes that range. from 0.2 to 1. cm. Representative sections are submitted in. nine cassettes. Cassette summary: E1 section from one grossly positive lymph. node, level 4; E2 section from one grossly positive lymph node,. level 1; E3 three whole lymph nodes, level 4; E4 cross-sections. of vessel, level 5; E5 two whole lymph nodes, level 5; E6 five. whole lymph nodes, level 5; E7 one bisected lymph node and. additional tissue; E8 five whole lymph node in additional. tissue; E9 five whole lymph nodes in additional tissue. Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic. findings of this case. Interpretation performed at.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. 1. SEX: M. PROCEDURE: SPHS. Patient with long-standing history of gastroesophageal reflux diagnosed with. barrett's esophagus in. had E-scope with biopsy of. esophageal mass, path revealed invasive adenocarcinoma arising in barrett's. mucosa. Operative Procedure/Tissue Submitted: THE/1) distal esophagus and. proximal stomach, stitch marks tumor. . barrett's adjacent to tumor. araesophageal lymph node. final proximal esophageal margin. PROCEDURE: SPGD. 1. ""Distal esophagus and proximal stomach. Stitch marks tumor."" Received in. formalin in a small container is a distal esophagectomy/proximal gastrectomy,. consisting of esophagus (7.9 cm long), stomach (4.5 x 4.7 cm), and. paraesophageal/perigastric soft tissue. The distal esophagus shows a firm,. exophytic, brown-tan mass, 3.3 cm in length x 1.3 cm, 3.2 cm from the proximal. esophageal mergin, 5.8 cm from the distal margin, 1.7 cm from the. gastroesophageal junction. Deep inked green. NOTE: A full-thickness portion. of the esophagus appears to have been procured adjacent to the tumor marked by. stitch (3.3 cm from proximal margin, 1.0 cm from gastroesophageel junction). Due to pre-grossing manipulation, there was apparent separation between mucosa. and underlying muscularis propria, making full thickness sections difficult to. obtain and exact reapproximation impossible. The mass is 0.7 cm from the. possible area of procurement. The gastroesophageal junction shows a 0.5 cm. area of hyperemia. Otherwise, the gastric and esophageal mucosa is. unremarkable. Multiple Lymph node candidates identified. Photographs taken. for reference. 1A-C. Mass, entirely submitted. 10. Strip of mucosa adjacent to possible procurement defect and mass. 1E-F. Additional tissue near possible procurement defect. 1G-H. Sections of muscularis underlying possible procurement defect. 11. Gastroesophageal junction erosion. and additional sections of. gastroesophageal junction. 1J. One lymph node candidate, sectioned. 1K-M. Seven lymph node candidates each. 2. ""Barrett's adiacent to tumor"" Received in formalin in a small container is. a 2.5 x 2.0 x 0.3 cm fragment of tan tissue, possibly partially surfaced by. brown-tan, granular mucosa without gross lesion. Sectioned and submitted in. cassette 2A. 3. ""Paraesophageal lymph node"" Received in formalin in a small container is. a. black-brown bit, 0.4 cm. 4. ""Final proximal esophageal margim Received in formal in in a smal. container is a 0.5 cm long x 2.5 cm in diameter, segment of esophagus, stapled. at one end. Staple line shaved and retained. PREVIOUS DIAGNOSIS INQUIRY. 2. SEX: M. PROCEDURE: SPMI. ESOPHAGUS, GASTROESOPHAGEAL JUNCTION, INCLUDING CARDIA,. CARCINOMA (RESECTION SPECIMENS): Esophagus, tower. SIZE: 3.3 x 1.3 cm. TYPE OF CARCINOMA: Adenocarcinoma, arising in Barrett's mucosa. GRADE: Poorly-differentiated. DEPTH OF INVASION: Submucosa. HAS IT BEEN TREATED PREOPERATIVELY WITH CHENO/RADIATION THERAPY? No. NUMBER OF POSITIVE LYMPH NODES / TOTAL NUMBER OF NODES EXAMINED: 1/18. NUMBER OF LYMPH NODES WITH SCAR BUT WITHOUT CARCINOMA CELLS POST TREATMENT: N/A. DISTANT METASTASIS: Unknown. RESECTION MARGIN INVOLVED: pT1b N1. PROCEDURE: SPDX. 1&4. Distal esophagus and stomach, resection: Poorly-differentiated. adenocarcinoma arising in Barrett's mucosa (3.3 cm), extending into submucosa. Margins free. One of eighteen lymph nodes positive for metastatic carcinoma. (1/18). Please see TEMPLATE for details. 2. Esophagus, ""Barrett's adjacent to tumor, excision: Adenocarcinoma arising. in Barrett's mucosa with high grade dysplasia. 3. Para-esophageal lymph node, excision: Fibrovascular tissue, no Lymphoid. tissue identified.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Histopathology Report. HISTORY. Right upper lobe mass. 1: Right lower lobe lung. 2: Right level 4 lymph node. 3: Right middle lobe lymph node. MACROSCOPIC. Five specimens received: 1: The second specimen is labelled ""right upper lobe for frozen section"" and. consists of a nodule measuring 17 x 9 x 6 mm. Frozen section diagnosis: Organising pneumonia with a BOOP pattern. Phoned to. [Residual frozen section fragments remnants blocked, 1A.]. 2: The first specimen is labelled ""right upper lobe nodule"" and consists of a. wedge of lung tissue measuring 20 X 13 X 5 mm. The tissue contains a pale. glistening nodule measuring approximately 7 mm in diameter. Frozen section diagnosis: Organising pneumonia. Phoned to. [Frozen section remnants blocked, 2A. Remaining fragments sectioned into 4RS. and blocked, 2B.]. 3: The third specimen is labelled ""right lower lobe"" and consists of a right. lower lobe of lung measuring 115 X 90 x 80 mm. The pleural surface appears. largely puckered, extending from the diaphragmatic surface of the lung and from. the posterior to anterior pleural surfaces. A large firm mass is palpable. beneath the area of pleural puckering. On sectioning, a large tumour mass is. confirmed, measuring 60 x 48 x 70 mm. The tumour has a cream to yellow cut. surface with areas of grey to black mottling. The tumour appears to approach. both the posterior and anterior and diaphragmatic surfaces. The tumour is. approximately 6 mm away from the medial pleural margin. On opening of the. bronchial tree, the tumour appears to arise from a bronchial branch. approximately 10 mm away from the bronchial resection margin. A large vessel. runs through the middle of the tumour. However it does not appear. macroscopically invaded. The uninvolved lung parenchyma appears unremarkable. [Bronchial resection margin, 3A; peribronchial lymph nodes, 3B; tumour with. anterior pleural margin, 3C; tumour with posterior pleural margin, 3D; tumour. in relation to bronchus, 3E; vascular resection margin and section through. tumour with large vessel, 3F; tumour with diaphragmatic pleural surface, 3G;. uninvolved lung, 3H.]. Page 1 of. Histopathology Report. 4: The fourth specimen is labelled ""right lymph node"" and consists of a lymph. node measuring 10 x 8 X 6 mm. The node has a pinkish red cut surface and is. soft. [Specimen bisected, wrapped and blocked in toto, 4A.]. 5: The fifth specimen is labelled ""middle lobe lymph node and consists of two. lymph nodes, the first measuring 20 x 12 x 10 mm and the second 12 x 7 X 9 mm. Both nodes feel firm and on sectioning have a cream cut surface. [Each node. bisected and one-half blocked, 5A]. MICROSCOPIC. 1-2: The specimens are similar. Paraffin sections confirm the frozen section. diagnosis of organising pneumonia. In areas the pneumonia has a BOOP-type. pattern. Fibrinous exudate is present on the pleural surface. There is no. evidence of malignancy. 3: Sections show a moderately to poorly differentiated squamous cell carcinoma. The tumour shows focal clear cell change. It is subpleural and there is a. suspicion of pleural invasion in an area of pleural scarring. Fibrinous. exudate but no tumour is present on the pleural surface. Focal blood vessel. invasion is present but there is no lymphatic permeation. Many of the. pulmonary arteries show fibrous intimal thickening and focally there are. features of a previously recanalised thrombus. The vessel infiltrated by. carcinoma appears distal to this. No perineural permeation is identified. The. lesion is well clear of the bronchial resection margin but there is mild active. chronic inflammation, squamous metaplasia with moderate dysplasia. Metastatic. deposits are noted within a peribronchial lymph node. The adjacent lung shows. evidence of emphysema, organising pneumonia and nodules of luminal fibrin. 4: Sections of the lymph nodes show reactive changes only. There is no. evidence of malignancy. 5: Sections of the lymph nodes show extensive replacement by metastatic. squamous cell carcinoma. SUMMARY. Right lower lobe and lymph nodes: 1: Moderately to poorly differentiated squamous cell carcinoma; 70 mm in. maximal dimension. 2: Blood vessel permeation identified but no lymphatic or perineural invasion. present. 3: Possible pleural invasion identified, special stains being performed; clear. of bronchial margin. 4: Peribronchial and right middle lobe lymph node metastases. 5: T2N1MX. Page 2 c. Histopathology Report. SUPPLEMENTARY REPORT. Carcinoma invades through the inner elastic lamina of the pleura but not. through the outer lamina or convincingly into the visceral pleura itself. c.c. Lung Cancer Registry.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with incidental left renal mass. Specimens Submitted: 1: Kidney, left, partial nephrectomy. 2: Kidney, deep margin #2, excision. 3: Kidney, satellite tumor #1, biopsy. DIAGNOSIS: 1. Kidney, left, partial nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 1.9 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Renal vein is not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. 2. Kidney, deep margin #2, excision. Benign renal parenchyma and perirenal fat. 3, Kidnay, satellite tumor #1, biopsy (sr): Tubulopapillary neoplasm, 0.2 cm, consistent with the so called papillary adenoma. TATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL). AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section consultation, labeled ""Left renal tumor, freeze stitched deep margin"". It. consists of a 4.8 X 3.7 x 2,3 cm segment of renal parenchyma with an attached black suture at the margin. The resected margin. is. inked black. The outer surface of the parinaphric fat is inked blua. A cut saction of the specimen shows a 1,9 X 1.6 x 1.5 cm. partially cystic bright orange hamorrhagic tumor. It is located less than 1 mm from the inked margin. The remainder of the renal. parenchyma is brown-tan and unremarkable. A representative section of the tumor is frozen. Representative sections are. submitted. A sample of the tumor is given to TPS. Summary of sactions: FSC - frozen section control. T tumor. U - undesignated. 2). Specimen is received in formalin labeled ""Deep margin #2"" and consists of a 4.5 x 2,5 x 2,5 cm tissue fragment,. represented by 0,5 cm thick perirenal fat and 2 cm thick conical renal parenchyma. A second tissue fragment in the containar. consists of parirenal fat measuring 4,0 x 2.8 x 0.5 cm. Tha perirenal surface is inked black, the ranal parenchymal surfaca is inkad. green. The specimen is serially sectioned and representatively submitted. Summary of sections: LF - large fragment with renal parenchyma. SF - small fragment of white perirenal fat. 3). Specimen is received in formalin labeled ""Satellite tumor #1"" and consists of a 0,4 cm brown tissue fragment. Entirely. submitted. Summary of sections. ET - entire tissue. Summary of Sections: Part 1: Kidney, left, partial naphractomy. Block. Sect. Site. PCs. 1. fsc. 1. 3. t. 3. u. 1. Part 2: Kidney, deep margin #2, excision. Block. Sact. Sita. PCs. 3. LF. 3. 1. SF. 3. Part. 3: Kidney, satellite tumor #1, biopsy. Block. Sect. Site. PCs. 1. ET. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: MARGIN NEGATIVE; FAVOR CLEAR CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Stomach (Antrum). I) Parietal peritoneum. - Uninvolved by neoplasia. II) Stomach + omentum. - Moderately differentiated papillary adenocarcinoma (intestinal type of Lauren) with. extensive areas of necrosis measuring 11.0 x 4.0 x 2.65 cm localized in the antrum and. pylorus. - The tumor infiltrates the adjacent fat and the gastric serosa. - Expansive tumoral edges. - Angiolymphatic and perineural infiltration not detected. - Adjacent gastric mucosae exhibiting atrophic gastritis with extensive intestinal. metaplasia. - Absence of neoplasia on the 37 lymph nodes examined of the lesser curvature (0/37). as well as on the 5 lymph nodes of the greater curvature (0/5). - Omentum uninvolved by neoplasia. - Surgical margins uninvolved by neoplasia. III) Esophageal margin. - Uninvolved by neoplasia. IV) Celiac trunk. - Lymph nodes uninvolved by neoplasia (0/4). V) Gallbladder. - Cholelithiasis. VI) Lymph node of the anterior hepatic artery. - Uninvolved by neoplasia (0/1). Note: we didn't observe lymph nodes along with the greater curvature. We put all the. material in alcohol and, if we find the lymph nodes, this result will be followed by a. supplementary report.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: 1, .5) PHARYNX, LARYNX, PHARYNGOLARYNGECTOMY: MODERATELY DIFFERENTIATED. KERATINIZING SQUAMOUS CELL CARCINOMA OF THE EPIGLOTTIS, 2.3 CM IN GREATEST. EXTENT, INVOLVING THE ANTERIOR COMMISURE, RIGHT AND LEFT FALSE VOCAL FOLDS,. AND THE PRE-EPIGLOTTIS, EXTENSION INTO THE EPIGLOTTIC CARTILAGE; FOCALLY. INVOLVING THE SUPERIOR INKED LEFT ANTERIOR SOFT TISSUE RESECTION MARGIN,. ALL OTHER MARGINS, NEGATIVE FOR MALIGNANCY (SEE COMMENT). 2) MARGIN, POSTERIOR CRICOID, EXCISION: NEGATIVE FOR MALIGNANCY. 3) MARGIN, LEFT HYPOPHARYNX, EXCISION: NEGATIVE FOR MALIGNANCY. 4) MARGIN, RIGHT HYPOPHARYNX, EXCISION: NEGATIVE FOR MALIGNANCY. 6) LYMPH NODES, LEFT NECK LEVEL 4, DISSECTION: 19 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. 7) LYMPH NODES, LEFT NECK LEVEL 2A, 3, DISSECTION: 43 LYMPH NODES, NEGATIVE. FOR MALIGNANCY. 8) LYMPH NODES, RIGHT NECK LEVEL 2, 3, 4, DISSECTION: 1 OF 40 LYMPH NODES. INVOLVED BY METASTATIC SQUAMOUS CELL CARCINOMA. 9) LYMPH NODES, LEVEL 1A, EXCISIONAL BIOPSY: 2 LYMPH NODES, NEGATIVE FOR. MALIGNANCY. COMMENT: These findings correspond to AJCC 6TH Edition Pathologic Stage III. (pT3N1Mn/a). CLINICAL DATA. Clinical Features: Unspecified. Operator: Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) epiglottis, 2) post cricoid, 3) left. hypopharynx, 4) right hypopharynx, 5). pharyngolaryngectomy; 6)left neck level. 4; 7)left neck levels 2A, 3; 8)right neck. levels 2,3,4;9)neck dissection level 1A. INSTRUCTIONS TO PATHOLOGIST: Frozen. GROSS DESCRIPTION: 1) SOURCE: Epiglottis. Received fresh labeled, ""epiglottis,"" is a 0.6 X 0.4 X 0.3 cm piece of. tan-white tissue. The specimen is submitted entirely for frozen section. Summary of sections: 1AFSC, 1/1. 2) SOURCE: Post Cricoid. The specimen labeled ""post cricoid,"" is received fresh and is comprised of. a 2.4 X 0.2 X 0.2 cm strip of pink-tan mucosa. The specimen is submitted. entirely for frozen section. Summary of sections: 2AFSC, entirely submitted, 1/1. 3) SOURCE: Left Hypopharynx. The specimen labeled ""left hypopharynx,"" is received fresh and is comprised. of a 2.7 X 0.2 X 0.2 cm strip of tan-pink mucosa. The specimen is inked. black, and submitted entirely for frozen section. Summary of sections: 3AFSC, 1/1. 4) SOURCE: Right Hypopharynx. The specimen labeled ""right hypopharynx,"" is received fresh and is. comprised of two pieces of tissue, one measuring 1.8 X 0.3 X 0.2 cm, the. second measuring 1.4 X 0.2 X 0.2 cm. The first piece of tissue does not. have an easily identifiable mucosal surface. The second strip of tissue. does have an identifiable mucosal surface. Each of these pieces of tissue. are inked blue, and the specimen is submitted entirely for frozen section. Summary of sections: 4AFSC, entirely submitted, 2/1. 5) SOURCE: Pharyngolaryngectomy. The specimen labeled ""pharyngolaryngectomy"" is received fresh and is. comprised of a laryngectomy with attached epiglottis, thyroid cartilage. with extension of the mucosa and trachea inferior to the thyroid cartilage. The thyroid gland is not present with the specimen. The specimen measures. 8.0 cm superior to inferior X 5.0 cm left to right X 4.8 cm anterior to. posterior. The specimen has been opened prior to receipt along the. posterior aspect. The specimen is inked as follows: anterior-orange,. posterior-black, superior-yellow, inferior-green, right-red, left-blue. Examination of the specimen shows a 2.3 X 1.8 cm ulcerated lesion on the. posterior face of the epiglottis present centrally, extending to the left. and right (more prominently leftward), and towards the epiglottic vocal. folds. The right and left superior vocal folds are involved, medially, with. the left involved laterally. The anterior commissure is involved. On. sectioning, the lesion penetrates 0.4 cm deep from the mucosal surface. There is a prominent 0.8 X 0.7 X 0.7 cm nodule in the left anterior. superior portion of the specimen abutting the anterior superior margin. There is no gross tumor involvement of the thyroid cartilage. The tumor. mass has borders and comes within 0.3 cm of the hyoid bone, which is. present with the specimen. The tumor mass does appear to wrap around the. superior aspect of the thyroid cartilage. There is no apparent extension. inferior to the vocal folds. Representative sections are submitted. Summary of sections: 5A, inferior margin, 1/1; 5B, anterior commissure,. 1/1; 5C, right superior margin with epiglottis, 1/1; 5D, right medial vocal. folds, 1/1; 5E, right lateral vocal folds, 1/1; 5F, right aryepiglottic. mucosa, 1/1; 5G, left anterior superior margin with prominent nodule, 2/1. (single section bisected); 2/1; 5H, left medial vocal fold with closest. approach to hyoid bone, 1/1; 5I, left lateral vocal fold, 1/1; 5J, left. aryepiglottic mucosa, 1/1; 5K, right and left soft tissue margins, 2/1; 5L,. anterior and posterior soft tissue margins, 2/1. NOTE: Appropriate sections. are decalcified. 6) SOURCE: Left Neck Level 4. The specimen labeled ""left neck level 4"" is received in saline, and is. comprised of a 5.2 X 4.2 X 0.5 cm collection of fibroadipose tissue. containing lymph node candidates. Lymph node candidates range in. measurement from 0.3 to 0.5 cm. The specimen is dissected and 21 lymph node. candidates are removed. These lymph node candidates are submitted entirely. Summary of sections: 6A, lymph node candidates, M/1; 6B, lymph node. candidates, m/1; 6C, lymph node candidates, M/1. 7) SOURCE: Left Neck Levels 2A&3. The specimen labeled ""left neck levels 2A, 3"" is received in saline and is. comprised of a 13.5 X 4.5 X 0.5 cm collection of fibroadipose tissue. containing lymph nodes and vessels, with suture ties investing the vascular. end. The specimen is dissected to reveal the presence of numerous lymph. node candidates measuring from 0.2 to 1.0 cm in greatest extent. The lymph. node candidates are submitted entirely. Summary of sections: 7A, lymph node candidates, M/1; 7B, lymph node. candidates, M/1; 7C, lymph node candidates, M/1; 7D, lymph node candidates,. 6/1; 7E, two lymph nodes, each bisected, one inked black, 4/1. 8) SOURCE: Right Neck Level 2,3,&4. The specimen labeled ""right neck level 2, 3, 4"" is received fresh and is. comprised of a 15.2 X 5.2 X 0.6 cm collection of fibroadipose tissue. containing lymph nodes and vessels. The specimen is dissected to reveal the. presence of numerous lymph nodes measuring from 0.2 to 1.2 cm. Lymph node. candidates are submitted entirely. Summary of sections: 8A, lymph node candidates, M/1; 8B, lymph node. candidates, M/1; 8C, lymph node candidates, M/1; 8D, lymph node candidates,. M/1; 8E, lymph node candidates, 2/1; 8F, single lymph node, bisected, 2/1. 9) SOURCE: Neck Dissection Level 1A. The specimen labeled ""neck dissection level 1A"" is received in saline and. is comprised of a 2.5 X 2.0 X 0.5 cm collection of fibroadipose tissue. containing lymph node candidates. The specimen is divided to reveal the. presence of possible lymph nodes measuring from 0.3 to 0.5 cm. The specimen. is submitted entirely. Summary of sections: 9A, 2/1; 9B, 2/1; 9C, 2/1. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Epiglottis. FROZEN SECTION DIAGNOSIS: SQUAMOUS CELL CARCINOMA. 2) SOURCE: Post Cricoid. FROZEN SECTION DIAGNOSIS: BENIGN. 3) SOURCE: Left Hypopharynx. FROZEN SECTION DIAGNOSIS: BENIGN. 4) SOURCE: Right Hypopharynx. FROZEN SECTION DIAGNOSIS: BENIGN. The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: 1xDECALCIFICATION. In some tests, analyte specific reagents (ASRs) are used. In the case of. an ASR, this test was developed and its performance characteristics. determined by this laboratory. It has not been cleared or approved by the. US Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for clinical. purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (CLIA '88) as qualified to perform high complexity. clinical laboratory testing.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Histopathology Report. SUPPLEMENTARY REPORT BELOW (22/2). HISTORY. LU lobectomy. Past history Hutchinson's melanotic freckle. MACROSCOPIC. Two specimens received. 1: The specimen is labelled left upper lobe' and consists of a lobectomy. specimen measuring in its partially inflated state 210 x 150 x 50 mm. Two. separate bronchi are seen at the hilum ranging in size from 10 to 12 mm in. diameter (lying approximately 30 mm apart). Surrounding the two bronchi is a. bare area measuring 55 mm in maximal diameter. A staple line is seen radiating. from the hilar to the periphery, it measures 80 mm in length. Differential. inking is as follows, the bare area is inked black and the staple line is. removed and inked blue. The pleural surface is tan to grey with a diffuse area. of induration over the lateral lower aspect of the lobe extending over the. lingular, which measures 60 mm in greatest dimension. There is also scarring. over the apex measuring 15 mm in greatest dimension. The cut surface of the. lung shows a centrally based/peri-bronchial tumour measuring 35 mm in greatest. dimension. It extends peripherally to focally abut the pleural surface. (posterior lateral). Definite macroscopic invasion of the pleura is not seen. The tumour has a white firm cut surface with focal areas of necrosis. It lles. 10 mm from the closest bronchial margin. A second firm tan nodule measuring 6. mm in greatest dimension in the apical portion of the lobe. It lies 2 mm from. the pleural surface (appears to abut the pleural surface) and over 70 mm to the. bronchial margin and 65 mm from the main tumour mass. There is normal. intervening lung. The residual lung shows moderate to severe emphysema and an. area of pleurally based fibrosis adjacent to the induration over the. lingular/lateral surface. [1A, bronchial margin; 1B, hilar lymph nodes; 1C-D,. TS through tumour with 1C including closest bronchial margin and 1D showing. extension to pleura; 1E-F, RS of tumour abutting pleural surface; 1G, second. possible tumour within apical aspect of lobe; 1H, RS of normal intervening lung. between main tumour mass and smaller tumour; 11, peri-bronchial lymph nodes;. 1J, area of fibrosis over lateral/lingular pleura; 1K, RS of emphysema within. upper portion of lobe]. 2: The specimen is labelled hilar lymph node left lung' and consists of over. ten fragments of what appears to be nodal tissue ranging in size from 2 mm to. the largest piece measuring 20 mm in greatest dimension. The fragments have. a. grey black cut surface. [BIT: 2A, largest plece bisected; 2B, multiple smaller. fragments]. MICROSCOPIC. 1: Sections reveal a moderate and poorly differentiated squamous cell. carcinoma. The tumour abuts but does not invade visceral pleura. The tumour. is clear of the bronchial resection margin. Within the confines of the tumour. there is focal vascular and lymphatic invasion. No perineural permeation by. tumour is seen. Peribronchial lymph nodes show reactive changes with sinus. histiocytosis, carbon pigment deposition and scattered flecks of birefringent. material in keeping with silicate. No tumour is identified within these nodes. Immediately adjacent to the tumour there is focal change within lung parenchyma. in keeping with obstructive pneumonitis characterised by focal organising. pneumonia, mild acute alveolitis, and a few collections of intra-alveolar foamy. macrophages. Marked emphysema is present. Associated with a mixed dust macule. there is a small non-necrotising granuloma. The separately described. macroscopic lesions represent foci of scarring and organising pneumonia. No. tumour is identified within these areas. 2: Sections of lymph node tissue reveal reactive changes with prominent sinus. histiocytosis, carbon pigment deposition and scattered flecks of birefringent. material in keeping with silicate. Reactive follicular hyperplasia is also. noted. Rare tiny ill-defined non-necrotising granulomata are also seen. focally. There is no evidence of malignancy. SUMMARY. 1&2: Left upper lobectomy with separately submitted left hilar lymph node: Moderately and poorly differentiated squamous cell carcinoma. Tumour size 35 mm in diameter. No visceral pleural invasion seen. Bronchial resection margin clear of tumour. Focal lymphatic and vascular invasion present within tumour. Peribronchial lymph nodes and separately submitted hilar lymph node not. involved by tumour. Pathological stage: pT2a NO. Emphysema, separate focal areas of scarring and organising pneumonia. T-28000 M-80703 P1-03000. SUPPLEMENTARY REPORT. No micro-organisms are identified with special stains Grocutt,. PAS; sections 1C and 2A). ANATOMICAL PATHOLOGY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT AXILLARY SENTINEL NODE #1, BIOPSY -. TWO SENTINEL LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). PART 2: LYMPH NODE, LEFT AXILLARY SENTINEL NODE #2, BIOPSY -. TWO SENTINEL LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). PART 3: BREASI, LEET, 12 O'CLOCK SEGMENTAL MASTECTOMY -. A. INFILTRATING MAMMARY CARCINOMA, WITH MIXED DUCTAL AND LOBULAR PHENOTYPES, NOTTINGHAM. GRADE 2/3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM. 3, MITOTIC ACTIVITY: 1, TOTAL SCORE: 7/9). B. THE INVASIVE CARCINOMA MEASURES 1.9 CM IN GREATEST DIMENSION (GROSS MEASUREMENT). C. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, SOLID TYPE. D. DCIS CONSTITUTES LESS THAN 5% OF THE TOTAL TUMOR MASS, AND IS PRESENT ADMIXED WITH THE. INVASIVE CARCINOMA. E. SURGICAL MARGINS ARE NEGATIVE FOR INFILTRATING CARCINOMA AND DCIS. INFILTRATING CARCINOMA. IS 0.3 CM FROM THE CLOSEST POSTERIOR MARGIN (3I). F. NO LYMPHOVASCULAR INVASION IDENTIFIED. G. FOCAL DUCTAL EPITHELIAL HYPERPLASIA. H. PREVIOUS BIOPSY SITE CHANGES. I. FIBROCYSTIC CHANGES WITH APOCRINE HYPERPLASIA AND SCLEROSING ADENOSIS. J. IMMUNOSTAIN FOR ESTROGEN RECEPTOR IS POSITIVE. NEGATIVE. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Upper outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 1.9 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS, Infiltrating lobular carcinoma. HISTOLOGIC TYPE: Classical. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: TUMOR TYPE, IN SITU: Solid, DCIS admixed with invasive carcinoma. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: negative. zero or 1+. COMMENT: invasive HER2/NEU: carcinoma show features of lobular carcinoma in H&E sections. ductal carcinoma The immunohistochemical (membranous stains stains for for E-. E-. The tumors cells show the patten of E-cadherin and strong. diffuse cytoplasmic stain for P120.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: In I) II) a moderately differentiated invasive carcinoma of the colorectal type with penetration of. all parietal layers and with vascular infiltration (G2, pT3, L1, V1), as well as free lymph nodes (0. of 13). Tumor classification: ICDO-DA M8140/3. G2, pT3, L1, V1, pNO (0 of 13), locally R0. M classification in the context of the oncology conference.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Total gastrectomy preparation with a focally poorly differentiated adenocarcinoma of mixed. partly diffuse and partly intestinal - type, with infiltration of the perigastric fatty tissue and. penetration of the serosa, as well as five regional lymph node metastases. Resection margins. in the region of the mucosa tumor-free.. Tumor classification (in conjunction with the preliminary findings). Adenocarcinoma of mixed type, 3, pT4 N1 (5/29) LO V0 RO.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PROCEDURE DATE: RECEIVED DATE: REPORT DATE: Pre-Op Diagnosis. Lung mass. Post-Op Diagnosis. Same. Clinical History. Nothing indicated on requisition. Gross Description: Container labeled. - right lower lobe of lung"" is a. 206 gram portion of recognizable pulmonary parenchyma grossly. consistent with right lower lobe of lung. The specimen as received. is 16.1 x 10.5 x 5.0 cm. The margin of resection is a previously. sectioned bronchi with multiple staple lines. The pleura is. wrinkled tan gray to brown and anthracotic streaked with a few. nodular gray tan plaques up to 0.1 cm. Noted in the apparent. lateral aspect in the central portion of the specimen there is a. previously sectioned area of indurated umbilication measuring on. reconstruction approximately 2.4 X 2.0 x 1.8 cm. This has been. previously sectioned to reveal a lobulated gray tan to brown nodular. lesion which grossly appears to extend to but not through the pleura. in this area. This appears at its nearest point approximately 3.6 cm. from the nearest bronchial margin. The remaining parenchyma is. slightly diffusely consolidated mottled gray tan to pink with. anthracotic streaking and focal areas of gross emphysematous change. No other gross lesions are identified. Also received in the same. container are three tissue cassettes each labeled. Representative sections are submitted labeled as. follows: A - shaved apparent bronchial margin, B through E - entire. remaining lesion and surrounding tissue, F - representative pleura. with nodular plaques, G - representative remaining parenchyma. Container labeled. lymph node right lung"". is a 2.0 x 2.0 x 1.0 cm portion of tan yellow fibroadipose tissue. which has an embedded 1.1 cm gray brown fleshy nodule. The nodule. is bisected and entirely submitted in a single cassette. Container labeled. lymph node right lung"". is a 2.3 x 1.5 X 0.6 cm slightly friable nodular portion of focally. shaggy fleshy gray brown to black tissue which on sectioning has a. mottled gray black fleshy cut surface. The bisected nodule is. entirely submitted in two cassettes. Container labeled. lymph node right lung"" are. 2.9 x 2.0 x 1.3 cm aggregate of gray yellow to brown black. fibrofatty tissue fragments with areas of fleshy gray black. discoloration. The specimen is sectioned and entirely submitted in. two cassettes. Container labeled. lymph node right. lung"" are 1.2 x 0.9 x 0.4 cm fleshy gray black tissue fragments. entirely submitted in a single cassette. Container labeled. right lung middle lobe wedge"". is a 17 gram roughly wedge-shaped portion of recognizable pulmonary. parenchyma having an intact staple line at the margin of resection. The specimen overall is 14.4 x 2.5 1.5 cm. The pleura is focally. shaggy mottled gray tan to brown with focal anthracotic streaking. and areas of focal fragmentation. On sectioning the parenchyma is. homogeneous and spongy with a slightly mottled tan brown cut. surface. No gross lesions or cystic structures are identified. Representative sections are submitted in eight cassettes. Microscopic Description: The slides labeled. are examined. See diagnosis. Final Diagnosis. Lung, right lower lobe of lung (lobectomy): Tumor characteristics: Specimen integrity: Intact. Specimen laterality: Right. Tumor site: Lower lobe. Tumor size: 2.4 cm in greatest diameter. Tumor focality: Unifocal. Histologic type: Adenocarcinoma (see comment). Histologic grade: Poorly differentiated. Visceral pleural invasion: Not identified, carcinoma extends up to. but not into pleura. Tumor extension: Not identified. Treatment effect: Not identified. Lymphovascular space invasion: No unequivocal lymphovascular space. invasion identified. Surgical margin status: Bronchial surgical margin: No carcinoma identified. Pleural margin: No carcinoma identified. Distance of tumor from closest margin: Less than 1 mm from the. pleural margin. Lymph node status: One peribronchial lymph node demonstrating no metastatic carcinoma. (0/1). PAS 9. Other: Areas of subpleural fibrosis with interstitial fibrosis,. interstitial chronic inflammation. PAS 4,6. Emphysematous changes. PAS 4. Focal subpleural bone formation. PAS 4. pTN stage: pT1b NO. Level 9 lymph node, right lung (biopsy): Reactive sinus histiocytosis and anthracosilicosis, no metastatic. carcinoma identified within one. lymph node (0/1). PAS 4. Level 7 lymph node, right lung (biopsy): Reactive sinus histiocytosis and anthracosilicosis, no metastatic. carcinoma identified within one. lymph node (0/1). PAS 4. 4R lymph node, right lung (biopsy): Multiple fragments of lymph node demonstrating reactive sinus. histiocytosis and. anthracosilicosis, no metastatic carcinoma identified (see. comment). PAS 4. Level 10 lymph node, right lung (biopsy): Fragments of lymph node demonstrating reactive sinus histiocytosis. and anthracosilicosis, no. metastatic carcinoma identified (see comment). PAS 4. Right lung middle lobe (wedge biopsy): Subpleural fibrosis and foci of interstitial fibrosis. Scattered areas of interstitial chronic inflammation. Emphysematous changes. Intraalveolar macrophages. No carcinoma identified. PAS 4,6 SPC-A. Comments. This is staged as a pT1b lesion based on the size of 2.4 cm in. greatest diameter. The final stage should be performed in. conjunction with the clinical information. Sections of the tumor show a poorly differentiated large cell. carcinoma. A panel of immunohistochemical stains is performed. including CK5/6, p63, TTF1 and CK7 (with appropriate positive and. negative controls). The neoplastic cells are positive for TTF1 and. CK7. The neoplastic cells are negative for CK5/6 and p63. The. overall histologic appearance in conjunction with the. immunohistochemical stains is consistent with a poorly. differentiated adenocarcinoma. In addition, some dense eosinophilic. collagenous scar tissue is present suggesting this may have. represented a so-called scar carcinoma. The carcinoma extends up to. but not into the visceral pleura, being separated from the pleural. margin by less than 1 mm. Clinical correlation and follow up is. recommended. At the request of the undersigned pathologist, these slides have. been additionally reviewed by. who concurs with the. diagnosis. This test has been finalized at the. This test was developed and its performance characteristics. determined by. Laboratory. It has not been. cleared or approved by the U.S. Food and Drug Administration. The. FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded. as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. as qualified to perform high complexity clinical. laboratory testing.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: ith metastatic renal cell carcinoma. Cytoreductive right nephrectomy. Specimens Submitted: 1: SP: Portion of right adrenal. 2: SP: Right kidney and adrenal gland. 3: SP: Hilar lymph nodes, right. DIAGNOSIS: 1). PORTION OF RIGHT ADRENAL GLAND; EXCISION: - FRAGMENTS OF BENIGN ADRENAL TISSUE,. 2). KIDNEY AND ADRENAL GLAND, RIGHT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE II/IV. - THE PATTERN OF GROWTH IS SOLIDAND ACINAR. - THE TUMOR'S GREATEST DIAMETER IS 9.0 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - THE TUMOR EXTENDS INTO THE RENAL PELVIS AND INVOLVES SINUS ADIPOSE TISSUE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. HOWEVER, TUMOR CELL CLUSTERS IN SMALL VEINS ARE. IDENTIFIED. - THE NON-NEOPLASTIC KIDNEY SHOWS INTERSTITIAL CHRONIC INFLAMMATION. - THE ADRENAL GLAND is UNREMARKABLE,. 3). LYMPH NODES, RIGHT HILAR; EXCISION: - TWO BENIGN LYMPH NODES (0/2). Gross Description: 1). The specimen is received fresh, labeled ""Portion of Right Adrenal"". It consists of a small segment of adrenal tissue with. a. small amount of adipose tissue attached measuring 2,0 x 2.0x0.8 cm in total. A staple line is attached to the specimen. The. specimen is sectioned and entirely submitted. Summary of Sections: A - adrenal gland. 2). The specimen is received fresh, labeled ""Right Kidney and Adrenal Gland"". It consists of a radical nephrectomy. specimen weighing in total 820 grams and it has a large amount of perinephric adipose tissue attached. A portion of adrenal. gland is identified measuring 3.0 x 1.0 x 0.8 cm. A segment of proximal ureter is also identified measuring 5.0 cm in length and. 0.3 cm in diameter. Grossly, the ureteral resection margin and the renal hilar vessel margin are free of tumor. The. specimen. is. bivalved from lateral to medial aspect to reveal a kidney measuring 12.0 x 10.0 x 8.0 cm in which a large tumor mass measuring. 9.0 x 8.0 x 7.0 cm is identified, and is replacing almost the entire kidney with a small portion of uninvolved renal parenchyma in the. inferior pole of the kidney. The tumor mass has a variegated cut surface ranging from tan-white, focally hemorrhagic area to. gelatinous and multiloculated cystic area. The tumor mass grossly extends to but not through the renal capsule. Grossly, tumor. mass extensively replaces the renal parenchyma and renal pelvis with focal evidence of invading into the renal pelvis. No gross. evidence of renal vein invasion is identified. A portion of tumor is submitted for TPS. Gross photograph taken. Representative. sections are submitted. Summary of Sections: A - adrenal gland. UM - urethral margin. VM - hilar vessel margin. TP - tumor invading renal pelvis. T - tumor mass and adjacent renal capsule and renal parenchyma. K - uninvolved renal parenchyma. 3). The specimen is received in formalin, labeled ""Hilar Lymph Nodes, Right"". It consists of multiple fragments of tan-yellow. adipose tissue aggregating to 3.5 cm. In the adipose tissue, multiple presumptive lymph nodes are identified. The largest lymph. node measures 0.6 cm. Lymph nodes are submitted. Summary of Sections: BLN - bisected lymph nodes. Summary of Sections: Part 1: SP: Portion of right adrenal. Block. Sect. Site. PCs. 1. A. 5. Part 2: SP: Right kidney and adrenal gland. Block. Sect. Site. PCs. 1. A. 1. 1. K. 1. 8. T. 8. 2. TP. 2. 1. UM. 1. 1. VM. 2. Part 3: SP: Hilar lymph nodes, right. Block. Sect. Site. PCs. 2. BLN. 4.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Surgery Date: DIAGNOSIS. (A) LEFT KIDNEY, ADRENAL AND PERIHILAR LYMPH NODES: RENAL CELL CARCINOMA, CONVENTIONAL (50% CLEAR CELLS AND 50% EOSINOPHILIC CELLS) WITH. FOCAL RHABDOID CELLS, FUHRMAN'S NUCLEAR GRADE 4. TUMOR EXTENDS INTO THE RENAL SINUS ADIPOSE TISSUE. TUMOR MEASURES 6.3 CM IN MAXIMUM DIMENSION. VASCULAR/LYMPHATIC INVASION PRESENT. Vascular, ureteral and soft tissue margins of resection free of tumor. Adrenal gland, no tumor present. GROSS DESCRIPTION. (A) LEFT KIDNEY, ADRENAL GLAND AND PERIHILAR LYMPH NODES - A 19.5 x 11.5 x 5.7 cm nephrectomy specimen including a 13.8 x. 8.0 x 5.3 cm kidney with attached 9.5 x 0.5 cm ureter and overlying 5.5 x 2.4 x 0.5 cm adrenal gland. There. is a 6.3 x 5.5 x 5.4 cm, well-circumscribed yellow-tan, hemorrhagic and necrotic tumor in the upper pole. The tumor is grossly. appears to be confined to within the kidney but focally pushing the renal sinus adipose tissue. The renal pelvis and renal hilum is. uninvolved. tumor, as well as is the renal vein, renal artery and renal ureter. The surgical margins of resection are free of tumor. No. lymph nodes are identified in the hilum of the kidney. Portions. of. tumor. and. normal parenchyma are submitted to tissue bank. Portion of tumor is submitted to possible electron microscopic. studies. SECTION CODE: A1, renal artery, renal vein and renal ureter margin (en face); A2, A3, representative sections of tumor in relationship. to renal pelvis/hilum; A4, A5, representative sections of tumor in relationship to overlying capsule; A6-A8, additional sections of tumor;. A9, normal renal parenchyma; A10, normal adrenal gland. CLINICAL HISTORY. Mass, renal left. SNOMED CODES. T-71000, M-83123, T-B3000, M-00110. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Colon resection material includes a mucinous, moderately differentiated adenocarcinoma of the. colorectal type, showing circular growth and measuring a maximum of 5 cm in diameter with. widespread infiltration of the pericolic fatty tissue and with five regional lymph node metastases. Tumor-free colon resection margins. Close to one resection margin a clip-marked mucosal defect. with florid inflammatory lesions and fibrin insudation of the submucosa, evidently in status post. excision of a polyp or a neoplasia (see previous finding. Tumor stage: pT3 pN2 (5/30) M1 (clinically liver metastases); G2, L0, V0, clinically R2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 1. PATIENT NBR: SEX: F. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: PROCEDURE: with. history of dysphagia, heartburn, regurg and weight. loss. Adenocarcinoma of distal esophagus. Operative Procedure: Esophagectomy. PROCEDURE: 1. ""Thoracic esophagus. A 15 cm long segment of esophagus and 2 x 3 cm. proximal stomach. The specimen is received open. Near the GE junction there is. a 3.5 x 2 cm ulcerated mass with depth of invasion 1.3 cm all the way through. muscularis propria and closely approximating to serosal surface. The mass. occupies 70% of the lumen circumference and with marked Lumen occlusion. Tumor. closely approximates the distal gastric surgical margin within 0.2 cm. The. remaining esophagus and stomach are grossly unremarkable. Several gross. positive lymph nodes identified, up to 1 cm in greatest dimension with no. obvious actual capsular extension. 1A-B. Tumor with deepest invasion and adjacent gastric mucosa. 1C-D. Tumor with deepest invasion with adjacent esophagus. 1E. Tumor with closest distal surgical margin after shaving the stapled. mucosa. 1F. Shaved stapled gastric mucosa. 1G. Normal appearing GE junction overlying the tumor. 1H. Normal appearing esophagus and unremarkable gastric mucosa. 11. Grossly positive Lymph nodes. Sectioned. 1J. Two grossly positive lymph nodes. Larger bisected and inked yellow. 1K. Grossly unremarkable lymph nodes. 1L. Grossly unremarkable lymph nodes. 2. ""Proximal cervical margin."" A 0.5 cm long segment of unremarkable. esophagus. 3. ""Lesser curve lymph node."" Two 0.3 to 0.5 cm lymph nodes. PROCEDURE: VERIFIED 8Y: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. If adenocarcinoma, is it arising in Barrett's mucosa, gastric cardia, or. GE. junction: GE junction. Depth of invasion: Adventitia. PREVIOUS DIAGNOSIS INQUIRY. 2. REPORT DATE: PATIENT NBR: SEX: F. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: Number of positive Lymph nodes, the total number sampled is irrelevant: 7/10. Extranodal metastasis: None. Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T3 N1 Mx. PROCEDURE: 1. Esophagus and proximal stomach, resection: Adenocarcinoma arising at the. GE junction with extension to perigastric and eriesophageal adipose tissue. Free margins of excision. Seven of 10 Lymph nodes positive for carcinoma. See. template. 2. Segment of esophagus, resection: Negative for carcinoma. 3. Lymph node of Lesser curvature of stomach, excision: One of two lymph. nodes positive for carcinoma. 1,. , the signing staff pathologist, have personally examined and. interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Final Pathologic Diagnosis: A. Lymph node, 4R lower paratracheal, excision: No significant pathologic change (1). Lymph node, 5 AP window, excision: No significant pathologic change (1). Lymph node, 2R upper paratracheal, excision: No significant pathologic change (1). Lymph node, 8R para-esophageal, excision: Lymphoid hyperplasia. Lymph node, 9 inferior pulmonary ligament, excision: No significant pathologic change (1). Lymph nodes, 10R, tracheobronchial, excision: No significant pathologic change (3). B. Lung, right lower lobe, excisional biopsy: Poorly differentiated adenocarcinoma involving the pleura, but not the. pleural margin (T2, NO, MX); bronchial margin free of tumor. Lymph nodes, right lobar and intralobar, excision: Granuloma (1/8). The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSA: Lung, right lower and middle, pleural margin: Margins are negative. Gross Description: The specimen is received in two parts, each with the patient's name, "". A. Part A consists of a lymph node box. Compartment number four - lower. paratracheal, consists of a 1.0 X 0.5 X 0.3 cm. gray-yellow to brown-black. pigmented lymph node which is submitted in toto in cassette ""A 1"". Compartment number five - AP window, consists of a 0.5 X 0.5 X 0.3 cm.,. brown-black, pigmented, rubbery tissue grossly consistent with lymph node which. is submitted in toto in cassette ""A 2"". Compartment number two - upper paratracheal, consists of a 0.8 X 0.3 X 0.2 cm. brown-black, rubbery tissue which is grossly consistent with lymph node and. submitted in toto in cassette ""A 3"". Compartment number eight - para esophagus, consists of two irregular, pink-tan. to brown-black, rubbery tissues with dimensions of 1.0 X 0.8 X 0.4 cm. and 5.0 X. 2.0 X 0.8 cm. The smallest tissue is grossly consistent with lymph node and is. submitted in toto in cassette ""A 4"" while the largest tissue is grossly. consistent with confluence of lymph node which is quadrisected and entirely. submitted in cassettes ""A 5-8"". Compartment number nine - inferior pulmonary ligament, consists of a 0.9 X 0.4. X. 0.3 cm. gray-tan to brown-black, rubbery tissue which is submitted in toto in. cassette ""A 9"". Compartment number ten- tracheobronchial, consists of three gray-tan to. brown-black, rubbery tissues ranging from 0.4 to 1.0 cm. The tissues are. grossly consistent with lymph nodes. The two smallest tissues are submitted in. toto in cassette ""A 10"" while th largest is bisected and entirely submitted in. cassette ""A 11"". B. Part B, received fresh for intraoperative consultation, labeled ""right lower. and middle lobe of lung pleural margin"", consists of a 340.0 gm. product of a. right middle and lower lobectomy. The hilar structures are grossly identified. and are surgically ligated. There are few hilar and peribronchial lymph nodes. identified. Within the lateral segment of the middle lobe is a large palpable. mass. The overlying pleura shows umbilication and granularity in an area that. has dimensions of 6.0 X 1.5 cm. The remaining pleura is gray-purple with mild. anthracotic pigment. Sectioning through the lung reveals a red-purple spongy. parenchyma that is remarkable for a large gray-tan, granular mass that is 2.8. cm. from the bronchial margin. The 6.3 X 4.7 X 4.5 cm mass is just subjacent to. the aforementioned area of pleural umbilication and granularity. Additionally,. the mass shows a central cavitation. The lower lower is grossly unremarkable. A portion of the pleural margin has been submitted for frozen section diagnosis. and the residue resubmitted for permanents labeled ""B 1"" while additional. representative sections are submitted as labeled: ""B 2"" bronchial margin; ""B 3"". vascular margin; ""B 4-7"" representative sections of aforementioned mass; ""B 8"". representative sections of normal most lung parenchyma; ""B 9-10"" five lymph. nodes submitted in toto; ""B 11"" two bisected lymph nodes; ""B 12"" a single. trisected lymph node. Microscopic Description: A microscopic examination is performed.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. LEFT BREAST. D. LEFT BREAST SKIN. E. RIGHT BREAST TISSUE. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. LEFT BREAST. D. LEFT BREAST SKIN. E. RIGHT BREAST TISSUE. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA/TPB-SLN #1, #2: Negative for carcinoma. Diagnosis called by Dr. to Dr. at. (A,B). GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification and ""sentinel LN #1"" is a fragment of yellow fibroadipose. tissue, 5 x 3 x 1 cm containing a lymph node measuring 2 x 1 x 0.9 cm. The lymph node is sectioned and a touch. prep performed; lymph node submitted entirely in A1. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with the patient's identification and ""sentinel LN #2"" is a fragment of yellow fibroadipose. tissue measuring 2.5 x 1.5 x 1 cm containing a 1.5 x 1 x 0.9 cm lymph node. It is sectioned, a touch prep is. performed, and lymph node is submitted entirely in B1. C. LEFT BREAST. Received fresh labeled with the patient's identification and ""left breast"" is an oriented 1408 g, 28 x 20 x 4 cm. mastectomy with 17 x 7 cm skin ellipse and a 0.9 cm everted nipple. Ink code: Anterior/superior-blue,. anterior/inferior-orange, posterior-black. Specimen is serially sectioned into 12 slices from lateral to medial with. nipple in slice 7 revealing a 7.2 x 5.8 x 3.2 cm ill-defined infiltrating mass extending from the 12 to 3 o'clock positions. in the upper outer quadrant in slices 3-7 that is closest to the anterior margin at 1.2 cm. In the axillary region is a. possible lymph node, 2.3 x 1.5 x 0.6 cm. Representatively submitted: C1: slice 2, UOQ lateral to lesion. C2-C3: slice 3, UOQ lesion (bisected). C4: slice 4, UOQ superior portion of lesion. C5-C6: slice 4, UOQ lesion (bisected). C7: slice 4, LOQ inferior lesion. C8: slice 5, UOQ superior to lesion. C9: slice 5, posterior margin (grossly closest deep margin). C10: slice 6, mid section including lesion. C11: slice 7, mid section. C12: slice 8, medial to lesion. C13: slice 9, UIQ. C14: slice 11, LIQ. C15: slice 2, LOQ. C16: slice 1, UOQ. C17: possible lymph node. C18-C19: skin and nipple (bisected perpendicular sections). D. LEFT BREAST SKIN. Received in formalin labeled with the patient's identification and ""left breast skin"" is an unoriented tan pink skin. excision 32 x 1cm excised to a depth ranging from 0.4cm to 1.8cm. The skin surface is grossly unremarkable. Representatively submitted in D1-D2. E. RIGHT BREAST TISSUE. Received in formalin labeled with the patient's identification and ""right breast tissue"" is a 236g, 27 x 12 x 5.4cm. aggregate of fibrofatty tissue with attached unremarkable tan pink skin 10.5 x 4.3cm. The specimen is serially. sectioned to reveal unremarkable breast parenchyma. Representatively submitted in B1-B2. DIAGNOSIS: A. SENTINEL LYMPH NODE 1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE 2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. BREAST, LEFT SIMPLE MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, WITH MUCINOUS. FEATURES. - INVASIVE CARCINOMA MEASURES AT LEAST 3 CM. - MARGINS, FREE OF TUMOR. - DUCTAL CARCINOMA IN SITU (DCIS), MICROPAPILLARY, PAPILLARY,. CRIBRIFORM, AND SOLID TYPES, NUCLEAR GRADE 2, WITH NECROSIS. - SKIN, NIPPLE, AND SKELETAL MUSCLE, NO TUMOR SEEN. NOTE: The tumor involves the upper outer quadrant and consists of multiple foci of invasive carcinoma admixed with. DCIS. On a single. slide, the largest focus of invasive carcinoma measures at least 3 cm. Invasive carcinoma spans. an area - 7 cm. D. SKIN, LEFT BREAST, EXCISION: - SKIN, NO TUMOR SEEN. E. BREAST, RIGHT, EXCISION: - APOCRINE METAPLASIA AND STROMAL FIBROSIS. - BENIGN SKIN. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor Site: Upper outer quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Lymph node status: Negative 0/2. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 35%. DCIS Type: Solid. Cribriform. Micropapillary. Papiliary. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT2N0. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY;. Multicentric cancer left breast; two areas were core biopsy showed invasive cancer. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 21. CLINICAL EXPERIENCE: Patients with a recurrence score of: 21 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 14%. ER Score: 12.1 Positive. PR Score: 5.5 Positive. Her2 Score: 10.3 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Final Review: Pathologist, (. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Surgery date: REVISED REPORT (Revised information underlined). DIAGNOSIS: A. Liver, left lobe nodule, biopsy: Bile duct hemartoma. B. Lymph node, hepatic artery, biopsy: A single (1) lymph node is. negative for tumor. C. Pancreas, neck margin, excision: Negative for tumor. D. Body and tail of pancreas, spleen, and portion omentum; distal. pancreatectomy: Invasive, well-differentiated (grade 2 of 4). adenocarcinoma involving an area measuring 6.8 x 4.0 x 2.6 cm. The. tumor is confined to the pancreas. Extensive perineural invasion is. present. Lymphovascular invasion is not identified. The adjacent. non-neoplastic pancreatic parenchyma shows chronic pancreatitis. The spleen is uninvolved. A single (of 33) regional. lymph node is positive for metastatic adenocarcinoma. All surgical resection margins are negative for tumor. With available surgical material, [AJCC pT2 N1. (7th edition, 2010). Frozen section histologic interpretation of nodule left lobe liver,. hepatic artery lymph node, and neck of pancreas margin performed by: This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. AMENDMENTS: (Previous Signout Date: Revision Description: A lymph node was found to be positve for. metastatic adenocarcinoma. Diagnosis is changed accordingly. Original Diagnosis. A. Liver, left lobe nodule, biopsy: Bile duct hemartoma. B. Lymph node, hepatic artery, biopsy: A single (1) lymph node is. negative for tumor. C. Pancreas, neck margin, excision: Negative for tumor. D. Body and tail of pancreas, spleen, and portion omentum; distal. pancreatectomy: Invasive, well-differentiated (grade 2 of 4). adenocarcinoma involving an area measuring 6.8 X 4.0 x 2.6 cm. The. tumor is confined to the pancreas. Extensive perineural invasion is. present. Lymphovascular invasion is not identified. The adjacent. non-neoplastic pancreatic parenchyma shows chronic pancreatitis. The spleen is uninvolved. Multiple (33) regional lymph nodes are. negative for tumor. All surgical resection margins are negative for. tumor. With available surgical material, [AJCC pT2N0] (7th edition, 2010). Frozen section histologic interpretation of nodule left lobe liver,. hepatic artery lymph node, and neck of pancreas margin performed by: This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""nodule left lobe liver"" is a 0.6 X 0.3 x. 0.2 cm aggregate of pale tan soft tissue with a 0.1 x 0.1 x 0,1 cm. white plaque within it. All submitted. Grossed by. B. Received fresh labeled ""hepatic artery lymph node"" is a 1.8 x 1.6. x 0.9 cm lymph node. All submitted. Grossed by. C. Received fresh labeled ""neck of pancreas margin up"" is a 2.8 X. 1.7 X 0.8 cm portion of neck of pancreas with orientation. Margin. submitted. Grossed by. D. Received fresh labeled ""body and tail of pancreas, spleen,. portion of omentum"" is a distal pancreatectomy specimen consisting. of 7.2 X 4.1 x 3.8 cm portion of pancreas and a 165.0 gram, 10.8 X. 7.7 x 5.2 cm spleen and a 14.8 x 11.4 X 2.6 cm portion of omentum. A 6.8 X 4.0 X 2.9 cm firm white fibrous mass is present within the. pancreas, 1.1 cm from the proximal pancreatic margin. The mass does. not appear to be confined to the pancreas, grossly. The. peripancreatic soft tissue is inked. Peripancreatic lymph nodes and. splenic hilar lymph nodes are identified. The spleen is grossly. unremarkable. Representative sections are submitted. Grossed by. BLOCK SUMMARY: Part A: Nodule left lobe liver. 1 Nodule Lt lobe liver. Part B: Hepatic artery lymph node. 1 Hepatic artery LN lof2 (B1). 2 Hepatic artery LN 2of2 (B1). Part C: Neck of pancreas margin. 1 Pancreatic neck margin 1. 2 Pancreatic neck margin 2. Part D: Body and tail of pancreas, spleen, portion omentum. 1 Proximal pancreas. 2 Pancreas mass splenic artery. 3 Dist pancreatic mass. 4 Pancreas w/post soft tissue. 5 Dist pancreatic mass 2. 6 Spleen. 7 Peripancreatic LN 3(D1). 8 Peripancreatic LN 5(D2). 9 Peripancreatic LN 5(D3). 10 Peripancreatic LN 5(D4). 11 Peripancreatic LN 5(D5). 12 Peripancreatic LN 4(D6). 13 Peripancreatic LN 1(D7). 14 Peripancreatic LN 1(D8). 15 Peripancreatic LN 2(D9).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
F. Pathologic Interpretation: A. Sentinel node #1 CT. -Metastatic carcinoma in one lymph node. Please see comment. Comment: The tumor is seen on deeper section. Tumor is not identified in frozen section slide. Immunostain for keratin Is used in the interpretation. B. Sentinel node#2. -No malignancy seen In one lymph node (0/1). -Imunostain for keratin is negative. C. Right breast: -Invasive tubulolobular carcinoma, low nuclear grade, Nottingham histologic score grade I. Resection margins are free of tumor. -Microcalcifications are present. Dr. concurs. Please see Tumor Summary. TUMOR SUMMARY: Specimen Type: Mastectomy. Lymph Node Sampling: Sentinel lymph node(s) only. Laterality: Right. Tumor Site: Upper inner quadrant. Size of invasive component: Greatest dimention: 1 cm. Additional dimensions: 1 x 0.6 cm. Histologic Type: Invasive tubulolobular. Histologic Grade: Nottingham Histologic Score: Tubule Formation: Moderate (score=2). Nuclear Pleomorphism: Small (score=1). Mitotic count: Less than 10 mitoses per 10 HPF (score =1). Total Nottingham Score: Grade I. Pathologic Staging: Primary Tumor: pT1b. Regional lymph nodes: pN1a. Distant Metastasis: pMX. Margins: Margins uninvolved by invasive carcinoma. Distance from closest margin: 4 mm. Specify margin: Deep (posterior). Venous/lymphatic: Absent. Comments: Tumor cells are positive for ER and PR and negative for Her2 and by immunohistochemistry. NOTE: Some immunohistochemical antibodies are analyte specific reagente (ASRs) validated by our laboratory (Her 2. Pervo, H. pylori, H8core). Thase ASRs are clinically useful indicators that. do. not require FDA approval. These clones are used: IDS-ER, POR 636-PR, A485-HER2. H-11=EGFR, CCH2/DOG9=CMV, F30.4 THAR and HPV by ISH. All immunohistochemical stains are used. with formalin or molecular fixed, paraffn embedded tiesue. Detection is by LSAB. The reaults are read by a pathologiet as positive or negative. SURGICAL PATHOL Report. As the attending patthologist, / attest that I: (i) Examined the relevent. preparation(s) for the specimen(s); and ("") Rendered the diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. C. The tumor cells are positive for E-Cadherin by immunohistochemistry. This immunophenotype is most consistent with an infiltrating ductal carcinoma. Intraoperative Consultation. AFS: No malignancy seen in one lymph node examined. BFS: No malignancy seen in one lymph node examined. Clinical History: Patient is a -year-old female with right breast cancer. Pre Operative Diagnosis: Not Provided. Specimen(s) Received: A: sentinel node #1 CT (. B: sentinel node#. C: right breast ( 1 suture superior, 2 sutures lateral ). Gross Description: A. Received fresh and labeled ""sentinel node #1 CT. )"" is a fragment of adipose tissue measuring 2.0 x 1.0 x 0.5 cm. The lymph node is bisected and submitted in toto for frozen section. B. Received fresh and labeled ""sentinel node#. is a fragment of adipose tissue measuring 0.6 x 0,5 x 0.5 cm. The. lymph node is bisected and submitted in toto for frozen section. C. Received in formalin and labeled ""right breast (1 suture superior, 2 sutures lateral)"" is oriented with one suture superior. and two sutures lateral. The specimen weighs 127.0 grams and measures 16.0 x 11.0 x 0.9 cm. The specimen consists. of a nipple and areola, which measures 3.3 x 2.5 cm. There is no retraction or scar. The specimen is inked as follows: superior, blue; inferior, green; medial, red; lateral, orange; posterior (tip), black; anterior, yellow. Cut section revealed a. scar-like, firm lesion is identified in the upper inner quadrant, which measures 1.0 x 1.0 x 0.6 cm. It is located 0.4 cm from. the deep margin, 2.0 cm from the superior margin, 3.0 cm from the medial margin, and 6.2 cm from the inferior margin. The stroma to fat ratio is 70:30. No other masses or lesions are identified. Sections are submitted as follows: 1-4. Mass in toto. 5. Upper inner quadrant. SURGICAL PATHOL Report. 6. Lower inner quadrant. 7. Upper outer quadrant. 8. Lower outer quadrant. 9. Nipple. ICD-9(s): 196.3 174.2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. Breast right, wide local excision: Infiltrating ductal carcinoma, Nottingham grade III (of III),. forming a mass, 1.2 x 1.1 x 0.9 cm. (AJCC pTIc). Angiolymphatic invasion is not identified. The surgical margins are negative for tumor. The closest margin (inferior) is free by 0.3 cm. Lymph nodes, right axillary sentinel, excision: Multiple (2) right axillary sentinel lymph nodes. are negative for tumor. Blue dye is not identified in either of the right axillary sentinel lymph. nodes. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel. lymph node tissue and confirms the H&E impression [AJCCpTN(i-)]. Lymph nodes, right axillary, excision: Multiple (6) right axillary lymph nodes are negative for. tumor. HER2/neu protein overexpression is negative, score of 0, according to the interpretation. guidelines in the FDA-approved HercepTest.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL PATHOLOGIC DIAGNOSIS. A. Lymph node, right sentinel #1, excision: - One lymph node involved by metastatic carcinoma (1/1). B. Lymph node, right sentinel #2, excision: - One lymph node, negative for carcinoma (0/1). C. Lymph node, right sentinel #3, excision: - One lymph node, negative for carcinoma (0/1). D. Lymph node, right sentinel #4, excision: - One lymph node, negative for carcinoma (0/1). E. Breast, right, wire-localization lumpectomy: - Invasive ductal carcinoma, grade III/III, 2.0 cm in greatest dimension,. surgical margins negative (see pathologic parameters and comment below). - Previous biopsy site. Breast Pathologic Parameters. 1. Invasive carcinoma: A. Gross measurement: 2.0 cm. B. Composite histologic (modified SBR) grade: III/III. C. Associated intraductal carcinoma in situ (DCIS/LCIS): None. 2. Excisional biopsy margins: Free of tumor. - Invasive carcinoma 6.0 mm from closest margin (posterior). 4. Blood vessel and lymphatic invasion: Present in breast parenchyma. 5. Axillary lymph nodes: One of four sentinel lymph nodes involved by carcinoma. (1/4). - Size of largest metastatic deposit: 5.0 mm. - Extranodal extension: present (2.0 mm; largest focus). 6. Special studies (see. - ER: No expression. - PR: No expression. - Her2/neu antigen (FISH): Non-amplified (ratio: 1.91). 7. pTNM (AJCC, 7th edition, 2010): pT1c, N1(sn), MX. Clinical History: The patient is a. year-old female with breast cancer undergoing lumpectomy. Comment. Immunohistochemical stains show the tumor cells to be positive for CK7 and. negative for CK20 and TTF-1, consistent with the above diagnosis. D240 stain is. noncontributory. Specimens Received: A: Sentinel node #1. B: Sentinel node #2. C: Sentinel node #3. D: Sentinel node #4. E: Right breast partial; lumpectomy. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, 'sentinel node #1'. Received fresh and placed in formalin the specimen consists of a 4 X 3 X 1.2. lymph node. Specimen is serially sectioned and entirely submitted in cassettes. A1-A8. B. The second container is additionally identified as, 'sentinel node #2'. Received fresh and placed in formalin the specimen consists of a 1 X 1x 0.5 cm. lymph node. Specimen is entirely submitted in cassette B1. C. The third container is additionally identified as, 'sentinel node #3'. Received fresh and placed in formalin the specimen consists of a 1 X 1 X 1 cm. lymph node. Specimen is bisected and entirely submitted in cassette C1. D. The fourth container is additionally identified as, 'sentinel node #4'. Received fresh and placed in formalin the specimen consists of a 2 X 1 X 1 cm. lymph node. Specimen is serially sectioned and entirely submitted in cassette. D1. E. The fifth container is additionally identified as, 'right breast partial. mastectomy'. Received fresh on a radiographic grid is a 96.5 gm lumpectomy. specimen measuring 8.0 cm from medial to lateral, 8.5 cm from superior to. inferior and 3.0 cm from anterior to posterior. The specimen is oriented with a. short suture designating the superior pole and a long suture designating the. lateral pole. There is a wire entering at the superomedial aspect of the. specimen at grid C2. Accompanying the specimen is an x-ray demonstrating a. metallic clip located in grid position D3. The wire terminates in grid position. D4. There is a circled mass in grid positions C3-D3, D4. The margins are inked. as follows: anterior- black posterior - red superior - blue inferior - green. medial - yellow lateral - violet The specimen is serially sectioned from lateral. to medial into 8 slices. There is a 2.0 X 2.0 x 1.5 cm lesion located in slices. 5 to 7. It is located 1.6 cm from the black margin, 0.6 cm from the red margin,. 1.4 cm from the blue margin and 4.5 cm from the green margin. A metallic clip is. identified in slice #5. The wire enters the specimen in slice #6 and terminates. in slice #7. Tissue is banked from slices 4 and 6. Lumpectomy is entirely. submitted. E1-E5: slice 1, medial margin. E4-E10: slice 2. E11-E17: slice 3. E18-E28 : slice 4. E29-E41 : slice 5 (clip in E29-E31). E42-E52: slice 6 (mass in E42-E43). E53-E65: slice 7. E66-E83: slice 8. Tissue fixed for at least 6 hours in 10% NBF and no more than 72 hours.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
SurgicalFinal Report. l'emporary. orderediby. Final Pathologic Diagnosis. CORRECTED REPORT: A) SENTINEL NODE #1 (EXCISION): One lymph node involved by metastatic carcinoma (1/1). B) SENTINEL NODE #2 (EXCISION): One out of two lymph nodes, involved by metastatic carcinoma. (micrometastases) (1/2). C) SENTINEL LYMPH NODE #3 (EXCISION): One out of two lymph nodes, involved by metastatic carcinoma. (micrometastases) (1/2). D) RIGHT BREAST (MASTECTOMY): Invasive ductal carcinoma, Nottingham grade 2. See synoptic report. E) NEW INFERIOR MARGIN (EXCISION): Breast tissue with benign fibrocystic changes, including ductal. hyperplasia and apocrine metaplasia. Negative for malignancy. NOTE: This corrected report is being issued due to a typographical error In the original report. The initial diagnosis rendered by. remains unchanged. I attest I have personally reviewed the specimen/slides and agree with the above findings. Synoptic Report. D: BREAST, MASTECTOMY -. SPECIMEN TYPE: Mastectomy. LYMPH NODE SAMPLING: Sentinel lymph node with axillary dissection. SPECIMEN SIZE: Surgical Final Report. Temporary Copy. case. Greatest dimension: 30 cm. Additional dimensions: 7.0 x 2.5. LATERALITY: Right. TUMOR SITE: Lower outer quadrant. SIZE OF INVASIVE COMPONENT: Greatest dimension: 2.0 cm. Additional dimensions: 1.5 x 1.0 cm. Two separate lesions were present, each one measuring 2.0 x 1.5 x 1.0 cm. HISTOLOGIC TYPE: Ductal carcinoma in situ. Invasive ductal carcinoma. HISTOLOGIC GRADE: Tubule formation: Moderate 10% to 75% (score = 2). Nuclear pleomorphism: Marked variation in size, nucleoli, chromatin clumping, etc. (score =. 3). 0 to 5 mitoses per 10 HPF (score = 1). Nottingham Grade II: 6-7 points. PRIMARY TUMOR (pT): pT1c: Tumor more than 1.0 cm but not more than 2.0 cm in greatest dimension. REGIONAL LYMPH NODES (pN): pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0. mm). Number examined: 18. Number involved: 5. DISTANT METASTASIS (M): pMX: Cannot be assessed. MARGINS: Margin(s) involved by invasive carcinoma. Specify which margin(s): Inferior margin at mastectomy (specimen D). See comment. EXTENT OF MARGIN INVOLVEMENT FOR INVASIVE CARCINOMA. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. MICROCALCIFICATIONS: Present in DCIS. ADDITIONAL PATHOLOGIC FINDINGS: Fibrocystic changes, biopsy site related changes, and columnar cell hyperplasia. COMMENT(S): The inferior margin is invovled by carcinoma in the mastectomy specimen (specimen D),. however, additionally submitted inferior resection margin is not involved (specimen E). Clinical. correlation is necessary for interpretation of these findings. Diagnostic Comment. According to previous biopsy, 65% of tumor cells show moderate to strong nuclear staining. for estrogen receptors, 80% of tumor cells show nuclear staining show strong nuclear staining. for progesterone receptors, and Her2-neu gene is not amplified by FISH (please see report. Surgical Final Report. emporary Copy. Intraonerative Diagnosis. TP A1: Touch prep positive for carcinoma. No frozen done. TP B1: No touch preps done because first sentinel lymph node is positive. TP C1: No touch preps done because first sentinei lymph node is positive. Clinical History. year old female with breast cancer. Pre/Post-operative Diagnosis. Breast cancer. Gross Anatomic Description. (SPECIMEN D: Dictated by. (SPECIMENS A-C and E: Dictated by. Specimens received in five containers. Snecimen A: Designated ""sentinel node #1"" is received fresh for intraoperative consultation on. labeled with the patient's name and ""sentinel node #1"". Specimen consists one piece of. yellow tissue measuring 1.2 x 1.0 x 0.6 cm. The lymph node is bisected. Touch prep is done. No. frozen section is performed. Section code: A1 - two pieces, one lymph node, entire specimen. Specimen B: Designated ""sentinel node #2"" is received fresh for intraoperative consultation on. labeled with the patient's name and ""sentinel node #2"". Specimen consists of one yellow/tan. irregular fragment of tissue measuring 0.8 x 0.6 x 0.3 cm. No intraoperative procedure performed. Entirely submitted for permanent sections. Section code: B1 - entire specimen. Specimen C: Designated ""sentinel node #3"" is received fresh for intraoperative consultation on. labeled with the patient's name and ""sentinel node #3"". Specimen consists of one yellow/tan. fatty fragment of tissue measuring 0.8 x 0.4 x 0.4 cm. The specimen is bisected revealing one lymph. node. No intraoperative procedure performed. Entirely submitted for permanent sections. Section code: C1 - two pieces, one lymph node, entire specimen. Specimen D: Designated ""right mastectomy (stitch on lateral margin, clip on apex of dissection)"" is. received fresh for Tumor Bank on. labeled with the patient's name, MRN and ""right. mastectomy (stitch on lateral margin, clip on apex of dissection). Specimen consists of one right. radical mastectomy with attached axillary tail weighing 220.8 g. The specimen measures 30.0 x 7.0. x. 2.5 cm. The axillary tail measures 13.0 x 3.5 x 2.0 cm. The breast measures 17.0 x 6.0 x 2.5 cm. There is an overlying ellipse of tan wrinkled skin measuring 15.0 x 6.0 cm. There is an unremarkable. nipple measuring 1.5 cm in diameter and 0.5 cm in thickness. The areola measures 4.0 x 3.5 cm and. is unremarkable. The external palpation of skin reveals two firm masses which are inferior lateral to. the nipple, at the outer lower quadrant. One is at 3.5 cm from the nipple and the other is at 2.0 cm. from the nipple. The suture is identified which denotes the lateral margin. Cut surface reveals two. white/tan spiculated tumors. The medial tumor measures 2.0 x 1.5 x 1.0 cm with what appears to be. a. previous biopsy site. The more lateral tumor mass measures 2.0 x 1.5 x 1.0 cm and also appears to. have a previous biopsy site. The tumor masses appear to be connected by a white/tan tract of tumor. Surgica Final Report. Temporary.Copy. Collectedal. D. orderediby. measuring 0.5 x 0.2 x 0.2 cm. The lateral tumor comes within <0.1 cm of the inferior margin and 0.2. cm of the deep margin. The medial tumor comes within 0.1 cm of the inferior margin and appears to. abut the deep margin. Both tumors are >3.0 cm from the superior and medial margins. The. remainder of the cut sections are grossly unremarkable as yellow/tan fatty fibrous tissue. There is a. free floating fragment of breast tissue measuring 8.5 x 1.5 x 0.5 cm with a staple denoting the medial. position. The fragment weighs 3.9 g. This fragment is oriented with the assistance of. and. according to him, it represents the deep margin. The fragment is oriented regarding lateral and medial. aspects. The axillary tail is dissected and eleven lymph nodes are identified. The lateral tumor comes. within -0.2 cm of skin and the medial tumor comes within 1.0 cm of skin. Inking code - breast: Green - superior portion of breast; Blue - inferior portion of breast; Black - deep. portion of breast; Orange - area of further resection, inferiorly, adjacent to additional inferior margin. (specimen E). Inking code - additional fragment of tissue (deep margin): Black - entire external surface of free deep. fragment; Green - medial tip of free deep fragment. Section code: D1 - representative section of tumor closest to nipple; D2 - representative section of. tumor farthest from nipple; D3 - tip of nipple, serially sectioned; D4 - remainder of nipple, en face; D5. - section of medial tumor with skin and orange margin; D6 - representative section of medial tumor. with skin and orange margin; D7 - representative portion of tissue between described tumors to. contain described tumor tract; D8 - representative section of lateral tumor with skin; D9-D10 -. representative sections of lateral tumor with skin (sections through tumor were made from medial. to. lateral); D11-D12 - two representative sections of unremarkable breast tissue from medial inferior. quadrant; D13-D14 - representative sections of unremarkable breast tissue from superior medial. quadrant; D15-D16 - representative portions of unremarkable breast tissue from superior lateral. quadrant; D17-D18 - representative sections of unremarkable breast tissue and lateral inferior. quadrant; D19 - one lymph node, bisected; D20 - one lymph node, bisected; D21 - two lymph nodes. submitted wholly with the more proximal node inked in black; D22 - two lymph nodes submitted wholly. with the more proximal lymph node inked in black; D23 - one lymph node, bisected; D24 - two lymph. nodes submitted wholly with the more proximal lymph node inked in black; D25 - two lymph nodes. with the more proximal node inked in black (the lymph nodes were submitted from proximal to distal);. D26 - inferior margin; D27 - lateral margin; D28 - medial margin; D29 - superior margin; D30 - deep. posterior margin; D31-D36 - deep free fragments of breast tissue serially sectioned from medial to. lateral. Specimen E: Designated ""new inferior margin"" is received in formalin labeled with the patient's name. and ""new inferior margin"". Specimen consists of one yellow/tan fatty fragment of tissue weighing 10.6. g and measuring 5.5 x 2.5 x 1.0 cm. The new inferior margin is inked in blue and the specimen is. serially sectioned. Cut sections reveal a yellow/tan fatty interior that is grossly unremarkable. Section code: E1-E6 - entire specimen.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Research Gross Description. male with liver and adrenal masses. Research Dx. Liver, right hepatectomy: Poorly-differentiated malignant neoplasm most consistent with hepatocellular carcinoma, see case. summary, see comment. CASE SUMMARY FOR HEPATOCELLULAR CARCINOMA - RIGHT HEPATECTOMY: Specimen: Liver, gallbladder, adrenal gland, periportal lymph node. Procedure: Right hepatectomy, left hepatic core biopsy, cholecystectomy, adrenalectomy,. periportal lymph node excisional biopsy. Tumor size: 12 cm (see gross description). Tumor focality: Multiple (right lobe, left lobe). Histologic type: Hepatocellular carcinoma, see comment. Histologic grade: Grade 3 (poorly-differentiated). Tumor extension: Tumor confined to liver. Margins: Negative for tumor. Parenchymal margin: Negative for tumor. Distance of invasive carcinoma from closest margin: At least 1 cm from parenchymal. resection margin. Lymphovascular invasion: Not identified. Perineural invasion: Not identified. Pathologic staging (pTNM): Primary tumor (pT): pT3a (m) - Multiple tumors more than 5 cm. Regional lymph nodes (pN): pN0 - No regional lymph node metastasis. Number lymph nodes examined: 1. Number lymph nodes involved: 0. Distant metastasis (pM): M (not applicable). Additional pathologic findings: Chronic hepatitis consistent with hepatitis C, inflammatory. activity grade 1 (portal chronic inflammation), fibrosis stage 3 (septal fibrosis with. architectural distortion). Mild macrovesicular steatosis. AJCC Staging (7th edition): pT3a(m) pNO M(not applicable). Research QC. Tumor: 75% tumor nuclei. 25% necrosis. 0% normal. Normal: 100% liver. Research Specimen. T1-178 mg, T2- mg, T3- mg, T4- mg. N1-222 mg, N2- mg, N3- mg, N4- mg. Specimen Process Time. Plasma/serum/buffy coat. Cold ischemia start time: Plasma frozen a. 1. Serum frozen @. Buffy coat frozen @. Tissue: Cold ischemia start time: Formalin fixation start time. Total cold ischemia time: Formalin fixation stop time: Total formalin fixation time. Specimen Weight. Specimen Size. Plasma x 3. Serum x 3. Buffy coat x 1. Cryovials x 8. Normal x 4. Tumor x 4. Metastatic x 0. FFPE x 8. Normal x 4. Tumor x 4. Metastatic x 0. Study. Patient Consent.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION. Left lung (565 grams), superior mediastinal (left lower paratracheal,. left tracheo-bronchial). aortic (aorto-pulmonary, anterior mediastinal). and inferior mediastinal (subcarinal, left inferior pulmonary ligament). lymph nodes. DIAGNOSIS: Lung, left, pneumonectomy : Invasive grade 3 (of 4) squamous cell. carcinoma forming a centrally located mass 2.8 X 2.0 X 1.2 cm involving. the pulmonary artery. Post-obstructive pneumonia and pleuritis is also. present. The pleura is not involved. The bronchial margin is free by 3. cm. Multiple (2) intrapulmonary peribronchial lymph nodes are negative. for tumor. Lymph nodes, superior and inferior mediastinal, excision : Multiple (3. left lower paratracheal, 1 tracheo-bronchial, 9 subcarinal, and 2 left. inferior pulmonary ligament) lymph nodes are negative for tumor. Lymph nodes, aortic, excision: Multiple (6 aorto-pulmonary, 2 anterior. mediastinal) lymph nodes are negative for tumor.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: Liver, total hepatectomy and liver transplantation: Hepatocellular carcinoma, S7. 1) Post-chemoembolization status: present. 2) Size of tumor: 7x6x5.5cm. 3) Gross type: nodular with perinodal extension. 4) Satellite nodule: absent. 5) Histologic type: trabecular and compact. 6) Cell type: classic and clear cell group. 7) Edmondson and Steiner's histologic grade: The worst differentiation: 3. The major differentiation: 2. 8) Fatty change: present (80%). 9) Hemorrhage/peliosis: absent. 10) Tumor necrosis: present (90%). 11) Vascular invasion(microscopic): absent. 12) Capsule formation: partial. 13) Infiltration of capsule: absent. 14) Septal formation: present. 15) Involvement of a major branch of the portal vein: absent. 16) Involvement of a major branch of the hepatic vein: absent. 17) Bile duct invasion: absent. 18) Serosal invasion: absent with fibrous adhesion. 19) Intrahepatic metastasis: absent. 20) Multicentric occurrence: absent. 21) Pathologic stage: AJCC ( pT1),. ( pT2). 22) Related biopsy; none. 23) Additional pathologic findings. - Chronic hepatitis. with a) no lobular activity. b) minimal portal activity. c) septal fibrosis. - Cirrhosis: absent. - Dysplasia: absent. - Fatty change, moderate. - Post-chemoembolization status. with parenchymal necrosis, S6: size; 4x3x2cm. - Partial adrenal adhesion.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SURGICAL REPORT. Sexc F. Date Collected: I. Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREASTS CANCER. PROCEDURE. RIGHT SENTINEL LYMPH NODE BIOPSY. TISSUES. A. LYMPH NODE (S) - SENT NODE #1 ""FS. B. LYMPH NODE (S) - SENT NODE #2 FS. C. BREAST EXCISION,NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST MASS. D. AXILLARY - AXILLARY CONTENTS. E. MARGINS - ADDITIONAL RIGHT BREAST TISSUE. F. MARGINS - ADDITIONAL LATERAL MAGINS. WRI TISSUE -. FS DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE#1, F.S. -. ONE POSITIVE LYMPH NODE (1/M). B. FS NOT PERFORMED PER DR. DEFER. C. RIGHT BREAST MASS, F.S. -. TUMOR MASS 4.7 CM. AND INVOLVING SUPERIOR, INFERIOR,. MEDIAL, ANTERIOR SURGICAL MARGINS. TUMOR IS ALSO VERY CLOSE TO POSTERIOR AND LATERAL SURGICAL MARGINS. (WITH SMALL INDURATED NODULES). E. ADDITIONAL RIGHT BREAST TISSUE (GROSS MARGINS ONLY) -. LATERAL SURGICAL MARGIN IS POSITIVE FOR MALIGNANCY. THE REMAINING SURGICAL MARGINS ARE FREE OF TUMOR. F. ADDITIONAL LATERAL MARGIN (GROSS MARGINS ONLY) -. SURGICAL MARGIN is FREE OF LESION. SURGICAL REPORT. nology Number. (Time Reported to Surgeon: FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. POSITIVE FOR MULTIPLE FOCI OF METASTATIC BREAST. CANCER. B. RIGHT SENTINEL LYMPH NODE #2 -. POSITIVE FOR METASTASIS, SUBCAPSULAR SINUS DEPOSITS,. MEASURING LESS THAN 0.2 MM. IN AGGREGATE (1/1). c. RIGHT BREAST MASS -. POSITIVE FOR INFILTRATING CARCINOMA MEASURING 4.7 CM. IN GREATEST. DIMENSION WITH FOCAL EXTENSION TO THE SUPERIOR, INFERIOR AND MEDIAL. MARGINS WITH EXTENSION TO WITHIN 1/2 MM. OF THE ANTERIOR AND LATERAL. MARGINS RESECTION. D. AXILLARY CONTENTS -. POSITIVE FOR METASTASIS IN FOUR OF TWENTY TWO LYMPH NODES, TWO OF FOUR. DISPLAY SUBCAPSULAR METASTASIS MEASURING MORE THAN 2 MM. IN GREATEST. DIMENSION, ONE OF FOUR DISPLAYS MICROMETASTASIS IN SUBCAPSULAR SINUS. MEASURING LESS THAN 2 MM. AND REMAINING ONE OF FOUR DISPLAYS ISOLATED. POSITIVE CELLS IN SUBCAPSULAR SINUSES (4/22). E. ADDITIONAL RIGHT BREAST TISSUE-. POSITIVE FOR ADDITIONAL CARCINOMA WITH FOCAL EXTENSION TO THE LATERAL,. ANTERIOR, SUPERIOR AND INFERIOR SURGICAL MARGINS OF RESECTION. F. ADDITIONAL LATERAL MARGINS. POSITIVE FOR FOCAL EXTENSION TO THE NEW LATERAL. SURGICAL MARGIN OF RESECTION. PTNM CLASSIFICATION: T2 N2a, MX, STAGE IIIA. Comment: This case is discussed with Dr. The Cytokeratin (AE1/AE3) performed on specimen ""B and 0"" support the diagnosis. given. E-cadherin stain on specimen ""C"" confirms the infiltrative duct carcinoma. (. Signature on file. GROSS DESCRIPTION. SURGICAL REPORT. nology Number. The specimen is received in six separate containers labeled. designated A, B, C, D, E. and F. A. The container is received fresh unfixed labeled ""right sentinel lymph node #1. for frozen section"". The specimen consist of an ovoid mass of pink-tan, firm,. rubbery tissue with attached fat measuring 1.5x 1x 1 cm in greatest overall. dimension. Touch prep and frozen section are obtained by Dr. The entire. specimen, including frozen section, submitted in two blocks. B. The container is received fresh unfixed labeled ""right sentinel lymph node #2. for frozen section"". The specimen consists of an ovoid mass of tan-gray, firm,. rubbery tissue with attached fat measuring 0.9 x 0.8 x 0.4 cm in greatest overall. dimension. A touch prep is obtained by Dr. A frozen section Is not. performed per Dr. Entire specimen one block. C. The container is received fresh unfixed labeled ""gross margins right breast. mass"". The specimen consists of an 18 gram ovoid mass of apparent fatty and fiber incased. ovoid mass which is 5.5 x 3 x 2 cm in greatest overali dimension. There is an Inserted Indicator. wire. There is an attached single suture indicating anterior margin inked with a blue dye. Posterior is inked with a black. There are two short sutures indicating superior margin inked with. a red dye. Inferior is inked with a yellow. There is a long suture indicating lateral margin Inked. with an orange. Medial is Inked with a green. Gross margins are observed by Dr. He. states tumor mass is 4.7 cm and involving superior, inferior, medial, anterior, surgical margins. Tumor mass is very close to the posterior and lateral surgical margin, with small indurated. nodules. The specimen is submitted in twelve blocks. Key note block summary: 1- superior, 2 - Inferior, 3 - anterior, 4 - posterior, 5 -. lateral, 6 - medial. All of those are perpendicular. 7 through 12 - remaining. D. The container is received fresh unfixed labeled ""exiliary contents"". The specimen. consists of an irregular mass of apparent fatty tissue measuring 10 x 8: x 3 cm in. greatest overali dimension. Serial sectioning reveais firm, purple-tan nodules. varying up to 0.9 cm in greatest dimension. The entire specimen is submitted in. five blocks. E. The container is received fresh unfixed for gross margins which are obtained by. Dr. labeled ""additional right breast tissue"". There is a single short suture indicating anterior. margin inked with an orange dye. Deep margin is inked with a black dye. There are two short. sutures indicating superior margin inked with a red dye. Inferior is inked with a yellow. There is a. single long suture indicating lateral margin inked with a green dye. Medial is inked with a blue. Sectioning reveais firm nodules varying up to 4 cm in greatest dimension. Lateral/green margin is. grossly positive. These nodules are chiefly located in the anterior lateral area and approximately. 0.2 cm from the anterior margin. The specimen is submitted in nine blocks. Key note block summary: 1 - lateral, 2 - medial, 3 - anterior, 4 - deep, 5 - superior, 6 - inferior,. 7 through 9 - random. F. The container is received fresh unfixed labeled ""additional lateral margins -. suture on new lateral margin which is inked with a green dye. Gross margins are. observed by Dr. Sectioning reveais firm paipable nodules varying up to. 0,3 cm in greatest dimension. They appear to be 0.4 cm from the new lateral. margin. The specimen is submitted as four sections in four blocks. SURGICAL REPORT. mology Number: MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: E-Cadherin (specimen C); Cytokeratin. (AE1/AE3) (specimens B and D). SURGICAL REPORT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: year old male with left renal mass. Specimens Submitted: 1: KIDNEY AND ADRENAL GLAND, LEFT, TOTAL NEPHRECTOMY, ADRENALECTOMY. DIAGNOSIS: 1. KIDNEY AND ADRENAL GLAND, LEFT, TOTAL NEPHRECTOMY, ADRENALECTOMY: Tumor Type: Renal cell carcinoma - Chromophobe type. Tumor Size: Greatest diameter is 15.5 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not involved. Lymph Nodes: Free of tumor. Number of nodes examined:5. Staging for renal cell carcinoma/oncocytoma: pT2 Tumor >7.0 cm in greatest dimension limited to the kidney. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen, labeled ""Left kidney, adrenal and hilar lymph nodes"". It consists of a grossly. recongnizable kidney whose appearance is markedly altered by a large mass localized to the lower pole. Attached to the upper. pole of the kidney is a portion of fatty tissue investing a grossly recognizable adrenal gland. An attached segment of ureter is. identified at the hilum. The overall measurements of the specimen are 22.0 x 14.0 x 8.5 cm. The specimen weighs altogether. 905 gm. The specimen is bivalved to demonstrate a large corasely lobulated well-circumscribed and possibly encapsulated tumor. with fleshy, homogenously pink-tan cut surface with multiple scattered small cystic areas. The tumor measures 15.5 x 13.0. x. 8.5. cm. The tumor replaces the entire lower pole of the kidney. It appears to be pushing on the renal sinus fat but does not seem to. invade it or extend into the collecting system. No macroscopic vascular invasion is noted. The tumor appears to grossly extend. into the perirenal fat but not through the gerota's fascia. The remainder of the kidney is grossly unremarkable. The adrenal gland. is. dissected off the kidney. It measures 5.3 x 2.6 x 0.9 cm, weighs 7 gm and is grossly unremarkable both from outside and on the. cross-section. The hilar fat is searched for lymph nodes. Several possible lymph nodes are dissected. Samples of tumor and. normal kidney tissue are submitted for. Gross photographs are taken. Representative sections are submitted for frozen. section diagnosis and paraffin blocks. Summary of Sections: FSC - frozen section control. M - margin. TC - tumor to capsule. TK - tumor to kidney. NLK - normal to kidney. AD - adrenal. PLN - probable lymph nodes. Summary of Sections: Part. 1: KIDNEY AND ADRENAL GLAND, LEFT, TOTAL NEPHRECTOMY, ADRENALECTOMY. Block. Sect. Site. PCs. 1. ad. 1. 1. fsc. 1. 1. m. 3. 1. nlk. 1. 2. pln. 4. 4. tc. 6. 5. tk. 5. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL TUMOR. FAVOR CHROMOPHOBE RENAL CELL. CARCINOMA. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
MEDICAL RECORD. I. Accession No. Submitted by: Date obtained: Specimen (Received. RIGHT THYROID LOBE STITCH MARK RIGHT SUPERIOR. + SUPPLEMENTARY REPORT HAS BEEN ADDED +. REFER TO BOTTOM OF REPORT +. BRIEF CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: right thyroid nodule. OPERATIVE FINDINGS: POSTOPERATIVE DIAGNOSIS: right thyroid nodule. Accession No. Pathology Resident: GROSS DESCRIPTION: The specimen consists of a 28 grams, 6.5 x 5.2 x 1.8 cm right thyroid. lobe. The specimen is surgically oeriented by a stitch demarcating. the superior lobe. The specimen is inked blue on the. anterior/superficial surface, and black on the posterior/deep surface. The specimen is serially sectioned from inferior to superior tip into. eleven slices. Serial sectioning reveals a 1.5 X 2.2 X 5.0 cm. tan-white partly cystic nodule surrounded by a thin capsule. The. adjacent thyroid tissue is red-brown and spongy. The specimen is. submitted entirely as follows: 1-11- entire thyroid nodule submitted. from inferior to superior; 12-20- associated grossly normal thyroid,. submitted entirely. MICROSCOPIC EXAM. DIAGNOSIS. THYROID, RIGHT, PARTIAL THYROIDECTOMY: - SEE COMMENT. Comment: The specimen is pending consultation. An addendum will. follow. SUPPLEMENTARY REPORT (S) : Supplementary Report Date: SUPPLEMENTARY REPORT HAS BEEN ADDED/MODIFIED. (Added/Last released: ADDENDUM DIAGNOSIS. Thyroid, right, partial thyroidectomy. - FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA. ARISING IN A BENIGN FOLLICULAR NODULE (SEE COMMENT. AND. CANCER SUMMARY) Pen TSS, follicular varient = 100% BCR. Comment: Slide 16 shows a small isolated focus of follicular variant. of papillary carcinoma. The case was submitted in consultation to. notified. at. Pathology Cancer Case Summary. Based on AJCC/UICC TNM, 7th edition. - Procedure: Thyroid lobectomy, right. - Received: In formalin. - Specimen Integrity: Intact. - Specimen Size: 6.5 x 5.2 x 1.8 cm. - Specimen Weight: 28 g. - Tumor Focality: Multifocal. - Dominant Tumor: - Tumor Size: 1.5 x 2.2 x 5.0. - Histologic Type: Papillary carcinoma, Follicular variant. - Architecture: Follicular. - Cytomorphology: Classical. - Histologic Grade: G1: Well differentiated. - Margins: Margins uninvolved by carcinoma. - Tumor Capsule: Totally encapsulated. - Lymph-Vascular Invasion: Not identified. - Second Tumor: - Tumor Size: 1 mm. - Histologic Type: Papillary carcinoma, Follicular variant. - Architecture: Follicular. - Cytomorphology Classical. - Histologic Grade: G1: Well differentiated. - Margins: Margins uninvolved by carcinoma. - Tumor Capsule: Totally encapsulated. - Lymph-Vascular Invasion: Not identified. - Pathologic Staging (pTNM) : pT3, pNx, pMx. - Additional Pathologic Findings. - - Hurtle cell hyperplasia. Follicular nodule.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
copy No. Examination: Histopathological examination (cito). Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - left breast and axillary tissues. ref. No. Expected time of examination: 5 working days. Clinical diagnosis: Macroscopic description: Left breast, sized 22 x 18 x 9 cm, removed with axillary tissues sized 10 x 11 x 5 cm and with a skin flap of 23 x 19 cm. Nipple. retracted, skin resembling orange peel. Tumour sized 6.0 x 6.0 x 3.5 found on the border of upper quadrants, located 3.0 cm from the upper boundary, 1.5 cm from the. base and 0 cm from the skin. Lymph nodes 1.8 cm in length. Microscopic description: Carcinoma ductale invasivum - NHG3 (3 + 2 + 3 / 35 mitoses/10 HPF - visual area 0.55 mm). Mamilla sine laesionibus. Glandular tissue showing lesions of the type mastopathia fibrosa et cystica. AXILLARY LYMPH NODES: Metastases carcinomatosae in lymphonodo (No I/XXI). Infiltratio capsulae lymphonodi et telae perinodalis. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast. Metastases carcinomatosae in lymphonodo (No I/XXI) (NHG3, pT3, pNIa). Cancer metastases in the lymph nodes (No I/XXI). (e 2/2. Results of immunohistochemical examination: Estrogen receptors found in 10-75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) rabbit antibody. Negative reaction in invasive cancerous cells. (Score=3+). Compliance validated by: -.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. Feast, right, wide local excision: Infiltrating ductal carcinoma, Nottingham grade II (of III) [tubules 2/3, nuclei 2/3, mitoses 2/3;. Nottingham score 7/9], forming a mass (2.4 x 1.7 x 1.6 cm) [AJCC pT2]. Biopsy site changes are present. Ductal carcinoma in. situ, solid and micropapillary type, intermediate nuclear grade, comprising 5-25% of the tumor mass. Angiolymphatic invasion. is. identified. All surgical resection margins, after re-excision of the medial margin, are negative for tumor (minimum tumor free. margin, 1.0 cm, inferior margin). Lymph nodes, right axillary sentinel Nos. 1 and 2, sentinel biopsy: A single (1 of 2) axillary sentinel lymph node is positive (for. micrometastasis [AJCC pN1mi(sn)]), with 2 metastases, the largest measuring 1.0 mm and smallest 0.5 mm. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and confirms the. H&E impression.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. A. RIGHT KIDNEY, PARTIAL NEPHRECTOMY: Renal cell carcinoma, papillary type 1. See Key Pathological Findings and Comment. B. RIGHT KIDNEY, DEEP MARGIN: Benign renal parenchyma. I,. the attending pathologist, personally reviewed all slides. and / or materials and rendered the final diagnosis. Electronically signed. out by. Comment. Immunoperoxidase stains performed on block A3 show the tumor cells positive for vimentin, CK7,. AMACR, AE1/AE3, CAM5.2, EMA and focally positive for CD10. Key Pathological Findings. A: Kidney Resection. PROCEDURE: Partial nephrectomy. SPECIMEN LATERALITY: Right. TUMOR SITE: Not specified. TUMOR SIZE (largest tumor if multiple): Dimension: 1.7 cm. TUMOR FOCALITY: Unifocal. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Papillary renal cell carcinoma. SARCOMATOID FEATURES: Not identified. TUMOR NECROSIS: Not identified. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G2: Nuclei slightly irregular, approximately 15 microns; nucleoli evident. PATTERN OF GROWTH: Papillary. MICROSCOPIC TUMOR EXTENSION: Tumor limited to kidney. MARGINS: Margins uninvolved by carcinoma. ANGIOLYMPHATIC INVASION: Absent. PRIMARY TUMOR (pT): T1a:Tumor 4 cm or less in greatest dimension, limited to the kidney. REGIONAL LYMPH NODES (pN): pNX: Regional lymph nodes cannot be assessed. DISTANT METASTASIS (pM): pMX. PATHOLOGIC FINDINGS IN NONNEOPLASTIC KIDNEY: Insufficient tissue (partial nephrectomy specimen with <5 mm of adjacent nonneoplastic. kidney). Specimen(s) Received. A. RIGHT PARTIAL NEPHRECTOMY FS. B. DEEP MARGIN FS. Clinical History. None given. Preoperative Diagnosis. Right renal mass. Intraoperative Consultation. FSA1. RIGHT PARTIAL NEPHRECTOMY: Papillary tumor, focally extending to inked margin. FSB1. DEEP MARGIN: Margin negative. Comment: This frozen section diagnosis/result was communicated to and acknowledged by Dr. I,. have performed the intraoperative consultations and issued the above. diagnosis. Gross Description. A. The specimen is received fresh. Part A labeled ""right partial nephrectomy, ink is margin"". The. specimen consists of a partial nephrectomy which measures 2 x 1.8 x 1.6 cm. Prior to sectioning the. specimen is inked as follows: Blue: Renal capsule. Black: Parenchymal resection margin. The specimen is serially sectioned to reveal an irregular to roughly ovoid, ill-defined, rubbery. intraparenchymal tumor which measures 1.7 x 1.5 x 1.3 cm. The tumor bulges capsule and extends. to within less than 0.1 cm of the closest parenchymal resection margin. The cut surface of the tumor. is variegated, pale-yellow to pink, focally hemorrhagic. No foci of necrosis are grossly identified. Representative sections of the specimen are submitted to the Tissue Procurement Laboratory. Representative section of the tumor in relation to the closest inked black parenchymal resection. margin is submitted for frozen section as FSA1. The remainder of the specimen is serially sectioned. and submitted entirely in 6 cassettes, A2-A7. B. Part B labeled ""deep margin, ink is margin"". The specimen consists of an irregular, oriented. fragment of tan-brown renal parenchyma measuring 1.5 x 0.5 x 0.2 cm. Prior to sectioning the total. resection margin is inked black. The specimen is bisected and submitted entirely for frozen section as. FSB1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Female. Surgery Date: DIAGNOSIS: Liver, right lobe and segment 1, partial hepatectomy: Grade 3 (of 4). cholangiocarcinoma forming a circumscribed mass (3.6 X 2.9 X 2.8 cm) within. the region of the caudate lobe. Surgical margins are negative (by 0.2 cm). Liver, segment 3, No. 2, excision: Bile duct adenoma. Liver, segment 3, biopsy : Benign liver parenchyma, negative for tumor. Liver, segment 4, biopsy: Benign liver and foci of. hemosiderin-lader. macrophages. No evidence of neoplasm. Lymph nodes, hepatic artery, excision: Non-necrotizing granulomatous. inflammation. Negative for tumor. Gallbladder, cholecystectomy: Benign. gallbladder. mucosa. with. cholesterolosis. No stones are identified. No cystic duct lymph node. identified. Sections of the non-neoplastic liver show prominent non-necrotizing. granulomatous infiltrates within portal areas and the lobular parenchyma. There is no apparent fibrosis or ductopenia, and in general. the. granulomatous infiltrates do not appear to be directed at bile ducts. This. likely represents a granulomatous reaction to the patient's neoplasm. However, obtaining an AMA would be helpful to exclude PBC . In addition,. there is granulomatous inflammation within the hilar lymph nodes. GMS and. AR stains are negative. Additional clinical correlation needed to exclude other granulomatous. processes, such as sarcoidosis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Temporary Copy. Diagnosis. A. SENTINEL LYMPH NODE, EXCISION: - ONE LYMPH NODE WITH REACTIVE SINUS HISTIOCYTOSIS. - NEGATIVE FOR CARCINOMA (0/1). B. RIGHT BREAST, TRUE MEDIAL MARGIN, EXCISION: - BENIGN BREAST TISSUE WITH USUAL DUCTAL HYPERPLASIA. - NEGATIVE FOR CARCINOMA. C. RIGHT BREAST, LUMPECTOMY: - INVASIVE DUCTAL CARCINOMA, GRADE 2, 2.2 CM. - DUCTAL CARCINOMA IN SITU, GRADE 2, CRIBIFORM TYPE WITH CENTRAL NECROSIS. (Electronic signature). Verified: Synoptic Report. TUMOR SIZE: SIZE OF LARGEST INVASIVE CARCINOMA: Greatest dimension of largest focus of invasion over 0.1 cm: 2.2 cm. Additional dimensions: 1.9 X 1.0 cm. TUMOR FOCALITY: Single focus of invasive carcinoma. MACROSCOPIC AND MICROSCOPIC EXTENT OF TUMOR: Skin: Skin is not present. Skeletal Muscle: No skeletal muscle present. DUCTAL CARCINOMA IN SITU (DCIS): DCIS is present. Extensive intraductal component (EIC) negative. SIZE (EXTENT) OF DCIS: Number of blocks with DCIS: 3. Number of blocks examined: 7. ARCHITECTURAL PATTERNS: Cribriform (with central necrosis). NUCLEAR GRADE: Grade II (intermediate). NECROSIS: Present, central (expansive ""comedo"" necrosis). LOBULAR CARCINOMA IN SITU (LCIS): Not identified. HISTOLOGIC TYPE OF INVASIVE CARCINOMA: Invasive ductal carcinoma (no special type or not otherwise specified). GLANDULAR (ACINAR)/TUBULAR DIFFERENTIATION: Score 3: <10% of tumor area forming glandular/tubular structures. NUCLEAR PLEOMORPHISM: Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in. both size and shape. MITOTIC COUNT: Temporary Copy. TD: Score 1. Number of mitoses per 10 high-power fields: 3. Diameter of microscope field: 0.55 mm. OVERALL GRADE: Grade 2: scores of 6 or 7. MARGINS: Margins uninvolved by invasive carcinoma. Distance from superior margin: 8.0 mm. Distance from inferior margin: 12.0 mm. Distance from anterior margin: 6.0 mm. Distance from posterior margin: 5.0 mm. Distance from medial margin: 5.0 mm (at least 5mm. Measurment obtained from specimen B). Distance from lateral margin: 14.0 mm. Margins uninvolved by DCIS (if present). Distance from closest margin: 12.0 mm. Distance from inferior margin: 12.0 mm. TREATMENT EFFECT: RESPONSE TO PRESURGICAL THERAPY: IN THE BREAST: No known presurgical therapy. TREATMENT EFFECT: RESPONSE TO PRESURGICAL THERAPY: IN THE LYMPH NODES: No known presurgical therapy. LYMPH-VASCULAR INVASION: Not identified. DERMAL LYMPH-VASCULAR INVASION: No skin present. LYMPH NODES: Number of sentinel lymph nodes examined: 1. Number of lymph nodes with macrometastases (>0,2 cm): 0. Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells): 0. METHOD OF EVALUATION OF SENTINAL LYMPH NODES: H&E, multiple levels. Immunohistochemistry. PRIMARY TUMOR (INVASIVE CARCINOMA (pT): pT2: Tumor >20 mm but less than or equal to 50 mm in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis identified histologically. DISTANT METASTASIS (M): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Intraductal papillomas. ESTROGEN RECEPTOR: Performed on another specimen. Specimen (accession number): Immunoreactive tumor cells present (greater than or equal to 1%). Quantitation: 100%. PROGESTERONE RECEPTOR: Performed on another specimen. Specimen (accession number): Immunoreactive turnor cells present (greater than or equal to 1%). Quantitation: 65%. Temporary Copy. lo. HER2/NEU IMMUNOPEROXIDASE STUDIES: Performed on another specimen. Specimen (accession number): Equivocal (Score 2+). FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR HER2/NEU: Performed on another specimen. Specimen (accession number): Not amplified (HER2 gene copy <4.0 or ratio <1.8). MICROCALCIFICATIONS: Not identified. COMMENT(S): Largest focus of residual tumor in lumpectomy identified was 1.2 x 0.9 cm. Largest biopsy dimension. was 1.1 cm. Therefore gross measurement including cavity is accurate for staging purposes. Specimen Source. A. Sentinel node. Clinical Information. Right breast carcinoma. Gross Description. A. the specimen is received fresh in her grouping agreed with the patient's name and ""sentinel lymph node"". It. consists of segment of fibroadipose tissue harboring a blue tinged lymph node which measures 2.0 x 1.3 x 0.9. cm in greatest dimension. Bisected and submitted entirely in 2 cassettes Al and A2. B. the specimen is received fresh in a container labeled with the patient's name and ""right breast and medial. margin"". It consists of a segment of ligament and fibroadipose tissue measuring 4 x 2 x 0.5 cm. Two long. stitches indicates the medial margin, a long single stitch indicates the superior margin. The specimen is serially. sectioned from superior to inferior and submitted entirely in 3 cassettes. Section key: B1 superior. B2 B3 inferior. C. the specimen is received fresh in a container labeled with the patient's name and ""right breast tissue"". It. consists of a segment of lobulated adipose tissue measuring 4.5 x 3 x 2.5 cm, double long stitch indicates 12:00,. a single long stitch indicates 6:00, double short stitch indicates the deep margin. There is an irregularly-shaped white brown mass that measures 2.2 x 1.9 x 1 cm with a central cavity and. numerous calcifications. This mass is very close to the medial margin (no specific color, see slide key), it is at. 0.9 cm from the inferior, 0.8 cm from superior, 1.4 cm from the lateral, 0.8 cm from anterior, 1.0 cm from. posterior. The remaining of the tissue is lobulated adipose tissue. Ink key: Inferior green, anterior red, superior orange, posterior back, lateral yellow, inferior green. The speciment is representatively submitted as follows: C1-C2 mass-medial margin. C3 lateral margin. C4 anterior margin. C5 posterior margin. C6 superior margin. C7 inferior margin. Surgical Pathology Finat Report. Temporary Copy. Pattent. DE. Specimen removed from patient at. Specimen sectioned and mass fixed in formalin at. for at least 6 hours and less than 48 hours. Cold ischemic time: 15 minutes. Special Stains / Slides. Immunohistochemical studies for AEI/AE3 were performed on formalin fixed, paraffin-embedded tissue (Block. A1-2) with adequate positive and negative control sections. The stains are negative, supporting the above. diagnosis. The performance characteristics of these antibodies were determined by the. They have not been cleared or approved by the U.S. Food and. Drug Administration The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They. should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA-88) as qualified to perform high-complexity clinical laboratory testing. 14he, 2ihc. Tissue Code.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
SURG PATH #: SPECIMEN CLASS: ALT ID #: SEX: M. DATE RECEIVED: DATE OF PRINTING: Material Received: A: liver mass. History: year-old male with a clinical history of cirrhosis, liver mass. Final Diagnosis: A. Liver, ""liver mass"", resection: Hepatocellular carcinoma (3.0 cm), moderately differentiated, in a background of cirrhosis, clinically non-alcoholic. steatohepatitis. Comment: Liver (Hepatectomy)-HCC. Specimen Type: Wedge resection. Tumor Size: 3.0 cm. Tumor Focality: Solitary. Histologic Type: Hepatocellular carcinoma (patchy intratumoral fibrosis is present). Histologic Grade: GII: Moderately differentiated. Tumor Extension: Tumor confined to liver. History of previous treatment (TACE or RFA): No. Treatment Effect: N/A. Margins: Parenchymal Margin: Uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.8 cm. Vascular Invasion: Macroscopic Venous (Large Vessel) Invasion (V): Absent. Microscopic (Small Vessel) Invasion (L): Present. Lymph Nodes: Not applicable. Additional Pathologic Findings: Cirrhosis, clinically non-alcoholic steatohepatitis. Pathologic Staging: pT2Nx. TNM Descriptors. m (multiple primary tumors). r (recurrent). y (post-treatment). Date of Printing: SURG PATH #: ALT ID #: Primary Tumor (pT). pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. Regional Lymph Nodes (pN). pNX: Cannot be assessed. Distant Metastasis (pM). Not applicable. The pathologic stage assigned here should be regarded as provisional, as it reflects only current pathologic data and does not. incorporate full knowledge of the patient's clinical status and/or prior pathology. Pursuant to the. this case has been concurrently reviewed by the following. pathologist: who agrees with the above diagnosis. Attestation: By this signature, I attest that I have personally formulated the final interpretation expressed in this report and that the above diagnosis is based. upon my examination of the slides and/or other material indicated in this report. Interpreted by: Gross Description: A. Received fresh labeled wit h the patient's name and ""liver mass"" is a liver wedge resection which weighs 346 grams and. measures 6.0 x 4.2x3.4 cm. The resection margin is red-brown and ragged, and demonstrates multiple staples; the resection. margin is inked black. The capsule is red-brown, smooth to focally nodular. The specimen is perviously incised to reveal a 3.0 x. 2.4 x 2.4 cm mass which bulges the capsule and is located 1.4 cm from the nearest resection margin. The cut surfaces of the. mass are tan, smooth and solid. The remainder of the liver parenchyma is tan-pink and uniformly nodular. A representative. portion of the mass and the liver parenchyma is submitted for tumor bank. A1. Mass in relation to nearest resection margin. A2. Mass in relation to resection margin. A3. Additional section of mass. A4-A5. One complete cross section of the mass, bisected. A6. Liver parenchyma, not grossly involved with the mass. Date of Printing:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & Aistory: Right renal mass. Specimens Submitted: 1: Kidney, right, partial nephrectomy. (g. DIAGNOSIS: 1. Kidney, right, partial nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 3.0 cm. Local invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3a Tumor invades the adrenal gland or perinephric tissues but not beyond Gerola's fascia. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section consultation, labeled ""Right renal tumor"" and consists of a partial. nephrectomy specimen, measuring 3,5 x 3.7 x 2.9 cm, with altached perinephric fat. The surgical margin is inked brown rough. and has been inked black, The specimen is sectioned to reveal a well-circumscribed dark red tan tumor mass, which measures. 3.0 x 2.5 x 2.4 cm, which is situated 0.2 cm from the nearest inked resected margin. The tumor is partially surrounded by a rim of. pink brown grossly unremarkable renal parenchyma. Sections of the perinephric fat reveal focal hemorrhage and no. abnormalities. Representative sections are submitted to TPS, for frozen section consultation, and for permanent section. The. specimen has been photographed. Summary of sections: FSC - frozen section control. N - normal kidney. T - tumor with margin, capsule, and perinephric fat. Summary of Sections: Part 1: Kidney, right, partial nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. 1. n. 1. 2. t. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1. FROZEN SECTION DIAGNOSIS; SP: Right renal tumor. Renal cortical neoplasm. Stitched margin benign. PERMANENT DIAGNOSIS:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Visit #: : Service Date. Male. Soc. Sec. #: Client: FINAL PATHOLOGIC DIAGNOSIS. A. Left Kidney, laparoscopic nephrectomy: 1. Papillary renal cell carcinoma, type 1, Fuhrman grade 2, 10cm in greatest. dimension, margins free of tumor; see comment. 2. Ureter with no tumor identified. 3. Adrenal gland with no tumor identified. B. Perirenal fat, laparoscopic nephrectomy: Adipose tissue, no tumor identified. COMMENT: This papillary renal cell carcinoma, Fuhrman grade 2, predominantly type 1, shows large areas of necrosis. (~40% of the tumor mass). Histologically the tumor is comprised of papillae with fibrovascular cores filled. with abundant foamy histiocytes (strongly CD68 positive). The papillae are lined by a single layer of low. cuboidal to columnar cells with relatively abundant cytoplasm and moderately enlarged nuclei with easily. discernable nucleoli, consistent with Fuhrman grade 2. Strikingly, the tumor cells and foamy histiocytes. show extensive granular cytoplasmic pigment, consistent with hemosiderin. There is a minor component of. solid/tubular architecture that is comprised of larger cells with granular eosinophilic cytoplasm and large. nuclei with prominent nucleoli. Given the marked hemosiderin pigment immunohistochemical stains for. cytokeratin and CD68 were necessarily performed to confirm the diagnosis. The cytokeratin strongly. stained the malignant cells while the CD68 highlighted the foamy histiocytes. Kidney Tumor Synoptic Comment. -Histologic type: Papillary renal. cell carcinoma (chromophil), type 1. Carcenoma payabley. -Grade: Fuhrman grade 2. -Maximum tumor diameter: 10 cm. -Site within kidney: Posterior mid kidney. -Renal pelvis: Normal. -Ureter: Normal. -Renal sinus: Normal, no tumor. -Hilar renal veins: Normal, no tumor. -Intrarenal veins and lymphatics: Normal, no tumor. -Adrenal gland: Normal. -Capsule/perirenal fat: Tumor does not penetrate capsule. -Hilar lymph nodes (number positive/number of nodes): 0/0. .Resection margins: Negative. -Proximity to nearest margin: 0.3 cm. Stage: pT2NOMX. -Additional comments: See above. has reviewed the case and concurs with the diagnosis. Specimen(s) Received. A:Left kidney. B:Peri-renal fat. Clinical History. The patient is a year-old male with left kidney cancer, who undergoes left laparoscopic radical. nephrectomy. Gross Description. The specimen is received in formalin in two parts, each labeled with the patient's name and medical record. number. Part A is not additionally labeled. It consists of a morcellated, single kidney and associated perinephric fat. weighing 1280 gm. The kidney itself measures 15.0 x 12.0 x 8.0 cm. The external surface of the. perinephric fat, as well as exposed renal surface, is inked with black ink, and the specimen is bisected,. revealing a single, oval tumor measuring 10.0 x 6.0 cm. The interior of the tumor is composed of grumous. red-brown and yellow-orange material. The tumor appears to be entirely encapsulated within the. substance of the kidney. The tumor is located primarily posteriorly within the kidney, and distorts, but does. not involve the renal pelvis or vascular pedicle. Additionally identified is a single adrenal gland measuring. 5.0 x 2.0 x 0.3 cm. The superior pole of the kidney appears to be avulsed, exposing the renal pelvis. The. area of avulsion does not grossly involve tumor. Representative sections are submitted as follows: Cassette A1: Vascular and ureteral margins. Cassette A2: Area of avulsion, closest approach to tumor. Cassettes A3-A4: Tumor, relation to renal pelvis. Cassette A5: Tumor, relation to capsule. Cassette A6: Uninvolved kidney. Cassette A7: Adrenal gland. Cassette A8: Candidate lymph nodes. Part B is additionally labeled ""peri-renal fat L."" It consists of multiple fragments of fat, measuring 12.0 x. 5.5 x 1.5 cm in aggregate. Excess fat is removed, and tan-red areas from within the fat are submitted in. cassettes B1 through B3. The immunoperoxidase stain(s) reported above were developed and their performance characteristics. determined by the. They have not been cleared or approved. by the U. S. Food and Drug Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not be regarded as investigational. or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of. 1988 (""CLIA"") as qualified to perform high-complexity clinical testing. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist. following review of all pathology slides. /Pathology Resident.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Examination: Histopathological examination. collected on: Clinical diagnosis: Adenocarcinoma ventriculi G2, intestinal type, invasive tumour of the gastric body. Examination performed or. Macroscopic description: Sent material consisting of the stomach, having been cut out along the greater curvature, sized 15 x 15.5 cm. with the omentum sized 30 x 14 cm. Ulcerous tumour on the lesser curvature sized 5 x 6 x 1.1 cm. Distance from the proximal end 0.7 cm, from. distal end, 8 cm. Microscopic description: Adenocarcinoma tubulare G2,. Tumour penetrated the full thickness of the stomach wall and perlintestinal fat tissue reaching the. peritoneum membrane. Surgical incision lines off cancer invaded area. Invasio carcinomatosa vassorum. Reactlo lymphocytaria. peritumoralis. Mucosa free of cancer, showing features of chronic immflamation. Omentum sine metastasibus lien. sccessorius. LYMPH NODES: - periorificial: metastases carcinomatosae in lymphonodis (No XII/XXI). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. of lesser curvature: metastases carcinomatosae in lymphonodis (No II/II). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. - of greater curvature: metastases carcinomatosae in lymphonodis (No II/III). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. - peripyloric: metastases carcinomatosae in lymphonodis (No III/VIII). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. Examination result: Adenocarcinoma tubulare ventriculi. Metastases carcinomatosae in lymphonodis NO XIX/XXXTV. G2, pT2b, pN3 ty pus intestinalis sec. lauren. METASTATIO LAMPH MODES Validated by: Results of immunohistochemical examination: HER2 protein stained with HercepTestâ¢M by DAKO. Negative reaction in invasive cancerous cells ( Score = 0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Not for Permanent Storage in Medical Records / Not Valid for Signing. Result Provider. Report Name. Surgical Report. URT. PROCEDURE DATE: SPECIMEN DESCRIPTION: A. SEGMENT 8 LIVER BIOPSY, APC. B. RE-RESECTION OF GROSSLY POSITIVE LIVER MARGINS. PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. CLINICAL INFORMATION: Biopsy-proven primary biliary cirrhosis with two separate foci of hepatitis C. INTRAOPERATIVE CONSULTATION: APC DIAGNOSIS: ""Specimen oriented; tumor submitted for genomics"" by F. T: GROSS DESCRIPTION: (Parts A and B are received in the same container). A/APC & B. The specimen consists of one portion of roughly ovoid, tan-brown. hepatic tissue. The deep surface reveals a portion of loosely attached,. irregular hepatic tissue. The larger portion is part A, and the smaller. portion on the deep surface is part B. Part B is sutured to part A by two. blue sutures. The entire specimen measures 9.3 X 8.0 X 3.5 cm and weighs 121. grams. The attached part B portion measures 3.0 X 2.5 X 1.2 cm. The capsular. surface is smooth and tan-brown. The deep surfaces of part A and part B are. inked black, and the specimen is serially sectioned. oThe sections show two-. well-defined, tan-brown nodules, measuring 2.2 x 2.0 x 1.8 cm and 4.5 X 3.4"". 3.0 cm. The smaller nodule is composed of lobulated, tan-white to tan-brown. tissue with focal hemorrhage. The larger nodule is composed of tan-white,. firm tissue with focal hemorrhage. The smaller nodule is 0.2 cm from the. surgical resection surface, and the larger nodule is 0.4 cm from the surgical. resection surface. The two nodules are 0.8 cm away from each other. Both. nodules bulge over the capsular surface. The sections away from the nodule. reveal lobulated, tan-brown, coarse hepatic parenchyma. The section away from. the two nodules is not normal homogeneous liver tissue. However, no discrete. fibrotic nodules can be identified. The part B portion is close to the deep. surface of the larger nodule, and the sections show the same lobulated,. tan-brown coarse parenchyma. Representative sections are submitted in. fourteen cassettes as follows cassette A1 - smaller nodule, with deep. margin; cassettes A2 through A4 - smaller nodule: cassette A5 - larger nodule,. with deep margin; cassettes A6 through A8 - sections of the larger nodule: Not for Permanent Storage in Medical Records / Not Valid for Signing. Result Provider. Report Name. : Surgical Report. cassettes A9 and A10 - sections away from the two nodules from part A;. cassettes 81 through B4 - entire B portion. T: MICROSCOPIC DESCRIPTION: A/APC & B. Sections of part A are examined on ten slides. A1 through A10. Sections of part B represents section examined on four slides B1 and B2. Multiple sections of the liver show a background of cirrhosis characterized by. anastomosing bands of fibrous tissue with regenerating nodules. Tissue shows. two separate nodules of hepatocellular carcinoma. There are areas with. trabecular pattern. as well as glandular and small cell pattern. Also present. are congested blood vessels. The tumors are subcapsular. The overall. sections of the margin on slides B1 through B4 show no tumor. FINAL DIAGNOSIS: A/APC & B. LIVER, SEGMENT EIGHT, WEDGE EXCISIONAL AND ADDITIONAL MARGIN: 1. CARCINOMA, WELL DIFFERENTIATED. 2. CLEAR TRUE SURGICAL RESECTION MARGIN. 3. BACKGROUND OF CIRRHOSIS. A-MAL IGNAMT. 0. T. (ETectronic Signature). DATE AND TIME OF REPORT:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Report Status : Amend/Add. Type : Surgical Pathology. Specimen Type: Kidney. partial or total resection. Procedure Date : Addended Report. PATHOLOGIC DIAGNOSIS: SPECIMEN DESIGNATED ""LEFT KIDNEY (323.5g). RENAL CELL CARCINOMA, clear cell (conventional) type (5.6 cm). Fuhrman nuclear grade 2 (of 4). Soft tissue, ureteral, and vascular margins are negative for tumor. The tumor extends into the renal vein. The tumor does not invade renal capsule. No lymphovascular invasion identified. Adrenal gland, negative for tumor. The non-neoplastic kidney will be evaluated by Renal Pathology, and the. findings will be reported in an addendum. AJCC Classification (6th Edition) : pT3b Nx MX. CLINICAL DATA: History: None given. Operation: Left radical nephrectomy. Operative Findings None given. Clinical Diagnosis: Renal cell CA. TISSUE SUBMITTED: A/1. Left kidney. GROSS DESCRIPTION: The specimen is received fresh, labeled with the patient's name, unit number,. and ""#1. Left kidney"", consists of a left kidney (323.5 9, 16.7 x 8.8 x 5.1. cm), to include a ureter (7.8 x 0.2 cm), artery (0.7 x 0.4 cm). and vein (0.5. x. 0.7 cm) The kidney is encapsulated by Gerota's fascia consisting of. tan/yellow lobulated adipose tissue. Sectioning of the specimen shows a. tan/pink to tan/yellow, interpolar, irregular mass (5.6 x 5.0 x 5.0 cm) that is. partially encapsulated. The mass is 2.5 cm to the arterial margin, 2.5 cm to. the renal vein margin, and 10.5 cm to the ureteral margin. The mass disrupts. two-thirds of the renal parenchyma, and abuts the kidney capsule, coming to. within less than 0.1 cm of the inked margin. The tumor also grossly extends. into the renal vein. The unremarkable urothelium is tan/gray smooth and. glistening and unremarkable. The remaining renal parenchyma is tan/brown and. has a focally well defined corticomedullary junction. Sectioning of the. perirenal adipose tissue (2.0 x 1.4 x, 1.0 cm) shows a centrally hemorrhagic. medulla, surrounded by a tan/yellow cortex. Further sectioning of the. perirenal adipose tissue shows no lymph nodes. Micro A1-A2: Section of tumor to capsule and surrounding pericolic adipose. tissue, 2 frags,. Micro A3: Section of tumor to normal kidney, 1 frag,. Micro A4: Renal vein, renal artery, and ureteral margins, 1 frag,. Micro A5: Section of tumor extending to renal vein, 2 frags,. Micro A6: Normal kidney, 1 frag,. Micro A7: Section of adrenal, 1 frag,. By his/her signature below, the senior physician certifies that he/she. Report Status: Final. Type: Cytogenetics. Cytogene'. KARYOTYPE: 72-83<4n>, XXXX, -1, der (3) t (3;8) (p173 : q173) x2, -4, add (7) (q3?5)x2,-8,-8,-9,. -10,-15,-17,-18 [cp5]. METAPHASES COUNTED: 5. ANALYZED: 5. SCORED: 0. BANDING: GTG. INTERPRETATION: All metaphases contained the clonal aberrations described above. Loss of the. short arm of chromosome 3 is a characteristic finding in renal cell carcinoma,. clear cell type. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: RCC.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description. Microscopic. Description. Diagnosis Details. Comments. Laterality. LUNG TISSUE CHECKLIST. Left-upper. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 2.5 X 2.5 X 4 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SurgPath Final. Temporary Copy. FINAL DIAGNOSIS. A) Thyroid, left lobe, lobectomy: Papillary carcinoma (6.5 cm). B) Trachea, superior margin, blopsy: Negative for tumor. C) Lymph nodes, right anterior neck, dissection: Four of seven lymph. nodes involved by metastatic papillary carcinoma (see Comment). Comment: The largest metastasis measures 1.5 cm in greatest dimension. D) Lymph nodes, right posterior neck, dissection: Six of thirty lymph. nodes involved by metastatic papillary carcinoma (see Comment). Comment: The largest metastasis measure 3.6 cm in greatest dimension. E) ""Residual thyroid tumor"", resection: Papillary carcinoma (4.5 cm),. extending beyond the thyroid capsule to invade the trachea. Three of. three lymph nodes involved by metastatic papillary carcinoma. E: Thyroid Gland. HISTOLOGIC TYPE: Papillary carcinoma. TUMOR FOCALITY: Unifocal. TUMOR SIZE: Greatest Dimension: 6.5 cm. HISTOLOGIC GRADE: Not applicable. PRIMARY TUMOR (pT): pT4a: Moderately advanced disease. Tumor of any size extending. beyond the thyroid capsule to invade subcutaneous soft tissues, larynx,. trachea, esophagus or recurrent laryngeal nerve. REGIONAL LYMPH NODES (pN): pN1b:Metastases to unilateral, bilateral or contralateral cervical (Levels. I, II, III, IV, V) or retropharyngeal or superior mediastinal lymph nodes. (Level VII). SurgPath Final. Temporary Copy. Page 2 0f 4. NUMBER OF LYMPH NODE(S) INVOLVED:: 13. NUMBER OF LYMPH NODE(S) EXAMINED:: 40. LYMPH NODE, EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. MARGINS: Margins uninvolved by carcinoma. TUMOR CAPSULE: Partially encapsulated. TUMOR CAPSULAR INVASION: Present: LYMPH-VASCULAR INVASION: Not identified. EXTRATHYROIDAL EXTENSION: Present. -electronic signature~. A) LEFT THYROID LOBE, F/S. B) TRACHEA, SUPERIOR MARGIN, F/S. C) RIGHT ANTERIOR NECK CONTENTS. D) RIGHT POSTERIOR NECK CONTENTS. E) RESIDUAL THYROID TUMOR. FROZEN SECTION. A) Left thyroid lobe: Papillary carcinoma. Seen with. B) Tracheal superior margin: Negative for tumor. SurgPath Final. Temporary Copy. GROSS DESCRIPTION. A) Received fresh for frozen section labeled ""left thyroid lobe"" is a 79.3-g unoriented. left thyroid lobe measuring 7.5 X 7.0 x 4.0 cm. The capsule is purple/red with. multiple fibrous adhesions. The capsule is entirely inked black. Serial sectioning. reveals a 6.5 x 5.5 x 4.0 cm cystic lesion filled with tan/pink solid papillary. excrescences. Portions of the mass wall are white/gray, thickened and fibrotic. Touch preps of the mass are made and a representative section submitted for. frozen section diagnosis and is subsequently submitted as A1. The remainder of the. thyroid parenchyma is purple/red, dense and unremarkable. Representative. sections are submitted as follows: A2 representative mass to normal thyroid, A3. through A7 representative mass and cyst wall, A8 representative thyroid. A portion. of the tissue is submitted for research study. B) Received fresh for frozen section diagnosis labeled ""trachea, superior margin"" is. an unoriented, irregular fragment of red/tan soft tissue measuring 0.3 cm in greatest. dimension. The specimen is entirely submitted for frozen section diagnosis and. subsequently submitted in B1. C) Received in formalin labeled ""right anterior neck contents"" is an unoriented. irregular fragment of yellow/pink/gray fibrofatty soft tissue measuring 7.5 x 4.7 X 1.2. cm in aggregate. There is a small amount of red/brown skeletal muscle adhered to. the specimen. Eight possible lymph nodes are identified ranging from 0.2 to 1.5 cm. in greatest dimension. The nodes are entirely submitted as follows: C1 largest. lymph node bisected, C2 four possible intact lymph nodes, C3 three possible intact. lymph nodes. D) Received in formalin labeled ""right posterior neck contents"" is a 6.5 x 5.0: x 2.3. cm aggregate of yellow/brown lobulated adipose tissue. Multiple possible lymph. nodes are identified ranging from 0.2 to 3.6 cm in greatest dimension. Serial. sectioning of the two largest lymph nodes reveals tan/white/pink papillary, solid and. cystic foci. The lymph nodes are entirely submitted as follows: D1 through D4. paired sections quadrisected largest lymph node, D5 through D9 second largest. lymph node serially sectioned (paired sections), D10 two bisected nodes (one is. dotted orange), D11 five possible intact lymph nodes, D12 six possible intact lymph. nodes, D13 six possible intact lymph nodes, D14 five possible intact lymph nodes,. D15 five possible intact lymph nodes. E) Received in formalin labeled ""residual thyroid tumor"" is a 28-g (formalin fixed). SurgPath Final. Temporary Copy. unoriented portion of thyroid (6.0 x 3.5 x 2.0 cm) attached to a C-shaped portion of. trachea measuring 3.9 cm in length by 2.4 cm in diameter. There is a small amount. of adherent red/brown skeletal muscle on the anterior surface of the thyroid. The. thyroid capsule is purple/red with fine fibrous adhesions. The mucosa lining the. trachea is tan/pink, nodular and appears to be involved by mass. The thyroid and. anterior trachea are inked black. The superior tracheal margin is inked orange and. the inferior tracheal margin is inked blue. Serial sectioning of the thyroid lobe. reveals 4.5 x 2.9 x 2.7 cm gray/white/pink firm nodule that is extending into the. tracheal cartilage. The mass abuts the thyroid capsule. There is only a scant. amount of red/brown, dense normal-appearing thyroid present. Representative. sections are submitted as follows: E1 perpendicular sections of mass invading. trachea to include superior tracheal margin, E2 representative sections of mass. invading trachea to include inferior tracheal margins, E3 and E4 paired sections. bisected full-thickness section showing mass to trachea, E5 through E7. representative mass, E8 representative mass to adjacent normal thyroid tissue, E9. two intact and one bisected possible lymph nodes (the bisected lymph node is. dotted orange). CLINICAL INFORMATION. THYROID MASS.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Coded sample ID: Histologic diagnosis: moderate differentiated adenocarcinoma located in Barrett-epithelium. Anatomic site with laterality: distal esophagus. Tumor size: maximal diameter 4 cm. Lymph node status: 13 lymph nodes, of which 2 contain tumor. Any comments or amendments: radical resection.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Surgery Date: DIAGNOSIS. (A) RIGHT RADICAL NEPHRECTOMY: RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, FUHRMAN NUCLEAR. GRADE 3 (5.2 CM),. CONFINED TO THE KIDNEY. Ureteral and hilar vascular margins, free of tumor. GROSS DESCRIPTION. (A) RIGHT RADICAL NEPHRECTOMY - A right kidney (11.0 x 7.0 x 3.7 cm). has a pale tan to brown tumor (5.2 x 4.7 x 3.0 cm) with a central scar. The tumor is well circumscribed with pushing area near the renal capsule. and renal sinus. No lymph nodes are identified. Portions of the tumor. are submitted for electron microscopy. A photograph is obtained. SECTION CODE: A1, vascular and ureteral margin; A2-A4, tumor with. renal sinus; A5, central scar; A6, A7, tumor with perinephric fat;. A8-A10, tumor with adjacent renal parenchyma; A11-A12, distant normal. kidney. CLINICAL HISTORY. None given. SNOMED CODES. T-71000, M-83123. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION. eived in formalin labeled ""segment 4A. liver"" is a fragment of liver measuring 3.0 x 1.4 X 1.0 cm. The. specimen is a wedge resection and triangular in shape. There is. cautery artifact on one side, the capsule is smooth and without. abnormalities on another surface, and the cut surface is golden. yellow. The specimen is serially sectioned and submitted in. cassettes A1 and A2. DIAGNOSIS: Liver, segment 4A, wedge biopsy: Fatty liver disease. characterized by marked steatosis, mildly active (grade 1 of 3). steatohepatitis, and periportal fibrosis with rare bridging. (stage 2-3 of 4). DIAGNOSIS COMMENT: This is a large wedge biopsy with numerous portal tracts,. although the cytology is distorted by moderate to marked cautery. artifact. Portal areas show intact bile ducts with mild. nonspecific lymphocytic inflammation and several bile duct. hamartomas (von Meyenburg complexes) Acinar parenchyma shows. marked, nearly panacinar, steatosis that is accompanied by only. rare ballooned hepatocytes and very spotty Lymphohistiocytic. infiltrates. There is no vell-formed Mallory's hyaline. Iron. and PAS-D stains are negative. Trichrome and reticulin stains. show only slight zone 3 fibrosis, but fairly extensive. periportal fibrosis and a rare portal-portal bridge. There is. no evidence of extensive fibrosis or cirrhosis. Addendum/Procedure included. TISSUE DESCRIPTION: Tissue from. liver (6.2 X 5.0 x 4.8 cm) . DIAGNOSIS: Liver, segment 4A/4B, resection: Hepatocellular carcinoma,. grade 3 (of 4) , forming a 3.1 X 2.5 X 1.8 cm mass. The surgical. resection margin is negative. Vascular invasion is not. identified. The section of the non-neoplastic hepatic parenchyma. demonstrates severe, predominantly macrovesicular steatosis. with a moderately active steatohepatitis and periportal and. focal bridging fibrosis (stage 2-3 of 4) Scattered non-. necrotizing portal and lobular granulomas are also seen (see. comment) . Comment: The section of non-neoplastic liver contains. numerous portal tracts for evaluation. Many of these contain. mild to moderate lymphocytic inflammatory infiltrates. Some. also contain granulomatous inflammation. The latter does not. appear to be directed at bile ducts. There is no significant. interface activity. The lobular parenchyma demonstrates severe,. predominantly. macrovesicular steatosis. Lobular inflammation, occasional. neutrophils, occasional microgranulomas, and hepatocyte. ballooning are seen. A trichrome stain confirms the presence of. periportal and focal bridging fibrosis. The iron stain is. negative for hemosiderosis. Results of GMS and Auramine-rhodamine stains will be reported. as an addendum. Given the clinical scenario, the granulomatous. inflammation may represent reaction to the patient's neoplasm. Clinical correlation is needed. ADDENDUM: Special stains for microorganisms (AR and GMS) are negative. AMENDMENTS: Revision Description: Amended to include non-. neoplastic liver component in final diagnosis. Original Diagnosis. Liver, segment 4A/4B, resection: Hepatocellular carcinoma,. grade 3 (of 4), forming a 3.1 X 2.5 X 1.8 cm mass, 0.1 cm from. the surgical margin. The surgical resection margin is negative. Vascular invasion is not identified. Evaluation of the non-. neoplastic liver parenchyma will be reported in an addendum. PRELIMINARY FROZEN SECTION CONSULTATION: Liver, segment 4A/4B, resection: Hepatocellular carcinoma. Surgical margin is negative. Non-neoplastic liver shows marked. steatosis. Defer to permanent sections for further assessment.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Case ID Gross Description. Microscopic. Diagnosis. Description. Details. Lower third of the. Adenocarcinoma of. Tumor Features: esophagus and a part of the. the stomach, G-2,. Ulcerated,. stomach with ulcer-like. with invasion into. Tumor Extent: tumor up to 5.5x4 cm in size the perigastric fat. Perigastric fat,. in the cardial region. and esophagus wall. Venous. Invasion into the fatty. Ten examined lymph. Invasion: tissue. In the fatty tissue. nodes demonstrated. Absent, Margins: there are hyperemic lymph. metastases. Absent,. nodes. Great omentum and. Omentum is. Treatment. surgical margins are of. hyperemic. Surgical. Effect: normal structure. margins are free of. tumor growth. Comments. ICA ID. Original records read. STOMACH TISSUE CHECKLIST. N2, but 10 positive. lymph nodes are. Specimen type: Subtotal. referred as N3a,. gastrectomy. according to the 7th. Tumor site: Cardia. edition of the TNM-. Tumor size: 4 X 0 X 5.5 cm. classification. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Subserosa. Lymph nodes: 10/10 positive for. metastasis (Greater and lesser. omentum 10/10). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Summary pathology report. Right orchidectomy; nonseminoma (EC 100%); diameter 3 cm; tumor confined to the testis: angioinvasion present; no invasion in rete testis. = date of orchidectomy): pathologist.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Female. Surgery Date: DIAGNOSIS: Liver, right lobe, resection: Invasive grade 3 (of 4) cholangiocarcinoma forming a. lobulated, firm mass (8.9 x 6.8 x 5.5 cm) located 1.1 cm from the surgical margin. The uninvolved liver parenchyma is unremarkable. Peritoneum, biopsy: Partially calcified fat necrosis. Gallbladder, cholecystectomy : without diagnostic abnormality. Lymph node, retrocholedochal, biopsy: A single lymph node is negative for tumor. Small bowel, fistula tract, biopsy: Fistula tract with associated abscess formation. colon, sigmoid, segmental resection: Diverticulosis with multiple (4) diverticula and. associated diverticulitis.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure: Diagnosis. Rectum with J-pouch, attached bladder and prostate, pelvic. exenteration: Recurrent poorly differentiated adenocarcinoma involving rectal. mucosa, submucosa, muscularis propria, perirectal adipose tissue and. extensively infiltrating prostatic parenchyma. Tumor is present at the right pelvic sidewall margins. The prostatic urethral margin is positive or tumor in parenchyma and. lymphatic spaces. The rectal mucosal and deep margins are negative for tumor. Extensive lymphovascular space invasion and perineural space invasion. Microscopic Description: Microscopic examination performed and summarized in the template below: Histologic type: Recurrent adenocarcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : Although the tumor with somewhat difficult to. define grossly its microscopic spread was quite extensive with. prominent involvement of the rectum and J-pouch and connective tissue. between the rectum and the prostate and extensive infiltration of the. prostate and prostatic urethra and seminal vesicles. Overall the. recurrent tumor measured greater than 5 cm in greatest dimension. Proximal margin: Proximal rectal margin negative for tumor. Distal margins: Distal rectal margin negative for tumor. Circumferential (radial) margin: Right pelvic sidewall is. microscopically positive for tumor with areas of perineural space. invasion. Also tumor was present at the prostatic urethral margin. Vascular invasion: Present and prominent with both lymphatic and venous. invasion identified. Regional lymph nodes (pN) : 1 residual lymph node was identified and it. is negative for metastatic tumor (0/1). Non-lymph node pericolonic tumor: Present. Distant metastasis (pM) : Not evaluated. Other findings: There is some acute colitis in the rectum that is. nonspecific. There are some nonspecific findings of chronic cystitis. in the bladder. The ureter margins were negative for tumor. However. some tumor was identified attached to the left side of the bladder in. deep nerves attached seminal vesicles. MSI testing was not ordered as this is a recurrent tumor and not a. primary tumor. Specimen. Bladder prostate and rectum. Clinical Information. Recurrent rectal cancer. Recurrence between J-pouch and. prostate/seminal vesicles. Gross Description. Received fresh and subsequently fixed in formalin labeled ""bladder. prostate and rectum"" is a specimen which includes a 4.3 x 3.7 white 3.7. cm prostate, an 8.5 cm portion of rectum with J-pouch, attached bladder. and prostate. The bladder is approximately 6.5 x 5.5 and is 4.0 cm. inflated. There is a catheter in the prostatic urethra and the specimen. is heavily stapled. Orientation of the specimen was reviewed by the. surgeon at time of tissue procurement. No frozen sections were. requested. Proximal end of the rectum is inked blue and the distal end. of the rectum is inked black. The J-pouch of the specimen is. approximately 3 x 2.5 cm and is heavily stapled, located within 2.5 cm. of the distal margin of the rectum. The mucosa of this area is smooth. and glistening showing an average circumference of 7.5 cm in its opened. state. In the J-pouch there is a 1.2 x 0.7 cm ulcer. This comes within. 2.5 cm of the distal rectal margin and 6.5 cm of the proximal rectal. margin. This comes within 1.2 cm of the anastomotic line surface of. this area shows tumor present and a scarred focus. This area of the. J-pouch is adherent to the posterior right side of the prostate. This. area is inked black. The cut surface of this area shows a white tan. scarred irregular focus which is approximately 2.5 x 2.5 x 2.5 cm. The. remainder of the cut surface of the prostate is pink-tan and diffusely. nodular. The remainder of the bladder and prostate are opened in an. anterior Y-shaped incision. Mucosa the bladder is pink-tan smooth. glistening with no other discrete gross lesions identified. The ureters. are propatent an average 4.5 x 0.3 cm. The seminal vesicles cannot be. grossly identified in a variegated and behind the rectum. Vas. deferentia cannot be grossly identified. From minimal fat is gross. identified surrounding the tissue. Possible lymph nodes may be present. Representative sections of the specimen are submitted as follows: 1 -. representative luminal margins of the rectum, 2 - 6 - entire J-pouch. ulceration and to tumor including anastomotic line (inked blue) and. possible seminal vesicle and prostatic tissue, (from proximal to. distal), 7 - left side bladder with ureteral orifice and possible. ureteral margin, 7 - right side bladder with possible ureteral margin. (ureteral orifice cannot be grossly identified) 9 - representative. posterior bladder, 10 - prostatic urethral margin en face, 11 - full. thickness prostate from prostatic urethra to rectum, 12 - 14. representative right sided prostate from apex to base, 13 - 17. representative left prostate from apex to base, 18 - possible lymph. node, 19 - 2 possible lymph nodes, 20 through 22 - additional portions. of perirectal fat.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. LUNG, RIGHT UPPER LOBE, WEDGE EXCISION: - ADENOCARCINOIMA, SEE COMMENT. B. PLEURA, BIOPSY: - ADENOCARCINOIMA, SEE COMMENT. C. LUNG, RIGHT LOWER LOBE, WEDGE EXCISION: - ADENOCARCINOMA, SEE COMMENT. D. PLEURA, BIOPSY: - ADENOCARICNOMA, SEE COMMENT. COMMENT (Parts A-D): Sections show a histologically similar moderately differentiated. adenocarcinoma in all specimens. Immunohistochemistry was performed on part A. and shows the tumor cells to be positive for TTF-1, CK7, Napsin-A, MOC-31 and ER (rare. positive), and negative for calretinin, CDX2, CK20, CK 5/6, GCDFP-15, mammaglobin, p63,. PAX-8, vilin and S-100. The histomorphology and immunohistochemistry staining. pattern are consistent with a lung primary adenocarcinoma. Results discussed with Dr. Source of Specimen: A. Lung;Wedge Excision Right Upper Lobe. B. Pleural. C. Lung;Wedge Excision Right Lower I obe. FINAL SURGICAL PATHOLOGY REPORT. Clinical History/Operative Dx: Right lung nodule. Intraoperative Diagnosis: A. Right lung nodule: Non-small cell carcinoma. B. Pleural biopsy: Poorly differentiated carcinoma (Dr. The intraoperative interpretation(s). was/were performed and rendered at. Gross Description: A. Part A is labeled wedge excision right upper lobe for frozen section. Received in the fresh state for. frozen section analysis is a 3.5 X 2.2 X 1.0 cm wedge of lung. The pleura is glistening, light pink and tan. Numerous surgical staples are present along one periphery, involving approximately 4 mm of lung tissue,. now trimmed and the resulting margin marked black. The specimen is serially sectioned demonstrating a. partially circumscribed, yellow-gray nodule, 1.2 X 1.1 X 1.0 cm, grossly within 0.2 cm of the margin now. marked black. Representative sections are submitted for frozen section analysis and the residual frozen. tissue submitted in A1 for permanent sections. The lesion appears to abut the overlying pleura. The. adjacent lung parenchyma is spongy, light pink and tan. The remainder of the specimen is submitted for. microscopic evaluation, excluding the remnant involved with surgical staples. Cassette summary: A1) frozen section tumor nodule, A2) remainder of wedge including lesion submitted. B. Part B is labeled pleural biopsy. Received in the fresh state for frozen section analysis are two pieces of. flimsy to rubbery, pink and tan soft tissue, measuring in aggregate 1.8 X 1.3 x 0.3 cm. The tissue is entirely. submitted for frozen section analysis, the residual frozen tissue entirely submitted in B1 for permanent. sections. C. Part C is labeled excision right lower lobe. Received in formalin is a wedge of lung, 3.3 x 1.3 x 0.5 cm. and less than 1 gram. The pleura is glistening, light tan and congested purple-tan. A palpable area of. nodularity is noted along the mid pleural surface. The surgical staples involve approximately 5 mm of. lung tissue, now trimmed, and the resulting margin is marked black. The specimen is serially sectioned. through the margin now marked black to reveal two circumscribed, bluish-gray areas of fibrous appearing. nodularity, 0.5 cm and 0.4 cm each. The specimen is entirely submitted for microscopic evaluation in C1. and C2. D. Part D is labeled pleural biopsy. Received in formalin are two soft to rubbery, triangular fragments of. light gray-tan fibrous appearing soft tissue, 0.6 X 0.4 X 0.2 cm and 2.3 X 0.4 x 0.2 cm each. Both fragments. are submitted in D1. Microscopic Description: FINAL SURGICAL PATHOLOGY REPORT. A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Immunohistochemistry was performed with adequate control for Calretinin, CDX-2, CK7, CK20,. CK5/6, ER, GCDFP-15, mammoglobin, MOC-31, Napsin-A, p63, PAX-8, S100, TTF-1, and Villin. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Sections show an adenocarcinoma histologically similar to that seen in part A. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Sections show an adenocarcinoma histologically similar to that seen in part A. D. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Sections show an adenocarcinoma histologically similar to that seen in part A. An intradepartmental consultation was obtained with Dr.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. Breast, right, excision: Invasive lobular carcinoma, Nottingham II (of. III), forming a 2.8 x 2.6 6 x 2 cm mass (AJCCpt2) No lymphovascular. involvement or carcinoma in situ component is identified. The surgical. resection margins, after one re-excision are negative for tumor. The. uninvolved breast tissue shows duct ectasia and stromal fibrosis. Lymph node, right axilla, sentinel, excision: A single right sentinel. lymph node is negative for tumor. Lymph nodes, right axilla, excision: Multiple (3) right axillary lymph. nodes are negative for tumor. Staining for estrogen and progesterone receptors is positive.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Concluding diagnosis: Left breast segment at 12 o'clock with a 3 cm moderately differentiated invasive ductal. carcinoma with concomitant low-grade DCIS grade II. The resection margins lie in healthy. tissue on all sides. Two of a total 16 lymph nodes with metastases (2/16). Tumor classification: pT2 (3 cm), pN1a (2/16), MX, R0; G2, L0, V0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
BIOPSY OR SURGICAL SPECIMEN,. Patient Information. Male. dis. Provider Status. Component. Lab. Final Diagnosis. A. Right distal ureter, excision: - Segment of benign ureter. - No carcinoma is seen. - Frozen section diagnosis is confirmed on permanent sections. B. Left distal ureter, excision: - Segment of benign ureter. - No carcinoma is seen. - Frozen section diagnosis is confirmed on permanent sections. C. Urinary bladder and prostate, radical cystoprostatectomy: Urinary Bladder. - Invasive high grade urothelial carcinoma with prominent micropapillary. features, extensively involving bladder wall and extending into prostatic. urethra, in a background of in situ flat and papillary urothelial carcinoma, see. note. - Urothelial carcinoma invades muscularis propria and extends into perivesical. adipose tissue (pT3). Metastatic urothelial carcinoma in three peivic lymph nodes (see parts D and. E). - Background urothelium with chronic inflammation and biopsy site changes. - Pathologic TNM stage: pT3b N2 MX. - See CAP template below for further details. Prostate: - High grade prostatic intraepithelial neoplasia (HG-PIN). CAP Template for Carcinoma of the Urinary Bladder: Procedure: Radical cystoprostatectomy. Tumor Site: Anterior and posterior bladder walls. Right and left lateral walls. Trigone. Dome. Tumor Size: Greatest dimension: 7.0 cm. Additional dimensions: 6.5 x 1.5 cm. Histologic Type: Urothelial (transitional cell) carcinoma with micropapillary. features. Associated Epithelial Lesions: None identified. Histologic Grade: Urothelial Carcinoma (WHO 2004/ISUP): High-grade. Tumor Configuration: Papillary / micropapillary. Microscopic Tumor Extension: Tumor invades perivesical tissue, macroscopically. (extravesical mass). Margins: Margins uninvolved by invasive carcinoma. Margins uninvolved by carcinoma in situ. Lymph-Vascular Invasion: Present. Pathologic Staging (pTNM): Primary Tumor (pT): pT3b: Tumor invades perivesical tissue, macroscopically. (extravesical mass). Regional Lymph Nodes (pN): pN2: Multiple regional lymph node metastases in true. pelvis. Specify: Number. examined: 6. Specify: Number. involved: 3. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Inflammation, regenerative and biopsy site changes. Ancillary Studies: Blocks C5 and C10 can be used for additional studies, if. needed. The above pathology diagnosis incorporates data elements as outlined in the CAP. Cancer Protocols and Checklists which are based on the AJCC/UICC TNM, 7th. edition. D. Left pelvic lymph nodes, lymphadenectomy: - Metastatic urothelial carcinoma in one of three lymph nodes (1/3). E. Right pelvic lymph nodes, lymphadenectomy: - Metastatic urothelial carcinoma in two of three lymph nodes (2/3). NotePart C: Sections show a large urothelial tumor extensively involving all. bladder walls and extending into the prostatic urethra. The tumor extends along. prostatic urethral urothellum and shows areas of focal (urethral) lamina propria. invasion but no involvement of the prostatic stroma itself. Tumor invades. through the bladder muscularis propria into perivesical adipose tissue (pT3). The tumor shows prominent micropapillary areas with back to back lacunar spaces. containing small tumor nests comprising. 60% of tumor. Areas of vascular and. perineural invasion are seen. Multiple deeper sections are obtained in the evaluation of this case. Select slides from the case are reviewed with Dr. Clinical History. Bladder cancer. Cystoprostatectomy with ureteroileal conduct. Source: A: Right distal ureter for margin. B: Left distal ureter for margin. C: Bladder and prostate. D: Left pelvic lymph node. E: Right pelvic lymph node. Gross Description. Specimen A is received fresh for frozen section labeled with the patient's name. and designated ""right distal ureter for margin"". The specimen consists of a. pink-tan segment of ureter 0.2 cm in length, 0.4 cm in diameter. Section key: A1 - specimen entirely submitted. Specimen B is received fresh for frozen section labeled with the patient's name. and designated ""left distal ureter for margin"". The specimen consists of a. single pink-tan and segment of ureter 0.2 cm in length and 0.5 cm in diameter. Section key: B1 specimen entirely submitted. Specimen C. Type of specimen: Urinary bladder, prostate, seminal vesicles, and vas deferens. The patient's name and case number on the specimen container match the. accompanying paperwork and cassettes. Procedure: Radical cystoprostatectomy. Fixative: Received fresh, subsequently placed in formalin (tissue procurement. retained a sample of tumor). Dimensions: Bladder. superior to inferior 8.0 cm, left to right 7.0 cm, anterior to. posterior 4.5 cm, ureter stumps (left 1.0 cm in length, 0.8 cm in diameter;. right 1.0 cm in length, 0.7 cm in diameter, prostate (apex to base 3.6 cm,. anterior to posterior 3.0 cm, left to right 5.0 cm), left attached seminal. vesicle 2.5 x 1.5 x 1.0 cm; right attached seminal vesicle 2.0 x 1.5 x 2.0 cm;. left attached vas deferens 4.0 cm in length, 0.3 cm in diameter; right attached. vas deferens 4.0 cm in length, 0.3 cm in diameter. Description of findings: Tumor: Large fungating, friable, pink-tan micropapillary mass invading the. entire bladder, no normal appearing bladder mucosa identified. The bladder mass. extends into the prostatic urethra to within 1.5 cm of the urethral margin. The. urethral margin is submitted en face. The bladder mass abuts both ureteral. orifices. The bladder mass measures 7.0 x 6.5 cm and up to 1.5 cm in thickness. The mass invades the muscularis and into the posterior fat to within 0.5 cm of. the peritonealized posterior surface. The mass does not grossly involve the. seminal vesicles or vas deferens, or prostate. Uninvolved mucosa: The entire effacement of normal bladder. Prostate, seminal vesicles and vasa deferentia: The prostate parenchyma is. nodular yellow-tan. The seminal vesicles and vas deferentia are grossly. unremarkable. Ink code: Bladder: Anterior. blue. Posterior: orange. Prostate: Left side: blue. Right side: orange. Anterior: green. Lymph nodes: No lymph nodes are grossly identified. Section key: C1 urethral margin, submitted en face. C2, C3 longitudinal section of prostatic urethra to prostatic apex, proximal. side. C4 left ureteral orifice. C5 right ureteral orifice. C6 left vas deferens margin. C7 right vas deferens margin. C8, C9 posterior wall, deepest invasion of tumor. C10 bladder trigone. C11 bladder, left lateral wall. C12 bladder, right lateral wall. C13 bladder dome. C14 anterior bladder. C15 C18 representative sections from left side of prostate from apex to base. C19 C22 representative sections of right side of prostate from apex to base. Specimen D is received in formalin labeled with the patient's name and. designated ""left pelvic lymph nodes"". The specimen consists of three irregular. fragments of fibrofatty tissue 5.0 x 4.5 x 2.0 cm in aggregate. Thorough. examination reveals three suspected lymph nodes ranging from 1.0 2.0 cm in. greatest dimension. Two of the lymph nodes are red-brown. One of the lymph nodes. is firm and off-white. Section key: D1 D3 one bisected lymph node per cassette. Specimen E is received in formalin labeled with the patient's name and. designated ""right pelvic lymph nodes"". The specimen consists of three irregular. fragments of fibrofatty tissue 6.0 x 4.0 x 2.0 cm in aggregate. Thorough. examination reveals three suspected lymph nodes ranging from 1.5 2.0 cm in. greatest dimension. One of the lymph nodes has a diffuse off-white appearance. The second lymph node has multiple foci of off-white, firm nodularities. Section key: E1 E3 one bisected lymph node per cassette. Microscopic Description. The stain quality is acceptable. A-E. The microscopic findings are reflected in the diagnoses rendered. Intraoperative Diagnosis. Time in: Ime out: AFS1, Right distal ureter margin: ""Negative for invasive carcinoma, focal. atypia"". BFS1, Left distal ureter margin: ""Negative for invasive carcinoma, focal atypia"". Reported to Dr.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. RIGHT RENAL TUMOR BASE. B. RIGHT KIDNEY TUMOR. SPECIMEN(S): A. RIGHT RENAL TUMOR BASE. B. RIGHT KIDNEY TUMOR. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-right renal tumor base: No malignancy identified. Diagnosis called by Dr. to Dr. at. DIAGNOSIS: A. KIDNEY, RIGHT, TUMOR BASE, EXCISION: - NEGATIVE FOR CARCINOMA. B. KIDNEY, RIGHT, PARTIAL NEPHRECTOMY: - PAPILLARY RENAL CELL CARCINOMA, TYPE 2. - TUMOR SIZE: 2.5 CM IN GREATEST DIMENSION. - SURGICAL RESECTION MARGIN IS INVOLVED BY CARCINOMA. - SEE SYNOPTIC REPORT. COMMENT;. The surface inked orange is not real margin as per conversation with Dr. on. SYNOPTIC REPORT - KIDNEY (PARTIAL OR RADICAL). Specimens Involved. Specimens: A: RIGHT RENAL TUMOR BASE. B: RIGHT KIDNEY TUMOR. Specimen Type: Partial nephrectomy. Without adrenal gland. Laterality: Right. Tumor Site: Not specified. Focality: Unifocal. Tumor Size (largest tumor if multiple): Greatest dimension: 2.5cm. Macroscopic Extent of Tumor: Tumor limited to kidney. WHO CLASSIFICATION. Papillary renal cell carcinoma 8260/3. Histologic Grade (Fuhrman Nuclear Grade): G2: Nuclei slightly irregular, approximately 15 u;. nucleoli evident. Invasion of Vascular/Lymphatic: Absent. Perinephric Tissue Invasion: Absent. Margins: Margin(s) involved by invasive carcinoma. Include: Renal parenchymal margin (partial nephrectomy only). Adrenal Gland: Not present. Regional Lymph Nodes: None sampled. Additional Findings: None identified. Pathological Staging (pTNM): pT 1a N x M x. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. pMX: Cannot be assessed. SUMMARY OF IMMUNOHISTOCHEMISTRY/SPECIAL STAINS. Material: Block B2. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN 7. Positive. CD 10. Positive. Material: Block B5. Population: Tumor Cells. Stain/Marker:Result: Comment: RACEMACE Positive. Carbonic Anhydrase IX. Positive Equivocal. The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of. staining performance and assay validation within the. The use. of one or more reagents in the above tests is regulated as an analyte specific reagent (ASR). These. tests were developed and their performance characteristic determined by the. They have not been cleared or approved by the U.S. Food and Drug Administration. The. FDA has determined that such clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive. and/or negative controls. GROSS DESCRIPTION: A. RIGHT RENAL TUMOR BASE. Received fresh labeled the patient's identification and ""right renal tumor base"" is a 0.3 x 0.2 x 0.1 cm. piece of red-tan soft tissue; submitted in the frozen section diagnosis, FSA. B. RIGHT KIDNEY TUMOR. Received fresh labeled with the patient's identification and ""right kidney tumor"" is a 9 g, 3.7 x 2.5 x 1.3. cm piece of kidney with 1.3 x 0.5 x 0.5 cm piece of attached perinephric fat. The surface has a 1.5 x 1. cm defect. The specimen is oriented by Dr.. The true margin (surrounding the defect) is inked black and. the remainder of the specimen is inked orange. On sectioning, there is a well-circumscribed mottled tan. and brown nodule, 2.5 x 2.3 x 1.8 cm, which abuts the true margin. Photographs are taken and tissue is. procured; submitted entirely, B1-B8. CLINICAL HISTORY: None Given. PRE-OPERATIVE DIAGNOSIS: Right renal mass. Microscopic/Diagnostic Dictation: Final Review:. Pathologist. Final: Pathologist,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Not answered. PROCEDURE: Total thyroidectomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION: No. OTHER DISEASES: No. ADDENDA: Addendum. Molecular Anatomic Pathology Testing: Block I: A. BRAF V600E mutation IDENTIFIED. B. Mutations in NRAS61, HRAS61, KRAS12/13 NOT identified. C. FISH test results are negative for RET/PTC rearrangement. Note: DNA was extracted in the amount sufficient for testing. FINAL DIAGNOSIS: THYROID, TOTAL THYROIDECTOMY (53.2 GRAMS) -. A. PAPILLARY THYROID CARCINOMA WITH TALL CELL FEATURES (4.5 CM) LOCATED IN THE LEFTLOBE. B. TUMOR INVADES PERITHYROIDAL SKELETAL MUSCLE AND EXTENDS TO MARGIN. C. THREE (3) LYMPH NODES WITH METASTATIC PAPILLARY THYROID CARCINOMA ATTACHED TO LEFT LOBE. OF THYROID (3/3). (NO EXTRANODAL SPREAD IS SEEN). D. NODULAR THYROID. E. ONE NORMOCELLULAR PARATHYROID GLAND ATTACHED TO THE LEFT LOBE OF THE THYROID. F. pT3N1MX. COMMENT: Molecular studies have been ordered and the results will be reported in an addendum. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Left Lobe. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 4.5 cm. HISTOLOGIC TYPE: Papiliary carcinoma. PATHOLOGIC STAGING (pTNM): pT3. pN1a. Number of regional lymph nodes examined: 3. Number of regional lymph nodes involved: 3. pMX. MARGINS: Margin(s) involved by carcinoma. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: NODULAR THYROID.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Stomach (Antrum). Product of gastrectomy. Adenocarcinoma: Histological pattern observed: Mucosecretor mucocelular with ""signet ring"" cells. Histological grade: III - Poorly differentiated. Lauren's classification: diffuse type. Measure of the longest axis of the tumor: 5.0 cm. Ulceration: present. Involvement of: serosa. Type of tumor invasion: expansive. Inflammatory reaction: moderate. Tumor implantation in perivisceral adipose tissue: absent. Proximal and distal margins: Absence of neoplasic involvement. Neural infiltration: not detected. Lymphatic vascular invasion: not detected. Blood vascular invasion: not detected. Lesser omentum: absence of neoplastic involvement. Lesser curvature lymph nodes: Absence of neoplasia: (0/8). Greater curvature lymph nodes: Absence of neoplasia: (0/6). Lymph nodes of the anterior hepatic artery: Absence of neoplasia: (0/4). Lymph nodes of the posterior hepatic artery: Absence of neoplasia: (0/2). Lymph nodes of the splenic artery: Absence of neoplasia: (0/3). Lymph nodes of the celiac trunk: Absence of neoplasia: (0/3).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Right renal cortical tumor. Laparoscopic right nephrectomy. Specimens Submitted: 1: SP: Right kidney (sr). DIAGNOSIS: 1). KIDNEY, RIGHT; LAPAROSCOPIC NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE II/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DIAMETER IS 4.5 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. THE NON-NEOPLASTIC KIDNEY SHOWS GLOMERULOSCLEROSIS AND INTERSTITIAL INFLAMMATION,. - THE ADRENAL GLAND IS NOT SUBMITTED. Special Studies: Special Stain. Comment. RECUT. Gross Description: The specimen is received fresh, labeled ""Right Kidney"". It consists of a kidney with focally attached perirenal fat,. superiorly, inferiorly and posteriorly measuring 440 grams, 20 x 8.6 x 4,5 cm altogether. The kidney measures 12 X 8 X 4 cm with. attached ureter measuring 6 x 0.3 cm, The anterior renal capsule is exposed. The posterior renal capsule is also focally. exposed. The margin is inked, The ureter and the vascular margins are taken, The specimen is bivalved revealing a. subcapsular, well-circumscribed, yellow-brown mass with a central scar measuring 4.5 x 4,5 : x 4,0 cm. The tumor is limited to the. renal cortex and abuts the renal capsule, but does not panatrate it. The renal calyces and pelvis are uninvolved. The renal vein,. artery and ureter are also uninvolved. Representative sections are submitted. A portion of the specimen is given to TPS. A. photograph is taken. Summary of Sections: UM - ureteral margin. VM - vascular margin. TAM - tumor with anterior margin. TPM - tumor with posterior margin. TP - tumor with renal pelvis. N - normal parenchyma. HF - hilar fat, for possible lymph nodes. Summary of Sections: Part 1: SP: Right kidney (sr). Block. Sect. Site. PCs. 1. HF. 2. 1. N. 1. 2. TAM. 2. 1. TP. 1. 2. TPM. 2. UM. 1. VM. 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Report for. Collected Date & Time: Result Name. Reference Range. SURGICAL P. (Age: Service: Surgery. Physician (s) : Specimen (s) Received. A: Thyroid. B: Right paratracheal lymph node level 6. Pathologic Diagnosis. A. Thyroid, total thyroidectomy: Papillary thyroid carcinoma, classical type. Tumor location Right thyroid lobe. Tumor size: 4.2 cm in greatest dimension. Tumor extends into perithyroidal adipose tissue with focal. superficial involvement of attached skeletal muscle. Resection margins negative. No lymph vascular invasion identified. Left thyroid lobe benign. Mild lymphocytic thyroiditis. Tumor tissue obtained for. B. Right paratracheal lymph nodes ( level 6) : Six lymph nodes, all negative for metastatic. carcinoma. CANCER CHECKLIST: THYROID: Procedure: Total thyroidectomy. Specimen Integrity: Intact. Specimen Size: Right lobe: 4.5 x 2.5 x 2.0 cm. Left lobe: 4.0 x 2.0 x 1.0 cm. Isthmus with pyramidal lobe: 5.5 x 1.5 x 0.7 cm. Specimen Weight : 21 g. Tumor Focality: Unifocal. Dominant Tumor: Tumor Laterality: Right lobe. Tumor Size: 4.2 cm. Histologic Type: Papillary carcinoma. Variant. Classical. Architecture: Classical. Cytomorphology Classical. Resection Margins: Uninvolved. 1. Tumor Capsule: Partial encapsulated. Lymph-Vascular Invasion Not identified. Extrathyroidal Extension: Present. Extent: Minimal. PATHOLOGIC STAGE: pT3, pNO, pMX. NOTE: Information on pathology stage and the operative procedure. is transmitted to this Institution' S Cancer Registry as required. for accreditation by the Commission on Cancer. Pathology stage. is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is. only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon' S. operative report. Additional Pathologic Findings: Thyroiditis, mild. Primary Pathologist: Clinical History. Papillary thyroid cancer. done on thyroid nodule. Gross Description. A. Received fresh for. research sampling labeled ""thyroid -. stitch at right superior pole"" is an intact 21 gram total. thyroidectomy specimen with attached stitch marking the right. superior pole. The capsule is intact, maroon-tan. Attached to. the anterior right lobe is an unremarkable fragment of tan. skeletal muscle (2.5 x 1.5 x 1.0 cm). The right lobe (4.5 x 2.5. X 2.0 cm) is inked blue. The left lobe (4.0 x 2.0 x 1.0 cm) is. inked black. The isthmus with pyramidal lobe (5.5 x 1.5 x 0. 7. cm) is inked yellow. The specimen is serially sectioned from. superior to inferior. Occupying the majority of the right lobe. is a partially encapsulated, ill-defined rubbery nodule (4.2 x. 2.- x 2.- cin) with a heterogenous tan-yellow cut surface. The. nodule is <0. cm from the capsule surface. No other discrete. masses or suspicious areas are grossly identified. The remainder. of the specimen has a homogenous maroon-red cut surface. A. portion of the nodule is submitted for. research. Representative sections are submitted for light microscopy as. labeled: A1-A5 - nodule (right lobe) every other slice from. superior to inferior with fragment of attached muscle in A3; A6 -. isthmus; A7-A9 - left lobe (majority) from superior to inferior. (nine cassettes) The specimen is reviewed with Dr. B. Received in formalin labeled ""level 6 right paratracheal. lymph node"" is a 2.5 x 2.0 x 0.3 cm aggregate of six tan-yellow,. irregular soft tissues which are submitted in toto (one. cassotte). Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic. findings of this case. Interpretation performed at.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: Site Code : breast, NOS C50.9. CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Left breast cancer 1.3 cm, positive nodes. Right invasive ductal. carcinoma 9 d'clock. LMP DATE: Not provided. PROCEDURE: Bilateral segmental mastectomies, right sentinel lymph node biopsy. left axillary lymph node dissection. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: BREAST, RIGHTAT 9 O'CLOCK, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE (See comment). B. NOTTINGHAM GRADE 2 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 2, MITOTIC ACTIVITY: 1;. TOTAL SCORE: 6/9). C. THE INVASIVE TUMOR MEASURES 0.8 CM IN LARGEST DIMENSION. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM, MICROPAPILLARY AND FOCAL. PAPILLARY TYPE WITH CALCIFICATIONS. E. LOBULAR INVOLVEMENT BY DCIS IS PRESENT. F. THE DCIS CONSTITUTES 60% OF THE TOTAL TUMOR VOLUME AND is PRESENT ADMIXED AND. ADJACENT TO THE INVASIVE COMPONENT. G. NO LYMPHOVASCULAR SPACE INVASION IS NOTED. H. RESECTION MARGINS ARE NEGATIVE FOR TUMOR. I. BOTH INVASIVE CARCINOMA AND IN SITU CARCINOMA ARE MORE THAN 0.5 CM FROM ALL MARGINS. J. FOCAL ATYPICAL DUCTAL HYPERPLASIA. K. PREVIOUS BIOPSY SITE CHANGES. L. THE NON-NEOPLASTIC BREAST SHOWS FIBROCYSTIC CHANGES. M. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN (H-score 230), POSITIVE FOR. PROGESTERONE RECEPTORS (H-score 180), AND NEGATIVE FOR HER-2/NEU (IHC 2+, FISH not amplified). AS PER THE PREVIOUS PATHOLOGY REPORT. PART 2: RIGHT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC TUMOR (0/1). PART 3: BREAST, LEFT. AT 12 O'CLOCK, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA NO SPECIAL TYPE. B. NOTTINGHAM GRADE 3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 2;. TOTAL SCORE: 8/9). C. THE INVASIVE TUMOR MEASURES 1.3 CM IN LARGEST DIMENSION. D. ADDITIONAL SATELLITE NODULE OF INVASIVE CARCINOMA MEASURING 0.2 CM IS IDENTIFIED. E. THE SATELLITE NODULE IS 0.5 CM FROM THE DOMINANT TUMOR NODUI E. F. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID TYPE. G. LOBULAR INVOLVEMENT BY DCIS IS PRESENT. H. THE DCIS CONSTITUTES 15% OF THE TOTAL TUMOR VOLUME AND IS PRESENT ADJACENT TO THE. INVASIVE COMPONENT. I. FOCAL LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. J. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. K. INVASIVE CARCINOMA IS 0.4 CM FROM THE NEAREST (POSTERIOR) MARGIN. L. DUCTAL CARCINOMA IN SITU IS MORE THAN 0.5 CM FROM ALL MARGINS. M. SKIN IS NEGATIVE FOR TUMOR. N. PREVIOUS BIOPSY SITE CHANGES. O. THE NON-NEOPLASTIC BREAST SHOWS FIBROCYSTIC CHANGES. P. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR (H-ccore 300), POSITIVE FOR. PROGESTERONE RECEPTOR (H-score 235), AND NEGATIVE FOR HER-2/NEU, AS PER PREVIOUS. PART 4: LEFT AXILLARY CONTENTS, EXCISION -. A. METASTATIC CARCINOMA INVOLVES TWO OF TWENTY-FOUR LYMPH NODES (2/24). B. THE LARGEST METASTATIC FOCUS MEASURES 4.0 CM. C. NO EXTRACAPSULAR EXTENSION IDENTIFIED. COMMENT: Part 1: The gross examination demonstrated an III-defined firm nodule with surrounding fibrous tissue measuring 2.0 x. 1.1 x 0.7 cm. This area was entirely submitted for histologic evaluation and shows Invasive carcinoma in only two. sections of 0.4 cm thickness and therefore, the invasive tumor size is estimated to be 0.8 cm in largest dimension. The. majority of this gross lesion is composed of ductal carcinoma in situ (DCIS). Part 3: The invasive tumor demonstrates scattered cells with intra-cytoplasmic lumina or signet ring cell morphology. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Clook position:9.00. SIZE OF TUMOR: Maximum dimension invasive component: 8 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (Invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Cribriform. Micropapillary. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of Invasive tumor to closest margin: 6 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 6 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC 1 BREAST TISSUE: ADH, FCD. T STAGE, PATHOLOGIC: pT1b. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 230. PROGESTERONE RECEPTORS: positive, H-score: 180. HER2/NEU: 2+. HER2/NEU (FISH): Not amplified. SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: ( Left. PROCEDURE: Segmental. Clock position: 12.00. SIZE OF TUMOR: Maximum dimension invasive component: 13 mm. MULIICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI;. TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 15 mm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 8. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 4 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 24. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 40 mm. LYMPH NODE METASTASIS(-ES WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pN1a. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 300. PROGESTERONE RECEPTORS: positive, H-score: 235. HER2/NEU: 1+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis/ Diagnoses. Resected colon and rectal sample with tumor-free resection margins and including an. ulcerated, moderately differentiated (G2) adenocarcinoma with infiltration of the. perimuscular fatty tissue and without local lymph node metastases (pT3 pNO 0/21 LO V0. R0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Right kidney, right hand assisted laparoscopic nephrectomy. Histologic tumor type/subtype: renal cell carcinoma, clear cell type. Sarcomatoid features: not identified. Histologic grade (if applicable): Fuhrman nuclear grade 2. Tumor size (greatest dimension): 5.4 cm. Tumor focality: focal. Extent of tumor invasion (if present specify if macroscopic or microscopic): Capsular invasion/perirenal adipose tissue: not identified. Gerota's fascia: not identified. Renal sinus: not identified. Major veins (renal vein or segmental branches, IVC): not identified. Ureter: not identified. Venous (large vessel): not identified. Lymphatic (small vessel): not identified. Histologic assessment of surgical margins: Gerota's fascia (nephrectomy): negative. Renal vein (nephrectomy): negative. Ureter (nephrectomy): negative. Adrenal gland: not present. Lymph nodes: none identified. AJCC Staging: pT1b. pNx. This staging information is based on information available at the time of this report, and is subject to change pending clinical review and. additional information. Comment: The frozen section diagnosis is confirmed. Intraoperative Consult Diagnosis: Frozen section was requested by. FSA1: Right kidney, excision. - Clear cell renal cell carcinoma. Frozen Section Pathologist: Clinical History: right renal mass. Gross Description: The specimen was opened in the OR and was a 266 gram 17.0 X 9.5 x 5.3 cm kidney. The serosal surface was inked green. Bivalve of the. kidney demonstrated a well-circumscribed cystic and solid mass, 5.4 X 3.5 x 2.5 cm. Representative sections of mass submitted in FSA1. Specimen fixation: Formalin. Type of specimen: Laparoscopic nephrectomy. Side of specimen: Right. Size and weight of specimen: 266 grams; 17.0 x 9.5 X 5.3 cm. Orientation: The perirenal soft tissue is inked green. Presence/absence of adrenal gland: Absent. Tumor site: Mass is present adjacent to the right lower pole of pyelocalyceal system. Tumor description: The mass is well-circumscribed with a surrounding pseudocapsule. Cut sections demonstrate a yellow/tan cystic and solid. cut surface. Possible areas of necrosis are identified. Tumor size: 5.4 X 3.5 X 2.5 cm. Presence/absence of multicentricity: Absent. Confinement/non-confinement to the kidney: Confined, closest area is 0.9 cm from medial lower pole renal parenchyma. Extent of invasion: Perirenal adipose tissue: Not grossly involved. Gerota's fascia: Not grossly involved. Renal vein: Not grossly involved. Ureter: Not grossly involved. Renal Sinus: Tumor abuts renal sinus grossly, defer to light microscopy. Pelvicaliceal: Grossly adjacent to the right lower pole pelvicaliceal system. Adrenal: N/A. Other organs: N/A. Surgical margins: Perirenal adipose tissue: Negative. Renal vein: Negative. Renal artery: Negative. Ureter: Negative. Description of kidney away from tumor: The rest of the right renal parenchyma is normal in appearance without additional masses, atrophy. or scarring. Hilar lymph nodes: Not present. Other significant findings: None. Tissue submitted for special investigations: Yes, per tissue procurement. Digital picture: No. Block Summary: Al - Section of ureter vein and artery margins. A2 - Mass in relation to hilar vessels. A3 - Mass in relation to hilar vessels. A4 - Mass in relation to closest green inked surgical margin. A5 - Mass in relation to collecting system. A6 - Mass in relation to collecting system and green inked renal capsule. A7 - Mass in relation to pyelocalyceal system. A8 - Grossly normal kidney. Light Microscopy: Light microscopic examination is performed by. Resident Physician: Attending Pathologist: I have personally conducted the evaluation of the above specimens and have. rendered the above diagnosis(es).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
SURGICAL PATHOLOGY ----. RGICAL PATHOLOGY. ?ORT. Accession No. Date obtained: Specimen (Received. A. LOW ANTERIOR RESECTION/STITCH MARKS PROXIMAL MARGIN. B. PROXIMAL DONUT. C. DISTAL DONUT. BRIEF CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: RECTO-SIGMOID ADENOCARCINOMA. OPERATIVE FINDINGS: POSTOPERATIVE DIAGNOSIS: RECTO-SIGMOID ADENOCARCINOMA. Laboratory: GROSS DESCRIPTION: A. The specimen consists of 21.0 cm in length segment of colon,. stapled at both ends with moderate amounts of attached fat. The. specimen is received fresh to the frozen section lab for. intraoperative gross consultation. Intraoperative findings are. communicated to the surgeon in person. The serosa is tan-pink, smooth. and glistening. There is a firm area of puckering in the mid portion. of. the serosa. The serosal aspect with the puckering is inked blue. Opening reveals a 2.8 x 2.5 cm, tan-pink, centrally ulcerated mass. with raised borders that is nearly circumferential, 9.5 cm from the. proximal resection margin, and 5.8 cm from the distal resection. margin. Sectioning through the mass reveals a tan-white, granular cut. surface that grossly extends into the underlying attached mesenteric. fat. The mass does not grossly extend to the inked serosal aspect. The mass is 9.3 cm from the mesenteric resection margin. The remaining colonic mucosa is tan-brown, smooth and glistening. No. subsequent lesions are identified. Sectioning through the attached. fat reveals multiple tan-pink, rubbery lymph nodes ranging from 0.3 to. 0.8 cm in greatest dimensions. ?epresentative sections are submitted as follows: Al- proximal. resection margin; A2 - distal resection margin; A3-A4- mass to closest. inked serosa; A5-A6- mass to include underlying fat and adjacent. uninvolved mucosa; A7- mesenterio resection margin closest to mass;. A8-A13- - multiple whole lymph nodes. GROSS DIAGNOSIS: RECTOSIGMOID COLON RESECTION: - TUMOR IDENTIFIED WITH MARGINS APPEARING GROSSLY FAR FROM THE. MASS. 3. The specimen consists of a 1.8 x 1.0 X 0.6 cm, tan-brown, annular. soft tissue partially surface by a tan-brown, smooth and glistening. mucosa. Sectioning reveals a tan-brown, unremarkable cut surface. No. discrete lesions are identified. Representative sections are. submitted in cassette B. C. The specimen consists of a 2.1 x 1.3 x 0.6 cm, tan-brown, annular. soft tissue partially surface by a tan-brown, smooth and glistening. mucosa. Sectioning reveals a tan-brown, unremarkable cut surface. No. discrete lesions are identified. Representative sections are. submitted in cassette C. MICROSCOPIC EXAM. FINAL DIAGNOSIS: A. LOW ANTERIOR COLON, RESECTION: - SPECIMEN TYPE: RECTOSIGMOID, EN, BLOC RESECTION. - TUMOR SITE: RECTOSIGMOID COLON. - TUMOR CONFIGURATION: INFILTRATIVE. - TUMOR SIZE: 2.8 CM IN GREATEST DIMENSION. - HISTOLOGIC TYPE: ADENOCARCINOMA. - HISTOLOGIC GRADE: WELL DIFFERENTIATED (G2). - SURGICAL MARGINS. PROXIMAL COLORECTAL: NEGATIVE. DISTAL COLORECTAL: NEGATIVE. RADIAL: NEGATIVE. DISTANCE OF INVASIVE CARCINOMA FROM NEAREST. SURGICAL MARGIN: 5.8 CM FROM DISTAL MARGIN. - LYMPHATIC INVASION: PRESENT. - VASCULAR INVASION: PRESENT. - PERINEURAL INVASION: PRESENT. PATHOLOGIC STAGING (pTN) : - PRIMARY TUMOR: pT3. - REGIONAL LYMPH NODES: pN1b. NUMBER EXAMINED: 38. NUMBER INVOLVED: 3. ADDITIONAL DIAGNOSES: - TUBULAR ADENOMA ASSOCIATED WITH ADENOCARCINOMA. B. PROXIMAL COLONIC DONUT, RESECTION: - SEGMENT OF COLON, NO TUMOR SEEN. C. DISTAL COLONIC DONUT, RESECTION: - SEGMENT OF COLON, NO TUMOR SEEN. COMMENT: THE TUMOR IS 0.5 CM FROM THE SEROSAL REGION IN FOCAL AREAS. AWAY FROM THE SURGICAL SEROSAL MARGINS. THE ORIGINAL DIAGNOSIS FROM. ALEXANDRIA WAS CORRELATED. DR. CONCURS WITH MALIGNANCY DIAGNOSIS. IMAGES ARE AVAILABLE IN VISTA. NOTIFIED VIA ALERT ON. MD. MD.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) LEFT KIDNEY AND ADRENAL: RENAL CELL CARCINOMA (12.0 CM MAXIMUM DIMENSION), CONVENTIONAL TYPE. (70% CLEAR CELLS, 30%. EOSINOPHILIC CELLS), FUHRMAN NUCLEAR GRADE 4, INVASIVE INTO RENAL VEIN. AND RENAL. SINUS ADIPOSE TISSUE. (SEE COMMENT). Margins of resection free of tumor. Adrenal gland, no tumor present. COMMENT. The renal cell carcinoma invades into the renal vein, but does not extend to the margin of resection. The tumor pushes into the. perinephric adipose tissue, but there is no unequivocal invasion into the perinephric adipose tissue. GROSS DESCRIPTION. (A) LEFT KIDNEY AND ADRENAL - A radical nephrectomy specimen (23.0 x. 11.0 cm) including kidney and adrenal gland (6.7 x 4.0 x 1.0 cm). Most of the kidney is replaced by a tumor (12.0 x 9.0 x 8.0 cm). The. tumor has a variegated cut surface with areas ranging from soft light. tan-brown to bright yellow and firm pink-white. Larger areas of the. tumor are necrotic and cystic. The tumor invades into the renal vein,. but does not extend to the renal vein margin of resection. Tumor pushes. up against the perinephric adipose tissue. The renal sinus is. completely obliterated by tumor. The limited amount of renal parenchyma that is present is. unremarkable. The adrenal gland is also unremarkable. INK CODE: Black - Gerota's fascia. SECTION CODE: A1, vascular margins; A2, tumor within renal vein;. A3-A7, firm white areas of tumor (A5-A7, tumor with renal sinus);. A8-A12, tan-yellow areas of tumor with renal sinus; A13-A15, tumor with. perinephric adipose tissue and soft tissue margin; A16, non-neoplastic. kidney; A17, normal adrenal gland. Tissue is also submitted for the. renal vaccine protocol. CLINICAL HISTORY. Left renal mass. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Examination report. Macroscopic findings: 1. (a-f) Left upper lobe of lung: resected lung tissue weighing 232g, and measuring 190 x 120 X 40 mm, with. anthracosis of the pleura. Located in the peripheral section of S 1 up to the segmental bronchi there is a. polycyclic and well demarcated, grayish-white, hyaline, tumorous node measuring max 28 mm, without pleural. infiltration. The peritumoral section has a significantly coarsened edge with an indication of a honeycomb. structure. In the hilar section there are small, lymph nodes with blackish pigment but without any suspicion of. a. tumor. No further pulmonary findings. 2. L 12: Torn, node measuring a good 10 mm, with blackish pigment. 3. L 11: 6 mm node with blackish pigment. 4. L10: Grayish-black lymph node tissue measuring 20 mm in total. 5. L 9: Grayish-white node measuring 5 mm with blackish pigment. 6. L 8: Piece of tissue measuring 4 mm with blackish pigment. 7. L 7: Node measuring just under 10 mm with blackish pigment. 8. L 6: Node measuring 12 mm with blackish pigment. 9. L 5: Node measuring 7 mm with blackish pigment. 10. L 4: Nodule measuring 2 mm with blackish pigment. Microscopic findings: 1. (HE, PAS, EvG) The bronchial resection margin is tumor-free with regular architecture. Next to this, in the. hilar and peribronchial area, there are tumor-free lymph nodes with significant anthracosis and slight. histiocytosis. The tumor described is made up of solid, growing structures of immature squamous cell. carcinoma cells with fusocellular morphology with a significantly misaligned nucleoplasmic ratio and frequent. mitosis, and with a very sparse and narrow cytoplasmic border. No keratinizing growth. Necrosis included,. alongside stromal desmoplasia. In the area of an embedded subsegmental bronchus there is subepithelial,. intramural tumor propagation. Apart from the tumor, unremarkable pulmonary parenchyma. 2. (HE) Torn lymph node tissue with haemorrhaging and moderate histiocytosis as well as anthracosis. No. indication of tumor. 3. (HE) Similar findings to 2. 4. (HE) Similar findings to 2. 5. (HE) Similar findings to 2. 6. (HE) Similar findings to 2. 7. (HE) Similar findings to 2. 8. (HE) Similar findings to 2. 9. (HE) Similar findings to 2. 10. (HE) Similar findings to 2. Diagnosis: Resected left superior pulmonary lobe with a badly differentiated and non-keratinizing squamous. cell carcinoma in S 1, measuring 28 mm, with subepithelial, intramural infiltration of a subsegmental bronchus. from B1, without pleural infiltration or discernible hemangioinvasion with tumor-free lymph nodes containing. anthracotic pigment. 2. to 10. Further tumor-free lymph nodes, containing anthracotic pigment. Tumor classification: M-8070/3, G3, pT 1, pN 0, pMX, stage IA. RO. Left upper lobe of lung. Lymph nodes.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Surgery date: DIAGNOSIS: A. Liver, right lobe, biopsy: Bile duct hamartoma. Negative for Suite Pancreas head. malignancy. B. Lymph nodes, hepatic hilar, biopsy: Multiple (2) lymph nodes are. negative for tumor. C. Common hepatic duct, margin, excision: Negative for malignancy. D. Pancreas, neck margin, excision: Negative for malignancy. E. Head of pancreas, common bile duct, duodenum, jejunum, and. gallbladder; Whipple resection: Invasive moderately differentiated. grade 3 (of 4) ductal adenocarcinoma is identified forming a solid. 3.5 x 2.8 X 2.4 cm mass located in the pancreatic head. The tumor. extends beyond the pancreas to involve pancreatic soft tissue and. distal common bile duct. Angiolymphatic invasion is identified. Perineural invasion is present. Tumor necrosis is absent. The. portal vein groove margin is focally positive for invasive. carcinoma. The portion of superior mesenteric vein is negative for. tumor. The adjacent non-neoplastic pancreatic parenchyma shows. chronic pancreatitis. Multiple (3 of 25) regional lymph nodes are. positive for metastatic adenocarcinoma. With available surgical material, [AJCC pT3N1] (7th edition, 2010). Frozen section histologic interpretation of right lobe of liver. This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""lesion, right lobe liver biopsy"" is a 1.2. X 0.6 x 0.6 cm fragment of liver with a 0.4 x 0.4 X 0.3 cm tan firm. nodule. All submitted. Grossed by. B. Received fresh labeled ""hepatic hilar lymph nodes"" is a 2.1 x 1.6. X 0.8 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. C. Received fresh labeled ""common hepatic duct margin"" is a 0.8 x. 0.7 X 0.3 cm portion of tan tubular tissue without orientation. Margin submitted. Grossed by. D. Received fresh labeled ""pancreatic neck margin"" is a 3.1 x 1.1 X. 0.4 cm portion of tan lobulated pancreas without orientation. Margin submitted. Grossed by. E. Received fresh labeled ""head of pancreas, portion of common. bilateral duct, portion of jejunum, portion of supramesenteric vein,. gallbladder"" is a Whipple specimen consisting of 30.3 cm in length. portion of duodenum, 7.0 X 6.3 x 2.8 cm portion of pancreas, a 10.9. X 4.7 x 3.0 cm gallbladder and a 1.4 x 0.4 X 0.3 cm portion of. superior mesenteric vein. The pancreatic uncinate margin is inked. yellow and shaved. The portal vein groove is inked black and. submitted perpendicularly. There is a 3.5 X 2.8 x 2.4 cm. infiltrative mass within the head of the pancreas, less than 0.1 cm. from the portal vein groove margin. The mass extends to. peripancreatic soft tissue. A stent is present within the common. bile duct measuring 9.5 cm. The gallbladder contains no choleliths. Peripancreatic lymph nodes and periduodenal lymph nodes are. identified. Representative sections are submitted. Grossed by. BLOCK SUMMARY: Part A: Lesion right lobe liver biopsy. 1 Rt lobe liver. Part B: Hepatic hilar lymph nodes. 1 Hepatic hilar LN2 (B1). 2 Hepatic hilar LN1 (B2). Part C: Common hepatic duct margin. 1 Common hepatic duct margin. Part D: Pancreatic neck margin. 1 Pancreatic neck margin 1. 2 Pancreatic neck margin 2. Part E: Head of pancreas, portion common bile duct, duodenum,. portion jejunum, portion supramesenteric vein, gallbladder. 1 Uncinate margin 1. 2 Uncinate margin 2. 3 Uncinate margin 3. 4 Uncinate margin 3. 5 Portal vein groove margin. 6 Mass w/ sup mesenteric vein. 7 Mass w/ common bile duct. 8 Pancreas mass 1. 9 Ampulla. 10 Pancreas mass 2. 11 Peri pancreatic LN5(E1). 12 Peri pancreatic tissue(E2). 13 Peri pancreatic LN5(E3). 14 Peri pancreatic LN1(E4). 15 Pericholedochal LN1(E5). 16 Gallbladder. 17 Peri pancreatic LN4(E6). 18 Peri pancreatic LN5(E7). 19 Peri pancreatic LN2(E8). 20 Peri pancreatic LN4(E9). 21 Peri pancreatic LN4(E10). 22 Peri pancreatic LN1(E11). 23 Peri pancreatic LN1 (E12). 24 Peri pancreatic LN2(E13). 25 Peri pancreatic LN3(E14). 26 Peri pancreatic LN5(E15).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Copy. Final Diagnosis. Left kidney, resection: Renal cell carcinoma, conventional clear cell type. Fuhrman grade 2. Tumor size: 5.3 cm in greatest dimension. Tumor appears confined to the kidney. No extension into perirenal fat. No lymphovascular invasion. No renal vein invasion. Negative vascular margin. Negative ureteral margin. Benign adrenal gland. AJCC pathologic staging data: pT1b,NX. Clinical Information. Left kidney mass. Gross Description. ""A, Left kidney."" The specimen consists of a 219 gram, 11.6 x 6.2 x 5.5 cm kidney with a small amount of attached perinephric. fat. Attached to the kidney is a 2 cm in length x 0.4 cm in diameter portion of ureter. The cortical surface is gray-pink. The. specimen has previously been bivalved and there is a 5.3 x 4.8 x 4,1 cm soft yellow-tan focally hemorrhagic mass which. grossly appears to abut the cortical surface and comes to within 0.1 cm of the surrounding fat. The surrounding fat has been. inked black. The mass does not grossly appear to involve the collecting system. There is no dilatation or compression of the. collecting system by the mass. The remaining renal parenchyma is red-tan and mildly congested. No additional masses or. areas of Interest are grossly identified. Adherent to the kidney is a 3 x 0.9 x 0.3 cm yellow-tan portion of adrenal gland. The. previously described renal mass comes to within 0.1 cm of the adrenal gland. The adrenal gland has a yellow-brown cut. surface and no masses or areas of interest are grossly identified. Lymphoid tissue is not grossly identified at the renal hilum. ""A1,"" ureter and vascular margins; ""A2,"" renal mass with adjacent radial margin; ""A3-A4,"" renal mass; ""A5,"" renal mass with. adjacent parenchyma; ""A6,"" renal mass with adjacent adherent adrenal gland. Received with the specimen for research purposes is 1 yellow cassette labeled. 1 green cassette labeled. and 1 blue cassette labeled. Performing Lab.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: Male. Race: White. Report Date: Tissue Procurement Date: FINAL PATHOLOGIC DIAGNOSIS. A. #11 lymph node; biopsy: - Two lymph nodes, no tumor (0/2). B. Level 7 lymph node; dissection: - Three lymph nodes, no tumor (0/3). C. #8 lymph node; biopsy: - One lymph node, no tumor (0/1). D. 4R lymph node; biopsy: - Two lymph nodes, no tumor (0/2). E. Right parietal and visceral pleura, diaphragm and pericardium: - Malignant biphasic mesothelioma; see comment. - See parameters. Thoracic Mesothelioma Pathologic Parameters. Pleura Resection. MACROSCOPIC. Specimen Type: Pleural resection. Tumor Site: Right pleura, pericardium, and diaphragm. Tumor Configuration and Size: Diffuse, maximum thickness: 3.5 cm. MICROSCOPIC. Histologic Type: Biphasic mesothelioma (80% epithelioid, 20% sarcomatoid). Tumor Extension: Confluent visceral pleural tumor (including fissure). Into but not through diaphragm. Into and through the pericardium. Venous/Lymphatic (Large/Small Vessel) Invasion: Absent. Margins: Cannot be assessed. Pathologic Staging (pTNM): pT4, NO. Primary Tumor (pT). pT4: Tumor (locally advanced technically unresectable) involves any of the. ipsilateral pleural surfaces, with at least lof the following: diffuse or. multifocal invasion of soft tissues of the chest wall, any involvement of rib,. invasion through the diaphragm to the peritoneum, invasion of any mediastinal. organ(s), direct extension to the contralateral pleura, invasion into the spine,. extension to the internal surface of the pericardium, pericardial effusion with. positive cytology, invasion of the myocardium. Regional Lymph Nodes (pN). pN0: No regional lymph node metastasis. Specify: Number examined: 8. Number involved: 0. Comment. Immunohistochemical staining with CAM5.2 was positive in both epithelioid and. sarcomatoid mesothelioma. Of note, expansile nodules composed of sarcomatoid. mesothelioma are seen at the diaphragm with epithelioid and spindle cells. extending into the muscle. In the invasive ares, only the epithelioid cells. stain positively for CAM5.2, whereas the spindled cells are negative. This shows. epithelioid mesothelioma extension into the diaphragm, but spindled cell within. the diaphragm may reflect desmoplastic stroma. In addition, CD34 stain shows no. venous or lymphatic invasion. All controls are appropriate. Dr. has. reviewed the case and concurs. M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow, , MD. Clinical History: The patient is a -year-old male with mesothelioma undergoing right. thoracotomy, pleurectomy, and decortication. Specimens Received: A: #11. B: Level 7. C: #8. D: 4R. E: Right parietal visceral pleura diaphragm and pericardium. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. #11"". Received fresh. and placed in formalin are 2 gray-black nodular, rubbery fibrofatty tissue. fragments measuring 0.8 x 0.7 X 0.6 cm and 1.2 x 0.7 x 0.6 cm. Each nodule is. bisected. A thin section of tissue is detached from the larger nodule during. bisection. The smaller nodule is submitted entirely in A1, and the larger nodule. along with the detached fragment is submitted in A2. B. The second container is additionally identified as, ""2. Level 7"". Received. fresh and placed in formalin are 3 grey-black nodular, rubbery fibrofatty tissue. fragments measuring 0.8 x 0.4 x 0.3 cm, 1.9 x 1.1 x 0.6 cm, and 1.9 x 1.1 x 0.8. cm. Each nodule is bisected and submitted entirely in B1-B3. C. The third container is additionally identified as, ""3. #8"". Received fresh. and placed in formalin is a grey-black nodular, rubbery fibrofatty tissue. fragment measuring 1.8 x 1.2 x 0.6 cm. The specimen is bisected and submitted. entirely in C1. D. The fourth container is additionally identified as, ""4. 4R"". Received fresh. and placed in formalin are 2 brown-tan rubbery tissue fragments measuring 1.1 x. 0.5 X 0.4 cm and 1.5 x 1 x 0.3 cm as well as a gray-black lobulated, rubbery. fibrofatty tissue fragment measuring 3.1 x 2.3 x 0.3 cm. The 2 brown-tan. fragments are submitted entirely in D1. The gray-black larger tissue fragment is. divided and submitted entirely in D2-D3. E. The fifth container is additionally identified as, ""5. Right parietal. visceral pleura, diaphragm + pericardium black stitch marks pericardium, white. stitch marks diaphragm"". Received fresh is a 575 gm, 600 ml pleurectomy specimen. measuring 31 x 16 x 3 cm. There is an attached 6.5 x 2.5 cm surface of smooth,. pink-tan pericardium, which is 0.2 cm thick. There is a 13 x 11 cm portion of. attached red-brown, ragged diaphragm, which is 0.8 cm thick. The specimen is. inked as follows: pericardial surface - blue, abdominal surface of diaphragm -. black. The specimen is sectioned to reveal white, firm, lobulated tumor present. throughout the visceral pleura. Greater than 90% of the pleura is involved by. tumor. The visceral and parietal pleura are thickened (up to 0.5 cm) and fused. The tumor invades the diaphragm up to a depth of 0.8 cm, which comes to <0.1 cm. to the inked margin. The abdominal surface of the diaphragm is free of tumor. The greatest tumor dimension is 3.5 cm. Gross photographs are taken. Representative sections are taken as follow: E1-E2: Pericardium. E3-E9: Diaphragm. E10-E15: Pleura and chest wall. MD.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) LEFT KIDNEY: RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR) CELL TYPE, FUHRMAN. NUCLEAR GRADE 4 (12.0 CM). TUMOR EXTENDING FOCALLY INTO PERIRENAL ADIPOSE TISSUE. TUMOR INVADING BLOOD VESSEL IN RENAL HILUM. (SEE COMMENT). Vascular, ureteral, and soft tissue margins of resection free of. tumor. Adrenal gland, no tumor present. COMMENT. Grossly no renal vein invasion was identified .In one of the sections. from the tumor in relation to the renal hilar region (parts A7 and A8). there is tumor invading the lumen and partially the wall of a thick. walled vessel. This is not consider diagnostic of renal vein invasion. GROSS DESCRIPTION. (A) LEFT KIDNEY - A left radical nephrectomy (24.0 12.5 x 10.5 cm). Within the upper to mid pole is a partially poorly circumscribed,. heterogenous, hemorrhagic, and necrotic mass (12.0 x 8.5 x 8.0 cm). The. tumor displays multiple focal areas of extension through the renal. capsule into the perirenal adipose tissue. Medially the tumor is seen. at the perirenal soft tissue margin. The mass also extends into the. sinus and also into the renal pelvis. No renal vein invasion is. identified. The uninvolved renal parenchyma appears unremarkable, The. left adrenal gland is present (3.2 x 1.5 x 1.0 cm) and is unremarkable,. A portion of renal parenchyma and tumor is submitted to the Tissue. Bank. INK CODE: Blue, medial soft tissue margin with tumor. SECTION CODE: A1, renal vein and ureter margin, en face; A2-A4,. tumor with medial soft tissue margin, perpendicular; A5-A8, tumor in. relation to renal pelvis and sinus; A9, tumor in relation to renal. sinus; A10, tumor in relation to normal kidney; A11, A12 tumor in. relation to periadipose tissue; A13, tumor in relation to normal kidney;. A14, A15, representative sections of more viable appearing tumor; A16,. representative sections of left adrenal gland; A17, A18, representative. sections of normal kidney. (B) LEFT 12TH RIB - A portion of rib (8.5 x 1.3 x 0.19 cm). There are. no gross abnormalities. No tissue is submitted for histology. Gross. diagnosis only. CLINICAL HISTORY. Left renal mass. SNOMED CODES. T-71000, M-82123. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cecal cancer. GROSS DESCRIPTION. Received fresh for tissue procurement labelled ""right. colon"" is a previously unopened 25 cm segment of proximal. right colon with attached 21 cm of distal ileum surfaced by smooth. to slightly scabrous tan-pink serosa with a copious amount of. attached mesocolon, mesentery, and unremarkable omentum. No. appendix is identified grossly. The proximal and distal margins. measure 4.5 and 10.2 cm in circumference respectively. On opening,. there is a moderately well-circumscribed, 5.0 X 4.2 cm rubbery. tan-white-red tumor mass located 3.5 cm distal to the ileocecal. valve. A portion of tumor and a portion of normal mucosa are. submitted for tissue procurement as requested. On sectioning, the. tumor measures up to 0.8 cm in thickness, grossly extending into. muscularis to within 0.15 cm of the inked free radial serosal. surface (see blocks 2-4) Two additional sessile rubbery pale tan. polypoid lesions measuring 0. and 1.0 cm in greatest dimension are. present 8 and 2 cm distal to the aforementioned tumor (see blocks 6. and 7 respectively) . The ileal and remaining uninvolved colonic. mucosa are unremarkable glistening tan-pink with regular folds and. the walls average 0.5 cm in thickness. Multiple soft to slightly. rubbery tan-pink tissues in keeping with lymph nodes measuring up. to. 1.4 cm in greatest dimension are recovered from the attached. mesocolon and mesentery. Representative sections are submitted in. 15 blocks as labelled. RS-15. BLOCK SUMMARY: 1 - proximal and distal margins; 2-4 - tumor. full - thickness to inked free radial serosal surface; 5 - tumor to. normal; 6 - small additional polypoid lesion; 7 - bisected larger. additional polypoid lesion; 8 - random ileum; 9 - ICV; 10 - random. colon; 11-12 - eight whole lymph nodes per cassette; 13 - S whole. lymph nodes; 14-15 - five whole lymph nodes per cassette. MICROSCOPIC DESCRIPTION. Histologic type: Invasive adenocarcinoma, not otherwise specified. Histologic grade Moderately differentiated. Primary tumor (pT) : Tumor invades into muscularis propria, no. invasion into pericolonic fat is identified and the serosal surface. is negative for tumor (pT2). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Not truly applicable, but the. serosal surface is negative for tumor. Distance of tumor from closest margin: 20 cm from distal margin. Vascular invasion: Not identified. Regional lymph nodes (pN) : Twenty-six lymph nodes are dissected. from the specimen. They are all negative for metastatic tumor. (pNO). Non-lymph node pericolonic tumor: Not identified. Distant metastasis (pM) : Could not evaluate, pMX. Other findings: One tubular adenoma is identified and one serrated. adenoma is identified. Random sections of colon and small. intestine. are unremarkable. 5x1, 3260F. DIAGNOSIS. A. Colon, right, ileocolectomy: Invasive adenocarcinoma, moderately differentiated, invasive. into muscularis propria (pT2). Twenty-six lymph nodes negative for metastatic tumor (pNO) . One tubular adenoma and one serrated adenoma. See Microscopic description. --- End Of Report ---.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor: Account Number: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT MODIFIED RADICAL MASTECTOMY. TISSUES. A. BREAST MASTECTOMY (WANO) NODES - LEFT BREAST & AXILLARY CONTENTS. B. MARGINS - ADDITIONAL INFERIOR SKIN LEFT BREAST. WRI TISSUE. FINAL DIAGNOSIS. A. LEFT BREAST AND AXILLARY CONTENTS, 1619 GMS. -. INFILTRATIVE DUCT CARCINOMA (CONFLUENT REGION MEASURES 13.6 CM.). SCARFF-BLOOM-RICHARDSON GRADING: GRADE 3 OF 3 (ABSENT TUBULAR FORMATIONS, HIGH NUCLEAR GRADE. AND MODERATE MITOTIC INDEX). DCIS: NONE IDENTIFIED. ANGIOLYMPHATIC INVASION: PRESENT, MULTIFOCAL. TUMORAL CALCIFICATION/NECROSIS: PRESENT. SURGICAL MARGINS: UNINVOLVED. NON-NEOPLASTIC BREAST -. FIBROADENOMA 0.3 CM. FIVE POSITIVE LYMPH NODES WITH EXTRACAPSULAR EXTENSION (6/5). THE LARGEST NODE MEASURES 1.6 CM. AND THE TUMOR INVOLVES THREE-FOURTHS. OF THE NODE. OVERLYING NIPPLE, AREOLA AND SKIN: FOCAL EXTENSION OF THE TUMOR INTO EPIDERMIS WITHOUT ULCERATION. B. ADDITIONAL INFERIOR SKIN LEFT BREAST -. POSITIVE FOR INFILTRATIVE DUCT CARCINOMA, THE TUMOR INVOLVES THE DERMIS. WITHOUT EXTENSION TO EPIDERMIS. (SATELLITE SKIN NODULE). THE INKED MARGINS ARE FREE. PTNM CLASSIFICATION: SURGICAL REPORT. T4B, N2a, MX, STAGE GROUPING IIIB. Diagnosed by: and. COMMENT. The multiple sections from the tumor reveal a poorly differentiated infiltrative duct carcinoma with. widespread angiolymphatic invasion. The satellite nodule grossly observed appears to be a direct. extension from the primary tumor with peripheral tumefaction. The overlying epidermis is involved by the. tumor but does not exhibit ulceration. The Bloom-Richardson grading was upgraded to 3 based on. complete evaluation of the entire tumor mass. The ER, PR, and Her-2/neu have been performed on the previous surgical. This case Is discussed with. on. GROSS DESCRIPTION. The specimen is received in two separate containers labelec. esignated A and B. A. The container is received fresh unfixed labeled ""left breast and axillary contents - suture on. upper outer quadrant"". The specimen consists of a 1,519 gm. apparent left breast which is 30 x. 20 x 7.5 cm. in greatest overall dimension. There is an attached suture indicating upper outer. quadrant inked with orange dye, lower outer quadrant is inked yellow, upper inner quadrant is. inked with green dye, lower inner quadrant is inked with red dye. The deep margin is inked black. Sectioning reveals a tumor mass directly beneath the nipple which is 13.5x 7 x 4 cm. in greatest. overall dimension and is 1.5 cm. from the deep margin, 2 cm. from the upper outer margin, 2.5. cm. from the lower outer margin, 2 cm. from the upper inner margin, and 4 cm. from the lower. inner margin. There is a satellite nodule which is 0.6 cm. in greatest dimension and is 1.5 cm. from the main tumor mass and has a distance of 0.6 cm. from the upper inner margin. Sectioning. through the remaining breast stroma reveals fatty and fibrous-encased tissue. Sectioning through. the attached axillary fat reveals rare tan-gray nodules varying up to 1 cm. in greatest dimension. The specimen is submitted in twelve blocks. Key Note Block Summary: 1-nipple with underlying tumor, 2 through 4-tumor mass, 5-. satellite nodule and upper inner quadrant, 6-lower inner quadrant, 7-lower outer quadrant, 8-. upper outer quadrant, 9-deep, 10 through 12-rare nodules. B. The container is received fixed labeled ""additional inferior skin left breast"". The specimen. consists of a skin ellipse which is 7 x 1x 1 cm. in greatest overall dimension. The skin. has been previously marked with purple-blue dye. The specimen is serially sectioned. revealing no apparent gross abnormalities. The entire specimen is submitted in two. blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Papillary carcinoma right thyroid lobe T2N0MO. Specimens Submitted: 1: Total thyroidectomy. 2: Left inferior parathyroid tissue?. DIAGNOSIS: 1. Total thyroidectomy: Tumor Type: Papillary carcinoma, classical type. Three foci. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Right lobe. Isthmus. Tumor Size: Right lobe: 4.6 cm carcÃ­noma and 2.0 cm carcinoma; isthmus: 3.5 cm carcinoma. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Present. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. 2. Left inferior parathyroid tissue?: Lymph Node Dissection: Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Psammoma bodY is identified, consistent with metastatic papillary thyroid carcinoma. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: M.D. 1. The specimen is received fresh and is labeled ""total thyroidectomy short stitch - right superior pole, long stitch - left lower pole"". and consists of a thyroid weighing 33.5 g. The right lobe measures 5.1 x 3.1 x 2.3 cm the left lobe measures 4 x 2.8 x 1.1 cm. and the isthmus measures 5.2 x 3x 2.2 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of. the. specimen is inked black, and the anterior is inked blue. Sectioning reveals the right lobe is predominantly replaced by a pink-tan. soft nodule measuring 4.6x 2.9x 2.6 cm (nodule 1). Immediately adjacent to the nodule is a second nodule (2 x 1.2 x 1 cm). with. a. thick capsule and filled with yellow-brown translucent fluid. The isthmus has a third nodule (3.5x 2.8x 2.3 cm) with a. heterogeneous cut surface composed of pale pink tissue with granular tan tissue. The remaining thyroid parenchyma is. red. tan. and beefy. Representative sections of nodule one and nodule three are submitted for TPS. The nodules are entirely submitted. and the left lobe Is representatively submitted. Summary of sections: N1 - nodule, right lobe. N1/2- nodule one and two. N2- nodule, right lower lobe. N3-nodule, isthmus. LL left lobe. 1.D. 2. The specimen is received fresh, ""left inferior parathyroid tissue?"" and consists of a fragment of pink-tan tissue (0.4 x 0.2 x 0.2. cm). The specimen is entirely submitted in one cassette. Summary of sections: U-undesignated. Summary of Sections: Part 1: Total thyroidectomy. Block. Sect. Site. PCs. 4. N1. 4. 1. N1/2. 1. 2. N2. 2. 7. N3. 7. Part 2: Left inferior parathyrold tissue?. Block. Sect. Site. PCs. 1. U. 1. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. PART 1: There is an additional papillary microcarcinoma (0.6 cm) with tall cell features in the isthmus. Signed out hy.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
CORRECTED. Report Type. Date of Event. Authored by. Hosp/Group. Record Status. CORRECTED. ADDENDA: Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: Block 3K: A. HRAS mutation IDENTIFIED (p.Q61K, c.181C>A). B. Mutations in BRAF, NRAS61, KRAS12/13 NOT identified. C. FISH test for RET/PTC rearrangement is pending. NOTE: DNA was extracted in the amount sufficient for testing. BACKGROUND: Mutations in either BRAF or RAS genes or RET/PTC rearrangements are found. in. more than 70% of papillary thyroid carcinomas (1). BRAF V600E (T1799A). mutation has been associated with more aggressive behavior of papillary. carcinoma (2,3). The association between BRAF V600E mutation and features of. tumor aggressiveness have also been observed in papillary microcarcinomas (4). Mutations in the RAS genes or PAX8/PPARg rearrangement occur in ~70% of. follicular thyroid carcinomas and with lower frequency in oncocytic (H?rthle. cell) carcinomas (5). Regarding the specificity of these mutations for cancer,. BRAF V600E mutation and RET/PTC and PAX8/PPARg rearrangements are overall. specific for malignancy in the thyroid, although they have been reported with. a very low frequency in benign thyroid lesions (6). RAS mutations occur in. malignant and benign thyroid tumors, being found in ~40-50% of follicular. and anaplastic carcinomas, 30-40% of follicular adenomas and 10-15% of. papillary carcinomas (6). 1. et al. Correlation between genetic alterations and microscopic. features, clinical manifestations, and prognostic characteristics of thyroid. papillary carcinomas. 2. et al. BRAF mutation predicts a poorer clinical prognosis for. papillary thyroid cancer. 3. et al. BRAF V600E mutation and outcome of patients with papillary. thyroid carcinoma: a. median follow-up study. 4. Analysis. of differential BRAF(V600E) mutational status in high aggressive papillary. thyroid microcarcinoma. 5. et al. RAS point mutations and5PAX8-PPARg rearrangement in. thyroid tumors: Evidence for distinct molecular pathways in thyroid follicular. carcinoma. 6. Recent developments in the molecular biology of the thyroid. Differential Diagnosis and Molecular. Advances. MUTATIONAL ANALYSIS: For paraffin-embedded surgical specimens, manual microdissection was performed. to collect tumor tissue. Specimens with the minimum of 50% of tumor cells in. a microdissection target are accepted for the analysis. Optical density. readings were obtained. Real-time PCR was performed on the LightCycler. platform to amplify BRAF codons 599-601, NRAS codon 61, HRAS codon 61, and. KRAS codons 12/13 sequences. Post-PCR melting curve analysis was used to. detect possible mutations. If required, the mutation type was confirmed by. Sanger sequencing of the PCR product on ABI3130. DNA from samples positive. for each of these mutations was used as positive controls. Amplification at 35. cycles or earlier was considered sufficient for the analysis. The limit of. detection is approximately 10-20% of alleles with mutation present in the. background of normal DNA. My signature is attestation that I have personally reviewed the submitted. material(s) and the above diagnosis reflects that evaluation. Addendum. In-situ hybridization and immunohistochemistry have been performed on the. invasive squamous cell carcinoma of the larynx in Part 3 and results are as. follows: STAIN. POSITIVE/NEGATIVE. HPV. negative. P16. negative. EGFR. 3+. My signature is attestation that I have personally reviewed the submitted. material(s) and the above diagnosis reflects that evaluation. FINAL DIAGNOSIS: PART 1: LYMPH NODES, NECK, LEVELS 2 - 4, SELECTIVE DISSECTION. SEVENTEEN LYMPH NODES, NO TUMOR PRESENT (0/17). PART 2: LYMPH NODES, RIGHT NECK, LEVELS 2 - 4 INCLUDING LEVEL 2B, SELECTIVE. DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA IN ONE OF FOURTEEN LYMPH NODES. (2.2 CM) WITH SPINDLE CELL FEATURES (1/14). B. EXTRACAPSULAR SPREAD IS PRESENT. PART 3: LARYNX AND THYROID LOBE, RIGHT, TOTAL LARYNGECTOMY AND RIGHT THYROID. LOBECTOMY (12 GRAMS). A. INVASIVE SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED,. KERATINIZING, WITH FOCAL SPINDLE CELL FEATURES, TRANSGLOTTIC, WITH SUPRA-AND. SUB-GLOTTIC EXTENSION TO THE RIGHT TRUE AND FALSE FOCAL CORDS AND LEFT TRUE. VOCAL CORD (5.5 CM). B. ANGIOLYMPHATIC INVASION IS PRESENT. C. PERINEURAL INVASION IS PRESENT. D. THYROID AND CRICOID CARTILAGE, INVASION PRESENT. E. MARGINS: THE RIGHT PYRIFORM SINUS SOFT TISSUE MARGIN AND RIGHT. PRE-EPIGLOTTIC SOFT TISSUE MARGINS ARE POSITIVE FOR SQUAMOUS CELL CARCINOMA;. OTHER MARGINS FREE (see also parts 5-9). F. PATHOLOGIC STAGE: pT4aN1. G. TRACHEOSTOMY WITH REACTIVE CHANGES, UNINVOLVED BY TUMOR. H. RIGHT THYROID LOBE: PAPILLARY THYROID MICROCARCINOMAS, TWO FOCI,. (0.9 AND 0.3 CM), CONFINED TO THYROID; NO ANGIOLYMPHATIC INVASION. I. PATHOLOGIC STAGE: pTlaNO. J. NON-NEOPLASTIC THYROID WITH KERATINIZING LYMPHOEPITHELIAL CYST. (see comment). K. NON-NEOPLASTIC THYROID WITH NODULAR HYPERPLASIA. L. TWO CENTRAL LYMPH NODES, NO SQUAMOUS CELL CARCINOMA OR PAPILLARY. THYROID CARCINOMA PRESENT (0/2). PART 4: DEEP PYRIFORM SINUS, EXCISION. INVASIVE SQUAMOUS CELL CARCINOMA. PART 5: RIGHT LATERAL MARGIN, EXCISION. NO TUMOR PRESENT. PART 6: INFERIOR MARGIN, EXCISION. NO TUMOR PRESENT. PART 7: LEFT PHARYNGEAL MARGIN, EXCISION. NO TUMOR PRESENT. PART 8: SUPERIOR MARGIN, EXCISION. NO TUMOR PRESENT. PART 9: NEW RIGHT LATERAL MARGIN, EXCISION. NO TUMOR PRESENT. COMMENT: The keratinizing lymphoepithelial cyst in the thyroid is lined by reactive,. but bland, epithelium that is distinct from the patient' solid high grade. laryngeal squamous cell carcinoma and papillary thyroid carcinomas which are. of the follicular variant. My signature is attestation that I have personally reviewed the submitted. material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in nine parts. Part 1 is received fixed, labeled with the patient's name (initials xx) and. ""left neck levels 2, 3, 4."" Received is an unoriented portion of fibroadipose. tissue measuring 11.1 X 2.0 X 1.5 cm. The first third of the specimen. contains up to eight potential soft, tan-pink lymph nodes ranging from 0.2 to. 1.1 cm in greatest dimension. The middle third of the specimen contains up to. two potential soft, tan-gray lymph nodes measuring 0.2 and 0.8 cm. The last. third of the specimen contains no grossly identifiable lymph nodes. Cassette code: 1A 1B multiple potential lymph nodes, first third. 1C multiple potential lymph nodes, middle third. 1D adipose tissue, last third. Part 2 is received fixed, labeled with the patient's name (initials xx) and. ""right neck levels 2, 3, 4 including 2B"". Received is an unoriented portion. of fibroadipose tissue measuring 12.0 X 2.5 X 1.4 cm. A 2.2 X 1.4 x 0.8 cm. lymph node in the middle third of the specimen (designated level 2B) has. a. firm, tan-white cut surface with central necrotic material and pinpoint. hemorrhages. Up to 6 other potential soft lymph nodes are identified in the. middle third of the specimen ranging from 0.1 to 0.3 cm. The first, adjacent. third of the specimen contains the most connective tissue and is presumed to. represent level 3, having anatomically bent inferior to the middle third of. the specimen. The first third of the specimen contains two soft tan lymph. nodes measuring 1.3 and 2.2 cm. The opposite, last fatty third of the. specimen is designated as level 4 and contains multiple potential lymph nodes. ranging from 0.2 X 0.2 X 0.2 cm to 1.0 X 0.4 X 0.3 cm. Cassette code: 2A enlarged lymph node, middle third (level 2B), serially sectioned and. entirely submitted. 2B multiple potential lymph nodes, middle third. 2C up to two potential lymph nodes, first third. 2D multiple potential lymph nodes, last third. Part 3 is received fixed, labeled with the patient's name (initials xx) and. ""total laryngectomy plus right thyroid lobe"". Received is a laryngectomy. specimen measuring 11.0 cm (superior to inferior) x 9.0 cm (medial to lateral). X 5.5 cm (anterior to posterior). The specimen contains a tracheostomy site. with 5.5 X 4.0 cm ellipse of skin, 5.5 X 3.0 X 1.5 cm right thyroid lobe with. 3.0 x 2.5 x 1.0 cm portion of isthmus, and seven tracheal rings. An ulcerated, white, firm mass originates in the right glottis, measuring 5.5. cm (medial to lateral) X 4.0 cm (superior to inferior) X 3.0 cm (anterior. to. posterior). The mass has supra- and infra-glottic extension, and involves the. right false vocal cord, right ventricle, right true vocal cord, left true. vocal cord, pre-epiglottic soft tissue, thyroid cartilage, cricoid cartilage,. anterior soft tissue and muscle, and right pyriform soft tissue margin. Grossly the hyoid bone is not involved. No lymph nodes are identified in the. soft tissue. The right thyroid lobe shows a dusky tan, firm, gelatinous mass measuring 1.4. X. 1.2 x 2.0 cm (12 grams) in the mid zone, with multiple tan-white, firm. nodules up to 0.3 cm immediately adjacent to and within the mass. Digital photographs are taken. Tissue from the lesion and normal tissue are banked for. Ink code. Red tissue bank. Blue pre-epiglottic soft tissue margin. Orange soft tissue exposed after removal of the hyoid bone (not true margin). Black all other margins. Cassette code: 3A bilateral posterior cricoid margins, shave. 3B right pyriform sinus soft tissue margin, perpendicular. 3C right pre-epiglottic soft tissue margin, perpendicular. 3D anterior soft tissue margin and thyroid cartilage, perpendicular. 3E mass involving thyroid cartilage with cricoid cartilage and thyroid gland. 3F right false vocal cord, ventricle, and true vocal cord. 3G left false vocal cord, ventricle, and true vocal cord. 3H tracheal margin, shave. 3I tracheostomy site with skin. 3J 3N right thyroid nodule submitted from inferior to superior. Part 4 was received fresh for frozen intraoperative consultation, labeled with. the patient's name (initials xx) and ""deep pyriform sinus"". The specimen. consists of two fragments of tan-white soft tissue measuring 0.4 X 0.2 X 0.2. cm and 0.1 X 0.1 X 0.1 cm. The specimen is entirely submitted for permanent. section in cassette 4AFS. Part 5 was received fresh for frozen intraoperative consultation, labeled with. the patient's name (initials xx) and ""right lateral margin"". It consists of a. tan-white soft tissue measuring 3.6 X 0.8 X 0.5 cm, with the clipped end inked. in black. The specimen is entirely submitted for permanent section in cassette. 5AFS. Part 6 was received fresh for frozen intraoperative consultation, labeled with. the patient's name (initials xx) and ""inferior margin"". It consists of a. portion of soft tan-white tissue measuring 5.0 X 0.6 x 0.5 cm, with the. clipped end inked in black. The specimen is entirely submitted for permanent. section in cassette 6AFS. Part 7 was received fresh for frozen intraoperative consultation, labeled with. the patient's name (initials xx) and ""left pharyngeal margin"". Received is a. portion of tan-white soft tissue measuring 3.5 x 0.4 x 0.4 cm, with the. clipped end inked in black. The specimen is entirely submitted for permanent. section in cassette 7AFS. Part 8 was received fresh for frozen intraoperative consultation, labeled with. the patient's name (initials xx) and ""superior margin"". Received is a portion. of soft tan-white soft tissue measuring 5.5 X 0.6 X 0.5 cm, with the clipped. end inked in black. The specimen is entirely submitted for permanent section. in cassette 8AFS. Part 9 was received fresh for frozen intraoperative consultation, labeled with. the patient's name (initials xx) and ""new right lateral margin, clip. superior"". Received is a portion of soft tan-white tissue measuring 3.7 X 0.6. x 0.5 cm, with the clipped end inked in black. The specimen is entirely. submitted for permanent section in cassette 9AFS. INTRAOPERATIVE CONSULTATION: 4AFS: RIGHT DEEP PYRIFORM SINUS, EXCISION (frozen section). A. MALIGNANT. B. INVASIVE SQUAMOUS CELL CARCINOMA. M.D.). 5AFS: RIGHT LATERAL MARGIN, EXCISION (frozen section). A. DEFER. B. SMALL DETACHED CLUSTER OF ATYPICAL SQUAMOUS CELLS. 6AFS: INFERIOR MARGIN, EXCISION (frozen section). A. BENIGN. B. NO TUMOR PRESENT. 7AFS: LEFT PHARYNGEAL MARGIN, EXCISION (frozen section). A. BENIGN. B. NO TUMOR PRESENT. 8AFS: SUPERIOR MARGIN, EXCISION (frozen section). A. BENIGN. B. NO TUMOR PRESENT. 9AFS: NEW RIGHT LATERAL MARGIN, CLIP SUPERIOR, EXCISION (frozen section). A. BENIGN. B. NO TUMOR PRESENT. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics determined by. the. Department of Pathology, as required by the CLIA. regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue fixation. ranges from a minimum of. to a maximum of. hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (""CLIA"" as qualified to perform high-complexity clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - LARYNX RESECTIONS. TYPE OF LARYNGECTOMY: Total. TUMOR LATERALITY: Bilateral. ATTACHED STRUCTURES: Neck dissection, Pyriform sinus, Tracheotomy,. Thyroid, Skin. TUMOR LOCATION/SEGMENT: Transglottic. TUMOR SIZE: Maximum dimension: 5.5 cm. HISTOLOGIC TYPE OF TUMOR: Squamous cell carcinoma. HISTOLOGIC GRADE: Poorly differentiated/Undifferentiated. STRUCTURES INVOLVED BY TUMOR: True cord, False cord, Ventricle, Pyriform. sinus, Subglottis (greater than 1 cm subglottic extension), Thyroid. cartilage, Pre-epiglottic space, Extralaryngeal soft tissue. LYMPH NODES: Lymph nodes positive, Right: 1. Total number of right sided lymph nodes examined: 16. Lymph nodes positive, Left: 0. Total number of left sided lymph nodes examined: 17. EXTRACAPSULAR SPREAD OF LYMPH NODE METASTASES. INTRA-PERINEURAL INVASION: Present. VASCULAR INVASION: SURGICAL MARGIN INVOLVEMENT: Positive (invasive tumor). T STAGE, PATHOLOGIC: Glottis, pT4a. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Lobectomy. TUMOR SITE: Right Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.0 cm. HISTOLOGIC TYPE. Papillary carcinoma. PRIMARY TUMOR (pT): pTla. REGIONAL LYMPH NODES (pN): pNO. Number of regional lymph nodes examined: 1. Number of regional lymph nodes involved: 0. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION: Not identified. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis. Other: Keratinizing lymphoepithelial cyst, and nodular hyperplasia. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Laryngeal cancer. PROCEDURE: Total laryngectomy. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: Not provided. PRIOR MALIGNANCY: Not provided. CHEMORADIATION THERAPY: Not provided. ORGAN TRANSPLANT: Not provided. IMMUNOSUPPRESSION Not provided. OTHER DISEASES: Not provided. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Left Neck Level 2-4. Stain/cnt. Block. H&E X 1. A. H&E x 1. B. H&E x 1. C. H&E x 1. D. Part 2: Right Neck Level 2-4 including Level 2B. Stain/cnt. Block. H&E x 1. A. H&E x 1. B. H&E X 1. C. H&E x 1. D. Part 3: Total Laryngectomy and Right Thyroid Lobe. Stain/cnt. Block. H&E X 1. A. H&E x 1. B. H&E x 1. C. Decal x 1. D. H&E x 1. D. H&E x 1. E. H&E Recut x 1. F. IEGFR X 1. F. IBNKNC x 1. F. IBNKNC x 1. F. IBNKNC x 1. F. IBNKNC x 1. F. IBNKNC X 1. F. IBNKNC x 1. F. H&E X 1. F. HPV x 1. F. IISH x 1. F. P16 x 1 F. V-EGFR x 1. F. H&E x 1. G. H&E x 1. H. H&E x 1. I. H&E x 1. J. MAP H&E Recut x 1. K. MAP H&E Recut x 1. K. MAPBNK x 1. K. MAPBNK X 1. K. MAPBNK x 1. K. MAPBNK x 1. K. MAPBNK x 1. K. MAPBNK x 1. K. MAPBNK x 1. K. MAPBNK x 1. K. MAPBNK X 1. K. MAPBNK x 1. K. H&E X 1. K. ISEQADDON x 1. K. ITHY-PEx 1 K. iret X 1 K. H&E X 1. L. H&E X 1 M. RHHE Lev. x. 1. N. RHHE Lev. X. 1. N. RHHE Lev. x. 1. N. RHHE Lev. X. 1. N. RHHE Lev. x. 1. N. H&E x 1. N. Part 4: Deep Piriform Sinus. Stain/cnt. Block. H&E x 1. AFS. Part 5: Right Lateral Margin. Stain/cnt. Block. H&E X 1. AFS. Part 6: Inferior Margin. Stain/cnt. Block. H&E x 1. AFS. Part 7: Left Pharyngeal Margin. Stain/cnt. Block. H&E X 1. AFS. Part 8: Superior Margin. Stain/cnt. Block. H&E x 1. AFS. Part 9: New Right Lateral Margin. Stain/cnt. Block. H&E X 1. AFS. SPECIAL Procedures: In Situ Procedure. Interpretation. PROBE: LSI EGFR/CEP7 Dual-Color Probe (. Cytogenetic Location: 7p12 / 7p11.1-q11.1. 3F: EGFR FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE NEGATIVE. Number of cells analyzed: 60. Ratio EGFR/CEP7: 1.10. High Polysomy: 0%. SNR (signal to nucleus ratio): 2.6. Low Polysomy: 13(21.7%). Trisomy: 13(21.7%). Disomy: 34(56.7%). 3K: RET/PTC: The targeted area of the tissue showed 0(0%) of the cells with. the rearrangement pattern and 60(100%) of the cells with the normal pattern. The targeted area is considered NOT rearranged for the RET/PTC region. The RET/PTC1 Probe did not contain the rearrangement pattern. My signature is attestation that I have personally reviewed the submitted. material(s) and the above diagnosis reflects that evaluation. EGFR FISH analysis was manually performed and quantitatively assessed by. analysis of a minimum of 60 cells using the EGFR SpectrumOrange and the CEP7. SpectrumGreer probes. EGFR FISH positive: High Polysomy: > four gene copies in > 40% of cells. Gene Amplification: Ratio gene/chromosome more than two or > 15 gene copies in. > 10% of cells. EGFR FISH negative: Disomy: < two gene copies in more than 90% of the cells. Trisomy: three gene copies in more than 10% of cells. Low Polysomy: > four gene copies in more than 10% but less than 40% of cells. References:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Index. 1. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. containers. container. Site. Matrix. Format. t. on. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. data. data. data. data. none. n/a. Squamous cell carcinoma. pending. pending. pending. pending. n/a. n/a. n/a. n/a. n/a. none. n/a. blood draw. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. 70. n/a. n/a.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
LINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Resection. Organs: Liver. [1] Segment 6: 14.0 x 5.5 X 4.5 cm, 133.0 gm. [2] Segment 8: 9.0 X 9.0 X 3.5 cm, 102.8 gm. Lesions: Multiple. [1] Segment 6. Size: 3.5 x 2.5 x 2.0 cm in toto. Cut surface: Well-defined, irregular shaped, whitish to brightly yellow, multinodular (the. size does not contain a satellite mass measuring 1.3 X 1.0 cm, which is present at the nearby. resection margin). Resection margin: Very close grossly (safety margin: 0.1 cm). [2] Segment 8. Size: 3.2 X 3.3 X 3.0 cm. Cut surface: Well-defined, ovoid, bulding-out, bile-tinged. Resection margin: Not involved grossly (safety margin: 1.2 cm). Gross type: [1] Segment 6: Multinodular confluent. [2] Segment 8: Expanding nodular. Satellite nodule: No. Remaining parenchyma: Cirrhotic. Portal vein invasion: No. Representative sections are submitted. Gross photo: Present. Blocks. T1-4 TB, irregular shaped mass and surrounding liver parenchyme of segment 6 X 5. A1-4, bile tinged mass and surrounding liver parenchyme of segment 8 X 4. L, NB, nontumorous liver parenchyme X 2. RM, resection margin of segment 6 X 1. ARM, resection margin of segment 8 X 1. MICROSCOPIC: [1] Segment 6. Hepatocellular carcinoma: Yes. Edmondson-Steiner grade. worst: III. major: II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes (10 %). Cholangiocarcinomal No. Combined hepatocellular and cholangiocarcinoma: No. Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: Very close (less than 0.1 cm). [2] Segment 8. Hepatocellular carcinoma: Yes. Edmondson-Steiner grade. worst: II. major: II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes (10%). Cholangiocarcinomal No. Combined hepatocellular and cholangiocarcinoma: No. Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Multicentric occurrence: Yes. Non-tumor liver pathology. Cirrhosis, mixed. NOT reported. Gross: Liver, segment 6 and 8, resection, Hepatocellular carcinoma. T56000, segment 6 and 8, P17, M81703. DIAGNOSIS: Liver, segment 6 and 8, resection: Hepatocellular carcinoma. Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: A. ""Right axilla palpable node."" A 2.2 X 1.5 X 0.6 cm portion of lymph node bearing. fat contains a 0.5 X 0.5 X 0.5 cm hard white nodule. Imprints are prepared, and a portion is selected for. frozen section examination. B. ""Right breast stitch marks axillary tail."" A he 14.9 X 13.5 X 4.0 cm right. breast with an overlying 8.0 X 4.0 cm keyhole-shaped skin. The areolar complex is unremarkable. There. is a 0.3 cm skin lesion (grossly consistent with seborrheic keratosis), 0.5 cm and located 0.6 cm medial to. the nipple. There is a stellate mass within the central breast 5.7 x 4.0 X 2.0 cm, located 2.0 cm from the. deep margin and occupies the upper and lower outer quadrants as well as the upper inner and outer. quadrants. There is a biopsy marker recognize in the lower outer quadrant (8 o'clock aspect), 3.7 cm. from the deep margin. A second biopsy marker is recognized and approximately 1 o'clock, 3.5 cm from. the deep margin. Superior to the main mass is a satellite nodule attached by fibrous strands, 0.7 X 0.5 x. 0.5 cm, located 2.0 cm from the deep margin and 1.8 cm superior to the main mass at approximately 12. o'clock. The remaining breast tissue is centrally dense. There are no intramammary lymph nodes. The. margin is a blue. C. ""Level 1 and 2 right axillary lymph nodes."" A 7.0 x 5.0 x 2.0 cm aggregate of adipose. tissue fragments containing 11 lymph nodes up to 1.5 cm. The lymph nodes all appear involved by. tumor with the largest metastasis measuring 1.4 cm. Extracapsular extension is noted. Microscopic Description: Biopsy type: Mastectomy. Tumor site: Central. Size: 5.7 cm. Specimen Margin: Free of invasive carcinoma by 20 mm (deep) Site R Breast NOS (509. Tumor grade (SBR/Nottingham):N/A. Tubule formation: N/A. Nuclear atypia: 2. Mitotic rate: 2 (focal). Lymphovascular invasion: Present (focal). In situ component: Lobular carcinoma in situ. Calcifications: Absent. Non-neoplastic breast: Atrophic with intramammary metastases. Estrogen (ER) and Progesterone (PR) Receptors (IMPX): ER strongly positive, PR strongly positive on. previous biopsyHer-2/Neu (H2N). Amplification: Negative on previous biopsy. Nipple involvement: Present. Skin involvement: No. Skeletal muscle: Not present. Lymph nodes: Axillary (specimens A and C): 12 metastases (12 nodes examined) The largest metastasis. is 14 mm; there is extensive extracapsular extension. PTNM Stage: pT3 N3. Diagnosis Details: Subcutis (right axilla): Metastatic invasive lobular carcinoma (presumable an effaced. lymph node) Breast (right): Invasive lobular carcinoma, pleomorphic type with intramammary and. axillary metastases. Comments: Multiple axillary lymph nodes exhibit effacement by invasive lobular carcinoma, with. extensive involvement of extranodal adipose tissue. Invasive lobular carcinoma extends to the. cauterized margin of axilla specimen. Formatted Path Reports: BREAST TISSUE CHECKLIST. Specimen type: Mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 5.7 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating lobular carcinoma. Histologic grade: Not specified. Tumor extent: Nipple. Lymph nodes: 12/12 positive for metastasis (Axillary 12/12). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right breast. Reviewer.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
NAL DIAGNOSIS. R4 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. IBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. STATION 7 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND. SSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. LUNG, LEFT UPPER LOBE (LOBECTOMY) INFILTRATING MODERATELY. IFFERENTIATED ADENOCARCINOMA (5 CM) . THE TUMOR HAS FEATURES OF. APILLARY ADENOCARCINOMA OF THE LUNG (AS DESCRIBED BY SILVER AND. SKIN ) , AND IS ASSOCIATED WITH A PERIPHERAL BRONCHIOLOALEVOLAR. OMPONENT. THE CARCINOMA ABUTS BUT DOES NOT INVOLVE THE PLEURA. ALL. ARGINS INCLUDING BRONCHIAL AND VASCULAR MARGINS ARE NEGATIVE FOR. UMOR. FOCAL VASCULAR INVASION IS SEEN. SURROUNDING LUNG SHOWS. TYPICAL PNEUMOCYTE HYPERPLASIA. METASTATIC CARCINOMA IN ONE (1) OF.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. 1. Examination: Histopathological examination. Material: Multiple organ resection - segment of the large intestine. Expected time of examination: Clinical diagnosis: Cancer of the rectosigmoid junction. Macroscopic description: A 21 cm length of the large intestine with a 3 cm mesorectum tissue. A cauliflower-shaped tumour sized 5.7 X 5.2 x 1 cm found in. the mucosa. The lesion surrounding 90% of the intestine circumference, is removed by 13.5 cm from the proximal line and 2.1 cm. from the distal line. Minimum side margin is 3 cm. Microscopic description: Adenocarcinoma tubulornpillare partim mucinosum (G3). Infiltratio carcinomatosa tunicae muscularispropriac et telae adipos. mesorecti. Incision lines free of neoplastic lesions. Lymplionodulitis reaefi (No XXI). Histopathological diagnosis: Adenocarcinoma tubulopapilare partim mucinosum recti. Tubulopapillar and partially mucinous adenocarcinoma of. the rectum. (G3, Dukes B, Astler-Coller B2, pT3, pNO, RO).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Print - !. Report for. TEST: Surgical Pathology. Collected Date & Time: Result Name. Reference Range. SURGICAL P. (Age: Service: Surgery. Gender: F. Physician (s) : Specimen (s) Received. A: Total thyroidectomy. B: Right central neck lymph nodes. Pathologic Diagnosis. A. Total thyroidectomy. - Papillary thyroid carcinoma, identified as two foci in. the right lobe (1.6 and 0.5 cm) and one focus in the left lobe. (1.3 cm). There is minimal extrathyroidal extension in the left. lobe. - No lymphovascular invasion identified. - Two benign lymph nodes identified (0/2). One unremarkable parathyroid gland identified on the. left side. Chronic thyroiditis. B. Right central neck lymph nodes: - Four lymph nodes negative for malignancy (0/4). Benign thymic tissue. Parathyroid tissue. Synoptic: Thyroid Gland Resection. Procedure: Total thyroidectomy with central compartment. dissection. Specimen Integrity: Intact. Specimen Size: Right lobe: 5.2 x 2.1 x 2.0 cm. Left lobe: 3.1 x 2.2 x 1.5 cm. Isthmus: 2.5 X 0.9 x 0.7 cm. Central Compartment: 2.2 x 1.5 x 1.4 cm. Tumor Focality: Multifocal bilateral. Dominant Tumor: Tumor Laterality: Right lobe. Tumor Size: Greatest dimension 1.6 cm. Histologic Type: Papillary carcinoma, classical. Variant: Classical. Print. Architecture: Classical. Cytomorphology: Classical. Margins: Margins uninvolved by invasive carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Extrathyroidal Extension: Not identified. Second Tumor: Tumor Laterality: Right lobe. Tumor Size: Greatest dimension 0.5 cm. Histologic Type: Papillary carcinoma, classical variant,. classical architecture, classical cytomorphology. Margins: Margins uninvolved by invasive carcinoma. Tumor Capsule: Totally encapsulated. Tumor Capsular Invasion: Present, minimal. Lymph-Vascular Invasion: Not identified. Extrathyroidal Extension: Not identified. Third Tumor : Tumor Laterality: Left lobe. Tumor Size: Greatest dimension 1.3 cm. Histologic Type : Papillary carcinoma, classical variant,. classical architecture, classical cytomorphology. Margins: Margins uninvolved by invasive carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Cannot be identified. Lymph-Vascular Invasion: Not identified. Extrathyroidal Extension: Present, minimal. PATHOLOGIC STAGE: pT3 NO MX. NOTE: Information on pathology stage and the operative procedure. is transmitted to this Institution' S Cancer Registry as required. for accreditation by the Commission on Cancer. Pathology stage. is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is. only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon' s. operative report. Primary Pathologist: Clinical History. Papillary thyroid cancer. Gross Description. Specimen A is labeled ""total thyroidectomy. "" Received fresh is a. 14 gm total thyroidectomy specimen. The specimen consists of. right thyroid lobe (5.2 x 2. 1 x 2.0 cm). left thyroid lobe (3.1. x. 2.2 x 1.5 cm), isthmus (2. x 0.9 x 0.7 cm). The specimen comes. oriented with a suture that marks right superior pole. There is a. possible 0.3 cm lymph node identified. The right lobe is serially sectioned to reveal a 0.5 cm in. greatest dimension, unencapsulated, firm, white-tan lesion that. grossly abuts the blue-inked margin and is in the superior half. of the right thyroid lobe. There is a second unencapsulated. lesion present towards the inferior pole of the right thyroid. that measures 1. 6 x 1.1 x 1.0 cm. This lesion is brown-tan,. soft, and has a hemorrhagic center. The remaining thyroid. parenchyma is red-tan and unremarkable. Print -. The left thyroid is serially sectioned to reveal a 1.3 x 1.1 x. 0.6 cm, white-tan, ill-defined lesion. The remaining left thyroid. lobe has red-tan parenchyma with no other discrete nodules or. masses present. The isthmus is serially sectioned to reveal a. red-tan cut surface with no discrete lesions or masses present. The case is reviewed by Dr. Sections are submitted as follows A1 - lesion in superior. portion of thyroid lobe, A2-A4 - lesion #2 in the inferior half. of the right thyroid, A5-A6 - lesion in left thyroid lobe, A7 -. representative section of isthmus, A8possible lymph node. Part B is labeled ""right central neck nodes. Received in. formalin is a 2.2 x 1.5 x 1.4 cm aggregate of two fragments of. adipose tissue. There are three possible lymph nodes identified,. ranging from 0.1 to 0.2 cm in greatest dimension. Sections are. submitted as follows: B1 - three possible lymph nodes, B2 -. remainder of specimen. Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic. findings of this case. Interpretation performed at.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
approved by the US Food and Drug Administration. The FDA has. determined that such clearance or approval is not necessary. This. test is used for clinical purposes. It should not be regarded as. investigational or for research. The laboratory is regulated under. the Clinical Laboratory Improvement Amendments of. (CLIA) as. qualified to perform high complexity clinical testing. Addendum #4 performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S LUNG, LEFT UPPER LOBE WEDGE. 2. LEVEL 5 LYMPH NODE, LEFT. 3. COMPLETION LEFT UPPER LOBECTOMY. 4. LEVEL 9 LYMPH NODE. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. Reason For Addendum #4: Biomarker Report. DIAGNOSIS: 1,3. LUNG, LEFT UPPER LOBE: WEDGE RESECTION AND COMPLETION. LOBECTOMY. - ADENOCARCINOMA, SOLID PREDOMINANT (3.2 CM), SEE NOTE. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. SEVEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/7). Note: The tumor consists of solid (90%) and micropapillary (10%). components and measures 3.2 cm in greatest dimension. microscopically. Results of mutational studies will be reported in. addenda. 2. LYMPH NODE, LEVEL 5: BIOPSY. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). 4. LYMPH NODE, LEVEL 9: BIOPSY. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). Specimens: 1: F/S LUNG, LEFT UPPER LOBE WEDGE. 2: LEVEL 5 LYMPH NODE, LEFT. 3: COMPLETION LEFT UPPER LOBECTOMY. 4: LEVEL 9 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). left upper lobe. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Left. Tumor Site: Upper lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Solid adenocarcinoma. Histologic Grade: G3: Poorly differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 3.2cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. STAGE (pTNM). Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest. dimension surrounded by lung or visceral pleura without. bronchoscopic evidence of invasion more proximal than the lobar. bronchus (i.e., not in the main bronchus); or Tumor 5 cm or less. in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades. the visceral pleura; associated with atelectasis or obstructive. pneumonitis that extends to the hilar region but does not inolve the. entire lung. Regional Lymph Nodes (pN). pN0: No regional lymph node metastasis. Number Examined. 11. Number Involved. 0. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: with a 4 cm LUL mass. MACROSCOPIC DESCRIPTION: The specimen is received in four parts, each labeled with the. patient's name. 1. Part one is received fresh, labeled 'left upper lobe wedge at 084. b'. It consists of a pre-incised wedge biopsy of the lung measuring. 9 X 3.5 X 2 cm. The stapled line measures 9 cm in length. The. stapled line is shaved and the pleura around is inked black. At the. pre-incised area there is a grey-white firm nodule measuring 2 X 1.1. X 1.1 cm located 0.4 cm from the stapled line margin. The remainder. of the parenchyma is pink-red and crepitant. Frozen section. performed on the nodule and resubmitted for permanent section. Representative sections are submitted. 2. Part two is received in saline, labeled 'level 5 lymph node'. It. consists of two pieces of tan-brown soft tissue measuring 1.0 X 0.8. X 0.3 cm and 0.4 X 0.3 X 0.2 cm. Entirely submitted. 3. Part three is received fresh, labeled 'completion left upper. lobectomy'. It consists of a 176 gram left upper lobe of the lung. measuring 23 X 6.5 X 4 cm. There are two staple lines at the medial. aspect of the specimen measuring 11 cm and 11.5 cm. The staples are. removed and this margin is inked black. The pleural surface is. inked blue. The specimen is serially sectioned from superior to. inferior. There is no grossly palpable mass or lesion identified. Representative sections are submitted. 4. Part four is received in saline, labeled 'level 9 lymph node'. It consists of a piece of tan-brown soft tissue measuring 0.9 X 0.4. X 0.2 cm. Entirely submitted. SUMMARY OF SECTIONS: 1A frozen section remaining of the nodule. 1B-1E remaining of the nodule. 1F stapled line margin. 1G random section of the parenchyma. 2A in toto. 3A bronchial margins. 3B vessel margins. 3C possible hilar lymph nodes. 3D one bisected hilar lymph node. 3E-3J representative sections, including entire hilar region. 4A in toto. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Lung, left upper lobe, wedge resection: - Adenocarcinoma. ADDENDUM # 1 FOR MOLECULAR TESTS: EGFR, KRAS and ALK (FISH) was sent on. 1. for patient. The test is to be performed on tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 1C appropriate to. the specifications of the ordered molecular analysis. 1 H& E and 9. unstained slides were prepared and forwarded to. where the. subject molecular test will be performed. An addendum report will be. issued when the results of this molecular test are available. Addendum #1 performed by. ADDENDUM #2: EGFR Mutation Analysis. Body Site: Left upper lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 80% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361G>A (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine kinase domain of the epidermal growth. factor receptor (EGFR) gene are reported to be associated with. differential responsiveness or resistance to EGFR tyrosine kinase. inhibitor (TKI) therapies. The objective response rate among. patients with a sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary electrophoresis. and fluorescence detection. False positive or negative results may. occur for reasons that include genetic variants or somatic. heterogeneity of the tissue sample. DISCLAIMER: This test was developed and its performance characteristics. determined by. The laboratory is regulated under the. Clinical Laboratory Improvement Amendments of. (CLIA) as. qualified to perform high complexity clinical testing. This. particular test is not considered a stand alone test and should be. used only in the context of other diagnostic tests or clinical. work-up related to treatment decisions. Addendum #2 performed by. ADDENDUM #3: MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Body Site: Left upper lobe of lung. Specimen Type: Slides. Clinical Data: Adenocarcinoma. RESULTS: Wild-type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated for. use in identifying KRAS codon 12 and codon 13 mutations in fresh,. frozen, or formalin-fixed paraffin embedded tissue. In particular. the test performance has been established in samples of colorectal. cancer and non-small cell lung carcinoma which harbor these. mutations, although several other tissues are also known to harbor. KRAS mutations (e.g. tumors of pancreas, bile duct, ovary, appendix,. etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATIONS. Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. This test was developed and its performance characteristics. determined by. The laboratory is regulated under. the Clinical Laboratory Improvement Amendments of. (CLIA) as. qualified to perform high complexity clinical testing. This. particular test is not considered a stand along test and should be. used only in the context of other diagnostic tests or clinical. work-up related to treatment decisions. Addendum #3 performed by. ADDENDUM 3: Fluorescence In-Situ Hybridization (FISH). Body Site: Left upper lobe of Lung. Clinical Data: Adenocarcinoma. INTERPRETATION: Negative for a rearrangement involving the ALK gene. Probe #Nuclei Examined % Positive Nuclei %. Control values. 2p23(ALK)V 100 0 <15.0. A total of 100 cells were scored. FINDINGS: FISH was performed on paraffin embedded tissue sections. using dual color break-apart probe. to the ALK. gene at 2p23. This probe flanks the entire gene. If a rearrangement. involving ALK is present, inversion or translocation, one of the two. probe signals separates as one red (orange) and one green signal. In. this specimen, separated signals were present in 0.5% of the nuclei. scored. Based on laboratory validation data, these results are. within the normal limits. COMMENTS: Three to four copies of ALK were observed in 27.0% of. cells. This gain of intact ALK fusion hybridization signals. represents an aneuploid population with extra copies of chromosomes. 2/2p ALK region. Additional copies of ALK are not uncommon in. NSCLCs, although the significance of extra copies of the ALK gene in. lung carcinoma is unclear at this time (. ISCN RESULTS: nuc ish(ALKx3 4) [42/100]. This test was developed and its performance characteristics. determined by. It has not been cleared or.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE or LMP: DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: L BREAST CA, ABN MAMMO R BREAST. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MAST, L SEGM MAST, AXILL DISS. CLINICAL HISTORY: MATERIAL SUBMITTED: A) RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEOURE. routine sutures. B) LEFT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. routine sutures. C) LEFT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: Left breast mass with orientation. Breast tissue 7.0 x 7.5 x 2.5 cm, mass 2.8 x 1.5 x 1.8 cm. Margins. grossly free. ER/PR taken. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) RIGHT BREAST TISSUE (7.0 BY 6.0 BY 1.7 CM) : - No. - ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA. - MICROCALCITICATIONS. B) LETTBREAST MASS (4.0 DY 2.0 BY 1.8 CMJ.: Â¿. - INFILTRATING DUCTAL CARCINOMA WITE EXTENSIVE LOBULAR FEATURES, NUCLEAR GRADE. - TUMOR APPROACKES BUT DOES NOT EXTEND TO ANTERIOR SURGICAL KARGIN (<1 MH IM PLANES or SECTION. - TUMOR APPROACKES BUT DOES NOT EXTEND TO POSTERIOR SURGICAL MARGIN (<1 MM) IN PLANES OF SECTION. c) LETT AXILLARY LYMPH NODES: - FOUR OF TWENTY-TMO (4/22) LYMPH NODES POSITIVE FOR TUMOR (SEE NOTE). - TUMOR PRESENT OUTSIDE or LYMPH BODES. NOTE: Two additional definitely positive lymph nodes were identified in deeper sections and with. immunostaine (CAM 5.2) for a total of (4/22) This tumor is a T2NIMX G2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure. Diagnosis. A. Sentinel lymph node #1, excision: Rare isolated cytokeratin positive cells (pNOi+). B. Right breast, resection: Invasive lobular carcinoma, 2.6 cm, extending to involve the inferior. and lateral margins. Microscopic Description: Microscopic examination performed. A. Sentinel lymph nodes examined at multiple levels section and H&E. staining as well as immunohistochemistry for pan-keratin. metastasis is seen on H&E staining. On pancytokeratin stain there are. rare isolated cytokeratin positive cells (pNOi+). B. The following template applies to the right breast: Invasive Carcinoma: Histologic type: Invasive lobular cancer. Histologic grade. Overall grade: 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT) : 2.6 cm, pT2. Specimen margins: Positive, invasive cancer extends to the. inferior margin, (green ink) in B1 and B3 and the lateral margin,. (yellow ink) B7. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: not identified. Description of non-tumorous breast: Biopsy site changes. Comments: None. Prognostic markers: Previously performed. Specimen. A. Sentinel node #1 -. B. Right breast (single long stitch lateral, double stitch anterior). Clinical Information. Right breast cancer. Gross Description. A. Container A is labeled with the patient's name, medical record. number and ""sentinel node #1"". The specimen container holds a single. rubbery tan lymph node measuring 1.2 x 1 x 0.8 cm. It is bisected and. submitted in blocks A1 and A2. B. Container B is labeled with the patient's name, medical record. number and ""right breast - single long lateral, double stitch. anterior"". The specimen is inked as follows blue - anterior; left -. posterior; yellow - lateral; orange - medial; red-tan superior; green -. inferior. The specimen measurements are 8.7 x 7.5 x 5.2 cm in greatest. dimensions. The specimen is serially sectioned. Near the inferior. lateral surgical margin there is a tumor mass which is more palpable. than visible and measures 2.6 x 2.2 x 1.5 cm. Biopsy site changes are. evident. This mass appears to extend close to the inferior margin. Tissue is obtained for tissue procurement. Representative. sections. are submitted in B1-B14.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS. LEFT KIDNEY, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR) CELL TYPE WITH SARCOMATOID FEATURES WITH. LARGE ""RHABDOID""-TYP CELLS WITH BIZARRE ATYPIA (See Comment). B. FUHRMAN NUCLEAR GRADE IS 4/4. C. RENAL CELL CARCINOMA GROWS IN ACINAR, PAPILLARY AND TUBULAR- PATTERNS OF GROWTH. D. THE GREATEST DIAMETER OF THE NEOPLASM IS 10.5 CM. E. THE NEOPLASM EXTENDS THROUGH THE RENAL CAPSULE WITH MULTIPLE SATELLITE NODULES, BUT IS. CONFINED WITHIN GEROTA FASCIA. F. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. G. ANGIOLYMPHATIC INVASION IS IDENTIFIED. H. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. I. THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. J. THE ADRENAL GLAND IS NOT SUBMITTED. K. NO LYMPH NODES ARE IDENTIFIED. L. TNM STAGE: pT3 NX MX. M INM LHISTOLOGIC GRADE = G4. COMMENT: This tumor has an unusal morphology with areas closely resembling clear cell type carcinoma which are admixed with. additional more high grade spindle cell components including those with tumor nuclei that are markedly enlarged, with. macronuclei, irregular nuclear shapes and pleomorphism. In addition, there are areas with glandular formation,. remniscent of an ""intestinal"" type morphology. Taken together, these are unusual histological findings.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Male. Clinical diagnosis: Melanoma. Gross description: The material presented - skin from right hand, surgical resection. Microscopic description: Received material is skin patch measured 5.5 cmx 6 cmx 5 cm Grade 3. presented with epitheloid melanoma. Final diagnosis: Epitheloid Melanoma. Confidential.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: year old male with right renal mass. Specimens Submitted: 1: SP: Right renal tumor (fs). 2: SP: Deep surgical margin, right kidney. 3: SP: Paracaval lymph node. DIAGNOSIS: 1. SP: Right renal tumor (fs): Tumor Type: Renal cell carcinoma - Unclassified type. High grade. See comment. Tumor Size: Greatest diameter is 3.7 cm. This pertains to the largest tumor although multiple lesions are present. See comment. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Tumor present at renal parenchymal margin (for partial nephrectomy specimens only). See comment. Non-Neoplastic Kidney: Marked chronic inflammation and arteriolonephrosclerosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. COMMENT: The tumors in this case exhibit a very unusual constellation of features that do not fit into any of our well defined. categories. The main tumor mass is predominantly papillary and solid with focal tubular areas. It is high grade. Focal areas of. necrosis are evident. In the adjacent renal parenchyma there are innumerable neoplastic foci that have tubular features and. basophilic cytoplasm. These measure from 3 millimeters to less than 0.1 millimeter. It is these foci of disease that are present at. the parenchymal margin of resection. The main tumor mass is immunoreactive for CK7 and focally for racemase. It is negative for. CA9. The satellite nodules are immunoreactive for CK7 but negative for racemase. BAF-47 is not interpretable. The overall. appearance is suggestive of a syndrome-associated tumor although the unusual morphology does not allow us to make this. statement with confidence or to suggest the syndrome involved, if such is the case. Close examination of the contralateral kidney. is advised. Some of the immunohistochemistry and ISH tests were developed and their performance characteristics were determined by the Department of. Pathology. They have not been cleared or approved by the US Food and Drug Administration The FDA has determined that such clearance or. approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement Amendments. as qualified to perform high complexity clinical. laboratory testing. 2. SP: Deep surgical margin, right kidney: - Benign renal medullary parenchyma. 3. SP: Paracaval lymph node: Lymph Nodes: Not involved. Number of nodes examined:2. with focal granulomas. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. RACEMASE. CK7. CA-1X. BAF-47. NEG CONT. IMM RECUT. CK7. RACEMASE. BAF-47. IMM RECUT. NEG CONT. Gross Description: 1) The specimen is received fresh for frozen section consultation and is labeled ""Right renal tumor"". It consists of a 4.5 X 4 X 4 cm. wedge shaped portion of kidney with a suture marking the deep margin. The margin is inked black and the specimen is serially. sectioned to reveal a tan white tumor with large areas of necrosis, measuring 3.7 x 3.5 X 2.5 cm. The clearance from the resection. margin is 0.5 cm. A representative section of the nearest margin is submitted for frozen section diagnosis. Representatively. submitted. Portions of the tumor are submitted for TPS. Summary of sections: FSC - frozen section control. T tumor. M margin. RS - representative sections. 2). The specimen is received in formalin, labeled ""deep surgical margin right kidney"" and consists of a 0.7 x 0.6 x 0.2 cm fragment. of tan soft tissue. Entirely submitted. Summary of sections: U - undesignated. 3). The specimen is received in formalin labeled ""Paracaval lymph node"" and consists of two pink tan firm lymph nodes with. attached fatty fibrous tissue ranging from 0.3 cm up to 1.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN-lymph node. BLN-bisected lymph node. Summary of Sections: Part 1: SP: Right renal tumor (fs). Block. Sect. Site. PCs. 5. add. 5. 1. fsc. 1. 1. m. 1. 1. rs. 1. 5. t. 5. Part 2: SP: Deep surgical margin, right kidney. Block. Sect. Site. PCs. 1. u. 1. Part 3: SP: Paracaval lymph node. Block. Sect. Site. PCs. 1. bin. 1. 1. In. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: SP: RIGHT RENAL TUMOR (FS): LARGELY NECROTIC RENAL TUMOR;. MARGIN NEGATIVE. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. 3. SEX: M. ADM DATE: OPER DATE: PROCEDURE: SPGD. 1. ""Spleen."" Received in a large container is a 420 gm, 14 x 12 x 6 cm. spleen, semi-firm and red on cut surfaces. Representative sections. 2. ""Omentum."" Received in a large container is a 56 x 10 x 2 cm,. fibroadipose and separate 13 x 6 x 2 cm. No mass or (esion. Representative. sections. 3. ""Perirenal lymph node."" Received is a 1 cm, pink-yellow Lymph node. Bisected. 4. ""Retroperitoneal fat."" Received in a small container are portions of. fibroadipose aggregating to 6 x 5 x 3 cm. No mass or lesion. Representative. sections. 5. ""Left adrenal and left kidney."" Received in a large container, a 1525. gram kidney and adrenal. A 17 x 11 x 12 cm adrenal mass attached to a 13 x 4 x. 5 cm kidney with attached adipose. The adrenal mass is completely encased by. a. pseudocapsule and membranous/fascial layer. Attached to the kidney is 2.5 cm. segment of ureter. Inferior pole of kidney contains a 3.6 x 3.5 x 1.5 cm. simple cyst bulging from the cortex. A 2 cm dilated vessel partially adherent. to inferior adrenal contains a branch entering inferior renal hilum. While the. adrenal is adherent to the renal capsule and sharing vessels, the kidney is. not involved by tumor. After trimming kidney and adipose, the adrenal mass. weighs 1125 grams. No grossly identifiable residual adrenal. The majority. of. the adrenal mass is soft and semi-solid with the central third yellow, grumous. and necrotic while the peripheral is nodular, pink-tan and soft with foci of. necrosis and hemorrhage. The mass abuts the fascia (less than 0.1 cm). 5A. Kidney. 58. Sewn vessels in ureter. 5C.-L. Representative adrenal including capsule and where fat adherent. Note: Portion sent to tissue procurement. PROCEDURE: SPDX. 1. Spleen, resection: No significant abnormality. 2. Omentum, resection: No significant abnormality. 3. Lymph node, perirenal, excision: One lymph node negative for neoplasm. (0/1). 4. Retroperitoneal fat, excision: Negative for neoplasm. 5. Left kidney and adrenal gland, resection: Adrenocortical carcinoma (17 cm). No vascular invasion. Margins free of tumor. Unremarkable kidney.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. SENTINEL L NODE 1. B. SENTINEL L NODE 2. C. LEFT BREAST. D. LEFT AXILLARY CONTENTS. E. ADDITIONAL LEFT AXILLARY CONTENTS. F. RIGHT BREAST. G. LEFT TUBE AND OVARY. H. RIGHT TUBE AND OVARY. SPECIMEN(S): A. SENTINEL L NODE 1. B. SENTINEL L NODE 2. C. LEFT BREAST. D. LEFT AXILLARY CONTENTS. E. ADDITIONAL LEFT AXILLARY CONTENTS. F. RIGHT BREAST. G. LEFT TUBE AND OVARY. H. RIGHT TUBE AND OVARY. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA1/TPA2-SLN #1: Negative for carcinoma (0/2). TPB-SLN #2: Positive for carcinoma (1/1). Diagnoses called by Dr. to Dr. at. B). G-H: Gross examination- left tube and ovary-right tube and ovary. No tumor identified. Diagnosis called to Dr. at. by Dr. GROSS DESCRIPTION: A. SENTINEL L NODE 1. Received fresh labeled with the patient's identification and ""sentinel lymph node #1"" are two lymph node, 0.8 x 0.5 x. 0.4 cm (A1) and 0.2 x 0.2 x 0.2 cm (A2). Two touch preps are performed; is submitted entirely/separately in. cassettes A1-A2. B. SENTINEL L NODE 2. Received fresh labeled with the patient's identification and ""sentinel lymph node #2"" is a 2 x 1 x 0.8 cm lymph node. Touch prep was performed and the lymph node is submitted entirely in cassette B1. C. LEFT BREAST. Received fresh labeled with the patient's identification and ""left breast"" is an oriented 254 g, 15 x 15 x 2.5 cm. mastectomy with 15 x 9.5 cm skin ellipse and 1.5 cm everted nipple. Ink code: Anterior/superior-blue,. anterior/inferior-orange, posterior-black. The specimen is serially sectioned into 7 slices from lateral to medial with. nipple in slice 3 revealing an ill-defined pink-tan infiltrating mass, measuring 4.6-cm, located in the upper inner and. upper outer quadrants in slices 2 through 6 that is closest to the posterior margin at 0.2 cm. Tissue is procured. Representatively submitted: C1: slice 1, UOQ-lateral to mass. C2: slice 2, UOQ-mass. C3-C4: slice 3, mid upper-mass. C5: slice 4, UIQ-mass and deep margin. C6: slice 5, UIQ-mass and deep margin. C7: slice 6, UIQ-mass. C8: slice 7, UIQ-medial to mass. C9: slice 5, LIQ. C10: slice 2, LOQ. C11-C12: nipple, perpendicular sections (skin in C12). D. LEFT AXILLARY CONTENTS. Received fresh labeled with the patient's identification and ""left axillary contents"" is a piece of yellow-tan fat, 6.5 x 3.5. x 1.5 cm containing 8 possible lymph nodes ranging from 0.1 to 0.9 cm in greatest dimension. Submitted entirely: D1-D2: 4 possible lymph nodes in each cassette. D3-D8: remainder of soft tissue. E. ADDITIONAL LEFT AXILLARY CONTENTS. Received fresh are multiple tan pink soft tissue fragments aggregating to 4.5 x 3.5 x 2.4cm. Dissection reveals 7. lymph nodes ranging from 0.3 x 0.3 x 0.3cm to 2.5 x 1.4 x 1cm. E1: 5 lymph nodes. E2: 1 lymph node. E3-E4: 1 lymph node. F. RIGHT BREAST. Received fresh labeled with the patient's identification and ""right breast"" is a 212g, 19 x 15 x 2cm oriented (stitch in. axilla) simple mastectomy with attached 17 x 8.5cm tan pink skin ellipse and 1.5cm everted nipple. Ink code: anterior-superior: blue, anterior-inferior: orange, posterior-black. The specimen is serially sectioned from lateral to. medial into 13 slices with nipple in slice 9, revealing unremarkable fibrous parenchyma. Representatively submitted: F1: nipple slice 9. F2: UOQ slice 5. F3: LIQ slice 7. F4: UOQ slice 7. F5: UOQ slice 8. F6: UC slice 9. F7: LC slice 9. F8: UIQ slice 10. F9: LIQ slice 10. F10: skin slice 11. F11: LIQ slice 11. F12: UIQ slice 12. G. LEFT TUBE AND OVARY. Received fresh is a 4 x 2 x 1.5cm tan pink ceribriform ovary with attached fimbriated fallopian tube 7 x 0.5 x 0.5cm. The ovary is bivalved to reveal multiple cysts, the largest of which is 0.4cm filled with clear straw like fluid. The. remaining ovarian parenchyma is grossly unremarkable. The fallopian tube is serially sectioned to reveal a patent. lumen. Entirely submitted: G1-G5: left ovary. G6-G9: fallopian tube. H. RIGHT TUBE AND OVARY. Received fresh is a 4.5 x 3 x 1.5cm tan pink ceribriform ovary with attached fimbriated fallopian tube 5.8 x 0.8 x. 0.5cm. The ovary is bivalved to reveal multiple cysts, the largest of which is 0.6cm filled with clear straw like fluid. The remaining ovarian parenchyma is grossly unremarkable. The fallopian tube is serially sectioned to reveal a. patent lumen. Entirely submitted in H1-H7. DIAGNOSIS: A. LYMPH NODES, SENTINEL #1, LEFT AXILLA, EXCISION: - TWO LYMPH NODES, NEGATIVE FOR METASTASES (0/2). B. LYMPH NODE, SENTINEL #2, LEFT AXILLA, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1), MEASURING 0.8-CM WITH NO. EXTRANODAL EXTENSION. C. BREAST, EFT,MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 3, MEASURING 4.6-CM. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES WITH. CENTRAL NECROSIS AND MICROCALCIFICATIONS. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - EXTENSIVE LYMPHOVASCULAR INVASION IDENTIFIED. - SEE SYNOPTIC REPORT. D. LYMPH NODES, LEFT, AXILLARY DISSECTION: - SEVEN LYMPH NODES, NEGATIVE FOR METASTASES (0/7). E. LYMPH NODES, LEFT, AXILLARY DISSECTION: - SEVEN LYMPH NODES, NEGATIVE FOR METASTASES (0/7). F. BREAST, RIGHT, MASTECTOMY: - BREAST TISSUE, NO TUMOR SEEN. G. OVARY AND FALLOPIAN TUBE, LEFT, RESECTION: - OVARY AND FALLOPIAN TUBE, NO TUMOR SEEN. H. OVARY AND FALLOPIAN TUBE, RIGHT, RESECTION: - OVARY AND FALLOPIAN TUBE, NO TUMOR SEEN. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: A: SENTINEL L NODE 1. B: SENTINEL L NODE 2. C: LEFT BREAST. D: LEFT AXILLARY CONTENTS. E: ADDITIONAL LEFT AXILLARY CONTENTS. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor. Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 4.6cm. Tumor Site: Upper outer quadrant. Upper inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Extent: extensive. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Axillary dissection. Lymph node status: Positive 1 /17. Micrometastases: DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 20%. DCIS Type: Solid. Cribriform. DCIS Location:Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Negative. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 2 N 1. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY: year-old BRCA2 (+) left breast invasive ductal carcinoma DCIS, right prophylactic mastectomy, left therapeutic. breast mastectomy with sentinel lymph node dissection. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. Microscopic/Diagnostic Dictation: t. Final Review: Pathologist,. Final: Pathologist, (.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
REVISED REPORT (Revised information underlined). TISSUE DESCRIPTION: Tissue from the left kidney (partial nephrectomy, 3.76. grams, 2.2 X. 2.0 X 1.9 cm). . DIAGNOSIS: Kidney, left, partial nephrectomy: Grade 1 (of 4) renal. cell. carcinoma, papillary type, forms a 1.9 X 1.7 x 1.7 cm. mass. The tumor is confined to the kidney. Coagulative. tumor. necrosis is absent. Sarcomatoid differentiation is. absent. The. surgical margins are negative for tumor (free by 0.2 cm). AMENDMENTS. Revision Description: Review of permanent sections reveals the tumor to be a. grade 1 (of. 4) renal cell carcinoma, papillary type. Original Diagnosis. Kidney, left, partial nephrectomy: Grade 1 (of 4) renal. cell. carcinoma, clear cell type, forms a 1.9 X 1.7 X 1.7 cm. mass. The. tumor is confined to the kidney. Coagulative tumor. necrosis is. absent. Sarcomatoid differentiation is absent. The. surgical. margins are negative for tumor (free by 0.2 cm).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
De-Identified Specimen Code: M. SPECIMEN SUBMITTED: Part A: 4R. Part B: #7. Part C: RIGHT LOWER LOBE WEDGE OF. SUPERIOR SEGMENT. Part D: PLEURA ADJACENT TO RIGHT. LOWER LOBE. Part E: LEVEL 11. Part F: #7. Part G: R9. Part H: R8. Part I: 11R. Part J: #7. Part K: #7. Part L: #12. Final Diagnosis. 1. Lymph nodes, 4R, #7, level 11, #7, R9, R8, 11R, #7, #7, #12, excision (A-B, E-N) - Lymph. nodes, negative for neoplasm. 2. Right lung, lower lobe, superior segment, segmentectomy (C) - Mucinous adenocarcinoma,. acinar-predominant (see comment). - Centrilobular emphysema with fibroelastosis. Extensive chronic bronchiolitis with rare ill-formed non-necrotizing granulomas. - Organizing acute fibrinous pleuritis. - Peribronchial lymph nodes, negative for neoplasm. 3. Pleural adjacent to right lower lobe, excision (D) - Organizing acute fibrinous pleuritis. Diagnosis Comment: Tumor Location: Right lower lobe, superior segment. Tumor Size: 7.5x6.4x4.7cm. Vascular Invasion: Negative. Lymphatic Invasion: Present. Bronchial Margin: Negative. Vascular Margin: Negative. Parenchymal Margins: Negative. Pleura/Soft Tissue Margin: The tumor invades into the visceral pleura but is not present at the pleural surface. Pathologic Stage (AJCC): p Stage IIIA (T3 NO MX). Intraoperative Diagnosis: A. Lymph node, negative for malignancy. B. Lymph node, negative for malignancy. C. Negative for malignancy. Clinical Diagnosis: LUNG CA. Gross Description: A. Received fresh for frozen section labeled ""4R"" are multiple fragments of brown-black soft tissue. aggregating to 1.7 X 1.4 X 0.2 cm. Totally submitted in cassette A1 for frozen section. B. Received fresh frozen section labeled ""7"" are multiple fragments of red soft tissue measuring 1.3 X. 0.3 X 0.3 cm in aggregate. Totally submitted in cassette B1 for frozen section. C. Received in formalin labeled ""right lower lobe wedge of superior segment"" is a specimen consisting. of a large pulmonary wedge weighing 223 grams, and measuring 13 X 11 X 4.5 cm. A bronchial remnant. measures 1.2 cm in diameter and 0.3 cm in length. The pleural surface shows adhesions and an area of. puckering with underlying firm mass. Three stapled margins are present measuring 3, 4 and 6.5 cm in. length and are inked orange. The pleural surface overlying the mass is inked blue. On sectioning, a. fleshy tan lobulated mass measuring 7.5 X 6.4 X 4.7 cm is present abutting the pleura with pleural. puckering and thickened. The mass is located 0.6 cm from the closet resection margin and 0.5 cm from. bronchial margin. The remainder of the uninvolved parenchyma is pink-red. Sections are submitted as. follows: C1 bronchial margin for frozen evaluation, C2 vascular margin, C3-C6 tumor with overlying. pleura, C7 tumor in relation to bronchus, C8-C9 tumor with closest resection margin (orange), C10. tumor, C11 uninvolved lung parenchyma, C12-C13 bronchial lymph nodes. D. Received in formalin labeled ""pleura adjacent to right lower lobe"" is an irregular segment of pleura. with adhered soft tissue measuring 12 X 6 X 0.5 cm. Cross sections reveal an unremarkable cut. surface. Representative sections are submitted in formalin in cassettes D1 and D2. E. Received fresh on Telfa gauze labeled ""Level 11"" is a tan anthracotic nodule measuring 0.4 X 0.3 X. 0.2 cm. The specimen is totally submitted in cassette E1. F. Received fresh on Telfa gauze labeled ""#7"" are multiple irregular anthracotic nodules aggregating to 2. x 2 X 0.5 cm. The specimen is totally submitted in formalin in cassette F1. G. Received fresh on Telfa gauze labeled ""R9"" is a solitary irregular anthracotic nodule measuring 0.7 X. 0,5 X 0.5 cm. The specimen is totally submitted in cassette G1. H. Received fresh on Telfa gauze labeled ""R8"" is a anthracotic nodule envelope and soft yellow adipose. tissue measuring 1.5 X 1 X 0.5 cm. The specimen is totally submitted in cassette H1. I. Received fresh on Telfa gauze labeled ""11R"" is a solitary anthracotic nodule measuring 1 X 0.7 X 0.5. cm. The nodule is totally submitted in formalin in cassette 11. J. Received fresh on Telfa gauze labeled ""#7"" are multiple irregular anthracotic nodules aggregating to 2. X 0.5 X 0.4 cm.. The nodules are totally submitted in formalin in cassette J1. K. Received fresh on Telfa gauze labeled ""#7"" is a gray soft nodule measuring 0,8 X 0.5 X 0.4 cm. The. nodules are totally submitted in formalin in cassette K1. Gross Description: L. Received fresh on Telfa gauze labeled ""#12"" are multiple irregular anthracotic nodules aggregating. to 1.5 X 1 x 0.6 cm. The nodules are totally submitted in formalin in cassette L1. Microscopic: {Not Entered}.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with renal mass. Specimens Submitted;. 1: SP: Kidney, left, partial nephrectomy. DIAGNOSIS: 1. SP: Kidney, left, partial nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 4.2 cm. Local Invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Renal Vein Invasion: Not identified. Small vessel angiolymphatic invesion is not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Shows a benign cortical cyst; otherwise unremarkable. Adrenal Gland: Not Identified. Lymph Nodes: Not identified. Steging for renal cell carcinoma/oncocytoma: pT3a Tumor invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section consultation and is labeled ""left renal tumor, stitch marks deep margin"". Il. consists of a 5,5 X 5.3 x 3.5 cm wedge shaped portion of kidney with a suture marking the deep margin. The margin is inked bleck,. the capsule is inked blue and the specimen is serially sectioned to reveal a yellow - orange focally hemorrhagic and cystic mass. measuring 4.2 X 4.2 x 4.5 cm. The clearance from the resection margin is 0.8 cm. The tumor grossly involves the capsule, and is 1. mm from the inked capsular margin. A representative section of the nearest margin is submitted for frozen section diagnosis. Representatively submitted. Portions of the tumor are submitted for TPS. Summary of sections;. FSC - frozen section control. T - tumor. TC-tumor with capsule. M - margin. Summary of Sections: Part 1: SP: Kidney, left, partial nephrectomy. Block. Sect. Site. PCs. 1. FSC. 2. M. 2. T. 1. 3. TC. 3. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the Intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS. RENAL CORTICAL NEOPLASM; MARGIN NEGATIVE. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Stomach. Tumor size: 7.5 X 0 X 0 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Subserosa. Lymph nodes: 0/15 positive for. metastasis (Lesser and greater. curvature 0/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Pathologic Interpretation: A. Station 8 lymph node: - One (1) lymph ode, no tumor seen. B. Station 9 lymph node: - One (1) lymph node, no tumor seen. C. Left 6th rib: - Pending decalcifdication. D. Posterior hjilar node: - One (1) lymph node, no tumor seen. E. Posterior hilar lymph node 2: - One (1) lymph node, no tumor seen. F. Inter-lobar lymph node: - One (1) lymph node, no tumor seen. G. Inter-lobar lymph node # 2: - One (1) ymph node, no tumor seen. H. Bronchial margin left lower lobe. - Poorly differentiated squamous cell carcinoma (4.8 cm in greatest dimension). - Bronchial and vascular margins are free of tumor. - No pleural involvement is present. - Three (3) lymph nodes, no tumor seen. - AJCC stage pT2, pNo, pMx. - See tumor summary. I. Station 7 lymph node: - One (1) lymph node, no tumor seen. J. Station 9 lymph node # 2: - Two (2) lymph odes, no tumor seen. K. Station 7 lymph node,. - One (1) lymph node, no tumor seen. L. AP window: - One (1) lymph node no tumor seen. Tumor Summary: Specimen Type: Lobectomy. Laterality: Left. Tumor Site: Lower lobe. Tumor Size: -Greatest dimension: 4.8 cm. -Additional dimensions: 4.5 x 3.0 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. Pathologic Staging: -Primary Tumor: pT2. - Regional Lymph Nodes: pNO. Specify: Number examined: 14. Number involved: 0. -Distant Metastasis: pMX. Margins: Uninvolved by invasive carcinoma. - Distance of invasive carcinoma from closest margin: 6 mm. - Specify margin: stapeled margin. Direct Extension of Tumor: None identified. As the attending pathologist, 1 attest that 1: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Addendum Diagnosis. C. Left 6th rib: - Fragments of bone and skeletal muscle, no tumor seen. Clinical History: None Provided. Operation Performed. Left thoracotomy. Pre Operative Diagnosis: Left lower lobe lung cancer. Specimen(s) Received: A: Station 8 lymph node. B: Station 9 lymph node. C: Left 6th rib. D: Posterior hjilar node. E: Posterior hilar lymph node 2. F: Inter-lobar lymph node. G: Inter-lobar lymph node # 2. H: Bronchial margin left lower lobe,. I: Station 7 lymph node. J: Station 9 lymph node # 2. K: Station 7 lymph node,. L: AP window. Gross Description: A. Received in formalin is a single dark brown tissue fragment (lymph node), measuring 0.2 x0.1 cm. In toto in one. cassette. B. Received in formalin is a brown lymph node, measuring 1.0 x 0.6 cm. Bisected in toto in one cassette. C. Received in formalin is a segment of bone (rib), measuring 2.0 x 1.0 x 0.8 cm. Sections in one cassette for decalcification. D. Received in formalin is a single dark brown lymph node, measuring 0.5 x 0.4 cm. Bisected in toto in one cassette. E. Received in formalin is a single dark brown tissue fragment, 0.3 X 0.2 cm. In toto in one cassette. F. Received in formalin is a lymph node, measuring 1.0 x 0.8 cm. Trisected in toto in one cassette. G. Received in formalin is a dark brown tissue fragment, 0.5 x 0.4 cm. Bisected in toto in one cassette. H. Received in formalin is a lung lobe (left lower), weighing 240 grams, measuring 14.0 X 12.0 x 4.0 cm. There is a line. of. staple that measures approximately 8.0 cm in length, 2.0 cm in width. The pleura is light brown, inked black. Cross. section through the specimen shows a red-brown parenchyma. There is an ill-defined light brown to grey firm mass,. measuring 4.8 x 4.5 x 3.0 cm. The mass appears situated to within 3.0 cm from the pleural and appears to invade the. medium size bronchus. At the hilum, two lymph nodes are identified, measuring up to 0.7 x 0.4 cm. Sections submitted. as follows: 1&2. For frozen section. 3. Vascular margin. 4. Section from the mass invading the medium size bronchus. 5. Section from the mass in relation with the stapled line of resection. 6-8. Additional section from the mass in relation with the pleura. 9. Additional section from the mass in relation with the bronchus (disrupted). 10. Two lymph nodes in toto. I. Received is a lymph node, measuring 0.7 x 0.5 cm. Bisected in toto in one cassette. J. Received in formalin are two lymph nodes, measuring up to 0.5 x 0.4 cm. Submitted in toto in one cassette. K. Received fresh is a single light brown tissue fragment, measuring 2.0 x 1.5 x 0.1 cm. In toto in one cassette. L. Received in formalin are multiple light brown tissue fragments, measuring 2.0 X 2.0 x 0.1 cm. Two possible lymph nodes. are grossly present, measuring up to 0.7 x 0.4 cm. In toto in one cassette.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Left renal mass, left partial nephrectomy. Specimens Submitted: 1: SP: Kidney, left upper pole, partial nephrectomy. 2: SP: Kidney, left lower pole hilum, partial nephrectomy. 3: SP: Lymph nodes, para-aortic, excision. 4: SP: Perinephric fat, left upper pole, excision. DIAGNOSIS: 1. SP: Kidney, left upper pole, partial nephrectomy: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 3.0 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Mild patchy interstitial chronic inflammation. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. 2. SP: Kidney, left lower pole hilum, partial nephrectomy: Tumor Type: Renal cell carcinoma . Papillary type. partially cystic, with low nuclear grade (see comment). Tumor Size: Greatest dlameter is 3.0 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Mild patchy interstitial chronic inflammation. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocyloma: pT1 Tumor <= 7,0 cm in greatest dimension limited to the kidney. Comment: The tumor cells are positive for CK7 and racemase. CA-9 stains tumor cells around areas of necrosis and. hemorrhage. This immunoprofile supports the dlagnosis. 3. SP: Lymph nodes, para-sortic, excision: Lymph Nodes: Not involved. Number of nodes examined:2. 4. Perinephric fat, left upper pole, excision: Benign fibroadipose tissue. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT,. Special Studies: Special Stain. Comment. RACEMASE. CK7. CA-1X. NEG CONT. IMM RECUT. Gross Description: 1). The specimen is received fresh for frozen section consultation and is labeled ""left upper pole kidney tumor, stitch marks deepest. surgical margin"". It consists of a 4.5 X 3.0 X 2.0 cm wedge shaped portion of kidney with a suture marking the deep margin. The. margin is inked black and the specimen is serially sectioned to reveal a bright yellow well circumscribed tumor with focal. hemorrhage measuring 3.0 x 2.0 X 2.0 cm. The clearance from the resection margin Is 0.1 cm. A representative section of the. nearest margin is submitted for frozen section diagnosis. Representatively submitted. Portions of the tumor are submitted for. Summary of sections: FSC . frozen section control. TC - tumor with renal capsule. TM - tumor to margin. TK - tumor with normal kidney. RS - representative section. 2). The specimen is received fresh for frozen section consultation labeled ""left lower pole hilar tumor (kidney) stitch marks deep. margin"". It consists of a 4.8 x 3.7 x 2,3 cm piece of renal parenchyma. The resected margin is inked black. Cut section of. the. specimen reveals a 3.0 x 3.0 x 3.0 cm friable bloody cystic tumor which is located 0.1 cm from the closest deep margin. A. representative section is submitted for frozen section consultation. A sample Is given to. Representative sections are. submitted. Summary of sections: FSC - frozen section control. T-tumor with margin. TC-tumor with capsule. 3). The specimen is received in formalin labeled ""para-sortic lymph nodes"". It consists of multiple lymph nodes measuring up to. 5.5 x 2.5 cm In greatest dimensions. The lymph nodes are serially sectioned at 3 mm Intervals and submitted. Summary of sections: LN1-lymph node number one. LN2-lymph node number two. LN-lymph nodes. BLN-bisected lymph node. 4). The specimen is received in formalin labeled ""upper pole peritumoral fat (kidney left)"". It consists of two pleces of yellow-tan. fatty tissue measuring 6.5 x 6,0 x 1.8 cm in aggregate. On sectioning the tissue there Is no discrete tumor nodule Identified. Representative sections are submitted. Summary of sections: U-undesignated. Summary of Sections: Part 1: SP: Kidney, left upper pole, partial nephrectomy. Block. Sect. Site. PCs. 1. FSC. 1. RS. 1. 1. TC. 1. 1. TK. 1. 1. TM. 1. Part 2: SP: Kidney, left lower pole hilum, partial nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. 2. t. 2. 1. tc. Part 3: SP: Lymph nodes, para-aortic, excision. Block. Sect. Site. PCs. 4. bIn. 4. 1. In. 1. 5. In 1. 5. 3. In2. 3. Part 4: SP: Perinephric fat, left upper pole, excision. Block. Sect. Site. PCs. 2. u. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only lo the tissue sample examined at the time of the intraoperative consultation. FROZEN SECTION DIAGNOSIS: RENAL CORTICAL CARCINOMA. MARGIN AT STITCH FREE OF TUMOR,. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL CARCINOMA. MARGIN AT STITCH FREE OF TUMOR. (TUMOR 0.5 MM AWAY FROM CLOSEST MARGIN). PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Stomach (Body). 1 - ""Lesion in transverse colon"": - Fragment of autolysed adipose tissue. 2 - ""Chain 5 lymph nodes"": - Fragment of congested fibroadipose tissue (0/0). 3 - ""Chain 3 lymph node"": - Fragment of congested fibroadipose tissue (0/0). 4 - ""Stomach and omentum"": - Poorly differentiated adenocarcinoma, diffuse pattern of LaurÃ©n, measuring 16.5 cm. in extension, infiltrating the wall up to perigastric adipose tissue;. - Presence of perineural invasion;. - Presence of angiolymphatic invasion;. - Proximal margin compromised by the neoplasia;. - Distal margin is free of neoplasia, but is exiguous (<1.0 mm);. - Fragment of epiplon constituted of mature adipose tissue, free of neoplasia in the. sample;. - Metastatic carcinoma in 13 of 13 dissected lymph nodes, with capsular transposition. (16/16);. - Metastatic carcinoma in 11 of 11 dissected lymph nodes with capsular transposition. (11/11). PATHOLOGIC STAGING. Topography. Morphology. Stage. Stomach, NOS. Adenocarcinoma, NOS. pT3 pN3b. del:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with 3,9 x 3 cm hypervascular right renal mass. Specimens Submitted: 1: SP: Right kidney tumor. 2: SP: Deep margin #2. DIAGNOSIS: 1). KIDNEY, RIGHT; PARTIAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, NUCLEAR GRADE III/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DIAMETER IS 3.9 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. . THE SURGICAL MARGIN IS FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. 2). MARGIN, DEEP #2; BIOPSY: - BENIGN RENAL PARENCHYMA. 1). The specimen Is received fresh for frozen section consultation labeled, ""Right kidney tumor, stitch marks deep margin"". consists of a partial nephrectomy specimen measuring 5.0 X 4.0 x 1.5 cm. The area with the black stitch is inked blue. Cut. section the specimen shows a 3.9 X 3.8 x 3.8 cm round, well encapsulated, hemorrhagic orange tumor mass located 0.2 cm from. the resected margin. The remainder of the kidney parenchyma is brown tan and unremarkable. Representatives sections are. frozen. Representative sections are submitted. A sample of the tumor Is given to. Summary of sections: FSCA - frozen section control A (tumor). FSCB - frozen section control B (margin). T- tumor. RS -representative section of uninvolved parenchyma. 2). The specimen is received fresh for frozen section consultation labeled, ""Deep margin #2"". It consists of a piece of gray. (an soft tissue measuring 0.4 x 0.2 x 0.2 cm in aggregate. The specimen is entirely frozen. Summary of sections: FSC - frozen section control. Summary of Sections: Part 1: SP: Right kidney tumor. Block. Sect. Site. PCs. fsca. 1. 1. fscb. 1. rs. 1. 4. Part 2: SP: Deep margin #2. Block. Sect. Site. PCs. 1. fsc. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1A). FROZEN SECTION DIAGNOSIS: TUMOR: CORTICAL CELL NEOPLASM, FAVOR RENAL CARCINOMA/CLEAR. CELL CONVENTIONAL TYPE. PERMANENT DIAGNOSIS: SAME. 1B). FROZEN SECTION DIAGNOSIS: MARGIN: BENIGN. PERMANENT DIAGNOSIS: SAME,. 2). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Revised Surgical Pathology Report. Procedure: Reason for revision: requested clarification of the lymph. node count. Diagnosis. A. Subtotal distal gastrectomy, perigastric lymph nodes and omentum,. resection: Adenocarcinoma, intestinal type, poorly differentiated. Tumor focally invades subserosal connective tissue (pT3). Metastatic adenocarcinoma in 2 of 19 lymph nodes (pN1). Resection margins negative for tumor. Background of moderate acute and chronic gastritis with intestinal. metaplasia. Immunohistochemical stain is negative for Helicobacter pylori. B. Hepatic artery lymph node, biopsy: Single lymph node negative for metastatic tumor. Benign adipose tissue. C. Portal vein lymph node, biopsy: 2 lymph nodes negative for metastatic tumor (0/2). Benign adipose tissue. D. Splenic artery lymph node, biopsy: 4 lymph nodes negative for metastatic tumor (0/4). Benign adipose tissue. Microscopic Description: Microscopic examination performed. A. Template summary of partial gastrectomy-. Histologic type: Adenocarcinoma, intestinal type. Histologic grade: Poorly differentiated. Tumor size: 7.4 X 4.5 X 1. CM. Primary tumor (pT) : Tumor invades through the muscular wall focally in. A6. (pT3). Proximal margin: Negative. Distal margin: Negative. Radial margin: Negative. Distance of tumor from closest margin: 2 cm from distal margin. Vascular invasion: Not identified. Regional lymph nodes (pN) : 2 of 19 regional lymph nodes positive for. metastatic tumor. One positive lymph node is from the lesser curvature. and one is from the greater curvature. Largest metastatic focus is. 4. mm (pN1). Distant metastasis (pM) : Not evaluated (pMX). Other findings: There is background moderate acute and chronic. gastritis with intestinal metaplasia. No Helicobacter pylori organisms. were identified by immunohistochemical stain. B. Separately submitted lymphnodes were all negative for tumor. Specimen. A. Subtotal distal gastrectomy, perigastric lymph nodes, and omentum. B. Hepatic artery lymph nodes. C. Portal vein lymph node. D. Splenic artery lymph node. Clinical Information. Gastric cancer. Procedure is a subtotal gastrectomy please count 15 lymph nodes. Gross Description. A. Received fresh is an unopened distal gastrectomy which measures 20. cm along the greater curvature, 13 cm along the lesser curvature, and. 4.5 cm from anterior to posterior. The serosa is smooth tan-pink with. an area of retraction and focal induration at the distal end. (subsequently inked blue) A scant amount of attached perigastric fat. and a copious amount of unremarkable omentum are received in. association with the specimen. The proximal and distal margins measure. 17.0 and 4.4 cm in circumference respectively. Both margins are. secured by a staple line which is subsequently removed. On opening,. there is a 7.4 X 4.5 cm rubbery tan-white-to red tumor mass within the. distal portion of the specimen with raised rolled edges. The tumor. is. located 2 cm from the distal margin (following removal of the staple. line) in the fresh state. A portion of tumor and a portion of normal. gastric mucosa are submitted for tissue procurement as requested. On. sectioning, the tumor has a maximal thickness of 1. cm, extending to. within 0.3 cm of the inked serosal surface the remaining gastric mucosa. is tan-pink with regular folds and the wall averages 0.8 cm. Several. slightly rubbery white pink tissues in keeping with Lymph nodes. measuring up to 1.3 cm in greatest dimension are recovered as follows: 9 along the lesser curvature and 14 along the greater curvature. RS 18. Summary: 1 - perpendicular sections proximal margin; 2 through 4. perpendicular sections to tumor to distal margin (inked orange) ; 5. through 8 - tumor to inked serosal surface; 9 - tumor to proximal. normal mucosa; 10 and 11 - random normal; 12 - 5 ymph nodes lesser. curve; 13 - 4 lymph nodes lesser curve; 14 - 6 lymph nodes greater. curve; 15 - 5 lymph nodes greater curve; 16 through 18 - one bisected. lymph node per cassette greater curve. B. Received fresh labeled ""hepatic artery lymph nodes"" is a 3.0 X 2.3. X 1.4 cm portion of soft, lobulated tan gold adipose tissue. A single,. 1.4 cm tan to red tissue in keeping with lymph node is recovered. AS3. Summary: 1 - bisected lymph node; 2 and 3 - residual adipose tissue. C. Received fresh labeled ""portal vein lymph node"" is a 1.5 cm soft. tan-red tissue in keeping with lymph node with a moderate amount of. associated adipose tissue. AS 2. Summary: 1 - bisected lymph node; 2 - residual adipose tissue. D. Received fresh labeled ""splenic artery lymph node"" is a 4.4 X 2.9. X. 1.5 cm portion of soft, lobulated tan gold adipose tissue. Two. slightly rubbery tan-red tissues in keeping with lymph nodes measuring. 0.5 and 0.9 cm in greatest dimension are recovered. AS 4. Summary: 1 - one lymph node; 2 - one bisected lymph node; 3 and 4. idual adipose tissue.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
OC ID: SPECIMEN(S): A: Lipoma. B: Left adrenal gland and mass. FINAL DIAGNOSIS: B. Adrenal gland, left, excision: - Adrenal cortical carcinoma, low grade. - 7.8 cm greatest dimension. - 171 gm. - Margins of resection free of malignancy. - See case summary. A. Soft tissue, back, excision: - Lipoma. COMMENT: This case has been reviewed, who concurs with the. interpretation of low-grade adrenal cortical carcinoma. The findings of. a sheet-like infiltration pattern, necrosis, capsular vascular invasion,. and nuclear atypia are fairly typical of carcinomas. In addition, the. size in excess of 7 cm and the weight of 171 gm are also both more. typical of carcinoma. The eosinophilic cytoplasm is also more typical. of carcinoma. Absolute distinction between adrenal cortical adenomas. and carcinomas is not always possible; however, multiple series have. shown having many of the features described are associated with. malignant behavior. American Journal Clinical Pathology, 1996;. 105:76-86. Specimen: Adrenal gland; received: Fresh. Procedure: Adrenalectomy, total. Specimen Integrity: Intact. Specimen Size: Greatest dimensions: 17 x 8 x 4.9 cm. Specimen Laterality: Left. Tumor Size: a 7.8 x 5.7 x 4.6 cm. Tumor Gland Weight: 171 gm. Histologic Type: Adrenal cortical carcinoma. Margins: Margins uninvolved by tumor. Lymph-Vascular Invasion: Small vessel (capillary lymphatic). Pathologic Staging: pT2 pNX. Primary Tumor (pT): pT2: Tumor greater than 5 cm, no extra-adrenal. invasion. Regional Lymph Nodes (pN): pNX: Cannot be assessed. No nodes submitted or found. Distant Metastasis (pM): Not applicable. I have personally reviewed all specimens and or slides, including the. listed special stains, and used them with my medical judgement to. determine the final diagnosis. CLINICAL HISTORY: The patient is a. -year-old male with growth on adrenal gland. Operative Procedure: Lipoma excision and left adrenal gland and mass. excision. GROSS: Two formalin-filled containers are received, each labeled with the. patient's name, and medical record number. A. The first container is labeled ""A-lipoma."" The specimen. consists of four tan-red-white, and cauterized rubbery tissue measuring. ranging from 0.7 to 1.6 cm in greatest dimension and 1.8 X 1.5 x 0.8 cm. in aggregate. Sectioning reveals yellow-red solid cut surface. Entirely submitted in A1 and A2. B. The second container is received fresh and subsequently. saved in formalin and labeled ""B - left adrenal gland and mass."" The. specimen consists of a 17 X 8 X 4.9 cm and 171 gm portion of yellow. lobulated fibroadipose tissue. The entire external surface is inked. black. Sectioning reveals a 7.8 X 5.7 X 4.6 cm yellow-brown solid,. ovoid mass. Focal white firm calcifications measuring up to 0.5 cm in. greatest dimension is noted in the central area. Also, a 2.5 X 1.5 X. 1.3 cm pink and lightly fleshy area is present on the peripheral area of. the mass. A purple-red hemorrhage is noted measuring up to 2.5 cm in. greatest dimension. Grossly, the mass is entirely encapsulated. On the. edge of the mass is a 4.5 x 2.5 x 1.0 cm bright yellow-brown adrenal. gland tissue. Representative tissue was procured for potential future. studies. The specimen is photographed. Representative sections are. submitted. Summary of Sections: B1 -B3 mass with adrenal gland. B4-B5 - mass to include the pink solid area. B6 - mass to include hemorrhage. B7-mass. B8 - mass to include calcification following fixation and. decalcification. MICROSCOPIC: Microscopic examination is performed. Sections show a low-grade adrenal cortical carcinoma. The adrenal is. expanded by a 7 cm nodule of eosinophilic cells, many with nucleomegaly. and poly-lobation. Tumor is arranged largely in sheets, without. trabecular or small cell patterning. The neoplasm is thickly. encapsulated, with foci of necrosis. Focally, there is vascular. penetration of the capsule; however, the marked margins of resection are. free of malignancy. Mitotic activity is inconspicuous. Immunohistochemical stains performed on the tumor show focal. immunoreactivity to vimentin. Melan-A is focally positive, with good. internal control. There is no immunoreactivity with antibodies to. Pan-Cytokeratin (AE1/AE3). There is weak focal immunoreactivity with. antibodies to synaptophysin, but not with antibodies to chromogranin. S-100 highlights normal adipocytes. An antibody to inhibin highlights. normal adrenal cortical cells, but does not react with the tumor.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN(S): A. 4R LYMPH NODE. B. LEVEL 7 LYMPH NODE. C. RIGHT CARINAL PNEUMONECTOMY. D. LEVEL 7 LYMPH NODE. E. LEVEL 9 LYMPH NODE. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: SCC of the lung. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA/TPA: Lymph node, 4R, excision: No malignancy identified. By. called. FSB/TPB: Lymph node, level 7, excision: No malignancy identified. FSC1; Inferior bronchial margin: Negative for tumor. FSC2: Lateral bronchial margin: Negative for tumor with focal mild squamous dysplasia. Comment: Superior margin is 1.5 cm from the tumor. Grossly negative for tumor. GROSS DESCRIPTION: A. 4R. Received fresh for frozen section are two tan-pink fragments of fibrofatty tissue 0.3 X 0.2 x 0.2. cm and 0.1 x 0.1 x 0.1 cm. The larger tissue fragment is bisected. One touch prep is taken and. the specimen is submitted in toto for frozen section in FSA1. B. LEVEL 7 LYMPH NODE. Received fresh for frozen section is a tan-pink lymph node 0.4 X 0.2 x 0.1 cm. The specimen is. submitted entirely for frozen section in FSB1 Touch preps are taken. C. RIGHT CARINAL PNEUMONECTOMY. Received fresh for frozen section diagnosis is a right carinal pneumonectomy specimen. containing all three lobes and portion of main bronchus measuring 24 x 17 x 6 cm with the. weight of 882 gm. The right main.bronchus is identified measuring 3.0 cm in the greatest. diameter. The right main bronchus shows a 6.0 x 4.5 x 4.0.cm gray-tan, firm and discrete mass. No necrosis or hemorrhage is grossly identified in the tumor. The pleural surface is grossly. uninvolved by the tumor. The inferior and lateral bronchus margin is taken for frozen section. diagnosis. The specimen is inked externally. Cutting through the lung reveals the tumor. involves the middle lobe and portion of the upper lobe. No tumor mass is grossly identified in the. lower lobe. Also identified away from the main tumor is a 3.5 x 2.5 x 2.5 cm necrotic area in the. upper lobe. The necrotic area is approximately 2.0 cm away from the main tumor. A 4.0 x 3.0 x. 2.0 cm hemorrhagic area is also identified in the upper lobe, superior to the necrotic area. Multiple subpleural blebs are identified in the upper lobe. Also noted that the parenchyma in the. upper lobe shows diffuse firm change compared to the lower lobe and middle lobe. Multiple. presumptive peribronchial lymph nodes are identified from specimen. Representative sections are. submitted for microscopic examination as follows: C1: frozen section resubmitted for the inferior bronchial margin. C2: frozen section resubmitted for the lateral bronchial margin. C3: superior bronchial margin. C4-C9: representative sections from tumor. C10-C11: representative sections of the necrotic area in upper lobe. C12-C13: representative section showing the hemorrhage area in upper lobe. C14: representative section showing the subpleural blebs. C15-C16: representative section of the upper lobe. C17: representative section of the middle lobe. C18: representative section of the lower lobe. C19: multiple peribronchial lymph nodes from the upper lobe. C20-C22: peribronchial lymph nodes from the middle lobe. C23-C24: peribronchial nodes from the lower lobe. D. LEVEL 7 LYMPH NODE. Received in formalin is anthracotic lymph node measuring 2 X 0.8 X 0.6 cm. Submitted entirely. in cassette D1. E. LEVEL 9 LYMPH NODE. Received in formalin in is a red-tan lymph node measuring in 1.1 X 0.7 X 0.3 cm. Bisected and. submitted entirely in cassette E1. DIAGNOSIS: A. LYMPH NODE, 4R, EXCISION: TWO REACTIVE LYMPH NODES NEGATIVE FOR TUMOR (0/2). B. LYMPH NODE, LEVEL 7, EXCISION: - ONE REACTIVE LYMPH NODE NEGATIVE FOR TUMOR (0/1). C. LUNG, RIGHT, CARINAL, PNEUMONECTOMY: - MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA OF. THE RIGHT MAIN BRONCHUS MEASURING 6 X 4.5 X 4 CM. - BRONCHIAL MARGIN IS FREE OF TUMOR. - BRONCHIOPNEUMONIA AND EXTENSIVE NECROSIS AND. INTRABRONCHIAL HEMORRHAGE. - PERIBRONCHIAL LYMPH NODES POSITIVE FOR CARCINOMA (3/39). - SEE SYNOPTIC REPORT. D. LYMPH NODE, LEVEL 7, EXCISION: - ONE REACTIVE LYMPH NODE (0/1). E. LYMPH NODE, LEVEL 9, EXCISION: - ONE REACTIVE LYMPH NODE (0/1). SYNOPTIC REPORT - LUNG. Surgical Procedure: Pneumonectomy. Laterality: Right. Tumor Site: Right main stem bronchus. Tumor Location: Central. Tumor Size: Greatest diameter: 6cm. Additional dimensions: 4.5cm x 4cm. WHO CLASSIFICATION. Squamous cell carcinoma. Histologic Grade: G2: Moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Tumor Distance from margin: 0.2cm. Visceral Pleural Involvement: Absent. Satellite Tumor(s): Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Positive 3 / 39. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0/5. Non-Neoplastic Lung: Emphysematous changes. Pneumonia. Hemorrhage. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 3 N1 MX.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
BD: SURGERY CASE #: SPECIMEN: A. Whipple with margins. B. Gallbladder and contents. FROZEN SECTION DIAGNOSIS: A. Common bile duct surgical margin free of. tumor. Pancreatic margin focally involved by. tumor. OPERATIVE PROCEDURE: Whipple procedure. PREOPERATIVE DIAGNOSIS: None given. POSTOPERATIVE DIAGNOSIS: None given. DIAGNOSIS. A, B. 1. Type of specimen: Pancreaticoduodenectomy (Whipple resection) and cholecystectomy. 2. Tumor type: Pancreatic ductal adenocarcinoma. 3. Histologic grade: Moderately to poorly differentiated. 4. Tumor size: 2.5 cm, extending into peripancreatic soft tissue. 5. Surgical margins: Pancreatic surgical involved by tumor. Tumor extends to inked soft tissue margin. All other surgical margins free of tumor. Venous (large vessel) invasion: Absent. 7. Lymphatic (small vessel) invasion: Present. 8. Perineural invasion: Present. 9. Lymph nodes: Total number of lymph nodes examined: 10. Number of lymph nodes involved: 4 (4/10). Focal extracapsular extension identified. 10. Additional pathologic findings: Chronic pancreatitis. Acute and chronic cholecystitis. Cholelithiasis. 11. TNM STAGING: pT3, pN1b, pMX. (See previous. MICROSCOPIC EXAMINATION: A. Multiple sections are examined and sections of the pancreatic mass. grossly described demonstrates an invasive malignant epithelial. neoplasm. The tumor demonstrates medium size to small glands as well. as small nests of cells that are lined by cells containing a moderate. amount of cytoplasm with enlarged pleomorphic nuclei with prominent. nucleoli. A desmoplastic stromal response surrounds the tumor. The. neoplasm is seen involving the pancreatic surgical margin with the. sections immediately taken adjacent to the margin extensively. involved by tumor. The tumor is also seen involving the. peripancreatic soft tissue and involving the inked uncinate. (retroperitoneal) soft tissue margin. There is perineural invasion. and a focus of lymphatic invasion is noted. There is no definite. venous (large vessel) invasion. The adjacent pancreas demonstrates. chronic inflammation and fibrosis. The common bile duct margin. is. free of tumor. No involvement of the overlying small bowel or. ampulla of Vater is seen, the latter demonstrating mucosal ulceration. with acute and chronic inflammation and hemorrhage with foreign body. multinucleated giant cell reaction. Sections taken from the gastric. and small bowel mucosal surgical margins are unremarkable, with. malignancy. Random sections of the stomach demonstrate no. significant distortion of the overall glandular architecture with no. Helicobacter pylori identified on special stain (Giemsa) Random. sections taken from the stomach, pylorus and small bowel are also. unremarkable. There are a total of ten lymph nodes identified, four. of which (peripancreatic) are involved by metastatic adenocarcinoma. with focal extracapsular extension identified. B. Sections are of gallbladder with mild acute and chronic inflammation. There is no malignancy. GROSS: A. Received labeled ""Whipple"" is a 13 cm segment of stomach in. continuity with small bowel measuring 14 cm and head of pancreas. measuring 5 cm, with surrounding soft tissue. Present on the head of. the pancreas is a firm mass measuring 2.5 cm maximally. The tumor. appears to closely approach the pancreatic margin, and grossly is. also seen involving the uncinate (retroperitoneal/mesopancreatic). soft tissue margin. The stomach is opened along the greater. curvature and small bowel along the antimesenteric side. The ampulla. of Vater is erythematous with metal clips present on the mucosa. The. tumor does not grossly involve the ampulla or small bowel mucosa. The gastric mucosa and small bowel mucosa appear unremarkable and the. pylorus also appears unremarkable. The remainder of the pancreas. demonstrates a lobulated, yellow parenchyma. Representative section. of the tumor is submitted for Genomics Project. The pancreatic duct. and parenchymal surgical margin are submitted for frozen section and. frozen section diagnosis in block #1, and the common bile duct margin. is submitted for frozen section and frozen section diagnosis in block. #2. Representative section of the tumor is also submitted for. chemosensitivity assay. Sections are then submitted for permanent as. follows: Cassette #3 - Sections immediately adjacent to the. pancreatic duct surgical margin. #4 through #8 - Additional sections. of tumor with #5, #6, and #7 containing inked soft tissue margin. #9. - Pancreas and overlying small bowel. #10 - Immediately adjacent. pancreas. #11 and #12 - Sections of ampulla of Vater. #13 - Small. peripancreatic lymph nodes. #14 - Proximal and distal mucosal. (gastric and small bowel) margins. #15 - Random sections of stomach. #16 - Sections of stomach, pylorus and small bowel. #17 and #18 -. Additional peripancreatic lymph nodes. #19 - Lymph nodes from lesser. curvature. #20 and #21 - Lymph nodes from greater curvature. B. Received in Formalin labeled with the patient's name, account number,. and ""gallbladder and contents"" is a gallbladder measuring 7 cm in. length x 4 cm in maximum diameter. The serosal surface is pink-tan. and diffusely hemorrhagic. The cystic duct is patent. A cystic duct. lymph node is not identified. The specimen is opened to reveal a. large amount of green-tan bile and two bile stones ranging in size. from 0.4 to 0.5 cm maximally. The mucosal surface is pale tan,. smooth and velvety. The wall measures 0.3 cm thick. Representative. sections are submitted in a single cassette. Dictated: Job# I. Transcribed: Doc#. MD. MD. MD.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histology. APRPT (Verified). Acc #: F. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LYMPH NODES, #7; EXCISION: - FOUR LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/4). B. LYMPH NODES, #11R; EXCISION: - FOUR LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/4). C. LUNG, RIGHT LOWER LOBE; LOBECTOMY, C1FS: ADENOCARCINOMA, MIXED SUBTYPE, WITH PREDOMINANTLY PAPILLARY AND MICROPAPILLARY. PATTERNS OF GROWTH. - THE TUMOR IS WELL-DIFFERENTIATED AND MEASURES 4.0 X 4.0 X 2.0 CM. - ANGIOLYMPHATIC INVASION IDENTIFIED. - BRONCHIAL AND VASCULAR MARGINS ARE NEGATIVE. - VISCERAL PLEURAL INVASION IS IDENTIFIED. - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). - SEE SYNOPTIC REPORT. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. D. LUNG, POSTERIOR SEGMENT RIGHT UPPER LOBE; WEDGE: BENIGN LUNG WITH APICAL CAP LIKE FIBROSIS AND SUBPLEURAL CYSTS. E. LYMPH NODE, 4R; EXCISION: - FOURTEEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/14). F. LUNG, INFERIOR PORTION OF RIGHT MIDDLE LOB; WEDGE: - BENIGN LUNG PARENCHYMA. Comment. Immunohistochemical and special stains: - Elastic (slides C4, C7). positive for visceral pleural invasion. - Mucicarmine (slide C4). negative. - CK 7 (slide C4). positive. - CK 20 (slide C4). negative. - TTF1 (slide C4). positive. - Napsin (slide C4). positive. - Pax 8 (slide C4). negative. - Thyroglobulin (slide C4). negative. This immunoprofile is compatible with a lung primary. Synoptic Worksheet. C. Right lower lobe: Specimen: Lobe(s) of lung: Right lower. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Lower lobe. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G1: Well differentiated. Tumor Size: Greatest dimension: 4.0 cm. Additional dimension: 4.0 cm. Additional dimension: 2.0 cm. Visceral Pleura Invasion: Present. Tumor Extension: Not applicable. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Bronchial Margin: Uninvolved by invasive carcinoma. Involvement by squamous cell carcinoma in situ (CIS) not applicable. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Not applicable. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension. surrounded by lung or visceral pleura, without bronchoscopic evidence of. invasion more proximal than the lobar bronchus (ie, not in the main. bronchus); or Tumor 5 cm or less in greatest dimension with any of the. following features of extent: involves main bronchus, 2 cm or more distal to. the carina; invades the visceral pleura; associated with atelectasis or. obstructive pneumonitis that extends to the hilar region but does not involve. th the entire lung. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Nodes examined: 23. Nodes involved: 0. Distant Metastasis (pM): Not applicable. Clinical History. Right VATS. Lobectomy. Specimen(s) Received. A: #7 Lymph node. B: #11R lymph node. C: Right lower lobe. D: Posterior segment right upper lobe. E: 4R lymph node. F: Inferior portion of right middle lobe wedge. Gross Description. Specimen A is received in formalin labeled with the patient's name, medical record number and is labeled as ""#7 lymph node."" It. consists of four lymph nodes that measure 0.7 to 1.6 cm in greatest dimension. The specimen is submitted in its entirety in. cassette ""A1."" Dictated by. Specimen B is received in formalin labeled with the patient's name, medical record number and is labeled as ""11R lymph node."". It consists of four lymph nodes that measure 0.5 to 0.6 cm in greatest dimension. The specimen is submitted in its entirety in. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. cassette ""B1."" Dictated by. Specimen C is received fresh labeled with the patient's name, medical record number and is labeled ""right lower lobe."" It. consists of a lobe of lung that measures 17.5 x 11.7 x 4.8 cm and weighs 229 grams. There is a firm, well-circumscribed mass. that measures 4.0 X 4.0 x 2.0 cm. The mass abuts the bronchial margin and puckers the overlying pleura. The remainder of the. lung is unremarkable. The bronchial margin is submitted for frozen section diagnosis and the contents of the cryoblock are. transferred to cassette ""C1FS."" Sections are submitted as stated below. Dictated by. C2: Vascular margin. C3: One bronchial lymph node submitted whole. C4: Tumor and inked green pleura. C5: Tumor and bronchus. C6: Tumor and representative normal lung. C7: Representative tumor. C8: Representative normal lung. Specimen D is received in formalin, labeled with the patient's name, medical record number and designated ""posterior segment. of right upper lobe."" The specimen consists of lung tissue measuring 6.1 x 2.3 x 1.2 cm. No lesions are identified within the lung. parenchyma. The parenchymal margin is inked blue. Representative sections are submitted in cassettes ""D1"" and ""D2."". Specimen E is received in formalin, labeled with the patient's name, medical record number and designated ""4R lymph node.'. The specimen consists of four pieces of soft tissue measuring 2.6 x 2.3 x 0.8 cm in aggregate. Multiple lymph nodes are. identified and vary in size between 0.5 cm and 0.3 cm in greatest diameter. The specimen is submitted in its entirety as stated. below. Dictated by. E1: At least three lymph node, whole. E2: At least four lymph nodes, whole. Specimen F is received in formalin, labeled with the patient's name, medical record number and designated ""inferior portion. of. right middle lobe wedge."" The specimen consists of lung tissue measuring 3.1 x 1.4 x 1.1 cm and is grossly unremarkable. Parenchymal margin is inked blue. The specimen is submitted entirely in cassette ""F1."" Dictated by. Intraoperative Consult Diagnosis. C1FS: RIGHT LOWER LOBE BRONCHIAL MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. out at. Microscopic Description. Microscopic examination performed. ANALYTE SPECIFIC REAGENT (ASR) DISCLAIMER: Some of the above tests may use Class I ASRs. These tests were developed and their performance characteristics determined. They have not been cleared or approved by the Federal Drug Administration (FDA). The FDA. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. does not require these tests to go through premarket FDA review. These tests are used for clinical purposes, and should not be. regarded as investigational or for research. laboratory is certified under the Clinical Laboratory Improvement. Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
M. DIAGNOSIS. (A) LYMPH NODE, 4R, LYMPHADENECTOMY: Two lymph nodes, no tumor present (0/2). (B) LYMPH NODE, STATION 7, LYMPHADENECTOMY: One lymph node, no tumor present (0/1). (C) DIAPHRAGM, BIOPSY: Portion of diaphragm, no tumor present. (D) RIGHT LIVER, BIOPSY: Liver parenchyma with fibrosis, no tumor present. (E) RIGHT PLEURA, BIOPSY: EPITHELIOID MALIGNANT MESOTHELIOMA. GROSS DESCRIPTION. (A). 4R LYMPH NODE - Received are two possible lymph nodes measuring 0.6 to 1.0 cm in greatest dimension. Specimen. submitted entirely in A. (B). STATION. 7 LYMPH NODE - Received is one possible lymph node measuring 0.6 cm in greatest dimension. Specimen. submitted entirely in B. (C). BIOPSY OF DIAPHRAGM - Received is a single fragment of tan-pink soft tissue measuring 0.2 cm in greatest dimension. Specimen submitted entirely in C. (D) RIGHT LIVER BIOPSY - Received are two fragments of tan-pink soft tissue both measuring 0.2 cm in greatest dimension. Specimen submitted entirely in D. (E). RIGHT. PLEURAL TUMOR - A single (2.3 X 1.1 x 0.9 cm) portion of pink-tan to white fibrous tissue that is entirely submitted for. frozen section evaluation in E. FS/DX: POSITIVE MALIGNANT MESOTHELIOMA. CLINICAL HISTORY. Mesothelioma. SNOMED CODES. T-2900, M-90503. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT----. Page : 2. M.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: 206 A1 A2 B1 C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14. C15 C16. Liver (460 grams, 17.5 x 7.9 x 3.8 cm) gallbladder (7.2 x 3.5 x 3.1. cm), omentum biopsy (2 pieces 2.6 x 0.8 x 0.5 cm) and hepatic artery. lymph node. DIAGNOSIS: Liver and gallbladder, resection: Grade 3 of 4, hepatocellular. carcinoma, usual type, forming a hilar mass 4.8 x 4.3 x 3.2 cm. involving segments V and VIII abutting the gallbladder, but no. involving it. The hepatic capsule is free of tumor. The surgical. margins are free of tumor, the clearance being 0. cm. microscopically Angiolymphatic invasion is identified (by VVG. stain) within the tumor however, extratumoral vascular invasion is. not identified. The tumor is partially encapsulated, infiltration. of parenchyma being of the pushing type. The adjacent liver. parenchyma is non-cirrhotic. The gallbladder shows subacute and. chronic cholecystitis with cholelithiasis (3 mixed stones) . All. surgical margins are free of tumor, closest 0.7 cm. Inmunoperoxidase studies were performed on paraffin sections of the. liver mass using antibodies directed against the following antigens: Hep-1, pCEA, keratin, TTF-1, CD10, mucicarmine, albumin ISH, and. VVG. The tumor cells are positive for albumin RNA by ISH with. patchy strong staining for keratin, Hep-1 with focal focal. canalicular pCEA positivity, and patchy cytoplasmic TTF-. positivity. The tumor cells are negative for CD10 and mucicarmine. These findings support the H&E diagnosis. Omentum, biopsy: Fat necrosis negative for malignancy. Lymph node, hepatic artery, excision: A single hepatic artery lymph. node is negative for tumor. PRELIMINARY FROZEN SECTION CONSULTATION: Liver and gallbladder, resection: Hepatocellular carcinoma. HOLD to. grade. TISSUE DESCRIPTION: A1 A2 B1 C1 C2 C3 C4 C5 C6 C7 CB C9 C10 C11 C12 C13 C14. C15 C16. Liver (460 grams, 17.5 x 7.9 x 3.8 cm) gallbladder (7.2 x 3.5 x 3.1. cm), omentum biopsy (2 pieces 2.6 x 0.8 x 0.5 cm) and hepatic artery. lymph node. DIAGNOSIS: Liver and gallbladder, resection: Grade 3 of 4, hepatocellular. carcinoma, usual type, forming a hiler mess 4.8 x 4.3 x 3.2 cm. involving segments V and VIII abutting the gallbladder, but no. involving it. The hepatic capsule is free of tumor. The surgical. margins are free of tumor, the clearance being 0.7 cm. microscopically. Angiolymphatic invasion is identified (by VVG. stain) within the tumor however, extratumoral vascular invasion is. not identified. The tumor is partially encapsulated, infiltration. of parenchyma being of the pushing type. The adjacent liver. parenchyma is non-cirrhotic. The gallbladder shows subacute and. chronic cholecystitis with cholelithiasis (3 mixed stones) . All. surgical margins are free of tumor, closest 0.7 cm. Inmunoperoxidase studies were performed on paraffin sections of the. liver mass using antibodies directed against the following antigens: Hep-1, pCEA, keratin, TTF-1, CD10, mucicarmine, albumin ISH, and. VVG. The tumor cells are positive for albumin RNA by ISH with. patchy strong staining for keratin, Hep-1 with focal focal. canalicular pCEA positivity, and patchy cytoplasmic TTF-1. positivity. The tumor cells are negative for CD10 and mucicarmine. These findings support the H&E diagnosis. Omentum, biopsy: Fat necrosis negative for malignancy. Lymph node, hepatic artery, excision: A single hepatic artery lymph. node is negative for tumor. PRELIMINARY FROZEN SECTION CONSULTATION: Liver and gallbladder, resection: Hepatocellular carcinoma. HOLD to. grade.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: A1 A2 A3 A4 A5 A6 A7 A8 A9 A10. Right lobe liver 17.0 x 15.0 x 7.5 cm with gallbladder (9.5 x 5.4. cm) together weighing 1,015 grams. DIAGNOSIS: Liver, right lobe, excision: Grade 3 (of 4) hepatocellula. carcinoma, usual type, forming a single mass (3. 1 x 2.4 x 2.3 cm). The tumor is located in the right lobe. The hepatic capsule is free. of tumor. The surgical margins are free of tumor (free by 0.5 cm). Extratumoral vascular invasion is identified. The tumor is not. encapsulated, infiltration of parenchyma being of pushing type. No. lymph nodes are identified. The gallbladder shows cholesterolosis,. otherwise unremarkable. Non-neoplastic hepatic parenchyma will be. assessed in permanent sections. ADDENDUM: Non-neoplastic liver shows chronic hepatitis, consistent with. hepatitis C virus (HCV) infection, mildly active (grade 2 of 4),. with portal and periportal fibrosis (stage 2) . TISSUE. DESCRIPTION: A1 A2 A3 A4 A5 A6 A7 AB A9 A10. Right lobe liver 17.0 x 15.0 x 7.5 cm with gallbladder (9.5 x 5.4. cm) together weighing 1,015 grams. DIAGNOSIS: Liver, right lobe, excision: Grade 3 (of 4) hepatocellular. carcinoma, usual type, forming a single mass (3. x 2.4 x 2.3 cm). The tumor is located in the right lobe. The hepatic capsule is free. of tumor. The surgical margins are free of tumor (free by 0.5 cm) . Extratumoral vascular invasion is identified. The tumor is not. encapsulated, infiltration of parenchyma being of pushing type. No. lymph nodes are identified. The gallbladder shows cholesterolosis,. otherwise unremarkeble. Non-neoplastic hepatic parenchyme will be. assessed in permanent sections. ADDENDUM: Non-neoplastic liver shows chronic hepatitis, consistent with. hepatitis C virus (HCV) infection, mildly active (grade 2 of 4). with portal and periportal fibrosis (stage 2) .

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Surgical Pathology Specimen Source (enter 1 per. line): #1 gallbladder (Order. Status (Last fupdated Date/Time). Accessioni #. Result Impression. Med. ReÃ§. #. (Age : Sex: Female. Soc. Sec. #: Visit # : Service Date: Client: Physician (s): FINAL PATHOLOGIC DIAGNOSIS. A. Left main bile duct, biopsy: Invasive adenocarcinoma. B. Right bile duct, biopsy: Bile duct epithelium with no significant. pathologic abnormality. C. Liver, left hepatectomy with caudate en bloc resection: Cholangiocarcinoma extending to left main bile duct margin with. extensive perineural and intraneural involvement; see comment. D. Extrahepatic bile duct, resection: No high-grade dysplasia or. carcinoma identified; see comment. E. Gallbladder, cholecystectomy: 1. Chronic cholecystitis. 2. Two benign lymph nodes (0/2) . F. Right hepatic artery lymph node, biopsy: One benign lymph node. COMMENT: Liver Tumor, Including Intrahepatic Bile Duct, Synoptic Comment. - Tumor type: Cholangiocarcinoma. Histologic grade: Moderately differentiated. - Tumor size (maximum diameter of largest lesion) : 3.3 cm. - Tumor necrosis: Less than 30%. - Multifocality (more than one tumor separated by nontumorous liver. parenchyma) : Absent. - Vascular invasion: None. - Hepatic capsule: Tumor abuts capsule. Local extension of tumor: Malignant glands are present in the wall of. the left main bile duct, but not in the surrounding adipose soft tissue. - Hepatic surgical margins: Negative; tumor is 1.5 cm from margin. - Bile duct margin (for cholangiocarcinoma) : Positive on slide C1. See. additional comments below. Non-neoplastic liver: Mass effect (portal-based inflammation, scant. lobular hepatocyte necrosis, enlargement of some intrahepatic bile. ducts, and periductal fibrosis; small portal tracts show mild ductular. proliferation). - Lymph node status: - Negative for tumor; total number of nodes examined: 3. - AJCC Stage: pT1NO. In part A (left main bile duct) atypical glands are seen invading. periductal nerve tissue. Level sections and immunohistochemistry for. keratin cocktail and S100 were performed and evaluated on block A1 to. further assess the atypical glands. The keratin cocktail shows diffuse. strong nuclear staining in the atypical glands. The S100 highlights the. nerves but does not stain the atypical cells involving the nerve tissue. This supports a diagnosis of invasive adenocarcinoma. In Part C (left hepatic resection) the hepatic parenchymal resection. margin is negative. Tumor is present in the left main bile duct margin. However, surgical correlation is required for final margin status as. additional tissue is submitted in Part D and the new common bile duct. margin in the additional tissue is negative. In Part C, sections of the hepatic mass show moderately differentiated. cholangiocarcinoma invading hepatic parenchyma and nerve tissue. One. area of the adenocarcinoma is better differentiated and has dilated,. angulated ducts closely resembling a large von Meyenburg complex. Immunohistochemical stains for p53, MIB-1, DPC-4, and glypican-3. were. performed on block C3 and compared in both areas. Both areas show weak. scattered nuclear p53 staining, no loss of DPC-4, and negative. Glypican-3. The mmoderately-differentiated area shows MIB-1 staining in. 30% of tumor nuclei and focally up to 50%, while the lower grade area. shows less than 5% MIB-1 nuclear staining. The morphologic appearance. and immunoprofile are most consistent with both areas being part of the. same. lesion. It is possible that the higher-grade area of the tumor. arose from this more ell-differentiated component at some point in. time. For part D, level sections were performed and evaluated on blocks D2 and. D5 (the extrahepatic bile duct). The levels do not show any high-grade. dysplasia or carcinoma. has reviewed parts A and D including additional. immunostains and levels and agrees with the above diagnosis for these. parts. Dr. has reviewed C3 and the MIB-1 immunostain and. concurs with its interpretation. Specimen (s) Received. A:Left main bile duct (FS). B:Right bile duct. C:Extended left hepatic resection with caudate and tumor. D:Extra hepatic bile duct (FS). E:Gallbladder. F:Right hepatic artery lymph node. Intraoperative Diagnosis. FS1 (A) Left main bile duct, biopsy: Atypical glands, most consistent. with invasive carcinoma. (Dr. FS2 (B) Right bile duct, biopsy: No in situ or invasive carcinoma. Epithelium predominantly denuded. (Dr. FS3 (D) Extrahepatic bile duct, biopsy: No in situ or invasive. carcinoma. (Dr. Clinical History. Relevant History:liver mass. The patient is a --year-old woman with a history of hepatic. adenocarcinoma (outside slides reviewed at. in consultation,. on biopsy of the left liver lobe. She undergoes a left hepatic. resection. Gross Description. The case is received in six parts, labeled with the patient's name and. medical record number. Part A is received fresh and additionally labeled ""left main bile duct,"". and consists of a single, donut-shaped fragment of white-tan soft tissue. (0.8 x 0.5 x 0.2 cm) with a 0.3 cm lumen and one inked surface. Per. discussion with the surgeon,. the inked surface is the most. proximal aspect, and the non-inked surrace is the true margin and most. distal surface. The entire specimen is frozen for frozen section. diagnosis 1 (inked surface side up), and subsequently submitted in. cassette A1. Part B is received fresh and additionally labeled ""right bile duct, up. is distal, "" and consists of an oriented, tubular segment of red-pink. soft tissue (0.5 x 0.3 x 0.2 cm in length) The specimen is submitted. for frozen section evaluation FS2 (cutting toward true margin), with the. frozen section remnant submitted in full in cassette B1. Part C. is received fresh and additionally labeled ""extended left. hepatic resection, caudate plus tumor, blue = bile duct, black = portal. vein,"" and consists of a partial hepatectomy (434 gm; 18.5 cm from right. to left x 5.3 cm from anterior to posterior x 12.8 cm from superior to. inferior; caudate lobe 6.2 x 3.7 x 3.1 cm). GROSS ABNORMALITIES: A white, circumscribed, firm mass with pushing. borders (3.3 x 3.1 x 4.5 cm) is present in the central portion of the. specimen and abuts the capsule on the visceral/posterior side. The. mass. invades into the left main bile duct, extends to the bile duct margin. grossly, and is located 1.5 cm from the inked hepatic resection margin. The mass also surrounds intraparenchymal blood vessels but does not. grossly invade into them. The intimal surfaces of these vessels and of. the portal vein are smooth and white. The uninvolved right liver lobe. is homogeneously red-brown and spongy-firm. The left lobe is attenuated. with dilated vessels. No gallbladder is present and no lymph nodes are. identified. ORIENTED BY: Surgeon's suture: Blue suture = left main bile duct,. black suture = portal vein. Also, per discussion with Dr. The specimen contains caudate. lobe and segment 8. INKING: - Liver capsule overlying mass: Blue. - Hepatic resection margin: Black. POTENTIAL STUDIES: Fresh tumor and uninvolved hepatic parenchyma are. submitted to the tissue bank. CASSETTES: Representative sections are submitted as follows: C1: Left main bile duct margin and neighboring portal. vein, en face. C2: Mass and left main bile duct. C3: Mass, portal vein and resection margin. C4-C5: Mass and overlying capsule. C6: Mass and large intraparenchymal vessels. C7: Uninvolved hepatic left lobe. C8-C9: Uninvolved hepatic right lobe. C10: Soft tissue near bile duct margin. Part D is received fresh and additionally labeled ""extrahepatic bile. duct, and consists of an oriented, branching, tubular structure (4 cm. in length x 1 cm in maximum diameter) . The specimen is oriented by the. surgeon with multiple stitches as follows: The cystic duct is tagged. with a double stitch, the right bile duct is tagged with a single black. stitch, and the left bile duct is tagged with a blue stitch. The common. bile duct is inked by the surgeon. Frozen section evaluation is. requested for the common bile duct margin. The common bile duct. contains a double-lumen structure (0.3 cm and 0.5 cm in diameter) The. cystic duct is 0.4 cm in length x 0. cm in diameter, the left bile duct. is 0.3 cm in length x 0.2 cm in diameter, and the right bile duct is 0.5. cm in length x 0.4 cm in diameter. Extending from the hepatic duct,. adjacent to the right bile duct, is a fragment of soft tissue measuring. 0.7 x 0.5 x 0.4 cm. No masses or lesions are noted. INKING: - Area adjacent to common bile duct surgical margin: Yellow, after the. frozen section has been removed. - Cystic duct resection margin: Blue. - Left bile duct resection margin: Black. - Right bile duct resection margin: Green. The surgeon designated common bile duct margin is submitted for frozen. section evaluation FS3 (designated extrahepatic bile duct biopsy) . CASSETTES: The specimen is entirely submitted as follows: D1: Frozen section remnant (FS3). D2: Right bile duct margin (inked) and adjacent slice. D3: Common bile duct adjacent to FS3 and remaining common. bile duct. D4: Cystic duct (inked) and adjacent cystic duct. D5: Left bile duct (inked) . D6: Hepatic duct at level' of cystic duct. Remainder of hepatic duct. D8: Attached soft tissue. Part E is received fresh and additionally labeled ""gallbladder, "" and. consists of a gallbladder (6.2 x 3 x 2.6 cm) The serosal surface is. tan-green, smooth and glistening. The surface opposed to the liver is. ragged and green-brown. The cystic duct is patent to the probe with a. diameter of 0.3 cm. Two firm, ovoid, red lymph node candidates (0.8 x. 0.5 x 0.4 cm and 0.5 x 0.3 x 0.3 cm) are identified near the cystic. duct. The gallbladder contains viscous green bile and its mucosa is. green and reticulated with numerous scattered punctate yellow spots (up. to 0.1 cm) No stones are identified. The gallbladder wall thickness. averages 0.1-0.2 cm. The cystic duct and surface opposed to the liver. are inked blue. Representative cassettes are submitted as follows: E1: Cystic duct margin and two intact lymph nodes. E2: Sections of body and fundus. Part F is received fresh and additionally labeled ""RT hepatic artery. lymph node, and consists of two unoriented, irregular, tan-white tissue. fragments with metal clips (1.9 x 1.3 x 0.5 cm and 0.7 x 0.6 x 0.2 cm). The specimen is submitted intact in cassette F1. The immunoperoxidase stain (s) reported above were developed and their. performance characteristics determined by the. Department of Pathology. They have not been cleared or approved by the. U. S. Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. These tests are used for. clinical purposes. They should not be regarded as investigational or. for research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of 1988 (""CLIA"") as qualified to. perform high-complexity clinical testing. Diagnosis based on gross and microscopic examinations. Final diagnosis. made by attending pathologist following review of all pathology slides. The attending pathologist has reviewed all dictations and preliminary. interpretations performed by any resident involved in the case and. performed all necessary edits before signing the final report. Pathology Resident. /Pathologist. Pathology PDF Report. Show images for Surgical Pathology Specimen Source (enter 1 per line): #1 gallbladder. Authorizing Provider Information. Date/Time. Result History. SURGICAL PATHOLOGY (Order. Surgical Pathology Specimen Source (enter 1 per line): #1 gallbladder (Order#. This is NOT a Requisition. Requisition hyperlink below. Surgical Pathology Specimen Source. (enter 1 per line): #1 gallbladder (Order. Authorizing: Pathology and Cytology. Released. Department: Images. Show images for Surgical Pathology Specimen Source (enter 1 per line): #1 gallbladder. Release Date/Time. Start Date/Time. End Date/Time. Release Information. Released On. Released Bv. Frequency. Duration. Priority. Once. 1 occurrence. Routine. Unit Collect. Question. Answer. Comment. COLLDATE. COLLTIME. Specimen Source (enter 1 per line). #1 gallbladder. liver mass. Lab Collection and Receipt Information. Collect Time. Collected By. Lab Receipt Date. Lab Receipt Time. Office. Pager/beeper E-mail. Authorizing Provider. Acknowledgement Info. For. At. Acknowledged By. Acknowledged On. Placing Order. Parent Status: Completed. (This order does not yet have any children). Surgical Pathology Specimen Source (enter 1 per line): #1 gallbladder (Order#.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
A: Soft tissue, ureteral carcinoma, menthelial NUS 8120/3. Diagnosis: margin, biopsy. - No tumor seen. B: Bladder and prostate, radical cystoprostatectomy. Bladder: Tumor histologic type: Invasive high grade urothelial carcinoma. with. squamous differentiation. Tumor histologic grade (WHO classification) : High grade. Microscopic tumor size (greatest dimension) : 6.0 cm by gross. examination. Microscopic extent of invasion: Into perivesicular soft tissues. Tumor site/focality of tumor: Unifocal, left wall, anterior. wall,. trigone and left ureterovesicular junction. Angiolymphatic space invasion: Focal hemangiovascular space. invasion. identified (B8) i negative for definite lymphovascular space. invasion. Associated epithelial lesions: Urothelial carcinoma in situ. Ureters: Negative. Histologic assessment of surgical margins : Ureter, left: Negative. Ureter, right: Negative. Urethra: Negative (FSA1; additional urethral en face section. from main. specimen shows few detached fragments of carcinoma within lumen,. negative for. definite stromal invasion or in situ carcinoma; superseded by. previous negative. frozen section result (FSA1). Paravesicular soft tissue: Negative but focally very close, left. lateral wall <0.1 cm (B7, B8), right anterior wall <0.1 cm (B9). Other significant findings: Right and left vas deferens. negative, moderate. to severe chronic cystitis, benign prostatic hyperplasia, acute. and chronic. prostatitis, prostate with no evidence of urothelial carcinoma. Lymph nodes: Separately submitted. Size and location of largest lymph node metastasis: N/A. Extracapsular extension: N/A. AJCC PATHOLOGIC TNM STAGE: pT3b pNO. NOTE: This pathologic stage assessment is based on information. available at the. time of this report, and is subject to change pending clinical. review and. additional information. Prostate: Tumor histologic type: prostatic adenocarcinoma. Tumor grade (Gleason system) : Gleason combined score 6 (3+3). Approximate percentage of prostate involved by tumor: right lobe. 2%. Extent of tumor: Location of tumor involvement in prostate: right lobe mid to. base. Confinement/non-confinement of tumor within the prostatic. capsule: confined. Location of extracapsular tumor involvement: not applicable. Type of extracapsular tissue involved within tumor: not. applicable. Lymphovascular space invasion: not identified. Seminal vesicles (invasion of muscular wall required) : negative. Histologic assessment of surgical margins: negative.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Information: Pancreatic cancer. Operative Procedure: Laparoscopic Whipple. Pre-Operative Diagnosis: Pancreatic cancer. A: whipple specimen - ( short black - panc. neck , long black - uncinate blue. - bile duct ) (FS). B: Gallbladder. C: portal lymph node. D: SMA tissue. Final Pathologic Diagnosis: A. Pancreas, Whipple resection: Specimen: Head of pancreas; Duodenum; Gallbladder. Procedure: Pancreaticoduodenectomy (Whipple resection);. Cholecystectomy. Tumor site: Pancreatic head. Tumor size: 3.1 X 2.1 X 1.1 cm (greatest dimensions). Tumor focality: Unifocal. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated (G2). Microscopic tumor extension: Tumor invades peripancreatic soft tissue and. duodenal wall. Margins. Margins uninvolved by tumor. Distance of tumor from closest margin: 4 mm. Specify margin: Uncinate. Lymph-vascular invasion: Not identified. Perineural invasion: Identified. Pathologic Staging (pTNM). TNM descriptors: none known. Primary tumor (pT): pT3. Regional lymph nodes (pN): pNo. Number examined: 21. Number involved: 0. Distant metastasis (pM): pMX. Additional pathologic findings: Chronic pancreatitis, duodenal ulcer. with. reactive changes, Submucosal lipoma of duodenum (2nd lesion noted in gross. description). B. Gallbladder, cholecystectomy: Chronic cholecystitis. Two lymph nodes, no evidence of malignancy (0/2). C. Lymph node, portal, resection: Two lymph nodes, no evidence of malignancy (0/2). D. SMA tissue, resection: No evidence of malignancy (2 lymph nodes). The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSA: Whipple: FSA1: Bile duct: Negative for carcinoma. FSA2: Uncinate: Negative for carcinoma. FSA3: Neck: Negative for carcinoma. F/S TAT: 33 mins. Gross Description: Received are four containers, all labeled with the patient's name. Part A is received fresh for frozen section diagnosis and additionally labeled. ""Whipple specimen, long black=uncinate, short black=pancreatic neck, blue=bile. duct.'. Specimen (components and dimensions): The specimen is the product of a Whipple. resection, previously sectioned, consisting of a 13.2 x 3.0 cm duodenum with. pancreatic head 4.7 cm in length and additional dimensions of 5.6 X 5.5 cm. Gallbladder: The gallbladder is submitted as a separate specimen (see part. B). Specimen inking pattern: Uncinate/retroperitoneal/posterior black, vascular. groove red, anterior-blue. (Please note the specimen has been previously inked. in focal areas: The bile duct inked blue, uncinate inked yellow, neck inked. black.). Tumor: Location: Pancreatic head. Size: 3.1 X 2.1 X 1.1 cm. Appearance: The tumor is white-tan to tan with ill defined borders and a. decrease in lobular architecture. The tumor is also firm. Gross impression of invasive growth: There is a biliary stent present in the. bile duct. After removal, the tumor appears to abut and obstruct the bile duct. The tumor appears to possibly abut the main pancreatic duct, however, there does. not appear to be any gross involvement and the pancreatic duct is of the usual. caliber. The tumor also appears to abut, but not grossly penetrate through the. vascular groove. Please defer to microscopic diagnosis. Resection margins (closest): Proximal duodenum or stomach: 2.1 cm. Distal duodenum: 7.4 cm. Bile duct: 2.9 cm. Pancreatic neck/duct: 2.3 cm. Uncinate/Retroperitoneum: 1.1 cm. Other findings: The attached portion of duodenum has a pink-tan to brown,. smooth and roughened serosal surface. There appears to be a 1.1 X 0.8 cm. transmural defect located 5.4 cm from the proximal end. Upon opening the. duodenum, the mucosa is pink-tan with the normal mucosal folds. The area of. transmural defect seems to the area opposing where the bile duct stent was. located. This could be a possible area of local trauma. There are two lesions. present on the duodenal mucosal surface. The first lesion is approximately 2.6. cm from the proximal duodenal margin. This lesion is concerning for possible. tumor. The lesion appears separate from the ampulla, located on the posterior. wall of the duodenum. This lesion has dimensions of 1.4 X 1.4 X 0.4 cm. The. lesion is pink-tan with raised borders with a central ulcerated area. Representative sections of the first lesion are placed in cassettes A14 and A15. The second lesion in the duodenum is approximately 4.6 cm from the proximal. surface, also located on the posterior wall of the duodenum. This lesion has. dimensions of 1.4 X 1.3 X 0.8 cm. This lesion is pink-tan with a smooth surface. The cut surface of this lesion is yellow-tan and homogeneous. Representative. sections of this lesion are placed in cassettes A16 and A17. The bile duct is removed and submitted for frozen section diagnosis (FSA1). The. tissue is resubmitted for permanent section in cassette A1. The uncinate margin. is shaved off and submitted for frozen section diagnosis (FSA2) and this tissue. is resubmitted for permanent section in cassette A2. The pancreatic neck is. shaved off and submitted for frozen section diagnosis (FSA3) and this tissue is. resubmitted for permanent section in cassette A3. Block List: A1. bile duct margin;. A2. uncinate margin;. A3. pancreatic neck margin;. A4. proximal duodenal margin;. A5. distal duodenal margin;. A6 ampulla;. A7. mass to vascular groove;. A8-10 representative sections of tumor;. A11. tumor to bile duct;. A12. tumor to pancreatic duct;. A13 tumor to uncinate;. A14-15. representative sections of first lesion in duodenum;. A16-17. representative sections from second lesion in duodenum;. A18. one possible lymph node bisected;. A19. one possible lymph node bisected;. A20. one possible lymph node submitted in toto;. A21. one possible lymph node bisected;. A22. one possible lymph node bisected;. A23. one possible lymph node bisected;. A24. one possible lymph node;. A25. one possible lymph node bisected;. A26. one possible lymph node;. A27. one possible lymph node;. A28. one possible lymph node;. A29. one possible lymph node;. A30. one possible lymph node;. A31. one possible lymph node;. A32. one possible lymph node;. A33. one possible lymph node;. A34. one possible lymph node;. A35. one possible lymph node;. A36. one possible lymph node bisected. Part B is received in formalin additionally labeled ""gallbladder"" and consists. of a gallbladder with overall dimensions of 5.9 x 2.5 x 1.7 cm. The surface is. purple-tan, smooth to roughened. There is a pericystic duct lymph node. identified, having a greatest dimension of 0.6 cm. Opening of the gallbladder. reveals a moderate amount of yellow-green markedly viscid bile. There are no. choleliths identified. The mucosa is pink-tan to brown with focal yellow. stippling. The thickness of the gallbladder wall is 0.3 cm. The cystic duct is. probe patent and appears slightly thickened. The usual sections are submitted in. a single cassette to include the pericystic duct lymph node. Part C is received in formalin additionally labeled ""portal lymph node"" and. consists of one pink-tan irregular fragment of soft tissue, having dimensions of. 1.3 X 0.8 x 0.3 cm. The specimen is submitted in toto in cassette C. Part D is received in formalin additionally labeled ""SMA tissue"" and consists of. two pink-tan irregular fragments of soft tissue, having dimensions of 1.6 X 0.7. X 0.4 cm and 1.9 x 0.5 X 0.3 cm. The specimen is submitted in toto in cassette. D. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Gender: M.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
LARGE INTESTINE TISSUE CHECKLIST. Specimen type: Colectomy. Specimen size: Not specified. Tumor site: Transverse colon. Tumor size: 2.5 X 4 X 3 cm. Tumor features: None specified. Histologic type: Mucinous adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Case ID Gross Description. Microscopic. Diagnosis. Description. Details. Comments. ICA ID. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 12 X 15 X 2.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma,. intestinal type. Histologic grade: Poorly. differentiated. Tumor extent: Adjacent structures. (specify) - Lesser omentum. Lymph nodes: 16/16 positive for. metastasis (Intraabdominal 16/16). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Not for Permanent Storage in Medical Records / Not Valid for Signing. sted by: Date of Service. Performing Facility. Result Provider. Report Name. PROCEDURE DATE: SPECIMEN DESCRIPTION: Right kidney. PRE-OPERATIVE DIAGNOSIS: Right renal mass. POST-OPERATIVE DIAGNOSIS: Same. CLINICAL INFORMATION: Same. GROSS DESCRIPTION: The specimen consists of a kidney with small amounts of attached perirenal. fat. The specimen weighs 253 g. It measures 12.5 X 7.4 X 4.5 cm in greatest. dimension. The capsule strips with ease. In the superior pole of the kidney,. there is a bulging mass. The kidney is bisected revealing a relatively well. circumscribed tumor mass which is yellow to grayish-brown in color with foci. of hemorrhage` and cyst formation. The tumor measures 5.0 X 3.6 X 4.0 cm in. greatest dimension. The renal pelvis and ureter are unremarkable. The renal. vessels appear to be widely patent. No tumor thrombi is identified grossly. Representative tissue is submitted in a total of eight cassettes. MICROSCOPIC DESCRIPTION: Sections from the renal mass show a clear cell carcinoma with some papillary. features. The malignant cells are present in sheets and also show tubule and. papillary formation. The cells show mild nuclear pleomorphism with some. nuclear enlargement. Occasional nuclei have distinct nucleoli. The cells. have moderate to abundant amounts of pale pink to clear cytoplasm. Some of. the cells lining the papillary structures appear to contain hemosiderin. pigment. The tumor shows several foci of calcification with the stroma. appearing hyalinized. The tumor is well demarcated from the adjacent. uninvolved renal tissue. The tumor does not extend to the capsule. There is. a thin rim of atrophic renal tissue between the tumor and the capsule. No. renal vein invasion is identified. The remaining renal parenchyma is. unremarkable. Sections from the pelvis and ureter show no significant. pathologic changes. The renal arteries show minimal intimal fibrosis. FINAL DIAGNOSIS: RIGHT RADICAL NEPHRECTOMY: RENAL CELL CARCINOMA, CLEAR CELL TYPE WITH CALCIFICATION AND FOCI OF. Not for Permanent Storage in Medical Records / Not Valid for Signing. ted by: Date of Service. Performing Facility. Result Provider. Report Name. PAPILLARY CHANGE, CONFINED TO THE KIDNEY. CODE 1,6. SUMMARY. PROCEDURE. Right radical nephrectomy. TUMOR LOCATION: Upper pole. TUMOR SIZE: 5.0 X 3.6 X 4.0 cm, tumor confined to the. kidney. NUCLEAR GRADE: II. PATHOLOGIC STAGING: T1,NX.M). MARGINS: Not involved. ADRENAL GLAND: Not identified. M.D. (Electroni.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
eck. Neck. Clinical Diagnosis & History: FNA left lobe. Specimens Submitted: 1: Total thyroid. DIAGNOSIS: 1. Total thyroid: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 1.2 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyrolditis. Parathyroid Glands: Not identified. Lymph Nodes: Four benign lymph nodes (0/4). LATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: b. 1. The specimen is received fresh labeled ""total thyroid"" and consists of a thyrold weighing 18.0 g. The right lobe measures 5.5. x. 3.0 x 0.9 cm, the left lobe measures 4 x 2x1 cm and the isthmus measures 2 x 1.5 x 0.6 cm. The external surface is covered by a. thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning of the left. lobe reveals a 1.2 CM light brown nodule with central cystic degeneration, located at the upper pole of the left lobe and abutting the. thyroid capsule. Sections through the right lobe reveal red tan and beefy thyrold parenchyma with a vague nodularity (gelatinous. fleshy nodules). The isthmus is red tan and beefy. Representative sections of the specimen (left lobe nodule) are submitted for. TPS. The remaining tissue is serially sectioned and representatively submitted. Summary of sections: N - nodule, entirely submitted. LL left lobe. RL right lobe. IS isthmus. Summary of Sections: Part 1: Total thyroid. Block. Sect. Site. PCs. 1. IS. 1. 1. LL. 1. 2. N. 2. 2. RL. 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: A. ""Gallbladder."" Length and greatest diameter: 9.5 X 2.1cm. Serosa: Smooth. Wall. thickness: 0.2 cm. Mucosa: Slightly granular. Cystic duct: Dilated. Stones: None. Lymph nodes: One. B. ""SMV lymph node."" Received is a 0.8 cm firm lymph node. C. ""Head o. Microscopic Description: Specimen resection type: Head/body/tail pancreas, duodenum, stomach,. common bile duct, gallbladder. Procedure: Pancreaticoduodenectomy. Tumor location:Head. Tumor. size (greatest dimension): 4.5 cm Histologic type: Ductal adenocarcinoma. Histologic grade: Poorly. differentiated (<50%). Microscopic Tumor Extension: Carcinoma in situ, tumor confined to pancreas. Surgical margins: Distal pancreas margin: Free of neoplasm. Common bile duct margin: Free of. neoplasm. Distal stomach/duodenum margin: Free of neoplasm. Retroperitoneal margins: Free of. neoplasm. Angiolymphatic spread: No Perineural spread: Yes Treatment effect: No prior treatment. TNM-Staging: pT2 pNO pMX LYMPH NODES: pNO Peripancreatic, superior: 0 of 4 contain metastases. Peripancreatic, inferior: 0 of 7 contain metastases Pancreaticoduodenal, anterior: 0 of 10 contain. metastases Pancreaticoduodenal, posterior: 0 of 13 contain metastases Distant metastasis: pMX. Other findings: Fibrosis, chronic pancreatitis, islet cell hyperplasia Other organs (if present): Gallbladder: Unremarkable Duodenum: Unremarkable Gastric antrum: Unremarkable LYMPH NODE. (PERIMESENTERIC VEIN): 1 LYMPH NODE NEGATIVE FOR METASTASES. ROUND LIGAMENT: NEGATIVE. FOR NEOPLASM. Diagnosis Details: Pancreas: Adenocarcinoma without lymp node metastases. Comments: B. LYMPH NODE(SMV): NEGATIVE FOR CARCINOMA. C. PANCREATIC DUCT MARGIN #1: ATYPICAL GLANDS, SUSPICIOUS FOR MALIGNANCY, DEFER TO. PERMANENTS. D. Formatted Path Reports: PANCREAS TISSUE CHECKLIST. Specimen type: Whipple resection. Tumor site: Head. Tumor size: 4.5 X 3.5 x 2 cm. Histologic type: Ductal adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Lymph nodes: 0/34 positive for metastasis (Peripancreatic superior, peripancreatic inferior, 0/34). Lymphatic invasion: Absent. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: None. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/POST-OP DIAGNOSIS: Squamous cell carcinoma of right tongue. PROCEDURE: Right neck dissection. SPECIFIC CLINICAL QUESTION: Check margin. OUTSIDE TISSUE DIAGNOSIS: Yes, squamous cell carcinoma. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: TONGUE, RIGHT LATERAL, PARTIAL GLOSSECTOMY -. A. INVASIVE SQUAMOUS CELL CARCINOMA, KERATINIZING, MODERATELY DIFFERENTIATED (2.8 CM, 0.6 CM. THICK), INFILTRATIVE BORDER. B. FOCAL PERINEURAL INVASION PRESENT. C. NO ANGIOLYMPHATIC INVASION. D. MARGINS FREE OF TUMOR (SEE ALSO PARTS 2 THROUGH 4). E. PATHOLOGIC STAGE: pT2, No. PART 2: TONGUE, MEDIAL, EXCISION -. NO TUMOR PRESENT. PART 3: TONGUE, LATERAL, AND FLOOR OF MOUTH, EXCISION -. NO TUMOR PRESENT. PART 4: SOFT TISSUE, DEEP MARGIN, EXCISION -. NO TUMOR PRESENT. PART 5: LYMPH NODES, RIGHT NECK LEVEL 1, SELECTIVE DISSECTION --. A. FOUR LYMPH NODES, NO TUMOR PRESENT (0/4). B. SUBMANDIBULAR GLAND WITH CHRONIC SIALADENITIS. PART 6: LYMPH NODES, RIGHT NECK LEVELS 3 AND 4, SELECTIVE DISSECTION -. EIGHT LYMPH NODES, NO TUMOR PRESENT (0/8). PART 7: LYMPH NODES, RIGHT NECK LEVEL 2B, SELECTIVE DISSECTION -. ONE LYMPH NODE, NO TUMOR PRESENT (0/1). PART 8: LYMPH NODES, RIGHT NECK LEVEL 2, SELECTIVE DISSECTION -. three LYMPH NODES, NO TUMOR PRESENT (0/3). COMMENT: Anciliary studies will be performed and reported as an addendum. My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in seven parts. Part 1 is labeled with the patient's name, medical record number, initia. and ""right lateral tongue, stitch anterior"". It consists of. a partial glossectomy, 3.4 x 2.5 X 0.9 cm. There is a 2.8 X 2.1 x 0.6 cm ulcerated raised, well-circumscribed, firm mass. It is 0.7. cm from the posterior margin, 0.6 cm from inferior margin, 0.5 cm from superior margin, and 0.3 cm from anterior margin. On cross. section, the tumor is 0.4 cm from the deep margin. Anterior margin is inked black and the posterior margin is inked green. Other. margins are sampled in Parts 2 through 4. Representative tumor is banked for. Banked area. is inked red. Representative midline cross section, including radial anterior, deep and posterior margin is taken for frozen. section. Section code: 1AFS- representative midline cross section, frozen section. 1B-E- remainder of specimen serially cross sectioned. Part 2 is labeled with the patient's name, initials. and ""medial tongue, stitch anterior"". It consists of a strip of tan-pink wrinkled. mucosa with underlying pink-red cauterized soft tissue 4.5 x 0.4 x 0.3 cm. Stitch marks anterior. The anterior resection margin. (site of stitch) is inked with blue dye. The entire specimen is submitted for intraoperative frozen section consultation. The. remalning frozen section tissue is submitted labeled 2AFS. Part 3 is labeled with the patlent's name, initials. and ""floor of mouth lateral tongue"". It consists of two portions of tan-pink,. focally cauterized, soft lissue 0.6 x 0.4 x 0.3 cm and 2.4 x,0.5 x 0.3 cm respectively. After intraoperative frozen section. consultation the tissue is submitted labeled 3AFS. Part 4 is labeled with the patlent's name, initials and ""deep margin"" It consists of a portlon of pink-red, roughened, cauterized,. soft tissue 2.0 X 0.5 x 0.4 cm. After intraoperative frozen sectlon consultation the tissue is submitted labeled 4AFS. Part 5 is labeled with the patient's name, initials and ""right neck level l"". It consists of soft yellow-red lobular fibroadlpose tissue. with a partially embedded submandibular gland 8.0 x 4.0 x 1.3 cm in overall dimensions. The submandibular gland is grossly intact, ovoid pale yellow to tan and lobular 4.0 x 2.2 x 1.2 cm. No gross suspicious leslons are. identified. Occasional ovold soft tan-pink lymph nodes ranging 0.3 to 0.6 cm in greatest dimension are identifled within the fibrofatly tissue. Section code;. 5A- submand|bular gland, representative section. 5B- intact lymph node. Part 6 is labeled with the patient's name, initials. and ""right neck level III and IV"". It consists of a fragment portion of soft, yellow-. red, lobular fibroadipose tissue 8.0 x 3.4 X 0.7 cm. The specimen is divided into halves and on dissection multiple ovoid soft tan-. pink lymph nodes ranging 0.2 to 1.3 cm in greatest dimension are identified. Section code: 6A-lymph nodes one half of specimen. 6B- lymph nodes remaining half of specimen. Part 7 is labeled with the patient's name, initials. hd ""right neck level IIB"". It consists of a 2.7 X 2.3 x 0.5 cm portion of soft,. yellow-red, lobular, focally cauterized fibroadipose tissue containing two soft pink lymph nodes each 0.2 cm in greatest dimension. Section code: 7A- yymph nodes (2). Part 8 is labeled with the patient's name, initials. ""right level II"". It consists of a 3.3 x 3.3 x 0.9 cm portion of soft, yellow-red,. lobular, focally cauterized fibroadipose tissue containing three ovoid tan-pink soft lymph nodes 0.3, 1.5 x 1.6 cm in greatest. dimension respectively. Section code: 8A- intact lymph nodes (2). 8B- intact lymph node (1). INTRAOPERATIVE CONSULTATION: 1A: RIGHT LATERAL TONGUE, RADIAL ANTERIOR (BLACK), AND POSTERIOR (GREEN) MARGINS (frozen sectlon) -. A. MALIGNANT. B. SQUAMOUS CELL CARCINOMA. C. DEEP AND POSTERIOR MARGINS ARE FREE OF CARCINOMA, CARCINOMA IS 0.2 CM FROM ANTERIOR MARGIN. 2A: MEDIAL TONGUE (frozen sectlon) -. A. BENIGN. B. NO TUMOR SEEN. 3A: FLOOR OF MOUTH (frozen section) -. A. BENIGN. B. NO TUMOR SEEN. 4A: DEEP MARGIN (frozen section) -. A. BENIGN. B. NO TUMOR SEEN. MICROSCOPIC: Microscopic examination substantlates the above dlagnosis. The following statement applies to all Immunohistochemistry, insitu hybridization (ISH & FISH), molecular anatomic pathology, and. immunofluorescence testing: The testing was developed and its performance characteristics determined by the. Department of Pathology, as. required by the. regulations. The testing has not been cleared or approved for the specific use by the U.S. Food and Drug. Administration, but the FDA has determined such approval is not necessary for clinical use. Tissue fixation ranges from a minimum of. to a maximum of. This laboratory is certified under the Clinical Laboratory Improvement Amendments of. (""CLIA"") as qualified to perform high-. complexity clinical testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory have been established and verified for. accuracy and precision. Additional information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY GLAND TUMORS. SPECIMEN TYPE: Resection: PARTIAL GLOSSECTOMY. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension: 2.8 cm. Additional dimensions: 0.6 THICK cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PRIMARY TUMOR (pT): pT2. REGIONAL LYMPH NODES (pN): pNO. Number of regional lymph nodes examined: 16. Number of regional lymph nodes involved: 0. DISTANT METASTASIS (pM): pMX. MARGINS: Margins uninvolved by tumor. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Absent. PERINEURAL INVASION: Present. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Right Lateral Tonque. Stitch Anterior. Stain/cht. BIOCK. H&E x 1. B. H&E x 1. C. H&E Recut x 1. D. IHPV: x I. D. cmet x 1. D. IEGFR x 1. D. IBNKNC x 1. IBNKNC x 1. D. IBNKNC x |. D. IBNKNC x I. D. IBNKNC x 1. D. IBNKNC x 1. D. H&E x 1. D. P16 x 1. D. V-EGFR x 1. D. H&E x I. E. H&E x |. AFS. Part 2: Medial tongue, Stitch Anterior. Stain/cnt. Block. H&E x 1. AFS. Part 3: Floor of Mouth, Lateral Tonque. Stain/cht. Block. H&E x 1. AFS. Part 4: Deep Margin. Stain/cht. Block. H&E x 1. AFS. Part 5: Right Neck Level 1. Stain/cht. BIOCK. H&E X 1. A. H&E X 1. B. Part 6: Right Neck Level 3 and 4. Stain/cht. Block. H&E X 1. A. H&E x 1. B. Part 7: Right Neck 1 level 2R. Stain/cht. Block. H&E X 1. A. Part 8: Right Level 2. Stain/. DIOCK. H&E X 1. A. H&E x 1. B. ICD-9 Diagnosis Codes: (None Entered}. 3 of 5.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
De-Identified Specimen Code: M. SPECIMEN SUBMITTED: Part A: POSTERIOR SEGMENT RIGHT. UPPER LOBE. Part B: LEVEL 10 R. Final Diagnosis. 1. Right lung, upper lobe, wedge excision (A) Adenocarcinoma, solid predominant (40%) with. acinar (40%), and lepidic (20%) patterns. - Mild centrilobular emphysema. - See comment. 2. Lymph node, level 10R, excision (B) Hylanized lymph node, negative for neoplasm. Diagnosis Comment: 1. The tumor measures 1.6 cm in greatest dimension. No invasion into or through the pleural is seen. The. parenchymal margin of excision is negative for neoplasm. Further studies to define the origin of this. adenocarcinoma will be performed and the results of those studies reported as an addendum. Intraoperative Diagnosis: A. Adenocarcinoma. Margin negative. Clinical Diagnosis: LUNG NODULES. Gross Description: A. Received fresh for frozen section diagnosis labeled ""posterior segment right upper lobe"" is a wedge. of lung measuring 14.8 X 5.2 x 2.7 cm, and weighing 39.1 grams. A staple line is present and inked. orange. The pleural surface displays a puckered area measuring 1.2 X 0.8 cm and is located 3.2 cm. from the orange inked parenchymal margin. The remainder of the pleural surface is smooth and. glistening. The puckered area is inked blue. Upon sectioning, a stellate tan-gray firm nodule is identified. in the puckered region measuring 1.6 X 1.2 X 1.0 cm, and extending within 2.7 cm of the parenchymal. line of resection and appears to extend into, but not through the pleura. The remainder of the. parenchyma is unremarkable. Other masses, lesions, nodules are not present. The mass is totally. submitted. The nodule is totally submitted as follows: A1 nodule with closest pleural involvement, A2. perpendicular line of resection representative section, A3-A5 nodule with pleural surface, A6 remainder. of nodule totally submitted, A7 additional representative section of parenchymal margin, A8. representative section of apparent uninvolved tissue. B. Received fresh is a tan-black nodule resembling lymph node measuring 0.4 X 0.3 X 0.2 cm. The. specimen is not sectioned. Totally submitted in one cassette. Microscopic: {Not Entered}.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Site : Liver (22.0. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder @. B. Segment 4/5 liver @. c. Final margin @. Clinical Information. Hx. htc and hep B. Diagnosis. A. Gallbladder, Cholecystectomy: Negative for malignancy. B. Liver, Segment 4/5, Resection: Well differentiated hepatocellular carcinoma, 4.4 x 2.7 x 2.3 cm. 0.1 cm to the blue inked specimen margin. Background liver show portal inflammation and steatosis (20%). c. Final Margin, Biopsy: Liver parenchyma, negative for hepatocellular carcinoma. Verified: Gross Description. Received are specimen containers A to C. All remisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers are. labelled with the Surgical Number. A. Specimen is received in formalin. The container is designated ""gallbladder @. The specimen consists of a non-intact gallbladder measuring 6.8 x 2.3 x 1.2 cm. The. serosal surface appears smooth and unremarkable. The lumen contains green bile and no. calculi, and the cystic duct appears patent. The mucosa is granular, and the wall. averages 0.2 cm in thickness. The cystic duct lymph node is identified and measures 0.6. cm in greatest dimension. Representative sections of the gallbladder are submitted in. A1. The entire lymph node is bisected and submitted in A2. B. Specimen is received fresh and is submitted in formalin. The container is. designated. ""segment 4/5 liver @. The specimen consists of an 81.3 g partial hepatectomy. specimen measuring 6.4 x 6.2 x 5.6 cm. The capsular surface appears smooth and. unremarkable. Roughened surgical resection margin is dyed with blue ink. The specimen. is serially sectioned to reveal a well circumscribed, ovoid mass which has lobular. features on cut surface. This mass measures 4.4 x 2.7 x 2.3 cm and grossly comes right. to the capsular surface, but does not grossly appear to invade the surface and to within. 0.1 cm of the blue inked surgical resection margin. No other lesions are grossly. identified. B1-B3. representative sections of the tumor and grossly closest point of invasion. to both capsular. surface and blue inked surgical resection margin. B4. further representative .section of the tumor. B5. representative section of normal liver adjacent to the liver. Specimen is received fresh and submitted in formalin. The container is designated. final margin. and consists of a single, soft, dark tan, triangular portion of. tissue measuring 1.5 x 1.0 x 0.7 cm. Surgical resection margin is grossly identified. which is dyed with blue ink. The specimen is serially sectioned and submitted in toto. in. one block. Pathologist Comment. Case seen in review by. Encounter Number. Patient Location.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Pathology. port. Pathology,. Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA (4.5 CM). TUMOR CONFINED WITHIN THYROID TISSUE. No extracapsular extension identified. Unremarkable parathyroid tissue, no tumor present. One lymph node, no tumor present. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - A total thyroidectomy with overall measurements, 8.0 x 5.0 x 3.5 cm. The right lobe appears. unremarkable and measures 4.0 x 3.0 x 1.0 cm and mostly appears fibrotic. The left lobe measures 6.0 X 5.0 X 3.5 cm and. contains well-defined friable light tan and soft mass measuring 4.5 x 4.0 x 3.0 cm. The tumor abuts the external surface and the. capsule of the lobe. No gross involvement of the surgical margin, but tumor is noted. The tumor also appears friable and. papillary in nature. The specimen is submitted entirely in A1-A5, sequential sectioning of the right lobe from superior to inferior;. A5, A6, isthmus; A8-A22, sequential sectioning of the left lobe from superior inferior including tumor and adjacent soft. tissue. CLINICAL HISTORY. History of papillary thyroid cancer. SNOMED CODES. T-B6000, M-80503. Released by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
with left lower lobe mass which is biopsy proven to be squamous cell. carcinoma. PRE OP DIAGNOSIS: Lung cancer. POST OP DIAGNOSIS: Same. PROCEDURE: Bronchoscopy. mediastinoscopy, left lower lobectomy. FINAL DIAGNOSIS. Summary Statement. The left lower lobe neoplasm is a poorly differentiated invasive squamous cell carcinoma (5.0 X 5.0 x 4.0 cm). with extensive necrosis. The vascular, bronchial and parenchymal surgical resection margins are free of tumor. However, the tumor extends to the visceral pleural margin. The lymph nodes are negative for metastatic. carcinoma. The stage is: T2N0MX. PART 1: LYMPH NODE, RIGHT LEVEL 4, EXCISION. FRAGMENTS OF BENIGN REACTIVE LYMPH NODE WITH NO CARCINOMA SEEN. PART 2: LYMPH NODE, LEFT LEVEL 4. EXCISION. FRAGMENTS OF BENIGN REACTIVE LYMPH NODE WITH NO CARCINOMA SEEN. PART 3: PRETRACHEAL LYMPH NODE, LEVEL 3, EXCISION. FRAGMENTS OF BENIGN REACTIVE LYMPH NODE WITH NO CARCINOMA SEEN. PART 4: LYMPH NODE, SUBCARINALI. EXCISION. TWO (2) BENIGN REACTIVE LYMPH NODES WITH NO CARCINOMA SEEN. PART 5: LYMPH NODE, 11, EXCISION. ONE (1) BENIGN REACTIVE LYMPH NODE WITH NO CARCINOMA SEEN. PART 6: PLEURAL, CHEST WALL, EXCISION. PARIETAL PLEURA WITH MODERATE CHRONIC INFLAMMATION BUT NO CARCINOMA SEEN. PART 7: LUNG, LEFT LOWER LOBE, LOBECTOMY. A. INVASIVE, POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA (5.0 X 5.0 X 4.0 CM) WITH. EXTENSIVE NECROSIS. B. TUMOR EXTENDING TO VISCERAL PLEURAL MARGIN. C. BRONCHIAL AND VASCULAR RESECTION MARGINS FREE OF TUMOR. D. SEVEN (7) PERIBRONCHIAL LYMPH NODES NEGATIVE FOR METASTATIC TUMOR. E. BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGES AND AIRSPACE ACCUMULATION OF. SMOKER' S MACROPHAGES. F. STAGE: T2, NO, MX. PART 8: LYMPH NODE, SUMP NODE, EXCISION. BENIGN REACTIVE LYMPH NODE WITH NO CARCINOMA SEEN. COMMENT. (Not Entered}. GROSS DESCRIPTION. The specimen is received fresh and in eight parts. Part 1 labeled ""right level 4 lymph node"" consists of multiple portions of tan and anthracotic lymphoid tissue, 0.5. to 0.7 cm in greatest dimension, entirely submitted in sections ""1A"" through ""1C"". Part 2 labeled ""left level 4 lymph node"" consists of three, irregular portions of tan and anthracotic lymphoid. tissue, 0.3 to 0.8 cm in greatest dimension, entirely submitted labeled ""2A"". Part 3 labeled ""pretracheal level 3 lymph node"" consists of multiple portions of tan and anthracotic lymphoid. tissue, 0.3 to 0.5 cm in greatest dimension, entirely submitted following frozen section evaluation, labeled ""3A"". Part 4 labeled ""subcarinal lymph node"" consists of three, irregular portions of anthracotic, soft, lymphoid tissue,. 0.3 to 0.7 cm in greatest dimension, entirely submitted labeled ""4A"". Part 5 labeled ""number 11 lymph node"" consists of a single, encapsulated, anthracotic node, 1.0 cm in greatest. dimension, bisected and entirely submitted labeled ""5A"". Part 6 labeled ""chest wall pleura"" consists of a 1.5 x 1.0 X 0.7 cm of pink to hemorrhagic, soft to rubbery tissue,. entirely submitted following frozen section evaluation labeled ""6A"" and ""6B"". uts. Part 7 is labeled ""left lower lobe"" and consists a 450 gram lung lobectomy, measuring 17.0 X 16.0 X 7.0 cm.,. with an irregular tan anthracotic pleural surface and a 5.0 x 5.0 X 4.0 cm. palpable mass umbilicating the pleura. at the posterior/lateral aspect. On cross-section, the tumor is irregular, grey-white and soft, not grossly. infiltrating bronchus. The surrounding uninvolved lung parenchyma is tan to anthracotic. No satellite lesions. are seen. The hilar structures and lymph nodes are grossly free of tumor. Representative tissue is frozen in. bulk. The following sections are submitted: 7A Bronchial resection margin following frozen section evaluation. 7B Vascular resection margin. 7C Hilar lymph node. 7D and 7E Tumor with relation to pleural surface. 7F and 7G Tumor and adjacent normal. 7H and 71 Parenchymal resection margins with ink. Part 8 is labeled ""sump node"" and consists of a 1.2 x 1.0 X 0.4 cm. anthracotic lymph node which is entirely. submitted labeled 8A. P.7,8 ncs. MICROSCOPIC DESCRIPTION. SYNOPTIC PRIMARY LUNG TUMORS. A.Location: 4. 1. RUL. 3. RLL. 5. LUL. 2. RML. 4. LLL. 6. Bronchus intermedius. B.Procedure: 2. 1.Wedge/Segmental. 3. Bilobectomy. 2.Lobectomy. 4. Pneumonectomy. C.Size of tumor (maximum dimension): 5 cm. D.Satellite nodules: 2. 1. yes. 2, no. E.Type: 1. 1.Invasive squamous carcinoma. 9. Sarcomatoid carcinoma. 2. Basaloid squamous carcinoma. 10. Blastoma. 3.Invasive adenocarcinoma. 11. Fetal type adenocarcinoma. 4.Bronchioloalveolar carcinoma, nonmucinous type. 12. Oat cell carcinoma. 5.Bronchioloalveolar carcinoma, mucinous type. 13. Carcinoid. 6.Large cell carcinoma. 14. Atypical carcinoid. 7.Clear cell carcinoma. 15. Sarcoma. 8.Glant cell carcinoma. 16. Other. F.Grade: 3. 1. well. 2. moderate. 3. poor/undifferentiated. G.Bronchogenic (versus parenchymal) origin: 1. 1. yes. 2. no. H.Visceral pleural invasion: 1. 1. yes. 2. no. I.Parietal pleural invasion: 2. 1. yes. 2. no. J. Chest wall invasion: 2. 1. yes. 2. no. K.Angiolymphatic invasion: 2. 1. yes. 2. no. L.Surgical margins involved: 2. 1. yes. 2. no. M.Inflammatory (desmoplastic) reaction: 2. 1. mild. 2. moderate. 3. severe. N.Hilar lymph node involvement: 2. 1. yes. 2. no. O.If hilar lymph nodes involved. P.Mediastinal nodes involved: 2. 1. yes. 2. no. 3. not applicable. Q.Mediastinal node group(s) involved: 1. Level 4R. 4. Level 7R. 7. Level 4L. 10. Level 7L. 2. Level 5R. 5. Level 9R. 8. Level 5L. 11. Level 9L. 3. Level 6R. 6. Level 10R. 9. Level 6L. 12. Level 10L. R.Underlying disease(s): 1. 1. Emphysema. 3. Tumorlets. 5. Asthma. 2. Bronchiectasis. 4. Smokers bronchiolitis. 6. Parenchymal scar. S. TNM Stage: T 2. M 1 X. INTRAOPERATIVE DIAGNOSIS. PART 1: RIGHT LEVEL 4 LYMPH NODES, BIOPSY (frozen section). A. BENIGN. B. NO TUMOR SEEN. PART 2: LEFT LEVEL 4 LYMPH NODE (frozen section). A. BENIGN. B. NO TUMOR SEEN. PART 3: PRETRACHEAL LEVEL 3 NODE (frozen section) -. A. BENIGN. B. NO TUMOR SEEN. PART 4: SUBCARINAL LYMPH NODES (frozen section) -. A. BENIGN. B. NO TUMOR SEEN. PART 6; CHEST WALL PLEURA (frozen section) -. A. BENIGN. B. NO TUMOR SEEN. uts. PART 7: LEFT LOWER LUNG, BRONCHIAL MARGIN (Frozen section). A. BENIGN. B. NO TUMOR SEEN.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: Lung up to 23x14x6 cm in size, with white dense tumor up to 5x3 cm in size. Microscopic Description: Squamous non-keratinizing carcinoma of the lung, G2. Five bronchopulmonary lymph nodes demonstrated reactive changes. Fragment of the bronchus is of normal structure. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: Localized, NOS, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 3 x0x5cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/5 positive for metastasis (Bronchopulmonary 0/5). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Left-lower.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
;urgical Pathology. TISSUE DESCRIPTION: A1 A2 A3 A4 A5 J1 K1 K2 B1 C1 C2 C3 C4 C5 C6 D1 D2 E1 F1. F2 G1 H1 H2 H3 H4 H5 H6 Il. Right middle/lower lobes lung (295.0 grams), tissue from right lung. fissure (0.4 x 0.4 x 0.3 cm), station 2R lymph nodes, station 4R. lymph nodes (2 sets), station 7 lymph nodes (2 sets) station 9R. lymph nodes, station 10R lymph nodes, bronchus intermedius lymph. nodes, right upper lobe lung superior pulmonary vein lymph node. DIAGNOSIS: Lung, right middle and lower lobes, bilobectomy: Invasive grade 4. (of 4) adenocarcinoma, forming a well-circumscribed 1.6 x 1.5 x 1.5. cm cm subpleural mass. visceral pleural invasion is absent. Angiolymphatic invasion is present. The bronchial margin is. negative for tumor (by 8.2 cm). with available surgical material,. AJCCpT1pN2. Lung, right fissure, biopsy: Grade 4 (of 4) adenocarcinoma. Lymph nodes, intrapulmonary/hilar, excision: Metastatic adenocarcinoma is identified in multiple (3 of. 4) intrapulmonary peribronchial lymph nodes. Extranodal extension. is identified and extends through the major fissure. No tumor is identified in a single (1) right hilar. (station 10R) lymph node. Lymph nodes, mediastinal, excision: Metastatic adenocarcinoma is identified in a single (1 of. 21) right lower paratracheal (station 4R) lymph node. Metastatic adenocarcinoma is identified in a single (1 of. 18) subcarinal (station 7) lymph node. No tumor is identified in multiple (5) right upper. paratracheal (station 2R) lymph nodes. No tumor is identified in multiple (2) right pulmonary. ligament (station 9R) lymph nodes. Lymph nodes, bronchus intermedius, excision: Metastatic. adenocarcinoma is identified in a single (1 of 3) bronchus. intermedius lymph nodes. Lymph nodes, right upper lobe lung superior pulmonary vein,. excision: A single (1) right upper lobe lung superior pulmonary vein. lymph node is negative for tumor.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis and History: Multicentric DCIS and invasive cancer of left breast (mass at. 12:00 and DCIS on core biopsy 9:00) . Specimens Submitted: 1: SP: Sentincl node #1, level 1, left axilla. 2: SP: Sentinel node #2, level 1, left axilla. 3: SP: Sontinel node #3, level 1, left axilla. 4: SP: Sentinel node #4, level 1. left axilla. 5: SP: Non-sentinel node, left axilla. 6: SP: Left total mastectomy (. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPK NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS will BE REPORTED IN AN ADDENDUM. 2). LYMPH NODE, SENTINEL #2, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS WILL BE REPORTED IN AN ADDENDUM. LYMPH NODE, SENTINEL #3, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS WILL BE REPORTED IN AN ADDENDUM. 4). LYMPH NODE, SENTINEL #4. LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - DEEPER LEVEL RECUTS AND SPECIAL STAINS HAVE BEEN ORDERED. THE RESULTS WILL BE REPORTED IN AN ADDENDUM. 5). LYMPH NODE, NON-SENTINEL, LEFT AXILLA; EXCISION: ONE BENIGN LYMPH NODE (0/1). 6). BREAST; LEFT; TOTAL MASTECTOMY: - IN-SITU AND INVASIVE PAPILLARY CARCINCMA. - THE TUMOR MEASURES 3 CM IN GREATEST DIMENSION. SINCE THE. TUMOR GROWS AS LARGE BROAD FRONTS, IT IS NOT POSSIBLE TO. ASSESS THE EXTENT OF INVASION. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED,. SOLID/CRIBRIFORM TYPES, WITH INERMEDIATE NUCLEAR GRADE. - THE INVASIVE CARCINOMA IS LOCATED IN THE CENTRAL/ SUPERIOR. 11. AREA. - THE DCIS IS LOCATED IN THE CENTRAL/SUPERIOR AREA AND. MEDIAL ASPECT AT THE PREVIOUS BIOPSY SITE. NO INVOLVEMENT OF THE NIPPLE BY EITHER IN-SITU OR INVASIVE. CARCINOMA IS IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN THE IN-SITU CARCINOMA AND IN. BENIGN BREAST PARENCHYMA. - NO VASCULAR INVASION IS NOTED. INVASIVE CARCINOMA IS 0.3 CM FROM THE NEAREST (SUPERIOR). MARGIN. - DUCTAL CARCINOMA IN-SITU IS 0.3 CH FROK THE NEAREST. (SUPERIOR) MARGIN. NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE IS UNREMARIABLE. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE. CHANGES, FIBROCYSTIC CHANGES, BENIGN PAPILLOMAS AND. SCLEROSING ADENOSIS. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL EE. REPORTED AS AN ADDENDUM. NOTE: DR. BROGI HAS REVIEWED SELECTED SLIDES AND CONCURS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION. OF THE SLIDES (AND/OR OTHER. MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED THIS REPORT. Special Studies: stain/Procedure Name. Comment. AE1:AE3. NEGATIVE. KERATIN (CAM5.2). NEGATIVE. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. AE1:AE3. NEGATIVE. KERATIN (CAM5.2). NEGATIVE. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. IMMUNO RECUT. Canceled. AE1:AE3. NEGATIVE. KERATIN (CAMS.2). NEGATIVE. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. AE1:AE3. NEGATIVE. KERATIN (CAMS.2). NEGATIVE. 11. page 3 or b. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. ESTROGEN RECEPTOR. POSITIVE. PROGESTERONE RECEPTOR. POSITIVE. HER2-C. NEGATIVE. INTENSITY o. NEGATIVE CONTROL. IMMUNO RECUT. SYNAPTOPHYSIN. CHROMOGRAUNIN. MIB-1 (xi-67). RECUT ADDITIONAL HE. CALPONIN. NEGATIVE CONTROL. Canceled. IMMUNO RECUT. Canceled. NEGATIVE CONTROL. IMMUNO RECUT. NEGATIVE CONTROL FOR HER2. Gross Description: 1). The specimen is received fresh for frozen section. diagnosis, labeled Sentinel node #1, level I, left axilla"". It. consists of a lymph node measuring 2 x 1.5 x 0.5 cm. The entire. specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 2). The specimen is received fresh for frozen section. diagnosis, labeled ""Sentinel node #2, level I, left axilla"". It. consists of a lymph node measuring 0.7 x 0.7 x 0.4 cm. The. entire specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 3). The specimen is received frech for frozen section. diagnosis, labeled ""Sentinel node #3, level I, left axilla"". It. consists of a lymph node measuring 2 x 1.5 x 0.7 cm. The entire. specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 11. rage  or D. 4). The specimen is received fresh for frozen section. diagnosis, labeled Sentinel node #4, level I, left axilla"". It. consists of a lymph node measuring 2.5 x 0.6 x 0.5 cm. The. entire specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 5). The specimen is received fresh for frozen section. diagnosis, labeled ""Non-sentinel node, left axilla. It consists. of a lymph node measuring 2.5 x 1.5 x 0.6 ca. The entire. specimen is submitted in one cassette. Summary of sections: FSC - frozen section control. 6) The specimen is received fresh, labeled ""Left Total. Mastectomy, Stitch Marks Axillary Aspect"" It consists of. a total mastectory measuring 20. 0 x 15.0 x 6.0 cm. The skin is. brown-black and measures 17.0 x 7.0 cm. Areola nipple complex is. unremarkable and measures 3.5 cm ic diameter. No scars were. grossly identified. The cut sections reveals a mass measuring. 3.0 x 2.5 x 2.0 cm. This macs is located 0.5 em from the. superior margin. This is the closest margin. The cut sections. through the other areas of the breast shows fibrocystic changes. Sections from the lateral upper and lower, medial upper and lower. quadrants are at least 1.0 cm from the closest deep margin. The. tumor is submitted entirely. The reprosentative sections are. also submitted. Summary of Sections: N nipple. TSM - tumor superior margin. T tumor. LL - lateral lower quadrant. LU - lateral upper quadrant. ML - medial lower quadrant. MU - medial upper quadrant. sx skin. Summary of Sections: Part. Sect. Site. Blocks. Pioces. All. 1. FSC. 1. 1. Y. 2. FSC. 1. 1. Y. 3. FSC. 1. Y. 4. FSC. Y. 5. FSC. 1. Y. 6. LL. 2. M. LU. 3. M. ML. 2. M. MU. 2. M. 11. N. 1. M. SK. 1. M. T. 3. M. TSM. 2. M. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the. intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 5). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. ADDENDUM: ADDENDUM REPORT. SITE: LEFT BREAST, #6. ER-ICA: POSITIVE. PR-ICA: POSITIVE. HER2/NEU (Hercep Test) : NEGATIVE (STAINING INTENSITY 0). CONTROLS ARE SATISFACTORY. ADDENDUM: ADDENDUM REPORT. 11. SITE: SENTINEL LYMPH NODES, LEFT AXILLA. PARTS #1, 2, 3. 4. ADDITIONAL HE STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS. FOR CYTOKERATINS (AE1:AE3 AND CAM5.2) SHOW NO EVIDENCE OF. METASTATIC TUMOR. "". 11.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Hepatectomy. Tumor size: 7.5 X 7.5 X 7.5 cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: CD10+, Hepar+, AFP+. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: 110 female with 5.5 cm right breast cancer. Specimens Submitted: 1: SP: Right breast and axillary contents levels 1 and 2 (sr). DIAGNOSIS: 1. BREAST, RIGHT; MODIFIED RADICAL MASTECTOMY: - MULTICENTRIC INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE, WITH A. SOLID PATTERN, MEASURING. 5.5 CM IN LARGEST DIMENSION GROSSLY. - LOBULAR CARCINOMA IN SITU (LCIS) IS ALSO IDENTIFIED,. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER OUTER QUADRANT, LEFT. INNER QUADRANT, CENTRAL AREA. - THE NIPPLE IS INVOLVED BY INVASIVE CARCINOMA. - NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. - NO VASCULAR INVASION IS NOTED. - PERINEURAL INVASION IS PRESENT. - INVASIVE CARCINOMA EXTENDS TO THE CAUTERIZED ANTERIOR FLAP MARGIN. - THE SKIN IS INVOLVED BY INVASIVE CARCINOMA BY DIRECT EXTENSION. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS USUAL DUCTAL HYPERPLASIA AND. MICROCALCIPICATIONS ASSOCIATED WITH BENIGN DUCTS. THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL. I: 0/7; LEVEL II: 0/6. IMMUNOSHISTOCHEMICAL STAIN DEMONSTRATE SINGLE. ISOLATED TUMOR CELLS WITHIN THE NODAL PARENCHYMA SEEN ONLY ON. IMMUNOHISTOCHEMICAL STAINED SLIDES (AE1/AE3) AND MEASURING LESS THAN 0.2 MM. - ER: 85Z NUCLEAR STAINING WITH MODERATE INTENSITY. - PR: 408 NUCLEAR STAINING WITH MODERATE INTENSITY. - IER2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 0). TUMOR STAGE: T3, PNO (I+), MX. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. a. Special Studies: Special Stain. Comment t. ER-C. PR-C. HER2-C. IMM RECUT. NEG CONT. NEG-HER2. AE1:AE3. AE1:AE3. IMM RECUT. NEG CONT. IMM RECUT. NEG CONT. Gross Description: 1). The specimen is received fresh labeled, "" Right modified radical. mastectomy with levels one axillary contents with level one and two"", and. consists of a breast measuring a 33.2 x 20.3 x 4.5 cm. with overlying skin. ellipse measuring 11.2 x 2.6 cm. and without scar. The nipple measures 1.6. cm in diameter. The posterior surface of the breast is inked black and. anterior inked yellow. The specimen is serially sectioned to reveal an. ill-defined mass above the nipple area (12:00), measuring 2.3 x 1.5 x 1.3. cm. The mass is closed to the skin and 2 cm away from deep margin. There is. fibrous tissue adjacent to the mass occupying the lower outer quadrant and. lower inner quadrant. Multiple lymph nodes are noted in the axillary area,. the largest one measures 1.2 cm in dimension. Representative sections are. submitted. Summary of sections: NIP - nipple. BASE - nipple base. D deep margin. T-mass. F- Fibrous tissue adjacent to the tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. L1- lymph nodes (level 1). L2- lymph nodes (level 2). Summary of Sections: Part 1: SP: Right breast and axillary contents levels 1 and 2. Block. Sect. Site. PCs. 1. base. 1. d. 9. 1. 3. 9. L1. 2. 4. L2. 2. 4. liq. 1. 2. In. 2. 1. log. 1. 2. nip. 3. 1. 2. 3. uig. 2. 2. uoq. 0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. -N.) LUNG, LEFT, WITH SUBCARINAL (N7), RIGHT HILAR (N10R), LEFT HILAR. (N10LX2), RIGHT AND LEFT LOWER PARATRACHEAL (N4R, N4L), SUBAORTIC (N5),. INTRALOBAR (N11L), PULMONARY LIGAMENT (N9LX2), AND PARA-AORTIC (N6). LYMPH NODES, PNEUMONECTOMY WITH REGIONAL LYMPHADENECTOMY: INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. - Involves left upper lobe and mainstem bronchus. - 7.5 cm in maximum dimension. - Visceral pleura invasion: Not identified. - MARGIN STATUS: NEGATIVE. - Bronchial and vascular margins uninvolved by invasive carcinoma. = THREE HILAR AND PERIBRONCHIAL) LYMPH NODES, OUT OF THIRTY TOTAL. LYMPH NODES, POSITIVE FOR METASTATIC CARCINOMA (3/30). - SEE TUMOR STAGING SUMMARY BELOW. PATHOLOGIC STAGING SUMMARY: - Type and grade: Squamous cell carcinoma, moderately differentiated. = Primary tumor: pT3 (7.5 cm in maximum dimension). - Regional lymph nodes: pN1 (3 [hilar and peribronchial] out of 30 total lymph nodes,. positive for metastasis; 3/30). - Distant metastasis: pMX. - Pathologic stage: IIIA. - Lymphovascular invasion: Present. - Margin status: R0. COMMENT: The above findings were discussed at. Conference on. FINAL SURGICAL PATHOLOGY REPORT. Lung Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol,. Specimen: Lung. Procedure: Pneumonectomy. Specimen integrity: Intact. Specimen laterality: Left. TUMOR FEATURES: Tumor site: Upper lobe and mainstem bronchus. Tumor size: Greatest dimension: 7.5 cm. Additional dimensions: 6 X 6 cm. Tumor focality: Unifocal. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated (G2). Visceral pleura invasion: Not identified. Tumor extension: Tumor involves main bronchus distal to the carina, but. does not involve the carina. MARGINS: R0 (Negative). Bronchial margin: Uninvolved by invasive carcinoma. Vascular margin: Uninvolved by invasive carcinoma. Parenchymal margin: Not applicable. Pariental pleural margin: Not applicable. Chest wall margin: Not applicable. Other attached soft tissue margin: Not applicable. Treatment effect: Not applicable. Lymphovascular invasion: Present. Lymph nodes: Three (hilar and peribronchial) lymph nodes, out of. thirty total lymph nodes, positive for metastasis (3/30). PATHOLOGIC STAGING SUMMARY: Primary tumor: pT3 (7.5 cm in greatest dimension). Regional lymph nodes: pN1 (3/30 total lymph nodes). Distant metastasis: pMX. Pathologic stage: IIIA. Margin status: R0. Additional findings: Pulmonary edema, and post-obstructive pneumonitis. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Lymph node;N7. B. Lymph node;N10R. C. Lymph node;N10L. D. Lymph node;N4R. E. Lymph node;N2R. F. Lymph node;N4L. G. Lymph node;N5. H. N11L. I. Lymph node;N9L. J. Lymph node;N9L#. K. Lymph node;N7. L. Left Lung. M. Lymph node;N10L#. N. Lymph node;N6. Clinical History/Operative Dx: Left lung cancer. Intraoperative Diagnosis: A. FSA: N7 - Negative for metastasis. The intraoperative interpretation(s) was/were performed and rendered at. B. FSB: N10R - Negative for metastasis. C. FSC: N10L - Negative for metastasis. D. FSD: N4R - Negative for metastasis. E. FSE: N2R - Negative for metastasis. F. FSF: N4L - Negative for metastasis. Gross Description: A. The specimen is labeled N7 and is received without fixative. It consists of a 0.4 X 0.3 X 0.3 cm. fragment of yellow-brown to anthracotic tissue which is entirely submitted for frozen section as FSA. The. tissue remaining from frozen section is submitted for permanent section in cassette A1. B. The specimen is labeled N10R and is received without fixative. It consists of a 1 X 0.4 X 0.2 cm. aggregate of yellow-tan to anthracotic tissue which is entirely submitted in for frozen section as FSB. The. FINAL SURGICAL PATHOLOGY REPORT. tissue remaining from frozen section is submitted for permanent section in cassette B1. C. The specimen is labeled N10L and is received without fixative. It consists of two fragments of yellow-. tan anthracotic tissue which measure 1 X 0.4 X 0.3 cm in aggregate. The tissue is submitted for frozen. section as FSC. The tissue remaining from frozen section is submitted for permanent section in cassette. C1. D. The specimen is labeled N4R and is received without fixative. It consists of a 1 X 0.7 X 0.3 cm fragment. of fatty and anthracotic tissue which is submitted for frozen section as FSD. The tissue remaining from. frozen section is submitted for permanent section in cassette D1. E. The specimen is labeled N2R and is received without fixative. It consists of a 1 X 0.7 X 0.3 cm. aggregate of fatty appearing tissue. It is submitted for frozen section as FSE. The tissue remaining from. frozen section is submitted for permanent section in cassette E1. F. The specimen is labeled N4L and is received without fixative. It consists of a 0.7 X 0.6 X 0.3 cm. fragment of pale yellow and focally anthracotic tissue which is submitted for frozen section as FSF. The. tissue remaining from frozen section is submitted for permanent section in cassette F1. G. The specimen is labeled N5 and is received in formalin. It consists of a single 2.4 X 0.9 X 0.9 cm. fragment of yellow-tan and anthracotic tissue which appears to have been centrally partially transected. It. is serially sectioned and entirely submitted in cassette G1-G2. H. The specimen is labeled N11L and is received in formalin. It consists of a 1 1 X 0.6 X 0,6 cm fragment. of gray-tan and anthracotic tissue. It is trisected and submitted in cassette H1. I. The specimen is labeled N9L and is received in formalin. It consists of a 0.7 X 0.7 X 0.3 cm fragment of. fibrofatty tissue with three 0.2 - 0.3 cm discrete areas of anthracotic discoloration. The specimen is. submitted intact in cassette 11. J. The specimen is labeled N9L #2 and is received in formalin. It consists of a 0.7 X 0.5 X 0.4 cm fragment. of tan and anthracotic tissue. It is bisected and submitted in cassette J1. K. The specimen is labeled N7 and is received in formalin. It consists of seven fragments of tan to reddish. violet and anthracotic tissue varying from 0.7 X 0.4 X 0.4 cm to the largest fragment measuring 1.7 X 1.4 X. 0,5 cm. The largest fragment is serially sectioned and submitted in cassette K1. A second fragment is. serially sectioned and submitted in cassette K2. Two fragments are serially sectioned and submitted in K3. (one inked). The three remaining fragments are submitted in cassette K4 (each inked and bivalved). L. The specimen is labeled left lung and is received without fixative. It consists of a pneumonectomy. specimen which weighs 628 grams. It measures 24 X 15 X 7 cm. The pleural surface of the left upper lobe. is pink-tan at the apical portion becoming consolidated red-violet and hemorrhagic in the basilar portion. of the lung. At the interlobar fissure there are multiple fibrous adhesions. The pleural surface of the lower. lobe is violet-tan adjacent to the interlobar fissure and is pink to pale tan along the basilar portion. At the. hilum of the lung the main bronchus is identified. The bronchus is surrounded by moderately firm. ES. FINAL SURGICAL PATHOLOGY REPORT. fibrofatty tissue with embedded anthracotic nodes. The upper lobe bronchus is obstructed with thick. mucous and possible tumor. The lower lobe bronchus appears patent. The bronchial margin is removed. as a thin shave and submitted for frozen section. Serial sections of the lung reveal glistening tan-white. tumor blocking and obstructing the upper lobar bronchus. Proceeding laterally tumor tracks outward along. the bronchi into the lung parenchyma over an area measuring 7.5 X 6 X 6 cm. There is consolidation and. yellowish firmness of the surrounding pulmonary parenchyma throughout most of the upper lobe. The. apical lung tissue is pink to tan and appears aerated. There is bronchiectasis of the lateral portion of the. upper lobe. The tumor does not involve the pleural surface but along the posterior apical portion of lung. is 0.3 cm from the pleural surface. There are additional anthracotic nodes along the lobar and segmental. bronchi. The superior edge of the inferior lobe appears consolidated and in one central area tumor is. within 0.7 cm of the inferior lobe. The parenchyma of the inferior lobe away from the interlobar fissure. is. red and consolidated. Representative sections are submitted. Section summary: L1) bronchial margin. from frozen section, L2-L3) vascular margin, L4-L5) hilar nodes, L6-L7) representative larger peribronchial. nodes, L8) tumor plug in main bronchus, L9-L12) representative sections of tumor from upper lobe. progressing from main bronchus laterally, L13) tumor with closest approach to posterior upper lobe pleural. surface, L14) interlobar fissure with closest approach to tumor to lower lobe, L15) upper lobe parenchyma. away from tumor, L16) representative lower lobe parenchyma. M. The specimen is labeled N10L #2 and is received in formalin. It consists of two 1.1 - 1.2 cm ovoid. fragments of gray-tan and partially anthracotic tissue. The tissue is serially sectioned and entirely. submitted in cassettes M1-M2 respectively. N. The specimen is labeled N6 and is received in formalin. It consists of a 1.3 X 0,6 X 0.5 cm fragment of. fibrofatty and anthracotic tissue. It is bisected and submitted in cassette N. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. D. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. E. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. F. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. G. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. FINAL SURGICAL PATHOLOGY REPORT. rendered. H. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. I. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. J. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. K. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. L. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. M. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. N. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Total gastrectomy preparation with inclusion of a gastric carcinoma of the prepyloric antrum. measuring a maximum of 3.5 cm in diameter, located on the side of the lesser curvature and. extending to within a maximum 1.8 cm of the aboral duodenal resection margin and as far as. the pylorus, characterized histologically as a moderately and in sections poorly differentiated. adenocarcinoma. Invasive tumor spread into the outer layers of the muscularis propria. Mucosa of antrum and corpus with non-florid, medium-grade chronic gastritis, foveolar. hyperplasia, foci of intestinal metaplasia and partial atrophy of the mucosa. No evidence of. Helicobacter pylori. Esophageal and duodenal aboral resection margin and greater omentum tumor-free. Two of 41 lymph nodes with metastases of the gastric carcinoma. Other lymph nodes with. uncharacteristically reactive lesions. Tumor stage: pT2a pN1 (2/41) L0 V0; G3 R0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Surgical Pathology Laboratorv. al Pathology Report. In Lab Date: Report Date: Submitted by: Telephone: CLINICAL INFORMATION: CA bladder. Specimen submitted: A. Bladder, prostate and seminal vesicle; B. Left pelvic lymph node; C. Left para aortic tissue; D. Right. pelvic lymph node; E. Left distal ureter; F. Right distal ureter. DIAGNOSIS: A. Bladder, prostate gland, and seminal vesicles (radical cystoprostatectomy): Bladder: Invasive high grade urothelial carcinoma. Tumor grossly and microscopically invades through the muscularis propria into perivesical fat (pT3b). Invasive carcinoma is centered primarily in the trigone and left lateral wall;. however, tumor also involves the right lateral wall, bilateral ureteral orifices,. and extends into the anterior and posterior walls. Foci of urothelial carcinoma in situ are present throughout the bladder. Extensive vascular invasion is present,. and metastatic tumor deposits are noted in perivesical soft tissue,. as well as within prostatic stroma (e.g., slides A46, A48; pMI). Perineural invasion is present. Tumor very focally abuts the inked anterior and posterior soft tissue resection margins. Distal urethral and bilateral ureteral margins are negative for carcinoma. Prostate: Multifocal prostatic adenocarcinoma, Gleason score 3+3=6. Tumors are organ-confined and present as two microscopic foci,. present in the right anterior para-apex (slide A38) and right anterior para-base (slide A50). No angiolymphatic invasion by prostatic carcinoma is identified. Seminal vesicles and all surgical margins are negative for prostatic carcinoma. TNM (bladder): pT3b N3 M1. TNM (prostate): pT2a NO Mx site: path bladder, NOS C67.9. Comment: Given the extent of lymph node dissection (see Parts B, C, and D), it is assumed that some of the nodes represent. common iliac lymph nodes, which are considered secondary sites of regional lymph node drainage and staged as pN3. Please. correlate with clinical and intraoperative findings to confirm the above pathologic ""N"" stage. B. Lymph nodes, left pelvis (excision): Metastatic urothelial carcinoma involving all fourteen lymph nodes (14/14). The largest tumor deposit measures at least 2.1 cm (microscopic). Extranodal extension of the carcinoma is identified. C. Para-aortic tissue, left (excision): Metastatic urothelial carcinoma involving all five lymph nodes (5/5). Tumor grossly spans the entire length of the specimen, which measured 7 cm in greatest extent. Extranodal extension of the carcinoma is identified. D. Lymph nodes, right pelvis (excision): Metastatic urothelial carcinoma involving all fifteen lymph nodes (15/15). The largest tumor deposit measures at least 1.9 cm (microscopic). Extranodal extension of the carcinoma is identified. E. Ureter, left distal (excision): Segment of ureter with acute and chronic inflammation and reactive epithelial changes. No carcinoma identified. F. Ureter, right distal (excision): Segment of ureter with acute and chronic inflammation and reactive epithelial changes. No carcinoma identified. GROSS DESCRIPTION: A. Received fresh, the specimen is labeled ""bladder, prostate and seminal vesicles"" and consists of bladder, prostate and seminal. vesicles. The specimen measures 16 x 12 x 5.5 cm. The bladder measures 7.5 x 7.0 x 5.0 cm. The anterior aspect of the bladder. is. inked green and the posterior aspect of the bladder is inked black. The right ureter is 0.8 cm in length and 0.9 cm in diameter with a. stent in place. The left ureter is 1.4 cm in length and 0.9 cm in diameter also with a stent in place. The specimen is opened from the. anterior aspect of the prostate and bladder to reveal a 2.2 x 2.0 x 0.4 cm area of firmness with ulceration and necrosis in the arca of. the bladder neck/trigone extending into the left and right lateral walls. A section of the ulcerated area is submitted for research. The. posterior wall mucosa adjacent to the ulcerated areas is polypoid and erythematous. The specimen is representatively submitted. The prostatectomy specimen includes a 4.5 x 4.5 x 3.0 cm prostate, a 4.5 x 1.7 x 1.0 cm left seminal vesicle, a 7.0 x 0.7 cm left vas. deferens, a 4.0 x 2.0 x 1.0 cm right seminal vesicle and a 9.0 x 0.3 cm right vas deferens. The right side of the specimen is inked. green, and the left side is inked black. The seminal vesicles and apical margins are shaved and submitted. The apical margin is. shaved and submitted. The prostate is serially sectioned from the apex to base with sections designated from A to E, respectively. On sectioning, multiple nodular and cystic areas are seen. The prostate is submitted entirely. Summary of sections: A1-urethral. margin; A2-right ureteral margin A3-left ureteral margin; A4-A7 representative bladder neck with ulcer (adjacent to the sections. taken for research) ; A8-left UVJ area; A9-right UVJ area with ulceration; A10-prostatic urethra to bladder neck; All-A13-anterior. wall; A14-A16-bladder neck with ulceration: A17-A18-posterior wall; A20-A22-left wall; A23-A25-right wall; A26-A28-dome;. A29-A-31-trigone; A32-RSV; A33-LSV; A34-RA apex; A35-RP apex; A36-LA apex; A37-LP apex; A38-RA A; A39-RP A;. A40-LA A; A41-LP A; A42-RA B; A43-RP B; A44-LA B; A45-LP B; A46-RA C; A47-RP C; A48-LA C; A49-RL C;. A50-RA. D;. A51-RP D; A52-LA D: A53-LP D; A54-RA E; A55-RP E; A56-LA E; A57-LP E. (Note: R=Right; L=Left; A=Anterior;. P=posterior). B. Received fresh, the specimen is labeled ""left pelvic lymph node"" and consists of aggregate of red-tan soft tissue measuring 6 x 6. x 2 cm. The lymph nodes are entirely submitted. Summary of sections: BI-one lymph node; B2-B-one lymph node bisected;. B4-two lymph nodes; B5-five lymph nodes; B6-B9-one lymph node bisected each cassette. C. Received fresh, the specimen is labeled ""right paraaortic tissue"" and consists of a 7 x 2 x 2 cm piece of firm fibrofatty tissue. with multiple matted lymph nodes. The specimen is sequentially sectioned and entirely submitted. Summary of sections: CI-CIO. D. Received fresh, the specimen is labeled ""right pelvic lymph node"" and consists of a 4 x I x. 1. cm. aggregate. of. fat. and. lymph. node. The lymph nodes are entirely submitted. Summary of sections: D1-one bisected lymph node; D2-D5-multiple intact lymph. nodes. E. Received fresh, the specimen is labeled ""left distal ureter"" and consists of segment of ureter measuring I cm in length and 0.3. cm in diameter. There is stitch marking on one end. The specimen is entirely submitted. Summary of sections: El-with stitch; E2. F. Received fresh, the specimen is labeled ""right distal ureter"" and consists of a segment of ureter measuring 4 cm in length and 0.8. cm in diameter. There is stitch marking on one end. The specimen is entirely submitted. Summary of sections: FI-F5-right distal. ureter (FI-with stitch). Attending Pathologist. The attending pathologist whose signature appears on this report has reviewed the diagnostic slides,. and has edited the gross and microscopic portions of the report in rendering the final diagnosis. Slides: A-57, B-9, C-10. D-5. E-2, F-5.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PATECLOGIC CIAGNOSIS: is: SPECIMEN LABELED ""LEFT KIDNEY"". HANA: CELL CARCINOMA 15.5 cm), predominantly Chromophobe type, Puhrman. grade : of IV (in a background of II of IV) See note. Tumor is well circemscribed and confined to the kidney. does not invade renal pelvis. the vascular and ureceral resection margins are free of tumor. NOTE; Kany tumor colls are positive for Hale's colloidal iron. (chromophobe component), but the tumor also has features of. oncocytoma; this is consistent with a mixed type cumor. B: SPECIMEN LABELED ""REGIONAL LYMPH NODES"": (6) lymph node; no tumor present. ACCO stage (6th Tlb NO Mx. CLINICAL DATA: Gistory: 45 year-old with incidental findings of solid mass left kidney. operation: Nephrectomy. Operative Findings: Not provided. Clinical Diagnosis: Incidental left kidney mass. TISSUE SUBMITTED: A: Left kidney. 0/2. Regional lymph nodes. GROSS DESCRIPTION: the specimen is received Eresh, in two parts, each labeled with the patient?s. name and unit number. is, labeled ""#l. Left kidney"". consists of a 603.5 gm left nephrectomy. apecimen including kidney 12.5 x 6.5 x 3.3 cm) and surrounding perirenal fat. from 0.9 cm to 2.2 em in thickness) Extending from the renal pelvis. a segment of ureter (11.0 cm in length with a diameter ranging from 0.1 cm. proximally up LO 0.4 c.a distally), bifurcated renal vein (averaging 0.4 cm in. length x 0.5 em in diameter), renal artery (0.6 cm x 0.3 cm in diameter). The. specimen is inked biack and sectioned to exhibit a circumscribed bulging mass. 15.0 x 4.8 x 3.7 cm) in the lateral lower pole. The mass is approximately 75%. vellow/t.an lobulated and solid with a peripheral component. lappreximately 258) which is very fibrotic red/brown to tan/white and centrally. benorrhagic. The mass is 8.5 cm from the ureteral margin, 4.7 em from the. venal artery margin, and 4.2 cm from the renal vein margin. Upon sectioning,. the mass exhibits a variegated focally hemorrhagic red/brown to yellow/tan. Socally tibrotic cut surface and grossly appears to expand but not grossly. invade through the renal capsule, pushing into the adjacent perinephric fat and. coming to within 0.1 C.T. of the black inked margin. The mass is approximately. 85 solid and 15% friable to necrotic. The remainder of the renal cortex is tan/brown with a well-defined cortical. medullary junet The pelvocaliceal system exhibits smooth glistening tan. present wrothelium with perinephric no masses lymph node. or lesions identified. The adrenal gland is not. The fat is thinly sectioned but no candidates. are identified The specimen is photographed. Representative sections of. .umor were previcusly aiven to Cytogenetics, Electron Microscopy, and the. Tissue Bank. Representative normal kidney was previously sent for Electron. Microscopy, Immunofluorescence, and given to the Tissue Bank. Micro Al: Creteral and vascular margins, en face, 4 frags,. Micro A2: Tumor and capsule and closest approach to black inked margin, : frag,. RSS. Micro A3: Tumor capsule and perirenal Sat, 1 frag,. Micro A4: Tumor to include junction of fleshy yellow/tan component. with. fibrotic red/brown to tan component, 1 frag, RSS. Micro AS: Tumor and adjacent uninvolyed kidney and renal sinus, 1 frag,. Micro A6: Uninvolved kidney, 1 frag,. Micro A7: Uninvolved calyx and unremarkable urothelium, 1 frag. Part R, labeled ""#2. Regional lymph"", consists of one fragment of yellow/tan. fibrofatty tissue (3.9 x x 1.1 cm), which is dissected for lymph node. candidates. Eight pink/tan rubbery lymph node candidates (ranging from 0.2 em. to 1.0 cm in greatest dimension) are identified and are entirely submitted as. follows: Micro B1: 2 lymph node candidates, 2. frags,. Micro B2: 3 lymph node candidates, 3 frags,. Micro B3: 3 small lymph node candidates, 3 f. By his/her signature below, the senior physician certifies that ho/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen(s) and rendered or confirmed the diagnosis(es). related theret.o. ADDENDUM FOR KIDNEY PARENCHYMA NOT INVOLVED BY TUMOR. PATHOLOGIC DIAGNOSIS. KIDNEY WITH MILD FOCAL GLOBAL GLOMERULOSCLEROSIS (5%) (SEE NOTE). ARTERIAL AND ARTERIOLAR SCLEROSIS, WITH SUBINTIMAL HYALINOSIS,. (SEE NOTE). NOTE: This surgical specimen of non-tumoral kidney does not reveal significant. findings in the parenchyma. Namely, the glomeruli show 5% focal global. sclerosis and there are no significant changes in the tubulo-interstitial. compartment. There is only mild vascular sclerosis and focal intimal hyal Jinosis. present. MICROSCOPIC DESCRIPTION: The sample consists of kidney cortex and medulla. There are up DO two. hundred eighty-three glomeruli present in the sample submitted for licht. microscopy. Fourteen (14) glomeruli are globally obsolescent (5%). The. preserved glomeruli show very mild signs of hypertrophy, with subtle increase. in cellularity and mesangial matrix. On PAS and Jones' silver methenamine. stain, the glomerular basement membranes appear of normal thickness. No. ""spikes"" or craters are recognized Tubules are well preserved; occasional. FAS-positive casts are seen. The interstitium shows no significant fibrosis or. active inflammation. Less than 58 of the sample shows tubular atrophy and. interstitial fibrosis, as evidenced on the trichrome stains (AFOG) these areas. are mostly subcapsular in location. Arteries and arterioles show focal and. mild sclerosis of the wall with subintimal hyalinosis. Pare: ? of. Printed: 11/28-2005 10:40.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
printed: REPORT Tel: Clinical Consultant & Location. Unit No. SPECIMEN. Right eye globe. CLINICAL DETAILS. Tumour size: 16.24 x 10.81 x 14. 79mm. History of blurred vision. Visual field defect. Pain since 6. months. MACROSCOPIC DESCRIPTION. A fresh, intact right globe. Dimensions: Axial 25mm, Horizontal 24.5mm, Vertical 24mm. Cornea: Horizontal 11.5mm, Vertical 11mm. Optic nerve. Length 12.5mm, Diameter 4mm. Pupil: regular. On trans-illumination, a shadow is seen in the supero medial. measuring 19mm in maximum diameter. Plane of section: vertical oblique. Intraocular description. On opening, a nodular, pale mass is seen, slightly anterior. to the equator. Tumour size. LBD 9mm, Height 8.5mm. MICROSCOPY. Sections show a virtually non-pigmented choroidal melanoma. extending from the ora serrata / pars plana up to the. equator. Tumour consists predominantly of spindle cells. The. number of mitosis is approximately 4/40 high power fields. Closed loops are focally present in the planes of sections. The lymphocytic infiltrate within the tumour is minimal. Tumour necrosis is not seen. There is no tumour extension. orinted: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. through the sclera, optic nerve or vortex veins examined. Tumour cells are not geen at the resection margins. Elsewhere, the cornea shows no significant abnormality. The. anterior chamber angles are open and the anterior chamber is. shallow. The iris shows no significant abnormality. Ciliary. processes away from tumour show slight hyalinisation. Retina. overlying the tumour is slightly atrophic and Bruch's. membrane appears intact. DIAGNOSIS. Right eye, enucleation: Choroidal melanoma of predominantly. spindle cell type. COMMENT. Immunohistochemistry will be carried out for completion. In. addition, molecular genetic examination of DNA extracted. from the tumour cells will be performed using. multiplex-ligation dependent probe amplification (MLPA),. looking at chromosomes 1, 3, 6 and 8. A supplementary report. will follow in due course. SUPPLEMENTARY REPORT -. Immunohistochemistry confirms that tumour cells express. Melan-A and HSP 27 (score 2). COMMENT. SPECIMEN. 2= Eye. TUMOUR PRESENT. TUMOUR TYPE. 1= Melanoma. CELL TYPE. 2= Spindle B. CT LOOPS. 2= Closed loops. NECROSIS. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. PIGMENTATION. LYMPHOCYTIC INFILTRATION. MITOTIC FREQUENCY. 4/40 HPF. DIFFUSE MELANOMA. SPREAD. 1= No. CLEARANCE. 2= Adequate. HSP-27 POSITIVITY. 2= 21-70%. LARGE DIAMETER. 9 mm. THICKNESS. 8.5 mm. SUPPLEMENTARY REPORT. In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using multiplex ligation-dependent probe amplification. (MLPA) These investigations were performed in the. The kit P027 from. which examines for gains or. losses in 37 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. In summary, sequence analysis. demonstrated: essentially normal chromogome 1p,. 3 borderline losses of chromosome 3 in the presence of 3. borderline gains,. gains in chromosome 6p. and normal chromosome 8.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with adenocarcinoma of ascending colon. Specimens Submitted: 1: SP: Right hemicolectomy. 2: SP: Small bowel. DIAGNOSIS: 1. SP: Right hemicolectomy: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Cecum. Tumor Size: Length is 3.7 cm. Width is 4.0 cm. Tumor Budding: Focal. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. Large Venous Invasion: Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 19. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). 2. SMALL INTESTINE; RESECTION. - SEGMENT OF SMALL INTESTINE WITH NO PATHOLOGIC DIAGNOSIS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Right colon"" and consists of. a. segment of terminal ileum, cecum with attached appendix and ascending colon. The terminal ileum measures 8.5 cm in length and 4.5 cm in circumference at. the proximal resected margin. The remaining colon measures 29.0 in length. with a circumference of 7.0 cm at the distal resected margin. The attached. appendix measures 4.0 cm in length and averages 0.5 cm in diameter. The. appendiceal and intestinal serosa is pink tan and smooth. Focally. hemorrhagic lobulated yellow tan adipose tissue spans the length of the. specimen measuring up to 4.5 cm in thickness. The specimen is opened to. reveal a mass lesion measuring 3.7 cm in length and 4.0 cm in width. The. mass is located in the large bowel 0.3 cm from the ileocecal valve, 11.0. cm. from the proximal margin and 24 cm from the distal margin. Sectioning shows. that the tumor grossly invades through the muscularis and serosa. The depth. of invasion is 0.3 cm grossly. The remaining mucosa is tan-brown with the. normal folds. There are multiple minute polypoid lesions on the terminal. ileum mucosa. The attached adipose tissue is thoroughly examined and all. identified lymph nodes are submitted. Representative sections of the. specimen are submitted for permanent sections and for TPS. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. A - appendix representative sections. RP polypoid lesion from terminal ileum. RS representative sections. PD -possible diverticulum. LN - lymph nodes. BLN - bisected lymph nodes. 2. The specimen is received fresh labeled ""small bowel"". . It consists of an. unoriented segment of small bowel measuring 21.5 cm in length and 3.6 cm in. circumference. The serosal and mucosal surface is grossly unremarkable. Representative sections are submitted. Summary of sections: SM1 - one margin. SM2 - the other margin. RS - representative sections. Summary of Sections: Part 1: SP: Right hemicolectomy. Block. Sect. Site. PCs. 1. A. 3. 2. DM. 4. 8. LN. 24. 1. PD. 1. 1. PM. 2. 2. RP. 6. 2. RS. 4. 7. T. 9. Part 2: SP: Small bowel. Block. Sect. Site. PCs. 2. RS. 2. 1. SM1. 1. 1. SM2. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. 2. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Partial organ resection - left breast, inner upper quadrant. Expected time of examination: 5 working days. Clinical diagnosis: Macroscopic description: Part of the breast sized 6.6 x 5.3 x 1.9 cm removed together with a skin flap of 5.8 x 3.3 cm, marked typically, with an. X-ray image. Tumour in cross section sized 0.9 x 0.8 x 1.7 cm. Location of margins: 0.4 cm to the base; 0.5 cm to the. front surface; 1.8 cm to the sternum; 3.7 cm to the axilla; 1.8 cm to the shoulder 2.3 cm, 1.7 cm to the lower edge. Radiogram showing a shadowing of 1.4 x 1.4 cm, skin injected with blue dye. Microscopic description: Carcinoma ductale invasivum partim mucinosum invasivum mammae sinistrae NHG2 (3 + 2 + 1/1 mitoza/10 HPF,. visual area diameter: 0.55 mm). Largest lesion dimension 1.7 cm. Normal tissue margines as in the macroscopic. description. Surgical specimen texture outside tumour showing mastopathia fibrosa partim lipomatosis. Histopathology Diagnosis: Carcinoma ductale partim mucinosum invasivum mammae sinistrae N1IG2, pTlc. Invasive ductal and in part mucinous carcinoma of the left breast. dr. dr.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Right renal mass and IVC thrombus. Specimens Submitted: 1: Kidney, right, radical nephrectomy. 2: SP: Segment vena caval thrombus and vena cava wal. 3: SP: Proximal vena caval wall. 4: Lymph nodes, paracaval and precaval, resection. 5: Lymph nodes, hilar, resection. 6: Lymph nodes, suprahilar, resaction. 7: Lymph nodes, interaortocaval, resection. DIAGNOSIS: 1. Kidney, right, radical nephrectomy: Tumor Type: Renal call carcinoma - Convantional (clear cell) type. with spindla cell/sarcomatoid features. Fuhrman Nuclear Grade: Nuclear grade IV/IV. Tumor Size: Greatest diameter is 12.2 cm. Local Invasion (for renal cortical types): Extands through renal capsule but confined within Gerota's fascia. Extends into renal pelvis. Involves renal sinus fat. Involves renal hilar fat. Renal Vein Invasion: Vena cava invasion is identified. (sae part 2) - Tumor also involves multiple medium- to large-caliber vassels in tha region of the renal sinus/hilum. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Paritumoral reaction and two renal calculi. Adrenal Gland: Not involved. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava below the diaphragm. 2. Vena caval thrombus and segment of vena cava, resection: Segment of venous wall and attached renal cell carcinoma (tumor thrombus). 3. Vena cava, proximal, resection: Segment of venous wall negative for tumor. 4. Lymph nodes, paracaval and precaval, resection: Lymph Nodes: Not involved. Number of nodes examined:3. 5. Lymph nodes, hilar, resection: Lymph Nodes: Not involved. Number of nodes examined:5. 6. Lymph nodes, suprahilar, resection: Lymph Nodes: Not involved. Number of nodes examined:1. 7. Lymph nodes, Interaortocaval, resection: Lymph Nodes: Not involved. Number of nodes examined:6. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIOES (AND/OR OTHER MATERIAL), ANO THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh labeled ""right kidney, adrenal gland and vena caval thrombus"" and consists of a kidney with. attached ureter, renal vessels and perinephric fat welghing 1205 g in total. The kidney measures 18.5 x 10.6 x 8.8 cm. The. attached ureter measures 8.1 cm in length and 0.5 cm in diameter. The attached portion of inferior vena cava measures 0.6 cm in. length and 3.9 cm in dlameter with a protruding mass measuring 6.3 X 5.1 x 3.1 cm attached to the wall of inferior vena cava and. completely obliterative the renal vein. The portion of renal artery measures 2.7 cm long and 0.4 cm in dlameter. The renal artery. and ureter margins are grossly unremarkable. An adrenal gland is identified, measures 5.5 x 3.5 X 1.3 cm and grossly appears. unremarkable. The perinephric fat is of thickness ranging from 0.4 to 1.7 cm, The kidney is inked bleck and bivalved to reveal an. irregular soft mass with variegated appearance, measures 12.2 x 9.8 x 8.9 cm, involving the entire upper pole and portion of the. middle pole of the kidney. The mass appears to involve the perinephric fat, renal sinus and peribilar fat and grossly extends into. the renal vessels. The pelvicaliceal system at the upper pole is completely compressed, while at the middle and lower poles, does. not appear to be involved by the mass. Two 0.5 cm in diameter renal calculi are noted present in the middle pole. The remainder. of. the. middle and lower pole shows a multiloculated cyst 2.4 cm in greatest dimension, which cannot be separated from the upper. pole mass as no uninvolved renal parenchyma is grossly identified. Sections through the remeinder of the kidney reveal a pink. brown paranchyma, with a well-defined cortico-medullary junction. The cortex measures 0.6 cm. No lymph nodes are grossly. identified in the parinephric fat. Representative sactions are submitted for. and for permanent sections. Specimen. photographs taken. Summary of sections: UM -- uretaral margins. IVCM -- inferior vena cava margin. RAM -- renal artery margin. T-- tumor. THF tumor with hilar fat. TSF -- tumor with sinus fat. RP -- renal pelvis representative sections. K -- representative sections kidney. MPK -- middle pola kidney. LPK -- lower pole kidney. A -- adrenal. 2). The specimen is received fresh labeled ""Segment vana caval thrombus and vena cava wall"". It consists of multiple pieces of. yellow-tan soft tissue measuring 3.5 x 3.5 x 0.4 cm in aggregate. The specimen is entirely submitted. Summary of sections: U-undesignated. 3). The specimen is received in formalin, labaled ""Proximal vena caval wall"" and consists of a flattened piece of grossly. unremarkable smooth pink-tan soft to rubbery tissue measuring 2,5x2x0.1 cm. A suture is identified at one and, and a staple. line is identified at the other end. The specimen is serially sectionad from the suturad to the stapled end, with a suture and staples. removed, and is entirely submitted. Summary of sections: SS-serial sections. 4). The specimen is receivad in formalin, labeled ""Paracaval and precaval nodes"" and consists of three pink-tan lymph nodes. ranging from 0.1 to 1.5 cm in greatest dimension, which are entirely submitted. Summary of sections: LN -- lymph nodes. BLN-- bisected lymph nodes. 5). The specimen is received in formalin, labelad ""Hilar lymph nodes"" and consists of five pink-tan lymph nodes ranging from 0.3. to 1.4 cm in greatest dimansion, which are antiraly submitted. Summary of sections: LN no lymph nodas. BLN-- bisected lymph nodes. 6). The specimen is received in formalin, labeled ""Suprahilar lymph node"" and consists of a tan lymph node measuring 0.8 cm. pouch is bisected and submitted antirely. Summary of sections: BLN - bisected lymph node. 7). The specimen is received in formalin, labeled ""Interaorfacaval lymph nodes"" and consists of six tan focally hemorrhagic lymph. nodes ranging from 0.3 to 1.8 cm in greatest dimension, which are entirely submitted. Summary of sections: LN-lymph nodes submitted whole. BLN3 -- bisected lymph node number three. BLN - bisected lymph nodes (two nodes). Summary of Sections: Part 1: Kidney, right, radical nephrectomy. Block. Sect. Site. PCs. 1. A. 1. 1. IVCM. 1. K. 1. 1. LPK. 1. 1. MPK. 1. RAM. 1. 4. RP. 8. 8. 4. THF. 4. 5. TSF. 5. 1. UM. 1. Part 2: SP: Segment vena caval thrombus and vena cava wall. Block. Sect. Site. PCs. 2. u. 2. Part 3: SP: Proximal vena caval wall. Block. Sect. Site. PCs. 3. SS. 3. Part 4: Lymph nodes, paracaval and precaval, resection. Block. Sect. Site. PCs. 1. bIn. 1. 1. In. 1. Part 5: Lymph nodes, hilar, resection. Block. Sect. Site. PCs. 1. bIn. 1. in. 1. Part 6: Lymph nodes, suprahilar, resection. Block. Sect. Site. PCs. 1. bIn. 1. Part 7: Lymph nodes, interaortocaval, resection. Block. Sect. Site. PCs. 3. bIn. 3. 2. bln3. 3. 1. In. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Material. Submitted: !eft breast with axillary contents. History: Clinical. Diagnosis: Operating. Dr. Gross Examination: The specimen is received in a single container, labeled with the patient's name, history. number, date and ""left breast and axillary contents"". Received is a breast measuring. approximately 23.0 x 16.0 x 8.5 cm. Also received is axillary contents measuring 8.0 cm. x. 9.0 cm.x 3.0 cm. There is no previous scars or other lesions on the surface of the breast. Noted grossly was a 5.0 x 5.0x 4.0 cm. mass submitted for receptors. The specimen has. been inked in blue and sectioned extensively before accessioning. Examination of the. specimen reveals a firm white nodule measuring approximately 3.5 x 3.0 cm. in two. dimensions. Gross inspection of the tumor at the deep margin does not show extension. through the deep margin grossly. Representative sections are submitted as follows: Block I: representative section of tumor to show deep margin. Block II: representative section of tumor to show deep margin. Blocks III and IV: representative sections of the tumor. Palpation of the remainder of the breast does not reveal any separate nodules from the. main tumor region. From the main mass, a couple of satellite nodules are noted that appear. to be contiguous with the main mass. A section of this area is submitted in Block V. Block VI: representative section of nipple. Block VII: representative section of skin over tumor. Block VIII: random sample of upper inner quadrant. Block IX: random sample of lower inner quadrant. Block X: random sample of upper outer quadrant. Block XI: random sample of lower outer quadrant. The axillary contents are separate from the remainder of the specimen and palpated for. lymph nodes. Lymph node candidates are submitted from the inferior to the superior. direction. They are submitted as follows: Block XII: two lymph node candidates. Block XIII: three lymph node candidates. Block XIV: three lymph node candidates. Block XV: five lymph node candidates. Block XVI: three lymph node candidates. Block XVII: three lymph node candidates. Block XVIII: five lymph node candidates. (Continued on. ragÃ© 2. Dr. Dr. (Continuation from page 1). Block XIX: five lymph node candidates. Block XX: three lymph node candidates. Block XXI: five lymph node candidates. Block XXII: five lymph node candidates. Block XXIII: three lymph node candidates. Block XXIV: three lymph node candidates. MICROSCOPIC: The apparent satellite nodules seen grossly (Block 5) consist of sclerosis and. hemangioma (so-called ""peritubular hemangioma""). Portions of the. carcinoma have intermediate grade nuclei, but areas have a high grade nuclear pattern. DIAGNOSIS: #i""LEFT"" BREAST, MASTECTOMY: A. LARGE (5.0 x 5.0 x 4.0 CM.) INFILTRATING DUCTAL. CARCINOMA, N.S.A.B.P. NUCLEAR GRADE POORLY. DIFFERENTIATED, HISTOLOGIC GRADE 3 OF 3. 13. FOCAL INTRATUMORAL INTRADUCTAL CARCINOMA. C. PROMINENT VASCULAR INVASION BY CARCINOMA. D. NO CARCINOMA IDENTIFIED IN SURGICAL MARGINS. E. HEMANGIOMA. F. FIBROCYSTIC CHANGES: 1. MARKED DUCTAL EPITHELIAL HYPERPLASIA. 2. PAPILLARY APOCRINE METAPLASIA. 3. DUCT ECTASIA. 4. SCLEROSIS. #2 ""LEFT"" AXILLARY DISSECTION: A. METASTATIC CARCINOMA IN 6 OF 32 LYMPH NODES. B. FOCAL CARCINOMA IN PERINODAL BLOOD VESSELS.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Operative Procedure: Radical cystectomy. A: Distal left ureter (FS). B: Distal right ureter (FS). C: Bladder and uterus, cervix, tubes and ovaries. D: Tissue near uterus. E: Right pelvic lymph nodes. F: Left pelvic lymph nodes. Final Pathologic Diagnosis: A. Distal left ureter margin, excision for frozen section A: Negative for tumor. Frozen section diagnosis is confirmed. B. Distal right ureter margin, excision for frozen section B: Negative for tumor. Frozen section diagnosis is confirmed. C. Urinary bladder, anterior exenteration: Tumor histologic type: Urothelial carcinoma. Variant histology (%): Micropapillary carcinoma (90%) and. transitional cell carcinoma (5%). Tumor size: 7.5 cm (greatest dimension). Additional dimensions: 6.5x4cm. Grade (WHO. High. Tumor configuration: Invasive. Associated epithelial lesions: None identified in sections examined. Microscopic tumor extension: Through the urinary bladder into the uterus. Lymph-vascular invasion: Present. Margins. Urethral: Negative. Ureteral: Negative. Paravesical soft tissue: Focally positive. Other (specify): N/A. Additional pathologic findings: None. Paravesical lymph nodes: None identified. All lymph nodes: Metastatic carcinoma in situ present in four. lymph nodes (total number of pelvic lymph nodes = 5). Size of largest lymph node metastasis: 1.5 cm. Part A is received fresh for frozen section evaluation additionally labeled. ""distal left ureter (FSA+X)"" and consists of a segment of apparent ureter,. having a length of 0.8 cm and a diameter that averages 0.6 cm. There is a suture. at one pole and the opposing pole is shaved and submitted for frozen section. evaluation (FSA) with residual frozen section tissue submitted in cassette A1. and remaining tissue is submitted entirely in cassette A2. Part B is received fresh for frozen section evaluation additionally labeled. ""distal right ureter (FSB+X)"" and consists of a segment of apparent ureter,. having a length of 0.8 cm and an average diameter of 0.5 cm. There is a suture. at one pole and the opposing pole is shaved and submitted for frozen section. evaluation (FSB) with residual frozen section tissue submitted in cassette B1. and remaining tissue submitted entirely in cassette B2. Part C is received in formalin additionally labeled ""bladder and uterus, tubes,. cervix and ovaries."" This composite specimen has aggregate dimensions of 10.5 x. 9 X 9 cm and consists of bladder with attached urethra, segment of bilateral. ureters, uterine corpus with attached cervix and ""vaginal patch,"" as well as. bilateral adnexa and a moderate amount of perivesical fat. The specimen. previously had its anterior aspect over inked in blue and the bladder has been. opened for procurement of tissues. The posterior aspect is subsequently inked. black. The bladder has dimensions of 4 x 4 X 4 cm to include an additional 1.5. cm in length of urethra. The uterine corpus is 3 cm in length by 3.8 x 2 cm with. an additional attached 2.3 cm in length of cervix, which averages 2 cm in. diameter. The ""vaginal patch"" has a length of 3.5 cm with additional width of 3. cm, 0.3 cm in thickness. The right ovary has dimensions of 2.5 x 1.5 x 0.8 cm. with an overlying fimbriated fallopian tube, which is 5 cm in length and. averages 0.8 cm in diameter. The left ovary is 2.5 x 2 x 1.1 cm with an. overlying fimbriated fallopian tube, which is 5 cm in length and averages 0.6 cm. in. diameter. The surface of the uterine corpus is remarkable for an area of. roughening, arising within the right cornu fundic aspect, which may represent. site of removal of tissues (see part D). Upon further bisecting the specimen,. the bladder is remarkable for diffuse thickening of the bladder wall,. particularly notable on the posterior aspect with ulcerated urothelium. particularly notable on the fundic aspect posterior wall with confluent. extension involving the anterior aspect. This mass has extensive involvement of. multiple structures with overall estimated dimensions of 7.5 x 6.5 cm with. invasion into the uterine corpus/cervix for a depth of 4 cm and into the. anterior superior aspect of the bladder for a depth of 2.5 cm (see also gross. photos). This mass approaches to within 2.5 cm of the urethral margin of. surgical resection. Both the left and right ureters are grossly probe patent. with an average length of 6 cm, each which open into a markedly edematous. trigone. This tumor abuts the perivesical fat adjacent to the left. adnexa/uterine corpus. Additionally this tumor does approach the. superior/posterior aspect of the bladder adjacent to the ""bladder flap"" site. (see cassette C11). There is no gross evidence of tumor involvement of the. surface of the vaginal patch or into the adnexal structures. Sections are submitted as follows: These lymph node candidates are submitted as follows: F1-2. one whole lymph node bisected, one half in each cassette;. F3-4. one whole lymph node quadrisected, one half in each cassette. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. (Age:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. reast, left, simple mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of III), forming a 1.9 x 1.2 x 1.0 cm mass in. the superior breast (AJCC pTlc). A minor component of ductal carcinoma in situ, intermediate nuclear grade, is also present. Surgical resection margins are negative for tumor. The nearest (deep) margin is free by 0.2 cm. Lymph nodes, left axillary sentinel, excision: Multiple (3) left axillary sentinel lymph nodes are negative for tumor. Lymph. nodes No.1, and No.2A contain no blue dye, lymph node No.2B contains blue dye. Immunohistochemical cytokeratin stain. was. performed on the paraffin embedded sentinel lymph node tissue and confirms the H&E impression. Lymph node, left axillary, excision: A single left axillary lymph node is negative for tumor (AJCC pN0). Her-2/NEU analysis has been ordered on paraffin embedded tissue.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. WLE RIGHT BREAST NEEDLE LOC. B. ADDITIONAL MARGIN RIGHT BREAST. C. WLE LEFT BREAST NEEDLE LOCALIZATION. SPECIMEN(S): A. WLE RIGHT BREAST NEEDLE LOC. B. ADDITIONAL MARGIN RIGHT BREAST. C. WLE LEFT BREAST NEEDLE LOCALIZATION. GROSS DESCRIPTION: A. WLE RIGHT BREAST NEEDLE LOC. Received fresh labeled with the patient's identification and ""WLE right breast needle loc"" is an oriented (short/1 clip-. superior, long/2 clips-lateral, air knot-anterior) needle localized lumpectomy with radiograph. Ink code: Anterior-. yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-orange. The specimen is serially sectioned. from lateral to medial into 8 slices revealing a 2.4 x 1.9 x 1.6 cm firm tan stellate mass that is closest to the superior. margin at 0.2 cm. Tissue is procured. Representatively submitted: A1-A2: lateral margin, perpendicular resection. A3: slice 2, anterior/superior. A4: slice 2, posterior superior (mass). A5: slice 3, anterior/superior (mass). A6: slice 3, posterior superior (mass). A7: slice 3, anterior/inferior (mass). A8: slice 3, posterior inferior (mass). A9: slice 4, anterior/superior (mass). A10: slice 4, mid superior (mass). A11: slice 4, posterior superior (mass). A12: slice 4, anterior inferior (mass). A13: slice 4, posterior inferior (mass). A14: slice 5, anterior superior (mass). A15: slice 5, mid superior (mass). A16: slice 5, anterior inferior (mass). A17: slice 5, mid inferior (mass). A18: slice 6, anterior superior. A19: slice 6, mid superior (mass). A20: slice 6, posterior superior. A21: slice 6, mid inferior. A22: medial margin, perpendicular sections. B. ADDITIONAL MARGIN RIGHT BREAST. Received fresh labeled with the patient's identification and ""additional margin right breast"" is in a oriented (short-. superior, long-lateral) 11 g, 0.2 x 3.4 x 1.1 cm fibrofatty tissue. Margins are inked black. Serial sectioning reveals no. discrete lesions. Inked margin submitted entirely in cassettes B1-B7. NOTE: specimen was received with only 1 suture. C. WLE LEFT BREAST NEEDLE LOCALIZATION. Received fresh labeled with patient's identification and ""WLE left breast needle localization"" is an oriented (short/1. clip-superior, long/2 clips-lateral, loop-anterior) 42 g, 4 x 4 x 3.5 cm needle localized lumpectomy with radiograph. Ink code: Anterior-yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-orange. Specimen is. serially sectioned from lateral to medial into 6 slices revealing a 2.4 x 1.9x1.8 cm firm tan stellate mass that. is. closest to the superior margin at 0.1 cm. Tissue is procured. Representatively submitted: C1-C2: lateral margin, perpendicular sections. C3: slice 2, anterior superior (mass). C4: slice 2, posterior superior (mass). C5: slice 2, anterior inferior (mass). C6: slice 2, posterior inferior (mass). C7: slice 3, mid superior (mass). C8: slice 3, posterior superior (mass). C9: slice 3, mid inferior (mass). C10: slice 3, posterior inferior (mass). C11: slice 4, anterior superior. C12: slice 4, mid superior (mass). C13: slice 4, posterior superior. C14: slice 5, anterior inferior. C15: slice 5, mid anterior. C16: slice 5, anterior superior. C17-C18: medial margin, perpendicular sections. DIAGNOSIS: A. BREAST, RIGHT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 2.4-CM. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES WITH. CENTRAL NECROSIS AND MICROCALCIFICATIONS. - INVASIVE TUMOR PRESENT WITHIN 1-MM FROM SUPERIOR/MEDIAL SURGICAL RESECTION MARGIN. - LOBULAR CARCINOMA IN SITU. - BIOPSY SITE CHANGES WITH FIBROSIS. - SEE SYNOPTIC REPORT AND SEE NOTE. B. BREAST, RIGHT, ADDITIONAL SUPERIOR MARGIN, EXCISION: - INVASIVE DUCTAL CARCINOMA INVOLVES NEW INKED SURGICAL RESECTION MARGIN, SEE NOTE. C. BREAST, LEFT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.8-CM. - SURGICAL RESECTION MARGIN NEGATIVE FOR TUMOR. - LOBULAR CARCINOMA IN SITU. - BIOPSY SITE CHANGES WITH FIBROSIS. - SEE SYNOPTIC REPORT. NOTE: Part B. was designated as superior by Dr. Therefore, invasive tumor is present at superior (part B) and within. 1-mm from medial (part A) surgical resection margin. E-cadherin is negative in LCIS component. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.4cm. Margins: Involved at. superior. and within 1-mm from medial. Extent:: focal. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: LCIS. Lymph nodes: Non-sentinel lymph node. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 10%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 2Nx. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left). Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.8cm. Margins: Negative. Distance from closest margin: 0.3cm. superior. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: LCIS. Lymph nodes: No lymph node sampling. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 1c N x. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY: female found with left breast lump. She had bilateral mammogram done showing bilateral breast. masses. Bilateral core needle biopsies done on. showed bilateral invasive ductal carcinoma.y Bilateral. needle localization scheduled and no sentinel lymph nodes will'be taken as her axilla are clinically negative and it. would not change post op management she will likely received radiation and endocrine therapy. PRE-OPERATIVE DIAGNOSIS: Bilateral invasive ductal carcinoma. Right-ER/PR+, Her2/neu SBR grade 2. Left-ER/PR+, SBR grade 1. ADDENDUM: The right breast excision (Part A) measures 5x5x4.5-cm and weighs 63 gms. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist. Final: Pathologist,. Addendum: Pathologist, r. Addendum Final: Pathologist.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 2. copy No. Examination: Histopathological examination. Gender: F. Material: 1. Multiple organ resection - left breast with axillary tissues. Expected time of examination: upto 8 working days. Clinical diagnosis: Cancer of the left breast. Macroscopic description: Left breast sizedi21 x 18 x 3 cm removed along with axillary tissues sized 10 x 5 x 2 cm and a 15 x 6 cm skin flap. Weight 520 g. Tumour sized 1.9 x 1.6 x 1.7 cm in the middle part, 1.5 cm from the upper boundary, 1.6 cm from the base and 0 cm from. the skin. Microscopic description: Carcinoma ductale invasivum - NHG2 (2+3+2/10 mitoses/10 HPF - visual area: 0.55mm). Foci of carcinoma ductale in situ (DCIS) found within the tumour (solid and cribrate type, with medium nuclear atypia,. without necrosis and with calcifications of below 5% of the tumour). Infiltratio carcinomatosa mamillae. Focus of carcinoma ductale invasivum found in the glandular tissue (inner lower quadrant - diameter 0.1 cm). Also showing also lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (UDH). AXILLARY LYMPH NODES: Metastases carcinomatosae in lymphonodis (No VI/XVIII). Infiltratio capsulae lymphonodi. Preliminary result: Final response to be given after whole of the material is analysed. I. Results of immunohistochemical. examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTestâ¢M by DAKO. Negative reaction in invasive cancerous cells ( Score = 1+ ). Examination: Histopathological examination. page 2 / 2. Gender: F. Histopathological diagnosis: Carcinoma ductale invasivum bifocal et ductale in situ mammae sinistrae. Invasive ductal bifocal carcinoma and ductal in situ carcinoma of the left breast. Metastases carcinomatosae in lymphonodis axillae (No VI/XVIII) (NHG2, pT1c, pN2a). Cancer Metastases in axillary lymph nodes.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
proceuare wave. Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF LMP. DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: A) LEFY (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. B) LEFT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. NODES. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) LEFT BREAST, MODIFIED RADICAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMA/ 4.0 BY 3.5 BY 3.0 CM. - HISTOLOGIC GRADE, POOR. - NUCLEAR CRADE, MODERATE. - NOTTINGHAM SCORE 7 (TUBULE 3, NUCLEI 2, MITOSIS 2). - TUMOR INVOLVING SUBAREOLAR AND NIPPLE LIMPHATICS. - TUMOR INVOLVING DERMIS AND DERMAL LYMPHATICS OVERLYING TUMOR AND EXTENDING INTO EPIDERMIS. - INTRADUCTAL COMPONENT, COMIDO VARIANT, COMPRISING 10% OF TUMOR. - INKED MARGINS INCLUDING SKIN MARGINS, FREE or TUMOR. (CROSS REFER. B) LEFT AXILLARY CONTENTS: - TWELVE OF THIRTEEN (12/13) LYMPH NODES CONTAINING METASTATIC TUMOR WITH PROMIMENT PERINODAL EXTENSION IN 6. NODES. - TWO (2) ADDITIONAL TUMOR NODULES ARE SEEN AS PERIVASCULAR TUMOR NODULES WITHOUT RECOGNIZABLE NODAL. FEATURES.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
ADDENDA: Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: (Thyroid left lobe and istmus, papillary thyrold carcinoma with predominant follicular growth 5.0 cm): NOT identified. Mutations in BRAF, NRAS61, HRAS61, KRAS12/13 and RET/PTC1 and RET/PTC3 rearrangements. NOTE: Nucleic acids were extracted in the amount sufficient for testing. (Thyroid right lobe, papillary thyroid carcinoma with predominant follicular growth 1.8 cm): Mutations in BRAF, NRAS61, HRAS61, KRAS12/13 and RET/PTC1 and RET/PTC3 rearrangements. NOT identified. NOTE: Nucleic acids were extracted in the amount sufficient for testing. FINAL DIAGNOSIS: PART 1: THYROID GLAND, LEFT AND ISTHMUS, LOBECTOMY AND ISTHMUSECTOMY (19 GRAMS) -. A. PAPILLARY THYROID CARCINOMA: WITH PREDOMINANT FOLLICULAR GROWTH, 5.0 CM. B. EXTENSIVE VASCULAR INVASION IS IDENTIFIED. C. EXTRATHYROIDAL EXTENSION IS ABSENT. D. CARCINOMA IS <0.1 CM FROM THE MARGIN. E. PATHOLOGIC STAGE: pT3. PART 2: THYROID GLAND, RIGHT, LOBECTOMY (7 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, WITH PREDOMINANT FOLLICULAR GROWTH, 1.8 CM. B. MULTIPLE FOCI OF CAPSULAR AND VASCULAR INVASION ARE IDENTIFIED. C. EXTRATHYROIDAL EXTENSION IS ABSENT. D. CARCINOMA IS <0.1 CM FROM THE MARGIN. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 5.0 cm. HISTOLOGIC TYPE: Papillary carcinoma. PRIMARY TUMOR (pT): pT3. REGIONAL LYMPH NODES (pN): pNX. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 1 mm. LYMPH-VASCULAR INVASION: Present.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. Date Coll: SPECIMEN. A. Right upper middle lobe. B. Level 7. C. R4. D. R2. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung mass. GROSS DESCRIPTION. A. Received fresh in a container labeled ""right upper. middle lobe"" is a 197 gm, 19 X 11.8 X 3.5 cm, portion of. lung tissue, compatible with right upper and middle lobes. The. pleural surface is tan-pink to gray-black, and mottled. There are. bronchial stumps averaging 1 cm in length associated with each of. the upper and middle lobes. In the hilar region surrounding each. bronchial stump there are several gray-black soft rubbery lymph. nodes. There is a 3.2 X 2.8 X 2.2 cm. rubbery pale tan lesion which. appears to be within the middle lobe, and which extends to within 1. cm from the bronchial stump. The lesion grossly extends to beneath. the pleural surface, but does not appear to involve the pleura. The. pleural surface overlying the tumor is inked blue. Tissue is. submitted for tissue procurement per the clinical request. The. parenchyma away from the mass is spongy and tan-pink-red, with some. bleb form. in the upper lobe. There are no additional mass. lesions. BLOCK SUMMARY: A1 - bronchial margin, right upper lobe; A2 -. vascular margins; A3 - hilar lymph nodes right upper lobe; A4 -. bronchial margin right middle lobe; A5 - hilar lymph nodes right. middle lobe; A6-A10 - tumor, including relation to pleural surface. and adjacent parenchyma; A11,A12 - representative right upper lobe;. A13,A14 - right middle lobe away from mass. B. Received fresh in a container labeled ""level 7"" are six. slightly fragmented portions of soft gray-black tissue. atible with lymph nodes, up to 1.2 cm in greatest dimension. C. Received fresh in a container labeled ""R4"" are five. pieces of soft gray-black to tan-gold tissue up to 0.8 cm. in greatest dimension. There appear to be three lymph nodes. present. D. Received fresh in a container labeled ""R2"" are six. fragmented soft gray-black to tan-yellow pieces of tissue. ranging from 0.3 cm up to 1.1 cm in greatest dimension. Due to the. degree. agm ation, it is difficult to enumerate the lymph. nodes. MICROSCOPIC DESCRIPTION. The following template summarizes the findings in this. case: Histologic type: Adenocarcinoma (mixed papillary and not otherwise. specified) , comprising the mass lesion in the right middle lobe in. part A. Histologic grade: Moderately differentiated. Primary tumor (pT) : pT2a. The tumor is 3.2 cm in greatest. dimension. Pleural invasion is not identified. Margins of resection: Negative for tumor. Direct extension of tumor: Not identified. Vascular invasion: Not definitively identified. Regional lymph nodes (pN) : pNO. The hilar lymph nodes identified in. part A, as well as the separately submitted lymph nodes in parts B,. C, and D, are negative for tumor. Distant metastasis (pM) : pMX. Other findings: Emphysematous change with bleb formation in the. upper lobe, with bronchiolar metaplasia, and subpleural fibrosis. Note: This case has been reviewed in Intradepartmental Consultation. with concurrence with the interpretation. DIAGNOSIS. A. Lung, right upper and middle lobes, excision. - Moderately differentiated adenocarcinoma, 3.2 cm in. greatest dimension (pT2a) , margins negative for malignancy. (see microscopic description) . - Emphysematous changes, with bleb formation. - Lymph nodes negative for malignancy. B,C,D. Lymph nodes, level 7, R4, and R2, excisions. - Negative for malignancy. End Of Report ---.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. SENTINEL LYMPH NODE #1. B. SENTINEL LYMPH NODE 2 RIGHT AXILLA. C. SENTINEL LYMPH NODE 3 RIGHT AXILLA. D. SENTINEL LYMPH NODE 4 RIGHT AXILLA. E. SENTINEL LYMPH NODE #5. F. RIGHT BREAST. G. ADDITIONAL LATERAL TISSUE RIGHT BREAST. H. ADDITIONAL SUPERIOR RIGHT BREAST TISSUE. SPECIMEN(S): A. SENTINEL LYMPH NODE #1. B. SENTINEL LYMPH NODE 2 RIGHT AXILLA. C. SENTINEL LYMPH NODE 3 RIGHT AXILLA. D. SENTINEL LYMPH NODE 4 RIGHT AXILLA. E. SENTINEL LYMPH NODE #5. F. RIGHT BREAST. G. ADDITIONAL LATERAL TISSUE RIGHT BREAST. H. ADDITIONAL SUPERIOR RIGHT BREAST TISSUE. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, B, C, D, E. Sentinel lymph nodes #1, 2, 3, 4, 5, biopsies: No tumor seen. By Dr, called to Dr. at. (A,B),. C, D) and al. (E). GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1. Received is a tan-pink fatty lymph node (1.8 X 0.9 X 0.3 cm). The specimen is serially sectioned, touch. prep was performed. The specimen is submitted is cassettes A1-A3. B. SENTINEL LYMPH NODE #2 RIGHT AXILLA. Received is a tan-pink fatty lymph node X 6 x .3 cm). The specimen is serially sectioned and touch. preps are taken. The specimen is submitted in toto in B. C. SENTINEL LYMPH NODE #3 RIGHT AXILLA. Received are two tan-pink lymph nodes (1.0 X 0.3 x 0.2 cm and 1.4x.6x. .5 cm). The specimen. is. serially sectioned and touch preps are taken. The specimen is submitted as follows: C1: one lymph node, trisected. C2: one lymph node serially sectioned. D. SENTINEL LYMPH NODE #4 RIGHT AXILLA. Received is a tan-pink lymph node (1.0 x .6 : x .3 cm). The specimen is serially sectioned and touch. preps are taken. The specimen is submitted in toto in cassette D. E. SENTINEL LYMPH NODE #5. Received is a tan-pink lymph node (.9 x 7 x .2 cm). The specimen is serially sectioned and touch preps. are taken. The specimen is submitted in toto in cassette E. F./ RIGHT/BREAST. Received fresh labeled with the patient name, designated ""right breast"", is a simple mastectomy. specimen weighing 1181 grams and measuring overall 28 x 23 x 4.5 cm. The specimen is received. with orientation, a suture indicating the axillary aspect. The overlying beige-tan ellipse of skin measures. 21 x 11 cm. The surface demonstrates three areas of brown hyperpigmentation, the largest measuring. 1 X 0.6 cm to the smallest measuring 0.5 x 0.3 cm. A light tan raised lesion is noted at 3 o'clock on the. skin measuring 0.5 x 0.5 cm. The light tan areola measures 2.3 cm in diameter, the everted nipple. measures 1 cm in diameter. The deep margin is inked black. The specimen is serially sectioned from. axilla to medial aspect and shows a firm beige-tan lesion in the upper outer quadrant at approximately. 10 o'clock approaching the deep surgical margin at a distance of 4.3 cm. The lesion measures 2.2 x. 1.9 x 1.5 cm. An ill defined white firm fibrous area is also demonstrated at approximately 12 o'clock. measuring 1.5 x 1.2 x 1 cm. This area is located 5.5 cm from the lesion. An ill defined irregular dense. white area is shown in the lower inner quadrant measuring 2.5 x 2 x 2 cm. This area is located. approximately 10.5 cm from the lesion. The remainder of the breast parenchyma shows dark yellow. adipose tissue. A portion of the specimen was submitted for tissue procurement. Representative. sections are submitted as follows: F1-F4: the lesion in the upper outer quadrant. F5: deep margin overlying lesion. F6-F8: sections of white firm fibrous tissue at 12 o'clock. F9-F16: multiple sections of ill defined firm area in lower inner quadrant. F17-F18: representative sections of upper inner quadrant. F19-F21: representative sections of the lower outer quadrant. F22-F23: additional sections from the upper outer quadrant adjacent to lesion. F24: section of nipple. F25: section of skin demonstrating the raised tan lesion at 3 o'clock. F26: additional section of skin. F27-F28: possible lymph nodes. G. ADDITIONAL LATERAL TISSUE RIGHT BREAST. Received in formalin in a container labeled with the patient name, designated ""additional lateral tissue"",. is a fragment of dark yellow adipose tissue measuring 8 x 2.2 x 0.5 cm. The exterior surface is inked. black. The entire specimen is submitted in cassettes G1-G4. H. ADDITIONAL SUPERIOR RIGHT BREAST TISSUE. Received in formalin in a container labeled with the patient name designated ""additional superior right. breast tissue"", is a fragment of yellow adipose tissue measuring 3 X 2.2 X 1 cm. The entire specimen. is. submitted in cassettes H1 and H2. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). B. SENTINEL LYMPH NODE #2, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). C. SENTINEL LYMPH NODE #3, RIGHT AXILLA, EXCISION: - TWO LYMPH NODES, NEGATIVE FOR TUMOR (0/2). D. SENTINEL LYMPH NODE #4, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). E. SENTINEL LYMPH NODE #5, EXCISION: ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). F. RIGHT BREAST, SIMPLE MASTECTOMY: - TWO FOCI OF INVASIVE DUCTAL CARCINOMA,. TUMOR SIZE 2.2 x 1.9 x 1.5 CM. AND 1 X 1 CM. RESPECTIVELY,. SBR GRADE III IN LARGE TUMOR FOCUS. - DUCTAL CARCINOMA IN-SITU, COMEDO AND SOLID TYPES, HIGH. NUCLEAR GRADE WITH MICROCALCIFICATIONS. - MARKED FIBROCYSTIC DISEASE AND ADENOSIS WITH EXTENSIVE. MICROCALCIFICATIONS. - SURGICAL RESECTION MARGINS, NEGATIVE FOR TUMOR. - FOCAL SEBORRHEIC KERATOSIS OF SKIN. - SEE TEMPLATE. Note: There are two foci of invasive ductal carcinoma identified: the large one is present in the upper. outer quadrant measuring 2.2 cm. This focus is SBR grade III. Another smÃ¤ll tumor focus is present in. the central area at the 12 o'clock position measuring 1 x 1 cm. This focus of tumor is SBR grade I, with. tubular formation. Ductal carcinoma in-situ containing microcalcifications is associated with the large. focus of invasive carcinoma. In addition microcalcifications are also present in mutifoci of adenosis and. fibrocystic disease. G. ADDITIONAL LATERAL TISSUE RIGHT BREAST, EXCISION: - BENIGN ADIPOSE TISSUE, NEGATIVE FOR TUMOR. H. ADDITIONAL SUPERIOR RIGHT BREAST TISSUE, EXCISION: - BENIGN ADIPOSE TISSUE, NEGATIVE FOR TUMOR. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: F: RIGHT BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Right,. Invasive tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Specimen size: Size of Invasive focus 2.2cm. Additional dimensions: 1.9cm x 1.5cm. Tumor Site: Upper outer quadrant. Central. Margins: Negative. Distance from closest margin: 4.3cm. Tubular score: 3 (<10% tubule). Nuclear grade: 3. Mitotic score (Olympus 40x): 2 (7-13/10. Modified Scarff Bloom Richardson Grade: III (8-9 points). Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/6. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate % 15. DCIS type: Comedo. Solid. DCIS location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. Location of CA++: DCIS. Benign epithelium. Pathological staging (pTN): pT 2NN0. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimens Involved. Specimens: F: RIGHT BREAST. SPECIMEN: Other. simple mastectomy. Block Number: F1. ER: Positive - Allred Score: 8 = Proportion score: 5 + Intensity Score 3. PR: Negative - Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of. less than or equal to 2. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin (. for no less than 8 and no longer than 24 hours. Antibody and Assay Metnodology: Mouse anti-human ER and PR, (. Comment: This assay can be used to select invasive breast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5,. 1:100) and PR (PGR 136, 1:100) antibody provided by. following the manufacturer's instructions. listed in the package insert. This assay was not modified, and adherence to all instruction and. guidelines were strictly followed. Interpretation of the ER/PR immunohistochemical staining. characteristics is guided by published results in the medical literature (1), information provided by the. reagent manufacturer and by internal review of staining performance within the. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding. assay for predicting response to adjuvant endocrine therapy in breast cancer. Clin Oncol. 17:1474-. 1481, 1999. CLINICAL HISTORY: Patient is a. year old white female who underwent an ultrasound guided core biopsy on. which. revealed invasive ductal carcinoma of right breast with extensive pleomorphic malignant appearing. microcalcifications on mammogram. The patient opted for a right simple mastectomy and sentinel. lymph node biopsy after consideration. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. ADDENDUM: SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimens Involved. Specimens: F: RIGHT BREAST. HER2 Status Results, Immunohistochemistry Evaluation. SPECIMEN. Surgical Excision. Block Number: Block. F1. Interpretation: Equivocal. Intensity: 2+. % Tumor Staining: 50%. FISH Ordered YES DATE. METHODOLOGY. Methodologv: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin (. ) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2, HerceptestTM (FDA-approved test kit),. Control. Slides Examined: External kit-slides provided by manufacturer (cell lines with high, low and negative. HER2 protein expression), and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. These control slides run along side of this patient's sample showed appropriate. staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive carcinoma identified for. HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Score) /Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, >10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal. may not indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all. HER2 IHC 2+ results. COMMENT. This assay can be used to select invasive breast cancer patients for Trastuzumab (Hereptin) therapy. (1,2). Clinical Trials have shown that Trastuzumab substantially increases the likelihood for an objective. response and overall survival for patients with metastatic HER2-positive breast cancer, regardless of. whether HER2 tumor status was determined as IHC 3+ or FISH positive. Trastuzumab added to. adjuvant chemotherapy substantially increase disease-free survival and decreases the risk of disease. recurrence by about 50% for patients with early-stage HER2 protein over-expressed or gene amplified. invasive breast cancer (3). HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved. (TM) test kit following the manufacturer's instructions listed in the package insert. This. assay was not modified, and adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical staining characteristics is guided by published results. in the medical literature (4), information provided by the reagent manufacturer and by internal review of. staining performance within the Institute Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised. recommendations and guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the. jointly issued recommendations and guidelines from ASCO and the CAP (5). 80 randomly selected. breast cancer samples were tested for HER2 by IHC as outline above and interpreted as, negative. (score 0/1+) equivocal (score 2+) and positive (score 3+) without knowledge of the previous reported. results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and. the HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance. between the IHC and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by. FISH and 6/9 (66%) were found to be amplified. Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests. performance and has programs in place to regularly monitor the proficiency and the interpretation of. HER2 assays. The laboratory also participates in external quality assurance HER2 programs including. the CAP proficiency testing program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in. oncology. J Natl Compr Canc Netw. 2005;3:238-289. 2. Carlson RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast. cancer. J Natl Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable. HER2-positive breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu. scoring validation by FISH and CISH. Appl Immunohistochem Mol Morphol. 2006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of. American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2. Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. The followings are ER and PR results of the second tumor focus measuring 1 cm. at the central area of. breast tissue. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimens Involved. Specimens: F: RIGHT BREAST. SPECIMEN: Surgical Excision. Block Number: F7. ER: Positive - Allred Score: 8 = Proportion score: 5 + Intensity Score 3. PR: Positive - Allred Score: 7 = Proportion Score 4 + Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30%. of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of. less than or equal to 2. Methodoloav: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin (. ) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Mouse anti-human ER and PR, (Dako, Carpenteria, CA). Comment: This assay can be used to select invasive breast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5,. 1:100) and PR (PGR 136, 1:100) antibody provided by. following the manufacturer's instructions. listed in the package insert. This assay was not modified, and adherence to all instruction and. guidelines were strictly followed. Interpretation of the ER/PR immunohistochemical staining. characteristics is guided by published results in the medical literature (1), information provided by the. reagent manufacturer and by internal review of staining performance within the Institute Pathology. Department. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding. assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474-. 1481, 1999. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimens Involved. Specimens: F: RIGHT BREAST. HER2 Status Results, Immunohistochemistry Evaluation. SPECIMEN. Surgical Excision. Block Number: Block. F7. Interpretation: Negative. Intensity: 1+. % Tumor Staining: 10%. FISH Ordered NO DATE. METHODOLOGY. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin (Pharmco. Inc. Brookfield, CT) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2, HerceptestTM (FDA-approved test kit), (. Control. Slides Examined: External kit-slides provided by manufacturer (cell lines with nign, low and negative. HER2 protein expression), and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. These control slides run along side of this patient's sample showed appropriate. staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive carcinoma identified for. HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Sco /Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, >10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal. may not indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all. HER2 IHC 2+ results. COMMENT. This assay can be used to select invasive breast cancer patients for Trastuzumab (Hereptin) therapy. (1,2). Clinical Trials have shown that Trastuzumab substantially increases the likelihood for an objective. response and overall survival for patients with metastatic HER2-positive breast cancer, regardless of. whether HER2 tumor status was determined as IHC 3+ or FISH positive. Trastuzumab added to. adjuvant chemotherapy substantially increase disease-free survival and decreases the risk of disease. recurrence by about 50% for patients with early-stage HER2 protein over-expressed or gene amplified. invasive breast cancer (3). HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved. (TM) test kit following the manufacturer's instructions listed in the package insert. This. assay was not modified, and adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical staining characteristics is guided by published results. in the medical literature (4), information provided by the reagent manufacturer and by internal review of. staining performance within the Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised. recommendations and guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the. jointly issued recommendations and guidelines from ASCO and the CAP (5). 80 randomly selected. breast cancer samples were tested for HER2 by IHC as outline above and interpreted as, negative. (score 0/1+) equivocal (score 2+) and positive (score 3+) without knowledge of the previous reported. results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and. the HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance. between the IHC and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by. FISH and 6/9 (66%) were found to be amplified. Institute Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests. performance and has programs in place to regularly monitor the proficiency and the interpretation of. HER2 assays. The laboratory also participates in external quality assurance HER2 programs including. the CAP proficiency testing program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in. oncology. J Nati Compr Canc Netw. 2005;3:238-289. 2. Carlson RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast. cancer. J Natl Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable. HER2-positive breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu. scoring validation by FISH and CISH. Appl Immunohistochem Mol Morphol. 006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of. American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2. Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the Pathology. Core Facility by Dr.. A majority of tumors cells displayed moderate polysomy 17. with 2 to 4 chromosome 17 signals and 2 to 4 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0,. consistent with no amplification of the HER2/neu gene. Block used F1. Source of case: RPCI. Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.46. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapv is being considered. These tests were performed in the. under the direction. of Dr.. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation: M.D.. Pathologist. Final Review: M.D., Pathologist,. Final: M.D., Pathologist, 1. Addendum:., Pathologist,. Addendum Final:., Pathologist,. Addendum: M.D., Pathologist, 1. Addendum Final: M.D., Pathologist,. Addendum: M.D., Pathologist,. Addendum Final:, M.D., Pathologist, 1. Addendum:., Pathologist,. Addendum Final:, M.D., Pathologist,. Addendum: M.D., Pathologist,. Addendum Final:, M.D., Pathologist,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description. Case ID. A. ""Station 10."" A 0.6 X 0.4 X 0.2 cm anthracotic. lymph node. B. 'Station 7."" A 2.0 X 1.6 X 1.0 cm aggregate of. anthracotic lymph nodes. C.""Station 11."" A 0.7 X 0.5 X 0.4 cm aggregate. D. ""Right lower lobe with en bloc wedge of. upper lobe marked by long stitch."" A 278 gram,. 18.0 X 14.0 X 4.0 cm right lower lobe and. attached 5.5 X 3.0 x 2.5 cm portion of upper. lobe wedge with suture at the surgical margin. There is a 3.7 X 3.0 cm mass that extends. possibly through the pleura, crosses the fissure. into the right upper lobe and is located. approximately 0.5 cm from this stapled margin. (inked black), 3.0 cm from the bronchial. margin. There are two additional stapled. margins 3.0 and 5.0 cm adjacent to the. bronchial margin on the right lower lobe. The. remaining parenchyma is unremarkable. E. ""Station 4."" A 1.2 X 0.5 X 0.5 cm and a 2.5 X. 1.5 X 1.0 cm anthracotic lymph node. Microscopic Description. Diagnosis Details. Tumor site: Right lower and upper lobes. Squamous cell carcinoma without lymph nodal. Tumor size: 3.7 cm. metastases. Bronchial margin: Uninvolved (more than 1 cm. free). Right upper lobe stapled margin: Uninvolved (4. mm free). Vascular margin: Uninvolved. Visceral pleura: Involved by tumor. Lymphovascular invasion: absent. Treatment effect: Not applicable. Other findings: Emphysematous changes. Atelectasis. Lymph nodes: main specimen (D): Not involved (1node). Station 4 (E): Not involved (2 nodes). Station 7 (B): Not involved (9 nodes). Station 10 (A): Not involved (1 node). Station 11 (C) : Not involved (3 nodes). Pathologic stage: pT2a NO MX. Comments. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 3.7 X 3 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Visceral pleura. Other tumor nodules: Not specified. Lymph nodes: 0/16 positive for metastasis. (Stations 4,7,10,11 0/16). Lymphatic invasion: Absent. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: Right-lower.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: This concerns in 1) liver metastases of a poorly differentiated adenocarcinoma of. the colon,. in II) further sections of the poorly differentiated adenocarcinoma of the colon. described. (G3) and in III) an invasive adenocarcinoma of the colon in the rectal position,. poorly. differentiated (G3), with extensive lymph vessel dilatation (L1, V1) and lymph node. conglomerate metastases (over five - pN2). Tumor classification: ICDO-DA M-8140/3,. pT3, pN2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: DIAGNOSIS. A) LIVER, BIOPSY: 1. Nonspecific subcapsular fibrotic nodule with calcification. 2. Unremarkable background liver. 3. Negative for neoplasm. B) PERITONEUM, PERICOLONIC TISSUE, BIOPSY: Metastatic poorly-differentiated adenocarcinoma, compatible. with pancreatic primary. C) PERITONEUM, PERIGASTRIC TISSUE, BIOPSY: 1. Mild nonspecific peritonitis. 2. Negative for neoplasm. D) PANCREAS, DISTAL PANCREATECTOMY: 1. Invasive boorly-differentiated pancreatic ductal adenocarcinoma,. featuring: a. Size: 9 X 8 X 3.2 cm. b. Extent of invasion: Invades peripancreatic soft tissues with. extension to colon wall and diaphragm. C. Margins: Positive, radial attachments to colon and diaphragm. d. Perineural invasion: Present. e. Angiolymphatic invasion: Present. f. See staging parameters. 2. Background pancreas, including pancreatic transection margin is normal. 3. Two lymph nodes, peripancreatic, negative for neoplasm (0/2). 4. Three accessory splenic nodules, two positive for adenocarcinoma. PANCREATIC CANCER STAGING PARAMETERS. Final TNM: pT3N0M1. stage: IV. MACROSCOPIC. SPECIMEN TYPE. Partial pancreatectomy, Tail. TUMOR SITE. Pancreatic tail. TUMOR SIZE. 9X8X3.2 cm. MICROSCOPIC. HISTOLOGIC TYPE. Ductal Adenocarcinoma. HISTOLOGIC GRADE. G3: (poorly differentiated) of G4. MARGINS - PANCREATICODUODECTOMY. Involved by invasive carcinoma. Location(s) Radial margins at attachment sites to diaphragm. and colon (surgical correlation). LYMPHATIC/ASCULAR INVASION. Present: Lymph-vascular invasion present/Identified. PERINEURAL INVASION. Present. PATHOLOGIC STAGING. EXTENT OF INVASION. pT3. (Tumor extends beyond the pancreas but without involvement. of the celiac axis or the superior mesenteric artery). REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 2. Total positive nodes: 0. DISTANT METASTASIS. pM1. (Distant metastasis): Colon, diaphragm, accessory. splenic nodules. PATHOLOGIC STAGE SUMMARY. Final TNM: pT3N0M1. stage: IV. Attending Pathologist: CLINICAL INFORMATION. Pancreatic cyst. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Liver biopsy, tumor. The specimen is received fresh labeled ""liver biopsy."" It consists of a 0.4. cm white-tan firm calcified nodule with adjacent liver parenchyma. It is. entirely submitted on one chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Liver with. calcified nodule; no malignancy."" is rendered by. B) SOURCE: Pericolic tissue. The specimen is received labeled ""pericolonic tissue."" It consists of a 0.9. X 0.2 X 0.1 cm thin strip of soft red-tan tissue, submitted in toto on one. block for frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Adenocarcinoma."" is rendered by. consultation with. C) SOURCE: Perigastric tissue. Received fresh labeled ""perigastric tissue"" is a 0.2 cm tan-red tissue. fragment entirely submitted on one chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Granulation. tissue. No malignancy. Pending permanents.' is rendered by. D) SOURCE: Pancreas, distal. Received fresh labeled ""distal pancreas"" are two separate portions of. pancreas. The first is the true proximal portion of the pancreas and. measures 3 cm in length and 3 cm in diameter. The true margin staple line. is removed and that portion of the tissue is submitted en face on chuck #1. for frozen section diagnosis. This portion of tissue is sectioned. Cut section of the parenchyma reveals. lobulated yellow tissue without a discrete mass or lesion. No fat is. attached. The second fragment of pancreas with attached firm tissue and omentum. measures 9 X 7.5 X 4.5 cm. The attached omentum measures 8 X 8 X 2 cm. The anterior portion of the specimen was attached per the surgeon to the. diaphragm and the soft tissue is inked red. The posterior aspect is ragged. and this is where the colon and stomach were attached to the pancreas, and. is inked black. The specimen is sectioned from proximal to distal. revealing total replacement of the soft tissue by white-tan slightly. heterogeneous presumed tumor measuring 9 X 8 X 3.2 cm. The pancreatic duct. is obliterated and normal appearing parenchyma is only found on the. proximal most aspect. A representative portion of the presumed tumor is. submitted on chuck #2 for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Pancreas margin. negative. Mass is adenocarcinoma."" is rendered by. NOTE: Tissue is taken for possible ancillary studies. The tumor extends to. the red and black ink of the soft tissue. The hemorrhagic soft tissue. distally may represent splenic riffs or lymphoid tissue. The omentum is. searched revealing no grossly identifiable lymph nodes. The peripancreatic. fat is searched revealing five hemorrhagic possible 0.4-1.2 cm lymph nodes. Representative sections are submitted labeled: 1-2. Frozen section. 3-5. Representative normal proximal pancreas. 6-7. Tumor and red ink attachment of diaphragm. 8-9. Posterior aspect of tumor to attached colon and stomach. 10-11. Random tumor. 12. Tumor near previous spleen. 13. One lymph node sectioned. 14. Two lymph nodes. 15. Two lymph nodes. 16-18. Remainder of pancreatic fat. This case is accessioned in FileMaker Pro. MICROSCOPIC. A-D) The microscopic appearance substantiates the diagnosis. Dictation by. transcribed b. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. on. Lab and Collection. Information.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: RIGHT KIDNEY AND ADRENAL GLAND, RADICAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, FUHRMAN'S GRADE 3 OF 4 WITH FOCI OF. NECROSIS AND HEMORRHAGE, INVOLVING THE MID PORTION OF THE KIDNEY. B. THE TUMOR IS 2.8 CM IN GREATEST DIMENSION. C. THE CARCINOMA INVOLVES THE RENAL CORTEX AND MEDULLA AND EXTENDS INTO THE ADIPOSE TISSUE. IN THE RENAL SINUS. D. VASCULAR INVASION IS PRESENT, INCLUDING A TUMOR THROMBUS IN A LARGER MUSCLE CONTAINING. BRANCH OF THE RENAL VEIN IN THE RENAL HILUM BUT THE MAIN RENAL VEIN AT THE SURGICAL MARGIN. IS FREE OF TUMOR (slide D and K). E. BENIGN URETER SEGMENT, RENAL ARTERY AND GEROTA'S FASCIA. F. ALL SURGICAL RESECTION MARGINS ARE FREE OF TUMOR. G. NO SIGNIFICANT PATHOLOGIC CHANGES ARE SEEN IN THE NON-NEOPLASTIC KIDNEY AWAY FROM THE. TUMOR. H. PORTION OF BENIGN, HISTOLOGICALLY UNREMARKABLE ADRENAL GLAND. I. PATHOLOGIC TNM STAGE: pT3b Nx M1 (see comment). COMMENT: Please cross refer to cases. and. which show probable metastatic renal cell carcinoma to the. lung.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Right renal mass. Specimens Submitted: 1: SP: Right renal tumor; partial nephrectomy. DIAGNOSIS: 1. SP: Right renal tumor; partial nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade IVAV. Tumor Size: Greatest diameter is 4.3 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. RECUT. RECUT. Gross Description: 1). The specimen is received fresh for frozen section consultation and is labeled ""right renal tumor stitch marks the deep surgical. margin"". It consists of a 5.6 x 5.2 x 4.1 cm wedge shaped portion of kidney with a suture marking the deep margin. Also received in. the same container is a 7.1 x 5.2 x 0.8 cm plece of unremarkable fibroadipose tissue. Attached to the cortical surface of the. portion of rectum specimen is an adherent 4.5 x 1.2 x 1.2 cm blood clot. The margin is inked black and the specimen is serially. sectioned to reveal a well-circumscribed yellow lobulated focally sclerotic and hemorrhaglc cortical lesion measuring 4.3 x 4.1 x 2.1. cm. The clearance from the resection margin is 0.2 cm. A representative section of the nearest margin is submitted for frozen. section diagnosis. Representatively submitted. Portions of the tumor are submitted for TPS. Summary of sections: FSC - frozen section control. T tumor. M margin. RS - representative sections. Summary of Sections: Part 1; SP: Right renal tumor; partial nephrectomy. Block. Sect. Site. PCs. 1. FSC. 1. 2. M. 2. 1. RS. 4. T. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to thetissue sample examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: RIGHT RENAL TUMOR. ): EPITHELIOID TUMOR, MARGIN IS. CLOSE (ABOUT 0.1 CM) BUT CLEAR. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: CHIEF COMPLAINT/HISTORY OF PRESENT ILLNESS (INCLUDING PREOP AND POSTOP DIAGNOSIS): Thyroid nodule. PROCEDURE: Thyroidectomy. SPECIFIC CLINICAL QUESTION TO ANSWER:.Not answered. OUTSIDE TISSUE DIAGNOSIS ON THIS SPECIMEN: No. PRIOR CANCER/MALIGNANCYITUMOR: No. CHEMORADIATION THERAPY: No. HISTORY OF ORGAN TRANSPLANT: No. HISTORY OF IMMUNOSUPPRESSION: No. ANY OTHER UNDERLYING DISEASES: No. FINAL DIAGNOSIS: PART 1: THYROID GLAND, LEFT LOBE. LOBECTOMY (14 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, 3.3 CM, WITH DOMINANT FOLLICULAR GROWTH PATTERN (see. comment). B. EXTRATHYROIDAL EXTENSION IS ABSENT. C. VASCULAR INVASION IS ABSENT. D. CARCINOMA IS 0.1 CM FROM MARGIN. E. PATHOLOGIC STAGE: T2. PART 2: THYROID GLAND, RIGHT LOBE, LOBECTOMY (2.6 AND 0.7 GRAMS) -. BENIGN THYROID TISSUE. COMMENT: Previously, fine needle aspiration of the left thyrold lobe. was shown to be positive for HRAS. mutation (see addendum for. r further details). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Left Lobe. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 3.3 cm. HISTOLOGIC TYPE: Papillary carcinoma. PRIMARY TUMOR (pT): pT2. REGIONAL LYMPH NODES (pN): pNX. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION: Distance of invasive carcinoma to closest margin: 1 mm. Not identified.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Patient ID: Gross Description: A mass is located in right feet skin, with 5x4x2cm, firm, brown, black-gray surface. Microscopic Description: Epidermis is necrotic, ulcerated. Tumor is composed of spindle or oval tumor. cells with quitely scant cytoplasm. Sometime the cytoplasm contains finely divided melanin pigment. granulaes. Tumor cells have a quite low nucleo-cytoplasmic ratio. Nucleus varies in shape and size with. large esinophilic nucleoli. Mitotic figures are present. Tumor cells invade into fat tissue. Diagnosis Details: Malignant melanoma. Breslow tumor thickness: 20mm. Comments: Formatted Path Reports: SKIN TISSUE CHECKLIST. Specimen type: Surgical resection. Tumor site: Skin, foot. Tumor size: 5x4x2cm. Tumor features: Ulcerated, Pigmented, Necrotic. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Poorly differentiated. Lymph nodes: 2/9 positive for metastasis (Right inguinal and pelvic lymph node 2/9). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Right foot, Breslow tumor thickness: 20mm. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: ESOPHAGUS, ESOPHAGECTOMY -. A. ADENOCARCINOMA, MODERATELY DIFFERENTIATED, SCM, INVASIVE INTO THE SUBMUCOSA (pT1b). B. NEGATIVE FOR ANGIOLYMPHATIC AND PERINEURAL INVASION. C. SURGICAL RESECTION MARGINS (PROXIMAL ESOPHAGUS, DISTAL STOMACH AND ADVENTITIAL MARGIN). ARE NEGATIVE FOR NEOPLASTIC INVOLVEMENT. D. THE TUMOR COMES WITHIN 0.2CM OF THE RADIAL/ADVENTITIAL SURGICAL RESECTION MARGIN. E. 1.6CM DISTALLY FROM THE MAIN TUMOR IS A 0.9CM FOCUS OF HIGH GRADE DYSPLASIA. F. BACKGROUND GASTROESOPHAGEAL MUCOSA WITH BARRETT'S MUCOSA. G. THERE IS NO EVIDENCE OF MALIGNANCY IN NINE LYMPH NODES (0/9). H. AJCC STAGING: pT1b NO. PART 2: LYMPH NODE, SUBCARINAL NEAR LEFT MAIN BRONCHUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 3: LYMPH NODE, SUBCARINAL NEAR RIGHT MAIN BRONCHUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 4: LYMPH NODE, SUBCARINAL NEAR PERICARDIUM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 5: LYMPH NODE, SUBCARINAL NEAR THORACIC DUCT, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 6: LYMPH NODE, PARAESOPHAGEAL NEAR LEFT VEIN, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 7: LYMPH NODE, PARAESOPHAGEAL NEAR RIGHT CRUS, EXCISION -. A. FIBROADIPOSE TISSUE, NO LYMPH NODES IDENTIFIED. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 8: LYMPH NODE, NEAR VAGUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 9: LYMPH NODE, SUBCARINAL NEAR ATRIUM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 10: LYMPH NODE, LESSER CURVE, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 11: LYMPH NODE, NEAR LEFT GASTRIC ARTERY, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 12: LYMPH NODE, GASTRIC FAT, EXCISION -. A. SKELETAL MUSCLE AND FIBROADIPOSE TISSUE, NO LYMPH NODE IDENTIFIED. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 13: LYMPH NODE, NEAR AZYGOUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 14: LYMPH NODE, FAT PAD, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 15: LYMPH NODE, PERIESOPHAGEAL AND FAT PAD NEAR DIAPHRAGM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES (0/2). PART 16: ANASTOMOTIC RINGS, EXCISION -. A. RING OF STOMACH WITH OXYNTIC MUCOSA. B. RING OF ESOPHAGUS WITH SKELETAL MUSCLE. C. THERE IS NO EVIDENCE OF MALIGNANCY. PART 17: FINAL GASTRIC MARGIN, EXCISION -. A. STOMACH WITH OXYNTIC MUCOSA. B. THERE IS NO EVIDENCE OF MALIGNANCY. COMMENT: Part one. Esophagus, esophagectomy: The 5.0cm present at the gastroesophageal junction is similar to previous blopsy. by report as siides are not available for review. The tumor. comes to within 2mm of the adventitial surgical resection margin. There is a separate 0.9cm lesion with high grade. dysplasia located 1.6 cm distally to the main 5cm adenocarcinoma. No anglolymphatic invasion Is seen using double. immunohistochemical stain D240/AE1/3. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectomy. TUMOR SITE: Esophagogastric junction (EGJ) region (tumor involves EGJ and epicenter within 5cm. of EGJ). TUMOR SIZE: Greatest dimension: 5 cm. Additional dimensions: 2.3 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (PTNM). pT1b. pNO. Number of lymph nodes examined: 22. Number of lymph nodes Involved: 0. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Proximal margin uninvolved by dysplasia. Proximal margin uninvolved by intestinal metaplasia. Distal margin uninvolved by invasive carcinoma. Distal margin uninvolved by dysplasia. Distal margin uninvolved by intestinal metaplasia. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 4 mm. Specify margin: adventitial margin. ANGIOLYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Intestinal metaplasia (Barrett's esophagus). High grade dysplasia.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: F. Date of Service: A copy of this report will be faxed to: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: LEFT BREAST, MODIFIED RADICAL MASTECTOMY: - Two foci of invasive ductal carcinoma, Nottingham grade 2 (see comment). - Size: 2.3 cm and 0.7 cm. - Location: lower outer (4:00) and inner (7:00) quadrants, respectively. Associated ductal carcinoma in situ (DCIS), intermediate nuclear. grade, cribriform and micropapillary patterns with punctate necrosis. and without calcifications. - Size: DCIS spans a region measuring approximately 3.8 cm and. comprises 10% of tumor. - Margins of resection are widely free of invasive and in situ tumor (at least 1.2 cm. away). - Focus suspicious for lymphovascular invasion identified. Micrometastatic carcinoma (1.7 mm) identified in one of fourteen axillary. lymph nodes (1/14); no extranodal extension identified. - Prior biopsy site changes present. - Uninvolved breast parenchyma with fibrocystic changes and vascular. calcifications. - Benign skin and nipple. COMMENT: The two foci of invasive ductal carcinoma are similar histologically. Although there was little tubule formation identified on prior needle biopsy of the 7:00. lesion, tubule formation is more apparent on excision (>10%). Thus, the overall. histologic grade is Nottingham grade 2 for both lesions. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive ductal carcinoma, Nottingham grade 2. Type and grade (in situ): DCIS, intermediate nuclear grade. Primary tumor: pT2(m). Regional lymph nodes: pN1(mi). Distant metastasis: N/A. Printed: This report continues. Pathology - Page 1/5. FINAL SURGICAL PATHOLOGY REPORT. Stage: IIB. Lymphovascular invasion: Not identified. Margin status: R0, negative. Invasive Breast Cancer Tumor Staging Information. AJCC Cancer Staging Handbook, 7th Ed., and CAP Protocol (revised. Previous pathology specimens. Printed: This report continues (FINAL). Pathology - Page 2/5. ) - Page 2 Doc# 1. SPECIMEN IDENTIFICATION. Procedure/specimen type: Modified radical mastectomy. Laterality: Left breast. Lymph node sampling: Axillary dissection. INVASIVE CARCINOMA TUMOR CHARACTERISTICS. Histologic type: Invasive ductal carcinoma. Tumor site: Lower outer (4:00) and inner (7:00) quadrants. Tumor size: 2.3 cm and 0.7 cm. Tumor focality: Multifocal (two foci). Histologic grade (Nottingham Score): 2 of 3 (Nottingham score 6 - -7 of 9). Tubule formation: 2 of 3. Nuclear pleomorphism: 2-3 of 3. Mitotic rate: 2 of 3. Lymphovascular invasion: Focus suspicious for lymphovascular invasion. identified. Macroscopic and microscopic extent of tumor: Benign skin and nipple. DUCTAL CARCINOMA IN SITU (DCIS): Associated DCIS, intermediate nuclear grade,. cribriform and micropapillary patterns,. comprising 10% of tumor and spanning about. 3.8 cm. MARGINS. Invasive carcinoma: Widely negative for tumor (at least 1.2 cm away). Ductal carcinoma in situ: Widely negative for tumor (at least 1.2 cm away). LYMPH NODES. Total lymph nodes examined. 14. Number of lymph nodes involved. 1 (micrometastasis). Size of largest metastatic deposit: 1.7 mm. Extranodal extension: Absent. PATHOLOGIC STAGING: Primary Tumor (pT): pT2(m). Regional lymph nodes (pN): pN1(mi). Distant metastasis (pM): N/A. AJCC Stage: IIB. ANCILLARY STUDIES: ProPath. Estrogen receptor: POSITIVE (80-85% positive cells,. moderate-strong intensity) (4:00). Progesterone receptor: Negative (0% positive cells) (4:00). HER2: Negative (score 0) (4:00). This report continues. (FINAL). Pathology - Page 3/5. ) - Page 3 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. Ki-67;. High (40% positive cells) (4:00). Estrogen receptor: POSITIVE (20% positive cells, moderate-strong. intensity) (7:00). Progesterone receptor: Negative (0% positive cells) (7:00). HER2: Negative (score 0) (7:00). Ki-67: High (65% positive cells) (7:00). Source of Specimen: Breast;let breast radical mastectomy. Clinical History/Operative Dx: Breast cancer. Gross Description: Single specimen designated left breast radical mastectomy. Initially received in a fresh state for. Oncogenotyping tissue harvest is a left modified radical mastectomy weighing 809 grams, and measuring. 20.8 x 17.3 x 5.8 cm (not including axillary extension). and the axillary wing extending 10.5 x 9,0 x 4.0. cm. The overlying ellipse of tan-brown skin is 22.8 x 11.3 cm, with a paracentral darken brown, wrinkled. areola, 3.2 cm in diameter and a flattened 1.1 cm nipple. A palpable mass is appreciated in the lower. outer quadrant. A suture marks the medial apex of the specimen. The surgical margins are now. differentially inked as follows: Superior-superficial is marked blue,. Inferior-superticial is marked orange,. Deep is marked black. The breast is serially sectioned perpendicularly through the medial-lateral long axis, to reveal a partially. circumscribed. dense pink-gray, tumor mass measuring upwards of 2.3 x 1.5 x 1.3 cm (slabs 4-6, from. lateral). This mass is placed in the lower outer quadrant, approximating the 4:00 position and grossly. approaching within 1.8 cm of the deep, 2.3 cm of the inferior superficial, 5.0 cm of the lateral extension of. breast (not including axillary) and greater than 12.0 cm from the most medial extension of breast. The. This report continues (FINAL). Acct No. Pathology - Page 4/5. Page 4 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. tumor includes an embedded hook-shaped metallic clip. Representative portion of the tumor,. peri-neoplastic, and normal breast parenchyma is submitted for Oncogenotyping studies. A second, discrete, poorly visualized glistening tan lesion, is within the lower inner quadrant,. approximating the 7:00 position, and measuring up to 0.7 x 0.5 x 0.5 cm and placed within 2.3 cm of the. inferior superficial, 2.4 cm of the deep. and greater than 5.0 cm from the most medial extension of breast,. A second biopsy site clip is not appreciated. The cut sections of the remainder of the breast demonstrate prominent ductal tracts in the subareolar. lesion, up to 0.5 cm in diameter, exuding yellow-gray cheesy material, and bluish purulent fluid. Several. blue dome cysts are up to 0.6 cm. Initial examination of the axillary extension of fat reveals fifteen lymph node candidates, ranging from 0.2. cm - 2.0 x 1.7 x 1.2 cm in greatest dimension. The lymph node tissue is represented for microscopic. evaluation. Cassette summary: A1) nipple, subareolar tissue, two pieces,. A2) medial and lateral extension of skin,. A3-A5) large tumor mass, lower outer quadrant, represented,. A6) deep margin adjacent to large tumor mass,. A7) inferior superficial margin adjacent to large tumor mass,. A8-A10) lateral extension of breast tissue, adjacent to large mass, slabs 3, 2, 1, respectively,. A11) breast tissue medial to large tumor, slab 7,. A12-A14) second nodular lesion and inferior superficial margin and deep margin (A14),. A15) central breast-subareolar,. A16) upper outer quadrant, slab 3,. A17) upper inner quadrant, second slab from medial,. A18) four small lymph node candidates,. A19) three lymph node candidates, most proximal to breast,. A20) four lymph node candidates,. A21) single lymph node candidate bisected,. A22) single lymph node candidate trisected,. A23) enlarged flattened lymph node bisected,. A24) largest lymph node candidate serially sectioned and submitted. Microscopic Description: Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Intradepartmental consultation: has reviewed selected slides and concurs. FND OF REPORT. Acct No. -. Pathology - Page 5/5. Jol.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PROCEDURE. Right breast lumpectomy. SPECIMEN: A. R. breast lump. Nylon suture at posterior margin. Beige suture. superior margin. B. Sentinel node #1. C. Sentinel node #2. D. Right breast tissue (black suture most superior margin) . E. Right breast tissue (black suture at most anterior margin). HISTORY. Right breast cancer. GROSS. A. Received fresh in a container labeled ""right breast tissue"" is. a. fragment of fibrofatty breast tissue (5.7 cm in medial-lateral. dimension, 7 cm in superior-inferior dimension, 1.8 cm in. anterior-posterior dimension) oriented by attached sutures. An. accompanying specimen radiograph reveals abundant radiodense. tissue. The density corresponds to a sclerotic, gray-white, hard tumor mass. (2.8 cm in greatest dimension) which is within 1-2 mm of the. anterior margin, 0.5 cm from the posterior margin, 0.6 cm from the. medial margin, approximately 1.4 cm from the lateral margin and 1.2. cm from the superior margin. The remaining parenchyma consists of. abundant firm white fibrous tissue with scattered cysts up to 2-3 mm. in diameter, along with dilated ducts containing opaque yellow-tan,. paste-like material. Total fixation time in formalin is. approximately 28 hours. A representative portion of the tumor is. submitted for the. Ink Code: Black - posterior. Blue - anterior. Green - lateral. Red - medial. Orange - superior. Purple - inferior. 1. Superior margin. 2-3 and 4-5. Full thickness bisected cross sections, including. nearest radial margins. 6-7. Indurated parenchyma away from tumor. 8. Inferior margin. B. Received in formalin in a container labeled ""sentinel node. #1"". is. a 1.8 cm in greatest dimension, blue-gray, fatty lymph node. C. Received in formalin in a container labeled sentinel node #2"". is a 0.6 cm, firm, tan and gray lymph node. D. Received in formalin in a container labeled ""right breast. tissue, black suture most superior margin"" is a sheet of fibrofatty. tissue (4 x 3 x 1.2 cm) oriented by an attached suture. Ink Code: Black - superior margin (adjacent to suture). Blue - opposing margin. The tissue is serially sectioned and submitted in its entirety in. three cassettes. E. Received in formalin in a container labeled right breast tissue. black suture most anterior margin"" is a fragment of fibrofatty. tissue (2.9 x 1.6 x 0.9 cm) oriented by an attached suture. Ink Code: Black - anterior margin (adjacent to suture) . Blue - opposing margin. The specimen is serially sectioned and submitted in its entirety in. two cassettes. MICROSCOPIC. See diagnosis. DIAGNOSIS. A. Right breast lump, lumpectomy: Invasive lobular carcinoma (see comment) . B. Sentinel lymph node #1, excision: One lymph node involved by metastatic adenocarcinoma (largest. metastatic focus 2 mm) (1/1) . C. Sentinel lymph node #2, excision: One benign lymph node, free of tumor (0/1) . D. Right breast tissue, excision: Microscopic foci of invasive lobular carcinoma (up to 5 mm in. greatest dimension). Tiny focus of lobular cancerization. Neoplasm is approximately 4-5 mm from most superior margin. (black inked margin, adjacent to suture) and at blue inked. opposing aspect. E. Right breast tissue, excision: No tumor is seen. COMMENT. BREAST CARCINOMA SUMMARY: SPECIMEN: Partial breast. PROCEDURE: Lumpectomy. SPECIMEN INTEGRITY: Single intact with additional margin submitted. in parts C (superior margin) and D (anterior margin). SPECIMEN LATERALITY: Right breast lumpectomy. SPECIMEN SIZE: 5.7 x 7 x 1.8 cm. TUMOR SIZE: 2.8 cm. TUMOR FOCALITY: A 2.8 cm focus of invasive lobular carcinoma, and. additional tiny foci (up to 5 mm) of invasive lobular carcinoma away. from tumor. SKIN INVOLVEMENT: Skin not present. NIPPLE INVOLVEMENT: Nipple not present. SKELETAL MUSCLE INVOLVEMENT: Skeletal muscle not present. DUCTAL CARCINOMA IN SITU (DCIS) : Negative. LOBULAR CARCINOMA IN SITU (LCIS) : Present. HISTOLOGIC TYPE: Invasive lobular carcinoma. GRADING (NOTTINGHAM) : Tubular formation score: Score 3. NUCLEAR PLEOMORPHISM SCORE: Score 2. MITOTIC RATE SCORE: Score 1. COMBINED GRADE (NOTTINGHAM) : Grade 2 (intermediate grade) . LYMPHOVASCULAR INVASION: Not identified. MARGIN OF EXCISION: Final margins appear free of tumor (closest. margin is superior, approximately 4-5 mm. part D). LYMPH NODES: One sentinel lymph node involved by metastatic lobular. carcinoma (sentinel lymph node #1, part B (largest tumor focus is 2. mm) (1/2). MICROCALCIFICATION: Not identified. OTHER FINDINGS: Fibrocystic changes, usual ductal hyperplasia. HORMONE RECEPTORS: Reported (estrogen receptor positive (70%,. strong) i Progesterone receptor positive (over 90%, strong). HER-2/NEU: Reported (equivocal (2+) by immunohistochemistry,. FISH pending. PATHOLOGIC TNM (AJCC EDITION) : T2 N1mic MX. NOTE: A cytokeratin E1/E3 immunohistochemical stain was performed. on parts B (sentinel lymph node #1) and C (sentinel lymph node #2). It is strongly positive on part B (sentinel lymph node #1) within. the metastatic tumor cells, and supports the diagnosis. It is. negative within part c (sentinel lymph node #2), consistent with. benign lymph node. ?ctronic Signature). Completed Action List: on. Type: Sura Path Final Report. Title:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LYMPH NODES, RIGHT LEVEL 2, EXCISION: - MULTIPLE LYMPH NODE FRAGMENTS NEGATIVE FOR METASTATIC CARCINOMA. B. LUNG, RIGHT LOWER LOBE, LOBECTOMY, B1FS: - POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA, 4.5 X 3.5 X 3.5 CM. - BRONCHIAL AND VASCULAR MARGINS ARE NEGATIVE FOR CARCINOMA. - ANGIOLYMPHATIC INVASION IDENTIFIED. - THREE PERIBRONCHIAL LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA WITH EXTRANODAL. EXTENSION (3/3). - SEE SYNOPTIC REPORT AND COMMENT. C. LYMPH NODES, RIGHT, LEVEL 7, EXCISION: - MULTIPLE LYMPH NODE FRAGMENTS NEGATIVE FOR METASTATIC CARCINOMA. D. LYMPH NODES, RIGHT, LEVEL 4, EXCISION: THREE LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/3). Comment. Immunohistochemical stains for p63 shows strong nuclear staining in areas of squamous differentiation. These same areas are. negative for TTF-1 stain. Although there is a small component showing focal glandular differentiation, the quantity is insufficent. for a diagnosis of adenosquamous carcinoma. Synoptic Worksheet. B. Right lower lobe; stitch at bronchial margin. Specimen: Lobe(s) of lung: right lower. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Lower lobe. Tumor Focality: Unifocal. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. Tumor Size: Greatest dimension: 4.5 cm. Additional dimension: 3.5 cm. Additional dimension: 3.5 cm. Visceral Pleura Invasion: Not identified. Tumor Extension: Not identified. Bronchial Margin: Uninvolved by invasive carcinoma. Squamous cell carcinoma in situ (CIS) not identified at bronchial margin. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Uninvolved by invasive carcinoma. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. All Margins Uninvolved By Invasive Carcinoma: Distance of invasive carcinoma from closest margin: 5 mm. Margin closest to invasive carcinoma: bronchial. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. Extranodal Extension: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension. surrounded by lung or visceral pleura, without bronchoscopic evidence of. invasion more proximal than the lobar bronchus (ie, not in the main. bronchus); or Tumor 5 cm or less in greatest dimension with any of the. following features of extent: involves main bronchus, 2 cm or more distal to. the carina; invades the visceral pleura; associated with atelectasis or. obstructive pneumonitis that extends to the hilar region but does not involve. th the entire lung. Regional Lymph Nodes (pN): pN1: Metastasis in ipsilateral peribronchial and/or lipsilateral hilar lymph. nodes, and intrapulmonary nodes, including involvement by direct extension. Nodes examined: 6. Nodes involved: 3. Involved nodal station(s): peribronchial. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None identified. Clinical History. Lung cancer. Right VATS with right lower lobectomy. Specimen(s) Received. A: Right level II lymph node. B: Right lower lobe; stitch at bronchial margin. C: Right level 7 lymph nodes. D: Right level 4 lymph nodes. Gross Description. Specimen A is received in formalin, labeled with the patient's name, medical record number and identified as ""right level 2 lymph. node."" The specimen consists of multiple fragments of adipose tissue measuring in aggregate 1.1 X 0.8 x 0.5 cm. The. specimen is submitted entirely in cassette ""A1."". Specimen B is received fresh, labeled with the patient's name, medical record number and titled ""right lower lobe, FS."" The. specimen consists of a single lung lobe that measures 18.5 x 15.0 x 3.0 cm and weighs 260 grams. The specimen contains a. 4.5 x 3.5 X 3.5 cm well-circumscribed, firm, white mass. The mass appears to be 0.5 cm away from bronchial margin and 1.0 cm. away from the vascular margin. The mass appears to abut but does not pucker the anterior pleura and is 0.5 cm away from the. posterior pleura, No tumor is grossly seen in the bronchial or vascular system. No other masses or lesions are identified. Dictated by Dr. Specimen C is received in formalin, labeled with the patient's name and medical record number, and identified as ""right level 7. lymph node.' The specimen consists of a single piece of fibroadipose tissue measuring 1.8 X 1.3 x 0.5 cm. The specimen is. submitted entirely in cassette ""C1."". Specimen D is received in formalin, labeled with the patient's name, medical record number, and identified as ""right level 4 lymph. node."" The specimen consists of multiple fragments of fibroadipose tissue measuring in aggregate 1.1 x 0.6 X 0.4 cm. The. specimen is submitted entirely in cassette ""D1."". CASSETTE SUMMARY: B2: Mass in relation to posterior pleura. B3: Mass in relation to bronchus edge. B4: Vascular margin. B5: Mass in relation to the anterior pleura. B6: Single lymph node at bronchial edge, bivalved. B7: Mass in relation to the vasculature. B8: Mass in relation to bronchial system. B9: Mass in relation to normal lung parenchyma and representative section of mass. B10: Representative section of normal lung tissue. Intraoperative Consult Diagnosis. B1FS: BRONCHIAL MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. Microscopic Description. Microscopic examination performed.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
De-Identified Specimen Code: F. SPECIMEN SUBMITTED: Part A: RIGHT SUPERIOR SEGMENT. Part B: R11 SUMP. Part C: R7. Part D: R11 NODE. Final Diagnosis. 1. Right lung, superior segment, segmentectomy (A) - Adenocarcinoma, micropapillary. predominant (WHO mixed adenocarcinoma, with micropapillary, acinar and bronchioloalveolar cell. carcinoma components), see comment. - Centrilobular emphysema. 2. Lymph nodes, R11 SUMP, excision (B) - Metastatic adenocarcinoma. 3. Lymph nodes, R7, R11, excision (C) - Lymph nodes; negative for neoplasm. Diagnosis Comment: Tumor Location: right lower lobe, superior segment. Tumor Size: 2x2x1cm. Vascular Invasion: not identified. Lymphatic Invasion: present. Bronchial Margin: negative. Vascular Margin: negative. Parenchymal Margins: negative. Pleura/Soft Tissue Margin: negative. Pathologic Stage (AJCC): p stage IIA (T1a N1 MX). Additional comments: the adenocarcinoma is composed of micropapillary (65%), acinar (30%) and lepidic. patterns (5%). Intraoperative Diagnosis: 1. Adenocarcinoma. Bronchial margin is negative for tumor. Clinical Diagnosis: LUNG CA. Gross Description: A. Received fresh for frozen section consultation is a specimen labeled ""right superior segment"" that. consists of a wedge shaped piece of lung parenchyma weighing 58 grams and measuring 8.5 x 4.5 x. 2.5 cm with a bronchial stump of 0.3 cm in length and 0.5 cm in diameter. A tan-gray solid nodule with. stellate borders measuring 2 X 2 X 1 cm is present within the lung parenchyma, adjacent and retracting. the overlying pleura and extending within 1.5 cm of the bronchial and 1.7 cm from the nearest. parenchymal margin. The remaining lung parenchyma appears red and soft. No peribronchial lymph. nodes are present. Representative sections are submitted as follows: A1 bronchial shave margin. frozen, A2 - A8 nodule (A2 for frozen section evaluation, A3 with pleura, with parenchymal margin), A9. of unremarkable parenchyma distal to mass, A10 vascular margin. B. Received fresh on Telfa gauze labeled ""R11 stump"" is an irregular-shaped segment of red-gray soft. tissue measuring 1.3 X 0.5 X 0.4 cm. The specimen is totally submitted in formalin in one cassette. C. Received fresh on Telfa gauze labeled ""R7"" is an irregular-shaped segment of red-gray soft tissue. measuring 0.8 X 0.5 X 0.4 cm. The specimen is totally submitted in formalin in one cassette. D. Received fresh on Telfa gauze labeled ""R11 node"" is an irregular-shaped segment of red-gray soft. tissue measuring 0.4 X 0.4 X 0.4 cm. The specimen is totally submitted in formalin in one cassette. Microscopic: {Not Entered}.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor Site: Body, lesser curvature. Tumor configuration: Exophytic. (polypoid). Tumor size: 11.0 x 9.0 x 2.5 cm. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Extent of invasion: Serosa (visceral peritoneum). Lymph nodes: 3 of 8 lymph nodes positive for metastasis. Margins - Proximal margin: Not specified. Distal. margin: Not specified. Omental (radial) margin: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural. invasion: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Service Date. Male. Soc. Sec. #: Client: FINAL PATHOLOGIC DIAGNOSIS. A. Ureter, left, biopsy: No carcinoma. B. Ureter, right, biopsy: No carcinoma. C. Bladder and prostate, cystoprostatectomy: - Urinary bladder: 1. High-grade urothelial carcinoma with micropapillary features, invading. through muscularis propria into perivesicular adipose tissue. 2. Mucosal ulceration with granulomatous inflammation and calcification. 3. No carcinoma in one perivesicular lymph node (0/1). Prostate: No carcinoma. - Seminal Vesicles: No carcinoma. D. Lymph nodes, right pelvic, excision: Metastatic carcinoma in one of nine. lymph nodes (1/9). E. Urethra, final margin, biopsy: No carcinoma. F. Lymph nodes, left pelvic, excision: Metastatic carcinoma in three of seven. lymph nodes (3/7). G. Ureter, left, biopsy: No carcinoma. H. Ureter, right, biopsy: No carcinoma. COMMENT: Bladder Tumor Synoptic Comment. - Tumor type: Urothelial carcinoma with micropapillary features and focal squamous and glandular. differentiation. - Tumor grade: High grade. - Tumor size: 4.2 x 1.7 x 1.6 cm. - Extent of tumor in bladder: Invasion through muscularis propria into perivesical tissue. - Lymphatic/vascular invasion: Present in lymphatics. - Epithelial abnormalities in bladder: Carcinoma in situ. - Extension of tumor into adjacent organs: None. - Margins: - Urethral margin: Negative (invasive tumor is greater than 1 cm from margin; dysplasia/CIS is. greater than 1 cm from margin). Final urethral margin specimen (part E) is negative for carcinoma. - Right ureter margin: Negative (invasive tumor is greater than 3.1 cm from margin; dysplasia/CIS. is greater than 3.1 cm from margin). Final right ureter margin specimen (part H) is negative for. carcinoma. - Left ureter margin: Negative (invasive tumor is greater than 0.8 cm from margin; dysplasia/CIS is. greater than 0.8 cm from margin). Final left ureter margin specimen (part G) is negative for carcinoma. - Perivesical margin: Negative (invasive tumor is 0.2 cm from margin (left lateral, slide C4;. dysplasia/CIS is greater than 1 cm from margin). - Lymph node status: Positive. - total number of positive nodes: 4. - total number of nodes examined: 17. - Size of largest metastasis in node: 0.8 cm. - Extranodal extension: None. - Other pathologic findings in bladder: Granulomatous inflammation, ulcer, calcifications. - AJCC/UICC stage: pT3aN2. Level sections were obtained and evaluated to confirm the diagnosis. Specimen(s) Received. A:Ureter, biopsy (FS). B:Ureter, biopsy (FS). C:Bladder and prostate (FS on urethral apex). D:Lymph node, right pelvic. E:Final urethral margin. F:Lymph node, left pelvic. G:Distal left ureter. H:Distal right ureter. Intraoperative Diagnosis. FS1 (A) Left ureter, biopsy: No carcinoma. FS2 (B) Right ureter, biopsy: No carcinoma. FS3 (C) Urethral margin on bladder and prostate, biopsy: No carcinoma. Clinical History. The patient is a Fyear-old man who, per the electronic medical record. has high-grade, T2. transitional cell carcinoma diagnosed on transurethral resection of bladder tumor on. He is. now undergoing a radical cystoprostatectomy and bilateral pelvic lymph node dissection. Gross Description. The specimen is received in eight parts, each labeled with the patient's name and medical record. number. Parts A-C are received fresh. Parts D-H are all received in formalin. Part A, labeled ""left ureter,"" consists of a single soft, irregular piece of off-white/pink tissue (0.4 x 0.4 x. 0.2 cm). The entire specimen is frozen for frozen section diagnosis 1 and subsequently submitted in. cassette A1. Part B, labeled ""right ureter,"" consists of a single soft, irregular piece of off-white pink tissue (0.4 x 0.4. x 0.2 cm). The entire specimen is frozen for frozen section diagnosis 2 and subsequently submitted in. cassette B1. Part C is labeled ""bladder and prostate,"" and consists of a cystoprostatectomy specimen (664 gm; 11.3. cm from right to left x 6.8 cm from anterior to posterior x 23 cm from superior to inferior). GROSS PATHOLOGIC FINDINGS: There is a soft, tan-pink, friable, papillary lesion (1.6 cm from right to. left x 4.2 cm from superior to inferior x 1.7 cm deep) apparently extending into the perivesicular fat. The lesion is centered above the left trigone area, abutting the left ureteral orifice, and extends. superiorly up the left lateral wall to 1.1 cm below the dome of the bladder. The muscular invasion. appears to extend from the left lateral to the right lateral wall just past the midline, and in the right. lateral wall involving a portion of the muscle that is 3.5 x 1 x 0.8 cm, and not extending into the fat of. the right lateral bladder wall. The main lesion is 1 cm from the urethral orifice, 0.8 cm from the left. ureteral orifice, 3.1 cm from the right ureteral orifice, and 0.9 cm at the closest approach to the. perivesicular fat margin (left, blue); 0.5 cm from the right external perivesicular margin the right lateral. wall portion of the lesion. The lesion does not involve the ureteral orifice. The surrounding bladder. mucosa is pink, smooth, boggy, and edematous with punctate hemorrhages in the trigone area. The. attached prostate is pink-tan and lobular with nodules ranging from 0.5-0.8 cm in greatest dimension,. mostly in the anterior portion of the gland. The ureters are not attached. The attached perivesicular and periprostatic fat is carefully searched for. lymph nodes. ORIENTED BY: Anatomic landmarks. INTRAOPERATIVE EVALUATION: Frozen section of left ureter, en face (frozen section 1), submitted as. A1. Frozen section of right ureter margin, en face (frozen section 2), submitted as B1. Frozen section. of bladder and prostate at apex (frozen section 3), submitted as C1. INKING: - Anterior right surface: Green. - Anterior left surface: Blue. - Posterior surface: Black. GROSS PHOTOGRAPHS: Yes. CASSETTES: Representative sections are submitted as follows: C1: Bladder and prostate frozen section remnant. C2-C3: Lesion, left lateral bladder wall, deepest extent of invasion, including deep margin (blue),. bisected (bisected surface is black). C4: Lesion, left lateral bladder wall, representative section (1.8 cm from ureteral orifice). C5: Lesion, left lateral bladder wall, with approach to left ureteral orifice. C6: Lesion, left lateral bladder wall, with approach to bladder dome. C7: Lesion, left lateral bladder wall, with approach to normal mucosa laterally. C8: Lesion, right lateral bladder wall, closest approach to deep perivesicular margin (black). C9: Lesion, with closest approach to deep black margin (0.8 cm). C10: Left ureteral margin, en face. C11: Right ureteral margin, en face. C12-C13: Uninvolved right ureteral orifice, bisected (perpendicular section). C14: Lesion with approach to left ureter, and deep margin (perpendicular section). C15: Bladder dome, apparently normal. C16: Right lateral bladder wall, apparently normal. C17: Lesion, posterior bladder wall. C18: Lesion, left lateral bladder wall, with closest approach to urethral orifice (perpendicular. section). C19: Lesion, left lateral bladder wall, closest approach to prostate (parallel section). C20: Prostate, prostatic urethral margin, en face. C21: Prostate, right anterior and posterior apical one-third of gland. C22: Prostate, right anterior and posterior middle third of gland. C23: Prostate, right anterior and posterior base of gland. C24: Prostate, left anterior and posterior apical one-third of gland. C25: Prostate, left anterior and posterior middle third of gland. C26: Prostate, left anterior and posterior base of gland. C27-C28: Candidate lymph nodes, right perivesicular fat. C29-C30: Candidate lymph nodes, left perivesicular fat. C31: Seminal vesicle, left, representative section. C32: Seminal vesicle, right, representative section. Part D is additionally labeled ""right pelvic lymph nodes,"" and consists of multiple soft to firm, irregular,. unoriented, tan-yellow/brown, fibrofatty tissue fragments (8.5 x 8 x 4 cm in aggregate). Multiple. candidate lymph nodes (0.6-5.4 cm in greatest dimension) are found. The largest candidate lymph. node has mostly pink-white tissue mixed with homogeneous, yellow parenchyma. The second-largest. candidate lymph node (3.5 cm in greatest dimension) has pink-yellow/red parenchyma. The remaining. candidate lymph nodes are left intact. Representative sections (but all candidate lymph nodes) are. submitted in cassettes as follows: D1-D4: Largest candidate lymph node. D5-D7: Second-largest candidate lymph node. D8: Two intact candidate lymph nodes. D9: Four intact candidate lymph nodes. Part E is additionally labeled ""final urethral margin,"" and consists of a single soft to firm, slightly ovoid,. unoriented, tan-white/pink tissue fragment (1.5 x 0.8 x 0.5 cm). There is an off-centered lumen. (internal luminal diameter is 0.2 cm) that is patent and present. The margin is inked blue. The entire. specimen is submitted in cassette E1. Part F is additionally labeled ""left pelvic lymph node,"" and consists of multiple soft to firm, irregular,. unoriented, tan-yellow/brown, fibrofatty tissue fragments (7.5 x 7.5 x 2.8 cm in aggregate). Multiple. candidate lymph nodes (0.3 cm to 8 cm in greatest dimension) are found. The largest candidate lymph. node has firm, pink, surrounded by yellow, parenchyma. The second-largest candidate lymph node (1.6. cm in greatest dimension) has firm, white-pink parenchyma. The remaining candidate lymph nodes are. left intact. Representative sections (but all candidate lymph nodes) are submitted in cassettes as. follows: F1-F6: Largest candidate lymph node. F7: Second-largest candidate lymph node. F8: Three intact candidate lymph nodes. F9: Four intact candidate lymph nodes. Part G is additionally labeled ""distal left ureter,"" and consists of a single unoriented, tubular, tan-brown. tissue fragment (1.2 cm in length x 0.4 cm in diameter). The lumen is patent (0.2 cm internal luminal. diameter). One-half of the tissue is inked blue and the other half is inked black. The entire specimen is. submitted in cassette G1. Part H is additionally labeled ""distal right ureter,"" and consists of a single unoriented, tubular,. tan-brown tissue fragment (2.6 cm in length x 1.5 cm in diameter). The lumen is patent (0.2 cm. internal luminal diameter). One-half is inked blue with the other half Inked black. The entire specimen. is submitted in cassettes H1 and H2. Diagnosis based on gross and microscopic examinations. Final diagnosis made by attending pathologist. following review of all pathology slides. Pathology Resident.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
CORRECTED. Report Type. Date of Event. M. Hosp/Group. Record Status. ADDENDA: Addendum. PROBE: LSI EGFR/CEP7 Jual-Color Probe. Cytogenetic Location: 7p12 / 7p11.1-q11.1. EGFR FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE. NEGATIVE. Number of cells analyzed: 71. Ratio EGFR/CEP7: 1.3. High Polysomy : 0%. SNR (signal to nucleus ratio) : 2.3. Low Polysomy: 13 (18.3%). Trisomy: 9(12.7%). Disomy: 49(69.0%). This result should be integrated with all clinical and pathologic data. in the. determination of a comprehensive diagnostic and treatment plan. EGFR FISH analysis was manually performed and quantitatively assessed. analysis of a minimum of 60 cells using the EGFR SpectrumOrange and. the CEP7. SpectrumGreen probes. EGFR FISH positive: High Polysomy: > four gene copies in > 40% of cells. Gene Amplification: Ratio gene/chromosome more than two or > 15 gene. copies in. > 10% of cells. EGFR FISH negative: Disomy < two gene copies in more than 90% of the cells. Trisomy: three gene copies in more than 10% of cells. Low Polysomy: > four gene copies in more than 10% but less than 40% of. cells. References: Rogers SJ, Box C, Chambers P, Barbachano Y, Nutting CM, Rhys-Evans P,. Workman. P, Harrington KJ, Eccles SA. Determinants of response to epidermal. growth. factor receptor tyrosine kinase inhibition in squamous cell carcinoma. of the. head and neck. J Pathol. 2009 May;218(1) 122-30. Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N,. Jarrett. C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A,. Levy. S, Yarbrough WG, Slebos RJ, Hirsch FR. Increased epidermal growth factor. receptor gene copy number is associated with poor prognosis in head and. neck. squamous cell carcinomas. J Clin Oncol. 2006 Sep 1;24(25) : 4170-6. My signature is attestation that I have personally reviewed the. submitted. material (s) and the above diagnosis reflects that evaluation. Addendum. Immunoperoxidase stain for EGFR is positive. Immunoperoxidase stain. for p16. is focally positive but negative as a surrogate marker for HPV. In-. situ. hybridization for HPV is negative. My signature is attestation that I have personally reviewed the. submitted. material (s) and the above diagnosis reflects that evaluation. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT CERVICAL, LEVELS 2, 3, AND 4, SELECTIVE. DISSECTION. TWENTY-EIGHT LYMPH NODES, NO TUMOR PRESENT (0/28). PART 2: LYMPH NODES, LEFT CERVICAL, LEVELS 2, 3, AND 4, SELECTIVE. DISSECTION. A. MICROSCOPIC FOCUS OF METASTATIC SQUAMOUS CELL CARCINOMA IN. ONE OUT. OF THIRTY-TWO LYMPH NODES (1/32). B. THE LYMPH NODE WITH METASTATIC SQUAMOUS CELL CARCINOMA IS IN. LEVEL 3. AND THERE IS NO EXTRACAPSULAR EXTENSION. PART 3: LARYNX, TOTAL LARYNGECTOMY. A. SUPRAGLOTTIC INVASIVE SQUAMOUS CELL CARCINOMA,. NONKERATINIZING. (2. 5 CM) . B. ANGIOLYMPHATIC INVASION PRESENT. C. PERINEURAL INVASION ABSENT. D. RESECTION MARGINS ARE FREE OF CARCINOMA (ALSO SEE PART 4). E. NINE LYMPH NODES, NO TUMOR PRESENT (0/9). F. PATHOLOGIC STAGE: pT1 N2. PART 4: LEFT LATERAL MARGIN, BIOPSY. NO TUMOR PRESENT. My signature is attestation that I have personally reviewed the. submitted. tissue. Grossly, there is a 2.5 X 2.3 X 0.9 cm tan-white, firm,. exophytic. supraglottic tumor mainly involving the right side. Anterior. commissure,. preepiglottic soft tissue, vocal cords, and aryepiglottic folds are not. involved. The rest of the mucosa is unremarkable. There are two possible lymph nodes attached to the left side of the. larynx. measuring in greatest dimension 1.8 cm each. Multiple possible lymph. nodes. from anterior soft tissue are identified ranging in greatest dimension. from. 0.1 to .5 cm. The tumor is entirely submitted. Normal tissue and tissue from tumor is banked for SPORE Head and Neck. Tissue. Bank. Digital imaging photographs are taken. INK CODE: Black anterior soft tissue. Blue pre-epiglottic soft tissue. Orange area under hyoid bone, not true margin. Red banked area. CASSETTE CODE: 3A base of tongue margin, shave. 3B left lateral edge, shave,. 3C right lateral margin, shave. 3D inferior margin, shave (including superior portion of the. tracheostomy. mucosal site). 3E tracheostomy skin site, perpendicular. 3F tracheostomy soft tissue opening, perpendicular. 3G. representative of left vocal cords. 3H representative of right vocal cords. 3I-J. tumor and preepiglottic soft tissue, right to left. 3K-L reminder of tumor,. 3M-N one lymph node in each, bisected (attached to left larynx). 30 one lymph node, bisected, anterior soft tissue. 3P one lymph node, anterior soft tissue. 3Q possible lymph nodes, anterior soft tissue. Part 4 is received fresh labeled with the patient's name, initials XX. and. ""left lateral margin"". Received are two, pale yellow-tan soft tissue. fragments cervical and some is 0.3 X 0.2 and 1.5 x 0.5 X 0.4 cm. A. frozen. section is performed with an intraoperative diagnosis completed. The. specimen. is entirely submitted for processing in a cassette labeled 4AFS. INTRAOPERATIVE CONSULTATION: 4AFS: LARYNX, LEFT LATERAL MARGIN, (frozen section) -. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in 4 parts. Part 1 is received fresh labeled with the patient's name, initials. and. ""right neck levels 2, 3, 4"". Received is an unoriented, irregular mass. of. finely lobulated to coarsely lobulated 11 x 6 x 2 cm adipose tissue. The. specimen is divided into 3 equal segments and designated as levels A. (finely. lobulated segment) through C. Multiple lymph nodes are identified. ranging in. size from 0.1 to 2 cm. The lymph nodes are entirely submitted. Section code: 1A - level A -bisected lymph node. 1B - level A - bisected lymph node. 1C - level A - 4 possible lymph nodes. 1D - level B - 2 larger lymph nodes. 1E - level B - 4 lymph nodes. 1F - level B - 2 bisected lymph nodes. 1G - level B. - 6 smallest lymph nodes. 1H - level C - 4 possible lymph nodes. 1I - level C - 3 possible lymph nodes. Part 2 is received fresh labeled with the patient's name, initials. and. ""left neck-levels 2, 3, 4 (tie superior)"" Received is an oriented,. irregular, 12 x 3 x 3 cm, adipose neck dissection with a single suture. designating superior. The specimen is subdivided into 3 equal segments. and. designated as levels 2 through 4. Multiple lymph nodes are identified. ranging. in size from 0.2 to 2.6 cm in greatest dimension. Several of the. larger lymph. nodes within level 2 appear suspicious. The lymph nodes are entirely. submitted. Section code: 2A - 2C - level 2 - trisected largest lymph node. 2D - level 2-bisected lymph node. 2E - level 2-two bisected lymph nodes (one LN inked blue). 2F - level 2- two possible smaller lymph nodes. 2G - level 3-bisected lymph node. 2H - level 3-bisected lymph node. 2I - level 3-four possible lymph nodes. 2J - level 3-three smaller possible lymph nodes. 2K - level 4- - four possible lymph nodes. 2L - level 4-five possible lymph nodes. 2M - level 4-seven minute possible lymph nodes. Part 3 is received fresh labeled with the patient's name, initials. and. ""larynx"". It consists of a total laryngectomy measuring 11.5 X 8.0 X. 7.0 cm. with attached hyoid bone, skin (4.0 x 3.5 cm) with a tracheostomy site,. and. fibroadipose tissue with multiple lymph nodes attached the anterior. soft. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics. determined by. the. Department of Pathology, as required by. the CLIA. '88 regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue. fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity. clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this. laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - LARYNX RESECTIONS. TYPE OF LARYNGECTOMY : Total. TUMOR LATERALITY : Other location: Primary right with extension. across. midline. ATTACHED STRUCTURES: Pyriform sinus, Base of tongue, Tracheotomy,. Skin. TUMOR LOCATION/SEGMENT : Supraglottic. TUMOR SIZE: Maximum dimension: 2.5 cm. HISTOLOGIC TYPE OF TUMOR: Squamous cell carcinoma. HISTOLOGIC GRADE: Moderately differentiated. STRUCTURES INVOLVED BY TUMOR: Epiglottis. LYMPH NODES: Lymph nodes positive, Right: 0. Total number of right sided lymph nodes examined: 28. Lymph nodes positive, Left: 1. Total number of left sided lymph nodes examined: 32. Site of 'other' lymph nodes: Anterior soft tissue. Lymph nodes positive, 'other': 0. Total number of 'other' lymph nodes examined: 9. EXTRACAPSULAR SPREAD OF LYMPH NODE METASTASES. INTRA-PERINEURAL INVASION: Absent. VASCULAR INVASION: SURGICAL MARGIN INVOLVEMENT. Free (2 mm or more). T STAGE, PATHOLOGIC: Supraglottis, pT1. N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: pMX. PATIENT HISTORY: As a negative shorter one with a CHIEF COMPLAINT/PRE-OP/POST-OP. DIAGNOSIS: Cancer of larynx. PROCEDURE: Laryngectomy and bilateral neck dissections. SPECIFIC CLINICAL QUESTION: Margins and nodes. OUTSIDE TISSUE DIAGNOSIS: Yes-squamous cell carcinoma. PRIOR MALIGNANCY: No. CHEMORADIATION: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION No. OTHER DISEASES: No. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Neck Dissection, Level 2, 3, 4. Stain. Block. H&E X 1. A. H&E x 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E X 1. H&E x 1. G. H&E x 1. H. H&E X 1. Part 2: Neck Dissection Levels 7. 3. 4. Stair. Block. H&E X 1. A. H&E x 1. B. H&E X 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E x 1. G. H&E X 1. H. H&E x 1. I. H&E X 1. H&E X 1. K. H&E x 1. L. H&E x 1. M. Part 3: Larynx, Total Laryngectomy. Stain/. Block. H&E x 1. A. H&E x 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E X 1. G. H&E X 1. H. H&E Recut x. 1. IEGFR x 1. IBNKNC x 1. I. IBNKNC x 1. IBNKNC x 1. IBNKNC X 1. IBNKNC X 1. IBNKNC X 1. H&E x 1. HPV X 1. IISH X 1. IISH x 1. P16 X 1. V-EGFR X 1. H&E x 1. H&E x 1. K. H&E X 1. H&E x 1. M. H&E X 1. N. H&E x 1. O. H&E X 1. P. H&E x 1. Q. H&E x 1. R. Part 4: Left Lateral Margin. Stain/. Block. H&E X 1. A FS. TC1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
SLIDE DISPOSITION: DIAGNOSIS: G. Lung, right upper lobe, lobectomy: Invasive grade 4 (of 4). non-small cell carcinoma most consistent with adenocarcinoma,. forming a well-circumscribed, solid 6.2 x 6.0 x 5.7 cm mass. visceral pleural invasion is present. The portion of parjetal pleura. is not involved. Angiolymphatic invasion is absent. The bronchial. margin is negative for tumor (by 3.2 cm). Multiple (8). intrapulmonary peribronchial lymph nodes are negative for tumor. A. Lymph nodes, station 4R set #1, biopsy: Multiple (4) fragments of. lymph nodes are negative for tumor. B. Lymph nodes, station 4R set #2, biopsy: Multiple (7) fragments. of. lymph nodes are negative for tumor. c. Lymph nodes, station 4L, biopsy: A single (1) lymph node is. negative for tumor. D. Lymph nodes, station 2R, biopsy: Multiple (14) fragments of lymph. nodes are negative for tumor. E. Lymph nodes, station 7 set #1, biopsy: Multiple (8) fragments of. lymph nodes are negative for tumor. F. Lymph nodes, station 9R, biopsy: A single (1) lymph node is. negative for tumor. H. Lymph nodes, station 7 set #2, biopsy: Multiple (7) fragments of. lymph nodes are negative for tumor. [with available surgical material, AJCCpT2bNO 7th edition,. This final pathology report is based on the gross/macroscopic. examination and frozen section histologic evaluation of the. specimen(s) Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""station 4 right lymph node"" is a 1.1 x. 0.9 x 0.4 cm aggregate of lymphatic tissue which is all submitted. B. Received fresh labeled ""station 4 right lymph node (set 2)"" is a. 0.2 x 0.2 x 0.1 cm aggregate of lymphatic tissue which is all. submitted. Grossed by. c. Received fresh labeled ""station 4 left lymph node"" is a 0.6 x 0.4. x 0.3 cm aggredate of lymphatic tissue which is all submitted. D. Received fresh labeled ""station 2 right lymph node"" is a 0.3 x. 0.3 x 0.2 cm aggregate of TymphÃ¤tic tissue which is all submitted. E. Received fresh labeled ""station 7 lymph node"" is a 0.3 x 0.2 x. 0.1 cm aggregate of lymphatic tissue which is all submitted. F. Received fresh labeled ""station 9 right lymph node"" is a 0.4 x. 03. x 02. cm aggregate of lymphatic tissue which is all submitted. G. Received fresh labeled ""right upper lobe lung"" is a 265.0 gram. lobectomy with a 2.2 x 1.7 x 0.4 cm portion of adhered parietal. pleura. There is a 6.2 x 6.0 x 5.7 cm well-circumscribed, solid,. necrotic mass located peripherally, 3.2 cm from the shaved bronchial. margin. The mass extends to the parietal pleura and umbilicates the. visceral pleura which is inked and submitted perpencidularly. Multiple intrapulmonary peribronchial lymph nodes are identified. Representative sections are submitted. Grossed by. H. Received fresh labeled ""station 7 lymph nodes"" is a 0.3 x 0.3 x. 0.2 cm aggregate of lymphatic tissue which is all submitted. BLOCK SUMMARY: Part A: Station 4 right lymph node. 1 Rt lower paratracheal Ln. Part B: Station 4 right lymph node set 2. 1 Rt lower paratracheal set 2. Part C: Station 4 left lymph node. 1 Lt lower paratracheal LN. Part D: Station 2 right lymph node. 1 Rt upper paratracheal LN(D1). Part E: Station 7 lymph node. 1 Subcarinal LN (E1). Part F: Station 9 right lymph node. 1 Pulmonary ligament LN. Part G: Right upper lobe lung. 1 Rt bronchial margin. 2 Peribronchial LN 1(G1). 3 Peribronchial LN 3(G2). 4 Peribronchial LN1of3(G3). 5 Peribronchial LN2of3(G3). 6 Peribronchial LN3of3(G3). 7 Rt upper lobe mass 1. 8 Rt upper lobe mass 1. 9 Rt upper lobe mass 2. 10 Rt upper lobe mass 3. 11 Peribronchial LN 2 (G4). 12 Peribronchial LN 2 (G5). 13 Rt upper lobe mass 4. 14 Rt upper lobe mass. 5. 15 Rt upper lobe mass 6. 16 Rt upper lobe mass 7. 17 Rt upper lobe mass 8. 18 Normal Rt lung. Part H: station 7 lymph nodes. 1 Subcarinal LN 1(H1). 2 Subcarinal LN 4(H2). 3 Subcarinal LN 1(H3). 4 Subcarinal LN 1(H4).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
F. Pathologic Interpretation: A. Right breast short stich superior long lateral right single mastectomy: - Benign mammary parenchyma, no malignancy seen. B. Left breast and level I and II of axilla to tumor short superior, left lateral: - Invasive ductal carcinoma, Nottingham grade 3 (3+3+2), 2.8 cm in greatest linear dimension, focally presert at the. anterior specimen margin. - Ductal carcinoma in situ, high grade (DIN 3) solid type. - Organizing previous biopsy cavity. - Lymphovascular space invasion is present. - Metastatic carcinoma in four out of nine lymph nodes (4/9). - Receptors to follow. C. Additional fat above left breast tumor: - No malignancy seen in adipose tissue. D. Left level III axilla: - No malignancy seen in four lymph nodes (0/4). Tumor Summary (Invasive Carcinoma of the Breast): Specimen Type: Total breast (including nipple and skin). Procedure: Total mastectomy (including nipple and skin). Lymph Node Sampling: Axillary dissection (partial or complete dissection). Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Laterality: Left. Tumor Site: Lower outer quadrant; Lower inner quadrant. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 2.8 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: Skin: Invasive carcinoma does not invade into the dermis or epidermis. Nipple: DCIS does not involve the nipple epidermis. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma in Situ: DCIS is present. Architectural Patterns: Solid. Nuclear Grade: Grade III (high). Lobular Carcinoma in Situ: Not identified. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise specified). Histologic Grade: Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 3. Mitotic Count: Score 2. Overall Grade: Grade 3. Margins: Uninvolved by invasive carcinoma. Distance from posterior margin: 2 cm. Uninvolved by DCIS (if present). Lymph-Vascular Invasion: Present. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 0. Total number of lymph nodes examined (sentinel and nonsentinel): 13. Number of lymph nodes with macrometastases: 4. Size of largest metastatic deposit: 2.0 cm. Extranodal Extension: Not identified. SURGICAL PATHOL Report. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Pathologic Staging (pTNM). TNM Descriptore: m (multiple foci of invasive carcinoma). Primary TumorÂ¿pT2. Regional Lymph Nodes: pN2. Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: Pending. Progesterone Receptor: Pending. Her2: Pending. NOTE: Some immunohistochemical antibodies are analyte spectific reagents (ASRs) validated by our laboratory (Her 2, Pervo, H. pylori, HBcore). These ASRs are clinically indicators that do. not require FDA approval. These clones are used: ID5=ER, POR 636=PR, A485HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4 1=AR and HPV by ISH. All immunohistochemidelt stains are used. with formalin or molecular fixed, paraffin embedded fissue. Detection is by LSAB. The results are read by a pathologist as positive or negative. As the attending pathologist, / attest that 1: (i) Exemined the relevent. preperation(s) for the specimen(s); and (i) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. The tumor cells are positive for ER and PR and negative for HER2 by immunohistochemistry. Immunohistochemistry for p63 was. used in the evaluation of the specimen. Clinical History: female with left breast cancer. Pre Operative Diagnosis: Left breast cancer. Specimen(s) Received: A: Right breast short stich superior long lateral right single mastectomy (fresh). B: Left breast and level 1 and Il of axilla to tumor short superior, left lateral (fresh). C: Additional fat above left breast tumor (perm). D: Left level III axilla (perm). Gross Description: A. Received fresh and labeled ""right breast short stich superior long lateral right single mastectomy (fresh)"" is a breast. specimen measuring 18.0 x 15.0 x 5.0 cm. It has a white-tan ellipse of skin measuring 4.0 x 1.0 cm. The nipplÃ© measures. 1.0 x 1.0 cm. The skin is unremarkable and nipple is unremarkable. Deep margin is smooth, facial plane without any. SURGICAL PATHOL Report. skeletal muscle. Deep margin is inked in black. Serial sectioning of the mastectomy specimen does not reveal any gross. lesion. Specimen submitted as follows: 1&2. Sections from upper outer quadrant. 3&4. Representative section from lower outer quadrant. 5&6. Representative section from upper inner quadrant. 7&8. Representative section from lower inner quadrant. 9&10. Representative section from central quadrant. 11. Representative section from nipple. B. Received fresh and labeled ""left breast and level 1 and II of axilla to tumor short superior, left lateral (fresh)"" is a. mastectomy specimen measuring 19.0 x 17.0 x 3.0 cm. It has a white-tan ellipse of skin measuring 2.5 x 2.0 cm. The. axillary tail measures 13.0 x 9.0 cm. The skin and nipple are unremarkable. Deep margin is smooth, facial plane without. any skeletal muscle. Deep margin is inked black, superior margin is inked blue, medial margin is inked red and inferior. margin is inked green. Serial sectioning of the mastectomy specimen reveals a 2.8 x 2.0 x 1.5 cm firm gray mass located. in the lower outer quadrant, less than 0.1 cm from the inked anterior specimen margin. There is also a 1 x 1 1 cm. mass. in the lower inner quadrant. The mass is well defined. It has a clip in it. in the upper inner quadrant, there is an area of. necrosis measuring 2.0 x 2.0 x 1.0 cm. it is brown in color and soft in consistency. Remainder of the breast parenchyma is. predominantly white and firm with small cyst measuring up to 0.3 cm in greatest dimension. The axillary tail is yellow and. soft. There are 13 possible lymph nodes. The largest measures 3.0 cm in greatest dimension. Sections submitte as. follows: 1-8. Mass in the lower inner quadrant. 9&10. Area of necrosis. 11&12 Representative section from upper outer quadrant. 13&14 Representative section from lower outer quadrant. 15&16 Representative section from upper inner quadrant. 17&18 Representative section from lower inner quadrant. 19820. Representative section from the central quadrant. 21. Representative section from the nipple. 22-24. Contains representative section from the largest lymph node. 25-37. One fymph node per cassette. 38-41. Additional section of mass in lower outer quadrant. C. Received in formalin and labeled ""additional fat above left breast tumor"" is a soft fragment measuring 2.5 x 1.0x 1.0 cm. Submitted in toto in three cassettes. D. Received in formalin and labeled ""left level III axilla"" is a pale yellow, soft tissue fragment measuring 4.0 x 3.0 x 2.0 cm. Four possible lymph nodes are bisected and submitted in toto in four cassettes. ICD-9(s);. 174.5 174.3 196.3.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Surgery date: DIAGNOSIS: A. Lymph nodes, common hepatic artery #1, excision: A single (1). lymph node is negative for tumor. B. Lymph nodes, common hepatic artery #2, excision: Fibroadipose. tissue with chronic inflammation. C. Soft tissue, pancreatic portal vein interface, excision: Fibrous. tissue with granulation tissue and acute inflammation. D. Pancreas, neck margin, excision: Negative for tumor. E. Head of pancreas, gallbladder, duodenum, and portion of jejunum;. Whipple resection: Invasive moderately differentiated ductal. adenocarcinoma is identified forming a solid mass (4.3 X 3.5 x 3.1. cm) located in the pancreatic head. The tumor extends beyond the. pancreas to involve the peripancreatic soft tissue, duodenal wall,. and bile duct. Both angiolymphatic and perineural invasion are. absent. Tumor necrosis is absent. The uncinate margin is positive. for invasive carcinoma whereas the portal vein groove and cystic. duct margins are negative. The adjacent non-neoplastic pancreatic. parenchyma shows marked chronic pancreatitis. A single (1) cystic. duct lymph node is negative for tumor. The gallbladder demonstrate. chronic cholecystitis. Multiple (2 of 10) regional lymph nodes are. positive for metastatic adenocarcinoma. F. Lymph nodes, peripancreatic, excision: Multiple (2) lymph nodes. are negative for tumor. G. Lymph nodes, gastrocolic, excision: Multiple (5) lymph nodes are. negative for tumor. H. Lymph nodes, celiac axis, excision: Multiple (2) lymph nodes are. negative for tumor. With available surgical material, [AJCC pT3N1] (7th edition, 2010). This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. Interpreted by: GROSS DESCRIPTION: A. Received fresh labeled ""common hepatic artery lymph nodes"" is a. 2.5 x 2.5 x 0.5 cm aggregate of adipose and lymphatic tissue. All. submitted. Grossed by. B. Received fresh labeled ""common hepatic artery lymph node #2"" is a. 2.5 x 2.1 X 0.7 cm aggregate of adipose tissue, lymphatic tissue not. identified grossly. All submitted. Grossed by. C. Received fresh labeled ""pancreatic portal vein interface"" is a. 0.7 x 0.6 X 0.2 cm portion of tan-pink tissue. All submitted. D. Received fresh labeled ""pancreatic neck margin"" is a 3.0 x 2.1 x. 0.8 cm portion of pancreatic tissue with orientation. All. submitted. Grossed by. E. Received fresh labeled ""head of pancreas, gallbladder, duodenum,. portion of jejunum, and pancreas stones"" is a Whipple specimen. consisting of 34.0 cm in length portion of duodenum, 7.0 x 5.2 X 4.8. cm portion of pancreas, and a 16.5 x 5.5 X 2.4 cm gallbladder. The. pancreatic uncinate margin is inked yellow and shaved. The portal. vein groove is inked blue and submitted perpendicularly. There is a. 4.3 x 3.5 x 3.1 cm annular and diffusely infiltrative mass within. the pancreas at the uncinate margin. The mass extends to. peripancreatic soft tissue. A stent is present within the common. bile duct. Multiple irregular fragmented stones are identified. within the pancreas and pancreatic duct system, showing obstruction. toward the ampulla and dilation toward the pancreatic neck margin. The gallbladder contains no choleliths. Peripancreatic lymph nodes. are identified. Representative sections are submitted. Grossed by. F. Received fresh labeled ""peripancreatic lymph nodes"" is a 2.9 X. 2.2 x 0.8 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. G. Received fresh labeled ""gastrocolic lymph nodes"" is a 6.7 x 2.5 x. 0.7 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. H. Received fresh labeled ""celiac axis lymph nodes"" is a 2.9 x 1.0 x. 0.8 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. BLOCK SUMMARY: Part A: Common hepatic artery lymph node. 1 Comm hepatic artery LN 1(A1). 2 Comm hepatic artery LN 1 (A2). Part B: Common hepatic artery lymph node #2. 1 Common hepat artery LN#2(B1). 2 Common hepat artery LN#2(B2). Part C: Pancreatic portal vein interface. 1 Pancreatic portal vein. Part D: Pancreatic neck margin. 1 Pancreatic neck margin 1. 2 Pancreatic neck margin 2. Part E: Head of pancreas, gallbladder, duodenum, portion jejunum,. and pancreas stone. 1 Uncinate margin 1. 2 Uncinate margin 2. 3 Uncinate margin 3. 4 Uncinate margin 4. 5 Bile duct margin. 6 Portal vein groove margin. 7 Ampulla. 8 Pancreatic duct. 9 Pancreatic duct. 10 Peripancreatic LN 1of5(E1). 11 Peripancreatic LN 20f5(E1). 12 Peripancreatic LN 3of5(E1). 13 Peripancreatic LN 4of5(E1). 14 Peripancreatic LN 5of5(E1). 15 Peripancreatic LN 4(E2). 16 Peripancreatic LN 7(E3). 17 Cystic duct LN 1(E4). 18 Gallbladder. 19 Peripancreatic LN 2(E5). 20 Pancreatic mass. 21 Pancreatic mass. Part F: Peripancreatic lymph nodes. 1 Peripancreatic LN 2 (F1). 2 Peripancreatic LN 2 (F2). Part G: Gastro colic lymph nodes. 1 Gastro colic LN 4(G1). 2 Gastro colic LN 2(G2). Part H: Celiac axis lymph nodes. 1 Celiac axis LN 2(H1).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Service: Thoracic. Account. Clinical Diagnosis & History: LUL lesion. Specimens Submitted: 1: SP: Biopsy left upper lobe lung mans. 2: SP: Level eleven lymph nodes. 3: SP: Left upper lobe of lung. 4: SP: Level seven lymph nodes. 5: SP: AP window lymph nodes. DIAGNOSIS: LUNG, LEFT UPPER LOBE; BIOPSY: - NON-SMALL CELL CARCINOMA. 2). LYMPH NODE, LEVEL XI; BIOPSY: - TWO BENIGN LYMPH NODES (0/2). LONG, LEFT UPPER LOBE) LOBECTOMY: - SQUAMOUS CELL CARCINOMA, WITH FOCAL PSEUDOVASCULAR CHANGES, OF LEFT. UPPER LOBE, POORLY DIPPERENTIATED. - THE TUHOR MEASURES 3.4 x 3.0 x 2.3. - EXTENSIVE VASCULAR INVASION IS PRESENT. - PERINEURAL INVASION IS PRESENT. at THE BRONCHIAL MARGIN IS PREE OF TUMOR. - THE PLEURA IS FREE OF TUMOR. - NO IN SITU CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC LUNG SHOWS THE FOLLOWING ABNORMALITY (IES). #. EMPHYSENATOUS CHANGES, RESPIRATORY BRONCHIOLITIS, RARE SMALL NON-NECROTIZING. INTTRAPULMONARY GRANULOMAS. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF METASTATIC. NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) : PERIBRONCHIAL: 4/6. - EXTRANODAL EXTENSION IS PRESENT. . METASTATIC CARCINOMA IS ALSO IDENTIFIED. IN AN INTRAPUIMONARY LYMPH NODE, WHICH IS MORE THAN 3 CM FROM THE MAIN. TUMOR,. NOTE: IMOUMOSTAINS SHOW THAT THE TUMOR CELLS ARE POSITIVE FOR CK7 AND. 34BE12, FOCALLY POSITIVE FOR CK20 and 4A4, WHILE NEGATIVE FOR TTF-1, PE-10,. THYROGLOBULIN AND CD31. THIS INUNOPROFILE SUPPORTS THE DIAGNOSIS OF. SQUAMOUS CELL CARCINOMA. THE SPECIAL STAINS FOR APB AND FUNGI ARE NEGATIVE. 4). LYMPH NODEM, LEVEL VII; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 5). LYMPH NODE, AP WINDOW; BIOP9Y: - HETASTATIC CARCINOMA INVOLVING ONE OUT OF ONE LYMPH NODE (1/1). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. MUCIN. GMS. FITE. RECUT. Gross Description: 1), The specimen is received fregh for frozen section consultation labeled. biopsy, left upper lung lobe mass and consists of a 0.9 x 0.5 x 0.3 cm. aggragate of red-tan soft tissue fragments, which are entiroly submitted for. frozen section consultation. Summary of sections. FSC-frozen section control. 2). The spacimen is recoived fresh labeled ""level 11 lymph nodes"" and. consists of multiple fragments of xed-tan soft tissue measuring 1,5 x 1.0 x. 0.4 cm in aggregata, which are entirely submitted for frozen section. consultation. Summary of sections: FSC-frozen section control. 3). The specimen is received in a fresh state for intraoperative. consultation, labeled as oleft upper lobe of lung, and consists of the laft. lung upper lobe lobectomy specimen measuring 15 x 12 x 4.2 cm, weighing 244. g. Sectioning reveals a well-ciraumgoribed gray firm nodule measuring 3.4 x. 3.0 x 2.3 em in the lateral aspect of the specimen at 3 cm fxom the. bronchial resection margin. The overlying pleura (inked) is grossly. uninvolved. The proximal portion of the tumor encases bronchial branches. Background pulmonary parenchyma shows diffuse emphysematous changes. Multiple peribronchial lymph nodes are identified. The specimen is. photographed. TPS is taken. Representative sections are submitted. Summary of sections: FSC -- frozen section control (bronchial margin). VM -- vascular margin. LN -- peribronchial lymph nodes. T -- tumor. RC - background lung parenchyma adjacent to the tumor. RA - - background lung parenchyma away from the tumor. 4). The specimen is received in formalin and is labeled level 7 lymph. nodes"" consists of a pink-tan lymph node with focal anthracosis which. measures 1.2 cm. The lymph node is bisected and entiroly submitted. Summary OÃ sections: U-undesignated. 5). The specimen ia received in formalin and is labeled ""AP window lymph. nodes and consists of a pink-tan lymph node which measures 1.5 cm. The. lymph node is bisected and entiroly submitted. Summary of sections: U-undesignated. Summary of Sections: Part 1: SP: Biopsy left upper lobe lung mags. Block. Sect. site. PCs. 1. fac. 1. Part 2: SP: Level eleven lymph nodes. Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Left upper lobo of lung. Block. Sect. Site. PCS. 1. fac. 1. 1. 1n. 1. 2. ra. 2. 2. xc. 2. 7. 1. vm. Part 4: SP: Level seven lymph nodes. Block. Sect. site. PCg. 1. u. 1. Part $ : SP: AP window lymph nodes. Block. Sect. Site. PCs. u. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tiasue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: BIOPSY LEFT UPPER LOBE LUNG. MASS (FS). NON-SMALL CELL CARCINOMA WITH PLEOMORPHIC FEATURES. PERMANENT DIAGNOSIS: SAME. FROZEN SECTION DIAGNOSIS: SP: LEVEL ELEVEN LYMPH NODES. BENIGN. PERMANENT DIAGNOSIS: SAME. FROZEN SECTION DIAGNOSIS: SP: LEFT UPPER LOBE OF LUNG. BRONCHIAL MARGIN BENIGN. PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the tissue gample. examined at the time of the intraoperative consultation. 1). PROZEN SECTION DIAGNOSIS: SP: BIOPSY LEFT UPPER LOBE LUNG. HASS. NON-SMALL CELL CARCINOMA WITH PLEOMORPHIC FEATURES. PERNAMENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: LEVEL ELEVEN LYMPH NODES. BENIGN. PERMANENT DIAGNOSIS: SAME. FROZEN SECTION DIAGNOSIS: SP: LEFT UPPER LOBE OF LUNG. BRONCHIAL MARGIN BENIGN. PERMANENT DIAGNOSIS: SANE.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Specimen(s) Received. 1. Soft-Tissue: left lateral tongue margin Quick section. 2. Soft-Tissue: left anterior tongue margin. 3. Soft-Tissue: left posterior tongue margin. 4. Soft-Tissue: deep margin. 5. Soft-Tissue: left alveolar margin. 6. Soft Tissue: Contents of left neck. 7. Oral Cavity: Left sublingual gland. 8. Oral Cavity: Contents left tongue & floor of mouth short suture anterior long suture posterior nylon double long suture inferior. 9. Soft Tissue: Revised: Deep margin single chip anterior double chip posterior triple chip inferior. Diagnosis. 1. Left lateral margin. Negative for malignancy. 2. Left anterior margin. Negative for malignancy. 3. Left posterior margin. Negative for malignancy. 4. Deep margin. Negative for malignancy. 5. Left alveolar margin. Negative for malignancy. 6. Left neck contents: Twenty nine lymph nodes negative for tumour (0/29). Submandibular gland with no pathologic changes. 7. Left sublingual gland. Salivary gland tissue with mild chronic sialadenitis. Negative for malignancy. 8. Oral cavity' left tongue and floor of mouth. Squamous cell carcinoma, poorly differentiated. a. Maximal tumour dimension 2.8 cm. b. Tumour thickness 0.9 cm. c. No perineural invasion. d. No vascular/lymphatic invasion. e. Moderate to severe squamous dysplasia is present. f. All margins negative for tumour. 9. Revised deep margin. Negative for malignancy. Synoptic Data. Specimen Type: Resection: Partial glossectomy. Tumor Site: Tongue. Histologic Type: Squamous cell carcinoma, conventional. Tumor Size: Greatest dimension: 2.8 cm. Tumor thickness: 0.9 cm. Histologic Grade: G2: Moderately differentiated. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Perineural Invasion: Absent. Additional Pathologic Findings: None identified. Margins: Margins uninvolved by tumor. Margins uninvolved by tumor - Distance of tumor from closest margin: 0.4 cm. Margins: deep. Pathologic Staging (pTNM): pT2: Tumor of lip or oral cavity more than 2 cm but not more than 4 cm in. greatest dimension. pNO: No regional lymph node metastasis for aerodigestive sites. Number of regional lymph nodes examined: 29. Number of regional lymph nodes involved: 0. pMX: Distant metastasis cannot be assessed. Gross Description. 1. The specimen is labeled with the patient's name and as ""Soft-Tissue: Left lateral tongue margin quick section"". It. consists of a fragment of tissue measuring 1.5 x 0.7 x 0.5 cm. The specimen is bisected and submitted in toto for frozen. section. 1A. frozen section control. 2. The specimen is labeled with the patient's name and as ""Soft-Tissue: Left anterior tongue margin"". It consists of a. fragment of tissue measuring 0.7 x 0.6 x 0.2 cm. The specimen is submitted in toto for frozen section. 2A. frozen section control. 3. The specimen is labeled with the patient's name and as ""Soft-Tissue: Left posterior tongue margin"". It consists of a. fragment of tissue measuring 1.4 X 0,6 x 0.3 cm. The specimen is submitted in toto for frozen section. 3A. frozen section control. 4. The specimen is labeled with the patient's name and as ""Soft-Tissue: Deep margin"". It consists of a fragment of tissue. measuring 0.8 x 0.6 X 0.3 cm. The specimen is submitted in toto for frozen section. 4A. frozen section control. 5. The specimen is labeled with the patient's name and as ""Soft-Tissue: Left alveolar margin"". It consists of a fragment of. fissue measuring 17x05x03cl The specimen is submitted in toto for frozen section. 5A. frozen section control. 6. The specimen is labeled with the patient's name and as ""Soft Tissue: Contents of left neck"". It consists of an oriented. left neck dissection with dimensions of 10.7 x 11.0 x 1.5 cm. Two portions of unremarkable muscle are identified and. measure 2.4 X 1.5 x 0.3 cm and 2.8 X 1.5 X 0.6 cm. The submandibular gland measures 3.8 X 2.9 X 1.4 cm and is. unremarkable. Multiple lymph nodes ranging from 0.1 to 2.5 cm are identified in multiple levels. Representative sections. are submitted as follows: 6A. one lymph node, level IA. 6B. one lymph node, level IA. 6C. one lymph node, level IA. 6D. submandibular gland. 6E-6G. one lymph node per block, level IB. 6H. two lymph nodes, level IIB. 6I. one lymph node, level IIB. 6J. one lymph node, level IIA. 6K. one lymph node, level IIA. 6L. one lymph node, level IIA. 6M. multiple lymph nodes, level III. 6N. two lymph nodes, level III. 6O-6P. one lymph node per block, level III. 6Q-6R multiple lymph nodes per block, level IV. 6S. one lymph node, level IV. 6T. one lymph node, level IV. 7. The specimen is labeled with the patient's name and as ""Oral Cavity: Left sublingual gland"". It consists of one piece of. tissue measuring 1.4 X 1.2 X 0.5 cm. 7A. specimen in toto. 8. The specimen is labeled the patient's name and as ""Oral Cavity: Contents left tongue & floor of mouth short suture. anterior, long suture posterior, nylon double long suture inferior"". It consists of an oriented portion of left lateral tongue. measuring 3.0 cm SI x 1.9 cm ML X 4.7 cm AP. There is a well-circumscribed tumor involving the left lateral surface of the. tongue. The tumor measures 2.1 cm SI x 1.2 cm ML x 2.8 cm AP. The tumor is solid and firm and is located at the lateral. margin, 0.2 cm from the medial/deep margin, 0.6 cm from the superior margin, 0.4 cm from the inferior margin, 0.6 cm. from the anterior margin, and 0.5 cm from the supero-posterior margin. Cross sections reveal a portion of left sublingual. gland, measuring 1.4 cm SI x 0.6 cm ML X 2.0 cm AP. All the margins of the specimen are painted with Silver nitrate. The superior aspect is also painted green. Two pieces of tumor and one piece of normal tongue are taken for the. tissue. bank. Representative sections are submitted. 8A. anterior margin and tumor. 8B-8C one full thickness section of tumor. 8D-8E one full thickness section of tumor. 8F-8G tumor. 8H. supero-posterior margin and tumor. 9. The specimen is labeled the patient's name and as ""Soft Tissue: Revised: Deep margin single clip anterior, double clip. posterior, triple clip inferior"". It consists of an unremarkable portion of tongue measuring 2.5 cm SI X 0.9 cm ML X 4.0 cm. AP. The margins of the specimen have been painted with Silver nitrate. The specimen is submitted in toto. 9A. anterior margin, en face. 9B-9G remaining specimen, anterior to posterior. 9H. posterior margin, en face.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: Partial colon/rectum resection material shows two colorectal carcinomas: An ulcerated carcinoma of the rectum characterized histologically as a moderately differentiated. colorectal adenocarcinoma, extending to within 3 cm of the aboral resection margin and. measuring 3.5 cm at its widest diameter. Invasive tumor spread within all layers of the intestinal. wall as far as the periproctic fatty tissue. 2.: A carcinoma of the colon characterized histologically as a moderately differentiated. colorectal adenocarcinoma, extending to within 4 cm of the oral resection margin and measuring. 2 cm at its widest diameter. Invasive tumor spread as far as the level of the muscularis propria. Oral and aboral resection margin tumor-free. Three of nineteen periproctic or mesocolic lymph nodes with metastases of the rectum or colon. carcinoma extending in some cases over the lymph node capsule. Tumor stage of the rectum carcinoma thus pT3; G2. that of the colon carcinoma pT2; G3. Lymph node status pN1 (3/19) LO V0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, NEEDLE LOCALIZED SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, 2.0 CM (GROSS), NOTTINGHAM GRADE 1 (COMBINED NOTTINGHAM. SCORE 4/9: TUBULE FORMATION 1/3, NUCLEAR PLEOMORPHISM 2/3, MITOTIC ACTIVITY 1/3). B. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM TYPE, CONSTITUTES. APPROXIMATELY 5% OF THE TUMOR VOLUME AND IS ADMIXED WITH THE INVASIVE COMPONENT. C. LYMPHOVASCULAR SPACE INVASION IS NOT IDENTIFIED. D. MARGINS FREE, CLOSEST ANTERIOR/SUPERIOR WITHIN 0.6 CM. E. DUCTAL EPITHELIAL HYPERPLASIA. F. FIBROCYSTIC CHANGES. G. SCLEROSING ADENOSIS. H. COLUMNAR CELL CHANGE. I. FIBROADENOMATOID NODULES. J. SKIN IS NEGATIVE FOR TUMOR. K. BIOPSY SITE CHANGES. PART 2: LYMPH NOVES, KIGNI, SENUINEL. A. METASTATIC CARCINOMA (0.4 CM.) INVOLVES ONE OF TWO LYMPH NODES (1/2) (see comment). B. EXTRACAPSULAR EXTENSION IS IDENTIFIED, 0.1 CM X 0.07 CM. PART 3: LYMPH NODE, RIGHT, SENTINEL #2, BIOPSY -. A. METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE (1/1) (see comment). B. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED. PART 4: LYMPH NODE, KIGNT, SENTINEL #3, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1) (see comment). PART 5: BREAST, RIGHT, NEW LATERAL MARGIN, EXCISION -. A. RADIAL SCAR. B. FIBROCYSTIC CHANGES. C. SCLEROSING ADENOSIS. D. DUCTAL EPITHELIAL HYPERPLASIA. E. COLUMNAR CELL CHANGE WITH ASSOCIATED CALCIFICATIONS. F. FAT NECROSIS. UNUE INOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.5 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 1. Mitotic activity score: 1. Total Nottingham score: 4. Nottingham grade (1, 2, 3): 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 5 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 4 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
uondupsa. uondupsa SSOUD. Diagnosis Details. Comme. nts. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 9 X 7 X 6.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma, intestinal type. Histologic grade: Poorly differentiated. Tumor extent: Adjacent structures (specify) -. Omentum. Lymph nodes: 8/17 positive for metastasis. (Intraabdominal 8/17). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None. Lateralit. y.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: PRE-OP DIAGNOSIS: Pulmonary nodule. POST-OP DIAGNOSIS: Same. PROCEDURE: Bronchoscopy; Biopsy; Lavage; Right video assisted thoracic surgery: Apical posterior segmentectomy. with fiducials. FINAL DIAGNOSIS: PART 1: LUNG, RIGHT UPPER LOBE, BIOPSY -. BENIGN BRONCHIAL MUCOSA WITH MILD CHRONIC INFLAMMATION. PART 2: LYMPH NODE, LEVEL 4, BIOPSY -. BENIGN LYMPH NODE FRAGMENT. RART 3:LYMPH NODE, LEVEL 4R PRIME, BIOPSY -. BENIGN LYMPH NODE FRAGMENT. PART 4:LYMPH NODE, LEVEL 10, BIOPSY -. BENIGN LYMPH NODE FRAGMENT. PART 5: LYMPH NODE, LEVEL 4R PART C, BIOPSY -. BENIGN LYMPH NODE FRAGMENT. PART 6: LYMPH NODE, LEVEL 7, BIOPSY -. BENIGN LYMPH NODE FRAGMENT. PART 7: LYMPH NODE, LEVEL 7 PRIME, BIOPSY -. BENIGN LYMPH NODE FRAGMENT. PART 8: LYMPH NODE, LEVEL 7C, BIOPSY -. BENIGN LYMPF NODE FRAGMENT. PART 9: LUNG, RIGHT APICAL POSTERIOR SEGMENT, SEGMENTECTOMY -. A. INVASIVE WELL-DIFFERENTIATED ADENOCARCINOMA, ACINAR TYPE WITH FOCAL BRONCHOALVEOLAR. FEATURES, MEASURING 1.4 CM. B. ALL SURGICAL MARGINS (BRONCHIAL, VASCULAR AND STAPLED MARGINS) ARE FREE OF TUMOR. C. VISCERAL PLEURA IS FREE OF TUMOR. D. NO DEFINITE LYMPHOVASCULAR SPACE PERMEATION SEEN. E. OTHER FINDINGS INCLUDE APICAL CAP FIBROSIS, FOCAL SMALL PARENCHYMAL SCARS, AND MILD. EMPHYSEMATOUS CHANGES. F. AJCC PATHOLOGIC TUMOR STAGE: pT1 NO MX. PART 10: BONE, FIFTH RIB, EXCISION -. BENIGN BONE. PART 11: LUNG, RIGHT, COMPLETION LOBECTOMY -. A. FOCAL SMALL PARENCHYMAL SCARS AND MILD EMPHYSEMATOUS CHANGES. B. ALL SURGICAL MARGINS (BRONCHIAL, VASCULAR AND STAPLED MARGINS) ARE FREE OF TUMOR. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Upper Lobe. LUNG SEGMENT(S) INVOLVED: Apical. PROCEDURE: Lobectomy. TUMOR SIZE: Maximum dimension: 1.4 cm. Minor dimension: 1.0 cm. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G1, Well differentiated. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: None identified. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. NFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 0. Number of N1 lymph nodes examined: 1. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 6. UNDERLYING DISEASE(S): Emphysema, Parenchymal scar, Other: Apical cap fibrosis. T STAGE, PATHOLOGIC: pT1. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. SEE REPORT. SPECIMEN DESCRIPTION: A. PORTION OF RIGHT LOWER LOBE OF LUNG, APC. B. SUBCARINAL LYMPH NODE. RIGHT LOWER LOBE OF LUNG. D. INFERIOR PULMONARY LIGAMENT LYMPH NODE. E. HILAR LYMPH NODE. =====. PRE-OPERATIVE DIAGNOSIS: Right lower lobe of lung mass. POST-OPERATIVE DIAGNOSIS: Same, pending pathology. CLINICAL INFORMATION: Right lower lobe of lung mass. INTRAOPERATIVE CONSULTATION: APC DIAGNOSIS: ""Adenocarcinoma (tissue submitted for genomics study)' by Dr. GROSS DESCRIPTION. A. Received in formalir is a wedge of lung, measuring -8.0 X 4.0 X 3.0 cm. There is a staple line, measuring 8.5 cm. The pleural surface is focally. hemorrhagic, congested, and moderately anthracotic. In addition, the pleura. is retracted adjacent to the staple line, measuring 2.5 cm in greatest. dimensions. The pleural surface is inked black and the staple line margin is. inked blue. On sectioning, a poorly circumscribed tan-gray tumor mass,. measuring 3.5 X 3.0 X 1.5 cm is identified. The tumor mass grossly abuts the. pleural surface and comes to within 0.1 cm of the staple line margin. The cut. surface of the mass is hemorrhagic, gritty, and focally friable. The. uninvolved portion of lung is tan-pink and spongy. Representative sections. are submitted in four cassettes as follows: cassette 1 - tumor mass, pleural. surface, and staple line margin; cassette 2 - tumor mass and pleural surface;. cassette 3 - tumor mass and staple line margin; cassette 4 - uninvolved lung. APC. Received in formalin is an irregular portion of tan-gray soft tissue,. measuring 2.2 X 1.0 X 0.2 cm. Its cut surface shows a poorly circumscribed. tan-gray area, measuring 1.2 X 1.0 X 0.2 cm. The specimen is entirely. submitted in one cassette. B. Received in formalir are multiple irregular pieces of tan-pink. fibroconnective tissue with adjoining lymph nodes, measuring 2.5 X 2.0 X 0.5. cm in aggregate. Upon palpation, two tan-gray nodules, measuring 0.2 cm and. Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. 0.8 cm in greatest dimension, are found. The nodules are entirely submitted. in one cassette. C. Received in formalin is a 230 gram lobe of lung, measuring 18.0 X 14.0 X. 4.5 cm in overall dimensions. There are multiple staple lines adjacent to the. hilum, ranging from 3.0 cm to 10.0 cm in greatest dimension. The pleural. surface is tan-pink, moderately anthracotic and diffusely hemorrhagic and. congested adjacent to the hilum. There is a portion of bronchus at the hilum,. measuring 0.6 cm in length X 2.5 cm in diameter. Also there is a portion of. vessel, measuring 0.4 cm in length X 1.0 cm in diameter. The vascular,. bronchial, and staple line margins are inked blue and the pleural surface is. inked black. On sectioning, a circumscribed tan-gray tumor mass, measuring. 0.8 X 0.6 X 0.5 cm is identified. The mass comes to within 2.5 cm from the. pleural surface, 6.0 cm from the bronchial resection margin, and 5.5 cm from. the closest staple line margin. The cut surface is gray and mucoid. In. addition, directly adjacent to the hilum, approximately 1.0 cm from the. bronchial margin, and 0.1 cm from the closest staple line margin is a very. poorly circumscribed tan-orange lesion, measuring 2.0 X 1.5 X 1.0 cm. The. lesion comes to within 1.0 cm from the pleural surface. The remainder of the. lung parenchyma is spongy and congested and shows a bulla located at the upper. pole, measuring 2.0 X 2.0 X 1.0 cm. A single anthracotic lymph node,. measuring 0.5 cm in greatest dimension, is identified at the hilum. Representative sections are submitted in eight cassettes as follows: cassette. 1 - bronchial margin; cassette 2 - vascular margin and lymph node at the. hilum; cassette 3 - small tumor; cassette 4 - pleural surface closest to the. tumor; cassette 5 - orange lesion adjacent to hilum; cassette 6 - orange. lesion and closest staple line margin; cassette 7 - bulla: cassette 8 - lung. parenchyma. D. Received in formalin is an irregular portion of tan-pink soft tissue,. measuring 1.5 X 0.7 X 0.4 cm. The specimen contains multiple staples. The. staples are removed and no discrete lymph node is found. The specimen is. entirely submitted in one cassette. E. Received in formalin is a dark brown to black ovoid nodule, measuring 1.2. X 0.5 X 0.3 cm. The specimen is serially sectioned to reveal an anthracotic. cut surface. The specimen is entirely submitted in one cassette. MICROSCOPIC DESCRIPTION: A & APC. Five slides are examined. Sections of lung include a tumor mass. composed of complex anastomosing glands and papillae within fibrous stroma. The tumor cells have abundant eosinophilic to clear cytoplasm with polygonal. cytoplasmic borders. The nuclei are enlarged and ovoid to irregular, with. thickened nuclear membranes, coarsely granular chromatin and prominent. nucleoli. Scattered mitoses are present. Tumor focally extends into the. visceral pleura, forming a fibrotic nodule on the pleural surface, composed of. Not for Permanent-Storage in Medical Records Not Valid for Signing. Date of Service. Performing Faciliti. Result Provider. Report Name. Surgical Report. more solid nests of cells within fibrotic stroma. B. One slide is examined. These are sections of lymph node characterized by. moderate sinus histiocytosis and anthracosis. There is no evidence of. involvement by tumor. C. Eight slides are examined. Sections of lung include residual tumor. (slides 5 and 6 ), composed of abnormal glands. There is surrounding. pneumonitis with aggregated foamy histiocytes present within alveoli,. associated with interstitial infiltration by inflammatory cells, including. lymphocytes, plasma cells and eosinophils. Sections of the second-described. mass (block C3) reveal a circumscribed, but non-encapsulated, nodular mass,. composed of a monotonous population of cells having ovoid to spindle-shaped. nuclei, arranged in a nested/organoid pattern. The cells have bland chromatin. with inconspicuous nucleoli. Mitotic figures are not readily identified. The. grossly-described bullous area is characterized by irregular disruption of the. subpleural alveolar architecture, associated with irregular fibrous thickening. of the pleura, which is infiltrated by chronic inflammatory cells, including. lymphocytes and plasma cells, forming occasional loose aggregates. Clusters. of pigmented histiocytes are present within the dilated alveolar spaces. Random sections of lung reveal mild patchy dilation of alveoli, most notably. within the peripheral portions of the parenchyma. No other tumor is. identified. Sections of the bronchial margin are lined by ciliated,. pseudostratified columnar epithelium with areas of squamous metaplasia. The. vascular margin of resection is uninvolved by tumor. A peribronchial lymph. node is characterized by sinus histiocytosis and anthracosis. There is no. morphologic evidence of involvement by tumor. D. One slide is examined, including the entirely submitted specimen. These. are sections of a biopsy portion of lung, composed of benign alveolar. parenchyma. There is adherent fibrofatty tissue, consistent with parietal. pleura. There is no evidence of involvement by tumor. No lymph node is. identified. E. One slide is examined. These are sections of clotted blood and organizing. fibrin. A few clusters of mildly reactive mesothelial cells are focally. present within the clot, occasionally forming gland-like structures. No lymph. node is identified within the entirely submitted specimen. SPECIAL STAINS: A. section of tumor (block A1) is stained by the immunoperoxidase method for. thyroid transcription factor-1 (TTF-1). The tumor cells reveal weak to. moderate intranuclear positivity, consistent with lung primary. A section of. block E is also stained for TTF -1. The clusters of cells morphologically. interpreted as mesothelial cells, are negative by this stain. Also stained is. a section of the spindle cell tumor, seen on block C3, within the completion. lobectomy specimen. The cells comprising the lesion are strongly and. Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. diffusely positive for synaptophysin with moderate positivity for. chromogranin, consistent with the morphologic interpretation of spindle cell. carcinoid tumor. The corresponding controls stain appropriately. FINAL DIAGNOSIS: &. APC. RIGHT LUNG, LOWER LOBE, WEDGE BIOPSY: 1. HISTOLOGIC TYPE: ADENOCARCINOMA. 2. HISTOLOGIC GRADE: GRADE II. 3. PRIMARY TUMOR: pT2 - SEE COMMENT. 4. REGIONAL LYMPH NODES: pNO (NO REGIONAL LYMPH NODE METASTASIS. SEE PARTS B AND C). 5. DISTANT METASTASIS: pMX (CANNOT BE ASSESSED). 6. MARGINS: TUMOR PRESENT AT VISCERAL PLEURAL SURFACE. 7. VENOUS (LARGE VESSEL) INVASION: NOT IDENTIFIED. 8. ARTERIAL (LARGE VESSEL) INVASION: NOT IDENTIFIED. B. LYMPH NODE (SUBCARINAL), EXCISION: NEGATIVE FOR TUMOR. RIGHT LUNG. LOWER LOBE, COMPLETION LOBECTOMY: 1. RESIDUAL ADENOCARCINOMA, WITH SURROUNDING OBSTRUCTIVE/LIPOID. PNEUMONIA. 2. BRONCHIAL MARGIN UNINVOLVED. 3. ONE PERIBRONCHIAL LYMPH NODE NEGATIVE FOR TUMOR. 4. SPINDLE CELL CARCINOID TUMOR (8MM). 5. SUBPLEURAL BULLA. D. INFERIOR PULMONARY LIGAMENT, BIOPSY: BENIGN LUNG PARENCHYMA AND. ADHERENT FIBROFATTY TISSUE, CONSISTENT WITH PARIETAL PLEURA; NO. EVIDENCE OF INVOLVEMENT BY TUMOR. E. LYMPH NODE (HILAR). BIOPSY: CLOTTED BLOOD AND FIBRIN WITH REACTIVE. MESOTHELIAL CELLS, NEGATIVE FOR TUMOR. COMMENT: The tumor within the wedge resection specimen grossly measures 3.5. cm in greatest dimension, with direct extension into the visceral pleura. A. small amount of residual tumor is present within the completion lobectomy. specimen. A-MALIGNANT. DATE AND TIME OF.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor Site: Body, posterior wall. Tumor configuration: Not specified. Tumor. size: 5x5 cm. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Extent of invasion: Muscularis propria. Lymph nodes: Negative for metastasis. Margins - Proximal margin: Uninvolved by invasive carcinoma. Distal margin: Uninvolved by invasive. carcinoma. Omental (radial) margin: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Left renal mass; patient with history of lymphoma. Specimens Submitted: 1: KIDNEY, LEFT; PARTIAL NEPHRECTOMY. DIAGNOSIS: 1. KIDNEY, LEFT; PARTIAL NEPHRECTOMY: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 3.g cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Exhibits mild focal interstitial fibrosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The spacimen is received fresh for frozen section consultation and is labeled ""left renal mass"". Il consists of a 7.7: x 4.8 x 4.7 cm. wedge shaped portion of kidney with 10.5 x 7.5 X 2,5 cm of overlying perirenal fat. The margin is inked black and the specimen is. serially sectioned to reveal a well-circumscribed golden yellow focally hemormhagic and cystic cortical mass measuring 3.9 x 3.1 X. 2.5 cm. The tumor does not appear to grossly infiltrate the overlying fat. The clearance from the resection margin is 0.6 cm. sectioning through the attached fat reveals no gross abnormalities. A representative section of the nearest margin is submitted for. frozen section diagnosis. Representatively submitted. Photographs are taken, Portions of the tumor are submitted for. Summary of sections: FSC - frozen section control. T tumor. M margin. RS - representative sections. Summary of Sections: Part 1: KIDNEY, LEFT; PARTIAL NEPHRECTOMY. Block. Sect. Site. PCs. fsc. 1. 3. M. 3. 2. RS. 2. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CELL CARCINOMA, MARGIN NEGATIVE ON REPRESENTATIVE. SECTION. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Sex: Female. Diagnosis: Melanoma Histological description: Melanoma. Anatomic Site: Skin Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Surgery Grade: 2. T Stage: 4 N Stage: 3 M Stage: 0 Treatment: no. Treatment Details: no/no. Normal Sample. Anatomic Site: Blood Sample Type: normal Type of Procurement: Blood draw. Matrix: Blood Specimen Format: Frozen Container: tube.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: BREASI, LEFT,12 O'CLOCK, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE. B. NOTTINGHAM GRADE 2 (TUBAL FORMATION: 2, NUCLEAR PLEOMORPHISM: 2, MITOTIC ACTIVITY: 2;. TOTAL SCORE 6/9). C. THE INVASIVE TUMOR MEASURES 1.5 CM IN LARGEST DIMENSION. D. LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. E. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM TYPE WITH COMEDO NECROSIS. F. THE DCIS CONSTITUTES 20% OF THE TOTAL TUMOR VOLUME AND IS PRESENT ADMIXED WITH AND. AWAY FROM THE INVASIVE COMPONENT. G. MARGINS ARE NEGATIVE FOR CARCINOMA; INVASIVE CARCINOMA IS 0.5 CM FROM THE NEAREST. (SUPERIOR) MARGIN. H. FIBROCYSTIC CHANGES, COLUMNAR CELL CHANGE, AND DUCTAL EPITHELIAL HYPERPLASIA. I. PREVIOUS BIOPSY SITE CHANGES. J. INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. NEGATIVE FOR HER-2/NEU BY FISH. K. PATHOLOGIC STAGE: pTic, pN1a, pMX. PART 2: SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY -. A. ONE LYMPH NODE, POSITIVE FOR METASTATIC CARCINOMA (1/3). B. THE LARGEST TUMOR DEPOSIT IS 2.1 MM. C. EXTRACAPSULAR EXTENSION IS NOT PRESENT. PART 3: SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY -. ONE LYMPH NODE. NEGATIVE FOR NEOPLASM (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Upper outer quadrant. Upper inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 1.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 2. Mitotic activity score: 2. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. DCIS admixed and outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 5.0 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. NON-NEOPLASTIC BREAST TISSUE: FCD, Other: columnar cell change, ductal epithelial hyperplasia. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
I. ANTERIOR FLOOR OF MOUTH (EACISION): NEGATIVE FOR TUMUR. 2. POSTERIOR FLOOR OF MOUTH (EXCISION) : NEGATIVE FOR TUMOR. 3. VENTRAL TONGUE MARGIN (EXCISION) : NEGATIVE FOR TUMOR. 4. RETROMOLAR TRIGONE (EXCISION) : NEGATIVE FOR TUMOR. 5. INNER TABLE MANDIBLE (EXCISION) : BONE WITH FIBROSIS AND REACTIVE. CHANGES. NEGATIVE FOR TUMOR. 6. TEETH (EXTRACTION) : GROSS ONLY DIAGNOSIS. 7. RIGHT NECK LEVEL 2 AND 3 (DISSECTION) : MINUTE (<1MM) FOCUS OF. METASTATIC CARCINOMA IN ONE (1) OF THIRTEEN (13) LYMPH NODES. LEVEL ONE LYMPH NODE (EXCISION) : THREE (3) LYMPH NODES AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 9, FLOOR OF MOUTH ALVEOLI TUMOR (EXCISION) : SPECIMEN TYPE: Resection (specify type) : Floor of mouth and marginal. mandibulectomy. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension at least 6. .ocm. HISTOLOGIC TYPE: Carcinomas of upper aerodigestive tract: Squamous cell carcinoma,. conventional. HISTOLOGIC GRADE: G2: Moderately differentiated. EXTENT OF INVASION. The carcinoma involves bone. PRIMARY TUMOR (pT) : pT3 Tumor more than 4cm in greatest dimension. REGIONAL LYMPH NODES (pN) : pN1: Single lymph node metastasis. DISTANT METASTASIS (pM) : pMX. MARGINS: Margins uninvolved by tumor (while the specimen margin is involved. seperately submitted submitted margins are negative). VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION: Absent. PERINEURAL INVASION: Present. 10,. RIGHT SUBMANDIBULAR GLAND (EXCISION) : BENIGN SALIVARY GLAND. NEGATIVE FOR TUMOR. End of Diagnosis. Clinical History: FLOOR OF MOUTH ALVEOLI TUMOR.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis. Resected rectosigmoid material with a centrally ulcerated, moderately differentiated. adenocarcinoma of the colorectal type, located 2.5 cm from the aboral resection margin,. measuring 2.5 cm in diameter, with infiltration deep into the tunica muscularis propria to. the border of the perirectal fatty tissue. Tumor-free local lymph nodes. Tumor-free colon. resection margins. Tumor-free mesenteric resection margin. Tumor stage: pT2, pNO (0/26) pMX; G2, LO, V0, R0.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Female. Admission Date: Discharge Date: Pathology Addendum Report. Collected Date/Time: Received Date/Time: Addendum Report. ASSAY PERFORMED: HER2 GENE AMPLIFICATION BY DUAL IN SITU HYBRIDIZATION USING THE. HER2 Dual ISH DNA PROBE COCKTAIL. Number of nuclei scored: 20. Total HER2 signals: 60. Total CHR 17 signals: 39. HER2/CHR 17 ratio: 1.5. INTERPRETATION: - NEGATIVE FOR HER2 GENE AMPLIFICATION. NOTE: THE ASSAY WAS PERFORMED AS A REFLEX TEST AFTER THE HER2/NEU IMMUNOSTAIN WAS 2+. SPECIMEN TYPE: The. HER2. is performed on a formalin-fixed paraffin-embedded tissue slide from. block C3. DESCRIPTION OF THE ASSAY: The. HER2. assay. enables the HER2. gene and Chr17 centromere to be co-hybridized and visualized via light microscopy on the same slide. Specifically for this assay,. HER2 is detected by a dinitrophenyl (DNP) labeled probe visualized utilizing. SISH DNP (silver in situ hybridization). detection kit. The Chr17 centromere is targeted with a digoxigenin (DIG) labeled probe and detected using. ISHDIG. detection kit. Dual ISH staining results in visualization by light microscopy and which HER2 appears as discrete black signals (SISH). and Chr17 as red signals in nuclei of normal cells serving as internal positive control for staining) as well as in carcinoma cells. SLIDE SCORING: Once an adequate target area is identified the reader records the scores for HER2 and Chr17 copy numbers that. are present in 20 representative nuclei. If the resulting HER2 / Chr17 ratio falls within 1.8-2.2 (EQUIVOCAL) the reader is. recommended to score an additional 20 nuclei and the resulting ratio is calculated from the total 40 nuclei. HER2 gene status is. reported as non-amplified (HER2/ Chr17 < 2.0) or amplified (HER2/Chr17> 2.0). Print Date/Time: Distribute to: Patient Locations: Pathology Addendum Report. Collected Date/Time: Received Date/Time: T. f this assay were determined by. is assay has been approved by the U.S. Food and Drug Administration This laboratory is certified under the. Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high-complexity clinical laboratory testing. cpt: 88368 x2. (Electronic signature). Verified: Collected Date/Time: Received Date/Time: Addendum Report. IMMUNOHUSTOCHEMICAL EVALUATION OF ESTROGEN RECEPTORS, PROGESTERONE RECEPTORS, AND. HER-2NEU IN INVASIVE MAMMARY CARCINOMA. ESTROGEN RECEPTORS: 99 %, positive. PROGESTERONE RECEPTORS: 40 %, positive. STAINING INTENSITY: moderate. HER-2NEU: SCORE 2+, EQUIVOCAL. Immunohistochemical studies were performed on formalin fixed paraffin embedded tissue (Block C3) using the following monoclonal. antibodies: Estrogen receptor (Clone SP1), Progesterone receptor (Clone 1E2) and Her-2neu. Clone 4B5); control sections. for HER-2Neu are provided within a kit (score 0 MCF-7, score 1+ T-47D, score 2+ MDA-MB-453, score 3+ BT-474). Detection. system used: polymer. Primary antibodies, reagents and control sections for HER-2neu are all provided by). All controls show appropriate reactivity. Reactivity of Estrogen and Progesterone receptors is determined based on the percentage of positively stained nuclei of tumor. cells. Reference values (CAP accreditation program checklist 2010 and guidelines on webpage): Positive: nuclear staining in 1% or greater than 1% of invasive carcinoma cells. Negative : nuclear staining in less than 1% of invasive carcinoma cells. Staining intensity: is reported as weak, moderate or strong. HER-2neu reactivity is reported applying the CAP scoring guidelines (CAP accreditation program checklist 2010 and guidelines. on. webpage): Score 0 = Negative: No immunoreactivity, or faint weak immunoreactivity in <10% of tumor cells but only a portion of the. membrane is positive.. Score 1 = Negative: Faint weak immunoreactivity in 10% or > 10% of tumor cells but only a portion of the membrane is positive. Score 2+ = Equivocal: Weak to moderate complete membrane immunoreactivity in >10% of tumor cells or. Print Date/Time. Pathology Addendum Report. Collected Date/Time: Received Date/Time: circumferential intense membrane staining in <30% of cells. Score 3+ = Positive: More than 30% of the tumor cells must show circumferential intense and uniform membrane staining. A. homogeneous (chicken wire) pattern should be present. Equivocal results for HER-2neu (Score 2+) will be subsequently followed by a reflex dual-color ISH testing. The performance characterietice of theee antihnding were determined by the. ey have not been cleared or approved by the U.S. Food and Drug Administration The FDA has determined that such. clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high-complexity clinical laboratory testing. (Electronic signature). Verified. Collected Date/Time: Received Date/Time: Final Diagnosis. A. RIGHT BREAST, CORE BIOPSY: - INVASIVE DUCTAL CARCINOMA. B. RIGHT SENTINEL LYMPH NODE, BIOPSY: - NO EVIDENCE OF CARCINOMA IN ONE LYMPH NODE. - SEE SPECIAL STAINS SECTION. C. RIGHT BREAST, TOTAL MASTECTOMY: INVASIVE DUCTAL CARCINOMA GRADE 2, 2.5 CM. - MARGINS OF RESECTION ARE FREE OF CARCINOMA. - SEE SYNOPTIC REPORT, SPECIAL STAINS SECTIONS AND NOTE. NOTE: hormonal receptors and Her2-neu status will be reported in an addendum. (Electronic signature). Verified: Synoptic Report. SPECIMEN: Total breast (including nipple and skin). PROCEDURE: Total mastectomy (including nipple and skin). Print Date/Time. Collected Date/Time: Received Date/Time: LYMPH NODE SAMPLING: Sentinel lymph node(s). SPECIMEN INTEGRITY: Single intact specimen (margins can be evaluated). SPECIMEN SIZE: Greatest dimension: 26 cm. Additional dimensions: 17 x 6 cm. SPECIMEN LATERALITY: Right. TUMOR SITE: INVASIVE CARCINOMA: Upper outer quadrant. TUMOR SIZE: SIZE OF LARGEST INVASIVE CARCINOMA: Greatest dimension of largest focus of invasion over 0.1 cm: 2.5 cm. Additional dimensions: 2.0 x 2,0 cm. TUMOR FOCALITY: Single focus of invasive carcinoma. MACROSCOPIC AND MICROSCOPIC EXTENT OF TUMOR: Skin: Invasive carcinoma does not invade into the dermis or epidermis. DUCTAL CARCINOMA IN SITU (DCIS): DCIS is present. Extensive intraductal component (EIC) negative. SIZE (EXTENT) OF DCIS: Estimated size (extent) of DCIS (greatest dimension using gross and microscopic evaluation) is at least 0.3 cm (constituting. about 5% of the entire tumor mass.). ARCHITECTURAL PATTERNS: Comedo. Cribriform. NUCLEAR GRADE: Grade III (high). NECROSIS: Present, central (expansive ""comedo"" necrosis). LOBULAR CARCINOMA IN SITU (LCIS): Not identified. HISTOLOGIC TYPE OF INVASIVE CARCINOMA: Invasive ductal carcinoma (no special type or not otherwise specified). GLANDULAR (ACINAR)/TUBULAR DIFFERENTIATION: Score 2: 10% to 75% of tumor area forming glandular/tubular structures. NUCLEAR PLEOMORPHISM: Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very. large and bizarre forms. MITOTIC COUNT: Score 2. OVERALL GRADE: Grade 2: scores of 6 or 7. MARGINS: Margins uninvolved by invasive carcinoma. Print Date/Time: Collected Date/Time: Received Date/Time: Distance from closest margin: 25 mm. Distance from posterior margin: 25 mm. Margins uninvolved by DCIS (if present). Distance from closest margin: posterior mm. Distance from posterior margin: 25 mm. LYMPH-VASCULAR INVASION: Present. DERMAL LYMPH-VASCULAR INVASION: Not identified. LYMPH NODES: Number of sentinel lymph nodes examined: 1 (no tumor seen). Total number of lymph nodes examined (sentinel and nonsentinel): 1. METHOD OF EVALUATION OF SENTINAL LYMPH NODES: H&E, multiple levels. Immunohistochemistry. PRIMARY TUMOR (INVASIVE CARCINOMA (pT): pT2: Tumor >20 mm but less than or equal to 50 mm in greatest dimension. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis identified histologically. DISTANT METASTASIS (M): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: intraductal papilloma. MICROCALCIFICATIONS: Present in DCIS. Source of Specimen. A. Core Biopsy, RT Breast. B. Lymph Nodes, Sentinel Right. C. RT Total Mastectomy. Clinical Information. Palpable mass upper central FNAB positive, patient with right breast mass. PRE-OP DIAGNOSIS: Right breast cancer. POST-OP DIAGNOSIS: Same. TYPE OF PROCEDURE: Right t mastectomy and sent to the node biopsy. Gross Description. Specimen is received in 3 parts: A. The specimen is labeled ""CORE BIOPSY"" and is received unfixed for frozen section diagnosis. It consists of 2 cylindrical pieces of. gray-tan soft tissue each measuring 1.5 cm in length and 0.1 cm diameter. Entirely submitted in cassette FSA 1. Time specimen was removed from the patient. Time specimen was placed in formalin. Print Date/Time: Collected Date/Time: Received Date/Time: Ischemic time: 20 minutes. B. The specimen is labeled ""RIGHT SENTINEL NODE"" and is received unfixed for frozen section diagnosis. (Specimen is in. formalin mother 6 hour and less than 48 hours). It consists of a ymph node measuring 1.6 x 1 x 0.5 cm. Sectioned and entirely. submitted in cassette FSB 1. Time specimen was removed from the patient: Time specimen was placed in formalin. Ischemic time: 22 minutes. C. The specimen is labeled ""RIGHT TOTAL MASTECTOMY and is received in formalin. (The specimen is in the formalin. more than 6 hours and less than 48 hours). It consist of mastectomy specimen without lymph nodes weighing 990 grams and. measuring 26 x 17 x 6 cm with brown skin ellipse measuring 24 x 12 cm, containing grossly unremarkable 1.5 cm in diameter nipple. The skin is tagged with a black stitch designating lateral breast. The posterior margin is composed of smooth fascia which is inked. black. The breast is sliced in sagittal planes revealing a 2.5 x 2 x 2 cm an ill-defined firm area which is 2.5 cm away from the deep. margin of resection. The remaining portions reveal unremarkable yellow mammary fat with streaks of white-gray mammary. parenchyma. Representative sections submitted as follows: C1 = nipple. C2-C6 = upper outer quadrant mass. C7 = upper outer quadrant, posterior margin of resection in correspondence of the mass. C8 = representative section upper inner quadrant. C9 = representative section upper outer quadrant. C10 = representative section lower outer quadrant. C11 = representative section lower inner quadreant. Time specimen was removed from the patient. Time specimen was sectioned and placed in formalin. Ischemic time: 15 minutes. Intra Operative Consultation. A. Right breast cores = carcinoms. B. Right sentinel node = no tumor seen. Special Stains / Slides. Immunohistochemical studies were performed on formalin fixed, paraffin-embedded tissue (Block B1) with adequate positive and. negative control sections. Cytokeratins AE1/AE3 and Cam5.2 fail to reveal metastatic carcinoma. The nerformance characteristics of these antibodies were determined by the. ley have not been cleared or approved by the U.S. Food and Drug Administration The FDA has determined that such. clearance or approval is not necessary. 1 nese sesus are used for clinical purposes. They should not be regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high-compiexity clinical laboratory testing. 16 H&E, 4 FS, 16 H&E. Print Date/Time. Collected Date/Time: Received Date/Time: Tissue Code. Print Date/Time:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN TAKEN: FINAL DIAGNOSIS. THYROID (TOTAL THYROIDECTOMY): carcinoma, papillary, follicular variest 8340/3. TUMOR SITE: Right lobe, isthmus, left lobe. HISTOLOGIC TYPE: Papillary carcinoma, follicular variant with angioinvasion. TUMOR SIzE: Greatest dimension: 4.5 cm (entirety of the left lobe, extending into. isthmus). FOCALITY: Multifocal. LYMPH NODES: All 2 nodes negative for tumor. EXTENT OF INVASION. PRIMARY TUMOR: pT3: Tumor >4 cm, limited to thyroid or with minimal extrathyroidal. extension. REGIONAL LYMPH NODES: pNO: No regional lymph node metastasis. DISTANT METASTASIS: pMX: Cannot be assessed. MARGINS: Margins are uninvolved. Distance of invasive carcinoma from nearest margin: <1 mm. (anterior, posterior). VENOUS/LYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Nodular hyperplasia with cystic degeneration. NOTE: This case was shown at the.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN. Right kidney, right ureter, bladder cuff. CLINICAL NOTES. PRE-OP DIAGNOSIS: Right renal mass. GROSS DESCRIPTION. Received fresh for tissue procurement labeled ""right. kidney, ureter and bladder cuff"" is a 513 gram, 11.5 x 7.0. x 4.0 cm. right kidney with attached, probe patent, 20 cm. ureter. measuring up to 0.8 cm. in diameter with a scant amount of apparent. bladder wall at the distal end (see distal margin block 1). A. moderate amount of perirenal adipose tissue is present. No adrenal. gland is identified superiorly. The renal capsule is delicate and. strips with relative ease from the underlying cortical surface. On. opening, the pelvis is dilated, granular tan pink-red and contains. a. superiorly located, 4.6 x 3.5 cm. papillary white pink lesion. A. portion of tumor and a portion of normal parenchyma are submitted. for tissue procurement as requested. On sectioning, the tumor has. a. maximal thickness of 2 cm. and is within 0.9 cm. of the anterior. inked capsular surface. No vascular invasion is identified. grossly. The parenchyma is uniform red-brown with multiple cortical cysts, a. well-defined corticomedullary junction and a maximal cortical. thickness of 1.3 cm. The ureter is received with a stent in place. and on opening the mucosa ranges from smooth and unremarkable white. pink to slightly bosselated tan pink-red. No discrete mass lesion. is identified. Representative sections are submitted in 15 blocks. as labeled. RS-15. BLOCK SUMMARY 1 - Vascular and ureteral margins; 2-5 - renal. pelvis tumor including inked capsular surface; 6 , 7 - additional. sections of tumor to adjacent parenchyma; 8, 9 - random pelvis;. 10-12 - random parenchyma including cortical cysts; 13 - proximal. ureter; 14 - mid ureter; 15 - distal ureter. GROSS DESCRIPTION. MICROSCOPIC DESCRIPTION. Histologic type: Papillary urothelial cell carcinoma. Histologic grade : High grade. Associated epithelial lesions: Primary tumor (pT) : Tumor has invaded through the muscularis. propria of the. renal pelvis (pT2) . Margins of resection: Distal ureteral margin of resection free of. tumor. Regional lymph nodes (pN) : Cannot be assessed (pNX). Distant metastasis (pM) : Cannot be assessed (pMX) . Vascular invasion: Negative. Other findings : Benign cortical cysts. Arteriolar. nephrosclerosis. 4. DIAGNOSIS. Kidney, right nephroureterectomy. High grade papillary urothelial cell carcinoma of the renal. pelvis. extending through the muscularis propria of the pelvis. Distal ureteral margin of resection is free of tumor. Associated carcinoma in situ. Benign cortical cysts. Arteriolar nephrosclerosis. --- End Of Report ---.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Gross Description: Lobe with the bronchus obstructed by a tumoral structure with a diameter of 6/7/6. cm; the tumor spreads to periphery without invading the pleura. Microscopic Description: TUMOR FRAGMENT: Bronchopulmonary neoplasm of epidermoid carcinoma type, with keratinization, G2, formed of solid. beaches of relatively pleomorphic cells with intralobular keratotic globes; fibrous-inflammatory stromal. reaction. INTERLOBAR LYMPH NODE: Lymph node with neoplastic infiltrates of the epidermoid carcinoma. HILAR LYMPH NODE: with tumoral infiltrates. ICD - 6 - 3. TRIANGULAR LIGAMENT LYMPH NODE: 3 lymph nodes; no metastases. SUBAORTIC LYMPH NODE: No metastases. Diagnosis Details: Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 6x7x6cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 2/6 positive for metastasis (Regional 2/6). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Left-lower.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN: Terminal ileum, cecum, appendix, ascending and transverse colon. PROCEDURE: Right hemicolectomy. MACROSCOPY. - Product of right hemicolectomy. - Segment of terminal ileum, cecum, segment of ascending colon and appendix. - The serosa is focally irregular, and displays multiple nodules in addition to a perforation 2.0 x. 1.5 cm large, which is continuous to an ulcerative, vegetative luminal lesion measuring 8.0 x 8.0. cm, located 8.0 cm from the nearest surgical margin. The lesion penetrates the colon wall to the serosa. - 11 lymph nodes were dissected from the pericolic fat; sizes ranging from 0.3 to 0.6 cm. MICROSCOPIC EXAMINATION. - Moderately differentiated tubular adenocarcinoma of the ascending colon;. - Microscopic tumor extension: invasion of pericolic soft tissues;. - Perineural invasion: present;. - Lymph-vascular invasion: present;. - Moderate desmoplastic stromal reaction;. - Surgical margins free of neoplastic involvement;. - Number of lymph nodes examined: 11;. - Number of lymph nodes involved: 10;. - Stage: pT4c/d, pN2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: Not given. PRE-OP DIAGNOSIS: Lung cancer. POST-OP DIAGNOSIS: Lung cancer. PROCEDURE: Not listed. ADDENDA: Addendum. TM. PROBE: Vysis LSI EGFR SpectrumOrange/ CEP 7 SpectrumGreen. Probe. Fluorescence in-situ hybridization studies performed on the adenocarcinoma shows a ratio of EGFR gene to the centromere of. chromosome 7 of 0.88 indicating no EGFR amplification in the targeted region. The rate of hyperploidy for the centromere of. chromosome 7 was 41% of the analyzed cells. The signal to nucleus ratio (SNR) for the EGFR gene was 2.0. Interpretation guidelines for EGFR Gene Copy Number by FISH. Ratio of EGFR to the centromere of chromosome 7: Less than 2.0: No EGFR amplification. Greater than 2.0: EGFR amplification. Hyperploidy: Greater than two centromere copies/cell. SNR The average number of EGFR signals per analyzed cell within the targeted region. Clinical studies show high EGFR gene copy number by FISH analysis to be associated with favorable clinical benefit (clinical. response, stable disease, time to progression, and survival) in patients with advanced non-small cell lung cancer treated with. EGFR tyrosine kinase inhibitors. The left lower lobe basilar segmentectomy reveals a 5.0 cm poorly differentiated adenocarcinoma with clear ceil type. change and CDX2 positivity demonstrating viscera) pleural and angiolymphatic invasion with negative lymph nodes and. margins. Pathologic stage T2, NO, MX. PART 1: BRONCHUS, LEFT SECONDARY CARINA, BIOPSY -. FRAGMENTS OF BENIGN RESPIRATORY MUCOSA WITH NO SIGNIFICANT ABNORMALITY. PART 2: LYMPH NODE, ""BASILAR LEVEL XI LYMPH NODE"", BIOPSY -. FRAGMENT OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. PART 3: LYMPH NODE, ""LEVEL VII LYMPH NODE"", BIOPSY -. TWO FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. PART 4: LUNG, LEFT LOWER LOBE BASILAR PORTON, SEGMENTECTOMY ...... A. POORLY DIFFERENTIATED ADENOCARCINOMA WITH CLEAR CELL CHANGE AND CDX2 POSITIVITY,. DIAMETER 5.0 CM, DEMONSTRATING VISCERAL PLEURAL AND ANGIOLYMPHATIC INVASION. ALL. MARGINS FREE. MILD HOST LYMPHOCYTIC RESPONSE. PATHOLOGIC STAGE T2, NO, MX. B. RESPIRATORY BRONCHIOLITIS WITH EMPHYSEMATOUS CHANGE. C. THREE SEGMENTAL LYMPH NODES WITH NO EVIDENCE OF METASTATIC CARCINOMA,. PART 5: LYMPH NODE, ""LEVEL V LYMPH NODE"", BIOPSY -. TWO FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. COMMENT: Because this carcinoma expresses CDX2 in the absence of TTF1, it is essential that an extrathoracic primary site of. origin, particularly in the GI tract be excluded be fore accepting this case as a primary lung adenocarcinoma. The. synoptic indicated below reflects an assumption that all other potential primary sites have been excluded. Approximately. 3-10% of lung carcinomas can be CDX2 positive, usually mucinous ones as is this case. CK7 is positive while stains for thyroglobulin and CK20 are negative. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Left Lower Lobe. LUNG SEGMENT(S) INVOLVED: Basilar. PROCEDURE: Segmental. TUMOR SIZE: Maximum dimension: 5.0 cm. Minor dimension: 4.0 cm. GROSS SATELLITES;. Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G3, Poorly differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARYI PARENCHYMAL. EXTENSION/INVASION OF TUMOR: Visceral pleura. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: > 50%. SURGICAL MARGIN INVOLVEMENT: SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 8.0 mm, Parenchymal margin. INFLAMMATORY(DESMOPLASTIC REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive 0. Number of N1 lymph nodes examined: 4. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 4. UNDERLYING DISEASE(S): Emphysema, Smokers bronchiolitis. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains, Immunohistochemical stains, FISH studies, Molecular studies. Comment: PAS, PAS//D and Mucicarmine stains are positive. Elastic tissue stains confirm. vascular invasion.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SSOUD ai ase. Microscopic Description. Diagnosis Details. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 31 X 15 X 2 cm. Tumor features: Ulcerated, Diffusely infiltrating. (linitus plastica). Histologic type: Adenocarcinoma, diffuse type. Histologic grade: Not specified. Tumor extent: Adjacent structures (specify) -. Esophagus. Lymph nodes: 11/11 positive for metastasis. (Intraabdominal 11/11). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Involved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None. Laterality. Case ID.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: PRE-OP DIAGNOSIS: Nasopharyngeal mass/right lung mass. POST-OP DIAGNOSIS: Not given. PROCEDURE: Not given. FINAL DIAGNOSIS: Summary Statement. The right upper lobe demonstrates a 1.7 cm invasive poorly differentiated adenocarcinoma associated with visceral. pleural invasion. No angiolymphatic invasion is identified. All sampled lymph nodes are benign. Surgical resection. margins are free of tumor. The pathologic stage is T2NOMx. PART 1: NASOPHARYNX, LEFT, BIOPSY -. RESPIRATORY MUCOSA WITH MILD CHRONIC INFLAMMATION. PARTS 2. AND 6: LUNG, RIGHT UPPER LOBE, WEDGE RESECTION AND COMPLETION LOBECTOMY-. A. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA (1.7 CM. IN DIAMETER) ARISING IN A SCAR AND. ASSOCIATED WITH VISCERAL PLEURAL INVASION. NO EVIDENCE OF ANGIOLYMPHATIC INVASION. MILD. LYMPHOCYTIC HOST RESPONSE. NINE (9) BENIGN N1 LYMPH NODES WITH ANTHRACOTIC PIGMENT. PATHOLOGIC STAGE: T2N0MX. B. SURGICAL MARGIN NEGATIVE FOR TUMOR. C. BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGE AND RESPIRATORY BRONCHIOLITIS. PART 3: LYMPH NODE, POSTERIOR HILAR, BIOPSY -. ONE (1) BENIGN ANTHRACOTIC LYMPH NODE. PART 4: LYMPH NODE, INTERLOBAR, BIOPSY 1. TWO (2) FRAGMENTS OF ANTHRACOTIC LYMPH NODE. PART 5: LYMPH NODE, RIGHT UPPER LOBE BRONCHUS, BIOPSY -. TWO (2) FRAGMENTS OF ANTHRACOTIC LYMPH NOUE. PART 7: LYMPH NODE, SUBCARINAL, BIOPSY -. TWO (2) FRAGMENTS OF ANTHRACOTIC LYMPH NODE. PART 8: LYMPH NODE, RIGHT TRACHEOBRONCHIAL ANGLE, BIOPSY -. THREE (3) FRAGMENTS OF ANTHRACOTIC LYMPH NODE. PART 9: LYMPH NODE, RIGHT PARATRACHEAL, BIOPSY -. FOUR (4) FRAGMENTS OF ANTHRACOTIC LYMPH NODE. MICROSCOPIC: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Upper Lobe. PROCEDURE: Lobectorny. TUMOR SIZE: Maximum dimension: 1.7 cm. Minor dimension: 1.3 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G3, Poorly differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: Visceral pleura. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: > 50%. SURGICAL MARGIN INVOLVEMENT: SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 6 mm. INFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 0. Number of N1 lymph nodes examined: 14. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. UNDERLYING DISEASE(S): Number of N2 lymph nodes examined: 9. T STAGE, PATHOLOGIC: Emphysema, Parenchymal scar, Smokers bronchiolitis. pT2. N STAGE, PATHOLOGIC: pNo. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains, Immunohistochemical stains, FISH studies, Molecular studies. The highlights tumor invasion into visceral pleura. Trichrome and Grocott stains are. Elastic Microscopic stain examination substantiates the diagnosis indicated above, Mucicarmine, PAS and PAS with diastase are positive. tumor cells are positive for cytokeratin 7, and negative for cytokeratin 20, TTF, mammoglobin negative. and GCDFP,.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
DATE OBTAINED: DATE RECEIVED: SUBMITTING MD: DIAGNOSIS. PARTIAL HEPATECTOMY (647 G) LEFT LATERAL (SEGMENT III): HEPATOCELLULAR CARCINOMA. Tumor type: Hepatocellular carcinoma. Histologic grade: Variable including grade I of IV (well differentiated adenoma-like) and grade II-III of IV. (moderately differentiated). Tumor size: 15 cm pedunculated tumor (with gastric compression clinically). 2 cm satellite tumor (approaching but not transected at parenchymal margin). Tumor multifocality: Present, as above. Vascular invasion: Not present. Hepatic capsule: No transcapsular invasion. Local extension: Organ-confined. Margins: -Hepatic parenchymal: negative (~1 mm). -Bile duct(s): N/A. -Vascular: N/A. Lymph nodes: N/A. Other findings: Steatosis (35-40%) and Mallory hyaline in well differentiated HCC; focal tumor necrosis. & hyalinization present; no background cirrhosis; non-specific triaditis; focal peliosis. AJCC stage: Stage IIIA; pT3a (assuming ""cN0"" and ""cM0"" status). COMMENT. As per the OP note, this represents a palliative resection to relieve gastric compression. Other lesions were reportedly present via. intraoperative ultrasound. Note is made of the prior core biopsy 1. Histologically this tumor shows equal components of well differentiated adenoma-like HCC with clonal evolution to a more. moderately differentiated HCC. 88329, 88309. Clinical Diagnosis and History: Hepatocellular cancer. Tissue(s) Submitted: LEFT LATERAL SEGMENT. Gross Description: The. specimen is received fresh for intraoperative consult and subsequently placed in formalin labeled left lateral liver segment and. consists. of a 21.5 (M to L) X 12 (S to I) x 5 (A to P) liver segment weighing 647 grams. The parenchymal resection margin is 6 x 14. cm in area. The capsule is dark brown and smooth with no capsular-invasive nodules. There is a 15 x 10 x 7.5 cm variegated. heterogenous, circular tan-yellow lesion with focal areas of hemorrhage and necrosis on the cut surface. There is also a satellite. nodule measuring 2 x 1.7 X 1.5 cm approaching but not transected at the parenchymal resection margin. The uninvolved liver. parenchyma is tan-brown without nodularity. Representative samples are submitted labeled 1A - 1R. 1A: satellite nodule to margin. 1B: main tumor to margin. 1C: main tumor to capsule. 1D: main tumor to normal. 1E-1M: representative tumor. 1N-10: representative normal parenchyma. 1P: normal parenchyma to margin. 1Q: tumor to normal parenchyma to capsule. 1R: additional tumor. Intraoperative Consult Diagnosis. Hepatocellular tumor; A representative section of tumor was submitted for. issue banking), upon O.R. receipt.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. Breast, left, modified radical mastectomy: Multifocal lobular carcinoma with focal ductal features, Nottingham grade I (of III). forming two separate masses, 5.3 x 2.7 x 1.4 cm and 1.2 x 1.0 x 1.0 cm in the inferior and medial breast respectively (AJCC. pT3). A biopsy cavity is identified adjacent to the tumor in the medial breast. Lymphovascular space invasion is not seen. The. remaining breast parenchyma shows adenosis and duct ectasia. The nipple shows no diagnostic abnormalities. Margins of. resection are negative for tumor (closest margin is anterior/inferior, free by at least 0.8 cm). Multiple (6 of 17) left axillary lymph. nodes are involved by metastatic lobular carcinoma (AJCC pN2). Focal extracapsular extension is also present. Her-2/NEU has been ordered on paraffin embedded tissue.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
ck. Neck. Clinical Diagn^sis & History: year old. vith left papillary thyroid carcinoma and right thyrold nodule showing atypical cells. Specimens Submitted: 1: Right paratracheal tissue, excision (fs). 2: Right level three and four lymph nodes, excision. 3: Left neck level three and four lymph nodes, excision (fs). 4: Thyroid, total thyroidectomy. 5: Left paratracheal tisssue, excision. DIAGNOSIS: 1. Right paratracheal tissue, excision (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.5cm. Size of the largest metastatic focus : 0.5 cm. Extranodal extension is identified. 2. Right level three and four lymph nodes, excision: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 10. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.9cm. Size of the largest metastatic focus : 0.3 cm. Extranodal extension is identified. 3. Left neck level three and four lymph nodes, excision (fs): Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 11. 4. Thyroid, total thyroidectomy: Tumor Type: Papillary carcinoma, classical type. Two foci. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Right lobe. Tumor Size: The tumor foci measure 2.8 cm (right lobe) and 1.5 cm (left lobe) in greatest dimension. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Identified at 3 foci of vascular invasion including a focus in the extrathyroidal tissue. Extrathyroid Extension: Invades:perithyroid fibroadipose tissue. Surgical Margins: Free of tumor. Tumor Multicentricity: Gross foci present. Non-Neoplastic Thyrold: No abnormalities identified. Parathyroid Glands: Identified. One unremarkable parathyroid gland in the left lobe. Lymph Nodes: Metastatic papillary carcinoma involving one lymph node (1/1). the lymph node measures 0.7 cm and is almost. totally replaced by tumor. 5. Left paratracheal tisssue, excision: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.4cm. Size of the largest metastatic focus : 0.4 cm. Extranodal extension is not Identified. Benign parathyroid gland is identifed. (ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Report Erectronically Signed Out. Gross Description: 1. The specimen is received fresh, labeled ""Right paratracheal tissue"". It consists of fat and a lymph node measuring 1.8 x 0.6 x 0.3. cm. The lymph node measures 0.6 x 0.5 x 0.3 cm. The lymph node is submitted entirely for frozen section. Summary of Sections: FSC- frozen section control. 2. The specimen is received fresh, labeled ""right level three and four lymph nodes"" and consists of multiple possible lymph nodes. measuring from 0.2 cm up to 1.0 cm in greatest dimensions. All possible lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. 3. The specimen is received fresh, labeled ""Left neck level III and IV lymph nodes"". It consists of fat and lymph nodes. The lymph. nodes range in size from 0.1 to 1.1 cm in greatest dimension. The lymph nodes are submitted entirely for frozen section. The. remaining fat is entirely submitted. Summary of Sections: FSCA - frozen section control, approximately 5 lymph nodes. FSCB - frozen section control, two lymph nodes. RS - remaining fat with possible lymph nodes. 4. The specimen is received fresh labeled ""total thyroidectomy, stitch marks left lobe of thyroid"" and consists of a thyroid weighing. 30.5 g. The right lobe measures keep on 3.0 x 2.0 x 2.0 cm, the left lobe measures 2.5 x 2.0 X 1.5 cm and the isthmus measures. 1.0 x 0.5 x 0.5 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black,. and the anterior is inked blue. Sectioning reveals one large previously open nodule in the right lobe measuring 2.8 x 1.8 x 1.0 cm. Sections through the remaining tissue reveal a nodule in the left lobe measuring 1.5 x 1.5 x 1.2 cm. The left lobe also contains. another second smaller nodule measuring 0.7 x 0.3 x 0.2 cm. The remaining thyroid parenchyma is red tan and beefy. Representative sections of the specimen are submitted for. The remaining tissue is serially sectioned and representatively. submitted. Summary of sections: RN - right nodule. LN (1)- Left nodule. LN (2)- left lobe. RL right lobe. LL left lobe. IS - isthmus. 6. 5. The specimen is received fresh, labeled ""left paratracheal tissue"" and consists of an irregular piece of adipose tissue. measuring 3.0 x 2.0 x 0.4 cm. It is dissected to reveal a lymph node measuring 0.3 x 0.3 x 0.3 cm. All identified lymph nodes are. submitted. Summary of sections: LN - lymph nodes. AD- rest of adipose tissue. Summary of Sections: Part 1: Right paratracheal tissue, excision (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Right level three and four lymph nodes, excision. Block. Sect. Site. PCs. 4. LN. 4. Part 3: Left neck level three and four lymph nodes, excision (fs).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Breast, left, wide local excision: Invasive ductal carcinoma, Nottingham grade 3 (of 13), forming a 2.3 x. 2.2 x 2.0 cm mass (AJCCpT2). All surgical margins, including separately submitted inferior margin, are. negative for tumor. Lymph node, left breast intramammary, excision: Metastatic adenocarcinoma. no extranodal extension is. identified. Lymph nodes, left axillary sentinel, excisions: Multiple (5) left axillary sentinel lymph nodes are. negative for tumor (blue dye identified in left axillary lymph node No. 1 only). Lymph nodes, left axillary, dissection: Multiple left highest (2) and left axillary (23) lymph nodes are. negative for tumor. Her-2/NEU has been ordered on paraffin embedded tissue.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Right-sided colon cancer. Specimens Submitted: 1: SP: Right colon. DIAGNOSIS: 1. COLON; RIGHT HEMICOLECTOMY: TUMOR TYPE: ADENOCARCINOMA. - HISTOLOGIC GRADE: MODERATELY DIFFERENTIATED. TUMOR LOCATION: ASCENDING COLON. - TUMOR SIZE: LENGTH IS 4.0 CM, WIDTH IS 5.4 CM. - GROSS CONFIGURATION: ULCERATING INFILTRATIVE. - TUMOR INVASION: INVASION INTO SUBSEROSA. - GROSS TUMOR PERFORATION: NOT IDENTIFIED. - SEROSAL INVOLVEMENT: NOT IDENTIFIED. - VASCULAR INVASION: NOT IDENTIPIED. - PERINEURAL INVASION: IDENTIFIED. - SURGICAL MARGINS (FOR COLONIC TUMORS) : FREE OF TUMOR. - NON-NEOPLASTIC BOWEL: UNREMARKABLE. - THE PATHOLOGIC STAGE IS. pT3. - LYMPH NODES: NUMBER WITH METASTASES: U; NUMBER EXAMINED: 23. - THE PATHOLOGIC STAGE IS. : pND. - APPENDIX AND OMENTUM WITH NO SIGNIFICANT PATHOLOGIC CHANGE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1) The apecimen is received fresh, labeled ""Right colon"" and consists of a. segment of terminal ileum, cecum with attached appendix and ascending colon. The terminal ileum measures B cm in length and 3.4 em in circunference at. the proximal resected margin. The remaining colon measures 34 cm in length. with a circumference of 8 cm at the distal resected margin. The attached. appendix meanures 7.2 em in length and averages 0.6 em in diameter. The. appendiceal and intestinal serosa is pink tan and amooth. Focally. hemorrhagic lobulated yellow tan adipose tissue apans the length of the. specimen measuring up to 5 cm in thickness. The specimen is opened to. reveal a mass lesion measuring 4 cm in length and 5.4 em in width. Sectioning showa that the tumor invades into the pericolio fat. The depth of. invasion is 0.5 em grossly. The lesion is 5 em from the distal margin. There is attached omental fat measuring 25 x 12 x 1.5 am. It in grossly. unremarkable. The remaining mucosa is unremarkable. Multiple lymph nodes. are identified in the attached adipose tiasue and are submitted. Representative sections of the specimen are submitted for permanent sections. and for TPS. Summary of sections: PM- proximal margin shave. DM -- distal margin shave. M- masa. A appendix representative sections. RS -representative sections. O- omentum representative sections. LN lymph nodes. Summary of Sections: Part 1: SP: Right colon. Block. Sect. Site. PCa. 1. A. 1. 4. BLN. 8. 1. DM. 1. 6. LN. 18. 4. M. 4. 2. o. 2. 1. PM. 1. 1. RS. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Information. Malignant neoplasm of head of pancreas. Pancreatitis, pancreatic adenocarcinoma. Diagnosis. A. PARTIAL PANCREAS AND DUODENUM, WHIPPLE RESECTION: - Invasive moderately differentiated pancreatic ductal adenocarcinoma. - Adenocarcinoma measures 2.0 X 1.7 X 1.5 cm. - Adenocarcinoma extends beyond the pancreas. - All surgical margins (pancreatic cut margin, bile duct margin, SMA margin, portal vein margin, anterior. pancreatic surface, posterior pancreatic surface, proximal duodenal margin and distal duodenal margin),. uninvolved by malignancy. - Non-neoplastic pancreatic parenchyma with areas of fat necrosis. - Twenty regional lymph nodes, negative for malignancy (0/20). B. LYMPH NODE, HEPATIC ARTERY, BIOPSY: - Single lymph node, negative for malignancy (0/1). C. GALLBLADDER, CHOLECYSTECTOMY: - Gallbladder, without significant pathologic change. Pathology Staging Summary. Specimen type: Whipple resection. Tumor location: Head of pancreas. Histologic type: Invasive pancreatic ductal adenocarcinoma. Histologic grade: Moderately differentiated. Tumor size and invasion of: Tumor limited to pancreas, 2.0 cm or less: No. Tumor limited to pancreas, greater than 2.0 cm: No. Tumor extends beyond the pancreas, but without involvement of. celiac axis or SMA: Yes. Tumor involves celiac axis or SMA: No. Lymphatic invasion: Not identified. Large vessel invasion: Not identified. Margins: Common bile duct: Negative. Proximal duodenal margin: Negative. Distal duodenal margin: Negative. Distal pancreatic margin: Negative. Peripancreatic soft tissue margin: Negative. Total regional lymph nodes: 21 Number positive: 0. Pathologic Stage (AJCC Cancer Staging Manual, 7th edition): pT3, pNO, MX. Dictated and authenticated by: Performing Location: Gross Description. A. WHIPPLE SPECIMEN. Received fresh labeled with the patient name. Specimen received: Duodenum and head of the pancreas. Orientation given: Double stitch on bile duct, single stitch on SMA margin. Integrity: Received intact. Size of pancreas: 5.0x5.0x4.0. Length of duodenum: 25.0 cm in length. Ducts: The common bile duct and pancreatic duct are patent to the ampulla. Ampulla: The mucosa around the ampulla is finely granular, dusky and brown. There are some. thickened duodenal folds around the ampulla. Inking scheme: Pancreatic cut margin green, SMA margin orange, portal vein margin purple, bile duct. margin yellow, posterior pancreas black, anterior pancreas blue. Tumor site: There is a tumor near the pancreatic cut margin and near the margin of the bile duct. Tumor size: 2.0 x 1.7 X 1.5 cm. Tumor description: Indurated, ill-defined gray-white. Invasion of: The tumor does not extend to the duodenum or involve the bile ducts or pancreatic duct. Distance from margins: 0.3 cm from the pancreatic cut margin close to the portal vein margin, 2.0 cm. from the SMA margin, 4.5 cm from the anterior surface and 2.0 cm from the posterior surface. Remaining specimen: The rest of the pancreas is lobulated, yellow-tan and soft with a few areas of. possible fat necrosis. Lymph nodes: Several lymph nodes are present. FROZEN SECTION DIAGNOSIS PERFORMED AT. Pancreatic. margin - benign. Bile duct margin - benign. SMA margin - benign. SECTIONS: A1. Frozen section control of pancreatic cut margin. A2. Frozen section control of bile duct margin. A3. Frozen section control of SMA margin. A4. Proximal duodenal margin. A5. Distal duodenal margin. A6-7. Ampulla. A8-11. Thickened duodenal folds around the ampulla. A12. Sections of tumor closest to bile duct. A13-14. Tumor. A15. One section of tumor perpendicular to portal vein margin. A16-17. Two sections perpendicular to portal vein and SMA margin. A18-20. Additional sections of pancreas and possible pancreatitis. A21. Anterior surface of pancreas. A22. Posterior surface of pancreas. A23. One common bile duct lymph node. A24. One whole posterior pancreatic lymph node. A25-27. One posterior pancreatic lymph node. A28. Two whole anterior pancreatic lymph nodes. A29. Seven whole SMA lymph nodes. A30. Two bisected SMA lymph nodes, one marked black. A31. Five whole SMA lymph nodes. A32. One bisected SMA lymph node. B. HEPATIC ARTERY LYMPH NODE. Received in formalin labeled with the patient name. Description: A 2.0 cm in greatest dimension lymph node. SECTIONS: B1. Bisected and entirely submitted. C. GALLBLADDER. Received in formalin labeled with the patient name. Size: 14.0 x 4.0 X 4.0 cm. Cystic duct: The cystic duct is intact with no surgical clip. Integrity: Received intact. Contents: Thick bile with no choleliths. Mucosa and wall: Velvety green mucosa. The wall measures 0.2 cm in thickness. SECTIONS: C1. Three sections. Microscopic Description. A. WHIPPLE SPECIMEN: Sections show moderately differentiated adenocarcinoma consisting of. irregular neoplastic glandular structures lined by columnar epithelial cells with enlarged, more vesicular. nuclei. The adenocarcinoma has an invasive appearance with surrounding stromal response. The. adenocarcinoma involves pancreatic tissue in slides A13 and A14, with extension into peripancreatic soft. tissue in slide A13 and extension up to the bile duct in slide A12 as well as beneath the duct leading up. to the ampulla in slide A7. The pancreatic cut margin, bile duct margin, SMA margin, anterior pancreatic. surface, posterior pancreatic surface, portal vein margin, proximal duodenal margin and distal duodenal. margin are all uninvolved by malignancy. The non-neoplastic pancreatic parenchyma shows areas of fat necrosis. Twenty regional lymph nodes are examined, all of which are negative for malignancy. A nodular focus of. fibrosis and fat necrosis is present in slide A29; this focus shows absence of staining for keratin AE1/AE3. and positive staining for CD68. B. HEPATIC ARTERY LYMPH NODE: Sections show a single lymph node which is negative for malignancy. C. GALLBLADDER: Sections of the gallbladder are unremarkable. Surg Path Non-Chartable Comment. Diagnosis given directly to surgeon over the telephone/speakerphone.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Breast, right, simple mastectomy: Invasive ductal and lobular carcinoma (mixed features), Nottingham grade II (of III) [tubules. 2/3,. nuclei 2/3, mitoses 1/3; Nottingham score 5/9], forming a mass, 2.1 x 1.4 x 1.3 cm, with associated biopsy site changes,. located in the superior/central region of the breast [AJCC pT2]. A second biopsy site is present in the subareolar region. A. separate nodule of ductal carcinoma in situ, 0.6 x 0.6 x 0.5 cm, is present in the upper inner quadrant. Lobular carcinoma in situ is. identified. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All surgical resection margins,. including the deep margin, are negative for tumor (minimum tumor free margin, 0.5 cm, anterior/superior margin). Lymph. nodes, right axillary sentinel, excision: Multiple (7) right axillary sentinel lymph nodes are negative for metastatic. carcinoma [AJCC pNO (i-) (sn)]. Blue dye is not identified in any of the seven right axillary sentinel lymph nodes. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and confirms the. H&E impression. Breast, left, simple mastectomy: Mild proliferative changes characterized by ductal hyperplasia without atypia. The prior biopsy. site is identified. The nipple is without diagnostic abnormalities. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered on paraffin-embedded tissue.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. A. RIGHT KIDNEY, PARTIAL NEPHRECTOMY: Renal cell carcinoma with hybrid oncocytic features and focal papillary features. See Key. Pathologic Findings. Surgical margin, free of malignancy. Pathologic stage: pT1b NX MX. B. DEEP MARGIN: Renal parenchyma, free of malignancy. the attending pathologist, personally reviewed all. slides and / or materials and rendered the final diagnosis. Electronically. Ancillary Testing. Immunohistochemical stains (AMACR, cytokeratin 7, cytokeratin 20, CD117, vimentin) performed with. appropriate positive and negative controls on blocks A3 and A5 support the diagnosis. Immunohistochemical stain (RCC antigen) performed with appropriate positive and negative control on. block A5 supports the diagnosis. Special stain (Hale's colloidal iron) performed with appropriate. control on block A5 supports the diagnosis. Key Pathological Findings. A: Kidney Resection. PROCEDURE: Partial nephrectomy. SPECIMEN LATERALITY: Right. TUMOR SIZE (largest tumor if multiple): Dimension: 4,5 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Renal cell carcinoma with hybrid oncocytic features and focal papillary features. SARCOMATOID FEATURES: Not identified. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G3: Nuclei very irregular, approximately 20 microns; nucleoli large and prominent. MICROSCOPIC TUMOR EXTENSION: Tumor limited to kidney. MARGINS: Margins uninvolved by carcinoma. ADRENAL GLAND: Not present. PERINEURAL INVASION: Absent. ANGIOLYMPHATIC INVASION: Absent. LYMPH-VASCULAR INVASION: Absent. PRIMARY TUMOR (pT): pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the. kidney. REGIONAL LYMPH NODES (pN): pNX: Regional lymph nodes cannot be assessed. DISTANT METASTASIS (pM): pMX. Specimen(s) Received. A. RIGHT PARTIAL NEPHRECTOMY FS. B. DEEP MARGIN FS. Preoperative Diagnosis. Right renal mass. Intraoperative Consultation. FSA1: RIGHT PARTIAL NEPHRECTOMY, INK EQUALS MARGIN: Oncocytic lesion, margin negative. FSB1: DEEP MARGIN, INK IS MARGIN: Negative. Comment: This frozen section diagnosis/result was communicated to and acknowledged by Dr. I,. have performed the intraoperative consultation and issued the above. diagnosis. Gross Description. A. Specimen A is received fresh for frozen section analysis labeled ""right partial nephrectomy ink. equals margin."" The specimen consists of a 5.5 x 5.5 x 4.0 cm partial nephrectomy. The surgical. margin resection is marked with black ink. Serial sectioning reveals a soft, red-brown mass (4.5 x 4.5. x 3.0 cm) grossly abutting the surgical margin resection. The overlying capsule is intact and marked. with blue ink. The remainder of the renal parenchyma is red-brown and grossly unremarkable. Representative frozen sections taken and submitted as FSA1. Representative section of the tumor. submitted to the Tissue Procurement Laboratory. Permanent representative sections are submitted as: A2: Mirror image of tumor submitted to the Tissue Bank. A3: Tumor shown in its relationship to overlying capsule. A4-A7: Representative sections of tumor showing its relationship to adjacent tissue. A8: Grossly unremarkable renal parenchyma. B. Specimen B is received fresh for frozen section analysis labeled ""deep margin, ink is margin."". The specimen consists of 1.5 x 0.2 x 0.1 cm soft, tan-pink, irregular fragment of renal parenchyma,. which is marked with ink on the surgical margin resection."" The specimen is serially resectioned and. entirely submitted for frozen section as FSB1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Case ID. Gross Description. Microscopic. Diagnosis Details. Description. Stomach with a polypoid. Adenocarcinoma of the. Tumor Features: Exophytic. tumour, up to 16 cm in its. stomach G2-3. In the. (polypoid), Tumor Extent: diameter, invades adjacent. exofytic component the. Perigastric fat , Venous. fatty tissue;. predominant type of growth. Invasion: Absent, Margins: fatty tissue lymph nodes. is G2. In the endophtyic. Absent, Treatment Effect: are free of metastases;. component the. omentum - hyperemia;. predominate component is. surgical margins are free of. G3 with necrosis. Tumor. metastases. invades into the perigastric. fat. Fifteen lymph nodes. demonstrated reactive. hyperplasia. Omentum is. hyperemic. Surgical. margins are free of tumor. elements. Comments. STOMACH TISSUE. CHECKLIST. Specimen type: Total. gastrectomy. Tumor site: Antrum. Tumor size: 16 X 0 X 0 cm. Tumor features: Exophytic. (polypoid). Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Subserosa. Lymph nodes: 0/15. positive for metastasis. (Greater and lesser. omentum 0/15). Lymphatic invasion: Not. specified. Venous invasion: Absent. Perineural invasion: Not. specified. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None. Laterality.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
History Case. Sex: F. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to 1. section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) RULE OUT RIGHT INFERIOR PARATHYROID: Parathyroid gland. (B) TOTAL THYROIDECTOMY: PAPILLARY CARCINOMA OF THYROID IN LEFT LOBE WITH EXTRA-GLANDULAR. EXTENSION. MARGINS OF EXCISION FREE. (TUMOR MEASURING 1.5 CM). One parathyroid gland, no tumor. Follicular adenoma right lobe of thyroid. Nodular goiter. Chronic inflammation. Benign lymphoid follicles in thyroid. Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) RULE OUT RIGHT INFERIOR PARATHYROID - Tan tissue fragment (0.6 x 0.2 x. 0.2 cm). A, submitted in toto for frozen section. FS/DX: PARATHYROID GLAND. (B). TOTAL THYROIDECTOMY - A total thyroidectomy with overall measurements of. 6.0 x 4.5 x 2.0 cm. The left lobe is smaller than the right lobe and appears. to be homogeneous, small, white-tan and firm nodule abutting the deep margin. grossly measuring 1.5 cm is noted located in the anterior aspect of the. thyroid lobe. The right lobe is multinodular and several small oncocytic to. colloid nodules are identified ranging from 0.5 to 1.5 cm in diameter. Representative sections are submitted under B2-86; left lobe and tumor in. B7-B17; right lobe with multiple nodules. FS/DX: PAPILLARY CARCINOMA. SNOMED CODES. M-80503 T-B6000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Multinodular golter. Specimens Submitted: 1: Thyrold, thyroidectomy. DIAGNOSIS: 1. Thyrold, thyroldectomy: Tumor Type: Papillary carcinoma, follicular variant. with oncocytic features. Histologic Grade: Well differentiated. Mitotic Activity: Mild to moderate. Tumor Necrosis: Not identified. Tumor Location: arising in a parasitic nodule. Tumor Size: Greatest diameter is 5 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Not identified. Blood Vessel invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Separate focus of papillary microcarcinoma measuring 0.35cm in right lobe. psammoma bodies also present. Non-Neoplastic Thyrold: Exhibits nodular hyperplasia. Clinical Diagnosis & History: Multinodular goiter. Specimens Submitted: 1: Thyroid, thyroidectomy. DIAGNOSIS: 1. Thyroid, thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. with oncocytic features. Histologic Grade: Well differentiated. Mitotic Activity: Mild to moderate. Tumor Necrosis: Not identified. Tumor Location: arising In a parasitic nodule. Tumor Size: Greatest diameter is 5 cm. Tumor Encapsulation: Completely surroundad. Capsular Invasion: Not identified. Blood Vassal Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Frea of tumor. Tumor Multicantricity: Separate focus of papillary microcarcinoma measuring 0.35cm in right lobe. psammoma bodies also present. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Not identified. Lymph Nodes: Two benign lymph nodes (0/2). LATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIOES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""total thyroid"" and consists of a thyroid weighing 74.5 G. The right lobe measures 5. x. 3.8 x .5 Cm the left lobe measures 6.5 x Cm and the isthmus measures 2.2 x 2 x 0.8 Cm. A 5 x 4.5 x 4 cm mass is. attached to the right lobe by a fibrous ""stalk"" measuring 2.2 x 1.8 x 0.3 cm. The mass is covered by a thin fibrous capsule. The. external surface is covered by a thin fibrous capsule. The posterior surface of the thyroid, the mass and the posterior surface. of. the stalk are inked black and the anterior surface of the thyroid and the stalk is inked blue. Sectioning reveals that the mass is not. connected through the thyroid parenchyma. The cut surface of the mass is tan with focal hemorrhage, homogeneous and fleshy. Sections through the remaining tissue reveal diffuse vague tan nodularity without a dominant nodule. Representative sections of. the specimen are submitted for TPS, cytogenetics and flow cytometry and a photograph has been taken. The remaining tissue. is. serially sectioned. The thyrold is submitted entirely from superior to inferior. The tumor is representatively submitted. Summary of sections: T tumor mass. TS - tumor with the ""stalk"". RL right lobe. LL left lobe. IS isthmus. Summary of Sections: Part 1: Thyroid, thyroidectomy. Block. Sect. Site. PCs. 2. IS. 2. 8. LL. 8. 8. RL. 8. 5. 5. 1. TS.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: former smoker, with right lung nodules discovered on chest CT. Blopgy => squamous caroÃ­noma. Specimens Submitted: 1: SP: Right leval four mediastinal lymph nodes. 2: SP: Left level four mediastinal lymph nodes. 3: SP: Right level 4 mediastinal lymph nodes #2. 4, SP: Level 7 subcarinal lymph nodes. 5: SP: Right upper lobe lung wadge. 6: SP: Level seven aubcarinal lymph nodea. 7: SP: Right level eleven interlobar lymph nodes. 8: SP: Right lower lobe lung. DIAGNOSIS: 1). LYMPH NODE, LEVEL IV, RIGHT MEDIASTINAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). LYMPH NODES, LEVEL IV, LEFT MEDIASTINAL; EXCISION: - MULTIPLE FRAGMENTS OF BENIGN ANTHRACOTIC LYMPH NODES. LYMPH NODES, LEVEL IV, RIGHT MEDIASTINAL #2; EXCISION: - NUL/TIPLE FRAGMENTS OF BENIGN ANTHRACOTIC LYMPH NODES. 4). LYMPH NODE, LEVEL vir, SUBCARINAL: EXCISION: - TWO FRAGMENTS or BENIGN ANTHRACOTIC LYMPK NODES. 5). LUNG, RIGKT UPPER LOBE; WEDGE RESECTION: SQUAMOUS CELL CARCINOMA OF THE RIGHT UPPER LOBE, MODERATELY. DIPFERENTIATED. THE TUMOR'S GREATEST DIAMETER IS 2.1 x 1.8 x 0.9 CM. - No VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - THE MAINSTEM BRONCHUS IS INVOLVED BY IN SITV CARCINOMA. - THE TUMOR EXTENDS SUBPLEURALLY BUT NOT TO THE PLEURAL SURFACE. - IN SITU CARCINOMA IS ALSO PRESENT. THE STAPLED MARGIN IS FREE OP TUMOR. - THE NON-NEOPIASIC LUNG SHOWS INTERSTITIAL FIBROSIS AND FOCAL. ORGANIZED PNEUMONIA. NOTE: THE TUMOR IS SIMILAR IN MORPHOLOGY TO THE TUMOR IN PART 8. 6). LYMPH NODES, LEVEL VII, SUBCARINAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). LYMPH NODES, LEVEL XI, RIGHT INTERLOBAR; EXCISION: - FOUR BENIGN LYMPH NODES (0/4). 8). LUNG, RIGHT, LOWER LOBE; LOBECTOMY: SQUAMOUS CELL CARCINOMA OF THE RIGHT LOWER LOBE, MODERATELY TO POORLY. DIPFERENTTIATED. - THE TUMOR'S GREATEST DIAMETER IS 6.6 x 5.1 x 3.4 CM. - THE MAINSTEM BRONCHUS IS INVOLVED BY INVASIVE CARCINOMA. - THE BRONCHIAL MARGIN IS FREE OF TUMOR. THE STAPLED MARGIN IS FREE OF TUMOR. - THE NON-NEOPLASTIC LUNG SHOWS EMPHYSEMAATOUS CHANGES, INTERSTITIAL. FIBROSIS AND OSSEOUS. METAPLASIA. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NOMBER OF. METASTATIC NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) : PERIBRONCHIAL 3/7. NO DIRECT TUMOR EXTENSION INTO LYMPH NODES IS IDENTIFIED. NOTE: WHILE THE FIBROSIS SHOWS FOCAL HONEYCOMBING AND FIBROTIC. CHANGES THAT RAISED. THE POSSIBILITY OF USUAL INTERSTITIAL PNEUMONIA. THE GROSS SPECIMEN SHOWS. THE FIBROTIC AREAS LOCALIZED AROUND THE TUMOR RATHER THAN DIFFOSELY FIBROTIC. CHANGE. THE CASE IS ALSO REVIEWED BY WHO AGREED WITH THE. RENDERED INTERERETATION. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1) The specimen is received fresh for intraoperative consultation, labeled. ""right level 4 mediastinal lymph nodes and consists of two pink tan firm. lymph nodes ranging from 0.6 x 0.3 x 0.3 cm to 0.7 x 0,4 x 0.3 cm in. greatest dimonsion. All identified lymph nodes are examined by frozen. section and entirely submitted. Summary of sections: FSC frozen section control. or. 2). The specimen is received fresh for intraoperative consultation, labeled. ""left level 4 mediastinal lymph nodes"" and consists of multiple pink tan. firm lymph nodes ranging from 0.3 x 0.2 x 0.2 cm to 0.5 x 0.3 x 0.3 cm in. greatest dimension. All identified lymph nodes are examined by frozen. section and entirely submitted. Summary of sections. PSC frozen section control. 3) The specimen is received fresh for intraoperative consultation, labeled. ""right level 4 mediastinal 1ymph nodes #2"" and consists of multiple pink tan. firm lymph nodes ranging from 0.2 x 0.2 x 0.1 cm to 0.4 x 0.3 x 0.2 em in. greatest dimension. All identified lymph nodes are examined by frozen. section and entirely submitted. Summary of sections: FSC frozen section control. 4). The specimen is received fresh for frozen section consultation,. labeled ""Level seven subcarinal lymph nodes and consists OF two pieces of. pink tan tissua measuring 0.3 x 0.3 x 0.2 cm each. Entirely submitted for. frozen section. Summary of sections: FSC -- frozen section control. 5). The specimon is received frash for frozen section consultation, labeled. ""Right upper lobe lung wedge"" and consists of a lung wedge measuring 5.3 x. 2.4 x 2.2 Cm. The pleural surface is pink-tan and smooth, with a centrally. located white tan and slightly puckered indurated area identified. Sectioning through this area reveals a 2 x 1.8 x 0.9 cm white-tan. 111-defined subpleural tumor nodule, which is located 0.2 cm from the. nearest stapled margin. The remainder of the lung parenchyma ig red-tan. and spongy with dilated areas identified. Representative sections of the. nodule are submitted for frozen section consultation, for permanent section. and the TPS. Sumenary of sections: FSC -- frozen section control. SM stapled margin shaved. RST-representative sections tumor. Rs representative sections. 6). The specimen is received in formalin, labeled ""Level seven subcarinal. lymph nodes and consists of two brown tan fleshy lymph nodes measuring 2.5. and 3 cm in greatest dimension. The lymph nodes are bisected and entirely. submitted,. Summary of sections: BLN- bisected lymph nodas. 7). The specimen is received in formalin, labeled ""Right level 11 interlobar. lymph nodes"" and consists of 4 brown tan fleshy lymph nodes moasuring fxom. 0.6 to 1.2 cm in greatest dimension. The lymph nodes are entirely submitted. Summary of sections: BLN- bisected lymph nodes. 8) The apecimen is received fresh, later placed in formalin, labeled. ""Right lower lobe lung"" and consists of a lung loba measuring 15 x 11.9 x. 5.9 cm. A previous incision is identified at the surface measuring 6.8 em. in greatest dimension. This area has been autured shut. The bronchial and. vascular margins are identified, and appear grosaly uninvolved by tumor. Upon opening, the bronchus is filled with thick red-tan mucoid material. The. ploural surface is pink-tan and primarily smooth. Sectioning through the. previously incised area reveals a 6.6 x 5.1 x 3.4 em ill defined gray tan. cantrally located tumor mass. The mass appears 3.5 cm from the nearest. stapled resection margin, 5.7 cm from the bronchial margin, and the edge. of. the mass abuts the pleural surface. Sectioning through the mass reveals an. extensive area of subpleural dilated spaces partially surrounding the tumor. Purther sectioning shows the mass abutting the distal bronchial wall of. the smaller portion of the bronchus, with partial possible obliteration of. the distal bronchials noted. Sectioning through the remaindex of the lung. reveals extensivo areas of dilated spaces, and few rod tan spongy soft. areas. Summary of sections: Summary of Sections. Part 1: SP: Right level four madiastinal lymph nodes. Block. Sect. Site. PCs. 1. Esc. 2. Part 2 : SP: Left level four mediastinal lymph nodes. Block. Sect. site. PCs. 1. FSC. 5. Part 3: SP: Right level 4 mediastinal lymph nodes #2. Block. Sect. site. PCS. 1. FSC. &. Part 4: SP: Level 7 subcarinal lymph nodes. Block. Sect. Site. PCg. 1. FSC. 1. Part 5: SP: Right upper lohe lung wedge. Block. Sect. site. PCs. 1. fac. 1. 2. zs. 2. 2. rst. 2. 1. sm. 1. Part 6: SP: Level seven subcarinal lymph nodes. Block. Sect. site. pCs. 3. BLN. 3. Part 7: SP: Right level eleven interlobar lymph nodes. Block. Seot. Site. PCs. 4. BLN. 8. Part 8; SP: Right lower lobe lung. Block. Sect. Site. PCs. 1. 1. 3. pbn. 3. 4. rs. 4. 2. xsb. 2. 3. rst. 3. 1. sm. 1. 2. twb. 2. 1. vm. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation,. 1). FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAMK. FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 5). FROZEN SECTION DIAGNOSIS. INFILTRATING SQUAMOUS CELL CARCINOMA. PERMANENT DIAGNOSIS:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Laterality:Papillary carcinoma. Path Report:Tumor type: Papillary carcinoma. Tumor size: 0.7 x 0.7 x 0.7. Laterality: Left. Focality: Unifocal. Extrathyroidal extension: Markers and special stains: Additional comments: No Lymph nodes examined.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. CAD. RIGHT PARTIAL GLOSSECTOMY : INVASIVE WELL DIFFERENTIATED SQUAMOUS CELL CARCINOMA. (SEE COMMENT). Peripheral and deep margins of resection, free of tumor. (B) TEETH: TWO teeth (gross only). COMMENT. The tumor has a maximum depth of invasion of 0.8 cm in an area. where the specimen thickness is 1.4 cm. No unequivocal vascular/Tymphatic or. perineural invasion is identified. SPECIMEN. (A) RIGHT PARTIAL GLOSSECTOMY: (B) TEETH: SNOMED CODES. T-53000, M-80703.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PRIMARY SITE: Stomach (Antrum). ""Stomach: Adenocarcinoma with the following features: Site: antrum. Histologic pattern: NOS (not otherwise specified). Histologic grade: III, poorly differentiated. Lauren classification: intestinal type. Largest tumor size: 5.5 cm. Ulceration: present. Local invasion: Muscularis propria. Tumor invasion type. Infiltrative. Inflammatory response. Mild. Tumor implant in perivisceral fat. Not observed. Proximal margin. Uninvolved by neoplasia. Distal margin. Uninvolved by neoplasia. Neural invasion. Present. Lymphatic invasion. Present. Blood vessel invasion. Doubtful. Greater omentum. Uninvolved by neoplasia. Other features: moderate chronic gastritis with focal intestinal metaplasia in adjacent. mucosa. Lymph nodes: Involved by neoplasia: 14 of 34 (14/34). Capsular invasion: not observed. Lymph node clusters: not observed. Soft tissue tumor implant: not observed. Report of examined lymph nodes according to standardization, JGCA-1998: F- Chain 1 - right paracardic: 2/5. G- Chain 2 - left paracardic: 0/2. H- Chain 3 - lesser curvature: 4/7. K - Chain 4d - right gastroepiploic vessels: 0/1. M - Chain 6 - infrapiloric: 3/5. O- Chain 8a - anterior hepatic artery (antero-superior group): 1/3. Q- Chain 9 - celiac trunk: 4/10. S- Chain 11p - proximal splenic artery: 0/1. Esophageal margin: Uninvolved by neoplasia.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Cample ID #. Diagnosis: 1.: Tumor-free lipomatous atrophic lymph node. 2.: Right hemicolectomy specimen with tumor-free resection margins and under inclusion. of an ulcerated, malignant, solid tumor in the cecum, conforming to the type of a poorly. differentiated adenocarcinoma, with infiltration of the lamina muscularis propria and. without regional lymph node metastases (G3, pT2 L0 V0 R0 pN0 0/27). Additional immunohistological investigations are being conducted due to the histological. peculiarities of the tumor. A follow-up report on this will be submitted at a later date. Follow-up report: From an immunohistological perspective, the tumor cells were positive for broad-. spectrum cytokeratins. Large numbers of CD3-positive and CD20-negative or T-. lymphocytes are also interspersed. Based on the histology and immunohistology, this is thus a poorly differentiated. colorectal adenocarcinoma, or cecum carcinoma, with a dense lymphocytic stromal. infiltrate. The poor tumor differentiation and the dense lymphocytic inflammatory infiltration may. be indicators of the presence of a microsatellite unstable (possibly HNPCC-associated). colorectal carcinoma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN: Sex: F. Date Collected: Date Received: Clinical History/Diagnosis: Left breast cancer. Source of Specimen(s): 1: Sentinel Nodes-left axilla. 2: left breast lumpectomy. 3: Margin-final medial. Gross Description: Received in three parts. Source of Tissue: 1. Labeled # 1, ""sentinel node left axilla"". Touch Preparation Evaluation: 1TP- NO TUMOR SEEN PER. (VERIFIED). Gross Description: Received fresh for intraoperative consultation/touch. impression in a container labeled ""sentinel node left axilla"". It consists of a tan to light. brown rubbery lymph node measuring 1.6 x 1.3 x 1.0 cm. There is a stitch at one end. marking the bluest portion. The node is sectioned. Touch impression of the bluest. end was submitted as 1TPA and the tissue is subsequently submitted in 1A. Touch impression of the opposite end was submitted as 1TPB and. subsequently the tissue is submitted in 1B. Source of Tissue: 2. Labeled # 2, ""left breast lumpectomy"". Gross Description: Received fresh in a container labeled ""left breast lumpectomy"". It. consists of a 7.4 x 7.4 x 3.5 cm ovoid rubbery fragment of fibroadipose tissue. There is a. short stitch marking the superior and a long marking the lateral. The anterior is. inked blue and the remaining margins are inked black. The specimen is. sectioned disclosing a large firm tan lesion with moderately defined. borders measuring 3.8 x 2.6 x 1.9 cm. The lesion occupies an appreciable. amount of the lumpectomy specimen. Laterally in the tumor there is. inspissated blood consistent with previous biopsy site changes. The. lesion comes very close to the medial, superior, and anterior resection. margins. Also adjacently the breast parenchyma is fibrous and there is a. 0.4 cm blue dome cyst noted. Representative sections are submitted in. 2A-K. Designation of Sections: 2A-2C- breast tissue with tumor in relationship. to anterior margin, 2D-2F- breast tissue with tumor in relationship to. posterior margin, 2G- additional sections of tumor, no margins are. represented with biopsy site, 2H- perpendicular sections of superior. resection margin, 2I- perpendicular sections of medial resection margin. [Note: specimen 3 presumably supercedes this margin.], 2J- perpendicular. sections of inferior margin, 2K- perpendicular sections of lateral margin. Source of Tissue: 3. Labeled # 3, ""final medial margin"". Gross Description: Received fresh in a container labeled "" final medial margin"". It. consists of a fragment of fibroadipose tissue measuring 2.5 x 2.0 x 1.0 cm. There is a. stitch marking the final margin which is inked black prior to sectioning. Sections disclose no obvious residual lesional tissue. Entirely submitted. in 3A and 3B. Final Diagnosis: 1. Sentinel lymph node, left axilla, excision: - One lymph node with no tumor seen (0/1). - Negative immunohistochemical staining for cytokeratin AE1/AE3. 2. Left breast, lumpectomy: Invasive and in situ lobular carcinoma. - Invasive lobular carcinoma, 3.8 cm in greatest dimension grossly, grade. II-III. Lobular carcinoma in situ, nuclear grade II-III, comprising. approximately 5% of the tumor mass. - Lymphovascular invasion is not identified. - Invasive carcinoma is less than 1mm to the inked closest medial margin. (see specimen 3 for final medial margin status), and remaining margins. with no tumor seen. - Changes consistent with prior biopsy site seen. Non-neoplastic breast tissue shows fibrocystic changes with. microcalcifications. 3. Left breast, final medial margin, excision: - Benign breast tissue, no tumor seen. Note: Case reviewed with. who concurs with the. diagnosis. Procedures/Addenda. Addendum Date Ordered: Date Complete: Addendum Diagnosis. Specimen sent tc. for additional. testing. Antibody/Tests. Prognostic. Grouping. DNA INDEX/PLOIDY. 1.59 Aneuploid. S-Phase. See Below. Ki-67 (MIB-1). <10%. Favorable. An accurate S-phase fraction (SPF) value cannot be determined due to DNA. aneuploid/tetraploidy cell population <20% of total cells analyzed. INVASIVE BREAST CANCER TEMPLATE: Excisions and Mastectomies. Specimen Type. Excision. Lymph Node Sampling. Sentinel lymph node only. Specimen Size (for excisions less than total mastectomy). Greatest dimension: 7.4 cm. Laterality. Left. Tumor Site(s). Not specified. Invasive Component. Solitary. Greatest dimension: 3.8 cm (grossly). Histologic Type(s). Lobular carcinoma in situ. Invasive lobular. Invasive Lobular Carcinoma Type. Classical, singet-ring, and pleomorphic. Invasion. Invasion confined to breast parenchyma. Angiolymphatic Invasion. Absent. Microcalcifications Associated with Carcinoma In Situ. Margins. Margins uninvolved by invasive carcinoma and in situ carcinoma. Regional Lymph Nodes. 1 regional lymph node examined. No regional lymph node metastasis histologically and by. immunohistochemical staining for cytokeratin AE1/AE3 (NO). Ancillary Immunopathology Studies (performed on. ER. Positive. PR. Positive. Her2-Neu. Negative (score 0). pTNM: T2 NO Mx.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. (A) SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: One lymph node, free of tumor. (See Comment). (B) SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: One lymph node, free of tumor. (See Comment). (C) LEFT BREAST, NEEDLE LOCALIZATION SEGMENTAL MASTECTOMY: INVASIVE DUCTAL CARCINOMA OF BREAST, MODIFIED BLACK'S NUCLEAR GRADE 3 (POORLY. DIFFERENTIATED). INVASIVE CARCINOMA MEASURES 1.2 CM IN GREATEST DIMENSION. Lymphatic/vascular invasion is not identified. INTRADUCTAL CARCINOMA (DCIS), MODIFIED BLACK'S NUCLEAR GRADE 3 (POORLY DIFFERENTIATED),. COMPRISING SOLID TYPE, WITH NECROSIS, COMPRISING <5% OF THE TUMOR AREA. INVASIVE CARCINOMA EXTENDS TO WITHIN 5.0 MM OF THE NEAREST DEEP MARGIN. All margins are free of tumor. (D) LEFT BREAST, SECOND DEEP MARGIN, EXCISION: Skeletal muscle, no tumor present. (E) LEFT BREAST, SECOND MEDIAL MARGIN, EXCISION: No tumor present. (F) LEFT BREAST, SECOND SUPERIOR MARGIN, EXCISION: No tumor present. (G) LEFT BREAST, SECOND INFERIOR MARGIN: No tumor present. Entire report and diagnosis completed by v. OMMENT. Immunohistochemical stains for cytokeratins have been requested on tissue sections from both sentinel lymph nodes. Those. results will be reported as an addendum. Molecular pathologic assays have been requested on tissue sections from block C1 of. the primary tumor. Those results will be reported as an addendum. The invasive carcinoma measures 1.2 cm in greatest. microscopic diameter (slide C1) and focally invades pectoralis muscle, extending to within 5.0 mm of the deep margin (slide C2). GROSS DESCRIPTION. (A) LEFT AXILLA, SENTINEL LYMPH NODE BIOPSY #1, IN VIVO 216, EX VIVO 4 - A 0.8 x 0.6 x 0.4 cm lymph node. The. specimen is transected and two touch imprints were performed. The remnant of the tissue is submitted in toto in A. TP/DX: NO CARCINOMA IDENTIFIED. (B) LEFT AXILLA SENTINEL BIOPSY #2, IN VIVO 416, EX VIVO 887 - A 2.0 x 1.0 x 0.6 cm lymph node with surrounding fat. tissue. Specimen is bisected and two touch imprints are performed. A remnant of the lymph node is submitted in B1-B2. TP/DX: NO CARCINOMA IDENTIFIED. (C). LEFT NEEDLE LOCALIZATION, SEGMENTAL MASTECTOMY - A segmental mastectomy specimen (7.0 x 7.0 x 4.0 cm). with a skin ellipse (2.8 x 1.2 cm). The specimen has two clips indicating anterior aspect and one clip indicating the middle aspect. The. specimen is serially sectioned from medial to lateral. The cut surface shows an ill-defined, white-firm lesion measuring 0.8 x. 6 x 0.6 cm that is 0.7 cm from the deep margin. The remnant of the breast tissue is predominantly composed of fatty tissue. INK CODE: Green - inferior; blue - superior; black - deep; yellow - superficial; red - lateral; orange - medial. SECTION CODE: C1-C2, tumor in relation to the deep margin; C3, extra section from the tumor; C4-C5, random section. from the breast including the skin. (D). SECOND. DEEP MARGIN, CLIP ON TRUE MARGIN - An oriented irregular fragment of skeletal muscle measuring 3.0 x 1.5 x. 5 cm. The specimen is oriented as clip on true margin. The true margin is inked in black. The specimen is serially sectioned and. entirely submitted in D1-D2. (E). SECOND MEDIAL MARGIN, CLIP ON TRUE MARGIN - An oriented irregular fragment of adipose tissue measuring 4.0 x 2.0. x. 0.8. cm. The. specimen. is. oriented as clip on true margin. The true margin is inked in black. The specimen is serially sectioned. and entirely submitted in E1-E4. (F) SECOND SUPERIOR MARGIN, CLIP ON TRUE MARGIN - An oriented irregular fragment of adipose tissue measuring 3.5 x. 2.0 x 0.8 cm. The specimen is oriented as clip on true margin. The true margin is inked in black. The specimen is serially. sectioned and entirely submitted in F1-F3. is oriented as clip on true margin. The true margin is inked in black. The specimen is serially sectioned and entirely submitted in. (G). SECOND. INFERIOR MARGIN - An oriented irregular fragment of adipose tissue measuring 3.5 x 2.5 x 0.6 cm. The specimen. G1-G3. I. CLINICAL HISTORY. Left breast cancer. SNOMED CODES. T-04050, M-85003, M-85002, T-C4714, M-00110. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration. Released by: Start of ADDENDUM. ADDENDUM. Addendum completed by .. COMMENT. Immunohistochemical stains for cytokeratin were reviewed on tissue sections from both sentinel lymph nodes and were negative. Released by: Start of ADDENDUM #2. ADDENDUM. Addendum completed by ,. This report is issued to give immunohistochemistry results. Immunohistochemical staining is performed on a representative section of INVASIVE DUCTAL CARCINOMA, left breast, block. C1. MARKER. % POSITIVE. STAINING. INTENSITY. Estrogen Receptor. Positive. 100 %. CC # 52. Progesterone Receptor. Positive. 90 %. C-erbB-2 (HER-2/neu). overexpression. Negative. 0%. 0. Ki-67. High (>35%). 50 %. N/A. FOOTNOTE. Estrogen receptor was assessed by immunohistochemistry using antibody 6F11 (. Progesterone receptor was assessed by immunohistochemistry using antibody 1A6. c-erbB-2 (HER-2/neu) was assessed by immunohistochemistry using antibody AB8. Ki-67 was assessed by immunohistochemistry using antibody MIB1. Released by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS: 1. Kidney, right, tumor #1, excision: Renal cell carcinoma with features of papillary RCC type 1 with solid and. clear cell areas; see note. 2. Kidney, right, tumor #2, excision: Multiple foci of renal cell carcinoma with features of papillary RCC type 1 with. solid areas; see note. NOTE: The case will be discussed with. and a supplemental report will follow, if indicated. CLINICAL INFORMATION: Brief Clinical History: with HPRC and right renal mass. Specimen Taken For Protocol: 01 - Yes Allocate Order to Protocol: PROCEDURE: Operative Findings: two right renal masses Post-Operative Diagnosis: renal mass Pre-Operative Diagnosis: renal mass. SPECIMENS SUBMITTED: 1. TUMOR, #1. 2. TUMOR, #2 Right Kidney. GROSS DESCRIPTION: Received for procurement labeled with the patient's name, medical record number, and. further described as follows are: 1. ""Tumor #1"" is a 1. 1 X 1.1 x 1 cm white soft tissue fragment. The cut surface is tan homogeneous. 60% is. procured for the. a 0.1 CC amount is procured for electron microscopy, and the remainder is sent to Surgical. Pathology. At Surgical Pathology, the specimen is received and matches the above description. It is serially. sectioned and entirely submitted in cassette. for permanent processing. 2. ""Tumor #2 right kidney"" is a 2.5 X 2.2 X 2 cm soft tissue fragment with a white/tan, variegated cut surface. Attached normal parenchyma is seen. 35% is procured the. a 0.1 CC fragment is sent for electron. microscopy, and the remainder is sent to. At. the specimen is received. and matches the above description and is entirely submitted in cassette. for permanent. processing. The above procurement was performed by. on. No consultants.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Amended. DATE OBTAINED: DATE RECEIVED: SUBMITTING MD: MD. DIAGNOSIS. 1. SUPERFICIAL RIGHT AXILLARY BREAST TISSUE, EXCISION: SMALL FOCUS OF INVASIVE LOBULAR. CARCINOMA (0.6MM) PRESENT AT THE EDGE OF ONE FRAGMENT, WITH SURROUNDING ADIPOSE. TISSUE; RARE BENIGN BREAST ACINI; SEE COMMENT. 2. RIGHT AXILLARY SENTINEL LYMPH NODE #1: ONE LYMPH NODE POSITIVE FOR MICROMETASTASIS. (0.6 MM); SEE COMMENT. 3. RIGHT AXILLARY SENTINEL LYMPH NODE #2: ONE LYMPH NODE POSITIVE FOR MULTIPLE FOCI OF. MICROMETASTASIS (LARGEST 1.5MM), CONFIRMED BY CYTOKERATIN STAIN; NO EXTRANODAL. EXTENSION. 4. RIGHT BREAST, MASTECTOMY: INVASIVE LOBULAR CARCINOMA. SIZE (INVASIVE): 3.5 cm. LATERALITY: Right. TUMOR FOCALITY: Unifocal. LESIONAL SITE: 10:00. HISTOLOGIC TYPE: Invasive lobular carcinoma, classical and pleomorphic types. NUCLEAR GRADE: II and III of III. HISTOLOGIC GRADE: N/A. (invasive lobular carcinoma). IN-SITU COMPONENT: LCIS. (Classical and focal pleomorphic types; NG II, focal III). LYMPH NODE SAMPLING: Positive (2/15), largest 3mm; no extranodal involvement; see specimens #2, #3 & #6. AJCC CATEGORIES: Stage IIB. pTNM: pT2. pN1mi. cTNM: cT2. cN1. cM0. INTEGRITY/ORIENTATION: Intact specimen with designated margins. MARGINS (invasive lobular): Focal positive superior/anterior margin (see final margin in #1);. Other margins negative (>3mm). LYMPHOVASCULAR INVASION: Present. MICROCALCIFICATIONS: Not identified. NIPPLE/SKIN: Negative skin and nipple. SKELETAL MUSCLE: Present, focal, negative for tumor. OTHER: Focal sclerosing adenosis, columnar cell changes and usual mild hyperplasia. 5. LEFT BREAST, PROPHYLACTIC MASTECTOMY: BENIGN BREAST WITH SMALL PAPILLOMATOSIS,. SCLEROSING ADENOSIS AND MILD USUAL DUCTAL HYPERPLASIA; NO ATYPIA; NEGATIVE SKIN AND. NIPPLE. 6. RIGHT AXILLARY CONTENTS, DISSECTION: THIRTEEN NEGATIVE LYMPH NODES (0/13). COMMENT. #1: There is one small focus of invasive carcinoma at the edge of a fragment (0.6mm, confirmed by negative calponin and p63. immunostain), with severe cautery artefact, which was not seen on frozen section. The tumor is surrounded by fatty tissue, and. thus would be regarded as negative final margin for specimen #4. #2: There is single focus of micrometastasis in the SLN #1. This focus is only present in slide 2B CTD2, and not on other levels,. frozen smears and cytokeratin immunostained slides. 88307x5, 88305, 88331, 88332, 88333x2, 88342x3. Clinical Diagnosis and History: Right breast cancer 10 o'clock. cT2,cNI,cMo, clinical stage 2B. Tissue(s) Submitted: 1: SUPERFICIAL RIGHT AXILLARY BREAST TISSUE. 2: RIGHT AXILLARY SENTINEL LYMPH NODE #1. 3: RIGHT AXILLARY SENTINEL LYMPH NODE #2. 4: RIGHT BREAST LONG STITCH LATERAL SHORT STITCH SUPERIOR. 5: LEFT BREAST LONG STITCH LATERAL SHORT STITCH SUPERIOR. 6: RIGHT AXILLARY CONTENTS. Gross Description: Specimen #1 is received fresh for intraoperative consultation, labeled with the patient's name and superficial right axillary breast. tissue, and consists of a 2.7 x 1.7 x 0.6 cm tan-yellow lobulated adipose tissue which is entirely submitted for frozen section. analysis labeled 1AFS-1BFS. Specimen #2 is received fresh for intraoperative consultation, labeled with the patient's name and right axillary sentinal lymph node. #1, and consists of a single tan-pink, nodular tissue consistent with lymph node measuring 1.3 x 0.7 x 0.5 cm. The specimen is. serially sectioned and two intraoperative smears are performed. The specimen is entirely submitted labeled 2A-2B. Specimen #3 is received fresh on a blue surgical towel for intraoperative consultation, labeled with the patient's name and right. axillary sentinal lymph node #2, and consists of a single tan-pink, nodular tissue consistent with lymph node measuring 1.0 x 0,5 x. 0.5 cm. The specimen is serially sectioned and an intraoperative smear is prepared. The specimen is entirely submitted labeled. 3A-3B. Specimen #4 is received fresh for formalin, labeled with the patient's name and right breast, long stitch lateral, short stitch superior,. and consists of a 520 gram, 18 (superior to inferior) by 17 (medial to lateral) by 4 (anterior to posterior) cm right mastectomy. specimen. A short suture designating superior, and a long suture designating lateral are present. A 14 x 4.5 x 0.3 cm white-tan,. unremarkable ellipse of skin is identified containing a 1.3 x 1.1 x 0.3 cm unremarkable, everted nipple. The areola measures 3.5 x. 2.5 cm. The specimen is differentially inked as follows: superior/anterior - blue, inferior/anterior - green, posterior/deep - black. and. serially. sectioned from lateral to medial to reveal a 3.5 x 2.5 x 1.1 cm firm, tan-pink, irregular mass at the 10 o'clock position. This mass is focally 0.2 cm from the posterior, 0.2 cm from the superior/anterior, and greater than 4 cm from the inferior margins. The mass is present in multiple sections and is seen to extend more centrally. No other lesions are grossly identified. The. surrounding breast parenchyma consists of white, fibrous tissue (60%) and tan lobular adipose tissue (40%). Time in formalin: 14:20. Representative sections are submitted as follows: 4A-4B: Mass closest to superior/anterior and deep margins, contiguous section. 4C: Mass to deep margin. 4D: Mass to superior/anterior margin. 4E: Mass to deep margin. 4F-4G: Tumor without margin. 4H: Mass to deep. 41: Tumor without margin. 4J: Inferior margin closest to tumor. 4K-4L: Fibrous tissue immediately medial to mass. 4M: Fibrous tissue in central breast. 4N: Fibrous tissue in medial most breast. 40: Nipple and skin section closest to mass. 4P: Outer upper quadrant. 4Q: Outer lower quadrant. 4R: Inner upper quadrant. 4S: Inner lower quadrant. Specimen #5 is received fresh for formalin, labeled with the patient's name and left breast, long stitch lateral, short stitch superior,. and consists of a 550-gram, 20 (superior to inferior) by 15.9 (medial to lateral) by 5.4 (anterior to posterior) product of left. mastectomy. An unremarkable, tan ellipse of skin is identified measuring 13.3 x 4.2 x 0.2 cm. The everted nipple measures 1 x. 0.9 cm and resides within a 4 x 2.9 cm areola. The specimen is differentially inked as follows: superior/anterior - blue,. inferior/anterior - green, posterior/deep - black and serially sectioned from medial to lateral to reveal no distinct mass but areas. consistent. with. fibrocystic changes containing blue domed cysts averaging 0.3 cm in greatest dimension. The surrounding breast. parenchyma consists of tan-yellow lobulated adipose tissue (60%) and white, fibrous areas (40%). No other lesions are grossly. identified. Time in formalin: Representative sections are submitted as follows: 5A: Nipple. 5B: Outer upper quadrant. 5C: Inner upper quadrant. 5D: Inner lower quadrant. 5E: Outer lower quadrant. 5F-5L: Fibrous areas. 5M: Superior margin to fibrous area. 5N: Deep margin to fibrous area. 50: Inferior margin to fibrous area. Specimen #6 is received fresh on a blue surgical towel, labeled with the patient's name and right axillary contents, and consists of. multiple tan-pink, nodular tissues consistent with lymph nodes ranging from 0.5 to 2 cm in greatest dimension. All grossly. identifiable lymph nodes are submitted as follows: 6A-B: One lymph node, bisected, each cassette. 6C-6D: One lymph node, bisected. 6E-F: One lymph node, bisected, each cassette. 6G-H: Intact lymph nodes. Intraoperative Consult Diagnosis. 1A-1B/FSDX: BENIGN BREAST TISSUE AND FAT; NO MALIGNANCY. 2A/GDX/SMDX: NEGATIVE LYMPH NODE (0/1). 3A/GDX/SMDX: POSITIVE LYMPH NODE (1/1). Amendments. Amended: Reason: Further review of case. SLN #2 should be counted as multiple micromet. Previous Signout Date:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Encounter Number. COPY ONLY DO NOT FILE. SURGICAL PATHOLO. Correction. Source of Specimen. A. LEFT DISTAL URETER MARGIN FS-. B. RIGHT DISTAL URETER MARGIN FS-. C. DISTAL URETHRAL MARGIN OF RADICAL CYSTECTOMY SPECIMEN FS-. D. LEFT PELVIC LYMPH NODE-. E. RIGHT PELVIC LYMPH NODE-. F. BLADDER AND PROSTATE GLAND, SEMINAL VESICLES-. Reason for Correction. TO CORRECT TYPOGRAPHICAL ERROR. FINAL DIAGNOSIS: A. LEFT DISTAL URETER MARGIN FS-. SEGMENT OF URETER, NO TUMOR SEEN. B. RIGHT DISTAL URETER MARGIN FS-. SEGMENT OF URETER, NO TUMOR SEEN. C. DISTAL URETHRAL MARGIN OF RADICAL CYSTECTOMY SPECIMEN FS-. NO TUMOR SEEN IN URETHRAL MUCOSA. PROSTATE TISSUE, SEE SPECIMEN ""F"". D. LEFT PELVIC LYMPH NODE-. FOUR LYMPH NODES, NO TUMOR SEEN. E. RIGHT PELVIC LYMPH NODE-. FOUR LYMPH NODES, NO TUMOR SEEN. F. BLADDER AND PROSTATE GLAND, SEMINAL VESICLES-. INVASIVE CARCINOMA, HIGH GRADE. TUMOR SITE: DOME, URINARY BLADDER. Prepared. HISTOLOGIC TYPE: UROTHELIAL. SQUAMOUS DIFFERENTIATION: IS PRESENT. GLANDULAR DIFFERENTIATION: IS NOT PRESENT. TUMOR SIZE: 2.5 CM. HISTOLOGIC GRADE: 3/3. DEPTH OF INVASION: DEEP PORTION OF MUSCULARIS PROPRIA. SPECIMEN TYPE: CYSTECTOMY/PROSTATECTOMY. TNM STAGE: pT2b, pNo, pMX. (T2a: inner half; T2b, outer half). (N1, single pelvic node; N2, multiple pelvic nodes; N3, common. iliac node). LYMPH NODE (s) INCLUDED IN ALL PARTS: NUMBER INVOLVED : o. NUMBER EXAMINED: 8. LYMPHATIC (SMALL VESSEL) INVASION: NOT SEEN. ASSOCIATED EPITHELIAL LESIONS: IDENTIFIED. NO TUMOR SEEN AT MARGIN(S). PROSTATE ADENOCARCINOMA, GLEASON 3+3=6/10. ADENOCARCINOMA OF PROSTATE. NO EXTRAPROSTATIC EXTENSION SEEN. TUMOR SITE: BILATERAL, APEX AND PERIPHERAL ZONES. SPECIMEN TYPE: CYSTOPROSTATECTOMY. GLEASON SCORE (PRIMARY + SECONDARY PATTERN) : 3 + 4 = 7/10. TERTIARY PATTERN: NOT PRESENT. SEVERITY IN EXTENT OF TUMOR: 1 /5. (1: <5%; 2: 5-15%; 3: 15-30% 4: 30-50%; 5: > 50% tissue. involvement). DOMINANT NODULE (AT LEAST 1 CM IN SIZE) : NOT PRESENT. Prepared fo. TREATMENT EFFECT ON CARCINOMA: NOT IDENTIFIED. TNM STAGE: pT2c, pNO, pMX. (T2a = one side, < 50% T2b = one side, > 50% T2c = bilateral). (NO: negative node; N1: positive regional node). LYMPHATIC (SMALL VESSEL) INVASION: NOT SEEN. PERINEURAL INVASION: NOT PRESENT. NO TUMOR SEEN IN SEMINAL VESICLES. NO TUMOR SEEN AT SPECIMEN MARGINS. Signed Others. Frozen Section. A. RIGHT DISTAL URETER - NO TUMOR SEEN. LEFT DISTAL URETER- NO TUMOR SEEN. DISTAL URETHRAL MARGIN FROM RADICAL CYSTECTOMY- - NO TUMOR SEEN. Case Clinical Information. MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA OF BLADDER. Gross Description. A. Received in formalin labeled with the patient's name and. ""left distal ureter margin-FS"" is a 0.7 cm frozen section tissue. remnant with a pinpoint lumen identified. Wrapped and entirely. submitted in A1. B. Received in formalin labeled with the patient's name and. ""right distal ureter margin-FS"" is a 0.8 cm frozen section. tissue remnant with a pinpoint lumen identified. Wrapped and. entirely submitted in B1. C. Received in formalin labeled with the patient's name and. ""distal urethral margin of radical cystectomy specimen-FS is. a. Prepared for. 3 x 2 x 0.5 cm thick frozen section tissue remnant. Entirely. submitted in C1. D. Received in formalin labeled with the patient's name and. left pelvic lymph node"" are four nodules of tan adipose tissue. consistent with lymphoid tissue ranging in size from 2 cm down. to 1.5 cm. The excess fat is trimmed. All four nodes are. submitted entirely as follows: D1= one lymph node bisected; D2=. one lymph node bisected; D3-D4= one lymph node bisected; D5-D6=. one lymph node bisected. E. Received in formalin labeled with the patient's name and. ""right pelvic lymph node"" are four nodules of tan fatty tissue. All four nodules are submitted as follows: E1-E2= one lymph node. bisected; E3= one single lymph node; E4= one single lymph node;. E5-E6= one lymph node bisected. F. Received in formalin labeled with the patient's name and. ""bladder, prostate gland and seminal vesicles"" is a radical. cystectomy specimen with attached fat measuring 16 x 11 x 7 cm. The attached prostate measures 4.5 x 4 x 4 cm. A 3 cm defect is. identified on the prostatic urethral margin. This is grossly. consistent with tissue taken for frozen section evaluation. The. specimen is inked black on the left and blue on the right. The. right seminal vesicle measures 5 x 1 x 1 cm. The right vas. deferens measures 7 cm in length. The left seminal vesicle. measures 5 x 1 x 1 cm. The left vas deferens measures 11 cm in. length. The left and right ureters are embedded in the fat and. have been previously taken for frozen section evaluation. The. bladder is opened anteriorly and in the dome of the bladder a. circumscribed tan, friable mass is identified measuring 2.4 x 2. x. 1 cm. The remainder of the bladder mucosa has a retracted. cobble-stoned appearance. No additional gross tumor is. identified. The cut surface of the mass has a very friable tan. glistening appearance and grossly appears to have invaded into. the muscularis. The posterior bladder all on cut surface is. grossly unremarkable. The left and right lateral bladder walls. are serially sectioned and are grossly unremarkable. The right. side of the prostate is serially sectioned to reveal a focally. nodular tan-pink grossly unremarkable parenchyma. The left. prostate is serially sectioned and in the lower one third the. parenchyma reveals a 1 cm cyst that is lined with a smooth. tissue. The lumen contains a clear fluid. Representative. sections of the specimen are submitted as follows: F1-F3= mass. at dome on right side; F4-F6= mass at dome on left side; F7-F8=. right posterior wall; F9-F10= left posterior wall; F11-F13=. right lateral wall; F14-F16= left lateral wall; F17= right. trigone; F18= left trigone; F19-F21= representative sections of. upper, mid and lower one third of prostate, right side; F22-F24=. representative sections of upper, mid and lower one third of. prostate, left side. Also, F24 demonstrates cystic structure on. left side of prostate previously described. Additional sections. Prepared il. submitted as follows: : F25-F27= additional full thickness cross. sections of prostate upper, mid and lower one third right side;. F28-F30= representative sections of upper, mid and lower one. third of prostate left side. procedure. A. AA ROUTINE H&E X1 BLOCK. H&E X1. B. AA ROUTINE H&E X1 BLOCK. H&E X1. C. AA ROUTINE H&E X1 BLOCK. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 2. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 4. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 5. H&E X1. D. AA ROUTINE H&E X1 BLOCK. 6. H&E X1. E. AA ROUTINE H&E X1 BLOCK. 1. H&E X1. E. AA ROUTINE H&E X1 BLOCK. 2. H&E X1. E. AA ROUTINE H&E X1 BLOCK. 3. H&E X1. E. AA ROUTINE H&E X1 BLOCK. 4. H&E X1. E. AA ROUTINE H&E X1 BLOCK.5. H&E X1. E. AA ROUTINE H&E X1 BLOCK. 6. H&E X1. F. AA ROUTINE H&E X1 BLOCK.1. H&E X1. F. AA ROUTINE H&E X1 BLOCK.2. H&E X1. F. AA ROUTINE H&E X1 BLOCK.3. H&E X1. F. AA ROUTINE H&E x1 BLOCK.4. H&E X1. F. AA ROUTINE H&E X1 BLOCK.5. Prepared fo. H&E X1. F. AA ROUTINE H&E X1 BLOCK.6. H&E X1. F. AA ROUTINE H&E X1 BLOCK.7. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 8. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 9. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 10. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 11. H&E X1. F. AA ROUTINE H&E X1 BLOCK.: 12. H&E X1. F. AA ROUTINE H&E X1 BLOCK.: 13. H&E X1. F. AA ROUTINE H&E X1 BLOCK.14. H&E X1. F. AA ROUTINE H&E X1 BLOCK.: 15. H&E X1. F. AA ROUTINE H&E X1 BLOCK.16. H&E X1. F. AA ROUTINE H&E X1 BLOCK.17. H&E X1. F. AA ROUTINE H&E X1 BLOCK.18. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 19. H&E X1. F. AA ROUTINE H&E X1 BLOCK.20. H&E X1. F. AA ROUTINE H&E X1 BLOCK.21. H&E X1. F. AA ROUTINE H&E X1 BLOCK.22. H&E X1. F. AA ROUTINE H&E X1 BLOCK.23. H&E X1. F. AA ROUTINE H&E X1 BLOCK.24. H&E X1. F. AA ROUTINE H&E X1 BLOCK.25. H&E X1. F. AA ROUTINE H&E X1 BLOCK.26. H&E X1. F. AA ROUTINE H&E X1 BLOCK. 27. H&E X1. F. AA ROUTINE H&E X1 BLOCK.28. H&E X1. F. AA ROUTINE H&E X1 BLOCK.29. H&E X1. Prepared. F. AA ROUTINE H&E X1 BLOCK. . 30. H&E X1. Prepared.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN(S): A. LEFT BREAST AND AXILLARY CONTENTS. B. ADDITIONAL AXILLARY CONTENTS. C. LEFT BREAST SKIN AND TISSUE. D. RIGHT BREAST NEEDLE LOCALIZATION. E. ADDITIONAL RIGHT BREAST RETROAREOLAR TISSUE. MARGIN. CLINICAL HISTORY: yo female with left clinical T2N1 IDC, 3.5 cm retroareolar (note ER + primary and ER. negative axillary mets) here for L MRM. Also, right breast mass bx shows ADH. Here. for R excisional biopsy. PRE-OPERATIVE DIAGNOSIS: Left - IDC, Right - ADH. INTRAOPERATIVE CONSULTATION. FSD: Right breast needle localization- Representative section of mass-no invasive. carcinoma on frozen. At least atypical ductal hyperplasia-cannot rule out DCIS-lesion. near anterior margin. Diagnosis called to Dr. at by Dr. DIAGNOSIS: A. BREAST, LEFT, AND AXILLARY CONTENTS, MODIFIED RADICAL. MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2, WITH. LOBULAR FEATURES, INVOLVING THE NIPPLE DERMIS. - 3.4 CM IN SIZE. - DUCTAL CARCINOMA IN SITU (DCIS), CRIBRIFORM AND SOLID. TYPES,. NUCLEAR GRADE 2, WITH NECROSIS AND MICROCALCIFICATIONS. - MARGINS, NEGATIVE FOR CARCINOMA. METASTATIC CARCINOMA IN SEVEN OF EIGHT LYMPH NODES. WITH. EXTRANODAL EXTENSION (7/8). B. ADDITIONAL AXILLARY CONTENTS, LEFT, DISSECTION: - METASTATIC CARCINOMA IN ONE OF FIVE LYMPH NODES (1/5). C. BREAST, LEFT, SKIN AND TISSUE, EXCISION: - SKIN AND ADIPOSE TISSUE, NEGATIVE FOR CARCINOMA. D. BREAST, RIGHT, NEEDLE LOCALIZATION EXCISIONAL BIOPSY: - DUCTAL CARCINOMA IN SITU (DCIS), CRIBRIFORM AND PAPILLARY. TYPES, NUCLEAR GRADE 1. - DCIS IS WITHIN 0.2 CM OF THE DESIGNATED RETROAREOLAR. MARGIN AND 0.3 CM FROM THE ANTERIOR MARGIN. - SEVERAL FOCI OF ATYPICAL DUCTAL HYPERPLASIA (ADH). - COLUMNAR CELL CHANGE, COMPLEX SCLEROSING LESION WITH. USUAL DUCTAL HYPERPLASIA, INTRADUCTAL PAPILLOMAS,. CYSTIC. APOCRINE METAPLASIA, MICROCALCIFICATIONS AND PREVIOUS. BIOPSY SITE CHANGES. NOTE: DCIS is present in two slides and measures 0.4 cm on a single slide. E. BREAST, RIGHT, ADDITIONAL RETROAREOLAR TISSUE MARGIN,. EXCISION: SMALL INTRADUCTAL PAPILLOMA WITH USUAL DUCTAL. HYPERPLASIA. AND FOCAL PREVIOUS BIOPSY SITE CHANGES. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: A: LEFT BREAST AND AXILLARY CONTENTS. B: ADDITIONAL AXILLARY CONTENTS. C: LEFT BREAST SKIN AND TISSUE. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3.4cm. Tumor Site: Central. Margins: Negative. Distance from closest margin: Greater than 2cm. deep. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Axillary dissection. Lymph node status: Positive 8 / 13 Extranodal extension. Non-neoplastic areas: complex sclerosing lesion, intraductal papillomas, usual ductal hyperplasia. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 10%. DCIS Type: Solid. Cribriform. DCIS Location: Both associated and separate from invasive tumor mass. Nuclear grade: Intermediate. Necrosis: Present. Location of CA++: DCIS. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative. Performed on Case: Pathological staging (pTN): pT 2 N 2. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimens Involved. Specimens: A: LEFT BREAST AND AXILLARY CONTENTS. Specimen: Surgical Excision. Block Number: A21 (lymph node). ER: Positive. Allred Score: 8 = Proportion Score 5 + Intensity Score 3. PR: Positive. Allred Score: 3 = Proportion Score 2 + Intensity Score 1. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-. 30% of cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score. (1 = weak intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of. staining), with a scoring range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR. (PGR 136, 1:100) provided by. bllowing the manufacturer s. instructions. This assay was not modified. Interpretation of the ER/PR immunohistochemical stain. is guided by published results in the medical literature, information provided by the reagent. manufacturer and by internal review of staining performance. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: D: RIGHT BREAST NEEDLE LOCALIZATION. E: ADDITIONAL RIGHT BREAST RETROAREOLAR TISSUE MARGIN. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive Tumor: Absent. Multifocality: N/A. WHO CLASSIFICATION. Intraductal proliferative lesions. Ductal carcinoma in situ 8500/2. DCIS present. Margins uninvolved by DCIS : see above. DCIS Type: Cribriform. Papillary. Nuclear grade: Low. Necrosis: Absent. Location of CA++: Benign epithelium. Pathological staging (pTN): pT is N X. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. GROSS DESCRIPTION: A. LEFT BREAST AND AXILLARY CONTENTS. Received fresh with the patient's identification and designated ""left breast and axillary. contents"" is an oriented 1143g, 19 x 19 x 3.6 cm mastectomy with 14 X 6 cm attached. tan-brown skin ellipse and a centrally located, non-retracted 1.2 x 1.4 cm nipple. Ink. code: posterior-black, anterior superior-blue, anterior inferior-orange. Serial sectioning. from medial to lateral into 14 slices reveals two lesions: Lesion 1: 3.4 x 3 x 2 cm white-tan, firm, irregular mass at 12:00 in slices 5 and 6, 3 cm. from the deep margin. Lesion 2: 8 x 7 X 3 cm ill-defined nodular and cystic area, involving the LIQ, mid to LOQ. and central area in slices 4-9, 2 cm from the deep margin, and inferior and adjacent to. lesion 1. In the axillary tail, there is a 4 x 3.2 x 2 cm mass consistent with tumor involving lymph. node(s) as well as several other grossly positive lymph nodes. Representatively submitted. as per the attached diagram: A1-A2: lesion 1 (mass), slice 5, 12:00. A3-A5: lesion 1 (mass), slice 6, 12:00 (biopsy clip in cassette A3). A6: deep margin, slice 5. A7: lesion 2, slice 4, LIQ. A8: lesion 2, slice 5, central lower. A9: lesion 2, slice 6, central lower. A10: lesion 2, slice 7, LOQ. A11: lesion 2, slice 8, LOQ. A12: lesion 2, slice 8, mid outer quadrant. A13: lesion 2, slice 9, LOQ. A14: deep margin, slice 9. A15: UIQ. A16: UOQ. A17-A19: nipple. A20: skin. A21-A22: representative sections of largest lymph node. A23: one lymph node, representative section. A24: one lymph node, bisected. A25: one possible lymph node, bisected. A26: two lymph nodes. A27: one lymph node, bisected. A28: two lymph nodes. A29-A32: additional axillary tissue. B. ADDITIONAL AXILLARY CONTENTS. Received fresh labeled with patient identification and designated ""additional axillary. contents"" is a tan-pink to tan-red and hemorrhagic, fibrofatty soft tissue fragment, 3.5 x. 2.5 x 1 9 cm. Examination reveals 8-10, firm, tan-white to tan-pink possible lymph nodes. ranging in size from 0.2 x 0.2 x 0.2 cm to 0.4 x 0.2 x 0.2 cm. The specimen is entirely. submitted as follows: B1: Possible lymph nodes. B2-B3: The remaining soft tissue. C. LEFT BREAST SKIN AND TISSUE. Received fresh with patient's identification and designated ""left breast skin and tissue"" are. 1) an unoriented, tan-pink to tan-yellow, partially skin covered soft tissue fragment. measuring 9.5 x 6.5 x 1.8 cm, serial sectioning reveals no grossly visible/possible. masses/lesions. The deep surface of the specimen is inked in black and representatively. submitted in C1-C3. 2) A fragment of tan-brown skin (the central part is missing), 2-1.5 x 7.5 x 1 cm,. examination reveals no grossly visible lesions, representatively submitted in C4-C5. D. RIGHT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and ""right breast needle. localization"" is an oriented 31g, 7 x 5 x 3cm needle localized lumpectomy with. radiograph. Ink code: retroareolar - purple, anterior-yellow, posterior-black, superior-. blue, inferior-orange, medial-green, lateral-red. Specimen is serially sectioned from. lateral to medial into 7 slices revealing a 1.4 x 1 x 1cm tan white irregular mass, 0.1cm. from the anterior-retroareolar margin in slices 3-4. A 0.5 x 0.5 x 0.3cm tan white firm. area is also identified, at the anterior-lateral-inferior margin of slice 1. A biopsy clip is. identified in slice 2 adjacent to the firm area in slice 1. A portion of the 1.4 cm mass is. submitted for frozen section in FSD. Representatively submitted: FSD: 1.4 cm mass slice 3. D2-D4: lateral margin with 0.5 cm firm area in D4. D5-D8: slice 2 with clip ID in D8. D9: superior margin slice 3. D10: posterior margin slice 3. D11-D12: inferior margin slice 3. D13-D14: superior margin slice 4. D15: mass with anterior margin slice 4. D16: posterior margin slice 4. D17: inferior margin slice 4. D18-D19: anterior margin slice 5. D20-D21: posterior margin slice 5. D22: superior margin slice 6. D23: anterior margin slice 6. D24: posterior margin slice 6. D25: inferior margin slice 6. D26-D27: medial margin slice 7. E. ADDITIONAL RIGHT BREAST RETROAREOLAR TISSUE MARGIN. Received fresh labeled with the patient's identification and 'additional right breast. retroareolar tissue' is an oriented 5g, 4.5 x 3.8 x 1.4cm tan pink fibrofatty tissue. Final. margin is inked blue. Serial sectioning reveals no discrete lesions. Entirely submitted in. E1-E4.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL DIAGNOSIS: Stomach cancer. GROSS: Specimen submitted: Subtotal gastrectomy, fresh. Measurement : Greater curvature 20.5 cm. Lesser curvature 12.0 cm. Proximal resection margin 14.0 cm. Distal resection margin 6.5 cm. Duodenum 2.0 cm. Tumor location: Stomach: Middle 1/3 (body), posterior wall,. From proximal resection margin - 4.0 cm. From distal resection margin - 6.0 cm. Tumor size: 3.8 X 2.5 x 2.0 cm. Tumor type: EGC I. Gross serosal invasion: No. Gross photo: Present. Blocks. T1-8 and TB, tumor and surrounding tissue x 9. A, antral mucosa x 1. B and NB, body mucosa x 2. P, proximal resection margin x 1. D, distal resection margin x 1. LN1-4, superior gastric lymph nodes x 4. LN5-8, inferior gastric lymph nodes x 4. LN9, 15' lymph nodes x 1. LN10, '6' lymph nodes x 1. LN11, 17' lymph nodes x 1. LN12, 18' lymph nodes X 1. LN13, '9' lymph nodes X 1. LN14, 11p' lymph nodes x 1. MICROSCOPIC: Tumor type: Adenocarcinoma - tubular, moderately differentiated. Depth of tumor invasion: T1: T1b-Submucosa middle 1/3 (SM2). Margins: Proximal resection margin (-). - over -. Distal resection margin (-). Lauren classification: Intestinal. Lymphoid reaction: Absent. Lymphovascular invasion: Absent. Venous (large vessel) invasion: Absent. Perineural invasion: Absent. Lymph node metastases: NO: No regional lymph node metastasis. number of involved nodes 0 total number of nodes 79. perinodal extension: No. Distant metastasis(M) Cannot evaluate. Pathologic stage: pT1bNOMx (AJCC 7th edition). SPECIAL STAIN: Cresyl Violet stain reveals no H. pylori. NOT reported. Gross: Stomach, prepylorus, scopic, chronic gastritis. Stomach. body, scopic. chronic gastritis, ulcer, intestinal metaplasia. Large intestine, sigmora coron, scopic, tubular adenoma, low grade,. dysplasia. Large intestine, rectum, scopic. tubular adenoma, low grade, dysplasia. DIAGNOSIS: Stomach, subtotal gastrectomy: Adenocarcinoma, moderately differentiated. (early gastric cancer). Lymph node, perigastric, subtotal gastrectomy. Superior gastric: No tumor present (0/28). Inferior gastric: No tumor present (0/33). Lymph node. regional, biopsy: - over -. Labeled '5' : No tumor present (0/3). Labeled '6' : No tumor present (0/4). Labeled '7' : No tumor present (0/3). Labeled '8' : No tumor present (0/1). Labeled '9' : No tumor present (0/3). Labeled '11p': No tumor present (0/4).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Asterand Case ID. Gross. Description. Tumor is located. in antrum, there is. an ulcerated. tumor with. 3x4x1.5cm in size,. firm and myxoid. gray surface. Microscopic Description. Diagnosis Details. Comments. Mucosa is ulcerated. The tumor. Mucinous Adenocarcinoma,. is composed of opened and. infiltrating serosa. mildly straitified glands. containing mucin, or pools of. extracellular mucin that contain. malignant epithelium as cord or. acinar structures. Tumor cells. are mildly straitifed and have. scant cytoplasm. Tumor in. invasion in serosa. Nuclei are. hyperchromatic and irregular. enlarged with prominent. nucleoli. Mitoses are present. Stroma is invasion of. inflammatory cells. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Antrum. Tumor size: 3 X 4 X 1.5 cm. Tumor features: Ulcerated. Histologic type: Mucinous adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 0/5 positive for metastasis. (Adjacent lymph node 0/5). Lymphatic invasion: Present. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel lymph node, resection: No evidence of metastasis in one lymph node (0/1) . B. Left breast, simple mastectomy: Infiltrating ductal carcinoma, grade 3, 3.2 cm in greatest dimension. Surgical margins negative but close, less than 2 mm. C. Left axillary contents, resection: No evidence of metastasis in 7 lymph nodes (0/7). Microscopic Description: Microscopic examination performed. A. Sections of the sentinel lymph node demonstrate no evidence of. metastatic disease. The node is examined by multiple sectioning with. hematoxylin and eosin and by immunohistochemistry for pankeratin. Invasive Carcinoma: present. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Overall grade: 3. Architectural score: 2. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 3.2 cm,. pT2. Specimen margins: Negative but close, less than 2 mm over a. distance of 5 mm. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Proliferative fibrocystic. changes with intraductal papillomatosis. Comments: None. Prognostic markers: Previously performed. C Sections of the left axillary contents demonstrate no evidence of. metastasis in 7 lymph nodes. Specimen. A. Left sentinel node-axillary. B. Left breast-tumor at 7 o'clock. C. Axillary contents. Clinical Information. Carcinoma left breast, core biopsy positive here. Intraoperative Consultation. AFS left axillary sentinel lymph node, excision: No evidence of metastasis in one lymph node. Gross Description. A. Container a is labeled with the patient's name, medical record. number and ""sentinel lymph node"". The specimen consists of a single. piece of fatty tissue which when bisected holds a single lymph node. measuring 1.0 x 0.0 0. cm. Bisected and submitted in block AFS. B. Received fresh labeled ""left breast"" is a 25.5 cm (medial to. lateral) by 17.0 cm (superior to inferior) by 4.5 cm (anterior to. posterior) soft, lobulated tan-white-gold portion of fibroadipose. tissue oriented per placement of designated tumor as stated previously. A 19.3 x 8.5 cm wrinkled tan skin ellipse with an eccentric, 1.0 x 1.0. x 0.5 cm nipple is present along the anterior aspect. A palpable mass. is evident at 7 o'clock, corresponding to the lower inner quadrant. The antero-inferior surface of the specimen in the vicinity of the mass. is inked blue. The intact deep margin is inked black and the specimen. is sectioned. There is a well-circumscribed, 3.2 cm (medial to. lateral) by 2.4 cm (anterior to posterior) by 2.0 cm (superior to. inferior) rubbery tan-white tumor mass within the lower outer quadrant. On sectioning the tumor appears to extend to within 0.2 cm of the. inked anteroinferior surface and 1.5 cm of the inked deep margin. A. portion of tumor and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consist predominantly of soft, lobulated tan. gold adipose tissue with a minimal amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality is. identified. Summary: 1 - tumor to inked deep margin, 2 through 4 - tumor to inked. anteroinferior margin, 5 and 6 - tumor to adjacent parenchyma, 7 -. random upper outer quadrant, 8 - upper inner quadrant, 9 - lower inner. quadrant, 10 - lower outer quadrant, 11 - junction of the 4 quadrants,. 12 - nipple. C. Received fresh labeled ""Axillary contents"" is a 9.3 x 7.8 x 1.7 cm. portion of soft, lobulated tan gold adipose tissue. A few slightly. rubbery pale tan to tan pink tissues in keeping with lymph nodes. measuring up to 3.4 cm in greatest dimension are recovered. The. lymphoid tissues are entirely submitted. RS 4. Summary: 1 - 2 lymph nodes, 2 - 1 bisected lymph node, 3 and 4 -. bisected largest lymph node. the. Criteria. Discrepancy. Temar S. Discripancy. PIP.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Anat Path Reports. Document Date: Histoloav. Acc #: Head and Neck. M. Client: Submitting Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LARYNX, TOTAL LARYNGECTOMY: - INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED (2.5 X 2.2X 1.9 CM). - TUMOR INVOLVES THE LEFT TRUE VOCAL CORD, VENTRICLE, ANTERIOR COMMISSURE, AND. INVADES TROUGH THE THYROID CARTILAGE. - SUBCUTANEOUS TISSUE WITH ABSCESS AND KERATINACEOUS DEBRIS. SURGICAL MARGINS NEGATIVE. - SEE SYNOPTIC REPORT. B. LYMPH NODES, LEVEL 1A, EXCISION: - THREE LYMPH NODES NEGATIVE FOR CARCINOMA (0/3). C. LYMPH NODES, LEFT NECK 2B, EXCISION: - EIGHT LYMPH NODES NEGATIVE FOR CARCINOMA (0/8). D. LYMPH NODES, RIGHT NECK LEVEL 2A, EXCISION: - TWELVE LYMPH NODES NEGATIVE FOR CARCINOMA (0/12). E. LYMPH NODES, RIGHT NECK LEVEL 3, EXCISION: ELEVEN LYMPH NODES NEGATIVE FOR CARCINOMA (0/11). F. LYMPH NODES, RIGHT NECK LEVEL 4, EXCISION: - EIGHT LYMPH NODES NEGATIVE FOR CARCINOMA (0/8). G. LYMPH NODES, LEFT NECK LEVEL 2, EXCISION: - TWELVE LYMPH NODES NEGATIVE FOR CARCINOMA (0/12). H. LYMPH NODES, LEFT NECK LEVEL 3, EXCISION: TWENTY LYMPH NODES NEGATIVE FOR CARCINOMA (0/20). I. LYMPH NODES, LEFT NECK LEVEL 4, EXCISION: - SEVEN LYMPH NODES NEGATIVE FOR CARCINOMA (0/7). Synoptic Worksheet. A. Total laryngectomy (study case): Clinical History: No Neoadjuvant therapy. Specimen: Larynx, glottis. Fresh. Procedure: Total laryngectomy. Neck (lymph node) dissection: Level 1A, Left neck (2B,. 2, 3, 4), Right neck (2A, 3, 4). Specimen Integrity: Intact. Laryngectomy: Unopened. Specimen Size: Greatest dimension: 9.3 cm. Additional dimension: 5.2 cm. Additional dimension: 4.3 cm. Tumor Laterality: Left. Tumor Site: Larynx, glottis, true vocal cord. Larynx, glottis, anterior commissure. Transglottic: Additional Sites Involved by Tumor: Ventricle. Tumor Focality: Single focus. Tumor Description: Endophytic. Ulcerated. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G2: Moderately differentiated. Tumor Size: Greatest dimension: 2.5 cm. Additional dimension: 1.9 cm. Additional dimension: 2.2 cm. Margins: Margins uninvolved by invasive carcinoma. Margins uninvolved by carcinoma in situ (includes. moderate and severe dysplasia). Treatment Effect: Not identified: Lymph-Vascular Invasion: Not indentified: Perineural Invasion: Not indentified: Lymph Nodes, Extranodal Extension: Not indentified: Primary Tumor (pT): Glottis pT4a: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid. cartilage and/or invades tissues beyond the larynx (eg,. trachea, soft tissues of neck including deep extrinsic. muscle of the tongue, strap muscles, thyroid, or. esophagus). Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of regional lymph nodes examined: 81. Number of regional lymph nodes involved: none. identified. Distant Metastasis (pM): Not applicable: not applicable. Mucosal Melanoma Distant Metastasis (pM): Not applicable: Additional Pathologic Findings: Inflammation (type):absess involving subcutaneous. tissue with keratin debris. Clinical History. Laryngeal cancer. Total laryngectomy, neck dissection, pectoralis flap, direct laryngoscopy. Specimen(s) Received. A: Total laryngectomy (study case). B: Level 1A. C: Left neck 2B. D: Right neck level 2A. E: Right neck level 3. F: Right neck level 4. G: Left neck level 2. H: Left neck level 3. I: Left neck level 4. Gross Description. Specimen A is received fresh in a container labeled with the patient's name, medical record number and identified. as. ""total laryngectomy."" The specimen consists of a total laryngectomy specimen measuring 9.3 x 5.2 x 4.3 cm in total. dimension from the tip of the epiglottis to the inferior tracheal edge with attached hyoid bone measuring 9.5 x 0.5 x. 0.7 cm and the left thyroid lobe measuring 4.1 x 3.3 x 2.2 cm. The larynx is opened posteriorly on the midline at the. time of frozen section analysis. There are three tracheal rings attached. There is a tan-white appearing mass measuring 2.5 X 1.9 cm in surface area and 2.2 cm in thickness involving the. glottic larynx. The mass is grossly located on the bilateral false cord, vestibule true cord and crosses the midline. The mass does not appear to involve pyriform sinus. Grossly, the mass extends 2.4 cm from the tip of the epiglottic. mucosal edge, 2.3 cm from the base of the tongue mucosal edge, 2.4 cm from the lateral right mucosal edge, 1.1 cm. from the lateral left mucosal edge and 3.1 cm from the distal tracheal edge. None of the tracheal rings grossly. appear involved the mass. On the anterior aspect of the specimen is an ellipse of abnormal skin measuring 4.5 x 4.3. x 1.0 cm. The inferior aspect of the skin ellipse measures 2.3 cm from the distal tracheal edge. A tan-white, irregular. ulceration is identified measuring 2.2 x 1.7 cm and is present 2.5 cm from the inferior skin edge, 1.6 cm from the left. skin edge, 1.1 cm from the right skin edge and 0.9 cm from the superior skin edge. The skin defect grossly does not. appear to communicate with the mass lesion. There is a left lobe of the thyroid gland present. The cut surface is. homogenous and beefy red. A colloid nodule measuring 1.3 x 1.1 x 0.5 cm is noted. On sectioning, the lesion. grossly invades the anterior commissure as well as the pre-epiglottic space as well as possible full thickness invasion. of the thyroid cartilage. Sections are taken as listed in the cassette summary after decalcification. Representative. section of tumor is submitted for Tumor Bank at the time of frozen section analysis. The specimen is inked as listed. in the inking code. Dictated by. Ink Code: Left blue. Right black. CASSETTE SUMMARY: A1FS - tracheal margin. A2FS - posterior margin. A3FS - right pharyngeal margin. A4FS - left pharyngeal margin. A5FS - tongue base margin. A6 - skin margin, superior shave. A7 - right skin margin, shave. A8FS - inferior skin margin, shave. A9FS - left skin margin, shave. A10 - right epiglottis, decal. A11,A12 - right false cord, ventricle, true cord and tumor submitted superior to inferiorly, decal. A13 - right aryepiglottic fold, decal. A14 - right anterior soft tissue anterior to the cord. A15-A16 - midline epiglottis (A16 submitted in decal). A17-A18 - superior anterior commissure and anterior soft tissues and skin submitted deep to superficial (A17. submitted in decal). A19-A20 - inferior, anterior commissure and anterior soft tissues and skin submitted from deep to superficial. A21 - left aryepiglottic foid. A22 - left epiglottis, decal. A23 - left false cord, decal. A24 - left soft tissues anterior to cord. A25 - left thyroid lobe with colloid nodule, representative sections. Specimens B through I are received in formalin, in containers labeled with the patient's name and medical record. number. Specimen B is identified as ""level 1A."" The specimen consists of a firm portion of fibrofatty tissue measuring 2.5 x 1.4. x 0.3 cm. The specimen is submitted entirely in cassettes ""B1"" and ""B2."" Dictated by. CASSETTE SUMMARY: B1,2 - level 1A. Specimen C is identified as ""left neck level 1B."" The specimen consists of a firm portion of fibrofatty tissue measuring. 3.0 x 1.4 x 1.3 cm. The specimen is submitted entirely in cassettes ""C1"" through ""C3."" Dictated by. CASSETTE SUMMARY: C1-3 - left neck level 1B, submitted entirely. Specimen D is identified as ""right neck level 2A."" The specimen consists of a portion of fibrofatty tissue measuring. 4.0x2.1 x 0.7 cm. Multiple possible Ivmph nodes are identified. Sections are submitted as listed in the cassette. summary. Dictated by. CASSETTE SUMMARY: D1-3 - multiple possible lymph nodes. Specimen E is identified as ""right neck level 3."" The specimen consists of two pieces of fibrofatty tissue measuring. 4.3 x 3.6 x 1.1 cm in aggregate. The specimen consists of multiple possible lymph nodes. Sections are submitted as. listed in the cassette summary. Dictated by. CASSETTE SUMMARY: E1-3 - multiple possible lymph nodes. E4 - one lymph node, bisected. E5 - one lymph node, bisected. Specimen F is identified as ""right neck level 4."" The specimen consists of a portion of fibrofatty tissue measuring 3.0. x 2.2 x 0.6 cm. Multiple possible lymph nodes are identified. Sections are submitted as listed in the cassette. summary. Dictated by. CASSETTE SUMMARY: F1,2 - multiple possible lymph nodes. F3 - one lymph node, bisected. F4 - one lymph node, bisected. Specimen G is identified as ""left neck level 2."" The specimen consists of multiple pieces of fibrofatty tissue. measuring 5.0 x 4.7 x 0.5 cm. Multiple possible lymph nodes are identified. Sections are submitted as listed in the. cassette summary. Dictated by. CASSETTE SUMMARY: G1-3 - multiple possible lymph nodes. G4 - one lymph node, bisected. Specimen H is identified as ""left neck level 3."" The specimen consists of a portion of fibrofatty tissue measuring 4.1 x. 3.0x1.0 cm. Multiple possible lymph nodes are identified within the tissue. Sections are submitted as listed in the. cassette summary. Dictated by. CASSETTE SUMMARY: H1-4 - multiple possible lymph nodes. H5 - one lymph node, bisected. H6 - one lymph node, bisected. H7 - one lymph node, bisected. Specimen I is identified as ""left neck level 4."" The specimen consists of a portion of fibrofatty tissue measuring 3.5. x. 2.7 x 1.6 cm. Multiple possible lymph nodes are identified. Sections are submitted as listed in the cassette summary. CASSETTE SUMMARY: 11,2 - multiple possible lymph nodes. 13,4 - one lymph node. Intraoperative Consult Diagnosis. A1FS-A5FS: LARYNGECTOMY (FROZEN SECTION): MARGINS NEGATIVE, MUCOSAL AND SKIN. Frozen section results were communicated to the surgical team and were repeated back by. and the specimen is received at.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, TOTAL MASTECTOMY -. A. B. INVASIVE LARGEST DUCTAL TUMOR (MASS CARCINOMAS #1): NOTTINGHAM (3). GRADE Il (TUBULE FORMATION 3, NUCLEAR PLEOMORPHISM. 2, SECOND LARGEST TUMOR (MASS #2): NO TINGHAM GRADE II (TUBULE FORMATION 3, NUCLEAR. MITOTIC ACTIVITY 1; TOTAL SCORE 6/9). c. PLEOMORPHISM 3, MITOTIC ACTIVITY 1; TOTAL SCORE 7/9). D. SMALLEST TUMOR (MASS #3): NOTTINGHAM GRADE II (TUBULE FORMATION 3, NUCLEAR. PLEOMORPHISM 2, MITOTIC ACTIVITY 1; TOTAL SCORE 6/9). is. INVASIVE TUMORS MEASURE 1.3 CM (SLIDE 1D), 0.8 CM. AND 0.5 CM l. E. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, SOLID PATTERN. G. F. DCIS CONSTITUTES 10% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED WITH AND AWAY. FROM THE INVASIVE COMPONENT. H. LOBULAR CARCINOMA IN-SITU (LCIS) IS ALSO IDENTIFIED. I. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. J. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. K. INVASIVE CARCINOMA IS 0.5 CM FROM THE NEAREST ANTERIOR MARGIN. L. DUCTAL CARCINOMA IN-SITU IS 0.5 CM FROM THE NEAREST ANTERIOR MARGIN. M. NIPPLE IS NEGATIVE FOR TUMOR. N. NON-NEOPLASTIC BREAST TISSUE SHOWS NON-PROLIFERATIVE FIBROCYSTIC CHANGES. O. BIOPSY SITE CHANGES. P. INVASIVE TUMOR CELLS (MASS #1) TESTED POSITIVE FOR ESTROGEN AND PROGESTERONE. RECEPTORS AND NEGATIVE FOR HER-2 AS PER PREVIOUS PATHOLOGY REPORT. PART 2: LYMPH NODE, RIGHT, SENTINEL NODE #1, BIOPSY -. NO METASTATIC MAMMARY CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). PART 3: BREAST, RIGHT, SENTINEL NODE #2, BIOPSY -. NO METASTATIC MAMMARY CARCINOMA IDENTIFIED IN TWO LYMPH NODES (0/2). PART 4: LYMPH NODE, RIGHT, SENTINEL NODE #3, BIOPSY -. NO METASTATIC MAMMARY CARCINOMA IDENTIFIED IN ONE LYMPH NODE (0/1). PART 5: BREAST, LEFT, TOTAL MASTECTOMY -. A. NIPPLE WITH NO EVIDENCE OF PAGET'S DISEASE. B. BENIGN BREAST PARENCHYMA WITH NON-PROLIFERATIVE FIBROCYSTIC CHANGES. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Simple mastectomy. Site: breast, NOS C50-9 3/0/11 her. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.3 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.6 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 5 mm. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: o. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO(i-). M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
OPER DATE: REQ DOC: PROCEDURE: year-old female with distal esophageal Barrett's adenocarcinoma, long. history of GERD, S/P. Laparoscopic NISSEN fundoplication. Hiatal. hernia 4 to 5 cm. Mistory of smoking, stopped. prior to the surgery. Barium swallow 3 cm sliding hiatal hernia. Clinical diagnosis: Esophageal CA. Operative procedure: Transhiatal esophagectomy. PROCEDURE: VERIFIED. 1. ""Thoracic esophagus"" Received in formalin is a gastroesophagectomy. specimen. The esophagus is 3.0 cm long x 3.0 cm in diameter and a portion of. proximal stomach is 4.0 cm long x 4.5 cm in diameter. Located 2.0 cm from the. esophageal margin and 4.0 cm from the distal gastric margin. At the area of. the GE junction is a 2.5 x 1.5 cm tan-pink, firm and well-defined mass that. is. shiny to granular and extends 0.5 cm from the mucosal surface. The mass. occupies 50% of the circumference. Sectioning reveals the mass to extend 0.6. cm below the surface and grossly abut the muscularis propria but does not. extend through. The wall is thickened adjacent to the mass. The remaining. esophageal mucosa is tan-pink and unremarkable. The remaining gastric mucosa. is normally folded, tan and unremarkable. Examination of the attached adipose. tissue reveais multiple probable Lymph nodes that range from 0.5 up to 0.9. cm. in greatest dimension. 1A. Distal margin. 18. Mass to esophageal mucosa. 1C. Mass to gastric mucosa. 1D. Tumor showing deepest invasion. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE. 3. PATIENT NBR: SEX: F. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: 1E. Adjacent thickened wall. 1F. Four possible nodes, one bisected. 1G. Four possible nodes, one bisected. 2. ""Mid left para-esophageal LN"" Received in formalin is a 1.0 x 0.6 x 0.4 cm. yellow-black lymph node. Bisected. 3. ""Prox cervical esoph margin"" Received in formal in is a 1.0 cm long x 2.0. cm in diameter segment of mucosal tissue that has a 2.5 cm long staple margin. at one end. The staple margin is removed. The mucosa is tan-white and. glistening. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Poorly differentiated carcinoma. If adenocarcinoma, it is arising in: Barrett's mucosa. Depth of invasion: Submucosa. Number of positive lymph nodes:0. Extranodal metastasis: Unknown. Specify site: Pattern of invasion: Expansile. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T1 NO MX. PROCEDURE: 1. ""Esophagus, resection: Poorly differentiated carcinoma arising in Barrett's. mucosa. Tumor invades submucosa. Margins negative. Nine lymph nodes negative. for metastasis. Please see template. 2. Mid left para-esophageal lymph nodes, resection: One lymph node negative. for metastasis. 3. Proximal cervical esophagus, resection: Negative for malignancy. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: NAMI. PATIENT NBR: SEX: F. BIRIHDAIE: ADM DATE: OPER DATE: REQ DOC: 1,. the signing staff pathologist, have personally examined. and interpreted the slides from this case. Code:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
sex: r. Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY: PAPILLARY CARCINOMA OF THYROID RIGHT LOBE (1.5 CM) TUMOR CONFINED TO THE THYROID GLAND. MARGINS FREE. METASTATIC PAPILLARY CARCINOMA IN ONE OF TWO PERITHYROIDEAL LYMPH NODES. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - A total thyroidectomy specimen consisting of right lobe (4.5 x 2.5 x 1.8), isthmus (1.0x 1.0x0.3. cm), and left lobe (3.0x2.0x0.8 cm). Both lobes are sectioned from the superior to inferior aspect. The inferior pole at the right. lobe shows encapsulated brown-tan soft tissue measuring 1.3 x 1,0 cm. Both isthmus and the left lobe are unremarkable. A. tissue sample of the tumor as well as of the left lobe are taken for the tumor bank. SECTION CODE: A1-A6, entire lobe from superior to inferior (A4-A5, including tumor); A7, isthmus, in toto; A8, A9,. remnant of left lobe. CLINICAL HISTORY. History of thyroid mass. SNOMED CODES. T-B6000, M-80503. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been specifically cleared of approved. by the U.S. Food and Drug Administration. Released by:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histology. Acc #: (Age: F. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. BILE DUCT MARGIN, EXCISION (A1FS): - NEGATIVE FOR CARCINOMA. B. PANCREATIC NECK MARGIN, EXCISION (B1FS): - NEGATIVE FOR CARCINOMA. C. RETROPERITONEAL MARGIN, EXCISION (C1FS): - NEGATIVE FOR CARCINOMA. D. LYMPH NODE, HEPATIC ARTERY, EXCISION: - ONE LYMPH NODE WITH CAUTERY ARTIFACT, NEGATIVE FOR METASTATIC CARCINOMA (0/1). E. PANCREAS AND DUODENUM, PANCREATICODUODENECTOMY: INVASIVE ADENOCARCINOMA, MODERATELY DIFFERENTIATED, PANCREATOBILIARY TYPE WITH FOCAL. MICROPAPILLARY COMPONENT, (2.3 X 2.2 X 2.0 CM). -Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. - CARCINOMA INVOLVES THE PERIPANCREATIC SOFT TISSUE. - PERINEURAL INVASION IS PRESENT. - LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. - CARCINOMA EXTENDS TO THE RETROPERITONEAL EDGE; REFER TO SPECIMEN 'C' FOR STATUS OF. RETROPERITONEAL MARGIN. - COMMON BILE DUCT EDGE AND PANCREATIC NECK EDGE ARE NEGATIVE FOR CARCINOMA; REFER TO PARTS. 'A' AND 'B' FOR STATUS OF BILE DUCT AND PANCREATIC NECK MARGINS, RESPECTIVELY. - PROXIMAL AND DISTAL DUODENAL MARGINS ARE NEGATIVE FOR CARCINOMA. EIGHT OF TWENTY-THREE LYMPH NODES ARE POSITIVE FOR METASTATIC CARCINOMA (8/23). - SEE SYNOPTIC REPORT AND COMMENT. Comment. There is a cystic component to the tumor (approximately 20% grossly) which is not clearly an intraductal papillary mucinous. neoplasm (IPMN). The differential diagnosis includes colonization of a retention cyst or large duct by carcinoma versus IPMN. replaced by carcinoma. Some of the positive lymph nodes appear to be positive by direct extension of the tumor. The micropapillary component accounts for approximately 10% of the tumor. Selected slides from this case have been reviewed at our daily. with. concurring with the diagnosis. Synoptic Worksheet. E. Whipple: Specimen: Head of pancreas. Duodenum. Common bile duct. Procedure: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. Tumor Site: Pancreatic head. Tumor Size: Greatest dimension: 2.3 cm. Additional dimension: 2.2 cm. Additional dimension: 2.0 cm. Histologic Type: Ductal adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Microscopic Tumor Extension: Tumor invades peripancreatic soft tissues. Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1 mm. Confidential Document. This information is subject to all Federal and State laws regarding contidentiality and privacy and to the policies and procedures of. regarding. patient information Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Margin: Retroperitoneal. Margins uninvolved by carcinoma in situ. Treatment Effect: No prior treatment. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT3: Tumor extends beyond the pancreas but without involvement of the celiac. axis or the superior mesenteric artery. Regional Lymph Nodes (pN): pN1: Regional lymph node metastasis. Number of lymph nodes examined: 8. Number of lymph nodes involved: 24. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None identified. Clinical History. Pancreatic head mass. Whipple. Specimen(s) Received. A: Bile duct margin. B: Pancreatic neck margin. C: Retroperitoneal margin. D: Hepatic artery node. E: Whipple. Gross Description. Five specimens are received, each labeled with the patient's name and medical record number. Specimen A is received fresh for intraoperative consultation, identified with the patient's name and medical record number and. designated as ""bile duct margin."" The specimen consists of luminal soft tissue measuring 0.8 x 0.5 x 0.2 cm. The entire. specimen is submitted for frozen section diagnosis and the contents of the cryoblock are transferred to cassette ""A1FS."". Specimen B is received fresh for intraoperative consultation, identified with the patient's name and medical record number and. designated as ""pancreatic neck margin."" The specimen consists of a fragment of soft tissue measuring 0.5 x 0.3 x 0.1 cm. The. entire specimen is submitted for frozen section diagnosis and the contents of the cryoblock are transferred to cassette ""B1FS.'. Specimen C is received fresh for intraoperative consultation, identified with the patient's name and medical record number and. designated as ""retroperitoneal margin."" The specimen consists of a fragment of soft tissue measuring 1.5 x 1.1 x 0.1 cm. The. entire specimen is submitted for frozen section diagnosis and the contents of the cryoblock are transferred to cassette ""C1FS."". Specimen D is received in formalin and is labeled ""hepatic artery node."" It consists of two fragments of soft tissue measuring in. -Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. egarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. aggregate cm. The specimen is submitted entirely, wrapped in lens paper in cassette ""D1."" Dictated by. Specimen E is received fresh and is labeled ""Whipple."" It consists of a pancreaticoduodenectomy specimen with duodenum. measuring 19.5 cm in length and 5.5 cm in circumference and pancreatic head measuring 4.5 cm anterior/posterior, 5.4 cm. superior-to-inferior. and. 5.0 cm from duodenal edge to neck edge. The stomach and gallbladder are not present. The common. bile duct is dilated and measures 2.9 cm in length and 0.6 cm in diameter. The pancreatic duct measures 3.0 cm in length and up. to 0.2 cm in diameter. The two ducts open to different ampullae through separate orifices. The accessory ampulla measures 0.5. x 0.4 cm, does not communicate with the common bile duct nor the cystic duct, and is 1.0 cm from the proximal duodenal margin. There is a mass located predominantly in the pancreatic head that has both solid (80%) and cystic components (20%). The mass. is tan-white with well-defined borders and measures 2.3 x 2.2 x 2.0 cm. Areas of necrosis are not identified. There are no. polypoid or soft friable papillary areas. The mass does not involve the ampulla. The mass abuts the common bile duct and. invasion cannot be grossly ruled out. The mass grossly involves the pancreatic duct causing constriction at 1.0 cm from the. ductal edge. The mass does not involve the duodenum and is grossly confined to the pancreatic head. The mass is located 1.0. cm. from the pancreatic neck edge and abuts and possibly involves the retroperitoneal edge and vascular bed. The mass abuts. the free posterior lateral surface and is 0.8 cm from the free anterior surface. The accessory ampulla is uninvolved by the mass. A representative section of the mass as well as uninvolved duodenum is submitted to. The. specimen is inked as follows: vascular bed-blue, retroperitoneal edge-black, accessory ampulla-green, serosal surface-blue. Representative sections are submitted as stated below. CASSETTE SUMMARY: E1: Common bile duct edge, shaved and en face. E2: Pancreatic neck edge, shaved and en face. E3: Representative vascular bed, perpendicular. E4, E5: Retroperitoneal edge, perpendicular. E6: Common bile duct lymph node. E7: Superior head lymph nodes. E8, E9: Anterior pancreaticoduodenal lymph nodes. E10, E11: Anterior pancreatic lymph nodes. E12: Inferior pancreatic head lymph nodes. E13: Posterior pancreaticoduodenal lymph nodes. E14, E15: Posterior pancreatic lymph nodes. E16: Proximal duodenal margin, shaved. E17: Distal duodenal margin, shaved. E18: Accessory ampulla, shaved. E19: Pancreatic duct, common bile duct, ampulla and mass (anterior). E20: Mass to pancreatic duct, common bile duct, duodenum and normal pancreas. E21: Cystic area within mass to common bile duct and possibly pancreatic duct with invasion (anterior). E22: Mass center (anterior half). E23: Mass and common bile duct (posterior half). E24: Tumor to normal (anterior half). E25: Normal pancreas (anterior half). E26, E27: Additional mass (posterior half). E28: Duodenum, representative. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Intraoperative Consult Diagnosis. A1FS: BILE DUCT MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in. at. out at. B1FS: PANCREATIC NECK MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in. at. out at. C1FS: RETROPERITONEAL MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in. at. out at. Microscopic Description. Microscopic examination performed.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Left kidney. Final Pathologic Diagnosis: Kidney, left, nephrectomy: Tumor histologic type: Papillary renal cell carcinoma, type 2. Sarcomatoid features (%): Tumor size: 4.5 cm (greatest dimension). Other dimensions: 4.5x: 3 cm. Macroscopic extent of tumor: Tumor is confined to the renal parenchyma. Focality: Multifocal. Number of tumors: 2 additional papillary renal cell carcinomas,. type 1 (0.6 cm each). 10 tubulo-papillary adenomas (0.2 to 0.4 cm). Fuhrman grade: 3 of 4 (largest lesion). Perinephric fat invasion: Renal sinus invasion: Renal vein involvement: Adrenal gland present: Cancer at resection margin: Pathologic findings in nonneoplastic kidney: chronic pyelonephritis. patchy interstitial fibrosis with a chronic. inflammatory infiltrate. arteriolosclerosis. Hilar lymph nodes present: Pathologic stage. pT1b pNX pMX. The examination of this case material and the preparation of this report were. Gross Description: Received in a single formalin filled container labeled with the patient's name and additionally labeled ""left. kidney."" The specimen consists. of the product of a radical nephrectomy with a marked amount of perinephric fat. with overall dimensions of 30 X 25 X 12 cm. A portion of this tissue was. procured with the tissue bank. The renal parenchyma has approximate dimensions. of 11 X 5 X 6 cm. The specimen is remarkable for a tan-brown nodular, well. circumscribed mass projecting off the lower pole of the kidney. This mass has. dimensions of 4.5 X 4.5 X 3 cm. This mass is grossly confined to the renal. parenchyma. This mass is greater than 4 cm from the nearest soft tissue edge. This tumor is greater than 2 cm from the renal sinus. This lesion grossly does. not involve any major vessels. The kidney is also remarkable for at least ten. additional lesions. These lesions range in size from 0.1 to 0.9 cm in greatest. dimension. These lesions are all present in the cortex involving lower, mid and. upper poles. The lesions are all yellow-brown and relatively well circumscribed. All of these lesions are confined to the renal parenchyma and do not involve the. sinus fat, perinephric fat or large vessels. The tissue is submitted as follows: 1. vascular and ureteral margins;. 2-3. sections of largest tumor to capsule;. 4-5. additional sections of largest tumor to include parenchyma;. 6-8. multiple additional lesions, further designated: 6. three lesions;. 7. four lesions;. 8. three lesions;. 9. section of uninvolved parenchyma to renal pelvis. The perinephric fat is searched extensively and an adrenal gland is not. identified. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Date of Recelpt: Clinical Diagnosis & History: Incidental 3 cm left upper pole renal mass. Specimens Submitted: 1: Kidney, Left Upper Pole; Partial Nephrectomy. DIAGNOSIS: 1. Kidney, Left Upper Pole; Partial Nephrectomy: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 2.4 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: shows focal chronic inflammation and focal superficial glomerulosclerosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT IHAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen Is received fresh for frozen section consultation, labeled ""left upper pole renal tumor stitch marks deep margin"". It consists of a 6.6 X 3.7 x 2.9 cm wedge shaped portion of kidney with a suture marking the deep margin and attached 12.2 x 8,5 x. 2.7 cm of perirenal. Also received in the same container Is a separate 11.6 x 8.4 x 4.6 cm aggregate of unremarkable. fibroadipose tissue. The margin is inked black and the specimen is serially sectioned to reveal a well-circumscribed cortically. based yellow focally hemorrhagic 2.4 x 2.0 x 1.9 cm tumor. The tumor appears grossly confined to the renal parenchyma, no. extension into perirenal fat is identified. The clearance from the resection margin is 1.1 cm. A representative section of the. nearest margin is submilted for frozen section diagnosis. Representatively submitted. A photograph Is taken. Portions of the. tumor are submitted for TPS. Summary of sections: FSC - frozen section control. T tumor. M margin. RS - representative sections. Summary of Sections: Part 1: Kidney, Left Upper Pole; Partial Nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. 2. m. 2. 1. rs. 1. 2. t. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: LEFT UPPER POLE RENAL TUMOR. RENAL CORTICAL NEOPLASM. WITH BENIGN MARGIN. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
(MR#. Printed bi. Description: r old male. Department. ED Encounter ED Encounter Report. Encounter Inpatient/Outpatient Encounter Report. Transcription. Type. Dictating Date/Time. Authenticated by. Document Text. SURGERY CASE #: SPECIMEN: A. Diaphragm nodule, right chest. B. Wedge, right lower lobe chest wall. C. Wedge, basilar, right lower lobe. FROZEN SECTION DIAGNOSIS: A. Malignant neoplasm. B. Surgical margins free of tumor. C. Malignant neoplasm. OPERATIVE PROCEDURE: Right video-assisted thoracoscopy,. possible thoracotomy, possible. lobectomy,. possible chest wall resection. PREOPERATIVE DIAGNOSIS: Right lung mass. POSTOPERATIVE DIAGNOSIS: None given. DIAGNOSIS. A,B,C: 1. Type of specimen: Right lower lobe wedge with chest wall resection, diaphragmatic. nodule right chest and wedge basilar right lower lobe. 2. Tumor histologic type and grade: Malignant mesothelioma, predominantly epithelial type, moderately. differentiated. 3. Tumor size: Multiple tumor nodules ranging from 6.0 cm to 0.5 cm maximally. 4. Extent of invasion: Multiple tumor nodules involving pleura, lung and diaphragmatic. muscle. 5. Lymphatic (small vessel) invasion: Absent. Venous (large vessel) invasion: Absent. Surgical margins: All surgical margins free of tumor. 8. TNM staging: pT2, pNX, pMX. 88331, 88307, 88342, 88342, 88342, 88342, 88342, 88342, 88331, 88332,. 88332, 88332, 88311, 88309,. 88331, 88307. LUL section allu pezmanent sections in. (MR#. MICROSCOPIC EXAMINATION: A. Sections are of diaphragm with a malignant epithelial neoplasm with a. tubulopapillary growth pattern. The cells demonstrate moderate to. abundant amount of cytoplasm with enlarged round nuclei with. irregularly clumped chromatin pattern and small, but prominent. nucleoli with mitotic activity seen. No definite lymphovascular. invasion is seen. Immunohistochemistry stains are obtained and the. neoplastic cells are strongly positive with calretinin, strongly. positive with cytokeratin5, positive with cytokeratin7, negative with. cytokeratin20, negative with Napsin A, negative with TTF-1 and shows. strong nuclear staining with WT-1. The tumor is seen involving the. diaphragmatic muscle. B. Multiple sections are examined, and sections from the soft tissue. surgical margins are free of tumor. Sections of the parenchymal lung. surgical margin is also free of tumor. Sections of the neoplasm. grossly described demonstrates a tumor with a predominantly tubular. growth pattern demonstrating similar morphology as previously. described in specimen A. In areas a papillary growth pattern is also. noted. There is no definite lymphovascular invasion. There is a. minor spindle cell component identified, and the tumor is pleural. based focally involving the lung parenchyma. The separate nodule. present in the pleura demonstrates malignancy with similar features. The additional smaller nodule present in the lung also demonstrates. similar morphology. Random sections taken from the grossly. uninvolved lung demonstrates no significant fibrosis or significant. inflanmation. Sections of the ribs including the rib adjacent to the. tumor demonstrates no intramedullary involvement by tumor. A focus. of neoplasm present in the adjacent soft tissue. The marrow. demonstrates myeloid and erythroid precursors with megakaryocytes. Sections of the rib surgical margins are free of tumor. C. Sections are of lung parenchyma with a subpleural tumor demonstrating. similar histology as described above with tumor extending to, but not. through, the ink pleural surface. Sections of the grossly uninvolved. lung demonstrate focal minimal chronic inflammation but no. significant fibrosis. GROSS: A. Received in Formalin labeled with the patient's name, account number,. and ""diaphragm nodule, right chest"" is a single fragment of pink-tan. tissue measuring 1.3 x 1.2 x 0.6 cm. The specimen is bisected to. reveal a pale tan, homogeneous interior. Representative sections are. submitted for frozen section and following permanent sections in. Cassette #1, with touch preparations also performed The remainder is. totally submitted in block #2 for permanent. TS-2. B. Received fresh labeled ""wedge, right lower lobe chest wall"" is a 7 x. 5 X 3 cm in maximum dimensions wedge resection of lung with staple. line and chest wall resection, including ribs and soft tissue. measuring 10 x 7.5 x 2 cm. There is grossly a tumor that appears to. be pleural-based, extending into the lung parenchyma, with the tumor. measuring up to 6 cm maximally. A separate nodule that also appears. pleural-based is identified measuring 0.9 cm. The tumor is at least. 1 cm from the rib and soft tissue surgical margins, and at least 1 cm. from the parietal pleural margin. The tumor is within 3 cm from the. parenchymal lung surgical margin. On cut surface, as previously. described, the tumor appears to be pleural-based, and attached to the. lung, but: not involving the parenchyma. The tumor appears to be. grossly approaching, but not involving, the underlying periosteum of. the rib, and the rib surgical margins appear grossly free of tumor. A small additional subpleural nodule is present in the wedge of the. lung that measures 0.5 cm maximally. Representative section of the. tumor is submitted for Genomics Project and chemosensitivity studies. Sections are submitted for frozen section and frozen section. (MR#. Printed. diagnosis as follows: Cassette #1 - Anterior and superior soft tissue. surgical margins with superior margin inked in black. #2 - Posterior. and inferior surgical margins with inferior margin inked in black. #3 - Parietal pleural margin. #4 - Parenchymal surgical margin. Sections are then submitted for permanent as follows: #5 through #9. Sections of tumor. #10 - Additional pleural-based nodule. #11 -. Additional subpleural nodule present in wedge of lung. #12 - Random. sections of grossly uninvolved lung. #13 - Sections of periosteum and. rib adjacent to tumor. #14 - Anterior rib surgical margins. #15 -. Posterior rib surgical margins with #13, #14, and #15 submitted after. decalcification. C. Received fresh labeled with the patient's name, account number, and. ""basilar wedge, right lower lobe"" is a wedge biopsy of lung measuring. 5.5 x 1.5 x 1.5 cm. The pleural surface is red-tan and focally. white. The pleural surface is inked in black. Sectioning reveals. a. white-tan firm area measuring 1.7 cm maximally on the pleural. surface. Representative sections are submitted for frozen section. and following permanent sections in Cassette #1, with touch. preparations also performed. Additional sections are submitted for. permanent in blocks #2 and #3, with block #3 containing normal lung. RS-3. MD. MD. Dictated: Job#. Transcribed: Doc#. on. Transcription. Transcription History. History. Date/Time. Filed. Date/Time. Treatment Team Report. All Treatment Team for Encounter. CSN #.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: Right kidney (285 grams, 12.0 x 9.0 x 6.0 cm), right periaortic. tissue (aggregating 4.0 x 4.0 x1.9 cm). right retroperitoneal lymph. node, and anterior vena cava lymph node. DIAGNOSIS: Kidney, right, radical nephrectomy: Grade 3 (of 4) renal cell. carcinoma, clear cell type, forms a 6.0 x 4.5 x 4.0 cm mass located. in the mid pole. The tumor extends into the peripheral perinephric. fat. A tumor thrombus is present in the renal vein. Coagulative. tumor necrosis is absent. Sarcomatoid differentiation is absent. The surgical margins are negative. No renal hilar lymph nodes are. identified. The adrenal gland is present and unremarkable. A. separate 4.0 x 4.0 x 4.0 cm benign cyst is present in the inferior. pole. Soft tissue, right periaortic, excision: Metastatic grade 3 (of. 4). renal cell carcinoma, clear cell type. Lymph node, right retroperitoneal, excision: One (of 1) lymph node. shows metastatic grade 3 (of 4) renal cell carcinoma, clear cell. type. Lymph node, anterior vena cava, excision: One (of 1) lymph node. shows metastatic grade 3 (of 4) renal cell carcinoma, clear cell. type. TISSUE DESCRIPTION: Right kidney (285 grams, 12.0 x 9.0 x 6.0 cm), right periaortic. tissue (aggregating 4.0 x 4.0 x1.9 cm). right retroperitoneal lymg h. node, and anterior vena cava lymph node. DIAGNOSIS: Kidney, right, radical nephrectomy: Grade 3 (of 4) wenal cell. carcÃ­noma, clear dell type, forms a 6.0 x 4.5 x 4.0 em mass lodated. in the mid pole. The tumor extends into the peripheral perinephric. fat. A tumox thrombus is present in the renal vein. Coagulative. tumor necrosis is absent. Sarcomatoid differentiation is absent. The surgical margins are negative. No renal hilar lymph nodes are. identified. The adrenal gland is present and unremarkable. A. separate 4.0 x 4.0 x 4.0 om benign cyst is present in the inferior. pole. Soft tissue, right periaortic, excision: Metastatic grade 3 (of. 4). renal cell carcinoma, clear cell type. Lymph node, right retroperitoneal, excision; One (of 1) lymph noÃ³ e. shows metastatic grade 3 (of 4) renal cell carcinoma, clear cell. type,. Lymph node, antexior vena dava, excision: one (of 1.1 lymph node. shows metastatic grade 3 (of 4) renal cell carcinoma, clear gell. type.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Service: Surgical Servic Collected: Visit # : Resulted: Facility: SPECIMEN (S) RECEIVED. 1. Lymph-Node: submental. 2. Neck: right neck level. 3. Neck: right neck level II. 4. Neck: right neck level III. 5. Neck: left neck level I. 6. Neck: left neck level II. 7. Neck: left neck level III. 8. Soft Tissue: anterior ginqival tissue. 9. Neck: anterior marginal mandibolectomy and floor of mouth. 10. Neck: right poterior margin. 11. Neck: anterior tongue. 12. Neck: left posterior margin. DIAGNOSIS. 1. ""Lymph node submental"". Adipose tissue with no pathologic changes. No lymph nodes present. 2. Right neck level I. Metastatic squamous cell carcinoma involving one of four lymph nodes. (1/4). a. The involved lymph node measures 0.8 cm. b. Negative for extracapsular invasion. Submandibular gland with mild non-specific chronic inflammation. 3. Right neck level II. Six lymph nodes negative for tumor (0/6). 4. Right neck level III. One lymph node negative for tumor (0/1) -. 5. Left neck level I. Six lymph nodes negative for tumor (0/6). Submandibular gland negative for tumor. Page: 1 of 6. Service: Surgical Servic Collected: Visit #: : Resulted: Facility: 6. Left neck level II. Four lymph nodes negative for tumor (0/4). 7. Left neck level III. Five lymph nodes negative for tumor (0/5). 8. Anterior gingival tissue. Negative for tumor. 9. Oral cavity; anterior marginal mandibulectomy and floor of mouth;. resection. Keratinizing squamous cell carcinoma, moderately differentiated. a. Maximum tumor dimension 2.0 cm. b. Tumor thickness 0.9 cm. C. Positive for perineural invasion. d. Negative for lymphovascular invasion. e. Margins negative for tumor. The tumor is close (0.3 cm) to the. anterior gingival mucosal margin. The remaining margins are negative for. tumor (>0.5 cm). f. Sections of bone are pending decalcification. An addendum report. will follow. 10. Right poterior margin. Negative for tumor. 11. Anterior tongue. Negative for tumor. 12. Left posterior margin. Negative for tumor. SYNOPTIC DATA. Clinical History: No neoadjuvant therapy. Specimen: Floor of mouth, NOS. Fresh. Procedure: Resection. Specimen Integrity: Intact. Specimen Size: Greatest dimension: 4.8 cm. Additional dimension: 4.5 cm. Page: 2 of 6. Service: Surgical Servic Collected: Resulted: Facility: Additional dimension: 2.5 cm. Specimen Laterality: : Not specified. Tumor Site: Floor of mouth, NOS. Tumor Focality. Single focus. Tumor Size: Greatest dimension: 2.0 cm. Additional dimension: 2.0 cm. Additional dimension: 0.9 cm. Tumor Thickness (pT1 and pT2 tumors) : Tumor thickness: 0.9 mm. Measured from ulcerated surface. Tumor Description: Ulcerated. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G2: Moderately differentiated. Margins. Margins uninvolved by invasive. carcinoma. Distance from closest margin: 0.3 cm. Margin (s) : anterior gingival mucosa. margin. Margin status for carcinoma in situ. is not applicable. Treatment Effect: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Lymph Nodes, Extranodal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT) : pT1: Tumor 2 cm or less in greatest. dimension. Regional Lymph Nodes (pN) : pN1: Metastasis in a single. ipsilateral lymph node, 3 cm or less in greatest dimension. Number of regional lymph nodes. examined: 26. Number of regional lymph nodes. involved: 1. Size (greatest dimension) of the. largest positive lymph node : 1.6 cm. Distant Metastasis (pM) : Not applicable. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Service: Surgical Servic Collected: Visit # : Resulted: Facility: GROSS DESCRIPTION. 1. The specimen is labeled with the patient's name and as ""submental"". It consists of one piece of adipose tissue measuring 2.6 x 1 x 0.1 cm. No lymph nodes are identified. 1A. specimen in toto. 2. The specimen is labeled with the patient's name and ""right neck level. 1"" It consists of portion of fibroadipose tissue measuring 4 x 3 x. 2cm. The submandibular gland is unremarkable and measures 3.5 x 2 x 2. cm. Multiple lymph nodes ranging from 0.8 to 1.4 cm are identified. Representative sections are submitted. 2A. submandibular gland. 2B. multiple lymph nodes. 3. The specimen is labeled with the patient's name and ""right neck level. 2"". It consists of a portion of fibroadipose tissue measuring 4.5 x 1.7. x 1.4 cm. Multiple lymph nodes ranging from 0.7 to 1.2 cm are. identified. 3A. multiple lymph nodes. 4. The specimen is labeled with the patient's name and ""right neck level. It consists of portion of fibroadipose tissue measuring 6 x 3 x 1.2. cm. One lymph node measuring 0.5 cm is identified. 4A. one lymph node bisected. 5. The specimen is labeled with the patient's name and ""left neck level. 1"". It consists of portion of fibroadipose tissue measuring 4 x 3 x 1.3. cm. The submandibular gland is unremarkable and measures 3.9 x 2.- 4 x 1. cm. Multiple lymph nodes ranging from 0.4 to 1.6 cm are identified. 5A. submandibular gland. 5B. multiple lymph nodes. 5C. 1 lymph node bisected. 6. The specimen is labeled with the patient's name and ""left neck level. Status: : complete. Page : 4 of 6. Service: Surgical Servic Collected: Visit # : Resulted: Facility: 2"". It consists of portion of fibroadipose tissue measuring 4.5 x 2. 4 x. 1.6 cm. Multiple lymph nodes ranging from 0.2 to 1.2 cm are identified. 6A. multiple lymph nodes. 7. The specimen is labeled with the patient's name and ""left neck level. It consists of portion of fibroadipose tissue measuring 7 x 3 x 1. cm. Multiple lymph nodes ranging from 0.2 to 0.8 cm are identified. 7A. multiple lymph nodes. 7B. one lymph node. 8. The specimen is labeled with the patient's name and as ""anterior. gingival tissue"". It consists of a fragment of tissue measuring 0.6 x. 0.3 x 0. 1 cm. The specimen is submitted in toto for frozen section. 8A. frozen section control. 9. The specimen is labeled with the patient's name and as ""anterior. marginal mandibulectomy and floor of mouth"". It consists of a mandible. with floor of mouth resection with overall dimensions of 2.5 AP x 4.5 SI. x. 4.8 ML cm. There is an ulcerated tumor arising in the floor of mouth. The tumor measures 2.0 AP x 0.9 SI x 2.0 ML cm. There is grossly no. involvement of bone by the tumour. The tumor is located at 0.3 cm from. the closest anterior gingiva margin. The distance to the remaining. margins are: 0.6 cm from the posterior floor of mouth margin; 0.8 cm. from the right mucosal floor of mouth margin; 1.2 cm from the left. mucosal floor mouth margin; and 1.7 cm from the deep inferior margin. Representative sections are submitted. 9A. frozen section posterior muscle/floor of mouth margin. 9B. anterior gingiva mucosal margin. 9C. right floor of mouth mucosal margin. 9D. left floor of mouth mucosal margin. 9E. deep inferior margin. 9F. posterior floor of mouth margin. 9G-9H. tumor. 9I. right mandible resection margin (decalcification). 9J. left mandible resection margin (decalcification). 9K. midsection mandible and tumor (decalcification). 10. The specimen is labeled with the patient's name and as ""right. posterior margin"". It consists of a fragment of tissue measuring 3 x 0.4. x 0.3 cm. The specimen is submitted in toto for frozen section. 5 of 6. Service: Surgical Servic Collected: Resulted: Facility: 10A. frozen section control. 11. The specimen is labeled with the patient's name and as ""anterior. tongue"". It consists of a fragment of tissue measuring 2. 8 x 0.2 x 0.2. cm. The specimen is submitted in toto for frozen section. 11A. frozen section control. 12. The specimen is labeled with the patient's name and as ""left. posterior margin"". It consists of a fragment of tissue measuring 4 x 0.2. x 0.3 cm. The specimen is submitted in toto for frozen section. 12A. frozen section control. QUICK SECTION. 8. Anterior gingival tissue: Negative for carcinoma. 9. Anterior mandibulectomy: Posterior muscle margin negative for carcinoma on macroscopic and. microscopic assessment. 10. Right posterior margin: Negative for carcinoma. 11. Anterior tongue : Negative for carcinoma. 12. Left posterior margin: Negative for carcinoma. Page : 6 of 6.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PATIENT HISTORY: The patient is a. A colonoscopy showed partially obstructing. fungating tumor of the left colon close to splenic flexure. No other abnormalities seen. Bowel prep was suboptimal as a result of. partial obstruction of poor bowel prep, evaluation Mas not continued. Biopsy of this lesion revealed adenocarcinoma. PRE OP DIAGNOSIS: Colon cancer. POST OP DIAGNOSIS: Same. PROCEDURE: Not given,. ADDENDA: Addendum. At the request of. EGFR immuhostaining was performed on a section of the colon cancer (slide 1H). The immunohistochemical stain for EGFR is negative, but this interpretation is based on an altered method (an original. H&E stained slide from this case had to be de-stained in order to be stained for EGFR, a process that could potentially. interfere. with. the. immunohistochemical reaction). Thus, an additional EGFR stain has been requested on this patient's. metastatic tumor. and is pendino: the results will be reported as an addendum of. FINAL DIAGNOSIS: PART 1. AND 2: LARGE INTESTINE, PARTIAL RESECT ON WITH SUBSEQUENT REVISION OF ""NEW PROXIMAL MARGIN"" -. A. INVASIVE MODERATELY DIFFERI INTIATED COLONIC ADENOCARCINOMA EXTENDING THROUGH THE. MUSCULARIS PROPRIA INTO THE SEROSAL ADIPOSE TISSUE. DIAMETER 6.5 CM. NO EVIDENCE OF. ANGIOLYMPHATIC INVASION. PERINEURAL INVASION IDENTIFIED. ALL MARGINS FREE. PATHOLOGIC. STAGE T3N0MX, DUKES' B, ASTI ER COLLER B2. B. TWELVE (12) PERICOLONIC LYMAH NODES WITH NO EVIDENCE OF METASTATIC CARCINOMA.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
F i i a y // o S i S R e Il 0 l' t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Final Pathologic Diagnosis. A) RIGHT TONGUE (PARTIAL GLOSSECTOMY): Invasive squamous cell carcinoma, keratinizing (see synoptic. report). B) ANTERIOR DEEP MARGIN (BIOPSY): Negative for malignancy. C) ANTERIOR LATERAL MARGIN (BIOPSY): Negative for malignancy. D) POSTERIOR MEDIAL MARGIN (BIOPSY): Negative for malignancy. E) POSTERIOR LATERAL MARGIN (BIOPSY): Negative for malignancy. F) POSTERIOR DEEP MARGIN (BIOPSY): Negative for malignancy. G) POSTERIOR MARGIN (BIOPSY): Negative for malignancy. H) ANTERIOR MEDIAL MARGIN (BIOPSY): Negative for malignancy. I) RIGHT LEVEL 1 (EXCISION): Two lymph nodes, negative for malignancy (0/2). Salivary gland with chronic sialadenitis. Page: 1 of 7. F i // a / P a I II 0 / 0 y D i a y Il 0 S i S R e Il 0 l' t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: J) RIGHT LEVEL 2 (EXCISION): Eight lymph nodes, negative for malignancy (0/8). K) RIGHT LEVEL 3 (EXCISION): Six lymph nodes, negative for malignancy (0/6). L) RIGHT LEVEL 4 (EXCISION): Nine lymph nodes, negative for malignancy (0/9). I attest I have personally reviewed the specimen/slides and agree with the above findings. Resident: Synoptic Report. A: Lip and Oral Cavity - MCGH. SPECIMEN (Select all that apply): Other (specify): Right Anterior Tongue. Fresh. PROCEDURE (Select all that apply): Resection. Other (specify): Partial Glossectomy. SPECIMEN INTEGRITY: Intact. SPECIMEN SIZE: Greatest dimensions: 4,2 X 2.5 X 1.3 cm. SPECIMEN LATERALITY: Right. TUMOR SITE (Select all that apply): Anterior two-thirds of tongue, NOS. Page: 2 of 7. F i Il a / P a D i a y Il 0 S i S R e [/ o l' t. Senior Patholopist. Collected Date/Time: Received Date/Time: Verified Date/Time: TUMOR FOCALITY: Single focus. TUMOR SIZE: Greatest dimensions: 1.6 cm. TUMOR THICKNESS (pT1 AND pT2 Tumors): Tumor thickness: 9 mm. TUMOR DESCRIPTION (Select all that apply): Gross subtype. Endophytic. MACROSCOPIC EXTENT OF TUMOR: Specify: Limited to resection specimen margins. HISTOLOGIC TYPE (Select all that apply): Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2: Moderately differentiated. MARGINS (Select all that apply): Margins uninvolved by invasive carcinoma. Distance from closest margin: 1 mm. Specify margin(s), per orientation, if possible: Deep Margin. Margins uninvolved by carcinoma in situ (includes moderate and severe dysplasia). Distance from closest margin: 12 mm. TREATMENT EFFECT: Not identified. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Present. LYMPH NODES, EXTRANODAL EXTENSION: Not identified. PATHOLOGIC STAGING (pTNM): PRIMARY TUMOR (pT). pT1: Tumor 2 cm or less in greatest dimension. REGIONAL LYMPH NODES (pN). pNO: No regional lymph node metastasis. Specify: Number examined: 25. Number involved: 0. DISTANT METASTASIS. Not Applicable. ADDITIONAL PATHOLOGIC FINDINGS (Select all that apply): Page: 3 of 7. F i // a / P a t h o / 0 y y D i a y Il o S i S R e Il o l' t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Keratinizing Dysplasia. Moderate. Inflammation (specify type): Chronic. Intraoperative Diagnosis. FS B1: Negative for neoplasia. FS C1: Negative for neoplasia. FS D1: Negative for neoplasia. FS E1: Negative for neoplasia. FS F1: Negative for neoplasia. FS G1: Negative for neoplasia. FS H1: Negative for neoplasia. Clinical History. Tumor Bank. Pre/Post-operative Diagnosis. SCCA of tongue. Gross Anatomic Description. (Dictated by. Specimens received in eight containers. Specimen A: Designated ""right tongue lesion, non-marginal tissue"" is received fresh for Tumor Bank labeled with the patient's. and. ""right tongue lesion, non-marginal tissue"". Specimen consists of a single portion of soft tan/pink tongue measuring. 4.2 X 2.5 X 1.3 cm. The surface is focally smooth with areas of erythema and irregularity. The surgical margin is. inked. blue. The. specimen is unoriented. Cut surface is tan/yellow and focally hemorrhagic and possibly necrotic with a central white. tumor measuring up to 1.6 cm in greatest dimension. Section code: A1 - tips; A2-A10 - remainder of specimen serially sectioned. Specimen B: Designated ""anterior deep"" is received fresh for intraoperative consultation and frozen section diagnosis on. abeled with the patient's name and ""anterior deep"". Specimen consists of one piece of red/tan tissue 0.9 X 0.6 X 0.2. cm, entirely frozen. Page: 4 of 7. F i // a / P a t /1 o / 0 y y D i a y Il 0 S i S R e [/ o l' t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Section code: B1 - frozen section control, entire specimen. Specimen C: Designated ""anterior lateral"" is received fresh for intraoperative consultation and frozen section diagnosis on. labeled with the patient's name and ""anterior lateral"". Specimen consists of one piece of tan tissue 2.5 X 0.2 X 0.1. cm, bisected. Section code: C1 - frozen section control. Specimen D: Designated ""posterior medial"" is received fresh for intraoperative consultation and frozen section diagnosis on. labeled with the patient's name and ""posterior medial"". Specimen consists of one piece of tan tissue 2.4 X 0.2 X 0.1. cm, bisected. Section code: D1 - frozen section control, entire specimen. Specimen E: Designated ""posterior lateral"" is received fresh for intraoperative consultation and frozen section diagnosis. on. abeled with the patient's name and ""posterior lateral"". Specimen consists of one piece of red tissue 2,0 X 0.2 X. 0.12. cm, bisected. Section code: E1 - frozen section control, entire specimen. Specimen F: Designated ""posterior deep"" is received fresh for intraoperative consultation and frozen section diagnosis on. abeled with the patient's name and ""posterior deep"". Specimen consists of two pieces of red tissue 0.9 X 0.7 X 0.2. cm and 0.3 X 0.1 X 0.1 cm, entirely frozen. Section code: F1 - frozen section control. Specimen G: Designated ""posterior margin"" is received fresh for intraoperative consultation and frozen section diagnosis on. labeled with the patient's name and ""posterior margin"". Specimen consists of one piece of red tissue 0.8 X 0.2 X 0.1. cm, entirely frozen. Section code: G1 - frozen section control, entire specimen. Specimen H: Designated ""anterior medial"" is received fresh for intraoperative consultation and frozen section diagnosis. on. labeled with the patient's name and ""anterior medial"". Specimen consists of one piece of tan tissue 3.0 X 0.2 x 0.2. cm, entirely frozen. Specimen is trisected. Section code: H1 - frozen section control, entire specimen. Specimen I: Designated ""right level one"" is received fresh for Tumor Bank labeled with the patient's name and ""right level. one"". Specimen consists of a single packet of light tan/yellow fibroadipose tissue measuring 5.0 X 4.0 X 2.0 cm in greatest. dimension. No grossly evident tumor is present. No specimen is sent for Tumor Bank. The specimen consists of a well. encapsulated unremarkable submandibular gland measuring 4.5 X 3.0 X 1.7 cm in greatest dimension and associated. fibroadipose tissue measuring 3.5 X 2.0 X 1.4 cm in greatest dimension. The submandibular glandis serially sectioned to. reveal no evidence of tumor. No associated lymphoid tissue is identified immediately surrounding the submandibular gland. The cut surface of the submandibular gland is light tan/yellow and homogenous in nature. Printed: Page: 5 of 7. F i // a / P a t II 0 / o y y D i a y // 0 S i S R e [/ 0 l' t. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Section code: I1 - five possible lymph nodes submitted intact; I2-13 - remainder of associated fibroadipose tissue; 14-15-. representative sections of submandibular gland. Specimen J: Designated ""right level 2"" is received fresh for Tumor Bank labeled with the patient's name and ""right level 2"". Specimen consists of a single packet of light tan/yellow fibroadipose tissue measuring 4.0 X 2.5 X 1.2 cm in greatest. dimension. No grossly evident tumor is identified. No specimen is sent for Tumor Bank. Section code: J1 - four possible lymph nodes submitted intact; J2- one lymph node, bisected; J3-J4 - remainder of associated. fibroadipose tissue. Specimen. K: Designated ""right level three"" is received fresh for Tumor Bank labeled with the patient's name and ""right level. three"". Specimen consists of a single packet of light tan/yellow fibroadipose tissue measuring 3.5 X 2.3 x 1.1 cm in greatest. dimension. No grossly evident tumor is identified. No specimen is sent for Tumor Bank. Section code: K1 - four possible lymph nodes submitted intact; K2- two possible lymph nodes, submitted intact; K3-K4 -. remainder of fibroadipose tissue. Specimen L: Designated ""right level four"" is received fresh for Tumor Bank labeled with the patient's name and ""right level. four"". Specimen consists of a single packet of light tan/yellow fibroadipose tissue measuring 3.8 x 2.8 X 1.4 cm in greatest. dimension. No grossly visible tumor is present throughout the lymph node packet. No specimen is given for Tumor Bank. Section code: L1 - six possible lymph nodes submitted intact; L2- one lymph node, bisected; L3- one lymph node bisected;. L4-L6 - remainder of fibroadipose tissue, submitted entirely. Page: 6 of 7. / Il t l' a 0 II e r a t i l/ e D i a y II o S i S R e Il o l' /. Senior Pathologist: Collected Date/Time: Received Date/Time: Verified Date/Time: Intraoperative Diagnosis. FS B1: Negative for neoplasia. FS C1: Negative for neoplasia. FS D1: Negative for neoplasia. FS E1: Negative for neoplasia. FS F1: Negative for neoplasia. FS G1: Negative for neoplasia. FS H1: Negative for neoplasia. Page: 7 of 7.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Report Type. Date of Event. M. Authored by. Hosp/Group. Record Status. FINAL DIAGNOSIS: PART 1: SKIN, STOMAL SITE, EXCISION. SKIN WITH STOMA SITE RELATED INFLAMMATORY CHANGES, NO TUMOR. PRESENT. PART 2: LYMPH NODES, RIGHT NECK LEVELS 2-4, SELECTIVE DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA IN TWO OF TWENTY-FIVE. LYMPH. NODES (2/25). B. POSITIVE LYMPH NODES ARE IN LEVELS 2 AND 4, WITH NO EXTRANODAL. SPREAD. C. LARGEST METASTASIS IS IN LEVEL 4 (0.5 CM). PART 3: LYMPH NODES, LEFT NECK LEVELS 2-4, SELECTIVE DISSECTION. A. TWENTY LYMPH NODES, NO TUMOR PRESENT (0/20). B. UNREMARKABLE PAROTID GLAND TISSUE. PART 4: LARYNX, TOTAL LARYNGECTOMY. A. INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY TO POORLY. DIFFERENTIATED (4.5 CM) , RIGHT SUPRAGLOTTIC WITH MICROSCOPIC GLOTTIC. EXTENSION. (TRANSGLOTTIC) . B. TUMOR INVOLVES BILATERAL EPIGLOTTIS, FALSE CORD, RIGHT. ARYEPIGLOTTIC. FOLD, AND MINIMAL RIGHT TRUE CORD. C. PARAGLOTTIC SPACE AND PRE-EPIGLOTTIC SPACE INVOLVEMENT PRESENT. D. ANGIOLYMPHATIC INVASION PRESENT; NO PERINEURAL INVASION. E. RESECTION MARGINS ARE FREE OF CARCINOMA (Also see Parts 5-. 9). F. PATHOLOGIC STAGE pT3 N2B. PART 5: POST CRICOID MARGIN, EXCISION. NO TUMOR PRESENT. PART 6: LEFT LATERAL PHARYNGEAL MARGIN, EXCISION. NO TUMOR PRESENT. PART 7: RIGHT LATERAL PHARYNGEAL MARGIN, EXCISION. NO TUMOR PRESENT. PART 8: RIGHT BASE OF TONGUE MARGIN, EXCISION. NO TUMOR PRESENT. PART 9: LEFT BASE OF TONGUE MARGIN, EXCISION. NO TUMOR PRESENT. By Pathologist: My signature is attestation that I have personally reviewed the. submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in nine parts. Part 1 is received fresh labeled with the patient' S name, initials XXX. and. ""stomal skin"". It consists of a 5.5 X 3.0 x 2.0 cm skin with. subcutaneous. tissue. No lesions are identified grossly. Representative section is. submitted in cassette 1A. Ink code: Black deep margin. Time in formalin: 37 hours. Part 2 is received fresh labeled with the patient' S name, initials XXX. and. ""right neck levels 2, 3, 4"". It consists of an 11 X 8 X 2 cm yellow. lobulated. fibroadipose tissue. Lymph nodes are dissected out and submitted. entirely as. follows : 2A-2C level 2 lymph nodes. 2D-2F - level 3 lymph nodes. 2G-2J level 4 lymph nodes. Time in formalin: 37 hours. Part 3 is received fresh labeled with the patient' S name, initials XXX. and. ""left neck levels 2, 3, 4"". It consists of a 15 x 6 X 4 cm tan-yellow. lobulated fibroadipose tissue. Lymph nodes are dissected out and. submitted. entirely as follows: 3A-3C level 2 lymph nodes. 3D-3F level 3 lymph nodes. 3G-3J level 4 lymph nodes. Time in formalin: 37 hours. Part 4 is received fresh labeled with the patient' S name, initials XXX. and. ""total laryngectomy"". It consists of an 8 X 9 X 5.5 cm total. laryngectomy. specimen. There is pedunculated, filiform, friable and ulcerated tan-. white. firm mass at right supraglottic area (4.5 X 3.0 X 0. 4 cm) that focally. permeates the adjacent aryepiglottic fold submucosa with a pushing. border. Anterior commissure is involved. Tumor is 2 cm deep, abuts thyroid. cartilage,. but does not involve it. The tumor grossly extends to pre-epiglottic. space. Right vocal cord is not involved. The tumor crosses midline to left. supraglottic region, within 0.5 cm from left aryepiglottic fold. The. tumor. involves right pyriform sinus. The surface of the epiglottis appears. ulcerated and the ulceration is within 0.3 cm from superior mucosal. edge of. epiglottis. The tumor is within 4.5 cm from inferior tracheal margin. and. within 2 cm from stoma site. The mucosa and area of the stoma appears. slightly nodular. The mucosa is uninvolved by the tumor. No thyroid. tissue. is grossly identified. Photographs are taken. Ink code: Red tissue banked. Blue- - pre-epiglottic space. Black anterior soft tissue margin. Orange hyoid bone area. Cassette code: 4A anterior soft tissue, shaved. 4B - vertical epiglottis and pre-epiglottis space. 4C - vertical left aryepiglottic fold with tumor. 4D - vertical right aryepiglottic fold with tumor. 4E inferior tracheal margin. 4F mucosa stoma area. 4G representative soft tissue around stoma area. 4H left vocal cord. 4I representative section of tumor. 4J tumor in relation to right vocal fold. 4K potential lymph nodes in anterior soft tissue. 4LDR tumor and thyroid cartilage. Time in formalin: 37 hours. Part 5 is received fresh labeled with the patient' S name, initials XXX. and. ""post cricoid margin"". It consists of a 2.5 X 0.3 X 0.4 cm tan soft. tissue. for intraoperative consultation. The remainder of the frozen section. specimen. is submitted in cassette 5AFS. Time in formalin: 37 hours. Part 6 is received fresh labeled with the patient' S name, initials XXX. and. ""left lateral pharyngeal margin"". It consist S of a 4.0 X 0.8 x 0.4 cm. tan. soft tissue for intraoperative consultation. The remainder of the. frozen. section specimen is entirely submitted in cassette 6AFS. Time in formalin: 37 hours. Part 7 is received fresh labeled with the patient' S name, initials XXX. and. ""right lateral pharyngeal margin"". It consists of a 2.2 X 0.3 X 0.3 cm. tan. soft tissue for intraoperative consultation. The remainder of the. frozen. section specimen is entirely submitted in cassette 7AFS. Time in formalin: 37 hours. Part 8 is received fresh labeled with the patient' S name, initials XXX. and. ""right base of tongue margin"". It consists of a 2.3 X 0.2 X 0.3 cm tan. soft. tissue for intraoperative consultation. The remainder of the frozen. section. specimen is entirely submitted in cassettes 8AFS. Time in formalin: 37 hours. Part 9 is received fresh labeled with the patient' S name, initials XXX. and. ""left base of tongue margin"". It consists of a 2 X 0.3 X 0.4 cm tan. soft. tissue for intraoperative consultation. The remainder of the frozen. section. specimen is entirely submitted in cassette 9AFS. Time in formalin: 37 hours. INTRAOPERATIVE CONSULTATION: 5AFS: POST CRICOID MARGIN (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. 6AFS: LEFT LATERAL PHARYNGEAL MARGIN (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. 7AFS: RIGHT LATERAL PHARYNGAL MARGIN (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. 8AFS: RIGHT BASE OF TONGUE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. 9AFS: LEFT BASE OF TONGUE (frozen section). A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. MICROSCOPIC: Microscopic examination substantiates the above diagnoses. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics. determined by. the. Department of Pathology, as required by. the CLIA. '88 regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue. fixation. ranges from a minimum of 2 to a maximum of 84 hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity. clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this. laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - LARYNX RESECTIONS. TYPE OF LARYNGECTOMY: Total. TUMOR LATERALITY: Bilateral. ATTACHED STRUCTURES: Pyriform sinus. TUMOR LOCATION/SEGMENT: Transglottic. TUMOR SIZE: Maximum dimension: 4.5 cm. HISTOLOGIC TYPE OF TUMOR: Squamous cell carcinoma. HISTOLOGIC GRADE: Moderately differentiated. STRUCTURES INVOLVED BY TUMOR: True cord, Anterior commissure,. False cord,. Epiglottis, A-E Fold - Medial surface, Pre-epiglottic space,. Paraglottic space. LYMPH NODES: Lymph nodes positive, Right: 2. Total number of right sided lymph nodes examined: 25. Lymph nodes positive, Left: 0. Total number of left sided lymph nodes examined: 20. EXTRACAPSULAR SPREAD OF LYMPH NODE METASTASES. INTRA-PERINEURAL INVASION: Absent. VASCULAR INVASION: SURGICAL MARGIN INVOLVEMENT: Free (2 mm or more). T STAGE, PATHOLOGIC: Supraglottis, pT3. N STAGE, PATHOLOGIC: pN2b. M STAGE, PATHOLOGIC: pMX. PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/ POST-OF DIAGNOSIS: Laryngeal cancer. PROCEDURE: Total laryngectomy, bilateral neck dissection. SPECIFIC CLINICAL QUESTION: Margins. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION: No. OTHER DISEASES: : No. CYTOGENETIC TESTS: No. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Stomal Skin. Stain/. Block. H&E x 1. A. Part 2: Right Levels 2-4. Stain. Block. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. Part 3: Left Neck Level 2-4. Stain/. Block. H&E x 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E x 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. Part 4: Total Laryngectomy. Stain. Block. H&E x 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E x 1. E. H&E X 1. F. H&E x 1. G. H&E x 1. H. H&E X 1. I. H&E x 1. H&E X 1. K. H&E X 1. M. H&E X 1. N. Decal x 1. H&E Recut X 1. H&E x 1. Part 5: Post Cricoid Margin. Stain/. Block. H&E x 1. AFS. Part 6: Left Lateral Pharyngeal Margin. Stain/. Block. H&E X 1. AFS. Part 7: Right Lateral Pharyngeal Margin. Stain,. Block. H&E x 1. AFS. Part 8: Right Base of Tongue Margin. Stain/. Block. H&E X 1. AFS. Part 9: Left Base of Tongue Margin. Stain/. Block. H&E X 1. AFS.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with large 9 x 9 cm right renal mass. Specimens Submitted: 1: SP: Right kidney. 2: SP: Paracaval nodes. DIAGNOSIS: 1). KIDNEY, RIGHT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, NUCLEAR GRADE III/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DÃAMETER IS 9.5 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - ALL SURGICAL MARGINS ARE FREE OF TUMOR,. - THE NON-NEOPLASTIC KIDNEY SHOWS FOCAL CHRONIC PYELONEPHRITIS AND GLOMERULOSCLEROSIS. - THE ADRENAL GLAND IS NOT SUBMITTED. 2). LYMPH NODES, PARACAVAL; EXCISION: - FIVE BENIGN LYMPH NODES (0/5). The specimen is received fresh, labeled ""Right Kidney"". It consists of a total nephrectomy specimen weighing 892 grams. and measuring 15.5 X 10.2 x 6.4 cm in overall dimensions. No adrenal gland identified. The tumor measures 9.5 x 7.2 X. 5.9. cm. and is located at the lower pole of the kidney, extending to the middle portion. The tumor is lobulated with a brown-yellow. parenchyma and multiple areas of hemorrhage and necrosis. The renal pelvis is not directly involved by tumor. The. non-neoplastic kidney has a normal architecture. The surface of the specimen is inked and a portion of the specimen. is. submitted for TPS. Photographs are taken before and after the bisection. Representative sections are submitted. Summary of Sections: FSC - frozen section control. T - tumor. NL - normal kidney. RPV - renal pelvis. TPCE - tumor with possible pericortical extension. MS - margin sections. 2). The specimen is received in formalin labeled, ""Paracaval nodes"". It consists of multiple pieces of yellow tan fatty tissue. measuring 4.0 x 3.0 x 0.8 cm in aggregate. On dissection, there are multiple lymph nodes identified measuring 1:2 X 1.2 X. 0.4. cm in aggregate. The lymph nodes are entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: SP: Right kidney (fs) (tl/Img). Block. Sect. Site. PCs. 1. fsc. 1. 1. ms. 1. 1. ni. 1. rpv. 1. 6. t. 6. 2. tpce. 2. Part 2: SP: Paracaval nodes (tl). Block. Sect. Site. PCs. 1. u. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: CORTICAL NEOPLASM, FAVORING RENAL CELL CARCINOMA, CONVENTIONAL. CLEAR CELL TYPE. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS. PART 1: KIDNEY, LEFT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL TYPE (CLEAR CELL), 6.0 CM IN GREATEST DIMENSION WITH. THIRTY PERCENT (30%) NECROSIS, WITH FUHRMAN GRADING OF 3/4. B. MICROSCOPIC IMPLANT OF CARCINOMA (0.2 CM) IS PRESENT IN THE PERINEPHRIC ADIPOSE TISSUE. C. NO EXTENSION OF CARCINOMA INTO GEROTA'S FASCIA. D. NO ANGIOLYMPHATIC INVASION SEEN. E. ONE (1) LYMPH NODE FREE OF TUMOR. F. ADRENAL GLAND WITH NO SIGNIFICANT HISTOLOGIC CHANGE. G. TNM STAGE = T3 NO MX. H. PART 2: REGION OF LYMPH NODES, EXCISION -. THREE (3) LYMPH NODES FREE OF TUMOR ZERO/THREE) (0/3). Final Diagnosis. BRONCHIAL WASHING: SATISFACTORY FOR INTERPRETATION. SUSPICIOUS FOR METASTATIC RENAL CELL CARCINOMA (SEE COMMENT). Comment: A few scattered large cells with low nuclear/cytoplasmic ratio, enlarged nuclei with nucleoli, and bubbly cytoplasm are. present, and are suspicious for renal cell carcinoma, clear cell type. Despite the atypical features, these cells, in this. context, cannot be definitively categorized as neoplastic without appropriate immunohistochemical confirmation. The. very scant nature of the specimen precludes additional confirmatory diagnostic studies.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Patien. surgical F. CLINICAL HISTORY: Right breast Ca, rule out deep margin positive. GROSS EXAMINATION: A. ""#1 right modified radical mastectomy"", in formalin. Received in the. container is a portion of breast with an attached skin ellipse containing the. nipple and an axillary dissection. The specimen measures 18.5 x 14 x 3.9 cm. The attached skin ellipse measures 14.7 x 6.3 cm. The nipple appears grossly. unremarkable. There is a small 0.5 cm hole 1.7 cm inferior to the nipple. The. deep surface of the specimen is inked in blue and the specimen is serially. sectioned revealing a 3.5 x 2 x 1.5 cm firm white mass in the medial portion. of the specimen. The mass is fairly well-circumscribed but very firm to. palpation. Grossly it appears to approach within 0.2 cm of the deep surgical. margin. There is no definite biopsy cavity; however, there is a small area of. hemorrhage just adjacent to the tumor mass. Tissue from the tumor mass has. been sent for estrogen and progesterone receptors. Block Summary: A1- section through nipple. A2- section through hole in skin ellipse. A3-A5- sections of tumor with adjacent deep margin. A6-A9- representative sections of tumor. A10- representative sections of upper lateral quadrant. A11- representative section of lower lateral quadrant. A12- representative section of upper medial quadrant. A13- five lymph node candidates from level three. A14-A15- one large lymph node bisected, level three. A16- one large lymph node bisected and one small lymph node candidate, level. three. A17- one lymph node candidate bisected, level three. A18- one lymph node candidate bisected, level three. A19- four lymph node candidates from level II. A20- one lymph node candidate bisected from level II. A21- two lymph node candidates from level II. A22- five lymph node candidates from level I. A23- two lymph node candidates from level I. A24- two lymph node candidates from level I. A25- two lymph node candidates from level I. MICROSCOPIC EXAMINATION: Most of the tumor consists of tubules and cribriform glands composed of. atypical cells with a moderate amount of eosinophilic cytoplasm and oval. nuclei with distinct relatively small nucleoli. There is a sparse. inflammatory response. A minor non-comedo intraductal component is present,. within or near the tumor mass. Away from the tumor, no intraductal carcinoma. or epithelial hyperplasia is seen. DIAGNOSIS: A. ""RIGHT"" BREAST, MODIFIED RADICAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMA (2.5 CM), NSABP HISTOLOGIC GRADE II/III,. NUCLEAR GRADE MODERATELY DIFFERENTIATED. A NON-COMEDO INTRADUCTAL CARCINOMA COMPONENT IS IDENTIFIED, COMPRISING. LESS THAN 10% OF THE CARCINOMA. NO TUMOR IS SEEN IN THE DEEP SURGICAL MARGIN. 1 of 2. NO VASCULAR INVASION IS IDENTIFIED. TWO OF SEVENTEEN (2/17) LYMPH NODES ARE POSITIVE FOR METASTATIC. ADENOCARCINOMA. BREAST TISSUE WITH APOCRINE METAPLASIA AND MICROCALCIFICATIONS IN. NON-NEOPLASTIC LOBULES. 2 of 2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Gross. Microsco. Diagnosi. Comment. d Case Descript. pic. S Details. S. ion. Descripti. on. STOMACH TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Antrum. Tumor size: 8 X 7 X 2 cm. Tumor features: None specified. Histologic type: Adenocarcinoma,. intestinal type. Histologic grade: Poorly. differentiated. Tumor extent: Adjacent structures. (specify) - Lesser omentum. Lymph nodes: 9/9 positive for. metastasis (Intraabdominal 9/9). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: HER2/NEU-negative. Excision. Laterality. ca ID.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
PATHOLOGIC DIAGNOSIS. A. THYROID, TOTAL THYROIDECTOMY: - PAPILLARY CARCINOMA, MULTIFOCAL (RIGHT 2.1 CM, ISTHMUS 2.6 CM, LEFT. 0.4 CM) WITH EXTRATHRYOIDA EXTENSION, SURGICAL MARGINS AND. LYMPHOVASCULAR. INVASION NEGATIVE. - PERICAPSULAR LYMPH NODES NEAR ISTHMUS, NO PATHOLOGIC DIAGNOSIS. (0/3). - ONE PARATHYROID IDENTIFIED, LEFT SIDE. B. LYMPH NODES, RIGHT PARATRACHEAL, DISSECTION: - METASTATIC PAPILLARY CARCINOMA (1/4). - PARATHYROID IDENTIFIED. C. LYMPH NODES, LEFT PARATRACHEAL, DISSECTION: - NO PATHOLOGIC DIAGNOSIS (0/2). - PARATHYROID IDENTIFIED. Comment. TUMOR STAGING FORM: T3, N1a, MX, STAGE I (less than 45 years old). Pertinent Clinical Information. Papillary thyroid cancer. Gross Description. Specimen Material: A- Total thyroidectomy and pretracheal lymph node, B-. Right paratracheal lymph node for permanent, C- Left paratracheal lymph node. for permanent. The case is received in three parts labeled with the patient's name, medical record number and. given accession number. and it is accompanied by a requisition form labeled with the same name. and same accession number. Part A: The specimen is received in one container labeled as ""TOTAL. THYROIDECTOMY PRETRACHEAL LYMPH NODE"". The specimen is a 160 gram, 9.8. cm. right to left, 6.4 cm superior to inferior, and 1.7 cm medial to lateral. total thyroid with a possible attached node measuring 3.5 x 2.4 x 1.1 cm. The surface of the thyroid is tan-red to tan-brown, multinodular, hard and. hyperemic. There are no parathyroid glands identified. The specimen is. inked blue anterior and black deep. The right lobe at the inferior aspect. displays a tan-red to tan-brown, finely nodular ovoid, peripheral. calcification smooth and glistening 2.1 x 1.8 x 1.2 cm abutting the margin. The left lobe displays a 0.3 cm tan-white to tan-yellow calcification. abutting the superficial surface. The isthmus displays tan-pink firm tissue. measuring 3.0 x 2.6 x 1.6 cm with 0.4 cm calcification, 0.2 cm from the. superficial surface. The possible lymph node is 2.4 x 2.3 x 1.3 cm with a. cut surface tan-yellow to tan-gray, fine nodular, fibroadipose tissue. No. hemorrhage or necrosis are identified. Representative sections are submitted as follows: A1: right lobe superior, uninvolved. A2: right lobe middle area of calcification. A3: right lobe tumor to margin. A4: left lobe superior, uninvolved. A5: left lobe medial calcification of possible additional tumor. A6: left lobe inferior, bisected slice. A7-A9: isthmus, additional tumor. A10: possible additional lymph node. A11-A12: largest, possible node bisected with tan nodular tissue. Part B: The specimen is received in formalin labeled as ""RIGHT PARATRACHEAL. LYMPH NODES FOR PERMANENT"". The specimen consists of a tan-yellow to. tan-brown multinodular, firm piece of adipose tissue measuring 3.1 x 2.4 x. 0.3 cm. Six possible lymph nodes are identified measuring from 1.0 x 0.7 x. 0.2 cm to 0.2 x 0.2 x 0.1 cm. Two lymph nodes are bisected and the cut. surface displays a tan-yellow a tan-brown irregular surface. Representative sections are submitted as follows: two bisected possible. lymph nodes in cassette B1, two possible lymph nodes in cassette B2, and two. possible lymph nodes in cassette B3. Part C: The specimen is received in formalin labeled as ""LYMPH NODE, PART. C"". The specimen consists of tan-yellow to tan-pink, 1.6 x 1.4 x 1.2 cm,. firm multinodular piece of adipose tissue. Two possible lymph nodes are. identified measuring 0.8 x 0.5 x 0.2 cm and 0.5 x 0.4 x 0.1 cm. Representative sections are submitted as follows: C1: one possible lymph node. C2: one possible lymph node. Pathology Resident. Microscopic Description. A-C: Performed. This case was reviewed by the staff pathologist listed below. Pathology Resident.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Patient. Identifier: TISSUE DESCRIPTION: Right kidney (14.5 x 7.5 x 6.5 cm) wich 8.5 cm right ureter. DIAGNOSIS: Kidney, right, nephrectomy: Grade 3 (of 4) renal cell carcinana,. clear cell type, forms a B x 8 x 6 cm mass located in the superior. mid kidney The tumor exhibits extension into perineghric fat. The. renal vein is free of involvement Coagulative tumor necrosis is. present. The surgical margins are negative. No renal hilar 1ympt. nodes are identified. No adrenal gland is present.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo. GROSS: Specimen status: Fresh. Operation: Right posterior sectionectomy. Organ: Liver, right posterior (15.0 X 10.5 X 8.5 cm, 780.0 gm), (16.0 x 5.0 x 3.5 cm, 75.5 gm). Adrenal gland (5.5 X 2.5 X 0.3 cm). Gallbladder (8.5 cm in length, 4.5 cm in diameter). Lesion: Heaptic mass. Size: 7.5 X 6.6 X 5.1 cm. Cut surface: Encapsulated, pale tan and nodular mass with central necrosis. Gross type: Multinodular confluent. Extent: Confined to the capsule. Resection margin: Not involved, grossly (safety margin: 1.5 cm). Remaining parenchyme: Unremarkable. [Gallbladder]. Serosal surface: Yellowish pink and smooth. Mucosal surface: Dark green and velvety, no mural nodule. Representative sections are submitted. Gross photo: Present. Blocks. T1-6, mass of liver X 6. RM, tumor with resection margin X 1. L, nontumorous liver parenchyme x 1. A1-2 tumor and adjacent adrenal gland X 2. B1-2, liver parenchyma X 2. GB, gallbladder x 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Edmondson-steiner grade. The worst differentiation IV. The major differentiation III. Histologic type: Cord-like and nesting. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: Yes, focal. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: Not identified. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Chronic hepatitis, HBV associated. NOT reported. Gross: liver,ectomy,Hepatocellular carcinoma. T56000, P10, M81703. adrenal gland,ectomy,no tumor. T93000, P10, M09450. gallbladder,ectomy,autolysis. T57000, P10, M54001. DIAGNOSIS: Liver, right posterior, sectionectomy: Hepatocellular carcinoma. Adrenal gland, right, adrenalectomy: No tumor present. Gallbladder, cholecystectomy: Autolysis. Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with right renal mass,. Specimens Submitted: 1: SP: Kidney, right upper pole, partial nephrectomy. DIAGNOSIS: 1. SP: Kidney, right upper pole, partial nephrectomy. Tumor Type: Renal cell carcinoma . Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 2.5 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invesion: Not identified. Small vessel invasion is also not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Mild arteriolosderosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Steging for renal cell carcinoma/oncocytoma: pT1 Tumor 7.0 cm in greatest dimension limited to the kidney. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section, labeled ""right upper pole renal tumor stitch marks deep margin"". It consists. of 6 x 5.5 x 4 cm wedge shaped portion of kidney with a suture marking the deep margin. The deep mergin is inked black and soft. tissue is inked blue, The specimen is serially sectioned to reveal a golden yellow 2.5 x 2.5 x2 cm tumor. The clearance from the. resection margin is 0.3 cm. A representative section of the nearest margin is submitted for frozen section diegnosis. The tumor. is. entirely submitted. Portions of the tumor are submitted for TPS. Summary of sections: FSC - frozen section control. T tumor. RS - representative sections. Summary of Sections: Part 1: SP: Kidney, right upper pole, partial nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. rs. 3. t. 3. Intraoperative Cousultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CELL CARCINOMA, MARGINS ARE FREE OF TUMOR. CLOSEST FREE. MARGIN is WITHIN 0.2 CM. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
/diagnoses: Locally advanced, peripheral bronchopulmonary, histologically mixed adenocarcinoma of the. left lower lobe of the lung with a large-cell and clear-cell, solid and acinar component, mucin. formation and localization in S8. TNM classification on the basis of this material: pT3 pN2 pMX V1 R0, stage IIIA. C 34.1 M 8255/3. Comment/supplementary remark: The carcinoma has infiltrated the pericardial fatty tissue. Lymph node metastases can be seen. in the hilar region both in the main preparation and in samples 1.) and 4.). The resection. margin of the bronchus and vessels as well as the pericardial resection material, the adhered. part of the parietal pleura sample 2.) and the lymph nodes of samples 3.) and 5.) are tumor-. free.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
CLINICAL DIAGNOSIS: HCC. Specimen : lt. lobe of liver. Gross Photo : 1. GROSS: Procedure: Laparoscopic assisted left lobectomy. Specimen: Liver: 13.0 x 10.0 X 4.5 cm, fresh (cirrhotic liver). Tumor location: Left lobe. Tumor number: Two. Tumor size: 3.4 X 2.9 X 1.9 cm, 0.9 X 0.6 X 0.6 cm. Satellite nodule: Absent. Gross type: Expanding nodular. Tumor necrosis: Absent. Hemorrhage/peliosis: Absent. Portal vein invasion: Absent. Bile duct invasion: Absent. Gross photo present. Blocks. T1-3, expanding nodular mass x 3. T4, another seperated mass X 1. L, remaining liver parenchyme X 1. RM, resection margin of liver X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Differentiation. The worst differentiation III. The major differentiation II. Histologic type: pseudoglandular, trabecular, solid and micropapillary. Cell type: Hepatic. Fatty change: Steatosis, mild. Fibrous capsule formation: Absent. Capsular infiltration: Absent. Septum formation: Absent. Surgical resection margin invasion: Free from tumor. Serosal invasion: Absent. Portal vein invasion: Absent. Bile duct invasion: Absent. Hepatic vein invasion: Absent. Hepatic artery invasion: Absent. Microvessel invasion: Absent. Multicentric occurrence: Present. Non-tumor liver pathology. Cirrhosis, mixed, HBV-associated. Dysplastic nodule: Absent. Ductal epithelial dysplasia: Absent. Other liver diseases: Absent. SPECIAL STAIN: Trichrome (+, consistent with liver cirrhosis). NOT reported. Gross: Peritoneal fluid, smear, atypical cells. liver, needle, chronic persistent hepatitis. Liver, needle biopsy, Cirrhosis. Skin, face, punch biopsy, granulomatous inflammation. Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. DIAGNOSIS: Liver, left, laparoscopic assisted left lobectomy: Hepatocellular carcinoma, moderately differentiated. Suggestion :

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 2. Da. Examination: Histopathological examination. Material: 1. Total organ resection - stomach. Expected time of examination. Clinical diagnosist (Cancer of the gastric body. Macroscopic description: Sent material consisting of the stomach, after being cut out along the greater curvature, sized 16 x. 18 cm with the omentum sized 24 x 18 cm. Edge-thickened ulceration in the pyloric region sized of 7 x 6 x 1.7 cm. The invasion macroscopically infiltrates the muscular membrane. Distance from the proximal end 7.5 cm, from distal end 1.5 cm. Microscopic description: Adenocarcinoma male differentiatum partim tubulare G3. The tumour invades through the full thickness of the stomach wall, vessels, perigastric fat tissue,. and reaches the surface of the peritoneum. Incision lines free of neoplastic invasion. Mucous membrane off tumour showing features of chronic inflammation. Lymph nodes: 1,2 - (periorificial): Lymphonodultis reactiva (No VI). 3 - (lesser curvature): metastases carcinomatosae in lymphonodis (No V/IX). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. 4 - (greater curvature): metastases carcinomatosae in lymphonodis (No VIII/X). Infiltratio carcinomatosa capsulae lymphonodorum. 6 - (peripyloric): metastases carcinomatosae in lymphonodis (No I/1). Histopathological diagnosis: Adenocarcinoma male differentiatum partim tubulare ventriculi. ,. tubular adenocarcinoma of the stomach. Metastases carcinomatosae in lymphonodis (No XIV/XXIV). Cancer metastases in the lymph nodes. (No XIV/XXIV). Invasio carcinomatosa vasorum. Cancerous invasion of the vessels. G3, pT2b, pN2 ty pus intestinalis sec. Examination: Histopathological examination (cito). page 2 / 2. Results of immunohistochemical examination: HER2 protein stained with HercepTestTM by DAKO. Negative reaction in invasive cancerous cells ( Score = 0).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Final Diagnosis. A. Breast, right, mastectomy: Infiltrating lobular carcinoma, Nottingham grade II (of III). [tubules 3/3, nuclei 2/3, mitoses 1/3; Nottingham score 5/9], forming a 2.8 x 2.0 x 1.2 cm mass. located in the upper outer quadrant of the breast [AJCC, 7th ed., pT2]. Angiolymphatic invasion. is present. The non-neoplastic breast parenchyma shows proliferative fibrocystic changes. Biopsy site changes present. The tumor does not involve the nipple, overlying skin, or underlying. chest wall. A seborrheic keratosis is identified in the skin. All surgical resection margins,. including deep margin, are negative for tumor (minimum tumor free margin, 2.0 cm, anterior-. superior margin). B. Lymph node, right axillary, sentinel biopsy: One (of1) axillary sentinel lymph node is. positive for metastatic carcinoma, the largest measuring 2.0 cm. Extranodal extension is present. [AJCC, 7th ed., pN1]. C. Breast, left, mastectomy: Infiltrating lobular carcinoma, Nottingham grade II (of III) [tubules. 3/3, nuclei 2/3, mitoses 1/3; Nottingham score 6/9], and lobular carcinoma in situ, forming a 4.1. x 3.8 x 2.4 cm mass located in the upper subareolar aspect of the breast [AJCC, 7th ed., pT2]. Angiolymphatic invasion is absent. The non-neoplastic breast parenchyma shows proliferative. fibrocystic changes. Biopsy site changes present. The tumor involves the nipple. The overlying. skin and underlying chest wall are uninvolved. All surgical resection margins, including deep. margin, are negative for tumor (minimum tumor free margin, 1.6 cm, anterior-superior margin). D. Lymph node, left axillary, sentinel biopsy: One axillary sentinel lymph node is negative for. metastatic carcinoma. Blue dye is identified. Immunohistochemical cytokeratin stain was. performed on the paraffin embedded sentinel lymph node tissue and confirms the H&E. impression. E. Lymph node, left axillary #2, sentinel biopsy: One axillary sentinel lymph node is negative. for metastatic carcinoma. Blue dye is not identified. Immunohistochemical cytokeratin stain was. performed on the paraffin embedded sentinel lymph node tissue and confirms the H&E. impression. [AJCC, 7th ed., pN0(i-)(sn)]. F. Lymph nodes, right axillary, dissection: Multiple (14) axillary lymph nodes are negative for. metastatic carcinoma.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: Male. Race: Report Date: FINAL PATHOLOGIC DIAGNOSIS. Cystoprostatectomy with bilateral pelvic lymph node dissection,. ""Bladder, prostate, vas deferens"" (part C): - Invasive high-grade urothelial carcinoma, see parameters below. - Benign prostate and seminal vesicles. ""Right pelvic lymph nodes"" (part A): - Three of nine lymph nodes are positive for metastatic carcinoma (the. largest implant almost completely replaces a 0.8 cm node). ""Left pelvic lymph nodes"" (part B): - Seven lymph nodes, no evidence of tumor (0/7). Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Flat urothelial carcinoma. 2. Grade of tumor: High-grade. 3. Depth of invasion: Tumor shows invasion to the outer half of the muscularis. propria. 4. Tumor distribution: Large solitary lesion involving the posterior wall,. right lateral wall and left lateral wall as lesion measuring 5 x 3 cm grossly. 5. Ureteral margins: Negative for tumor. 6. Distal urethral margin: Negative for tumor. 7. Soft tissue margin: Negative for tumor. 8. Lymph nodes: Positive for tumor (see above parts A and B). 9. pTNM: pT2b, N2, MX. Effective. this Checklist utilizes the. edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). , MD. Interpretation performed by the Attending Pathologist. Clinical History. The patient is a. -year-old male with bladder cancer undergoing radical. cystectomy, bilateral pelvic lymph node dissection, ileal conduit. Specimens Received: A: Right pelvic lymph node. B: Left pelvic lymph node. C: Bladder, prostate, vas deferens; cystoprostatectomy. Gross Description: The specimens are received in three containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""right pelvic lymph. node"". Received fresh and placed in formalin is a 6.5 x 5.0 x 1.8 cm aggregate. of lobulated yellow fibrofatty tissue. The specimen is dissected for lymph. nodes to reveal 9 apparent lymph nodes ranging from 0.3 x 0.2 x 0.1 to 6.1 x 1.1. x 1.0 cm in greatest dimension. All apparent lymph nodes are submitted as. follows: A1-A2: 5 lymph node candidates. A3: One lymph node, bisected. A4: One lymph node, bisected. A5: One lymph node, bisected. A6-A7: One lymph node, sectioned. B. The second container is additionally identified as, ""left pelvic lymph. node"". Received fresh and placed in formalin is a 6.7 x 4.5 x 2.0 cm aggregate. of lobulated yellow fibrofatty tissue. The specimen is dissected for lymph. nodes to reveal 8 apparent lymph nodes ranging from 0.5 x 0.2 x 0.1 to 2.7 x 1.5. X 0.8 cm in greatest dimension. All apparent lymph nodes are submitted as. follows: B1: 3 lymph node candidates. B2: One lymph node, bisected. B3: One lymph node, bisected. B4: One lymph node, bisected. B5: One lymph node, bisected. B6-B7: One lymph node, sectioned. C. The third container is additionally identified as, ""bladder, prostate, vas. deferens"". Received fresh and placed in formalin is a 396.8 gm, 15.0 x 12.0 x. 4.5 cm cystoprostatectomy specimen with attached mesenteric fat. The bladder. measures 9.5 x 8.0 x 4.0 cm. The bilateral ureteral orifices are identified and. probe patent. The right ureteral stump measures 4.5 x 0.4 cm and the left 4.5 x. 0.5 cm, and both demonstrate patent lumina. The prostate measures 4.5 x 4.0 x. 3.5 cm. The right half of the prostate and bladder is inked blue and the left. half is inked black. The prostate is opened anteriorly along the urethra and. continued superiorly through the bladder in a Y-shaped incision. The prostate is. serially sectioned from apex to base to reveal unremarkable, bulging yellow-tan. parenchyma without indurations; there is periurethral nodularity. The bladder. demonstrates an area of ulceration with underlying induration on the right. posterolateral wall that measures 5.0 x 3.0 cm. The mucosal surface overlying. this induration has a flattened, granular appearance. Serial sectioning reveals. tumor invasion to within 0.2 cm of the inked margin, and grossly apparent. invasion into the muscularis propria. Adjacent to this area of ulceration and. induration, toward the left posterolateral wall, there is a poorly defined area. of mucosa with a granular appearance without prominent papillary excrescences;. the tissue underlying this granular mucosa is somewhat indurated. The remainder. of the mucosa is tan-brown, edematous, and glistening with a uniform 2.5 cm wall. thickness. The external surface of the bladder is red-tan and glistening with no. grossly identifiable lymph nodes. Representative sections are submitted as. follows: C1: Distal urethral margin. C2: Prostatic apical margin. C3: Right ureteral margin. C4: Left ureteral margin. C5: Right ureteral orifice. C6: Left ureteral orifice. C7-C12: Multiple tumor sections, including deepest invasion in C12. C13: Representative section from adjacent, granular mucosa. C14-C22: Representative sections of prostate from apex to base. C23: Seminal vessels and vasa deferentia. C24: Uninvolved dome. C25: Uninvolved anterior wall. C26: Uninvolved posterior wall. C27: Uninvolved right wall. C28: Uninvolved left wall. Gross photograph was taken of a representative section of the ulcerated,. indurated region. M.D.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis: A: Kidney, right, partial nephrectomy. Procedure: Partial nephrectomy. Laterality: Right. Histologic tumor type/subtype: Renal cell carcinoma, papillary. type. Sarcomatoid features: Not identified. Histologic grade (if applicable) : Furman grade 3 (of 4). Tumor size (greatest dimension) : 11.8 cm (gross measurement). Tumor focality: Unifocal. Extent of tumor invasion (if present specify if macroscopic or. microscopic) : Capsular invasion/perirenal adipose tissue: Not submitted. Gerota' S fascia: Not submitted. Renal sinus: Not submitted. Major veins (renal vein or segmental branches, IVC) : Not. submitted. Ureter: Not submitted. Venous (large vessel) : Not submitted. Lymphatic (small vessel) : Not identified. Histologic assessment of surgical margins: Renal parenchymal margin (partial nephrectomy only) : Negative,. 2mm (A1). Renal capsular margin (partial nephrectomy only) : Negative, < 1. mm (A5). Adrenal gland: Not submitted. Lymph nodes: Not submitted. Pathologic findings in non-neoplastic kidney: Scattered. sclerotic glomeruli and arterioles with intimal thickening are. present in sections taken from grossly uninvolved kidney. parenchyma adjacent to tumor. AJCC Staging: pT2b. pNX. This staging information is based on information available at. the time of this report, and is subject to change pending. clinical review and additional information. Clinical History: +year-old man with a right renal mass. Per , the patient has a. 9 cm right renal mass suggestive of possible renal cell. carcinoma and most likely brain metastasis. Gross Description: Specimen fixation: formalin. Type of specimen: partial nephrectomy. Side of specimen: right. Size and weight of specimen: 745.0 grams, 12.0 X 9.2 X 9.5 cm. Orientation: The parenchymal margin is inked black, and the. capsule is inked blue. Presence/absence of adrenal gland: absent. Tumor site: per , posterior central right kidney. Tumor description: yellow/brown, multinodular and well. circumscribed with extensive areas of hemorrhage and necrosis. Tumor size: 11.8 X 9.2 X 9.5 cm. Presence/absence of multicentricity: absent. Confinement/non-confinement to the kidney: grossly confined. Extent of invasion: Perirenal adipose tissue: not submitted. Gerota' S fascia: not submitted. Renal vein: not submitted. Ureter: not submitted. Renal Sinus: not submitted. Pelvicaliceal: limited uninvolved kidney for evaluation. Adrenal: not submitted. Parenchymal margin: 2 mm. Capsule: 1 mm. Description of kidney away from tumor: extremely limited,. uninvolved kidney available for evaluation (4.7 X 7.5 X 0.1-2.1. cm) i appears tan and firm without grossly evident lesions; no. urothelium is available for evaluation. Hilar lymph nodes: not submitted. Other significant findings: none. Tissue submitted for special investigations: Tumor is submitted. to Tissue Procurement. Digital picture: not taken. Block summary: (Inking: parenchymal margin=black, capsule=blue). A1-A3 - tumor in relation to black inked parenchymal margin. A4 - tumor in relation to grossly uninvolved kidney. A5-A6 - - tumor in relation to blue inked capsule. A7-A12 - additional representative sections of tumor. A13 - representative section of grossly uninvolved kidney. (nearest tumor 3 mm away). Tissue remains.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Material examined: Left upper lobe, among others. Clinical diagnosis and question. Space-occupying lesion of unclear pathogenesis left upper lobe, with pleural contact. REPORT ON FINDINGS. Macroscopy. 1.) Inflated, fixed upper lobe of left lung measuring 24 x 14 x 7 cm, central bronchus resection plane located 0.8. cm proximal to the birfurcation of the lingular bronchus. A 4.5 cm long staple suture line runs in a dorsocaudal. direction from the hilus. At the hilus are four lesioned grayish-black nodes between 0.8 and 1.4 cm. Lateral. pleural over segment 2 shows an unclearly demarcated 3 cm area of whitish discoloration characterized by a. depression-like retraction, under which is a moderately solid, predominantly pale brownish and partly patchy. grayish-black tumor, max. 5.5 cm in size, with a relatively clear and somewhat arcuate demarcation, extending. to the pleura in the region of the retraction. Truncation or opening of peripheral branches of B2, B1 and B3 in. the tumor. Lateral pleural region at the junction of S3/S4 shows an unclearly demarcated 0,4 cm area of. induration. Rest of parenchyma shows rarefaction in apical region of segment 1 with lacunae or lacuna systems. up to 0.6 cm in size, otherwise inconspicuous. 2.) Parietal pleura: membranous tissue measuring 10,5 x 8.5 cm and up to 0.1 cm thick with partly smooth,. partly rough surface,. 3) Interlobar LN (item 11) left: three lesioned grayish-black nodes or node parts, 0.3 and 1.1 cm in size. 4) Hilar LN (item 10) left: two lesioned grayish-black nodes or node parts, 0.4 and 1.3 cm in size, partly with. some surrounding tissue. 5) Subcarinal LN (item 7): 1 cm lesioned grayish-black node or node part. 6) Paraaortic LN (item 6) left: combined 1.5 cm quantity of party grayish-red, partly blackish specimens. between 0.1 and 0.8 cm. 7) Subaortic LN (aortopulmonary window) (item 5) left: 2 cm lesioned grayish-black nodes with some. surrounding tissue. 8.) Low paratracheal LN (item 4) left: 2.2 cm lesioned grayish-brown node with some surrounding tissue. Examined: 1.) 2 sections of tumor with remaining parenchyma, 3 sections with pleura, indurated area (halved), 2 sections. of apical S1, central bronchus resection plane, resection margins of vessels, hilar nodes,. 2.) All material (lamellated),. 3.) - 8.) All material (in 7. + 8. preparations lamellated),. 15 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Intermediate to peripheral manifest bronchopulmonary, histologically poorly differentiated, partly. gigantocellular and polymorphocellular squamous cell carcinoma of the upper lobe of the left lung. TNM. classification according to this picture pT2 pNO V1 R0, stage IB. C 34.1; M 8070/3. Secondary diagnosis/diagnoses: Small tumor necroses and tumor-related inflammation. Active, partly resorptive inflammation of the lung. parenchyma surrounding the tumor with inclusion of numerous macrophages. Circumscribed subpleural. alveolar and interstitial organizing and remodeling zone of the lung parenchyma with inclusion of immature or. atypical squamous cell metaplasia also involving the bronchioles (S3 /4). Apical emphysematous stromal. remodeling with formation of small subpleural cysts. Slight anthracotic pigment deposits in the lung. parenchyma and moderately marked deposits in the lymph nodes. Chronic parietal pleuritis with fibrosis. of. varying degrees (sample 2.)). Remark/addendum: This is probably a primarily peripheral carcinoma of the lung which, after central growth, has infiltrated. intermediate or subsegmental bronchi of segments 1 - 3 there, because there is tumor invasion of the overlying. visceral pleura, where there is also marked fibrosis. The main tumor mass is located in segment 2. The fibrosing. lesion of the lung parenchyma in the boundary region of segments S3/4, which includes atypical squamous cell. nests, could be the initial stage of a second bronchopulmonary carcinoma focus, because the histological picture. is not typical of a satellite nodule. But ultimately, the differential diagnosis of an atypical squamous cell. metaplasia in the context of a circumscribed fibrosing process initiated by inflammation cannot be made with. a. sufficient degree of reliability.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
DIAGNOSIS. BIOPSY, RIGHT ORAL TONGUE: INVASIVE SQUAMOUS CARCINOMA. BILATERAL NECK DISSECTION, TOTAL LARYNGECTOMY, TOTAL GLOSSECTOMY AND. SEGMENTAL MANDIBULECTOMY: INVASIVE SQUAMOUS CARCINOMA OF TONGUE, TUMOR PRESENT APPROXIMATELY. 1.0 MM FROM DEEP RESECTION MARGIN, LATERAL MARGIN OF RESECTION. FREE OF TUMOR. EXTENSIVE PERINEURAL INVASION PRESENT. Eighteen left level I axillary neck lymph nodes, negative for tumor. METASTATIC SQUAMOUS CARCINOMA IN 2 OF 4 LEFT LEVEL II NECK LYMPH. NODES. METASTATIC CARCINOMA GROSSLY MEASURES APPROXIMATELY 2.0 CM IN. DIAMETER COMPLETELY REPLACES THE INVOLVED LYMPH NODES. EXTRANODAL EXTENSION TO ADIPOSE TISSUE PRESENT. METASTATIC SQUAMOUS CARCINOMA IN 1 OF 7 LEVEL III LYMPH NODES. Five left level IV lymph nodes, negative for tumor. Right submandibular gland, negative for tumor. Three right level III and IV Tymph nodes, negative for tumor. (C) PALATAL MARGIN: Squamous mucosa with foci of mild dysplasia, no tumor present. ANTERIOR MUCOSAL MARGIN: Squamous mucosa, no tumor present. (E) TEETH: Multiple teeth (gross description only) squamous mucosa shows mild to. moderate chronic inflammation. Entire report and diagnosis completed bv: Report released by: GROSS DESCRIPTION. (A) BIOPSY, RIGHT ORAL TONGUE - Two fragments of tan and pink-reg soft. tissue, measuring 1.0 X 0.5 X 0.3 cm and e 6 X 0.5 x 0.4 cm. Entirely. submitted for frozen section as A. FS/DX: DIFFERENTIATED INVASIVE SQUAMOUS CARCINOMA. (B) BILATERAL NECK DISSECTION, TOTAL LARYNGECTOMY, TOTAL GLOSSECTOMY AND. SEGMENTAL MANDIBULECTOMY - A total tongue resection (12.8 X 4.5 X 4.2 cm),. attached segmental resection of right mandible (9.6 X 2.8 X 0.8 cm), and. intact larynx (5.0 x 3.3 X 2.5 cm) with epiglottis and hyoid bone. Bilateral. neck. dissections are attached, measuring 12.5 X 4.8 X 1.5 cm on the right and. 7.0 X 4.5 X 1.2 cm on the left. The left level I region contains multiple. pink to dark red soft lymph nodes, ranging from 0.2 to 1.3 cm in greatest. dimension. No gross tumor is identified. The left level II region contains. multiple lymph nodes, ranging from 0.2 up to 3.0 cm in greatest dimension. Two. lymph nodes grossly involved by tumor are identified. The left level III. region contains multiple lymph nodes ranging from 0.3 to 0.7 cm in greatest. dimension. No gross tumor is identified. The left level IV region contains. multiple lymph nodes, ranging from 0.2 to 0.5 cm in greatest dimension. No. gross tumor is identified. The right level I region contains a unremarkable. salivary gland measuring 3.8 X 2.3 X 1.3 cm. No lymph nodes are identified. The right level II region contain an unremarkable salivary gland measuring 3.0. cm. Two additional lymph nodes are present, measuring 0.3 to 0.5 cm in. greatest dimension, respectively. The right level III and IV regions contains. multiple lymph nodes, ranging from 0.1 to 0.4 cm in greatest dimension. No. gross tumor is identified. A tan-pink, rubbery circumscribed mass (8.5 X 4.0 X 3.0 cm), occupies the. entire right side of the tongue. An area of ulceration (4.7 X 2.4 cm) is. present overlying the mass on the right lateral aspect of the tongue. The. remaining mucosa on the tongue is intact. The mass is 0.5 cm from the closest. right lateral mucosal margin, 1.1 cm from the closest anterior mucosal margin. and 1.4 cm from the closest left lateral mucosal margin. The tumor approachs. within 1.0 mm of the deep soft tissue in the region overlying the tumor in the. tongue base and anterior tongue. Mucosa with ulceration and tumor is adherent to the medial portion of the. mandibular segment. This bone segment is submitted to the Bone Lab for further. sections and processing. The largynx is grossly unremarkable with the base of the epiglottis. approximately 1.0 cm from the closest tumor and bone base. Portions of tumor and normal tissue are submitted for research protocol. and flow cytometry. INK CODE: Yellow-mucosal surgical margins; black-deep soft tissue. margins. SECTION CODE: B1-B3, right tongue base tumor and deep margin; B4, right. anterior tongu tumor and deep margin; B5, left lateral anterior tongue mucosal. margin; B6, left lateral posterior tongue mucosal marign; B7-B10, tongue tumor. and mucosa; B11-B13, tumor and ulcerated surface; B14, left pyriform sinus. margin; B15, inferior laryngeal mucosal margin; B16, right pyriform sinus. margin; B17, left true and false vocal cord; B18, right true and false vocal. cord; B19, epiglottis; B20-B25, left level I lymph nodes (20-21, three lymph. nodes per cassette; B22, four 1ymph nodes; B23, two lymph nodes; B24-B25,. three lymph nodes per cassette); B26-B28, left level II lymph nodes (B26,. representative cross section of grossly positive lymph node; B27,. representative section of second grossly positive lymph node; B28, two. possible lymph nodes) ; B29-B30, left level III lymph nodes (3 possible lymph. nodes per cassette) B31-B32, left level IV lymph nodes (B31, three possible. lymph nodes; B32, two possible lymph nodes) ; B33, right level I salivary. gland; B34-B36, right level II lymph nodes (B34, salivary gland; B35, one. bisected lymph node; B36, one lymph node) ; B37-B38, right level III-IV lymph. nodes (B37. three possible lymph node; B38, two possible lymph nodes). PALATAL MARGIN - An oval, tan-pink soft tissue specimen (3.3 X 0.4 X 0.3. cm) The true margin is indicated to be away from the ink side and a single. suture is present at the inferior aspect. No focal lesions are identified. SECTION CODE: C1, superior half, en face for frozen section; C2, inferior. half, en face for frozen section. ES/DX: SQUAMOUS MUCOSA WITH FOCI OF MILD DYSPLASIA, NO TUMOR PRESENT. (D) ANTERIOR MUCOSAL MARGIN - A tan-pink mucosal fragment (3.0 X 0.2 x 0.2. cm). An ink dot is present on the mucosal surface which is indicated as a. true margin. A white-tan, fibrous nodule (0.4 x 0.3 X 0.2 cm) is present. SECTION CODE: D1-D2, entire true margin, submitted en face for frozen. section. (E) TEETH - Multiple anterior teeth and tooth fragments, some of which have. focal metallic material on the exterior surfaces; two teeth appear to have. porcelain crowns, and there are focal caries. Minimal adherent soft tissue is. present. Soft tissue submitted as E.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
OC#: Eaterality:NA. Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Skin. Tumor size: 2.5x2x1cm. Tumor features: None specified. Satellite nodules: Not specified. Histologic type: flanoma/. Histologic grade: Moderately differentiated. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Clark level III invasion.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
Final Pathologic Diagnosis: A. Anterior lymph node, excision: Metastatic carcinoma, non-small cell.. Small sclerotic granulomata. B. Inferior ligament lymph nodes, excision: No evidence of metastatic carcinoma. Multiple small sclerotic granulomata. C. Hilar lymph node, excision: Metastatic carcinoma, non-small cell. Extranodal extension of tumor, present. D. Lymph nodes, five, excision: No evidence of metastatic carcinoma. E. Left lung, upper lobe, left upper lobectomy: Non-small cell carcinoma, moderate to poorly differentiated. Maximal diameter of tumor 10.2 cm. Bronchial margin, free of tumor. Frozen section diagnosis FSE1, confirmed. Chest wall margin, soft tissues, resection margin, free of tumor. Frozen section diagnosis FSE2, confirmed. Ribs and soft tissue, pending decalcification. Vascular margin, free of tumor. Peripheral margins of resection, free of tumor. Extensive tumor necrosis. Lymph nodes, three, no evidence of metastatic carcinoma. Moderate to marked sinus histiocytosis and anthracosis. F. Subcarinal lymph node, excision: No evidence of metastatic carcinoma. G. Lymph nodes, AP window, excision: Metastatic carcinoma in three of three lymph nodes (3/3). H. Lymph nodes, lower paratracheal, excision: Lymph nodes, four, free of tumor. AJCC Staging: pT2, pN2, MX. The examination of this case material and the preparation of this report were. Signing Location: Intraoperative Consult Diagnosis: FSE1: Left upper lobe, bronchial resection margin: Bronchus with no tumor seen. FSE2: Left upper lobe, tumor relative to chest wall margin: Chest wall margin with no tumor seen. F/S TAT: 20 mins. Gross Description: The specimen is received in eight parts each labeled with the patient name. "". Part A received in formalin labeled ""anterior lymph node,"" and consists of a. single probable lymph node received with some associated fat that has a greatest. dimension of 1.9 cm. The lymph node is bisected and entirely submitted in. cassette A. Part B received in formalin labeled ""inferior pulmonary ligament lymph node,"". and consists of a portion of irregular, ragged, gray-yellow, lobulated fat that. has dimensions of 3.2 X 2.8 X 0.6 cm. The fat contains six probable lymph nodes. that range from 0.2 to 1.6 cm in greatest dimension. Lymph nodes are entirely. submitted as labeled: B1. five lymph nodes submitted in toto;. B2. one bisected lymph node. Part C received in formalin labeled ""hilar lymph node,"" and consists of a single. probable lymph node received with some associated fat that has a greatest. dimension of 1.6 cm. The lymph node is bisected and entirely submitted in. cassette C. Part D received in formalin labeled ""tracheobronchial lymph node,"" and consists. of five probable lymph nodes that range from 0.3 to 1.6 cm in greatest. dimension. The lymph nodes are entirely submitted as labeled: D1. two lymph nodes submitted in toto;. D2. one lymph node submitted in toto;. D3. one bisected lymph node;. D4. one bisected lymph node. Part E received fresh for intraoperative consultation labeled ""left upper lobe,"". and consists of a left upper lung lobe that has a weight of 491 g and dimensions. of 18.2 X 10.6 X 8.5 cm. There is an attached portion of chest wall that is. comprised of a single rib with some associated soft tissue that has dimensions. of 7.8 X 4.2 X 2.6 cm. This chest wall is only loosely attached to this. specimen. The hilar structures are identified with the bronchus opened and the. vessels stapled. There are a few extra parenchymal peribronchial lymph nodes. present. There is a staple line that radiates superiorly from the hilum that. has a length of 8.9 cm. The pleura is gray-purple, smooth and glistening to. shaggy with focal cautery effect where the chest wall is adherent to the lung. lobe. The specimen is serially sectioned to reveal a red-brown spongy lung. parenchyma that is 75% replaced by a gray-yellow to red-brown, focally granular,. markedly degenerated and roughly spherical mass that has dimensions of 10.2 X. 8.4 X 7.2 cm. This mass extends to within 1.8 cm of the bronchial margin. This. mass extends to within 0.2 cm of the inked parenchymal margin. This mass. extends to the pleura at the site of the adherent chest wall. This mass grossly. appears to invade through the pleura and into the chest wall. This mass extends. to within 0.2 cm of the rib and to within 1.2 cm of the anterior chest wall. margin. The lung parenchyma distal to the mass is markedly consolidated. There. are no additional lesions identified. Representative sections have been. submitted for frozen section diagnosis FSE1 and FSE2 with the residue. resubmitted for permanent sections in cassettes E1 and E2 respectively. Additional representative sections are submitted as labeled: E3. anterior rib margin en face after decalcification;. E4. posterior rib margin en face after decalcification;. E5. mass to rib and anterior soft tissue margin after decalcification;. E6. vascular margins en face;. E7-11 mass to include inked, stapled parenchymal margin in. cassettes E7-E8 and pleura at the site of adherent chest wall in cassettes E9. and E10;. E12. consolidated lung parenchyma distal to mass;. E13. normal most lung parenchyma;. E14. two lymph nodes submitted in toto;. E15. one bisected lymph node. Part F received in formalin labeled ""subcarinal lymph node,"" and consists of two. portions of irregular, ragged, gray-yellow, lobulated fat that have dimensions. of 2.2 X 2.0 X 0.8 cm and 2.3 X 2.0 X 0.6 cm. The fat contains eight probable. lymph nodes that range from 0.4 to 1.7 cm in greatest dimension. The lymph. nodes are submitted in toto in cassettes F1 and F2. Part G received in formalin labeled ""AP window,"" and consists of three probable. lymph nodes that have greatest dimensions of 0.7, 1.3 and 1.4 cm which are. submitted in toto in cassette G. Part H received in formalin labeled ""lower paratracheal,"" and consists of four. probable lymph nodes received with some associated fat that have greatest. dimensions of 0.4, 0.5, and 1.0 cm which are submitted in toto in cassette H. Please note: all cassettes are labeled with the case number. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings. Addendum Report. Date Complete: Addendum Diagnosis. Sections of the previously decalcified ribs and soft tissues (specimen E). demonstrate a focus of invasive carcinoma involving the posterior rib margin. (block E4). Date Complete: Results-Comments. At the request of Dr. a representative portion of this case was. sent to Molecular Pathology for KRAS mutation analysis. This addendum is. created to report those findings. Cerner accession number: Body site: Left lung, left upper lobe. Specimen type: Paraffin embedded tissue. Surgical Pathology Block number: No KRAS mutations were detected (Wild Type KRAS) at codon 12 of the. KRAS gene in the provided specimen. The codon 13 mutations could not be. analyzed. INTERPRETATION: No KRAS mutations were identified at codon 12 of the KRAS gene. in the provided specimen. The codon 13 mutations could not be analyzed. METHODIASSAY LIMITATIONS: Tissue sections are reviewed by a pathologist before. processing. DNA is isolated and the exon 2 of the KRAS gene is amplified by PCR. PCR products are subjected to Shifted Termination Assay (STA-TrimGen) technology. to detect mutations at codons 12 and 13. STA products are analyzed by capillary. gel electrophoresis and fluorescence detection. This assay is validated for the. detection of mutations in codons 12 and 13 of the KRAS gene. Mutations in other. codons of KRAS are not evaluated. False positive or negative results may occur. for reasons that include genetic variants or somatic heterogeneity of the tissue. sample analyzed. Mutations present in a low percentage of cells may not be. detected. Results should be interpreted in conjunction with clinical and other. laboratory information findings for the most accurate interpretation.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Date 5 noceuure. & Neck. And Neck. Clinical Diagnosis & History: Papillary thyroid carcinoma. PTC. Specimens Submitted: 1: Blopsy of trachea (fs). 2: Left paratracheal tissue (fs). 3: Total thyroidectomy. DIAGNOSIS: 1. Trachea; biopsy( fs): - Benign respiratory mucosa. 2. Paratracheal Left ; blopsy(fs): - Metastatic papillary carcinoma to lymph node, the node is 0.5cm and the metastatic focus is 0.25cm in size. -No extranodal extension seen. Note : the carcinoma was not present on the original frozen section slide. 3. Total thyroidectomy: Part # 3. Tumor Type: Papillary carcinoma, tall cell variant > 50% Tall all varient pen TSS /. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 5.2 cm. Tumor Encapsulation: Partially surrounded. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:peri-thyroid fibroadipose tissue. Surgical Margins: Free of tumor. Tumor Multicentricity: Separate foci of papillary carcinoma, follicular and microcarcinoma variants in right lobe. The follicular variant is. encapsulated non-invasive (3.7 cm). Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled ""blopsy of trachea"" and consists of two tiny fragments of. tissue each measuring less than 0.1 cm in greatest dimension. The entire specimen is submitted for frozen section. The specimen. may not survive processing. Summary of sections: FSC - frozen section control. 2) The specimen is received fresh for frozen section consultation, labeled ""left paratracheal tissue"" and consists of a 1.1 x 1.0 x. 0.3. cm piece of soft tissue. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 3). The specimen is received in formalin, labeled ""total thyroidectomy, suture marks right lobe of thyroid"" and consists of a 52 g. thyroid with a suture marking the right pole. The right lobe measures 6.7 x 3.4 x 1.7 cm, the left lobe measures 5.7 x 5.2 x 2.5 cm. and the isthmus measures 3 x 2.6 x 1 cm. The external surface is covered by a thin fibrous capsule with an anteriorly attached, 5.5. x 3.5 x 2 cm portion of muscular tissue on the isthmus and left lobe. The specimen is previously inked anterior blue and posterior. black. Sectioning reveals three ovoid, tan-white to pink-tan, rubbery, focally tan-yellow, gelatinous, unencapsulated nodules in. the. mid to lower poles of the right lobe, the two smaller measuring 0.6 x 0.4 x 0.4 cm and the largest measuring 3.7 x 2.4 x 2.4 cm. The largest nodule abuts both the anterior and posterior capsular aspects. In the left lobe is a 5.2 x 2.4 x 2.3 cm tan-brown,. friable, finely focally encapsulated nodule which abuts the anterior and posterior capsular aspects. The remaining thyrold. parenchyma is red tan and meaty. Representative sections are submitted. Summary of sections: RLN - right lobe nodules. RL - right lobe. LLN - left lobe nodule. LL left lobe. IS isthmus. Summary of Sections: Part 1: Blopsy of trachea (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Left paratracheal tissue (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: Total thyroldectomy. Block. Sect. Site. PCs. 2. IS. 2. 1. LL. 2. 15. LLN. 15. 3. RL. 3. 8. RLN. 8. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. Frozen Section Diagnosis: Biopsy of trachea (fs): Predominantly calcified tissue with rare epithelial cells. Defer. 4. Permanent Diagnosis: same. 2. Frozen Section Diagnosis: Left paratracheal tissue (fs): Benign lymph node. Permanent Diagnosis: see final. abl.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: History right thyroid nodule leading to PTC on FNA. Specimens Submitted: 1: SP: Rule out parathyroid (fs). 2: THYROID; TOTAL THYROIDECTOMY: DIAGNOSIS: 1. PARATHYROID, SIDE UNSPECIFIED; BIOPSY (FS): -PARATHYROID TISSUE, SLIGHTLY HYPERCELLULAR, 0.3 CM. 2. THYROID; TOTAL THYROIDECTOMY:: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Mild to moderate. 1/10 HPFs. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammoma type. Psammoma bodies. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 3.0 cm. Tumor Encapsulation: Partially surrounded. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: !. Six papillary microcarcinomas, in both lobes and isthmus, ranging in size from 0.08 to 0.6 cm in greatest. dimension. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. i. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT,. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1) The specimen is received fresh, labeled ""rule out parathyroid"". It consists of one fragment of tan-pink fibrotic tissue measuring. 0.3 x 0.3 x 0.2 cm and weighs 3 mg. The specimen is entirely submitted for frozen section. Summary of sections: FSC-frozen section control. 2) The specimen is received fresh, labeled ""Total thyroidectomy"" and consists of a thyroid weighing 26.5g. The right lobe measures. 6.0 x 2.5 x 2.5 cm, the left lobe measures 4.0 x 2.5 x 1.1 cm and the isthmus measures 2.0 x 2.0 x 0.6 cm. The external surface is. covered by a thin fibrous capsule. The posterior surface of the specimen is Inked black, and the anterior is inked blue. Sectioning. reveals a 3.0 x 2.5 x 2.5 cm pink-tan nodule in the right lobe. The nodule abuts the anterior and posterior capsules and is focally. cystic. Further sectioning reveals two firm white nodules in the isthmus measuring 0.3 x 0.2 x 0.2 and 0.6 x 0.5 x 0.5 cm. Both. nodules are abutting the anterior surface. The remaining thyroid parenchyma is red tan and beefy. Representative sections of. the. specimen are submitted for TPS, and a photograph has been taken. The remaining tissue is serially sectioned and entirely. submitted. Summary of sections: N nodule. RL right lobe. LL left lobe. I1--smaller isthmus nodule. I2--larger isthmus nodule. IS isthmus. Summary of Sections: Part 1: SP: Rule out parathyroid (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: THYROID; TOTAL THYROIDECTOMY: Block. Sect. Site. PCs. 3. 3. 1. 2. 12. 2. 7. LL. 10. 8. 10. 6. RL. 8. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1. FROZEN SECTION DIAGNOSIS: SP: Rule out parathyroid (fs): Parathyroid tissue. PERMANENT DIAGNOSIS: Same.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Anatomic site: intrahepatic. Histology diagnosis: moderately differentiated intrahepatic cholangiocarcinoma. Immunohistochemistry: CK7 positive, CK20 and TTF1 negative. Histological examination: Liver left: resected parenchyma of 18x11x7 cm containing a grayish-white nodule of 12 cm, located 0.5 cm. distant from the resection margin and the retractile capsular. Histologically it is a moderately differentiated. adenocarcinoma with an immunohistochemical profile consistent with intrahepatic cholangiocarcinoma with. positivity for cytokeratin 7 and negative for cytokeratin 20 and TTF1. The liver tissue shows mild steatosis (5-. 10%) associated with chronic cholestasis and fibrosis of mild to moderate (grade 2-3/6 fibrosis, Ishak).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Sura Path Final Report. Result Date: Final Diagnosis (Verified). Distal left ureter, frozen section examination, excision: Negative for neoplasm. Distal right ureter, frozen section examination, excision: Negative for neoplasm. Additional prostatic apical tissue: Benign prostatic glandular tissue with scattered areas of squamous metaplasia. involving the duct lumen, no invasive malignancy identified. Radical cystoprostatectomy: Infiltrating high-grade urothelial carcinoma with diffuse squamous. differentiation extending through entire bladder muscular wall and to. inked. radial margin of surgical excision. Bladder tumor measures 5.5 cm in maximum dimension and is positioned on. the. posterior bladder wall. Marked necrosis is present. Prostate is negative for malignancy. Seminal vessicles are negative. Left lymph node dissection: Seven (7) negative lymph nodes. Right lymph node dissection: Four (4) negative lymph nodes. Comment: This large, partially necrotic, diffusely infiltrating, high-grade transitional cell. carcinoma shows diffuse areas of squamous differentiation. The tumor extends to the inked. radial margin of excision. This case corresponds to a pathological AJCC stage of T3a,NO. Signature Line. (Electronically signed by). Verified on: Gross Description (Verifled). ""FSA."" All frozen section control tissue is submitted in cassette ""FSA,"". ""FSB."" All frozen section control tissue is submitted in cassette ""FSB,"". ""C, Additional apical tissue."" The specimen consists of 3 unoriented soft gray-pink fragments ranging in size from 1.6 x 1.6 x 0.7 cm to 2.4 x. 1. x 0.8 cm. Inked black. ""C1-C2,"" fragments, representative. ""D, Bladder."" The specimen consists of an 11.8 x 9.5 x 6.6 cm bladder with attached fat. Attached is the prostate gland. Bilateral distal. ureters have previously been submitted for frozen section. The specimen is opened on the anterior aspect and there is a 5.5 x 3.5 cm soft. red-tan friable ulcerated mass on the posterior bladder wall which extends to the right aspect of the bladder. The mass grossly appears to. extend into the bladder musculature to a depth of 2.5 cm and grossly appears to abut the radial margin. The radial margin has been inked. black. The mass does not grossly appear to involve the left and right ureteral orifices. The remaining bladder mucosa is red-tan and. edematous and no additional areas of interest are grossly identified in the bladder. The attached prostate gland measures 4.2 x 4 x 1.8 cm. The. posterior apex will be inked orange. The remaining prostate is inked black. The seminal vesicles and vas deferens will be submitted at. their junction with the prostate. The prostatic parenchyma is tan and no discrete yellow masses are grossly identified. ""D1,"" distal urethral. margin; ""D2-D5,"" bladder mass with adjacent radial margin (NOTE: Cassette deeply represents 1 full-thickness section submitted in steps);. ""D6,"". mass;. ""D7,"" left bladder mucosa; ""D8,"" bladder dome; ""D9,"" right bladder mucosa; ""D10,"" trigone; ""D11,"" left seminal vesicle and vas. deferens; ""D12,"" right seminal vesicle and vas deferens; ""D13,"" left anterior prostate; ""D14,"" right anterior prostate; ""D15,"" left posterior. prostate; ""D16,"" right posterior prostate. ""E,. Left lymph node."" The specimen consists of a 3.6 x 3.6 x 2 cm aggregate of yellow lobulated tissue. On sectioning, 7 possible lymph. nodes are identified. These range in size from 0.3 to 1.5 cm. ""E1-E3,"" fragments, representative. ""F, Right lymph node."" The specimen consists of a 4.4 x 3.2 x 1.5 cm aggregate of yellow lobulated tissue. On sectioning, 4 possible lymph. nodes are identified. These range in size from 0.4 to 1.8 cm. ""F1-F2,"" fragments, representative. Received for research purposes is 1 yellow cassette labeled "". Signature Line. Frozen Section Diagnosis (Verified). FSA: Distal left ureter: No tumor noted. FSB: Distal right ureter: No tumor noted. Clinical Information (Verified). This year-old white male is a patient with spina bifida who has been on lifelong intermittent catheterizations. The patient has a long history. of smoking (3 to 4 packs a day). Completed Action List: VERIFY by.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. SPECIMEN. A. Left upper lobe. B. Level 10 lymph node. C. Level 5 lymph node. D. Level 7 lymph node. CLINICAL NOTES. PRE-OP DIAGNOSIS: Chest mass. GROSS DESCRIPTION. A. Received fresh, subsequently fixed in formalin labeled. ""left upper lobe"" is a 196 gram, 16 X 11 X 4.5 cm. lobe of. lung which is partially covered with a gray violaceous smooth. glistening pleura which shows diffuse black stippling. The hilum. is. heavily stapled. There is a 1.5 cm. umbilication which is located. opposite of the hilum. This area is inked blue and the specimen is. sectioned in this area to show a 3.2 X 3.2 X 2.3 cm. ell-circumscribed white-tan indurated lesion. This comes within 4.5. cm. of the hilar margin. This is contiguous with the umbilication. The remainder of the parenchyma is red-pink and spongy showing no. other discrete gross lesions identified. Possible hilar node is. grossly identified. Representative sections of the specimen are. submitted as follows: BLOCK SUMMARY: 1 - bronchial and vascular margins; 2 - possible. hilar node; 3 - representative normal; 4-8 - representative section. of tumor which inclu. o. o normal parenchyma and tumor to. umbilication. RS-8. B. Received fresh, subsequently fixed in formalin labeled. ""level 10 lymph node"" is a 1.5 X 1.0 X 0.4 cm aggregate of. pink-red irregular soft tissue fragments which are grossly. consistent with possible lymphoid tissue. The specimens are. entirely submitted in one cassette. AS-1. C. Received fresh, subsequently fixed in formalin labeled. ""level 5 lymph node"" are multiple pink-gray irregular soft. friable tissue fragment which have an aggregate measurement of 3.5 X. 2.5 X 0.5 cm. The. e ens are entirely submitted in two. cassettes. AS-2. D. Recei. sh subsequently fixed in formalin labeled. ""level 7 lymph node"" are multiple pink, gray irregular soft. tissue fragments which have aggregate measurement of 2.0 X 2.0 X 0.4. The specimens are entirely submitted in one cassette. AS-1. MICROSCOPIC DESCRIPTION. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated with extensive areas of. necrosis. Primary tumor (pT) : pT2a, the tumor measures 3.2 cm. in dimension. and extends up to the visceral pleura and very focal visceral. pleural invasion cannot be excluded. Margins of resection: Negative. Direct extension of tumor: The tumor is limited to the lung. Vascular invasion: Present. Regional lymph nodes (pN) : pNO . Distant metastasis (pM) : pMx. 5x1 and 3x3. DIAGNOSIS. A. Lung, left upper lobe, excision - Poorly differentiated squamous. cell carcinoma (see tumor characteristics in the microscopic. description). Five hilar lymph nodes negative for metastatic carcinoma. (0/5). B. Lymph nodes, level 10, excision - Two lymph nodes negative for. metastatic carcinoma (0/2). C. Lymph nodes, level 5, excision - Multiple fragments of lymph. node negative for metastatic carcinoma. D. Lymph node, level 7, excision - Three lymph nodes negative for. metastatic carcinoma (0/3).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Laterality:Distal. Path Report: :ESOPHAGUS TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Esophagus. Tumor size: 2 X 1.5 x 0.3 cm. Histologic type: Squamous cell carcinoma, keratinizing. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/7 positive for metastasis (Regional 0/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
TISSUE DESCRIPTION: : Tissue from right kidney (3.2 x 2.5 x 1.0 cm) and right. kidney. (180grams, 12 X 6 X 4.6 cm) 10.5 cm ureter, adrenal (5.5 X. 3.5 x 1.3. cm), right hilar, paracaval, adrenal hilar, intraoarta. caval lymph. nodes. DIAGNOSIS: Kidney, right, radical nephrectomy Grade 2 (of 4) renal. cell. carcinoma clear cell type, forms a 6 X 6 X 3.5 cm mass. located in. the inferior pole of the kidney. The tumor is confined to. the. kidney. The renal vein is grossly free of tumor. The tumor. does not. involve the collecting system. Coagulative tumor necrosis. is absent. The surgical margins are negative. No renal hilar lymph. nodes are. identified. The adrenal gland is present and unremarkable. Kidney, right, biopsy: Grade 2 (of 4) renal cell. carcinoma, clear. cell type, no coagulative necrosis identified. Lymph nodes, right hilar, paracaval, intraaorta-caval,. excision: Multiple (3) right hilar, (1) right paracaval, (6) right. intra-aorta -. caval lymph nodes are negative for tumor. Soft tissue, right adrenal hilar region, excision: Nerve. tissue and. ganglion. Negative for malignancy.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: BREAST, LEFT, SKIN SPEARING PROPHYLACTIC TOTAL MASTECTOMY -. A. FIBROCYSTIC CHANGES. WUID:82328EE4-8579-4E26-B45C-8A5BFCOCEDBD. B. COLUMNAR CELL CHANGES. c. SCLEROSING ADENOSIS. D. PSEUDOANGIOMATOUS STROMAL HYPERPLASIA. E. DUCTAL EPITHELIAL HYPERPLASIA. F. NIPPLE AND SKIN. PART 2: BREAST, RIGHI-SKIN SPEARING TOTAL MASTECTOMY -. A. INVASIVE LÃBULAR CARCINOMA, CLASSIC TYPE, TWO FOCI, 3 CM (UPPER AND LOWER OUTER. QUADRANTS) AND 4.2 CM (UPPER OUTER QUADRANT) (GROSS), NOTTINGHAM GRADE 2/3 (COMBINED. NOTTINGHAM SCORE 6/9: TUBULE FORMATION- 3/3, NUCLEAR ATYPIA 2/3, MITOTIC ACTIVITY 1/3)). B. LOBULAR CARCINOMA IN SITU (LCIS), NUCLEAR GRADE 2, CLASSICAL TYPE WITH COMEDO NECROSIS. C. NO LYMPHOVASCULAR INVASION. D. MARGINS FREE, INVASIVE CARCINOMA WITHIN LESS THAN 1 MM FROM ANTERIOR MARGIN. E. FIBROCYSTIC CHANGES. F. COLUMNAR CELL CHANGES AND HYPERPLASIA. G. FIBROADENOMATOIO CHANGES. H. PSEUDOANGIOMATOUS STROMAL HYPERPLASIA (PASH). 1. MICROSCOPIC RADIAL SCAR. J. BIOPSY SITE CHANGES X2. K. NIPPLE AND SKIN. ER/PR- POSITIVE, HER-2- - 2+, WITHOUT AMPLIFICATION BY FISH. PART 3: SENTINEL NODE, RIGHT AXILLA, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: BREAST SKIN, RIGHT, EXCISION -. A. BENIGN BREAST P(PARENCHYMA. B. SKIN AND SUBCUTANEOUS TISSUE. PART 5: BREAST SKIN, LEFT, EXCISION -. SKIN AND SUBCUTANEOUS TISSUE. COMMENT: Negative status of the lymph node was confirmed by cytokeratin immunostain. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Simple mastectomy. Upper outer quadrant. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 42 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of muitiple invasive tumors: 72 mm. TUMOR TYPE (Invasive component): inflitrating lobular carcinoma. HISTOLOGIC TYPE: Classical. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitatic activity score: 1. Total Nottingham score: 6. Nottingham grade (1. 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. T STAGE, PATHOLOGIC: N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, previously performed, H-score: 295. PROGESTERONE RECEPTORS: positive, previously performed. H-score: 275. HER2/NEU: HER2/NEU (FISH): Not amplified.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
OPER DATE: PROCEDURE: APMI. ADDENDUM TO REPORT CHANGE IN MARGIN STATUS AFTER DISCUSSION WITH SURGEON: Please see revised template and revised diagnosis below. ADRENOCORTICAL CARCINOMA. V4. Tumor Size: 17.1 x 12.5 x 10.3 cm. Tumor Weight: Cannot determine. Capsular Invasion: Yes. Vascular Invasion: Yes. Surgical Margins: Negative. Necrosis: 75% (gross). Mitotic Rate: 60/50 hps. Grade: High. Lymph nodes status: 1/2. Extra-adrenal extension: Present. Stage: 4 (pT3 N1 M1). Immunohistochemistry Results: N.A. PROCEDURE: APDX. 2. Right adrenal and kidney, resection: High-grade adrenocortical carcinoma. (17.1 cm) with capsular and extensive vascular invasion, including invasion of. vasa cava. Margins negative. Please see TEMPLATE for details. Metastatic. carcinoma in one of two lymph nodes (1/2). Incidental renomedullary. interstitial cell tumor. 1 and 3. Please see previous report for diagnoses which remain unchanged. the signing staff pathologist, have personally. examineu and. the slides from this case. PREVIOUS DIAGNOSIS INQUIRY. 3. REPORT DAIE: SEX: F. BIRTHDATE: ADM DATE: OPER DATE: OPER DATE: PROCEDURE: SPHS. History of anemia and right upper quadrant pain. PROCEDURE: SPGD. 1. ""Right liver surface nodule, rule out metastatic cancer.' Received fresh. for frozen section is a 0.5 x 0.5 x 0.3 cm, tan nodule. 1A. Frozen section control. 2. ""Right adrenal gland and kidney."" Received in formalin in a large container. is a radical nephrectomy specimen (1585 gm), consisting of: kidney (11.7 x. 7.5 x 6.2 cm), adrenal tumor (17.1 x 12.5 x 10.3 cm), vena cava (1.5 x 1.8. cm), renal vein (3.2 x 2.6 cm), renal artery (3.9 x 0.5 cm), ureter (5.7 x 0.4. cm) and attached perirenal/periadrena adipose. The vena cava is remarkable. for an exophytic tumor thrombus, which extends 5.7 cm past the margin of. resection. The adrenal tumor is inked blue and sectioned to reveal. yellow-brown, variegated and friable cut surfaces remarkable for extensive. areas of hemorrhage and necrosis (75%). The adrenal tumor is encapsulated. within a thin, intact membrane. No normal adrenal parenchyma is identified. The adrenal tumor abuts the superior pole of the kidney, however, no. involvement is identified. Found within the renal medulla of the mid pole is a. 0.4 x 0.3 x 0.3 cm, gray, well-circumscribed nodule. The remaining renal. parenchyma is unremarkable. The perirenal/periadrenal adipose, renal vein,. renal artery and ureter are uninvolved and unremarkable. There are multiple. possible lymph nodes up to 2.1 cm in greatest dimension. This case has been. consulted with. 2A. Vena cava margin including tumor thrombus. 28. Renal vein, renal artery and ureter margins. 2C. Two possible lymph nodes submitted whole. 2D. One possible Lymph node, serially sectioned. 2E. Ore possible Lymph node, serially sectioned. 2F-1. Adrenal tumor including capsule. 2J-K. Center of adrenal tumor. 2L. Agrenal tumor to kidney. 2M. Renal nodute. PREVIOUS DIAGNOSIS INQUIRY. REPORI DALE: SEX: F. BIRTHOATE: ADM DATE: OPER DATE: 3. ""Costochondral cartilage."" Received in formalin in a small container is a. 2.7 x 1.8 x 0.9 cm soft tissue and bone excision, including two embedded ribs,. 1.7 cm segments each, and surrounded by grossly unremarkable skeletal muscle. and fibrous tissue. No lesions are present. Specimen submitted for gross. examination only. FROZEN SECTION REPORT. 1. Positive for metastatic carcinoma. have reviewed and interpreted the frozen section. material at the time it was requested. PROCEDURE: SPM1. ADRENOCORTICAL CARCINOMA. V4. Tumor Size: 17.1 x 12.5 x 10.3 cm. Tumor Weight: Cannot determine. Capsular Invasion: Yes. Vascular Invasion: Yes. Surgical Margins: Positive (vena cava and soft tissue). Necrosis: 75% (gross). Mitotic Rate: 60/50hpf. Grade: High. Lymph nodes status: 1/2. Extra-adrenal extension: Present. Stage: 4 (pT3 N1 M1). Immunohistochemistry Results: N/A. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 5. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: SPDX. 1. Liver, right surface nodule, biopsy: Metastatic carcinoma. 2. Right adrenal and kidney, resection: High-grade adrenocortical carcinoma. (17.1 cm) with capsular and extensive vascular invasion, including invasion of. the vena cava. Carcinoma present at vena cava margin and focally at soft. tissue margin. See TEMPLATE. Metastatic carcÃ­noma in one of two Lymph nodes. (1/2). Incidental renomedullary interstitial cell tumor. 3. Bone and soft tissue, ""costochondral cartilage"", resection: Unremarkable. bone and soft tissue. Gross only. the signing pathologist, have personally examined. and interpreted the stides from this case. I. END OF PREVIOUS DIAGNOSIS INQUIRY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
PHYSICIANUNFORMATION. DIAGNOSIS. DIAGNOSIS: A. Lymph node, inferior pulmonary ligament, excision: No metastatic carcinoma identified in one anthracotic lymph node (0/1). B. Lymph node, hilar; excision: No metastatic carcinoma identified in three anthracotic lymph nodes (0/3). C. Lymph node, interlobar; excision: No metastatic carcinoma identified in four anthracotic lymph nodes (0/4). D. Lung, left lower lobe; lobectomy: Specimen type, procedure: Tumor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Location of tumor: Left lower lobe. 3. Size: 3,3 x 3.0 x 2.7 cm. 4. Grade: Moderately to poorly differentiated. 5. Pleural invasion: No. 6. Lymphovascular space invasion: No. Surgical Margin Status: 1. Tumor distance from bronchial margin: 2.8 cm. 2. Tumor distance from pleural surface: 0.1 cm. Lymph Node Status. 1. Total number of lymph nodes examined: Fourteen. a. One inferior pulmonary ligament node, see specimen A. b. Three hilar nodes, see specimen B. c. Four interlobar nodes, see specimen C. d. One peribronchial node. e. Two AP window lymph node, see specimen E. f. Three subcarinal nodes, see specimen F. 2. Total number of lymph nodes containing metastatic carcinoma: Zero (0/14). Other: 1. pTNM stage: pT2 NO Mx. E. Lymph node, AP window; excision: No metastatic carcÃ­noma identified in two lymph nodes (0/2). F. Lymph node, subcarinal; excision: No metastatic carcinoma identified in three lymph nodes (0/3). CLINICAL,INFORMATION. CLINICALINFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Left lower lobe lung cancer, biopsy proven at I. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Inferior pulmonary ligament lymph node. B. Hilar lymph node. C. Interlobar lymph node. D. Left lower lobe node. E. AP window lymph node. F. Subcarinal lymph node. SPECIMENDATA. GROSS DESCRIPTION: A. The first container A is labeled. is, #1. The specimen consists of a gray tan nodule measuring 3.0 x 1.0 x 0.5 cm consistent with a lymph. node. The lymph node is bisected and entirely submitted in a single cassette. B. The second container B is labeled. #2. The specimen consists of a brown tan tissue that on sectioning reveals three possible lymph. nodes measuring from 0.9 to 1.5 cm. The lymph nodes are entirely submitted in a single cassette. C. The third container C is labeled. 13. The specimen consists of five brown tan nodules consistent with lymph nodes, 0.5 to 2.5 cm in. greatest dimension consistent with probable lymph nodes. The lymph nodes are entirely submitted in cassettes. S as follows: four probable. lymph nodes--1; one probable lymph node bisected-2. D. The fourth container D is labeled. left lower lobe. The specimen consists of a lung lobectomy specimen measuring 16.0 x 11.0 x 3.0 cm. and weighs 132 grams. The pleural surface is brown tan to gray tan anthracotic. The pleura has been inked. Sectioning reveals a circumscribed gray. tan slightly anthracotic mass measuring 3.3 x 3.0 x 2.7 cm that is within 0.1 cm of the pleural margin and 2.8 cm of the bronchial margin. There is no. stapled edge identified. The surrounding lung tissue is brown tan to red tan and spongy. There are no other lesions identified. There are no lymph. nodes noted within the peribronchial soft tissue. Recrived with the specimen are two cassettes, one green and one yellow, labeled. Representative sections are submitted in cassettes. follows: sections from the mass--1 to 4; bronchial and vascular margin--5;. representative sections from the uninvolved lung--6. E. The fifth container E is labeled. #5. The specimen consists of four brown anthracotic nodules consistent with lymph nodes measuring. from 0,5 to 2.5 cm. The lymph nodes are entirely submitted in cassettes. as follows: three probable nodes--1; one probable node bisected-. -2 and 3. F. The sixth container F is labeled. #6. The specimen consists of a brown tan portion of soft tissue measuring 3.0 x 1.0 x 0,5 cm that on. sectioning reveals three possible lymph nodes measuring from 0.5 to 1.3 cm. The lymph nodes are entirely submitted in cassettes. as. follows: one probable node bisected--1; two probable nodes--2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
P.23/33. SNOSIS: MODIFIED RADICAL MASTECTOMY -. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM SCORE 3; NUCLEAR GRADE 3, TUBULES 3, MITOSIS 3, TOTAL. SCORE 9/9. B. TUMOR SIZE 5.5 CM WITH EXTENSIVE INTRATUMORAL LYMPHOCYTIC INFILTRATION. C. TUMOR LOCATED IN THE UPPER/OUTER AND LOWER/OUTER QUADRANT. D. DUCTAL CARCINOMA IN-SITU, NUCLEAR GRADE 3, SOLID AND CRIBRIFORM WITH COMEDO NECROSIS. PRESENT ADMIXED WITH TUMOR AND ACCOUNTS FOR 25% OF TUMOR MASS. E. ANGIOLYMPHATIC INVASION IDENTIFIED. F. POSTERIOR MARGIN OF UPPER/OUTER AND LOWER/OUTER QUADRANT FREE OF TUMOR. CLOSEST. MARGIN IS POSTERIOR MARGIN WHICH IS 0.6 CM AWAY FROM THE TUMOR. G. BIOPSY SITE CHANGES. H. ESTROGEN RECEPTOR IS NEGATIVE, PROGESTERONE RECEPTOR IS NEGATIVE, HER-2/NEU IS NEGATIVE. (1+) PER CORE BIOPSY. 1. ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA (see comment). J. TEN OF TWENTY-ONE LYMPH NODES WITH METASTATIC CARCINOMA (10/21)WITH EXTRACAPSULAR. SPREAD IN ONE. K. FIBROCYSTIC CHANGES, WITH DUCTAL EPITHELIAL HYPERPLASIA AND APOCRINE METAPLASIA. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 5.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 5.5 cin. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASIÃN: CALCIFICATION: TUMOR TYPE, IN SITU: Cribriform. Solid. Comedo. DCIS admixed and outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 6 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 6 mm. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 10. LYMPH NODES EXAMINED: 21. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 28 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NOOE (IF APPLICABLE): SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH, FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pNX. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: ncgative. PROGESTERONE RECEPTORS: negative. HER2/NEU:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: with left renal mass. Specimens Submitted: 1: SP: Left kidney. DIAGNOSIS: 1). KIDNEY, LEFT, NEPHRECTOMY: RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL TYPE) NUCLEAR GRADE II/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DIAMETER IS 2.1 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE,. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. THERE IS FOCAL TUMOR NECROSIS AS WELL AS FAT NECROSIS IN PERINEPHRIC SOFT TISSUE. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled, ""Left kidney"". It consists of a 415 gram, 15.0 x 9.0 x 6.0 cm nephrectomy with. 5.0 x 0.4 cm segment of ureter and dilated proximal ureter (approximately 1.5 cm), and 1.0 cm segment of the renal vein. The. specimen is bivalved to reveal a 2.1 x 1.6 x 1.2 cm tan-yellow partially cystic, friable mass in the superior pole of the kidney. The. lesion. is. cortically based with no gross extension through the capsule. The perirenal fat is grossly adherent above the mass. The. remaining cortex is 0.5 cm and uniform. A 0,5 cm lower pole cortical cyst is present. No other lesions are grossly identified. The renal pelvis is dilated. The capsule overlying the tumor is inked black. A 1.5 cm focus of firm, tan-yellow fat and fibrous. tissue is present outside the capsule adjacent to the renal lesion. The adrenal gland is not present. A portion of the tumor is. saved for TPS and photographs are also taken. Summary of Sections: M - vascular and ureteral margins. T - tumor. NL - normal. PEL - representative renal pelvis. UR - representative ureter. PNF - perinephric fat with firm area adjacent to tumor. PF - representative pelvic fat. Summary of Sections: Part 1: SP: Left kidney. Block. Sect. Site. PCs. 1. m. 1. 1. nl. 1. 1. pel. 1. 2. pf. 2. 2. pnf. 2. 4. t. 4. 1. ur. 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. copy No. 5. Examination: Histopathological examination. Material: 1. Total organ resection - sigmoid colon. Expected time of examination: Clinical diagnosis: Tumour of the sigmoid colon tumour. Macroscopic description: A 18 cm length of the large intestine with a piece of mesentery and fat tissue sized 23 X 10.5 X 3 cm. A cauliflower-. shaped, partially ulcerous tumour sized 7.5 X 5.5 X 3 cm found in the mucosa sized 4.5 x 4 X 1.3 cm. The lesion. surrounds 100% of the intestine circumference and narrows its lumen, is located 4.4 cm from one of the incision lines. and 5.9 cm from the other one. The lesion infiltrates macroscopically the whole thickness of the intestine wall and. periintestinal tissues. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa tunicae muscularis propriae et serosae coli et telae. adiposae mesenterii pericolicae. Of note is a massive inflammatory invasion, mainly plasmocytic, in the tumour in its. surroundings. Intestine ends free of neoplastic lesions. Minimum side margin is 0.1 cm. Intestine ends free of neoplastic lesions. Metastases carcinomatosae in lymphonodis. (No III/XXXIV). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. Histopathological diagnosis: Adenocarcinoma tubulopapillare coli. Tubulopapillar adenocarcinoma of the colon. Metastases carcinomatosae in. lymphonodis. Cancer metastases in the lymph nodes. (No III/XXXIV). (p2, Dukes C, Astler-Coller C2, pT4a, pNI).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. SEE REPORT. ADDENDUM INFORMATION. PROCEDURE DATE. ADDENDUM REPORT #2; COMMENT: The panel of breast cancer markers was performed at. using material from block B/BPC3. The results are summarized in part B/BPC. line 10. I have seen the results and concur with the findings as stated. T: ADDENDUM REPORT #2: DIAGNOSIS: A/APC & C. SEE ORIGINAL DIAGNOSES. B/BPC. RIGHT BREAST MASS, EXCISTON: 1 - 9. SEE ORIGINAL DIAGNOSES. 10. ANCILLARY STUDIES: BREAST CANCER PROGNOSTIC PANEL: ASSAY RESULTS. Staining. Percent. Test Name. Intensity. Positive. Prognostic. Assay Type. Average. Average. Significance. ER. N/A. 37%. Favorable. PR. N/A. 71%. Favorable. HER-2/neu. 1.7. N/A. Normal Limit. Ki-67. N/A. 18%. Borderline. REFERENCE RANGES. Test. Favorable. Borderline. Unfavorable. ER. <5%. >5%. Her2/neu. <2.0. >2.0. Ki-67. <10%. >10% - <20%. >20%. 11. SEE ORIGINAL DIAGNOSIS. A-MALIGNANT. T: ADDENDUM REPORT #1;. ENT: An immunostain for E-cadherin utilizing material from block A is entirely. negative. This supports the light microscopic diagnosis of lobular carcinoma. ADDENDUM REPORT #1; DIAGNOSIS: PENDING BREAST CANCER PANEL STUDIES ON 8/BPC-3. A & APC. SENTINEL LYMPH NODE. RIGHT AXILLA: METASTATIC LOBULAR CARCINOMA. Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. PRESENT IN ONE LYMPH NODE ; NEGATIVE E.-CADHERIN IMMUNOSTAIN. B & BPC. RIGHT BREAST MASS. EXCISION: 1. TUMOR TYPE: INFILTRATING LOBULAR CARC1NOMA, SEE COMMENT. BELOW. 2 - 11. SEE ORIGINAL DIAGNOSES. C. SEE ORIGINAL DIAGNOSIS. COMMENT: As noted. breast cancer marker studies will be performed on B/BPC-3. A-MALIGNANT. (Electronic Signature). PROCEDURE DATE: SPECIMEN DESCRIPTION: A. RIGH AXILLARY SENTINEL LYMPH NODE, APC. B. RIGHT BREAST BIOPSY, BPC. C. AXILLARY CONTENTS. PRE-OPERATIVE - DIAGNOSIS: Right breast cancer. POST-OPERATIVE DIAGNOSIS: Same. CLINICAL INFORMATION: Invasive ductal carcinoma in retroareolar space; right breast mass. INTRAOPERATIVE CONSULTATION: APC DIAGNOSIS: ""Metastatic carcinoma, by Dr. BPC DIAGNOSIS: ""Tissue obtained for genomics, by. T: GROSS DESCRIPTION: A. Received in formalin is an irregular tan-gray nodule, measuring 2.0 X 1.6. X 0.5 cm. The specimen is bisected and entirely submitted in one cassette. APC. Received in formalin is an irregular portion of tan-gray soft tissue,. measuring 1.5 X 1.5 X 0.2 cm. The specimen is entirely submitted in one. cassette. B/BPC. Received in formalin is a portion of tan-yellow fibrofatty tissue,. measuring 6.8 cm from medial to lateral, 6.7 cm from superior to inferior. and. 4.8 cm from anterior to posterior. The specimen is orrented as follows: short. stitch - superior: long stitch - lateral. The anterior aspect is covered by. skin, measuring 5.0 X 3.0 X 0.2 cm. Centrally located on the skin surface is. the nipple, measuring 1.0 X 1.0 X 0.8 cm. The cut surface of the nipple is. tan and unremarkable. The specimen is inked as follows: superior - blue;. inferior - green; medial - red: lateral - yellow; anterior - orange: posterior. black. Sectioning from medial to lateral reveals a poorly-defined tan-gray. Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. tumor mass, measuring approximately 5.0 X 3.0 X 1.5 cm. This area is. diffusely covered with blue radiographic dye. The cut surface is firm and. gritty. The tumor mass blends into the adjacent thick fibrotic tissue. The. tumor comes to within 1.0 cm of the medial margin. 0.2 cm of the lateral. margin. 2.0 cm of the superior margin, 0.7 cm of the inferior margin. 1.5 cm. of the skin and nipple, and abuts the posterior margin. The reinaining cut. surface is composed of approximately 50% adipose tissue and 50% fibrous. tissue. A biopsy cavity or metallic clip is not found. Representative. sections are sequentially submitted, from medial to lateral. in six cassettes. as follows: cassette 1 - medial margin; cassette 2 - nipple with anterior. aspect: cassette 3 - tumor mass with closest posterior margin; cassette 4 -. tumor mass with superior margin; cassette 5 - tumor mass with inferior margin;. cassette 6 - tumor mass with lateral margin. C. Received in formalin is an irregular portion of tan-yellow fatty tissue. measuring 5 X 4 x 2 cm. Six possible lymph nodes. ranging from 0.4 X 0.3 x. 0.3 cm to 1.5 x 1.0 X 0.8 cm, are identified. The cut surface of the largest. lymph node shows foci of tan-gray discoloration. The lymph nodes are entirely. submitted in four cassettes as follows cassette 1 - one intact and one. bisected lymph node; cassette 2 - one lymph node: cassette 3 - two bisected. lymph nodes (one inked black): cassette 4 - largest lymph node. MICROSCOPIC DESCRIPTION: A & APC. One slide is examined for each portion of the case. Both slides. demonstrate extensive lymph node involvement by poorly differentiated. carcinoma. Because of the obvious nature of this finding, it will not be. necessary to perform a cytokeratin stain. B/BPC. Six slides are examined. Slide 1 show benign breast tissue without. evidence of tumor involvement. The red inked medial margin is free of. tumor. Slide 2 shows tissue from the region of the nipple. There is patchy. ductal hyperplasia and no evidence of Paget's disease is evident. Slide 3. shows extensive infiltrating carcinoma with a pattern most suggestive of. lobular carcinoma with periductal targetoid-lik areas and numerous foci of. ""Indian file"" arrangement. On this slide, tumor is present approximately 0.1. mm to the black inked posterior surface. The tumor shows no evidence of. tubular formation (tubules = 3). Nuclei exhibit occasional prominent nucleoli. and these seem to be multiple in some scattered foci. In the most mitotically. active areas of tumor, approximately eighteen to nineteen mitoses are present. within ten high power field (mitoses = 2). The Nottingham score of this. lesion is therefore 7 (3+3+2). making this a grade II lesion. Slide 4 shows. no evidence of malignancy. Slide 5 shows infiltrating carcinoma with a clear. inferior green inked margin. Changes consistent with a prior biopsy site dre. also present. No tumor is seen on slide 6. C. Four slides are examined. These show six lymph nodes. Positive lymph. Not for Permanent Slorage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. nodes are present on C1 and C3 for a total of two positive Tymph nodes out of. six. Including the sentinel Tymph node in part A/APC, a total of three out of. seven lymph nodes are positive for metastatic carcinoma. FINAL DIAGNOSIS: (PRELIMINARY - PENDING BREAST CANCER PANEL STUDIES TO BE PERFORMED ON. B/BPC-3). A & APC. SENTINEL LYMPH NODE, RIGHT AXILLA: METASTATIC CARCINOMA PRESENT IN. ONE LYMPH NODE (1/1). B/BPC. RIGHT BREAST MASS. EXCISION: 1. TUMOR TYPE: INFILTRATING CARCINOMA MOST LIKELY LOBULAR<"". CARCINOMA, SEL COMMENT BELOW. 2. NOTTINGHAM PROGNOSTIC INDEX: 7 (3+2+2). GRADE II. 3. MAXIMUM INVASIVE TUMOR SIZE: GROSSLY ESTIMATED AT. APPROXIMATELY 5 CM (pT2). 4. PERCENT DCIS: ZERO. 5. LVI: NOT IDENTIFIED. 6. DISTANCE TO CLOSEST MARGIN: APPROXIMATELY 0.1 MM TO POSTERIOR. INKED MARGIN (B/BPC-3 SLIDE). 7. MICROCALCIFICATIONS: NOT IDENTIFIED. 8. LYMPH NODES: SEE PART C BELOW. 9. TNM STATUS: pT2,N1.MX. 10. ANCILLARY STUDIES: TO FOLLOW ON BLOCK B/BPC-3. 11. OTHER FINDINGS: SEE REPORI. PROCEDURE DATE. =====. FINAL DIAGNOSIS: CHANGES CONSISTENT WITH PRIOR BIOPSY. FOCAL FIBROCYSTIC CHANGES OF REMAINING BREAST PARENCHYMA. C. AXILLARY CONTENTS. RIGHT: METASTATIC CARCINOMA IDENTIFIED IN TWO OF. SIX AXILLARY LYMPH NODES. TOTAL 3/7 INCLUDING SENTINEL LYMPH NODE. AS. ABOVE. COMMENT: As noted. breast cancer marker studies will be performed on B/BPC-3;. in addition to confirm the lobular nature of this tumor, I will order an. E-Cadherin immunostain on block A. A-MALIGNANT. DATE AND TIME OF REPORT:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Operative Procedure: Bilateral neck dissection, mandible resection. A: Right perifacial lymph node. B: Level 1A neck dissection. C: Right mental nerve. D: Right masseter margin. E: Right buccal fat pad margin. F: Right distal lingual nerve. G: Right hammulus. H: Right proximal lingual nerve. I: Deep soft palate margin. J: Right composite mandible resection. K: Additional right lateral pterygoid. L: Right lateral pterygoid margin. M: Additional right medial pterygoid. N: Right parapharyngeal fat margin. O: Right medial pterygoid margin. P: Floor of mouth. Q: Right tongue base. R: Right hard palate. S: Right soft palate. T: Right lateral pharyngeal wall. U: Right buccal. V: Right neck dissection 2-4. W: Right proximal mandible margin. X: Right distal mandible margin. Final Pathologic Diagnosis: Mandible composite, right, mandibulectomy: Keratinizing squamous cell. carcinoma, moderately differentiated. Histologic type/grade: Keratinizing squamous cell carcinoma,. moderately differentiated. Tumor size: 5.4 cm (greatest dimension). Depth of invasion: 2.9 cm (greatest dimension). Lymph-vascular invasion: Identified. Perineural invasion: Identified. Tumor site: Right retromolar trigone. Tumor focality: Unifocal. Margins: Margins involved by invasive carcinoma. Specify margin, per orientation: Proximal (posterior) bone margin positive on permanent sections. Margins involved by moderate epithelial dysplasia. Specify margin, per orientation: Right hard and soft palate, right lateral pharyngeal wall. Lymph nodes, extranodal extension: Metastatic squamous cell carcinoma. (2/40 positive, maximal dimension 2.0 cm, extranodal extension identified). Pathologic staging (pTNM): TNM descriptors: None. Primary tumor: pT4a. Regional lymph nodes: pN2b. Number examined: 40. Number involved: 2 (size of the largest positive lymph node: 2.0 cm). Distant metastasis: pMX. Additional pathologic findings: None. Specimen: Right mandible. In formalin. Procedure: Mandibulectomy, right. Specimen size: 9.0 X 8.5 X 6.1 cm. Specimen laterality: Right. A. Lymph node, right perifacial, resection: Three lymph nodes, negative for malignancy (0/3). B. Lymph node, 1A, neck dissection: One lymph node, negative for malignancy (0/1). C. Nerve, right mental, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. D. Masseter, right, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. E. Buccal fat pad, right, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. F. Nerve, right distal lingual, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. G. Hamulus, right, excision: Negative for malignancy. H. Nerve, right proximal lingual, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. I. Soft palate, deep margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. J. Mandible, right, resection. Squamous cell carcinoma -- see synoptic report above. Five benign lymph nodes (0/5). K. Lateral pterygoid, additional right, biopsy: Negative for malignancy. L. Lateral pterygoid, right margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. M. Medial pterygoid, additional right, biopsy: Negative for malignancy. N. Parapharyngeal fat, right margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. O. Medial pterygoid, right margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. P. Mouth, floor, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. Q. Tongue, right base, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. R. Hard palate, right, biopsy: Moderate epithelial dysplasia, negative for invasion. Frozen section diagnosis confirmed. S. Soft palate, right, biopsy: Moderate epithelial dysplasia, negative for invasion. Frozen section diagnosis confirmed. T. Pharyngeal wall, right lateral, biopsy: Moderate epithelial dysplasia, negative for invasion. Frozen section diagnosis confirmed. U. Right buccal biopsy: Negative for malignancy. Frozen section diagnosis confirmed. V. Lymph node, right, neck dissection, 2-4: Metastatic squamous cell carcinoma (2/30 lymph nodes involved, maximal. dimension 2.0 cm, extranodal extension present). W. Mandible, right proximal margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. X. Mandible, right distal margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSC: Right mental nerve: No tumor in sections examined. FSD: Right masseter margin: No tumor in sections examined. FSE: Right buccal fat margin: No tumor in sections examined. F/S TAT: 20 mins. FSF: Right distal lingual nerve: No tumor in sections examined. FSH: Right proximal lingual nerve: No tumor in sections examined. FSI: Deep soft palate margin: No tumor in sections examined. FSL: Right lateral pterygoid margin: No tumor in sections examined. FSN: Right parapharyngeal fat margin: No tumor in sections examined. F/S TAT: 30 mins. FSO: Right medial pterygoid margin: No tumor in sections examined. FSP: Floor of mouth: No tumor in sections examined. FSQ: Right tongue base: No tumor in sections examined. FSR: Right hard palate: No tumor in sections examined. FSS: Right soft palate: No tumor in sections examined. F/S TAT: 50 mins. FST: Right lateral pharyngeal wall: Focal squamous dysplasia-favor low grade. FSU: Right buccal: No tumor in sections examined. F/S TAT: 50 mins. FSW: Right proximal mandible margin: No tumor in sections examined. FSX: Right distal mandible margin: No tumor in sections examined. F/S TAT: 10 mins. Gross Description: A. Received in formalin, labeled ""right perifacial lymph. nodes"" are two tan-pink, irregular, lobulated soft tissues, 0.8 X 0.3 X 0.2 cm. and 2.3 X 0.9 X 0.2 cm, submitted in toto in one cassette. B. Received in formalin, labeled ""level 1A neck dissection"". is a 3.9 X 3.0 X 0.8 cm tan, lobulated irregular fatty tissue. A submandibular. gland is not present. Sectioning reveals two tan-pink, rubbery possible lymph. nodes, 0.2 cm and 0.4 cm. Representative sections are submitted as follows: B1. one whole lymph node bisected;. B2. one whole possible lymph node. C. Received without fixative labeled ""right mental nerve"" is. a. 0.4 X 0.3 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen. section microscopy, now in cassette C. D. Received without fixative labeled ""right masseter margin"". is a 1.8 X 0.7 X 0.4 cm tan, irregular soft tissue. A representative section is. submitted for frozen section microscopy, now in cassette D1. The remaining. tissue is entirely submitted in cassette D2. E. Received without fixative labeled ""right buccal fat pad. margin"" is a 3.0 X 2.2 X 0.9 cm aggregate of tan, lobulated irregular fatty. tissue. Representative sections are submitted for frozen section microscopy, now. in cassette E1. Representative sections of the remaining tissue are submitted in. cassette E2. F. Received without fixative labeled ""right distal lingual. nerve"" are three tan, irregular soft tissues, ranging from 0.3 X 0.1 X 0.1 cm to. 0.5 X 0.4 X 0.1 cm, submitted in toto for frozen section microscopy, now in. cassette F. G. Received in formalin, labeled ""right hamulus"" is a 1.4 X. 1.4 X 0.3 cm aggregate of tan, irregular soft tissue admixed with scant bone,. submitted in toto in one cassette following decalcification. H. Received without fixative labeled ""right proximal lingual. nerve"" are four tan, irregular soft tissues, ranging from 0.3 X 0.1 X 0.1 cm to. 0.9 X 0.5 X 0.1 cm, submitted in toto for frozen section microscopy, now in. cassette H. I. Received without fixative labeled ""deep soft palate. margin"" is a 0.9 X 0.4 X 0.2 cm tan, irregular soft tissue, submitted in toto. for frozen section microscopy, now in cassette I. J. Received in formalin, labeled ""right composite mandible. resection including right level 1B dissection"" is a 9.0 X 8.5 X 6.1 cm composite. resection, which consists of a 6.9 X 6.1 X 1.3 cm partial right posterior. mandible, 3.5 X 2.4 X 2.4 cm right partial base of tongue (double suture), 2.0 X. 1.2 X 0.9 cm apparent right tonsil, 3.9 X 3.1 X 1.8 cm right submandibular. gland, minimal adherent soft palate (single suture) and associated soft tissues. Involving the retromolar trigone is a 5.4 X 4.2 cm tan-pink, irregular well. delineated ulcerated mass, which comes to within 0.5 cm from the nearest/soft. palate mucosal edge, 0.5 cm from the anterior mucosal edge and 0.6 cm from the. nearest tongue mucosal edge. This mass on sectioning is tan, firm, heterogeneous. with a total thickness of 2.9 cm, abutting the lateral soft tissue edge and. coming to within 1.2 cm from the posterior inked soft tissue edge. The mass. appears to involve the tonsil with no definite extension into the submandibular. gland. There is focal apparent bony involvement. The uninvolved mucosa is. tan-pink and smooth. The uninvolved tonsil on sectioning is tan and homogeneous. The uninvolved submandibular gland is tan and lobulated. A few tan-pink, rubbery. lymph nodes are identified adjacent to the submandibular gland, up to 1.9 cm. Representative sections are submitted as follows: J1. anterior mandibular margin taken en face, submitted following. decalcification;. J2. posterior mandibular margin taken en face, submitted following. decalcification;. J3. mass to nearest/posterior palate mucosal edge;. J4. mass to base of tongue mucosal edge;. J5. mass to tonsil;. J6. mass to lateral soft tissue edge;. J7. mass to posterior soft tissue edge;. J8. mass to mandible, submitted following decalcification;. J9. mass to submandibular gland;. J10. whole possible lymph nodes adjacent to submandibular gland;. J11. representative section from one lymph node adjacent to. submandibular gland. K. Received in formalin, labeled ""additional right lateral. pterygoid"" is a 2.6 X 2.0 X 1.3 cm tan, irregular ragged soft tissue. Representative sections are submitted in one cassette. L. Received without fixative labeled ""right lateral. pterygoid margin"" is a 1.4 X 1.4 X 0.2 cm tan, irregular soft tissue, submitted. in toto for frozen section microscopy, now in cassette L. M. Received in formalin, labeled ""additional right medial. pterygoid"" are three tan, irregular soft tissues, ranging from 0.3 X 0.2 X 0.2. cm to 1.5 X 0.9 X 0.4 cm. The specimens are step sectioned and entirely. submitted in one cassette. N. Received without fixative labeled ""right parapharyngeal. fat margin"" is a 1.6 X 1.3 X 0.2 cm tan, irregular soft tissue, submitted in. toto for frozen section microscopy, now in cassette N. O. Received without fixative labeled ""right medial pterygoid. margin"" is a 1.8 X 1.3 X 0.3 cm tan, irregular soft tissue, submitted in toto. for frozen section microscopy, now in cassette O. P. Received without fixative labeled ""floor of mouth"" is a. 2.4 X 0.5 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen. section microscopy, now in cassette P. Q. Received without fixative labeled ""right tongue base"" are. two tan, irregular soft tissues, 2.5 X 0.6 X 0.2 cm and 3.0 X 0.6 X 0.2 cm,. submitted in toto for frozen section microscopy, now in cassette Q. R. Received without fixative labeled ""right hard palate"" is. a. 1.3 X 0.3 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen. section microscopy, now in cassette R. S. Received without fixative labeled ""right soft palate"" are. three tan, irregular soft tissues ranging from 0.7 X 0.7 X 0.2 cm to 2.3 X 0.3 X. 0.2 cm, submitted in toto for frozen section microscopy, now in cassette S. T. Received without fixative labeled ""right lateral. pharyngeal wall"" are two tan, irregular soft tissues, 0.9 X 0.5 X 0.2 cm and 1.3. X 0.5 X 0.2 cm, submitted in toto for frozen section microscopy, now in cassette. T. U. Received without fixative labeled ""right buccal"" is a 3.8. X 0.5 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen section. microscopy, now in cassette U. V. Received in formalin, labeled ""right neck dissection. level 2-4"" is a 12.8 X 4.7 X 3.5 cm tan, lobulated irregular soft tissue with. attached single suture designating level 2 and double suture designating level. 4. The specimen is divided into levels 2-4. Sectioning reveals multiple. tan-pink, rubbery to firm lymph nodes up to 3.1 cm. Representative sections are submitted as follows: V1. multiple whole lymph nodes, level 2;. V2. representative section from one lymph node, level 2;. V3. representative section from one lymph node, level 2;. V4. multiple whole lymph nodes, level 3;. V5. one whole lymph node bisected, level 3;. V6. whole possible lymph nodes, level 3;. V7. whole possible lymph nodes, level 3;. V8. one whole lymph node bisected, level 4;. V9-10 whole possible lymph nodes, level 4. W. Received without fixative labeled ""right proximal. mandible margin"" is a 0.3 X 0.3 X 0.2 cm tan, irregular soft tissue with minimal. bone. The soft tissue is submitted for frozen section microscopy, now in. cassette W. The remaining tissue is entirely submitted in cassette 2 following. decalcification. X. Received without fixative labeled ""right distal mandible. margin"" is a 0.3 X 0.2 x 0.2 cm tan, irregular soft tissue with minimal bone. Representative sections of the soft tissue are submitted for frozen section. microscopy, now in cassette X1. The remaining tissue is entirely submitted in. cassette X2 following decalcification. Microscopic Description: H&E stained sections of tumor reveal islands and cords of cells with squamous. differentiation. Multiple areas of keratin pearls are identified throughout the. specimen. Please see final diagnosis for further description.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: 1. F/S LUNG, RIGHT UPPER LOBECTOMY. 2. STATION 10 LYMPH NODE, RIGHT. 3. STATION 11 LYMPH NODE, RIGHT. 4. STATION 4 LYMPH NODE, RIGHT. 5. STATION 7 LYMPH NODE, RIGHT. SEE ADDENDUM. Reason For Addendum #1: Special Stains Results. DIAGNOSIS: 1. LUNG, RIGHT UPPER LOBE: LOBECTOMY. - INVASIVE SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED (SEE. SUMMARY). - ONE OF FOUR PERIBRONCHIAL/HILAR LYMPH NODES IS POSITIVE FOR. CARCINOMA BY DIRECT EXTENSION (1/4). Comment: The carcinoma cells are diffusely positive for P63, CK5/6,. and negative for TTE-Lar CK7. The findings are confirmatory for. the histologic diagnosis of invasive squamous cell carcinoma. 2. LYMPH NODE, STATION #10: EXCISION. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA, (0/1). 3. LYMPH NODE, STATION #11: EXCISION. FOUR LYMPH NODES, NEGATIVE FOR CARCINOMA (0/4). 4. LYMPH-NODE, STATION #4:EXCISION. THREE LYMPH NODES, NEGATIVE FOR CARCINOMA, (0/3). 5. LYMPH NODE, STATION #7: EXCISION. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA, (0/2). Specimens: 1: F/S LUNG, RIGHT UPPER LOBECTOMY. 2: STATION 10 LYMPH NODE, RIGHT. 3: STATION 11 LYMPH NODE, RIGHT. 4: STATION 4 LYMPH NODE, RIGHT. 5: STATION 7 LYMPH NODE, RIGHT. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). Right Upper Lobe. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Upper lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 3.7cm. Additional Dimension (cm): 3cm x 3cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Bronchial Margin Involvement by Squamous Cell Carcinoma in situ. (CIS): Squamous cell carcinoma in situ (CIS) not identified at bronchial. margin. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Uninvolved by invasive carcinoma. Parietal Pleural Margin: Uninvolved by invasive carcinoma. Chest Wall Margin: Not applicable. ACCESSORY FINDINGS. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. Comment(s): venous invasion. STAGE (pTNM). TNM Descriptors: Not applicable. Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest. dimension surrounded by lung or visceral pleura without. bronchoscopic evidence of invasion more proximal than the lobar. bronchus (i.e., not in the main bronchus); or Tumor 5 cm or less. in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades. the visceral pleura; associated with atelectasis or obstructive. pneumonitis that extends to the hilar region but does not inolve the. entire lung. Regional Lymph Nodes (pN). pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral. hilar lymph nodes, and intrapulmonary nodes including involvement. by direct extension. Number Examined. 14. Number Involved. 1. Lymph node(s) involved, (specify involved nodal station(s)). Peribronchial/hilar. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Hyalinized nodule. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: Lung mass. MACROSCOPIC DESCRIPTION: The specimen is received in five parts, each labeled with the. patient's name. 1. Part one is received fresh, labeled 'right lobectomy, r/o. carcinoma'. It consists of a right upper lobe of the lung measuring. 18 x 17 x 5 cm. The stapled line measures 11 cm and 7 cm in length. The bronchial margin measures 2 cm and the vascular margin measures. 1. cm at the hilar area. The pleura is gray pink glistening and. heavily mottled with fine black streaks. There is a surgical cut. overlying a tumor mass. The serial sectioning reveals a gray white. firm tumor with ill-defined borders measuring 3.7 x 3 x 3 cm,. located 1 cm from the overlying pleura and 1.5 cm from the bronchial. resection margin. The mass grossly surrounds the bronchus and. vascular structure at the hilum. Also noted a pink nodular area. measuring 1.5 cm, located at the upper pole of the lung on the. pleural surface. The remainder of the parenchyma is pink red blotchy. and emphysematous. Representative sections are submitted. 2. Part two is received in saline, labeled 'station #10 lymph node'. It consists of one anthracotic lymph node measuring 1.2 x 1 x 0.5. cm. Entirely submitted in one cassette. 3. Part three is received in saline, labeled 'station #11 lymph. node'. It consists of four anthracotic lymph nodes, ranging from. 0.5 cm to 1 cm in greatest dimension. Entirely submitted in one. cassette. 4. Part four is received in saline, labeled 'station #4 lymph node'. It consists of three anthracotic lymph nodes, measuring from 0.7 cm. up to 1 cm in greatest dimension. Entirely submitted in one. cassette. 5. Part five is received in saline, labeled 'station #7 lymph node'. It consists of two anthracotic lymph nodes, measuring from 0.5 cm up. to 0.7 cm in greatest dimension. Entirely submitted in one cassette. SUMMARY OF SECTIONS: 1A frozen section of tumor. 1B-1C bronchial and vascular margins. 1D-1E tumor bisected. 1F-1G tumor, bisected. 1H-1I overlying pleura. 1J tumor and adjacent bronchus. 1K tumor and adjacent blood vessel. 1L stapled line margin. 1M nodular area from upper pole of the lung. 1N random section of lung parenchyma. 2A entirely submitted. 3A entirely submitted. 4A entirely submitted. 5A entirely submitted. SPECIAL PROCEDURES: CK7, CK5/6, TTF-1, P63 (1F). Elastic stain (1J). INTRA - OPERATIVE CONSULTATION: 1. Lung, right upper lobe: lobectomy (FS & TP). - Invasive squamous cell carcinoma. repeat-back provided by. Intra-Operative Consultation #1 performed by. Final Diagnosis performed by. ADDENDUM 1: Special stain (Elastic) is confirmatory for venous invasion. Addendum #1 performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMEN (s) RECEIVED. 1. Pleura: PLEURAL DISEASE - APICAL SEGMENT RIGHT LOWER LOBE. 2. Lymph node : Interlobar ST11. 3. Lung Both bronchial Margin Rt Upper Lobe. Single suture on tracheal. margin, Double suture on Bronchial Margin. 4. Lymph node : Rt low Paratracheal ST4R. Lymph node : Rt TB angle ST1OR. U. Lymph node : Interlobar ST11. 7. Lymph node : Subcarinal ST7. DIAGNOSIS. 1. Apical segment right lower lobe wedgÃ© biopsy: Subpleural fibrosis and chronic inflammation, negative for malignancy. 2. Interlobar ST11: Negative for tumor, lymph node. 3 . Right upper lobe lung lobectomy with sleeve resection: poorly differentiated squamous cell carcinoma, central, 4.7 cm in. greatest diameter. (pT2). - Peri-tumoral chronic interstitial pneumonia and mucous plugging,. consistent with obstructive pneumonitis. Tumor extensively infiltrates the peribronchial lymph nodes. (See. comment). Bronchial resection margin negative for tumor. - Tracheal resection margin negative for tumor. Remaining lung parenchyma shows moderate to marked centroacinar. emphysematous changes. 4. Right low paratracheal ST4R: Positive for metastatic squamous cell carcinoma. (pN2). Right TB angle ST10R: Positive for metastatic squamous cell carcinoma. Page: 1 of 4. 6. Interlobar ST11: Positive for metastatic squamous cell carcinoma in 1 of 3 lymph nodes. 7. Subcarinal ST7: - Negative for tumor. COMMENT. The peribronchial tissue circumference was painted with Indian ink, and. e bronchus was serially cross-sectioned. One of the sections shows. -ymph node infiltrated by tumor, which also extends to the painted radial. margin of this lymph node. The significance of this finding should be. interpreted in the context of surgical procedure performed. CLINICAL HISTORY. LUNG CANCER. GROSS DESCRIPTION. 1. The specimen container labeled with the patient S name and as ""apical. segment right lower lobe"", contains fragments of tan hemorrhagic tissue. measuring 3.0 x 1.5 x 0.3 cm received fresh. This is examined at. intraoperative consultation by frozen section performed on part of the. specimen. On sectioning there is a white circular lesion in the center. measuring 0.5 x 0.3 cm. The specimen is submitted in toto as follows. 1A - frozen section representative section resubmitted. 1B-1C - remainder of the specimen submitted in toto. 2. The specimen container labeled with the patient' S name and as. ""interlobar ST11"", contains a piece of greyish-brown node measuring 0.6 x. 0.4 x 0. cm received in 10% buffered formalin. 2A - specimen bisected and submitted in toto. The specimen container labeled with the patient' S name and as 11 both. :onchial margin right upper lobe, single suture on tracheal margin,. double suture on bronchial margin"", contains a lobe of lung received. Page: 2 of 4. fresh. This is examined at intraoperative consultation by frozen section. performed on part of the specimen. The lobe of lung measures 14.0 x 10.5. x 6.7 cm. On the hilar area there are two tubular cartilaginous tissue. noted both marked with stitch, one double stitch marking as bronchial. margin and one single stitch marking as the tracheal margin. The. tracheal margin measures 1.5 cm in diameter while the bronchial margin. measures 1. cm in diameter. Surrounding this bronchial and tracheal. area is an area of soft tissue, which is firm and is grey-tan in color. The peripheries of these peri-bronchial and tracheal margins are painted. with India ink. The pleural surface generally is smooth, shiny except. for an area measuring 3.0 x 2.0 cm. This area has some fibrous adhesions. the pleura. On further sectioning underneath this puckered area is a. .11-defined tumor mass measuring 4. 7 x 2.5 x 2.5 cm. The cut surface of. the tumor mass is grey-tan to tan-white in color. On further sectioning. about 1. 8 cm to this tumor is an area of firmness, yellowish-brown to. grey in color or areas of consolidation noted measuring about 2. x 2. 0. cm. The tumor is partly solid and some necrotic areas. The remainder of. the lung tissue appears to be grossly unremarkable with no other discrete. lesion noted. Two pieces of tumor, one piece of bronchial mucosa and one. piece of normal lung tissue were taken for snap freezing. Sections are. submitted as follows: 3A - frozen section, bronchial margin resubmitted. 3B - frozen section tracheal margin resubmitted. (Tracheal margin broke after resection from major specimen). 3C - frozen section tracheal margin representative deeper section from. site of break resubmitted. 3D-3M - bronchial area (bronchus, tracheal) serially sectioned. circumferentially in relation to tumor. 3N-3p - representative section of tumor in relation to the pleura with. fibrous adhesion. 3Q-3R - representative sections of the tumor in relation to normal tissue. 3S -3V - representative sections of adjacent area of the tumor area of. consolidation. 3W - -3X - representative sections of normal lung tissue away from the. tumor. 4. The specimen container labeled with the patient S name and as "" right. ow paratracheal ST4LR"", contains a piece of black-tan node measuring 1.0. 0. 6 x 0.3 cm received in 10% buffered formalin. 4A - submitted in toto. Page: 3 of 4. 5. The specimen container labeled with the patient S name and as II right. TB angle ST10R"", contains a piece of grey-tar node measuring 1.4 x 0.8 x. 0. 6 cm received in 10% buffered formalin. 5A - specimen bisected and submitted in toto. 6. The specimen container labeled with the patient S name and as. ""interlobar ST11"", contains two pieces of greyish-tan nodes measuring 0.9. x 0.6 x 0.5 cm and 1.2 x 0.6 x 0.4 cm received in 10% buffered formalin. 6A - submitted in toto. The specimen container labeled with the patient' S name and as. ""subcarinal ST7"", contains a piece of greyish-brown soft tissue measuring. 1.6 x 1.0 x 0.7 cm received in 10% buffered formalin. 7A - submitted in toto. QUICK SECTION. 1A ""Inflammatory changes identified no malignancy. "". 3A "" Bronchial margin negative for malignancy "". 3B,3C "" Tracheal margin negative for malignancy"". Page: 4 of 4.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
Report Type. Date of Event. Authored by. Hosp/Group. Record Status. FINAL DIAGNOSIS: PART 1: FLOOR OF MOUTH, ANTERIOR, BIOPSY. INVASIVE SQUAMOUS CELL CARCINOMA. PART 2: LYMPH NODES, LEFT LEVEL 1, SELECTIVE DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA IN ONE OF SEVEN LYMPH NODES,. LEVEL 1B (0.3 CM) (1/7). B. NO EXTRACAPSULAR SPREAD. C. SUBMANDIBULAR GLAND WITH CHRONIC SIALADENITIS AND ATROPHY. PART 3: LYMPH NODES, RIGHT LEVEL 1, SELECTIVE DISSECTION. A. FOUR LYMPH NODES, NO TUMOR PRESENT (0/4). B. SUBMANDIBULAR GLAND WITH CHRONIC SIALADENITIS AND ATROPHY. PART 4: TONGUE, FLOOR OF MOUTH AND MANDIBLE, ANTERIOR COMPOSITE RESECTION WITH. MARGINAL MANDIBULECTOMY. A. INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED (3.8. CM) (see comment). B. PERINEURAL INVASION PRESENT. C. MARGINS ARE FREE (SEE ALSO PART 7). D. PATHOLOGIC STAGE: pT2 N1. E. SUBLINGUAL GLAND WITH CHRONIC SIALADENITIS. PART 5: LYMPH NODES, LEFT, LEVEL 2-4, SELECTIVE DISSECTION. A. THIRTY-ONE LYMPH NODES, NO TUMOR PRESENT (0/31). B. UNREMARKABLE PAROTID TISSUE. PART 6: LYMPH NODES, RIGHT, LEVEL 2-4, SELECTIVE DISSECTION. TWENTY-SIX LYMPH NODES, NO TUMOR PRESENT (0/26). PART 7: TONGUE, RIGHT ANTERIOR MARGIN, BIOPSY. KERATOSIS, NO TUMOR PRESENT. COMMENT: Ancillary studies will be performed and the results will be reported as an. addendum. My signature is attestation that I have personally reviewed the submitted. material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in 7 parts. Part 1 is received fresh labeled with the patient's name, initials XX and. ""anterior floor of mouth"". Received are multiple, irregular, soft, tan,. tissue biopsies ranging from 0.4 to 1.0 cm in greatest dimension. A frozen. section is performed with an intraoperative diagnosis completed. The specimen. is entirely submitted for processing in a cassette labeled 1A FS. Part 2 is received fresh labeled with the patient's name, initials XX and. ""left neck dissection level I"". Received is an irregular portion of yellow. lobulated adipose tissue consistent with a neck dissection, 7.5 X 5 X 1.5 cm. The specimen is subdivided into two equal parts. Segment one (Level 1B) has 6. possible lymph nodes identified ranging in size from 0.2 to 1.5 cm with a. salivary gland, 3.8 X 2.4 x 1.6 cm and a separate portion of similar glandular. tissue, 1.8 X 1.5 X 1.5 cm. The salivary gland on cut section has a light tan,. lobulated cut surface, without tumor. The larger lymph nodes are hemorrhagic. on cut section. Digital images of the glandular tissue are taken. Segment two. has two recognizable lymph nodes measuring 0.8 and 0.7 cm in greatest. dimension. The smaller lymph node appears suspicious. The lymph nodes and. submandibular gland are submitted in the following cassettes. Section code: Segment one. 2A - two smallest possible lymph nodes. 2B - 2E - bisected possible lymph nodes. 2F - bisected smaller glandular tissue. 2G - 2H - representative sections (90% submitted) of salivary gland. Segment two. 2I - single possible lymph node. 2J - single bisected possible lymph node. Part 3 is received fresh labeled with the patient's name, initials XX and. ""right neck dissection level I"". Received is an irregular portion of yellow. lobulated adipose tissue consistent with a neck dissection, 6.5 X 3.5 X 1.5. cm. The specimen is subdivided into two equal parts. No lymph nodes are. identified within segment one, however, a salivary gland, 4.2 X 2 X 1.6 cm, is. identified. The salivary gland on cut section has a light tan, lobulated cut. surface, without tumor. Digital images of the glandular tissue are taken. Segment two (Level 1A?) has 4 possible lymph nodes identified ranging in size. from 0.3 to 1.3 cm The largest lymph node is hemorrhagic on cut section. The. lymph nodes and salivary gland are submitted in the following cassettes. Section code: Segment one. 3A - 3B - representative sections (80% submitted) of salivary gland. Segment two. 3C - bisected lymph node. 3D - 3 possible lymph nodes. Part 4 is received fresh labeled with the patient's name, initials XX and. ""anterior composite"". Received is an anterior composite resection measuring 7. X. 4.5 X 3.5 cm and consisting of anterior tongue, 4 X 6x 2 cm, a marginal. anterior mandibulectomy, 6 X 1.1 x 1 cm, and floor of mouth soft tissue. including lacerated sublingual glands, overall, 3.5 X 2.5 X 1.1 cm. A poorly. circumscribed, firm, left and midline tumor 3.8 X 3.2 X 2.7 cm, involves the. inferior tongue and floor of mouth. It extends to within 0.7 cm of the. gingival/mandibular resection margin, and 0.8 cm from the deep tongue. resection margin. The tumor is approximately 1 cm from the mandibular. horizontal resection margin, approximately 0.7 cm from the left mandibular. resection margin and 0.6 cm from the right mandibular resection margin. Tumor. involves the alveolar ridge and possibly the mandibular cortical bone. Bone. resection margins appear free of tumor. No teeth are present. The sublingual. glands appear grossly unremarkable. Three frozen sections are performed with. intraoperative diagnoses completed. Digital images are taken. The specimen. is representatively submitted. Additional studies: Digital images are taken. Tissue is banked (normal and tumor). Ink code: Black - deep tongue resection margin. Blue - right shaved marginal mandibular resection margin. Green - left shaved marginal mandibular resection margin. Yellow - inferior marginal mandibular resection margin. Section code: 4AFS - left posterior floor of mouth shave resection margin. 4BFS - anterior left gingival shave resection margin. 4CFS - right posterior floor mouth shave resection margin. 4DDR - right marginal mandibular resection margin. 4EDR - left marginal mandibular resection margin. 4FDR - inferior marginal mandibular resection margin. 4GDR - left alveolar ridge. 4H - left lateral tongue/tumor. 4I - right lateral tongue/tumor/deep tongue resection margin. 4J - 4M - full sagittal section of anterior composite (4J - posterior. tongue/margin, 4K - anterior tongue, 4L - posterior/inferior. tongue/margin, 4MDR - anterior floor of mouth/inferior mandible resection. margin). 4N - left anterior floor of mouth. 40 - right anterior floor of mouth. Part 5 is received fresh labeled with the patient's name, initials XX and. ""left neck level 2, 3, and 4, suture level 2A"". Received is an irregular. oriented 12.7 x 8 x 1.6 cm left neck dissection consisting of lymph node. levels 2A through 4. Specimen is oriented by a suture- 2A. The following. lymph nodes were identified: Level 2A - 18 possible lymph nodes are notified and ranging in size from 0.1. to 1.6 cm in greatest dimension. Level 2B - 6 possible lymph nodes are identified and ranging in size from 0.3. to 2.6 cm in greatest dimension. Level 3 - 8 possible lymph nodes are identified and ranging. in size from 0.1 to 1.4 in greatest dimension. Level 4 - 2 possible lymph nodes are identified measuring. 0.5 and 1 cm in greatest dimension. Lymph nodes are entirely submitted in cassettes labeled: 5A - level 2A - 2 largest lymph nodes. 5B - level 2A - 8 possible lymph nodes. 5C - level 2A - 8 possible lymph nodes. 5D - level 2A - single minute possible lymph node. 5E - Level 2B - bisected largest lymph node. 5F - level 2B - bisected lymph node. 5G - level 2B - 3 remaining possible lymph nodes. 5H - level 3 - bisected largest lymph node. 5I - level 3 - 7 possible lymph nodes. 5J - level 4 - 2 possible lymph nodes. 5K - level 4 - remaining soft tissue for possible additional lymph nodes. Part 6 is received fresh labeled with the patient's name, initials XX and. ""right neck dissection 2, 3, and 4, suture level II"". Received is an. irregular oriented 10 X 7.5 X 1.5 cm right neck dissection consisting of lymph. node levels 2 through 4. A portion of vein is identified, 3 cm in length and. 0.8 cm in diameter. Also received is a single separate portion of yellow. lobulated adipose tissue, 2 X 1.8 X 0.8 cm. Specimen is oriented by a suture-. zone II. The following lymph nodes were identified: Level 2 - 11 possible lymph nodes are notified and ranging. in size from 0.1 to 1.7 cm in greatest dimension. Level 3 9 possible lymph nodes are identified and ranging. in size from 0.3 to 1.3 in greatest dimension. Level 4 - 8 possible lymph nodes are identified measuring. 0.3 and 1.9 cm in greatest dimension. Separate tissue - single possible minute lymph node, 0.2 cm. in. greatest dimension. Lymph nodes are entirely submitted in cassettes labeled: 6A - Level 2 - bisected largest lymph node. 6B - Level 2 - 5 possible lymph nodes. 6C - Level 2 - 5 possible lymph nodes. 6D - Level 3 - 3 largest lymph nodes. 6E - Level 3 - 3 lymph nodes. 6F - Level 3 - 3 possible lymph nodes. 6G - Level 4 - bisected largest lymph node. 6H - Level 4 - 3 possible lymph nodes. 6I - Level 4 - 4 possible lymph nodes. 6J - Separate tissue - single minute possible lymph node. Part 7 is received fresh labeled with the patient's name, initials XX and. ""right anterior tongue margin"". Received is a single, unoriented triangular. segment of grossly unremarkable marginal tongue, 2 X 2 X 1.2 cm. The. periphery of tongue excision shows minor cauterization effects. The specimen. is representatively submitted for processing in a cassette labeled 7A - shaved. true margin. INTRAOPERATIVE CONSULTATION: 1AFS: ANTERIOR FLOOR MOUTH, BIOPSY (frozen section)-. A. SUFFICIENT FOR ANCILLARY STUDIES. B. MALIGNANT. C. INVASIVE SQUAMOUS CELL CARCINOMA. 4AFS: LEFT POSTERIOR FLOOR OF MOUTH, SHAVE MARGIN, ANTERIOR COMPOSITE (frozen. section)-. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. 4BFS: ANTERIOR LEFT GINGIVA, SHAVE MARGIN, ANTERIOR COMPOSITE (frozen. section)-. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. 4CFS: RIGHT POSTERIOR FLOOR MOUTH, SHAVE MARGIN, ANTERIOR COMPOSITE (FROZEN. SECTION)-. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. NO TUMOR SEEN. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. 3 H&E levels. were performed on block 4GDR and 4MDR. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics determined by. the. Department of Pathology, as required by the CLIA. regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue fixation. ranges from a minimum of. to a maximum of. hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (""CLIA"") as qualified to perform high-complexity clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY GLAND. TUMORS. SPECIMEN TYPE: Resection: anterior composite resection. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension: 3.8 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PRIMARY TUMOR (pT): pT2. REGIONAL LYMPH NODES (pN): pN1. DISTANT METASTASIS (pM): pMX. MARGINS: Margins uninvolved by tumor. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. PERINEURAL INVASION: Present. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Intraoral mass. PROCEDURE: Direct laryngoscopy, bilateral neck dissections, anterior. mandibulectomy, excision lesion floor of mouth, partial glossectomy and free. flap. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Anterior floor of mouth. Stain/cnt. Block. H&E X 1. A FS. Part 2: Left Neck Level 1. Stain/cnt. Block. H&E X 1. A. H&E x 1. B. H&E X 1. C. H&E X 1. D. H&E x 1. E. H&E x 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. I. H&E X 1. J. Part 3: Right Neck Level 1. Stain/cnt. Block. H&E x 1. A. H&E x 1. B. H&E x 1. C. H&E x 1. D. Part 4: Anterior Composite. Stain/cnt. Block. H&E X 1. H&E X 1. H&E X 1. Decal x 1. H&E X 1. H&E x 1. H&E x 1. RHHE Lev. x 1. RHHE Lev. x 1. RHHE Lev. x 1. H&E X 1. H&E Recut x. H. IEGFR X 1. H. IBNKNC X 1. H. IBNKNC x 1. H. IBNKNC x 1. H. IBNKNC x 1. H. IBNKNC x 1. H. IBNKNC x 1. H. H&E x 1. H. HPV x 1. H. P16 x 1. H. V-EGFR X 1. H. H&E x 1. I. H&E X 1. J. H&E X 1. K. H&E x 1. L. RHHE Lev. X 1. RHHE Lev. X 1. RHHE Lev. x 1. H&E x 1. H&E x 1. N. H&E x 1. O. Part 5: Left Neck Level 2-4. Stain/cnt. Block. H&E X 1. A. H&E x 1. B. H&E X 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E X 1. G. H&E X 1. H. H&E x 1. I. H&E X 1. J. H&E x 1. K. Part 6: Right Neck Level 2-4. Stain/cnt. Block. H&E x 1. A. H&E X 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E X 1. G. H&E x 1. H. H&E x 1. I. H&E x 1. J. H&E x 1. K. Part 7: Right Anterior Tongue Margin. Stain/cnt Block. H&E x 1. A.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL DIAGNOSIS: PART 1: LEFI BREAST, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM SCORE 8/9 (TUBULES 3, NUCLEI 3, MITOSIS 2), 2.6 CM. B. DUCTAL CARCINOMA IN SITU, MICROPAPILLARY AND SOLID TYPES WITH COMEDO NECROSIS, NUCLEAR. GRADE 3, REPRESENTING 5% OF THE TUMOR VOLUME. C. LYMPHOVASCULAR SPACE INVOLVEMENT SEEN. D. INVASIVE CARCINOMA IS 0.1 CM FROM INFERIOR MARGIN. E. DUCTAL CARCINOMA IN SITU IS <0.1 CM (1MM) FROM INFERIOR MARGIN. F. MARGINS FREE OF LESION. G. MICROCALCIFICATION ASSOCIATED WITH BENIGN CHANGES AND TUMOR. H. CHANGES CONSISTENT WITH BIOPSY SITE. I. PROLIFERATIVE FIBROCYSTIC CHANGES WITH ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA AND. COLUMNAR CELL CHANGES. J. MICROSCOPIC PERIPHERAL PAPILLOMA AND SCLEROSING ADENOSIS. K. SKIN NOT REMARKABLE. PART 2: LEFT AXILLA, SENTINEL LYMPH NODE #1, EXCISION -. A. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (0.9 CM). B. NO EXTRACAPSULAR EXTENSION SEEN. PART 3: LEFT AXILLA, SENTINEL LYMPH NODE #2, EXCISION -. ONE LYMPH NODE WITH RARE CLUSTERS OF METASTATIC TUMOR CELLS IN PERIPHERAL SINUS. PART 4: LEFT AXILLA, LYMPH NODE EXCISION -. ONE LYMPH NODE WITH EXTENSIVE THERMAL EFFECT, PROBABLY FREE OF TUMOR. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Lower outer quadrant. SIZE OF TUMOR: MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2.6 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 8. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 3. DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Yes, malignant zones. Soia. Micropapillary. Comedo. DCIS admixed and outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by in situ component: 5 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of invasive tumor to closest margin: 1 mm. PAGET'S DISEASE OF NIPPLE: Distance of in situ disease to closest margin: 0.7 mm. LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 9 mm. SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH, Papilloma, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Sex: M. Case type: Surgical'Filstory. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. DIAGNOSIS: (E) ANTERIOR FLOOR OF MOUTH: Bone, no tumor present. (See Comment). COMMENT: This supplemental report is issued to aid as an additional diagnosis for the. bone portion of the specimen. The previous diagnosis remains the same. Entire report and diagnosis completed bv: Report released by: DIAGNOSIS. CONTENTS RIGHT SUPRAOMOHYOID NECK DISSECTION: METASTATIC SQUAMOUS CELL CARCINOMA IN 3 OF 6 LEVEL I LYMPH NODES. AND 1 OF 2 LEVEL III LYMPH NODES. Two level II, twelve level V and two submental triangle lymph nodes,. no tumor present. salivary gland with atrophy, fibrosis and chronic inflammation, no. tumor present. (B) GINGIVAL LABIAL MARGIN: Squamous mucosa, no tumor present. (c). MUCOSAL TONGUE MARGIN: Squamous mucosa, no tumor present. DEEP TONGUE MARGIN: Muscle and fibrous tissue, no tumor present. ANTERIOR FLOOR OF MOUTH: INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED,. MARGIN OF RESECTION FREE OF TUMOR. (F) TEETH: Teeth (gross only). Sex: M. Case type: Surgical History. Entire report and diagnosis completed. Report released by: GROSS DESCRIPTION. (A) CONTENTS, RIGHT SUPRA OMOHYOID NECK DISSECTION - The specimen is. received in five separate containers with designation as to different levels. Level I consists of a fragment of tan-yellow grossly hemorrhagic. fibroadipose tissue (5.6 x 4.2 x 1.1 cm). Dissection reveals an unremarkable. tan lobulated submandibular gland (2.6 x 1.7 x 1.1 cm) as well as six possible. lymph nodes (ranging from 0.6 x 0.4 x 0.3 cm to 1.2 x 0.9 x 0.7 cm). The level II contents measure (3.6 x 3.4 x 0.8 cm). Dissection. reveals. two possible lymph nodes (0.6 x 0.4 x 0.4 cm and 1.3 x 0.7 x 0.! cm). The level III contents consist of a fragment of tan-yellow focally. hemorrhagic fibroadipose tissue (2.: 1 x 1.7 x 0.7 cm). Dissection reveals. two apparent lymph nodes (0.3 x 0.2 x 0.1 cm and 1.6 x 0.7 x 0.6 cm). The level V contents consist of a fragment of tan-yellow grossly. hemorrhagic fibroadipose tissue (6.8 x 2.1 x 0.6 cm). Dissection. reveals. 13. possible lymph nodes (ranging from 0.2 cm to 1.3 x 0.7 x 0.4 cm). The specimen from the submental triangle consists of a fragment of. tan-yellow grossly hemorrhagic fibroadipose tissue (3.0 x 2.8 x 0.6 cm). Dissection reveals two apparent lymph nodes (each 0.4 cm in diameter). SECTION CODE: A1, submandibular gland, level I, representative. section. A2, two level I lymph nodes. A3-A6, one bisected level I lymph node. per casette. A7, two level I and II lymph nodes. A8, one bisected. level III lymph node. A9, one level III lymph node. A10, four level V lymph. nodes. A11, nine level V lymph nodes. A12, two submental lymph nodes. (B) GINGIVAL LABIAL MARGIN - A pink-tan linear tissue fragment (1.8 x 0.2 x. 0.2 cm). SECTION CODE: 8, submitted in toto for frozen section. FS/DX: BENIGN SQUAMOUS MUCOSA. MUCOSAL TONGUE MARGIN - A fragment OT tan-red mucosa (3.7 x 0.3 x 0.2. cm). Specimen is received on Telfa pad with designations as to the left and. right ends of the specimen. INK CODE: Black - tip of section. SECTION CODE: C1, right half of specimen for frozen section examination;. C2, left half of specimen for frozen section examination. FS/DX: BENIGN SQUAMOUS MUCOSA. (D) DEEP TONGUE MARGIN - A fragment of red-purple soft tissue (0.7 x 0.4 x. 0.3 cm). Entirely submitted for frozen section examination as D. FS/DX: BENIGN MUSCLE AND FIBROUS TISSUE; NO TUMOR PRESENT. (E). ANTERIOR FLOOR OF MOUTH - A segment of mandible with overall measurements. (5.0 x 4.0 x 2.5 cm). In the anterior aspect of the bone an ulcerated friable. and soft lesion approximately (2.5 x 1.0 x 1.5 cm). The tumor appears to be. eroding the upper bony portion and invading between teeth. No bony fracture. is identified. Tumor appear to grossly confine within the surgical margin. Tumor is submitted entirely from E1-E10. (F) TEETH - Received are 13 teeth, the smallest (1.7 x 0.6 x 0.3 cm), and the. largest (2.0 x 1.0 x 0.9 cm). Also received are tooth fragments (3.0 x 1.5 x. Sex: M. Case type: Surgical History. 0.6 cm) in aggregate. For gross description only. No sections taken. SNOMED CODES. M-80703 T-53000.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
F. SPECIMEN SUBMITTED: Part A: SUPERIOR SEGMENT WITH. WEDGE OF LATERAL BASILAR SEGMENT. Part B: R12. Part C: R9. Part D: R4. Final Diagnosis. 1. Right lung, lower lobe, superior segmentectomy and lateral basilar segment wedge resection (A). Invasive poorly differentiated squamous cell carcinoma (see comment). 2. Lymph nodes, R12, R9, R4, excision (B-D) - Lymph nodes, negative for neoplasm. Diagnosis Comment: SPECIMEN: Right lower lobe. PROCEDURE: superior segmentectomy and lateral basilar segment wedge excision. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Right. TUMOR SITE: Lower lobe. TUMOR SIZE: 4.9 x 4.8 x 3.5 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Squamous cell carcinoma. HISTOLOGIC GRADE: Grade 3 poorly differentiation. VISCERAL PLEURAL INVASION: pending Movat stains; addendum report will follow. TUMOR EXTENSION: Not identified. MARGINS: - Bronchial margin: negative. - Vascular Margin negative. - Parenchymal margin: negative. - Parietal pleural margin: Not applicable. - Chest wall margin: Not applicable. - Other attached tissue margin: Not applicable. TREATMENT EFFECT: Not applicable. TUMOR ASSOCIATED ATELECTASIS OR OBSTRUCTIVE PNEUMONITIS: Negative. LYMPH-VASCULAR INVASION: Not identified. LYMPH NODES: negative. PATHOLOGIC STAGING: p stage IB (T2a NO MX). Intraoperative Diagnosis: A. Non-small cell carcinoma. Bronchial margin and staple line margin negative for tumor. Clinical Diagnosis: RIGHT LOWER LOBE MASS-SQUAMOUS CELL CA. Gross Description: A. Received fresh for frozen diagnosis labeled ""superior segment with wedge of lateral basilar segment"". is a wedge of lung tissue measuring 12.7 x 7.5 X 3.4 cm, and weighing 197 grams. The parenchymal. line of resection is inked blue. A tan firm lobulated mass with necrosis is present within the lung. parenchyma measuring 4.9 X 4.8 x 3.5 cm, extending to the pleural surface and located 2.7 cm from. the bronchial margin and 0.9 cm from the parenchymal margin. Focal anthracotic pigment is identified. The remaining lung parenchyma is red-brown and unremarkable. Representative sections are submitted. as follows: A1 frozen section bronchial margin, A2 frozen section of mass with inked parenchymal line. of resection, A3-A8 mass (A3-A4with pleural surface, A5 with parenchymal line of resection) A9. vascular margin, A10 non-tumoral lung, A11 possible lymph node tissue. B. Received fresh labeled ""R12"" are twelve red-black to gray nodules ranging in size from 0.4-2.5 cm in. greatest dimension. The segments are totally submitted in formalin as follows: B1six nodules, B2 four. nodules, B3 two nodules. C. Received fresh labeled ""R9"" is a segment of black-tan soft tissue measuring 0.5 x 0.2 x 0.2 cm. The specimen is totally submitted in formalin in C1. D. Received fresh labeled ""R4"" are four segments of yellow-tan to red soft tissue ranging in size from. 0.5-1.5 cm in greatest dimension. The segments are totally submitted in formalin in D1. Microscopic: {Not Entered}.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you extract the AJCC Stage of the cancer from the text provided? Please output it as a JSON object, just generate the JSON object without explanations.
ADDENDUM 3: EGFR Mutation Analysis. Clinical Data: Adenocarcinoma. RESULTS: Positive for the E746 A750del5 mutation in Exon 19. INTERPRETATION: Deletion mutations in exon 19, mostly involving the. LREA motif, are reported to correlate with responsiveness to EGFR. tyrosine kinase inhibitor therapies in patients with non-small-cell. lung carcinoma. COMMENT: Forty percent (40%) or more cellularity is optimal for. this mutation analysis. The sample submitted showed 70% tumor. cellularity upon pathologist review. E746 A750del5 corresponds to 2235 2249dell5. Mutations in the tyrosine kinase domain of the epidermal growth. factor receptor (EGFR) gene are reported to be associated with. differential responsiveness or resistance to EGFR tyrosine kinase. inhibitor (TKI) therapies. The objective response rate among. patients with a sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression of the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the samples, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. DISCLAIMER: This test was developed and its performance characteristics. determined by. It has not been cleared or approved by the. US Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for. clinical purposes. It should not be regarded as investigation or. for research. The laboratory is regulated under the Clinical. Laboratory Improvement Amendments of. as qualified to. perform high complexity clinical testing. This particular test is. not considered a stand alone test and should be used only in the. context of other diagnostic tests or clinical work-up related to. treatment decisions. Addendum #3 performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S PLEURAL BIOPSY. 2. F/S MEDIASTINAL PLEURAL BIOPSY. 3. F/S DIAPHRAGMATIC PLEURAL BIOPSY. 4. F/S RIGHT UPPER AND MIDDLE LOBE. 5. STATION 9 LYMPH NODE, RIGHT. 6. STATION 11 LYMPH NODE, RIGHT. 7. STATION 10 LYMPH NODE, RIGHT. 8. STATION 12 LYMPH NODE, RIGHT. 9. STATION 4 LYMPH NODE, RIGHT. 10. STATION 2 LYMPH NODE, RIGHT. 11. STATION 7 LYMPH NODE, RIGHT. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Biomarker Report. DIAGNOSIS: 1. PLEURA: BIOPSY. - METASTATIC ADENOCARCINOMA WITH ACINAR PATTERN (SEE NOTE). 2. PLEURA, MEDIASTINAL: BIOPSY. METASTATIC ADENOCARCINOMA WITH ACINAR PATTERN (SEE NOTE). 3. PLEURA, DIAPHRAGMATIC: BIOPSY. - METASTATIC ADENOCARCINOMA WITH ACINAR PATTERN (SEE NOTE). Note (1-3): The foci of tumor are small and have low-grade. cytologic features, so the morphologic differential diagnosis. includes a reactive mesothelial proliferation, especially on the. frozen section slides. However, immunohistochemical stains on. permanent material show that the tumor cells are positive for TTF-1. while negative for calretinin, supporting the diagnosis. This case. was discussed with. 4. LUNG, RIGHT UPPER AND MIDDLE LOBES: BI-LOBECTOMY. - ADENOCARINOMA, PAPILLARY PREDOMINANT (4.5 CM), SEE NOTE. - VISCERAL PLEURAL INVASION IS PRESENT (CONFIRMED BY AN ELASTIC. STAIN). THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. METASTATIC ADENOCARCINOMA INVOLVING ONE OF NINE LYMPH NODES. (1/9), WITH EXTRACAPSULAR EXTENSION. Note: The tumor consists of papillary (60%), acinar (20%), lepidic. (10%) and micropapillary (10%) components and is seen in both the. upper and middle lobes. Results of mutational studies will be. reported in addenda. 5. LYMPH NODE, RIGHT LEVEL 9: BIOPSY. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 6. LYMPH NODE, RIGHT LEVEL 11: BIOPSY. THREE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/3). 7. LYMPH NODE, RIGHT LEVEL 10: BIOPSY. - METASTATIC ADENOCARCINOMA WITH PAPILLARY AND ACINAR. PATTERNS. INVOLVING ONE LYMPH NODE (1/1). 8. LYMPH NODE, RIGHT LEVEL 12: BIOPSY. - METASTATIC ADENOCARCINOMA WITH PAPILLARY AND ACINAR. PATTERNS. INVOLVING TWO OF THREE LYMPH NODES (2/3). 9. LYMPH NODE, RIGHT LEVEL 4: BIOPSY. - METASTATIC ADENOCARCINOMA WITH PAPILLARY AND ACINAR. PATTERNS. INVOLVING TWO LYMPH NODES (2/2). 10. LYMPH NODE, RIGHT LEVEL 2: BIOPSY. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 11. LYMPH NODE, RIGHT LEVEL 7: BIOPSY. - METASTATIC ADENOCARCINOMA WITH MICROPAPILLARY PATTERN. INVOLVING ONE LYMPH NODE (1/1). Specimens: 1: F/S PLEURAL BIOPSY. 2: F/S MEDIASTINAL PLEURAL BIOPSY. 3: F/S DIAPHRAGMATIC PLEURAL BIOPSY. 4: F/S RIGHT UPPER AND MIDDLE LOBE. 5: STATION 9 LYMPH NODE, RIGHT. 6: STATION 11 LYMPH NODE, RIGHT. 7: STATION 10 LYMPH NODE, RIGHT. 8: STATION 12 LYMPH NODE, RIGHT. 9: STATION 4 LYMPH NODE, RIGHT. 10: STATION 2 LYMPH NODE, RIGHT. 11: STATION 7 LYMPH NODE, RIGHT. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). Middle and Upper Lobes. Procedure: Bilobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Upper lobe. Middle lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G2: Moderately differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 4.5cm. Comment(s): 2.5 cm in middle lobe and 2 cm in upper lobe. Visceral Pleura Invasion: Present. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Present. LYMPH NODES. Extranodal Extension: Present. STAGE (pTNM). Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest. dimension surrounded by lung or visceral pleura without. bronchoscopic evidence of invasion more proximal than the lobar. bronchus (i.e., not in the main bronchus); or Tumor 5 cm or less. in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades. the visceral pleura; associated with atelectasis or obstructive. pneumonitis that extends to the hilar region but does not inolve the. entire lung. Regional Lymph Nodes (pN). pN2: Metastasis in ipsilateral mediastinal and / or subcarinal. lymph node(s). Number Examined. 21. Number Involved. 7. Distant Metastases (pM): pM1a: Separate tumor nodule(s) in contralateral lung; tumor with. pleural nodules or malignant pleural (or pericardial) effusion. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Inflammation (specify type). Respiratory Bronchiolitis. Emphysema. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: M with hx of COPD, now with a 4.5 cm right lung mass. MACROSCOPIC DESCRIPTION: The specimen is received in eleven parts, each labeled with the. patient's name. 1. Part one is received fresh, labeled 'pleural biopsy'. It. consists of three pieces of red-tan soft tissue ranging in size from. 0.2 X 0.2 X 0.2 cm to 2.0 X 0.3 X 0.2 cm. The specimen is entirely. submitted for frozen section and subsequently entirely submitted for. permanent section. 2. Part two is received fresh, labeled 'mediastinal pleural biopsy'. It consists of one piece of red-tan soft tissue measuring 0.5 X 0.4. X 0.2 cm. The specimen is entirely submitted for frozen section and. subsequently entirely submitted for permanent section. 3. Part three is received fresh, labeled 'diaphragmatic pleural. biopsy : It consists of two pieces of tan-yellow soft tissue. measuring 0.2 X 0.1 X 0.1 cm and 0.1 X 0.1 X 0.1 cm. The specimen. is entirely submitted for frozen section and subsequently entirely. submitted for permanent section. 4. Part four is received fresh, labeled 'right upper and middle lobe. rule out carcinoma : It consists of a right upper and middle lobe. of lung measuring 22 X 10 X 3.5 cm. The pleura on the middle lobe. are grey-pink glistening, and mottled moderately with fine black. streaks. Also noted is a puckered area measuring 2 X 2 cm. Beneath. the puckered pleura is a grey-white firm tumor measuring 2.5 X 2.3 X. 2 cm located between upper and middle lobe, medial aspect of the. lung, 1.5 cm from the bronchial resection margin of the medial lobe. and 3 cm from the bronchial resection margin of the upper lobe. The. mass is located 2 cm from the vascular margin of the middle lobe. Also noted is a bleb on the medial lobe measuring 2 cm in greatest. dimension, located 1.5 cm from the tumor. The remainder of the. middle lobe parenchyma is pink-red, crepitant and emphysematous. The upper lobe pleura is grey-pink glistening and reveals a. thickened and puckered pleura measuring 2 X 2 cm located at the. lower pole of the upper lobe. The remainder of the upper lobe. parenchyma is pink-red, crepitant and blotchy. No nodule is grossly. identified. Also noted are multiple anthracotic firm lymph nodes. noted from the hilar area of upper and middle lobe ranging from 0.2. cm to 0.5 cm in greatest dimension. Frozen section performed and. resubmitted for permanent section. Representative sections are. submitted. 5. Part five is received in saline, labeled 'station 9 lymph node,. right'. It consists of a red black lymph node measuring 1 X 0.7 X. 0.5 cm. Entirely submitted in one cassette. 6. Part six is received in saline, labeled 'station 11 lymph node,. right'. It consists of multiple soft red black lymph nodes,. measuring 2.3 X 1.8 X 0.7 cm in aggregate. Entirely submitted in one. cassette. 7. Part seven is received in saline, labeled 'station 10 lymph node,. right'. It consists of one soft red black lymph node measuring 1.8. X 0.6 X 0.5 cm. Entirely submitted in one cassette. 8. Part eight is received in saline, labeled 'station 12 lymph node,. right'. It consists of multiple soft red black lymph nodes,. measuring 3 X 2.1 X 0.8 cm in aggregate. Entirely submitted in one. cassette. 9. Part nine is received in saline, labeled 'station 4 lymph node,. right : It consists of one soft red black lymph node, measuring. 1.3 X 0.7 X 0.4 cm in aggregate. Entirely submitted in one cassette. 10. Part ten is received in saline, labeled 'station 2 lymph node,. right'. It consists of one soft red black lymph node, measuring 1 X. 0.5 X 0.3 cm in aggregate. Entirely submitted in one cassette. 11. Part eleven is received in saline, labeled 'station 7 lymph. node, right'. It consists of one soft red black lymph node,. measuring 1.3 x 0.8 X 0.6 cm in aggregate. Entirely submitted in one. cassette. SUMMARY OF SECTIONS: 1A in toto. 2A in toto. 3A in toto. 4A frozen section remaining of the nodule. 4B bronchial margin of the middle lobe, shaved. 4C vascular margin of the middle lobe, shaved. 4D-4G nodule and underlying puckered pleura. 4H bleb and underlying parenchyma from middle lobe. 4I firm area between two lobes. 4J anthracotic lymph node from middle lobe hilar area. 4K bronchial margin upper lobe. 4L vascular margin, upper lobe. 4M-4N puckered pleura from upper lobe. 40-4P random section from upper lobe. 4Q anthracotic lymph nodes from hilar area of upper lobe. 5A entirely submitted. 6A entirely submitted. 7A entirely submitted. 8A entirely submitted. 9A entirely submitted. 10A entirely submitted. 11A entirely submitted. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Pleural biopsy; frozen section. Pleural fibrosis with mesothelial hyperplasia and entrapped. epithelial tubules, favor reactive mesothelial proliferation. Slide. peer-reviewed at frozen section. Results reported by. at. and repeat-back provided by. 2. Mediastinal pleural biopsy; frozen section. Pleural fibrosis with mesothelial hyperplasia and entrapped. atypical epithelial tubules, favor reactive mesothelial. proliferation. Slide peer-reviewed at frozen section. Results. reported by. ), and repeat-back. provided by. 3. Diaphragmatic pleural biopsy; frozen section. Pleural fibrosis with mesothelial hyperplasia and entrapped. atypical epithelial tubules, favor reactive mesothelial. proliferation. Slide peer-reviewed at frozen section. Results. reported by. and repeat-back. provided by. 4. Right upper, middle lobe; frozen section. Adenocarcinoma with papillary features. Results reported by Dr. and repeat-back provided by. ADDENDUM #1 FOR MOLECULAR TESTS: KRAS, EGFR and ALK were sent on. or patient. The test is to be performed on tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 4E appropriate to. the specifications of the ordered molecular analysis. x1 H&E and x9. unstained slides were prepared and forwarded to. where the. subject molecular test will be performed. An addendum report will be. issued when the results of this molecular test are available. Addendum #1 performed by. ADDENDUM 2: MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Specimen #: RESULTS: Wild type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of. the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated. for use in identifying KRAS codon 12 and codon 13 mutations in. fresh, frozen, or formalin-fixed paraffin embedded tissue. In. particular the test performance has been established in samples of. colorectal cancer and non-small cell lung carcinoma which harbor. these mutations, although several other tissues are also known to. harbor KRAS mutations (e.g. tumors of pancreas, bile duct, ovary,. appendix, etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: This test was developed and its performance characteristics. determined by. It has not been cleared or approved by the. US Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. This test is used for. clinical purposes. It should not be regarded as investigational or. for research. The laboratory is regulated under the Clinical. Laboratory Improvement Amendments of. as qualified to. perform high complexity clinical testing. This particular test is. not considered a stand alone test and should be only used in the. context of other diagnostic tests or clinical work-up related to. treatment decisions. Addendum #2 performed by.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis. Resected colon material with an ulcerated, slightly differentiated adenocarcinoma of the. colorectal type, located 3 cm from a resection margin, with infiltration of the pericolic fatty. tissue, circumscribed penetration of the covering serosa as well as 23 local lymph node. metastases. Partly angioinvasive tumor branches, extending up to the mesenteric. resection margin. Tumor-free colon resection margins. Tumor classification: pT4, pN2 (23/29), pMX; G3, L1, V1, R1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: F. Provider Group : Date of Service: Date Received: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. - F. LEFT BREAST, LEFT AXILLARY TISSUE, PALPABLE NODE, LEFT. SENTINEL NODE (. ), AND SUPERIOR AND INFERIOR SKIN. EDGES, SIMPLE MASTECTOMY, EXCISION OF AXILLARY TISSUE,. BIOPSY OF PALPABLE NODE, EXCISION OF SUPERIOR AND INFERIOR. SKIN EDGES, AND SENTINEL NODE BIOPSY: - Invasive mucinous carcinoma, Nottingham grade 1. - Tumor size: 1.7 cm in greatest dimension. - Tumor location: Subareolar. - No in situ component identified. - Margins of resection are negative: - Invasive carcinoma is at least 3.5 cm from all margins. - No lymphovascular invasion identified. - One sentinel and one non-sentinel lymph node, negative for tumor (0/2). - Focal atypical ductal hyperplasia identified. - Uninvolved breast parenchyma with fibrocystic changes. - Benign skin and nipple. - Palpable node biopsy consists of only adipose tissue. - Separate left axillary tissue consists of benign fibroadipose tissue. - Additional superior and inferior skin edges consists of benign skin and. subcutaneous tissue. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive mucinous carcinoma, Nottingham grade 1. Primary tumor: pT1c. Regional lymph nodes: pN0(i-)(sn). Distant metastasis: N/A. Stage: IA. Lymphovascular invasion: Not identified. Margin status: R0, negative. Printed: This report continues (FINAL). Acct No. -. Pathology - Page 1/6. Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. Invasive Breast Cancer Tumor Staging Information. AJCC Cancer Staging Handbook, 7th Ed., and CAP Protocol (revised June 2012). Previous pathology speciment. Printed: This report continues (FINAL). Acct No. -. tient Name -. Pathology - Page 2/6. Page 2 Doc# 1. SPECIMEN IDENTIFICATION. Procedure/specimen type: Simple mastectomy. Laterality: Left breast. Lymph node sampling: Sentinel node biopsy. INVASIVE CARCINOMA TUMOR CHARACTERISTICS. Histologic types. Invasive mucinous carcinoma. Tumor site: Subareolar. Tumor size: 1.7 cm. Tumor focality: Unifocal. Histologic grade (Nottingham Score): 1 of 3 (Nottingham score 5 of 9). Tubule formation: 2 of 3. Nuclear pleomorphism: 2 of 3. Mitotic rate: 1 of 3. Lymphovascular invasion: Not identified. Macroscopic and microscopic extent of tumor: Benign skin and nipple. DUCTAL CARCINOMA IN SITU (DCIS): Not identified. MARGINS. Invasive carcinoma: At least 3.5 cm away from all margins. LYMPH NODES. Total lymph nodes examined. 2 (one sentinel and one non-sentinel). Number of lymph nodes involved. 0,. Size of largest metastatic deposit: N/A. Extranodal extension: N/A,. PATHOLOGIC STAGING: Primary Tumor (pT): Regional lymph nodes (pN): pN0(i-)(sn). Distant metastasis (pM). N/A,. AJCC Stage: IA,. ANCILLARY STUDIES. Estrogen receptor: Positive (100%, strong intensity). Progesterone receptor: Positive (99%, strong intensity). HER2: Negative (score 1+). Ki-67;. 7% positive cells. Printed: This report continues. (FINAL). MR No. -. Pathology - Page 3/6. Page 3 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. bigneu by : Source of Specimen: A. Sentinel lymph node:Left sentinel node #7. B. Breast surgical Left axillary tissue. C. Breast total mastectomy; Lett. D. Lymph node;Palpable node. E. Skin; ;Superior skin edge. F. Skininferior skin edge. Clinical History/Operative Dx: Breast cancer. Intraoperative Diagnosis: A. Left sentinel node. Negative for metastasis. The intraoperative interpretation(s) was/were performed and rendered at. Gross Description: A. Part A designated left sentinel node (FS). Initially received in a fresh state for frozen section/touch. prep evaluation, is a 3.0 x 2.5 x 1.5 cm portion of yellow-tan fat. Examination reveals a single soft to. rubbery pink and tan lymph node measuring 2.5 cm in greatest dimension. A single touch imprint slide is. forwarded for microscopic evaluation, The lymph node is entirely submitted for routine histology with a. sentinel node protocol performed, on A1 and A2. B. Part B designated left axillary tissue. Received in formalin is a 4 gram portion of yellow-tan fibrofatty. soft tissue measuring 3.8 x 2.2 x 1.5 cm. Examination reveals softened yellow-tan fat, without prominent. lymph node content, The fatty tissue is entirely submitted for microscopic evaluation for possible minute. lymph node content, in B1-B3. C. Received in the fresh state for tumor harvest for. tumor bank. The specimen is. Printed: This report continues (FINAL). MR No. -. cct No. Pathology - Page 4/6. Job. age - Loc# 1. FINAL SURGICAL PATHOLOGY REPORT. labeled ""left breast mastectomy Sutures present for orientation purposes: Suture - medial. Laterality: Left. Specimen: Simple mastectomy. Size of mastectomy: (M-L x S-IXA-P): 21.4 X 12.4 x 5.5 cm (including lateral extension of fat). Axillary tail: 8.0 x x .8 cm extension of lateral fat. Skin: 17.7 x 6.4 cm. Nipple/areola: Present. Specimen weight: 489 grams. Ink code: Blue - superior-anterior, orange - inferior-anterior, black - deep. Slabs: Total #12, M=1, L=12. Nipple in stabs #6-7. Time of resection: Not documented. Time placed into formalin. Time out of formalin: Lesion 1: Biopsy site: Spring and hook-shaped radiologic marker appreciated along anterior-lateral. periphery of lesion (slab 7). Size 1.7 x 1.5 x 1.5 cm, well-circumscribed, pink-tan, gelatinous appearing, mucinous turnor mass. Location: Subareolar. Involves slabs #6-7. Distance to nearest margin(s): 3.5 cm from superior superficial and inferior superficial, 1.0 cm from skin,. greater than 4.5 cm from most medial and lateral edges of breast. Non-lesional breast: Serial sections of the breast demonstrate predominantly fatty. glistening. lobular. adipose tissue without additional discrete nodularity/lesion. Examination of the most lateral extension. of. breast reveals a single lymph node, measuring 0.8 x 0.7 0.4 cm. Several embedded staples are present. Cassette summary: C1) nipple,. C2) medial and lateral extension of skin. C3) slab 5, medially adjacent to lesion,. C4) slab 6. tumor,. C5) slab 6, lesion and skin relationship. C6) slab 7. lesion,. C7) slab 7. tumor, site marked by radiologic marker,. C8) slab 7, tissue medially inferior to lesion (dense changes),. C9) slabs 6-7, deep margin. C10) slab 7, superior superficial surgical margin adjacent to lesion,. C11) siab 7. inferior superficial surgical margin adjacent to lesion,. C12) stab 8, adjacent to lesion,. C13) stab 10, upper outer quadrant,. C14) slab 10. lower outer quadrant,. C15) slab 3, lower inner quadrant. C16) stab 3, upper inner quadrant,. C17) single lymph node,. D. Part D designated palpable node. Received in formalin is a fatty tissue fragment measuring 10x08x. Printed: This report continues. (FINAL). Pathology Page 5/6. S Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. 0.3 cm. The tissue is serially sectioned and entirely submitted for microscopic evaluation in D1. E. Part E is superior skin edge, clip medial. Received in formatin is an elliptical strip of erythematous. pink. and tan skin with subcutaneous fat measuring 12,0 x 0.8 cm with a 1.0 cm deep surgical margin. A clip is. near one apex designating medial. The superior edge of the skin and surgical margin is now marked blue,. Sectioning reveals glistening, yellow-tan subcutaneous fat without grossly unusual areas of change. suggestive of neoplasia. Representative sections are submitted for microscopic evaluation in E1. F. Part F is inferior skin edge, clip medial. Received in formalin is an elliptical strip of erythematous, pink. and tan skin with subcutaneous fat measuring 12 5 x 1.0 cm with a 1.8 cm deep surgical margin. A clip. is. near one apex designating medial. The inferior edge of the skin including superficial surgical margin are. now marked green. The specimen is serially sectioned demonstrating glistening, yellow-tan, lobular. subcutaneous fat without discrete nodularity or grossly unusual areas of change suggestive of neoplasia. Representative sections are submitted for microscopic evaluation in F1 (two pieces). Microscopic Description: A. . F. Microscopic sections have been examined The microscopic findings are reflected in the diagnosis. rendered. The sentinel node (part A) was evaluated by H&E levels and OSCAR-cytokeratin immunostains. Controls are appropriate. Printed: END OF REPORT (FINAL). Pathology - Page 6/6. aya J Doc# 1.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
CONFIDENTIAL. Demographics (for. verification purposes). Sex: F. Surgical Pathology Renor+. Collected Date/Time. Received Date/Time. Specimen Description. A. Lymph node number 12 at. B. Gallbladder at. c. Lymph node number 8 at. D. Bile duct margin at. E. Whipple's specimen at. F. Pancreatic margin at. Clinical Information. Pancreatic Ca. Infectious patient: No. Diagnosis. A. Lymph Node, Number 12, Excision: - One lymph node negative for carcinoma (0/1). B. Gallbladder, Cholecystectomy: - Chronic cholecystitis. - One reactive lymph node. - Negative for malignancy. Lymph Node, Number 8, Excision: One lymph node negative for carcinoma (0/1). D. Bile Duct Margin, Excision: - Negative for malignancy. E. Pancreas, Distal Stomach, Proximal Duodenum, Whipple's Procedure: - Adenocarcinoma, see synoptic report and comment. F. Pancreatic Margin, Excision: - Adenocarcinoma is present at the margin, see comment. Verified: Synoptic Report. SPECIMEN: Head of pancreas. Body of pancreas. Duodenum. Stomach. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. Uncinate process. Pancreatic body. TUMOR SIZE: Greatest dimension: 4.0 cm. Additional dimensions: 4.0 x 3.0. cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades ampulla of Vater or sphincter of Oddi. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3 : Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1 Regional lymph node metastasis. Number examined: 14. Number involved: 2. ANCILLARY STUDIES: Gross Description. Received are specimen containers A to F. All requisitions and specimen containers are. labelled with the patient'e name,. The cassettes and. identifiers. are labelled with the Surgical Numbe. A. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""A: Lymph node number 12"". Specimen consists of a possible lymph. node measuring 2.5 x 2.2 x 0.4 cm. Specimen is bisected. Cut surface is tan, brown, and. variegated. Specimen is bisected and submitted in toto in two cassettes. B. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""B: Gallbladder"". Specimen consists of a grey green, intact. gallbladder, measuring 10.0 x 3.5 x 1.5 cm. Serosal surface is tan and smooth. Cystic. duct lymph node is identified, measuring 1.8 x 1.0 x 0.7 cm. Cystic duct is patent. Lumen. contains thick dark green mucus bile. Mucosa is green and velvety. The gallbladder wall. averages 0.4 cm in thickness and appears somewhat edematous. Sections are submitted as. follows: B1. cystic duct lymph node bisected and submitted in toto. B2. representative section. c. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""C: Lymph node number 8"". Specimen consists of tan possible lymph. node, measuring 2.2 x 0.8 x 0.3 cm. Specimen is bisected and submitted in toto in one. cassette. D. The specimen consists of tan tissue measuring 1.5 x 0.5 x 0.2 cm. Submitted for quick. section. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""D: Bile duct margin"". E. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""E: Whipple specimen"". Specimen consists of a whipple's resection. including distal stomach, measuring 4.0 cm along the lesser curvature, 5.0 cm along the. greater curvature and ranging in circumference from 4.0 cm of the pylorus to 7.5 cm of. the proximal margin, which was received stapled. There is a portion of pancreas,. measuring 5.5 x 4.0 x 2.0 cm. The duodenum measures 22.5 cm in length and averages 4.0 cm. in circumference. Attached peripancreatic soft tissue, extends to a maximum depth of 4.0. cm. Proximal margin of stomach and distal margin and received stapled. Specimen is inked. as follows: vessel bed margin- green, pancreatic body- blue, uncinate process- black,. anterior soft tissue surface- orange, and the posterior soft tissue surface- yellow. The. common bile duct measures 5.5 cm in length and averages 1.3 cm in circumference. There is an ill defined, firm tan mass identified within the pancreas, 4.0 x 4.0 x 3.0 cm. and comes within 1.0 cm to the body margin, 0.3 cm to the uncinate margin, 1.0 cm to the. anterior surface, 0.2 cm to the posterior surface, grossly extends to the vessel bed. margin, 16.0 cm to the distal margin, 5.5 cm to the proximal margin and 2.5 cm to the. common bile duct margin. The mass appears to involve the ampulla and pancreatic duct. There is a submucosal soft yellow nodule, located in the duodenum. The serosal surfaces. of the stomach and duodenum are tan, smooth and appear grossly unremarkable. Sections are. submitted as follows: E1. common bile duct margin. E2 to 4. proximal margin trisected. E5/6. distal margin bisected. E7/8. mass in relation to the ampulla. E9 to 11. mass in relation to the vessel bed margin. E12. mass in relation to the anterior surface with E11, E12 being a contiguous. section bisected. E13 to 15. mass in relation to the body margin. E16/17. mass in relation to the uncinate margin and anterior surface. E18/19. mass in relation to the posterior surface. E20. representative section of the submucosal nodule from duodenum and the. duodenum. E21. transition from pylorus to duodenum. E22 to 25. eight possible peripancreatic lymph nodes, ranging in size from 0.5 to 1.5. cm in. maximum dimension with E22 containing four possible lymph nodes, E23 two. possible. lymph nodes, and E24/25 each containing one possible lymph node bisected. F. The specimen consists of a 2.5 x 2.0 x 0.5 cm friable tissue in toto for quick. section. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""F: Pancreatic margin"". Sample and Test Request Deficiency. D. Bile Duct Margin: Negative for carcinoma. F. Pancreatic Margin: Negative for carcinoma. Pathologist Comment. Sections demonstrate carcinoma at the pancreatic margin in part F. Multiple foci are. better visualized in the permanent sections. In part E, the Body margin is negative. The. vascular bed margin is close (0.1 cm) The anterior and posterior soft tissue surfaces. are also close (<0.1 cm) The remaining margins are negative. Fourteen lymph nodes were examined in total, from parts A. C, and E. The following slides were shown in consultation to Dr. E7, E9-E11, E13-E17. Encounter Number. Patient Location.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Patient ID: Gross Description: Stomach part with saucer-like tumor up to 5x4.5 cm in size, with invasion into the. perigastric fat tissue. In the fatty tissue there are hyperemic lymph nodes up to 0.6 cm in size. Omentum is of normal structure. Microscopic Description: Gastric adenocarcinoma, G-3, with invasion into the fatty tissue. One from. fifteen examined lymph nodes demonstrated metastasis. Diagnosis Details: Tumor Features: Ulcerated, Tumor Extent: Perigastric fat, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Fundus. Tumor size: 4.5x0x5cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 1/15 positive for metastasis (Greater and lesser curvature. 1/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
Gender: Male. Race: White. Report Date: FINAL PATHOLOGIC DIAGNOSIS. A. Left pelvic lymph nodes: - Eight lymph nodes (0/8), no tumor. B. Right pelvic lymph nodes: - Twenty lymph nodes (0/20), no tumor. C. Bladder, prostate, seminal vesicles, vas deferens: - Papillary urothelial carcinoma of the bladder. - One lymph node (0/1), no tumor. - Prostatic hyperplasia, no tumor. - Seminal vesicles and vas deferens, no tumor. - Focal chronic and granulomatous inflammation consistent with treatment. effect. D. Distal right ureter: - Ureteral segment, no tumor. Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Papillary urothelial carcinoma. 2. Grade of tumor: High grade. 3. Depth of invasion: Lamina propria. Muscularis propria: Inner half with focus of lymphovascular invasion (C25). 4. Tumor distribution: Multifocal (confluent), 8.5 cm largest size. Dome. Right lateral wall. Left lateral wall. Trigone. Anterior wall. Posterior wall. 5. Ureteral margins: Negative. 6. Distal urethral margin: Negative. 7. Soft tissue margin or serosa: Negative. 8. Lymph nodes: 0/28. 9. pTNM: ypT2a, NO, MX. this Checklist utilizes the 7th edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow,  MD. Clinical History: The patient is an. year-old male with high grade urothelial carcinoma of the. bladder undergoing cystoprostatectomy. Specimens Received: A: Left pelvic lymph nodes. B: Right pelvic lymph nodes. C: Bladder, prostate, seminal vesicles, vas deferens. D: Distal right ureter. Gross Description: The specimen is received in four containers each labeled with the patient's name. and medical record number. A. The first container is additionally identified as, ""1. Left pelvic lymph. nodes"". Received fresh and placed in formalin is a 4.5 x 2.5 x 1.5 cm aggregate. of lobulated yellow fibrofatty tissue. The specimen is dissected for lymph. nodes to reveal 8 apparent lymph nodes ranging from 0.5-3.5 cm in greatest. dimension. All apparent lymph nodes are submitted as follows: A1: 1 candidate lymph node, serially sectioned. A2: 3 candidate lymph nodes. A3: 3 candidate lymph nodes. A4: 1 candidate lymph node, bisected. B. The second container is additionally identified as, ""2. Right pelvic lymph. nodes"". Received fresh and placed in formalin is a 6.5 x 4.0 x 1.5 cm aggregate. of lobulated yellow fibrofatty tissue. The specimen is dissected for lymph. nodes to reveal 20 apparent lymph nodes ranging from 0.3-3.0 cm in greatest. dimension. All apparent lymph nodes are submitted as follows: B1: 6 lymph node candidates. B2: 4 lymph node candidates. B3: 4 lymph node candidates. B4: 1 lymph node candidate, bisected. B5: 1 lymph node candidate, bisected. B6: 1 lymph node candidate, bisected. B7: 3 lymph node candidates. C. The third container is additionally identified as, ""3. Bladder, prostate,. seminal vesicles, vas deferens"". Received fresh and placed in formalin is an. 18.0 X 11.5 x 7.5 cm cystoprostatectomy specimen with attached mesenteric fat. The bladder measures 8.5 x 8.5 x 7.0 cm. The right ureteral stump measures 0.5. cm and the left 1.0 cm, and both demonstrate patent lumina. The prostate. measures 4.8 x 4.0 x 3.6 cm. The right seminal vesicle measures 3.0 x 2.5 x 0.6. cm and the right vas deferens 3.0 cm. The left seminal vesicle measures 3.0 x. 2.2 x 0.6 cm and the left vas deferens 7.0 cm. The right half of the prostate is. inked blue and the left half is inked black, and the outside of the bladder is. inked black. The prostate is opened anteriorly along the urethra and continued. superiorly through the bladder in a Y-shaped incision. The prostate is serially. sectioned from apex to base to reveal bulging, yellow to tan parenchyma with a. 0.4 x 0.3 x 0.3 cm area of induration located on the right prostate. posterolaterally. The bladder mass extends near the base of the prostate. The. bladder demonstrates a fungating, focally friable, tan-pink mass involving the. entire surface of the bladder. Serial sectioning reveals partial tumor invasion. into bladder wall to a depth of 1.5 cm, abutting the inked margin in multiple. locations of the anterior and posterior bladder. There is no normal mucosa. present. The bladder wall thickness is 0.5 cm in areas not grossly involved by. the mass. The bilateral ureteral orifices are identified and probe patent. Photographs are taken. Representative sections are submitted as follows: C1: Distal urethral margin. C2: Right ureter margin. C3: Left ureter margin. C4: Prostate apex, serially sectioned. C5: Representative sections of right vas deferens and seminal vesicle. C6: Representative sections of left vas deferens and seminal vesicle. C7: Representative section of right prostate through verumontanum. C8: Representative section of left prostate through verumontanum. C9-C10: Representative sections of right prostate above verumontanum in. region of induration. C11-C12: Representative sections of left prostate above verumontanum. C13: Right prostate in region of bladder tumor invasion. C14: Left prostate in region of bladder tumor invasion. C15: Representative section of mass in anterior bladder. C16: Representative section of mass in anterior bladder in region. abutting inked margin. C17-C18: Representative sections of mass in anterior bladder. C19-C21: Representative sections of mass in dome of bladder. C22-C25: Representative sections of mass in posterior bladder. D. The fourth container is additionally identified as, ""4. Distal right ureter"". Received fresh and placed in formalin is an unoriented 2.5 cm in length and 0.4. cm in diameter tan, rubbery, tube-like structure with attached adipose tissue. There is a long suture at one end of the specimen and this end is inked black. The specimen is serially sectioned and submitted as follows: D1: Margins. D2: Central sections. , MD.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis. This is an advanced mucinous carcinoma (G3) with infiltration of the bordering fatty. connective tissue (pTT3) and an inflammatory connection to the uterus. Otherwise the uterus condition is normal relative to the patient's age and there are free. lymph nodes (p N 0). Tumor classification: ICDO-DA-M. G3, P T 3, L1, V1, p NO (0/30).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Amended. DATE OBTAINED: DATE RECEIVED: SUBMITTING MD: DIAGNOSIS. #1-AXILLARY CONTENTS, LEFT: TWENTY THREE LYMPH NODES POSITIVE FOR METASTATIC. CARCINOMA, LARGEST MEASURING 3.7 CM WITH EXTRANODAL EXTENSION (23/23). #2-BREAST, LEFT, 2 O'CLOCK, EXCISIONAL BIOPSY: INVASIVE MAMMARY CARCINOMA. SIZE (INVASIVE): 2.8 cm. LATERALITY: Left. TUMOR FOCALITY: Unifocal. LESIONAL SITE: 2 o'clock. HISTOLOGIC TYPE: Ductal focal lobular features pw BS, lubular features total 73. NUCLEAR GRADE: III of III. HISTOLOGIC GRADE(EEmSBR): II of III (Tubules score 2 + NG score 3 + mitoses score 1). IN-SITU COMPONENT: DCIS solid and cribriform types, nuclear grade III with comedonecrosis. LYMPH NODE SAMPLING. Twenty three lymph nodes positive for carcinoma (23/23). (see specimen #1) with extranodal extension, largest measuring 3.7 cm. AJCC CATEGORIES: Stage IIIC (assuming ""cM0"" status). pTNM: pT2. pN3a. cTNM: cT2. cN1. INTEGRITY/ORIENTATION: Intact specimen with designated margins. MARGINS: Positive posterior/superior margin focally (slide 2K, scut); medial margin 0.5 mm; other. margins widely negative. LYMPHOVASCULAR INVASION: Present. MICROCALCIFICATIONS: Present in association with in situ and invasive carcinoma. NIPPLE/SKIN: (If applicable). Not applicable. SKELETAL MUSCLE: Not present. OTHER: Biopsy site changes, fibrocystic changes. #3-BREAST, LEFT, DEEP MARGIN, REEXCISION: 2 MM FOCUS OF RESIDUAL INVASIVE CARCINOMA. PRESENT 4 MM FROM FINAL DEEP MARGIN; BACKGROUND PROLIFERATIVE BREAST PARENCHYMA WITH. INTRADUCTAL PAPILLOMA. COMMENT. The tumor was grossly measured as 2.4 cm with an additional tumor present at medial slice, not grossly appreciated; with an -. 4mm span to make the final dimension 2.8 cm. The tumor is present 1 mm from deep margin in multiple foci at main specimen, and focally in slice 1K is present at. posterior/superior margin; final deep margin (specimen #3) negative. 88307 X2, 88305. Clinical Diagnosis and History: Left breast Ca. + LN met). cT2; cN1: Clinical Stage IIB. Tissue(s) Submitted: 1: LEFT AXILLARY CONTENTS. 2: LEFT BREAST CANCER @ 2:00 (SUTURE MARKS ANTERIOR). 3: LEFT BREAST TRUE DEEP MARGIN. Gross Description: Specimen #1 is received fresh, subsequently placed in formalin labeled left axillary content and consists of a 10 x 8.5 x 3 cm. aggregate of adipose tissue which is palpated to reveal multiple indurated lymph nodes ranging from 0.3 cm to 3.7 cm in greatest. dimension. A representative section of each node is submitted as follows: 1A-1B- each cassette containing a representative section of each of four grossly positive nodes. 1C-. four halves of grossly four positive nodes. 1D-1E- each cassette containing half of two grossly positive nodes. 1F-. three representative sections of three grossly positive nodes. 1G-. four representative sections of four grossly positive nodes. Additional sections are submitted as follows: 1H-. remaining node corresponding to negative node in slide 1B. 11-. remaining nodes corresponding to fibrofatty tissue in slide 1A. Specimen #2 is received in formalin labeled left breast cancer at 2 o'clock (suture marks anterior) and consists of an oriented. portion of fibrofatty tissue measuring 10 cm from medial to lateral, 7 cm from superior to inferior and 2.7 cm from anterior to. posterior. Loosely received outside of the tissue is a localization wire. The specimen is radiographed to document the loose. localization wire, a mass and a clip. The tissue is inked per protocol such that the superior is blue, the anterior is green, the medial is red, the lateral is yellow, the. anterior is orange, and the posterior is black. The specimen is serially sectioned from lateral to medial into 9 slices to reveal a 2.4. x 2.3 x 2.2 cm indurated gray-white stellate mass in slices #4-8, grossly coming to within 0.5 cm of the posterior and superior. margin, information relayed to the surgeon intraoperatively. The remaining cut surfaces are made up of approximately 10% dense. fibrous tissue. Note the tissue is triaged per. protocol. Representative sections, concentrating on the closest margins, are. submitted as follows: 2A-2B- representative perpendicular sections with lateral margin. 2C-. middle fibrous tissue from slice #2. 2D-. middle fibrous tissue from slice #3. 2E-. posterior margin with tumor slice #4. 2F-. superior posterior margin from slice #4. 2G-. anterior margin with tumor slice #5. 2H-. anterior inferior margin slice #5. 21-. superior posterior margin with tumor slice #5. 2J-2K-. bisected section of posterior superior margin with tumor slice #6. 2L-. anterior inferior margin with tumor slice #6. 2M-. interior margin with tumor slice #7. 2N-. posterior margin with tumor slice #7. 20-. superior margin with tumor slice #7. 2P-2R- representative medial margin. Additional sections are submitted as follows: 2S-2T- tumor slice 8, no real margins, ink run over. 2U-2BB-remaining superior half of medial margin (true margin over-inked red. TIF: approximately. Specimen #3 is received fresh for orientation labeled left breast true deep margin and consists of an oriented portion of fibrofatty. tissue measuring 6 X 5 cm from medial to lateral, 3.5 cxm from superior to inferior and 0.4 cm from anterior to posterior. The true. margin is inked per protocol such that the center is black, the superior edge is blue, the inferior edge is green, lateral edge yellow. and the medial edge is red. The specimen is serially sectioned from medial to lateral into 12 slices to reveal focally dense fibrosis. No tumor is palpated or grossly identified. The specimen is submitted entirely labeled 3A-3K at approximately. Intraoperative Consult Diagnosis. 2A. 2.4CM GROSS TUMOR WITH NEGATIVE MARGINS, POSTERIOR CLOSEST. Amendments. Amended: Reason: Proofreading error. Previous Signout Date:

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a proficient and intelligent pathology AI assistant, you role primarily is to interpret the pathology report, extract the stage of the cancer detailed within, and reply using only a specified set of options. All responses must be formatted as JSON Objects and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
page 1 / 1. Examination: Histopathological examination. Material: 1. Total organ resection - colon and rectum. Expected time of examination: Clinical diagnosis: Cancer of the rectos gmoid junction. Macroscopic description: 17 cm length of the large intestine with periintestinal tissue sized 2.5 x 15 x 8 cm. Cauliflower-shaped ulcerous. tumour sized 6 X 6 X 1 cm found in the mucosa. The lesion surrounds 100% of the intestine circumference, located. 5 cm from one of the excision lines and 5 cm from the opposite one. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa telae adiposae pericolicae. Intestine ends free of neoplastic lesions. Metastases carcinomatosae in lymphonodis (No I/XVII). Histopathological diagnosis: Adenocarcinoma tubulare coli. Tubulopapillar adenocarcinoma of the colon. Metastases carcinomatosae in lymphonodis (No I/XVII). Cancer metastases in the lymph nodes (No I/XVII). (G2, Dukes C, Astler-Coller C2, pT3, pN1).

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
"You are a highly informed and intelligent pathology AI assistant, your key job is to process the pathology report, ascertain the stage of the cancer, and provide responses only from a certain set of options, exclusively outputting in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Report Status. Type: Surgical Pathology. Specimen Type : Kidney, partial or total resection. Procedure Date: PATHOLOGIC DIAGNOSIS: 1. A. /LEFT KIDNEY, NEPHRECTOMY: CLEAR CELL RENAL, CELL CARCINOMA, present as two separated nodules in the. posterior mid-to-upper pole (4.7 cm) and at the anterior subcapsular. (1.0 cm). Fuhrman nuclear grade 2. The tumor is confined to the kidney. The vascular and ureteral margins are negative for tumor. Adrenal gland not present. AJCC Classification: T1b Nx MX. PAPILLARY ADENOMA (0.3 cm), located in the subcortex. Incidental microadenoma, 0.1 Cm. Focal global glomerulosclerosis. Cortical scar. Arteriolosclerosis, mild to moderate. The renal parenchyma and special stains will be reviewed by Kidney. Pathology Service, and reported in an addendum. CLINICAL DATA: History: None given. Operation: Left radical nephrectomy. Operative Findings None given. Clinical Diagnosis: Left renal cell cancer. TISSUE SUBMITTED: A/1. Left kidney - Tissue Bank. GROSS DESCRIPTION: The specimen is received fresh, labeled with the patients name, unit number,. and. ""#1 Left kidney"", and consists of a left radical nephrectomy specimen. (653.5 grams, 21 x 9.5 x 6.8 cm - overall dimensions), to include left kidney. (13.0 x 8.0 x 5.8 cm), ureter (10.5 cm in length x 0. cm in diameter), renal. vein (0.6 cm in length x 1.3 cm in diameter), renal arteries (1.4 cm in length. x. 0.3 cm in diameter and 2.2 cm in length x 0.4 cm in diameter), and abundant. perinephric fat. An adrenal gland is not identified. A small portion of red/tan. probable Gerota's fascia (6.2 x 3.7 x 0.1 cm) is present along the anterior. aspect. The specimen is inked black along the deep margin and bivalved. There. is a golden yellow/red; lobulated, hemorrhagic, encapsulated mass (4.7 x 3.6 x. 3. ( cm) along the posterior aspect of the mid to upper pole, abutting the renal. capsule, coming to within 0.8 cm of the deep margin, 2.5 cm from artery #2, 3.2. cm from artery #1, 3.8 cm from the renal vein margin, 13.5 cm from the ureteral. margin, and does not grossly appear to extend in the perinephric fat. The renal. vein is grossly unremarkable. Representative tumor is submitted to. Cytogenetics, Electron Microscopy, and Tissue Bank for special studies. Representative normal cortex is submitted to the Tissue Bank and Electron. Microscopy/Immunofluorescence for special studies. There is a second, grossly. encapsulated, golden yellow/red mass (1.0 x 0.9 x 0.7 cm) in the renal cortex,. abutting and distending the anterior renal capsule, coming to within 0.5 cm of. the black-inked deep margin, 14 cm from the ureteral margin, 5.5 cm from renal. artery margin #1, 7.2 cm from renal artery #2, and 5.3 cm from the renal vein. margin. There is a small < 0.2 cm nodule in the cortex. The medullary pyramids. are diffusely hyperemic at the periphery and the corticomedullary junction is. distinct. The pelvis displays an unremarkable tan urothelium. No lymph nodes. identified within the hilum. Micro Al: Ureter, renal vein and renal artery margins, 4 frags,""ESS: the. Micro A2: ""T1"", 2 frags,. Micro A3: ""T2"", 2 frags,. Micro A4-A6: Renal mass at posterior aspect to include deepest extension, 3. frags,. Micro A7: Posterior renal mass in relationship to pelvis, 1 frag,. Micro A8: Renta D mass in relationship to adjacent renal parenchyma, 1. frag. RSS. Micro A9 Anterior upper pole mass at deepest extension, 2 frags total,. RSS. Micro All: Corticomedullary junction, 1 frag,. Micro(A12) Remainder upper pole mass, 1 frag,. Micro AI3 : Additional small nodular area 100.2 cm), 1 frag,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. RENAL PATHOLOGY EVALUATION OF THE KIDNEY PARENCHYMA: LEFT KIDNEY, NEPHRECTOMY. IMMUNE COMPLEX MEDIATED GLOMERULONEPHRITIS, PREDOMINANTLY WITH. SUBEPITHELIAL AND INTRAMEMBRANOUS DEPOSITS, MOST SUGGESTIVE OF. A MEMBRANOUS PATTERN OF GLOMERULAR INJURY (SEE NOTE). MODERATE CHRONIC CHANGES OF THE KIDNEY PARENCHYMA: - FOCAL GLOBAL GLOMERULOSCLEROSIS (18 of OF GLOMERULI) ;. - MILD TUBULAR ATROPHY AND INTERSTITIAL FIBROSIS (108 OF THE. PARENCHYMA) ;. ARTERIAL AND ARTERIOLAR SCLEROSIS, MODERATE (SEE NOTE). NOTE: The immunofluorescence and electron microscopic evaluation of the tissue. suggests an immune complex mediated glomerulonephritis. Electron microscopic. evaluation shows that the majority of the deposits are subepithelial and. intramembranous in location. This pattern of injury suggests a membranous. nephropathy, currently probably not very active. A systemic autoimmune disease. (SLE) or a remote post -infectious - glomerulonephritis cannot be ruled out with. absolute certainty. Kidney Pathologist, performed the evaluation and. interpretation of this material. DESCRIPTION: Sections of formalin-fixed, paraffin-embedded tissue (block A11) were evaluated. using HE, PAS, Jones silver methenamine, and AFOG (trichrome) stains; an. HE-stained frozen section and semithin submitted for light microscopy. The sample consists of renal cortex and medulla. There are up to 173 glomeruli. present in the sample. Thirty- two (32) glomeruli are globally obsolescent. (sclerosed) The preserved glomeruli show a mild increase in mesangial matrix. as seen on the PAS stain. The peripheral capillary walls reveal thick basement. membranes, with fine ""spike""-like projections and many ""craters"". These changes. are best visible on the Jones' silver methenamine stain. Tubules show normal. cellular details. There are isolated, PAS-positive casts present in some. distal tubules. Focal tubular atrophy is seen in areas of interstitial. fibrosis. Significant interstitial inflammation is not evident in the sample. examined. Approximately 10 % of the tissue included in this biopsy shows. tubular atrophy and interstitial fibrosis, as evidenced on the trichrome stains. (AFOG) Arteries show moderate sclerosis of the media, with focal replacement. of smooth muscle cells by connective tissue. Arterioles reveal moderate. subintimal hyaline accumulation toluidine blue-stained sections were also. evaluated by light microscopy. IMMUNOFLUORESCENCE MICROSCOPY REPORT. Sections of frozen tissue were incubated with antibodies specific for the heavy. chains of IgG, IgA, and IgM, kappa and lambda light chains, C3, Clq, albumin,. and fibrin-related antigens. The sample consists of kidney cortex and. medulla. There are four (4). glomeruli present, of which three (3) are globally sclerosed. There is diffuse. granular deposition of IgM (trace), IgG (+/4+) and fibrinogen (+/4+) in the. mesangial areas and along the peripheral capillary walls. There is also diffuse. linear deposition of albumin (+/4+) along all basement membranes. Tubules. contain reabsorbed proteins (albumin, IgG, C3) in the form of cytoplasmic. granules. Tubular basement membranes reveal focal deposition of C3 (trace). Few casts in distal tubules are reactive for polyclonal IgA. The interstitium. reveals scattered fibrin deposits. There is no difference noted in the. intensity of the staining for kappa and lambda light chains in the casts, in. the deposits, or in the background of the tissue. ELECTRON MICROSCOPY REPORT. Blocks: 4; Blocks examined: 4 thick sections; 1 thin section. The tissue examined at the ultrastructural level includes five (5) glomeruli. The glomerular capillary walls are greatly distorted by the presence of. numerous subepithelial and intramembranous electron dense deposits and. thickening of the basement membranes. Individual deposits are often surrounded. by basement membrane material and ""spikes"". The electron dense deposits are. finely granular but they do not show organized substructures There is. extensive effacement of visceral epithelial cell foot processes present and. widespread microvillous degeneration of the epithelial cell membrane. Several. epithelial cells also show prominent vacuoles and increased numbers of. lysosomes. Glomerular endothelial cells appear unremarkable and do not contain. tubuloreticular structures. Subendothelial electron dense deposits are not. seen. The mesangium shows normal cell elements and an extracellular matrix with. few irregular electron dense deposits. Report Status : Final. Type: Cytogenetics. Cytogeneticist. KARYOTYPE: T1: 45,XY,-8[10] T2: 45,XY,-8[10]. METAPHASES COUNTED: 20. ANALYZED: 10. SCORED: 10. BANDING GTG. INTERPRETATION: Two different specimens were received from this tumor. Loss of one chromosome. 8, as the sole chromosome abnormality, was seen in both specimens This. aberration is not known to be characteristic of any particular type of tumor. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: ? RCC.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. LEFT KIDNEY MASS, PARTIAL NEPHRECTOMY: - Papillary renal cell carcinoma, Fuhrman nuclear grade 2. - Multifocal, largest focus 2.5 cm. - Surgical margin POSITIVE at parenchymal cauterized margin. PATHOLOGIC TUMOR STAGING SYNOPSIS (KIDNEY): Type and grade: Papillary renal cell carcinoma, type I, Fuhrman nuclear. grade 2. Primary tumor: pT1a. Regional lymph nodes: pNX. Distant metastasis: pMX. Pathologic stage: I. Lymphovascular invasion: Not identified. Margin status: R1, cauterized parenchymal margin POSITIVE. B., E., F.) PROSTATE, NEW LEFT LATERAL MARGIN, NEW RIGHT LATERAL. MARGIN, RADICAL PROSTATECTOMY AND RE-EXCISION OF RIGHT AND LEFT. LATERAL MARGINS: - Prostatic adenocarcinoma, Gleason score 3 + 4 = 7. - Largest tumor focus 1.7 cm (multifocal). - Involves right and left prostate lobes. - Extraprostatic extension identified. = Perineural invasion identified. - Surgical margin POSITIVE at left bladder neck margin. PATHOLOGIC TUMOR STAGING SYNOPSIS (Prostate): Type and grade: Prostatic adenocarcinoma, Gleason score 3 + 4 =. 7. Primary tumor: pT3a. Regional lymph nodes: pN0 (0/8, negative for metastatic carcinoma). Distant metastasis: pMX. Pathologic stage: III. Lymphovascular invasion: Not identified. FINAL SURGICAL PATHOLOGY REPORT. PROSTATE TUMOR STAGING INFORMATION: (data derived from current specimen, staging in. accordance with or modified from AJCC Cancer. Staging Handbook, 7th Ed, and CAP protocol,. Procedure: Radical prostatectomy. Specimen type: Prostate. Prostate size/weight: , 3.7 X 3.5 X 3.4 cm. Tumor Features: Tumor site: Right and left prostate lobes. Tumor size: Largest focus is 1.7 cm, multifocal. Tumor quantification: 15% of prostate involved. Histologic type: Prostatic adenocarcinoma. Histologic grade (Gleason pattern): Primary pattern: 3. Secondary pattern: 4. Tertiary pattern: N/A. Total Gleason score: 7. Lymphovascular invasion: Not identified. Perineural invasion: Present. Extraprostatic extension: Present. Seminal vesicle invasion: Not identified. Treatment effect: N/A. Lymph Nodes: Negative (0/8). Margin Evaluation: Distance to closest margin: Surgical margin positive at left bladder neck. Other margins: N/A. Pathologic tumor staging descriptors: Primary tumor (pT): pT3a. Regional lymph nodes (pN): pNO (0/8). Distant metastasis (pM): pMX. Margin status (R): R1, positive at left bladder neck. Additional findings: High-grade prostatic intraepithelial neoplasia. Comment: On the original radical prostatectomy specimen. (part B), the right lateral margin is positive,. however, the additional tissue submitted as right. lateral margin (part F) shows no tumor, therefore. the final margin of the right lateral margin is. negative. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Left Kidney Mass. B. Prostatectomy. C. Right Iliac Obturator. D. Left Iliac Obturator. E. Left Lateral Margin. F. Right Lateral Margin. Clinical History/Operative Dx: Left kidney mass, prostate cancer. Gross Description: A. The specimen is labeled left kidney mass and is received without fixative. It consists of a cortical. portion of kidney which overall measures 3.3 X 3.1 X 2.9 cm and. The cortical surface of. the kidney appears smooth with intact renal capsule. The surgical margin is inked. The specimen is. serially sectioned to reveal a well circumscribed mass measuring 2.5 X 2.5 X 1.8 cm. This mass is variably. composed of pale tan to granular reddish and hemorrhagic tissue. It abuts the cortical surface but there is. no overlying perirenal fat. It is grossly 0.5 cm from the closest cortical resection margin. Representative. sections of this neoplasm are obtained for research purposes. Also in the specimen container is a 4 cm. aggregate of lobulated fatty tissue which is serially sectioned and contains no obvious tumor. Representative sections are submitted. Section summary: A1-A4) renal neoplasm and cortical resection. margin, A5) peripheral section of neoplasm and representative separate fatty tissue. B. The specimen is labeled prostate and is received in formalin. It consists of a prostatectomy specimen. which. The prostate gland measures 3.7 X 3.5 X 3.4 cm and includes a partially. disrupted. 2.5. X. 1.5 X 0.7 cm right seminal vesicle, a 1.7 cm segment of right vas deferens, a 1.7 cm. segment of left vas deferens, and a short but intact appearing 1.8 X 1.3 X 0.9 cm left seminal vesicle. The. right anterior surface of the prostate is inked blue, the left anterior surface is inked green, and the posterior. surface is inked black. The prostatic apex, bladder neck, and seminal vesicle / vasa are trimmed. The. prostate is divided into right and left halves and is sectioned from apex to bladder neck. The right apical. portion of the prostate anteriorly displays pale yellow-tan discoloration in two discrete foci, each 0.7 cm in. maximum dimensions. One of these areas is just adjacent to the apical portion of the prostate and the. other is located in the mid gland. The prostatic gland parenchyma throughout the left prostate is spongy. tan and fibrous. Representative sections are submitted. Section summary: B1) right prostatic apex, B2) left. prostatic apex, B3) right bladder neck, B4) left bladder neck, B5) surgical margin right vas deferens, right. seminal vesicle, B6) surgical margin left vas deferens, left seminal vesicle, B7-B24) prostate, apex-. bladder neck. C. The specimen is labeled right iliac obturator and is received in formalin. It consists of a 5.5 X 3 X 1.8. cm ovoid portion of fibrofatty tissue and a small 1.1 cm fragment of similar tissue. On dissection there is. an ovoid partially fatty replaced 4.5 cm node. In the remaining tissue there is a 2.3 cm node, 1.2 cm. FINAL SURGICAL PATHOLOGY REPORT. fragment of nodal tissue, and three additional fragmented portions of nodal tissue varying from 0.8 - 1 cm. in maximum dimension. On sectioning the largest node has a firm pale tan glistening appearance. throughout. The smaller node and nodal fragments have a similar appearance. Representative sections. of the largest node are submitted in cassettes C1-C2. The second largest node is bivalved and submitted. in cassette C3. A single node is serially sectioned and submitted in cassette C4. Representative sections. of the remaining nodal fragments are submitted in cassette C5. D. The specimen is labeled left iliac obturator and is received in formalin. It consists of a 7.2 X 2,8 X 1.5. cm ovoid portion of fibrofatty tissue. On dissection there is a large matted portion of nodal tissue. measuring 6.5 X 2.7 X 1.5 cm. In the small amount of adherent fatty tissue are three 0.5 - 0.7 cm. additional nodes. The largest matted set of nodes is serially sectioned and is composed of pale tan. glistening uniform appearing tissue with a peripheral small amount of fatty tissue. Representative sections. of the largest matted node are submitted in cassettes D1-D4. The smaller nodes are submitted in cassette. D5. E. The specimen is labeled left lateral margin and is received in formalin. It consists of a 0.7 X 0.4 X 0.2. cm fragment of tan to reddish brown tissue with a metallic clip along one edge. The specimen is. submitted in cassette E1. F. The specimen is labeled right lateral margin and is received in formalin. It consists of two metallic clips. with a small amount of intervening red-brown soft tissue. The clips are removed and the intervening tissue. is submitted in cassette F1. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Immunohistochemistry was performed and interpreted at. for BCL-2, BCL-. 6, CD10, CD3, CD20, CD23, CD5, CD21, cyclin D1, IHD, and Ki-67. Immunohistochemistry was performed. at ProPath and interpreted at. for ZAP 70. Sections show lymph node with effaced. architecture with a pseudofollicular pattern of regularly distributed pale areas (proliferation centers) and a. dark background of smaller cells. The tumor cells are positive for CD20, CD5, CD23, lgD, and Bcl-2 and. negative for CD10, Bcl-6, cyclin D1 and CD3. CD3 stains background T cells. CD21 highlights rare. follicular dendritic networks. Ki-67 shows increased staining in the proliferation center areas. The tumor. cells are positive for ZAP70, No metastatic carcinoma is identified. No large cell transformation is. identified. D. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Sections show an atypical small lymphoid proliferation histologically similar to that seen in. part C. FINAL SURGICAL PATHOLOGY REPORT. E. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. F. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. FINAL SURGICAL PATHOLOGY REPORT. Perineural invasion: Present. Margin status: R1, surgical margin POSITIVE at left bladder neck. C. - D). LYMPH NODES, ILIAC OBTURATOR, RIGHT AND LEFT, REGIONAL. LYMPH NODE BIOPSIES: - Small lymphocytic lymphoma/chronic lymphocytic leukemia,. see comment. - Eight lymph nodes, negative for metastatic carcinoma (0/8). COMMENT (specimens C & D): Sections show an atypical small lymphoid proliferation. that is positive by immunohistochemistry for CD5, CD20 and CD23 and negative for. CD3, cyclin D1, and CD10, consistent with small lymphocytic lymphoma/chronic. lymphocytic leukemia. No large cell transformation is identified. The tumor cells are. positive for ZAP-70 by immunohistochemistry. An intradepartmental consultation with. was obtained. Results discussed with. hours. Kidney Tumor Staging Information. (data derived from current specimen, staging in accordance with or modified from AJCC Cancer Staging. Handbook, 7th Ed, and CAP protocol. Procedure: Partial nephrectomy. Specimen type: Partial nephrectomy. Specimen laterality: Left. Tumor Features: Tumor size: 2.5 cm. Tumor focality: Multifocal. Histologic type: Papillary renal cell carcinoma, type I. Histologic grade (Fuhrman nuclear grade): Fuhrman nuclear grade 2. Sarcomatoid features: Not identified. Macroscopic extent of tumor: Limited to kidney. Microscopic tumor extension: Tumor limited to kidney. Lymph Nodes: N/A. Margin Evaluation: Distance to closest margin: Cauterized parenchymal margin POSITIVE. Other margins: Peri-renal capsule margin negative. FINAL SURGICAL PATHOLOGY REPORT. Pathologic tumor staging descriptors: Primary tumor (pT): pT1a. Regional Lymph nodes (pN): pNX. Distant metastasis (pM): pMX. Margin status (R): R1, cauterized parenchymal margin POSITIVE. Pathologic stage: I. Pathologic findings in non-neoplastic kidney: Focal glomerulosclerosis, chronic inflammatory. cell infiltrate histologically similar to that seen in. patient's lymph node (small B-cell lymphoma). Additional pathologic findings: N/A.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
SPECIMENS: A. PERITONEAL IMPLANT. B. SMALL BOWEL IMPLANT. C. SIGMOID COLON. D. RECTAL DONUT. E. COLON DONUT. DIAGNOSIS: A. PERITONEAL IMPLANT: - POSITIVE FOR ADENOCARCINOMA. B. SMALL BOWEL IMPLANT: - POSITIVE FOR ADENOCARCINOMA. C. SIGMOID COLON, RESECTION: - CIRCUMFERENTIAL EXOPHYTIC ULCERATED MODERATELY DIFFERENTIATED INVASIVE. ADENOCARCINOMA OF SIGMOID COLON WITH FULL MUSCLE WALL THICKNESS INVASION,. EXTENSION TO SUBSEROSAL FAT WITH METASTASIS TO ONE OUT OF TWENTY FIVE. LYMPH NODES AND WITH PERICOLIC FAT TUMOR IMPLANTS. (1/25). - SIZE OF TUMOR 5 X 3.5 X 1.6 CM. - MARGINS OF RESECTION- NEGATIVE FOR TUMOR. D. RECTAL DONUT: - RING SEGMENT OF COLONIC TISSUE- NEGATIVE FOR TUMOR. E. COLON DONUT: - RING SEGMENT OF COLONIC TISSUE, NEGATIVE FOR TUMOR. COLORECTAL CANCER TEMPLATE. Specimen Type: Sigmoidectomy. Tumor Site: Sigmoid colon. Tumor Configuration: Exophytic (polypoid), infiltrative, ulcerating. Tumor Size: 5.0 x 3.5 x 1.6 cm. Histologic Type: adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Extent of Invasion: Lamina propria, submucosa, muscularis propria. Margins: Margins uninvolved by invasive carcinoma (proximal,. distal,. radial). Venous/Lymphatic Invasion: Present. Perineural Invasion: Absent. Additional Pathologic Findings: tubular adenoma. Extent of Resection: R0: Complete resection with grossly and. microscopically negative margins. Lymph Nodes: Positive (1/25). Implants: Present. EGFR Expression: na. Pathologic Stage: pT3 N1 Mx. NOTE: Nodular focus of tumor implant seen in slide #C13 and #C16. Small focus of tubular adenoma in association with carcinoma seen in slide. labelled #C 31. SPECIMEN(S): A. PERITONEAL IMPLANT B. SMALL BOWEL IMPLANT C. SIGMOID COLON D. RECTAL DONUT E. COLON DONUT. CLINICAL HISTORY: with carcinoma sigmoid colon. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA: Soft tissue, peritoneal implant, bx: - Metastatic poorly differentiated adenocarcinoma by. GROSS DESCRIPTION: A. PERITONEAL IMPLANT: Received fresh is a 1x0.8x0.7 cm. tan-red piece of tissue with tan-white solid cut surface. Half is. submitted for frozen section and the other half is submitted in cassette A2. B. SMALL BOWEL IMPLANT: Received fresh is one fragment of tan-pink soft tissue measuring 1x0.5x0.4 cm. The specimen is. submitted in toto in one cassette. C. SIGMOID COLON:RESECTION. Received in fresh state is a resected segment of sigmoid colon with attached indurated pericolic fat. measuring 17 cm in length. There is a firm, palpable mass with overlying indurated mesocolic fat in the. mid segment of the specimen, which when opened shows an ulcerated exophytic circumferential tumor. situated 10.5 cm and 9.0 cm from margins of resection. The tumor measures 5 X 3.5 X 1.6 cm. Cut. section shows a tan dirty white granular firm surface infiltrating the full thickness of the colonic wall. with extension into the subjacent adipose tissue. The remainder of the colonic mucosa shows. prominent mucosal fold with hyperemia. Approximately 25 lymph nodes are identified ranging in size. from 0.1 to 0.8 cm in diameter Multiple sections are submitted as follows: C1-C5: en bloc section of tumor with pericolic fat. C6-C7: sections from the resecte margins. C8-10-sections form tumor areathe colonic wall and area of tumor. C11-C24: sections from lymph nodes. C25-C31: additional more sections tumor and adjacent areas. D. RECTAL DONUT: Received in formalin is a piece of donut tissue measuring 2.5x1.8x0.8 cm. Specimen is bisected and. submitted in toto in cassette D1 and D2. E. COLON DONUT: Received in formalin is a donut shaped tissue measuring 2.0x1.7x0.6 cm. The specimen is bisected. and submitted in toto in cassette E1 and E2. Also included is a n umbrella shaped like metallic object (rod measures 3.0cm.in length and head. measures 3.0 cm in diameter.. Gross exam only.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage IV"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Extract the AJCC cancer stage from the text provided. Please output it as a JSON object, just generate the JSON object without explanations.
Clinical Diagnosis & History: Right renel tumor. Specimens Submitted: 1: SP: Kidney, Right, partial nephrectomy. DIAGNOSIS: 1. SP: Kidney, Right, partial nephrectomy. Tumor Type: Renal cell carcÃ­noma - Conventional (clear cell) type. with sarcometoid features (10%). Fuhrmen Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diemeter is 3.2 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: N/A. Surgical Margins: Free of tumor. Non-Neoplestic Kidney: Unremerkable. Adrenal Glend: Not Identified. Lymph Nodes: Not identified. Staging for ronal cell carcinomeloncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT I HAVE. REVIEWED ANO APPROVED THIS REPORT. Gross Description: The specimen is received fresh for frozen section consultation, labeled ""Right renal tumor, stitch marks deep margin"". It. consists of a partial nephrectomy specimen measuring 4.5 x 4.5 x 1.9 cm. A plece of irregular shaped flat fat atteched with. capsule surtace measuring 4.5 X 2,5 X 0.3 cm. The deep surgical margin is inked black. The capsular margin is inked yellow. The fat is inked green. Frozen section was performed on surgical margin. Tissue submitted for TPS. Gross photographs taken. A segment of normal kidney atteched with the specimen measuring 3.0 x 1.5 x 1.5 cm. The resection reveals a well-circumscribed. mass measuring 3.2 x 2.5 x 1.5 cm. The tumor eppears cystic with bright yellow and hemorrhagic cut surface. The cyst contains. clear fluid. The cystic wall is thick and partially calcified. The tumor protrudes from the renal capsule into the adjecent fatty. tissue, however there is no perinephric fat seen grossly. Summary of Sections: FSC-frozen section control. T - tumor. P - renal parenchyma. Summary of Sections: Part 1: SP: Kidney, Right, partial nephrectomy. Block. Sect. Site. PCs. 1. fsc. 1. 1. p. 1. 9. 9. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined ot the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: CONVENTIONALLICLEAR CELL RENAL CELL CARCINOMA, MARGIN CLEAR. PERMANENT DIAGNOSIS: SAME.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Identify the AJCC stage of the cancer based on the information in this text. Please output it as a JSON object, just generate the JSON object without explanations.
F. Facility: MD: Specimen(s) Received. 1. Parathyroid: Right Upper. 2. Parathyroid: Left lower parathyroid. 3. Lymph node: Left paratracheal node. 4. Thyroid: Total thyroid, stitch marks upper pole right lobe. Diagnosis. 1. No pathological diagnosis: Parathyroid (right upper) biopsy. 2. No pathological diagnosis: Parathyroid (left lower) biopsy. 3. Follicular nodular disease: Thyroid (left paratracheal region) biopsy. 4. Multifocal papillary carcinoma, dominant 2.6 cm, follicular variant, right: Thyroid. No pathological diagnosis: Lymph nodes, 3. No pathological diagnosis: Parathyroid, right x2, left. Total thyroidectomy specimen. Synoptic Data. Procedure: Total thyroidectomy. Fresh. Specimen Integrity: Intact. Specimen Size: Right lobe: 5.0 cm. 3.5 cm. 2.0 cm. Left lobe: 4.0 cm. 2.4 cm. 1.5 cm. Isthmus +/- pyramidal lobe: 3.4 cm. 2.3 cm. 1.0 cm. Specimen Weight: 24.2 g. Tumor Focality: Multifocal, bilateral. DOMINANT TUMOR. Tumor Laterality: Tumor Size: Greatest dimension: 2.6cm. Additional dimension: 2.4 cm. Additional dimension: 2.2 cm. Histologic Type: careinome folliqular variantive POrTSS, follicular varient = 1067,. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: Totally encapsulated. Tumor Capsular Invasion: Present, extent minimal. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. SECOND TUMOR. Tumor Laterality: Left lobe. Tumor Size: Greatest dimension: 0.1cm. Histologic Type: Papillary carcinoma, microcarcinoma (occult, small or. microscopic) variant. Follicular architecture. Classical cytomorphology. Histologic Grade: Not applicable. Margins: Margins uninvolved by carcinoma. Tumor Capsule: None. Tumor Capsular Invasion: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Extrathyroidal Extension: Not identified. TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT2: Tumor more than 2 cm, but not more than 4 cm, limited. to thyroid. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of regional lymph nodes examined: 3. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Adenomatoid nodule(s) or Nodular follicular disease. Parathyroid gland(s), within normal limits. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Clinical History. for qs. Gross Description. 1. The specimen labeled with the patient's name and as ""Right Upper"" contains a piece of. tissue that measures 0.3 X 0.2 x 0.05 cm. It is frozen for intraoperative consultation. 1A. frozen tissue resubmitted. 2. The specimen labeled with the patient's name and as ""Left Lower Parathyroid for QS"" contains. a piece of tissue that measures 0.4 x 0.2 x 0.1 cm. It is frozen for intraoperative consultation. 2A. frozen tissue resubmitted. 3. The specimen labelled with the patient's name and as ""Left Paratracheal Node"" consists of a. piece of brown tissue that measures 0.7 x 0.6 x 0.3 cm. 3A. submitted in toto. 4. The specimen labeled with the patient's name and as ""Total Thyroid, Stitch Marks Upper Pole. Right Lobe"" consists of a thyroid gland that is oriented with a suture and weighs 24.2 g. The right. lobe measures 5.0 cm SI x 3.5 cm ML x 2.0 cm AP, the left lobe measures 4.0 cm SI x 2.4 cm ML. x 1.5 cm AP and the isthmus measures 3.4 cm SI x 2.3 cm ML x 1.0 cm AP. The external. surfaces have fibrous adhesions. No parathyroid glands or lymph nodes are identified grossly. The external surface is painted with blue dye. The mid to lower right lobe contains a well. delineated nodule that measures 2.6 cm SI x 2.4 cm ML x 2.2 cm AP. The remainder of the. thyroid tissue is unremarkable. Sections of the nodule and normal tissue are stored frozen. The. remainder of the specimen is submitted in toto as follows: 4A-M right lobe, superior to inferior [E-F;G-H;J-K section bisected]. 4N-Q. isthmus. 4R-V. left lobe, superior to inferior. Quick Section Diagnosis. 1. Parathyroid: Right Upper QS: Parathyroid tissue identified. Surgeon informed at. 2. Parathyroid: Left lower parathyroid: Parathyroid tissue identified. Surgeon called at.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: PATIENT NBR: BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: PROCEDURE: SPHS. Patient is a year-old i. with left thyroid nodule, picked up on a. routine physical exam. Left thyroid nodule. Total thyroidectomy. PROCEDURE: SPGD. 1. ""Left level VI Lymph node"" Two, 0.4 cm diameter and 0.7 cm diameter. tan-red bits of tissue. Entirely submitted. 2 ""Total thyroid"" A 17.6 gram, 4.5 x 7.2 x 4.2 cm total thyroidectomy with. isthmus. The parenchyma is beefy-red-brown with a grossly lobulated. appearance. There is a single, 2.3 x 2.1 x 1.8 cm nodule within the left lower. lobe of the gland. This nodule approaches to within 0.2 cm of the inked. surface. This nodule is well-encapsulated and does not infiltrate the adjacent. unremarkable beefy red-brown parenchyma. The nodule is soft, fleshy pink-tan. and without areas of hemorrhage or necrosis. Left half of the specimen inked. black and right half of specimen inked blue and specimen serially sectioned. Representative sections submitted as follows: 2A.-C. Left lobe nodule with entire capsule. 2D. Isthmus. 2E.&F. Right lobe. PROCEDURE: SPDX. 1. Lymph node, left level VI, excision: Two of two Lymph nodes positive. for. metastatic carcinoma, consistent with papillary thryroid carcinoma. 2. Total thyroid, thyroidectomy: Papillary thyroid carcinoma, closely. approximating inked margin, in background of lymphocytic thyroiditis. 1,. the signing staff pathologist, have personally. examined and interpreted the slides from this case. END OF PREVIOUS DIAGNOSIS INQUIRY.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage I"" 
}"
"You are a deeply knowledgeable and intelligent pathology AI assistant, your primary task is to comprehend the pathology report, identify the cancer stage from the given report, and deliver responses strictly from a predefined set of options. Your outputs must be exclusively in JSON Object format. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Determine the AJCC stage of the cancer from this text. Please output it as a JSON object, just generate the JSON object without explanations.
P.32/33. TIAAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT AXILLARY, SENTINEL NODE #1, BIOPSY. ONE LYMPH NODE, POSITIVE FOR CARCINOMA (1/1) (SEE COMMENT). PART 2: BREAST, RIGHT,,MODIFIED RADICAL MASTECTOMY -. A, INVASIVE LOBULAR CARCINOMA. PLEOMORPHIC TYPE WITH FOCAL SIGNET CELLS. B. NOTTINGHAM GRADE II (TUBULE FORMATION- 3: NUCLEAR PLEOMORPHISM-3; MITOTIC ACTIVITY - 1;. TOTAL SCORE 7/9). C. THE INVASIVE CARCINOMAS ARE LOCATED AT THE 12 O'CLOCK AND 6 O'CLOCK POSITIONS. THE. INVASIVE TUMOR MEASURES 2.5 CM IN GREATEST DIMENSION (TUMOR IN 12 O'CLOCK, GROSS. MEASUREMENT). D. LOBULAR CARCINOMA IN SITU (LCIS), NUCLEAR GRADE 2-3, ADMIXED WITH INVASIVE CARCINOMA. E. RESECTION MARGINS ARE NEGATIVE FOR IN SITU AND INVASIVE CARCINOMA. F. LYMPHOVASCULAR INVASION IS NOT NOTED. G. NIPPLE AND SKIN ARE NEGATIVE FOR TUMOR. H. TWO OF 11 LYMPH NODES (2/11) ARE POSITIVE FOR CARCINOMA. I. MICROCALCIFICATIONS ARE ASSOCIATED WITH THE INVASIVE AND IN SITU CARCINOMA. J. FIBROCYSTIC CHANGES AND SCLEROSING ADENOSIS. K. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND. NEGATIVE FOR HER2/NEU, AS PER PREVIOUS PATHOLOGY REPORT. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Central subareolar. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 2.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 4.5 cm. TUMOR TYPE (invasive component): Infiltrating lobular carcinoma. HISTOLOGIC TYPE: Pleomorphic, Signet ring. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 7. Nottingham grade (1. 2. 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes. malignant zones. TUMOR TYPE, IN SITU: I.CIS, Percent of tumor occupied by in situ component: 30 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 3. LYMPH NODES EXAMINED: 12. METHOD(S) OF LYMPH NODE EXAMINATION: SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 15 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSIÃN: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are highly knowledgeable and intelligent pathology AI assistant. Your main responsibilty is to understand the patholgy report and extract the stage of the cancer from the pathology report provided and give an answer only from the set of options. You will only output it as a JSON Object and nothing else. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you determine the AJCC Stage of the cancer from the following text? Please output it as a JSON object, just generate the JSON object without explanations.
Diagnosis/ diagnoses: 1. Excised soft tissue (abdominal wall) with fibrosis and chronically granulating. inflammation. No sections of the rectal carcinoma described in (2) below. 2. Resected part of colon and rectosigmoid colon shows an ulcerated, rectal carcinoma. characterized histologically as a moderately differentiated colorectal. adenocarcinoma, extending to within 1.3 cm of the aboral resection margin, and. encircling the intestinal wall at a length of 6.5 cm, with necrotic tumor lesion. Invasive tumor spread within all intestinal wall layers, deep into the bordering. periproctic fatty tissue. The minimum distance from the tumor to the soft tissue. resection margin is 2 mm according to microscopy. Tumor-free oral and aboral resection margin as well as the intestine adherent to the. vaginal section and the uterus. Uterus with epidermoid glandular portio ectopy,. slightly chronic cervicitis, cystic atrophy of the corpus endometrium and individual. intramural leiomyomas. Sigmoid colon wall with individual pseudodiverticula and. chronic peridiverticulitis, tending toward scarring. All 38 periproctic and mesocolic lymph nodes are tumor-free, with non-. characteristic reactive lesions. Tumor stage therefore pT3, pNo, (0/38) LO V0; G2.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage II"" 
}"
"You are an expert and highly intelligent pathology AI assistant. Your chief responsibility involves interpreting the pathology report to determine the cancer stage and providing answers only from an established set of options, with responses formatted solely as JSON Objects. Here are the set of options - 
'Stage I','Stage II','Stage III', 'Stage IV'. You have to pick one these options without fail and you cannot print any other text. You as an assistant cannot lie.","Can you identify the AJCC Stage of the Cancer from the following Pathology Report? Please output it as a JSON objectWhat is the AJCC Stage of the cancer from this text? Please output it as a JSON object, just generate the JSON object without explanations.
Facility. Provider Status. Observation Date and Time. Component. SPECIMEN DESCRIPTION. (NOTE). Clinical History. Melanoma left eye. Final Pathologic Diagnosis. A. Eye, left, enucleation: Malignant melanoma, mixed cell type. Ciliary body involvement present. No extrascleral extension. See Synoptic Report. All controls show appropriate reactivity. The immunohistochemical and/or in situ hybridization tests reported here,. except for those addressing HER-2Neu overexpression, have been developed. and their performance characteristics determined by the. Immunohistochemistry and. have nor do they have FDA approval. id are not required to. The above diagnosis is based on my personal examination of the slides and,. if indicated, other material relevant to the case. I have reviewed and. approved this report prior to its release. Ophthalmologist. Synoptic Report. SYNOPTIC REPORT FOR UVEAL MELANOMA: Specimen type: E=enucleation. Laterality: L=left. Specimen size (mm) : For Enucleation. Anteroposterior diameter: 22.0. Horizontal diameter: 22.0. Vertical diameter: 24.0. Length of optic nerve: 0.0 (optic nerve cut flush against globe). Diameter of optic nerve: 4.0. Tumor site: superior anterior (10:00-1:00 o' clock) adjacent to ciliary. body. Tumor basal size on transillumination (mm) : 15.0x13.0. Tumor size after sectioning (mm) : Base at cut edge: 14.0. Greatest height: 9.0. Tumor location after sectioning: Distance from posterior margin of tumor base to edge of optic disc. (mm) : 19.0. Tumor extent (N=no, Y=yes, NA=not applicable) : Involvement of sclera: N. Involvement of vortex vein (s) : N. Involvement of optic disc: N. Involvement of vitreous N. Involvement of choroid: Y. Involvement of ciliary body: Y. Involvement of iris: N. Involvement of lens N. Involvement of anterior chamber: N. Involvement of extrascleral extension (anterior) : N. Involvement of extrascleral extension (posterior) : N. Involvement of Angle/SchlemmÂ¹ S canal: N. Involvement of optic nerve: N. Involvement of retina: N. Involvement of cornea: N. Growth pattern: S=solid. Histologic type: M=mixed (90% spindled, 10% epithelioid). Histologic grade (pGX-3) : pG2 mixed cell type. Margins (N=negative, P=positive, NA=not applicable) : Surgical margins N. Extrascleral extension: N. Regional lymph nodes (NA=not applicable). Number examined: 0. Number positive: NA. Number negative: NA. Additional pathologic findings: : Mitotic rate: 6 mitoses per 10 high power fields. Vascular invasion: Not present. Degree of pigmentation: Light. Inflammatory cells: Scattered intratumoral lymphocytes. Retinal detachment: Present. Invasion of Bruch' S membrane: Not identified. Hemorrhage: Not present. Immunostains: Ki-67 marker: 10%. Pathologic staging (pTNM) : pT3b pNX. Comments: >. Pathologic Staging Definitions (pTNM) : Primary Tumor (pT). Ciliary Body and Choroid. pT3b: Tumor size category 3 with ciliary body involvement. Regional Lymph Nodes (pN). pNX: Regional lymph nodes cannot be assessed. Distant Metastasis (pM). Not applicable - No pM reported if distant metastasis is unknown. The above synoptic report complies, in slightly modified form, with the. guidelines of the College of American Pathologists Protocols and the AJCC. Cancer Staging Manual, 7th edition, 2010, for the reporting of cancer. specimens. MICROSCOPIC: A microscopic examination of H&E and PAS stained slides was performed. SPECIMEN(S) RECEIVED: Eye, enucleation. GROSS DESCRIPTION: The specimen is received in one properly labeled container with the. patient' S name and accession number. A. The specimen is designated ""left eye"" and consists of a left. eye that is 2.2 cm horizontally, 2.4 cm vertically, and 2.2 cm from. anterior to posterior. Translumination of the specimen reveals a tumor. that is 1.5 x 1.3 cm in the superior anterior aspect of the globe. The. optic nerve is cut flush with the globe. Upon trisecting, the tan-gray. rubbery tumor is 1.4 x 1.3 x 0.9 cm. The tumor is present on the superior. anterior aspect of the globe adjacent to the ciliary body. The tumor is 1.9. cm from the optic nerve stump. No gross extrascleral extension is noted. Summary of Cassettes: A1-2, two horizontal cross sections including. entire tumor. Lab Use Only: Job ID. Gross description by: Patient Release Status: This result is not viewable by the patient. Patient Care Team. Relationship. Specialty. Notifications. Start. End. MD. Ophthalmology. MD. Ophthalmology. Dermatology. Ophthalmology. Family Medicine. MD. Procedures with Linked Chargeables. Chargeable. CPT Code. 88305. 88305. Facility. SURG PATH REQUEST (Order #. Authorizing: M.D. Department: Released By: Results. Incoming. Patient Demographics. Male. Office/Hospital Location. Allergies as of. No Known Allergies. Release Date/Time. Start Date/Time. End Date/Time.

 Options - 
 (A) Stage I 
 (B) Stage II 
 (C) Stage III 
 (D) Stage IV 
","{
 ""stage"": ""Stage III"" 
}"
